PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Denis, MM; Tolley, ND; Bunting, M; Schwertz, H; Jiang, HM; Lindemann, S; Yost, CC; Rubner, FJ; Albertine, KH; Swoboda, KJ; Fratto, CM; Tolley, E; Kraiss, LW; McIntyre, TM; Zimmerman, GA; Weyrich, AS				Denis, MM; Tolley, ND; Bunting, M; Schwertz, H; Jiang, HM; Lindemann, S; Yost, CC; Rubner, FJ; Albertine, KH; Swoboda, KJ; Fratto, CM; Tolley, E; Kraiss, LW; McIntyre, TM; Zimmerman, GA; Weyrich, AS			Escaping the nuclear confines: Signal-dependent Pre-mRNA splicing in anucleate platelets	CELL			English	Article							GENE-EXPRESSION; PROTEIN; U1; RIBONUCLEOPROTEIN; TRANSLATION; PARTICLES; BIRTH	Platelets are specialized hemostatic cells that circulate in the blood as anucleate cytoplasts. We report that platelets unexpectedly possess a functional spliceosome, a complex that processes pre-mRNAs in the nuclei of other cell types. Spliceosome components are present in the cytoplasm of human megakaryocytes and in proplatelets that extend from megakaryocytes. Primary human platelets also contain essential spliceosome factors including small nuclear RNAs, splicing proteins, and endogenous pre-mRNAs. In response to integrin engagement and surface receptor activation, platelets precisely excise introns from interleukin-1 beta pre-mRNA, yielding a mature message that is translated into protein. Signal-dependent splicing is a novel function of platelets that demonstrates remarkable specialization in the regulatory repertoire of this anucleate cell. While this mechanism may be unique to platelets, it also suggests previously unrecognized diversity regarding the functional roles of the spliceosome in eukaryotic cells.	Univ Utah, Eccles Inst Human Genet, Salt Lake City, UT 84112 USA; Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA; Univ Utah, Dept Neurol, Salt Lake City, UT 84112 USA; Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA; Univ Utah, Dept Pediat, Salt Lake City, UT 84112 USA; Univ Utah, Dept Surg, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Weyrich, AS (corresponding author), Univ Utah, Eccles Inst Human Genet, Salt Lake City, UT 84112 USA.	andy.weyrich@hmbg.utah.edu	Schwertz, Hansjorg/Q-3305-2019; Lindemann, Stephan/AAH-3888-2020	Weyrich, Andrew/0000-0001-9622-4647; Swoboda, Kathryn/0000-0002-4593-6342; Yost, Christian/0000-0002-1258-3595; Albertine, Kurt/0000-0001-8497-0861	NCRR NIH HHS [UL1 RR025764] Funding Source: Medline; NHLBI NIH HHS [R01 HL066277, HL-62875, R37 HL044525, R01 HL062875, HL-75507, HL-66277, R01 HL075507, R01 HL044525, R01 HL044513, HL-44525, HL-44513] Funding Source: Medline; NICHD NIH HHS [R01 HD054599] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD054599] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025764] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044525, R37HL044525, R01HL062875, R01HL044513, R01HL066277, R01HL075507] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Albertine KH, 1999, AM J RESP CRIT CARE, V159, P945, DOI 10.1164/ajrccm.159.3.9804027; Bahou WF, 2004, SEMIN THROMB HEMOST, V30, P473, DOI 10.1055/s-2004-833482; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blencowe BJ, 1998, GENE DEV, V12, P996, DOI 10.1101/gad.12.7.996; Brogren H, 2004, BLOOD, V104, P3943, DOI 10.1182/blood-2004-04-1439; Graveley BR, 2001, RNA, V7, P806, DOI 10.1017/S1355838201010317; Hartwig J, 2003, J THROMB HAEMOST, V1, P1580, DOI 10.1046/j.1538-7836.2003.00331.x; Hastings ML, 2001, CURR OPIN CELL BIOL, V13, P302, DOI 10.1016/S0955-0674(00)00212-X; Hato T., 2002, PLATELETS, P105; Italiano JE, 2003, J THROMB HAEMOST, V1, P1174, DOI 10.1046/j.1538-7836.2003.00290.x; Italiano JE, 1999, J CELL BIOL, V147, P1299, DOI 10.1083/jcb.147.6.1299; JARROUS N, 1994, J BIOL CHEM, V269, P23141; Kochetov AV, 1998, FEBS LETT, V440, P351, DOI 10.1016/S0014-5793(98)01482-3; KOHTZ JD, 1994, NATURE, V368, P119, DOI 10.1038/368119a0; KRAINER AR, 1988, NUCLEIC ACIDS RES, V16, P9415, DOI 10.1093/nar/16.20.9415; Lindemann S, 2001, J BIOL CHEM, V276, P33947, DOI 10.1074/jbc.M104281200; Lindemann S, 2001, J CELL BIOL, V154, P485, DOI 10.1083/jcb.200105058; Lindemann SW, 2004, P NATL ACAD SCI USA, V101, P7076, DOI 10.1073/pnas.0401901101; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; MANIATIS T, 1987, NATURE, V325, P673, DOI 10.1038/325673a0; Martin KC, 2004, CURR OPIN NEUROBIOL, V14, P305, DOI 10.1016/j.conb.2004.05.009; Matter N, 2002, NATURE, V420, P691, DOI 10.1038/nature01153; Mayeda A, 1999, METH MOL B, V118, P309; MCEVER RP, 1990, BLOOD CELLS, V16, P73; McRedmond JP, 2004, MOL CELL PROTEOMICS, V3, P133, DOI 10.1074/mcp.M300063-MCP200; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Ravid K, 2002, J CELL PHYSIOL, V190, P7, DOI 10.1002/jcp.10035; Reed R, 2001, NAT CELL BIOL, V3, pE201, DOI 10.1038/ncb0901-e201; ROMAC JMJ, 1994, MOL CELL BIOL, V14, P4662, DOI 10.1128/MCB.14.7.4662; RUBY SW, 1988, SCIENCE, V242, P1028, DOI 10.1126/science.2973660; Weyrich AS, 1996, J CLIN INVEST, V97, P1525, DOI 10.1172/JCI118575; Weyrich AS, 1998, P NATL ACAD SCI USA, V95, P5556, DOI 10.1073/pnas.95.10.5556; Weyrich AS, 2004, SEMIN THROMB HEMOST, V30, P491, DOI 10.1055/s-2004-833484; Weyrich AS, 2003, J THROMB HAEMOST, V1, P1897, DOI 10.1046/j.1538-7836.2003.00304.x; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; Xie JY, 2001, NATURE, V410, P936, DOI 10.1038/35073593; Yong JS, 2002, EMBO J, V21, P1188, DOI 10.1093/emboj/21.5.1188; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031; Zhou ZL, 2002, P NATL ACAD SCI USA, V99, P12203, DOI 10.1073/pnas.182427099	40	455	476	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 12	2005	122	3					379	391		10.1016/j.cell.2005.06.015	http://dx.doi.org/10.1016/j.cell.2005.06.015			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	955UZ	16096058	Green Accepted, Bronze			2022-12-01	WOS:000231254400010
J	Muller, P; Kuttenkeuler, D; Gesellchen, V; Zeidler, MP; Boutros, M				Muller, P; Kuttenkeuler, D; Gesellchen, V; Zeidler, MP; Boutros, M			Identification of JAK/STAT signalling components by genome-wide RNA interference	NATURE			English	Article							DROSOPHILA; PATHWAY; GENE; EXPRESSION; PROTEIN; KINASE; CELLS; TRANSCRIPTION; TRANSDUCTION; ACTIVATION	Signalling pathways mediating the transduction of information between cells are essential for development, cellular differentiation and homeostasis(1). Their dysregulation is also frequently associated with human malignancies. The Janus tyrosine kinase/ signal transducer and activator of transcription (JAK/STAT) pathway represents one such signalling cascade whose evolutionarily conserved roles include cell proliferation and haematopoiesis(2). Here we describe a systematic genome-wide survey for genes required for JAK/STAT pathway activity. Analysis of 20,026 RNA interference (RNAi)-induced phenotypes in cultured Drosophila melanogaster haemocyte-like cells identified interacting genes encoding 4 known and 86 previously uncharacterized proteins. Subsequently, cell-based epistasis experiments were used to classify these proteins on the basis of their interaction with known components of the signalling cascade. In addition to multiple human disease gene homologues, we have found the tyrosine phosphatase Ptp61F and the Drosophila homologue of BRWD3, a bromo-domain-containing protein disrupted in leukaemia(3). Moreover, in vivo analysis demonstrates that disrupted dBRWD3 and overexpressed Ptp61F function as suppressors of leukaemia-like blood cell tumours. This screen represents a comprehensive identification of novel loci required for JAK/STAT signalling and provides molecular insights into an important pathway relevant for human cancer. Human homologues of identified pathway modifiers may constitute targets for therapeutic interventions.	German Canc Res Ctr, D-69120 Heidelberg, Germany; Max Planck Inst Biophys Chem, Dept Mol Dev Biol, D-37077 Gottingen, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Max Planck Society	Zeidler, MP (corresponding author), German Canc Res Ctr, Neuenheimer Feld 580, D-69120 Heidelberg, Germany.	mzeidle@gwdg.de; m.boutros@dkfz.de	Zeidler, Martin/E-6209-2010; Boutros, Michael/C-3566-2008; Müller, Patrick/C-8096-2014	Boutros, Michael/0000-0002-9458-817X; Müller, Patrick/0000-0002-0702-6209; Zeidler, Martin/0000-0003-2942-1135				Bach EA, 2003, GENETICS, V165, P1149; Betz A, 2001, P NATL ACAD SCI USA, V98, P9563, DOI 10.1073/pnas.171302098; BINARI R, 1994, GENE DEV, V8, P300, DOI 10.1101/gad.8.3.300; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Brivanlou AH, 2002, SCIENCE, V295, P813, DOI 10.1126/science.1066355; Brown S, 2001, CURR BIOL, V11, P1700, DOI 10.1016/S0960-9822(01)00524-3; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Hannon GJ, 2004, NATURE, V431, P371, DOI 10.1038/nature02870; Harrison DA, 1998, GENE DEV, V12, P3252, DOI 10.1101/gad.12.20.3252; HARRISON DA, 1995, EMBO J, V14, P2857, DOI 10.1002/j.1460-2075.1995.tb07285.x; Hombria JCG, 2002, CURR BIOL, V12, pR569, DOI 10.1016/S0960-9822(02)01057-6; Hou XS, 1996, CELL, V84, P411, DOI 10.1016/S0092-8674(00)81286-6; Kalla C, 2005, GENE CHROMOSOME CANC, V42, P128, DOI 10.1002/gcc.20131; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Karsten P, 2002, MECH DEVELOP, V117, P343, DOI 10.1016/S0925-4773(02)00216-2; Kittler R, 2004, NATURE, V432, P1036, DOI 10.1038/nature03159; Kwon FJ, 2000, J BIOL CHEM, V275, P19824, DOI 10.1074/jbc.M001114200; Lagueux M, 2000, P NATL ACAD SCI USA, V97, P11427, DOI 10.1073/pnas.97.21.11427; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; LUO H, 1995, EMBO J, V14, P1412, DOI 10.1002/j.1460-2075.1995.tb07127.x; MCLAUGHLIN S, 1993, J BIOL CHEM, V268, P6839; Meister M, 2003, CELL MICROBIOL, V5, P573, DOI 10.1046/j.1462-5822.2003.00302.x; Mesilaty-Gross S, 1999, GENE, V231, P173, DOI 10.1016/S0378-1119(99)00053-0; Mukherjee T, 2005, ONCOGENE, V24, P2503, DOI 10.1038/sj.onc.1208487; O'Shea JJ, 2004, NAT REV DRUG DISCOV, V3, P555, DOI 10.1038/nrd1441; Sefton L, 2000, NATURE, V405, P970, DOI 10.1038/35016119; Spradling AC, 1999, GENETICS, V153, P135; Yan RQ, 1996, P NATL ACAD SCI USA, V93, P5842, DOI 10.1073/pnas.93.12.5842; Yan RQ, 1996, CELL, V84, P421, DOI 10.1016/S0092-8674(00)81287-8	30	224	234	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2005	436	7052					871	875		10.1038/nature03869	http://dx.doi.org/10.1038/nature03869			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953XG	16094372	Green Published			2022-12-01	WOS:000231116500051
J	Winch, PJ; Alam, MA; Akther, A; Afroz, D; Ali, NA; Ellis, AA; Baqui, AH; Darmstadt, GL; El Arifeen, S; Seraji, MHR				Winch, PJ; Alam, MA; Akther, A; Afroz, D; Ali, NA; Ellis, AA; Baqui, AH; Darmstadt, GL; El Arifeen, S; Seraji, MHR		Bangladesh PROJAHNMO Study Grp	Local understandings of vulnerability and protection during the neonatal period in Sylhet district, Bangladesh: a qualitative study	LANCET			English	Article							CARE-SEEKING; POPULAR THERAPEUTICS; CHILDHOOD DEATHS; RURAL BANGLADESH; PRETERM INFANTS; NEWBORN BABIES; SKIN BARRIER; HEALTH; INDIA; WOMEN	Background Understanding of local knowledge and practices relating to the newborn period, as locally defined, is needed in the development of interventions to reduce neonatal mortality. We describe the organisation of the neonatal period in Sylhet District, Bangladesh, the perceived threats to the well-being of neonates, and the ways in which families seek to protect them. Methods We did 39 in-depth, unstructured, qualitative interviews with mothers, fathers, and grandmothers of neonates, and traditional birth attendants. Data on neonatal knowledge and practices were also obtained from a household survey of 6050 women who had recently given birth. Findings Interviewees defined the neonatal period as the first 40 days of life (chollish din). Confinement of the mother and baby is most strongly observed before the noai ceremony on day 7 or 9, and involves restriction of movement outside the home, sleeping where the birth took place rather than in the mother's bedroom, and sleeping on a mat on the floor. Newborns are seen as vulnerable to cold air, cold food or drinks (either directly or indirectly through the mother), and to malevolent spirits or evil eye. Bathing, skin care, confinement, and dietary practices all aim to reduce exposure to cold, but some of these practices might increase the risk of hypothermia. Interpretation Although fatalism and cultural acceptance of high mortality have been cited as reasons for high levels of neonatal mortality, Sylheti families seek to protect newborns in several ways. These actions reflect a set of assumptions about the newborn period that differ from those of neonatal health specialists, and have implications for the design of interventions for neonatal care.	Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Social & Behav Intervent Program, Baltimore, MD 21205 USA; Project Adv Hlth Newborns & Mothers, Sylhet, Bangladesh; ICDDR B, Ctr Hlth & Populat Res, Dhaka, Bangladesh; Save Children USA, Saving Newborn Lives, Washington, DC USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; International Centre for Diarrhoeal Disease Research (ICDDR); Save the Children	Winch, PJ (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Social & Behav Intervent Program, Room E5030,615 N Wolfe St, Baltimore, MD 21205 USA.	pwinch@jhsph.edu	Darmstadt, Gary/AAU-7488-2020	Darmstadt, Gary/0000-0002-7522-5824; Arifeen, Shams/0000-0002-5372-5932; Alam, Neeloy Ashraful/0000-0001-7034-1095				Afsana K, 2000, DISCOURSING BIRTHING; Ahmed S, 2001, J TROP PEDIATRICS, V47, P98, DOI 10.1093/tropej/47.2.98; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; BANG AT, 1994, B WORLD HEALTH ORGAN, V72, P897; Baqui AH, 1998, B WORLD HEALTH ORGAN, V76, P161; Baqui AH, 2001, ACTA PAEDIATR, V90, P682, DOI 10.1080/080352501750258775; Bell C., 1997, RITUAL PERSPECTIVES; BERLAND J, 2000, CULTURE CREATION PRO, P157; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; CARTER AT, 1982, CONCEPTS PERSON KINS, P118, DOI DOI 10.1525/AA.1984.86.4.02A00190; Cecil R., 1996, ANTHR PREGNANCY LOSS; COMAROFF J, 1977, MED ENCOUNTERS EXPER, P115; Cosminsky Sheila, 1994, ETHNOGRAPHY FERTILIT, P195; Darmstadt GL, 2005, LANCET, V365, P1039, DOI 10.1016/S0140-6736(05)74228-8; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Darmstadt GL, 2004, PEDIATR INFECT DIS J, V23, P719, DOI 10.1097/01.inf.0000133047.50836.6f; Darmstadt GL, 2002, ACTA PAEDIATR, V91, P546, DOI 10.1080/080352502753711678; Davis-Floyd Robbie E, 1997, CHILDBIRTH AUTHORITA; de Souza ACT, 2000, SOC SCI MED, V51, P1675, DOI 10.1016/S0277-9536(00)00100-3; De Zoysa I, 1998, SOC SCI MED, V47, P2101, DOI 10.1016/S0277-9536(98)00275-5; DeLoache Judy, 2000, WORLD BABIES IMAGINE; Dundes L., 2003, MANNER BORN BIRTH RI; Fikree FF, 2005, SOC SCI MED, V60, P911, DOI 10.1016/j.socscimed.2004.06.034; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.1353/dem.2001.0003; GIDEON TEC, 1962, AM ANTHROPOL, V64, P1220; GOODBURN EA, 1995, STUD FAMILY PLANN, V26, P22, DOI 10.2307/2138048; Gottlieb Alma, 2004, AFTERLIFE IS WE COME; Hart Don V., 1965, SE ASIAN BIRTH CUSTO; Jeffery PM, 1985, CONTAMINATING STATES; JEFFERY PM, 1989, LABOUR PAINS LAOUR P; Jeffery R., 1993, KNOWLEDGE POWER PRAC, P7; Kay Margarita Artschwager, 1982, ANTHR HUMAN BIRTH; KITZINGER S, 1994, ETHNOGRAPHY FERTILIT, P171; Knippenberg R, 2005, LANCET, V365, P1087, DOI 10.1016/S0140-6736(05)74233-1; LADERMAN C, 1987, SOC SCI MED, V25, P357, DOI 10.1016/0277-9536(87)90274-7; Laderman Carol, 1983, WIVES MIDWIVES CHILD; LAMBERT H, 1992, SOC SCI MED, V34, P1069, DOI 10.1016/0277-9536(92)90280-4; Lambert H, 1996, LANCET, V348, P1706, DOI 10.1016/S0140-6736(96)07135-8; Lambert Helen, 2000, CULTURES RELATEDNESS, P73; LANCHET T, 1984, WOMEN POLLUTION MARG; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2004, LANCET, V364, P399, DOI 10.1016/S0140-6736(04)16783-4; LAYNE L.L., 2003, MOTHERHOOD LOST; MACCORMACK CP, 1994, ETHNOGRAPHY FERTILIT; Mahon-Daly P, 2002, HEALTH PLACE, V8, P61, DOI 10.1016/S1353-8292(01)00026-0; MANDERSON L, 1981, SOC SCI MED-MED ANTH, V15, P509, DOI 10.1016/0160-7987(81)90025-9; Marsh David R, 2002, J Perinatol, V22, P572, DOI 10.1038/sj.jp.7210793; MCCLAIN CS, 1975, ANTHR Q, V40, P38; McGilvray Dennis B., 1994, ETHNOGRAPHY FERTILIT, P15; Niang C.I., 2004, FORMATIVE RES PERINE; NICHTER M, 1983, HUM ORGAN, V42, P235, DOI 10.17730/humo.42.3.43081445235366lk; NICHTER M, 1987, SOC SCI MED, V25, P377, DOI 10.1016/0277-9536(87)90276-0; REISSLAND N, 1987, SOC SCI MED, V25, P231, DOI 10.1016/0277-9536(87)90226-7; REISSLAND N, 1988, SOC SCI MED, V27, P461, DOI 10.1016/0277-9536(88)90369-3; Rice PL, 2000, MIDWIFERY, V16, P22, DOI 10.1054/midw.1999.0180; Rice PL, 2000, EARLY HUM DEV, V57, P189, DOI 10.1016/S0378-3782(99)00062-6; RICE PL, 1994, MED J AUSTRALIA, V160, P577, DOI 10.5694/j.1326-5377.1994.tb138351.x; Romney A. Kimball, 1963, 6 CULTURES STUDIES C, P541; Sesia PM, 1996, MED ANTHROPOL Q, V10, P121, DOI 10.1525/maq.1996.10.2.02a00020; Subbarayappa BV, 1997, LANCET, V350, P1841, DOI 10.1016/S0140-6736(97)04223-2; SUTRISNA B, 1993, LANCET, V342, P787, DOI 10.1016/0140-6736(93)91545-W; THOMPSON C, 1985, SOC SCI MED, V21, P701, DOI 10.1016/0277-9536(85)90210-2; Turner V., 1969, RITUAL PROCESS STRUC, V94, P125; Van Gennep A., 1960, RITES PASSAGE; VanHollen C, 2003, BIRTH ON THE THRESHOLD: CHILDBIRTH AND MODERNITY IN SOUTH INDIA, P1	65	136	136	0	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 6	2005	366	9484					478	485		10.1016/S0140-6736(05)66836-5	http://dx.doi.org/10.1016/S0140-6736(05)66836-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	952RD	16084256				2022-12-01	WOS:000231022300029
J	Niessing, J; Ebisch, B; Schmidt, KE; Niessing, M; Singer, W; Galuske, RAW				Niessing, J; Ebisch, B; Schmidt, KE; Niessing, M; Singer, W; Galuske, RAW			Hemodynamic signals correlate tightly with synchronized gamma oscillations	SCIENCE			English	Article							OPTICAL INTRINSIC SIGNALS; VISUAL-CORTEX; NEURONAL-ACTIVITY; MODULATION; ATTENTION; FMRI; MECHANISMS; PATHWAYS; PATTERNS; AROUSAL	Functional imaging methods monitor neural activity by measuring hemodynamic signals. These are more closely related to local field potentials (LFPs) than to action potentials. We simultaneously recorded electrical and hemodynamic responses in the cat visual cortex. Increasing stimulus strength enhanced spiking activity, high-frequency LFP oscillations, and hemodynamic responses. With constant stimulus intensity, the hemodynamic response fluctuated; these fluctuations were only loosely related to action potential frequency but tightly correlated to the power of LFP oscillations in the gamma range. These oscillations increase with the synchrony of synaptic events, which suggests a close correlation between hemodynamic responses and neuronal synchronization.	Max Planck Inst Brain Res, D-60528 Frankfurt, Germany; Tech Univ Darmstadt, Dept Biol, D-64238 Darmstadt, Germany	Max Planck Society; Technical University of Darmstadt	Galuske, RAW (corresponding author), Max Planck Inst Brain Res, D-60528 Frankfurt, Germany.	gatuske@mpih-frankfurt.mpg.de	Singer, Wolf/D-6874-2012; anand, amit/A-7222-2009					Arthurs OJ, 2002, TRENDS NEUROSCI, V25, P27, DOI 10.1016/S0166-2236(00)01995-0; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Azouz R, 1999, J NEUROSCI, V19, P2209; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Cauli B, 2004, J NEUROSCI, V24, P8940, DOI 10.1523/JNEUROSCI.3065-04.2004; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; Herculano-Houzel S, 1999, J NEUROSCI, V19, P3992; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Kayser C, 2004, CEREB CORTEX, V14, P881, DOI 10.1093/cercor/bhh047; Kosslyn SM, 2001, NAT REV NEUROSCI, V2, P635, DOI 10.1038/35090055; Lauritzen M, 2005, NAT REV NEUROSCI, V6, P77, DOI 10.1038/nrn1589; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Mathiesen C, 1998, J PHYSIOL-LONDON, V512, P555, DOI 10.1111/j.1469-7793.1998.555be.x; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; MITZDORF U, 1978, EXP BRAIN RES, V33, P371; Muller MM, 2000, INT J PSYCHOPHYSIOL, V38, P283, DOI 10.1016/s0167-8760(00)00171-9; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Pouratian N, 2002, MAGN RESON MED, V47, P766, DOI 10.1002/mrm.10096; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; Rodriguez R, 2004, J NEUROSCI, V24, P10369, DOI 10.1523/JNEUROSCI.1839-04.2004; Schmidt KE, 2004, J NEUROPHYSIOL, V91, P1661, DOI 10.1152/jn.00878.2003; Sheth S, 2003, NEUROIMAGE, V19, P884, DOI 10.1016/S1053-8119(03)00086-7; Smith AJ, 2002, P NATL ACAD SCI USA, V99, P10765, DOI 10.1073/pnas.132272199; Steriade M, 1996, SCIENCE, V272, P225, DOI 10.1126/science.272.5259.225; Tallon-Baudry C, 2003, J PHYSIOL-PARIS, V97, P355, DOI 10.1016/j.jphysparis.2003.09.009; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; VALTSCHANOFF JG, 1993, NEUROSCI LETT, V157, P157, DOI 10.1016/0304-3940(93)90726-2; Volgushev M, 1998, NEUROSCIENCE, V83, P15, DOI 10.1016/S0306-4522(97)00380-1; Williams BR, 2003, RRD CANCER, V5, P101	31	599	611	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2005	309	5736					948	951		10.1126/science.1110948	http://dx.doi.org/10.1126/science.1110948			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953SS	16081740				2022-12-01	WOS:000231101400051
J	Picollo, A; Pusch, M				Picollo, A; Pusch, M			Chloride/proton antiporter activity of mammalian CLC proteins ClC-4 and ClC-5	NATURE			English	Article							DENTS-DISEASE; CHANNEL; ACIDIFICATION; ENDOCYTOSIS; DISRUPTION; ENDOSOMES; INHIBITOR; VESICLES; FUSION; CELLS	ClC-4 and ClC-5 are members of the CLC gene family(1), with ClC-5 mutated in Dent's disease(2), a nephropathy associated with low-molecular-mass proteinuria and eventual renal failure. ClC-5 has been proposed to be an electrically shunting Cl- channel in early endosomes, facilitating intraluminal acidification(3,4). Motivated by the discovery that certain bacterial CLC proteins are secondary active Cl-/H+ antiporters(5), we hypothesized that mammalian CLC proteins might not be classical Cl- ion channels but might exhibit Cl-- coupled proton transport activity. Here we report that ClC-4 and ClC-5 carry a substantial amount of protons across the plasma membrane when activated by positive voltages, as revealed by measurements of pH close to the cell surface. Both proteins are able to extrude protons against their electrochemical gradient, demonstrating secondary active transport. H+, but not Cl-, transport was abolished when a pore glutamate was mutated to alanine (E211A). ClC-0, ClC-2 and ClC-Ka proteins showed no significant proton transport. The muscle channel ClC-1 exhibited a small H+ transport that might be physiologically relevant. For ClC-5, we estimated that Cl- and H+ transport contribute about equally to the total charge movement, raising the possibility that the coupled Cl-/H+ transport of ClC-4 and ClC-5 is of significant magnitude in vivo.	CNR, Ist Biofis, I-16149 Genoa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR)	Pusch, M (corresponding author), CNR, Ist Biofis, Via Marini 6, I-16149 Genoa, Italy.	pusch@ge.ibf.cnr.it	Picollo, Alessandra/AAC-7529-2022; Picollo, Alessandra/G-1709-2014; Picollo, Alessandra/O-1696-2016	Picollo, Alessandra/0000-0003-2980-7951; Pusch, Michael/0000-0002-8644-8847	Telethon [GGP04018] Funding Source: Medline	Telethon(Fondazione Telethon)		Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; BAUER CK, 1991, P NATL ACAD SCI USA, V88, P11052, DOI 10.1073/pnas.88.24.11052; Bayer MJ, 2003, J CELL BIOL, V162, P211, DOI 10.1083/jcb.200212004; Chandy G, 2001, AM J PHYSIOL-CELL PH, V281, pC908, DOI 10.1152/ajpcell.2001.281.3.C908; Chen TY, 2005, ANNU REV PHYSIOL, V67, P809, DOI 10.1146/annurev.physiol.67.032003.153012; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Estevez R, 2003, NEURON, V38, P47, DOI 10.1016/S0896-6273(03)00168-5; Estevez R, 2001, NATURE, V414, P558, DOI 10.1038/35107099; Friedrich T, 1999, J BIOL CHEM, V274, P896, DOI 10.1074/jbc.274.2.896; GRUNDER S, 1992, NATURE, V360, P759, DOI 10.1038/360759a0; Hara-Chikuma M, 2005, J BIOL CHEM, V280, P1241, DOI 10.1074/jbc.M407030200; Hara-Chikuma M, 2005, BIOCHEM BIOPH RES CO, V329, P941, DOI 10.1016/j.bbrc.2005.02.060; Hebeisen S, 2003, BIOPHYS J, V84, P2306, DOI 10.1016/S0006-3495(03)75036-X; Holroyd C, 1999, MOL BIOL CELL, V10, P3035, DOI 10.1091/mbc.10.9.3035; Jentsch TJ, 2005, ANNU REV PHYSIOL, V67, P779, DOI 10.1146/annurev.physiol.67.032003.153245; JURMAN ME, 1994, BIOTECHNIQUES, V17, P876; Li XH, 2000, J BIOL CHEM, V275, P35994, DOI 10.1074/jbc.M002712200; Lin YW, 1999, J GEN PHYSIOL, V114, P1, DOI 10.1085/jgp.114.1.1; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; MILLER C, 1982, PHILOS T ROY SOC B, V299, P401, DOI 10.1098/rstb.1982.0140; Piwon N, 2000, NATURE, V408, P369, DOI 10.1038/35042597; Saviane C, 1999, J GEN PHYSIOL, V113, P457, DOI 10.1085/jgp.113.3.457; Steinmeyer K, 1995, J BIOL CHEM, V270, P31172, DOI 10.1074/jbc.270.52.31172; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; Traverso S, 2003, J GEN PHYSIOL, V122, P295, DOI 10.1085/jgp.200308784; TSAI TD, 1995, AM J PHYSIOL-CELL PH, V268, pC1173, DOI 10.1152/ajpcell.1995.268.5.C1173; VANDYKE RW, 1994, AM J PHYSIOL, V266, pC81, DOI 10.1152/ajpcell.1994.266.1.C81; Wang SS, 2000, HUM MOL GENET, V9, P2937, DOI 10.1093/hmg/9.20.2937; Weinreich F, 2001, J BIOL CHEM, V276, P2347, DOI 10.1074/jbc.M005733200	30	370	385	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2005	436	7049					420	423		10.1038/nature03720	http://dx.doi.org/10.1038/nature03720			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	16034421				2022-12-01	WOS:000230623400048
J	Blais, JM; Kimpe, LE; McMahon, D; Keatley, BE; Mattory, ML; Douglas, MSV; Smol, JP				Blais, JM; Kimpe, LE; McMahon, D; Keatley, BE; Mattory, ML; Douglas, MSV; Smol, JP			Arctic seabirds transport marine-derived contaminants	SCIENCE			English	Article							POLLUTANTS; SALMON; LAKE		Univ Ottawa, Dept Biol, Ctr Adv Res Environm Genom, Ottawa, ON K1N 6N5, Canada; Queens Univ, Dept Biol, Paleoecol Environm Assessment & Res Lab, Kingston, ON K7L 3N6, Canada; Environm Canada, Canadian Wildlife Serv, Iqaluit, NU X0A 0H0, Canada; Univ Toronto, Dept Geol, Toronto, ON M5S 3B1, Canada	University of Ottawa; Queens University - Canada; Environment & Climate Change Canada; Canadian Wildlife Service; University of Toronto	Blais, JM (corresponding author), Univ Ottawa, Dept Biol, Ctr Adv Res Environm Genom, Ottawa, ON K1N 6N5, Canada.	jblais@science.uottawa.ca	Blais, Jules/AAV-2321-2020; Bond, Alexander L/A-3786-2010; Smol, John P/A-8838-2015	Blais, Jules/0000-0002-7188-3598; Smol, John/0000-0002-2499-6696				Evenset A, 2004, SCI TOTAL ENVIRON, V318, P125, DOI 10.1016/S0048-9697(03)00365-6; Ewald G, 1998, ARCTIC, V51, P40; HOBSON KA, 1993, MAR ECOL PROG SER, V95, P7, DOI 10.3354/meps095007; Kendall C, 1998, ISOTOPE TRACERS IN CATCHMENT HYDROLOGY, P519; Krummel EM, 2003, NATURE, V425, P255, DOI 10.1038/425255a; Mallory M.L., 2004, 109 CAN WILDL SERV	6	190	199	2	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 15	2005	309	5733					445	445		10.1126/science.1112658	http://dx.doi.org/10.1126/science.1112658			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946LY	16020729				2022-12-01	WOS:000230574900039
J	Bastien, GJ; Schepens, B; Willems, PA; Heglund, NC				Bastien, GJ; Schepens, B; Willems, PA; Heglund, NC			Energetics of load carrying in Nepalese porters	SCIENCE			English	Article							HUMAN WALKING; COST		Catholic Univ Louvain, Fac Med, Unite Physiol & Biomecan Locomot, B-3000 Louvain, Belgium	Universite Catholique Louvain	Heglund, NC (corresponding author), Catholic Univ Louvain, Fac Med, Unite Physiol & Biomecan Locomot, B-3000 Louvain, Belgium.	norman.heglund@loco.ucl.ac.be						Bastien GJ, 2005, EUR J APPL PHYSIOL, V94, P76, DOI 10.1007/s00421-004-1286-z; Cavagna GA, 2002, J EXP BIOL, V205, P3413; HEGLUND NC, 1995, NATURE, V375, P52, DOI 10.1038/375052a0; MALOIY GMO, 1986, NATURE, V319, P668, DOI 10.1038/319668a0	4	68	69	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2005	308	5729					1755	1755		10.1126/science.1111513	http://dx.doi.org/10.1126/science.1111513			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937LY	15961662				2022-12-01	WOS:000229926800044
J	Sangrithi, MN; Bernal, JA; Madine, M; Philpott, A; Lee, J; Dunphy, WG; Venkitaraman, AR				Sangrithi, MN; Bernal, JA; Madine, M; Philpott, A; Lee, J; Dunphy, WG; Venkitaraman, AR			Initiation of DNA replication requires the RECQL4 protein mutated in Rothmund-Thomson syndrome	CELL			English	Article							SISTER-CHROMATID COHESION; S-PHASE; WERNER-SYNDROME; FISSION YEAST; HELICASE; PHOSPHORYLATION; COMPLEX; BRCA2; CDC45; RECOMBINATION	How the replication machinery is loaded at origins of DNA replication is poorly understood. Here, we implicate in this process the Xenopus laevis homolog (xRTS) of the RECOL4 helicase mutated in Rothmund-Thomson syndrome. xRTS, which bears homology to the yeast replication factors SId2/DRC1, is essential for DNA replication in egg extracts. xRTS can be replaced in extracts by its human homolog, while RECOL4 depletion from mammalian cells induces proliferation failure, suggesting an evolutionarily conserved function. xRTS accumulates on chromatin during replication initiation, after prereplication-complex (pre-RC) proteins, Cut5, SId5, or Cdc45 but before replicative polymerases. xRTS depletion suppresses the loading of RPA, the ssDNA binding protein that marks unwound origins before polymerase recruitment. However, xRTS is unaffected by xRPA depletion. Thus, xRTS functions after pre-RC formation to promote loading of replication factors at origins, a previously unrecognized activity necessary for initiation. This role connects defective replication initiation to a chromosome-fragility disorder.	Univ Cambridge, Canc Res UK Dept Oncol, Cambridge CB2 2XZ, England; Hutchison MRC Res Ctr, MRC, Canc Cell Unit, Cambridge CB2 2XZ, England; CALTECH, Div Biol, Pasadena, CA 91125 USA	Cancer Research UK; University of Cambridge; California Institute of Technology	Venkitaraman, AR (corresponding author), Univ Cambridge, Canc Res UK Dept Oncol, Hills Rd, Cambridge CB2 2XZ, England.	arv22@cam.ac.uk	Bernal, Juan A/N-4544-2014	Bernal, Juan A/0000-0002-9933-5550; Sangrithi, Mahesh/0000-0002-0008-4588; Philpott, Anna/0000-0003-3789-2463	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070891] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM070891] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CHEN JJ, 1995, NATURE, V374, P386, DOI 10.1038/374386a0; COX LS, 1990, J CELL SCI, V97, P177; Davies SL, 2004, MOL CELL BIOL, V24, P1279, DOI 10.1128/MCB.24.3.1279-1291.2004; Ellis NA, 1997, CURR OPIN GENET DEV, V7, P354, DOI 10.1016/S0959-437X(97)80149-9; Hashimoto Y, 2003, EMBO J, V22, P2526, DOI 10.1093/emboj/cdg238; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Hoki Y, 2003, HUM MOL GENET, V12, P2293, DOI 10.1093/hmg/ddg254; Ichikawa Koji, 2002, Nihon Yakurigaku Zasshi, V119, P219; JENKINS TM, 1992, SCIENCE, V258, P475, DOI 10.1126/science.1411545; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; Kitao S, 1998, GENOMICS, V54, P443, DOI 10.1006/geno.1998.5595; Kubota Y, 2003, GENE DEV, V17, P1141, DOI 10.1101/gad.1070003; Laskey RA, 2003, EMBO REP, V4, P26, DOI 10.1038/sj.embor.embor706; Lee H, 1999, MOL CELL, V4, P1, DOI 10.1016/S1097-2765(00)80182-3; Li WH, 2004, J CELL BIOL, V165, P801, DOI 10.1083/jcb.200402095; Liao SR, 2000, GENE DEV, V14, P2570, DOI 10.1101/gad.822400; Lindor NM, 2000, AM J MED GENET, V90, P223, DOI 10.1002/(SICI)1096-8628(20000131)90:3<223::AID-AJMG7>3.0.CO;2-Z; Lomonosov M, 2003, GENE DEV, V17, P3017, DOI 10.1101/gad.279003; Mann MB, 2005, HUM MOL GENET, V14, P813, DOI 10.1093/hmg/ddi075; Masumoto H, 2002, NATURE, V415, P651, DOI 10.1038/nature713; MECHALI M, 1982, CELL, V30, P93, DOI 10.1016/0092-8674(82)90015-0; MILLS AD, 1989, J CELL SCI, V94, P471; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Noguchi E, 2002, CURR BIOL, V12, P599, DOI 10.1016/S0960-9822(02)00739-X; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Pichierri P, 2001, MOL BIOL CELL, V12, P2412, DOI 10.1091/mbc.12.8.2412; Prince PR, 2001, GENE DEV, V15, P933, DOI 10.1101/gad.877001; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Saintigny Y, 2002, MOL CELL BIOL, V22, P6971, DOI 10.1128/MCB.22.20.6971-6978.2002; Siitonen HA, 2003, HUM MOL GENET, V12, P2837, DOI 10.1093/hmg/ddg306; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Tanaka K, 2000, MOL CELL BIOL, V20, P3459, DOI 10.1128/MCB.20.10.3459-3469.2000; Toth A, 1999, GENE DEV, V13, P320, DOI 10.1101/gad.13.3.320; VENNOS EM, 1995, DERMATOL CLIN, V13, P143, DOI 10.1016/S0733-8635(18)30117-7; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Wang H, 1999, P NATL ACAD SCI USA, V96, P3824, DOI 10.1073/pnas.96.7.3824; Wohlschlegel JA, 2002, MOL CELL, V9, P233, DOI 10.1016/S1097-2765(02)00456-2; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Yin JH, 2004, HUM MOL GENET, V13, P2421, DOI 10.1093/hmg/ddh269; Zou L, 2000, MOL CELL BIOL, V20, P3086, DOI 10.1128/MCB.20.9.3086-3096.2000	41	215	218	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 17	2005	121	6					887	898		10.1016/j.cell.2005.05.015	http://dx.doi.org/10.1016/j.cell.2005.05.015			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	938NX	15960976	Bronze			2022-12-01	WOS:000230011200011
J	Metzger, E; Wissmann, M; Yin, N; Muller, JM; Schneider, R; Peters, AHFM; Gunther, T; Buettner, R; Schule, R				Metzger, E; Wissmann, M; Yin, N; Muller, JM; Schneider, R; Peters, AHFM; Gunther, T; Buettner, R; Schule, R			LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription	NATURE			English	Article							COMPLEX; COACTIVATOR; FHL2	Gene regulation in eukaryotes requires the coordinate interaction of chromatin-modulating proteins with specific transcription factors such as the androgen receptor(1). Gene activation and repression is specifically regulated by histone methylation status at distinct lysine residues(2). Here we show that lysine-specific demethylase 1 (LSD1; also known as BHC110)(3) co-localizes with the androgen receptor in normal human prostate and prostate tumour. LSD1 interacts with androgen receptor in vitro and in vivo, and stimulates androgen-receptor-dependent transcription. Conversely, knockdown of LSD1 protein levels abrogates androgen-induced transcriptional activation and cell proliferation. Chromatin immunoprecipitation analyses demonstrate that androgen receptor and LSD1 form chromatin-associated complexes in a ligand-dependent manner. LSD1 relieves repressive histone marks by demethylation of histone H3 at lysine 9 (H3-K9), thereby leading to de-repression of androgen receptor target genes. Furthermore, we identify pargyline as an inhibitor of LSD1. Pargyline blocks demethylation of H3-K9 by LSD1 and consequently androgen-receptor-dependent transcription. Thus, modulation of LSD1 activity offers a new strategy to regulate androgen receptor functions. Here, we link demethylation of a repressive histone mark with androgen-receptor-dependent gene activation, thus providing a mechanism by which demethylases control specific gene expression.	Univ Freiburg Klinikum, Univ Frauenklin, D-79106 Freiburg, Germany; Univ Freiburg Klinikum, Zentrum Klin Forsch, D-79106 Freiburg, Germany; Max Planck Inst Immunbiol, D-79108 Freiburg, Germany; Novartis Res Fdn, Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; Univ Klinikum Bonn, Inst Pathol, D-53127 Bonn, Germany	University of Freiburg; University of Freiburg; Max Planck Society; Friedrich Miescher Institute for Biomedical Research; Novartis; University of Bonn	Schule, R (corresponding author), Univ Freiburg Klinikum, Univ Frauenklin, Breisacherstr 66, D-79106 Freiburg, Germany.	roland.schuele@uniklinik-freiburg.de		Peters, Antoine/0000-0002-0311-1887; Gunther, Thomas/0000-0003-3903-9490				Eimer S, 2002, EMBO J, V21, P5787, DOI 10.1093/emboj/cdf561; Glass CK, 2000, GENE DEV, V14, P121; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Hakimi MA, 2003, J BIOL CHEM, V278, P7234, DOI 10.1074/jbc.M208992200; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; Metzger E, 2003, EMBO J, V22, P270, DOI 10.1093/emboj/cdg023; Muller JM, 2000, EMBO J, V19, P359, DOI 10.1093/emboj/19.3.359; Muller JM, 2002, EMBO J, V21, P736, DOI 10.1093/emboj/21.4.736; ONEILL TE, 1992, J MOL BIOL, V223, P67, DOI 10.1016/0022-2836(92)90716-W; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Shatkina L, 2003, MOL CELL BIOL, V23, P7189, DOI 10.1128/MCB.23.20.7189-7197.2003; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003	16	1268	1393	8	131	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2005	437	7057					436	439		10.1038/nature04020	http://dx.doi.org/10.1038/nature04020			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964AS	16079795				2022-12-01	WOS:000231849100059
J	Wolfe, CDA; Smeeton, NC; Coshall, C; Tilling, K; Rudd, AG				Wolfe, CDA; Smeeton, NC; Coshall, C; Tilling, K; Rudd, AG			Survival differences after stroke in a multiethnic population: follow-up study with the south London stroke register	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIALS; PUBLICATION BIAS; ETHNIC-DIFFERENCES; PHARMACEUTICAL-INDUSTRY; CLINICAL-RESEARCH; ISCHEMIC-STROKE; RISK-FACTORS; ABSTRACTS; MORTALITY; BLACKS	Objectives To identify ethnic differences in survival after stroke and examine the factors that influence survival. Design Population based stroke register with follow-up. Settings South London stroke register. Participants 2321 patients with first stroke registered between January 1995 and December 2002. Main outcome measures Sociodemographic factors, risk factors for stroke and their management, severity of stroke, and acute service provision factors. Survival analysis with Kaplan-Meier curves, log rank test, and Cox's proportional hazard model with stratification. Results In univariable analyses of survival, outcome was better for black people than white people (median 33.7 v 20.0 months). After stratification by socioeconomic status, type of stroke, and Glasgow coma score, and adjustment for other potential confounders, being black was generally associated with better survival, taking into account the interaction between ethnicity and age, and ethnicity and prior Barthel score. Of the risk factors for stroke considered, current smoking (hazard ratio 1.21, 95% confidence interval 1.01 to 1.45, P = 0.044), untreated atrial fibrillation (1.36,1.08 to 1.72, P = 0.009), untreated diabetes (1.53, 1.05 to 2.22, P = 0.027), and treated diabetes (1.61, 1.27 to 2.03, P < 0.001) were associated with reduced survival. Conclusion In general, black patients in a south London population with first ever stroke are more likely to survive than white patients, the exceptions being in those aged < 65 and those with a prior Barthel score < 15. Some pre-stroke risk factors that have the potential to be modified, including the appropriate treatment of existing health problems, have a strong impact on survival.	Kings Coll London, Div Hlth & Social Care, London SE1 3QD, England; Dept Social Med, Bristol BS8 2PR, Avon, England; St Thomas Hosp, Dept Ageing & Hlth, London SE1 7EH, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Wolfe, CDA (corresponding author), Kings Coll London, Div Hlth & Social Care, London SE1 3QD, England.	charles.wolfe@kcl.ac.uk	Tilling, Kate/AAY-1578-2021	Smeeton, Nigel/0000-0001-9460-5411; Tilling, Kate/0000-0002-1010-8926; Wolfe, Charles/0000-0001-8264-0981				[Anonymous], 2001, STAT SQUARE 2 UNDERS; Balarajan R, 1995, Health Trends, V27, P114; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Bardy AH, 1998, BRIT J CLIN PHARMACO, V46, P147, DOI 10.1046/j.1365-2125.1998.00759.x; Bhopal R, 1997, BRIT MED J, V314, P1751, DOI 10.1136/bmj.314.7096.1751; Callaham ML, 1998, JAMA-J AM MED ASSOC, V280, P254, DOI 10.1001/jama.280.3.254; CHALMERS I, 1990, JAMA-J AM MED ASSOC, V263, P1401, DOI 10.1001/jama.263.10.1401; Cheng K, 1998, PEDIATR PULM, V26, P101, DOI 10.1002/(SICI)1099-0496(199808)26:2<101::AID-PPUL5>3.3.CO;2-C; Collett D, 2003, MODELLING SURVIVAL D; Comstock RD, 2004, AM J EPIDEMIOL, V159, P611, DOI 10.1093/aje/kwh084; Daniels CE, 2002, ACAD MED, V77, P266, DOI 10.1097/00001888-200203000-00019; DEBELLEFEUILLE C, 1992, ANN ONCOL, V3, P187, DOI 10.1093/oxfordjournals.annonc.a058147; DICKERSIN K, 1992, JAMA-J AM MED ASSOC, V267, P374, DOI 10.1001/jama.267.3.374; DICKERSIN K, 1987, CONTROL CLIN TRIALS, V8, P343, DOI 10.1016/0197-2456(87)90155-3; DICKERSIN K, 1993, J CURR CLIN TRI 0428; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Egger E, 1997, LANCET, V350, P326, DOI 10.1016/S0140-6736(97)02419-7; Evers JLH, 2000, HUM REPROD, V15, P2063, DOI 10.1093/humrep/15.10.2063; Gillum RF, 1999, STROKE, V30, P1711, DOI 10.1161/01.STR.30.8.1711; Gillum RF, 2003, J CLIN EPIDEMIOL, V56, P188, DOI 10.1016/S0895-4356(02)00535-8; Hajat C, 2004, STROKE, V35, P1562, DOI 10.1161/01.STR.0000131903.04708.b8; Hartmann A, 2001, NEUROLOGY, V57, P2000, DOI 10.1212/WNL.57.11.2000; HOWARD G, 1994, STROKE, V25, P2120, DOI 10.1161/01.STR.25.11.2120; HOWARD G, 1995, STROKE, V26, P1759, DOI 10.1161/01.STR.26.10.1759; Kaufman JS, 2001, AM J EPIDEMIOL, V154, P291, DOI 10.1093/aje/154.4.291; Klassen TP, 2002, ARCH PEDIAT ADOL MED, V156, P474, DOI 10.1001/archpedi.156.5.474; KOREN G, 1989, LANCET, V2, P1440; Krzyzanowska MK, 2003, JAMA-J AM MED ASSOC, V290, P495, DOI 10.1001/jama.290.4.495; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; McKevitt C, 2005, STROKE, V36, P315, DOI 10.1161/01.STR.0000152332.32267.19; Melander H, 2003, BMJ-BRIT MED J, V326, P1171, DOI 10.1136/bmj.326.7400.1171; Misakian AL, 1998, JAMA-J AM MED ASSOC, V280, P250, DOI 10.1001/jama.280.3.250; Olson CM, 2002, JAMA-J AM MED ASSOC, V287, P2825, DOI 10.1001/jama.287.21.2825; Petticrew M, 1999, J EPIDEMIOL COMMUN H, V53, P442, DOI 10.1136/jech.53.7.442; Rosamond WD, 1999, STROKE, V30, P736, DOI 10.1161/01.STR.30.4.736; Sacco RL, 2001, STROKE, V32, P1725, DOI 10.1161/01.STR.32.8.1725; SCHERER RW, 1994, JAMA-J AM MED ASSOC, V272, P158, DOI 10.1001/jama.272.2.158; *SECR STAT HLTH, 1997, OUR HLTH NAT STRAT H; Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640; Stewart JA, 1999, BRIT MED J, V318, P967, DOI 10.1136/bmj.318.7189.967; Tilling K, 2001, INT J EPIDEMIOL, V30, P1351, DOI 10.1093/ije/30.6.1351; Timmer Antje, 2002, BMC Med Res Methodol, V2, P7, DOI 10.1186/1471-2288-2-7; Weber EJ, 1998, JAMA-J AM MED ASSOC, V280, P257, DOI 10.1001/jama.280.3.257; Wolfe CDA, 2002, J NEUROL NEUROSUR PS, V72, P211, DOI 10.1136/jnnp.72.2.211; Zimpel T, 2000, FORSCH KOMP KLAS NAT, V7, P71, DOI 10.1159/000021324	45	50	50	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 20	2005	331	7514					431	433		10.1136/bmj.38510.458218.8F	http://dx.doi.org/10.1136/bmj.38510.458218.8F			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	958WB	16055452	Bronze, Green Published			2022-12-01	WOS:000231477800015
J	Flores, I; Cayuela, ML; Blasco, MA				Flores, I; Cayuela, ML; Blasco, MA			Effects of telomerase and telomere length on epidermal stem cell behavior	SCIENCE			English	Article							SELF-RENEWAL; MAMMALIAN TELOMERES; CANCER; MOUSE; SKIN; MICE; SENESCENCE; NICHE	A key process in organ homeostasis is the mobilization of stem cells out of their niches. We show through analysis of mouse models that telomere length, as well as the catalytic component of telomerase, Tert, are critical determinants in the mobilization of epidermal stem cells. Telomere shortening inhibited mobilization of stem cells out of their niche, impaired hair growth, and resulted in suppression of stem cell proliferative capacity in vitro. In contrast, Tert overexpression in the absence of changes in telomere length promoted stem cell mobilization, hair growth, and stem cell proliferation in vitro. The effects of telomeres and telomerase on stem cell biology anticipate their role in cancer and aging.	Spanish Natl Canc Ctr, Mol Oncol Program, Telomeres & Telomerase Grp, E-28029 Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO)	Blasco, MA (corresponding author), Spanish Natl Canc Ctr, Mol Oncol Program, Telomeres & Telomerase Grp, Melchor Fernandez Almagro 3, E-28029 Madrid, Spain.	mblasco@cnio.es	Blasco, Maria A./M-1694-2014; Flores, Ignacio/E-8304-2016	Blasco, Maria A./0000-0002-4211-233X; Flores, Ignacio/0000-0001-8789-6396				Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Bell DR, 2004, ONCOGENE, V23, P7290, DOI 10.1038/sj.onc.1207949; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blasco MA, 2003, EUR J CELL BIOL, V82, P441, DOI 10.1078/0171-9335-00335; Blasco MA, 2002, NAT REV CANCER, V2, P627, DOI 10.1038/nrc862; Blasco MA, 2003, CANCER LETT, V194, P183, DOI 10.1016/S0304-3835(02)00705-X; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; Collins K, 2002, ONCOGENE, V21, P564, DOI 10.1038/sj.onc.1205083; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; Ferron S, 2004, DEVELOPMENT, V131, P4059, DOI 10.1242/dev.01215; Gonzalez-Suarez E, 2000, NAT GENET, V26, P114, DOI 10.1038/79089; Gonzalez-Suarez E, 2003, CANCER RES, V63, P7047; Gonzalez-Suarez E, 2002, MOL CELL BIOL, V22, P7291, DOI 10.1128/MCB.22.20.7291-7301.2002; Gonzalez-Suarez E, 2001, EMBO J, V20, P2619, DOI 10.1093/emboj/20.11.2619; Harrington L, 2004, ONCOGENE, V23, P7283, DOI 10.1038/sj.onc.1207948; Harrington L, 2003, CANCER LETT, V194, P139, DOI 10.1016/S0304-3835(02)00701-2; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Perez-Losada J, 2003, NAT REV CANCER, V3, P434, DOI 10.1038/nrc1095; Samper E, 2002, BLOOD, V99, P2767, DOI 10.1182/blood.V99.8.2767; Sharpless NE, 2004, J CLIN INVEST, V113, P160, DOI 10.1172/JCI200420761; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Van Zant G, 2003, EXP HEMATOL, V31, P659, DOI 10.1016/S0301-472X(03)00088-2; WILSON C, 1994, DIFFERENTIATION, V55, P127, DOI 10.1046/j.1432-0436.1994.5520127.x	28	329	369	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2005	309	5738					1253	1256		10.1126/science.1115025	http://dx.doi.org/10.1126/science.1115025			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	957TE	16037417				2022-12-01	WOS:000231395400050
J	Jorgensen, R; Merrill, AR; Yates, SP; Marquez, VE; Schwan, AL; Boesen, T; Andersen, GR				Jorgensen, R; Merrill, AR; Yates, SP; Marquez, VE; Schwan, AL; Boesen, T; Andersen, GR			Exotoxin A-eEF2 complex structure indicates ADP ribosylation by ribosome mimicry	NATURE			English	Article							PSEUDOMONAS-AERUGINOSA; CRYSTAL-STRUCTURE; DIPHTHERIA-TOXIN; CONFORMATIONAL-CHANGES; CLOSTRIDIUM-BOTULINUM; CATALYTIC MECHANISM; TRANSFER-RNA; DOMAIN; RECOGNITION; ACID	The bacteria causing diphtheria, whooping cough, cholera and other diseases secrete mono-ADP-ribosylating toxins that modify intracellular proteins. Here, we describe four structures of a catalytically active complex between a fragment of Pseudomonas aeruginosa exotoxin A (ETA) and its protein substrate, translation elongation factor 2 (eEF2). The target residue in eEF2, diphthamide (a modified histidine), spans across a cleft and faces the two phosphates and a ribose of the non-hydrolysable NAD(+) analogue, beta TAD. This suggests that the diphthamide is involved in triggering NAD(+) cleavage and interacting with the proposed oxacarbenium intermediate during the nucleophilic substitution reaction, explaining the requirement of diphthamide for ADP ribosylation. Diphtheria toxin may recognize eEF2 in a manner similar to ETA. Notably, the toxin-bound beta TAD phosphates mimic the phosphate backbone of two nucleotides in a conformational switch of 18S rRNA, thereby achieving universal recognition of eEF2 by ETA.	Aarhus Univ, Ctr Struct Biol, Dept Mol Biol, DK-8000 Aarhus, Denmark; Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; Univ Guelph, Dept Chem, Guelph, ON N1G 2W1, Canada; NCI, Med Chem Lab, Canc Res Ctr, NIH, Frederick, MD 21702 USA	Aarhus University; University of Guelph; University of Guelph; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Andersen, GR (corresponding author), Aarhus Univ, Ctr Struct Biol, Dept Mol Biol, Gustav Wieds Vej 10C, DK-8000 Aarhus, Denmark.	rmerrill@uoguelph.ca; gra@mb.au.dk	Merrill, Rod/M-8313-2014; Marquez, Victor/AAP-3549-2021; Jørgensen, René/P-5619-2014	Jørgensen, René/0000-0003-0672-466X; Andersen, Gregers Rom/0000-0001-6292-3319; Schwan, Adrian/0000-0003-3362-9633; Boesen, Thomas/0000-0002-5633-6844	NATIONAL CANCER INSTITUTE [Z01BC006176] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Armstrong S, 2004, BIOCHEMISTRY-US, V43, P183, DOI 10.1021/bi034772u; Armstrong S, 2002, J BIOL CHEM, V277, P46669, DOI 10.1074/jbc.M206916200; Beattie BK, 1996, BIOCHEMISTRY-US, V35, P15134, DOI 10.1021/bi961985t; Bell CE, 1997, PROTEIN SCI, V6, P2084; Bell CE, 1996, BIOCHEMISTRY-US, V35, P1137, DOI 10.1021/bi9520848; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHIRON MF, 1994, J BIOL CHEM, V269, P18167; Collier RJ, 2001, TOXICON, V39, P1793, DOI 10.1016/S0041-0101(01)00165-9; Corda D, 2003, EMBO J, V22, P1953, DOI 10.1093/emboj/cdg209; DeLano W.L, 2002, PYMOL USERS MANUA; DOUGLAS CM, 1987, J BACTERIOL, V169, P4967, DOI 10.1128/jb.169.11.4967-4971.1987; Evans HR, 2003, J BIOL CHEM, V278, P45924, DOI 10.1074/jbc.M307719200; Han S, 1999, NAT STRUCT BIOL, V6, P932, DOI 10.1038/13300; Han SI, 2001, J MOL BIOL, V305, P95, DOI 10.1006/jmbi.2000.4292; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.3.CO;2-I; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jorgensen R, 2004, J BIOL CHEM, V279, P45919, DOI 10.1074/jbc.M406218200; Jorgensen R, 2003, NAT STRUCT BIOL, V10, P379, DOI 10.1038/nsb923; Jorgensen R, 2002, ACTA CRYSTALLOGR D, V58, P712, DOI 10.1107/S0907444902003001; KOUNNAS MZ, 1992, J BIOL CHEM, V267, P12420; Li M, 1996, P NATL ACAD SCI USA, V93, P6902, DOI 10.1073/pnas.93.14.6902; Liu SH, 2003, MOL CELL, V12, P603, DOI 10.1016/j.molcel.2003.08.003; LUKAC M, 1988, BIOCHEMISTRY-US, V27, P7629, DOI 10.1021/bi00420a009; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; MARQUEZ VE, 1986, J MED CHEM, V29, P1726, DOI 10.1021/jm00159a027; Mattos-Guaraldi AL, 2003, MEM I OSWALDO CRUZ, V98, P987, DOI 10.1590/S0074-02762003000800001; Menetrey J, 2002, J BIOL CHEM, V277, P30950, DOI 10.1074/jbc.M201844200; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Parikh SL, 2004, BIOCHEMISTRY-US, V43, P1204, DOI 10.1021/bi035907z; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; VANNESS BG, 1980, J BIOL CHEM, V255, P717; Wedekind JE, 2001, J MOL BIOL, V314, P823, DOI 10.1006/jmbi.2001.5195; WEISS MS, 1995, BIOCHEMISTRY-US, V34, P773, DOI 10.1021/bi00003a010; Yates SP, 2005, BIOCHEM J, V385, P667, DOI 10.1042/BJ20041480; Yates SP, 2005, ANAL BIOCHEM, V340, P41, DOI 10.1016/j.ab.2005.01.051; Yates SP, 2001, J BIOL CHEM, V276, P35029, DOI 10.1074/jbc.M105002200; Zhou GC, 2004, J AM CHEM SOC, V126, P5690, DOI 10.1021/ja038159+	38	100	103	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2005	436	7053					979	984		10.1038/nature03871	http://dx.doi.org/10.1038/nature03871			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955XQ	16107839				2022-12-01	WOS:000231263900041
J	Wigge, PA; Kim, MC; Jaeger, KE; Busch, W; Schmid, M; Lohmann, JU; Weigel, D				Wigge, PA; Kim, MC; Jaeger, KE; Busch, W; Schmid, M; Lohmann, JU; Weigel, D			Integration of spatial and temporal information during floral induction in Arabidopsis	SCIENCE			English	Article							LATE-FLOWERING MUTANTS; GENE-EXPRESSION; TARGET GENES; CONSTANS; TIME; ACTIVATION; THALIANA; PROTEIN; ROLES	Flowering of Arabidopsis is regulated by several environmental and endogenous signals. An important integrator of these inputs is the FLOWERING LOCUS T (FT) gene, which encodes a small, possibly mobile protein. A primary response to floral. induction is the activation of FT RNA expression in leaves. Because flowers form at a distant site, the shoot apex, these data suggest that FT primarily controls the timing of flowering. Integration of temporal and spatial information is mediated in part by the bZIP transcription factor FD, which is already expressed at the shoot apex before floral. induction. A complex of FT and FD proteins in turn can activate flora[ identity genes such as APETALA1 (AP1).	Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany; Max Planck Inst Dev Biol, Arbeitsgrp Lohmann, D-72076 Tubingen, Germany; Max Planck Inst Dev Biol, Arbeitsgrp Schmid, D-72076 Tubingen, Germany; Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA	Max Planck Society; Max Planck Society; Max Planck Society; Salk Institute	Wigge, PA (corresponding author), Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany.	philip.wigge@bbsrc.ac.uk; weigel@weigelworld.org	Wigge, Philip Anthony/ABD-5113-2021; Weigel, Detlef/GSJ-0799-2022; Schmid, Markus/I-4384-2015; Weigel, Detlef/C-1418-2008; Weigel, Detlef/AAR-3312-2021; Wigge, Philip/B-3333-2010; Busch, Wolfgang/B-8593-2008; Lohmann, Jan/T-3776-2019	Wigge, Philip Anthony/0000-0003-4822-361X; Weigel, Detlef/0000-0002-2114-7963; Schmid, Markus/0000-0002-0068-2967; Weigel, Detlef/0000-0002-2114-7963; Busch, Wolfgang/0000-0003-2042-7290; Lohmann, Jan/0000-0003-3667-187X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		An HL, 2004, DEVELOPMENT, V131, P3615, DOI 10.1242/dev.01231; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Ayre BG, 2004, PLANT PHYSIOL, V135, P2271, DOI 10.1104/pp.104.040592; Banfield MJ, 2000, J MOL BIOL, V297, P1159, DOI 10.1006/jmbi.2000.3619; Cardon GH, 1997, PLANT J, V12, P367, DOI 10.1046/j.1365-313X.1997.12020367.x; He YH, 2005, TRENDS PLANT SCI, V10, P30, DOI 10.1016/j.tplants.2004.11.003; Henderson IR, 2004, DEVELOPMENT, V131, P3829, DOI 10.1242/dev.01294; IZAWA T, 1993, J MOL BIOL, V230, P1131, DOI 10.1006/jmbi.1993.1230; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; KNOTT JAMES E., 1934, PROC AMER SOC HORT SCI, V31, P152; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Koornneef M, 1998, GENETICS, V148, P885; Lemon WJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r67; MANDEL MA, 1995, NATURE, V377, P522, DOI 10.1038/377522a0; Parcy F, 1998, NATURE, V395, P561, DOI 10.1038/26903; Pnueli L, 2001, PLANT CELL, V13, P2687, DOI 10.1105/tpc.13.12.2687; RuizGarcia L, 1997, PLANT CELL, V9, P1921, DOI 10.1105/tpc.9.11.1921; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Schmid M, 2003, DEVELOPMENT, V130, P6001, DOI 10.1242/dev.00842; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Takada S, 2003, PLANT CELL, V15, P2856, DOI 10.1105/tpc.016345; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996; ZEEVAART JAD, 1976, ANNU REV PLANT PHYS, V27, P321, DOI 10.1146/annurev.pp.27.060176.001541	27	997	1126	11	232	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2005	309	5737					1056	1059		10.1126/science.1114358	http://dx.doi.org/10.1126/science.1114358			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955MN	16099980				2022-12-01	WOS:000231230100040
J	Holden, PJP				Holden, PJP			The London attacks - A chronicle - Improvising in an emergency	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	15	15	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 11	2005	353	6					541	543		10.1056/NEJMp058179	http://dx.doi.org/10.1056/NEJMp058179			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	953ST	16093459	Bronze			2022-12-01	WOS:000231101500001
J	Kim, TH; Barrera, LO; Zheng, M; Qu, CX; Singer, MA; Richmond, TA; Wu, YN; Green, RD; Ren, B				Kim, TH; Barrera, LO; Zheng, M; Qu, CX; Singer, MA; Richmond, TA; Wu, YN; Green, RD; Ren, B			A high-resolution map of active promoters in the human genome	NATURE			English	Article							EXPRESSED GENES; IDENTIFICATION; TRANSCRIPTOME; SEQUENCE; UPDATE; MOUSE	In eukaryotic cells, transcription of every protein-coding gene begins with the assembly of an RNA polymerase II preinitiation complex (PIC) on the promoter(1). The promoters, in conjunction with enhancers, silencers and insulators, define the combinatorial codes that specify gene expression patterns(2). Our ability to analyse the control logic encoded in the human genome is currently limited by a lack of accurate information regarding the promoters for most genes(3). Here we describe a genome-wide map of active promoters in human fibroblast cells, determined by experimentally locating the sites of PIC binding throughout the human genome. This map defines 10,567 active promoters corresponding to 6,763 known genes and at least 1,196 un-annotated transcriptional units. Features of the map suggest extensive use of multiple promoters by the human genes and widespread clustering of active promoters in the genome. In addition, examination of the genome-wide expression profile reveals four general classes of promoters that define the transcriptome of the cell. These results provide a global view of the functional relationships among transcriptional machinery, chromatin structure and gene expression in human cells.	Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Moores Canc Ctr, La Jolla, CA 92093 USA; Univ Calif Los Angeles, Dept Stat, Los Angeles, CA 90095 USA; NimbleGen Syst Inc, Madison, WI 53711 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Los Angeles; Roche Holding; Roche NimbleGen	Ren, B (corresponding author), Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.	biren@ucsd.edu		Soriaga, Leah/0000-0001-5852-741X; Kim, Tae Hoon/0000-0003-3950-7557	NCI NIH HHS [R21 CA105829, F32 CA108313, R33 CA105829] Funding Source: Medline; NHGRI NIH HHS [U01 HG003151] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA105829, R33CA105829] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG003151] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; Benson DA, 2004, NUCLEIC ACIDS RES, V32, pD23, DOI 10.1093/nar/gkh045; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Birney E, 2004, NUCLEIC ACIDS RES, V32, pD468, DOI 10.1093/nar/gkh038; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; *ENCODE PROJ CONS, 2001, SCIENCE, V306, P636; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Kim TH, 2005, GENOME RES, V15, P830, DOI 10.1101/gr.3430605; KRUMM A, 1995, GENE DEV, V9, P559, DOI 10.1101/gad.9.5.559; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Ohler U, 2002, GENOME BIOL, V3, DOI [10.1186/gb-2002-3-12-research0087, DOI 10.1186/GB-2002-3-12-RESEARCH0087]; Pruitt KD, 2003, NUCLEIC ACIDS RES, V31, P34, DOI 10.1093/nar/gkg111; Reinberg D, 1998, COLD SPRING HARB SYM, V63, P83, DOI 10.1101/sqb.1998.63.83; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rinn JL, 2003, GENE DEV, V17, P529, DOI 10.1101/gad.1055203; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; RUPPERT S, 1993, NATURE, V362, P175, DOI 10.1038/362175a0; Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Singh-Gasson S, 1999, NAT BIOTECHNOL, V17, P974, DOI 10.1038/13664; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Spellman Paul T, 2002, J Biol, V1, P5, DOI 10.1186/1475-4924-1-5; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Suzuki Y, 2004, NUCLEIC ACIDS RES, V32, pD78, DOI 10.1093/nar/gkh076; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5; Trinklein ND, 2003, GENOME RES, V13, P308, DOI 10.1101/gr.794803; Yuh CH, 1998, SCIENCE, V279, P1896, DOI 10.1126/science.279.5358.1896	30	724	756	2	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2005	436	7052					876	880		10.1038/nature03877	http://dx.doi.org/10.1038/nature03877			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953XG	15988478	Green Accepted			2022-12-01	WOS:000231116500052
J	Schafmeier, T; Haase, A; Kaldi, K; Scholz, J; Fuchs, M; Brunner, M				Schafmeier, T; Haase, A; Kaldi, K; Scholz, J; Fuchs, M; Brunner, M			Transcriptional feedback of Neurospora circadian clock gene by phosphorylation-dependent inactivation of its transcription factor	CELL			English	Article							LIGHT SIGNAL-TRANSDUCTION; PROTEIN PHOSPHATASE 2A; CASEIN KINASE-II; WHITE COLLAR-1; CRASSA; FREQUENCY; DROSOPHILA; BINDING; COMPLEX; SYSTEM	The circadian clock protein Frequency (FRO) feedback-regulates its own expression by inhibiting its transcriptional activator, White Collar Complex (WCC). We present evidence that FRO regulates the bulk of WCC through modulation of its phosphorylation status rather than via direct complex formation. In the absence of FRO, WCC is hypophosphorylated and transcriptionally active, while WCC is hyperphosphorylated and transcriptionally inactive when FRO is expressed. The phosphorylation status of WCC changes rhythmically over a circadian cycle. Dephosphorylation and activation of WCC depend on protein phosphatase 2A (PP2A), and WCC is a substrate of PP2A in vitro. Hypophosphorylated WCC binds to the clock box of the frq promoter even in the presence of FRO, while binding of hyperphosphorylated WCC is compromised even when FRO is depleted. We propose that negative feedback in the circadian clock of Neurospora is mediated by FRO, which rhythmically promotes phosphorylation of WCC, functionally equivalent to a cyclin recruiting cyclin-dependent kinase to its targets.	Univ Heidelberg, Biochem Ctr, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Brunner, M (corresponding author), Univ Heidelberg, Biochem Ctr, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	michael.brunner@urz.uni-heidelberg.de	Káldi, Krisztina/X-4080-2019	Kaldi, Krisztina/0000-0002-5724-0182; Brunner, Michael/0000-0001-9798-3047				Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; ARONSON BD, 1994, P NATL ACAD SCI USA, V91, P7683, DOI 10.1073/pnas.91.16.7683; ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; BellPedersen D, 1996, P NATL ACAD SCI USA, V93, P13096, DOI 10.1073/pnas.93.23.13096; Byrne M, 2004, J MOL BIOL, V335, P57, DOI 10.1016/j.jmb.2003.10.035; Carroll AS, 2002, TRENDS BIOCHEM SCI, V27, P87, DOI 10.1016/S0968-0004(01)02040-0; Cheng P, 2005, GENE DEV, V19, P234, DOI 10.1101/gad.1266805; Cheng P, 2003, J BIOL CHEM, V278, P3801, DOI 10.1074/jbc.M209592200; Cheng P, 2002, MOL CELL BIOL, V22, P517, DOI 10.1128/MCB.22.2.517-524.2002; Cheng P, 2001, P NATL ACAD SCI USA, V98, P7408, DOI 10.1073/pnas.121170298; Correa A, 2003, P NATL ACAD SCI USA, V100, P13597, DOI 10.1073/pnas.2233734100; Denault DL, 2001, EMBO J, V20, P109, DOI 10.1093/emboj/20.1.109; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Froehlich AC, 2003, P NATL ACAD SCI USA, V100, P5914, DOI 10.1073/pnas.1030057100; Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681; Gachon F, 2004, CHROMOSOMA, V113, P103, DOI 10.1007/s00412-004-0296-2; Gao ZH, 2002, P NATL ACAD SCI USA, V99, P1182, DOI 10.1073/pnas.032468199; GORI M, 2001, EMBO J, V20, P7074; He QY, 2005, J BIOL CHEM, V280, P17526, DOI 10.1074/jbc.M414010200; He QY, 2002, SCIENCE, V297, P840, DOI 10.1126/science.1072795; Kim EY, 2002, NEURON, V34, P69, DOI 10.1016/S0896-6273(02)00639-6; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee C, 1999, MOL CELL BIOL, V19, P5316; Lee CG, 1998, NEURON, V21, P857, DOI 10.1016/S0896-6273(00)80601-7; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; Lee K, 2003, GENETICS, V163, P103; Linden H, 1997, EMBO J, V16, P98, DOI 10.1093/emboj/16.1.98; Luo CH, 1998, EMBO J, V17, P1228, DOI 10.1093/emboj/17.5.1228; Merrow M, 2001, EMBO J, V20, P307, DOI 10.1093/emboj/20.3.307; Nawathean P, 2004, MOL CELL, V13, P213, DOI 10.1016/S1097-2765(03)00503-3; Nowrousian M, 2003, GENETICS, V164, P923; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Roenneberg T, 2003, CURR BIOL, V13, pR198, DOI 10.1016/S0960-9822(03)00124-6; Sanada K, 2002, J BIOL CHEM, V277, P267, DOI 10.1074/jbc.M107850200; Sathyanarayanan S, 2004, CELL, V116, P603, DOI 10.1016/S0092-8674(04)00128-X; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Schwerdtfeger C, 2000, EUR J BIOCHEM, V267, P414, DOI 10.1046/j.1432-1327.2000.01016.x; Stanewsky R, 2003, J NEUROBIOL, V54, P111, DOI 10.1002/neu.10164; Swiatek W, 2004, J BIOL CHEM, V279, P13011, DOI 10.1074/jbc.M304682200; Talora C, 1999, EMBO J, V18, P4961, DOI 10.1093/emboj/18.18.4961; Tomita J, 2005, SCIENCE, V307, P251, DOI 10.1126/science.1102540; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; Yang YH, 2004, GENE DEV, V18, P255, DOI 10.1101/gad.1152604; Yang YH, 2003, MOL CELL BIOL, V23, P6221, DOI 10.1128/MCB.23.17.6221-6228.2003; Yang YH, 2002, GENE DEV, V16, P994, DOI 10.1101/gad.965102; Yang YH, 2001, J BIOL CHEM, V276, P41064, DOI 10.1074/jbc.M106905200; Yatzkan E, 1999, MOL MICROBIOL, V31, P197, DOI 10.1046/j.1365-2958.1999.01161.x; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zhu H, 2001, GENETICS, V157, P1057	49	188	193	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 29	2005	122	2					235	246		10.1016/j.cell.2005.05.032	http://dx.doi.org/10.1016/j.cell.2005.05.032			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	951CR	16051148	Bronze			2022-12-01	WOS:000230907000011
J	Lindenauer, PK; Pekow, P; Wang, KJ; Mamidi, DK; Gutierrez, B; Benjamin, EM				Lindenauer, PK; Pekow, P; Wang, KJ; Mamidi, DK; Gutierrez, B; Benjamin, EM			Perioperative beta-blocker therapy and mortality after major noncardiac surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	26th Annual Meeting of the Society-of-General-Internal-Medicine	APR 30-MAY 03, 2003	VANCOUVER, CANADA	Soc Gen Internal Med			POSTOPERATIVE MYOCARDIAL-INFARCTION; CARDIAC RISK; CARDIOVASCULAR MORBIDITY; ADRENERGIC-BLOCKADE; ADMINISTRATIVE DATA; VASCULAR-SURGERY; EVENTS; INDEX; QUALITY; PROGRAM	BACKGROUND: Despite limited evidence from randomized trials, perioperative treatment with beta-blockers is now widely advocated. We assessed the use of perioperative beta-blockers and their association with in-hospital mortality in routine clinical practice. METHODS: We conducted a retrospective cohort study of patients 18 years of age or older who underwent major noncardiac surgery in 2000 and 2001 at 329 hospitals throughout the United States. We used propensity-score matching to adjust for differences between patients who received perioperative beta-blockers and those who did not receive such therapy and compared in-hospital mortality using multivariable logistic modeling. RESULTS: Of 782,969 patients, 663,635 (85 percent) had no recorded contraindications to beta-blockers, 122,338 of whom (18 percent) received such treatment during the first two hospital days, including 14 percent of patients with a Revised Cardiac Risk Index (RCRI) score of 0 and 44 percent with a score of 4 or higher. The relationship between perioperative beta-blocker treatment and the risk of death varied directly with cardiac risk; among the 580,665 patients with an RCRI score of 0 or 1, treatment was associated with no benefit and possible harm, whereas among the patients with an RCRI score of 2, 3, or 4 or more, the adjusted odds ratios for death in the hospital were 0.88 (95 percent confidence interval, 0.80 to 0.98), 0.71 (95 percent confidence interval, 0.63 to 0.80), and 0.58 (95 percent confidence interval, 0.50 to 0.67), respectively. CONCLUSIONS: Perioperative beta-blocker therapy is associated with a reduced risk of in-hospital death among high-risk, but not low-risk, patients undergoing major noncardiac surgery. Patient safety may be enhanced by increasing the use of beta-blockers in high-risk patients.	Baystate Med Ctr, Div Healthcare Qual, Springfield, MA 01199 USA; Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA; Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Amherst, MA 01003 USA; Premier Inc, Premier Healthcare Informat, Charlotte, NC USA	Baystate Medical Center; Tufts University; University of Massachusetts System; University of Massachusetts Amherst	Lindenauer, PK (corresponding author), Baystate Med Ctr, Div Healthcare Qual, 759 Chestnut St P-5928, Springfield, MA 01199 USA.	Peter.Lindenauer@bhs.org		MAMIDI, DHEERESH/0000-0003-2058-5002				Auerbach AD, 2002, JAMA-J AM MED ASSOC, V287, P1435, DOI 10.1001/jama.287.11.1435; Best WR, 2002, J AM COLL SURGEONS, V194, P257, DOI 10.1016/S1072-7515(01)01183-8; Cohn SL, 2003, MED CLIN N AM, V87, P111, DOI 10.1016/S0025-7125(02)00143-8; DETSKY AS, 1986, ARCH INTERN MED, V146, P2131, DOI 10.1001/archinte.146.11.2131; Devereaux PJ, 2004, CAN MED ASSOC J, V171, P245, DOI 10.1503/cmaj.1031619; EAGLE KA, 1989, ANN INTERN MED, V110, P859, DOI 10.7326/0003-4819-110-11-859; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fleisher LA, 2001, NEW ENGL J MED, V345, P1677, DOI 10.1056/NEJMcp002842; GOLDMAN L, 1977, NEW ENGL J MED, V297, P845, DOI 10.1056/NEJM197710202971601; Grayburn PA, 2003, ANN INTERN MED, V138, P506, DOI 10.7326/0003-4819-138-6-200303180-00017; HALL MJ, 2000, ADV DATA VITAL HLTH, V329; Juul AB, 2004, AM HEART J, V147, P677, DOI 10.1016/j.ahj.2003.10.030; JUUL AB, 2004, AM HEART ASS SCI SES; Khuri SF, 1998, ANN SURG, V228, P491, DOI 10.1097/00000658-199810000-00006; Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043; Lindenauer PK, 2004, ARCH INTERN MED, V164, P762, DOI 10.1001/archinte.164.7.762; Mangano DT, 1997, NEW ENGL J MED, V336, P1039; Mangano DT, 1996, NEW ENGL J MED, V335, P1713, DOI 10.1056/NEJM199612053352301; *NAT QUAL FOR, 2003, PUBL NAT QUAL FOR; Nettleman MD, 1997, AM J MED, V103, P357, DOI 10.1016/S0002-9343(97)00162-9; Parsons LS, REDUCING BIAS PROPEN; Poldermans D, 1999, NEW ENGL J MED, V341, P1789, DOI 10.1056/NEJM199912093412402; Quan HD, 2002, MED CARE, V40, P675, DOI 10.1097/00005650-200208000-00007; Selzman CH, 2001, ARCH SURG-CHICAGO, V136, P286, DOI 10.1001/archsurg.136.3.286; SHOJANIA K, 2001, AHRQ PUBLICATION; WROBLEWSKI F, 1952, JAMA-J AM MED ASSOC, V150, P1212, DOI 10.1001/jama.1952.63680120015010f; YANG H, 2004, CAN J ANAESTH, V51, pA7	27	597	613	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 28	2005	353	4					349	361		10.1056/NEJMoa041895	http://dx.doi.org/10.1056/NEJMoa041895			13	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949JW	16049209	Green Published			2022-12-01	WOS:000230782800007
J	Sieburth, D; Ch'ng, Q; Dybbs, M; Tavazoie, M; Kennedy, S; Wang, D; Dupuy, D; Rual, JF; Hill, DE; Vidal, M; Ruvkun, G; Kaplan, JM				Sieburth, D; Ch'ng, Q; Dybbs, M; Tavazoie, M; Kennedy, S; Wang, D; Dupuy, D; Rual, JF; Hill, DE; Vidal, M; Ruvkun, G; Kaplan, JM			Systematic analysis of genes required for synapse structure and function	NATURE			English	Article							CAENORHABDITIS-ELEGANS; PROTEIN; KINASE; ACTIN; RELEASE; TRANSMISSION; UNC-13; BETA; UBIQUITINATION; INTERFERENCE	Chemical synapses are complex structures that mediate rapid intercellular signalling in the nervous system. Proteomic studies suggest that several hundred proteins will be found at synaptic specializations. Here we describe a systematic screen to identify genes required for the function or development of Caenorhabditis elegans neuromuscular junctions. A total of 185 genes were identified in an RNA interference screen for decreased acetylcholine secretion; 132 of these genes had not previously been implicated in synaptic transmission. Functional profiles for these genes were determined by comparing secretion defects observed after RNA interference under a variety of conditions. Hierarchical clustering identified groups of functionally related genes, including those involved in the synaptic vesicle cycle, neuropeptide signalling and responsiveness to phorbol esters. Twenty-four genes encoded proteins that were localized to presynaptic specializations. Loss-of-function mutations in 12 genes caused defects in presynaptic structure.	Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Univ Wisconsin, Dept Pharmacol, Madison, WI 53706 USA; Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Kaplan, JM (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	kaplan@molbio.mgh.harvard.edu	Hill, David E/B-6617-2011; Ch'ng, QueeLim/C-5348-2009	Ch'ng, QueeLim/0000-0003-1941-3828; Kennedy, Scott/0000-0002-7974-8155; Dupuy, Denis/0000-0002-4781-5595; Rual, Jean-Francois/0000-0003-4465-8819	NIDDK NIH HHS [R01 DK070147] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070147] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Ann K, 1997, J BIOL CHEM, V272, P19637, DOI 10.1074/jbc.272.32.19637; Bloom O, 2003, J CELL BIOL, V161, P737, DOI 10.1083/jcb.200212140; Boulton SJ, 2002, SCIENCE, V295, P127, DOI 10.1126/science.1065986; Colbert HA, 1997, J NEUROSCI, V17, P8259; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; Dunaevsky A, 2000, J NEUROSCI, V20, P6007, DOI 10.1523/JNEUROSCI.20-16-06007.2000; Fuchs F, 2005, MOL BIOL CELL, V16, P153, DOI 10.1091/mbc.E04-05-0413; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; Grant SGN, 2003, CURR OPIN NEUROBIOL, V13, P577, DOI 10.1016/j.conb.2003.09.016; Greener T, 2000, J BIOL CHEM, V275, P1365, DOI 10.1074/jbc.275.2.1365; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Jacob TC, 2003, J NEUROSCI, V23, P2122; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kass J, 2001, J NEUROSCI, V21, P9265, DOI 10.1523/JNEUROSCI.21-23-09265.2001; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Kohn RE, 2000, MOL BIOL CELL, V11, P3441, DOI 10.1091/mbc.11.10.3441; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; Lindberg I, 1998, DNA CELL BIOL, V17, P727, DOI 10.1089/dna.1998.17.727; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Muly EC, 2004, J COMP NEUROL, V469, P185, DOI 10.1002/cne.11001; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; Nathoo AN, 2001, P NATL ACAD SCI USA, V98, P14000, DOI 10.1073/pnas.241231298; NGUYEN M, 1995, GENETICS, V140, P527; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; Oliver CJ, 2002, MOL CELL BIOL, V22, P4690, DOI 10.1128/MCB.22.13.4690-4701.2002; Paganoni S, 2003, J NEUROSCI RES, V73, P429, DOI 10.1002/jnr.10674; Premkumar LS, 2000, NATURE, V408, P985, DOI 10.1038/35050121; Reboul J, 2003, NAT GENET, V34, P35, DOI 10.1038/ng1140; Renden R, 2001, NEURON, V31, P421, DOI 10.1016/S0896-6273(01)00382-8; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Robatzek M, 2000, GENETICS, V156, P1069; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; Sankaranarayanan S, 2003, NAT NEUROSCI, V6, P127, DOI 10.1038/nn1002; Schuske KR, 2003, NEURON, V40, P749, DOI 10.1016/S0896-6273(03)00667-6; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Sone M, 2000, DEVELOPMENT, V127, P4157; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Weimer RM, 2003, NAT NEUROSCI, V6, P1023, DOI 10.1038/nn1118; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zahn TR, 2004, TRAFFIC, V5, P544, DOI 10.1111/j.1600-0854.2004.00195.x; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886; Zito K, 2004, NEURON, V44, P321, DOI 10.1016/j.neuron.2004.09.022	54	281	351	1	28	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 28	2005	436	7050					510	517		10.1038/nature03809	http://dx.doi.org/10.1038/nature03809			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049479				2022-12-01	WOS:000230788800052
J	Scheel, O; Zdebik, AA; Lourdel, S; Jentsch, TJ				Scheel, O; Zdebik, AA; Lourdel, S; Jentsch, TJ			Voltage-dependent electrogenic chloride/proton exchange by endosomal CLC proteins	NATURE			English	Article							MOLECULAR-BASIS; DENTS-DISEASE; CHANNELS; LEADS; ACIDIFICATION; SELECTIVITY; MOUSE; DISRUPTION; CLONING; MODEL	Eukaryotic members of the CLC gene family function as plasma membrane chloride channels, or may provide neutralizing anion currents for V-type H+-ATPases that acidify compartments of the endosomal/lysosomal pathway(1). Loss-of-function mutations in the endosomal protein ClC-5 impair renal endocytosis(2) and lead to kidney stones(3), whereas loss of function of the endosomal/ lysosomal protein ClC-7 entails osteopetrosis(4) and lysosomal storage disease(5). Vesicular CLCs have been thought to be Cl- channels, in particular because ClC-4 and ClC-5 mediate plasma membrane Cl- currents upon heterologous expression(6,7). Here we show that these two mainly endosomal CLC proteins instead function as electrogenic Cl-/H+ exchangers ( also called antiporters), resembling the transport activity of the bacterial protein ClC-e1 ( ref. 8), the crystal structure of which has already been determined(9). Neutralization of a critical glutamate residue not only abolished the steep voltage-dependence of transport(7), but also eliminated the coupling of anion flux to proton counter-transport. ClC-4 and ClC-5 may still compensate the charge accumulation by endosomal proton pumps, but are expected to couple directly vesicular pH gradients to Cl- gradients.	Univ Hamburg, ZMNH, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Jentsch, TJ (corresponding author), Univ Hamburg, ZMNH, Zentrum Mol Neurobiol, Falkenried 94, D-20246 Hamburg, Germany.	Jentsch@zmnh.uni-hamburg.de		Lourdel, Stephane/0000-0002-3626-7650; Jentsch, Thomas/0000-0002-3509-2553				Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Davis-Kaplan SR, 1998, P NATL ACAD SCI USA, V95, P13641, DOI 10.1073/pnas.95.23.13641; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Fahlke C, 1997, NATURE, V390, P529, DOI 10.1038/37391; Friedrich T, 1999, J BIOL CHEM, V274, P896, DOI 10.1074/jbc.274.2.896; Gunther W, 2003, PFLUG ARCH EUR J PHY, V445, P456, DOI 10.1007/s00424-002-0950-6; Hara-Chikuma M, 2005, J BIOL CHEM, V280, P1241, DOI 10.1074/jbc.M407030200; Hara-Chikuma M, 2005, BIOCHEM BIOPH RES CO, V329, P941, DOI 10.1016/j.bbrc.2005.02.060; Jentsch TJ, 2005, ANNU REV PHYSIOL, V67, P779, DOI 10.1146/annurev.physiol.67.032003.153245; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Li XH, 2002, AM J PHYSIOL-CELL PH, V282, pC1483, DOI 10.1152/ajpcell.00504.2001; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; MYERS VB, 1972, BIOCHIM BIOPHYS ACTA, V274, P313, DOI 10.1016/0005-2736(72)90179-4; Piwon N, 2000, NATURE, V408, P369, DOI 10.1038/35042597; Poet M, 2001, EMBO J, V20, P5595, DOI 10.1093/emboj/20.20.5595; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Soleimani M, 2001, AM J PHYSIOL-RENAL, V280, pF356, DOI 10.1152/ajprenal.2001.280.2.F356; Steinmeyer K, 1995, J BIOL CHEM, V270, P31172, DOI 10.1074/jbc.270.52.31172; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; Traverso S, 2003, J GEN PHYSIOL, V122, P295, DOI 10.1085/jgp.200308784; Waldegger S, 2000, J BIOL CHEM, V275, P24527, DOI 10.1074/jbc.M001987200; Yoshikawa M, 2002, GENES CELLS, V7, P597, DOI 10.1046/j.1365-2443.2002.00539.x	26	383	397	4	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2005	436	7049					424	427		10.1038/nature03860	http://dx.doi.org/10.1038/nature03860			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	16034422				2022-12-01	WOS:000230623400049
J	Ford, ES; Ajani, UA; Mokdad, AH				Ford, ES; Ajani, UA; Mokdad, AH			Brief communication: The prevalence of high intake of vitamin E from the use of supplements among US adults	ANNALS OF INTERNAL MEDICINE			English	Article							ALPHA-TOCOPHEROL; GAMMA-TOCOPHEROL; CARDIOVASCULAR-DISEASE; METAANALYSIS; PREVENTION	Background: People who consume at least 400 IU of vitamin E per day from supplements may be at slightly increased risk for premature mortality. Objective: To estimate the percentage of U.S. adults age 20 years or older who consume at least 400 IU of vitamin E per day through the use of vitamins, minerals, or other dietary supplements. Design: Cross-sectional analysis. Setting: The 1999-2000 National Health and Nutrition Examination Survey. Patients: Representative sample of the civilian, noninstitutionalized U.S. population. Measurements: Participants answered questions about the use of vitamins, minerals, or other dietary supplements. Results: Among 4609 adults, 11.3% (95% CI, 9.7% to 13.1%) consumed at least 400 IU of vitamin E per day from supplements. Such intake increased with age, was about equal for men and women, and was more common among white persons (14.1%; CI, 11.9% to 16.7%) than African-American (3.7% [CI, 2.6% to 5.2%]) or Mexican-American persons (3.9% [CI, 2.8% to 5.4%]). The median dietary intake of vitamin E was 8.8 IU per day. Limitations: information about vitamin E intake was self-reported. Conclusions: The use of vitamin E supplements in dosages of at least 400 IU per day is common among U.S. adults.	Ctr Dis Control & Prevent, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Ford, ES (corresponding author), Ctr Dis Control & Prevent, 470 Buford Highway,MS K66, Atlanta, GA 30341 USA.		Mokdad, Ali H./AAD-1232-2022	Mokdad, Ali H./0000-0002-4994-3339				Briefel RR, 2004, ANNU REV NUTR, V24, P401, DOI 10.1146/annurev.nutr.23.011702.073349; Centers for Disease Control and Prevention, NHANES 1999 2000 PUB; Centers for Disease Control and Prevention National Center for Health Statistics, NAT HLTH NUTR EX SUR; HANDELMAN GJ, 1985, J NUTR, V115, P807, DOI 10.1093/jn/115.6.807; Hensley Kenneth, 2004, Free Radic Biol Med, V36, P1; Huang HY, 2003, J NUTR, V133, P3137, DOI 10.1093/jn/133.10.3137; Lonn E, 2005, JAMA-J AM MED ASSOC, V293, P1338, DOI 10.1001/jama.293.11.1338; Maras JE, 2004, J AM DIET ASSOC, V104, P567, DOI 10.1016/j.jada.2004.01.004; Millen AE, 2004, J AM DIET ASSOC, V104, P942, DOI 10.1016/j.jada.2004.03.022; Miller ER, 2005, ANN INTERN MED, V143, P156, DOI 10.7326/0003-4819-143-2-200507190-00029; Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110; Muntwyler J, 2002, ARCH INTERN MED, V162, P1472, DOI 10.1001/archinte.162.13.1472; *RES TRIANGL I, 2002, SUDAAN US MAN REL 8; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Vivekananthan DP, 2003, LANCET, V361, P2017, DOI 10.1016/S0140-6736(03)13637-9	15	45	47	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 19	2005	143	2					116	120		10.7326/0003-4819-143-2-200507190-00010	http://dx.doi.org/10.7326/0003-4819-143-2-200507190-00010			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946YG	16027453				2022-12-01	WOS:000230608600004
J	Yabroff, KR; Kerner, JF				Yabroff, KR; Kerner, JF			Variations in surgery for early-stage breast cancer: what are we measuring?	LANCET			English	Editorial Material							OLDER WOMEN; GEOGRAPHIC-VARIATION; MASTECTOMY; RADIATION; THERAPY; CARE		NCI, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Yabroff, KR (corresponding author), NCI, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA.	yabroffr@mail.nih.gov		Kerner, Jon/0000-0002-8792-3830; Yabroff, K. Robin/0000-0003-0644-5572				BallardBarbash R, 1996, JNCI-J NATL CANCER I, V88, P716, DOI 10.1093/jnci/88.11.716; Caldon LJM, 2005, BRIT J CANCER, V92, P55, DOI 10.1038/sj.bjc.6602264; Charles C, 1999, SOC SCI MED, V49, P651, DOI 10.1016/S0277-9536(99)00145-8; FARROW DC, 1992, NEW ENGL J MED, V326, P1097, DOI 10.1056/NEJM199204233261701; FISHER B, 1985, NEW ENGL J MED, V312, P665, DOI 10.1056/NEJM198503143121101; HALL WH, 1991, JAMA-J AM MED ASSOC, V265, P391; Hebert-Croteau N, 2000, EPIDEMIOL REV, V22, P228, DOI 10.1093/oxfordjournals.epirev.a018035; Hewitt M, 1999, ENSURING QUALITY CAN; Keating NL, 2003, J CLIN ONCOL, V21, P4532, DOI 10.1200/JCO.2003.05.131; Lantz PM, 2002, HEALTH SERV RES, V37, P417, DOI 10.1111/1475-6773.030; Liang WH, 2002, J CLIN ONCOL, V20, P1008, DOI 10.1200/JCO.20.4.1008; Lipscomb Joseph, 2004, J Natl Cancer Inst Monogr, P178; Mandelblatt JS, 1999, CANCER-AM CANCER SOC, V86, P2378, DOI 10.1002/(SICI)1097-0142(19991201)86:11<2378::AID-CNCR28>3.3.CO;2-C; Mandelblatt JS, 2001, MED CARE, V39, P228, DOI 10.1097/00005650-200103000-00004; Morris AD, 1997, CANCER J, V3, P6; NATTINGER AB, 1992, NEW ENGL J MED, V326, P1102, DOI 10.1056/NEJM199204233261702	16	4	4	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 16	2005	366	9481					188	190		10.1016/S0140-6736(05)66888-2	http://dx.doi.org/10.1016/S0140-6736(05)66888-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	945RG	16023495				2022-12-01	WOS:000230519200009
J	Collier, LS; Carlson, CM; Ravimohan, S; Dupuy, AJ; Largaespada, DA				Collier, LS; Carlson, CM; Ravimohan, S; Dupuy, AJ; Largaespada, DA			Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse	NATURE			English	Article							SLEEPING-BEAUTY; EXPRESSION; GENOME; CELLS; FISH; MICE	Retroviruses, acting as somatic cell insertional mutagens, have been widely used to identify cancer genes in the haematopoietic system and mammary gland(1,2). An insertional mutagen for use in other mouse somatic cells would facilitate the identification of genes involved in tumour formation in a wider variety of tissues. Here we report the ability of the Sleeping Beauty transposon to act as a somatic insertional mutagen to identify genes involved in solid tumour formation. A Sleeping Beauty transposon, engineered to elicit loss-of-function or gain-of-function mutations, transposed in all somatic tissues tested and accelerated tumour formation in mice predisposed to cancer. Cloning transposon insertion sites from these tumours revealed the presence of common integration sites, at known and candidate cancer genes, similar to those observed in retroviral mutagenesis screens. Sleeping Beauty is a new tool for unbiased, forward genetic screens for cancer genes in vivo.	Univ Minnesota Twin Cities, Ctr Canc, Arnold & Mabel Beckman Ctr Transposon Res, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Largaespada, DA (corresponding author), Univ Minnesota Twin Cities, Ctr Canc, Arnold & Mabel Beckman Ctr Transposon Res, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	larga002@umn.edu	Largaespada, David/C-9832-2014; Wilson, Matthew H/K-3193-2013	Dupuy, Adam/0000-0002-8561-4911				Abdallah B, 1996, HUM GENE THER, V7, P1947, DOI 10.1089/hum.1996.7.16-1947; Akagi K, 2004, NUCLEIC ACIDS RES, V32, pD523, DOI 10.1093/nar/gkh013; Carlson CM, 2003, GENETICS, V165, P243; Cherry SR, 2000, MOL CELL BIOL, V20, P7419, DOI 10.1128/MCB.20.20.7419-7426.2000; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Dupuy AJ, 2001, GENESIS, V30, P82, DOI 10.1002/gene.1037; Fischer SEJ, 2001, P NATL ACAD SCI USA, V98, P6759, DOI 10.1073/pnas.121569298; Geurts AM, 2003, MOL THER, V8, P108, DOI 10.1016/S1525-0016(03)00099-6; HAWLEY RG, 1994, GENE THER, V1, P136; HEIDECKER G, 1990, MOL CELL BIOL, V10, P2503, DOI 10.1128/MCB.10.6.2503; Horie K, 2003, MOL CELL BIOL, V23, P9189, DOI 10.1128/MCB.23.24.9189-9207.2003; Horie K, 2001, P NATL ACAD SCI USA, V98, P9191, DOI 10.1073/pnas.161071798; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Johansson FK, 2004, P NATL ACAD SCI USA, V101, P11334, DOI 10.1073/pnas.0402716101; Jonkers J, 1996, BBA-REV CANCER, V1287, P29, DOI 10.1016/0304-419X(95)00020-G; Kamijo T, 1999, CANCER RES, V59, P2217; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Lund AH, 2002, NAT GENET, V32, P160, DOI 10.1038/ng956; Mikkers H, 2002, NAT GENET, V32, P459, DOI 10.1038/ng1102-459b; Montini E, 2002, MOL THER, V6, P759, DOI 10.1006/mthe.2002.0812; Neil JC, 2002, CANCER CELL, V2, P253, DOI 10.1016/S1535-6108(02)00158-7; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Seidel C, 2005, INT J CANCER, V114, P442, DOI 10.1002/ijc.20707; Vigdal TJ, 2002, J MOL BIOL, V323, P441, DOI 10.1016/S0022-2836(02)00991-9; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Yant SR, 2000, NAT GENET, V25, P35, DOI 10.1038/75568	27	324	342	2	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2005	436	7048					272	276		10.1038/nature03681	http://dx.doi.org/10.1038/nature03681			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944VR	16015333				2022-12-01	WOS:000230459500044
J	Ockene, JK; Barad, DH; Cochrane, BB; Larson, JC; Gass, M; Wassertheil-Smoller, S; Manson, JE; Barnabei, VM; Lane, DS; Brzyski, RG; Rosal, MC; Wylie-Rosett, J; Hays, J				Ockene, JK; Barad, DH; Cochrane, BB; Larson, JC; Gass, M; Wassertheil-Smoller, S; Manson, JE; Barnabei, VM; Lane, DS; Brzyski, RG; Rosal, MC; Wylie-Rosett, J; Hays, J			Symptom experience after discontinuing use of estrogen plus progestin	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HORMONE REPLACEMENT THERAPY; POSTMENOPAUSAL WOMEN; ATTITUDES; TRIALS; KNEE	Context Little is known about women's experiences after stopping menopausal hormone therapy. Objective To describe women's symptoms and management strategies after stopping the intervention in a large estrogen plus progestin trial. Design, Setting, and Participants Cross-sectional survey of 8405 women (89.9%; N = 9351) at 40 clinical centers who were still taking study pills (conjugated equine estrogens plus medroxyprogesterone [CEE + MPA] or placebo) when the estrogen plus progestin intervention (Women's Health Initiative) was stopped. Surveys were mailed 8 to 12 months after the stop date. Logistic regression was used to model vasomotor symptoms and pain or stiffness symptoms as functions of former treatment and baseline symptoms, adjusted for appropriate covariates. Main Outcome Measures Symptoms (vasomotor or pain and stiffness) and management strategies. Results Respondents' mean (SD) age at trial stop date was 69.1 (6.7) years. They averaged 5.7 years of taking study pills. Moderate or severe vasomotor symptoms after discontinuing study pill use were reported by 21.2% of former CEE + MPA and 4.8% of placebo group respondents overall and by 55.5% and 21.3%, respectively, with these symptoms at baseline (randomization). Compared with respondents in the former placebo group, moderate or severe vasomotor symptoms (adjusted odds ratio [AOR] 5.82; 95% confidence interval [CI], 4.92-6.89) and pain or stiffness symptoms (AOR, 2.16; 95% Cl, 1.95-2.40) were more likely in respondents in the former CEE + MPA group. Both vasomotor symptoms (AOR, 5.36; 95% Cl, 4.51-6.38) and pain or stiffness symptoms (AOR, 3.21; 95% Cl, 2.90-3.56) also were more likely in women with these symptoms at baseline. Women reported a wide range of strategies to manage symptoms. Conclusions More than half of the women with vasomotor symptoms at randomization to active CEE + MPA also reported these symptoms after discontinuing use of the study pills. However, these participants did not include women who were unwilling to be randomized or who had stopped taking the study pills earlier. These findings should be considered when advising women to treat menopausal symptoms with hormone therapy for as short duration as possible. Investigation of alternative strategies to manage menopausal symptoms is warranted.	Univ Massachusetts, Sch Med, Div Prevent & Behav Med, Worcester, MA 01655 USA; Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, Bronx, NY 10467 USA; Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; Univ Cincinnati, Coll Med, Dept Obstet & Gynecol, Cincinnati, OH 45267 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Prevent Med, Boston, MA USA; Med Coll Wisconsin, Dept Obstet & Gynecol, Milwaukee, WI 53226 USA; SUNY Stony Brook, Dept Prevent Med, Stony Brook, NY 11794 USA; Univ Texas, Hlth Sci Ctr, Dept Obstet & Gynecol, San Antonio, TX 78284 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA	University of Massachusetts System; University of Massachusetts Worcester; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Fred Hutchinson Cancer Center; University System of Ohio; University of Cincinnati; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Medical College of Wisconsin; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; University of Texas System; University of Texas Health San Antonio; Baylor College of Medicine	Ockene, JK (corresponding author), Univ Massachusetts, Sch Med, Div Prevent & Behav Med, 55 Lake Ave N, Worcester, MA 01655 USA.	Judith.Ockene@umassmed.edu	Barad, David/AAF-4332-2021	Barnabei, Vanessa/0000-0002-9650-0143; Hays-Grudo, Jennifer/0000-0002-8107-1243				*AM COLL OBST GYN, 2004, OBSTET GYNECOL, V104, pS62; *AM COLL OBST GYN, QUEST ANSW HORM THER; Avis NE, 2001, SOC SCI MED, V52, P345, DOI 10.1016/S0277-9536(00)00147-7; BARNABEI V, IN PRESS OBSTET GYNE; Barnabei VM, 2002, OBSTET GYNECOL, V100, P1209, DOI 10.1016/S0029-7844(02)02369-4; BARRETTCONNOR E, 2002, BEST CLIN PRACTICES; Blumel JE, 2004, MENOPAUSE, V11, P57, DOI 10.1097/01.GME.0000075503.60230.61; Collins D, 2003, QUAL LIFE RES, V12, P229, DOI 10.1023/A:1023254226592; Conboy L, 2001, MATURITAS, V38, P129, DOI 10.1016/S0378-5122(00)00211-5; David W, 2000, APPL LOGISTIC REGRES, P26, DOI 10.1002/0471722146; Drennan J, 2003, J ADV NURS, V42, P57, DOI 10.1046/j.1365-2648.2003.02579.x; *FOOD DRUG ADM, FDA UPD HORM THER IN; Freedman L, 1996, CONTROL CLIN TRIALS, V17, P509, DOI 10.1016/S0197-2456(96)00016-5; Gordon FT, 1996, HORM BEHAV, V30, P244, DOI 10.1006/hbeh.1996.0029; Gordon S, 2004, OBSTET GYNECOL, V103, P267, DOI 10.1097/01.AOG.0000110247.98588.ff; Grady D, 2003, OBSTET GYNECOL, V102, P1233, DOI 10.1016/j.obstetgynecol.2003.09.025; Greendale GA, 1998, OBSTET GYNECOL, V92, P982, DOI 10.1016/S0029-7844(98)00305-6; Hammar M, 1999, MATURITAS, V31, P117, DOI 10.1016/S0378-5122(98)00101-7; HANNAN MT, 1990, ARTHRITIS RHEUM-US, V33, P525, DOI 10.1002/art.1780330410; Hays J, 2003, NEW ENGL J MED, V348, P1839, DOI 10.1056/NEJMoa030311; Hays J, 2003, ANN EPIDEMIOL, V13, pS18, DOI 10.1016/S1047-2797(03)00042-5; Hersh AL, 2004, JAMA-J AM MED ASSOC, V291, P47, DOI 10.1001/jama.291.1.47; Matthews KA, 1997, AM PSYCHOL, V52, P101, DOI 10.1037/0003-066X.52.2.101; *N AM MEN SOC, 2003, MEN GUID; *N AM MEN SOC, ESTR PROG US PER POS; National Institute of Aging, 2001, MEN ON WOM STOR EV W; Nevitt MC, 2001, ARTHRITIS RHEUM-US, V44, P811, DOI 10.1002/1529-0131(200104)44:4<811::AID-ANR137>3.3.CO;2-6; Newton KM, 2002, OBSTET GYNECOL, V100, P18, DOI 10.1016/S0029-7844(02)02005-7; Reginster JY, 2003, OSTEOARTHR CARTILAGE, V11, P87, DOI 10.1053/joca.2002.0872; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; ROTHERT M, 1994, EXP GERONTOL, V29, P463, DOI 10.1016/0531-5565(94)90026-4; Santoro NF, 2004, MENOPAUSE, V11, P11; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Stefanick ML, 2003, ANN EPIDEMIOL, V13, pS78, DOI 10.1016/S1047-2797(03)00045-0; Will Constance I, 2003, J Holist Nurs, V21, P368, DOI 10.1177/0898010103258605; Zethraeus N, 1997, BRIT J OBSTET GYNAEC, V104, P1191, DOI 10.1111/j.1471-0528.1997.tb10945.x	36	131	134	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 13	2005	294	2					183	193		10.1001/jama.294.2.183	http://dx.doi.org/10.1001/jama.294.2.183			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944DO	16014592	Bronze			2022-12-01	WOS:000230406100022
J	Mayhew, PM; Thomas, CD; Clement, JG; Loveridge, N; Beck, TJ; Bonfield, W; Burgoyne, CJ; Reeve, J				Mayhew, PM; Thomas, CD; Clement, JG; Loveridge, N; Beck, TJ; Bonfield, W; Burgoyne, CJ; Reeve, J			Relation between age, femoral neck cortical stability, and hip fracture risk	LANCET			English	Article							X-RAY ABSORPTIOMETRY; OSTEOPOROTIC FRACTURES; COMPUTED-TOMOGRAPHY; DISTAL FOREARM; BONE TISSUE; STRENGTH; FEMUR; MECHANISM; EVOLUTION; POROSITY	Background Hip fracture risk rises 100 to 1000-fold over 60 years of ageing. Loss of resistance to bending is not a major feature of normal ageing of the femoral neck. Another cause of fragility is local buckling or elastic instability. Bones adapt to their local experience of mechanical loading. The suggestion that bipedalism allows thinning of the underloaded superolateral. femoral neck cortex arises from the failure of walking to transmit much mechanical load to this region. We aimed to measure whether elastic instability increases greatly with age since it might trigger hip fracture in a sideways fall. Methods We measured with computed tomography the distribution of bone in the mid-femoral neck of 77 proximal femurs from people who died suddenly aged 20-95 years. We then calculated the critical stress, from the geometric properties and density of the cortical zone most highly loaded in a sideways fall, as a threshold for elastic instability. Findings With normal ageing, this thin cortical zone in the upper femoral neck became substantially thinner. Relative to mean values at age 60 years, female cortical thickness declined by 6.4% (SD 1.1) per decade (p<0.0001), and critical stress by 13.2% (4.3) per decade (p=0.004) in the superoposterior octant compressed most in a sideways fall. Similar, but significantly smaller, effects were evident in men (p=0.004). This thinning compromised the capacity of the femur to absorb energy independently of osteoporosis. Patients with hip fracture had further reduced stability. Interpretation As women age, hip fragility increases because underloading of the superolateral cortex leads to atrophic thinning. Because walking does not sufficiently load the upper femoral neck, the fragile zones in healthy bones may need strengthening, for example with more well targeted exercise.	Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England; Univ Cambridge, Dept Mat Sci, Cambridge, England; Univ Cambridge, Dept Engn, Cambridge, England; Univ Melbourne, Sch Dent Sci, Parkville, Vic 3052, Australia; Johns Hopkins Univ, Dept Radiol, Baltimore, MD USA	University of Cambridge; University of Cambridge; University of Cambridge; University of Melbourne; Johns Hopkins University	Reeve, J (corresponding author), Addenbrookes Hosp, Dept Med, Box 157, Cambridge CB2 2QQ, England.	jr357@cam.ac.uk	Reeve, Jonathan/C-7551-2012; Thomas, Christopher DL/B-1117-2008; clement, john G/C-9303-2013	Reeve, Jonathan/0000-0002-4364-2682; Thomas, Christopher DL/0000-0001-7668-4259; clement, john/0000-0001-5348-5898; Loveridge, Nigel/0000-0002-5550-7584				ADEBAJO AO, 1991, AGE AGEING, V20, P435, DOI 10.1093/ageing/20.6.435; Aspray TJ, 1996, J BONE MINER RES, V11, P1019; Beck TJ, 2000, J BONE MINER RES, V15, P2297, DOI 10.1359/jbmr.2000.15.12.2297; Bell KL, 1999, BONE, V24, P57, DOI 10.1016/S8756-3282(98)00143-4; Bell KL, 2000, BONE, V27, P297, DOI 10.1016/S8756-3282(00)00318-5; BURSTEIN AH, 1976, J BONE JOINT SURG AM, V58, P82, DOI 10.2106/00004623-197658010-00015; CARTER DR, 1977, J BONE JOINT SURG AM, V59, P954, DOI 10.2106/00004623-197759070-00021; COUPLAND C, 1993, J EPIDEMIOL COMMUN H, V47, P441, DOI 10.1136/jech.47.6.441; Crabtree N, 2001, J BONE MINER RES, V16, P1318, DOI 10.1359/jbmr.2001.16.7.1318; Crabtree NJ, 2002, OSTEOPOROSIS INT, V13, P48, DOI 10.1007/s198-002-8337-y; *GAL GAL LINC, 1638, DISC DIM MAT INT DUE; Hangartner TN, 1996, J BONE MINER RES, V11, P1518, DOI 10.1002/jbmr.5650111019; Kaptoge S, 2003, BONE, V32, P561, DOI 10.1016/S8756-3282(03)00055-3; Kaptoge S, 2003, OSTEOPOROSIS INT, V14, P941, DOI 10.1007/s00198-003-1484-2; LOTZ JC, 1995, OSTEOPOROSIS INT, V5, P252, DOI 10.1007/BF01774015; LOVEJOY CO, 1988, SCI AM, V259, P118, DOI 10.1038/scientificamerican1188-118; Loveridge N, 2004, BONE, V35, P929, DOI 10.1016/j.bone.2004.05.025; Mayhew P, 2004, BONE, V34, P352, DOI 10.1016/j.bone.2003.11.012; MELTON LJ, 1990, CALCIFIED TISSUE INT, V46, P285; Mosley JR, 1997, BONE, V20, P191, DOI 10.1016/S8756-3282(96)00385-7; NEVITT MC, 1993, J AM GERIATR SOC, V41, P1226, DOI 10.1111/j.1532-5415.1993.tb07307.x; Noble BS, 2003, AM J PHYSIOL-CELL PH, V284, pC934, DOI 10.1152/ajpcell.00234.2002; ONeill TW, 1995, J EPIDEMIOL COMMUN H, V49, P597, DOI 10.1136/jech.49.6.597; POWER J, 2004, OSTEOPOROS INT  1126; ROBINOVITCH SN, 1991, J BIOMECH ENG-T ASME, V113, P366, DOI 10.1115/1.2895414; Thomas CDL, 2000, J ANAT, V196, P463, DOI 10.1046/j.1469-7580.2000.19630463.x; TIMOSHENKO SP, 1979, THEORY ELASTIC STABI; Van Rietbergen B, 2003, J BONE MINER RES, V18, P1781, DOI 10.1359/jbmr.2003.18.10.1781; VANBUSKIRK WC, 1989, BONE MECH, P43; Vashishth D, 2003, J BIOMECH, V36, P121, DOI 10.1016/S0021-9290(02)00319-6; WAND JS, 1990, CLIN ORTHOP RELAT R, V278, P88; Yan L, 1999, BONE, V24, P151, DOI 10.1016/S8756-3282(98)00168-9; YOSHIKAWA T, 1994, J BONE MINER RES, V9, P1053; Zioupos P, 1998, BONE, V22, P57, DOI 10.1016/S8756-3282(97)00228-7	34	307	315	0	27	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 9	2005	366	9480					129	135		10.1016/S0140-6736(05)66870-5	http://dx.doi.org/10.1016/S0140-6736(05)66870-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	943JH	16005335				2022-12-01	WOS:000230349200031
J	Shakarishvili, A; Dubovskaya, LK; Zohrabyan, LS; St Lawrence, JS; Aral, SO; Dugasheva, LG; Okan, SA; Lewis, JS; Parker, KA; Ryan, CA				Shakarishvili, A; Dubovskaya, LK; Zohrabyan, LS; St Lawrence, JS; Aral, SO; Dugasheva, LG; Okan, SA; Lewis, JS; Parker, KA; Ryan, CA		LIBRA Project Investigation Team	Sex work, drug use, HIV infection, and spread of sexually transmitted infections in Moscow, Russian Federation	LANCET			English	Article								Rates of HIV-1 infection are growing rapidly, and the epidemic of sexually transmitted infections is continuing at an alarming rate, in the Russian Federation. We did a cross-sectional study of sexually transmitted infections, HIV infection, and drug use in street youth at a juvenile detention facility, adults at homeless detention centres, and women and men at a remand Centre in Moscow. 160 (79%) women at the remand Centre were sex workers. 91 (51%) homeless women had syphilis. At least one bacterial sexually transmitted infection was present in 97 (58%) female juvenile detainees, 120 (64%) women at the remand Centre, and 133 (75%) homeless women. HIV seroprevalence was high in women at the remand Centre (n=7 [4%]), adolescent male detainees (5 [3%]), and homeless women (4 [2%]). In view of the interaction between sexually transmitted infections and HIV infection, these findings of high prevalence of sexually transmitted infections show that these disenfranchised populations have the potential to make a disproportionately high contribution to the explosive growth of the HIV epidemic unless interventions targeting these groups are implemented in the Russian Federation.	US Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; Russian Assoc Prevent STIs Sanam, Moscow, Russia; Sechenov Moscow Med Acad, Moscow, Russia	Centers for Disease Control & Prevention - USA; Sechenov First Moscow State Medical University	Shakarishvili, A (corresponding author), US Ctr Dis Control & Prevent, Mail Stop E-04,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	afsg@cdc.gov						Aral SO, 2003, SEX TRANSM DIS, V30, P39, DOI 10.1097/00007435-200301000-00009; Field MG, 2004, NEW ENGL J MED, V351, P117, DOI 10.1056/NEJMp048066; Lowndes C. M., 2003, International Journal of Drug Policy, V14, P45, DOI 10.1016/S0955-3959(02)00208-6; *MOSC CIT HLTH COM, 2002, SAN EP SURV REP HIV; *MOSC CIT HLTH COM, 2001, SAN EP SURV REP HIV; *UN, 2004, HIV AIDS E EUR COMM	6	54	54	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 2	2005	366	9479					57	60		10.1016/S0140-6736(05)66828-6	http://dx.doi.org/10.1016/S0140-6736(05)66828-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942JB	15993234				2022-12-01	WOS:000230277600035
J	Ammann, P; Sticherling, C; Kalusche, D; Eckstein, J; Bernheim, A; Schaer, B; Osswald, S				Ammann, P; Sticherling, C; Kalusche, D; Eckstein, J; Bernheim, A; Schaer, B; Osswald, S			An electrocardiogram-based algorithm to detect loss of left ventricular capture during cardiac resynchronization therapy	ANNALS OF INTERNAL MEDICINE			English	Article							CHRONIC HEART-FAILURE; BUNDLE-BRANCH-BLOCK; DEFIBRILLATION; ASYNCHRONY; MORTALITY; TRIAL; SITE	Background: Loss of left ventricular capture in patients with cardiac resynchronization devices may account for worsening heart failure and can be difficult to diagnose without a programmer. Objective: To determine whether distinct morphologic changes on the surface electrocardiogram indicate loss of left ventricular capture. Design: After analysis of the R-S spike ratio in the 12-lead electrocardiogram during right ventricular and biventricular pacing in 10 patients, an algorithm to detect loss of left ventricular capture was developed. Setting: University hospital. Patients: 54 patients with a cardiac resynchronization device and underlying left bundle-branch block. Measurements: Leads V1 and I of a 12-lead electrocardiogram were assessed after biventricular pacing was confirmed and after the device was programmed to right ventricular pacing only (simulating loss of left ventricular capture). Results: The sensitivity of the algorithm to correctly identify loss of left ventricular capture was 94% (95% Cl, 88.2% to 97.7%), and the specificity was 93% (Cl, 86.3% to 95.8%). The likelihood ratio of a positive test result was 12.8 (Cl, 6.443 to 23.310), and the likelihood ratio of a negative test result was 0.06 (Cl, 0.024 to 0.137). Limitations: The algorithm was tested in patients in whom the right ventricular electrode was placed in the apex of the right ventricle only. Conclusion: Presence of biventricular capture-the prerequisite for successful cardiac resynchronization therapy-and loss of left ventricular capture can be accurately detected by an algorithm based on analysis of the R-S ratio on leads V1 and I of the surface electrocardiogram.	Univ Basel Hosp, CH-4031 Basel, Switzerland; Kantonsspital St Gallen, St Gallen, Switzerland; Herz Zentrum Bad Krozingen, Bad Krozingen, Germany	University of Basel	Ammann, P (corresponding author), Univ Basel Hosp, CH-4031 Basel, Switzerland.	peter.ammann@kssg.ch	Sticherling, Christian/AAY-4435-2021; Osswald, Stefan/A-6904-2018	Sticherling, Christian/0000-0001-8428-7050; Osswald, Stefan/0000-0002-9240-6731				Abraham WT, 2002, NEW ENGL J MED, V346, P1845, DOI 10.1056/NEJMoa013168; Auricchio A, 1999, AM J CARDIOL, V83, p136D; Bradley DJ, 2003, JAMA-J AM MED ASSOC, V289, P730, DOI 10.1001/jama.289.6.730; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Bristow MR, 2000, J CARD FAIL, V6, P276, DOI 10.1054/jcaf.2000.9501; Cazeau S, 2001, NEW ENGL J MED, V344, P873, DOI 10.1056/NEJM200103223441202; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Eriksson P, 1998, CIRCULATION, V98, P2494, DOI 10.1161/01.CIR.98.22.2494; Fleiss J.L., 1981, STAT METHODS RATES P; Garrigue S, 2001, AM J CARDIOL, V88, P1436, DOI 10.1016/S0002-9149(01)02131-2; GRINES CL, 1989, CIRCULATION, V79, P845, DOI 10.1161/01.CIR.79.4.845; Janousek J, 2004, J AM COLL CARDIOL, V44, P1927, DOI 10.1016/j.jacc.2004.08.044; Meisel E, 2001, CIRCULATION, V104, P442, DOI 10.1161/hc2901.093145; Muntwyler J, 2002, EUR HEART J, V23, P1861, DOI 10.1053/euhj.2002.3282; Pitzalis MV, 2002, J AM COLL CARDIOL, V40, P1615, DOI 10.1016/S0735-1097(02)02337-9; Ricci R, 2002, J INTERV CARD ELECTR, V6, P279, DOI 10.1023/A:1019570022647; Yee R, 2004, PACE, V27, P894, DOI 10.1111/j.1540-8159.2004.00553.x; Young JB, 2003, JAMA-J AM MED ASSOC, V289, P2685, DOI 10.1001/jama.289.20.2685	18	32	34	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2005	142	12	1				968	973		10.7326/0003-4819-142-12_Part_1-200506210-00006	http://dx.doi.org/10.7326/0003-4819-142-12_Part_1-200506210-00006			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	937IN	15968011				2022-12-01	WOS:000229917900003
J	Scott, TF; Schneider, AD; Cook, WD; Bowman, CN				Scott, TF; Schneider, AD; Cook, WD; Bowman, CN			Photoinduced plasticity in cross-linked polymers	SCIENCE			English	Article							RING-OPENING POLYMERIZATION; CONTROLLED MOLECULAR-WEIGHT; CYCLIC ALLYLIC SULFIDES	Chemically cross-linked polymers are inherently limited by stresses that are introduced by post-gelation volume changes during polymerization. It is also difficult to change a cross-linked polymer's shape without a corresponding loss of material properties or substantial stress development. We demonstrate a cross-linked polymer that, upon exposure to light, exhibits stress and/or strain relaxation without any concomitant change in material properties. This result is achieved by introducing radicals via photocleavage of residual photoinitiator in the polymer matrix, which then diffuse via addition-fragmentation chain transfer of midchain functional groups. These processes lead to photoinduced plasticity, actuation, and equilibrium shape changes without residual stress. Such polymeric materials are critical to the development of microdevices, biomaterials, and polymeric coatings.	Univ Colorado, Dept Biol & Chem Engn, Boulder, CO 80309 USA; Monash Univ, Sch Phys & Mat Engn, Clayton, Vic 3800, Australia	University of Colorado System; University of Colorado Boulder; Monash University	Bowman, CN (corresponding author), Univ Colorado, Dept Biol & Chem Engn, Boulder, CO 80309 USA.	christopher.bowman@colorado.edu	Bowman, Christopher N/B-1490-2008; Cook, Wayne D/A-4787-2012	Bowman, Christopher N/0000-0001-8458-7723; 	NIDCR NIH HHS [DE12998, DE10959] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE010959, R01DE012998, R29DE010959] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Adhikari B, 2000, PROG POLYM SCI, V25, P909, DOI 10.1016/S0079-6700(00)00020-4; BILLMEYER FW, 1984, TXB POLYM SCI, P436; Chen XX, 2002, SCIENCE, V295, P1698, DOI 10.1126/science.1065879; Cramer NB, 2001, J POLYM SCI POL CHEM, V39, P3311, DOI 10.1002/pola.1314; Evans RA, 2001, J POLYM SCI POL CHEM, V39, P202, DOI 10.1002/1099-0518(20010101)39:1<202::AID-POLA230>3.0.CO;2-6; Evans RA, 1996, MACROMOLECULES, V29, P6983, DOI 10.1021/ma960573p; EVANS RA, 1994, MACROMOLECULES, V27, P7935, DOI 10.1021/ma00104a062; Evans RA, 2000, MACROMOLECULES, V33, P6722, DOI 10.1021/ma9917646; Kim BK, 1996, POLYMER, V37, P5781, DOI 10.1016/S0032-3861(96)00442-9; Lendlein A, 2001, P NATL ACAD SCI USA, V98, P842, DOI 10.1073/pnas.031571398; MEIJS GF, 1991, MACROMOLECULES, V24, P3689, DOI 10.1021/ma00012a033; MEIJS GF, 1988, MACROMOLECULES, V21, P3122, DOI 10.1021/ma00188a039; Sanda F, 2001, J POLYM SCI POL CHEM, V39, P265, DOI 10.1002/1099-0518(20010115)39:2<265::AID-POLA20>3.0.CO;2-D; Sunder A, 1999, MACROMOL CHEM PHYSIC, V200, P58, DOI 10.1002/(SICI)1521-3935(19990101)200:1<58::AID-MACP58>3.0.CO;2-C	14	542	558	17	369	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2005	308	5728					1615	1617		10.1126/science.1110505	http://dx.doi.org/10.1126/science.1110505			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	936BH	15947185				2022-12-01	WOS:000229827000053
J	Nelson, R; Sawaya, MR; Balbirnie, M; Madsen, AO; Riekel, C; Grothe, R; Eisenberg, D				Nelson, R; Sawaya, MR; Balbirnie, M; Madsen, AO; Riekel, C; Grothe, R; Eisenberg, D			Structure of the cross-beta spine of amyloid-like fibrils	NATURE			English	Article							X-RAY-DIFFRACTION; MOLECULAR-BASIS; PROTEIN MODELS; CORE STRUCTURE; SHEET; PEPTIDE; TRANSTHYRETIN; CONFORMATION; CONVERSION; REVEALS	Numerous soluble proteins convert to insoluble amyloid-like fibrils that have common properties. Amyloid fibrils are associated with fatal diseases such as Alzheimer's, and amyloid-like fibrils can be formed in vitro. For the yeast protein Sup35, conversion to amyloid-like fibrils is associated with a transmissible infection akin to that caused by mammalian prions. A seven-residue peptide segment from Sup35 forms amyloid-like fibrils and closely related microcrystals, from which we have determined the atomic structure of the cross-beta spine. It is a double beta-sheet, with each sheet formed from parallel segments stacked in register. Side chains protruding from the two sheets form a dry, tightly self-complementing steric zipper, bonding the sheets. Within each sheet, every segment is bound to its two neighbouring segments through stacks of both backbone and side-chain hydrogen bonds. The structure illuminates the stability of amyloid fibrils, their self-seeding characteristic and their tendency to form polymorphic structures.	Univ Calif Los Angeles, Howard Hughes Med Inst, UCLA DOE Inst Genom & Proteom, Los Angeles, CA 90095 USA; European Synchrotron Radiat Facil, F-38043 Grenoble, France; Univ Copenhagen, Ctr Crystallog Studies, Dept Chem, DK-2100 KBH, Denmark	Howard Hughes Medical Institute; United States Department of Energy (DOE); University of California System; University of California Los Angeles; European Synchrotron Radiation Facility (ESRF); University of Copenhagen	Eisenberg, D (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, UCLA DOE Inst Genom & Proteom, Box 951570, Los Angeles, CA 90095 USA.	david@mbi.ucla.edu	Madsen, Anders Østergaard/B-4760-2015	Madsen, Anders Østergaard/0000-0001-5422-8076; Sawaya, Michael/0000-0003-0874-9043	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM031299, T32GM007185] Funding Source: NIH RePORTER; NIGMS NIH HHS [P01 GM031299, T32 GM007185] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balbirnie M, 2001, P NATL ACAD SCI USA, V98, P2375, DOI 10.1073/pnas.041617698; Benzinger TLS, 1998, P NATL ACAD SCI USA, V95, P13407, DOI 10.1073/pnas.95.23.13407; COHEN AS, 1959, NATURE, V183, P1202, DOI 10.1038/1831202a0; COULSON CA, 1966, PROC R SOC LON SER-A, V291, P445, DOI 10.1098/rspa.1966.0105; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; DeLano WL., 2002, PYMOL USERS MANUAL D; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Diaz-Avalos R, 2003, J MOL BIOL, V330, P1165, DOI 10.1016/S0022-2836(03)00659-4; EANES ED, 1968, J HISTOCHEM CYTOCHEM, V16, P673, DOI 10.1177/16.11.673; EISENBERG D, 1989, CHEM SCRIPTA, V29A, P217; Fandrich M, 2002, EMBO J, V21, P5682, DOI 10.1093/emboj/cdf573; GEDDES AJ, 1968, J MOL BIOL, V32, P343, DOI 10.1016/0022-2836(68)90014-4; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Ivanova MI, 2004, P NATL ACAD SCI USA, V101, P10584, DOI 10.1073/pnas.0403756101; Jaroniec CP, 2002, P NATL ACAD SCI USA, V99, P16748, DOI 10.1073/pnas.252625999; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Jimenez JL, 1999, EMBO J, V18, P815, DOI 10.1093/emboj/18.4.815; Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Kishimoto A, 2004, BIOCHEM BIOPH RES CO, V315, P739, DOI 10.1016/j.bbrc.2004.01.117; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Makin OS, 2005, P NATL ACAD SCI USA, V102, P315, DOI 10.1073/pnas.0406847102; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5591, DOI 10.1073/pnas.042681399; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Pickersgill RW, 2003, STRUCTURE, V11, P137, DOI 10.1016/S0969-2126(03)00009-1; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Riekel C, 2004, J SYNCHROTRON RADIAT, V11, P4, DOI 10.1107/S090904950302541X; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; Serag AA, 2001, BIOCHEMISTRY-US, V40, P9089, DOI 10.1021/bi010655s; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; Sivaraman T, 1998, J BIOL CHEM, V273, P10181, DOI 10.1074/jbc.273.17.10181; Sunde M, 1998, Q REV BIOPHYS, V31, P1, DOI 10.1017/S0033583598003400; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tjernberg L, 2002, J BIOL CHEM, V277, P43243, DOI 10.1074/jbc.M205570200; Torok M, 2002, J BIOL CHEM, V277, P40810, DOI 10.1074/jbc.M205659200; VARLEY P, 1993, SCIENCE, V260, P1110, DOI 10.1126/science.8493553; VRIEND G, 1993, J APPL CRYSTALLOGR, V26, P47, DOI 10.1107/S0021889892008240; Wetzel R, 2002, STRUCTURE, V10, P1031, DOI 10.1016/S0969-2126(02)00809-2; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Williams AD, 2004, J MOL BIOL, V335, P833, DOI 10.1016/j.jmb.2003.11.008	50	1729	1765	5	420	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2005	435	7043					773	778		10.1038/nature03680	http://dx.doi.org/10.1038/nature03680			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933NK	15944695	Green Accepted			2022-12-01	WOS:000229638700041
J	Sotin, C; Jaumann, R; Buratti, BJ; Brown, RH; Clark, RN; Soderblom, LA; Baines, KH; Bellucci, G; Bibring, JP; Capaccioni, F; Cerroni, P; Combes, M; Coradini, A; Cruikshank, DP; Drossart, P; Formisano, V; Langevin, Y; Matson, DL; McCord, TB; Nelson, RM; Nicholson, PD; Sicardy, B; LeMouelic, S; Rodriguez, S; Stephan, K; Scholz, CK				Sotin, C; Jaumann, R; Buratti, BJ; Brown, RH; Clark, RN; Soderblom, LA; Baines, KH; Bellucci, G; Bibring, JP; Capaccioni, F; Cerroni, P; Combes, M; Coradini, A; Cruikshank, DP; Drossart, P; Formisano, V; Langevin, Y; Matson, DL; McCord, TB; Nelson, RM; Nicholson, PD; Sicardy, B; LeMouelic, S; Rodriguez, S; Stephan, K; Scholz, CK			Release of volatiles from a possible cryovolcano from near-infrared imaging of Titan	NATURE			English	Article							OCEAN	Titan is the only satellite in our Solar System with a dense atmosphere. The surface pressure is 1.5 bar ( ref. 1) and, similar to the Earth, N-2 is the main component of the atmosphere. Methane is the second most important component(2), but it is photodissociated on a timescale of 10(7) years ( ref. 3). This short timescale has led to the suggestion that Titan may possess a surface or subsurface reservoir of hydrocarbons(4,5) to replenish the atmosphere. Here we report near-infrared images of Titan obtained on 26 October 2004 by the Cassini spacecraft. The images show that a widespread methane ocean does not exist; subtle albedo variations instead suggest topographical variations, as would be expected for a more solid ( perhaps icy) surface. We also find a circular structure similar to 30 km in diameter that does not resemble any features seen on other icy satellites. We propose that the structure is a dome formed by upwelling icy plumes that release methane into Titan's atmosphere.	Univ Nantes, CNRS, UMR 6112, Lab Planetol & Geodynam, F-44100 Nantes, France; DLR, Inst Planetary Explorat, D-12489 Berlin, Germany; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Univ Arizona, Stewart Observ, Tucson, AZ 85721 USA; US Geol Survey, Denver, CO 80225 USA; US Geol Survey, Flagstaff, AZ 86011 USA; CNR, Ist Fis Spazio Interplanetario, I-00133 Rome, Italy; Univ Paris 11, Inst Astrophys Spatiale, F-91405 Orsay, France; CNR, Ist Astrofis Spaziale & Fis Cosmica, I-00133 Rome, Italy; Observ Paris, F-92195 Meudon, France; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Nantes Universite; Helmholtz Association; German Aerospace Centre (DLR); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Arizona; University of Arizona; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale Astrofisica (INAF); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale Astrofisica (INAF); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Washington; University of Washington Seattle; Cornell University	Sotin, C (corresponding author), Univ Nantes, CNRS, UMR 6112, Lab Planetol & Geodynam, F-44100 Nantes, France.	Christophe.Sotin@univ-nantes.fr	Bellucci, Giancarlo/ABA-9201-2020; Drossart, Pierre/H-8670-2013; Stephan, Katrin/U-2524-2018; Rodriguez, Sebastien/H-5902-2016; Jaumann, Ralf/N-1001-2018	Bellucci, Giancarlo/0000-0003-0867-8679; Rodriguez, Sebastien/0000-0003-1219-0641; Jaumann, Ralf/0000-0002-9759-6597; Capaccioni, Fabrizio/0000-0003-1631-4314; Le Mouelic, Stephane/0000-0001-5260-1367; Cerroni, Priscilla/0000-0003-0239-2741				Brown RH, 2003, ICARUS, V164, P461, DOI 10.1016/S0019-1035(03)00134-9; Gibbard SG, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019803; KUIPER GP, 1944, ASTORPHYS J, V100, P329; LELLOUCH E, 1990, ANN GEOPHYS-ATM HYDR, V8, P653; LUCCHITTA BK, 1980, ICARUS, V44, P481, DOI 10.1016/0019-1035(80)90039-1; LUNINE JI, 1993, REV GEOPHYS, V31, P133, DOI 10.1029/92RG02794; LUNINE JI, 1983, SCIENCE, V222, P1229, DOI 10.1126/science.222.4629.1229; Meier R, 2000, ICARUS, V145, P462, DOI 10.1006/icar.2000.6360; Sotin C, 2004, CR PHYS, V5, P769, DOI 10.1016/j.crhy.2004.08.001; Sotin C, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013844; YUNG YL, 1984, ASTROPHYS J SUPPL S, V55, P465, DOI 10.1086/190963	11	149	152	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2005	435	7043					786	789		10.1038/nature03596	http://dx.doi.org/10.1038/nature03596			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933NK	15944697	Green Submitted			2022-12-01	WOS:000229638700043
J	Marketon, MM; DePaolo, RW; DeBord, KL; Jabri, B; Schneewind, O				Marketon, MM; DePaolo, RW; DeBord, KL; Jabri, B; Schneewind, O			Plague bacteria target immune cells during infection	SCIENCE			English	Article							YERSINIA YOP PROTEINS; V-ANTIGEN; III SECRETION; BETA-LACTAMASE; BUBONIC PLAGUE; HELA-CELLS; PESTIS; TRANSLOCATION; ENTEROCOLITICA; CYTOSOL	The plague is caused by the bacterium Yersinia pestis. Plague bacteria are thought to inject effector Yop proteins into host cells via the type III pathway. The identity of the host cells targeted for injection during plague infection is unknown. We found, using Yop beta-lactamase hybrids and fluorescent staining of live cells from plague-infected animals, that Y. pestis selected immune cells for injection. In vivo, dendritic cells, macrophages, and neutrophils were injected most frequently, whereas B and T lymphocytes were rarely selected. Thus, it appears that Y. pestis disables these cell populations to annihilate host immune responses during plague.	Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA; Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Schneewind, O (corresponding author), Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA.	oschnee@bsd.uchicago.edu		DePaolo, William/0000-0002-3880-4544	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153] Funding Source: NIH RePORTER; NIAID NIH HHS [U54 AI057153-01, U54 AI057153-02, U54 AI057153, 1-U54-AI-057153] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLAOUI A, 1994, J BACTERIOL, V176, P4534, DOI 10.1128/JB.176.15.4534-4542.1994; Anderson GW, 1996, INFECT IMMUN, V64, P4580, DOI 10.1128/IAI.64.11.4580-4585.1996; BRUBAKER RR, 1969, J BACTERIOL, V98, P1404, DOI 10.1128/JB.98.3.1404-1406.1969; Charpentier X, 2004, J BACTERIOL, V186, P5486, DOI 10.1128/JB.186.16.5486-5495.2004; Cheng LW, 1997, MOL MICROBIOL, V24, P757, DOI 10.1046/j.1365-2958.1997.3831750.x; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; Cornelis GR, 2002, J CELL BIOL, V158, P401, DOI 10.1083/jcb.200205077; Day JB, 2003, MOL MICROBIOL, V47, P807, DOI 10.1046/j.1365-2958.2003.03343.x; HAKANSSON S, 1993, INFECT IMMUN, V61, P71; Hakansson S, 1996, EMBO J, V15, P5812, DOI 10.1002/j.1460-2075.1996.tb00968.x; Lee VT, 2000, J BIOL CHEM, V275, P36869, DOI 10.1074/jbc.M002467200; Lee VT, 1998, MOL MICROBIOL, V28, P593, DOI 10.1046/j.1365-2958.1998.00822.x; PERRY RD, 1986, INFECT IMMUN, V54, P428, DOI 10.1128/IAI.54.2.428-434.1986; Philipovskiy AV, 2005, INFECT IMMUN, V73, P1532, DOI 10.1128/IAI.73.3.1532-1542.2005; ROSQVIST R, 1994, EMBO J, V13, P964, DOI 10.1002/j.1460-2075.1994.tb06341.x; Sebbane F, 2005, AM J PATHOL, V166, P1427, DOI 10.1016/S0002-9440(10)62360-7; Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998; UNE T, 1984, J IMMUNOL, V133, P2226; Zlokarnik G, 1998, SCIENCE, V279, P84, DOI 10.1126/science.279.5347.84	19	265	276	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2005	309	5741					1739	1741		10.1126/science.1114580	http://dx.doi.org/10.1126/science.1114580			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963WK	16051750	Green Accepted			2022-12-01	WOS:000231836700049
J	Pillai, RS; Bhattacharyya, SN; Artus, CG; Zoller, T; Cougot, N; Basyuk, E; Bertrand, E; Filipowicz, W				Pillai, RS; Bhattacharyya, SN; Artus, CG; Zoller, T; Cougot, N; Basyuk, E; Bertrand, E; Filipowicz, W			Inhibition of translational initiation by Let-7 microRNA in human cells	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; PROCESSING BODIES; MESSENGER-RNAS; PROTEIN-SYNTHESIS; EIF4E; MECHANISMS; EXPRESSION; SITES; DECAY	MicroRNAs (miRNAs) are similar to 21-nucteotide-long RNA molecules regulating gene expression in multicellular eukaryotes. In metazoa, miRNAs act by imperfectly base-pairing with the 3' untranslated region of target messenger RNAs (mRNAs) and repressing protein accumulation by an unknown mechanism. We demonstrate that endogenous let-7 microribonucleoproteins (miRNPs) or the tethering of Argonaute (Ago) proteins to reporter mRNAs in human cells inhibit translation initiation. M(7)G-cap-independent translation is not subject to repression, suggesting that miRNPs interfere with recognition of the cap. Repressed mRNAs, Ago proteins, and miRNAs were all found to accumulate in processing bodies. We propose that localization of mRNAs to these structures is a consequence of translational repression.	Friedrich Miescher Inst Biomed Res, CH-4002 Basel, Switzerland; Inst Genet Mol Montpellier, F-34000 Montpellier, France	Friedrich Miescher Institute for Biomedical Research; Universite de Montpellier	Filipowicz, W (corresponding author), Friedrich Miescher Inst Biomed Res, CH-4002 Basel, Switzerland.	Filipowi@fmi.ch	Cougot, Nicolas/K-8688-2012	Cougot, Nicolas/0000-0001-6614-8380; bertrand, edouard/0000-0002-9642-7994; Basyuk, Eugenia/0000-0001-9768-4557				Anderson P, 2002, J CELL SCI, V115, P3227; Andrei MA, 2005, RNA, V11, P717, DOI 10.1261/rna.2340405; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; CHANG J, 2004, RNA BIOL, V1, P2; Cho PF, 2005, CELL, V121, P411, DOI 10.1016/j.cell.2005.02.024; De Gregorio E, 2001, RNA, V7, P106, DOI 10.1017/S1355838201000577; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kolb FA, 2005, METHOD ENZYMOL, V392, P316, DOI 10.1016/S0076-6879(04)92019-8; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; PILLAI R, UNPUB; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Seggerson K, 2002, DEV BIOL, V243, P215, DOI 10.1006/dbio.2001.0563; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; Seydoux G, 1999, DEVELOPMENT, V126, P3275; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100	25	1056	1124	0	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2005	309	5740					1573	1576		10.1126/science.1115079	http://dx.doi.org/10.1126/science.1115079			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962EY	16081698				2022-12-01	WOS:000231715000053
J	Zhou, FJ; Harpaz, R; Jumaan, AO; Winston, CA; Shefer, A				Zhou, FJ; Harpaz, R; Jumaan, AO; Winston, CA; Shefer, A			Impact of varicella vaccination on health care utilization	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; HOSPITALIZATIONS; ZOSTER; IMMUNIZATION; MORTALITY; CHILDREN; DECLINE	Context Since varicella vaccine was first recommended for routine immunization in the United States in 1995, the incidence of disease has dropped substantially. However, national surveillance data are incomplete, and comprehensive data regarding outpatient as well as hospital utilization have not been reported. Objective To examine the impact of the varicella vaccination program on medical visits and associated expenditures. Design, Setting, and Patients Retrospective population-based study examining the trends in varicella health care utilization, based on data from the MarketScan databases, which include enrollees (children and adults) of more than 100 health insurance plans of approximately 40 large US employers, from 1994 to 2002. Main Outcome Measures Trends in rates of varicella-related hospitalizations and ambulatory visits and direct medical expenditures for hospitalizations and ambulatory visits, analyzed using 1994 and 1995 as the prevaccination baseline. Results From the prevaccination period to 2002, hospitalizations due to varicella declined by 88% (from 2.3 to 0.3 per 100000 population) and ambulatory visits declined by 59% (from 215 to 89 per 100000 population). Hospitalizations and ambulatory visits declined in all age groups, with the greatest declines among infants younger than 1 year. Total estimated direct medical expenditures for varicella hospitalizations and ambulatory visits declined by 74%, from an average of $84.9 million in 1994 and 1995 to $22.1 million in 2002. Conclusion Since the introduction of the varicella vaccination program, varicella hospitalizations, ambulatory visits, and their associated expenditures have declined dramatically among all age groups in the United States.	Ctr Dis Control & Prevent, Natl Immunizat Program, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Zhou, FJ (corresponding author), Ctr Dis Control & Prevent, Natl Immunizat Program, 1600 Clifton Rd NE,Mail Stop E-52, Atlanta, GA 30333 USA.	faz1@cdc.gov						[Anonymous], 1999, MMWR Recomm Rep, V48, P1; [Anonymous], 2001, MMWR-MORBID MORTAL W, V50, P637; Barker L, 2002, MMWR Morb Mortal Wkly Rep, V51, P664; Bramley J C, 2000, Commun Dis Public Health, V3, P282; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P884; Comm Infect Dis, 2000, PEDIATRICS, V105, P136; Davis MM, 2005, VACCINE, V23, P3053, DOI 10.1016/j.vaccine.2004.10.047; Davis MM, 2004, PEDIATRICS, V114, P786, DOI 10.1542/peds.2004-0012; Galil K, 2002, PEDIATR INFECT DIS J, V21, P931, DOI 10.1097/00006454-200210000-00009; GERSHON AA, 1999, VACCINES, P475; HALL CB, 1995, PEDIATRICS, V95, P791; HALLORAN ME, 1994, AM J EPIDEMIOL, V140, P81, DOI 10.1093/oxfordjournals.aje.a117238; Jumaan AO, 2005, J INFECT DIS, V191, P2002, DOI 10.1086/430325; Kann Laura, 1996, Morbidity and Mortality Weekly Report, V45, P1; Kuter B, 2004, PEDIATR INFECT DIS J, V23, P132, DOI 10.1097/01.inf.0000109287.97518.67; Lee BW, 1998, TROP MED INT HEALTH, V3, P886; Liu S C, 1998, J Microbiol Immunol Infect, V31, P217; *MEDSTAT GROUP, 2000, MARKETSCAN; Meyer PA, 2000, J INFECT DIS, V182, P383, DOI 10.1086/315714; National Center for Health Statistics, 2004, HLTH US 2004 CHARTB; Nguyen HQ, 2005, NEW ENGL J MED, V352, P450, DOI 10.1056/NEJMoa042271; Patel RA, 2004, J PEDIATR-US, V144, P68, DOI 10.1016/j.jpeds.2003.10.025; Ratner AJ, 2002, PEDIATR INFECT DIS J, V21, P927, DOI 10.1097/00006454-200210000-00008; Seward JF, 2002, JAMA-J AM MED ASSOC, V287, P606, DOI 10.1001/jama.287.5.606; *US CENS BUR, PROJ TOT RES POP 5 Y; *US CENS BUR, METR MICR STAT AR DE; *US CENS BUR, RES POP EST US AG SE; US Department of Labor. Bureau of Labor Statistics, CONS PRIC IND; Vazquez M, 2001, NEW ENGL J MED, V344, P955, DOI 10.1056/NEJM200103293441302; Wharton M, 1996, INFECT DIS CLIN N AM, V10, P571, DOI 10.1016/S0891-5520(05)70313-5; 2003, MMWR MORB MORTAL WKL, V52, P728; 1999, MMWR MORB MORTAL WKL, V48, P829; 2004, MMWR MORB MORTAL WKL, V53, P658; 1998, MMWR MORB MORTAL WKL, V47, P547; 2000, MMWR MORB MORTAL WKL, V49, P585	35	167	182	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 17	2005	294	7					797	802		10.1001/jama.294.7.797	http://dx.doi.org/10.1001/jama.294.7.797			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	955LI	16106004	Bronze			2022-12-01	WOS:000231227000019
J	Lehrman, G; Hogue, IB; Palmer, S; Jennings, C; Spina, CA; Wiegand, A; Landay, AL; Coombs, RW; Richman, DD; Mellors, JW; Coffin, JM; Bosch, RJ; Margolis, DM				Lehrman, G; Hogue, IB; Palmer, S; Jennings, C; Spina, CA; Wiegand, A; Landay, AL; Coombs, RW; Richman, DD; Mellors, JW; Coffin, JM; Bosch, RJ; Margolis, DM			Depletion of latent HIV-1 infection in vivo: a proof-of-concept study	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; CD4(+) T-CELLS; LONG TERMINAL REPEAT; HUMAN-FACTORS YY1; CELLULAR RESERVOIRS; HIV-1-INFECTED PATIENTS; IMMUNE-ACTIVATION; VALPROIC ACID; TYPE-1 HIV-1	Background Persistent infection in resting CD4+ T cells prevents eradication of HIV-1. Since the chromatin remodeling enzyme histone deacetylase 1 (HDAC1) maintains latency of integrated HIV, we tested the ability of the HDAC inhibitor valproic acid to deplete persistent, latent infection in resting CD4+ T cells. Procedures We did a proof-of-concept study in four volunteers infected with HIV and on highly-active antiretroviral therapy (HAART). After intensifying the effect of HAART with subcutaneous enfuvirtide 90 mu g twice daily for 4-6 weeks to prevent the spread of HIV, we added oral valproic acid 500-750 mg twice daily to their treatment regimen for 3 months. We quantified latent infection of resting CD4+ T cells before and after augmented treatment by limiting-dilution culture of resting CD4+ T cells after ex-vivo activation. Findings The frequency of resting cell infection was stable before addition of enfuvirtide and valproic acid, but declined thereafter. This decline was significant in three of four patients (mean reduction 75%, range 68% to >84%). Patients had slight reactions to enfuvirtide at the injection site, but otherwise tolerated treatment well. Interpretation Combination therapy with an HDAC inhibitor and intensified HAART safely accelerates clearance of HIV from resting CD4+ T cells in vivo, suggesting a new and practical approach to eliminate HIV infection in this persistent reservoir. This finding, though not definitive, suggests that new approaches will allow the cure of HIV in the future.	Univ Texas, SW Med Ctr, Dept Med, Div Infect Dis, Dallas, TX 75390 USA; NCI, HIV Drug Resistance Program, NIH, Frederick, MD USA; Rush Presbyterian St Lukes Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA; Univ Calif San Diego, San Diego, CA 92103 USA; Vet Affairs Med Ctr, San Diego, CA 92161 USA; Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA USA; Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; N Texas Vet Hlth Care Syst, Dallas, TX USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Rush University; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Harvard T.H. Chan School of Public Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System	Margolis, DM (corresponding author), Univ Texas, SW Med Ctr, Dept Med, Div Infect Dis, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	dmargo@med.unc.edu	Margolis, David M./Y-2468-2019	Margolis, David M./0000-0001-5714-0002; Hogue, Ian/0000-0002-1977-5573	DIVISION OF BASIC SCIENCES - NCI [Z01BC010526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R24AI106039, R56AI047745, R01AI047745, U01AI027670, N01AI085354, R21AI047745, R37AI029164, U01AI043638, U01AI038858, P30AI027757, R01AI045297, P30AI036214, R01AI064074, R01AI029164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049477] Funding Source: NIH RePORTER; NIAID NIH HHS [R24 AI106039, N01AI85354, P30 AI027757, P30 AI036214, R56 AI047745, AI-27757, U01 AI043638, U01 AI038858, AI-047745, R37 AI029164, R01 AI-45297, U01 AI-38858, AI-38858, AI-043638, AI-29164, U01 AI027670, R01 AI045297, R21 AI047745, AI-27670, N01-AI-85354, AI-36214, R01 AI047745, R01 AI064074] Funding Source: Medline; NIDDK NIH HHS [DK-49477] Funding Source: Medline; PHS HHS [20XS190A] Funding Source: Medline	DIVISION OF BASIC SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Al-Harthi L, 2000, AIDS, V14, P761, DOI 10.1097/00002030-200005050-00001; Antoniou T, 2004, CLIN INFECT DIS, V38, pE38, DOI 10.1086/381760; Brooks DG, 2003, IMMUNITY, V19, P413, DOI 10.1016/S1074-7613(03)00236-X; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1999, NAT MED, V5, P651, DOI 10.1038/9498; Clotet B, 2004, AIDS, V18, P1137, DOI 10.1097/00002030-200405210-00007; Coombs RW, 1998, J INFECT DIS, V177, P320, DOI 10.1086/514213; Coull JJ, 2002, J VIROL, V76, P12349, DOI 10.1128/JVI.76.23.12349-12354.2002; Coull JJ, 2000, J VIROL, V74, P6790, DOI 10.1128/JVI.74.15.6790-6799.2000; Demonte D, 2004, BIOCHEM PHARMACOL, V68, P1231, DOI 10.1016/j.bcp.2004.05.040; Di Mascio M, 2003, J VIROL, V77, P2271, DOI 10.1128/JVI.77.3.2271-2275.2003; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fraser C, 2000, AIDS, V14, P659, DOI 10.1097/00002030-200004140-00005; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; He GC, 2002, MOL CELL BIOL, V22, P2965, DOI 10.1128/MCB.22.9.2965-2973.2002; JENNINGS C, 10 C RETR OPP INF BO; Kulkosky J, 2002, J INFECT DIS, V186, P1403, DOI 10.1086/344357; Lehrman G, 2004, JAIDS-J ACQ IMM DEF, V36, P1103, DOI 10.1097/00126334-200408150-00015; LERTORA JJL, 1994, CLIN PHARMACOL THER, V56, P272, DOI 10.1038/clpt.1994.137; Macken C, 1999, J IMMUNOL METHODS, V222, P13, DOI 10.1016/S0022-1759(98)00133-1; McCullagh P, 2019, GEN LINEAR MODELS; MYERS LE, 1994, J CLIN MICROBIOL, V32, P732, DOI 10.1128/JCM.32.3.732-739.1994; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Pierson T, 2000, ANNU REV IMMUNOL, V18, P665, DOI 10.1146/annurev.immunol.18.1.665; Pomerantz RJ, 2003, HIV CLIN TRIALS, V4, P137, DOI 10.1310/80JH-148K-NADQ-U927; Prins JM, 1999, AIDS, V13, P2405, DOI 10.1097/00002030-199912030-00012; Ramratnam B, 2004, JAIDS-J ACQ IMM DEF, V35, P33, DOI 10.1097/00126334-200401010-00004; Romerio F, 1997, J VIROL, V71, P9375, DOI 10.1128/JVI.71.12.9375-9382.1997; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Stellbrink HJ, 2002, AIDS, V16, P1479, DOI 10.1097/00002030-200207260-00004; Strain MC, 2003, P NATL ACAD SCI USA, V100, P4819, DOI 10.1073/pnas.0736332100; Strain MC, 2005, J INFECT DIS, V191, P1410, DOI 10.1086/428777; Wang FX, 2005, J CLIN INVEST, V115, P128, DOI 10.1172/JCI200522574; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Ylisastigui L, 2004, J INFECT DIS, V190, P1429, DOI 10.1086/423822; Ylisastigui L, 2004, AIDS, V18, P1101, DOI 10.1097/00002030-200405210-00003	36	413	444	0	38	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 13	2005	366	9485					549	555		10.1016/S0140-6736(05)67098-5	http://dx.doi.org/10.1016/S0140-6736(05)67098-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	955LL	16099290	Green Accepted			2022-12-01	WOS:000231227300026
J	Parsons, DW; Wang, TL; Samuels, Y; Bardelli, A; Cummins, JM; DeLong, L; Silliman, N; Ptak, J; Szabo, S; Willson, JKV; Markowitz, S; Kinzler, K; Vogelstein, B; Lengauer, C; Velculescu, VE				Parsons, DW; Wang, TL; Samuels, Y; Bardelli, A; Cummins, JM; DeLong, L; Silliman, N; Ptak, J; Szabo, S; Willson, JKV; Markowitz, S; Kinzler, K; Vogelstein, B; Lengauer, C; Velculescu, VE			Colorectal cancer - Mutations in a signalling pathway	NATURE			English	Editorial Material							GENE		Johns Hopkins Univ, Inst Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; Johns Hopkins Univ, Inst Med, Howard Hughes Med Inst, Baltimore, MD 21231 USA; Univ Texas, SW Med Ctr, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; Case Western Reserve Univ, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Howard Hughes Med Inst, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Ireland Canc Ctr, Cleveland, OH 44106 USA	Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Case Western Reserve University; Howard Hughes Medical Institute; University Hospitals of Cleveland; University Hospitals of Cleveland	Parsons, DW (corresponding author), Johns Hopkins Univ, Inst Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA.	velculescu@jhmi.edu	Velculescu, Victor/ABF-4846-2020; BARDELLI, Alberto/J-9721-2018	Velculescu, Victor/0000-0003-1195-438X; BARDELLI, Alberto/0000-0003-1647-5070; Samuels, Yardena/0000-0002-3349-7266; Parsons, Donald/0000-0002-8775-3501				Bardelli A, 2003, SCIENCE, V300, P949, DOI 10.1126/science.1082596; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Teng DHF, 1997, CANCER RES, V57, P4177; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang TL, 2002, P NATL ACAD SCI USA, V99, P16156, DOI 10.1073/pnas.202610899; Wells CM, 2002, J CELL SCI, V115, P3947, DOI 10.1242/jcs.00080	10	462	509	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2005	436	7052					792	792		10.1038/436792a	http://dx.doi.org/10.1038/436792a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953XG	16094359	Bronze			2022-12-01	WOS:000231116500033
J	Dissanayake, C				Dissanayake, C			Global voices of science - Of stones and health: Medical geology in Sri Lanka	SCIENCE			English	Editorial Material									Univ Peradeniya, Peradeniya 20400, Sri Lanka	University of Peradeniya	Dissanayake, C (corresponding author), Univ Peradeniya, Peradeniya 20400, Sri Lanka.	cbdissa@hotmail.com							0	38	41	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2005	309	5736					883	885		10.1126/science.1115174	http://dx.doi.org/10.1126/science.1115174			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953SS	16081722				2022-12-01	WOS:000231101400029
J	Kerfeld, CA; Sawaya, MR; Tanaka, S; Nguyen, CV; Phillips, M; Beeby, M; Yeates, TO				Kerfeld, CA; Sawaya, MR; Tanaka, S; Nguyen, CV; Phillips, M; Beeby, M; Yeates, TO			Protein structures forming the shell of primitive bacterial organelles	SCIENCE			English	Article							ANGSTROM RESOLUTION; CARBONIC-ANHYDRASE; CARBOXYSOME SHELL; POLYHEDRAL BODIES; VIRUS; PROKARYOTES; CYANOBACTERIA; HOMOLOGS	Bacterial microcompartments are primitive organelles composed entirely of protein subunits. Genomic sequence databases reveal the widespread occurrence of microcompartments across diverse microbes. The prototypical bacterial microcompartment is the carboxysome, a protein shell for sequestering carbon fixation reactions. We report three-dimensional crystal structures of multiple carboxysome shell proteins, revealing a hexameric unit as the basic microcompartment building block and showing how these hexamers assemble to form flat facets of the polyhedral shell. The structures suggest how molecular transport across the shell may be controlled and how structural variations might govern the assembly and architecture of these subcellular compartments.	Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, US DOE, Inst Genom & Proteom, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; United States Department of Energy (DOE); University of California System; University of California Los Angeles	Yeates, TO (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Box 951570, Los Angeles, CA 90095 USA.	yeates@mbi.ucla.edu	Beeby, Morgan/G-2768-2013	Beeby, Morgan/0000-0001-6413-9835; Yeates, Todd/0000-0001-5709-9839				Badger MR, 2002, FUNCT PLANT BIOL, V29, P161, DOI 10.1071/PP01213; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Cannon GC, 2002, FUNCT PLANT BIOL, V29, P175, DOI 10.1071/PP01200; Cannon GC, 2001, APPL ENVIRON MICROB, V67, P5351, DOI 10.1128/AEM.67.12.5351-5361.2001; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; CODD GA, 1984, BIOL REV, V59, P389, DOI 10.1111/j.1469-185X.1984.tb00710.x; Diprose JM, 2001, EMBO J, V20, P7229, DOI 10.1093/emboj/20.24.7229; GANTT E, 1969, J BACTERIOL, V97, P1486, DOI 10.1128/JB.97.3.1486-1493.1969; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; HARRISON SC, 1995, CURR OPIN STRUC BIOL, V5, P157, DOI 10.1016/0959-440X(95)80070-0; Harrison SC, 2001, CURR OPIN STRUC BIOL, V11, P195, DOI 10.1016/S0959-440X(00)00189-5; Havemann GD, 2003, J BACTERIOL, V185, P5086, DOI 10.1128/JB.185.17.5086-5095.2003; HOGLE JM, 1987, SCI AM, V256, P42, DOI 10.1038/scientificamerican0387-42; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Jensen TE, 1961, P IOWA ACAD SCI, V68, P89; Johnson JE, 1997, J MOL BIOL, V269, P665, DOI 10.1006/jmbi.1997.1068; Kofoid E, 1999, J BACTERIOL, V181, P5317, DOI 10.1128/JB.181.17.5317-5329.1999; Naitow H, 2002, NAT STRUCT BIOL, V9, P725, DOI 10.1038/nsb844; PRICE GD, 1992, PLANT PHYSIOL, V100, P784, DOI 10.1104/pp.100.2.784; PRICE GD, 1990, CAN J BOT, V69, P693; ROSSMANN MG, 1989, ANNU REV BIOCHEM, V58, P533, DOI 10.1146/annurev.bi.58.070189.002533; San Martin C, 2002, NAT STRUCT BIOL, V9, P756, DOI 10.1038/nsb837; Shively JM, 1998, CAN J BOT, V76, P906, DOI 10.1139/b98-088; SHIVELY JM, 1991, CAN J BOT, V69, P957, DOI 10.1139/b91-123; SHIVELY JM, 1973, SCIENCE, V182, P584, DOI 10.1126/science.182.4112.584; SHIVELY JM, 1970, J BACTERIOL, V96, P2138; So AKC, 2004, J BACTERIOL, V186, P623, DOI 10.1128/JB.186.3.623-630.2004; So AKC, 1998, PLANT MOL BIOL, V37, P205, DOI 10.1023/A:1005959200390; Stehle T, 1996, STRUCTURE, V4, P165, DOI 10.1016/S0969-2126(96)00020-2; Yuan P, 2003, NAT STRUCT BIOL, V10, P264, DOI 10.1038/nsb910	30	316	326	4	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2005	309	5736					936	938		10.1126/science.1113397	http://dx.doi.org/10.1126/science.1113397			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953SS	16081736				2022-12-01	WOS:000231101400047
J	Butler, D				Butler, D			Parasitology - Triple genome triumph	NATURE			English	Editorial Material																		[Anonymous], 2005, SCIENCE, V309, P436; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; 2005, SCIENCE, V309, P416	3	3	3	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2005	436	7049					337	337		10.1038/436337b	http://dx.doi.org/10.1038/436337b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	16034405				2022-12-01	WOS:000230623400028
J	Minamimoto, T; Hori, Y; Kimura, M				Minamimoto, T; Hori, Y; Kimura, M			Complementary process to response bias in the centromedian nucleus of the thalamus	SCIENCE			English	Article							CM-PF COMPLEX; BASAL GANGLIA; ANTERIOR CINGULATE; NEURONAL SIGNALS; DOPAMINE NEURONS; PARIETAL CORTEX; REWARD; PREDICTION; MOTIVATION; DECISION	Activity in several areas of the human brain and the monkey brain increases when a subject anticipates events associated with a reward, implicating a role for bias of decision and action. However, in real life, events do not always appear as expected, and we must choose an undesirable action, More than half of the neurons in the monkey centromedian (CM) thalamus were selectively activated when a small-reward action was required but a Large-reward option was anticipated. Electrical stimulation of the CM after a large-reward action request substituted a brisk performance with a sluggish performance. These results suggest involvement of the CM in a mechanism complementary to decision and action bias.	Kyoto Prefectural Univ Med, Dept Physiol, Kamigyo Ku, Kyoto 6028566, Japan	Kyoto Prefectural University of Medicine	Kimura, M (corresponding author), Kyoto Prefectural Univ Med, Dept Physiol, Kamigyo Ku, Kyoto 6028566, Japan.	mkimura@koto.kpu-m.ac.jp	Minamimoto, Takafumi/AAD-8726-2020; Minamimoto, Takafumi/D-6610-2012	Minamimoto, Takafumi/0000-0003-4305-0174; Minamimoto, Takafumi/0000-0003-4305-0174				Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; GROENEWEGEN HJ, 1994, TRENDS NEUROSCI, V17, P52, DOI 10.1016/0166-2236(94)90074-4; Hatanaka N, 2003, J COMP NEUROL, V462, P121, DOI 10.1002/cne.10720; HERMSTEIN RJ, 1961, J EXPT ANAL BEHAV, V4, P267; Kimura M, 2004, NEUROSCI RES, V48, P355, DOI 10.1016/j.neures.2003.12.002; Lauwereyns J, 2002, NATURE, V418, P413, DOI 10.1038/nature00892; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; Matsumoto N, 2001, J NEUROPHYSIOL, V85, P960, DOI 10.1152/jn.2001.85.2.960; Minamimoto T, 2002, J NEUROPHYSIOL, V87, P3090, DOI 10.1152/jn.2002.87.6.3090; Nakahara H, 2004, NEURON, V41, P269, DOI 10.1016/S0896-6273(03)00869-9; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Redgrave P, 1999, TRENDS NEUROSCI, V22, P146, DOI 10.1016/S0166-2236(98)01373-3; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Satoh T, 2003, J NEUROSCI, V23, P9913; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Shidara M, 1998, J NEUROSCI, V18, P2613; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Smith Y, 2004, TRENDS NEUROSCI, V27, P520, DOI 10.1016/j.tins.2004.07.004; STERIADE M, 1997, THALAMUS, V1, P55; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; THORNDIKE EL, 1898, ANIMAL INTELLIGENCE; Watanabe M, 2001, EXP BRAIN RES, V140, P511, DOI 10.1007/s002210100856	24	97	102	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2005	308	5729					1798	1801		10.1126/science.1109154	http://dx.doi.org/10.1126/science.1109154			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937LY	15961671				2022-12-01	WOS:000229926800058
J	Sipkins, DA; Wei, XB; Wu, JW; Runnels, JM; Cote, D; Means, TK; Luster, AD; Scadden, DT; Lin, CP				Sipkins, DA; Wei, XB; Wu, JW; Runnels, JM; Cote, D; Means, TK; Luster, AD; Scadden, DT; Lin, CP			In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment	NATURE			English	Article							CHEMOKINE RECEPTOR CXCR4; STEM-CELLS; ADHESION MOLECULES; NOD/SCID MICE; CANCER-CELLS; PRECURSOR-B; EXPRESSION; LEUKEMIA; MICROVESSELS; VOLUNTEERS	The organization of cellular niches is known to have a key role in regulating normal stem cell differentiation and regeneration, but relatively little is known about the architecture of microenvironments that support malignant metastasis(1,2). Using dynamic in vivo confocal imaging, here we show that murine bone marrow contains unique anatomic regions defined by specialized endothelium. This vasculature expresses the adhesion molecule E-selectin and the chemoattractant stromal-cell-derived factor 1 (SDF-1) in discrete, discontinuous areas that influence the homing of a variety of tumour cell lines. Disruption of the interactions between SDF-1 and its receptor CXCR4 inhibits the homing of Nalm-6 cells (an acute lymphoblastic leukaemia cell line) to these vessels. Further studies revealed that circulating leukaemic cells can engraft around these vessels, suggesting that this molecularly distinct vasculature demarcates a microenvironment for early metastatic tumour spread in bone marrow. Finally, purified haematopoietic stem/progenitor cells and lymphocytes also localize to the same microdomains, indicating that this vasculature might also function in benign states to demarcate specific portals for the entry of cells into the marrow space. Specialized vascular structures therefore appear to delineate a microenvironment with unique physiology that can be exploited by circulating malignant cells.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Regenerat Med & Technol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Hematol Oncol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp E, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA; Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard University	Lin, CP (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed, 55 Fruit St, Boston, MA 02114 USA.	dsipkins1@partners.org; lin@helix.mgh.harvard.edu	Côté, Daniel/D-5185-2011; Luster, Andrew/ABE-6504-2020	Luster, Andrew/0000-0001-9679-7912	NATIONAL EYE INSTITUTE [R01EY014106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000664] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA086355, T32 CA071345] Funding Source: Medline; NEI NIH HHS [R01 EY014106] Funding Source: Medline; NIBIB NIH HHS [R01 EB000664] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Burger JA, 2002, LEUKEMIA LYMPHOMA, V43, P461, DOI 10.1080/10428190290011921; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Cao YA, 2004, P NATL ACAD SCI USA, V101, P221, DOI 10.1073/pnas.2637010100; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Christopherson KW, 2004, SCIENCE, V305, P1000, DOI 10.1126/science.1097071; CRISTY M, 1981, PHYS MED BIOL, V26, P389, DOI 10.1088/0031-9155/26/3/003; Darash-Yahana M, 2004, FASEB J, V18, P1240, DOI 10.1096/fj.03-0935fje; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Hatse S, 2002, FEBS LETT, V527, P255, DOI 10.1016/S0014-5793(02)03143-5; Hendrix CW, 2000, ANTIMICROB AGENTS CH, V44, P1667, DOI 10.1128/AAC.44.6.1667-1673.2000; HONN KV, 1992, CANCER METAST REV, V11, P353, DOI 10.1007/BF01307187; Jo DY, 2003, BRIT J HAEMATOL, V121, P649, DOI 10.1046/j.1365-2141.2003.04326.x; Liles WC, 2003, BLOOD, V102, P2728, DOI 10.1182/blood-2003-02-0663; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Mastro AM, 2003, CLIN EXP METASTAS, V20, P275, DOI 10.1023/A:1022995403081; Mazo IB, 1999, J LEUKOCYTE BIOL, V66, P25, DOI 10.1002/jlb.66.1.25; Mazo IB, 1998, J EXP MED, V188, P465, DOI 10.1084/jem.188.3.465; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murphy PM, 2001, NEW ENGL J MED, V345, P833, DOI 10.1056/NEJM200109133451113; Novak J, 2004, OPT LETT, V29, P77, DOI 10.1364/OL.29.000077; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Peled A, 1999, J CLIN INVEST, V104, P1199, DOI 10.1172/JCI7615; REUSSBORST MA, 1995, LEUKEMIA, V9, P869; Shen HM, 2001, J IMMUNOL, V166, P5027, DOI 10.4049/jimmunol.166.8.5027; Shen W, 2001, EXP HEMATOL, V29, P1439, DOI 10.1016/S0301-472X(01)00741-X; Spano JP, 2004, ANN ONCOL, V15, P613, DOI 10.1093/annonc/mdh136; Spiegel A, 2004, BLOOD, V103, P2900, DOI 10.1182/blood-2003-06-1891; Tavor S, 2004, CANCER RES, V64, P2817, DOI 10.1158/0008-5472.CAN-03-3693	30	638	677	4	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2005	435	7044					969	973		10.1038/nature03703	http://dx.doi.org/10.1038/nature03703			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935RN	15959517	Green Accepted			2022-12-01	WOS:000229799700052
J	Blumberg, HM; Leonard, MK; Jasmer, RM				Blumberg, HM; Leonard, MK; Jasmer, RM			Update on the treatment of tuberculosis and latent tuberculosis infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RIFAMPIN PREVENTIVE THERAPY; PULMONARY TUBERCULOSIS; ANTIRETROVIRAL THERAPY; TREATMENT COMPLETION; PYRAZINAMIDE; HEPATOTOXICITY; TWICE; ACCEPTABILITY; RIFAPENTINE; EXPERIENCE	Tuberculosis (TB) has emerged as a global public health epidemic. Despite decreasing numbers of cases in the United States since 1992, TB remains a serious public health problem among certain patient populations and is highly prevalent in many urban areas. The responsibility for prescribing an appropriate drug regimen and ensuring that treatment is completed is assigned to the public health program or the clinician not to the patient. The initial prescribed regimen for the treatment of TB usually consists of 4 drugs: isoniazid, rifampin, pyrazinamide, and ethambutol. The minimum length for the treatment of drug-susceptible TB with a rifampin-based regimen is 6 to 9 months. Providing medications directly to the patient and watching him/ her swallow the anti-TB drugs, which is termed directly observed therapy, is recommended for all patients diagnosed with TB and can help ensure higher completion rates, prevent the emergence of drug resistant TB, and enhance TB control. There has been renewed interest in the treatment of those with latent TB infection as a TB-control strategy in the United States for eliminating the large reservoir of individuals at risk for progression to TB. The 2 broad categories of persons who should be tested for latent TB infection are those who are likely to have been recently infected (such as contacts to infectious TB cases) and persons who are at increased risk of progression to TB disease following infection with Mycobacterium tuberculosis (eg, human immunodeficiency virus infection and selected medical conditions; recent immigrants to the United States from high TB-burden countries). The preferred regimen for the treatment of latent TB infection is 9 months of isoniazid. There is now renewed interest in and great need for the development of new drugs to treat TB and latent TB infection.	Emory Univ, Sch Med, Div Infect Dis, Dept Med, Atlanta, GA 30303 USA; Grady Mem Hosp, Dept Epidemiol, Atlanta, GA USA; Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, San Francisco, CA USA	Emory University; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Blumberg, HM (corresponding author), Emory Univ, Sch Med, Div Infect Dis, Dept Med, 49 Jesse Hill Jr Dr, Atlanta, GA 30303 USA.	henry.m.blumberg@emory.edu	Blumberg, Henry/W-2156-2019	Blumberg, Henry/0000-0002-3110-2443	FIC NIH HHS [D43TW007124] Funding Source: Medline; NHLBI NIH HHS [K07 HL03078] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [D43TW007124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K07HL003078] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		*AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, pS221, DOI DOI 10.1164/AJRCCM.161.SUPPLEMENT_; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; [Anonymous], 1999, MMWR Recomm Rep, V48, P1; [Anonymous], 2003, AM J RESP CRIT CARE, V167, P603; Anonymous, 2005, Morbidity and Mortality Weekly Report, V54, P245; [Anonymous], 1948, BMJ-BRIT MED J, V2, P769; Barnes PF, 2004, AM J RESP CRIT CARE, V170, P5, DOI 10.1164/rccm.2404004; Benator D, 2002, LANCET, V360, P528, DOI 10.1016/S0140-6736(02)09742-8; Blumberg HM, 2004, CLIN INFECT DIS, V39, P1772, DOI 10.1086/425620; Bock NN, 2001, CHEST, V119, P833, DOI 10.1378/chest.119.3.833; Brodie D, 2005, CLIN CHEST MED, V26, P247, DOI 10.1016/j.ccm.2005.02.012; Burman WJ, 2005, CLIN CHEST MED, V26, P283, DOI 10.1016/j.ccm.2005.02.002; BYRD RB, 1979, JAMA-J AM MED ASSOC, V241, P1239, DOI 10.1001/jama.241.12.1239; *CDCP, 2004, MMWR-MORBID MORTAL W, V53, P37; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P735; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P214; Chaisson RE, 2002, JAMA-J AM MED ASSOC, V288, P165, DOI 10.1001/jama.288.2.165; Chaulk CP, 1998, JAMA-J AM MED ASSOC, V279, P943, DOI 10.1001/jama.279.12.943; COHN DL, 1990, ANN INTERN MED, V112, P407, DOI 10.7326/0003-4819-76-3-112-6-407; COMBS DL, 1990, ANN INTERN MED, V112, P397, DOI 10.7326/0003-4819-76-3-112-6-397; Comstock GW, 1999, INT J TUBERC LUNG D, V3, P847; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; Fox W, 1999, INT J TUBERC LUNG D, V3, pS231; FOX W, 1986, AM REV RESPIR DIS, V133, P779; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; GIRLING DJ, 1992, AM REV RESPIR DIS, V145, P36; Gordin F, 2000, JAMA-J AM MED ASSOC, V283, P1445, DOI 10.1001/jama.283.11.1445; Gordin FM, 2004, CLIN INFECT DIS, V39, P561, DOI 10.1086/422724; GROSS PA, 1994, CLIN INFECT DIS, V18, P428, DOI 10.1093/clinids/18.3.428; Halsey NA, 1998, LANCET, V351, P786, DOI 10.1016/S0140-6736(97)06532-X; *I MED, 2000, END NEGL EL TUB US; Jasmer RM, 2002, ANN INTERN MED, V137, P640, DOI 10.7326/0003-4819-137-8-200210150-00007; Kwara A, 2005, INT J TUBERC LUNG D, V9, P248; Lalvani A, 2001, LANCET, V357, P2017, DOI 10.1016/S0140-6736(00)05115-1; Lee AM, 2002, INT J TUBERC LUNG D, V6, P995; Leung CC, 2003, CHEST, V124, P2112, DOI 10.1378/chest.124.6.2112; Lobato MN, 2005, CHEST, V127, P1296, DOI 10.1378/chest.127.4.1296; LoBue PA, 2003, AM J RESP CRIT CARE, V168, P443, DOI 10.1164/rccm.200303-390OC; Marks SM, 2000, AM J RESP CRIT CARE, V162, P2033, DOI 10.1164/ajrccm.162.6.2004022; Mazurek Gerald H, 2003, MMWR Recomm Rep, V52, P15; McNeill L, 2003, CHEST, V123, P102, DOI 10.1378/chest.123.1.102; MITCHELL JR, 1976, ANN INTERN MED, V84, P181, DOI 10.7326/0003-4819-84-2-181; Mori T, 2004, AM J RESP CRIT CARE, V170, P59, DOI 10.1164/rccm.200402-179OC; Mwinga A, 1998, AIDS, V12, P2447, DOI 10.1097/00002030-199818000-00014; Narita M, 1998, AM J RESP CRIT CARE, V158, P157, DOI 10.1164/ajrccm.158.1.9712001; Nolan CM, 1999, JAMA-J AM MED ASSOC, V281, P1014, DOI 10.1001/jama.281.11.1014; Nolan CM, 2003, AM J RESP CRIT CARE, V168, P412, DOI 10.1164/rccm.2306004; O'Brien RJ, 2005, CLIN CHEST MED, V26, P327, DOI 10.1016/j.ccm.2005.02.013; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Polesky A, 1996, AM J RESP CRIT CARE, V154, P1473, DOI 10.1164/ajrccm.154.5.8912767; Priest DH, 2004, CLIN INFECT DIS, V39, P1764, DOI 10.1086/425610; Saiman L, 2004, PEDIATRICS, V114, P1175, DOI 10.1542/peds.2004-0809; Sotir MJ, 1999, CLIN INFECT DIS, V29, P1138, DOI 10.1086/313453; *TB ALL, GLOB ALL TB DRUG DEV; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Tortajada C, 2005, INT J TUBERC LUNG D, V9, P276; Vernon A, 1999, LANCET, V353, P1843, DOI 10.1016/S0140-6736(98)11467-8; Villarino ME, 1997, AM J RESP CRIT CARE, V155, P1735, DOI 10.1164/ajrccm.155.5.9154885; *WHO, 2004, GLOB TUB CONTR SURV	59	119	127	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	2005	293	22					2776	2784		10.1001/jama.293.22.2776	http://dx.doi.org/10.1001/jama.293.22.2776			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933OV	15941808				2022-12-01	WOS:000229643700027
J	Butler, D				Butler, D			China rejects Internet claims of human cases	NATURE			English	News Item								Reports that the outbreak of avian influenza among wild birds in Qinghai has resulted in any human cases of the disease are being denied by China. Rumours that people had been infected began when the ProMED-mail Internet alert system relayed a translation of an article from the independent Chinese website BoxunNews, which is based in the United States. ProMED warned that the informationwas unofficial and needed to be confirmed.											0	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 2	2005	435	7042					542	543						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931HK	15954220				2022-12-01	WOS:000229476200005
J	Lamming, DW; Latorre-Esteves, M; Medvedik, O; Wong, SN; Tsang, FA; Wang, C; Lin, SJ; Sinclair, DA				Lamming, DW; Latorre-Esteves, M; Medvedik, O; Wong, SN; Tsang, FA; Wang, C; Lin, SJ; Sinclair, DA			HST2 mediates SIR2-independent life-span extension by catorie restriction	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; CALORIE RESTRICTION; DEACETYLASE ACTIVITY; PROTEIN SIR2; GENE FAMILY; YEAST; NAD; LONGEVITY; NICOTINAMIDE; REQUIREMENT	Calorie restriction (CR) extends the life span of numerous species, from yeast to rodents. Yeast Sir2 is a nicotinamide adenine dinucleotide (NAD+)dependent histone deacetylase that has been proposed to mediate the effects of CR. However, this hypothesis has been challenged by the observation that CR can extend yeast life span in the absence of Sir2. Here, we show that Sir2-independent life-span extension is mediated by Hst2, a Sir2 homolog that promotes the stability of repetitive ribosomal DNA, the same mechanism by which Sir2 extends life span. These findings demonstrate that the maintenance of DNA stability is critical for yeast life-span extension by CR and suggest that, in higher organisms, multiple members of the Sir2 family may regulate life span in response to diet.	Harvard Univ, Sch Med, Dept Pathol, Paul F Glenn Labs Biol Mech Aging, Boston, MA 02115 USA; Univ Calif Davis, Ctr Genet & Dev, Davis, CA 95616 USA; Univ Calif Davis, Microbiol Sect, Davis, CA 95616 USA	Harvard University; Harvard Medical School; University of California System; University of California Davis; University of California System; University of California Davis	Lin, SJ (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Paul F Glenn Labs Biol Mech Aging, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	slin@ucdavis.edu; david_sindair@hms.harvard.edu	Latorre-Esteves, Magda/GMW-6353-2022; Lamming, Dudley/O-7191-2015	Lamming, Dudley/0000-0002-0079-4467; Sinclair, David/0000-0002-9936-436X	NIA NIH HHS [R01 AG024351] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG024351] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; Defossez PA, 1999, MOL CELL, V3, P447, DOI 10.1016/S1097-2765(00)80472-4; Falcon AA, 2003, J BIOL CHEM, V278, P41607, DOI 10.1074/jbc.M307025200; Gallo CA, 2004, MOL CELL BIOL, V24, P1301, DOI 10.1128/MCB.24.3.1301-1312.2004; Gasser SM, 2001, GENE, V279, P1, DOI 10.1016/S0378-1119(01)00741-7; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.0.CO;2-K; Halme A, 2004, CELL, V116, P405, DOI 10.1016/S0092-8674(04)00118-7; Houthoofd K, 2003, EXP GERONTOL, V38, P947, DOI 10.1016/S0531-5565(03)00161-X; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jiang JC, 2002, EXP GERONTOL, V37, P1023, DOI 10.1016/S0531-5565(02)00064-5; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2005, MECH AGEING DEV, V126, P491, DOI 10.1016/j.mad.2004.10.007; Kaeberlein M, 2004, PLOS BIOL, V2, P1381, DOI 10.1371/journal.pbio.0020296; KENNEDY BK, 1995, CELL, V80, P485, DOI 10.1016/0092-8674(95)90499-9; Kobayashi T, 1998, GENE DEV, V12, P3821, DOI 10.1101/gad.12.24.3821; Landry J, 2000, BIOCHEM BIOPH RES CO, V278, P685, DOI 10.1006/bbrc.2000.3854; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X; Perrod S, 2001, EMBO J, V20, P197, DOI 10.1093/emboj/20.1.197; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Tanny JC, 2001, P NATL ACAD SCI USA, V98, P415, DOI 10.1073/pnas.031563798; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789	30	180	191	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2005	309	5742					1861	1864		10.1126/science.1113611	http://dx.doi.org/10.1126/science.1113611			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965ZN	16051752				2022-12-01	WOS:000231989500051
J	Getz, L; Sigurdsson, JA; Hetlevik, I; Kirkengen, AL; Romundstad, S; Holmen, J				Getz, L; Sigurdsson, JA; Hetlevik, I; Kirkengen, AL; Romundstad, S; Holmen, J			Estimating the high risk group for cardiovascular disease in the Norwegian HUNT 2 population according to the 2003 European guidelines: modelling study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							JOINT TASK-FORCE; CLINICAL-PRACTICE; CORONARY RISK; PRIMARY PREVENTION; PUBLIC-HEALTH; SOCIETIES; BARRIERS; MATTER; TRIAL; HEART	Objective To estimate the high risk group for cardiovascular disease in a well defined Norwegian population according to European guidelines and the systematic coronary risk evaluation system. Design Modelling study. Setting Nord-Trondelag health study 1995-7 (HUNT 2), Nor-way. Participants 5548 participants of the Nord-Trondelag health study 1995-7, aged 40, 50, 55, 60, and 65. Main outcome measures Distribution of risk categories for cardiovascular disease, with emphasis on the high risk group. Main results At age 40,22.5% (95% confidence interval 19.3% to 25.7%) of women and 85.9% (83.2% to 88.6%) of men were at high risk of cardiovascular disease. Corresponding numbers at age 50 were 39.5% (35.9% to 43.1%) and 88.7% (86.3% to 91.0%) and at age 65 were 84.0% (80.6% to 87.4%) and 91.6% (88.6% to 94.1%). At age 40, one out of 10 women and no men would be classified at low risk for cardiovascular disease. Conclusion Implementation of the 2003 European guidelines on prevention of cardiovascular disease in clinical practice would classify most adult Norwegians at high risk for fatal cardiovascular disease.	Landspitali Univ Hosp, Off Human Resources, IS-101 Reykjavik, Iceland; Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Pratice, N-7489 Trondheim, Norway; Univ Iceland, Dept Family Med, IS-107 Reykjavik, Iceland; Norwegian Univ Sci & Technol, HUNT Res Ctr, Fac Med, Dept Publ Hlth & Gen Practice, N-7650 Verdal, Norway	Landspitali National University Hospital; Norwegian University of Science & Technology (NTNU); University of Iceland; Norwegian University of Science & Technology (NTNU)	Getz, L (corresponding author), Landspitali Univ Hosp, Off Human Resources, IS-101 Reykjavik, Iceland.	linngetz@med.is		Sigurdsson, Johann Agust/0000-0002-5646-6411				Brindle P, 2003, BMJ-BRIT MED J, V327, P1267, DOI 10.1136/bmj.327.7426.1267; Callahan D, 2002, AM J PUBLIC HEALTH, V92, P169, DOI 10.2105/AJPH.92.2.169; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; DAHLOF B, 1991, LANCET, V338, P1281, DOI 10.1016/0140-6736(91)92589-T; De Backer G, 2003, EUR J CARDIOV PREV R, V10, pS1, DOI 10.1097/01.hjr.0000087913.96265.e2; De Backer G, 2003, EUR HEART J, V24, P1601, DOI 10.1016/S0195-668X(03)00347-6; Getz L, 2005, SCAND J PRIM HEALTH, V23, P65, DOI 10.1080/02813430510018518; Getz L, 2004, SCAND J PRIM HEALTH, V22, P202, DOI 10.1080/02813430410006693; Getz L, 2003, SCAND J PRIM HEALTH, V21, P3, DOI 10.1080/02813430310000483; Hetlevik I., 1999, THESIS NORWEGIAN U S; Holmen JMK., 2003, NORSK EPIDEMIOL, V13, P19, DOI [10.5324/nje.v13i1.305, DOI 10.5324/NJE.V13I1.305]; Marshall T, 2002, BMJ-BRIT MED J, V325, P197, DOI 10.1136/bmj.325.7357.197; Marteau TM, 2002, BRIT MED J, V325, P78, DOI 10.1136/bmj.325.7355.78; Midthjell K, 1999, DIABETES CARE, V22, P1813, DOI 10.2337/diacare.22.11.1813; OTTERSTAD JE, NEW EUROPEAN GUIDELI; PEDERSEN TR, 1994, LANCET, V344, P1383; Phillips LS, 2001, ANN INTERN MED, V135, P825, DOI 10.7326/0003-4819-135-9-200111060-00012; Reynolds TM, 2004, CURR MED RES OPIN, V20, P811, DOI 10.1185/030079904125003647; Shekelle PG, 1999, BRIT MED J, V318, P593, DOI 10.1136/bmj.318.7183.593; TUNSTALL-PEDOE H, 2003, MONICA MONOGRAPH MUL; van Steenkiste B, 2004, PATIENT EDUC COUNS, V55, P301, DOI 10.1016/j.pec.2003.11.005; van Steenkiste B, 2004, SCAND J PRIM HEALTH, V22, P32, DOI 10.1080/02813430310004489; *WHO, EUR HLTH ALL; *WHO, COR HLTH IND NORW; World Health Organization, COR HLTH IND; World Health Organization, EUR HLTH ALL DAT; Yarnall KSH, 2003, AM J PUBLIC HEALTH, V93, P635, DOI 10.2105/AJPH.93.4.635	27	67	68	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2005	331	7516					551	554A		10.1136/bmj.38555.648623.8F	http://dx.doi.org/10.1136/bmj.38555.648623.8F			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965GX	16103030	Green Published, Bronze			2022-12-01	WOS:000231939700018
J	Glatter, KA; Chiamvimonvat, N; Viitasalo, M; Wang, Q; Tuteja, D				Glatter, KA; Chiamvimonvat, N; Viitasalo, M; Wang, Q; Tuteja, D			Risk stratification in Brugada syndrome	LANCET			English	Editorial Material							ST-SEGMENT-ELEVATION; SUDDEN CARDIAC DEATH; BUNDLE-BRANCH BLOCK; INDIVIDUALS		Univ Calif Davis, Dept Cardiol, Sacramento, CA 95817 USA; Univ Helsinki Hosp, Dept Cardiol, Helsinki, Finland; Cleveland Clin Fdn, Ctr Cardiovasc Genet, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Mol Cardiol Cardiol, Cleveland, OH 44195 USA	University of California System; University of California Davis; University of Helsinki; Helsinki University Central Hospital; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Glatter, KA (corresponding author), Univ Calif Davis, Dept Cardiol, Sacramento, CA 95817 USA.	kaglatter@ucdavis.edu			NHLBI NIH HHS [R01 HL066251] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066251] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Antzelevitch C, 2005, CIRCULATION, V111, P659, DOI 10.1161/01.CIR.0000152479.54298.51; Belhassen B, 2004, CIRCULATION, V110, P1731, DOI 10.1161/01.CIR.0000143159.30585.90; Brugada J, 2003, CIRCULATION, V108, P3092, DOI 10.1161/01.CIR.0000104568.13957.4F; BRUGADA P, 1992, J AM COLL CARDIOL, V20, P1391, DOI 10.1016/0735-1097(92)90253-J; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Eckardt L, 2005, CIRCULATION, V111, P257, DOI 10.1161/01.CIR.0000153267.21278.8D; Glatter KA, 2004, AM J CARDIOL, V93, P1320, DOI 10.1016/j.amjcard.2004.02.023; Priori SG, 2000, CIRCULATION, V102, P2509, DOI 10.1161/01.CIR.102.20.2509; Priori SG, 2002, CIRCULATION, V105, P1342, DOI 10.1161/hc1102.105288; Veerakul G, 2000, Cardiol Rev, V8, P90, DOI 10.1097/00045415-200008020-00005; Wang Q, 1996, GENOMICS, V34, P9, DOI 10.1006/geno.1996.0236	11	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 13	2005	366	9485					530	531		10.1016/S0140-6736(05)67078-X	http://dx.doi.org/10.1016/S0140-6736(05)67078-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	955LL	16099276	Green Accepted			2022-12-01	WOS:000231227300008
J	Abe, M; Kobayashi, Y; Yamamoto, S; Daimon, Y; Yamaguchi, A; Ikeda, Y; Ichinoki, H; Notaguchi, M; Goto, K; Araki, T				Abe, M; Kobayashi, Y; Yamamoto, S; Daimon, Y; Yamaguchi, A; Ikeda, Y; Ichinoki, H; Notaguchi, M; Goto, K; Araki, T			FD, a bZIP protein mediating signals from the floral pathway integrator FT at the shoot apex	SCIENCE			English	Article							FLOWERING-TIME GENES; ARABIDOPSIS; CONSTANS; ACTIVATION; ROLES; APETALA1; IDENTITY; LEAFY; RICE	FLOWERING LOCUS T (FT) is a conserved promoter of flowering that acts downstream of various regulatory pathways, including one that mediates photoperiodic induction through CONSTANS (CO), and is expressed in the vasculature of cotyledons and leaves. A bZIP transcription factor, FD, preferentially expressed in the shoot apex is required for FT to promote flowering. FD and FT are interdependent partners through protein interaction and act at the shoot apex to promote floral transition and to initiate floral development through transcriptional activation of a floral meristem identity gene, APETALA1 (AP1). FT may represent a long-distance signal in flowering.	Kyoto Univ, Grad Sch Sci, Dept Bot, Sakyo Ku, Kyoto 6068502, Japan; Japan Sci & Technol Agcy, CREST, Kawaguchi 3320012, Japan; Res Inst Biol Sci Okayama, Okayama 7161241, Japan; Natl Inst Genet, Adjunct Div Appl Genet, Mishima, Shizuoka 4118540, Japan	Kyoto University; Japan Science & Technology Agency (JST); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Araki, T (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Bot, Sakyo Ku, Kyoto 6068502, Japan.	taraqui@cosmos.bot.kyoto-u.ac.jp	Araki, Takashi/G-1760-2013; Notaguchi, Michitaka/AAL-8676-2021; Abe, Mitsutomo/AAX-4110-2021; Abe, Mitsutomo/Y-6065-2019; Notaguchi, Michitaka/GVS-9676-2022	Araki, Takashi/0000-0002-3616-1493; Abe, Mitsutomo/0000-0002-8423-1716; Ikeda, Yoko/0000-0002-3150-8902				An HL, 2004, DEVELOPMENT, V131, P3615, DOI 10.1242/dev.01231; CHAILAKHYAN MK, 1937, DOKL AKAD NAUK SSSR, V16, P227; Ferrandiz C, 2000, DEVELOPMENT, V127, P725; Hayama R, 2003, NATURE, V422, P719, DOI 10.1038/nature01549; Hempel FD, 1997, DEVELOPMENT, V124, P3845; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Lee H, 2000, GENE DEV, V14, P2366, DOI 10.1101/gad.813600; Liljegren SJ, 1999, PLANT CELL, V11, P1007, DOI 10.1105/tpc.11.6.1007; Nilsson O, 1998, GENETICS, V150, P403; Onouchi H, 2000, PLANT CELL, V12, P885, DOI 10.1105/tpc.12.6.885; Ratcliffe OJ, 1999, DEVELOPMENT, V126, P1109; RuizGarcia L, 1997, PLANT CELL, V9, P1921, DOI 10.1105/tpc.9.11.1921; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Takada S, 2003, PLANT CELL, V15, P2856, DOI 10.1105/tpc.016345; Yamaguchi A, 2005, PLANT CELL PHYSIOL, V46, P1175, DOI 10.1093/pcp/pci151; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996; ZEEVAART JAD, 1976, ANNU REV PLANT PHYS, V27, P321, DOI 10.1146/annurev.pp.27.060176.001541	24	1055	1234	26	332	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2005	309	5737					1052	1056		10.1126/science.1115983	http://dx.doi.org/10.1126/science.1115983			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955MN	16099979				2022-12-01	WOS:000231230100039
J	Redhead, J; Ward, P; Batrick, N				Redhead, J; Ward, P; Batrick, N			The London attacks - Response - Prehospital and hospital care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									St Marys Hosp, Dept Accid & Emergency, London, England	Imperial College London	Redhead, J (corresponding author), St Marys Hosp, Dept Accid & Emergency, London, England.								0	20	20	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 11	2005	353	6					546	547		10.1056/NEJMp058178	http://dx.doi.org/10.1056/NEJMp058178			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	953ST	16093461				2022-12-01	WOS:000231101500003
J	Benitah, SA; Frye, M; Glogauer, M; Watt, FM				Benitah, SA; Frye, M; Glogauer, M; Watt, FM			Stem cell depletion through epidermal deletion of Rac1	SCIENCE			English	Article							LABEL-RETAINING CELLS; MOUSE EPIDERMIS; MYC ACTIVATION; RHO-GTPASES; DIFFERENTIATION; PROLIFERATION	Mammalian epidermis is maintained by self-renewal of stem cells, but the underlying mechanisms are unknown. Deletion of Rac1, a Rho guanosine triphosphatase, in adult mouse epidermis stimulated stem cells to divide and undergo terminal differentiation, leading to failure to maintain the interfollicular epidermis, hair follicles, and sebaceous glands. Rac1 exerts its effects in the epidermis by negatively regulating c-Myc through p21-activated kinase 2 (PAK2) phosphorylation. We conclude that a pleiotropic regulator of cell adhesion and the cytoskeleton plays a critical role in controlling exit from the stem cell niche and propose that Rac and Myc represent a global stem cell regulatory axis.	Canc Res UK London Res Inst, Keratinocyte Lab, London WC2A 3PX, England; Univ Toronto, Fac Dent, Toronto, ON M5S 1A8, Canada	Cancer Research UK; University of Toronto	Watt, FM (corresponding author), Canc Res UK London Res Inst, Keratinocyte Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	fiona.watt@cancer.org.uk	Glogauer, Michael/D-2504-2011; Aznar-Benitah, Salvador/F-4761-2016; Watt, Fiona/AHB-0226-2022	Aznar-Benitah, Salvador/0000-0002-9059-5049; Watt, Fiona/0000-0001-9151-5154; Frye, Michaela/0000-0002-5636-6840; Glogauer, Michael/0000-0002-6248-5977				Arnold I, 2001, CURR BIOL, V11, P558, DOI 10.1016/S0960-9822(01)00154-3; Benitah SA, 2004, BBA-REV CANCER, V1705, P121, DOI 10.1016/j.bbcan.2004.10.002; BENITAH SA, UNPUB; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Frye M, 2003, DEVELOPMENT, V130, P2793, DOI 10.1242/dev.00462; Gandarillas A, 1997, GENE DEV, V11, P2869, DOI 10.1101/gad.11.21.2869; Glogauer M, 2003, J IMMUNOL, V170, P5652, DOI 10.4049/jimmunol.170.11.5652; Gu Y, 2003, SCIENCE, V302, P445, DOI 10.1126/science.1088485; Hong KU, 2004, AM J PATHOL, V164, P577, DOI 10.1016/S0002-9440(10)63147-1; Huang ZD, 2004, MOL CELL BIOL, V24, P1582, DOI 10.1128/MCB.24.4.1582-1594.2004; Legg J, 2003, DEVELOPMENT, V130, P6049, DOI 10.1242/dev.00837; Morris RJ, 1999, J INVEST DERMATOL, V112, P470, DOI 10.1046/j.1523-1747.1999.00537.x; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Murphy MJ, 2005, TRENDS CELL BIOL, V15, P128, DOI 10.1016/j.tcb.2005.01.008; Owens DM, 2003, NAT REV CANCER, V3, P444, DOI 10.1038/nrc1096; Stappenbeck TS, 2000, DEVELOPMENT, V127, P2629; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Waikel RL, 2001, NAT GENET, V28, P165, DOI 10.1038/88889; Walmsley MJ, 2003, SCIENCE, V302, P459, DOI 10.1126/science.1089709; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399	21	213	220	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2005	309	5736					933	935		10.1126/science.1113579	http://dx.doi.org/10.1126/science.1113579			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953SS	16081735				2022-12-01	WOS:000231101400046
J	Koelle, K; Rodo, X; Pascual, M; Yunus, M; Mostafa, G				Koelle, K; Rodo, X; Pascual, M; Yunus, M; Mostafa, G			Refractory periods and climate forcing in cholera dynamics	NATURE			English	Article							RURAL BANGLADESH; ENDEMIC CHOLERA; VARIABILITY; ENSO	Outbreaks of many infectious diseases, including cholera, malaria and dengue, vary over characteristic periods longer than 1 year(1,2). Evidence that climate variability drives these interannual cycles has been highly controversial, chiefly because it is difficult to isolate the contribution of environmental forcing while taking into account nonlinear epidemiological dynamics generated by mechanisms such as host immunity(2-4). Here we show that a critical interplay of environmental forcing, specifically climate variability, and temporary immunity explains the interannual disease cycles present in a four-decade cholera time series from Matlab, Bangladesh. We reconstruct the transmission rate, the key epidemiological parameter affected by extrinsic forcing, over time for the predominant strain ( El Tor) with a nonlinear population model that permits a contributing effect of intrinsic immunity. Transmission shows clear interannual variability with a strong correspondence to climate patterns at long periods ( over 7 years, for monsoon rains and Brahmaputra river discharge) and at shorter periods ( under 7 years, for flood extent in Bangladesh, sea surface temperatures in the Bay of Bengal and the El Nino Southern Oscillation). The importance of the interplay between extrinsic and intrinsic factors in determining disease dynamics is illustrated during refractory periods, when population susceptibility levels are low as the result of immunity and the size of cholera outbreaks only weakly reflects climate forcing.	Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; Univ Barcelona, ICREA, E-08028 Barcelona, Spain; Univ Barcelona, Climat Res Lab, E-08028 Barcelona, Spain; Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh	University of Michigan System; University of Michigan; ICREA; University of Barcelona; University of Barcelona; International Centre for Diarrhoeal Disease Research (ICDDR)	Pascual, M (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, 2045 Kraus Nat Sci Bldg,830 N Univ Ave, Ann Arbor, MI 48109 USA.	pascual@umich.edu	Rodó, Xavier/F-7663-2017	Rodó, Xavier/0000-0003-4843-6180	ICREA Funding Source: Custom	ICREA(ICREA)		ANDERSON R M, 1991; [Anonymous], 1990, GEN ADDITIVE MODELS; Bouma MJ, 2001, HYDROBIOLOGIA, V460, P147, DOI 10.1023/A:1013165215074; CLEMENS JD, 1991, LANCET, V337, P883, DOI 10.1016/0140-6736(91)90207-6; De Jong M., 1995, EPIDEMIC MODELS THEI, P84; Dixon PA, 1999, SCIENCE, V283, P1528, DOI 10.1126/science.283.5407.1528; Elsner J. B., 1996, SINGULAR SPECTRUM AN; GLASS RI, 1982, AM J EPIDEMIOL, V116, P959, DOI 10.1093/oxfordjournals.aje.a113498; Glass Roger I., 1992, P129; Hay SI, 2000, P NATL ACAD SCI USA, V97, P9335, DOI 10.1073/pnas.97.16.9335; KAPLAN D, 1995, TXT APPL MATH, P342; KAWAMURA R, 1998, J MET SOC JPN, P76; Koelle K, 2004, AM NAT, V163, P901, DOI 10.1086/420798; Lau NC, 2004, J CLIMATE, V17, P245, DOI 10.1175/1520-0442(2004)017<0245:CGSOAV>2.0.CO;2; Lau NC, 2000, J CLIMATE, V13, P4287, DOI 10.1175/1520-0442(2000)013<4287:IOEOTV>2.0.CO;2; Levine Myron M., 1992, P285; LUI WM, 1987, J MATH BIOL, V25, P359; Parthasarathy B, 1995, RR065 IITM; Pascual M, 2000, SCIENCE, V289, P1766, DOI 10.1126/science.289.5485.1766; Pascual M, 2002, MICROBES INFECT, V4, P237, DOI 10.1016/S1286-4579(01)01533-7; Rodo X, 2002, P NATL ACAD SCI USA, V99, P12901, DOI 10.1073/pnas.182203999; Rogers DJ, 2002, NATURE, V415, P710, DOI 10.1038/415710a; SCHWARTZ IB, 1992, J MATH BIOL, V30, P473, DOI 10.1007/BF00160532; SHUKLA J, 1994, P INT C MONS VAR PRE, P567; SIDDIQUE AK, 1991, LANCET, V337, P1125, DOI 10.1016/0140-6736(91)92789-5; Taubes G, 1997, SCIENCE, V278, P1004, DOI 10.1126/science.278.5340.1004; WALDOR MK, 1994, P NATL ACAD SCI USA, V91, P11388, DOI 10.1073/pnas.91.24.11388; Webster P.J., 2002, METEOROLOGY MILLENNI, V83, P198, DOI DOI 10.1016/S0074-6142(02)80168-1; WOODWARD WE, 1972, AM J EPIDEMIOL, V96, P342, DOI 10.1093/oxfordjournals.aje.a121465; Zhou G, 2004, P NATL ACAD SCI USA, V101, P2375, DOI 10.1073/pnas.0308714100	30	273	280	0	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2005	436	7051					696	700		10.1038/nature03820	http://dx.doi.org/10.1038/nature03820			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951XA	16079845	Green Published			2022-12-01	WOS:000230964500043
J	Krantz, BA; Melnyk, RA; Zhang, S; Juris, SJ; Lacy, DB; Wu, ZY; Finkelstein, A; Collier, RJ				Krantz, BA; Melnyk, RA; Zhang, S; Juris, SJ; Lacy, DB; Wu, ZY; Finkelstein, A; Collier, RJ			A phenylalanine clamp catalyzes protein translocation through the anthrax toxin pore	SCIENCE			English	Article							PROTECTIVE ANTIGEN CHANNEL; POTASSIUM CHANNEL; LETHAL; MUTATIONS; BILAYERS; RECEPTOR; BLOCK	The protective antigen component of anthrax toxin forms a homoheptameric pore in the endosomal membrane, creating a narrow passageway for the enzymatic components of the toxin to enter the cytosol. We found that, during conversion of the heptameric precursor to the pore, the seven phenylalanine-427 residues converged within the lumen, generating a radially symmetric heptad of solvent-exposed aromatic rings. This "phi-clamp" structure was required for protein translocation and comprised the major conductance-blocking site for hydrophobic drugs and mode[ cations. We conclude that the clamp serves a chaperone-like function, interacting with hydrophobic sequences presented by the protein substrate as it unfolds during translocation.	Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA	Harvard University; Harvard Medical School; Yeshiva University; Albert Einstein College of Medicine	Collier, RJ (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, 200 Longwood Ave, Boston, MA 02115 USA.	jcollier@hms.harvard.edu	Melnyk, Roman/GQA-9908-2022; Lacy, D. Borden/AFQ-2203-2022	Collier, R John/0000-0002-2427-4239; Krantz, Bryan/0000-0002-4911-5824; Lacy, Borden/0000-0003-2273-8121	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI062204, R01AI022021, R37AI022021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029210, R37GM029210] Funding Source: NIH RePORTER; NIAID NIH HHS [F32 AI062204-01, R37 AI022021, F32 AI062204, AI022021, AI062204] Funding Source: Medline; NIGMS NIH HHS [GM29210, R37 GM029210] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Benson EL, 1998, BIOCHEMISTRY-US, V37, P3941, DOI 10.1021/bi972657b; BLAUSTEIN RO, 1989, P NATL ACAD SCI USA, V86, P2209, DOI 10.1073/pnas.86.7.2209; BLAUSTEIN RO, 1990, J GEN PHYSIOL, V96, P905, DOI 10.1085/jgp.96.5.905; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; FRIEDLANDER AM, 1986, J BIOL CHEM, V261, P7123; HILLE B, 1968, J GEN PHYSIOL, V51, P199, DOI 10.1085/jgp.51.2.199; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; Krantz BA, 2004, J MOL BIOL, V344, P739, DOI 10.1016/j.jmb.2004.09.067; KRANTZ BA, UNPUB; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P13147, DOI 10.1073/pnas.0405405101; Miller CJ, 1999, BIOCHEMISTRY-US, V38, P10432, DOI 10.1021/bi990792d; Mourez M, 2003, P NATL ACAD SCI USA, V100, P13803, DOI 10.1073/pnas.2436299100; Nassi S, 2002, BIOCHEMISTRY-US, V41, P1445, DOI 10.1021/bi0119518; Orlik F, 2005, BIOPHYS J, V88, P1715, DOI 10.1529/biophysj.104.050336; SCHIRMER T, 1995, SCIENCE, V267, P512, DOI 10.1126/science.7824948; Sellman BR, 2001, J BIOL CHEM, V276, P8371, DOI 10.1074/jbc.M008309200; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Wesche J, 1998, BIOCHEMISTRY-US, V37, P15737, DOI 10.1021/bi981436i; WESSON L, 1992, PROTEIN SCI, V1, P227; Zacharias N, 2002, TRENDS PHARMACOL SCI, V23, P281, DOI 10.1016/S0165-6147(02)02027-8; Zhang S, 2004, P NATL ACAD SCI USA, V101, P16756, DOI 10.1073/pnas.0405754101; Zhang S, 2004, BIOPHYS J, V87, P3842, DOI 10.1529/biophysj.104.050864; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500	24	232	241	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2005	309	5735					777	781		10.1126/science.1113380	http://dx.doi.org/10.1126/science.1113380			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951NU	16051798	Green Accepted			2022-12-01	WOS:000230938200052
J	Remy, JJ; Hobert, O				Remy, JJ; Hobert, O			An interneural chemoreceptor required for olfactory imprinting in C-elegans	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; NERVOUS-SYSTEM; RECEPTORS; GENES; NEURONS	Animals alter their behavioral patterns in an experience-dependent manner. Olfactory imprinting is a process in which the exposure of animals to olfactory cues during specific and restricted time windows leaves a permanent memory ("olfactory imprint") that shapes the animal's behavior upon encountering the olfactory cues at later times. We found that Caenorhabditis elegans displays olfactory imprinting behavior that is mediated by a single pair of interneurons. To function in olfactory imprinting, this interneuron pair must express a G protein-coupled chemoreceptor family member encoded by the Sra-11 gene. Our study provides insights into the cellular and molecular basis of olfactory imprinting and reveals a function for a chemosensory receptor family member in interneurons.	Inst Dev Biol, CNRS, UMR 6156, Lab NMDA, F-13288 Marseille, France; Columbia Univ, Med Ctr, Ctr Neurobiol & Behav, Dept Biochem & Mol Biophys,Howard Hughes Med Inst, New York, NY 10032 USA	Centre National de la Recherche Scientifique (CNRS); Columbia University; Howard Hughes Medical Institute	Remy, JJ (corresponding author), Inst Dev Biol, CNRS, UMR 6156, Lab NMDA, F-13288 Marseille, France.	remy@ibdm.univ-mrs.fr; or38@columbia.edu		Hobert, Oliver/0000-0002-7634-2854	NINDS NIH HHS [NS039996-05] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039996, R37NS039996] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Altun-Gultekin Z, 2001, DEVELOPMENT, V128, P1951; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Hobert O, 2003, J NEUROBIOL, V54, P203, DOI 10.1002/neu.10168; Hudson Robyn, 1993, Current Opinion in Neurobiology, V3, P548, DOI 10.1016/0959-4388(93)90054-3; Sullivan RM, 2003, ANN NY ACAD SCI, V1008, P122, DOI 10.1196/annals.1301.013; TRENT C, 1982, THESIS MIT; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Tsalik EL, 2003, DEV BIOL, V263, P81, DOI 10.1016/S0012-1606(03)00447-0; Tsalik EL, 2003, J NEUROBIOL, V56, P178, DOI 10.1002/neu.10245; TSALIK EL, 2003, THESIS COLUMBIA U; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	12	65	72	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2005	309	5735					787	790		10.1126/science.1114209	http://dx.doi.org/10.1126/science.1114209			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951NU	16051801				2022-12-01	WOS:000230938200055
J	Pagani, M; Zachos, JC; Freeman, KH; Tipple, B; Bohaty, S				Pagani, M; Zachos, JC; Freeman, KH; Tipple, B; Bohaty, S			Marked decline in atmospheric carbon dioxide concentrations during the Paleogene	SCIENCE			English	Article							DRILLING PROJECT LEG-71; ISOTOPE FRACTIONATION; C-4 PHOTOSYNTHESIS; SOUTHWEST ATLANTIC; EMILIANIA-HUXLEYI; FALKLAND PLATEAU; MIDDLE EOCENE; CO2; EVOLUTION; OCEAN	The relation between the partial pressure of atmospheric carbon dioxide (pCO(2)) and Paleogene climate is poorly resolved. We used stable carbon isotopic values of di-unsaturated alkenones extracted from deep sea cores to reconstruct pCO(2) from the middle Eocene to the late Oligocene (similar to 45 to 25 million years ago). Our results demonstrate that pCO(2) ranged between 1000 to 1500 parts per million by volume in the middle to late Eocene, then decreased in several steps during the Oligocene, and reached modem levels by the latest Oligocene. The fall in pCO(2) likely allowed for a critical expansion of ice sheets on Antarctica and promoted conditions that forced the onset of terrestrial C-4 photosynthesis.	Yale Univ, Dept Geol & Geophys, New Haven, CT 06511 USA; Univ Calif Santa Cruz, Dept Earth Sci, Santa Cruz, CA 95064 USA; Penn State Univ, Dept Geosci, University Pk, PA 16802 USA	Yale University; University of California System; University of California Santa Cruz; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Pagani, M (corresponding author), Yale Univ, Dept Geol & Geophys, 210 Whitney Ave, New Haven, CT 06511 USA.		Zachos, James C/A-7674-2008; Pagani, Mark/B-3233-2008; Freeman, Katherine H/H-5140-2011	Zachos, James C/0000-0001-8439-1886; Freeman, Katherine H/0000-0002-3350-7671				BACKMAN J, 1986, PALAEOGEOGR PALAEOCL, V57, P103, DOI 10.1016/0031-0182(86)90009-X; BASOV IA, 1983, INITIAL REP DEEP SEA, V71, P445; BERGGREN WA, 1995, SEPM SPECIAL PUBLICA, V54; Berner RA, 2001, AM J SCI, V301, P182, DOI 10.2475/ajs.301.2.182; Bidigare RR, 1999, GLOBAL BIOGEOCHEM CY, V13, P251, DOI 10.1029/1998GB900011; Bidigare RR, 1997, GLOBAL BIOGEOCHEM CY, V11, P279, DOI 10.1029/96GB03939; Bohaty SM, 2003, GEOLOGY, V31, P1017, DOI 10.1130/G19800.1; Browning JV, 1996, GEOLOGY, V24, P639, DOI 10.1130/0091-7613(1996)024<0639:GIOLTM>2.3.CO;2; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; CONTE MH, 1994, HAPTOPHYTE ALGAE, P351; Coxall HK, 2005, NATURE, V433, P53, DOI 10.1038/nature03135; DeConto RM, 2003, NATURE, V421, P245, DOI 10.1038/nature01290; Eek MK, 1999, DEEP-SEA RES PT II, V46, P2863, DOI 10.1016/S0967-0645(99)00086-7; EHLERINGER JR, 1991, TRENDS ECOL EVOL, V6, P95, DOI 10.1016/0169-5347(91)90183-X; Ennyu A, 2002, MAR MICROPALEONTOL, V46, P317, DOI 10.1016/S0377-8398(02)00079-8; EREZ J, 1983, GEOCHIM COSMOCHIM AC, V47, P1025, DOI 10.1016/0016-7037(83)90232-6; Fox DL, 2003, GEOLOGY, V31, P809, DOI 10.1130/G19580.1; FREEMAN KH, 2005, HIST ATMOSPHERIC CO2, P35, DOI DOI 10.1007/0-387-27048-5_3; Gaut BS, 1997, P NATL ACAD SCI USA, V94, P6809, DOI 10.1073/pnas.94.13.6809; HATCH MD, 1987, BIOCHIM BIOPHYS ACTA, V895, P81, DOI 10.1016/S0304-4173(87)80009-5; KELLOGG EA, 1999, C4 PLANT BIOL, P313; Laws EA, 2001, GEOCHEM GEOPHY GEOSY, V2, DOI 10.1029/2000GC000057; LECKIE RM, 1993, P OCEAN DRILLING PRO, V0130; MILLER K G, 1991, Palaios, V6, P17, DOI 10.2307/3514951; Miller KG, 1987, PALEOCEANOGRAPHY, V2, P1, DOI 10.1029/PA002i001p00001; MOOK WG, 1974, EARTH PLANET SC LETT, V22, P169, DOI 10.1016/0012-821X(74)90078-8; Pagani M, 1999, PALEOCEANOGRAPHY, V14, P273, DOI 10.1029/1999PA900006; Pagani M, 1999, SCIENCE, V285, P876, DOI 10.1126/science.285.5429.876; Pagani M, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2002PA000756; Pagani M, 2000, PALEOCEANOGRAPHY, V15, P486, DOI 10.1029/1999PA000484; PEARCY RW, 1984, PLANT CELL ENVIRON, V7, P1, DOI 10.1111/j.1365-3040.1984.tb01194.x; Pearson PN, 2000, NATURE, V406, P695, DOI 10.1038/35021000; Pearson PN, 2001, NATURE, V413, P481, DOI 10.1038/35097000; Popp BN, 1998, PALEOCEANOGRAPHY, V13, P35, DOI 10.1029/97PA02594; Popp BN, 1998, GEOCHIM COSMOCHIM AC, V62, P69, DOI 10.1016/S0016-7037(97)00333-5; Popp BN, 1999, RECONSTRUCTING OCEAN HISTORY, P381; PUJOL C, 1983, INITIAL REP DEEP SEA, V72, P623; RAYMO ME, 1991, GEOLOGY, V19, P344, DOI 10.1130/0091-7613(1991)019<0344:GESTCC>2.3.CO;2; Riebesell U, 2000, GEOCHIM COSMOCHIM AC, V64, P4179, DOI 10.1016/S0016-7037(00)00474-9; Robert C, 1997, GEOLOGY, V25, P587, DOI 10.1130/0091-7613(1997)025<0587:ACWCDE>2.3.CO;2; ROMANEK CS, 1992, GEOCHIM COSMOCHIM AC, V56, P419, DOI 10.1016/0016-7037(92)90142-6; Rost B, 2003, LIMNOL OCEANOGR, V48, P55, DOI 10.4319/lo.2003.48.1.0055; ROYER DL, 2001, NATURE, V292, P2310; Sage RF, 2004, NEW PHYTOL, V161, P341, DOI 10.1111/j.1469-8137.2004.00974.x; Schrag DP, 1999, CHEM GEOL, V161, P215, DOI 10.1016/S0009-2541(99)00088-1; SHACKLETON NJ, 1984, INITIAL REP DEEP SEA, V74, P599; Shackleton NJ, 1975, INITIAL REPORTS DEEP, V29, P743, DOI DOI 10.2973/DSDP.PROC.29.117.1975; Stott L.D., 1990, Proceedings of the Ocean Drilling Program Scientific Results, V113, P849, DOI 10.2973/odp.proc.sr.113.187.1990; VALENTINE PC, 1987, INITIAL REP DEEP SEA, V95, P359; WEI WC, 1989, MAR MICROPALEONTOL, V14, P119, DOI 10.1016/0377-8398(89)90034-0; Weiss R. F., 1974, MAR CHEM, V2, P203, DOI DOI 10.1016/0304-4203(74)90015-2; WISE SW, 1983, INITIAL REP DEEP SEA, V71, P481; Young John W., COMMUNICATION; YOUNGDAHL CK, 1990, INT J IMPACT ENG, V9, P71, DOI 10.1016/0734-743X(90)90023-O; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 1996, PALEOCEANOGRAPHY, V11, P251, DOI 10.1029/96PA00571; Zachos JC, 1999, CHEM GEOL, V161, P165, DOI 10.1016/S0009-2541(99)00085-6; ZACHOS JC, 1994, PALEOCEANOGRAPHY, V9, P353, DOI 10.1029/93PA03266	58	639	676	6	218	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 22	2005	309	5734					600	603		10.1126/science.1110063	http://dx.doi.org/10.1126/science.1110063			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SE	15961630				2022-12-01	WOS:000230735200045
J	Jha, AK; Li, ZH; Orav, EJ; Epstein, AM				Jha, AK; Li, ZH; Orav, EJ; Epstein, AM			Care in US hospitals - The Hospital Quality Alliance Program.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; OF-CARE; MEDICARE BENEFICIARIES; MYOCARDIAL-INFARCTION; GUIDELINES; MANAGEMENT; MORTALITY; OUTCOMES; ADULTS	Background: The Hospital Quality Alliance (HQA) is the first initiative that routinely reports data on hospitals' performance nationally. Heretofore, such data have been unavailable. Methods: We used data collected by the Centers for Medicare and Medicaid Services on 10 indicators of the quality of care for acute myocardial infarction, congestive heart failure, and pneumonia. The main outcome measures were hospitals' performance with respect to each indicator and summary scores for each clinical condition. Predictors of a high level of performance were determined with the use of multivariable linear regression. Results: A total of 3558 hospitals reported data on at least one stable measure (defined as information obtained from discharge data from at least 25 patients) during the first half of 2004. Median performance scores (expressed as the percentage of patients who satisfied the criterion) were at least 90 percent for 5 of the 10 measures but lower for the other 5. Performance varied moderately among large hospital-referral regions, with the top-ranked regions scoring 12 percentage points (for acute myocardial infarction) to 23 percentage points (for pneumonia) higher than the bottom-ranked regions. A high quality of care for acute myocardial infarction predicted a high quality of care for congestive heart failure but was only marginally better than chance at predicting a high quality of care for pneumonia. Characteristics associated with small but significant increases in performance included being an academic hospital, being in the Northeast or Midwest, and being a not-for-profit hospital. Conclusions: Analysis of data from the new HQA national reporting system shows that performance varies among hospitals and across indicators. Given this variation and small differences based on hospitals' characteristics, performance reporting will probably need to include numerous clinical conditions from a broad range of hospitals.	Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Gen Med, Boston, MA 02115 USA; Boston Vet Affairs Healthcare Syst, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	Jha, AK (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.	ajha@hsph.harvard.edu						Allison JJ, 2000, JAMA-J AM MED ASSOC, V284, P1256, DOI 10.1001/jama.284.10.1256; Antman Elliott M., 2004, J Am Coll Cardiol, V44, pE1, DOI 10.1016/j.jacc.2004.07.014; Ayanian JZ, 2002, MILBANK Q, V80, P569, DOI 10.1111/1468-0009.00023; Bradley EH, 2001, JAMA-J AM MED ASSOC, V285, P2604, DOI 10.1001/jama.285.20.2604; Devereaux PJ, 2002, JAMA-J AM MED ASSOC, V288, P2449, DOI 10.1001/jama.288.19.2449; DEVEREAUX PJ, 2004, JAMA-J AM MED ASSOC, V291, P186; Friend JAR, 2001, THORAX, V56, P1, DOI 10.1136/thorax.56.1.1; Galvin R, 2002, NEW ENGL J MED, V347, P939, DOI 10.1056/NEJMsb012850; Institute of Medicine, 2001, CROSSING QUALITY CHA; Jencks SF, 2003, JAMA-J AM MED ASSOC, V289, P305, DOI 10.1001/jama.289.3.305; Jencks SF, 2002, JAMA-J AM MED ASSOC, V289, P2649; Mandell LA, 2003, CLIN INFECT DIS, V37, P1405, DOI 10.1086/380488; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Meehan TP, 1997, JAMA-J AM MED ASSOC, V278, P2080, DOI 10.1001/jama.278.23.2080; Milstein A, 2000, Eff Clin Pract, V3, P313; MILSTEIN A, 2001, EFF CLIN PRACT, V4, P94; *NAT COMM QUAL ASS, 2005, HEDIS 2005, V2; Niederman MS, 2001, AM J RESP CRIT CARE, V163, P1730, DOI 10.1164/ajrccm.163.7.at1010; Sloan FA, 2003, MED CARE, V41, P1193, DOI 10.1097/01.MLR.0000088569.50763.15; Wennberg JE, 1999, DARTMOUTH ATLAS HLTH; Williams SC, 2005, NEW ENGL J MED, V353, P255, DOI 10.1056/NEJMsa043778	22	372	374	1	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2005	353	3					265	274		10.1056/NEJMsa051249	http://dx.doi.org/10.1056/NEJMsa051249			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946YH	16034012				2022-12-01	WOS:000230608700007
J	Rosen, RC				Rosen, RC			Reproductive health problems in ageing men	LANCET			English	Editorial Material							URINARY-TRACT SYMPTOMS; BENIGN PROSTATIC HYPERPLASIA; RANDOMIZED CONTROLLED-TRIAL; ERECTILE DYSFUNCTION; SEXUAL DYSFUNCTION; POPULATION; PREVALENCE		Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Rosen, RC (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA.	rosen@umdnj.edu						Araujo AB, 1998, PSYCHOSOM MED, V60, P458, DOI 10.1097/00006842-199807000-00011; Bacon CG, 2003, ANN INTERN MED, V139, P161, DOI 10.7326/0003-4819-139-3-200308050-00005; Brookes ST, 2002, BRIT MED J, V324, P1059, DOI 10.1136/bmj.324.7345.1059; Esposito K, 2004, JAMA-J AM MED ASSOC, V291, P2978, DOI 10.1001/jama.291.24.2978; FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1; HOPPS CV, 2003, J UROL S4, V169, P168; Kaiser DR, 2004, J AM COLL CARDIOL, V43, P179, DOI 10.1016/j.jacc.2003.07.042; Kirby M, 2001, INT J CLIN PRACT, V55, P614; MAATMAN TJ, 1987, UROLOGY, V29, P589, DOI 10.1016/0090-4295(87)90097-5; McVary KT, 2003, BJU INT, V91, P770, DOI 10.1046/j.1464-410X.2003.04252.x; Narayan P, 2001, UROLOGY, V57, P466, DOI 10.1016/S0090-4295(00)01042-6; Nicolosi A, 2003, INT J IMPOT RES, V15, P253, DOI 10.1038/sj.ijir.3901010; Rosen R, 2003, EUR UROL, V44, P637, DOI 10.1016/j.eururo.2003.08.015; Rosen RC, 2004, CURR MED RES OPIN, V20, P607, DOI 10.1185/030079904125003467	14	14	14	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 16	2005	366	9481					183	185		10.1016/S0140-6736(05)66885-7	http://dx.doi.org/10.1016/S0140-6736(05)66885-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	945RG	16023492				2022-12-01	WOS:000230519200006
J	Dagan, R; Leventhal, A; Anis, E; Slater, P; Ashur, Y; Shouval, D				Dagan, R; Leventhal, A; Anis, E; Slater, P; Ashur, Y; Shouval, D			Incidence of hepatitis A in Israel following universal immunization of toddlers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMMUNITY-WIDE OUTBREAK; VIRAL-HEPATITIS; RISK-FACTORS; VACCINATION; IMMUNOGENICITY; EPIDEMIOLOGY; SURVEILLANCE; TRANSMISSION; PROTECTION; PROGRAM	Context In Israel, the mean annual incidence of hepatitis A disease was 50.4 per 100 000 during 1993-1998. A 2-dose universal hepatitis A immunization program aimed at children aged 18 and 24 months (without a catch-up campaign) was started in 1999. Objective To observe the impact of toddlers-only universal vaccination on hepatitis A virus disease in Israel. Design and Setting Ongoing passive national surveillance of hepatitis A cases in Israel has been conducted since 1993 by the Ministry of Health. An active surveillance program in the Jerusalem district in 1999-2003 provided validation for the passive program. Main Outcome Measure Incidence of reported hepatitis A disease, 1993-2004. Results Overall vaccine coverage in Israel in 2001-2002 was 90% for the first dose and 85% for the second dose. A decline in disease rates was observed before 1999 among the Jewish but not the non-Jewish population. After initiation of the program, a sharp decrease in disease rates was observed in both populations. The annual incidence of 2.2 to 2.5 per 100000 during 2002-2004 represents a 95% or greater reduction for each year with respect to the mean incidence during 1993-1998 (P<.001). For children aged 1 through 4 years, a 98.2% reduction in disease was observed in 2002-2004, compared with the prevaccination period (P<.001). However, a sharp decline was also observed in all other age groups (84.3% [<1 year], 96.5% [5-9 years], 95.2% [10-14 years], 91.3% [15-44 years], 90.6% [45-64 years], and 77.3% [ >= 65 years]). Among the Jewish population in the Jerusalem district, in whom the active surveillance program was successfully conducted, a more than 90% reduction of disease was demonstrated. Of the 433 cases reported nationwide in 2002-2004 in whom vaccination status could be ascertained, 424 (97.9%) received no vaccine and none received 2 doses. Conclusion This universal toddlers-only immunization program in Israel demonstrated not only high effectiveness of hepatitis A vaccination but also marked herd protection, challenging the need for catch-up hepatitis A vaccination programs.	Soroka Univ Med Ctr, Pediat Infect Dis Unit, IL-84101 Beer Sheva, Israel; Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel; Minist Hlth, Publ Hlth Serv, Jerusalem, Israel; Minist Hlth, Dept Infect Dis, Jerusalem, Israel; Minist Hlth, Dept Epidemiol, Jerusalem, Israel; Hadassah Hebrew Univ, Liver Unit, Jerusalem, Israel	Ben Gurion University; Soroka Medical Center; Ben Gurion University; Hebrew University of Jerusalem; Hadassah University Medical Center	Dagan, R (corresponding author), Soroka Univ Med Ctr, Pediat Infect Dis Unit, POB 151, IL-84101 Beer Sheva, Israel.	rdagan@bgu.ac.il	Shouval, Daniel/U-2779-2017	Shouval, Daniel/0000-0002-0512-6513				Allard R, 2001, J EPIDEMIOL COMMUN H, V55, P251, DOI 10.1136/jech.55.4.251; ALTER MJ, 1987, AM J EPIDEMIOL, V125, P133, DOI 10.1093/oxfordjournals.aje.a114496; Andre Francis, 2002, Expert Rev Vaccines, V1, P9, DOI 10.1586/14760584.1.1.9; Anis Emilia, 2000, Harefuah, V138, P177; [Anonymous], 1999, MMWR Recomm Rep, V48, P1; Armstrong GL, 2002, PEDIATRICS, V109, P839, DOI 10.1542/peds.109.5.839; Averhoff F, 2001, JAMA-J AM MED ASSOC, V286, P2968, DOI 10.1001/jama.286.23.2968; BEHRENS RH, 1994, BRIT MED J, V309, P918, DOI 10.1136/bmj.309.6959.918; Bialek SR, 2004, AM J PUBLIC HEALTH, V94, P996, DOI 10.2105/AJPH.94.6.996; Bovier PA, 2002, J MED VIROL, V68, P489, DOI 10.1002/jmv.10244; *CDCP, 1997, MMWR-MORBID MORTAL W, V46, P600; CLEMENS R, 1995, J INFECT DIS, V171, pS44, DOI 10.1093/infdis/171.Supplement_1.S44; Craig AS, 2004, NEW ENGL J MED, V350, P476, DOI 10.1056/NEJMcp031540; Craig AS, 1998, CLIN INFECT DIS, V27, P531, DOI 10.1086/514700; FATTAL B, 1988, Harefuah, V115, P111; Ginsberg GM, 2001, J HEPATOL, V34, P92, DOI 10.1016/S0168-8278(00)00007-6; GREEN MS, 1989, REV INFECT DIS, V11, P464; Green MS, 2001, ISRAEL MED ASSOC J, V3, P347; GUST ID, 1992, VACCINE, V10, pS56, DOI 10.1016/0264-410X(92)90544-T; HADLER SC, 1980, NEW ENGL J MED, V302, P1222, DOI 10.1056/NEJM198005293022203; HADLER SC, 1991, VIRAL HEPATITIS AND LIVER DISEASE, P14; INNIS BL, 1994, JAMA-J AM MED ASSOC, V271, P1328, DOI 10.1001/jama.271.17.1328; *ISR CENTR BUR STA, 2003, STAT ABSTR ISR; *ISR CTR DIS CONTR, 1999, 7001 ISR MIN HLTH IS; *ISR MIN HLTH, 1999, REP INF COMP SERV DE; Jacobs RJ, 2003, PEDIATR INFECT DIS J, V22, P904, DOI 10.1097/01.inf.0000091295.53969.6a; Koff RS, 1999, NEW ENGL J MED, V340, P644, DOI 10.1056/NEJM199902253400810; LERMAN Y, 1999, HAREFUAH, V136, P514; Lerman Yehuda, 1999, Harefuah, V136, P441; LEVY BS, 1977, AM J EPIDEMIOL, V105, P127, DOI 10.1093/oxfordjournals.aje.a112364; McMahon BJ, 1996, ARCH PEDIAT ADOL MED, V150, P733, DOI 10.1001/archpedi.1996.02170320079014; Meyerhoff AS, 2001, J VIRAL HEPATITIS, V8, P454, DOI 10.1046/j.1365-2893.2001.00317.x; REISLER DM, 1970, AM J EPIDEMIOL, V92, P62, DOI 10.1093/oxfordjournals.aje.a121180; ROSENBLUM LS, 1991, J INFECT DIS, V164, P476, DOI 10.1093/infdis/164.3.476; SHOUVAL D, 1993, VACCINE, V11, pS9, DOI 10.1016/0264-410X(93)90151-M; Smith PF, 1997, EPIDEMIOL INFECT, V118, P243, DOI 10.1017/S0950268897007462; Staes CJ, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.4.e54; VANDAMME P, 1994, J MED VIROL, V44, P446, DOI 10.1002/jmv.1890440425; VOGT RL, 1983, AM J PUBLIC HEALTH, V73, P795, DOI 10.2105/AJPH.73.7.795; WERZBERGER A, 1992, NEW ENGL J MED, V327, P453, DOI 10.1056/NEJM199208133270702; Werzberger A, 2002, VACCINE, V20, P1699, DOI 10.1016/S0264-410X(02)00042-7; *WHO, 1998, B WORLD HEALTH ORGAN, V76, P94; Wiens BL, 1996, J MED VIROL, V49, P235, DOI 10.1002/(SICI)1096-9071(199607)49:3&lt;235::AID-JMV13&gt;3.0.CO;2-B; YAO G, 1990, VIRAL HEPATITIS LIVE; Zamir C, 2001, EUR J CLIN MICROBIOL, V20, P185, DOI 10.1007/s100960100461	45	168	180	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 13	2005	294	2					202	210		10.1001/jama.294.2.202	http://dx.doi.org/10.1001/jama.294.2.202			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944DO	16014594	Bronze			2022-12-01	WOS:000230406100024
J	Radisky, DC; Levy, DD; Littlepage, LE; Liu, H; Nelson, CM; Fata, JE; Leake, D; Godden, EL; Albertson, DG; Nieto, MA; Werb, Z; Bissell, MJ				Radisky, DC; Levy, DD; Littlepage, LE; Liu, H; Nelson, CM; Fata, JE; Leake, D; Godden, EL; Albertson, DG; Nieto, MA; Werb, Z; Bissell, MJ			Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability	NATURE			English	Article							MAMMARY EPITHELIAL-CELLS; OXIDATIVE STRESS; MATRIX METALLOPROTEINASES; SPLICE VARIANT; TUMOR; EXPRESSION; TRANSFORMATION; SUPPRESSION; PROGRESSION; TRANSITION	The tumour microenvironment can be a potent carcinogen, not only by facilitating cancer progression and activating dormant cancer cells, but also by stimulating tumour formation(1). We have previously investigated stromelysin-1/matrix metalloproteinase-3 (MMP-3), a stromal enzyme upregulated in many breast tumours(2), and found that MMP-3 can cause epithelial-mesenchymal transition (EMT) and malignant transformation in cultured cells(3-5), and genomically unstable mammary carcinomas in transgenic mice(3). Here we explain the molecular pathways by which MMP-3 exerts these effects: exposure of mouse mammary epithelial cells to MMP-3 induces the expression of an alternatively spliced form of Rac1, which causes an increase in cellular reactive oxygen species (ROS). The ROS stimulate the expression of the transcription factor Snail and EMT, and cause oxidative damage to DNA and genomic instability. These findings identify a previously undescribed pathway in which a component of the breast tumour microenvironment alters cellular structure in culture and tissue structure in vivo, leading to malignant transformation.	Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Dharmacon Inc, Lafayette, CO 80026 USA; Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA; Inst Neurosci Alicante, Dept Dev Neurobiol, Alacant 03550, Spain	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Bissell, MJ (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA.	dcradisky@lbl.gov; mjbissell@lbl.gov	Radisky, Derek/B-6569-2018; Nelson, Celeste/AAT-7612-2021; Nieto, M. Angela/A-6531-2008	Radisky, Derek/0000-0002-1962-8784; Nelson, Celeste/0000-0001-9973-8870; Nieto, M. Angela/0000-0002-3538-840X	NATIONAL CANCER INSTITUTE [R01CA057621] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA057621-07, R01 CA057621] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; BOUDREAU N, 1995, SCIENCE, V267, P891, DOI 10.1126/science.7531366; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fiegen D, 2004, J BIOL CHEM, V279, P4743, DOI 10.1074/jbc.M310281200; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; JOHNSON RK, 1976, CANCER RES, V36, P2720; Jordan P, 1999, ONCOGENE, V18, P6835, DOI 10.1038/sj.onc.1203233; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kheradmand F, 1998, SCIENCE, V280, P898, DOI 10.1126/science.280.5365.898; Lochter A, 1997, J BIOL CHEM, V272, P5007, DOI 10.1074/jbc.272.8.5007; Lochter A, 1997, J CELL BIOL, V139, P1861, DOI 10.1083/jcb.139.7.1861; Madesh M, 2001, J CELL BIOL, V155, P1003, DOI 10.1083/jcb.200105057; Matos P, 2003, J BIOL CHEM, V278, P50442, DOI 10.1074/jbc.M308215200; Mori K, 2004, CANCER RES, V64, P7464, DOI 10.1158/0008-5472.CAN-04-1725; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Puri PL, 2002, NAT GENET, V32, P585, DOI 10.1038/ng1023; Samper E, 2003, AGING CELL, V2, P277, DOI 10.1046/j.1474-9728.2003.00062.x; Schnelzer A, 2000, ONCOGENE, V19, P3013, DOI 10.1038/sj.onc.1203621; Shin C, 2004, NAT REV MOL CELL BIO, V5, P727, DOI 10.1038/nrm1467; Singh A, 2004, ONCOGENE, V23, P9369, DOI 10.1038/sj.onc.1208182; Snijders AM, 2003, ONCOGENE, V22, P4370, DOI 10.1038/sj.onc.1206482; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Sternlicht MD, 1999, CELL, V98, P137, DOI 10.1016/S0092-8674(00)81009-0; Struthers L, 1998, ANAL BIOCHEM, V255, P20, DOI 10.1006/abio.1997.2354; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; WAHL GM, 1979, J BIOL CHEM, V254, P8679; Werner E, 2002, J CELL BIOL, V158, P357, DOI 10.1083/jcb.200111028	30	951	982	1	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2005	436	7047					123	127		10.1038/nature03688	http://dx.doi.org/10.1038/nature03688			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942QJ	16001073	Green Accepted			2022-12-01	WOS:000230296600051
J	Ng, KL; Li, JD; Cheng, MY; Leslie, FM; Lee, AG; Zhou, QY				Ng, KL; Li, JD; Cheng, MY; Leslie, FM; Lee, AG; Zhou, QY			Dependence of olfactory bulb neurogenesis on prokineticin 2 signaling	SCIENCE			English	Article							NEURONAL MIGRATION; SUBVENTRICULAR ZONE; POSTNATAL NEUROGENESIS; DIRECTIONAL GUIDANCE; FOREBRAIN; PROTEIN; IDENTIFICATION; RECEPTORS; CELLS; RAT	Neurogenesis persists in the olfactory bulb (OB) of the adult mammalian brain. New interneurons are continually added to the OB from the subventricular zone (SVZ) via the rostral migratory stream (RMS). Here we show that secreted prokineticin 2 (PK2) functions as a chemoattractant for SVZ-derived neuronal progenitors. Within the OB, PK2 may also act as a detachment signal for chain-migrating progenitors arriving from the RMS. PK2 deficiency in mice leads to a marked reduction in OB size, loss of normal OB architecture, and the accumulation of neuronal progenitors in the RMS. These findings define an essential role for G protein-coupled PK2 signaling in postnatal and adult OB neurogenesis.	Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA	University of California System; University of California Irvine	Zhou, QY (corresponding author), Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA.	qzhou@uci.edu		Li, Jia-Da/0000-0002-4236-3518; Cheng, Michelle/0000-0003-3241-5174				ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; BAYER SA, 1983, EXP BRAIN RES, V50, P329; BAYNASH AG, 1994, CELL, V79, P1277, DOI 10.1016/0092-8674(94)90018-3; Betarbet R, 1996, INT J DEV NEUROSCI, V14, P921, DOI 10.1016/S0736-5748(96)00066-4; Bullock CM, 2004, MOL PHARMACOL, V65, P582, DOI 10.1124/mol.65.3.582; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Hack I, 2002, NAT NEUROSCI, V5, P939, DOI 10.1038/nn923; Hu HY, 1996, NEURON, V16, P933, DOI 10.1016/S0896-6273(00)80116-6; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; KISHI K, 1990, ARCH HISTOL CYTOL, V53, P219, DOI 10.1679/aohc.53.219; LeCouter J, 2003, P NATL ACAD SCI USA, V100, P2685, DOI 10.1073/pnas.0337667100; LeCouter J, 2001, NATURE, V412, P877, DOI 10.1038/35091000; Li J. P. H., UNPUB; Li M, 2001, MOL PHARMACOL, V59, P692, DOI 10.1124/mol.59.4.692; Lin DCH, 2002, J BIOL CHEM, V277, P19276, DOI 10.1074/jbc.M202139200; Liu GF, 2003, J NEUROSCI, V23, P6651; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Mollay C, 1999, EUR J PHARMACOL, V374, P189, DOI 10.1016/S0014-2999(99)00229-0; Negri L, 2002, BRIT J PHARMACOL, V137, P1147, DOI 10.1038/sj.bjp.0704995; Ng K., UNPUB; ONO K, 1994, NEURON, V13, P595, DOI 10.1016/0896-6273(94)90028-0; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Pencea V, 2001, EXP NEUROL, V172, P1, DOI 10.1006/exnr.2001.7768; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Saghatelyan A, 2004, NAT NEUROSCI, V7, P347, DOI 10.1038/nn1211; Soga T, 2002, BBA-GENE STRUCT EXPR, V1579, P173, DOI 10.1016/S0167-4781(02)00546-8; TOMASIEWICZ H, 1993, NEURON, V11, P1163, DOI 10.1016/0896-6273(93)90228-J; Ward M, 2003, J NEUROSCI, V23, P5170; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Zhang HX, 2003, J CELL BIOL, V163, P1375, DOI 10.1083/jcb.200308040	34	230	250	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2005	308	5730					1923	1927		10.1126/science.1112103	http://dx.doi.org/10.1126/science.1112103			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940BZ	15976302				2022-12-01	WOS:000230120000044
J	Avorn, J				Avorn, J			Torcetrapid and atorvastatin - Should marketing drive the research agenda?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ESTER TRANSFER PROTEIN; CHOLESTEROL; INHIBITOR		Harvard Univ, Sch Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Avorn, J (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							Avorn J, 2004, POWERFUL MED BENEFIT; Brousseau ME, 2005, ARTERIOSCL THROM VAS, V25, P1057, DOI 10.1161/01.ATV.0000161928.16334.dd; Brousseau ME, 2004, NEW ENGL J MED, V350, P1505, DOI 10.1056/NEJMoa031766; Davidson M, 2005, J AM COLL CARDIOL, V45, p394A; Fischer MA, 2004, JAMA-J AM MED ASSOC, V291, P1850, DOI 10.1001/jama.291.15.1850	5	23	24	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 23	2005	352	25					2573	2576		10.1056/NEJMp058075	http://dx.doi.org/10.1056/NEJMp058075			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	937VJ	15972861				2022-12-01	WOS:000229953700002
J	Ward, MD				Ward, MD			Snapshots of crystal growth	SCIENCE			English	Editorial Material							ATOMIC-FORCE MICROSCOPY; CRYSTALLIZATION; SURFACES; MECHANISMS; KINETICS		Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Ward, MD (corresponding author), Univ Minnesota, Dept Chem Engn & Mat Sci, 421 Washington Ave SE, Minneapolis, MN 55455 USA.	wardx004@umn.edu						BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; De Yoreo JJ, 2004, SCIENCE, V306, P1301, DOI 10.1126/science.1100889; DEYOREO JJ, 1994, PHYS REV LETT, V73, P838, DOI 10.1103/PhysRevLett.73.838; DURBIN SD, 1992, J CRYST GROWTH, V122, P71, DOI 10.1016/0022-0248(92)90228-B; Feeling-Taylor AR, 2004, BIOPHYS J, V87, P2621, DOI 10.1529/biophysj.104.039743; HILLIER AC, 1994, SCIENCE, V263, P1261, DOI 10.1126/science.263.5151.1261; Jung T, 2004, LANGMUIR, V20, P8587, DOI 10.1021/la0488755; LAND TA, 1995, PHYS REV LETT, V75, P2774, DOI 10.1103/PhysRevLett.75.2774; Last JA, 1998, CHEM MATER, V10, P422, DOI 10.1021/cm970582s; Liu XG, 2005, SCIENCE, V307, P1763, DOI 10.1126/science.1109487; MANNE S, 1993, J CRYST GROWTH, V130, P333, DOI 10.1016/0022-0248(93)90874-V; Orme CA, 2001, NATURE, V411, P775, DOI 10.1038/35081034; Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661; Qiu SR, 2004, P NATL ACAD SCI USA, V101, P1811, DOI 10.1073/pnas.0307900100; Reviakine I, 2003, J AM CHEM SOC, V125, P11684, DOI 10.1021/ja030194t; Sheng XX, 2005, P NATL ACAD SCI USA, V102, P267, DOI 10.1073/pnas.0406835101; Sours RE, 2005, J PHYS CHEM B, V109, P9989, DOI 10.1021/jp0455733; Ward MD, 2001, CHEM REV, V101, P1697, DOI 10.1021/cr000020j; WEISENHORN AL, 1989, APPL PHYS LETT, V54, P2651, DOI 10.1063/1.101024; Yip CM, 1998, BIOPHYS J, V74, P2199, DOI 10.1016/S0006-3495(98)77929-9	20	21	23	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2005	308	5728					1566	1567		10.1126/science.1111099	http://dx.doi.org/10.1126/science.1111099			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	936BH	15947165				2022-12-01	WOS:000229827000032
J	Akiyama, K; Matsuzaki, K; Hayashi, H				Akiyama, K; Matsuzaki, K; Hayashi, H			Plant sesquiterpenes induce hyphal branching in arbuscular mycorrhizal fungi	NATURE			English	Article							SEED-GERMINATION STIMULANT; STRIGA-LUTEA LOUR; SYNTHETIC ANALOGS; RED-CLOVER; OROBANCHE; (+)-STRIGOL; RECOGNITION; SIGNALS; GROWTH	Arbuscular mycorrhizal (AM) fungi form mutualistic, symbiotic associations with the roots of more than 80% of land plants(1). The fungi are incapable of completing their life cycle in the absence of a host root. Their spores can germinate and grow in the absence of a host, but their hyphal growth is very limited. Little is known about the molecular mechanisms that govern signalling and recognition between AM fungi and their host plants. In one of the first stages of host recognition, the hyphae of AM fungi show extensive branching in the vicinity of host roots before formation of the appressorium(2-4), the structure used to penetrate the plant root. Host roots are known to release signalling molecules that trigger hyphal branching(5-7), but these branching factors have not been isolated. Here we have isolated a branching factor from the root exudates of Lotus japonicus and used spectroscopic analysis and chemical synthesis to identify it as a strigolactone, 5-deoxy-strigol. Strigolactones are a group of sesquiterpene lactones, previously isolated as seed-germination stimulants for the parasitic weeds Striga and Orobanche(8). The natural strigolactones 5-deoxy-strigol, sorgolactone and strigol, and a synthetic analogue, GR24, induced extensive hyphal branching in germinating spores of the AM fungus Gigaspora margarita at very low concentrations.	Osaka Prefecture Univ, Grad Sch Agr & Biol Sci, Div Appl Biol Chem, Osaka 5998531, Japan; Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320112, Japan	Osaka Metropolitan University; Japan Science & Technology Agency (JST)	Akiyama, K (corresponding author), Osaka Prefecture Univ, Grad Sch Agr & Biol Sci, Div Appl Biol Chem, Osaka 5998531, Japan.	akiyama@biochem.osakafu-u.ac.jp	Akiyama, Kohki/B-4668-2012	Akiyama, Kohki/0000-0002-9171-9058				BECARD G, 1988, NEW PHYTOL, V108, P211, DOI 10.1111/j.1469-8137.1988.tb03698.x; BERGMANN C, 1993, J PLANT PHYSIOL, V142, P338, DOI 10.1016/S0176-1617(11)80432-3; Bouwmeester HJ, 2003, CURR OPIN PLANT BIOL, V6, P358, DOI 10.1016/S1369-5266(03)00065-7; BROOKS DW, 1985, J ORG CHEM, V50, P3779, DOI 10.1021/jo00220a020; Buee M, 2000, MOL PLANT MICROBE IN, V13, P693, DOI 10.1094/MPMI.2000.13.6.693; COOK CE, 1966, SCIENCE, V154, P1189, DOI 10.1126/science.154.3753.1189; COOK CE, 1972, J AM CHEM SOC, V94, P6198, DOI 10.1021/ja00772a048; FRISCHMUTH K, 1991, TETRAHEDRON, V47, P9793, DOI 10.1016/S0040-4020(01)80719-5; Giovannetti M, 1996, NEW PHYTOL, V133, P65, DOI 10.1111/j.1469-8137.1996.tb04342.x; GIOVANNETTI M, 1994, NEW PHYTOL, V127, P703, DOI 10.1111/j.1469-8137.1994.tb02973.x; GIOVANNETTI M, 1993, NEW PHYTOL, V125, P587, DOI 10.1111/j.1469-8137.1993.tb03907.x; HAUCK C, 1992, J PLANT PHYSIOL, V139, P474, DOI 10.1016/S0176-1617(11)80497-9; JOHNSON AW, 1981, J CHEM SOC PERK T 1, P1734, DOI 10.1039/p19810001734; MANGNUS EM, 1992, J AGR FOOD CHEM, V40, P1066, DOI 10.1021/jf00018a032; MOSSE B, 1975, PHYSIOL PLANT PATHOL, V5, P215, DOI 10.1016/0048-4059(75)90088-0; MULLER S, 1992, J PLANT GROWTH REGUL, V11, P77, DOI 10.1007/BF00198018; Nagahashi G, 1999, BIOTECHNOL TECH, V13, P893, DOI 10.1023/A:1008938527757; Nagahashi G, 2000, MYCOL RES, V104, P1453, DOI 10.1017/S0953756200002860; NAKANO S, 1995, BIOSCI BIOTECH BIOCH, V59, P1699, DOI 10.1271/bbb.59.1699; Parniske M, 2004, CURR OPIN PLANT BIOL, V7, P414, DOI 10.1016/j.pbi.2004.05.011; Sato D, 2003, J AGR FOOD CHEM, V51, P1162, DOI 10.1021/jf025997z; Schussler A, 2001, MYCOL RES, V105, P1413, DOI 10.1017/S0953756201005196; SIAME BA, 1993, J AGR FOOD CHEM, V41, P1486, DOI 10.1021/jf00033a025; Smith S. E., 2010, MYCORRHIZAL SYMBIOSI; Sugimoto Y, 1998, J ORG CHEM, V63, P1259, DOI 10.1021/jo9718408; Tamasloukht M, 2003, PLANT PHYSIOL, V131, P1468, DOI 10.1104/pp.012898; Westwood JH, 2000, WEED SCI, V48, P742, DOI 10.1614/0043-1745(2000)048[0742:COTOAS]2.0.CO;2; Yasuda N, 2003, PHYTOCHEMISTRY, V62, P1115, DOI 10.1016/S0031-9422(02)00679-9; Yokota T, 1998, PHYTOCHEMISTRY, V49, P1967, DOI 10.1016/S0031-9422(98)00419-1; Yoneyama K, 2001, PHYSIOL PLANTARUM, V112, P25, DOI 10.1034/j.1399-3054.2001.1120104.x	30	1425	1546	40	858	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2005	435	7043					824	827		10.1038/nature03608	http://dx.doi.org/10.1038/nature03608			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933NK	15944706				2022-12-01	WOS:000229638700052
J	Wu, KY; Hengst, U; Cox, LJ; Macosko, EZ; Jeromin, A; Urquhart, ER; Jaffrey, SR				Wu, KY; Hengst, U; Cox, LJ; Macosko, EZ; Jeromin, A; Urquhart, ER; Jaffrey, SR			Local translation of RhoA regulates growth cone collapse	NATURE			English	Article							ACTIN MESSENGER-RNA; PROTEIN-SYNTHESIS; HIPPOCAMPAL-NEURONS; SYMPATHETIC NEURONS; SEMAPHORIN-III; LOCALIZATION; SEQUENCES; TRANSPORT; DEGRADATION; NEUROPILIN	Neuronal development requires highly coordinated regulation of the cytoskeleton within the developing axon. This dynamic regulation manifests itself in axonal branching, turning and pathfinding, presynaptic differentiation, and growth cone collapse and extension. Semaphorin 3A (Sema3A), a secreted guidance cue that primarily functions to repel axons from inappropriate targets, induces cytoskeletal rearrangements that result in growth cone collapse(1). These effects require intra-axonal messenger RNA translation. Here we show that transcripts for RhoA, a small guanosine triphosphatase ( GTPase) that regulates the actin cytoskeleton, are localized to developing axons and growth cones, and this localization is mediated by an axonal targeting element located in the RhoA 30 untranslated region (UTR). Sema3A induces intra-axonal translation of RhoA mRNA, and this local translation of RhoA is necessary and sufficient for Sema3A-mediated growth cone collapse. These studies indicate that local RhoA translation regulates the neuronal cytoskeleton and identify a new mechanism for the regulation of RhoA signalling.	Cornell Univ, Dept Pharmacol, Weill Med Coll, New York, NY 10021 USA; Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Cornell University; Baylor College of Medicine	Jaffrey, SR (corresponding author), Cornell Univ, Dept Pharmacol, Weill Med Coll, New York, NY 10021 USA.	srj2003@med.cornell.edu	Hengst, Ulrich/L-1413-2014; Macosko, Evan/X-4664-2019	Hengst, Ulrich/0000-0002-8061-2861; Jaffrey, Samie/0000-0003-3615-6958	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066204] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056306] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH066204] Funding Source: Medline; NINDS NIH HHS [R01 NS056306] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Aktories K, 1997, TRENDS MICROBIOL, V5, P282, DOI 10.1016/S0966-842X(97)01067-6; Bassell GJ, 1998, J NEUROSCI, V18, P251; Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Chen L, 2003, NEUROSCIENCE, V120, P1005, DOI 10.1016/S0306-4522(03)00406-8; Dontchev VD, 2002, J NEUROSCI, V22, P6659; Eng H, 1999, J NEUROSCI, V19, P1; Fiore R, 2003, FRONT BIOSCI-LANDMRK, V8, pS484, DOI 10.2741/1080; Gallo G, 2004, J NEUROBIOL, V58, P92, DOI 10.1002/neu.10282; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Jeromin A, 2003, J NEUROPHYSIOL, V90, P2741, DOI 10.1152/jn.00464.2003; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; KISLAUSKIS EH, 1994, J CELL BIOL, V127, P441, DOI 10.1083/jcb.127.2.441; Kohrmann M, 1999, MOL BIOL CELL, V10, P2945, DOI 10.1091/mbc.10.9.2945; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; OlinkCoux M, 1996, J NEUROSCI, V16, P1346; Raju R, 1999, J VIROL, V73, P2410, DOI 10.1128/JVI.73.3.2410-2419.1999; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Steward O, 2003, NEURON, V40, P347, DOI 10.1016/S0896-6273(03)00635-4; Svenningsen AF, 2003, J NEUROSCI RES, V72, P565, DOI 10.1002/jnr.10610; Svitkin YV, 1998, J VIROL, V72, P5811, DOI 10.1128/JVI.72.7.5811-5819.1998; Tang SJ, 2001, NEURON, V32, P463, DOI 10.1016/S0896-6273(01)00493-7; TENNYSON VM, 1970, J CELL BIOL, V44, P62, DOI 10.1083/jcb.44.1.62; Tietjen I, 2003, NEURON, V38, P161, DOI 10.1016/S0896-6273(03)00229-0; Zheng JQ, 2001, J NEUROSCI, V21, P9291, DOI 10.1523/JNEUROSCI.21-23-09291.2001	30	327	334	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2005	436	7053					1020	1024		10.1038/nature03885	http://dx.doi.org/10.1038/nature03885			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955XQ	16107849	Green Accepted			2022-12-01	WOS:000231263900051
J	Adger, WN; Hughes, TP; Folke, C; Carpenter, SR; Rockstrom, J				Adger, WN; Hughes, TP; Folke, C; Carpenter, SR; Rockstrom, J			Social-ecological resilience to coastal disasters	SCIENCE			English	Article							CLIMATE-CHANGE; VULNERABILITY; HURRICANES; RESISTANCE; CAPACITY	Social and ecological vulnerability to disasters and outcomes of any particular extreme event are influenced by buildup or erosion of resilience both before and after disasters occur. Resilient social-ecological. systems incorporate diverse mechanisms for living with, and learning from, change and unexpected shocks. Disaster management requires multilevel governance systems that can enhance the capacity to cope with uncertainty and surprise by mobilizing diverse sources of resilience.	Univ E Anglia, Sch Environm Sci, Tyndall Ctr Climate Change Res, Norwich NR4 7TJ, Norfolk, England; James Cook Univ N Queensland, Sch Marine Biol & Aquaculture, Ctr Coral Reef Biodivers, Townsville, Qld 4811, Australia; Stockholm Univ, Dept Syst Ecol, SE-10691 Stockholm, Sweden; Stockholm Univ, Ctr Transdisciplinary Environm Res, SE-10691 Stockholm, Sweden; Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA; Stockholm Environm Inst, SE-10314 Stockholm, Sweden	University of East Anglia; James Cook University; Stockholm University; Stockholm University; University of Wisconsin System; University of Wisconsin Madison; Stockholm Environment Institute	Adger, WN (corresponding author), Univ E Anglia, Sch Environm Sci, Tyndall Ctr Climate Change Res, Norwich NR4 7TJ, Norfolk, England.	n.adger@uea.ac.uk	Hughes, Terry P/L-4721-2013; Adger, Neil/F-7676-2010; Folke, Carl/Z-1545-2019; Carpenter, Stephen/AAQ-6404-2020	Hughes, Terry P/0000-0002-5257-5063; Adger, Neil/0000-0003-4244-2854; Rockstrom, Johan/0000-0001-8988-2983; Folke, Carl/0000-0002-4050-3281	Economic and Social Research Council [M545285002] Funding Source: researchfish	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Adger W. N., 2003, NATURAL DISASTERS DE, P19; ADGER WN, IN PRESS GLOBAL ENV; Allen MR, 2004, NATURE, V432, P551, DOI 10.1038/432551a; Allison EH, 2004, FISH FISH, V5, P215, DOI 10.1111/j.1467-2679.2004.00153.x; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Berkes F., 2003, NAVIGATING SOCIAL EC; Blaikie Piers., 1994, RISK NATURAL HAZARDS; Brown K, 1997, ENVIRON CONSERV, V24, P316, DOI 10.1017/S0376892997000428; Brown K., 2012, MAKING WAVES INTEGRA; Carpenter S, 2001, ECOSYSTEMS, V4, P765, DOI 10.1007/s10021-001-0045-9; Colding J., 2003, NAVIGATING SOCIAL EC, P163, DOI [10.1017/cbo9780511541957.011, DOI 10.1017/CBO9780511541957.011]; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; Costanza R, 2000, BIOSCIENCE, V50, P149, DOI 10.1641/0006-3568(2000)050[0149:MOEP]2.3.CO;2; DAGER WN, 2001, LIVING ENV CHANGE SO; Dahdouh-Guebas F, 2005, CURR BIOL, V15, pR443, DOI 10.1016/j.cub.2005.06.008; DIAMOND J., 1999, GUNS GERMS STEEL; Dietz T, 2003, SCIENCE, V302, P1907, DOI 10.1126/science.1091015; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Folke C, 2002, AMBIO, V31, P437, DOI 10.1639/0044-7447(2002)031[0437:RASDBA]2.0.CO;2; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; FOLKE C, IN PRESS ANN REV ENV; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Holt-Gimenez E, 2002, AGR ECOSYST ENVIRON, V93, P87, DOI 10.1016/S0167-8809(02)00006-3; Hughes TP, 2005, TRENDS ECOL EVOL, V20, P380, DOI 10.1016/j.tree.2005.03.022; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Huq S, 1999, VULNERABILITY ADAPTA; Ives AR, 1999, SCIENCE, V286, P542, DOI 10.1126/science.286.5439.542; Jansen K, 2003, DEV CHANGE, V34, P45, DOI 10.1111/1467-7660.00296; Liu PLF, 2005, SCIENCE, V308, P1595, DOI 10.1126/science.1110730; Lugo AE, 2000, AMBIO, V29, P106, DOI 10.1579/0044-7447-29.2.106; MCCLEAN RF, 2001, CLIMATE CHANGE 2001, P345; MILLER F, 2005, SUSTAINABLE DEV UPDA, V1, P2; Mirza MMQ, 2003, CLIM POLICY, V3, P233, DOI 10.1016/S1469-3062(03)00052-4; Nicholls RJ, 2004, GLOBAL ENVIRON CHANG, V14, P69, DOI 10.1016/j.gloenvcha.2003.10.007; Nystrom M, 2001, ECOSYSTEMS, V4, P406, DOI 10.1007/s10021-001-0019-y; O'Brien K, 2004, GLOBAL ENVIRON CHANG, V14, P303, DOI 10.1016/j.gloenvcha.2004.01.001; OKEEFE P, 1976, NATURE, V260, P566, DOI 10.1038/260566a0; Pielke RA, 2003, NAT HAZARDS REV, V4, P101, DOI 10.1061/(ASCE)1527-6988(2003)4:3(101); Sidle RC, 2004, QUATERN INT, V118, P181, DOI 10.1016/S1040-6182(03)00137-X; Small C, 2003, J COASTAL RES, V19, P584; Tompkins EL, 2004, ECOL SOC, V9; Tompkins EL, 2005, GLOBAL ENVIRON CHANG, V15, P139, DOI 10.1016/j.gloenvcha.2004.11.002; Trenberth K, 2005, SCIENCE, V308, P1753, DOI 10.1126/science.1112551; Turner BL, 2003, P NATL ACAD SCI USA, V100, P8074, DOI 10.1073/pnas.1231335100; WALKER B, 2004, ECOL SOC, V9, pU165; Westley F., 2002, PANARCHY UNDERSTANDI, P103	47	1439	1485	25	714	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2005	309	5737					1036	1039		10.1126/science.1112122	http://dx.doi.org/10.1126/science.1112122			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	955MN	16099974				2022-12-01	WOS:000231230100034
J	Bader, MW; Sanowar, S; Daley, ME; Schneider, AR; Cho, US; Xu, WQ; Klevit, RE; Le Moual, H; Miller, S				Bader, MW; Sanowar, S; Daley, ME; Schneider, AR; Cho, US; Xu, WQ; Klevit, RE; Le Moual, H; Miller, S			Recognition of antimicrobial peptides by a bacterial sensor kinase	CELL			English	Article							2-COMPONENT REGULATORY SYSTEM; SALMONELLA-TYPHIMURIUM; LIPID-A; OUTER-MEMBRANE; VIRULENCE GENE; PMRA-PMRB; LOW PH; PROTEIN; RESISTANCE; SIGNAL	PhoQ is a membrane bound sensor kinase important for the pathogenesis of a number of Gram-negative bacterial species. PhoQ and its cognate response regulator PhoP constitute a signal-transduction cascade that controls inducible resistance to host antimicrobial peptides. We show that enzymatic activity of Salmonella typhimurium PhoQ is directly activated by antimicrobial peptides. A highly acidic surface of the PhoQ sensor domain participates in both divalentcation and antimicrobial-peptide binding as a first step in signal transduction across the bacterial membrane. Identification of PhoQ signaling mutants, binding studies with the PhoQ sensor domain, and structural analysis of this domain can be incorporated into a model in which antimicrobial peptides displace divalent cations from PhoQ metal binding sites to initiate signal transduction. Our findings reveal a molecular mechanism by which bacteria sense small innate immune molecules to initiate a transcriptional program that promotes bacterial virulence.	Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Biol Struct, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Biochem, Seattle, WA 98195 USA; McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; McGill Univ, Fac Dent, Montreal, PQ H3A 2B4, Canada	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; McGill University; McGill University	Miller, S (corresponding author), Univ Washington, Sch Med, Dept Microbiol, 1959 NE Pacific St, Seattle, WA 98195 USA.	millersi@u.washington.edu	Klevit, Rachel/AAI-7038-2021	Klevit, Rachel/0000-0002-3476-969X; cho, uhn-soo/0000-0002-6992-2455; Xu, Wenqing/0000-0002-2884-3101	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030479] Funding Source: NIH RePORTER; NIAID NIH HHS [AI030479] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARANDA CMA, 1992, P NATL ACAD SCI USA, V89, P10079, DOI 10.1073/pnas.89.21.10079; ARTHUR M, 1992, J BACTERIOL, V174, P2582, DOI 10.1128/jb.174.8.2582-2591.1992; Bader MW, 2003, MOL MICROBIOL, V50, P219, DOI 10.1046/j.1365-2958.2003.03675.x; Bearson BL, 1998, J BACTERIOL, V180, P2409, DOI 10.1128/JB.180.9.2409-2417.1998; Castelli ME, 2000, J BIOL CHEM, V275, P22948, DOI 10.1074/jbc.M909335199; Christensen KA, 2002, J CELL SCI, V115, P599; Dathe M, 1999, BBA-BIOMEMBRANES, V1462, P71, DOI 10.1016/S0005-2736(99)00201-1; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Derzelle S, 2004, J BACTERIOL, V186, P1270, DOI 10.1128/JB.186.5.1270-1279.2004; Ernst RK, 1999, SCIENCE, V286, P1561, DOI 10.1126/science.286.5444.1561; FIELDS PI, 1989, SCIENCE, V243, P1059, DOI 10.1126/science.2646710; GALAN JE, 1989, MICROB PATHOGENESIS, V6, P433, DOI 10.1016/0882-4010(89)90085-5; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; GARCIADELPORTILLO F, 1992, MOL MICROBIOL, V6, P3289, DOI 10.1111/j.1365-2958.1992.tb02197.x; Georgellis D, 2001, SCIENCE, V292, P2314, DOI 10.1126/science.1059361; Gibbons HS, 2005, MOL MICROBIOL, V55, P425, DOI 10.1111/j.1365-2958.2004.04409.x; GILLESGONZALEZ MA, 1991, NATURE, V350, P170, DOI 10.1038/350170a0; Grabenstein JP, 2004, INFECT IMMUN, V72, P4973, DOI 10.1128/IAI.72.9.4973-4984.2004; GROISMAN EA, 1989, P NATL ACAD SCI USA, V86, P7077, DOI 10.1073/pnas.86.18.7077; Gunn JS, 2000, INFECT IMMUN, V68, P6139, DOI 10.1128/IAI.68.11.6139-6146.2000; Guo L, 1997, SCIENCE, V276, P250, DOI 10.1126/science.276.5310.250; Hancock REW, 2000, TRENDS MICROBIOL, V8, P402, DOI 10.1016/S0966-842X(00)01823-0; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Hohmann EL, 1996, J INFECT DIS, V173, P1408, DOI 10.1093/infdis/173.6.1408; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kaspar S, 1999, MOL MICROBIOL, V33, P858, DOI 10.1046/j.1365-2958.1999.01536.x; Lee YW, 1995, P NATL ACAD SCI USA, V92, P12245, DOI 10.1073/pnas.92.26.12245; Lesley JA, 2001, J BIOL CHEM, V276, P30827, DOI 10.1074/jbc.M104262200; Llama-Palacios A, 2003, MOL MICROBIOL, V49, P347, DOI 10.1046/j.1365-2958.2003.03583.x; MAGNUSON R, 1994, CELL, V77, P207, DOI 10.1016/0092-8674(94)90313-1; McPhee JB, 2003, MOL MICROBIOL, V50, P205, DOI 10.1046/j.1365-2958.2003.03673.x; MEKALANOS JJ, 1992, J BACTERIOL, V174, P1; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; Montagne M, 2001, J BACTERIOL, V183, P1787, DOI 10.1128/JB.183.5.1787-1791.2001; Moss JE, 2000, CELL MICROBIOL, V2, P443, DOI 10.1046/j.1462-5822.2000.00065.x; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; PAPPENHEIMER AM, 1993, PROTEIN SCI, V2, P292; Peschel A, 2002, TRENDS MICROBIOL, V10, P179, DOI 10.1016/S0966-842X(02)02333-8; PIERS KL, 1994, MOL MICROBIOL, V12, P951, DOI 10.1111/j.1365-2958.1994.tb01083.x; POLLACK C, 1986, NATURE, V322, P834, DOI 10.1038/322834a0; Preston A, 2003, MOL MICROBIOL, V48, P725, DOI 10.1046/j.1365-2958.2003.03484.x; Rebeil R, 2004, MOL MICROBIOL, V52, P1363, DOI 10.1111/j.1365-2958.2004.04059.x; Robey M, 2001, INFECT IMMUN, V69, P4276, DOI 10.1128/IAI.69.7.4276-4286.2001; Rosenberger CM, 2004, P NATL ACAD SCI USA, V101, P2422, DOI 10.1073/pnas.0304455101; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; SAWYER JG, 1988, INFECT IMMUN, V56, P693, DOI 10.1128/IAI.56.3.693-698.1988; Vescovi EG, 1996, CELL, V84, P165, DOI 10.1016/S0092-8674(00)81003-X; Waldburger CD, 1996, J BIOL CHEM, V271, P26630, DOI 10.1074/jbc.271.43.26630	51	412	430	10	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 12	2005	122	3					461	472		10.1016/j.cell.2005.05.030	http://dx.doi.org/10.1016/j.cell.2005.05.030			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	955UZ	16096064	Bronze			2022-12-01	WOS:000231254400016
J	Ding, S; Wu, XH; Li, G; Han, M; Zhuang, Y; Xu, T				Ding, S; Wu, XH; Li, G; Han, M; Zhuang, Y; Xu, T			Efficient transposition of the piggyBac resource (PB) transposon in mammalian cells and mice	CELL			English	Article							EMBRYONIC STEM-CELLS; MOUSE GERM-LINE; SLEEPING-BEAUTY; CHROMOSOMAL TRANSPOSITION; INSERTIONAL MUTAGENESIS; GENETIC-TRANSFORMATION; FUNCTIONAL-ANALYSIS; BACULOVIRUS GENOME; DROSOPHILA; VECTOR	Transposable elements have been routinely used for genetic manipulation in lower organisms, including generating transgenic animals and insertional mutagenesis. In contrast, the usage of transposons in mice and other vertebrate systems is still limited due to the lack of an efficient transposition system. We have tested the ability of piggyBac (PB), a DNA transposon from the cabbage looper moth Trichoplusia ni, to transpose in mammalian systems. We show that PB elements carrying multiple genes can efficiently transpose in human and mouse cell lines and also in mice. PB permits the expression of the marker genes it carried. During germline transposition, PB could excise precisely from original insertion sites and transpose into the mouse genome at diverse locations, preferably transcription units. These data provide a first and critical step toward a highly efficient transposon system for a variety of genetic manipulations including transgenesis and insertional mutagenesis in mice and other vertebrates.	Fudan Univ, Sch Life Sci, Inst Dev Biol & Mol Med, Shanghai 200433, Peoples R China; Univ Colorado, Dept MCDB, Howard Hughes Med Inst, Boulder, CO 80309 USA; Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Genet,Howard Hugh Med Inst, New Haven, CT 06536 USA	Fudan University; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; Duke University; Yale University	Wu, XH (corresponding author), Fudan Univ, Sch Life Sci, Inst Dev Biol & Mol Med, 220 Handan Rd, Shanghai 200433, Peoples R China.	xiaohui_wu@fudan.edu.cn; tian.xu@yale.edu	Li, Gang/H-5714-2015; Wilson, Matthew H/K-3193-2013	zhuang, yuan/0000-0002-2964-3654				Behringer R., 2003, MANIPULATING MOUSE E; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CARY LC, 1989, VIROLOGY, V172, P156, DOI 10.1016/0042-6822(89)90117-7; COOLEY L, 1988, SCIENCE, V239, P1121, DOI 10.1126/science.2830671; Drabek D, 2003, GENOMICS, V81, P108, DOI 10.1016/S0888-7543(02)00030-7; Dupuy AJ, 2001, GENESIS, V30, P82, DOI 10.1002/gene.1037; Fischer SEJ, 2001, P NATL ACAD SCI USA, V98, P6759, DOI 10.1073/pnas.121569298; FRASER MJ, 1995, VIROLOGY, V211, P397, DOI 10.1006/viro.1995.1422; Fraser MJ, 1996, INSECT MOL BIOL, V5, P141, DOI 10.1111/j.1365-2583.1996.tb00048.x; Gonzalez-Estevez C, 2003, P NATL ACAD SCI USA, V100, P14046, DOI 10.1073/pnas.2335980100; Handler AM, 2002, INSECT BIOCHEM MOLEC, V32, P1211, DOI 10.1016/S0965-1748(02)00084-X; HANDLER AM, 1993, ARCH INSECT BIOCHEM, V22, P373, DOI 10.1002/arch.940220306; Handler AM, 2001, INSECT BIOCHEM MOLEC, V31, P199, DOI 10.1016/S0965-1748(00)00119-3; Herron BJ, 2002, NAT GENET, V30, P185, DOI 10.1038/ng812; Horie K, 2003, MOL CELL BIOL, V23, P9189, DOI 10.1128/MCB.23.24.9189-9207.2003; Horie K, 2001, P NATL ACAD SCI USA, V98, P9191, DOI 10.1073/pnas.161071798; Horn C, 2003, GENETICS, V163, P647; Horn C, 2000, DEV GENES EVOL, V210, P630, DOI 10.1007/s004270000110; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Izsvak Z, 2000, J MOL BIOL, V302, P93, DOI 10.1006/jmbi.2000.4047; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li X, 2005, INSECT MOL BIOL, V14, P17, DOI 10.1111/j.1365-2583.2004.00525.x; Lorenzen MD, 2003, INSECT MOL BIOL, V12, P433, DOI 10.1046/j.1365-2583.2003.00427.x; Luo GB, 1998, P NATL ACAD SCI USA, V95, P10769, DOI 10.1073/pnas.95.18.10769; MCCLINTOCK B, 1950, P NATL ACAD SCI USA, V36, P344, DOI 10.1073/pnas.36.6.344; Nguyen QT, 1998, SCIENCE, V279, P1725, DOI 10.1126/science.279.5357.1725; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Robertson Hugh M., 2002, P1093; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; SAITOU M, 1995, NATURE, V374, P159, DOI 10.1038/374159a0; Sarkar A, 2003, MOL GENET GENOMICS, V270, P173, DOI 10.1007/s00438-003-0909-0; Sumitani M, 2003, INSECT BIOCHEM MOLEC, V33, P449, DOI 10.1016/S0965-1748(03)00009-2; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Vilen H, 2003, J VIROL, V77, P123, DOI 10.1128/JVI.77.1.123-134.2003; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Zagoraiou L, 2001, P NATL ACAD SCI USA, V98, P11474, DOI 10.1073/pnas.201392398	41	663	760	9	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 12	2005	122	3					473	483		10.1016/j.cell.2005.07.013	http://dx.doi.org/10.1016/j.cell.2005.07.013			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	955UZ	16096065	Bronze			2022-12-01	WOS:000231254400017
J	Masle, J; Gilmore, SR; Farquhar, GD				Masle, J; Gilmore, SR; Farquhar, GD			The ERECTA gene regulates plant transpiration efficiency in Arabidopsis	NATURE			English	Article							RECEPTOR-LIKE KINASE; CARBON-ISOTOPE DISCRIMINATION; WATER-USE EFFICIENCY; RESISTANCE; TRAITS; LEAVES; CO2; THALIANA; GROWTH; WHEAT	Assimilation of carbon by plants incurs water costs. In the many parts of the world where water is in short supply, plant transpiration efficiency, the ratio of carbon fixation to water loss, is critical to plant survival, crop yield and vegetation dynamics(1). When challenged by variations in their environment, plants often seem to coordinate photosynthesis and transpiration(2), but significant genetic variation in transpiration efficiency has been identified both between and within species(3,4). This has allowed plant breeders to develop effective selection programmes for the improved transpiration efficiency of crops(5), after it was demonstrated that carbon isotopic discrimination, Delta, of plant matter was a reliable and sensitive marker negatively related to variation in transpiration efficiency(3,4,6). However, little is known of the genetic controls of transpiration efficiency. Here we report the isolation of a gene that regulates transpiration efficiency, ERECTA. We show that ERECTA, a putative leucine-rich repeat receptor-like kinase (LRR-RLK)(7,8) known for its effects on inflorescence development(7,9), is a major contributor to a locus for Delta on Arabidopsis chromosome 2. Mechanisms include, but are not limited to, effects on stomatal density, epidermal cell expansion, mesophyll cell proliferation and cell - cell contact.	Australian Natl Univ, Res Sch Biol Sci, Environm Biol Grp, Canberra, ACT 2601, Australia	Australian National University	Masle, J (corresponding author), Australian Natl Univ, Res Sch Biol Sci, Environm Biol Grp, Canberra, ACT 2601, Australia.	josette.masle@anu.edu.au	FARQUHAR, GRAHAM D/A-3722-2008; Masle, Josette/D-1289-2009	Farquhar, Graham/0000-0002-7065-1971				Basten CJ, 2000, QTL CARTOGRAPHER; Bowman J., 1994, ARABIDOPSIS ATLAS MO; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; Douglas SJ, 2002, PLANT CELL, V14, P547, DOI 10.1105/tpc.010391; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; FARQUHAR GD, 1978, PLANT PHYSIOL, V61, P1000, DOI 10.1104/pp.61.6.1000; FARQUHAR GD, 1984, AUST J PLANT PHYSIOL, V11, P539, DOI 10.1071/PP9840539; FARQUHAR GD, 1982, OECOLOGIA, V52, P121, DOI 10.1007/BF00349020; Godiard L, 2003, PLANT J, V36, P353, DOI 10.1046/j.1365-313X.2003.01877.x; LANDER ES, 1989, GENETICS, V121, P185; Lease KA, 2001, NEW PHYTOL, V151, P133, DOI 10.1046/j.1469-8137.2001.00150.x; LISTER C, 1993, PLANT J, V4, P745, DOI 10.1046/j.1365-313X.1993.04040745.x; Loudet O, 2002, THEOR APPL GENET, V104, P1173, DOI 10.1007/s00122-001-0825-9; MARTIN B, 1989, SCIENCE, V243, P1725, DOI 10.1126/science.243.4899.1725; MASLE J, 1993, PLANT PHYSIOL, V103, P1075, DOI 10.1104/pp.103.4.1075; MASLE J, 1993, PERSPECTIVES PLANT C, P371; Nadeau Jeanette A, 2002, Arabidopsis Book, V1, pe0066, DOI 10.1199/tab.0066; Rebetzke GJ, 2002, CROP SCI, V42, P739, DOI 10.2135/cropsci2002.0739; Shpak ED, 2004, DEVELOPMENT, V131, P1491, DOI 10.1242/dev.01028; Shpak ED, 2003, PLANT CELL, V15, P1095, DOI 10.1105/tpc.010413; Thumma BR, 2001, J EXP BOT, V52, P203, DOI 10.1093/jexbot/52.355.203; Torii KU, 1996, PLANT CELL, V8, P735, DOI 10.1105/tpc.8.4.735; VONCAEMMERER S, 1981, PLANTA, V153, P376, DOI 10.1007/BF00384257; WONG SC, 1979, NATURE, V282, P424, DOI 10.1038/282424a0; Xu L, 2003, DEVELOPMENT, V130, P4097, DOI 10.1242/dev.00622; Yokoyama R, 1998, PLANT J, V15, P301, DOI 10.1046/j.1365-313X.1998.00203.x; ZENG ZB, 1994, GENETICS, V136, P1457; ZHU Y, 1998, PLANT PHYSIOL, V116, P1603	29	387	427	20	159	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 11	2005	436	7052					866	870		10.1038/nature03835	http://dx.doi.org/10.1038/nature03835			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953XG	16007076				2022-12-01	WOS:000231116500050
J	Nelson, LJ; Talbot, EA; Mwasekaga, MJ; Ngirubiu, PK; Mwansa, RA; Notha, M; Wells, CD				Nelson, LJ; Talbot, EA; Mwasekaga, MJ; Ngirubiu, PK; Mwansa, RA; Notha, M; Wells, CD			Antituberculosis drug resistance and anonymous HIV surveillance in tuberculosis patients in Botswana, 2002	LANCET			English	Article								Two surveys undertaken in Botswana in the 1990s have recorded low rates of antituberculosis drug resistance, despite a three-fold rise in tuberculosis since 1989. We under-took a third survey to determine both trends since 1995 and HIV prevalence in tuberculosis patients in Botswana. Sputum specimens were obtained from patients nationwide in 2002 who also underwent anonymous, rapid HIV testing by use of Oraquick. Of 2200 sputum smear-positive patients and 219 previously treated patients with suspected recurrent tuberculosis, 1457 (60%) were infected with HIV. Resistance to at least one drug in new patients rose from 16 (3.7%) isolates in 1995 to 123 (10.4%; p<0.0001) in 2002. interventions for tuberculosis control are urgently needed in Botswana to prevent further emergence of drug resistance.	BOTUSA Project, Gaborone, Botswana; Natl TB Reference Lab, Gaborone, Botswana; Minist Hlth, Botswana Natl TB Programme, Epidemiol Unit, Gaborone, Botswana		Nelson, LJ (corresponding author), CDC, Div TB Eliminat, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA.	LBN9@CDC.G0V						Kenyon TA, 1999, INT J TUBERC LUNG D, V3, P4; Sonnenberg P, 2001, LANCET, V358, P1687, DOI 10.1016/S0140-6736(01)06712-5; Talbot EA, 2004, CLIN INFECT DIS, V39, pE1, DOI 10.1086/421388; Talbot EA, 2003, INT J TUBERC LUNG D, V7, P710; Talbot EA, 2003, INT J TUBERC LUNG D, V7, P72; *WHO, 1996, WHOTB96216; World Health Organization, 2004, GUID HIV SURV TUB PA	7	34	38	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 6	2005	366	9484					488	490		10.1016/S0140-6736(05)67062-6	http://dx.doi.org/10.1016/S0140-6736(05)67062-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	952RD	16084258				2022-12-01	WOS:000231022300031
J	Dichgans, M; Freilinger, T; Eckstein, G; Babini, E; Lorenz-Depiereux, B; Biskup, S; Ferrari, MD; Herzog, J; van den Maagdenberg, AMJM; Pusch, M; Strom, TM				Dichgans, M; Freilinger, T; Eckstein, G; Babini, E; Lorenz-Depiereux, B; Biskup, S; Ferrari, MD; Herzog, J; van den Maagdenberg, AMJM; Pusch, M; Strom, TM			Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine	LANCET			English	Article							SEVERE MYOCLONIC EPILEPSY; FEBRILE SEIZURES; HIPPOCAMPAL-FORMATION; SPREADING DEPRESSION; GENERALIZED EPILEPSY; SUBUNIT; GENE; MECHANISMS; TYPE-2; AURA	Background Familial hemiplegic migraine is an autosomal dominant severe subtype of migraine with aura characterised by some degree of hemiparesis during the attacks. So far, mutations in two genes regulating ion translocation-CACNA1A and ATP1A2-have been identified in pedigrees with this disease. Methods To identify additional genes for familial hemiplegic migraine, we did a genome-wide linkage analysis of two disease pedigrees without mutations in CACNA1A and ATP1A2. Ion channel genes in the candidate interval were analysed for mutations, and the functional consequences of the recorded sequence alteration were determined. Findings We identified a novel locus for familial hemiplegic migraine on chromosome 2q24. Sequencing of candidate genes in this region revealed a heterozygous missense mutation (Gln1489Lys) in the neuronal voltage-gated sodium channel gene SCN1A, mutations of which have been associated with epilepsy. This same mutation was present in three families with familial hemiplegic migraine. It results in a charge-altering aminoacid exchange in the so-called hinged-lid domain of the protein, which is critical for fast inactivation of the channel. Whole-cell recordings in transiently transfected tsA201 cells expressing the highly homologous SCN5A sodium channel showed that the mutation induces a two-fold to four-fold accelerated recovery from fast inactivation without altering any of the other channel parameters investigated. Interpretation Dysfunction of the neuronal sodium channel SCN1A can cause familial hemiplegic migraine. Our findings have implications for the understanding of migraine aura. Moreover, our study reinforces the molecular links between migraine and epilepsy, two common paroxysmal disorders.	Univ Munich, Klinikum Grosshadern, Dept Neurol, D-81377 Munich, Germany; GSF Natl Res Ctr Environm & Hlth, Inst Human Genet, Munich, Germany; CNR, Ist Biofis, Genoa, Italy; Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; Tech Univ Munich, Klinikum Rechts Isar, Inst Human Genet, D-8000 Munich, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Technical University of Munich	Dichgans, M (corresponding author), Marchioninistr 15, D-81377 Munich, Germany.	martin.dichgans@med.uni-muenchen.de	Ferrari, Michel D./ABE-3758-2021; Dichgans, Martin/HCH-3247-2022	Ferrari, Michel D./0000-0001-9691-9449; Dichgans, Martin/0000-0002-0654-387X; Pusch, Michael/0000-0002-8644-8847	Telethon [GGP04018] Funding Source: Medline	Telethon(Fondazione Telethon)		BENNETT PB, 1995, NATURE, V376, P683, DOI 10.1038/376683a0; Bowyer SM, 2001, ANN NEUROL, V50, P582, DOI 10.1002/ana.1293; Ceulemans BPGM, 2004, PEDIATR NEUROL, V30, P236, DOI 10.1016/j.pediatrneurol.2003.10.012; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; Ducros A, 1997, ANN NEUROL, V42, P885, DOI 10.1002/ana.410420610; Ducros A, 2002, LANCET NEUROL, V1, P285, DOI 10.1016/S1474-4422(02)00134-5; Ducros A, 2001, NEW ENGL J MED, V345, P17, DOI 10.1056/NEJM200107053450103; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Goldin AL, 2003, CURR OPIN NEUROBIOL, V13, P284, DOI 10.1016/S0959-4388(03)00065-5; Goldin AL, 1999, ANN NY ACAD SCI, V868, P38, DOI 10.1111/j.1749-6632.1999.tb11272.x; GRAFSTEIN B, 1956, J NEUROPHYSIOL, V19, P154, DOI 10.1152/jn.1956.19.2.154; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; Kors EE, 2004, NEUROLOGY, V63, P1136, DOI 10.1212/01.WNL.0000138571.48593.FC; Launer LJ, 1999, NEUROLOGY, V53, P537, DOI 10.1212/WNL.53.3.537; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; Lossin C, 2002, NEURON, V34, P877, DOI 10.1016/S0896-6273(02)00714-6; Lossin C, 2003, J NEUROSCI, V23, P11289; Marconi R, 2003, ANN NEUROL, V53, P376, DOI 10.1002/ana.10464; Moskowitz MA, 2004, ANN NEUROL, V55, P276, DOI 10.1002/ana.20035; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; PATTON DE, 1992, P NATL ACAD SCI USA, V89, P10905, DOI 10.1073/pnas.89.22.10905; Pietrobon D, 2003, NAT REV NEUROSCI, V4, P386, DOI 10.1038/nrn1102; Rhodes TH, 2004, P NATL ACAD SCI USA, V101, P11147, DOI 10.1073/pnas.0402482101; Segall L, 2004, J BIOL CHEM, V279, P43692, DOI 10.1074/jbc.M407471200; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; SOMJEN GG, 1985, J NEUROPHYSIOL, V53, P1098, DOI 10.1152/jn.1985.53.4.1098; Spampanato J, 2004, J NEUROSCI, V24, P10022, DOI 10.1523/JNEUROSCI.2034-04.2004; Spampanato J, 2003, NEUROSCIENCE, V116, P37, DOI 10.1016/S0306-4522(02)00698-X; Spampanato J, 2001, J NEUROSCI, V21, P7481, DOI 10.1523/JNEUROSCI.21-19-07481.2001; STEWART WF, 1992, JAMA-J AM MED ASSOC, V267, P64, DOI 10.1001/jama.267.1.64; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; Thomsen LL, 2002, BRAIN, V125, P1379, DOI 10.1093/brain/awf132; Ulrich V, 1999, ANN NEUROL, V45, P242, DOI 10.1002/1531-8249(199902)45:2<242::AID-ANA15>3.0.CO;2-1; van den Maagdenberg AMJM, 2004, NEURON, V41, P701, DOI 10.1016/S0896-6273(04)00085-6; VANHARREVELD A, 1959, J NEUROCHEM, V3, P300; Vanmolkot KRJ, 2003, ANN NEUROL, V54, P360, DOI 10.1002/ana.10674; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; Whitaker WRJ, 2000, J COMP NEUROL, V422, P123, DOI 10.1002/(SICI)1096-9861(20000619)422:1<123::AID-CNE8>3.0.CO;2-X	41	548	574	0	44	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 30	2005	366	9483					371	377		10.1016/S0140-6736(05)66786-4	http://dx.doi.org/10.1016/S0140-6736(05)66786-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	950IB	16054936				2022-12-01	WOS:000230849700023
J	Hinchliffe, P; Sazanov, LA				Hinchliffe, P; Sazanov, LA			Organization of iron-sulfur clusters in respiratory complex I	SCIENCE			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; QUINONE OXIDOREDUCTASE; 3-DIMENSIONAL STRUCTURE; ELECTRON-TRANSFER; MEMBRANE DOMAIN; SUBUNIT; DEHYDROGENASE; EXPRESSION; MECHANISM; BACTERIAL	Complex I of respiratory chains plays a central role in bioenergetics and is implicated in many human neurodegenerative diseases. An understanding of its mechanism requires a knowledge of the organization of redox centers. The arrangement of iron-sulfur clusters in the hydrophilic domain of complex I from Thermus thermophilus has been determined with the use of x-ray crystatiography. One binuclear and six tetranuclear clusters are arranged, maximally 14 angstroms apart, in an 84-angstrom-long electron transfer chain. The binuclear cluster N1a and the tetranuclear cluster N7 are not in this pathway. Cluster N1a may play a role in the prevention of oxidative damage. The structure provides a framework for the interpretation of the large amounts of data accumulated on complex I.	MRC, Dunn Human Nutr Unit, Cambridge CB2 2XY, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research	Sazanov, LA (corresponding author), MRC, Dunn Human Nutr Unit, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 2XY, England.	sazanov@mrc-dunn.cam.ac.uk	Sazanov, Leonid A/ABF-2125-2021	Sazanov, Leonid A/0000-0002-0977-7989; Hinchliffe, Philip/0000-0001-8611-4743				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; BELOGRUDOV G, 1994, BIOCHEMISTRY-US, V33, P4571, DOI 10.1021/bi00181a018; Finel M, 1998, BBA-BIOENERGETICS, V1364, P112, DOI 10.1016/S0005-2728(98)00022-X; Friedrich T, 1998, BBA-BIOENERGETICS, V1364, P134, DOI 10.1016/S0005-2728(98)00024-3; Friedrich T, 2001, J BIOENERG BIOMEMBR, V33, P169, DOI 10.1023/A:1010722717257; Friedrich T, 2000, FEBS LETT, V479, P1, DOI 10.1016/S0014-5793(00)01867-6; Grigorieff N, 1998, J MOL BIOL, V277, P1033, DOI 10.1006/jmbi.1998.1668; Guenebaut V, 1997, J MOL BIOL, V265, P409, DOI 10.1006/jmbi.1996.0753; Guenebaut V, 1998, J MOL BIOL, V276, P105, DOI 10.1006/jmbi.1997.1518; Holt PJ, 2003, J BIOL CHEM, V278, P43114, DOI 10.1074/jbc.M308247200; LEIF H, 1995, EUR J BIOCHEM, V230, P538, DOI 10.1111/j.1432-1033.1995.tb20594.x; Mamedova AA, 2004, J BIOL CHEM, V279, P23830, DOI 10.1074/jbc.M401539200; Nakamaru-Ogiso E, 2005, J BIOL CHEM, V280, P301, DOI 10.1074/jbc.M410377200; Ohnishi T, 1998, BBA-BIOENERGETICS, V1364, P186, DOI 10.1016/S0005-2728(98)00027-9; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Page CC, 2003, CURR OPIN CHEM BIOL, V7, P551, DOI 10.1016/j.cbpa.2003.08.005; Peng GH, 2003, BIOCHEMISTRY-US, V42, P3032, DOI 10.1021/bi026876v; Rasmussen T, 2001, BIOCHEMISTRY-US, V40, P6124, DOI 10.1021/bi0026977; Sazanov LA, 2000, BIOCHEMISTRY-US, V39, P7229, DOI 10.1021/bi000335t; Schapira AHV, 1998, BBA-BIOENERGETICS, V1364, P261, DOI 10.1016/S0005-2728(98)00032-2; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; Yagi T, 2003, BIOCHEMISTRY-US, V42, P2266, DOI 10.1021/bi027158b; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605; Yano T, 1996, J BIOL CHEM, V271, P5907, DOI 10.1074/jbc.271.10.5907; Yano T, 1999, J BIOL CHEM, V274, P28598, DOI 10.1074/jbc.274.40.28598; Yano T, 2005, BIOCHEMISTRY-US, V44, P1744, DOI 10.1021/bi048132i; Yano T, 2003, J BIOL CHEM, V278, P15514, DOI 10.1074/jbc.M212275200; Zickermann V, 2003, J BIOL CHEM, V278, P29072, DOI 10.1074/jbc.M302713200	29	148	156	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2005	309	5735					771	774		10.1126/science.1113988	http://dx.doi.org/10.1126/science.1113988			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951NU	16051796				2022-12-01	WOS:000230938200050
J	Ramamoorthi, N; Narasimhan, S; Pal, U; Bao, FK; Yang, XFF; Fish, D; Anguita, J; Norgard, MV; Kantor, FS; Anderson, JF; Koski, RA; Fikrig, E				Ramamoorthi, N; Narasimhan, S; Pal, U; Bao, FK; Yang, XFF; Fish, D; Anguita, J; Norgard, MV; Kantor, FS; Anderson, JF; Koski, RA; Fikrig, E			The Lyme disease agent exploits a tick protein to infect the mammalian host	NATURE			English	Article							BORRELIA-BURGDORFERI; MICE; SPIROCHETE; IMMUNITY; DISSEMINATION; INHIBITION; ANTIBODIES; ARTHRITIS; IXODIDAE; ACARI	The Lyme disease agent, Borrelia burgdorferi, is maintained in a tick-mouse cycle(1,2). Here we show that B. burgdorferi usurps a tick salivary protein, Salp15 (ref. 3), to facilitate the infection of mice. The level of salp15 expression was selectively enhanced by the presence of B. burgdorferi in Ixodes scapularis, first indicating that spirochaetes might use Salp15 during transmission. Salp15 was then shown to adhere to the spirochaete, both in vitro and in vivo, and specifically interacted with B. burgdorferi outer surface protein C. The binding of Salp15 protected B. burgdorferi from antibody-mediated killing in vitro and provided spirochaetes with a marked advantage when they were inoculated into naive mice or animals previously infected with B. burgdorferi. Moreover, RNA interference-mediated repression of salp15 in I. scapularis drastically reduced the capacity of tick-borne spirochaetes to infect mice. These results show the capacity of a pathogen to use a secreted arthropod protein to help it colonize the mammalian host.	Yale Univ, Sch Med, Dept Internal Med, Rheumatol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Internal Med, Sect Allergy & Immunol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; Univ Texas, SW Med Ctr, Dept Microbiol, Dallas, TX 75390 USA; Univ N Carolina, Dept Biol, Charlotte, NC 28223 USA; Connecticut Agr Expt Stn, Dept Entomol, New Haven, CT 06504 USA; L2 Diagnost, New Haven, CT 06511 USA	Yale University; Yale University; Yale University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of North Carolina; University of North Carolina Charlotte; Connecticut Agricultural Experiment Station	Fikrig, E (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Rheumatol Sect, 333 Cedar St, New Haven, CT 06520 USA.	erol.fikrig@yale.edu	Pal, Utpal/I-5265-2015; Yang, X. Frank/F-3266-2010; Anguita, Juan/D-5432-2011	Anguita, Juan/0000-0003-2061-7182	NIAID NIH HHS [R01 AI053064, R01 AI053064-05] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053064] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anguita J, 2002, IMMUNITY, V16, P849, DOI 10.1016/S1074-7613(02)00325-4; BARTHOLD SW, 1990, J INFECT DIS, V162, P133, DOI 10.1093/infdis/162.1.133; BRUNET LR, 1995, INFECT IMMUN, V63, P3030, DOI 10.1128/IAI.63.8.3030-3036.1995; Bunikis J, 2004, J INFECT DIS, V189, P1515, DOI 10.1086/382594; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; Coleman JL, 1997, CELL, V89, P1111, DOI 10.1016/S0092-8674(00)80298-6; Das S, 2001, J INFECT DIS, V184, P1056, DOI 10.1086/323351; de Silva AM, 1998, J INFECT DIS, V177, P395, DOI 10.1086/514200; Fikrig E, 1997, J IMMUNOL, V159, P5682; Grimm D, 2004, P NATL ACAD SCI USA, V101, P3142, DOI 10.1073/pnas.0306845101; MALAWISTA SE, 1994, J INFECT DIS, V170, P1312, DOI 10.1093/infdis/170.5.1312; McKisic MD, 2000, INFECT IMMUN, V68, P5190, DOI 10.1128/IAI.68.9.5190-5197.2000; Nagamune K, 2004, J EXP MED, V199, P1445, DOI 10.1084/jem.20030635; Narasimhan S, 2004, P NATL ACAD SCI USA, V101, P1141, DOI 10.1073/pnas.0307669100; Nazario S, 1998, AM J TROP MED HYG, V58, P780, DOI 10.4269/ajtmh.1998.58.780; Pal U, 2004, J CLIN INVEST, V113, P220, DOI 10.1172/JCI200419894; Pal U, 2001, J IMMUNOL, V166, P7398, DOI 10.4049/jimmunol.166.12.7398; PIESMAN J, 1993, J MED ENTOMOL, V30, P199, DOI 10.1093/jmedent/30.1.199; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; RIBEIRO JMC, 1987, J MED ENTOMOL, V24, P201, DOI 10.1093/jmedent/24.2.201; SADZIENE A, 1993, J INFECT DIS, V167, P165, DOI 10.1093/infdis/167.1.165; SAUER JR, 1995, ANNU REV ENTOMOL, V40, P245, DOI 10.1146/annurev.en.40.010195.001333; Schwan TG, 2000, J CLIN MICROBIOL, V38, P382; Steere AC, 2004, J CLIN INVEST, V113, P1093, DOI 10.1172/JCI200421681; Steere AC, 2004, NAT REV IMMUNOL, V4, P143, DOI 10.1038/nri1267; Wikel SK, 1996, ANNU REV ENTOMOL, V41, P1, DOI 10.1146/annurev.en.41.010196.000245; Wooten RM, 2002, J IMMUNOL, V168, P348, DOI 10.4049/jimmunol.168.1.348; Zeidner NS, 2002, J PARASITOL, V88, P1276, DOI 10.1645/0022-3395(2002)088[1276:COBSWT]2.0.CO;2	28	354	369	2	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2005	436	7050					573	577		10.1038/nature03812	http://dx.doi.org/10.1038/nature03812			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049492	Green Accepted			2022-12-01	WOS:000230788800065
J	Kato, H; Goto, DB; Martienssen, RA; Urano, T; Furukawa, K; Murakami, Y				Kato, H; Goto, DB; Martienssen, RA; Urano, T; Furukawa, K; Murakami, Y			RNA polymerase II is required for RNAi-dependent heterochromatin assembly	SCIENCE			English	Article							FISSION YEAST; LYSINE-9 METHYLATION; EPIGENETIC CONTROL; NUCLEAR-RNA; TRANSCRIPTION; RITS; DNA	In Schizosaccharomyces pombe, the RNA interference (RNAi) machinery con. verts pericentromeric transcripts into small interfering RNAs (siRNAs) and is, required for the assembly of pericentromeric heterochromatin. Here we describe a. mutation in the second largest subunit of RNA polymerase II (RNAPII). Both wild-type and mutant RNAPII localized to the pericentromere. However, the mutation resulted in the loss of heterochromatic histone modifications and in the accumulation of pericentromeric transcripts, accompanied by the loss of siRNAs. This phenotype resembles mutants in RNAi and suggests that RNAPII couples pericentromeric transcription with siRNA processing and heterochromatin assembly.	Kyoto Univ, Inst Virus Res, Dept Viral Oncol, Sakyo Ku, Kyoto 6068507, Japan; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Nagoya Univ, Grad Sch Med, Dept Biochem 2, Nagoya, Aichi 4668550, Japan	Kyoto University; Cold Spring Harbor Laboratory; Nagoya University	Murakami, Y (corresponding author), Kyoto Univ, Inst Virus Res, Dept Viral Oncol, Sakyo Ku, Kyoto 6068507, Japan.	yota@virus.kyoto-u.ac.jp	Kato, Hiroaki/T-1674-2017; Murakami, Yota/F-8850-2012; Goto, Derek B/B-7053-2009; Kato, Hiroaki/B-2799-2008	Kato, Hiroaki/0000-0001-9591-1875; Urano, Takeshi/0000-0003-3383-3554	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067014] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01-GM067014] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Armache KJ, 2005, J BIOL CHEM, V280, P7131, DOI 10.1074/jbc.M413038200; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Chen J, 2003, NUCLEIC ACIDS RES, V31, P474, DOI 10.1093/nar/gkg086; Hamada M, 2000, J BIOL CHEM, V275, P29076, DOI 10.1074/jbc.M003980200; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; KAWAGISHIKOBAYASHI, 1996, MOL GEN GENET, V250, P1; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Martienssen RA, 2003, NAT GENET, V35, P213, DOI 10.1038/ng1252; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; SUGIMOTO A, 1991, GENE DEV, V5, P1990, DOI 10.1101/gad.5.11.1990; TANI T, 1989, NATURE, V337, P87, DOI 10.1038/337087a0; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Zorio DAR, 2004, EXP CELL RES, V296, P91, DOI 10.1016/j.yexcr.2004.03.019	19	230	240	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2005	309	5733					467	469		10.1126/science.1114955	http://dx.doi.org/10.1126/science.1114955			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946LY	15947136				2022-12-01	WOS:000230574900047
J	Zhao, Y; Samal, E; Srivastava, D				Zhao, Y; Samal, E; Srivastava, D			Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis	NATURE			English	Article							BHLH TRANSCRIPTION FACTOR; C-ELEGANS; CAENORHABDITIS-ELEGANS; POSTTRANSCRIPTIONAL REGULATION; CARDIAC DEVELOPMENT; GENE-EXPRESSION; SMALL RNAS; HEART; PREDICTION; MYOCARDIN	Gradients of signalling and transcription factors govern many aspects of embryogenesis, highlighting the need for spatiotemporal control of regulatory protein levels. MicroRNAs are phylogenetically conserved small RNAs that regulate the translation of target messenger RNAs, providing a mechanism for protein dose regulation. Here we show that microRNA-1-1 (miR-1-1) and miR-1-2 are specifically expressed in cardiac and skeletal muscle precursor cells. We found that the miR-1 genes are direct transcriptional targets of muscle differentiation regulators including serum response factor, MyoD and Mef2. Correspondingly, excess miR-1 in the developing heart leads to a decreased pool of proliferating ventricular cardiomyocytes. Using a new algorithm for microRNA target identification that incorporates features of RNA structure and target accessibility, we show that Hand2, a transcription factor that promotes ventricular cardiomyocyte expansion, is a target of miR-1. This work suggests that miR-1 genes titrate the effects of critical cardiac regulatory proteins to control the balance between differentiation and proliferation during cardiogenesis.	Univ Texas, SW Med Ctr, Dept Pediat Cardiol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Childrens Med Ctr Dallas, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Srivastava, D (corresponding author), Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, 1650 Owens St, San Francisco, CA 94158 USA.	dsrivastava@gladstone.ucsf.edu						Abrahante JE, 2003, DEV CELL, V4, P625, DOI 10.1016/S1534-5807(03)00127-8; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Chang S, 2004, NATURE, V430, P785, DOI 10.1038/nature02752; Chen F, 2002, CELL, V110, P713, DOI 10.1016/S0092-8674(02)00932-7; Chien KR, 2002, CELL, V110, P153, DOI 10.1016/S0092-8674(02)00834-6; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Dsouza M, 1997, TRENDS GENET, V13, P497, DOI 10.1016/S0168-9525(97)01347-4; Firulli AB, 1998, NAT GENET, V18, P266, DOI 10.1038/ng0398-266; Grosshans H, 2005, DEV CELL, V8, P321, DOI 10.1016/j.devcel.2004.12.019; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Kelly RG, 2002, TRENDS GENET, V18, P210, DOI 10.1016/S0168-9525(02)02642-2; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lee NS, 2002, NAT BIOTECHNOL, V20, P500, DOI 10.1038/nbt0502-500; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; McFadden DG, 2005, DEVELOPMENT, V132, P189, DOI 10.1242/dev.01562; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Miano JM, 2004, P NATL ACAD SCI USA, V101, P17132, DOI 10.1073/pnas.0406041101; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Shin CH, 2002, CELL, V110, P725, DOI 10.1016/S0092-8674(02)00933-9; SRIVASTAVA D, 1995, SCIENCE, V270, P1995, DOI 10.1126/science.270.5244.1995; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang DZ, 2004, CURR OPIN GENET DEV, V14, P558, DOI 10.1016/j.gde.2004.08.003; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yamagishi H, 2003, GENE DEV, V17, P269, DOI 10.1101/gad.1048903; Yamagishi H, 2001, DEV BIOL, V239, P190, DOI 10.1006/dbio.2001.0417; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yelon D, 2000, DEVELOPMENT, V127, P2573; Zhou JL, 2005, J BIOL CHEM, V280, P10861, DOI 10.1074/jbc.M411586200; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	49	1275	1437	4	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2005	436	7048					214	220		10.1038/nature03817	http://dx.doi.org/10.1038/nature03817			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944VR	15951802				2022-12-01	WOS:000230459500031
J	Rieping, W; Habeck, M; Nilges, M				Rieping, W; Habeck, M; Nilges, M			Inferential structure determination	SCIENCE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; MACROMOLECULAR STRUCTURE DETERMINATION; MODEL-FREE APPROACH; NMR-SPECTROSCOPY; MONTE-CARLO; RELAXATION; CRYSTALLOGRAPHY; SPECTRIN; DOMAIN	Macromolecular structures calculated from nuclear magnetic resonance data are not fully determined by experimental data but depend on subjective choices in data treatment and parameter settings. This makes it difficult to objectively judge the precision of the structures. We used Bayesian inference to derive a probability distribution that represents the unknown structure and its precision. This probability distribution also determines additional unknowns, such as theory parameters, that previously had to be chosen empirically. We implemented this approach by using Markov chain, Monte Carlo techniques. Our method provides an objective figure of merit and improves structural quality.	Inst Pasteur, CNRS, URA 2185, Untie Bioinformat Struct, F-75724 Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite	Nilges, M (corresponding author), Inst Pasteur, CNRS, URA 2185, Untie Bioinformat Struct, 25-28 Rue Docteur Roux, F-75724 Paris, France.	nilges@pasteur.fr	Nilges, Michael/E-4803-2011	Nilges, Michael/0000-0002-1451-8092; Habeck, Michael/0000-0002-2188-5667				Adams PD, 1997, P NATL ACAD SCI USA, V94, P5018, DOI 10.1073/pnas.94.10.5018; ALTMAN RB, 1989, METHOD ENZYMOL, V177, P218; Andrec M, 1999, J MAGN RESON, V139, P408, DOI 10.1006/jmre.1999.1839; Bricogne G, 1997, METHOD ENZYMOL, V276, P361, DOI 10.1016/S0076-6879(97)76069-5; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; BRUNGER AT, 1993, SCIENCE, V261, P328, DOI 10.1126/science.8332897; BRUNGER AT, 1993, Q REV BIOPHYS, V26, P49, DOI 10.1017/S0033583500003966; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHEN MH, 2002, MONTE CARLO METHODS; COX RT, 1946, AM J PHYS, V14, P1, DOI 10.1119/1.1990764; DUANE S, 1987, PHYS LETT B, V195, P216, DOI 10.1016/0370-2693(87)91197-X; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; Habeck M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018105; Jaynes E.T., 2003, PROBABILITY THEORY L; KARPLUS M, 1963, J AM CHEM SOC, V85, P2870, DOI 10.1021/ja00901a059; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; MACURA S, 1980, MOL PHYS, V41, P95, DOI 10.1080/00268978000102601; Mal TK, 1998, J BIOMOL NMR, V12, P259, DOI 10.1023/A:1008238009056; Nilges M, 1998, PROG NUCL MAG RES SP, V32, P107, DOI 10.1016/S0079-6565(97)00025-3; Nilges M, 1997, J MOL BIOL, V269, P408, DOI 10.1006/jmbi.1997.1044; NOBLE MEM, 1993, EMBO J, V12, P2617, DOI 10.1002/j.1460-2075.1993.tb05922.x; RIEPING W, UNPUB; SWENDSEN RH, 1986, PHYS REV LETT, V57, P2607, DOI 10.1103/PhysRevLett.57.2607	24	252	258	4	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2005	309	5732					303	306		10.1126/science.1110428	http://dx.doi.org/10.1126/science.1110428			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944SP	16002620				2022-12-01	WOS:000230449800046
J	Kurz, T; Ozlu, N; Rudolf, F; O'Rourke, SM; Luke, B; Hofmann, K; Hyman, AA; Bowerman, B; Peter, M				Kurz, T; Ozlu, N; Rudolf, F; O'Rourke, SM; Luke, B; Hofmann, K; Hyman, AA; Bowerman, B; Peter, M			The conserved protein DCN-1/Dcn1p is required for cullin neddylation in C-elegans and S-cerevisiae	NATURE			English	Article							FUNCTIONAL GENOMIC ANALYSIS; MODIFICATION PATHWAY; UBIQUITIN LIGASES; NEDD8; CUL1; DEGRADATION; COMPLEX; SCF; DESTRUCTION; CLEAVAGE	SCF-type E3 ubiquitin ligases are multi-protein complexes required for polyubiquitination and subsequent degradation of target proteins by the 26S proteasome(1). Cullins, together with the RING-finger protein Rbx1, form the catalytic core of the ligase, and recruit the substrate-recognition module(1-4). Cycles of covalent modification of cullins by the ubiquitin-like molecule Nedd8 (neddylation)(5) and removal of Nedd8 by the COP9 signalosome (deneddylation) positively regulate E3 ligase activity(6,7). Here we report the identification and analysis of a widely conserved protein that is required for cullin neddylation in the nematode Caenorhabditis elegans and the yeast Saccharomyces cerevisiae. C. elegans DCN-1 and S. cerevisiae Dcn1p ( defective in cullin neddylation) are characterized by a novel UBA-like ubiquitin-binding domain and a DUF298 domain of unknown function. Consistent with their requirements for neddylation, DCN-1 and Dcn1p directly bind Nedd8 and physically associate with cullins in both species. Moreover, overexpression of Dcn1p in yeast results in the accumulation of Nedd8-modified cullin Cdc53p. Both in vivo and in vitro experiments indicate that Dcn1p does not inhibit deneddylation of Cdc53p by the COP9 signalosome, but greatly increases the kinetics of the neddylation reaction.	Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; ETH Honggerberg, Inst Biochem, CH-8093 Zurich, Switzerland; Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Memorec Biotec GmbH, D-50829 Cologne, Germany	University of Oregon; Swiss Federal Institutes of Technology Domain; ETH Zurich; Max Planck Society	Peter, M (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	matthias.peter@bc.biol.ethz.ch	Kurz, Thimo/E-4116-2012; Hyman, Anthony A/B-3917-2017; Hyman, Tony/F-1923-2011; Hofmann, Kay/D-6714-2011	Hyman, Anthony A/0000-0003-3664-154X; Hofmann, Kay/0000-0002-2289-9083; Peter, Matthias/0000-0002-2160-6824; Luke, Brian/0000-0002-1648-5511; Kurz, Thimo/0000-0003-0700-6993				Bucher P, 1996, COMPUT CHEM, V20, P3, DOI 10.1016/S0097-8485(96)80003-9; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Dharmasiri S, 2003, EMBO J, V22, P1762, DOI 10.1093/emboj/cdg190; Dow MR, 1998, GENETICS, V150, P119; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Furukawa M, 2002, J BIOL CHEM, V277, P15758, DOI 10.1074/jbc.M108565200; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Guthrie C, 1991, GUIDE YEAST GENETICS; Hofmann K, 2000, Brief Bioinform, V1, P167, DOI 10.1093/bib/1.2.167; Jaquenoud M, 1998, EMBO J, V17, P5360, DOI 10.1093/emboj/17.18.5360; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; Kile BT, 2002, TRENDS BIOCHEM SCI, V27, P235, DOI 10.1016/S0968-0004(02)02085-6; Kurz T, 2002, SCIENCE, V295, P1294, DOI 10.1126/science.1067765; Lammer D, 1998, GENE DEV, V12, P914, DOI 10.1101/gad.12.7.914; Liakopoulos D, 1998, EMBO J, V17, P2208, DOI 10.1093/emboj/17.8.2208; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; MCNALLY FJ, 1993, CELL, V75, P419, DOI 10.1016/0092-8674(93)90377-3; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; Morimoto M, 2003, BIOCHEM BIOPH RES CO, V301, P392, DOI 10.1016/S0006-291X(02)03051-6; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Pintard L, 2003, CURR BIOL, V13, P911, DOI 10.1016/S0960-9822(03)00336-1; Srayko M, 2000, GENE DEV, V14, P1072; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Verma R, 1997, METHOD ENZYMOL, V283, P366; Zheng JY, 2002, MOL CELL, V10, P1519, DOI 10.1016/S1097-2765(02)00784-0	29	146	159	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2005	435	7046					1257	1261		10.1038/nature03662	http://dx.doi.org/10.1038/nature03662			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940JJ	15988528				2022-12-01	WOS:000230140500048
J	Bhandawat, V; Reisert, J; Yau, KW				Bhandawat, V; Reisert, J; Yau, KW			Elementary response of olfactory receptor neurons to odorants	SCIENCE			English	Article							RETINAL RODS; CELLS; CALCIUM; DESENSITIZATION; TRANSDUCTION; PHOTOTRANSDUCTION; ADAPTATION; SALAMANDER; MECHANISM; MAGNESIUM	Signaling by heterotrimeric GTP-binding proteins (G proteins) drives numerous cellular processes. The number of G protein molecules activated by a single membrane receptor is a determinant of signal amplification, although in most cases this parameter remains unknown. In retinal rod photoreceptors, a long-lived photoisomerized rhodopsin molecule activates many G protein molecules (transducins), yielding substantial amplification and a large elementary (single-photon) response, before rhodopsin activity is terminated. Here we report that the elementary response in olfactory transduction is extremely small. A ligand-bound odorant receptor has a low probability of activating even one G protein molecule because the odorant dwell-time is very brief. Thus, signal amplification in olfactory transduction appears fundamentally different from that of phototransduction.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Bhandawat, V (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Room 907,Preclin Teaching Bldg,725 N Wolfe St, Baltimore, MD 21205 USA.	vbhanda@mail.jhmi.edu; kwyau@mail.jhmi.edu			NATIONAL EYE INSTITUTE [R01EY014596, R01EY006837, R37EY006837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006904] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY014596-01, R01 EY006837-18, R01 EY014596, R01 EY014596-02, R01 EY014596-03, R37 EY006837, R01 EY006837-17, R01 EY006837-16A1, R01 EY006837, R37 EY006837-15, R37 EY006837-15S1] Funding Source: Medline; NIDCD NIH HHS [R01 DC006904, DC06904, R01 DC006904-01] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; Buck LB, 2000, CELL, V100, P611, DOI 10.1016/S0092-8674(00)80698-4; DAWSON TM, 1993, SCIENCE, V259, P825, DOI 10.1126/science.8381559; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; FIRESTEIN S, 1993, J PHYSIOL-LONDON, V468, P1; GOLD GH, 1995, NATURE, V376, P27, DOI 10.1038/376027a0; KLEENE SJ, 1995, NEUROSCIENCE, V66, P1001, DOI 10.1016/0306-4522(94)00634-H; LAMB TD, 1981, J PHYSIOL-LONDON, V319, P463, DOI 10.1113/jphysiol.1981.sp013921; Leskov IB, 2000, NEURON, V27, P525, DOI 10.1016/S0896-6273(00)00063-5; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; LOWE G, 1995, P NATL ACAD SCI USA, V92, P7864, DOI 10.1073/pnas.92.17.7864; LOWE G, 1991, J PHYSIOL-LONDON, V442, P147, DOI 10.1113/jphysiol.1991.sp018787; Matthews HR, 2003, CURR OPIN NEUROBIOL, V13, P469, DOI 10.1016/S0959-4388(03)00097-7; MENINI A, 1995, NATURE, V373, P435, DOI 10.1038/373435a0; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; NAKATANI K, 1988, J PHYSIOL-LONDON, V395, P695, DOI 10.1113/jphysiol.1988.sp016942; NAKATANI K, 1988, NATURE, V334, P69, DOI 10.1038/334069a0; Peppel K, 1997, J BIOL CHEM, V272, P25425, DOI 10.1074/jbc.272.41.25425; Reisert J, 1998, J GEN PHYSIOL, V112, P529, DOI 10.1085/jgp.112.5.529; Schild D, 1998, PHYSIOL REV, V78, P429, DOI 10.1152/physrev.1998.78.2.429; SCHLEICHER S, 1993, P NATL ACAD SCI USA, V90, P1420, DOI 10.1073/pnas.90.4.1420; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; YAU KW, 1994, INVEST OPHTH VIS SCI, V35, P9	24	110	114	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2005	308	5730					1931	1934		10.1126/science.1109886	http://dx.doi.org/10.1126/science.1109886			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940BZ	15976304	Green Accepted			2022-12-01	WOS:000230120000046
J	Waxman, HA				Waxman, HA			The lessons of Vioxx - Drug safety and sales	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Dai CL, 2005, ARCH INTERN MED, V165, P171, DOI 10.1001/archinte.165.2.171; *FDA ADV COMM, 2001, 21042S007 NDA FDA AD; Graham DJ, 2005, LANCET, V365, P475, DOI 10.1016/S0140-6736(05)17864-7; ROSE JL, 2002, PHYS EXPECTATIONS IN; *US HOUS REPR COMM, MERCK DOC SHOW AGGR	5	80	83	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 23	2005	352	25					2576	2578		10.1056/NEJMp058136	http://dx.doi.org/10.1056/NEJMp058136			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	937VJ	15972862				2022-12-01	WOS:000229953700003
J	Kuzuyama, T; Noel, JP; Richard, SB				Kuzuyama, T; Noel, JP; Richard, SB			Structural basis for the promiscuous biosynthetic prenylation of aromatic natural products	NATURE			English	Article							FARNESYL DIPHOSPHATE SYNTHASE; CRYSTAL-STRUCTURE; PROTEIN FARNESYLTRANSFERASE; POLYKETIDE SYNTHASE; BINDING PROTEIN; RESOLUTION; PRENYLTRANSFERASE; IDENTIFICATION; MECHANISM; ENZYMES	The anti-oxidant naphterpin is a natural product containing a polyketide-based aromatic core with an attached 10-carbon geranyl group derived from isoprenoid ( terpene) metabolism(1-3). Hybrid natural products such as naphterpin that contain 5-carbon ( dimethylallyl), 10-carbon ( geranyl) or 15-carbon ( farnesyl) isoprenoid chains possess biological activities distinct from their non-prenylated aromatic precursors(4). These hybrid natural products represent new anti-microbial, anti-oxidant, anti-inflammatory, anti-viral and anti-cancer compounds. A small number of aromatic prenyltransferases (PTases) responsible for prenyl group attachment have only recently been isolated and characterized(5,6). Here we report the gene identification, biochemical characterization and high-resolution X-ray crystal structures of an architecturally novel aromatic PTase, Orf2 from Streptomyces sp. strain CL190, with substrates and substrate analogues bound. In vivo, Orf2 attaches a geranyl group to a 1,3,6,8-tetrahydroxynaphthalene-derived polyketide during naphterpin biosynthesis. In vitro, Orf2 catalyses carbon-carbon-based and carbon-oxygen-based prenylation of a diverse collection of hydroxyl-containing aromatic acceptors of synthetic, microbial and plant origin. These crystal structures, coupled with in vitro assays, provide a basis for understanding and potentially manipulating the regio-specific prenylation of aromatic small molecules using this structurally unique family of aromatic PTases.	Salk Inst Biol Studies, Jack Skirball Chem Biol & Proteom Lab, La Jolla, CA 92037 USA; Univ Tokyo, Biotechnol Res Ctr, Lab Cell Biotechnol, Tokyo 1138657, Japan	Salk Institute; University of Tokyo	Richard, SB (corresponding author), Salk Inst Biol Studies, Jack Skirball Chem Biol & Proteom Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	richard@salk.edu	Noel, Joseph P/A-9459-2009	Kuzuyama, Tomohisa/0000-0002-7221-5858	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Botta B, 2005, CURR MED CHEM, V12, P713, DOI 10.2174/0929867053202241; Branden C. I., 2012, INTRO PROTEIN STRUCT; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BRUNO M, 1985, HETEROCYCLES, V23, P1147, DOI 10.3987/R-1985-05-1147; CANE DE, 1998, ISOPRENOIDS INCLUDIN; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Edwards DJ, 2004, J AM CHEM SOC, V126, P11432, DOI 10.1021/ja047876g; Funa N, 1999, NATURE, V400, P897, DOI 10.1038/23748; Gerlt JA, 2003, CURR OPIN CHEM BIOL, V7, P252, DOI 10.1016/S1367-5931(03)00019-X; Izumikawa M, 2003, J IND MICROBIOL BIOT, V30, P510, DOI 10.1007/s10295-003-0075-8; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kharel Y, 2003, NAT PROD REP, V20, P111, DOI 10.1039/b108934j; Koyama T, 1996, BIOCHEMISTRY-US, V35, P9533, DOI 10.1021/bi960137v; Liang PH, 2002, EUR J BIOCHEM, V269, P3339, DOI 10.1046/j.1432-1033.2002.03014.x; Long SB, 2002, NATURE, V419, P645, DOI 10.1038/nature00986; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park HW, 1997, SCIENCE, V275, P1800, DOI 10.1126/science.275.5307.1800; Pojer F, 2003, P NATL ACAD SCI USA, V100, P2316, DOI 10.1073/pnas.0337708100; SACCHETTINI JC, 1989, J MOL BIOL, V208, P327, DOI 10.1016/0022-2836(89)90392-6; SCHUTZ BA, 1995, PHYTOCHEMISTRY, V40, P1273, DOI 10.1016/0031-9422(95)00508-5; Seto H, 1996, TETRAHEDRON LETT, V37, P7979, DOI 10.1016/0040-4039(96)01787-X; SHIN-YA K, 1990, Tetrahedron Letters, V31, P6025, DOI 10.1016/S0040-4039(00)98019-5; SHINYA K, 1990, J ANTIBIOT, V43, P444, DOI 10.7164/antibiotics.43.444; TARSHIS LC, 1994, BIOCHEMISTRY-US, V33, P10871, DOI 10.1021/bi00202a004; Taura F, 1996, J BIOL CHEM, V271, P17411, DOI 10.1074/jbc.271.29.17411; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P1937, DOI 10.1107/S0907444902016438; XU ZH, 1993, J BIOL CHEM, V268, P7874	29	237	251	3	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2005	435	7044					983	987		10.1038/nature03668	http://dx.doi.org/10.1038/nature03668			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935RN	15959519	Green Submitted, Green Accepted			2022-12-01	WOS:000229799700055
J	Flewelling, LJ; Naar, JP; Abbott, JP; Baden, DG; Barros, NB; Bossart, GD; Bottein, MYD; Hammond, DG; Haubold, EM; Heil, CA; Henry, MS; Jacocks, HM; Leighfield, TA; Pierce, RH; Pitchford, TD; Rommel, SA; Scott, PS; Steidinger, KA; Truby, EW; Van Dolah, FM; Landsberg, JH				Flewelling, LJ; Naar, JP; Abbott, JP; Baden, DG; Barros, NB; Bossart, GD; Bottein, MYD; Hammond, DG; Haubold, EM; Heil, CA; Henry, MS; Jacocks, HM; Leighfield, TA; Pierce, RH; Pitchford, TD; Rommel, SA; Scott, PS; Steidinger, KA; Truby, EW; Van Dolah, FM; Landsberg, JH			Brevetoxicosis: Red tides and marine mammal mortalities	NATURE			English	Editorial Material							DINOFLAGELLATE		Florida Fish & Wildlife Conservat Commiss, Fish & Wildlife Res Inst, St Petersburg, FL 33701 USA; Univ N Carolina, Ctr Marine Sci, Wilmington, NC 28409 USA; Mote Marine Lab, Sarasota, FL 34236 USA; Harbor Branch Oceanog Inst Inc, Ft Pierce, FL 34946 USA; NOAA, NOS, Ctr Coastal Environm Hlth & Biomol Res, Charleston, SC 29412 USA	Florida Fish & Wildlife Conservation Commission; University of North Carolina; University of North Carolina Wilmington; Mote Marine Laboratory & Aquarium; Harbor Branch Oceanographic Institute Foundation; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA	Flewelling, LJ (corresponding author), Florida Fish & Wildlife Conservat Commiss, Fish & Wildlife Res Inst, St Petersburg, FL 33701 USA.	naarj@uncw.edu	Bottein, Marie-Yasmine Dechraoui/J-8851-2018	Dechraoui Bottein, Marie-Yasmine/0000-0002-6468-7222	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES010594] Funding Source: NIH RePORTER; NIEHS NIH HHS [P01 ES010594-05, P01 ES010594] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		[Anonymous], HARMFUL ALGAL BLOOMS; BADEN DG, 1982, TOXICON, V20, P457, DOI 10.1016/0041-0101(82)90009-5; Bossart GD, 1998, TOXICOL PATHOL, V26, P276, DOI 10.1177/019262339802600214; GERACI J, 1989, CLIN INVESTIGATION 1; OSHEA TJ, 1991, MAR MAMMAL SCI, V7, P165, DOI 10.1111/j.1748-7692.1991.tb00563.x; Ross PS, 2000, HUM ECOL RISK ASSESS, V6, P29, DOI 10.1080/10807030091124437; Steidinger Karen A., 1993, P1; Van Dolah FM, 2003, N P TOX ENV, P247; *WORK GROUP MAR MA, 2004, BOTTL DOLPH TURS TRU	9	296	307	3	157	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2005	435	7043					755	756		10.1038/nature435755a	http://dx.doi.org/10.1038/nature435755a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933NK	15944690	Green Accepted			2022-12-01	WOS:000229638700036
J	Drobniewski, F; Balabanova, Y; Nikolayevsky, V; Ruddy, M; Kuznetzov, S; Zakharova, S; Melemyev, A; Fedorin, I				Drobniewski, F; Balabanova, Y; Nikolayevsky, V; Ruddy, M; Kuznetzov, S; Zakharova, S; Melemyev, A; Fedorin, I			Drug-resistant, tuberculosis, clinical virulence, and the dominance of the Beijing strain family in Russia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; TREATMENT FAILURE; IMMUNE-RESPONSE; GENOTYPE; EPIDEMIOLOGY; VIETNAM; SPREAD; RISK	Context Tuberculosis and multidrug-resistant tuberculosis is a serious public health problem in Russia. Objective To address the extent of "Beijing strain" transmission in the prison/civil sectors and the association of drug resistance, clinical, and social factors with the Beijing genotype. Design and Setting Cross-sectional population-based molecular epidemiological study of all civilian and penitentiary tuberculosis facilities in the Samara region, Russia. Patients Consecutively recruited patients with bacteriologically proven tuberculosis (n = 880). Main Outcome Measure Proportion of Beijing strains and association with drug resistance, human immunodeficiency virus infection, imprisonment, radiological, clinical, and other social factors. Results Beijing-family strains (identified by spoligotyping and composed of 2 main types by mycobacterial interspersed repetitive unit analysis) were predominant: 586/880 (66.6%; 95% confidence interval ICU, 63.4%-69.7%) with a significantly higher prevalence in the prison population (rate ratio [RR], 1.3; 95% Cl, 1.2-1.5) and those aged younger than 35 years (RR, 1.2; 95% Cl, 1.0-1.3). Comparable proportions were coinfected with the human immunodeficiency virus ( 10%), concurrent hepatitis B and C (21.6%), drank alcohol (approximate to 90%), smoked (approximate to 90%), and had a similar sexual history. Drug resistance was nearly 2-fold higher in patients infected with Beijing strains compared with non-Beijing strains: multidrug resistance (RR, 2.4; 95% Cl, 1.9-3.0), for isoniazid (RR, 1.8; 95% Cl, 1.5-2.1), for rifampicin (RR, 2.2; 95% Cl, 1.7-2.7), for streptomycin (RR, 1.9; 95% Cl, 1.5-2.3), and for ethambutol (RR, 2.2; 95% Cl, 1.63.2). Univariate analysis demonstrated that male sex (odds ratio [OR], 1.5; 95% Cl, 1.1-1.9), advanced radiological abnormalities (OR, 3.3; 95% Cl, 1.3-8.4), homelessness (OR, 5.6; 95% Cl, 1.1-6.3), and previous imprisonment (OR, 2.0; 95% Cl, 1.52.7) were strongly associated with Beijing-strain family disease. Multivariate analysis supported previous imprisonment to be a risk factor (OR, 2.0; 95% Cl, 1.4-3.3) and night sweats to be less associated (OR 0.7; 95% Cl, 0.5-1.0) with Beijing-strain disease. Conclusions Drug resistance and previous imprisonment but not human immunodeficiency virus co-infection were significantly associated with Beijing-strain infection. There was evidence that Beijing isolates caused radiologically more advanced disease.	Guys & St Thomas Med Sch, Dept Microbiol & Infect, HPA Mycobacterium Reference Unit, London, England; Samara Reg TB Serv, Samara Oblast Dispensary, Samara, Russia; Samara City TB Serv, Samara, Russia; Samara Reg Minist Hlth, Samara, Russia; Samara Prison TB Serv, Samara, Russia	University of London; King's College London	Drobniewski, F (corresponding author), Queen Marys Sch Med, Inst Cell & Mol Sci, Ctr Clin Sci, Newark St, London E1, England.	francis.drobniewski@kcl.ac.uk	Nikolayevskyy, Vladyslav/HFZ-7738-2022	Nikolayevskyy, Vladyslav/0000-0002-9502-0332				ABRAMSON JH, 2001, COMPUTER PROGRAMS EP; Anh DD, 2000, EMERG INFECT DIS, V6, P302; Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Borydorff MW, 2004, TUBERCULOSIS, V84, P337, DOI 10.1016/j.tube.2003.10.002; Caminero JA, 2001, AM J RESP CRIT CARE, V164, P1165, DOI 10.1164/ajrccm.164.7.2101031; Coker RJ, 2003, INT J TUBERC LUNG D, V7, P920; Drobniewski F, 2004, CURR OPIN PULM MED, V10, P211, DOI 10.1097/00063198-200405000-00011; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; Kimerling ME, 2003, INT J TUBERC LUNG D, V7, P866; Kruuner A, 2002, CLIN INFECT DIS, V35, P146, DOI 10.1086/340980; Kruuner A, 2001, J CLIN MICROBIOL, V39, P3339, DOI 10.1128/JCM.39.9.3339-3345.2001; Lan NTN, 2003, EMERG INFECT DIS, V9, P1633, DOI 10.3201/eid0912.030169; Lillebaek T, 2003, EMERG INFECT DIS, V9, P1553, DOI 10.3201/eid0912.030276; Lopez B, 2003, CLIN EXP IMMUNOL, V133, P30, DOI 10.1046/j.1365-2249.2003.02171.x; Mokrousov I, 2004, J CLIN MICROBIOL, V42, P2438, DOI 10.1128/JCM.42.6.2438-2444.2004; NARVSKAIA OV, 2002, PROBL TUBERK, V3, P50; Narvskaya O, 2002, EUR J CLIN MICROBIOL, V21, P596, DOI 10.1007/s10096-002-0775-4; Pfyffer GE, 2001, EMERG INFECT DIS, V7, P855, DOI 10.3201/eid0705.017514; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; Toungoussova OS, 2002, INT J TUBERC LUNG D, V6, P406; Tracevska T, 2003, INT J TUBERC LUNG D, V7, P1097; Van Soolingen D, 2001, J MED MICROBIOL, V50, P749, DOI 10.1099/0022-1317-50-9-749; van Soolingen D, 2001, J INTERN MED, V249, P1, DOI 10.1046/j.1365-2796.2001.00772.x; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; VANSOOLINGEN D, 1995, EUR RESPIR J, V8, pS649	26	193	204	1	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	2005	293	22					2726	2731		10.1001/jama.293.22.2726	http://dx.doi.org/10.1001/jama.293.22.2726			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933OV	15941801	Bronze			2022-12-01	WOS:000229643700020
J	Varela, I; Cadinanos, J; Pendas, AM; Gutierrez-Fernandez, A; Folgueras, AR; Sanchez, LM; Zhou, ZJ; Rodriguez, FJ; Stewart, CL; Vega, JA; Tryggvason, K; Freije, JMP; Lopez-Otin, C				Varela, I; Cadinanos, J; Pendas, AM; Gutierrez-Fernandez, A; Folgueras, AR; Sanchez, LM; Zhou, ZJ; Rodriguez, FJ; Stewart, CL; Vega, JA; Tryggvason, K; Freije, JMP; Lopez-Otin, C			Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation	NATURE			English	Article							A-TYPE LAMINS; HUTCHINSON-GILFORD PROGERIA; LIFE-SPAN; IN-VIVO; METALLOPROTEINASE; SENESCENCE; PHENOTYPES; MUTATIONS; CANCER; CELLS	Zmpste24 ( also called FACE- 1) is a metalloproteinase involved in the maturation of lamin A ( Lmna), an essential component of the nuclear envelope(1 - 3). Both Zmpste24- and Lmna- deficient mice exhibit profound nuclear architecture abnormalities and multiple histopathological defects that phenocopy an accelerated ageing process(1,2,4,5). Similarly, diverse human progeroid syndromes are caused by mutations in ZMPSTE24 or LMNA genes(6 - 10). To elucidate the molecular mechanisms underlying these devastating diseases, we have analysed the transcriptional alterations occurring in tissues from Zmpste24- deficient mice. We demonstrate that Zmpste24 deficiency elicits a stress signalling pathway that is evidenced by a marked upregulation of p53 target genes, and accompanied by a senescence phenotype at the cellular level and accelerated ageing at the organismal level. These phenotypes are largely rescued in Zmpste24 (-/-) Lmna (+/-) mice and partially reversed in Zmpste24 (-/-) p53 (-/-) mice. These findings provide evidence for the existence of a checkpoint response activated by the nuclear abnormalities caused by prelamin A accumulation, and support the concept that hyperactivation of the tumour suppressor p53 may cause accelerated ageing(11).	Inst Univ Oncol, Fac Med, Dept Bioquim & Biol Mol, Oviedo, Spain; Univ Oviedo, Dept Morfol & Biol Celular, E-33006 Oviedo, Spain; Karolinska Inst, Dept Biochem & Biophys, Div Matrix Biol, S-17177 Stockholm, Sweden; NCI, Frederick, MD 21702 USA	University of Oviedo; Instituto Universitario de Oncologia de Asturias; University of Oviedo; Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lopez-Otin, C (corresponding author), Inst Univ Oncol, Fac Med, Dept Bioquim & Biol Mol, Oviedo, Spain.	clo@uniovi.es	Folgueras, Alicia/B-3281-2017; zhou, zhongjun/D-4818-2012; Vega, Jose A/AAG-3209-2021; Freije, José M.P./A-6535-2008; Varela, Ignacio/G-1699-2016; Varela, Ignacio/AAA-7680-2021; Gutierrez-Fernandez, Ana/ABG-6678-2020; Pendas, Alberto M/L-1017-2014; Gutierrez-Fernandez, Ana/AAS-9954-2021; López-Otín, Carlos/AAB-2106-2020; Zhou, Zhongjun/C-4476-2009	Folgueras, Alicia/0000-0003-3426-9502; Freije, José M.P./0000-0002-4688-8266; Varela, Ignacio/0000-0002-0969-506X; Varela, Ignacio/0000-0002-0969-506X; Gutierrez-Fernandez, Ana/0000-0002-9287-8843; López-Otín, Carlos/0000-0001-6964-1904; Zhou, Zhongjun/0000-0001-7092-8128; Pendas, Alberto M/0000-0001-9264-3721; Cadinanos, Juan/0000-0001-7561-7759	NATIONAL CANCER INSTITUTE [Z01BC010377] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agarwal AK, 2003, HUM MOL GENET, V12, P1995, DOI 10.1093/hmg/ddg213; Bergo MO, 2002, P NATL ACAD SCI USA, V99, P13049, DOI 10.1073/pnas.192460799; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Campisi J, 2003, NAT REV CANCER, V3, P339, DOI 10.1038/nrc1073; Chen LS, 2003, LANCET, V362, P440, DOI 10.1016/S0140-6736(03)14069-X; Corrigan DP, 2005, BIOCHEM J, V387, P129, DOI 10.1042/BJ20041359; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Fei PW, 2002, CANCER RES, V62, P7316; Fong LG, 2004, P NATL ACAD SCI USA, V101, P18111, DOI 10.1073/pnas.0408558102; Hutchison CJ, 2004, NAT CELL BIOL, V6, P1062, DOI 10.1038/ncb1104-1062; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Johnson BR, 2004, P NATL ACAD SCI USA, V101, P9677, DOI 10.1073/pnas.0403250101; LIU B, 2005, NAT MED, V111, P780; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Mounkes LC, 2003, NATURE, V423, P298, DOI 10.1038/nature01631; Navarro CL, 2005, HUM MOL GENET, V14, P1503, DOI 10.1093/hmg/ddi159; Pendas AM, 2002, NAT GENET, V31, P94, DOI 10.1038/ng871; Petriv OI, 2004, J BIOL CHEM, V279, P19996, DOI 10.1074/jbc.M400207200; Qiu WH, 2004, AM J PATHOL, V165, P1689, DOI 10.1016/S0002-9440(10)63425-6; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Serrano M, 2001, CURR OPIN CELL BIOL, V13, P748, DOI 10.1016/S0955-0674(00)00278-7; Sharpless NE, 2004, J CLIN INVEST, V113, P160, DOI 10.1172/JCI200420761; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wei WY, 2001, MOL CELL BIOL, V21, P6748, DOI 10.1128/MCB.21.20.6748-6757.2001; Yan T, 1999, BIOCHEM BIOPH RES CO, V257, P163, DOI 10.1006/bbrc.1999.0423; Yu J, 1999, P NATL ACAD SCI USA, V96, P14517, DOI 10.1073/pnas.96.25.14517	30	336	353	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2005	437	7058					564	568		10.1038/nature04019	http://dx.doi.org/10.1038/nature04019			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966FF	16079796				2022-12-01	WOS:000232004800053
J	Donlan, J; Berger, J; Bock, CE; Bock, JH; Burney, DA; Estes, JA; Foreman, D; Martin, PS; Roemer, GW; Smith, FA; Soule, ME; Greene, HW				Donlan, J; Berger, J; Bock, CE; Bock, JH; Burney, DA; Estes, JA; Foreman, D; Martin, PS; Roemer, GW; Smith, FA; Soule, ME; Greene, HW			Re-wilding North America	NATURE			English	Editorial Material									Cornell Univ, Dept Ecol & Evolut Biol, Ithaca, NY 14853 USA; Wildlife Conservat Soc, Teton Field Off, Bronx, NY 10460 USA; Univ Colorado, Boulder, CO 80309 USA; Fordham Univ, New York, NY 10023 USA; Univ Calif Santa Cruz, US Geol Survey, Santa Cruz, CA 95064 USA; Rewilding Inst, Albuquerque, NM USA; Univ Arizona, Dept Geosci, Tucson, AZ USA; Univ New Mexico, Albuquerque, NM 87131 USA; New Mexico State Univ, Dept Fishery & Wildlife Sci, Las Cruces, NM 88003 USA	Cornell University; Wildlife Conservation Society; University of Colorado System; University of Colorado Boulder; Fordham University; United States Department of the Interior; United States Geological Survey; University of California System; University of California Santa Cruz; University of Arizona; University of New Mexico; New Mexico State University	Donlan, J (corresponding author), Cornell Univ, Dept Ecol & Evolut Biol, Ithaca, NY 14853 USA.		Smith, Felisa/ABE-6160-2021	Smith, Felisa/0000-0001-6262-436X				Byers J.A., 1997, AM PRONGHORN SOCIAL; DUFFIELD WJ, 1996, T 61 N AM WILDL NAT, P285; JANZEN DH, 1982, SCIENCE, V215, P19, DOI 10.1126/science.215.4528.19; Lonsdale RE, 1998, J GEOGR, V97, P108, DOI 10.1080/00221349808978835; Phillips A., 2001, COGRAZING CATTLE CAM; Schmidly, 2002, TEXAS NATURAL HIST C; Tordoff HB, 2001, CONSERV BIOL, V15, P528, DOI 10.1046/j.1523-1739.2001.015002528.x	7	214	222	9	325	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 18	2005	436	7053					913	914		10.1038/436913a	http://dx.doi.org/10.1038/436913a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955XQ	16107817				2022-12-01	WOS:000231263900020
J	Tsang, KWT; Eng, P; Liam, CK; Shim, YS; Lam, WK				Tsang, KWT; Eng, P; Liam, CK; Shim, YS; Lam, WK			H5N1 influenza pandemic: contingency plans	LANCET			English	Editorial Material							ZANAMIVIR; EFFICACY; ASTHMA; SAFETY		Univ Hong Kong, Queen Mary Hosp, Univ Dept Med, Pokfulam, Hong Kong, Peoples R China; Singapore Gen Hosp, Dept Resp & Crit Care Med, Singapore, Singapore; Univ Malaya, Med Ctr, Dept Med, Kuala Lumpur, Malaysia; Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea	University of Hong Kong; Singapore General Hospital; Universiti Malaya; Seoul National University (SNU)	Tsang, KWT (corresponding author), Univ Hong Kong, Queen Mary Hosp, Univ Dept Med, Pokfulam, Hong Kong, Peoples R China.	kwttsang@hku.hk	Liam, Chong-Kin/AAC-8475-2022	Liam, Chong-Kin/0000-0002-3639-9231				Cass LMR, 1999, CLIN PHARMACOKINET, V36, P1, DOI 10.2165/00003088-199936001-00001; *GLAXOSMITHKLINE, 2000, REL DAT; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Hill LS, 1998, RESP MED, V92, P105, DOI 10.1016/S0954-6111(98)90040-3; *HOFFM LAR, 2004, TAM DAT COR DAT SHEE; Imuta F, 2003, PEDIATR INT, V45, P366, DOI 10.1046/j.1442-200X.2003.01724.x; Kirkbride H A, 2003, Commun Dis Public Health, V6, P123; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; McKimm-Breschkin Jennifer L, 2005, Treat Respir Med, V4, P107, DOI 10.2165/00151829-200504020-00004; Murphy KR, 2000, CLIN DRUG INVEST, V20, P337, DOI 10.2165/00044011-200020050-00005; Silagy C, 1998, LANCET, V352, P1877, DOI 10.1016/S0140-6736(98)10190-3; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; Tzeng HM, 2004, NURS ETHICS, V11, P277, DOI 10.1191/096733004ne695oa; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; Webby RJ, 2003, SCIENCE, V302, P1519, DOI 10.1126/science.1090350; *WHO, 2005, NAT INFL PAND PLANS; *WHO, 2005, CUM NUMB CONF HUM CA; Zeitlin Gary Adam, 2005, Curr Infect Dis Rep, V7, P193, DOI 10.1007/s11908-005-0034-9	18	16	18	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 13	2005	366	9485					533	534		10.1016/S0140-6736(05)67080-8	http://dx.doi.org/10.1016/S0140-6736(05)67080-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	955LL	16099278	Green Published, Bronze			2022-12-01	WOS:000231227300010
J	Weiner, S; Sagi, I; Addadi, L				Weiner, S; Sagi, I; Addadi, L			Choosing the crystallization path less traveled	SCIENCE			English	Editorial Material							AMORPHOUS CALCIUM-CARBONATE; RADULAR TEETH; MINERALIZATION; TRANSFORMATION; PHOSPHATE; PHASE		Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Weiner, S (corresponding author), Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel.	steve.weiner@weizmann.ac.il						Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381; Aizenberg J, 1996, ADV MATER, V8, P222, DOI 10.1002/adma.19960080307; Beniash E, 1997, P ROY SOC B-BIOL SCI, V264, P461, DOI 10.1098/rspb.1997.0066; Dillaman R, 2005, J MORPHOL, V263, P356, DOI 10.1002/jmor.10311; GLIMCHER MJ, 1984, PHILOS T R SOC B, V304, P479, DOI 10.1098/rstb.1984.0041; Li M, 2002, ADV FUNCT MATER, V12, P773, DOI 10.1002/adfm.200290006; Loste E, 2004, ADV FUNCT MATER, V14, P1211, DOI 10.1002/adfm.200400268; LOWENSTAM HA, 1985, SCIENCE, V227, P51, DOI 10.1126/science.227.4682.51; LOWENSTAM HA, 1962, GEOL SOC AM BULL, V73, P435, DOI 10.1130/0016-7606(1962)73[435:MIDCIR]2.0.CO;2; MANN S, 1985, MAGNETITE BIOMINERAL, P311, DOI DOI 10.1007/978-1-4613-0313-8_15; Marxen JC, 2003, J MOLLUS STUD, V69, P113, DOI 10.1093/mollus/69.2.113; Meibom A, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021313; Politi Y, 2004, SCIENCE, V306, P1161, DOI 10.1126/science.1102289; TOWE KM, 1967, J ULTRA MOL STRUCT R, V17, P1, DOI 10.1016/S0022-5320(67)80015-7; Weiss IM, 2002, J EXP ZOOL, V293, P478, DOI 10.1002/jez.90004	15	265	271	4	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2005	309	5737					1027	1028		10.1126/science.1114920	http://dx.doi.org/10.1126/science.1114920			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955MN	16099970				2022-12-01	WOS:000231230100030
J	Karsenty, G				Karsenty, G			An aggrecanase and osteoarthritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ADAMTS5		Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine	Karsenty, G (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.							Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417	2	21	23	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 4	2005	353	5					522	523		10.1056/NEJMcibr051399	http://dx.doi.org/10.1056/NEJMcibr051399			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951OB	16079379				2022-12-01	WOS:000230939000015
J	Park, SK; Nguyen, MD; Fischer, A; Luke, MPS; Affar, EB; Dieffenbach, PB; Tseng, HC; Shi, Y; Tsai, LH				Park, SK; Nguyen, MD; Fischer, A; Luke, MPS; Affar, EB; Dieffenbach, PB; Tseng, HC; Shi, Y; Tsai, LH			Par-4 links dopamine signaling and depression	CELL			English	Article							PROSTATE APOPTOSIS RESPONSE-4; ELEMENT-BINDING PROTEIN; NUCLEUS-ACCUMBENS; NEURONAL DEGENERATION; HUNTINGTONS-DISEASE; AFFECTIVE-DISORDERS; MAJOR DEPRESSION; MOUSE MODEL; RECEPTOR; ANTIDEPRESSANT	Prostate apoptosis response 4 (Par-4) is a leucine zipper containing protein that plays a role in apoptosis. Although Par-4 is expressed in neurons, its physiological role in the nervous system is unknown. Here we identify Par-4 as a regulatory component in dopamine signaling. Par-4 directly interacts with the dopamine D2 receptor (D2DR) via the calmodulin binding motif in the third cytoplasmic loop. Calmodulin can effectively compete with Par-4 binding in a Ca2+- dependent manner, providing a route for Ca2+-mediated downregulation of D2DR efficacy. To examine the importance of the Par-4/D2DR interaction in dopamine signaling in vivo, we used a mutant mouse lacking the D2DR interaction domain of Par-4, Par-4 Delta LZ Primary neurons from Par-4 Delta LZ embryos exhibit an enhanced dopamine-cAMP-CREB signaling pathway, indicating an impairment in dopamine signaling in these cells. Remarkably, Par-4 Delta LZ mice display significantly increased depression-like behaviors. Collectively, these results provide evidence that Par-4 constitutes a molecular link between impaired dopamine signaling and depression.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Massachusetts Institute of Technology (MIT)	Tsai, LH (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	li-huei_tsai@hms.harvard.edu		Fischer, Andre/0000-0001-8546-1161				American Psychiatric Association, 2000, DIAGNOSTIC STAT MANU, V4th ed., P345; BALDESSARINI RJ, 1989, J CLIN PSYCHIAT, V50, P117; Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Bieberich E, 2003, J CELL BIOL, V162, P469, DOI 10.1083/jcb.200212067; BLAZER DG, 1994, AM J PSYCHIAT, V151, P979; Bofill-Cardona E, 2000, J BIOL CHEM, V275, P32672, DOI 10.1074/jbc.M002780200; Bowden C, 1997, BRAIN RES, V769, P135, DOI 10.1016/S0006-8993(97)00692-6; BUNNEY WE, 1965, ARCH GEN PSYCHIAT, V13, P483; BUNZOW JR, 1988, NATURE, V336, P783, DOI 10.1038/336783a0; Burn DJ, 2002, EUR J NEUROL, V9, P44, DOI 10.1046/j.1468-1331.9.s3.6.x; Cheema SK, 2003, J BIOL CHEM, V278, P19995, DOI 10.1074/jbc.M205865200; Chen ACH, 2001, BIOL PSYCHIAT, V49, P753, DOI 10.1016/S0006-3223(00)01114-8; COPPEN ALEC, 1967, BRIT J PSYCHIAT, V113, P1237, DOI 10.1192/bjp.113.504.1237; DECAMILLI P, 1979, NATURE, V278, P252, DOI 10.1038/278252a0; DELAY J, 1952, Ann Med Psychol (Paris), V110, P689; Diaz-Meco MT, 1999, J BIOL CHEM, V274, P19606, DOI 10.1074/jbc.274.28.19606; DiazMeco MT, 1996, CELL, V86, P777, DOI 10.1016/S0092-8674(00)80152-X; Dowlatshahi D, 1998, LANCET, V352, P1754, DOI 10.1016/S0140-6736(05)79827-5; Duan WZ, 1999, ANN NEUROL, V46, P587, DOI 10.1002/1531-8249(199910)46:4<587::AID-ANA6>3.0.CO;2-M; Duan WZ, 1999, J NEUROCHEM, V72, P2312, DOI 10.1046/j.1471-4159.1999.0722312.x; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; El Yacoubi M, 2003, P NATL ACAD SCI USA, V100, P6227, DOI 10.1073/pnas.1034823100; FISHBURN CS, 1995, J BIOL CHEM, V270, P29819; Fuller R W, 1995, Prog Drug Res, V45, P167; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; GREENBERG PE, 1993, J CLIN PSYCHIAT, V54, P405; Guo Q, 1998, NAT MED, V4, P957, DOI 10.1038/nm0898-957; HERSCH SM, 1995, J NEUROSCI, V15, P5222; JARVIE KR, 1989, J BIOCHEM-TOKYO, V106, P17, DOI 10.1093/oxfordjournals.jbchem.a122809; Johnstone RW, 1996, MOL CELL BIOL, V16, P6945; Jones SR, 1998, J NEUROSCI, V18, P1979; KINNEY JL, 1985, CLIN PHARMACY, V4, P625; KUHN R, 1958, AM J PSYCHIAT, V115, P459, DOI 10.1176/ajp.115.5.459; Leonard B E, 1978, Acta Psychiatr Belg, V78, P770; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Maj J, 1996, EUR J PHARMACOL, V304, P49, DOI 10.1016/0014-2999(96)00123-9; Manier DH, 2002, J NEURAL TRANSM, V109, P91, DOI 10.1007/s702-002-8239-6; Manji HK, 2001, NAT MED, V7, P541, DOI 10.1038/87865; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Murer MG, 2002, CELL MOL NEUROBIOL, V22, P611, DOI 10.1023/A:1021840504342; Nader K, 1997, ANNU REV PSYCHOL, V48, P85, DOI 10.1146/annurev.psych.48.1.85; Nestler EJ, 2001, AM J ADDICTION, V10, P201, DOI 10.1080/105504901750532094; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Newton SS, 2002, J NEUROSCI, V22, P10883; Ona VO, 1999, NATURE, V399, P263, DOI 10.1038/20446; Ouimet CC, 1998, BRAIN RES, V808, P8, DOI 10.1016/S0006-8993(98)00724-0; Pedersen WA, 2000, FASEB J, V14, P913, DOI 10.1096/fasebj.14.7.913; Pliakas AM, 2001, J NEUROSCI, V21, P7397, DOI 10.1523/JNEUROSCI.21-18-07397.2001; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; SCHILDKRAUT JJ, 1965, J PSYCHIAT RES, V3, P213, DOI 10.1016/0022-3956(65)90003-8; Scott L, 2002, P NATL ACAD SCI USA, V99, P1661, DOI 10.1073/pnas.032654599; SELLS SF, 1994, CELL GROWTH DIFFER, V5, P457; SOKOLOFF P, 1992, EUR J PHARM-MOLEC PH, V225, P331, DOI 10.1016/0922-4106(92)90107-7; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Viggiano D, 2003, NEUROSCI BIOBEHAV R, V27, P623, DOI 10.1016/j.neubiorev.2003.08.006; Willner Paul, 1995, P921; Wong ML, 2001, NAT REV NEUROSCI, V2, P343, DOI 10.1038/35072566	60	104	115	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 29	2005	122	2					275	287		10.1016/j.cell.2005.05.031	http://dx.doi.org/10.1016/j.cell.2005.05.031			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	951CR	16051151	Bronze			2022-12-01	WOS:000230907000014
J	Padma, TV				Padma, TV			Ayurveda	NATURE			English	Article																			0	29	29	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 28	2005	436	7050					486	486		10.1038/436486a	http://dx.doi.org/10.1038/436486a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049472				2022-12-01	WOS:000230788800041
J	Dodd, AN; Salathia, N; Hall, A; Kevei, E; Toth, R; Nagy, F; Hibberd, JM; Millar, AJ; Webb, AAR				Dodd, AN; Salathia, N; Hall, A; Kevei, E; Toth, R; Nagy, F; Hibberd, JM; Millar, AJ; Webb, AAR			Plant circadian clocks increase photosynthesis, growth, survival, and competitive advantage	SCIENCE			English	Article							RECIPROCAL REGULATION; STOMATAL CONDUCTANCE; ELEVATED CO2; ARABIDOPSIS; TRANSCRIPTION; RHYTHMS; FITNESS; OSCILLATIONS; ASSIMILATION; RESPONSES	Circadian clocks are believed to confer an advantage to plants, but the nature of that advantage has been unknown. We show that a substantial photosynthetic advantage is conferred by correct matching of the circadian clock period with that of the external tight-dark cycle. In wild type and in long- and short-circadian period mutants of Arabidopsis thaliana, plants with a clock period matched to the environment contain more chlorophyll, fix more carbon, grow faster, and survive better than plants with circadian periods differing from their environment. This explains why plants gain advantage from circadian control.	Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England; Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; Hungarian Acad Sci, Biol Res Ctr, Inst Plant Biol, H-6701 Szeged, Hungary	University of Cambridge; University of Warwick; Hungarian Academy of Sciences; Hungarian Biological Research Center	Webb, AAR (corresponding author), Univ Cambridge, Dept Plant Sci, Downing St, Cambridge CB2 3EA, England.	alex.webb@plantsci.cam.ac.uk	Nagy, Ferenc/D-3532-2015; Jansen, Heiko T./A-5770-2008; Hall, Anthony/D-2844-2009; Kevei, Eva/J-4828-2016; Millar, Andrew J/G-2423-2012	Nagy, Ferenc/0000-0002-6157-9269; Jansen, Heiko T./0000-0003-0178-396X; Hall, Anthony/0000-0002-1806-020X; Kevei, Eva/0000-0002-0560-9208; Millar, Andrew J/0000-0003-1756-3654; Toth, Reka/0000-0003-4099-5359; Webb, Alex/0000-0003-0261-4375; Salathia, Neeraj/0000-0002-1235-2439	Biotechnology and Biological Sciences Research Council [P19207] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Arntz AM, 2000, ECOLOGY, V81, P2567, DOI 10.1890/0012-9658(2000)081[2567:FFTFVI]2.0.CO;2; Curtis PS, 1998, OECOLOGIA, V113, P299, DOI 10.1007/s004420050381; Dodd AN, 2004, NEW PHYTOL, V162, P63, DOI 10.1111/j.1469-8137.2004.01005.x; Green RM, 2002, PLANT PHYSIOL, V129, P576, DOI 10.1104/pp.004374; Griffiths H, 1999, PHYSIOLOGICAL PLANT ECOLOGY, P415; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hayama R, 2003, CURR OPIN PLANT BIOL, V6, P13, DOI 10.1016/S1369-5266(02)00011-0; HENNESSEY TL, 1991, PLANT PHYSIOL, V96, P831, DOI 10.1104/pp.96.3.831; HIGHKIN HR, 1954, PLANT PHYSIOL, V29, P301, DOI 10.1104/pp.29.3.301; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Michael TP, 2003, SCIENCE, V302, P1049, DOI 10.1126/science.1082971; Millar, 1998, BIOL RHYTHMS PHOTOPE, P1; MILLAR AJ, 1995, SCIENCE, V267, P1161, DOI 10.1126/science.7855595; MitchellOlds T, 1996, EVOLUTION, V50, P140, DOI 10.1111/j.1558-5646.1996.tb04480.x; Plautz JD, 1997, J BIOL RHYTHM, V12, P204, DOI 10.1177/074873049701200302; Prombona A, 2004, PLANT SCI, V167, P117, DOI 10.1016/j.plantsci.2004.03.006; Roden LC, 2002, P NATL ACAD SCI USA, V99, P13313, DOI 10.1073/pnas.192365599; SALATHIA N, UNPUB; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; Somers DE, 2004, PLANT CELL, V16, P769, DOI 10.1105/tpc.016808; Somers DE, 1998, DEVELOPMENT, V125, P485; Wang ZY, 1997, PLANT CELL, V9, P491, DOI 10.1105/tpc.9.4.491; Ward JK, 2004, ECOL LETT, V7, P427, DOI 10.1111/j.1461-0248.2004.00589.x; WITHROW AP, 1949, PLANT PHYSIOL, V24, P657, DOI 10.1104/pp.24.4.657; Woelfle MA, 2004, CURR BIOL, V14, P1481, DOI 10.1016/j.cub.2004.08.023; Yan OY, 1998, P NATL ACAD SCI USA, V95, P8660, DOI 10.1073/pnas.95.15.8660; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996; Yanovsky MJ, 2001, CURR OPIN PLANT BIOL, V4, P429, DOI 10.1016/S1369-5266(00)00196-5; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	30	993	1046	9	357	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2005	309	5734					630	633		10.1126/science.1115581	http://dx.doi.org/10.1126/science.1115581			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SE	16040710				2022-12-01	WOS:000230735200054
J	Ash, C; Jasny, BR				Ash, C; Jasny, BR			Trypanosomatid genomes - Introduction	SCIENCE			English	Editorial Material																			0	10	11	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 15	2005	309	5733					399	400		10.1126/science.309.5733.399	http://dx.doi.org/10.1126/science.309.5733.399			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946LY	16020722				2022-12-01	WOS:000230574900032
J	Ozaki, M; Wada-Katsumata, A; Fujikawa, K; Iwasaki, M; Yokohari, F; Satoji, Y; Nisimura, T; Yamaoka, R				Ozaki, M; Wada-Katsumata, A; Fujikawa, K; Iwasaki, M; Yokohari, F; Satoji, Y; Nisimura, T; Yamaoka, R			Ant nestmate and non-nestmate discrimination by a chemosensory sensillum	SCIENCE			English	Article							KIN RECOGNITION; HYMENOPTERA; INSECTS; ODOR	In animal societies, chemical communication plays an important role in conflict and cooperation. For ants, cuticular hydrocarbon (CHC) blends produced by non-nestmates elicit overt aggression. We describe a sensory sensillum on the antennae of the carpenter ant Camponotus japonicus that functions in nestmate discrimination. This sensillum is multiporous and responds only to non-nestmate CHC blends. This suggests a role for a peripheral recognition mechanism in detecting colony-specific chemical signals.	Kyoto Inst Technol, Fac Text Sci, Dept Appl Biol, Sakyo Ku, Kyoto 6068585, Japan; Fukuoka Univ, Fac Sci, Dept Earth Syst Sci, Fukuoka 8140180, Japan	Kyoto Institute of Technology; Fukuoka University	Ozaki, M (corresponding author), Kyoto Inst Technol, Fac Text Sci, Dept Appl Biol, Sakyo Ku, Kyoto 6068585, Japan.	mamiko@kit.ac.jp		Wada-Katsumata, Ayako/0000-0002-2895-1102				Breed M.D., 1987, P243; CROZIER RH, 1979, BEHAV ECOL SOCIOBIOL, V4, P217, DOI 10.1007/BF00297645; GETZ WM, 1987, INT J NEUROSCI, V32, P963, DOI 10.3109/00207458709043353; GETZ WM, 1994, BEHAV NEURAL BIOL, V61, P191, DOI 10.1016/S0163-1047(05)80075-5; GETZ WM, 1982, J THEOR BIOL, V99, P585, DOI 10.1016/0022-5193(82)90212-0; Holldobler B., 1980, Evolution of social behaviour: hypotheses and empirical tests, P35; HOWARD RW, 1993, INSECT LIPIDS: CHEMISTRY, BIOCHEMISTRY AND BIOLOGY, P179; Isidoro N, 2001, MICROSC RES TECHNIQ, V55, P350, DOI 10.1002/jemt.1183; LACY RC, 1983, AM NAT, V121, P489, DOI 10.1086/284078; Lahav S, 1999, NATURWISSENSCHAFTEN, V86, P246, DOI 10.1007/s001140050609; OBIN MS, 1989, ANIM BEHAV, V38, P430, DOI 10.1016/S0003-3472(89)80036-3; Tegoni M, 2004, TRENDS BIOCHEM SCI, V29, P257, DOI 10.1016/j.tibs.2004.03.003; Vander Meer Robert K., 1998, P79; VANDERMEER RK, 1989, J CHEM ECOL, V15, P2115, DOI 10.1007/BF01207442; Wilson E.O., 1971, INSECT SOC; YAMAOKA R, 1990, PHYSL ECOL JPN, V27, P3152	16	305	330	3	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2005	309	5732					311	314		10.1126/science.1105244	http://dx.doi.org/10.1126/science.1105244			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944SP	15947139				2022-12-01	WOS:000230449800049
J	Gourine, AV; Llaudet, E; Dale, N; Spyer, KM				Gourine, AV; Llaudet, E; Dale, N; Spyer, KM			ATP is a mediator of chemosensory transduction in the central nervous system	NATURE			English	Article							P2X(2) RECEPTOR SUBUNIT; RESPIRATORY CONTROL; SENSORY NEURONS; PAIN; MICE; RELEASE; RAT	Extracellular signalling by the purine nucleotide ATP has long been associated with sensory function(1-8). In the periphery, ATP mediates nociception(3-5), mechanosensitivity(3,6), thermal sensitivity(7) and O-2 chemosensitivity(8). These processes share a common mechanism that involves the release of ATP to excite afferent fibres via activation of ionotropic P2X and/or metabotropic P2Y receptors. Chemosensors located in the brainstem are crucial for the maintenance of physiological levels of blood gases through the regulation of breathing(9-11). Here we show that an increase in p(CO 2) in the arterial blood triggers the immediate release of ATP from three chemosensitive regions located on the ventral surface of the medulla oblongata. Blockade of ATP receptors at these sites diminishes the chemosensory control of breathing, suggesting that ATP release constitutes a key step in central chemosensory transduction. These new data suggest that ATP, a phylogenetically ancient, unique and simple molecule, has been widely used in the evolution of afferent systems to mediate distinct forms of sensory transduction not only in the periphery but also within the central nervous system.	UCL Royal Free & UCL Med Sch, Dept Physiol, London NW3 2PF, England; Univ Warwick, Dept Biol Sci, Warwick Biosensor Grp, Coventry CV4 7AL, W Midlands, England	University of London; University College London; University of Warwick	Gourine, AV (corresponding author), UCL Royal Free & UCL Med Sch, Dept Physiol, Rowland Hill St, London NW3 2PF, England.	a.gourine@medsch.ucl.ac.uk	Dale, Nicholas/C-7772-2011	Dale, Nicholas/0000-0003-2196-2949; Llaudet, Enrique/0000-0003-1136-0602	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		CHEN CC, 1995, NATURE, V377, P428, DOI 10.1038/377428a0; Cockayne DA, 2000, NATURE, V407, P1011, DOI 10.1038/35039519; Cook SP, 2002, PAIN, V95, P41, DOI 10.1016/S0304-3959(01)00372-4; Cook SP, 1997, NATURE, V387, P505, DOI 10.1038/387505a0; Feldman JL, 2003, ANNU REV NEUROSCI, V26, P239, DOI 10.1146/annurev.neuro.26.041002.131103; Gourine AV, 2003, J PHYSIOL-LONDON, V552, P197, DOI 10.1113/jphysiol.2003.045294; Kawai A, 1996, J PHYSIOL-LONDON, V492, P277, DOI 10.1113/jphysiol.1996.sp021308; LEWIS C, 1995, NATURE, V377, P432, DOI 10.1038/377432a0; Llaudet E, 2005, ANAL CHEM, V77, P3267, DOI 10.1021/ac048106q; Llaudet E, 2003, BIOSENS BIOELECTRON, V18, P43, DOI 10.1016/S0956-5663(02)00106-9; LOESCHCKE HH, 1982, J PHYSIOL-LONDON, V332, P1; Mulkey DK, 2004, NAT NEUROSCI, V7, P1360, DOI 10.1038/nn1357; Richter DW, 2001, TRENDS NEUROSCI, V24, P464, DOI 10.1016/S0166-2236(00)01867-1; Souslova V, 2000, NATURE, V407, P1015, DOI 10.1038/35039526; Vlaskovska M, 2001, J NEUROSCI, V21, P5670, DOI 10.1523/JNEUROSCI.21-15-05670.2001	16	399	404	3	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2005	436	7047					108	111		10.1038/nature03690	http://dx.doi.org/10.1038/nature03690			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942QJ	16001070				2022-12-01	WOS:000230296600048
J	Hersch, GL; Burton, RE; Bolon, DN; Baker, TA; Sauer, RT				Hersch, GL; Burton, RE; Bolon, DN; Baker, TA; Sauer, RT			Asymmetric interactions of ATP with the AAA+ ClpX(6) unfoldase: Allosteric control of a protein machine	CELL			English	Article							MOLECULAR CHAPERONE; CRYSTAL-STRUCTURE; DEPENDENT PROTEOLYSIS; DEGRADATION MACHINE; HYDROLYSIS; BINDING; DNA; MECHANISM; HELICASE; HEXAMER	ATP hydrolysis by AAA+ ClpX hexamers powers protein unfolding and translocation during ClpXP degradation. Although ClpX is a homohexamer, positive and negative allosteric interactions partition six potential nucleotide binding sites into three classes with asymmetric properties. Some sites release ATP rapidly, others release ATP slowly, and at least two sites remain nucleotide free. Recognition of the degradation tag of protein substrates requires ATP binding to one set of sites and ATP or ADP binding to a second set of sites, suggesting a mechanism that allows repeated unfolding attempts without substrate release over multiple ATPase cycles. Our results rule out concerted hydrolysis models involving ClPX6 center dot ATP(6) or ClPX6 center dot ADP(6) and highlight structures of hexameric AAA+ machines with three or four nucleotides as likely functional states. These studies further emphasize commonalities between distant AAA+ family members, including protein and DNA translocases, helicases, motor proteins, clamp loaders, and other ATP-dependent enzymes.	MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Sauer, RT (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	bobsauer@mit.edu		Bolon, Daniel/0000-0001-5857-6676; Sauer, Robert/0000-0002-1719-5399	NIAID NIH HHS [AI-15706] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015706, R37AI015706] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Bolon DN, 2004, MOL CELL, V16, P343, DOI 10.1016/j.molcel.2004.10.001; Bolon DN, 2004, MOL CELL, V13, P443, DOI 10.1016/S1097-2765(04)00027-9; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Burton RE, 2005, NAT STRUCT MOL BIOL, V12, P245, DOI 10.1038/nsmb898; Burton RE, 2003, PROTEIN SCI, V12, P893, DOI 10.1110/ps.0237603; Burton RE, 2001, EMBO J, V20, P3092, DOI 10.1093/emboj/20.12.3092; Flynn JM, 2001, P NATL ACAD SCI USA, V98, P10584, DOI 10.1073/pnas.191375298; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Glover JR, 2001, BIOCHEM CELL BIOL, V79, P557, DOI 10.1139/bcb-79-5-557; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Guo FS, 2002, J BIOL CHEM, V277, P46743, DOI 10.1074/jbc.M207796200; Hishida T, 2004, P NATL ACAD SCI USA, V101, P9573, DOI 10.1073/pnas.0403584101; Jeong YJ, 2002, J BIOL CHEM, V277, P43778, DOI 10.1074/jbc.M208634200; Jeruzalmi D, 2001, CELL, V106, P417, DOI 10.1016/S0092-8674(01)00462-7; Joshi SA, 2004, NAT STRUCT MOL BIOL, V11, P404, DOI 10.1038/nsmb752; Kenniston JA, 2005, P NATL ACAD SCI USA, V102, P1390, DOI 10.1073/pnas.0409634102; Kenniston JA, 2004, J STRUCT BIOL, V146, P130, DOI 10.1016/j.jsb.2003.10.023; Kim DY, 2003, J BIOL CHEM, V278, P50664, DOI 10.1074/jbc.M305882200; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; Kon T, 2004, BIOCHEMISTRY-US, V43, P11266, DOI 10.1021/bi048985a; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Marrione PE, 1996, BIOCHEMISTRY-US, V35, P11228, DOI 10.1021/bi960316c; MARRIONE PE, 1995, BIOCHEMISTRY-US, V34, P9809, DOI 10.1021/bi00030a019; Orelle C, 2003, J BIOL CHEM, V278, P47002, DOI 10.1074/jbc.M308268200; Ortega J, 2000, MOL CELL, V6, P1515, DOI 10.1016/S1097-2765(00)00148-9; PATEL SS, 1995, BIOPHYS J, V68, pS186; Piszczek G, 2005, J BIOL CHEM, V280, P12221, DOI 10.1074/jbc.M411733200; Putnam CD, 2001, J MOL BIOL, V311, P297, DOI 10.1006/jmbi.2001.4852; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Schwacha A, 2001, MOL CELL, V8, P1093, DOI 10.1016/S1097-2765(01)00389-6; Segel IH, 1976, BIOCH CALCULATIONS; Siddiqui SM, 2004, GENE DEV, V18, P369, DOI 10.1101/gad.1170304; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Sousa MC, 2000, CELL, V103, P633, DOI 10.1016/S0092-8674(00)00166-5; Stitt BL, 2001, BIOCHEMISTRY-US, V40, P2276, DOI 10.1021/bi002253a; STITT BL, 1988, J BIOL CHEM, V263, P11130; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; Wah DA, 2002, CHEM BIOL, V9, P1237, DOI 10.1016/S1074-5521(02)00268-5; Wang J, 2001, STRUCTURE, V9, P177, DOI 10.1016/S0969-2126(01)00570-6; Wang J, 2001, STRUCTURE, V9, P1107, DOI 10.1016/S0969-2126(01)00670-0; Wang JM, 1997, CELL, V91, P447, DOI 10.1016/S0092-8674(00)80431-6; Zalk R, 2003, BIOCHEM J, V374, P473, DOI 10.1042/BJ20030219	44	133	133	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 1	2005	121	7					1017	1027		10.1016/j.cell.2005.05.024	http://dx.doi.org/10.1016/j.cell.2005.05.024			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	944RZ	15989952	Bronze			2022-12-01	WOS:000230448000009
J	Maione, D; Margarit, I; Rinaudo, CD; Masignani, V; Mora, M; Scarselli, M; Tettelin, H; Brettoni, C; Iacobini, ET; Rosini, R; D'Agostino, N; Miorin, L; Buccato, S; Mariani, M; Galli, G; Nogarotto, R; Nardi-Dei, V; Vegni, F; Fraser, C; Mancuso, G; Teti, G; Madoff, LC; Paoletti, LC; Rappuoli, R; Kasper, DL; Telford, JL; Grandi, G				Maione, D; Margarit, I; Rinaudo, CD; Masignani, V; Mora, M; Scarselli, M; Tettelin, H; Brettoni, C; Iacobini, ET; Rosini, R; D'Agostino, N; Miorin, L; Buccato, S; Mariani, M; Galli, G; Nogarotto, R; Nardi-Dei, V; Vegni, F; Fraser, C; Mancuso, G; Teti, G; Madoff, LC; Paoletti, LC; Rappuoli, R; Kasper, DL; Telford, JL; Grandi, G			Identification of a universal group B Streptococcus vaccine by multiple genome screen	SCIENCE			English	Article							PROTECTIVE IMMUNITY; INFECTIONS; ANTIBODY; PROTEIN; IMMUNIZATION; PATHOGEN; SEQUENCE; WOMEN	Group B Streptococcus (CBS) is a multiserotype bacterial pathogen representing a major cause of life-threatening infections in newborns. To develop a broadly protective vaccine, we analyzed the genome sequences of eight GBS isolates and cloned and tested 312 surface proteins as vaccines. Four proteins elicited protection in mice, and their combination proved highly protective against a large panel of strains, including all circulating serotypes. Protection also correlated with antigen accessibility on the bacterial surface and with the induction of opsonophagocytic antibodies. Multigenome analysis and screening described here represent a powerful strategy for identifying potential vaccine candidates against highly variable pathogens.	Chiron Srl, I-53100 Siena, Italy; Inst Genome Res, Rockville, MD 20850 USA; Univ Messina, Sch Med, Dept Pathol & Expt Microbiol, I-98125 Messina, Italy; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Channing Lab, Boston, MA 02125 USA	Novartis; J. Craig Venter Institute; University of Messina; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Grandi, G (corresponding author), Chiron Srl, Via Fiorentina 1, I-53100 Siena, Italy.	guido_grandi@chiron.com	D'Agostino, Nunzio/A-6071-2017; Telford, John Laird/ABG-8144-2020	D'Agostino, Nunzio/0000-0001-9840-3817; Mancuso, Giuseppe/0000-0001-5454-3228; Fraser, Claire/0000-0003-1462-2428; Grandi, Guido/0000-0001-9724-2185	NIAID NIH HHS [U01 AI060603, AI-060603] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI060603] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAKER CJ, 1988, NEW ENGL J MED, V319, P1180, DOI 10.1056/NEJM198811033191802; BAKER CJ, 1976, NEW ENGL J MED, V294, P753, DOI 10.1056/NEJM197604012941404; Brodeur BR, 2000, INFECT IMMUN, V68, P5610, DOI 10.1128/IAI.68.10.5610-5618.2000; Cheng Q, 2001, INFECT IMMUN, V69, P2302, DOI 10.1128/IAI.69.4.2302-2308.2001; Gibbs RS, 2004, OBSTET GYNECOL, V104, P1062, DOI 10.1097/01.AOG.0000144128.03913.c2; Jones N, 2003, J CLIN MICROBIOL, V41, P2530, DOI 10.1128/JCM.41.6.2530-2536.2003; Lachenauer CS, 1999, J INFECT DIS, V179, P1030, DOI 10.1086/314666; Lauer P, 2005, SCIENCE, V309, P105, DOI 10.1126/science.1111563; Lin FYC, 2004, J INFECT DIS, V190, P928, DOI 10.1086/422756; MADOFF LC, 1992, INFECT IMMUN, V60, P4989, DOI 10.1128/IAI.60.12.4989-4994.1992; Paoletti Lawrence C, 2002, Semin Neonatol, V7, P315, DOI 10.1053/siny.2002.0114; Paoletti LC, 2003, EXPERT OPIN BIOL TH, V3, P975, DOI 10.1517/14712598.3.6.975; Paoletti LC, 2001, VACCINE, V19, P2118, DOI 10.1016/S0264-410X(00)00437-0; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; SCHNEEWIND O, 1993, EMBO J, V12, P4803, DOI 10.1002/j.1460-2075.1993.tb06169.x; Schuchat A, 1999, LANCET, V353, P51, DOI 10.1016/S0140-6736(98)07128-1; STALHAMMARCARLEMALM M, 1993, J EXP MED, V177, P1593, DOI 10.1084/jem.177.6.1593; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.182380799	18	410	475	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 1	2005	309	5731					148	150		10.1126/science.1109869	http://dx.doi.org/10.1126/science.1109869			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	941KD	15994562	Green Accepted			2022-12-01	WOS:000230212800081
J	Jacobson, MZ; Colella, WG; Golden, DM				Jacobson, MZ; Colella, WG; Golden, DM			Cleaning the air and improving health with hydrogen fuel-cell vehicles	SCIENCE			English	Article							GATOR-GCMM; POLLUTION; ECONOMY; US; STRATOSPHERE; TROPOSPHERE; WEATHER; BUDGET; IMPACT; OZONE	Converting all U.S. onroad vehicles to hydrogen fuel-cell vehicles (HFCVs) may improve air quality, health, and climate significantly, whether the hydrogen is produced by steam reforming of natural gas, wind electrolysis, or coal gasification. Most benefits would result from eliminating current vehicle exhaust. Wind and natural gas HFCVs offer the greatest potential health benefits and could save 3700 to 6400 U.S. lives annually. Wind HFCVs should benefit climate most. An all-HFCV fleet would hardly affect tropospheric water vapor concentrations. Conversion to coal HFCVs may improve health but would damage climate more than fossil/electric hybrids. The real cost of hydrogen from wind electrolysis may be below that of U.S. gasoline.	Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA; Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA	Stanford University; Stanford University	Jacobson, MZ (corresponding author), Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA.	jacobson@stanford.edu		Jacobson, Mark/0000-0002-4315-4128				Archer CL, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002076; BOLINGER M, SUMMARY POWER AUTHOR; COLELLA WC, IN PRESS J POWER SOU; Delucchi MA, 2000, J TRANSP ECON POLICY, V34, P135; Demirdoven N, 2004, SCIENCE, V305, P974, DOI 10.1126/science.1093965; Derwent RG, 2001, CLIMATIC CHANGE, V49, P463, DOI 10.1023/A:1010648913655; Heywood JB, 2018, INTERNAL COMBUSTION, Vsecond; Jacobson MZ, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004945; Jacobson MZ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018448; Jacobson MZ, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD002044; Jacobson MZ, 2001, J GEOPHYS RES-ATMOS, V106, P5385, DOI 10.1029/2000JD900560; Jacobson MZ, 2001, J GEOPHYS RES-ATMOS, V106, P5403, DOI 10.1029/2000JD900559; Jacobson MZ, 2001, SCIENCE, V293, P1438, DOI 10.1126/science.1063376; LEE K, 2004, WORLD REN EN C, V8; McCubbin DR, 1999, J TRANSP ECON POLICY, V33, P253; Myers DB, 2003, HYDROGEN RENEWABLE E; National Academy of Science, 2004, HYDR EC OPP COSTS BA; Novelli PC, 1999, J GEOPHYS RES-ATMOS, V104, P30427, DOI 10.1029/1999JD900788; *NREL, 2004, FS56036705 NREL; Rahn T, 2003, NATURE, V424, P918, DOI 10.1038/nature01917; Schultz MG, 2003, SCIENCE, V302, P624, DOI 10.1126/science.1089527; Service RF, 2004, SCIENCE, V305, P958, DOI 10.1126/science.305.5686.958; Tromp TK, 2003, SCIENCE, V300, P1740, DOI 10.1126/science.1085169; Turner JA, 2004, SCIENCE, V305, P972, DOI 10.1126/science.1103197; *US EPA, 2003, CLEAR INV EM FACT; Warwick NJ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019224; 1998, EXTERNE EXTERNALITIE, V7	27	738	751	13	424	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2005	308	5730					1901	1905		10.1126/science.1109157	http://dx.doi.org/10.1126/science.1109157			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940BZ	15976300				2022-12-01	WOS:000230120000038
J	Baba, D; Maita, N; Jee, JG; Uchimura, Y; Saitoh, H; Sugasawa, K; Hanaoka, F; Tochio, H; Hiroaki, H; Shirakawa, M				Baba, D; Maita, N; Jee, JG; Uchimura, Y; Saitoh, H; Sugasawa, K; Hanaoka, F; Tochio, H; Hiroaki, H; Shirakawa, M			Crystal structure of thymine DNA glycosylase conjugated to SUMO-1	NATURE			English	Article							UBIQUITIN; RECOGNITION; PROTEINS; NUCLEAR; COMPLEX	Members of the small ubiquitin-like modifier ( SUMO) family can be covalently attached to the lysine residue of a target protein through an enzymatic pathway similar to that used in ubiquitin conjugation(1), and are involved in various cellular events that do not rely on degradative signalling via the proteasome or lysosome(2-5). However, little is known about the molecular mechanisms of SUMO-modification-induced protein functional transfer. During DNA mismatch repair, SUMO conjugation of the uracil/ thymine DNA glycosylase TDG promotes the release of TDG from the abasic (AP) site created after base excision, and coordinates its transfer to AP endonuclease 1, which catalyses the next step in the repair pathway(6). Here we report the crystal structure of the central region of human TDG conjugated to SUMO-1 at 2.1 angstrom resolution. The structure reveals a helix protruding from the protein surface, which presumably interferes with the product DNA and thus promotes the dissociation of TDG from the DNA molecule. This helix is formed by covalent and non-covalent contacts between TDG and SUMO-1. The non-covalent contacts are also essential for release from the product DNA, as verified by mutagenesis.	Yokohama City Univ, Grad Sch Integrated Sci, Yokohama, Kanagawa 2300045, Japan; Japan Biol Informat Consortium, Tokyo 1040032, Japan; RIKEN Genom Sci Ctr, Kanagawa 2300045, Japan; Kumamoto Univ, Inst Mol Embryol & Genet, Dept Regenerat Med, Kumamoto 8600811, Japan; RIKEN, Discovery Res Inst, Cellular Physiol Lab, Wako, Saitama 3510198, Japan; Japan Sci & Technol Univ, SORST, Kawaguchi, Saitama 3320012, Japan; Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; Kyoto Univ, Grad Sch Engn, Kyoto 6158510, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi, Saitama 3320012, Japan	Yokohama City University; RIKEN; Kumamoto University; RIKEN; Japan Science & Technology Agency (JST); Osaka University; Kyoto University; Japan Science & Technology Agency (JST)	Shirakawa, M (corresponding author), Yokohama City Univ, Grad Sch Integrated Sci, Yokohama, Kanagawa 2300045, Japan.	shirakawa@moleng.kyoto-u.ac.jp	HIROAKI, HIDEKAZU/N-1658-2019; Hiroaki, Hidekazu/G-9564-2012; Maita, Nobuo/J-1443-2012; Tochio, Hidehito/F-6109-2011	HIROAKI, HIDEKAZU/0000-0003-1621-5893; Maita, Nobuo/0000-0003-2260-5783; Tochio, Hidehito/0000-0003-3843-3330				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barrett TE, 1999, EMBO J, V18, P6599, DOI 10.1093/emboj/18.23.6599; Barrett TE, 1998, CELL, V92, P117, DOI 10.1016/S0092-8674(00)80904-6; Bayer P, 1998, J MOL BIOL, V280, P275, DOI 10.1006/jmbi.1998.1839; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Hardeland U, 2000, J BIOL CHEM, V275, P33449, DOI 10.1074/jbc.M005095200; Hardeland U, 2002, EMBO J, V21, P1456, DOI 10.1093/emboj/21.6.1456; Hardeland U, 2001, PROG NUCLEIC ACID RE, V68, P235; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim KI, 2002, J CELL PHYSIOL, V191, P257, DOI 10.1002/jcp.10100; Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; MOL CD, 1995, CELL, V80, P869, DOI 10.1016/0092-8674(95)90290-2; MOL CD, 1995, CELL, V82, P701, DOI 10.1016/0092-8674(95)90467-0; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; ROBERTS RJ, 1995, CELL, V82, P9, DOI 10.1016/0092-8674(95)90046-2; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Uchimura Y, 2004, ANAL BIOCHEM, V331, P204, DOI 10.1016/j.ab.2004.04.034; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Waters TR, 1998, J BIOL CHEM, V273, P20007, DOI 10.1074/jbc.273.32.20007; Waters TR, 1999, J BIOL CHEM, V274, P67, DOI 10.1074/jbc.274.1.67	25	177	187	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2005	435	7044					979	982		10.1038/nature03634	http://dx.doi.org/10.1038/nature03634			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935RN	15959518				2022-12-01	WOS:000229799700054
J	van Es, JH; van Gijn, ME; Riccio, O; van den Born, M; Vooijs, M; Begthel, H; Cozijnsen, M; Robine, S; Winton, DJ; Radtke, F; Clevers, H				van Es, JH; van Gijn, ME; Riccio, O; van den Born, M; Vooijs, M; Begthel, H; Cozijnsen, M; Robine, S; Winton, DJ; Radtke, F; Clevers, H			Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells	NATURE			English	Article							COLORECTAL-CANCER; NOTCH; RECOMBINATION; COMMITMENT; EXPRESSION; ENHANCER; COMPLEX; SPLIT; DELTA; FATE	The self-renewing epithelium of the small intestine is ordered into stem/progenitor crypt compartments and differentiated villus compartments. Recent evidence indicates that the Wnt cascade is the dominant force in controlling cell fate along the crypt-villus axis(1). Here we show a rapid, massive conversion of proliferative crypt cells into post-mitotic goblet cells after conditional removal of the common Notch pathway transcription factor CSL/RBP-J (ref. 2). We obtained a similar phenotype by blocking the Notch cascade with a gamma-secretase inhibitor. The inhibitor also induced goblet cell differentiation in adenomas in mice carrying a mutation of the Apc tumour suppressor gene. Thus, maintenance of undifferentiated, proliferative cells in crypts and adenomas requires the concerted activation of the Notch and Wnt cascades. Our data indicate that gamma-secretase inhibitors, developed for Alzheimer's disease, might be of therapeutic benefit in colorectal neoplastic disease.	Netherlands Inst Dev Biol, Hubrecht Lab, NL-3584 CT Utrecht, Netherlands; Ludwig Inst Canc Res, CH-1066 Epalinges, Switzerland; Inst Curie, CNRS, UMR 144, F-75248 Paris, France; Addenbrookes Hosp, Cambridge Inst Med Res, Canc Res UK Dept Oncol, Cambridge CB2 2XY, England	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Ludwig Institute for Cancer Research; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Universite Paris Cite; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; Cancer Research UK; University of Cambridge	Clevers, H (corresponding author), Netherlands Inst Dev Biol, Hubrecht Lab, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	clevers@niob.knaw.nl	Vooijs, Marc/K-3522-2019; van+Es, Johan/ABD-5411-2021; Radtke, Freddy/Q-3198-2017	Radtke, Freddy/0000-0003-4315-4045				Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Baron M, 2003, SEMIN CELL DEV BIOL, V14, P113, DOI 10.1016/S1084-9521(02)00179-9; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Citron M, 2004, NAT REV NEUROSCI, V5, P677, DOI 10.1038/nrn1495; Crosnier C, 2005, DEVELOPMENT, V132, P1093, DOI 10.1242/dev.01644; DE SB, 1999, NATURE, V398, P518; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Heitzler P, 1996, DEVELOPMENT, V122, P161; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Kopan R, 2000, GENE DEV, V14, P2799, DOI 10.1101/gad.836900; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Moorman AFM, 2001, J HISTOCHEM CYTOCHEM, V49, P1, DOI 10.1177/002215540104900101; OELLERS N, 1994, MOL GEN GENET, V244, P465, DOI 10.1007/BF00583897; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Sander GR, 2004, J HISTOCHEM CYTOCHEM, V52, P509, DOI 10.1177/002215540405200409; Schroeder Natalia, 2002, Gene Expression Patterns, V2, P247, DOI 10.1016/S1567-133X(02)00060-1; Searfoss GH, 2003, J BIOL CHEM, V278, P46107, DOI 10.1074/jbc.M307757200; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Zheng JL, 2000, DEVELOPMENT, V127, P4551	28	1204	1256	4	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2005	435	7044					959	963		10.1038/nature03659	http://dx.doi.org/10.1038/nature03659			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935RN	15959515				2022-12-01	WOS:000229799700050
J	Frank, KT; Petrie, B; Choi, JS; Leggett, WC				Frank, KT; Petrie, B; Choi, JS; Leggett, WC			Trophic cascades in a formerly cod-dominated ecosystem	SCIENCE			English	Article							FOOD WEBS; FISHERIES; DYNAMICS	Removal of top predators from ecosystems can result in cascading effects through the trophic levels below, completely restructuring the food Web. Cascades have been observed in small-scale or simple food webs, but not in large, complex, open-ocean ecosystems. Using data spanning many decades from a once cod-dominated northwest Atlantic ecosystem, we demonstrate a trophic cascade in a large marine ecosystem. Several cod stocks in other geographic areas have also collapsed without recovery, suggesting the existence of trophic cascades in these systems.	Fisheries & Oceans Canada, Bedford Inst Oceanog, Ocean Sci Div, Dartmouth, NS B2Y 4A2, Canada; Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada	Bedford Institute of Oceanography; Fisheries & Oceans Canada; Queens University - Canada	Frank, KT (corresponding author), Fisheries & Oceans Canada, Bedford Inst Oceanog, Ocean Sci Div, POB 1006, Dartmouth, NS B2Y 4A2, Canada.	frankk@mar.dfo-mpo.gc.ca	Leggett, William C/F-6009-2011					Bowen WD, 2003, ICES J MAR SCI, V60, P1265, DOI 10.1016/S1054-3139(03)00147-4; Choi JS, 2005, OCEANOGR MAR BIOL, V43, P47; Choi JS, 2004, CAN J FISH AQUAT SCI, V61, P505, DOI 10.1139/F04-079; Estes JA, 1998, SCIENCE, V282, P473, DOI 10.1126/science.282.5388.473; FANNING LP, 2003, 27 CAN SCI ADV; Frank KT, 2000, ICES J MAR SCI, V57, P1023, DOI 10.1006/jmsc.2000.0587; Frank KT, 2000, CAN J FISH AQUAT SCI, V57, P513, DOI 10.1139/cjfas-57-3-513; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jackson JBC, 2001, SCI MAR, V65, P273, DOI 10.3989/scimar.2001.65s2273; Micheli F, 1999, SCIENCE, V285, P1396, DOI 10.1126/science.285.5432.1396; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Polis GA, 2000, TRENDS ECOL EVOL, V15, P473, DOI 10.1016/S0169-5347(00)01971-6; Reid PC, 2000, ICES J MAR SCI, V57, P495, DOI 10.1006/jmsc.2000.0740; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Shurin JB, 2002, ECOL LETT, V5, P785, DOI 10.1046/j.1461-0248.2002.00381.x; Steele J. H., 2004, GLOBAL COASTAL OCEAN, V13; STRONG DR, 1992, ECOLOGY, V73, P747, DOI 10.2307/1940154; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Worm B, 2003, ECOLOGY, V84, P162, DOI 10.1890/0012-9658(2003)084[0162:MAOCSI]2.0.CO;2	20	866	907	9	620	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 10	2005	308	5728					1621	1623		10.1126/science.1113075	http://dx.doi.org/10.1126/science.1113075			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	936BH	15947186				2022-12-01	WOS:000229827000055
J	Granich, RM; Oh, P; Lewis, B; Porco, TC; Flood, J				Granich, RM; Oh, P; Lewis, B; Porco, TC; Flood, J			Multidrug resistance among persons with tuberculosis in California, 1994-2003	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; UNITED-STATES; TRANSMISSION; OUTBREAK; INFECTIONS; OUTCOMES	Context Between 1994 and 2003, tuberculosis (TB) cases in California declined 33% (4834 to 3224). However, in 2003 California reported the largest number of cases in the nation, and over the past decade the proportion of cases with multidrug-resistant tuberculosis (MDR-TB) has not decreased. Objective To describe the magnitude, trends, geographic distribution, clinical characteristics, risk factors, and outcomes of MDR-TB cases reported to the California registry of Reports of Verified Cases of TB. Design, Setting, and Cases Analysis of 38 291 TB cases reported from all 61 local health jurisdictions in California during 1994-2003. Multidrug-resistant TB was defined as resistance to at least isoniazid and rifampin. Main Outcome Measures Results of univariate and multivariable analyses of MDR-TB magnitude, trends, geographic distribution, clinical characteristics, associated factors, and outcomes. Results Of 38 291 reported TB cases, 28 712 (75%) were tested for resistance to at least isoniazid and rifampin; of these, 407 MDR-TB cases (1.4%) were reported from 38 of 61 California health jurisdictions (62%); the proportion of MDR-TB cases did not significantly change over the study period (P=.87). Cases of MDR-TB were twice as likely to have cavitary lesions compared with non-MDR-TB cases (P<.001) and were 7 times more likely to have reported previous treatment for TB (P<.001). Of MDR-TB cases with outcomes, 231 (67%) completed therapy, and those with MDR-TB were significantly less likely to complete therapy than those without MDR-TB (P<.001). Multivariate analysis identified previous TB diagnosis, positive acid-fast bacilli sputum smear results, Asian/Pacific Islander ethnicity, time in the United States less than 5 years at the time of diagnosis, and outcomes of "died" and "moved" as factors associated with MDR-TB. Conclusions Multidrug-resistant TB, an airborne disease with limited, costly treatment options, persists in 1% to 2 % of all cases despite California's control efforts. Local and global TB control efforts are needed to prevent the further development and spread of MDR-TB.	Ctr Dis Control & Prevent, Div TB Eliminat, Natl Ctr HIV STD & TB Prevent, Atlanta, GA USA; Calif Dept Hlth Serv, TB Control Branch, Sacramento, CA USA	Centers for Disease Control & Prevention - USA; California Department of Health Care Services	Granich, RM (corresponding author), Off US Global AIDS Coordinator, 2100 Penn Ave NW, Washington, DC 20522 USA.	granichrm@state.gov	Lewis, Bryan/AGI-2140-2022	Lewis, Bryan/0000-0003-0793-6082				Agerton T, 1997, JAMA-J AM MED ASSOC, V278, P1073, DOI 10.1001/jama.278.13.1073; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; BECKSAGUE C, 1992, JAMA-J AM MED ASSOC, V268, P1280, DOI 10.1001/jama.268.10.1280; BLOCH AB, 1994, JAMA-J AM MED ASSOC, V271, P665, DOI 10.1001/jama.271.9.665; *CA DEP HLTH SERV, 2001, REP TUB CAL 2000; *CDCP, 1993, JAMA-J AM MED ASSOC, V269, P978; *CDCP, 1990, JAMA-J AM MED ASSOC, V264, P173; Chan ED, 2004, AM J RESP CRIT CARE, V169, P1103, DOI 10.1164/rccm.200308-1159OC; CORONADO VG, 1993, J INFECT DIS, V168, P1052, DOI 10.1093/infdis/168.4.1052; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; FRIEDMAN CR, 1995, AM J RESP CRIT CARE, V152, P355, DOI 10.1164/ajrccm.152.1.7599845; GOBLE M, 1993, NEW ENGL J MED, V328, P527, DOI 10.1056/NEJM199302253280802; Granich RM, 2001, INT J TUBERC LUNG D, V5, P53; KOO D, 1995, WESTERN J MED, V163, P441; Lobato MN, 1998, PEDIATR INFECT DIS J, V17, P407, DOI 10.1097/00006454-199805000-00012; Lockman S, 2001, CLIN INFECT DIS, V32, P373, DOI 10.1086/318489; MILLER A, 2003, SUBSET SELECTION REG; Moore M, 1997, JAMA-J AM MED ASSOC, V278, P833, DOI 10.1001/jama.278.10.833; NEVILLE K, 1994, CHEST, V105, P45, DOI 10.1378/chest.105.1.45; Pablos-Mendez A, 1998, NEW ENGL J MED, V338, P1641, DOI 10.1056/NEJM199806043382301; Peter CR, 1998, WESTERN J MED, V169, P208; Rajbhandary SS, 2004, INT J TUBERC LUNG D, V8, P1012; Raviglione MC, 2001, ANN NY ACAD SCI, V953, P88, DOI 10.1111/j.1749-6632.2001.tb11364.x; Ridzon R, 1997, J PEDIATR-US, V131, P863, DOI 10.1016/S0022-3476(97)70034-9; RILEY LW, 1989, AM REV RESPIR DIS, V139, P1282, DOI 10.1164/ajrccm/139.5.1282; *STAT CA DEP FIN, 2003, CAL CURR POP SURV RE; *STAT CA DEP FIN, 2002, REV HIST CIT COUNT S; Viallefont V, 2001, STAT MED, V20, P3215, DOI 10.1002/sim.976.abs; BAYESIAN MODEL AVERI; 1991, MMWR MORB MORTAL WKL, V40, P649	30	59	63	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	2005	293	22					2732	2739		10.1001/jama.293.22.2732	http://dx.doi.org/10.1001/jama.293.22.2732			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933OV	15941802	Bronze			2022-12-01	WOS:000229643700021
J	Halpern, SD				Halpern, SD			HIV testing without consent in critically ill patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							AMERICANS		Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Educ & Res Therapeut, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Bioeth, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Halpern, SD (corresponding author), Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Dept Med, 115 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	shalpern@cceb.med.upenn.edu						Akinola NO, 2004, CLIN INFECT DIS, V39, P579, DOI 10.1086/422722; Aldrich J, 2000, ARCH INTERN MED, V160, P715, DOI 10.1001/archinte.160.5.715; *AM MED ASS, H 20 920 HIV TEST; Annas GJ, 1998, NEW ENGL J MED, V339, P1255, DOI 10.1056/NEJM199810223391723; BAYER R, 1991, NEW ENGL J MED, V324, P1500, DOI 10.1056/NEJM199105233242111; BAYER R, 2000, AIDS DOCTORS VOICES, P156; BEAUCHAMP TL, 1994, RESPECT AUTONOMY PRI, P120; Bernard GR, 2004, AM J RESP CRIT CARE, V170, P1375, DOI 10.1164/rccm.200406-726ST; Bogart LM, 2005, JAIDS-J ACQ IMM DEF, V38, P213, DOI 10.1097/00126334-200502010-00014; Burris Scott, 1994, John Marshall Law Rev, V27, P251; Domingo P, 1997, LANCET, V349, P1554, DOI 10.1016/S0140-6736(05)62136-8; Dyer G, 2000, BRIT MED J, V320, P135; ELLEMENT J, 1996, BOSTON GLOBE CI 0601, P13; *GEN MED COUNC, 1997, SER COMM DIS; Luce JM, 2003, CRIT CARE MED, V31, pS153, DOI 10.1097/01.CCM.0000054901.80339.01; MARKS HM, 1997, PROGR EXPT SCI THERA, P229; PAUKER SG, 1980, NEW ENGL J MED, V302, P1109, DOI 10.1056/NEJM198005153022003; Sommerville A, 2002, BRIT MED J, V325, P1226; *TUL LAW SCH, 2004, LAW SEXUALITY REV LE, V13, P5; TURNOCK BJ, 1989, JAMA-J AM MED ASSOC, V261, P3415, DOI 10.1001/jama.261.23.3415	20	15	16	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 10	2005	294	6					734	737		10.1001/jama.294.6.734	http://dx.doi.org/10.1001/jama.294.6.734			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	953IA	16091576				2022-12-01	WOS:000231068600027
J	Lam, TKT; Gutierrez-Juarez, R; Pocai, A; Rossetti, L				Lam, TKT; Gutierrez-Juarez, R; Pocai, A; Rossetti, L			Regulation of blood glucose by hypothalamic pyruvate metabolism	SCIENCE			English	Article							FOOD-INTAKE; MITOCHONDRIAL DYSFUNCTION; LACTATE-DEHYDROGENASE; LEPTIN RECEPTOR; ARCUATE NUCLEUS; BRAIN; RATS; HYPERGLYCEMIA; NEURONS; OBESITY	The brain keenly depends on glucose for energy, and mammalians have redundant systems to control glucose production. An increase in circulating glucose inhibits glucose production in the liver, but this negative feedback is impaired in type 2 diabetes. Here we report that a primary increase in hypothalamic glucose levels lowers blood glucose through inhibition of glucose production in rats. The effect of glucose requires its conversion to lactate followed by stimulation of pyruvate metabolism, which leads to activation of adenosine triphosphate (ATP)-sensitive potassium channels. Thus, interventions designed to enhance the hypothalamic sensing of glucose may improve glucose homeostasis in diabetes.	Yeshiva Univ Albert Einstein Coll Med, Dept Med, Ctr Diabet Res, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Ctr Diabet Res, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Rossetti, L (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Med, Ctr Diabet Res, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	rossetti@aecom.yu.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020541, R01DK048321, R29DK045024, R01DK045024, R37DK048321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG023475, P01AG021654] Funding Source: NIH RePORTER; NIA NIH HHS [AG 21654, T32-AG023475] Funding Source: Medline; NIDDK NIH HHS [DK 20541, DK 45024, DK 48321] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bittar PG, 1996, J CEREBR BLOOD F MET, V16, P1079, DOI 10.1097/00004647-199611000-00001; Borg MA, 1997, J CLIN INVEST, V99, P361, DOI 10.1172/JCI119165; Brooks GA, 1999, P NATL ACAD SCI USA, V96, P1129, DOI 10.1073/pnas.96.3.1129; Cohen P, 2001, J CLIN INVEST, V108, P1113, DOI 10.1172/JCI200113914; Coppari R, 2005, CELL METAB, V1, P63, DOI 10.1016/j.cmet.2004.12.004; Cryer PE, 2003, DIABETES CARE, V26, P1902, DOI 10.2337/diacare.26.6.1902; DAVIS JD, 1981, SCIENCE, V212, P81, DOI 10.1126/science.7193909; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; GUTIERREZJUAREZ.R, UNPUB; Itoh Y, 2003, P NATL ACAD SCI USA, V100, P4879, DOI 10.1073/pnas.0831078100; Kasischke KA, 2004, SCIENCE, V305, P99, DOI 10.1126/science.1096485; Lam TKT, 2005, NAT MED, V11, P320, DOI 10.1038/nm1201; Levin BE, 2004, DIABETES, V53, P2521, DOI 10.2337/diabetes.53.10.2521; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Magistretti PJ, 1999, SCIENCE, V283, P496, DOI 10.1126/science.283.5401.496; MAHER F, 1994, FASEB J, V8, P1003, DOI 10.1096/fasebj.8.13.7926364; Mevorach M, 1998, J CLIN INVEST, V102, P744, DOI 10.1172/JCI2720; Morton GJ, 2003, ENDOCRINOLOGY, V144, P2016, DOI 10.1210/en.2002-0115; Obici S, 2003, NAT MED, V9, P756, DOI 10.1038/nm873; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Pellerin L, 2004, SCIENCE, V305, P50, DOI 10.1126/science.1100428; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Pocai A, 2005, NATURE, V434, P1026, DOI 10.1038/nature03439; ROSSETTI L, 1987, J CLIN INVEST, V80, P1037, DOI 10.1172/JCI113157; ROSSETTI L, 1993, J CLIN INVEST, V92, P1126, DOI 10.1172/JCI116681; SACCA L, 1978, J CLIN ENDOCR METAB, V47, P1160, DOI 10.1210/jcem-47-5-1160; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; Taylor SI, 1999, CELL, V97, P9, DOI 10.1016/S0092-8674(00)80709-6; THOMPSON DA, 1977, SCIENCE, V198, P1065, DOI 10.1126/science.929188; WOODS SC, 1978, SCIENCE, V202, P1209, DOI 10.1126/science.725595	32	257	269	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2005	309	5736					943	947		10.1126/science.1112085	http://dx.doi.org/10.1126/science.1112085			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953SS	16081739				2022-12-01	WOS:000231101400050
J	Stramer, SL; Fang, CT; Foster, GA; Wagner, AG; Brodsky, JP; Dodd, RY				Stramer, SL; Fang, CT; Foster, GA; Wagner, AG; Brodsky, JP; Dodd, RY			West Nile virus among blood donors in the United States, 2003 and 2004	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMMUNOGLOBULIN-M; ESTIMATED RISK; NEW-YORK; TRANSFUSION; TRANSMISSION; ENCEPHALITIS; INFECTIONS; EPIDEMIC; ANTIBODY	BACKGROUND: West Nile virus first appeared in the United States in 1999 and has since spread throughout the contiguous states, resulting in thousands of cases of disease. By 2002, it was clear that the virus could be transmitted by blood transfusion, and by the middle of 2003, essentially all blood donations were being tested for West Nile virus RNA with the use of investigational nucleic acid amplification tests; testing was performed on individual samples or on ``minipools'' of up to 16 donations. METHODS: We analyzed data from the West Nile virus testing program of the American Red Cross for 2003 and 2004 to identify geographic and temporal trends. In areas with a high incidence of infection, individual donations were tested to increase the sensitivity of testing. Donors with reactive results participated in follow-up studies to confirm the original reactivity and to assess the natural history of infection. RESULTS: Routine testing in 2003 and 2004 identified 540 donations that were positive for West Nile virus RNA, of which 362 (67 percent) were IgM-antibody-negative and most likely infectious. Of the 540 positive donations, 148 (27 percent) were detectable only by testing of individual donations, but only 15 of the 148 (10 percent) were negative for IgM antibody. The overall frequencies of RNA-positive donations during the epidemic periods were 1.49 per 10,000 donations in 2003 and 0.44 per 10,000 in 2004. In 2004, 52 percent of the positive donations were from donors in four counties in southern California. CONCLUSIONS: Rapid implementation of a nucleic acid amplification test led to the prospective identification of 519 donors who were positive for West Nile virus RNA and the removal of more than 1000 potentially infectious related components from the blood supply of the Red Cross. No cases of transfusion-transmitted infection were confirmed among recipients of the tested blood.	Amer Red Cross, Gaithersburg, MD 20877 USA; Amer Red Cross, Rockville, MD USA; Qual Analyt, Riverwoods, IL USA	American Red Cross; American Red Cross	Stramer, SL (corresponding author), Amer Red Cross, 9315 Gaither Rd, Gaithersburg, MD 20877 USA.	stramers@usa.redcross.org						[Anonymous], 2002, MMWR MORB MORTAL WKL, V51, P833; Biggerstaff BJ, 2003, TRANSFUSION, V43, P1007, DOI 10.1046/j.1537-2995.2003.00480.x; Biggerstaff BJ, 2002, TRANSFUSION, V42, P1019, DOI 10.1046/j.1537-2995.2002.00167.x; BUSCH MP, VIREMIA ANTIBODY STU; Custer B, 2004, TRANSFUSION, V44, P1547, DOI 10.1111/j.0041-1132.2004.04227.x; de Oliveira AM, 2004, TRANSFUSION, V44, P1695, DOI 10.1111/j.0041-1132.2004.04130.x; *DEP HLTH HUM SERV, 2005, GUID IND REV REC ASS; *DEP HLTH HUM SERV, 2003, GUID IND REV REC ASS; *DEP HLTH HUM SERV, 2002, GUID IND REC ASS DON; Dodd RY, 2003, NEW ENGL J MED, V349, P1205, DOI 10.1056/NEJMp038138; Iwamoto M, 2003, NEW ENGL J MED, V348, P2196, DOI 10.1056/NEJMoa022987; Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0; ORTON S, IN PRESS TRANSFUSION; Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969; Petersen LR, 2004, NEW ENGL J MED, V351, P2257, DOI 10.1056/NEJMp048261; Prince HE, 2003, CLIN DIAGN LAB IMMUN, V10, P764, DOI 10.1128/CDLI.10.5.764-768.2003; Roehrig JT, 2003, EMERG INFECT DIS, V9, P376, DOI 10.3201/eid0903.020531; SAZAMA K, 2004, AABB B, V403, P1; SMITHBURN K. C, 1940, AMER JOUR TROP MED, V20, P471; Stramer SL, 2004, NEW ENGL J MED, V351, P760, DOI 10.1056/NEJMoa040085; STRAMER SL, 2005, 6 NAT C W NIL VIR US; STRAMER SL, 2003, TRANSFUSION S2A, V43; STRAMER SL, 2003, TRANSFUSION S3A, V43; 1999, MMWR MORB MORTAL WKL, V48, P845; 2003, MMWR MORB MORTAL WKL, V52, P769; 2004, MMWR MORB MORTAL WKL, V53, P281; 2005, 2003 2004 W NIL VIR; 2004, MMWR MORB MORTAL WKL, V53, P842	28	160	162	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 4	2005	353	5					451	459		10.1056/NEJMoa044333	http://dx.doi.org/10.1056/NEJMoa044333			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951OB	16079368				2022-12-01	WOS:000230939000004
J	Dekel, E; Alon, U				Dekel, E; Alon, U			Optimality and evolutionary tuning of the expression level of a protein	NATURE			English	Article							ADAPTIVE EVOLUTION; DIAUXIC GROWTH; OPERON; DYNAMICS; FITNESS; GLUCOSE; MODEL	Different proteins have different expression levels. It is unclear to what extent these expression levels are optimized to their environment. Evolutionary theories suggest that protein expression levels maximize fitness(1-11), but the fitness as a function of protein level has seldom been directly measured. To address this, we studied the lac system of Escherichia coli, which allows the cell to use the sugar lactose for growth(12). We experimentally measured the growth burden(13,14) due to production and maintenance of the Lac proteins (cost), as well as the growth advantage (benefit) conferred by the Lac proteins when lactose is present. The fitness function, given by the difference between the benefit and the cost, predicts that for each lactose environment there exists an optimal Lac expression level that maximizes growth rate. We then performed serial dilution evolution experiments at different lactose concentrations. In a few hundred generations, cells evolved to reach the predicted optimal expression levels. Thus, protein expression from the lac operon seems to be a solution of a cost-benefit optimization problem, and can be rapidly tuned by evolution to function optimally in new environments.	Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Alon, U (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	urialon@weizmann.ac.il	Yang, Chen/G-1379-2010					Bremer H, 1996, ESCHERICHIA COLI SAL, P1553; Conant GC, 2003, NAT GENET, V34, P264, DOI 10.1038/ng1181; Cooper TF, 2003, P NATL ACAD SCI USA, V100, P1072, DOI 10.1073/pnas.0334340100; Dekel E, 2005, PHYS BIOL, V2, P81, DOI 10.1088/1478-3975/2/2/001; DYKHUIZEN DE, 1987, GENETICS, V115, P25; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Endy D, 2000, P NATL ACAD SCI USA, V97, P5375, DOI 10.1073/pnas.090101397; Fay JC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r26; Hartl D.L., 1997, PRINCIPLES POPULATIO; HARTL DL, 1984, ANNU REV GENET, V18, P31, DOI 10.1146/annurev.ge.18.120184.000335; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Heinrich R., 1996, REGULATION CELLULAR; Honisch C, 2004, GENOME RES, V14, P2495, DOI 10.1101/gr.2977704; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; KOCH AL, 1983, J MOL EVOL, V19, P455, DOI 10.1007/BF02102321; Kremling A, 2001, METAB ENG, V3, P362, DOI 10.1006/mben.2001.0199; Liebermeister W, 2004, BIOSYSTEMS, V76, P261, DOI 10.1016/j.biosystems.2004.05.022; Maynard Smith J., 1997, MAJOR TRANSITIONS EV; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; Muller-Hill B, 1996, LAC OPERON SHORT HIS, V1st; NGUYEN TNM, 1989, MOL BIOL EVOL, V6, P213; Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523; Rosen R., 1967, OPTIMALITY PRINCIPLE; Savageau M, 1976, BIOCH SYSTEMS ANAL S; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Stephanopoulos G, 2001, SCIENCE, V292, P2024, DOI 10.1126/science.1062556; Wong P, 1997, BIOTECHNOL PROGR, V13, P132, DOI 10.1021/bp970003o; Yildirim N, 2004, CHAOS, V14, P279, DOI 10.1063/1.1689451; Yokobayashi Y, 2002, P NATL ACAD SCI USA, V99, P16587, DOI 10.1073/pnas.252535999	30	519	522	4	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2005	436	7050					588	592		10.1038/nature03842	http://dx.doi.org/10.1038/nature03842			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049495				2022-12-01	WOS:000230788800068
J	Rhodes, T; Simic, M				Rhodes, T; Simic, M			Transition and the HIV risk environment	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BOSNIA; HEALTH; VIOLENCE; CROATIA; WAR		Univ London Imperial Coll Sci Technol & Med, Ctr Res Drugs & Hlth Behav, London W6 8RP, England	Imperial College London	Rhodes, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Res Drugs & Hlth Behav, London W6 8RP, England.	t.rhodes@imperial.ac.uk	Rhodes, Tim/DNJ-9679-2022; Manzotti, Grazia/C-5985-2008	Rhodes, Tim/0000-0003-2400-9838				ARGOVINO T, 1997, LANCET, V350, P1757; BARNETT T, 1999, EUR J DEV RES, V11, P200; Blankenship KM, 2000, AIDS, V14, pS11, DOI 10.1097/00002030-200006001-00003; Carballo M, 2004, J BIOSOC SCI, V36, P463, DOI 10.1017/S0021932004006753; CARBALLO M, 1998, 12 WORLD AIDS C GEN; DJILAS A, 1993, FOREIGN AFF, V72, P81, DOI 10.2307/20045624; Duff CH, 1999, J EPIDEMIOL COMMUN H, V53, P578, DOI 10.1136/jech.53.9.578; *EUR BANK REC DEV, 2001, TRANS REP EN TRANS; *EUR ROM RIGHTS CT, 2002, ROM FUND RIGHTS FORM; FARMER PE, 1996, WOMEN POVERTY AIDS S; GODINHO J, 2004, HIV AIDS W BALKANS P; Gordy Eric D., 1999, CULTURE POWER SERBIA; Horton R, 1999, LANCET, V353, P2223, DOI 10.1016/S0140-6736(99)06043-2; McKEE M., 2002, INT J DRUG POLICY, V13, P453; *MIN SOC AFF REP S, 2003, POV RED STRAT PAP S; Olujic MB, 1998, MED ANTHROPOL Q, V12, P31, DOI 10.1525/maq.1998.12.1.31; Pedersen D, 2002, SOC SCI MED, V55, P175, DOI 10.1016/S0277-9536(01)00261-1; Poundstone KE, 2004, EPIDEMIOL REV, V26, P22, DOI 10.1093/epirev/mxh005; PYLE GF, 1998, CROAT MED J, V39, P3; Rhodes T, 1999, ADDICTION, V94, P1323, DOI 10.1046/j.1360-0443.1999.94913235.x; Rhodes T, 1999, AIDS, V13, pS259; Rhodes T., 2004, International Journal of Drug Policy, V15, P1, DOI 10.1016/j.drugpo.2003.09.001; Rhodes Tim., 2002, INT J DRUG POLICY, V13, P85, DOI [10.1016/S0955-3959(02)00007-5, DOI 10.1016/S0955-3959(02)00007-5]; *UN DEV PROGR, 2003, BUILD BLOCKS REF FEC; *UN DEV PROGR, 1997, HUM DEV REP YUG; WONG T, 2002, RAPID ASSESSMENT SER	26	148	149	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	2005	331	7510					220	223		10.1136/bmj.331.7510.220	http://dx.doi.org/10.1136/bmj.331.7510.220			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	951EA	16037463	Bronze, Green Accepted, Green Published			2022-12-01	WOS:000230910700032
J	Ceballos, G; Ehrlich, PR; Soberon, J; Salazar, I; Fay, JP				Ceballos, G; Ehrlich, PR; Soberon, J; Salazar, I; Fay, JP			Global mammal conservation: What must we manage?	SCIENCE			English	Article							HUMAN-POPULATION; BIODIVERSITY; EXTINCTION; HOTSPOTS	We present a global conservation analysis for an entire "flagship" taxon, [and mammals. A combination of rarity, anthropogenic impacts, and political endemism has put about a quarter of terrestrial mammal species, and a larger fraction of their populations, at risk of extinction. A new global database and complementarity analysis for selecting priority areas for conservation shows that similar to 11% of Earth's land surface should be managed for conservation to preserve at least 10% of terrestrial mammal geographic ranges. Different approaches, from protection (or establishment) of reserves to countryside biogeographic enhancement of human-dominated landscapes, will be required to approach this minimal goal.	Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico; Stanford Univ, Dept Biol Sci, Ctr Conservat Biol, Stanford, CA 94305 USA; Comis Nacl Biodivers, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Stanford University	Ceballos, G (corresponding author), Univ Nacl Autonoma Mexico, Inst Ecol, Apdo Postal 70-275, Mexico City 04510, DF, Mexico.	gcebatto@miranda.ecologia.unam.mx	Soberon, Jorge/ABF-1306-2021	Soberon, Jorge/0000-0003-2160-4148				Balmford A, 2001, SCIENCE, V291, P2616, DOI 10.1126/science.291.5513.2616; Brooks TM, 2004, BIOSCIENCE, V54, P1081, DOI 10.1641/0006-3568(2004)054[1081:CPBTGP]2.0.CO;2; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; Daily G.C., 1997, NATURES SERVICES, DOI DOI 10.1023/A:1023307309124; Daily GC, 2003, CONSERV BIOL, V17, P1814, DOI 10.1111/j.1523-1739.2003.00298.x; Duff A, 2004, MAMMALS WORLD CHECKL; Ehrlich A., 2004, ONE NINEVEH POLITICS; Ehrlich PR., 1981, EXTINCTION; *ESRI, 2002, ESRI DAT MAPS 2002; Gaston KJ, 2003, P ROY SOC B-BIOL SCI, V270, P1293, DOI 10.1098/rspb.2002.2303; Hughes JB, 1997, SCIENCE, V278, P689, DOI 10.1126/science.278.5338.689; IUCN, 2003, 2003 IUCN RED LIST T; Kareiva P, 2003, AM SCI, V91, P344, DOI 10.1511/2003.26.869; Liu JG, 2003, NATURE, V421, P530, DOI 10.1038/nature01359; Long AJ, 1996, GLOBAL ECOL BIOGEOGR, V5, P281, DOI 10.2307/2997796; Luck GW, 2003, TRENDS ECOL EVOL, V18, P331, DOI 10.1016/S0169-5347(03)00100-9; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; McKee JK, 2004, BIOL CONSERV, V115, P161, DOI 10.1016/S0006-3207(03)00099-5; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; Possingham Hugh, 2000, P291, DOI 10.1007/0-387-22648-6_17; Ramankutty N, 1999, GLOBAL ECOL BIOGEOGR, V8, P381, DOI 10.1046/j.1365-2699.1999.00141.x; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wikramanayake E, 2004, CONSERV BIOL, V18, P839, DOI 10.1111/j.1523-1739.2004.00145.x; World Bank, 2004, WORLD DEV IND 2004	28	209	220	1	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2005	309	5734					603	607		10.1126/science.1114015	http://dx.doi.org/10.1126/science.1114015			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SE	16040704				2022-12-01	WOS:000230735200046
J	Anderson, GF				Anderson, GF			Medicare and chronic conditions	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RISK-ADJUSTMENT; CHRONIC CARE		Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Hosp Finance & Management, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Anderson, GF (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Hosp Finance & Management, Baltimore, MD USA.							*AG HEALTHC RES QU, 2001, 2001 MED EXP PAN SUR; Anderson G, 2001, HEALTH AFFAIR, V20, P146, DOI 10.1377/hlthaff.20.6.146; Anderson GF, 2003, ARCH INTERN MED, V163, P437, DOI 10.1001/archinte.163.4.437; ANDERSON GF, 2004, DOUGHNUT HOLES PRICE; BERENSON RA, 2003, CONFRONTING BARRIERS; Congressional Budget Office, 2004, AN LIT DIS MAN PROGR; CORRIGAN J, 2003, LEADERSHIP EXAMPLE C; *CTR MED MED SERV, 2005, MED HLTH SUPP; Darer JD, 2004, ACAD MED, V79, P541, DOI 10.1097/00001888-200406000-00009; Frank RG, 2004, NEW ENGL J MED, V351, P1375, DOI 10.1056/NEJMp048158; Hwang W, 2001, HEALTH AFFAIR, V20, P267, DOI 10.1377/hlthaff.20.6.267; *J HOPK U, PARTN SOL BETT LIV P; Kuttner R, 1998, NEW ENGL J MED, V339, P1952, DOI 10.1056/NEJM199812243392625; Pope GC, 2004, HEALTH CARE FINANC R, V25, P119; THORPE KE, 2004, WHICH MED CONDITIONS; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; WILLIAMS RD, 2004, 10 NAT AC SOC I; Wu SY, 2000, PROJECTION CHRONIC I	18	94	94	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2005	353	3					305	309		10.1056/NEJMsb044133	http://dx.doi.org/10.1056/NEJMsb044133			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946YH	16034019				2022-12-01	WOS:000230608700015
J	Wilson, JF				Wilson, JF			Gene therapy yields to RNA interference	ANNALS OF INTERNAL MEDICINE			English	News Item							MICE					jenwilson@acponline.org	Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136				Ge Q, 2004, P NATL ACAD SCI USA, V101, P8676, DOI 10.1073/pnas.0402486101; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hannon GJ, 2004, NATURE, V431, P371, DOI 10.1038/nature02870; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Ling XY, 2005, CANCER RES, V65, P2532, DOI 10.1158/0008-5472.CAN-04-2425; Shankar P, 2005, JAMA-J AM MED ASSOC, V293, P1367, DOI 10.1001/jama.293.11.1367; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Zhang Y, 2004, CLIN CANCER RES, V10, P3667, DOI 10.1158/1078-0432.CCR-03-0740	8	2	4	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 19	2005	143	2					161	164		10.7326/0003-4819-143-2-200507190-00033	http://dx.doi.org/10.7326/0003-4819-143-2-200507190-00033			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946YG	16027472				2022-12-01	WOS:000230608600025
J	Fetler, L; Amigorena, S				Fetler, L; Amigorena, S			Brain under surveillance: The microglia patrol	SCIENCE			English	Editorial Material							IN-VIVO		Inst Curie, Lab Physicochim Curie, CNRS, UMR 168, F-75245 Paris, France; Inst Curie, INSERM, U365, F-75245 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Fetler, L (corresponding author), Inst Curie, Lab Physicochim Curie, CNRS, UMR 168, 26 Rue Ulm, F-75245 Paris, France.	luc.fetler@curie.fr; sebastian.amigorena@curie.fr	Fetler, luc/M-9034-2018	Amigorena, Sebastian/0000-0001-8583-8416				Backskai BJ, 2001, NAT MED, V7, P369, DOI 10.1038/85525; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	5	115	126	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2005	309	5733					392	393		10.1126/science.1114852	http://dx.doi.org/10.1126/science.1114852			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946LY	16020721				2022-12-01	WOS:000230574900031
J	Hosoya, T; Baccus, SA; Meister, M				Hosoya, T; Baccus, SA; Meister, M			Dynamic predictive coding by the retina	NATURE			English	Article							HUMAN VISUAL-SYSTEM; CONTRAST ADAPTATION; SALAMANDER RETINA; GANGLION-CELLS; TEMPORAL CONTRAST; NEURAL CODE; IMAGES; INHIBITION; ORIENTATION; STATISTICS	Retinal ganglion cells convey the visual image from the eye to the brain. They generally encode local differences in space and changes in time rather than the raw image intensity. This can be seen as a strategy of predictive coding, adapted through evolution to the average image statistics of the natural environment. Yet animals encounter many environments with visual statistics different from the average scene. Here we show that when this happens, the retina adjusts its processing dynamically. The spatio-temporal receptive fields of retinal ganglion cells change after a few seconds in a new environment. The changes are adaptive, in that the new receptive field improves predictive coding under the new image statistics. We show that a network model with plastic synapses can account for the large variety of observed adaptations.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA	Harvard University; Stanford University	Meister, M (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	meister@fas.harvard.edu	Hosoya, Toshihiko/Q-2514-2018	Hosoya, Toshihiko/0000-0001-8559-8344; Meister, Markus/0000-0003-2136-6506				Aizenman CD, 2000, PROG BRAIN RES, V124, P257; ATICK JJ, 1992, NEURAL COMPUT, V4, P196, DOI 10.1162/neco.1992.4.2.196; Baccus SA, 2004, NEURON, V42, P5, DOI 10.1016/S0896-6273(04)00187-4; Baccus SA, 2002, NEURON, V36, P909, DOI 10.1016/S0896-6273(02)01050-4; BARLOW H, 1989, COMP NEUR S, P54; Barlow H.B., 1961, SENSORY COMMUNICATIO; BARLOW HB, 1953, J PHYSIOL-LONDON, V119, P69, DOI 10.1113/jphysiol.1953.sp004829; Bell CC, 2001, CURR OPIN NEUROBIOL, V11, P481, DOI 10.1016/S0959-4388(00)00238-5; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V203, P237, DOI 10.1113/jphysiol.1969.sp008862; Blakemore C., 2010, VISION CODING EFFICI, P363, DOI 10.1017/cbo9780511626197.034; BLOOMFIELD SA, 1994, J NEUROPHYSIOL, V71, P1672, DOI 10.1152/jn.1994.71.5.1672; Chander D, 2001, J NEUROSCI, V21, P9904, DOI 10.1523/JNEUROSCI.21-24-09904.2001; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Cook PB, 1998, J NEUROSCI, V18, P2301; Cook PB, 1998, NAT NEUROSCI, V1, P714, DOI 10.1038/3714; Cook PB, 2000, J NEUROSCI, V20, P806, DOI 10.1523/JNEUROSCI.20-02-00806.2000; DEVALOIS KK, 1977, VISION RES, V17, P1057, DOI 10.1016/0042-6989(77)90010-4; DONG DW, 1995, NETWORK-COMP NEURAL, V6, P345, DOI 10.1088/0954-898X/6/3/003; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Gaiarsa JL, 2002, TRENDS NEUROSCI, V25, P564, DOI 10.1016/S0166-2236(02)02269-5; Graham N. V., 1989, VISUAL PATTERN ANAL; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; MOLLON JD, 1977, PERCEPTUAL WORLD, P71; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; Rieke F, 2001, J NEUROSCI, V21, P9445, DOI 10.1523/JNEUROSCI.21-23-09445.2001; Schnitzer MJ, 2003, NEURON, V37, P499, DOI 10.1016/S0896-6273(03)00004-7; Shapley R., 1984, PROG RETIN RES, V3, P263, DOI DOI 10.1016/0278-4327(84)90011-7; Smirnakis SM, 1997, NATURE, V386, P69, DOI 10.1038/386069a0; Snippe HP, 2004, J VISION, V4, P1, DOI 10.1167/4.1.1; SNOWDEN RJ, 1992, NATURE, V355, P248, DOI 10.1038/355248a0; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; VANHATEREN JH, 1992, NATURE, V360, P68, DOI 10.1038/360068a0; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336; YANG CY, 1991, J COMP NEUROL, V312, P19, DOI 10.1002/cne.903120103	38	311	320	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2005	436	7047					71	77		10.1038/nature03689	http://dx.doi.org/10.1038/nature03689			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942QJ	16001064				2022-12-01	WOS:000230296600041
J	Imai, Y; Kuba, K; Rao, S; Huan, Y; Guo, F; Guan, B; Yang, P; Sarao, R; Wada, T; Leong-Poi, H; Crackower, MA; Fukamizu, A; Hui, CC; Hein, L; Uhlig, S; Slutsky, AS; Jiang, CY; Penninger, JM				Imai, Y; Kuba, K; Rao, S; Huan, Y; Guo, F; Guan, B; Yang, P; Sarao, R; Wada, T; Leong-Poi, H; Crackower, MA; Fukamizu, A; Hui, CC; Hein, L; Uhlig, S; Slutsky, AS; Jiang, CY; Penninger, JM			Angiotensin-converting enzyme 2 protects from severe acute lung failure	NATURE			English	Article							ACUTE RESPIRATORY SYNDROME; DISTRESS-SYNDROME; FUNCTIONAL RECEPTOR; SARS CORONAVIRUS; DEFICIENT MICE; HONG-KONG; EXPRESSION; IDENTIFICATION; REGULATOR; CLONING	Acute respiratory distress syndrome (ARDS), the most severe form of acute lung injury, is a devastating clinical syndrome with a high mortality rate (30-60%) (refs 1-3). Predisposing factors for ARDS are diverse(1,3) and include sepsis, aspiration, pneumonias and infections with the severe acute respiratory syndrome (SARS) corona-virus(4,5). At present, there are no effective drugs for improving the clinical outcome of ARDS(1-3). Angiotensin-converting enzyme (ACE) and ACE2 are homologues with different key functions in the renin-angiotensin system(6-8). ACE cleaves angiotensin I to generate angiotensin II, whereas ACE2 inactivates angiotensin II and is a negative regulator of the system. ACE2 has also recently been identified as a potential SARS virus receptor and is expressed in lungs(9,10). Here we report that ACE2 and the angiotensin II type 2 receptor (AT(2)) protect mice from severe acute lung injury induced by acid aspiration or sepsis. However, other components of the renin-angiotensin system, including ACE, angiotensin II and the angiotensin II type 1a receptor (AT(1)a), promote disease pathogenesis, induce lung oedemas and impair lung function. We show that mice deficient for Ace show markedly improved disease, and also that recombinant ACE2 can protect mice from severe acute lung injury. Our data identify a critical function for ACE2 in acute lung injury, pointing to a possible therapy for a syndrome affecting millions of people worldwide every year.	Austrian Acad Sci, IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria; Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100005, Peoples R China; Peking Union Med Coll, Beijing 100005, Peoples R China; St Michaels Hosp, Dept Cardiol, Toronto, ON M5B 1W8, Canada; Merck Frosst Ctr Therapeut Res, Dept Biochem & Mol Biol, Montreal, PQ H3R 4P8, Canada; Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058577, Japan; Hosp Sick Children, Program Dev Biol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5G 1X8, Canada; Univ Freiburg, Dept Pharmacol, D-79104 Freiburg, Germany; Res Ctr Borstel, Div Pulm Pharmacol, D-23845 Borstel, Germany; Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada; Univ Toronto, St Michaels Hosp, Interdepartmental Div Crit Care, Toronto, ON M5B 1W8, Canada	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Merck & Company; University of Tsukuba; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Freiburg; Forschungszentrum Borstel; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Penninger, JM (corresponding author), Austrian Acad Sci, IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria.	Josef.penninger@imba.oeaw.ac.at	Slutsky, Arthur S/A-6013-2008; Uhlig, Stefan/A-7290-2014; fukamizu, akiyoshi/J-5350-2012; Imai, Yumiko/GXW-1144-2022; Slutsky, Arthur/M-3325-2019; Penninger, Josef/I-6860-2013	Slutsky, Arthur S/0000-0002-6063-3876; Uhlig, Stefan/0000-0003-2332-1280; fukamizu, akiyoshi/0000-0002-8786-6020; Rao, Shuan/0000-0002-5268-7006; Guo, Feng/0000-0002-4506-7618; Penninger, Josef/0000-0002-8194-3777				Boehm M, 2002, NEW ENGL J MED, V347, P1795, DOI 10.1056/NEJMcibr022472; CORVOL P, 1995, METHOD ENZYMOL, V248, P283; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; GASC JM, 1994, HYPERTENSION, V24, P531, DOI 10.1161/01.HYP.24.5.531; Goggel R, 2004, NAT MED, V10, P155, DOI 10.1038/nm977; Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570; HANSEN TN, 1985, J APPL PHYSIOL, V58, P812, DOI 10.1152/jappl.1985.58.3.812; HEIN L, 1995, NATURE, V377, P744, DOI 10.1038/377744a0; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; HUDSON LD, 1995, AM J RESP CRIT CARE, V151, P293, DOI 10.1164/ajrccm.151.2.7842182; Imai Y, 2003, JAMA-J AM MED ASSOC, V289, P2104, DOI 10.1001/jama.289.16.2104; INAGAMI T, 1995, ADV EXP MED BIOL, V377, P311; KREGE JH, 1995, NATURE, V375, P146, DOI 10.1038/375146a0; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Marshall RP, 2002, AM J RESP CRIT CARE, V166, P646, DOI 10.1164/rccm.2108086; Martin EL, 2003, AM J PHYSIOL-LUNG C, V285, pL1222, DOI 10.1152/ajplung.00141.2003; Nagase T, 2000, NAT IMMUNOL, V1, P42, DOI 10.1038/76897; Plante GE, 1996, CAN J PHYSIOL PHARM, V74, P824, DOI 10.1139/cjpp-74-7-824; Poutanen SM, 2003, NEW ENGL J MED, V348, P1995, DOI 10.1056/NEJMoa030634; Roy BJ, 1996, AM J PHYSIOL-HEART C, V271, pH222, DOI 10.1152/ajpheart.1996.271.1.H222; Skeggs L T, 1980, Adv Exp Med Biol, V130, P1; SUGAYA T, 1995, J BIOL CHEM, V270, P18719, DOI 10.1074/jbc.270.32.18719; Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200; Tsang KW, 2003, NEW ENGL J MED, V348, P1977, DOI 10.1056/NEJMoa030666; Vincent JL, 2003, CRIT CARE MED, V31, pS296, DOI 10.1097/01.CCM.0000057906.89552.8F; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806	30	1656	1803	12	181	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2005	436	7047					112	116		10.1038/nature03712	http://dx.doi.org/10.1038/nature03712			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942QJ	16001071	Green Published, Bronze			2022-12-01	WOS:000230296600049
J	Yen, AS; Gellert, R; Schroder, C; Morris, RV; Bell, JF; Knudson, AT; Clark, BC; Ming, DW; Crisp, JA; Arvidson, RE; Blaney, D; Bruckner, J; Christensen, PR; DesMarais, DJ; de Souza, PA; Economou, TE; Ghosh, A; Hahn, BC; Herkenhoff, KE; Haskin, LA; Hurowitz, JA; Joliff, BL; Johnson, JR; Klingelhofer, G; Madsen, MB; McLennan, SM; McSween, HY; Richter, L; Rieder, R; Rodionov, D; Soderblom, L; Squyres, SW; Tosca, NJ; Wang, A; Wyatt, M; Zipfel, J				Yen, AS; Gellert, R; Schroder, C; Morris, RV; Bell, JF; Knudson, AT; Clark, BC; Ming, DW; Crisp, JA; Arvidson, RE; Blaney, D; Bruckner, J; Christensen, PR; DesMarais, DJ; de Souza, PA; Economou, TE; Ghosh, A; Hahn, BC; Herkenhoff, KE; Haskin, LA; Hurowitz, JA; Joliff, BL; Johnson, JR; Klingelhofer, G; Madsen, MB; McLennan, SM; McSween, HY; Richter, L; Rieder, R; Rodionov, D; Soderblom, L; Squyres, SW; Tosca, NJ; Wang, A; Wyatt, M; Zipfel, J			An integrated view of the chemistry and mineralogy of martian soils	NATURE			English	Article							THERMAL EMISSION SPECTROMETER; X-RAY SPECTROMETER; MINI-TES EXPERIMENT; GUSEV CRATER; MERIDIANI-PLANUM; MARS PATHFINDER; SPIRIT ROVER; CHEMICAL-COMPOSITION; OPPORTUNITY ROVER; MOSSBAUER SPECTROMETER	The mineralogical and elemental compositions of the martian soil are indicators of chemical and physical weathering processes. Using data from the Mars Exploration Rovers, we show that bright dust deposits on opposite sides of the planet are part of a global unit and not dominated by the composition of local rocks. Dark soil deposits at both sites have similar basaltic mineralogies, and could reflect either a global component or the general similarity in the compositions of the rocks from which they were derived. Increased levels of bromine are consistent with mobilization of soluble salts by thin films of liquid water, but the presence of olivine in analysed soil samples indicates that the extent of aqueous alteration of soils has been limited. Nickel abundances are enhanced at the immediate surface and indicate that the upper few millimetres of soil could contain up to one per cent meteoritic material.	CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Max Planck Inst Chem, D-55128 Mainz, Germany; Johannes Gutenberg Univ Mainz, D-55128 Mainz, Germany; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; Lockheed Martin Corp, Littleton, CO 80127 USA; Washington Univ, St Louis, MO 63130 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; Co Vale Rio Doce, BR-29030900 Rio De Janeiro, Brazil; Univ Chicago, Enrico Fermi Inst, Chicago, IL 60637 USA; Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; US Geol Survey, Flagstaff, AZ 86001 USA; Univ Copenhagen, Niels Bohr Inst, DS-2100 Copenhagen, Denmark; DLR, Inst Raumsimulat, D-51170 Cologne, Germany	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Max Planck Society; Johannes Gutenberg University of Mainz; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Cornell University; Arizona State University; Arizona State University-Tempe; Lockheed Martin; Washington University (WUSTL); National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Chicago; University of Tennessee System; University of Tennessee Knoxville; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; United States Department of the Interior; United States Geological Survey; University of Copenhagen; Niels Bohr Institute; Helmholtz Association; German Aerospace Centre (DLR)	Yen, AS (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	Albert.Yen@jpl.nasa.gov	Hurowitz, Joel A/A-8862-2008; de Souza, Paulo A/B-8961-2008; de Souza, Paulo/P-7294-2019; Johnson, Jeffrey R/F-3972-2015; de Souza, Paulo/W-2993-2019; Crisp, Joy/H-8287-2016; Schröder, Christian/B-3870-2009; Madsen, Morten Bo/D-2082-2011; Blaney, Diana/M-1756-2019	de Souza, Paulo A/0000-0002-0091-8925; Johnson, Jeffrey R/0000-0002-5586-4901; de Souza, Paulo/0000-0002-0091-8925; Crisp, Joy/0000-0002-3202-4416; Schröder, Christian/0000-0002-7935-6039; Madsen, Morten Bo/0000-0001-8909-5111; Blaney, Diana/0000-0002-4267-7939; Tosca, Nicholas/0000-0003-4415-4231; McLennan, Scott/0000-0003-4259-7178				ADAMS JB, 1969, J GEOPHYS RES, V74, P4851, DOI 10.1029/JB074i020p04851; ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; Arvidson RE, 2004, SCIENCE, V305, P821, DOI 10.1126/science.1099922; Bandfield JL, 2000, SCIENCE, V287, P1626, DOI 10.1126/science.287.5458.1626; Bandfield JL, 2003, ICARUS, V161, P47, DOI 10.1016/S0019-1035(02)00025-8; Bell JF, 2004, SCIENCE, V306, P1703, DOI 10.1126/science.1105245; Bell JF, 2004, SCIENCE, V305, P800, DOI 10.1126/science.1100175; Bell JF, 2000, J GEOPHYS RES-PLANET, V105, P1721, DOI 10.1029/1999JE001060; BELL JF, 2003, J GEOPHYS RES-PLANET, V108, DOI DOI 10.1029/2003JE002070; Bertelsen P, 2004, SCIENCE, V305, P827, DOI 10.1126/science.1100112; Binder A. B., 1977, Journal of Geophysical Research, V82, P4439, DOI 10.1029/JS082i028p04439; Bishop JL, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001581; Bruckner J, 2003, J GEOPHYS RES-PLANET, V108, DOI [10.1029/2003JE002060, 10.1029/2003JE002150]; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9609, DOI 10.1029/1999JE001127; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9623, DOI 10.1029/1999JE001093; Christensen PR, 2004, SCIENCE, V305, P837, DOI 10.1126/science.1100564; Christensen PR, 2004, SCIENCE, V306, P1733, DOI 10.1126/science.1104909; Christensen PR, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002117; Clark B. C.  III, 1977, Journal of Geophysical Research, V82, P4577, DOI 10.1029/JS082i028p04577; CLARK BC, 1982, J GEOPHYS RES, V87, P59, DOI 10.1029/JB087iB12p10059; CLARK BC, 1979, J GEOPHYS RES, V84, P8395, DOI 10.1029/JB084iB14p08395; FLYNN GJ, 1990, J GEOPHYS RES-SOLID, V95, P14497, DOI 10.1029/JB095iB09p14497; FOLEY CN, 2003, J GEOPHYS RES, V108, DOI DOI 10.1029/2003JE002019; GANAPATHY R, 1970, P APOLLO 11 LUNAR SC, V2, P1117; Gellert R, 2004, SCIENCE, V305, P829, DOI 10.1126/science.1099913; Golombek MP, 1997, SCIENCE, V278, P1743, DOI 10.1126/science.278.5344.1743; Gorevan SP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002061; Hamilton VE, 2001, J GEOPHYS RES-PLANET, V106, P14733, DOI 10.1029/2000JE001353; Herkenhoff KE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002076; Huck F. O., 1977, Journal of Geophysical Research, V82, P4401, DOI 10.1029/JS082i028p04401; Klingelhofer G, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002138; Klingelhofer G, 2004, SCIENCE, V306, P1740, DOI 10.1126/science.1104653; Lane MD, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021231; Madsen MB, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002029; McLennan SM, 2000, GEOPHYS RES LETT, V27, P1335, DOI 10.1029/1999GL008432; McSween HY, 2004, SCIENCE, V305, P842, DOI 10.1126/science.1099851; Morris RV, 2004, SCIENCE, V305, P833, DOI 10.1126/science.1100020; Morris RV, 2000, J GEOPHYS RES-PLANET, V105, P1757, DOI 10.1029/1999JE001059; Mutch T. A., 1977, Journal of Geophysical Research, V82, P4452, DOI 10.1029/JS082i028p04452; Rieder R., 2003, Journal of Geophysical Research, V108, pROV7, DOI 10.1029/2003JE002150; Rieder R, 2004, SCIENCE, V306, P1746, DOI 10.1126/science.1104358; Rieder R, 1997, J GEOPHYS RES-PLANET, V102, P4027, DOI 10.1029/96JE03918; Smith PH, 1997, SCIENCE, V278, P1758, DOI 10.1126/science.278.5344.1758; Soderblom LA, 2004, SCIENCE, V306, P1723, DOI 10.1126/science.1105127; Squyres SW, 2004, SCIENCE, V305, P794, DOI 10.1126/science.3050794; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; YEN AS, 2001, LUNAR PLANET SCI C, V32, P1766	47	281	282	3	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2005	436	7047					49	54		10.1038/nature03637	http://dx.doi.org/10.1038/nature03637			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942QJ	16001059				2022-12-01	WOS:000230296600036
J	Morris, CR; Kato, GJ; Poljakovic, M; Wang, XD; Blackwelder, WC; Sachdev, V; Hazen, SL; Vichinsky, EP; Morris, SM; Gladwin, MT				Morris, CR; Kato, GJ; Poljakovic, M; Wang, XD; Blackwelder, WC; Sachdev, V; Hazen, SL; Vichinsky, EP; Morris, SM; Gladwin, MT			Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NITRIC-OXIDE SYNTHASE; ARGINASE ACTIVITY; P-SELECTIN; AIRWAY HYPERRESPONSIVENESS; ADHESION MOLECULES; ENDOTHELIAL-CELLS; AMINO-ACID; ANEMIA; ERYTHROCYTES; EXPRESSION	Context Sickle cell disease is characterized by a state of nitric oxide resistance and limited bioavailability of L-arginine, the substrate for nitric oxide synthesis. We hypothesized that increased arginase activity and dysregulated arginine metabolism contribute to endothelial dysfunction, pulmonary hypertension, and patient outcomes. Objective To explore the role of arginase in sickle cell disease pathogenesis, pulmonary hypertension, and mortality. Design Plasma amino acid levels, plasma and erythrocyte arginase activities, and pulmonary hypertension status as measured by Doppler echocardiogram were prospectively obtained in outpatients with sickle cell disease. Patients were followed,up for survival up to 49 months. Setting Urban tertiary care center and community clinics in the United States between February 2001 and March 2005. Participants Two hundred twenty-eight patients with sickle cell disease, aged 18 to 74 years, and 36 control participants. Main Outcome Measures Plasma amino acid levels, plasma and erythrocyte arginase activities, diagnosis of pulmonary hypertension, and mortality. Results Plasma arginase activity was significantly elevated in patients with sickle cell disease, with highest activity found in patients with secondary pulmonary hypertension. Arginase activity correlated with the arginine-ornithine ratio, and lower ratios were associated with greater severity of pulmonary hypertension and with mortality in this population (risk ratio, 2.5; 95% confidence interval [CI] 1.2-5.2; P=.006). Global arginine bioavailability, characterized by the ratio of arginine to ornithine plus citrulline, was also strongly associated with mortality (risk ratio, 3.6; 95% Cl, 1.5-8.3; P<.001). Increased plasma arginase activity was correlated with increased intravascular hemolytic rate and, to a lesser extent, with markers of inflammation and soluble adhesion molecule levels. Conclusions These data support a novel mechanism of disease in which hemolysis contributes to reduced nitric oxide bioavailability and endothelial dysfunction via release of erythrocyte arginase, which limits arginine bioavailability, and release of erythrocyte hemoglobin, which scavenges nitric oxide. The ratios of arginine to ornithine and arginine to ornithine plus citrulline are independently associated with pulmonary hypertension and increased mortality in patients with sickle cell disease.	Childrens Hosp & Res Ctr Oakland, Dept Emergency Med, Oakland, CA 94609 USA; Childrens Hosp & Res Ctr Oakland, Dept Hematol Oncol, Oakland, CA 94609 USA; NHLBI, Vasc Therapeut Sect, Cardiovasc Branch, NIH, Bethesda, MD 20892 USA; NIH, Dept Crit Care Med, Ctr Clin, Bethesda, MD 20892 USA; NIH, Echocardiog Lab, Bethesda, MD 20892 USA; Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Pittsburgh, PA 15261 USA; Cleveland Clin Fdn, Ctr Cardiovasc Diagnost & Prevent, Dept Cell Biol, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Ctr Cardiovasc Diagnost & Prevent, Dept Cardiovasc Med, Cleveland, OH 44195 USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Morris, SM (corresponding author), Childrens Hosp & Res Ctr Oakland, Dept Emergency Med, 747 52nd St, Oakland, CA 94609 USA.	claudiamorris@comcast.net	Hazen, Stanley L/ABD-5845-2021; Kato, Gregory J/I-7615-2014; Morris, Sidney M/I-3440-2015; Vichinsky, Elliott P/F-8541-2011	Kato, Gregory J/0000-0003-4465-3217; Vichinsky, Elliott P/0000-0002-0500-9579	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001271] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL004386, P01HL076491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057384] Funding Source: NIH RePORTER; CLINICAL CENTER [Z01CL001174] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 HL999999, Z01 CL001174-07, ZIA HL006012-01] Funding Source: Medline; NCRR NIH HHS [M01-RR01271, M01 RR001271] Funding Source: Medline; NHLBI NIH HHS [K23 HL004386, HL-04386-05, P01 HL076491] Funding Source: Medline; NIGMS NIH HHS [R01 GM057384, R01 GM57384] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); CLINICAL CENTER; Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AESSOPOS A, 1995, CHEST, V107, P50, DOI 10.1378/chest.107.1.50; [Anonymous], 2000, NITRIC OXIDE BIOL PA; Archer SL, 1998, AM J RESP CRIT CARE, V158, P1061, DOI 10.1164/ajrccm.158.4.9802113; Aslan M, 2001, P NATL ACAD SCI USA, V98, P15215, DOI 10.1073/pnas.221292098; AZIZI E, 1970, CLIN CHIM ACTA, V28, P391, DOI 10.1016/0009-8981(70)90063-X; Bank N, 1996, KIDNEY INT, V50, P184, DOI 10.1038/ki.1996.301; BELFIORE F, 1964, Riforma Med, V78, P1052; Boucher JL, 1999, CELL MOL LIFE SCI, V55, P1015, DOI 10.1007/s000180050352; Castro O, 2003, BLOOD, V101, P1257, DOI 10.1182/blood-2002-03-0948; Chou R, 2001, AM J HEMATOL, V67, P197, DOI 10.1002/ajh.1107; Chung KF, 1999, THORAX, V54, P825, DOI 10.1136/thx.54.9.825; Closs E, 2000, NITRIC OXIDE BIOL PA, P225; Closs EI, 2002, CURR OPIN NEPHROL HY, V11, P99, DOI 10.1097/00041552-200201000-00015; Cooper CJ, 1996, CIRCULATION, V93, P266, DOI 10.1161/01.CIR.93.2.266; DiasDaMotta PM, 1996, BRIT J HAEMATOL, V93, P333, DOI 10.1046/j.1365-2141.1996.4951036.x; Diwan BA, 2002, TOXICOL PATHOL, V30, P254, DOI 10.1080/019262302753559597; Embury SH, 2004, BLOOD, V104, P3378, DOI 10.1182/blood-2004-02-0713; ENWONWU C O, 1989, Medical Science Research, V17, P997; FEATHERSTON WR, 1973, AM J PHYSIOL, V224, P127, DOI 10.1152/ajplegacy.1973.224.1.127; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Gladwin MT, 2003, CIRCULATION, V107, P271, DOI 10.1161/01.CIR.0000044943.12533.A8; Grunfeld C, 1996, NUTRITION, V12, pS24; Hebbel RP, 2004, MICROCIRCULATION, V11, P129, DOI 10.1080/10739680490278402; HEINZEL B, 1992, BIOCHEM J, V281, P627, DOI 10.1042/bj2810627; HELLER PG, 1992, CHEST, V102, P642, DOI 10.1378/chest.102.2.642; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Jison ML, 2004, BLOOD, V104, P270, DOI 10.1182/blood-2003-08-2760; Jison ML, 2003, AM J RESP CRIT CARE, V168, P3, DOI 10.1164/rccm.2304002; JUBELIRER SJ, 1991, ARCH INTERN MED, V151, P1221, DOI 10.1001/archinte.151.6.1221; Kaneko FT, 1998, AM J RESP CRIT CARE, V158, P917, DOI 10.1164/ajrccm.158.3.9802066; Kaul DK, 2004, J CLIN INVEST, V114, P1136, DOI 10.1172/JCI200421633; Kaul DK, 2000, AM J PHYSIOL-HEART C, V278, pH1799, DOI 10.1152/ajpheart.2000.278.6.H1799; Kim PS, 2002, MOL GENET METAB, V76, P100, DOI 10.1016/S1096-7192(02)00034-3; Komai M, 2003, BRIT J PHARMACOL, V138, P912, DOI 10.1038/sj.bjp.0705105; Koumbourlis AC, 2001, J PEDIATR-US, V138, P188, DOI 10.1067/mpd.2001.111824; Labrune P, 1999, EUR J PEDIATR, V158, P734, DOI 10.1007/s004310051190; Leong MA, 1997, J PEDIATR-US, V131, P278, DOI 10.1016/S0022-3476(97)70166-5; Maggi FM, 2004, J CLIN ENDOCR METAB, V89, P2946, DOI 10.1210/jc.2003-031977; Mansoor MA, 2004, CLIN BIOCHEM, V37, P408, DOI 10.1016/j.clinbiochem.2004.01.003; Marchesi S, 2003, J CLIN PHARM THER, V28, P419, DOI 10.1046/j.0269-4727.2003.00512.x; Matsui NM, 2001, BLOOD, V98, P1955, DOI 10.1182/blood.V98.6.1955; MEHTA S, 1995, CIRCULATION, V92, P1539, DOI 10.1161/01.CIR.92.6.1539; Meurs H, 2003, TRENDS PHARMACOL SCI, V24, P450, DOI 10.1016/S0165-6147(03)00227-X; Meurs H, 2002, BRIT J PHARMACOL, V136, P391, DOI 10.1038/sj.bjp.0704725; Mori M, 2000, BIOCHEM BIOPH RES CO, V275, P715, DOI 10.1006/bbrc.2000.3169; Morris CR, 2000, BRIT J HAEMATOL, V111, P498, DOI 10.1046/j.1365-2141.2000.02403.x; Morris CR, 2003, AM J RESP CRIT CARE, V168, P63, DOI 10.1164/rccm.200208-967OC; Morris CR, 2004, BLOOD, V104, p463A, DOI 10.1182/blood.V104.11.1666.1666; Morris CR, 2004, AM J RESP CRIT CARE, V170, P148, DOI 10.1164/rccm.200309-1304OC; Morris CR, 2003, J PEDIAT HEMATOL ONC, V25, P629, DOI 10.1097/00043426-200308000-00008; Morris CR, 2000, J PEDIAT HEMATOL ONC, V22, P515, DOI 10.1097/00043426-200011000-00009; Morris SM, 2002, ANNU REV NUTR, V22, P87, DOI 10.1146/annurev.nutr.22.110801.140547; Morris SM, 1998, AM J PHYSIOL-ENDOC M, V275, pE740, DOI 10.1152/ajpendo.1998.275.5.E740; Pathare Anil, 2003, Hematology, V8, P329; Raghupathy R, 2000, ACTA HAEMATOL-BASEL, V103, P197, DOI 10.1159/000041049; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Reiter CD, 2003, CURR OPIN HEMATOL, V10, P99, DOI 10.1097/00062752-200303000-00001; REYNOLDS J, 1957, J LAB CLIN MED, V50, P78; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Schnog JJB, 2004, ANN HEMATOL, V83, P371, DOI 10.1007/s00277-004-0856-9; Shores J, 2003, J NATL MED ASSOC, V95, P813; Solovey A, 1997, NEW ENGL J MED, V337, P1584, DOI 10.1056/NEJM199711273372203; Solovey A, 1998, J CLIN INVEST, V101, P1899, DOI 10.1172/JCI1932; STUARD ID, 1972, NEW ENGL J MED, V287, P869, DOI 10.1056/NEJM197210262871710; SUTTON LL, 1994, AM J CARDIOL, V74, P626, DOI 10.1016/0002-9149(94)90760-9; VanderJagt DJ, 1997, J TROP PEDIATRICS, V43, P220, DOI 10.1093/tropej/43.4.220; VERRESEN D, 1991, EUR RESPIR J, V4, P629; Wang XD, 2004, P NATL ACAD SCI USA, V101, P11477, DOI 10.1073/pnas.0402201101; Waugh WH, 1999, NUTR RES, V19, P501, DOI 10.1016/S0271-5317(99)00017-2; Wood K, 2004, MICROCIRCULATION, V11, P377, DOI 10.1080/10739680490437559; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Xia Y, 1996, P NATL ACAD SCI USA, V93, P6770, DOI 10.1073/pnas.93.13.6770; Xu WL, 2004, FASEB J, V18, P1746, DOI 10.1096/fj.04-2317fje; Zimmermann N, 2003, J CLIN INVEST, V111, P1863, DOI 10.1172/JCI200317912; [No title captured]	75	490	515	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 6	2005	294	1					81	90		10.1001/jama.294.1.81	http://dx.doi.org/10.1001/jama.294.1.81			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	941JD	15998894	Green Submitted, Bronze, Green Accepted			2022-12-01	WOS:000230210200028
J	Dubos, F; Leclerc, F				Dubos, F; Leclerc, F			Infants refusing to walk	LANCET			English	Editorial Material									Hop Jeanne de Flandre, F-59037 Lille, France	Universite de Lille - ISITE; CHU Lille	Leclerc, F (corresponding author), Hop Jeanne de Flandre, F-59037 Lille, France.	fleclerc@chru-lille.fr	Dubos, Francois/AGD-5638-2022	dubos, francois/0000-0003-2151-1638					0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 2	2005	366	9479					93	93		10.1016/S0140-6736(05)66831-6	http://dx.doi.org/10.1016/S0140-6736(05)66831-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942JB	15993238				2022-12-01	WOS:000230277600039
J	Fournier, D; Estoup, A; Orivel, J; Foucaud, J; Jourdan, H; Le Breton, J; Keller, L				Fournier, D; Estoup, A; Orivel, J; Foucaud, J; Jourdan, H; Le Breton, J; Keller, L			Clonal reproduction by males and females in the little fire ant	NATURE			English	Article							SEX; PARTHENOGENESIS; EVOLUTION	Sexual reproduction can lead to major conflicts between sexes and within genomes(1-4). Here we report an extreme case of such conflicts in the little fire ant Wasmannia auropunctata. We found that sterile workers are produced by normal sexual reproduction, whereas daughter queens are invariably clonally produced. Because males usually develop from unfertilized maternal eggs in ants and other haplodiploid species, they normally achieve direct fitness only through diploid female offspring. Hence, although the clonal production of queens increases the queen's relatedness to reproductive daughters, it potentially reduces male reproductive success to zero. In an apparent response to this conflict between sexes, genetic analyses reveal that males reproduce clonally, most likely by eliminating the maternal half of the genome in diploid eggs. As a result, all sons have nuclear genomes identical to those of their father. The obligate clonal production of males and queens from individuals of the same sex effectively results in a complete separation of the male and female gene pools. These findings show that the haplodiploid sex-determination system provides grounds for the evolution of extraordinary genetic systems and new types of sexual conflict.	INRA, Ctr Biol & Gest Populat, F-34988 Montferrier Sur Lez, France; Univ Toulouse 3, Lab Evolut & Divers Biol, CNRS, UMR 5174, F-31062 Toulouse, France; IRD, Lab Zool Appl, Noumea 98948, New Caledonia; Univ Ryukyus, Lab Subtrop Zool, Okinawa 9030213, Japan; Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland	INRAE; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Institut de Recherche pour le Developpement (IRD); University of Ryukyus; University of Lausanne	Fournier, D (corresponding author), Univ Libre Bruxelles, CP 160-12,50 Ave FD Roosevelt, B-1050 Brussels, Belgium.	denis.fournier@ulb.ac.be; estoup@ensam.inra.fr	Orivel, Jerome/C-4034-2011; keller, laurent/AAI-7175-2020; Jourdan, Herve/D-1452-2011; Fournier, Denis/EZX-2474-2022	Orivel, Jerome/0000-0002-5636-3228; Jourdan, Herve/0000-0002-3756-4008; Fournier, Denis/0000-0003-4094-0390; keller, laurent/0000-0002-5046-9953; Foucaud, Julien/0000-0003-2272-3149				Arnqvist G, 2002, NATURE, V415, P787, DOI 10.1038/415787a; Baudry E, 2004, GENETICS, V167, P243, DOI 10.1534/genetics.167.1.243; Cahan SH, 2003, NATURE, V424, P306, DOI 10.1038/nature01744; Chapuisat M, 1998, MOL ECOL, V7, P1097, DOI 10.1046/j.1365-294x.1998.00422.x; Cole BJ, 1999, SCIENCE, V285, P891, DOI 10.1126/science.285.5429.891; COOK JM, 1995, TRENDS ECOL EVOL, V10, P281, DOI 10.1016/0169-5347(95)90011-X; CROZIER RH, 1985, BEHAV ECOL SOCIOBIOL, V18, P105, DOI 10.1007/BF00299039; EBERHARD WG, 1980, Q REV BIOL, V55, P231, DOI 10.1086/411855; Fournier D, 2005, MOL ECOL NOTES, V5, P239, DOI 10.1111/j.1471-8286.2005.00889.x; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Holldobler B., 1990, pi; HURST LD, 1992, P ROY SOC B-BIOL SCI, V248, P135, DOI 10.1098/rspb.1992.0053; KOENIGER N, 1989, APIDOLOGIE, V20, P391, DOI 10.1051/apido:19890503; Normark BB, 2003, ANNU REV ENTOMOL, V48, P397, DOI 10.1146/annurev.ento.48.091801.112703; NUR U, 1988, SCIENCE, V240, P512, DOI 10.1126/science.3358129; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Parker JD, 2004, TRENDS ECOL EVOL, V19, P83, DOI 10.1016/j.tree.2003.10.001; Pearcy M, 2004, SCIENCE, V306, P1780, DOI 10.1126/science.1105453; Pomiankowski A, 1999, MG BEH ECOL, P121; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; SHERMAN PW, 1988, AM NAT, V131, P602, DOI 10.1086/284809; Simon JC, 2003, BIOL J LINN SOC, V79, P151, DOI 10.1046/j.1095-8312.2003.00175.x; Swanson WJ, 2001, P NATL ACAD SCI USA, V98, P2509, DOI 10.1073/pnas.051605998; Torres JA, 2001, SOCIOBIOLOGY, V37, P601; Ulloa-Chacon P., 1988, Actes des Colloques Insectes Sociaux, V4, P177; WERREN JH, 1987, NATURE, V327, P75, DOI 10.1038/327075a0	27	201	209	2	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2005	435	7046					1230	1234		10.1038/nature03705	http://dx.doi.org/10.1038/nature03705			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940JJ	15988525	Green Published			2022-12-01	WOS:000230140500043
J	Gu, KY; Yang, B; Tian, DS; Wu, LF; Wang, DJ; Sreekala, C; Yang, F; Chu, ZQ; Wang, GL; White, FF; Yin, ZC				Gu, KY; Yang, B; Tian, DS; Wu, LF; Wang, DJ; Sreekala, C; Yang, F; Chu, ZQ; Wang, GL; White, FF; Yin, ZC			R gene expression induced by a type-III effector triggers disease resistance in rice	NATURE			English	Article							BACTERIAL-BLIGHT-RESISTANCE; XANTHOMONAS-ORYZAE PV; TRANSCRIPTIONAL ACTIVATION; PROTEIN; AVRBS3; IDENTIFICATION; CAMPESTRIS; ENCODES; AVRRPT2; RIN4	Disease resistance (R) genes in plants encode products that specifically recognise incompatible pathogens and trigger a cascade of events leading to disease resistance in the host plant(1). R-gene specificity is dictated by both host R genes and cognate avirulence (avr) genes in pathogens(2,3). However, the basis of gene-for-gene specificity is not well understood. Here, we report the cloning of the R gene Xa27 from rice and the cognate avr gene avrXa27 from Xanthomonas oryzae pv. oryzae. Resistant and susceptible alleles of Xa27 encode identical proteins. However, expression of only the resistant allele occurs when a rice plant is challenged by bacteria harbouring avrXa27, whose product is a nuclear localized type-III effector. Induction of Xa27 occurs only in the immediate vicinity of infected tissue, whereas ectopic expression of Xa27 resulted in resistance to otherwise compatible strains of the pathogen. Thus Xa27 specificity towards incompatible pathogens involves the differential expression of the R gene in the presence of the AvrXa27 effector.	Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117604, Singapore; Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA; Natl Univ Singapore, Inst Mol Agrobiol, Singapore 117604, Singapore	National University of Singapore; Kansas State University; National University of Singapore	Yin, ZC (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, 1 Res Link, Singapore 117604, Singapore.	yinzc@tll.org.sg	Yang, Bing/D-3628-2019	Yang, Bing/0000-0002-2293-3384; YANG, Fan/0000-0002-9664-3953; ?, ??/0000-0002-3982-9858; Wang, Guo-Liang/0000-0001-8877-3064; Chellamma, Sreekala/0000-0002-4615-6719				Belkhadir Y, 2004, CURR OPIN PLANT BIOL, V7, P391, DOI 10.1016/j.pbi.2004.05.009; Belkhadir Y, 2004, PLANT CELL, V16, P2822, DOI 10.1105/tpc.104.024117; Bing Y, 2004, MOL PLANT MICROBE IN, V17, P1192, DOI 10.1094/MPMI.2004.17.11.1192; BONAS U, 1989, MOL GEN GENET, V218, P127, DOI 10.1007/BF00330575; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Greenberg JT, 2003, CURR OPIN MICROBIOL, V6, P20, DOI 10.1016/S1369-5274(02)00004-8; Gu K, 2004, THEOR APPL GENET, V108, P800, DOI 10.1007/s00122-003-1491-x; HERBERS K, 1992, NATURE, V356, P172, DOI 10.1038/356172a0; HOPKINS CM, 1992, MOL PLANT MICROBE IN, V5, P451, DOI 10.1094/MPMI-5-451; Iyer AS, 2004, MOL PLANT MICROBE IN, V17, P1348, DOI 10.1094/MPMI.2004.17.12.1348; KAUFFMAN HE, 1973, PLANT DIS REP, V57, P537; Levy M, 2004, PLANT PHYSIOL, V135, P2392, DOI 10.1104/pp.104.044859; Lim MTS, 2004, PLANT J, V40, P790, DOI 10.1111/j.1365-313X.2004.02251.x; Marois E, 2002, MOL PLANT MICROBE IN, V15, P637, DOI 10.1094/MPMI.2002.15.7.637; Martin GB, 2003, ANNU REV PLANT BIOL, V54, P23, DOI 10.1146/annurev.arplant.54.031902.135035; Radwan O, 2005, J EXP BOT, V56, P567, DOI 10.1093/jxb/eri030; Schornack S, 2004, PLANT J, V37, P46, DOI 10.1046/j.1365-313X.2003.01937.x; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; Sun XL, 2004, PLANT J, V37, P517, DOI 10.1046/j.1365-313X.2003.01976.x; SWARUP S, 1991, PHYTOPATHOLOGY, V81, P802, DOI 10.1094/Phyto-81-802; Szurek B, 2001, PLANT J, V26, P523, DOI 10.1046/j.0960-7412.2001.01046.x; WANG GL, 1995, PLANT J, V7, P525, DOI 10.1046/j.1365-313X.1995.7030525.x; White SD, 1998, ADVANCES IN VETERINARY DERMATOLOGY, VOL 3, P291; Wu AJ, 2004, PLANT CELL, V16, P2809, DOI 10.1105/tpc.104.024141; Yang B, 2000, P NATL ACAD SCI USA, V97, P9807, DOI 10.1073/pnas.170286897; Yin Z, 2000, THEOR APPL GENET, V100, P461, DOI 10.1007/s001220050060; Yoshimura S, 1998, P NATL ACAD SCI USA, V95, P1663, DOI 10.1073/pnas.95.4.1663; Zhu WG, 1998, MOL PLANT MICROBE IN, V11, P824, DOI 10.1094/MPMI.1998.11.8.824	29	405	532	2	117	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 23	2005	435	7045					1122	1125		10.1038/nature03630	http://dx.doi.org/10.1038/nature03630			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937ZT	15973413				2022-12-01	WOS:000229970400054
J	Warrick, DR; Tobalske, BW; Powers, DR				Warrick, DR; Tobalske, BW; Powers, DR			Aerodynamics of the hovering hummingbird	NATURE			English	Article							VORTEX WAKE; FLIGHT; HAWKMOTH; MECHANICS; KINEMATICS; FORCES; WINGS	Despite profound musculoskeletal differences, hummingbirds (Trochilidae) are widely thought to employ aerodynamic mechanisms similar to those used by insects. The kinematic symmetry of the hummingbird upstroke and downstroke(1-3) has led to the assumption that these halves of the wingbeat cycle contribute equally to weight support during hovering, as exhibited by insects of similar size(4). This assumption has been applied, either explicitly or implicitly, in widely used aerodynamic models(1,5-7) and in a variety of empirical tests(8,9). Here we provide measurements of the wake of hovering rufous hummingbirds (Selasphorus rufus) obtained with digital particle image velocimetry that show force asymmetry: hummingbirds produce 75% of their weight support during the downstroke and only 25% during the upstroke. Some of this asymmetry is probably due to inversion of their cambered wings during upstroke. The wake of hummingbird wings also reveals evidence of leading-edge vortices created during the downstroke, indicating that they may operate at Reynolds numbers sufficiently low to exploit a key mechanism typical of insect hovering(10,11). Hummingbird hovering approaches that of insects, yet remains distinct because of effects resulting from an inherently dissimilar-avian-body plan.	Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; Univ Portland, Dept Biol, Portland, OR 97203 USA; George Fox Univ, Dept Biol, Newberg, OR 97132 USA	Oregon State University; University of Portland	Warrick, DR (corresponding author), Oregon State Univ, Dept Zool, 3029 Cordley Hall, Corvallis, OR 97331 USA.	warrickd@science.oregonstate.edu	Powers, Donald/A-1704-2009	Powers, Donald/0000-0003-1126-7141				Altshuler DL, 2004, J ZOOL, V264, P327, DOI 10.1017/s0952836904005813; Combes SA, 2003, J EXP BIOL, V206, P2999, DOI 10.1242/jeb.00502; Dickinson MH, 1999, SCIENCE, V284, P1954, DOI 10.1126/science.284.5422.1954; Dudley R., 2000, BIOMECHANICS INSECT; ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P79, DOI 10.1098/rstb.1984.0052; GREENEWALT CRAWFORD H., 1960, PROC AMER PHIL SOC, V104, P605; Hedrick TL, 2002, J EXP BIOL, V205, P1389; Norberg, 1990, VERTEBRATE FLIGHT ME; Raffel M., 2000, PARTICLE IMAGE VELOC, V3rd; RAYNER JMV, 1979, J FLUID MECH, V91, P697, DOI 10.1017/S0022112079000410; Spedding GR, 2003, J EXP BIOL, V206, P2313, DOI 10.1242/jeb.00423; Spedding GR, 2003, EXP FLUIDS, V34, P291, DOI 10.1007/S00348-002-0559-8; Stolpe M., 1939, Journal fuer Ornithologie, V87, P136, DOI 10.1007/BF01950821; Tobalske BW, 2003, J AVIAN BIOL, V34, P177, DOI 10.1034/j.1600-048X.2003.03006.x; Tobalske BW, 2004, J EXP BIOL, V207, P1345, DOI 10.1242/jeb.00889; Tytell ED, 2003, PHILOS T R SOC B, V358, P1559, DOI 10.1098/rstb.2003.1355; Usherwood JR, 2002, J EXP BIOL, V205, P1547; VandenBerg C, 1997, PHILOS T ROY SOC B, V352, P329, DOI 10.1098/rstb.1997.0024; WEISFOGH T, 1972, J EXP BIOL, V56, P79; WELLS DJ, 1993, J EXP BIOL, V178, P39; Willmott AP, 1997, PHILOS T ROY SOC B, V352, P303, DOI 10.1098/rstb.1997.0022; Willmott AP, 1997, J EXP BIOL, V200, P2705; Willmott AP, 1997, J EXP BIOL, V200, P2723; WOOTTON RJ, 1995, P ROY SOC B-BIOL SCI, V262, P181, DOI 10.1098/rspb.1995.0194	24	222	225	2	100	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 23	2005	435	7045					1094	1097		10.1038/nature03647	http://dx.doi.org/10.1038/nature03647			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937ZT	15973407	Green Submitted			2022-12-01	WOS:000229970400048
J	Smit, P; Raedts, J; Portyanko, V; Debelle, F; Gough, C; Bisseling, T; Geurts, R				Smit, P; Raedts, J; Portyanko, V; Debelle, F; Gough, C; Bisseling, T; Geurts, R			NSP1 of the GRAS protein family is essential for rhizobial Nod factor-induced transcription	SCIENCE			English	Article							RECEPTOR KINASE GENE; MEDICAGO-TRUNCATULA; BACTERIAL; FUNGAL; IDENTIFICATION; TRANSDUCTION; SYMBIOSIS; MUTANTS; CALCIUM	Rhizobial Nod factors induce in their legume hosts the expression of many genes and set in motion developmental processes leading to root nodule formation. Here we report the identification of the Medicago GRAS-type protein Nodulation signaling pathway 1 (NSP1), which is essential for all known Nod factor-induced changes in gene expression. NSP1 is constitutively expressed, and so it acts as a primary transcriptional regulator mediating all known Nod factor-induced transcriptional responses, and therefore, we named it a Nod factor response factor.	Univ Wageningen & Res Ctr, Dept Plant Sci, Mol Biol Lab, NL-6703 HA Wageningen, Netherlands; Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA; INRA, CNRS, Lab Interact Plantes Microorganismes, F-31326 Castanet Tolosan, France	Wageningen University & Research; University of Minnesota System; University of Minnesota Twin Cities; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Bisseling, T (corresponding author), Univ Wageningen & Res Ctr, Dept Plant Sci, Mol Biol Lab, NL-6703 HA Wageningen, Netherlands.	ton.bisseling@wur.nl	Bisseling, Ton/A-2421-2013					Ane JM, 2004, SCIENCE, V303, P1364, DOI 10.1126/science.1092986; Bolle C, 2004, PLANTA, V218, P683, DOI 10.1007/s00425-004-1203-z; Borisov AY, 2003, PLANT PHYSIOL, V131, P1009, DOI 10.1104/pp.102.016071; Catoira R, 2000, PLANT CELL, V12, P1647, DOI 10.1105/tpc.12.9.1647; Endre G, 2002, NATURE, V417, P962, DOI 10.1038/nature00842; Imaizumi-Anraku H, 2005, NATURE, V433, P527, DOI 10.1038/nature03237; Kalo P, 2005, SCIENCE, V308, P1786, DOI 10.1126/science.1110951; Levy J, 2004, SCIENCE, V303, P1361, DOI 10.1126/science.1093038; Limpens E, 2003, SCIENCE, V302, P630, DOI 10.1126/science.1090074; Madsen EB, 2003, NATURE, V425, P637, DOI 10.1038/nature02045; Mitra RM, 2004, P NATL ACAD SCI USA, V101, P10217, DOI 10.1073/pnas.0402186101; Mitra RM, 2004, P NATL ACAD SCI USA, V101, P4701, DOI 10.1073/pnas.0400595101; Oldroyd GED, 2004, NAT REV MOL CELL BIO, V5, P566, DOI 10.1038/nrm1424; Oldroyd GED, 2003, PLANT PHYSIOL, V131, P1027, DOI 10.1104/pp.102.010710; Pysh LD, 1999, PLANT J, V18, P111, DOI 10.1046/j.1365-313X.1999.00431.x; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Schauser L, 1999, NATURE, V402, P191, DOI 10.1038/46058; Stracke S, 2002, NATURE, V417, P959, DOI 10.1038/nature00841; Ulmasov T, 1997, SCIENCE, V276, P1865, DOI 10.1126/science.276.5320.1865; Wais RJ, 2000, P NATL ACAD SCI USA, V97, P13407, DOI 10.1073/pnas.230439797	20	414	445	5	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2005	308	5729					1789	1791		10.1126/science.1111025	http://dx.doi.org/10.1126/science.1111025			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937LY	15961669				2022-12-01	WOS:000229926800055
J	Sigurdson, AJ; Ronckers, CM; Mertens, AC; Stovall, M; Smith, SA; Liu, Y; Berkow, RL; Hammond, S; Neglia, JP; Meadows, AT; Sklar, CA; Robison, LL; Inskip, PD				Sigurdson, AJ; Ronckers, CM; Mertens, AC; Stovall, M; Smith, SA; Liu, Y; Berkow, RL; Hammond, S; Neglia, JP; Meadows, AT; Sklar, CA; Robison, LL; Inskip, PD			Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control study	LANCET			English	Article							2ND MALIGNANT NEOPLASMS; BONE-MARROW-TRANSPLANTATION; HODGKINS-DISEASE; EPIDEMIOLOGIC EVIDENCE; THERAPEUTIC RADIATION; RISK; RADIOTHERAPY; NEUROBLASTOMA; IRRADIATION; LEUKEMIA	Background Survivors of malignant disease in childhood who have had radiotherapy to the head, neck, or upper thorax have an increased risk of subsequent primary thyroid cancer, but the magnitude of risk over the therapeutic dose range has not been well established. We aimed to quantify the long-term risk of thyroid cancer after radiotherapy and chemotherapy. Methods In a nested case-control study, 69 cases with pathologically confirmed thyroid cancer and 265 matched controls without thyroid cancer were identified from 14 054 5-year survivors of cancer during childhood from the Childhood Cancer Survivor Study cohort. Childhood cancers were diagnosed between 1970 and 1986 with cohort follow-up to 2000. Findings Risk of thyroid cancer increased with radiation doses up to 20-29 Gy (odds ratio 9.8 [95% Cl 3.2-34.8]). At doses greater than 30 Gy, a fall in the dose-response relation was seen. Both the increased and decreased risks were more pronounced in those diagnosed with a first primary malignant disease before age 10 years than in those older than 10 years. Furthermore, the fall in risk remained when those diagnosed with Hodgkin's lymphoma were excluded. Chemotherapy for the first cancer was not associated with thyroid-cancer risk, and it did not modify the effect of radiotherapy. 29 (42%) cases had a first diagnosis of Hodgkin's lymphoma compared with 49 (19%) controls. 11 (42%) of those who had Hodgkin's lymphoma had subsequent thyroid cancers smaller than 1 cm compared with six (17%) of those who had other types of childhood cancer (p=0.07). Interpretation The reduction in radiation dose-response for risk of thyroid cancer after childhood exposure to thyroid doses higher than 30 Gy is consistent with a cell-killing effect. Standard long-term follow-up of patients who have had Hodgkin's lymphoma for detection of thyroid cancer should also be undertaken for survivors of any cancer during childhood who received radiotherapy to the thorax or head and neck region.	NCI, Radiat Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA; Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA; Univ Texas, MD Anderson Canc Ctr, Dept Radiat Phys, Houston, TX 77030 USA; Fred Hutchinson Canc Res Ctr, Canc Prevent Res Program, Seattle, WA 98104 USA; Univ Alabama Birmingham, Birmingham, AL USA; Childrens Hosp, Dept Lab Med & Pathol, Columbus, OH 43205 USA; Ohio State Univ, Coll Med, Columbus, OH 43210 USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; UTMD Anderson Cancer Center; Fred Hutchinson Cancer Center; University of Alabama System; University of Alabama Birmingham; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Memorial Sloan Kettering Cancer Center	Sigurdson, AJ (corresponding author), NCI, Radiat Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Serv, 6120 Execut Blvd,EPS 7092,MSC 7238, Bethesda, MD 20892 USA.	sigurdsa@mail.nih.gov	Ronckers, Cecile/GWN-0737-2022; Robison, Leslie/N-8122-2018	Ronckers, Cecile M./0000-0003-3524-4657; Neglia, Joseph/0000-0002-5525-0598	NATIONAL CANCER INSTITUTE [U01CA055727, U24CA055727] Funding Source: NIH RePORTER; NCI NIH HHS [CA 55727, U24 CA055727] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Acharya S, 2003, CANCER-AM CANCER SOC, V97, P2397, DOI 10.1002/cncr.11362; [Anonymous], 1983, BRIT J RADIOL, V17, P1; BARNES ND, 1988, HORM RES, V30, P84, DOI 10.1159/000181034; Bhatia S, 2002, NAT REV CANCER, V2, P124, DOI 10.1038/nrc722; Black P, 1998, MED PEDIATR ONCOL, V31, P91, DOI 10.1002/(SICI)1096-911X(199808)31:2<91::AID-MPO8>3.0.CO;2-U; BOICE JD, 1987, J NATL CANCER I, V79, P1295; BOULAD F, 1995, BONE MARROW TRANSPL, V15, P71; DANGIO GJ, 1976, CANCER, V37, P1177, DOI 10.1002/1097-0142(197602)37:2+<1177::AID-CNCR2820370829>3.0.CO;2-3; Davis S, 2004, RADIAT RES, V162, P241, DOI 10.1667/RR3233; de Vathaire F, 1999, BRIT J CANCER, V79, P1884, DOI 10.1038/sj.bjc.6690300; de Vathaire F, 1999, ARCH INTERN MED, V159, P2713, DOI 10.1001/archinte.159.22.2713; DEVATHAIRE F, 1988, LANCET, V2, P455; DEVATHAIRE F, 1992, BRIT J CANCER, V65, P425, DOI 10.1038/bjc.1992.87; Eden K, 2001, MED PEDIATR ONCOL, V36, P583, DOI 10.1002/mpo.1134; Garwicz S, 2000, INT J CANCER, V88, P672, DOI 10.1002/1097-0215(20001115)88:4<672::AID-IJC24>3.0.CO;2-N; Gilbert ES, 2003, RADIAT RES, V159, P161, DOI 10.1667/0033-7587(2003)159[0161:LCATFH]2.0.CO;2; Gold DG, 2003, CANCER-AM CANCER SOC, V97, P2588, DOI 10.1002/cncr.11356; Goldin LR, 2004, CANCER-AM CANCER SOC, V100, P1902, DOI 10.1002/cncr.20189; Gray LH., 1965, CELLULAR RAD BIOL CO, P7; HALL EJ, 2000, RADIOBIOLOGY RADIOLO, P144; HANCOCK SL, 1991, NEW ENGL J MED, V325, P599, DOI 10.1056/NEJM199108293250902; HAWKINS MM, 1988, LANCET, V2, P804; Inskip PD, 2001, MED PEDIATR ONCOL, V36, P568, DOI 10.1002/mpo.1132; Inskip PD, 1999, MULTIPLE PRIMARY CANCERS, P91; LAND CE, 1981, MEASUREMENT RISKS, V21, P71; LITTLEY MD, 1990, BAILLIERE CLIN ENDOC, V4, P147, DOI 10.1016/S0950-351X(05)80321-0; Metayer C, 2000, J CLIN ONCOL, V18, P2435, DOI 10.1200/JCO.2000.18.12.2435; Michel G, 1997, J CLIN ONCOL, V15, P2238, DOI 10.1200/JCO.1997.15.6.2238; Moppett J, 2001, EUR J RADIOL, V38, P234, DOI 10.1016/S0720-048X(01)00342-4; Neglia JP, 2001, J NATL CANCER I, V93, P618, DOI 10.1093/jnci/93.8.618; Oeffinger KC, 2003, AM FAM PHYSICIAN, V68, P1016; *PHIL MED SYST, RAD ONC SYST; PRESTON DL, 2003, EPICURE 2 10 PECAN; RIES LAG, 1996, CANC EPIDEMIOLOGY PR, P168; Robison LL, 2002, MED PEDIATR ONCOL, V38, P229, DOI 10.1002/mpo.1316; RON E, 1995, RADIAT RES, V141, P259, DOI 10.2307/3579003; Ron E, 1996, CANC EPIDEMIOLOGY PR, P1000; Rubino C, 2003, INT J CANCER, V107, P791, DOI 10.1002/ijc.11455; SHORE RE, 1992, RADIAT RES, V131, P98, DOI 10.2307/3578322; Sklar C, 2000, J CLIN ENDOCR METAB, V85, P3227, DOI 10.1210/jc.85.9.3227; SKLAR CA, 1995, INT J RADIAT ONCOL, V31, P1113, DOI 10.1016/0360-3016(94)00427-M; STOVALL M, 1995, MED PHYS, V22, P63, DOI 10.1118/1.597525; STOVALL M, 1989, MED PHYS, V16, P726, DOI 10.1118/1.596331; TRAVIS LB, 2003, JAMA-J AM MED ASSOC, V290, P165; TUCKER MA, 1991, CANCER RES, V51, P2885; *U MINN CANC CTR, CHILDH CANC SURV STU; *UN SCI COMM EFF A, 2000, 2000 REP GEN ASS ANN; van Santen HM, 2003, J CLIN ENDOCR METAB, V88, P3657, DOI 10.1210/jc.2003-030209; WILLIAMS ED, 1993, HISTOPATHOLOGY, V23, P387, DOI 10.1111/j.1365-2559.1993.tb01227.x	49	262	273	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 11	2005	365	9476					2014	2023		10.1016/S0140-6736(05)66695-0	http://dx.doi.org/10.1016/S0140-6736(05)66695-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	934IB	15950715				2022-12-01	WOS:000229701400023
J	Gordon, MD; Dionne, MS; Schneider, DS; Nusse, R				Gordon, MD; Dionne, MS; Schneider, DS; Nusse, R			WntD is a feedback inhibitor of Dorsal/NF-kappa B in Drosophila development and immunity	NATURE			English	Article							SIGNALING PATHWAY; NUCLEAR IMPORT; TOLL; HOST; ACTIVATION; PROTEIN; EMBRYO; GENE; MELANOGASTER; MORPHOGEN	Regulating the nuclear factor-kappa B (NF-kappa B) family of transcription factors is of critical importance to animals, with consequences of misregulation that include cancer, chronic inflammatory diseases and developmental defects(1). Studies in Drosophila melanogaster have proved fruitful in determining the signals used to control NF-kappa B proteins, beginning with the discovery that the Toll/NF-kappa B pathway, in addition to patterning the dorsal - ventral axis of the fly embryo, defines a major component of the innate immune response in both Drosophila and mammals(2,3). Here, we characterize the Drosophila wntD (Wnt inhibitor of Dorsal) gene. We show that WntD acts as a feedback inhibitor of the NF-kappa B homologue Dorsal during both embryonic patterning and the innate immune response to infection. wntD expression is under the control of Toll/Dorsal signalling, and increased levels of WntD block Dorsal nuclear accumulation, even in the absence of the I kappa B homologue Cactus. The WntD signal is independent of the common Wnt signalling component Armadillo (beta-catenin). By engineering a gene knockout, we show that wntD loss-of-function mutants have immune defects and exhibit increased levels of Toll/Dorsal signalling. Furthermore, the wntD mutant phenotype is suppressed by loss of zygotic dorsal. These results describe the first secreted feedback antagonist of Toll signalling, and demonstrate a novel Wnt activity in the fly.	Stanford Univ, Sch Med, Beckman Ctr, Howard Hughes Med Inst,Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University	Nusse, R (corresponding author), Stanford Univ, Sch Med, Beckman Ctr, Howard Hughes Med Inst,Dept Dev Biol, Stanford, CA 94305 USA.	rnusse@stanford.edu	Dionne, Marc/J-2572-2013; Gordon, Michael D/H-9586-2012	Gordon, Michael D/0000-0002-5440-986X; Dionne, Marc/0000-0002-8283-1750	NIAID NIH HHS [R01 AI053080] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060388] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BELVIN MP, 1995, GENE DEV, V9, P783, DOI 10.1101/gad.9.7.783; Bettencourt R, 2004, J CELL BIOCHEM, V92, P849, DOI 10.1002/jcb.20123; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Brandt SM, 2004, PLOS BIOL, V2, P2067, DOI 10.1371/journal.pbio.0020418; Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; Dionne MS, 2003, INFECT IMMUN, V71, P3540, DOI 10.1128/IAI.71.6.3540-3550.2003; Drier EA, 2000, CURR BIOL, V10, P23, DOI 10.1016/S0960-9822(99)00267-5; Ganguly A, 2005, DEVELOPMENT, V132, P3419, DOI 10.1242/dev.01903; GILLESPIE SKH, 1994, MOL CELL BIOL, V14, P3559, DOI 10.1128/MCB.14.6.3559; Green C, 2000, GENETICS, V156, P1117; Gross I, 1996, NUCLEIC ACIDS RES, V24, P1238, DOI 10.1093/nar/24.7.1238; Hamada F, 1999, SCIENCE, V283, P1739, DOI 10.1126/science.283.5408.1739; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Lemaitre B, 2004, NAT REV IMMUNOL, V4, P521, DOI 10.1038/nri1390; LEMAITRE B, 1995, EMBO J, V14, P536, DOI 10.1002/j.1460-2075.1995.tb07029.x; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; Llimargas M, 2001, P NATL ACAD SCI USA, V98, P14487, DOI 10.1073/pnas.251304398; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mansfield BE, 2003, CELL MICROBIOL, V5, P901, DOI 10.1046/j.1462-5822.2003.00329.x; Meng XJ, 1999, GENE DEV, V13, P792, DOI 10.1101/gad.13.7.792; MORISATO D, 1994, CELL, V76, P677, DOI 10.1016/0092-8674(94)90507-X; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; RUSCH J, 1994, GENE DEV, V8, P1247, DOI 10.1101/gad.8.11.1247; RUSHLOW CA, 1989, CELL, V59, P1165, DOI 10.1016/0092-8674(89)90772-1; Stathopoulos A, 2002, CELL, V111, P687, DOI 10.1016/S0092-8674(02)01087-5; Zambon RA, 2005, P NATL ACAD SCI USA, V102, P7257, DOI 10.1073/pnas.0409181102; Zettervall CJ, 2004, P NATL ACAD SCI USA, V101, P14192, DOI 10.1073/pnas.0403789101	30	123	134	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 29	2005	437	7059					746	749		10.1038/nature04073	http://dx.doi.org/10.1038/nature04073			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968JD	16107793	Green Accepted			2022-12-01	WOS:000232157900055
J	Vollbrecht, E; Springer, PS; Goh, L; Buckler, ES; Martienssen, R				Vollbrecht, E; Springer, PS; Goh, L; Buckler, ES; Martienssen, R			Architecture of floral branch systems in maize and related grasses	NATURE			English	Article							MERISTEM IDENTITY; GENE; SHOOT; EVOLUTION; MORPHOGENESIS; SELECTION; PATTERNS; ENCODES; TASSEL	The external appearance of flowering plants is determined to a large extent by the forms of flower-bearing branch systems, known as inflorescences, and their position in the overall structure of the plant. Branches and branching patterns are produced by tissues called shoot apical meristems. Thus, inflorescence architecture reflects meristem number, arrangement and activity, and the duration of meristem activity correlates with branch length. The inflorescences of maize, unlike those of related grasses such as rice and sorghum, predominantly lack long branches, giving rise to the tassel and familiar corncob. Here we report the isolation of the maize ramosa1 gene and show that it controls inflorescence architecture. Through its expression in a boundary domain near the nascent meristem base, ramosa1 imposes short branch identity as branch meristems are initiated. A second gene, ramosa2, acts through ramosa1 by regulating ramosa1 gene expression levels. ramosa1 encodes a transcription factor that appears to be absent in rice, is heterochronically expressed in sorghum, and may have played an important role in maize domestication and grass evolution.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Cornell Univ, Dept Plant Breeding, Ithaca, NY 14850 USA	Cold Spring Harbor Laboratory; Cornell University	Martienssen, R (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	martiens@cshl.org	Buckler, Edward/L-7651-2019; Buckler, Edward/GPS-4932-2022	Buckler, Edward/0000-0002-3100-371X; Vollbrecht, Erik/0000-0003-4919-1365				Bommert P, 2005, DEVELOPMENT, V132, P1235, DOI 10.1242/dev.01671; CHENG PC, 1983, AM J BOT, V70, P450, DOI 10.2307/2443252; Chuck G, 2002, SCIENCE, V298, P1238, DOI 10.1126/science.1076920; Chuck G, 1998, GENE DEV, V12, P1145, DOI 10.1101/gad.12.8.1145; Clifford H.T., 1986, GRASS SYSTEMATICS EV, P21; Collins GN, 1917, P NATL ACAD SCI USA, V3, P345, DOI 10.1073/pnas.3.5.345; DAWE RK, 1990, DEV BIOL, V142, P233, DOI 10.1016/0012-1606(90)90167-H; Doebley J, 2004, ANNU REV GENET, V38, P37, DOI 10.1146/annurev.genet.38.072902.092425; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; DOEBLEY J, 1993, GENETICS, V134, P559; Doust AN, 2002, AM J BOT, V89, P1203, DOI 10.3732/ajb.89.8.1203; EMERSON RA, 1935, CORNELL U AGR EXP ST, V180, P3; Gallavotti A, 2004, NATURE, V432, P630, DOI 10.1038/nature03148; Gernert WB, 1912, AM NAT, V46, P616, DOI 10.1086/279312; HUDSON RR, 1987, GENETICS, V116, P153; JACKSON D, 1994, DEVELOPMENT, V120, P405; KELLOGG E, 2000, GRASSES SYSTEMATICS; Kellogg EA, 2004, CURR OPIN PLANT BIOL, V7, P92, DOI 10.1016/j.pbi.2003.11.004; Kelly AL, 1997, INT DAIRY J, V7, P411, DOI 10.1016/S0958-6946(97)00038-1; Martienssen R, 1997, NATURE, V386, P443, DOI 10.1038/386443a0; MCCLINTOCK B, 1953, GENETICS, V38, P579; McSteen P, 2000, TRENDS PLANT SCI, V5, P61, DOI 10.1016/S1360-1385(99)01541-1; NICKERSON NORTON H., 1955, ANN MISSOURI BOT GARDEN, V42, P195, DOI 10.2307/2394655; POETHIG RS, 1990, SCIENCE, V250, P923, DOI 10.1126/science.250.4983.923; POSTLETHEWAIT SN, 1964, AM J BOT, V51, P238, DOI 10.2307/2440292; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; SAKAI H, 1995, NATURE, V378, P199, DOI 10.1038/378199a0; Sambrook JF., 2001, MOL CLONING LAB MANU; Sussex IM, 2001, CURR OPIN PLANT BIOL, V4, P33, DOI 10.1016/S1369-5266(00)00132-1; Taguchi-Shiobara F, 2001, GENE DEV, V15, P2755, DOI 10.1101/gad.208501; Takatsuji H, 1999, PLANT MOL BIOL, V39, P1073, DOI 10.1023/A:1006184519697; Takeda T, 2003, PLANT J, V33, P513, DOI 10.1046/j.1365-313X.2003.01648.x; Tenaillon MI, 2001, P NATL ACAD SCI USA, V98, P9161, DOI 10.1073/pnas.151244298; Troll W., 1964, INFLORESZENZEN TYPOL; VEIT B, 1993, PLANT CELL, V5, P1205, DOI 10.1105/tpc.5.10.1205; Vollbrecht E, 2000, DEVELOPMENT, V127, P3161; Walsh J, 1999, PLANT J, V19, P489, DOI 10.1046/j.1365-313X.1999.00541.x; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; Weberling F., 1989, MORPHOLOGY FLOWERS I; Whitt SR, 2002, P NATL ACAD SCI USA, V99, P12959, DOI 10.1073/pnas.202476999; Wilson LM, 2004, PLANT CELL, V16, P2719, DOI 10.1105/tpc.104.025700	42	237	274	4	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2005	436	7054					1119	1126		10.1038/nature03892	http://dx.doi.org/10.1038/nature03892			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958AK	16041362				2022-12-01	WOS:000231416600037
J	Mills, E				Mills, E			Insurance in a climate of change	SCIENCE			English	Article							EXTREMES; FLUCTUATIONS; TRAGEDY; IMPACTS; WEATHER; COMMONS; HEALTH; RISK	Catastrophe insurance provides peace of mind and financial security. Climate change can have adverse impacts on insurance affordability and availability, potentially slowing the growth of the industry and shifting more of the burden to governments and individuals. Most forms of insurance are vulnerable, including property, liability, health, and life. It is incumbent on insurers, their regulators, and the policy community to develop a better grasp of the physical and business risks. Insurers are well positioned to participate in public-private initiatives to monitor loss trends, improve catastrophe modeling, address the causes of climate change, and prepare for and adapt to the impacts.	Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Mills, E (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, MS 90-4000, Berkeley, CA 94720 USA.	emills@lbl.gov						*ALL GROUP WORLD W, 2005, CLIM CHANG FIN SECT; All Industry Research Advisory Council, 1986, CAT LOSS INS SYST WO; Allen MR, 2004, NATURE, V432, P551, DOI 10.1038/432551a; ALLEY RB, 2003, SCIENCE, V10, P1126; *AM RE, 2005, ANN REV N AM CAT 200; *ASS BRIT INS, 2005, FIN RISKS CLIM CHANG; Association of British Insurers, 2004, CHANG CLIM INS; Changnon SA, 1996, CLIMATIC CHANGE, V32, P411, DOI 10.1007/BF00140354; Changnon SA, 2000, B AM METEOROL SOC, V81, P437, DOI 10.1175/1520-0477(2000)081<0437:HFETIL>2.3.CO;2; Changnon SD, 2003, B AM METEOROL SOC, V84, P1231, DOI 10.1175/BAMS-84-9-1231; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Epstein PR, 1999, SCIENCE, V285, P347, DOI 10.1126/science.285.5426.347; Fried JS, 2004, CLIMATIC CHANGE, V64, P169, DOI 10.1023/B:CLIM.0000024667.89579.ed; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hardin G, 1998, SCIENCE, V280, P682, DOI 10.1126/science.280.5364.682; Karl TR, 2003, SCIENCE, V302, P1719, DOI 10.1126/science.1090228; Kunkel KE, 1999, B AM METEOROL SOC, V80, P1077, DOI 10.1175/1520-0477(1999)080<1077:TFIWAC>2.0.CO;2; KUNREUTHER H, 2005, INSURANCE COPING GLO; LACOMMARE K, 2004, 55718 LAWR BERK NAT; LINNEROOTHBAYER J, 2003, UNFCCC UN NAT FRAM C; MENZINGER I, 2002, FLOODS ARE INSURABLE; Millan EJ, 2002, J PROTEIN CHEM, V21, P1, DOI 10.1023/A:1014174630063; Mills E, 2003, ENERG POLICY, V31, P1257, DOI 10.1016/S0301-4215(02)00186-6; MILLS E, 2004, 52220 LAWR BERK NAT; MILLS E, 1996, J SOC INSUR RES  FAL, P21; MILLS E, IN PRESS MITIGATION; *MUN RE GEOSC RES, 2000, TOP 2000 NAT CAT CUR; *MUN RE MUN REINS, 1973, FLOOD IN; *MUNCH RUCKV GES, 2005, WEATH CAT CLIM CHANG; *N AM EL REL COUNC, ANN DIST REP 1992 20; Nelson FE, 2001, NATURE, V410, P889, DOI 10.1038/35073746; Nutter F. W., 1996, J SOC INSUR RES  FAL, P15; Reeve N, 1999, Q J ROY METEOR SOC, V125, P893, DOI 10.1002/qj.49712555507; Schar C, 2004, NATURE, V427, P332, DOI 10.1038/nature02300; Schwartz Peter, 2003, ABRUPT CLIMATE CHANG; *SWISS RE CTR GLOB, 2004, CLIM CHANG FUT EX RO; *SWISS RE SWISS RE, 2002, OPP RISKS CLIM CHANG; UNEP, 2002, CLIM CHANG FIN SERV; *US GOV ACC OFF, 2005, GAO05199; Vellinga P.V, 2001, CLIMATE CHANGE 2001; WHO, 2003, CLIM CHANG HUM HLTH; ZHANG K, 2005, CLIMATIC CHANGE, V64, P41	42	221	223	4	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2005	309	5737					1040	1044		10.1126/science.1112121	http://dx.doi.org/10.1126/science.1112121			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955MN	16099975				2022-12-01	WOS:000231230100035
J	Banin, A				Banin, A			Planetary science - The enigma of the Martian soil	SCIENCE			English	Editorial Material							X-RAY SPECTROMETER; MERIDIANI-PLANUM; GUSEV CRATER; MOSSBAUER SPECTROMETER; CHEMICAL-COMPOSITION; MICROBIAL LIFE; ATACAMA DESERT; MARS; ROCKS; MINERALOGY		Hebrew Univ Jerusalem, Dept Soil & Water Sci, IL-76100 Rehovot, Israel; SETI Inst, Mountain View, CA 94043 USA	Hebrew University of Jerusalem	Banin, A (corresponding author), Hebrew Univ Jerusalem, Dept Soil & Water Sci, IL-76100 Rehovot, Israel.	amos.banin@huji.ac.il						Banin A, 1997, J GEOPHYS RES-PLANET, V102, P13341, DOI 10.1029/97JE01160; Banin A., 1992, MARS, P594; Benner SA, 2000, P NATL ACAD SCI USA, V97, P2425, DOI 10.1073/pnas.040539497; Biemann K., 1977, Journal of Geophysical Research, V82, P4641, DOI 10.1029/JS082i028p04641; BURNS RG, 1990, J GEOPHYS RES-SOLID, V95, P14415, DOI 10.1029/JB095iB09p14415; CLARK BC, 1982, J GEOPHYS RES, V87, P59, DOI 10.1029/JB087iB12p10059; Gellert R, 2004, SCIENCE, V305, P829, DOI 10.1126/science.1099913; Klingelhofer G, 2004, SCIENCE, V306, P1740, DOI 10.1126/science.1104653; Levin G. V., 1977, Journal of Geophysical Research, V82, P4663, DOI 10.1029/JS082i028p04663; Maier RM, 2004, SCIENCE, V306, P1289; Morris RV, 2004, SCIENCE, V305, P833, DOI 10.1126/science.1100020; Navarro-Gonzalez R, 2003, SCIENCE, V302, P1018, DOI 10.1126/science.1089143; Rieder R, 1997, SCIENCE, V278, P1771, DOI 10.1126/science.278.5344.1771; Rieder R, 2004, SCIENCE, V306, P1746, DOI 10.1126/science.1104358; Squyres SW, 2004, SCIENCE, V305, P794, DOI 10.1126/science.3050794; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; Squyres SW, 2004, SCIENCE, V306, P1709, DOI 10.1126/science.1104559; Tosca NJ, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002218; Toulmin P.  III, 1977, Journal of Geophysical Research, V82, P4625, DOI 10.1029/JS082i028p04625	19	13	13	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 5	2005	309	5736					888	890		10.1126/science.1112794	http://dx.doi.org/10.1126/science.1112794			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953SS	16081725				2022-12-01	WOS:000231101400032
J	VanderVen, BC; Harder, JD; Crick, DC; Belisle, JT				VanderVen, BC; Harder, JD; Crick, DC; Belisle, JT			Export-mediated assembly of mycobacterial glycoproteins parallels eukaryotic pathways	SCIENCE			English	Article							ESCHERICHIA-COLI; O-MANNOSYLATION; TUBERCULOSIS; GLYCOSYLATION; ANTIGEN; BIOSYNTHESIS; SECRETION; RESPONSES; MEMBRANE; PROTEINS	Protein O-mannosylation is an essential and evolutionarily conserved post-translational modification among eukaryotes. This form of protein modification is also described in Mycobacterium tuberculosis; however, the mechanism of mannoprotein assembly remains unclear. Evaluation of differentially translocated chimeric proteins and mass spectrometry to monitor glycosylation demonstrated that specific translocation processes were required for protein O-mannosylation in M. tuberculosis. Additionally, Rv1002c, a M. tuberculosis membrane protein homolog of eukaryotic protein mannosyltransferases, was shown to catalyze the initial step of protein mannosylation. Thus, the-process of protein mannosylation is conserved between M. tuberculosis and eukaryotic organisms.	Colorado State Univ, Dept Microbiol Immunol & Pathol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA	Colorado State University	Belisle, JT (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA.	jbelisle@colostate.edu	Crick, Dean/H-8251-2017; Belisle, John/B-8944-2017	Crick, Dean/0000-0001-9281-7058; Belisle, John/0000-0002-2539-2798	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044042] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI-44042] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDERSEN P, 1991, INFECT IMMUN, V59, P1905, DOI 10.1128/IAI.59.6.1905-1910.1991; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; Bensing BA, 2004, J BACTERIOL, V186, P638, DOI 10.1128/JB.186.3.638-645.2004; Braunstein M, 2003, MOL MICROBIOL, V48, P453, DOI 10.1046/j.1365-2958.2003.03438.x; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Cooper HN, 2002, GLYCOBIOLOGY, V12, P427, DOI 10.1093/glycob/cwf051; Danese PN, 1998, ANNU REV GENET, V32, P59, DOI 10.1146/annurev.genet.32.1.59; Dobos KM, 1996, J BACTERIOL, V178, P2498, DOI 10.1128/jb.178.9.2498-2506.1996; Ecker M, 2003, EMBO REP, V4, P628, DOI 10.1038/sj.embor.embor864; ESPITIA C, 1989, CLIN EXP IMMUNOL, V77, P378; GARBE T, 1993, INFECT IMMUN, V61, P260, DOI 10.1128/IAI.61.1.260-267.1993; Girrbach V, 2000, J BIOL CHEM, V275, P19288, DOI 10.1074/jbc.M001771200; Horn C, 1999, J BIOL CHEM, V274, P32023, DOI 10.1074/jbc.274.45.32023; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Josenhans C, 2002, FEMS MICROBIOL LETT, V210, P165, DOI 10.1016/S0378-1097(02)00638-9; Michell SL, 2003, J BIOL CHEM, V278, P16423, DOI 10.1074/jbc.M207959200; NILSSON I, 1993, J BIOL CHEM, V268, P5798; Romain F, 1999, INFECT IMMUN, V67, P5567, DOI 10.1128/IAI.67.11.5567-5572.1999; Ronning DR, 2000, NAT STRUCT BIOL, V7, P141; Schmidt MA, 2003, TRENDS MICROBIOL, V11, P554, DOI 10.1016/j.tim.2003.10.004; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Strahl-Bolsinger S, 1999, BBA-GEN SUBJECTS, V1426, P297, DOI 10.1016/S0304-4165(98)00131-7; Upreti RK, 2003, PROTEOMICS, V3, P363, DOI 10.1002/pmic.200390052; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Willer T, 2003, CURR OPIN STRUC BIOL, V13, P621, DOI 10.1016/j.sbi.2003.09.003	25	108	117	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2005	309	5736					941	943		10.1126/science.1114347	http://dx.doi.org/10.1126/science.1114347			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953SS	16081738				2022-12-01	WOS:000231101400049
J	Giorgio, M; Migliaccio, E; Orsini, F; Paolucci, D; Moroni, M; Contursi, C; Pelliccia, G; Luzi, L; Minucci, S; Marcaccio, M; Pinton, P; Rizzuto, R; Bernardi, P; Paolucci, F; Pelicci, PG				Giorgio, M; Migliaccio, E; Orsini, F; Paolucci, D; Moroni, M; Contursi, C; Pelliccia, G; Luzi, L; Minucci, S; Marcaccio, M; Pinton, P; Rizzuto, R; Bernardi, P; Paolucci, F; Pelicci, PG			Electron transfer between cytochrome c and p66(Shc) generates reactive oxygen species that trigger mitochondrial apoptosis	CELL			English	Article							CELL-DEATH; SUPEROXIDE; MECHANISMS; OXIDANTS; DOMAIN; OUTER; PROBE	Reactive oxygen species (ROS) are potent inducers of oxidative damage and have been implicated in the regulation of specific cellular functions, including apoptosis. Mitochondrial ROS increase markedly after proapoptotic signals, though the biological significance and the underlying molecular mechanisms remain undetermined. P66(Shc) is a genetic determinant of life span in mammals, which regulates ROS metabolism and apoptosis. We report here that p66(Shc) is a redox enzyme that generates mitochondrial ROS (hydrogen peroxide) as signaling molecules for apoptosis. For this function, p66(Shc) utilizes reducing equivalents of the mitochondrial electron transfer chain through the oxidation of cytochrome c. Redox-defective mutants of p66(Shc) are unable to induce mitochondrial ROS generation and swelling in vitro or to mediate mitochondrial apoptosis in vivo. These data demonstrate the existence of alternative redox reactions of the mitochondrial electron transfer chain, which evolved to generate proapoptotic ROS in response to specific stress signals.	European Inst Oncol, Expt Oncol Dept, Milan, Italy; FIRC Inst Mol Oncol, Milan, Italy; Univ Bologna, G Ciamician Chem Dept, Bologna, Italy; Congenia Srt, Bologna, Italy; Univ Padua, Dept Biomed Sci, Padua, Italy; Univ Ferrara, Expt & Diagnost Med Dept, I-44100 Ferrara, Italy; Univ Milan, Dept Med & Surg, Milan, Italy	IRCCS European Institute of Oncology (IEO); IFOM - FIRC Institute of Molecular Oncology; University of Bologna; University of Padua; University of Ferrara; University of Milan	Giorgio, M (corresponding author), European Inst Oncol, Expt Oncol Dept, Milan, Italy.	marco.giorgio@ifom-ieo-campus.it; piergiuseppe.pellici@ifom-ieo-campus.it	Pinton, Paolo/J-8025-2012; Giorgio, Marco/I-9425-2012; Franzeck, Fabian C/B-5055-2011; Paolucci, Francesco/A-8708-2008; Minucci, Saverio/J-9669-2012; Rizzuto, Rosario/B-6312-2008; Bernardi, Paolo/C-3656-2008; Luzi, Lucilla/K-4350-2018; Pelicci, Pier Giuseppe/AAL-6572-2020; Migliaccio, Enrica/AAQ-8880-2020	Pinton, Paolo/0000-0001-7108-6508; Giorgio, Marco/0000-0002-5842-6042; Paolucci, Francesco/0000-0003-4614-8740; Bernardi, Paolo/0000-0001-9187-3736; Luzi, Lucilla/0000-0002-8746-4179; Rizzuto, Rosario/0000-0001-7044-5097				Armstrong FA, 2002, J CHEM SOC DALTON, P661, DOI 10.1039/b108359g; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Becker LB, 2004, CARDIOVASC RES, V61, P461, DOI 10.1016/j.cardiores.2003.10.025; BERNARDI P, 1981, J BIOL CHEM, V256, P7187; Bernardi P, 2001, TRENDS BIOCHEM SCI, V26, P112, DOI 10.1016/S0968-0004(00)01745-X; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Cai JY, 1998, J BIOL CHEM, V273, P11401, DOI 10.1074/jbc.273.19.11401; Callegari A, 2004, J MATER CHEM, V14, P807, DOI 10.1039/b316806a; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Chen XX, 2002, LANGMUIR, V18, P7009, DOI 10.1021/la0204794; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; DIWAN JJ, 1988, BIOCHEM PHARMACOL, V37, P957, DOI 10.1016/0006-2952(88)90188-8; Francia P, 2004, CIRCULATION, V110, P2889, DOI 10.1161/01.CIR.0000147731.24444.4D; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Griparic L, 2004, J BIOL CHEM, V279, P18792, DOI 10.1074/jbc.M400920200; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; MAYER M, 1994, P NATL ACAD SCI USA, V91, P7496, DOI 10.1073/pnas.91.16.7496; Migliaccio E, 1997, EMBO J, V16, P706, DOI 10.1093/emboj/16.4.706; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Napoli C, 2003, P NATL ACAD SCI USA, V100, P2112, DOI 10.1073/pnas.0336359100; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Orsini F, 2004, J BIOL CHEM, V279, P25689, DOI 10.1074/jbc.M401844200; Pacini S, 2004, MOL CELL BIOL, V24, P1747, DOI 10.1128/MCB.24.4.1747-1757.2004; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; Pelicci PG, 2004, J CLIN INVEST, V113, P4, DOI 10.1172/JCI200420750; PETRONILLI V, 1994, J BIOL CHEM, V269, P16638; Sakon S, 2003, EMBO J, V22, P3898, DOI 10.1093/emboj/cdg379; Sarti P, 2003, IUBMB LIFE, V55, P605, DOI 10.1080/15216540310001628726; Scorrano L, 2003, BIOCHEM BIOPH RES CO, V304, P437, DOI 10.1016/S0006-291X(03)00615-6; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Trinei M, 2002, ONCOGENE, V21, P3872, DOI 10.1038/sj.onc.1205513; Ventura A, 2004, J BIOL CHEM, V279, P2299, DOI 10.1074/jbc.M307655200; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Zaccagnini G, 2004, CIRCULATION, V109, P2917, DOI 10.1161/01.CIR.0000129309.58874.0F; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4; Zhen YJ, 1999, J BIOL CHEM, V274, P38032, DOI 10.1074/jbc.274.53.38032	36	864	906	8	88	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 29	2005	122	2					221	233		10.1016/j.cell.2005.05.011	http://dx.doi.org/10.1016/j.cell.2005.05.011			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	951CR	16051147	Bronze			2022-12-01	WOS:000230907000010
J	Murdoch, W; Briggs, CJ; Swarbrick, S				Murdoch, W; Briggs, CJ; Swarbrick, S			Host suppression and stability in a parasitoid-host system: Experimental demonstration	SCIENCE			English	Article							CALIFORNIA RED SCALE; BIOLOGICAL-CONTROL; APHYTIS-MELINUS; POPULATION; MODELS; SIZE	We elucidate the mechanisms causing stability and severe resource suppression in a consumer-resource system. The consumer, the parasitoid Aphytis, rapidly controlled an experimentally induced outbreak of the resource, California red scale, an agricultural pest, and imposed a low, stable pest equilibrium. The results are well predicted by a mechanistic, independently parameterized model. The key mechanisms are widespread in nature: an invulnerable adult stage in the resource population and rapid consumer development. Stability in this biologically nondiverse agricultural system is a property of the local interaction between these two species, not of spatial processes or of the larger ecological community.	Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Santa Barbara; University of California System; University of California Berkeley	Murdoch, W (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.	murdoch@lifesci.ucsb.edu	Briggs, Cheryl/F-7456-2013					DeBach P., 1971, BIOL CONTROL, P165, DOI DOI 10.1007/978-1-4615-6531-4_7; HASSELL MP, 1978, MONOGRAPHS POPULATIO, V13; LUCK RF, 1985, ECOLOGY, V66, P904, DOI 10.2307/1940553; May R.M., 1976, P49; MCNAIR JN, 1987, THEOR POPUL BIOL, V32, P383, DOI 10.1016/0040-5809(87)90056-6; MURDOCH WW, 1994, ECOLOGY, V75, P271, DOI 10.2307/1939533; Murdoch WW, 1996, AM NAT, V148, P807, DOI 10.1086/285957; MURDOCH WW, 1995, ECOLOGY, V76, P206, DOI 10.2307/1940642; Murdoch WW, 1996, AM NAT, V147, P424, DOI 10.1086/285859; MURDOCH WW, 1992, J ANIM ECOL, V61, P533, DOI 10.2307/5608; Murdoch WW, 2003, MONOGRAPHS POPULATIO; REEVE JD, 1986, J ANIM ECOL, V55, P1069, DOI 10.2307/4434; REEVE JD, 1985, J ANIM ECOL, V54, P797, DOI 10.2307/4379; Rosen D., 1979, SPECIES APHYTIS WORL; ROSENZWE.ML, 1971, SCIENCE, V171, P385, DOI 10.1126/science.171.3969.385; SMITH RH, 1974, THEOR POPUL BIOL, V6, P308, DOI 10.1016/0040-5809(74)90014-8	16	45	47	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 22	2005	309	5734					610	613		10.1126/science.1114426	http://dx.doi.org/10.1126/science.1114426			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SE	16040706				2022-12-01	WOS:000230735200048
J	Greene, M; Schill, K; Takahashi, S; Bateman-House, A; Beauchamp, T; Bok, H; Cheney, D; Coyle, J; Deacon, T; Dennett, D; Donovan, P; Flanagan, O; Goldman, S; Greely, H; Martin, L; Miller, E; Mueller, D; Siegel, A; Solter, D; Gearhart, J; McKhann, G; Faden, R				Greene, M; Schill, K; Takahashi, S; Bateman-House, A; Beauchamp, T; Bok, H; Cheney, D; Coyle, J; Deacon, T; Dennett, D; Donovan, P; Flanagan, O; Goldman, S; Greely, H; Martin, L; Miller, E; Mueller, D; Siegel, A; Solter, D; Gearhart, J; McKhann, G; Faden, R			Moral issues of human-non-human primate neural grafting	SCIENCE			English	Editorial Material							STEM-CELLS; CHIMPANZEES		Johns Hopkins Univ, Phoebe R Berman Bioeth Inst, Baltimore, MD 21218 USA; Univ Delaware, Newark, DE 19716 USA; Case Western Reserve Univ, Cleveland, OH 44106 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; Columbia Univ, New York, NY 10027 USA; Georgetown Univ, Washington, DC 20057 USA; Univ Penn, Philadelphia, PA 19104 USA; Harvard Univ, Cambridge, MA 02138 USA; Univ Calif Berkeley, Berkeley, CA 94720 USA; Tufts Univ, Medford, MA 02155 USA; Duke Univ, Durham, NC 27706 USA; Univ Rochester, Rochester, NY 14627 USA; Stanford Univ, Stanford, CA 94305 USA; MIT, Cambridge, MA 02139 USA; Univ Maryland, College Pk, MD 20742 USA; Max Planck Inst Immunobiol, Freiburg, Germany	Johns Hopkins University; University of Delaware; Case Western Reserve University; Johns Hopkins University; Columbia University; Georgetown University; University of Pennsylvania; Harvard University; University of California System; University of California Berkeley; Tufts University; Duke University; University of Rochester; Stanford University; Massachusetts Institute of Technology (MIT); University System of Maryland; University of Maryland College Park; Max Planck Society	Faden, R (corresponding author), Johns Hopkins Univ, Phoebe R Berman Bioeth Inst, Baltimore, MD 21218 USA.	rfaden@jhsph.edu	Miller, Earl K./AAE-8187-2019; Solter, Davor/Q-5476-2019; Bateman-House, Alison/AAP-6213-2021	Miller, Earl K./0000-0002-0582-6958; Bateman-House, Alison/0000-0001-6921-9666; Goldman, Steven/0000-0002-5498-4303; Greene, Mark/0000-0001-9512-4943; Solter, Davor/0000-0002-8438-347X				Brustle O, 1998, NAT BIOTECHNOL, V16, P1040, DOI 10.1038/3481; Committee on Guidelines for Human Embryonic Stem Cell Research, 2005, GUID HUM EMBR STEM C; Fink JS, 2000, CELL TRANSPLANT, V9, P273, DOI 10.1177/096368970000900212; FUKUYAMA F, 2004, WASHINGTON POST 0215; KANT I, 1998, CAMBRIDGE TEXTS HIST, P37; Karpowicz P, 2004, NAT MED, V10, P331, DOI 10.1038/nm0404-331; Long KD, 2001, P NATL ACAD SCI USA, V98, P5862, DOI 10.1073/pnas.091080098; MILL JS, UTILITARIANISM, P87; Ourednik V, 2001, SCIENCE, V293, P1820, DOI 10.1126/science.1060580; Oxnard CE, 2004, INT J PRIMATOL, V25, P1127, DOI 10.1023/B:IJOP.0000043355.96393.8b; Pau K-Y Francis, 2004, Reprod Biol Endocrinol, V2, P41, DOI 10.1186/1477-7827-2-41; Rakic P, 2004, NATURE, V427, P685, DOI 10.1038/427685a; Robert JS, 2004, BIOESSAYS, V26, P1005, DOI 10.1002/bies.20100; SINGER P, 1979, INQUIRY, V22, P145, DOI 10.1080/00201747908601869; TOMASELLO M, 1993, CHILD DEV, V64, P1688, DOI 10.1111/j.1467-8624.1993.tb04207.x; Tomasello M, 2003, TRENDS COGN SCI, V7, P153, DOI 10.1016/S1364-6613(03)00035-4	16	69	70	2	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2005	309	5733					385	386		10.1126/science.1112207	http://dx.doi.org/10.1126/science.1112207			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946LY	16020716				2022-12-01	WOS:000230574900026
J	Daniels, N				Daniels, N			Fair process in patient selection for antiretroviral treatment in WHO's goal of 3 by 5	LANCET			English	Article							AFRICA; TECHNOLOGIES; MEDICINE; CARE		Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Daniels, N (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	ndaniels@hsph.harvard.edu						Brock D., 1988, ORGAN SUBSTITUTION T, P86; Creese A, 2002, LANCET, V359, P1635, DOI 10.1016/S0140-6736(02)08595-1; DANIELS N, 1993, BIOETHICS, V7, P224, DOI 10.1111/j.1467-8519.1993.tb00288.x; Daniels N, 1997, PHILOS PUBLIC AFF, V26, P303, DOI 10.1111/j.1088-4963.1997.tb00082.x; Daniels N, 2002, SETTING LIMITS FAIRL; Gibson JL, 2002, BMC HEALTH SERV RES, V2, DOI 10.1186/1472-6963-2-14; Gilson L, 1997, HEALTH POLICY PLANN, V12, P273, DOI 10.1093/oxfordjournals.heapol.a018882; Ham C., 2003, REASONABLE RATIONING; KAMM FM, 1993, MORALITY MORTALITY, V1, P233; Marseille E, 2002, LANCET, V359, P1851, DOI 10.1016/S0140-6736(02)08705-6; Martin DK, 2003, J NEUROL NEUROSUR PS, V74, P1299, DOI 10.1136/jnnp.74.9.1299; Martin DK, 2002, HEALTH POLICY, V61, P279, DOI 10.1016/S0168-8510(01)00237-8; McCoy D, 2003, HLTH SECTOR RESPONSE; *NAT AIDS COMM MAL, EQ ACC ANT THER ART; Singer PA, 2000, BMJ-BRIT MED J, V321, P1316, DOI 10.1136/bmj.321.7272.1316; SONTAG D, 2004, NY TIMES        0425, pA1; *WHO JOINT UN PROG, 2004, CONS EQ ACC TREATM C; World Health Organization, 2004, GUID ETH EQ ACC HIV; World Health Organization, 2003, SCAL ANT THER RES LT	19	36	36	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 9	2005	366	9480					169	171		10.1016/S0140-6736(05)66518-X	http://dx.doi.org/10.1016/S0140-6736(05)66518-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	943JH	16005341				2022-12-01	WOS:000230349200037
J	Thompson, IM; Ankerst, DP; Chi, C; Lucia, MS; Goodman, PJ; Crowley, JJ; Parnes, HL; Coltman, CA				Thompson, IM; Ankerst, DP; Chi, C; Lucia, MS; Goodman, PJ; Crowley, JJ; Parnes, HL; Coltman, CA			Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/mL or lower	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CANCER MORTALITY; TRENDS; SURVEILLANCE; VERIFICATION; PREVALENCE; SURVIVAL; DISEASE; IMPACT	Context Three fourths of US men older than 50 years have been screened with prostate-specific antigen (PSA) for prostate cancer. Objective To estimate the receiver operating characteristic (ROC) curve for PSA. Design, Setting, and Participants Calculation of PSA ROC curves in the placebo group of the Prostate Cancer Prevention Trial, a randomized, prospective study conducted from 1993 to 2003 at 221 US centers. Participants were 18 882 healthy men aged 55 years or older without prostate cancer and with PSA levels less than or equal to 3.0 ng/mL and normal digital rectal examination results, followed up for 7 years with annual PSA measurement and digital rectal examination. If PSA level exceeded 4.0 ng/mL or rectal examination result was abnormal, a prostate biopsy was recommended. After 7 years of study participation, an end-of-study prostate biopsy was recommended in all cancer-free men. Main Outcome Measures Operating characteristics of PSA for prostate cancer detection, including sensitivity, specificity, and ROC curve. Results Of 8575 men in the placebo group with at least 1 PSA measurement and digital rectal examination in the same year, 5587 (65.2%) had had at least 1 biopsy; of these, 1225 (21.9%) were diagnosed with prostate cancer. Of 1213 cancers with Gleason grade recorded, 250 (20.6%) were Gleason grade 7 or greater and 57 (4.7%) were Gleason grade 8 or greater. The areas under the ROC curve (AUC) for PSA to discriminate any prostate cancer vs no cancer, Gleason grade 7 or greater cancer vs no or lower-grade cancer, and Gleason grade 8 or greater cancer vs no or lower-grade cancer were 0.678 (95% confidence interval [CI], 0.666-0.689), 0.782 (95% Cl, 0.748-0.816), and 0.827 (95% Cl, 0.761-0.893), respectively (all P values <.001 for AUC vs 50%). For detecting any prostate cancer, PSA cutoff values of 1.1, 2.1, 3.1, and 4.1 ng/mL yielded sensitivities of 83.4%, 52.6%, 32.2%, and 20.5%, and specificities of 38.9%, 72.5%, 86.7%, and 93.8%, respectively. Age-stratified analyses showed slightly better performance of PSA in men younger than 70 years vs those 70 years or older with AUC values of 0.699 (SD, 0.013) vs 0.663 (SD, 0.013) (P=.03). Conclusion There is no cutpoint of PSA with simultaneous high sensitivity and high specificity for monitoring healthy men for prostate cancer, but rather a continuum of prostate cancer risk at all values of PSA.	SW Oncol Grp, Operat Off, San Antonio, TX 78245 USA; Univ Texas, Hlth Sci Ctr, Dept Urol, San Antonio, TX USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; Univ Colorado, Denver, CO 80202 USA; Canc Res & Biostat, Seattle, WA USA; NCI, NIH, Bethesda, MD 20892 USA	Southwest Oncology Group; University of Texas System; University of Texas Health San Antonio; Fred Hutchinson Cancer Center; University of Colorado System; University of Colorado Denver; Cancer Research & Biostatistics; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Thompson, IM (corresponding author), SW Oncol Grp, Operat Off, 14980 Omicron Dr, San Antonio, TX 78245 USA.	thompsoni@uthscsa.edu		Ankerst, Donna/0000-0003-4229-2462	NATIONAL CANCER INSTITUTE [U01CA086402, U10CA045808, U10CA037429, U10CA035178] Funding Source: NIH RePORTER; NCI NIH HHS [CA 45808, CA 35178, CA 37429, CA 86402] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		*AM CANC SOC, 2004, CANC FACTS FIG 2004; Antenor JAV, 2004, J UROLOGY, V172, P90, DOI 10.1097/01.ju.0000132133.10470.bb; BEGG CB, 1983, BIOMETRICS, V39, P207, DOI 10.2307/2530820; Brawley OW, 2004, UROL ONCOL-SEMIN ORI, V22, P353, DOI 10.1016/j.urolonc.2004.04.014; CATALONA WJ, 1993, JAMA-J AM MED ASSOC, V270, P948, DOI 10.1001/jama.270.8.948; Clegg LX, 2002, ARCH INTERN MED, V162, P1985, DOI 10.1001/archinte.162.17.1985; Etzioni R, 1998, AM J EPIDEMIOL, V148, P775; Etzioni R, 1999, J NATL CANCER I, V91, P1033, DOI 10.1093/jnci/91.12.1033; Feuer EJ, 2002, CANCER-AM CANCER SOC, V95, P870, DOI 10.1002/cncr.10726; GANN PH, 1995, JAMA-J AM MED ASSOC, V273, P289, DOI 10.1001/jama.273.4.289; GELFAND AE, 1990, J AM STAT ASSOC, V85, P398, DOI 10.2307/2289776; Krumholtz JS, 2002, UROLOGY, V60, P469, DOI 10.1016/S0090-4295(02)01875-7; Lu-Yao G, 2002, BMJ-BRIT MED J, V325, P740, DOI 10.1136/bmj.325.7367.740; LuYao GL, 1996, J NATL CANCER I, V88, P166, DOI 10.1093/jnci/88.3-4.166; Oliver S, 2000, LANCET, V355, P1788, DOI 10.1016/S0140-6736(00)02269-8; Oliver SE, 2001, INT J CANCER, V92, P893, DOI 10.1002/ijc.1260; Pepe MS, 2001, J NATL CANCER I, V93, P1054, DOI 10.1093/jnci/93.14.1054; PROROK PC, 1999, CANC SCREENING THEOR, P29; Punglia RS, 2003, NEW ENGL J MED, V349, P335, DOI 10.1056/NEJMoa021659; Quinn M, 2002, BJU INT, V90, P162, DOI 10.1046/j.1464-410X.2002.2822.x; Sirovich BE, 2003, JAMA-J AM MED ASSOC, V289, P1414, DOI 10.1001/jama.289.11.1414; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Weir HK, 2003, JNCI-J NATL CANCER I, V95, P1276, DOI 10.1093/jnci/djg040	24	488	517	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 6	2005	294	1					66	70		10.1001/jama.294.1.66	http://dx.doi.org/10.1001/jama.294.1.66			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	941JD	15998892				2022-12-01	WOS:000230210200026
J	Lauer, P; Rinaudo, CD; Soriani, M; Margarit, I; Maione, D; Rosini, R; Taddei, AR; Mora, M; Rappuoli, R; Grandi, G; Telford, JL				Lauer, P; Rinaudo, CD; Soriani, M; Margarit, I; Maione, D; Rosini, R; Taddei, AR; Mora, M; Rappuoli, R; Grandi, G; Telford, JL			Genome analysis reveals pili in group B Streptococcus	SCIENCE			English	Article									Chiron Srl, I-53100 Siena, Italy; Univ Tuscia, Ctr Interdipartimentale Microscopia Elettron, Viterbo, Italy	Novartis; Tuscia University	Telford, JL (corresponding author), Chiron Srl, Via Fiorentina 1, I-53100 Siena, Italy.	john_telford@chiron.com	Telford, John Laird/ABG-8144-2020	SORIANI, Marco/0000-0002-9752-5844; Grandi, Guido/0000-0001-9724-2185	NIAID NIH HHS [U01-AI060693-01] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		LAUER P, UNPUB; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; Merz AJ, 2000, ANNU REV CELL DEV BI, V16, P423, DOI 10.1146/annurev.cellbio.16.1.423; Paterson GK, 2004, TRENDS MICROBIOL, V12, P89, DOI 10.1016/j.tim.2003.12.007; Schuchat A, 1998, CLIN MICROBIOL REV, V11, P497, DOI 10.1128/CMR.11.3.497; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.182380799; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Ton-That H, 2004, TRENDS MICROBIOL, V12, P228, DOI 10.1016/j.tim.2004.03.004	8	243	258	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2005	309	5731					105	105		10.1126/science.1111563	http://dx.doi.org/10.1126/science.1111563			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	941KD	15994549				2022-12-01	WOS:000230212800066
J	Levey, DJ; Bolker, BM; Tewksbury, JJ; Sargent, S; Haddad, NM				Levey, DJ; Bolker, BM; Tewksbury, JJ; Sargent, S; Haddad, NM			Effects of landscape corridors on seed dispersal by birds	SCIENCE			English	Article							INDIVIDUAL BEHAVIOR; POPULATION-DYNAMICS; MOVEMENT CORRIDORS; HABITAT; CONSERVATION; MODELS	Habitat fragmentation threatens biodiversity by disrupting dispersal. The mechanisms and consequences of this disruption are controversial, primarily because most organisms are difficult to track. We examined the effect of habitat corridors on long-distance dispersal of seeds by birds, and tested whether small-scale (< 20 meters) movements of birds could be scaled up to predict dispersal of seeds across hundreds of meters in eight experimentally fragmented landscapes. A simulation model accurately predicted the observed pattern of seed rain and revealed that corridors functioned through edge-following behavior of birds. Our study shows how models based on easily observed behaviors can be scaled up to predict landscape-level processes.	Univ Florida, Dept Zool, Gainesville, FL 32611 USA; N Carolina State Univ, Dept Zool, Raleigh, NC 27695 USA; Allegheny Coll, Dept Biol, Meadville, PA 16335 USA	State University System of Florida; University of Florida; University of North Carolina; North Carolina State University; Allegheny College	Levey, DJ (corresponding author), Univ Florida, Dept Zool, POB 118525, Gainesville, FL 32611 USA.	dlevey@zoo.ufl.edu		Bolker, Benjamin/0000-0002-2127-0443				Anderson GS, 1997, LANDSCAPE ECOL, V12, P261, DOI 10.1023/A:1007933623979; Beier P, 1998, CONSERV BIOL, V12, P1241, DOI 10.1046/j.1523-1739.1998.98036.x; Calabrese JM, 2004, FRONT ECOL ENVIRON, V2, P529, DOI 10.1890/1540-9295(2004)002[0529:ACGTCM]2.0.CO;2; Cantrell RS, 1999, THEOR POPUL BIOL, V55, P189, DOI 10.1006/tpbi.1998.1397; Fagan WE, 1999, AM NAT, V153, P165, DOI 10.1086/303162; FIEDLER PL, 1998, CONSERVATION BIOL CO; Haddad NM, 1999, AM NAT, V153, P215, DOI 10.1086/303163; Haddad NM, 1999, ECOL APPL, V9, P623, DOI 10.1890/1051-0761(1999)009[0623:AETOCE]2.0.CO;2; Hanski I., 2004, ECOLOGY GENETICS EVO; Harrison S, 1999, ECOGRAPHY, V22, P225, DOI 10.1111/j.1600-0587.1999.tb00496.x; Levey DJ, 2000, ECOLOGY, V81, P267, DOI 10.1890/0012-9658(2000)081[0267:ASMFTV]2.0.CO;2; Lima SL, 1996, TRENDS ECOL EVOL, V11, P131, DOI 10.1016/0169-5347(96)81094-9; Machtans CS, 1996, CONSERV BIOL, V10, P1366, DOI 10.1046/j.1523-1739.1996.10051366.x; MANN CC, 1995, SCIENCE, V270, P1428, DOI 10.1126/science.270.5241.1428; Morales JM, 2004, ECOLOGY, V85, P2436, DOI 10.1890/03-0269; Nathan R, 2003, OIKOS, V103, P261, DOI 10.1034/j.1600-0706.2003.12146.x; Ovaskainen O, 2004, ECOLOGY, V85, P242, DOI 10.1890/02-0706; Revilla E, 2004, AM NAT, V164, pE130, DOI 10.1086/424767; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; Rosenberg DK, 1997, BIOSCIENCE, V47, P677, DOI 10.2307/1313208; Schultz CB, 2001, ECOLOGY, V82, P1879, DOI 10.1890/0012-9658(2001)082[1879:EMDBIA]2.0.CO;2; SIMBERLOFF D, 1992, CONSERV BIOL, V6, P493, DOI 10.1046/j.1523-1739.1992.06040493.x; Tewksbury JJ, 2002, P NATL ACAD SCI USA, V99, P12923, DOI 10.1073/pnas.202242699; Tischendorf L, 2000, LANDSCAPE ECOL, V15, P633, DOI 10.1023/A:1008177324187; Turchin Peter, 1998; Wiegand T, 1999, AM NAT, V154, P605, DOI 10.1086/303272; WILLSON MF, 1993, VEGETATIO, V108, P261	27	244	254	1	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2005	309	5731					146	148		10.1126/science.1111479	http://dx.doi.org/10.1126/science.1111479			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	941KD	15994561				2022-12-01	WOS:000230212800080
J	Zhong, Q; Gao, WH; Du, FH; Wang, XD				Zhong, Q; Gao, WH; Du, FH; Wang, XD			Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis	CELL			English	Article							BCL-2 FAMILY; PROTEIN UBIQUITINATION; CELL-DIFFERENTIATION; SURVIVAL FACTOR; UBA DOMAIN; SEQUENCE; CLEAVAGE; DEATH; BINDING; MEMBER	The elimination of Mcl-1, an anti-apoptotic Bcl-2 family member, is an early and required step for DNA damage-induced apoptosis. The degradation of Mcl-1 can be blocked by proteasome inhibitors, suggesting a role for the ubiquitin proteasome pathway in apoptosis. Here, we demonstrate that Mcl-1 is ubiquinated at five lysines. Biochemical fractionation of cell extracts allowed us to identify a 482 kDa HECT-domain-containing ubiquitin ligase named Mule (Mcl-1 ubiquitin ligase E3) that is both required and sufficient for the polyubiquitination of Mcl-1. Mule also contains a region similar to the Bcl-2 homology region 3 (BH3) domain that allows Mule to specifically interact with Mcl-1. Elimination of Mule expression by RNA interference stabilizes Mcl-1 protein, resulting in an attenuation of the apoptosis induced by DNA-damage agents. Thus, Mule is a unique BH3-containing E3 ubiquitin ligase apical to Bcl-2 family proteins during DNA damage induced apoptosis.	Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Wang, XD (corresponding author), Univ Texas, SW Med Ctr, Howard Hughes Med Inst, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	xwang@biochem.swmed.edu	Zhong, Qing/GLT-4858-2022	Zhong, Qing/0000-0001-6979-955X; Wang, Xiaodong/0000-0001-9885-356X	NIGMS NIH HHS [GMR01-57158] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057158] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravind L, 2001, TRENDS BIOCHEM SCI, V26, P273, DOI 10.1016/S0968-0004(01)01787-X; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Clohessy JG, 2004, BRIT J HAEMATOL, V125, P655, DOI 10.1111/j.1365-2141.2004.04949.x; Cuconati A, 2003, GENE DEV, V17, P2922, DOI 10.1101/gad.1156903; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Derouet M, 2004, J BIOL CHEM, V279, P26915, DOI 10.1074/jbc.M313875200; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; GU J, 1994, MOL BRAIN RES, V24, P77, DOI 10.1016/0169-328X(94)90120-1; Harada H, 2004, P NATL ACAD SCI USA, V101, P15313, DOI 10.1073/pnas.0406837101; Herrant M, 2004, ONCOGENE, V23, P7863, DOI 10.1038/sj.onc.1208069; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/S0968-0004(96)30015-7; Huang HM, 2000, BLOOD, V96, P1764, DOI 10.1182/blood.V96.5.1764.h8001764_1764_1771; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Kelekar A, 1998, TRENDS CELL BIOL, V8, P324, DOI 10.1016/S0962-8924(98)01321-X; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; Le Gouill S, 2004, BLOOD, V104, P2886, DOI 10.1182/blood-2004-05-1760; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Martinou JC, 2001, NAT REV MOL CELL BIO, V2, P63, DOI 10.1038/35048069; Nencioni A, 2005, BLOOD, V105, P3255, DOI 10.1182/blood-2004-10-3984; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Piret JP, 2005, J BIOL CHEM, V280, P9336, DOI 10.1074/jbc.M411858200; Reed JC, 1997, SEMIN HEMATOL, V34, P9; Rinkenberger JL, 2000, GENE DEV, V14, P23; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Varshavsky A, 2000, Harvey Lect, V96, P93; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Weng CJ, 2005, J BIOL CHEM, V280, P10491, DOI 10.1074/jbc.M412819200; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Yang T, 1996, J CELL PHYSIOL, V166, P523, DOI 10.1002/(SICI)1097-4652(199603)166:3<523::AID-JCP7>3.0.CO;2-R; YANG T, 1995, J CELL BIOL, V128, P1173, DOI 10.1083/jcb.128.6.1173; Zhang B, 2002, BLOOD, V99, P1885, DOI 10.1182/blood.V99.6.1885; Zhou P, 1997, BLOOD, V89, P630, DOI 10.1182/blood.V89.2.630	40	655	670	6	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 1	2005	121	7					1085	1095		10.1016/j.cell.2005.06.009	http://dx.doi.org/10.1016/j.cell.2005.06.009			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	944RZ	15989957	Bronze			2022-12-01	WOS:000230448000014
J	van Zanten, SV				van Zanten, SV			Upper gastrointestinal alarms: the 2-week rule	LANCET			English	Editorial Material							DYSPEPSIA; ENDOSCOPY; SYMPTOMS		Queen Elizabeth II Hlth Sci Ctr, Halifax, NS B3H 2Y9, Canada	Queen Elizabeth II Health Sciences Centre	van Zanten, SV (corresponding author), Queen Elizabeth II Hlth Sci Ctr, Victoria Gen Hosp Site, Halifax, NS B3H 2Y9, Canada.	Zanten@dal.ca						Axon ATR, 1997, GASTROENTEROLOGY, V112, P1376, DOI 10.1016/S0016-5085(97)70153-7; Department of Health, 2001, GUID COMM CANC SERV; Fransen GAJ, 2004, ALIMENT PHARM THERAP, V20, P1045, DOI 10.1111/j.1365-2036.2004.02251.x; Jacobson BC, 2003, AM J GASTROENTEROL, V98, P51, DOI 10.1111/j.1572-0241.2003.07186.x; Kapoor N, 2005, GUT, V54, P40, DOI 10.1136/gut.2004.039438; *NAT GUID RES DEV, 2004, DYSP MAN AD PRIM CAR; RYDER SD, 1994, BRIT MED J, V308, P827, DOI 10.1136/bmj.308.6932.827; *SIGN, 2003, CLIN LAUNCH SIGN DYS; Talley NJ, 1998, GASTROENTEROLOGY, V114, P582, DOI 10.1016/S0016-5085(98)70542-6; Vakil NB, 2004, CLIN GASTROENTEROL H, V2, P665, DOI 10.1016/S1542-3565(04)00289-7; van Zanten SJOV, 1999, AM J GASTROENTEROL, V94, P9; van Zanten SJOV, 2000, CAN MED ASSOC J, V162, pS3	12	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 25	2005	365	9478					2163	2164		10.1016/S0140-6736(05)66757-8	http://dx.doi.org/10.1016/S0140-6736(05)66757-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	938WT	15978912				2022-12-01	WOS:000230034800010
J	Kmita, M; Tarchini, B; Zakany, J; Logan, M; Tabin, CJ; Duboule, D				Kmita, M; Tarchini, B; Zakany, J; Logan, M; Tabin, CJ; Duboule, D			Early developmental arrest of mammalian limbs lacking HoxA/HoxD gene function	NATURE			English	Article							SONIC-HEDGEHOG; MICE LACKING; HOX GENES; AXIAL SKELETON; FORELIMB; ANTAGONISM; EVOLUTION; OUTGROWTH; DELETION; HOXD-11	Vertebrate HoxA and HoxD cluster genes are required for proper limb development(1-3). However, early lethality, compensation and redundancy have made a full assessment of their function difficult(3-5). Here we describe mice that are lacking all Hoxa and Hoxd functions in their forelimbs. We show that such limbs are arrested early in their developmental patterning and display severe truncations of distal elements, partly owing to the absence of Sonic hedgehog expression. These results indicate that the evolutionary recruitment of Hox gene function into growing appendages might have been crucial in implementing hedgehog signalling, subsequently leading to the distal extension of tetrapod appendages. Accordingly, these mutant limbs may be reminiscent of an ancestral trunk extension, related to that proposed for arthropods(6).	Univ Geneva, Dept Zool & Anim Biol, CH-1211 Geneva, Switzerland; Univ Geneva, Natl Res Ctr Frontiers Genet, CH-1211 Geneva, Switzerland; Natl Inst Med Res, Div Dev Biol, London NW7 1AA, England; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	University of Geneva; University of Geneva; MRC National Institute for Medical Research; Harvard University; Harvard Medical School	Duboule, D (corresponding author), Univ Geneva, Dept Zool & Anim Biol, Sci 3,Quai Ernest Ansermet 30, CH-1211 Geneva, Switzerland.	denis.duboule@zoo.unige.ch	kmita, marie/AAU-9620-2020	Tarchini, Basile/0000-0003-2708-6273; duboule, denis/0000-0001-9961-2960; Kmita, Marie/0000-0003-4021-0478	Medical Research Council [MC_U117560477] Funding Source: Medline; NICHD NIH HHS [R37 HD032443] Funding Source: Medline; MRC [MC_U117560477] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032443] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Capdevila J, 1999, MOL CELL, V4, P839, DOI 10.1016/S1097-2765(00)80393-7; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; DAVIS AP, 1995, NATURE, V375, P791, DOI 10.1038/375791a0; Dupe V, 1997, DEVELOPMENT, V124, P399; Favier B, 1996, DEVELOPMENT, V122, P449; FromentalRamain C, 1996, DEVELOPMENT, V122, P461; FromentalRamain C, 1996, DEVELOPMENT, V122, P2997; Gonzalez-Crespo S, 1998, NATURE, V394, P196, DOI 10.1038/28197; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Knezevic V, 1997, DEVELOPMENT, V124, P4523; Kraus P, 2001, MECH DEVELOP, V100, P45, DOI 10.1016/S0925-4773(00)00492-5; Lewis PM, 2001, CELL, V105, P599, DOI 10.1016/S0092-8674(01)00369-5; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Medina-Martinez O, 2000, DEV BIOL, V222, P71, DOI 10.1006/dbio.2000.9683; Mercader N, 1999, NATURE, V402, P425, DOI 10.1038/46580; Rallis C, 2003, DEVELOPMENT, V130, P2741, DOI 10.1242/dev.00473; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Ros MA, 2003, DEVELOPMENT, V130, P527, DOI 10.1242/dev.00245; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; Snodgrass RE, 1935, PRINCIPLES INSECT MO; Sordino P, 1996, TRENDS ECOL EVOL, V11, P114, DOI 10.1016/0169-5347(96)81089-5; Spitz F, 2001, GENE DEV, V15, P2209, DOI 10.1101/gad.205701; Suemori H, 2000, DEV BIOL, V220, P333, DOI 10.1006/dbio.2000.9651; TABIN C, 1993, NATURE, V361, P692, DOI 10.1038/361692a0; van den Akker E, 2001, DEVELOPMENT, V128, P1911; Wellik DM, 2003, SCIENCE, V301, P363, DOI 10.1126/science.1085672; Welscher PT, 2002, SCIENCE, V298, P827, DOI 10.1126/science.1075620; Zakany J, 2004, SCIENCE, V304, P1669, DOI 10.1126/science.1096049	29	194	199	3	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2005	435	7045					1113	1116		10.1038/nature03648	http://dx.doi.org/10.1038/nature03648			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937ZT	15973411				2022-12-01	WOS:000229970400052
J	Lochhead, PA; Sibbet, G; Morrice, N; Cleghon, V				Lochhead, PA; Sibbet, G; Morrice, N; Cleghon, V			Activation-loop autophosphorylation is mediated by a novel transitional intermediate form of DYRKs	CELL			English	Article							GLYCOGEN-SYNTHASE KINASE-3; DEPENDENT PROTEIN-KINASE; DUAL-SPECIFICITY; TYROSINE-PHOSPHORYLATION; DOWN-SYNDROME; CATALYTIC SUBUNIT; REGULATED KINASE; FAMILY; CELLS; INHIBITORS	Autophosphorylation of a critical residue in the activation loop of several protein kinases is an essential maturation event required for full enzyme activity. However, the molecular mechanism by which this happens is unknown. We addressed this question for two dual-specificity tyrosine-phosphorylation-regulated protein kinases (DYRKs), as they autophosphorylate their activation loop on an essential tyrosine but phosphorylate their substrates on serine and threonine. Here we demonstrate that autophosphorylation of the critical activation-loop tyrosine is intramolecular and mediated by the nascent kinase passing through a transitory intermediate form. This DYRK intermediate differs in residue and substrate specificity, as well as sensitivity to small-molecule inhibitors, compared with its mature counterpart. The intermediate's characteristics are lost upon completion of translation, making the critical tyrosine autophosphorylation a "one-off" inceptive event. This mechanism is likely to be shared with other kinases.	Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; Univ Dundee, MRC, Prot Phosphorylat Unit, Sch Life Sci, Dundee DD1 5EH, Scotland	Beatson Institute; University of Dundee	Lochhead, PA (corresponding author), Beatson Inst Canc Res, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	p.lochhead@beatson.gla.ac.uk; v.cleghon@beatson.gla.ac.uk						Abe MK, 2001, J BIOL CHEM, V276, P21272, DOI 10.1074/jbc.M100026200; Abe MK, 1999, MOL CELL BIOL, V19, P1301; Bahler J, 1998, GENE DEV, V12, P1356, DOI 10.1101/gad.12.9.1356; Bahler J, 2001, EMBO J, V20, P1064, DOI 10.1093/emboj/20.5.1064; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Becker W, 1999, PROG NUCLEIC ACID RE, V62, P1; Campbell LE, 2002, FEBS LETT, V510, P31, DOI 10.1016/S0014-5793(01)03221-5; Cauthron RD, 1998, MOL CELL BIOL, V18, P1416, DOI 10.1128/MCB.18.3.1416; Cheng XD, 1998, P NATL ACAD SCI USA, V95, P9849, DOI 10.1073/pnas.95.17.9849; Cole A, 2004, BIOCHEM J, V377, P249, DOI 10.1042/BJ20031259; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; de Wit NJW, 2002, MELANOMA RES, V12, P57, DOI 10.1097/00008390-200202000-00009; Fedorov AN, 1997, J BIOL CHEM, V272, P32715, DOI 10.1074/jbc.272.52.32715; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; Gray NS, 1998, SCIENCE, V281, P533, DOI 10.1126/science.281.5376.533; Guimera J, 1999, GENOMICS, V57, P407, DOI 10.1006/geno.1999.5775; Hammerle B, 2003, J NEURAL TRANSM-SUPP, P129; Hammerle B, 2003, EUR J NEUROSCI, V17, P2277, DOI 10.1046/j.1460-9568.2003.02665.x; Hammerle B, 2002, DEV BIOL, V246, P259, DOI 10.1006/dbio.2002.0675; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Himpel S, 2000, J BIOL CHEM, V275, P2431, DOI 10.1074/jbc.275.4.2431; Himpel S, 2001, BIOCHEM J, V359, P497, DOI 10.1042/0264-6021:3590497; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kentrup H, 1996, J BIOL CHEM, V271, P3488; KORNBLUTH S, 1988, MOL CELL BIOL, V8, P5541, DOI 10.1128/MCB.8.12.5541; Lee K, 2000, CANCER RES, V60, P3631; Lochhead PA, 2003, BIOCHEM J, V374, P381, DOI 10.1042/BJ20030500; Miller CT, 2003, CANCER RES, V63, P4136; Miyata Y, 1999, BIOCHEM BIOPH RES CO, V266, P291, DOI 10.1006/bbrc.1999.1705; Moore MJ, 2002, J BIOL CHEM, V277, P47878, DOI 10.1074/jbc.M204970200; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Pang KM, 2004, DEV BIOL, V265, P127, DOI 10.1016/j.ydbio.2003.09.024; Pellettieri J, 2003, DEV CELL, V5, P451, DOI 10.1016/S1534-5807(03)00231-4; Quintin S, 2003, EMBO REP, V4, P1175, DOI 10.1038/sj.embor.7400029; Sarno S, 2003, BIOCHEM J, V374, P639, DOI 10.1042/BJ20030674; Smith CM, 1999, PROG BIOPHYS MOL BIO, V71, P313, DOI 10.1016/S0079-6107(98)00059-5; STEINBERG RA, 1993, MOL CELL BIOL, V13, P2332, DOI 10.1128/MCB.13.4.2332; SZYSZKA R, 1995, BIOCHEM BIOPH RES CO, V208, P418, DOI 10.1006/bbrc.1995.1354; TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4; Villerbu N, 2002, INT J CANCER, V97, P761, DOI 10.1002/ijc.10125; Way G, 2002, MOL BIOL CELL, V13, P3344, DOI 10.1091/mbc.E01-10-0094; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Williams MR, 2000, CURR BIOL, V10, P439, DOI 10.1016/S0960-9822(00)00441-3	44	216	219	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 17	2005	121	6					925	936		10.1016/j.cell.2005.03.034	http://dx.doi.org/10.1016/j.cell.2005.03.034			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	938NX	15960979	Bronze			2022-12-01	WOS:000230011200014
J	Gales, NJ; Kasuya, T; Clapham, PJ; Brownell, RL				Gales, NJ; Kasuya, T; Clapham, PJ; Brownell, RL			Japan's whaling plan under scrutiny	NATURE			English	Editorial Material									Australian Antarctic Div, Kingston, Tas 7050, Australia; Teikyo Univ Sci & Technol, Yamanashi 4090193, Japan; Natl Marine Mammal Lab, Alaska Fisheries Sci Ctr, Seattle, WA 98115 USA; SW Fisheries Sci Ctr, Pacific Grove, CA 93950 USA	Australian Antarctic Division; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Gales, NJ (corresponding author), Australian Antarctic Div, Channel Highway, Kingston, Tas 7050, Australia.							Brownell RL, 2000, SCIENCE, V290, P1696; DELAMARE W, 1990, NATURE, V345, P771, DOI 10.1038/345771a0; NAGASAKI F, 1990, NATURE, V344, P189, DOI 10.1038/344189a0; Normile D, 2000, SCIENCE, V289, P2264, DOI 10.1126/science.289.5488.2264	4	45	45	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 16	2005	435	7044					883	884		10.1038/435883a	http://dx.doi.org/10.1038/435883a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935RN	15959491	Green Submitted			2022-12-01	WOS:000229799700020
J	de Beaufort, I				de Beaufort, I			Patients in a persistent vegetative state - A dutch perspective	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Erasmus Univ, Erasmus Med Ctr, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	de Beaufort, I (corresponding author), Erasmus Univ, Erasmus Med Ctr, Rotterdam, Netherlands.							*HLTH COUNC, 1994, PAT VEG TOEST; Lavrijsen J, 2005, BRAIN INJURY, V19, P67, DOI 10.1080/02699050410001720013; LAVRIJSEN JCM, IN PRESS J NEUROL NE; *ROYAL DUTCH MED A, 1997, MED HAND ROND LEV BI	4	13	13	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 9	2005	352	23					2373	2375		10.1056/NEJMp058094	http://dx.doi.org/10.1056/NEJMp058094			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933NL	15944421				2022-12-01	WOS:000229638900002
J	Orme, CDL; Davies, RG; Burgess, M; Eigenbrod, F; Pickup, N; Olson, VA; Webster, AJ; Ding, TS; Rasmussen, PC; Ridgely, RS; Stattersfield, AJ; Bennett, PM; Blackburn, TM; Gaston, KJ; Owens, IPF				Orme, CDL; Davies, RG; Burgess, M; Eigenbrod, F; Pickup, N; Olson, VA; Webster, AJ; Ding, TS; Rasmussen, PC; Ridgely, RS; Stattersfield, AJ; Bennett, PM; Blackburn, TM; Gaston, KJ; Owens, IPF			Global hotspots of species richness are not congruent with endemism or threat	NATURE			English	Article							INDICATOR TAXA; CONSERVATION; RARITY; BIODIVERSITY; PATTERNS; COMPLEMENTARITY; COINCIDENCE; DIVERSITY	Biodiversity hotspots have a prominent role in conservation biology(1-9), but it remains controversial to what extent different types of hotspot are congruent(4,10-14). Previous studies were unable to provide a general answer because they used a single biodiversity index, were geographically restricted, compared areas of unequal size or did not quantitatively compare hotspot types(1-10,12-22). Here we use a new global database on the breeding distribution of all known extant bird species to test for congruence across three types of hotspot. We demonstrate that hotspots of species richness, threat and endemism do not show the same geographical distribution. Only 2.5% of hotspot areas are common to all three aspects of diversity, with over 80% of hotspots being idiosyncratic. More generally, there is a surprisingly low overall congruence of biodiversity indices, with any one index explaining less than 24% of variation in the other indices. These results suggest that, even within a single taxonomic class, different mechanisms are responsible for the origin and maintenance of different aspects of diversity. Consequently, the different types of hotspots also vary greatly in their utility as conservation tools.	Univ London Imperial Coll Sci Technol & Med, Div Biol, Ascot SL5 7PY, Berks, England; Univ London Imperial Coll Sci Technol & Med, NERC, Ctr Populat Biol, Ascot SL5 7PY, Berks, England; Univ Sheffield, Biodivers & Macroecol Grp, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; Zool Soc London, Inst Zool, London NW1 4RY, England; Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; Natl Taiwan Univ, Sch Forestry & Resource Conservat, Taipei 106, Taiwan; Michigan State Univ Museum, E Lansing, MI 48824 USA; Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA; Acad Nat Sci Philadelphia, Philadelphia, PA 19103 USA; Birdlife Int, Cambridge CB3 0NA, England	Imperial College London; Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of Sheffield; Zoological Society of London; University of Birmingham; National Taiwan University; Michigan State University; Michigan State University; Drexel University; BirdLife International	Owens, IPF (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Biol, Silwood Pk, Ascot SL5 7PY, Berks, England.	i.owens@imperial.ac.uk	Blackburn, Tim/AAC-3144-2019; DING, Tzung-Su/AAG-7712-2019; Davies, Richard/H-7447-2019; Blackburn, Tim M/A-7685-2011; Owens, Ian PF/F-1392-2010; Burgess, Malcolm D/B-5793-2014	Blackburn, Tim/0000-0003-0152-2663; Burgess, Malcolm D/0000-0003-1288-1231; Eigenbrod, Felix/0000-0001-8982-824X; DING, Tzung-Su/0000-0002-1102-3879; Owens, Ian/0000-0001-6080-3321	Natural Environment Research Council [NER/O/S/2001/01230] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Baillie J. E. M., 2004, 2004 IUCN RED LIST T; Berg A, 1996, BIODIVERS CONSERV, V5, P101, DOI 10.1007/BF00056294; Bibby C.J., 1992, PUTTING BIODIVERSITY; BirdLife International, 2000, THREAT BIRDS WORLD; Bonn A, 2002, ECOL LETT, V5, P733, DOI 10.1046/j.1461-0248.2002.00376.x; Brooks T, 2001, BIOSCIENCE, V51, P613, DOI 10.1641/0006-3568(2001)051[0613:TABFCI]2.0.CO;2; Dobson AP, 1997, SCIENCE, V275, P550, DOI 10.1126/science.275.5299.550; Gaston KJ, 1996, P ROY SOC B-BIOL SCI, V263, P235, DOI 10.1098/rspb.1996.0037; Howard PC, 1998, NATURE, V394, P472, DOI 10.1038/28843; Jetz W, 2004, ECOL LETT, V7, P1180, DOI 10.1111/j.1461-0248.2004.00678.x; Jetz W, 2002, SCIENCE, V297, P1548, DOI 10.1126/science.1072779; Lawton JH, 1998, NATURE, V391, P72, DOI 10.1038/34166; Lennon JJ, 2004, ECOL LETT, V7, P81, DOI 10.1046/j.1461-0248.2004.00548.x; Mittermeier R. A., 1999, CHELONIAN CONSERV BI; Mittermeier Russell A., 2004, P1; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Myers N, 1988, Environmentalist, V8, P187, DOI 10.1007/BF02240252; Myers N, 1990, Environmentalist, V10, P243, DOI 10.1007/BF02239720; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; PRENDERGAST JR, 1993, NATURE, V365, P335, DOI 10.1038/365335a0; PRESSEY RL, 1993, TRENDS ECOL EVOL, V8, P124, DOI 10.1016/0169-5347(93)90023-I; Rahbek C, 2001, P NATL ACAD SCI USA, V98, P4534, DOI 10.1073/pnas.071034898; Sibley CG, 1990, DISTRIBUTION TAXONOM; Stattersfield A.J., 1998, ENDEMIC BIRD AREAS W, V115, P1089, DOI 10.2307/4089533; THOMAS CD, 1985, BIOL CONSERV, V33, P95, DOI 10.1016/0006-3207(85)90098-9; Virolainen KM, 2000, P ROY SOC B-BIOL SCI, V267, P1143, DOI 10.1098/rspb.2000.1120; Williams P, 1996, CONSERV BIOL, V10, P155, DOI 10.1046/j.1523-1739.1996.10010155.x	27	798	859	4	362	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 18	2005	436	7053					1016	1019		10.1038/nature03850	http://dx.doi.org/10.1038/nature03850			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955XQ	16107848				2022-12-01	WOS:000231263900050
J	Bower, M; Gazzard, B; Mandalia, S; Newsom-Davis, T; Thirlwell, C; Dhillon, T; Young, AM; Powles, T; Gaya, A; Nelson, M; Stebbing, J				Bower, M; Gazzard, B; Mandalia, S; Newsom-Davis, T; Thirlwell, C; Dhillon, T; Young, AM; Powles, T; Gaya, A; Nelson, M; Stebbing, J			A prognostic index for systemic AIDS-related non-Hodgkin lymphoma treated in the era of highly active antiretroviral therapy	ANNALS OF INTERNAL MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CYCLOPHOSPHAMIDE; SURVIVAL; CHEMOTHERAPY; VINCRISTINE; DOXORUBICIN; IMPACT; COMBINATION; INHIBITORS; SARCOMA	Background: The established international Prognostic index for lymphomas has not included patients with systemic AIDS-related non-Hodgkin lymphoma. Objective: To establish the most appropriate prognostic index for use in patients with systemic AIDS-related non-Hodgkin lymphoma. Design: A prospective study involving univariate and multivariable analyses of patients with AIDS-related non-Hodgkin lymphoma whose data were used to examine standard and new criteria for survival after diagnosis. Setting: The Chelsea and Westminster cohort of HIV-1-infected persons. Patients: 9621 HIV-positive patients, 111 in whom AIDS-related non-Hodgkin lymphoma was treated after 1996, in the era of highly active antiretroviral therapy (HAART). Intervention: Cox proportional hazards regression analysis to determine the prognostic significance of multiple clinicopathologic variables. Results: Survival of patients with AIDS-related non-Hodgkin lymphoma has increased in the HAART era (log-rank chi-square, 9.23; P = 0.002). Univariate analyses using the established International Prognostic Index factors of age, tumor stage, lactate dehydrogenase level, Eastern Cooperative Oncology Group performance status, and number of extranodal sites were confirmed to be significant variables. Regression modeling for patients in whom disease was diagnosed after 1996 revealed only 2 independent predictors of death: International Prognostic Index risk group and CD4 cell count. These predictors yielded 4 internally validated risk strata with predicted 1-year survival rates of 82%, 47%, 20%, and 15% (P < 0.001). Prognostic risk scores in the highest quartile yielded a likelihood ratio for death of 7.90 (hazard ratio, 1.0), whereas a prognostic score less than 1.0 yielded a likelihood ratio of 0.23 (hazard ratio, 0.15 [95% Cl, 0.06 to 0.33]). Limitations: The sample was small, and different HAART regimens were used. Conclusions: For patients with AIDS-related non-Hodgkin lymphoma that was diagnosed in the era of HAART, application of the International Prognostic Index remains useful. The addition of CD4 cell count provides further independent prognostic information. Patients who present with AIDS-related non-Hodgkin lymphoma and a low CD4 cell count have a poor prognosis; this information can be used to guide therapeutic options.	Chelsea & Westminster Hosp, London SW10 9NH, England	Imperial College London	Bower, M (corresponding author), Chelsea & Westminster Hosp, 369 Fulham Rd, London SW10 9NH, England.	m.bower@imperial.ac.uk; j.stebbing@imperial.ac.uk		Stebbing, Justin/0000-0002-1117-6947; Bower, Mark/0000-0002-4077-6351				Appleby P, 2000, JNCI-J NATL CANCER I, V92, P1823, DOI 10.1093/jnci/92.22.1823; Benzel J E, 1968, Del Med J, V40, P78; Bower M, 2004, BLOOD, V104, P2943, DOI 10.1182/blood-2004-05-1747; Cortes J, 2002, CANCER, V94, P1492, DOI 10.1002/cncr.10365; Efron B, 1996, P NATL ACAD SCI USA, V93, P13429, DOI 10.1073/pnas.93.23.13429; EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844; Efron B., 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Gabarre J, 2004, HAEMATOLOGICA, V89, P1100; HARRELL FE, 1984, STAT MED, V3, P143, DOI 10.1002/sim.4780030207; Jacobson LP, 1999, J ACQ IMMUN DEF SYND, V21, pS34; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KNAUS WA, 1995, ANN INTERN MED, V122, P191, DOI 10.7326/0003-4819-122-3-199502010-00007; LITTLE R, 1999, P AN M AM SOC CLIN, V18, pA10; Little RF, 2003, BLOOD, V101, P4653, DOI 10.1182/blood-2002-11-3589; Lossos IS, 2004, NEW ENGL J MED, V350, P1828, DOI 10.1056/NEJMoa032520; Matthews GV, 2000, BLOOD, V96, P2730; Mocroft A, 2000, LANCET, V356, P291, DOI 10.1016/S0140-6736(00)02504-6; Murdaca G, 2002, AIDS, V16, P304, DOI 10.1097/00002030-200201250-00029; Navarro JT, 1998, HAEMATOLOGICA, V83, P508; Navarro JT, 2001, BRIT J HAEMATOL, V112, P909, DOI 10.1046/j.1365-2141.2001.02656.x; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; Ratner L, 2001, J CLIN ONCOL, V19, P2171, DOI 10.1200/JCO.2001.19.8.2171; ROSENBERG SA, 1977, CANCER TREAT REP, V61, P1023; Rossi G, 1999, CANCER-AM CANCER SOC, V86, P2391, DOI 10.1002/(SICI)1097-0142(19991201)86:11<2391::AID-CNCR29>3.3.CO;2-S; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Sparano JA, 2004, J CLIN ONCOL, V22, P1491, DOI 10.1200/JCO.2004.08.195; Stebbing J, 2004, J CLIN ONCOL, V22, P2177, DOI 10.1200/JCO.2004.11.097; Stebbing J, 2004, CANCER TREAT REV, V30, P249, DOI 10.1016/j.ctrv.2003.12.004; Stebbing J, 2004, INT J CANCER, V108, P473, DOI 10.1002/ijc.11601; Stebbing J, 2003, LANCET ONCOL, V4, P438, DOI 10.1016/S1470-2045(03)01142-2; Stebbing J, 2003, J ANTIMICROB CHEMOTH, V51, P1095, DOI 10.1093/jac/dkg199; Steyerberg EW, 2001, MED DECIS MAKING, V21, P45, DOI 10.1177/0272989X0102100106; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; THIRLWELL C, 2002, 6 INT C DRUG THER HI, P94; Tibshirani R.J., 1993, MONOGRAPHS STAT APPL, VVolume 57, P1, DOI 10.1007/978-1-4899-4541-9; Vaccher E, 2001, CANCER-AM CANCER SOC, V91, P155, DOI 10.1002/1097-0142(20010101)91:1<155::AID-CNCR20>3.0.CO;2-B; Yeni PG, 2004, JAMA-J AM MED ASSOC, V292, P251, DOI 10.1001/jama.292.2.251	38	87	92	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2005	143	4					265	273		10.7326/0003-4819-143-4-200508160-00007	http://dx.doi.org/10.7326/0003-4819-143-4-200508160-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	955PA	16103470				2022-12-01	WOS:000231237100003
J	Harvey, SL; Charlet, A; Haas, W; Gygi, SP; Kellogg, DR				Harvey, SL; Charlet, A; Haas, W; Gygi, SP; Kellogg, DR			Cdk1-dependent regulation of the mitotic inhibitor Wee1	CELL			English	Article							CDC28 PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; MORPHOGENESIS CHECKPOINT; FISSION YEAST; CELL-SIZE; BUDDING YEAST; SCHIZOSACCHAROMYCES-POMBE; TYROSINE PHOSPHORYLATION; NEGATIVE REGULATION; SYSTEMATIC IDENTIFICATION	The Wee1 kinase phosphorylates and inhibits cyclin-dependent kinase 1 (Cdk1), thereby delaying entry into mitosis until appropriate conditions have been met. An understanding of the mechanisms that regulate Wee1 should provide new insight into how cells make the decision to enter mitosis. We report here that Swe1, the budding-yeast homolog of Wee1, is directly regulated by Cdk1. Phosphorylation of Swe1 by Cdk1 activates Swe1 and is required for formation of a stable Swe1-Cdk1 complex that maintains Cdk1 in the inhibited state. Dephosphorylation of Cdk1 leads to further phosphorylation of Swe1 and release of Cdk1. Thus, Cdk1 both positively and negatively regulates its own inhibitor. Regulation of the Swe1-Cdk1 complex is likely to play a critical role in controlling the transition into mitosis.	Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	University of California System; University of California Santa Cruz; Harvard University; Harvard Medical School	Kellogg, DR (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	kellogg@darwin.ucsc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053959] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM53959] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ballif BA, 2004, MOL CELL PROTEOMICS, V3, P1093, DOI 10.1074/mcp.M400085-MCP200; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; BOOHER RN, 1993, EMBO J, V12, P3417, DOI 10.1002/j.1460-2075.1993.tb06016.x; Breeding CS, 1998, MOL BIOL CELL, V9, P3399, DOI 10.1091/mbc.9.12.3399; COLEMAN TR, 1993, CELL, V72, P919, DOI 10.1016/0092-8674(93)90580-J; DUNPHY WG, 1991, CELL, V67, P189, DOI 10.1016/0092-8674(91)90582-J; EDGAR BA, 1989, CELL, V57, P177, DOI 10.1016/0092-8674(89)90183-9; EDGAR BA, 1990, CELL, V62, P469, DOI 10.1016/0092-8674(90)90012-4; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; FANTES P, 1977, EXP CELL RES, V107, P377, DOI 10.1016/0014-4827(77)90359-7; FEATHERSTONE C, 1991, NATURE, V349, P808, DOI 10.1038/349808a0; FITCH I, 1992, MOL BIOL CELL, V3, P805, DOI 10.1091/mbc.3.7.805; GAUTIER J, 1991, CELL, V67, P197, DOI 10.1016/0092-8674(91)90583-K; GOULD KL, 1989, NATURE, V342, P39, DOI 10.1038/342039a0; HADWIGER JA, 1989, MOL CELL BIOL, V9, P2034, DOI 10.1128/MCB.9.5.2034; Harvey SL, 2003, CURR BIOL, V13, P264, DOI 10.1016/S0960-9822(03)00049-6; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kanoh J, 1998, MOL BIOL CELL, V9, P3321, DOI 10.1091/mbc.9.12.3321; Kellogg DR, 2003, J CELL SCI, V116, P4883, DOI 10.1242/jcs.00908; KUMAGAI A, 1991, CELL, V64, P903, DOI 10.1016/0092-8674(91)90315-P; Lew DJ, 2003, CURR OPIN CELL BIOL, V15, P648, DOI 10.1016/j.ceb.2003.09.001; LUNDGREN K, 1991, CELL, V64, P1111, DOI 10.1016/0092-8674(91)90266-2; MCGOWAN CH, 1993, EMBO J, V12, P75, DOI 10.1002/j.1460-2075.1993.tb05633.x; McMillan JN, 1999, MOL CELL BIOL, V19, P5981; McMillan JN, 1999, MOL CELL BIOL, V19, P6929; McMillan JN, 1998, J CELL BIOL, V142, P1487, DOI 10.1083/jcb.142.6.1487; Mortensen EM, 2002, MOL BIOL CELL, V13, P2091, DOI 10.1091/mbc.01-10-0500; MUELLER PR, 1995, MOL BIOL CELL, V6, P119, DOI 10.1091/mbc.6.1.119; Nasmyth K, 1993, CURR OPIN CELL BIOL, V5, P166, DOI 10.1016/0955-0674(93)90099-C; NURSE P, 1975, NATURE, V256, P547, DOI 10.1038/256547a0; PARKER LL, 1992, P NATL ACAD SCI USA, V89, P2917, DOI 10.1073/pnas.89.7.2917; PARKER LL, 1992, SCIENCE, V257, P1955, DOI 10.1126/science.1384126; Peng JM, 2001, J MASS SPECTROM, V36, P1083, DOI 10.1002/jms.229; RICHARDSON H, 1992, GENE DEV, V6, P2021, DOI 10.1101/gad.6.11.2021; Rudner AD, 2000, J CELL BIOL, V149, P1361, DOI 10.1083/jcb.149.7.1361; Rupes I, 2002, TRENDS GENET, V18, P479, DOI 10.1016/S0168-9525(02)02745-2; Rupes I, 2001, MOL BIOL CELL, V12, P3892, DOI 10.1091/mbc.12.12.3892; RUSSELL P, 1986, CELL, V45, P145, DOI 10.1016/0092-8674(86)90546-5; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; Sakchaisri K, 2004, P NATL ACAD SCI USA, V101, P4124, DOI 10.1073/pnas.0400641101; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shulewitz MJ, 1999, MOL CELL BIOL, V19, P7123; Sia RAL, 1998, EMBO J, V17, P6678, DOI 10.1093/emboj/17.22.6678; Sreenivasan A, 1999, MOL CELL BIOL, V19, P7983; STRAUSFELD U, 1991, NATURE, V351, P242, DOI 10.1038/351242a0; Takeda DY, 2001, J BIOL CHEM, V276, P1993, DOI 10.1074/jbc.M005719200; TANG ZH, 1993, EMBO J, V12, P3427, DOI 10.1002/j.1460-2075.1993.tb06017.x; Tjandra H, 1998, CURR BIOL, V8, P991, DOI 10.1016/S0960-9822(07)00419-8; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; YOUNG PG, 1987, J CELL SCI, V88, P295	51	156	160	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 12	2005	122	3					407	420		10.1016/j.cell.2005.05.029	http://dx.doi.org/10.1016/j.cell.2005.05.029			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	955UZ	16096060	Bronze			2022-12-01	WOS:000231254400012
J	Li, XL; Manley, JL				Li, XL; Manley, JL			Inactivation of the SR protein splicing factor ASF/SF2 results in genomic instability	CELL			English	Article							RNA-POLYMERASE-II; R-LOOP FORMATION; MESSENGER-RNA; COUPLING TRANSCRIPTION; SITE SELECTION; DNA; COMPLEX; BINDING; PHOSPHORYLATION; STABILITY	SR proteins constitute a family of pre-mRNA splicing factors now thought to play several roles in mRNA metabolism in metazoan cells. Here we provide evidence that a prototypical SR protein, ASF/SF2, is unexpectedly required for maintenance of genomic stability. We first show that in vivo depletion of ASF/SF2 results in a hypermutation phenotype likely due to DNA rearrangements, reflected in the rapid appearance of DNA double-strand breaks and high-molecular-weight DNA fragments. Analysis of DNA from ASF/ SF2-depleted cells revealed that the nontemplate strand of a transcribed gene was single stranded due to formation of an RNA:DNA hybrid, R loop structure. Stable overexpression of RNase H suppressed the DNA-fragmentation and hypermutation phenotypes. Indicative of a direct role, ASF/SF2 prevented R loop formation in a reconstituted in vitro transcription reaction. Our results support a model by which recruitment of ASF/SF2 to nascent transcripts by RNA polymerase 11 prevents formation of mutagenic R loop structures.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Manley, JL (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	jlm2@columbia.edu		Li, Xialu/0000-0002-5631-6245; Manley, James/0000-0002-8341-1459	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM048259] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM48259] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aguilera A, 2002, EMBO J, V21, P195, DOI 10.1093/emboj/21.3.195; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; BROWN DG, 1993, J BIOL CHEM, V268, P3037; Caceres JF, 1998, GENE DEV, V12, P55, DOI 10.1101/gad.12.1.55; Chen Z, 2000, MOL CELL BIOL, V20, P5064, DOI 10.1128/MCB.20.14.5064-5076.2000; Chen Z, 2003, MOL CELL BIOL, V23, P7350, DOI 10.1128/MCB.23.20.7350-7362.2003; Daneholt B, 2001, P NATL ACAD SCI USA, V98, P7012, DOI 10.1073/pnas.111145498; Daneholt B, 2001, CHROMOSOMA, V110, P173, DOI 10.1007/s004120000127; DROLET M, 1995, P NATL ACAD SCI USA, V92, P3526, DOI 10.1073/pnas.92.8.3526; Drolet M, 2003, FRONT BIOSCI, V8, pD210, DOI 10.2741/970; Duquette ML, 2004, GENE DEV, V18, P1618, DOI 10.1101/gad.1200804; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; FU XD, 1993, NATURE, V365, P82, DOI 10.1038/365082a0; Gall JG, 1999, MOL BIOL CELL, V10, P4385, DOI 10.1091/mbc.10.12.4385; Gallardo M, 2003, J BIOL CHEM, V278, P24225, DOI 10.1074/jbc.M302900200; GE H, 1990, CELL, V62, P25, DOI 10.1016/0092-8674(90)90236-8; Hacker S, 2004, J BIOL CHEM, V279, P5049, DOI 10.1074/jbc.C300522200; Hirose Y, 1998, NATURE, V395, P93, DOI 10.1038/25786; Hirose Y, 2000, GENE DEV, V14, P1415; Huang YQ, 2003, MOL CELL, V11, P837, DOI 10.1016/S1097-2765(03)00089-3; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Hurt E, 2004, P NATL ACAD SCI USA, V101, P1858, DOI 10.1073/pnas.0308663100; Johnson VL, 2000, J CELL SCI, V113, P2941; KADESCH TR, 1982, J BIOL CHEM, V257, P5286; KOHTZ JD, 1994, NATURE, V368, P119, DOI 10.1038/368119a0; KRAINER AR, 1990, CELL, V62, P35, DOI 10.1016/0092-8674(90)90237-9; Lemaire R, 2002, GENE DEV, V16, P594, DOI 10.1101/gad.939502; LIBER HL, 1982, MUTAT RES, V94, P467, DOI 10.1016/0027-5107(82)90308-6; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Longman D, 2000, EMBO J, V19, P1625, DOI 10.1093/emboj/19.7.1625; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Manley JL, 1996, GENE DEV, V10, P1569, DOI 10.1101/gad.10.13.1569; Masse E, 1999, J BIOL CHEM, V274, P16659, DOI 10.1074/jbc.274.23.16659; Millhouse S, 2005, MOL CELL BIOL, V25, P533, DOI 10.1128/MCB.25.2.533-544.2005; Misteli T, 1999, MOL CELL, V3, P697, DOI 10.1016/S1097-2765(01)80002-2; O'Connell MJ, 2000, TRENDS CELL BIOL, V10, P296, DOI 10.1016/S0962-8924(00)01773-6; Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599; REABAN ME, 1994, J BIOL CHEM, V269, P21850; Reed R, 2003, CURR OPIN CELL BIOL, V15, P326, DOI 10.1016/S0955-0674(03)00048-6; Rehwinkel J, 2004, NAT STRUCT MOL BIOL, V11, P558, DOI 10.1038/nsmb759; RING HJ, 1994, MOL CELL BIOL, V14, P7499, DOI 10.1128/MCB.14.11.7499; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rondon AG, 2003, J BIOL CHEM, V278, P39037, DOI 10.1074/jbc.M305718200; Sakahira H, 1999, CURR BIOL, V9, P543, DOI 10.1016/S0960-9822(99)80240-1; Sanford J R, 2003, Prog Mol Subcell Biol, V31, P33; Sanford JR, 2004, GENE DEV, V18, P755, DOI 10.1101/gad.286404; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; Tacke R, 1999, CURR OPIN CELL BIOL, V11, P358, DOI 10.1016/S0955-0674(99)80050-7; TACKE R, 1995, EMBO J, V14, P3540, DOI 10.1002/j.1460-2075.1995.tb07360.x; Takagaki Y, 1998, MOL CELL, V2, P761, DOI 10.1016/S1097-2765(00)80291-9; Wang J, 1996, GENE DEV, V10, P2588, DOI 10.1101/gad.10.20.2588; Wang J, 1998, GENE DEV, V12, P2222, DOI 10.1101/gad.12.14.2222; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; Xu XD, 2005, CELL, V120, P59, DOI 10.1016/j.cell.2004.11.036; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919; Zimmer C, 2001, RNA, V7, P1628	57	512	524	3	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 12	2005	122	3					365	378		10.1016/j.cell.2005.06.008	http://dx.doi.org/10.1016/j.cell.2005.06.008			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	955UZ	16096057	Bronze			2022-12-01	WOS:000231254400009
J	Shah, S; Lee, SF; Tabuchi, K; Hao, YH; Yu, C; LaPlant, Q; Ball, H; Dann, CE; Sudhof, T; Yu, G				Shah, S; Lee, SF; Tabuchi, K; Hao, YH; Yu, C; LaPlant, Q; Ball, H; Dann, CE; Sudhof, T; Yu, G			Nicastrin functions as a gamma-secretase-substrate receptor	CELL			English	Article							AMYLOID PRECURSOR PROTEIN; SIGNAL PEPTIDE PEPTIDASE; INTRAMEMBRANE PROTEOLYSIS; TRANSMEMBRANE DOMAIN; CHEMICAL LIGATION; BINDING-SITE; ACTIVE-SITE; PRESENILIN; CLEAVAGE; COMPLEX	gamma-secretase catalyzes the intramembrane cleavage of amyloid precursor protein (APP) and Notch after their extracellular domains are shed by site-specific proteolysis. Nicastrin is an essential glycoprotein component of the gamma-secretase complex but has no known function. We now show that the ectodomain of nicastrin binds the new amino terminus that is generated upon proteolysis of the extracellular APP and Notch domains, thereby recruiting the APP and Notch substrates into the gamma-secretase complex. Chemicalor anti body-mediated blocking of the free amino terminus, addition of purified nicastrin ectodomain, or mutations in the ectodomain markedly reduce the binding and cleavage of substrate by gamma-secretase. These results indicate that nicastrin is a receptor for the amino-terminal stubs that are generated by ectodomain shedding of type I transmembrane proteins. Our data are consistent with a model where nicastrin presents these substrates toy-secretase and thereby facilitates their cleavage via intramembrane proteolysis.	Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Yu, G (corresponding author), Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA.	gang.yu@utsouthwestern.edu	Dann, Charles E/C-2747-2018		NIA NIH HHS [R01 AG023104] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG023104] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Chen FS, 2001, NAT CELL BIOL, V3, P751, DOI 10.1038/35087069; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Dawson PE, 2000, ANNU REV BIOCHEM, V69, P923, DOI 10.1146/annurev.biochem.69.1.923; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Fagan R, 2001, TRENDS BIOCHEM SCI, V26, P213, DOI 10.1016/S0968-0004(01)01789-3; Farmery MR, 2003, J BIOL CHEM, V278, P24277, DOI 10.1074/jbc.M211992200; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kornilova AY, 2005, P NATL ACAD SCI USA, V102, P3230, DOI 10.1073/pnas.0407640102; Lee SF, 2002, J BIOL CHEM, V277, P45013, DOI 10.1074/jbc.M208164200; Lee SF, 2004, J BIOL CHEM, V279, P4144, DOI 10.1074/jbc.M309745200; Lemberg MK, 2002, MOL CELL, V10, P735, DOI 10.1016/S1097-2765(02)00655-X; Lichtenthaler SF, 1999, P NATL ACAD SCI USA, V96, P3053, DOI 10.1073/pnas.96.6.3053; Luciani N, 1998, BIOCHEMISTRY-US, V37, P686, DOI 10.1021/bi971705p; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Shirotani K, 2004, J NEUROCHEM, V89, P1520, DOI 10.1111/j.1471-4159.2004.02447.x; Spector S, 2003, PROTEIN EXPRES PURIF, V32, P317, DOI 10.1016/j.pep.2003.08.004; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Thompson MW, 2003, ARCH BIOCHEM BIOPHYS, V413, P236, DOI 10.1016/S0003-9861(03)00123-1; Urban S, 2003, MOL CELL, V11, P1425, DOI 10.1016/S1097-2765(03)00181-3; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Vazeux G, 1998, BIOCHEM J, V334, P407, DOI 10.1042/bj3340407; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xia WM, 2000, P NATL ACAD SCI USA, V97, P9299, DOI 10.1073/pnas.97.16.9299; Ye J, 2000, P NATL ACAD SCI USA, V97, P5123, DOI 10.1073/pnas.97.10.5123; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Yu G, 1998, J BIOL CHEM, V273, P16470, DOI 10.1074/jbc.273.26.16470	32	371	390	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 12	2005	122	3					435	447		10.1016/j.cell.2005.05.022	http://dx.doi.org/10.1016/j.cell.2005.05.022			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	955UZ	16096062	Bronze			2022-12-01	WOS:000231254400014
J	Shiono, M; Matsugaki, N; Takeda, K				Shiono, M; Matsugaki, N; Takeda, K			Structure of the blue cornflower pigment - Packaging red-rose anthocyanin as part of a 'superpigment' in another flower turns it brilliant blue.	NATURE			English	Editorial Material							SUPRAMOLECULAR PIGMENT; COLOR DEVELOPMENT; CENTAUREA-CYANUS; PROTOCYANIN		Kyushu Univ, Grad Sch Sci, Dept Phys, Fukuoka 8128581, Japan; High Energy Accelerator Res Org, Photon Factory, Tsukuba, Ibaraki 3050801, Japan; Tokyo Gakugei Univ, Dept Biol, Tokyo 1848501, Japan	Kyushu University; High Energy Accelerator Research Organization (KEK); Tokyo Gakugei University	Shiono, M (corresponding author), Kyushu Univ, Grad Sch Sci, Dept Phys, Hakozaki 6-10-1, Fukuoka 8128581, Japan.	takedks@ss.iij4u.or.jp		Matsugaki, Naohiro/0000-0001-9640-1949				BAYER E, 1958, CHEM BER-RECL, V91, P1115, DOI 10.1002/cber.19580910539; Bayer E., 1966, ANGEW CHEM, V78, P834; Brouillard R., 1994, FLAVONOIDS ADV RES 1, P565; Hayashi A, 1997, SCRIPTA MATER, V37, P393, DOI 10.1016/S1359-6462(97)00129-2; KONDO T, 1994, ANGEW CHEM INT EDIT, V33, P978, DOI 10.1002/anie.199409781; KONDO T, 1992, NATURE, V358, P515, DOI 10.1038/358515a0; Kondo T, 1998, TETRAHEDRON LETT, V39, P8307, DOI 10.1016/S0040-4039(98)01858-9; Robinson GM, 1931, BIOCHEM J, V25, P1687, DOI 10.1042/bj0251687; SAITO N, 1961, P JPN ACAD, V37, P485, DOI 10.2183/pjab1945.37.485; Shibata K, 1919, J AM CHEM SOC, V41, P208, DOI 10.1021/ja01459a008; Takeda K, 2005, PHYTOCHEMISTRY, V66, P1607, DOI 10.1016/j.phytochem.2005.04.002; Willstatter R, 1913, LIEBIGS ANN CHEM, V401, P189; Willstatter R, 1915, LIEBIGS ANN CHEM, V408, P147	13	114	123	3	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2005	436	7052					791	791		10.1038/436791a	http://dx.doi.org/10.1038/436791a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953XG	16094358				2022-12-01	WOS:000231116500032
J	de Anda, FC; Pollarolo, G; Da Silva, JS; Camoletto, PG; Feiguin, F; Dotti, CG				de Anda, FC; Pollarolo, G; Da Silva, JS; Camoletto, PG; Feiguin, F; Dotti, CG			Centrosome localization determines neuronal polarity	NATURE			English	Article							HIPPOCAMPAL-NEURONS; ESTABLISHMENT	Neuronal polarization occurs shortly after mitosis. In neurons differentiating in vitro, axon formation follows the segregation of growth-promoting activities to only one of the multiple neurites that form after mitosis(1,2). It is unresolved whether such spatial restriction makes use of an intrinsic program, like during C. elegans embryo polarization(3), or is extrinsic and cue-mediated, as in migratory cells(4). Here we show that in hippocampal neurons in vitro, the axon consistently arises from the neurite that develops first after mitosis. Centrosomes, the Golgi apparatus and endosomes cluster together close to the area where the first neurite will form, which is in turn opposite from the plane of the last mitotic division. We show that the polarized activities of these organelles are necessary and sufficient for neuronal polarization: ( 1) polarized microtubule polymerization and membrane transport precedes first neurite formation, ( 2) neurons with more than one centrosome sprout more than one axon and ( 3) suppression of centrosome-mediated functions precludes polarization. We conclude that asymmetric centrosome-mediated dynamics in the early post-mitotic stage instruct neuronal polarity, implying that pre-mitotic mechanisms with a role in division orientation may in turn participate in this event.	Univ Turin, Cavalieri Ottolenghi Sci Inst, I-10043 Turin, Italy; Catholic Univ Louvain, Dept Human Genet, B-3000 Louvain, Belgium; Flanders Interuniv Inst Biotechnol, B-3000 Louvain, Belgium	University of Turin; Universite Catholique Louvain	Feiguin, F (corresponding author), Univ Turin, Cavalieri Ottolenghi Sci Inst, I-10043 Turin, Italy.	fabian.feiguin@unito.it; carlos.dotti@unito.it	Feiguin, Fabian/ABC-2514-2020; de Anda, Froylan Calderon/AAQ-4811-2021; Dotti, Carlos G/I-5533-2015	Dotti, Carlos G/0000-0003-4052-1719; Calderon de Anda, Froylan/0000-0003-2743-7774; Pollarolo, Giulia/0000-0002-7140-8981				Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Carney GE, 1997, P NATL ACAD SCI USA, V94, P12024, DOI 10.1073/pnas.94.22.12024; Cowan CR, 2004, NATURE, V431, P92, DOI 10.1038/nature02825; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.neuro.17.1.267; Da Silva JS, 2005, NAT NEUROSCI, V8, P606, DOI 10.1038/nn1442; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; de Hoop MJ, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 1, P154; DOTTI CG, 1988, J NEUROSCI, V8, P1454; DOTTI CG, 1991, J CELL SCI, P75; Eda M, 2001, J CELL SCI, V114, P3273; Feiguin F, 1998, CURR TOP DEV BIOL, V36, P279; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; HOULISTON E, 1989, J CELL BIOL, V108, P543, DOI 10.1083/jcb.108.2.543; Megraw TL, 2002, J CELL SCI, V115, P4707, DOI 10.1242/jcs.00134; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Shi SH, 2004, CURR BIOL, V14, P2025, DOI 10.1016/j.cub.2004.11.009; SINGER SJ, 1986, ANNU REV CELL BIOL, V2, P337, DOI 10.1146/annurev.cb.02.110186.002005; Surrey T, 1998, P NATL ACAD SCI USA, V95, P4293, DOI 10.1073/pnas.95.8.4293; Sydor AM, 1996, J CELL BIOL, V134, P1197, DOI 10.1083/jcb.134.5.1197; Ueda M, 1997, P NATL ACAD SCI USA, V94, P9674, DOI 10.1073/pnas.94.18.9674; WU CF, 1990, J NEUROBIOL, V21, P499, DOI 10.1002/neu.480210310; WU CF, 1983, J NEUROSCI, V3, P1888; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012	28	243	247	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2005	436	7051					704	708		10.1038/nature03811	http://dx.doi.org/10.1038/nature03811			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951XA	16079847				2022-12-01	WOS:000230964500045
J	Berkley, J; Mwangi, I; Griffiths, K; Ahmed, I; Mithwani, S; English, M; Newton, C; Maitland, K				Berkley, J; Mwangi, I; Griffiths, K; Ahmed, I; Mithwani, S; English, M; Newton, C; Maitland, K			Assessment of severe malnutrition among hospitalized children in rural Kenya - Comparison of weight for height and mid upper arm circumference	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROTEIN-ENERGY MALNUTRITION; DEVELOPING-COUNTRIES; MALNOURISHED CHILDREN; AFRICAN CHILDREN; MANAGEMENT; MORTALITY; DEATH; ANTHROPOMETRY; INDICATORS; DIARRHEA	Context Severe malnutrition has a high mortality rate among hospitalized children in sub-Saharan Africa. However, reports suggest that malnutrition is often poorly assessed. The World Health Organization recommends using weight for height, but this method is problematic and often not undertaken in practice. Mid Upper arm circumference (MUAC) and the clinical sign "visible severe wasting" are simple and inexpensive methods but have not been evaluated in this setting. Objectives To evaluate MUAC and visible severe wasting as predictors of inpatient mortality at a district hospital in sub-Saharan Africa and to compare these with weight-for-height z score (WHZ). Design, Setting, and Participants Cohort study with data collected at admission and at discharge or death. Predictive values for inpatient death were determined using the area under receiver operating characteristic curves. Participants were children aged 12 to 59 months admitted to a district hospital in rural Kenya between April 1, 1999, and July 31, 2002. Main Outcome Measure MUAC, WHZ, and visible severe wasting as predictors of inpatient death. Results Overall, 4.4% (359) of children included in the study died while in the hospital. Sixteen percent (1282/8190) of admitted children had severe wasting (WHZ <= -3) (n=756), kwashiorkor (n=778), or both. The areas under the receiver operating characteristic curves for predicting inpatient death did not significantly differ (MUAC: 0.75 [95% confidence interval, 0.72-0.78]; WHZ: 0.74 [95% confidence interval, 0.71-0.77]) (P=39). Although sensitivity and specificity for subsequent inpatient death were 46% and 91%, respectively, for MUAC less than or equal to 11.5 cm, 42% and 92% for WHZ less than or equal to -3, and 47% and 93% for visible severe wasting, the 3 indices identified different sets of children and were independently associated with mortality. Clinical features of malnutrition were significantly more common among children with MUAC less than or equal to 11.5 cm than among those with WHZ less than or equal to -3. Conclusions MUAC is a practical screening tool that performs at least as well as WHZ in predicting subsequent inpatient mortality among severely malnourished children hospitalized in rural Kenya. Visible severe wasting is also a potentially useful sign at this level, providing appropriate training has been given.	Kenya Med Inst Ctr Geog Med Res Coast, Kilifi, Kenya; Univ Oxford, Ctr Clin Vaccinol & Trop Med, Oxford, England; Univ Oxford, Dept Paediat, Oxford, England; Inst Child Hlth, London, England; Univ London Imperial Coll Sci & Technol, Dept Paediat, London, England	University of Oxford; University of Oxford; University of London; University College London; Imperial College London	Berkley, J (corresponding author), Kenya Med Inst Ctr Geog Med Res Coast, POB 230, Kilifi, Kenya.	jberkley@kilifi.mimcom.net	Newton, Charles/V-7872-2019; Newton, Charles/C-6222-2009; Newton, Charles RJC/B-7578-2014	Newton, Charles/0000-0002-6999-5507; Newton, Charles RJC/0000-0002-6999-5507; Berkley, James/0000-0002-1236-849X; Maitland, Kathryn/0000-0002-0007-0645; English, Michael/0000-0002-7427-0826	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ahmed T, 1999, LANCET, V353, P1919, DOI 10.1016/S0140-6736(98)07499-6; Ashworth A, 2004, LANCET, V363, P1110, DOI 10.1016/S0140-6736(04)15894-7; BAKER JP, 1982, NEW ENGL J MED, V306, P969, DOI 10.1056/NEJM198204223061606; Berkley JA, 2003, BRIT MED J, V326, P361, DOI 10.1136/bmj.326.7385.361; Bern C, 1997, B WORLD HEALTH ORGAN, V75, P87; BERN C, 1995, LANCET, V345, P631, DOI 10.1016/S0140-6736(95)90527-8; Bhan MK, 2003, BMJ-BRIT MED J, V326, P146, DOI 10.1136/bmj.326.7381.146; BRIEND A, 1986, BRIT MED J, V293, P373, DOI 10.1136/bmj.293.6543.373; Collins S, 1996, JAMA-J AM MED ASSOC, V276, P391, DOI 10.1001/jama.276.5.391; English M, 2004, LANCET, V363, P1948, DOI 10.1016/S0140-6736(04)16408-8; *GOV KEN, 2000, AIDS KEN; Hamer C, 2004, ARCH DIS CHILD, V89, P181, DOI 10.1136/adc.2002.022715; Lee LA, 1995, B WORLD HEALTH ORGAN, V73, P779; Maitland K, 2003, QJM-INT J MED, V96, P427, DOI 10.1093/qjmed/hcg077; *OXF CTR EV BAS ME, LIK RAT; PELLETIER DL, 1994, J NUTR, V124, pS2047; Rice AL, 2000, B WORLD HEALTH ORGAN, V78, P1207; ROSS DA, 1990, INT J EPIDEMIOL, V19, P636, DOI 10.1093/ije/19.3.636; Schellenberg D, 1999, AM J TROP MED HYG, V61, P431, DOI 10.4269/ajtmh.1999.61.431; Schofield C, 1996, B WORLD HEALTH ORGAN, V74, P223; VELLA V, 1993, AM J PUBLIC HEALTH, V83, P1616, DOI 10.2105/AJPH.83.11.1616; World Health Organization, 2000, MAN CHILD SER INF SE	22	121	124	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 3	2005	294	5					591	597		10.1001/jama.294.5.591	http://dx.doi.org/10.1001/jama.294.5.591			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951NN	16077053	Bronze			2022-12-01	WOS:000230937500019
J	Huang, QS; Greening, G; Baker, MG; Grimwood, K; Hewitt, J; Hulston, D; van Duin, L; Fitzsimons, A; Garrett, N; Graham, D; Lennon, D; Shimizu, H; Miyamura, T; Pallansch, M				Huang, QS; Greening, G; Baker, MG; Grimwood, K; Hewitt, J; Hulston, D; van Duin, L; Fitzsimons, A; Garrett, N; Graham, D; Lennon, D; Shimizu, H; Miyamura, T; Pallansch, M			Persistence of oral polio vaccine virus after its removal from the immunisation schedule in New Zealand	LANCET			English	Article							ERADICATION	On Feb 1, 2002, inactivated poliomyelitis vaccines replaced live-attenuated oral poliovirus vaccine (OPV) in New Zealand's immunisation schedule, allowing systematic monitoring of OPV virus circulation. Findings of paediatric-inpatient surveillance indicate that 7% of children excreted polioviruses before this switch, but none did so 1 month afterwards. Acute flaccid paralysis surveillance detected no poliovirus during and after the switch, whereas enterovirus surveillance detected poliovirus only once during the switch. Environmental surveillance identified polioviruses in sewage samples until May, 2002, after which they were detected infrequently. Intratypic differentiation and sequencing showed that all polioviruses were Sabin-like. Multiple surveillance methods hence showed that OPV strains did not persist for extended periods after a vaccine switch in a developed country with a temperate climate. Sequence homology with Sabin vaccine parent strains indicated that polioviruses detected more than 4 months after the switch were of recent origin, consistent with importation from OPV-using countries.	Inst Environm Sci & Res, Porirua, New Zealand; Univ Otago, Wellington Sch Med & Hlth Sci, Dept Paediat, Wellington, New Zealand; Auckland Univ Technol, Fac Hlth, Auckland, New Zealand; Waikato Hosp, Hamilton, New Zealand; Middlemore Hosp, S Auckland Clin Sch, Auckland 6, New Zealand; Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan; Ctr Dis Control & Prevent, Enterovirus Sect, Natl Ctr Infect Dis, Atlanta, GA USA	Institute of Environmental Science & Research (ESR) - New Zealand; University of Otago; Auckland University of Technology; Waikato Hospital; National Institute of Infectious Diseases (NIID); Centers for Disease Control & Prevention - USA	Huang, QS (corresponding author), Inst Environm Sci & Res, POB 50348, Porirua, New Zealand.	Sue.Huang@esr.cri.nz	Grimwood, Keith/F-9334-2011; Shimizu, Hiroyuki/AAU-9621-2020	Shimizu, Hiroyuki/0000-0002-2987-2377; Huang, Q. Sue/0000-0002-3923-5195; Hewitt, Joanne/0000-0003-0370-6394; Garrett, Nick/0000-0001-9289-9743; Grimwood, Keith/0000-0003-3174-9834				Dowdle WR, 2003, REV MED VIROL, V13, P277, DOI 10.1002/rmv.401; Halsey NA, 2004, B WORLD HEALTH ORGAN, V82, P3; HEFFERNAN H, 1999, NZ PUBLIC HLTH REPOR, V6, P33; Huang QS, 2003, CLIN INFECT DIS, V37, P650, DOI 10.1086/376915; Lago PM, 1999, B WORLD HEALTH ORGAN, V77, P681; Wood DJ, 2000, B WORLD HEALTH ORGAN, V78, P347; Yang CF, 2003, J VIROL, V77, P8366, DOI 10.1128/JVI.77.15.8366-8377.2003	7	57	58	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 30	2005	366	9483					394	396		10.1016/S0140-6736(05)66386-6	http://dx.doi.org/10.1016/S0140-6736(05)66386-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	950IB	16054940				2022-12-01	WOS:000230849700027
J	Aminetzach, YT; Macpherson, JM; Petrov, DA				Aminetzach, YT; Macpherson, JM; Petrov, DA			Pesticide resistance via transposition-mediated adaptive gene truncation in Drosophila	SCIENCE			English	Article							MELANOGASTER; POPULATION; ELEMENTS; LOCUS	To study adaptation, it is essential to identify multiple adaptive mutations and to characterize their molecular, phenotypic, selective, and ecological consequences. Here we describe a genomic screen for adaptive insertions of transposable elements in Drosophila. Using a pilot application of this screen, we have identified an adaptive transposable element insertion, which truncates a gene and apparently generates a functional protein in the process. The insertion of this transposable element confers increased resistance to an organophosphate pesticide and has spread in D. melanogaster recently.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Petrov, DA (corresponding author), Stanford Univ, Dept Biol Sci, 371 Serra Mall, Stanford, CA 94305 USA.	dpetrov@stanford.edu		Petrov, Dmitri/0000-0002-3664-9130				Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; BENDER W, 1983, J MOL BIOL, V168, P17, DOI 10.1016/S0022-2836(83)80320-9; CHARLESWORTH B, 1989, ANNU REV GENET, V23, P251, DOI 10.1146/annurev.ge.23.120189.001343; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD222, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; Kaminker JS, 2002, GENOME BIOL, V3, P0084, DOI DOI 10.1186/GB-2002-3-12-RFESEARCH84; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; MONTGOMERY E, 1987, GENET RES, V49, P31, DOI 10.1017/S0016672300026707; Petrov DA, 2003, MOL BIOL EVOL, V20, P880, DOI 10.1093/molbev/msg102; RUSSO CAM, 1995, MOL BIOL EVOL, V12, P391; Schlenke TA, 2004, P NATL ACAD SCI USA, V101, P1626, DOI 10.1073/pnas.0303793101; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Singh ND, 2005, GENETICS, V169, P709, DOI 10.1534/genetics.104.032250; Singh ND, 2004, MOL BIOL EVOL, V21, P670, DOI 10.1093/molbev/msh060; Slatkin M, 2000, ANNU REV GENOM HUM G, V1, P225, DOI 10.1146/annurev.genom.1.1.225	16	181	184	0	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 29	2005	309	5735					764	767		10.1126/science.1112699	http://dx.doi.org/10.1126/science.1112699			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951NU	16051794				2022-12-01	WOS:000230938200048
J	Lee, JT				Lee, JT			Regulation of X-chromosome counting by Tsix and Xite sequences	SCIENCE			English	Article							INACTIVATION CENTER; XIST GENE	In mammals, X-inactivation establishes X-chromosome dosage parity between mates and females. How X-chromosome counting regulates this process remains elusive, because neither the hypothesized inactivation "blocking factor" nor the required cis-elements have been defined. Here, a mouse knockout and transgenic analysis identified DNA sequences within the noncoding Tsix and Xite genes as numerators. Homozygous deficiency of Tsix resulted in "chaotic choice" and a variable number of inactive X's, whereas overdosage of TsixlXite inhibited X-inactivation. Thus, counting was affected by specific TsixlXite mutations, suggesting that counting is genetically separable from but molecularly coupled to choice. The mutations affect XX and XY cells differently, demonstrating that counting and choice are regulated not by one "blocking factor," but by both a "blocking" and a "competence" factor.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Mol Biol,Howard Hughes Med Inst,Dept Genet, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Howard Hughes Medical Institute	Lee, JT (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Mol Biol,Howard Hughes Med Inst,Dept Genet, Boston, MA 02114 USA.	tee@molbio.mgh.harvard.edu			NIGMS NIH HHS [R01-GM58839] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058839] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Clerc P, 1998, NAT GENET, V19, P249, DOI 10.1038/924; Heard E, 1999, MOL CELL BIOL, V19, P3156; Lee JT, 1999, P NATL ACAD SCI USA, V96, P3836, DOI 10.1073/pnas.96.7.3836; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lee JT, 2002, NAT GENET, V32, P195, DOI 10.1038/ng939; Lee JT, 1996, CELL, V86, P83, DOI 10.1016/S0092-8674(00)80079-3; LYON MF, 1972, BIOL REV, V47, P1; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Morey C, 2004, EMBO J, V23, P594, DOI 10.1038/sj.emboj.7600071; Ogawa Y, 2003, MOL CELL, V11, P731, DOI 10.1016/S1097-2765(03)00063-7; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; RASTAN S, 1983, J EMBRYOL EXP MORPH, V78, P1; Stavropoulos N, 2005, MOL CELL BIOL, V25, P2757, DOI 10.1128/MCB.25.7.2757-2769.2005	14	113	119	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2005	309	5735					768	771		10.1126/science.1113673	http://dx.doi.org/10.1126/science.1113673			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951NU	16051795				2022-12-01	WOS:000230938200049
J	Reinking, J; Lam, MMS; Pardee, K; Sampson, HM; Liu, SY; Yang, P; Williams, S; White, W; Lajoie, G; Edwards, A; Krause, HM				Reinking, J; Lam, MMS; Pardee, K; Sampson, HM; Liu, SY; Yang, P; Williams, S; White, W; Lajoie, G; Edwards, A; Krause, HM			The Drosophila nuclear receptor E75 contains heme and is gas responsive	CELL			English	Article							LIGAND-BINDING DOMAIN; NITRIC-OXIDE; CARBON-MONOXIDE; TRANSCRIPTION FACTOR; CRYSTAL-STRUCTURE; PROTHORACICOTROPIC HORMONE; DEVELOPMENTAL EXPRESSION; CIRCADIAN TRANSCRIPTION; RHODOSPIRILLUM-RUBRUM; SUPERFAMILY MEMBERS	Nuclear receptors are a family of transcription factors with structurally conserved ligand binding domains that regulate their activity. Despite intensive efforts to identify ligands, most nuclear receptors are still "orphans." Here, we demonstrate that the ligand binding pocket of the Drosophila nuclear receptor E75 contains a heme prosthetic group. E75 absorption spectra, resistance to denaturants, and effects of site-directed mutagenesis indicate a single, coordinately bound heme molecule. A correlation between the levels of E75 expression and the levels of available heme suggest a possible role as a heme sensor. The oxidation state of the heme iron also determines whether E75 can interact with its heterodimer partner DHR3, suggesting an additional role as a redox sensor. Further, the E75-DHR3 interaction is also regulated by the binding of NO or CO to the heme center, suggesting that E75 may also function as a diatomic gas sensor. Possible mechanisms and roles for these interactions are discussed.	Charles H Best Inst, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; Univ Western Ontario, Siebens Drake Res Inst, London, ON N6A 5C1, Canada; GlaxoSmithKline Inc, Res Triangle Pk, NC 27709 USA	University of Toronto; Western University (University of Western Ontario); GlaxoSmithKline	Krause, HM (corresponding author), Charles H Best Inst, Banting & Best Dept Med Res, 112 Coll St, Toronto, ON M5G 1L6, Canada.	h.krause@utoronto.ca		Krause, Henry/0000-0002-6182-7074; Edwards, Aled/0000-0002-4782-6016; Williams, Shawn/0000-0001-8311-2638; Lam, Mandy/0000-0001-7984-9709				Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Aono S, 1996, BIOCHEM BIOPH RES CO, V228, P752, DOI 10.1006/bbrc.1996.1727; Artinian LR, 2001, EXP NEUROL, V171, P293, DOI 10.1006/exnr.2001.7781; Bauer M, 2004, PHYSIOL GENOMICS, V17, P230, DOI 10.1152/physiolgenomics.00203.2003; Bialecki M, 2002, DEV CELL, V3, P209, DOI 10.1016/S1534-5807(02)00204-6; Bicker G, 2001, CELL TISSUE RES, V303, P137, DOI 10.1007/s004410000321; Billas IML, 2001, J BIOL CHEM, V276, P7465, DOI 10.1074/jbc.M008926200; Brennan CA, 1998, DEVELOPMENT, V125, P2653; Buszczak M, 1999, DEVELOPMENT, V126, P4581; Chan SM, 1998, FEBS LETT, V436, P395, DOI 10.1016/S0014-5793(98)01148-X; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; D'Avino PP, 1998, DEVELOPMENT, V125, P1733; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P37973, DOI 10.1074/jbc.C200420200; DING JM, 1994, SCIENCE, V266, P1713, DOI 10.1126/science.7527589; Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456; Dubrovskaya VA, 2004, GENE, V340, P171, DOI 10.1016/j.gene.2004.07.022; EVANS LA, 1988, SCIENCE, V240, P1522, DOI 10.1126/science.2836951; Gevantman LH, 2004, CRC HDB CHEM PHYS; Gilles-Gonzalez MA, 2005, J INORG BIOCHEM, V99, P1, DOI 10.1016/j.jinorgbio.2004.11.006; Glass CK, 2000, GENE DEV, V14, P121; Hiruma K, 2004, DEV BIOL, V272, P510, DOI 10.1016/j.ydbio.2004.04.028; HORNER MA, 1995, DEV BIOL, V168, P490, DOI 10.1006/dbio.1995.1097; Ignarro L. J., 2000, NITRIC OXIDE BIOL PA; Jain R, 2003, J BIOL INORG CHEM, V8, P1, DOI 10.1007/s00775-002-0405-8; JINDRA M, 1994, EUR J BIOCHEM, V221, P665, DOI 10.1111/j.1432-1033.1994.tb18779.x; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Kurokawa H, 2004, J BIOL CHEM, V279, P20186, DOI 10.1074/jbc.M314199200; Loo JA, 2000, INT J MASS SPECTROM, V200, P175, DOI 10.1016/S1387-3806(00)00298-0; LORENZ RT, 1991, LIPIDS, V26, P598, DOI 10.1007/BF02536423; Nakajima Y, 2004, FEBS LETT, V565, P122, DOI 10.1016/j.febslet.2004.03.083; Neill SJ, 2003, NEW PHYTOL, V159, P11, DOI 10.1046/j.1469-8137.2003.00804.x; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Orlicky SM, 2001, J BIOL CHEM, V276, P10097, DOI 10.1074/jbc.M003165200; PALLI SR, 1995, INSECT BIOCHEM MOLEC, V25, P697, DOI 10.1016/0965-1748(95)00008-J; Palli SR, 1997, DEV GENET, V20, P36, DOI 10.1002/(SICI)1520-6408(1997)20:1&lt;36::AID-DVG5&gt;3.0.CO;2-A; PARDEE K, 2004, SCI AGING KNOWLEDGE, pRE8, DOI DOI 10.1126/SAGEKE.2004.47.RE8; Potier N, 2003, PROTEIN SCI, V12, P725, DOI 10.1110/ps.0232503; POULOS TL, 1988, PHARMACEUT RES, V5, P67, DOI 10.1023/A:1015920931701; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Regulski M, 2004, CURR BIOL, V14, pR881, DOI 10.1016/j.cub.2004.09.068; Reynolds MF, 2000, BIOCHEMISTRY-US, V39, P388, DOI 10.1021/bi991378g; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Ryter SW, 2004, BIOESSAYS, V26, P270, DOI 10.1002/bies.20005; Sasakura Y, 2002, J BIOL CHEM, V277, P23821, DOI 10.1074/jbc.M202738200; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Schwartz CJE, 2001, EMBO J, V20, P510, DOI 10.1093/emboj/20.3.510; SEGRAVES WA, 1990, GENE DEV, V4, P204, DOI 10.1101/gad.4.2.204; Shelver D, 1997, P NATL ACAD SCI USA, V94, P11216, DOI 10.1073/pnas.94.21.11216; Siaussat D, 2004, INSECT MOL BIOL, V13, P179, DOI 10.1111/j.0962-1075.2004.00475.x; Snyder SH, 2000, AM J PSYCHIAT, V157, P1738, DOI 10.1176/appi.ajp.157.11.1738; Stehlin C, 2001, EMBO J, V20, P5822, DOI 10.1093/emboj/20.21.5822; STONE JR, 1994, BIOCHEMISTRY-US, V33, P5636, DOI 10.1021/bi00184a036; Sullivan AA, 2003, MOL ENDOCRINOL, V17, P2125, DOI 10.1210/me.2002-0430; Swevers L, 2002, J BIOL CHEM, V277, P41637, DOI 10.1074/jbc.M203581200; Swevers L, 2002, INSECT BIOCHEM MOLEC, V32, P1643, DOI 10.1016/S0965-1748(02)00104-2; THUMMEL CS, 1995, CELL, V83, P871, DOI 10.1016/0092-8674(95)90203-1; Vafopoulou X, 1996, GEN COMP ENDOCR, V102, P123, DOI 10.1006/gcen.1996.0053; Vafopoulou X, 1996, P NATL ACAD SCI USA, V93, P3368, DOI 10.1073/pnas.93.8.3368; Wagener FADTG, 2003, PHARMACOL REV, V55, P551, DOI 10.1124/pr.55.3.5; Ward RE, 2003, DEV BIOL, V256, P389, DOI 10.1016/S0012-1606(02)00100-8; White KP, 1997, SCIENCE, V276, P114, DOI 10.1126/science.276.5309.114; Wisely GB, 2002, STRUCTURE, V10, P1225, DOI 10.1016/S0969-2126(02)00829-8; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; YANG P, 2005, IN PRESS PROTEOMICS; Zhang RG, 2001, STRUCTURE, V9, P1095, DOI 10.1016/S0969-2126(01)00675-X; Zhang XH, 2004, EUR J BIOCHEM, V271, P1713, DOI 10.1111/j.1432-1033.2004.04077.x	67	200	213	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 29	2005	122	2					195	207		10.1016/j.cell.2005.07.005	http://dx.doi.org/10.1016/j.cell.2005.07.005			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	951CR	16051145	Bronze			2022-12-01	WOS:000230907000008
J	Ratnieks, F				Ratnieks, F			Outsmarted by ants	NATURE			English	Editorial Material									Univ Sheffield, Dept Anim & Plant Sci, Lab Apiculture & Social Insects, Sheffield S10 2TN, S Yorkshire, England; Inst Adv Study, D-14193 Berlin, Germany	University of Sheffield	Ratnieks, F (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Lab Apiculture & Social Insects, Sheffield S10 2TN, S Yorkshire, England.							Feynman R. P., 2005, DONT YOU HAVE TIME T; FEYNMAN RP, 1985, SURLEY YOURE JOKING; Jackson DE, 2004, NATURE, V432, P907, DOI 10.1038/nature03105	3	3	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 28	2005	436	7050					465	465		10.1038/436465a	http://dx.doi.org/10.1038/436465a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049456	Bronze			2022-12-01	WOS:000230788800024
J	Kidane, D; Graumann, PL				Kidane, D; Graumann, PL			Intracellular protein and DNA dynamics in competent Bacillus subtilis cells	CELL			English	Article							ESCHERICHIA-COLI RECA; SINGLE-STRANDED-DNA; SMC PROTEIN; TRANSFORMATION; RECOMBINATION; REPAIR; BINDING; LOCALIZATION; CONDENSATION; REPLICATION	We have found that two DNA repair/recombination proteins localize differentially to the cell poles in competent Bacillus subtilis cells. RecA protein colocalized with competence protein ComGA, and its polar localization largely depended on ComGA and ComK activity, while RecN oscillated between the poles in a minute time frame, independent of any competence factor. Oscillation of RecN arrested upon addition of external DNA, suggesting that an interaction with incoming single-stranded (ss) DNA favors the localization of RecN at the pole containing the competence machinery. In agreement with this model, purified RecN protein showed ATP-dependent binding to ssDNA. Addition of DNA resulted in the formation of RecA threads emanating from the competence machinery. Our data show that in competent bacteria there exists a specifically positioned and dynamic ssDNA binding apparatus that accepts ssDNA taken up through the polar competence machinery and processes ssDNA for recombination with chromosomal DNA via extended RecA filaments.	Univ Freiburg, Fachbereich Biol 2, Inst Mikrobiol, D-79104 Freiburg, Germany	University of Freiburg	Graumann, PL (corresponding author), Univ Freiburg, Fachbereich Biol 2, Inst Mikrobiol, Stefan Meier Str 19, D-79104 Freiburg, Germany.	peter.graumann@biologie.uni-freiburg.de		Graumann, Peter/0000-0002-8033-5171				Arnold DA, 2000, J BIOL CHEM, V275, P12261, DOI 10.1074/jbc.275.16.12261; Ayora S, 2004, P NATL ACAD SCI USA, V101, P452, DOI 10.1073/pnas.2533829100; Berka RM, 2002, MOL MICROBIOL, V43, P1331, DOI 10.1046/j.1365-2958.2002.02833.x; Bork JM, 2001, EMBO J, V20, P7313, DOI 10.1093/emboj/20.24.7313; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Chung YS, 1998, J BACTERIOL, V180, P41, DOI 10.1128/JB.180.1.41-45.1998; Cox MM, 2003, ANNU REV MICROBIOL, V57, P551, DOI 10.1146/annurev.micro.57.030502.090953; Cromie GA, 2001, MOL CELL, V8, P1163, DOI 10.1016/S1097-2765(01)00419-1; DUBNAU D, 1973, J BACTERIOL, V113, P1512, DOI 10.1128/JB.113.3.1512-1514.1973; Dubnau D, 1999, ANNU REV MICROBIOL, V53, P217, DOI 10.1146/annurev.micro.53.1.217; DUBNAU D, 1971, J MOL BIOL, V56, P209, DOI 10.1016/0022-2836(71)90460-8; Gruber S, 2003, CELL, V112, P765, DOI 10.1016/S0092-8674(03)00162-4; Haber JE, 2000, TRENDS GENET, V16, P259, DOI 10.1016/S0168-9525(00)02022-9; Hahn J, 2005, CELL, V122, P59, DOI 10.1016/j.cell.2005.04.035; Haijema BJ, 2001, MOL MICROBIOL, V40, P52, DOI 10.1046/j.1365-2958.2001.02363.x; Hamoen LW, 2001, J BIOL CHEM, V276, P42901, DOI 10.1074/jbc.M104407200; Hirano M, 2002, EMBO J, V21, P5733, DOI 10.1093/emboj/cdf575; Hirano T, 2002, GENE DEV, V16, P399, DOI 10.1101/gad.955102; Kantake N, 2002, P NATL ACAD SCI USA, V99, P15327, DOI 10.1073/pnas.252633399; Kidane D, 2004, MOL MICROBIOL, V52, P1627, DOI 10.1111/j.1365-2958.2004.04102.x; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Lewis PJ, 1999, GENE, V227, P101, DOI 10.1016/S0378-1119(98)00580-0; LONDONOVALLEJO JA, 1994, J BACTERIOL, V176, P4642; Maier B, 2004, NAT STRUCT MOL BIOL, V11, P643, DOI 10.1038/nsmb783; Mascarenhas J, 2002, EMBO J, V21, P3108, DOI 10.1093/emboj/cdf314; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; Provvedi R, 1999, MOL MICROBIOL, V31, P271, DOI 10.1046/j.1365-2958.1999.01170.x; Provvedi R, 2001, MOL MICROBIOL, V40, P634, DOI 10.1046/j.1365-2958.2001.02406.x; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Sanchez H, 2005, NUCLEIC ACIDS RES, V33, P2343, DOI 10.1093/nar/gki533; Sciochetti SA, 2001, J BACTERIOL, V183, P2963, DOI 10.1128/JB.183.9.2963-2968.2001; Shih YL, 2003, P NATL ACAD SCI USA, V100, P7865, DOI 10.1073/pnas.1232225100; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; Teleman AA, 1998, CURR BIOL, V8, P1102, DOI 10.1016/S0960-9822(98)70464-6; Volkov A, 2003, MOL CELL BIOL, V23, P5638, DOI 10.1128/MCB.23.16.5638-5650.2003; Webb BL, 1997, CELL, V91, P347, DOI 10.1016/S0092-8674(00)80418-3; Webb CD, 1997, CELL, V88, P667, DOI 10.1016/S0092-8674(00)81909-1; Xing X, 2004, J MOL BIOL, V342, P1471, DOI 10.1016/j.jmb.2004.07.091	38	82	84	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 15	2005	122	1					73	84		10.1016/j.cell.2005.04.036	http://dx.doi.org/10.1016/j.cell.2005.04.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	950EC	16009134	Bronze			2022-12-01	WOS:000230839400012
J	Kujoth, GC; Hiona, A; Pugh, TD; Someya, S; Panzer, K; Wohlgemuth, SE; Hofer, T; Seo, AY; Sullivan, R; Jobling, WA; Morrow, JD; Van Remmen, H; Sedivy, JM; Yamasoba, T; Tanokura, M; Weindruch, R; Leeuwenburgh, C; Prolla, TA				Kujoth, GC; Hiona, A; Pugh, TD; Someya, S; Panzer, K; Wohlgemuth, SE; Hofer, T; Seo, AY; Sullivan, R; Jobling, WA; Morrow, JD; Van Remmen, H; Sedivy, JM; Yamasoba, T; Tanokura, M; Weindruch, R; Leeuwenburgh, C; Prolla, TA			Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging	SCIENCE			English	Article							MICE; MUSCLE; AGE; ABNORMALITIES; DELETION; ATROPHY; HEARING	Mutations in mitochondrial DNA. (mtDNA) accumulate in tissues of mammalian species and have been hypothesized to contribute to aging. We show that mice expressing a proof reading-deficient version of the mitochondrial DNA polymerase gamma (POLG) accumulate mtDNA mutations and display features of accelerated aging. Accumulation of mtDNA mutations was not associated with increased markers of oxidative stress or a defect in cellular proliferation, but was correlated with the induction of apoptotic markers, particularly in tissues characterized by rapid cellular turnover. The levels of apoptotic markers were also found to increase during aging in normal mice. Thus, accumulation of mtDNA mutations that promote apoptosis may be a central mechanism driving mammalian aging.	Univ Wisconsin, Dept Genet & Med Genet, Madison, WI 53706 USA; Univ Florida, Coll Med, Dept Aging & Geriatr Res, Inst Aging,Biochem Aging Lab, Gainesville, FL 32610 USA; Univ Wisconsin, Dept Med, Madison, WI 53705 USA; Univ Wisconsin, Vet Adm Hosp, Madison, WI 53705 USA; Univ Tokyo, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; Brown Univ, Ctr Genom & Proteom, Providence, RI 02912 USA; Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA; Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78284 USA; Univ Texas, Hlth Sci Ctr, Barshop Inst Longev & Aging Studies, San Antonio, TX 78284 USA; Univ Tokyo, Dept Otolaryngol, Bunkyo Ku, Tokyo 1138657, Japan	University of Wisconsin System; University of Wisconsin Madison; State University System of Florida; University of Florida; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Tokyo; University of Wisconsin System; University of Wisconsin Madison; Brown University; Brown University; Vanderbilt University; Vanderbilt University; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Tokyo	Prolla, TA (corresponding author), Univ Wisconsin, Dept Genet & Med Genet, Madison, WI 53706 USA.	taprolla@wisc.edu		Kujoth, Gregory/0000-0002-6636-2800; Tanokura, Masaru/0000-0001-5072-2480; Leeuwenburgh, Christiaan/0000-0003-0826-4257	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021905, R01AG018922, R01AG021042, R01AG017994, R37AG016694, R01AG016694, T32AG000213] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00095] Funding Source: Medline; NIA NIH HHS [AG021905, AG18922, AG17994, T32 AG00213, AG16694, AG21042] Funding Source: Medline; NIDDK NIH HHS [DK48831] Funding Source: Medline; NIGMS NIH HHS [T32 GM07601] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aspnes LE, 1997, FASEB J, V11, P573, DOI 10.1096/fasebj.11.7.9212081; Chang S, 2004, NAT GENET, V36, P877, DOI 10.1038/ng1389; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324; de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174; FLEMING JE, 1982, GERONTOLOGY, V28, P44, DOI 10.1159/000212510; Gratton Michael Anne, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P367, DOI 10.1097/00020840-200310000-00010; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Keithley EM, 2004, HEARING RES, V188, P21, DOI 10.1016/S0378-5955(03)00365-4; Khaidakov M, 2003, MUTAT RES-FUND MOL M, V526, P1, DOI 10.1016/S0027-5107(03)00010-1; LEE CM, 1993, J GERONTOL, V48, P201; LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3; Melov S, 1997, NUCLEIC ACIDS RES, V25, P974, DOI 10.1093/nar/25.5.974; Roberts LJ, 2002, CELL MOL LIFE SCI, V59, P808, DOI 10.1007/s00018-002-8469-8; Shelke RRJ, 2003, FASEB J, V17, P494, DOI 10.1096/fj.02-0803fje; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Vogel H, 1999, P NATL ACAD SCI USA, V96, P10770, DOI 10.1073/pnas.96.19.10770; Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com; Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	23	1466	1561	6	206	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2005	309	5733					481	484		10.1126/science.1112125	http://dx.doi.org/10.1126/science.1112125			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946LY	16020738				2022-12-01	WOS:000230574900051
J	Garraway, LA; Widlund, HR; Rubin, MA; Getz, G; Berger, AJ; Ramaswamy, S; Beroukhim, R; Milner, DA; Granter, SR; Du, JY; Lee, C; Wagner, SN; Li, C; Golub, TR; Rimm, DL; Meyerson, ML; Fisher, DE; Sellers, WR				Garraway, LA; Widlund, HR; Rubin, MA; Getz, G; Berger, AJ; Ramaswamy, S; Beroukhim, R; Milner, DA; Granter, SR; Du, JY; Lee, C; Wagner, SN; Li, C; Golub, TR; Rimm, DL; Meyerson, ML; Fisher, DE; Sellers, WR			Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma	NATURE			English	Article							NUCLEOTIDE POLYMORPHISM ARRAYS; ANTICANCER DRUG SCREEN; CANCER-CELL LINES; HETEROZYGOSITY ANALYSIS; EXPRESSION PATTERNS; PROSTATE-CANCER; COPY NUMBER; MELANOCYTES; GENE; MICROPHTHALMIA	Systematic analyses of cancer genomes promise to unveil patterns of genetic alterations linked to the genesis and spread of human cancers. High-density single-nucleotide polymorphism (SNP) arrays enable detailed and genome-wide identification of both loss-of-heterozygosity events and copy-number alterations in cancer(1-5). Here, by integrating SNP array-based genetic maps with gene expression signatures derived from NCI60 cell lines, we identified the melanocyte master regulator MITF (microphthalmia-associated transcription factor) as the target of a novel melanoma amplification. We found that MITF amplification was more prevalent in metastatic disease and correlated with decreased overall patient survival. BRAF mutation and p16 inactivation accompanied MITF amplification in melanoma cell lines. Ectopic MITF expression in conjunction with the BRAF(V600E) mutant transformed primary human melanocytes, and thus MITF can function as a melanoma oncogene. Reduction of MITF activity sensitizes melanoma cells to chemotherapeutic agents. Targeting MITF in combination with BRAF or cyclin-dependent kinase inhibitors may offer a rational therapeutic avenue into melanoma, a highly chemotherapy-resistant neoplasm. Together, these data suggest that MITF represents a distinct class of 'lineage survival' or 'lineage addiction' oncogenes required for both tissue-specific cancer development and tumour progression.	Dana Farber Canc Inst, Dept Med Oncol, Pediat Oncol Biostat Sci & Melonam Program Med On, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Broad Inst Harvard, Cambridge, MA 02141 USA; MIT, Cambridge, MA 02141 USA; Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Dept Med, Charlestown, MA 02129 USA; Austrian Acad Sci, Ctr Mol Med, A-1090 Vienna, Austria; Med Univ Vienna, Dept Dermatol, DIAID, A-1090 Vienna, Austria	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Yale University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Austrian Academy of Sciences; Medical University of Vienna	Sellers, WR (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Pediat Oncol Biostat Sci & Melonam Program Med On, 44 Binney St, Boston, MA 02115 USA.	William_Sellers@dfci.harvard.edu	Meyerson, Matthew L/E-7123-2012; Milner, Danny/K-3568-2019	Wagner, Stephan/0000-0003-4941-7029; Widlund, Hans/0000-0002-7506-2447; Rimm, David/0000-0001-5820-4397; Milner, Jr, Danny Arnold/0000-0002-6685-8208; Rubin, Mark/0000-0002-8321-9950	NATIONAL CANCER INSTITUTE [T32CA009172] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA009172] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BERGER AJ, IN PRESS CANC RES; Berger R, 2004, CANCER RES, V64, P8867, DOI 10.1158/0008-5472.CAN-04-2938; Bignell GR, 2004, GENOME RES, V14, P287, DOI 10.1101/gr.2012304; Camp RL, 2003, CANCER RES, V63, P1445; Carreira S, 2005, NATURE, V433, P764, DOI 10.1038/nature03269; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chu W, 2000, ONCOGENE, V19, P395, DOI 10.1038/sj.onc.1203315; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; JAFARI M, 1995, J CANCER RES CLIN, V121, P23, DOI 10.1007/BF01202725; Kubo A, 1999, CLIN CANCER RES, V5, P4279; Lieberfarb ME, 2003, CANCER RES, V63, P4781; Lindblad-Toh K, 2000, NAT BIOTECHNOL, V18, P1001, DOI 10.1038/79269; Loercher AE, 2005, J CELL BIOL, V168, P35, DOI 10.1083/jcb.200410115; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Mei R, 2000, GENOME RES, V10, P1126, DOI 10.1101/gr.10.8.1126; Monks A, 1997, ANTI-CANCER DRUG DES, V12, P533; Nishizuka S, 2003, P NATL ACAD SCI USA, V100, P14229, DOI 10.1073/pnas.2331323100; Price ER, 1998, J BIOL CHEM, V273, P17983, DOI 10.1074/jbc.273.29.17983; Roschke AV, 2003, CANCER RES, V63, P8634; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Rubin MA, 2004, CANCER RES, V64, P3814, DOI 10.1158/0008-5472.CAN-03-3881; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; STINSON SF, 1992, ANTICANCER RES, V12, P1035; Wu M, 2000, GENE DEV, V14, P301; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308	29	1084	1126	2	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2005	436	7047					117	122		10.1038/nature03664	http://dx.doi.org/10.1038/nature03664			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942QJ	16001072				2022-12-01	WOS:000230296600050
J	Saether, BE; Lande, R; Engen, S; Weimerskirch, H; Lillegard, M; Altwegg, R; Becker, PH; Bregnballe, T; Brommer, JE; McCleery, RH; Merila, J; Nyholm, E; Rendell, W; Robertson, RR; Tryjanowski, P; Visser, ME				Saether, BE; Lande, R; Engen, S; Weimerskirch, H; Lillegard, M; Altwegg, R; Becker, PH; Bregnballe, T; Brommer, JE; McCleery, RH; Merila, J; Nyholm, E; Rendell, W; Robertson, RR; Tryjanowski, P; Visser, ME			Generation time and temporal scaling of bird population dynamics	NATURE			English	Article							LIFE-HISTORY VARIATION; DENSITY-DEPENDENCE; CLIMATE; PARAMETERS; TRENDS	Theoretical studies have shown that variation in density regulation strongly influences population dynamics(1), yet our understanding of factors influencing the strength of density dependence in natural populations still is limited(2). Consequently, few general hypotheses have been advanced to explain the large differences between species in the magnitude of population fluctuations(3-6). One reason for this is that the detection of density regulation in population time series is complicated by time lags induced by the life history of species(7,8) that make it difficult to separate the relative contributions of intrinsic and extrinsic factors to the population dynamics. Here we use population time series for 23 bird species to estimate parameters of a stochastic density-dependent age-structured model. We show that both the strength of total density dependence in the life history and the magnitude of environmental stochasticity, including transient fluctuations in age structure, increase with generation time. These results indicate that the relationships between demographic and life-history traits in birds(9,10) translate into distinct population dynamical patterns that are apparent only on a scale of generations.	Norwegian Univ Sci & Technol, Dept Biol, N-7491 Trondheim, Norway; Univ Calif San Diego, Dept Biol 0116, La Jolla, CA 92093 USA; Norwegian Univ Sci & Technol, Dept Math Sci, N-7491 Trondheim, Norway; CNRS, CEBC, FR-79360 Villiers En Bois, France; Univ Victoria, Dept Biol, Victoria, BC V8W 3N5, Canada; Inst Vogelforsch Vogelwarte Helgoland, D-26386 Wilhelmshaven, Germany; Natl Environm Res Inst, Dept Coastal Zone Ecol, DK-8410 Ronde, Denmark; Univ Helsinki, Dept Biol & Environm Sci, FIN-00014 Helsinki, Finland; Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Umea Univ, Dept Ecol & Environm Sci, S-90187 Umea, Sweden; Loyalist Coll, Belleville, ON K8N 5B9, Canada; Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; Adam Mickiewicz Univ, Dept Behav Ecol, PL-61614 Poznan, Poland; Netherlands Inst Ecol, NL-6666 ZG Heteren, Netherlands	Norwegian University of Science & Technology (NTNU); University of California System; University of California San Diego; Norwegian University of Science & Technology (NTNU); Centre National de la Recherche Scientifique (CNRS); University of Victoria; Aarhus University; University of Helsinki; University of Oxford; Umea University; Queens University - Canada; Adam Mickiewicz University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Saether, BE (corresponding author), Norwegian Univ Sci & Technol, Dept Biol, N-7491 Trondheim, Norway.	bernt-erik.sather@bio.ntnu.no	Weimerskirch, Henri/K-7306-2019; Tryjanowski, Piotr/C-1367-2009; Brommer, Jon E/C-3613-2008; Merila, Juha/A-4061-2008; Weimerskirch, Henri/F-5562-2013; Visser, Marcel E/A-9151-2009; Bregnballe, Thomas/L-1890-2013	Weimerskirch, Henri/0000-0002-0457-586X; Brommer, Jon E/0000-0002-2435-2612; Merila, Juha/0000-0001-9614-0072; Visser, Marcel E/0000-0002-1456-1939; Bregnballe, Thomas/0000-0003-2867-478X				ARINO A, 1995, EVOL ECOL, V9, P429, DOI 10.1007/BF01237765; Barbraud C, 2003, P ROY SOC B-BIOL SCI, V270, P2111, DOI 10.1098/rspb.2003.2488; Bennett P.M., 2002, EVOL ECOL; BULMER MG, 1975, BIOMETRICS, V31, P901, DOI 10.2307/2529815; Charnov EL, 2000, EVOL ECOL RES, V2, P365; CHARNOV EL, 1995, EVOL ECOL, V9, P288, DOI 10.1007/BF01237774; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; CROXALL JP, 1991, BIRD POPULATION STUD, P272; De Valpine P, 2002, ECOL MONOGR, V72, P57, DOI 10.1890/0012-9615(2002)072[0057:FPMIPN]2.0.CO;2; DEKROON H, 1986, ECOLOGY, V67, P1427, DOI 10.2307/1938700; HANSKI I, 1990, PHILOS T R SOC B, V330, P141, DOI 10.1098/rstb.1990.0188; Holyoak M, 1996, OECOLOGIA, V108, P54, DOI 10.1007/BF00333214; Lande R, 2002, AM NAT, V159, P321, DOI 10.1086/338988; Lande R, 2002, POPULATION VIABILITY ANALYSIS, P18; Lande R., 2003, STOCHASTIC POPULATIO; May R.M., 1973, STABILITY COMPLEXITY; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; Micol T, 2001, POLAR BIOL, V24, P175, DOI 10.1007/s003000000193; Newton I., 1998, POPULATION LIMITATIO; Nisbet R.M., 1997, STRUCTURED POPULATIO, V18, P89; Pimm S.L., 1991, BALANCE NATURE; Royama T., 1992, ANAL POPULATION ECOL; Saether BE, 2004, ADV ECOL RES, V35, P185, DOI 10.1016/S0065-2504(04)35009-9; Saether BE, 2004, AM NAT, V164, P793, DOI 10.1086/425371; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; Shumway R.H., 1988, APPL STAT TIME SERIE; Sibly Richard M., 2003, P11, DOI 10.1017/CBO9780511615740.002; Thompson PM, 2001, NATURE, V413, P417, DOI 10.1038/35096558; Weimerskirch H, 2003, ANTARCT SCI, V15, P249, DOI 10.1017/S0954102003001202; Zeng Z, 1998, ECOLOGY, V79, P2193, DOI 10.1890/0012-9658(1998)079[2193:CPDITR]2.0.CO;2	30	135	139	2	71	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 7	2005	436	7047					99	102		10.1038/nature03666	http://dx.doi.org/10.1038/nature03666			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942QJ	16001068				2022-12-01	WOS:000230296600046
J	Seligson, DB; Horvath, S; Shi, T; Yu, H; Tze, S; Grunstein, M; Kurdistani, SK				Seligson, DB; Horvath, S; Shi, T; Yu, H; Tze, S; Grunstein, M; Kurdistani, SK			Global histone modification patterns predict risk of prostate cancer recurrence	NATURE			English	Article							TARGETED RECRUITMENT; ACETYLATION; CHROMATIN; ANTIGEN; P300	Aberrations in post-translational modifications of histones have been shown to occur in cancer cells but only at individual promoters(1); they have not been related to clinical outcome. Other than being targeted to promoters, modifications of histones, such as acetylation and methylation of lysine and arginine residues, also occur over large regions of chromatin including coding regions and non-promoter sequences, which are referred to as global histone modifications(2). Here we show that changes in global levels of individual histone modifications are also associated with cancer and that these changes are predictive of clinical outcome. Through immunohistochemical staining of primary prostatectomy tissue samples, we determined the percentage of cells that stained for the histone acetylation and dimethylation of five residues in histones H3 and H4. Grouping of samples with similar patterns of modifications identified two disease subtypes with distinct risks of tumour recurrence in patients with low-grade prostate cancer. These histone modification patterns were predictors of outcome independently of tumour stage, preoperative prostate-specific antigen levels, and capsule invasion. Thus, widespread changes in specific histone modifications indicate previously undescribed molecular heterogeneity in prostate cancer and might underlie the broad range of clinical behaviour in cancer patients.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Kurdistani, SK (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.	skurdistani@mednet.ucla.edu		Kurdistani, Siavash/0000-0003-3295-3511; , Tao/0000-0001-5489-2655				Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 1984, CLASSIFICATION REGRE, DOI 10.1201/9781315139470; Bunting PS, 2002, CLIN CHIM ACTA, V315, P71, DOI 10.1016/S0009-8981(01)00717-3; Cleveland W.S., 1993, VISUALIZING DATA; Debes JD, 2003, CANCER RES, V63, P7638; Farkas A, 1998, UROLOGY, V52, P444, DOI 10.1016/S0090-4295(98)00242-8; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Gayther SA, 2000, NAT GENET, V24, P300, DOI 10.1038/73536; Giles RH, 1998, TRENDS GENET, V14, P178, DOI 10.1016/S0168-9525(98)01438-3; GLEASON DONALD F., 1966, CANCER CHEMO THERAP REP, V50, P125; Han M, 2001, J UROLOGY, V166, P416, DOI 10.1016/S0022-5347(05)65955-1; Jacobson S, 1999, CURR OPIN GENET DEV, V9, P175, DOI 10.1016/S0959-437X(99)80027-6; Jemal A, 2003, CA-CANCER J CLIN, V53, P5, DOI 10.3322/canjclin.53.1.5; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Krebs JE, 2000, CELL, V102, P587, DOI 10.1016/S0092-8674(00)00081-7; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Muraoka M, 1996, ONCOGENE, V12, P1565; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Reid JL, 2000, MOL CELL, V6, P1297, DOI 10.1016/S1097-2765(00)00128-3; Rezai-Zadeh N, 2003, GENE DEV, V17, P1019, DOI 10.1101/gad.1068003; Shi T, 2005, MODERN PATHOL, V18, P547, DOI 10.1038/modpathol.3800322; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; Vogelauer M, 2000, NATURE, V408, P495, DOI 10.1038/35044127	24	780	847	1	76	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 30	2005	435	7046					1262	1266		10.1038/nature03672	http://dx.doi.org/10.1038/nature03672			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940JJ	15988529				2022-12-01	WOS:000230140500049
J	Govindarajulu, M; Pfeffer, PE; Jin, HR; Abubaker, J; Douds, DD; Allen, JW; Bucking, H; Lammers, PJ; Shachar-Hill, Y				Govindarajulu, M; Pfeffer, PE; Jin, HR; Abubaker, J; Douds, DD; Allen, JW; Bucking, H; Lammers, PJ; Shachar-Hill, Y			Nitrogen transfer in the arbuscular mycorrhizal symbiosis	NATURE			English	Article							FUNGUS GLOMUS-INTRARADICES; IN-VITRO; GENE-EXPRESSION; TRANSPORT; CARBON; ASSIMILATION; ROOTS; METABOLISM; TRANSLOCATION; CARBOHYDRATE	Most land plants are symbiotic with arbuscular mycorrhizal fungi (AMF), which take up mineral nutrients from the soil and exchange them with plants for photosynthetically fixed carbon. This exchange is a significant factor in global nutrient cycles(1) as well as in the ecology(2), evolution(3) and physiology(4) of plants. Despite its importance as a nutrient, very little is known about how AMF take up nitrogen and transfer it to their host plants(5). Here we report the results of stable isotope labelling experiments showing that inorganic nitrogen taken up by the fungus outside the roots is incorporated into amino acids, translocated from the extraradical to the intraradical mycelium as arginine, but transferred to the plant without carbon. Consistent with this mechanism, the genes of primary nitrogen assimilation are preferentially expressed in the extraradical tissues, whereas genes associated with arginine breakdown are more highly expressed in the intraradical mycelium. Strong changes in the expression of these genes in response to nitrogen availability and form also support the operation of this novel metabolic pathway in the arbuscular mycorrhizal symbiosis.	New Mexico State Univ, Dept Chem & Biochem, Las Cruces, NM 88003 USA; ARS, USDA, Eastern Reg Res Ctr, Wyndmoor, PA 19038 USA; Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA	New Mexico State University; United States Department of Agriculture (USDA); Michigan State University	Lammers, PJ (corresponding author), New Mexico State Univ, Dept Chem & Biochem, Las Cruces, NM 88003 USA.	ppfeffer@arserrc.gov; plammers@nmsu.edu	Shachar-Hill, Yair/B-6165-2013; Allen, James/AAG-6465-2019; Lammers, Peter/K-6661-2018	Shachar-Hill, Yair/0000-0001-8793-5084; Lammers, Peter/0000-0002-7312-0797; Abubaker, Jehad/0000-0003-0681-7305; Bucking, Heike/0000-0002-4040-0944				Allen MF, 2003, ANNU REV PHYTOPATHOL, V41, P271, DOI 10.1146/annurev.phyto.41.052002.095518; AMES RN, 1983, NEW PHYTOL, V95, P381, DOI 10.1111/j.1469-8137.1983.tb03506.x; Bago B, 2003, PLANT PHYSIOL, V131, P1496, DOI 10.1104/pp.102.007765; Bago B, 2002, PLANT PHYSIOL, V128, P108, DOI 10.1104/pp.010466; Bago B, 1996, NEW PHYTOL, V133, P273, DOI 10.1111/j.1469-8137.1996.tb01894.x; Bago B, 2001, NEW PHYTOL, V149, P4, DOI 10.1046/j.1469-8137.2001.00016.x; Bago B, 2000, PLANT PHYSIOL, V124, P949, DOI 10.1104/pp.124.3.949; Breuninger M, 2004, FUNGAL GENET BIOL, V41, P542, DOI 10.1016/j.fgb.2004.01.003; Bucking H, 2005, NEW PHYTOL, V165, P899, DOI 10.1111/j.1469-8137.2004.01274.x; CLIQUET JB, 1993, PLANT PHYSIOL, V101, P865, DOI 10.1104/pp.101.3.865; HARRISON MJ, 1995, NATURE, V378, P626, DOI 10.1038/378626a0; He XH, 2003, CRIT REV PLANT SCI, V22, P531, DOI 10.1080/713608315; Hildebrandt U, 2002, PHYSIOL PLANTARUM, V115, P125, DOI 10.1034/j.1399-3054.2002.1150115.x; Hodge A, 2001, NATURE, V413, P297, DOI 10.1038/35095041; Johansen A, 1996, NEW PHYTOL, V133, P705, DOI 10.1111/j.1469-8137.1996.tb01939.x; KALDORF M, 1994, MYCORRHIZA, V5, P23, DOI 10.1007/BF00204016; Lammers PJ, 2001, PLANT PHYSIOL, V127, P1287, DOI 10.1104/pp.010375; Marschner H., 1995, MINERAL NUTR PLANTS; MARTIN F, 1986, NEW PHYTOL, V102, P85, DOI 10.1111/j.1469-8137.1986.tb00800.x; MARTIN F, 1985, FEBS LETT, V182, P350, DOI 10.1016/0014-5793(85)80331-8; Nielsen JS, 2002, NEW PHYTOL, V154, P809, DOI 10.1046/j.1469-8137.2002.00412.x; Pfeffer PE, 1999, PLANT PHYSIOL, V120, P587, DOI 10.1104/pp.120.2.587; Pfeffer PE, 2004, NEW PHYTOL, V163, P617, DOI 10.1111/j.1469-8137.2004.01152.x; Read DJ, 2003, NEW PHYTOL, V157, P475, DOI 10.1046/j.1469-8137.2003.00704.x; Redecker D, 2000, SCIENCE, V289, P1920, DOI 10.1126/science.289.5486.1920; Smith S. E., 2010, MYCORRHIZAL SYMBIOSI; StArnaud M, 1996, MYCOL RES, V100, P328, DOI 10.1016/S0953-7562(96)80164-X; Toussaint JP, 2004, CAN J MICROBIOL, V50, P251, DOI [10.1139/w04-009, 10.1139/W04-009]; Vallorani L, 2002, NEW PHYTOL, V154, P779, DOI 10.1046/j.1469-8137.2002.00409.x; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085	30	605	675	22	533	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2005	435	7043					819	823		10.1038/nature03610	http://dx.doi.org/10.1038/nature03610			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933NK	15944705				2022-12-01	WOS:000229638700051
J	Lee, MG; Wynder, C; Cooch, N; Shiekhattar, R				Lee, MG; Wynder, C; Cooch, N; Shiekhattar, R			An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation	NATURE			English	Article							SANT DOMAIN; GENE-EXPRESSION; NEURONAL GENES; N-COR; COMPLEX; COMPONENT; OXIDASE; REPRESSION; SMRT; SNF	We have previously described a multiprotein complex termed the BHC or BRAF - HDAC complex, which is required for the repression of neuronal-specific genes(1). We have shown that the BHC complex is recruited by a neuronal silencer, REST (RE1-silencing transcription factor), and mediates the repression of REST-responsive genes1. BHC is a multiprotein complex consisting of two enzymatic activities: a histone deacetylase (HDAC1 or 2) and a recently described histone demethylase (BHC110, also known as LSD1 or AOF2)(1-3). Here we show that BHC110-containing complexes show a nearly fivefold increase in demethylation of histone H3 lysine 4 (H3K4) compared to recombinant BHC110. Furthermore, recombinant BHC110 is unable to demethylate H3K4 on nucleosomes, but BHC110-containing complexes readily demethylate nucleosomes. In vitro reconstitution of the BHC complex using recombinant subunits reveals an essential role for the REST corepressor CoREST, not only in stimulating demethylation on core histones but also promoting demethylation of nucleosomal substrates. We find that nucleosomal demethylation is the result of CoREST enhancing the association between BHC110 and nucleosomes. Depletion of CoREST in in vivo cell culture results in de-repression of REST-responsive gene expression and increased methylation of H3K4. Together, these results highlight an essential role for CoREST in demethylation of H3K4 both in vitro and in vivo.	Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	The Wistar Institute	Shiekhattar, R (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	shiekhattar@wistar.org						Aasland R, 1996, TRENDS BIOCHEM SCI, V21, P87, DOI 10.1016/S0968-0004(96)30009-1; Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; Barak O, 2003, EMBO J, V22, P6089, DOI 10.1093/emboj/cdg582; Battaglioli E, 2002, J BIOL CHEM, V277, P41038, DOI 10.1074/jbc.M205691200; Binda C, 1999, STRUCTURE, V7, P265, DOI 10.1016/S0969-2126(99)80037-9; Binda C, 2003, P NATL ACAD SCI USA, V100, P9750, DOI 10.1073/pnas.1633804100; Boyer LA, 2002, MOL CELL, V10, P935, DOI 10.1016/S1097-2765(02)00634-2; Dallman JE, 2004, J NEUROSCI, V24, P7186, DOI 10.1523/JNEUROSCI.0238-04.2004; Ding ZH, 2003, MOL CELL BIOL, V23, P250, DOI 10.1128/MCB.23.1.250-258.2003; Dong YS, 2003, MOL CELL, V12, P1087, DOI 10.1016/S1097-2765(03)00424-6; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Grimes JA, 2000, J BIOL CHEM, V275, P9461, DOI 10.1074/jbc.275.13.9461; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Hakimi MA, 2003, J BIOL CHEM, V278, P7234, DOI 10.1074/jbc.M208992200; Humphrey GW, 2001, J BIOL CHEM, V276, P6817, DOI 10.1074/jbc.M007372200; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Sterner DE, 2002, J BIOL CHEM, V277, P8178, DOI 10.1074/jbc.M108601200; Yamagoe S, 2003, MOL CELL BIOL, V23, P1025, DOI 10.1128/MCB.23.3.1025-1033.2003; You A, 2001, P NATL ACAD SCI USA, V98, P1454, DOI 10.1073/pnas.98.4.1454; Yu JJ, 2003, EMBO J, V22, P3403, DOI 10.1093/emboj/cdg326	23	578	616	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2005	437	7057					432	435		10.1038/nature04021	http://dx.doi.org/10.1038/nature04021			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964AS	16079794				2022-12-01	WOS:000231849100058
J	Safina, C; Rosenberg, AA; Myers, RA; Quinn, TJ; Collie, JS				Safina, C; Rosenberg, AA; Myers, RA; Quinn, TJ; Collie, JS			US ocean fish recovery: Staying the course	SCIENCE			English	Article							BLUEFIN TUNA; ATLANTIC COD; POPULATION; COLLAPSE		SUNY Stony Brook, Marine Sci Res Ctr, Stony Brook, NY 11794 USA; Univ New Hampshire, Coll Agr & Life Sci, Durham, NH 03824 USA; Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada; Univ Alaska, Sch Fisheries & Ocean Sci, Juneau Ctr, Juneau, AK 99801 USA; Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA	State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; University System Of New Hampshire; University of New Hampshire; Dalhousie University; University of Rhode Island	Safina, C (corresponding author), SUNY Stony Brook, Marine Sci Res Ctr, Stony Brook, NY 11794 USA.	csafina@blueocean.org		Quinn II, Terrance/0000-0002-9502-8959				Ames EP, 2004, FISHERIES, V29, P10, DOI 10.1577/1548-8446(2004)29[10:ACSSIT]2.0.CO;2; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Berkeley SA, 2004, FISHERIES, V29, P23, DOI 10.1577/1548-8446(2004)29[23:FSVPOA]2.0.CO;2; Conover DO, 2002, SCIENCE, V297, P94, DOI 10.1126/science.1074085; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Friedland KD, 2003, CAN J FISH AQUAT SCI, V60, P563, DOI 10.1139/F03-047; Hauser L, 2002, P NATL ACAD SCI USA, V99, P11742, DOI 10.1073/pnas.172242899; Hilborn R, 2003, P NATL ACAD SCI USA, V100, P6564, DOI 10.1073/pnas.1037274100; Hutchings JA, 2000, NATURE, V406, P882, DOI 10.1038/35022565; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Myers RA, 1999, CAN J FISH AQUAT SCI, V56, P2404, DOI 10.1139/cjfas-56-12-2404; Myers RA, 1997, FISH B-NOAA, V95, P762; Pauly D, 2003, SCIENCE, V302, P1359, DOI 10.1126/science.1088667; QUINN TJ, 1999, BIOL RES MANAG SER, P1; Safina C, 2004, ISSUES SCI TECHNOL, V21, P37; SAFINA C, 1993, CONSERV BIOL, V7, P229, DOI 10.1046/j.1523-1739.1993.07020229.x; Silliman BR, 2002, P NATL ACAD SCI USA, V99, P10500, DOI 10.1073/pnas.162366599; Sissenwine MP, 1998, T AM FISH SOC, V127, P838, DOI 10.1577/1548-8659(1998)127<0838:ACOWAB>2.0.CO;2; Staneck RS, 1998, TRENDS ECOL EVOL, V13, P429, DOI 10.1016/S0169-5347(98)01494-3; [No title captured]; [No title captured]; [No title captured]; [No title captured]	24	45	47	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2005	309	5735					707	708		10.1126/science.1113725	http://dx.doi.org/10.1126/science.1113725			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951NU	16051773				2022-12-01	WOS:000230938200026
J	Weinberger, LS; Burnett, JC; Toettcher, JE; Arkin, AP; Schaffer, DV				Weinberger, LS; Burnett, JC; Toettcher, JE; Arkin, AP; Schaffer, DV			Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 Tat fluctuations drive phenotypic diversity	CELL			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; COUPLED CHEMICAL-REACTIONS; DNA METHYLATION; SINGLE-CELL; TRANSCRIPTIONAL ACTIVITY; LATENT INFECTION; TYPE-1; GENOME; INTEGRATION; VECTOR	HIV-1 Tat transactivation is vital for completion of the viral life cycle and has been implicated in determining proviral latency. We present an extensive experimental/computational study of an HIV-1 model vector (LTR-GFP-IRES-Tat) and show that stochastic fluctuations in Tat influence the viral latency decision. Low GFP/Tat expression was found to generate bifurcating phenotypes with clonal populations derived from single proviral integrations simultaneously exhibiting very high and near zero GFP expression. Although phenotypic bifurcation (PheB) was correlated with distinct genomic integration patterns, neither these patterns nor other extrinsic cellular factors (cell cycle/size, aneuploidy, chromatin silencing, etc.) explained PheB. Stochastic computational modeling successfully accounted for PheB and correctly predicted the dynamics of a Tat mutant that were subsequently confirmed by experiment. Thus, Tat stochastics appear sufficient to generate PheB (and potentially proviral latency), illustrating the importance of stochastic fluctuations in gene expression in a mammalian system.	Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Dept Bioengn, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem Engn, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Weinberger, LS (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	leor@princeton.edu; aparkin@lbl.gov	Arkin, Adam P/A-6751-2008; Arkin, Adam/M-9941-2019	Arkin, Adam P/0000-0002-4999-2931; Arkin, Adam/0000-0002-4999-2931; Burnett, John/0000-0002-8817-6064	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073058] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM73058] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arkin A, 1998, GENETICS, V149, P1633; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Brooks DG, 2001, NAT MED, V7, P459, DOI 10.1038/86531; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Cohen JISS., 2001, FIELDS VIROLOGY, P2707; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; HANAHAN D, 1980, CELL, V21, P127, DOI 10.1016/0092-8674(80)90120-8; He Hongpeng, 2003, Briefings in Functional Genomics & Proteomics, V2, P234, DOI 10.1093/bfgp/2.3.234; Horie R, 1998, INT IMMUNOL, V10, P203, DOI 10.1093/intimm/10.2.203; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; JAENISCH R, 1982, J CELL BIOCHEM, V20, P331, DOI 10.1002/jcb.240200403; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Jordan A, 2001, EMBO J, V20, P1726, DOI 10.1093/emboj/20.7.1726; Kaehlcke K, 2003, MOL CELL, V12, P167, DOI 10.1016/S1097-2765(03)00245-4; KARN J, 2000, HIV SEQUENCE COMPEND, P2; Kiernan RE, 1999, EMBO J, V18, P6106, DOI 10.1093/emboj/18.21.6106; Kutsch O, 2002, J VIROL, V76, P8776, DOI 10.1128/JVI.76.17.8776-8786.2002; Lai K, 2004, BIOPHYS J, V86, P2748, DOI 10.1016/S0006-3495(04)74328-3; Lewinski MK, 2005, J VIROL, V79, P6610, DOI 10.1128/JVI.79.11.6610-6619.2005; Lin X, 2003, J VIROL, V77, P8227, DOI 10.1128/JVI.77.15.8227-8236.2003; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Mizuguchi H, 2000, MOL THER, V1, P376, DOI 10.1006/mthe.2000.0050; Nightingale S, 2004, MOL THER, V9, pS159; Okada M, 2002, J RHEUMATOL, V29, P1678; OTT M, 2004, NOVART FDN SYMP, V259, P223; Ott M., 2004, NOVART FDN SYMP, V259, P193; Ott Melanie, 2004, Novartis Found Symp, V259, P182; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Pagans S, 2005, PLOS BIOL, V3, P210, DOI 10.1371/journal.pbio.0030041; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Pierson T, 2000, ANNU REV IMMUNOL, V18, P665, DOI 10.1146/annurev.immunol.18.1.665; Pion M, 2003, J VIROL, V77, P4025, DOI 10.1128/JVI.77.7.4025-4032.2003; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Reddehase MJ, 2002, J CLIN VIROL, V25, pS23; Reddy B, 1999, AIDS RES HUM RETROV, V15, P273, DOI 10.1089/088922299311457; REUTER G, 1992, BIOESSAYS, V14, P605, DOI 10.1002/bies.950140907; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; SPUDICH JL, 1976, NATURE, V262, P467, DOI 10.1038/262467a0; Srivastava R, 2002, J THEOR BIOL, V218, P309, DOI 10.1006/jtbi.2002.3078; STEVENS SW, 1994, P NATL ACAD SCI USA, V91, P5557, DOI 10.1073/pnas.91.12.5557; STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x; Sverdlov ED, 2000, BIOESSAYS, V22, P161, DOI 10.1002/(SICI)1521-1878(200002)22:2<161::AID-BIES7>3.0.CO;2-X; Wu Yuntao, 2004, Retrovirology, V1, P13, DOI 10.1186/1742-4690-1-13; Yik JHN, 2004, MOL CELL BIOL, V24, P5094, DOI 10.1128/MCB.24.12.5094-5105.2004	53	456	463	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 29	2005	122	2					169	182		10.1016/j.cell.2005.06.006	http://dx.doi.org/10.1016/j.cell.2005.06.006			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	951CR	16051143	Green Submitted, Bronze			2022-12-01	WOS:000230907000006
J	Delatycki, MB; Allen, KJ; Nisselle, AE; Collins, V; Metcalfe, S; du Sart, D; Halliday, J; Aitken, MA; Macciocca, I; Hill, V; Wakefield, A; Ritchie, A; Gason, AA; Nicoll, AJ; Powell, LW; Williamson, R				Delatycki, MB; Allen, KJ; Nisselle, AE; Collins, V; Metcalfe, S; du Sart, D; Halliday, J; Aitken, MA; Macciocca, I; Hill, V; Wakefield, A; Ritchie, A; Gason, AA; Nicoll, AJ; Powell, LW; Williamson, R			Use of community genetic screening to prevent HFE-associated hereditary haemochromatosis	LANCET			English	Article							PENETRANCE	HFE-associated hereditary haemochromatosis is a recessive, iron-overload disorder that affects about one in 200 north Europeans and that can be easily prevented. However, genetic screening for this disease is controversial, and so we assessed whether such screening was suitable for communities. Cheek-brush screening for the Cys282Tyr HFE mutation was offered to individuals in the workplace. Outcomes were assessed by questionnaires before and after testing. 11307 individuals were screened. We recorded no increase in anxiety. in individuals who were homozygous for the Cys282Tyr mutation or non-homozygous. Self-reported tiredness before testing was significantly higher in homozygous participants than in non-homozygous participants (chi(2) test, p=0.029). Of the 47 homozygous individuals identified, 46 have taken steps to treat or prevent iron accumulation. Population genetic screening for HFE-associated hereditary haemochromatosis can be practicable and acceptable.	Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; Bruce Lefroy Ctr Genet Hlth Res, Parkville, Vic, Australia; Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; Royal Childrens Hosp, Dept Gastroenterol & Clin Nutr, Melbourne, Vic, Australia; Royal Melbourne Hosp, Dept Gastroenterol, Melbourne, Vic, Australia; Univ Queensland, Brisbane, Qld, Australia; Queensland Inst Med Res, Brisbane, Qld 4006, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; Royal Melbourne Hospital; University of Queensland; QIMR Berghofer Medical Research Institute	Allen, KJ (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	katie.allen@rch.org.au	Metcalfe, Sylvia A/B-5303-2014; Delatycki, Martin B/A-5409-2013; Allen, Katrina/I-4361-2018; , Amy/M-3622-2019; halliday, jane/T-1476-2019	Allen, Katrina/0000-0002-1921-4493; , Amy/0000-0002-8908-5906; 				Allen KJ, 2002, LANCET, V360, P412, DOI 10.1016/S0140-6736(02)09583-1; Beutler E, 2002, LANCET, V359, P211, DOI 10.1016/S0140-6736(02)07447-0; Delatycki M, 2002, LANCET, V359, P1433, DOI 10.1016/S0140-6736(02)08369-1; Guyader D, 1998, GASTROENTEROLOGY, V115, P929, DOI 10.1016/S0016-5085(98)70265-3; McDonnell SM, 1999, AM J MED, V106, P619, DOI 10.1016/S0002-9343(99)00120-5; Nisselle AE, 2004, CLIN GENET, V65, P358, DOI 10.1111/j.1399-0004.2004.0239.x; Pietrangelo A, 2004, NEW ENGL J MED, V350, P2383, DOI 10.1056/NEJMra031573; Powell LW, 2004, HEPATOLOGY, V40, p574A	8	75	76	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2005	366	9482					314	316		10.1016/S0140-6736(05)63012-7	http://dx.doi.org/10.1016/S0140-6736(05)63012-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	948RJ	16039334				2022-12-01	WOS:000230733100030
J	Shuster, DL; Weiss, BP				Shuster, DL; Weiss, BP			Martian surface paleotemperatures from thermochronology of meterorites	SCIENCE			English	Article							MAGNETIC-PROPERTIES; METEORITES; MARS; AGES; TEMPERATURE; DIFFUSION; NAKHLITES; EVOLUTION; ALH84001; ARGON	The temporal evolution of past martian surface temperatures is poorly known. We used thermochronology and published noble gas and petrographic data to constrain the temperature histories of the nakhlites and martian meteorite ALH84001. We found that the nakhlites have not been heated to more than 350 degrees C since they formed. Our calculations also suggest that for most of the past 4 billion years, ambient near-surface temperatures on Mars are unlikely to have been much higher than the present cold (<0 degrees C) state.	MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	Massachusetts Institute of Technology (MIT); California Institute of Technology	Weiss, BP (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, 54-724, Cambridge, MA 02139 USA.	bpweiss@mit.edu	Shuster, David/A-4838-2011					Artemieva N, 2004, ICARUS, V171, P84, DOI 10.1016/j.icarus.2004.05.003; Bogard DD, 1999, METEORIT PLANET SCI, V34, P451, DOI 10.1111/j.1945-5100.1999.tb01353.x; Bridges JC, 2001, SPACE SCI REV, V96, P365, DOI 10.1023/A:1011965826553; BURGESS R, 2000, J C ABSTR, V5, P266; Carr M.H, 1996, WATER MARS; Collinson DW, 1997, METEORIT PLANET SCI, V32, P803, DOI 10.1111/j.1945-5100.1997.tb01571.x; Eugster O, 2002, METEORIT PLANET SCI, V37, P1345, DOI 10.1111/j.1945-5100.2002.tb01033.x; FANALE FP, 1982, ICARUS, V50, P381, DOI 10.1016/0019-1035(82)90131-2; Fechtig H., 1966, POTASSIUM ARGON DATI, P68, DOI DOI 10.1007/978-3-642-87895-4_4; FRITZ J, 2003, LUNAR PLANET SCI, V26; GANAPATHY R, 1969, GEOCHIM COSMOCHIM AC, V33, P775, DOI 10.1016/0016-7037(69)90026-X; Gilder SA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019844; Greenwood JP, 2001, METEORIT PLANET SCI, V36, P43, DOI 10.1111/j.1945-5100.2001.tb01809.x; Hartmann WK, 2001, SPACE SCI REV, V96, P165, DOI 10.1023/A:1011945222010; Laskar J, 2004, ICARUS, V170, P343, DOI 10.1016/j.icarus.2004.04.005; Lentz RCF, 1999, METEORIT PLANET SCI, V34, P919, DOI 10.1111/j.1945-5100.1999.tb01410.x; Lovera OM, 2002, GEOCHIM COSMOCHIM AC, V66, P1237, DOI 10.1016/S0016-7037(01)00846-8; Marti K., 2004, ANTARCT METEORITE RE, V17, P117; McDougall I., 1999, GEOCHRONOLOGY THERMO; MCSWEEN HY, 1998, PLANETARY MAT; MELOSH HJ, 1993, NATURE, V363, P498, DOI 10.1038/363498a0; MELOSH HJ, 1986, IMPACT CRATERING GEO; Meyer C., 2003, MARS METEORITE COMPE; Mikouchi T., 2003, ANT METEORIT RES, V16, P34; Min K, 2004, GEOLOGY, V32, P677, DOI 10.1130/G20510.1; MIN K, 2005, LUNAR PLANET SCI, V36; MURTY SVS, 2005, LUNAR PLANET SCI, V36; Nyquist LE, 2001, SPACE SCI REV, V96, P105, DOI 10.1023/A:1011993105172; Shuster DL, 2004, EARTH PLANET SC LETT, V217, P1, DOI 10.1016/S0012-821X(03)00595-8; Swindle TD, 2004, METEORIT PLANET SCI, V39, P755, DOI 10.1111/j.1945-5100.2004.tb00117.x; Terada K, 2003, METEORIT PLANET SCI, V38, P1697, DOI 10.1111/j.1945-5100.2003.tb00009.x; Weiss BP, 2002, EARTH PLANET SC LETT, V201, P465, DOI 10.1016/S0012-821X(02)00729-X; Weiss BP, 2000, SCIENCE, V290, P791, DOI 10.1126/science.290.5492.791; [No title captured]	34	81	81	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 22	2005	309	5734					594	597		10.1126/science.1113077	http://dx.doi.org/10.1126/science.1113077			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SE	16040703				2022-12-01	WOS:000230735200043
J	Negrete, OA; Levroney, EL; Aguilar, HC; Bertolotti-Ciarlet, A; Nazarian, R; Tajyar, S; Lee, B				Negrete, OA; Levroney, EL; Aguilar, HC; Bertolotti-Ciarlet, A; Nazarian, R; Tajyar, S; Lee, B			EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus	NATURE			English	Article							ENDOTHELIAL-CELLS; HAMSTER MODEL; SMOOTH-MUSCLE; FUSION; HENDRA; ROLES; NEOVASCULARIZATION; GLYCOPROTEINS; ENCEPHALITIS; VACCINATION	Nipah virus (NiV) is an emergent paramyxovirus that causes fatal encephalitis in up to 70 per cent of infected patients(1), and there is evidence of human - to - human transmission(2). Endothelial syncytia, comprised of multinucleated giant-endothelial cells, are frequently found in NiV infections, and are mediated by the fusion ( F) and attachment ( G) envelope glycoproteins. Identification of the receptor for this virus will shed light on the pathobiology of NiV infection, and spur the rational development of effective therapeutics. Here we report that ephrinB2, the membrane-bound ligand for the EphB class of receptor tyrosine kinases (RTKs)(3), specifically binds to the attachment (G) glycoprotein of NiV. Soluble Fc-fusion proteins of ephrinB2, but not ephrinB1, effectively block NiV fusion and entry into permissive cell types. Moreover, transfection of ephrinB2 into non-permissive cells renders them permissive for NiV fusion and entry. EphrinB2 is expressed on endothelial cells and neurons(3,4), which is consistent with the known cellular tropism for NiV5. Significantly, we find that NiV-envelope-mediated infection of microvascular endothelial cells and primary cortical rat neurons is inhibited by soluble ephrinB2, but not by the related ephrinB1 protein. Cumulatively, our data show that ephrinB2 is a functional receptor for NiV.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, UCLA AIDS Inst, Los Angeles, CA 90095 USA; Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Pennsylvania	Lee, B (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA.	bleebhl@ucla.edu	Lee, Benhur/A-8554-2016; Aguilar, Hector/AAD-6663-2022	Lee, Benhur/0000-0003-0760-1709; 	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI059051] Funding Source: NIH RePORTER; NIAID NIH HHS [R21 AI059051] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bossart Katharine N, 2004, Methods Mol Biol, V269, P309; Bossart KN, 2002, J VIROL, V76, P11186, DOI 10.1128/JVI.76.22.11186-11198.2002; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Estus S, 1997, J NEUROSCI, V17, P7736; Field H, 2001, MICROBES INFECT, V3, P307, DOI 10.1016/S1286-4579(01)01384-3; Gale NW, 2001, DEV BIOL, V230, P151, DOI 10.1006/dbio.2000.0112; Guillaume V, 2004, J VIROL, V78, P834, DOI 10.1128/JVI.78.2.834-840.2004; Harcourt BH, 2000, VIROLOGY, V271, P334, DOI 10.1006/viro.2000.0340; Hooper P, 2001, MICROBES INFECT, V3, P315, DOI 10.1016/S1286-4579(01)01385-5; Hsu VP, 2004, EMERG INFECT DIS, V10, P2082, DOI 10.3201/eid1012.040701; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lam SK, 2003, ANTIVIR RES, V57, P113, DOI 10.1016/S0166-3542(02)00204-8; Liu J, 2002, MED RES REV, V22, P1, DOI 10.1002/med.1026; Noren NK, 2004, P NATL ACAD SCI USA, V101, P5583, DOI 10.1073/pnas.0401381101; Palmer A, 2003, GENE DEV, V17, P1429, DOI 10.1101/gad.1093703; Parashar UD, 2000, J INFECT DIS, V181, P1755, DOI 10.1086/315457; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Rucker J, 1997, METHOD ENZYMOL, V288, P118; Shao R, 2004, BIOCHEM BIOPH RES CO, V321, P788, DOI 10.1016/j.bbrc.2004.07.033; Shin D, 2001, DEV BIOL, V230, P139, DOI 10.1006/dbio.2000.9957; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; Tamin A, 2002, VIROLOGY, V296, P190, DOI 10.1006/viro.2002.1418; Tollefsen S, 2003, SCAND J IMMUNOL, V57, P229, DOI 10.1046/j.1365-3083.2003.01218.x; Wong KT, 2003, AM J PATHOL, V163, P2127, DOI 10.1016/S0002-9440(10)63569-9; Wong KT, 2002, AM J PATHOL, V161, P2153, DOI 10.1016/S0002-9440(10)64493-8; 2004, HLTH SCI B, V2, P5	27	330	354	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2005	436	7049					401	405		10.1038/nature03838	http://dx.doi.org/10.1038/nature03838			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	16007075				2022-12-01	WOS:000230623400044
J	Parkes, RJ; Webster, G; Cragg, BA; Weightman, AJ; Newberry, CJ; Ferdelman, TG; Kallmeyer, J; Jorgensen, BB; Aiello, IW; Fry, JC				Parkes, RJ; Webster, G; Cragg, BA; Weightman, AJ; Newberry, CJ; Ferdelman, TG; Kallmeyer, J; Jorgensen, BB; Aiello, IW; Fry, JC			Deep sub-seafloor prokaryotes stimulated at interfaces over geological time	NATURE			English	Article							SUBSEAFLOOR SEDIMENTS; MICROBIAL COMMUNITIES; BACTERIAL DIVERSITY; MARINE-SEDIMENTS; BIOSPHERE; METHANE; OXIDATION; SULFIDE; DENMARK; MARGIN	The sub-seafloor biosphere is the largest prokaryotic habitat on Earth(1) but also a habitat with the lowest metabolic rates(2). Modelled activity rates are very low, indicating that most prokaryotes may be inactive or have extraordinarily slow metabolism(2). Here we present results from two Pacific Ocean sites, margin and open ocean, both of which have deep, subsurface stimulation of prokaryotic processes associated with geochemical and/or sedimentary interfaces. At 90 m depth in the margin site, stimulation was such that prokaryote numbers were higher ( about 13-fold) and activity rates higher than or similar to near-surface values. Analysis of high-molecular-mass DNA confirmed the presence of viable prokaryotes and showed changes in biodiversity with depth that were coupled to geochemistry, including a marked community change at the 90-m interface. At the open ocean site, increases in numbers of prokaryotes at depth were more restricted but also corresponded to increased activity; however, this time they were associated with repeating layers of diatom-rich sediments ( about 9 Myr old). These results show that deep sedimentary prokaryotes can have high activity, have changing diversity associated with interfaces and are active over geological timescales.	Cardiff Univ, Sch Earth Ocean & Planetary Sci, Cardiff CF10 3YE, Wales; Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3TL, Wales; Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany; Moss Landing Marine Labs, Moss Landing, CA 95039 USA	Cardiff University; Cardiff University; Max Planck Society; Moss Landing Marine Laboratories	Parkes, RJ (corresponding author), Cardiff Univ, Sch Earth Ocean & Planetary Sci, Main Bldg,Pk Pl, Cardiff CF10 3YE, Wales.	j.parkes@earth.cf.ac.uk	Weightman, Andrew/W-7659-2019; chen, qi/C-8585-2011; Fry, John C/H-6081-2012; Weightman, Andrew/W-8681-2019; Cragg, Barry/D-2690-2009; Weightman, Andrew J/A-2970-2010; Kallmeyer, Jens/AAF-6906-2020; Webster, Gordon/A-1877-2008; Ferdelman, Timothy G/A-3758-2013; Parkes, Ronald/B-1731-2010; Kallmeyer, Jens/I-3554-2012; Jorgensen, Bo B/C-2214-2013	Weightman, Andrew/0000-0002-6671-2209; Weightman, Andrew J/0000-0002-6671-2209; Kallmeyer, Jens/0000-0002-6440-1140; Webster, Gordon/0000-0002-9530-7835; Ferdelman, Timothy G/0000-0002-9701-3793; Parkes, Ronald/0000-0001-9402-5943; Kallmeyer, Jens/0000-0002-6440-1140; Jorgensen, Bo B/0000-0001-9398-8027				Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; CHAPELLE FH, 1990, APPL ENVIRON MICROB, V56, P1865, DOI 10.1128/AEM.56.6.1865-1874.1990; Coolen MJL, 2002, SCIENCE, V296, P2407, DOI 10.1126/science.1071893; D'Hondt S, 2004, SCIENCE, V306, P2216, DOI 10.1126/science.1101155; D'Hondt S, 2002, SCIENCE, V295, P2067, DOI 10.1126/science.1064878; D'Hondt S.L., 2003, INITIAL REPORTS, V201, P1, DOI DOI 10.2973/ODP.PROC.IR.201.111.2003; Ibaraki M., 1990, Proceedings of the Ocean Drilling Program Scientific Results, V112, P239, DOI 10.2973/odp.proc.sr.112.197.1990; Inagaki F, 2003, APPL ENVIRON MICROB, V69, P7224, DOI 10.1128/AEM.69.12.7224-7235.2003; IVERSEN N, 1985, LIMNOL OCEANOGR, V30, P944, DOI 10.4319/lo.1985.30.5.0944; Kallmeyer J, 2004, LIMNOL OCEANOGR-METH, V2, P171, DOI 10.4319/lom.2004.2.171; Kemp PF, 2004, FEMS MICROBIOL ECOL, V47, P161, DOI 10.1016/S0168-6496(03)00257-5; Krumholz LR, 1997, NATURE, V386, P64, DOI 10.1038/386064a0; Leloup J, 2004, FEMS MICROBIOL ECOL, V47, P207, DOI 10.1016/S0168-6496(03)00262-9; LOVLEY DR, 1995, REV GEOPHYS, V33, P365, DOI 10.1029/95RG01305; Marchesi JR, 2001, FEMS MICROBIOL ECOL, V34, P221, DOI 10.1111/j.1574-6941.2001.tb00773.x; MCMAHON PB, 1992, J SEDIMENT PETROL, V62, P1; Mitterer RM, 2001, GEOPHYS RES LETT, V28, P3931, DOI 10.1029/2001GL013320; Newberry CJ, 2004, ENVIRON MICROBIOL, V6, P274, DOI 10.1111/j.1462-2920.2004.00568.x; Parkes RJ, 2000, HYDROGEOL J, V8, P11, DOI 10.1007/PL00010971; PARKES RJ, 1990, PHILOS T R SOC A, V331, P139, DOI 10.1098/rsta.1990.0061; PARKES RJ, 2004, MICROBIAL DIVERSITY, P120; Schippers A, 2005, NATURE, V433, P861, DOI 10.1038/nature03302; Teske A, 1996, APPL ENVIRON MICROB, V62, P1405, DOI 10.1128/AEM.62.4.1405-1415.1996; Webster G, 2004, APPL ENVIRON MICROB, V70, P5708, DOI 10.1128/AEM.70.9.5708-5713.2004; Webster G, 2003, J MICROBIOL METH, V55, P155, DOI 10.1016/S0167-7012(03)00140-4; Wellsbury P, 1997, NATURE, V388, P573, DOI 10.1038/41544; WELLSBURY P, 1993, FEMS MICROBIOL ECOL, V12, P87; Wellsbury P., 2000, PROC OCEAN DRILL SCI, V164, P379, DOI DOI 10.2973/ODP.PROC.SR.164.216.2000; WHELAN JK, 1990, P ODP SCI RESULTS, V112, P573; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578	30	327	347	1	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 21	2005	436	7049					390	394		10.1038/nature03796	http://dx.doi.org/10.1038/nature03796			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	16034418	Green Accepted			2022-12-01	WOS:000230623400042
J	Wasley, A; Samandari, T; Bell, BP				Wasley, A; Samandari, T; Bell, BP			Incidence of hepatitis A in the United States in the era of vaccination	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EPIDEMIOLOGY	Context In the United States, hepatitis A is a frequently reported vaccine-preventable disease. Vaccination has been recommended for persons at increased risk since 1996. In 1999, it was recommended that children living in 11 states with the highest incidence of hepatitis A be routinely vaccinated, and that children living in 6 additional states, with incidence above the national average, be considered for routine vaccination. Objective To assess impact of the current vaccination strategy by evaluating trends in reported cases of hepatitis A since implementation. Design, Setting, and Cases A longitudinal analysis of characteristics of cases of hepatitis A reported in the United States since 1990 to the National Notifiable Diseases Surveillance System. Main Outcome Measure Incidence rates of reported cases of hepatitis A. Incidence rates in 2003 were compared with those for the prevaccination baseline period (1990-1997) overall and in the 17 states in which children should be routinely vaccinated or considered for routine vaccination (vaccinating states). Incidence rates in vaccinating states were also compared with those in the remaining states where there is no recommendation for statewide vaccination of children (nonvaccinating states). Results Between the baseline period (1990-1997) and 2003, overall hepatitis A rates declined 76% to 2.6 per 100 000, significantly lower than previous nadirs in 1983 (9.2/ 100000) and 1992 (9.1/100000). The rate in vaccinating states declined 88% to 2.5 per 100000 compared with 53% elsewhere (to 2.7/100 000). In 2003, cases from vaccinating states accounted for 33% of the national total vs 65% during the baseline period. Declines were greater among children aged 2 to 18 years (87%) than among persons older than age 18 years (69%); the proportion of cases in children dropped from 35% to 19%. Since 2001, rates in adults have been higher than among children, with the highest rates now among men aged 25 through 39 years. Conclusions Following implementation of routine hepatitis A vaccination of children, hepatitis A rates have declined to historic lows, accompanied by substantial changes in the epidemiologic profile. Greater decreases in the age groups and regions where routine vaccination of children is recommended likely reflect the results of implementation of this novel vaccination strategy. Continued monitoring is needed to verify that implementation continues to proceed and that low rates are sustained.	Ctr Dis Control & Prevent, Div Viral Hepatitis, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Epidem Intelligence Serv, Epidemiol Program Off, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Wasley, A (corresponding author), Ctr Dis Control & Prevent, Div Viral Hepatitis, 1600 Clifton Rd NE,Mailstop G-37, Atlanta, GA 30333 USA.	awasley@cdc.gov						ALTER MJ, 1987, AM J EPIDEMIOL, V125, P133, DOI 10.1093/oxfordjournals.aje.a114496; AMON JJ, 2003, IN PRESS PEDIATRICS; ANDERSON RM, 1998, INFECT DIS HUMANS DY; [Anonymous], 1999, MMWR Recomm Rep, V48, P1; ARMITAGE P, 1990, STAT INFERENCE STAT, P120; Armstrong GL, 2002, PEDIATRICS, V109, P839, DOI 10.1542/peds.109.5.839; Averhoff F, 2001, JAMA-J AM MED ASSOC, V286, P2968, DOI 10.1001/jama.286.23.2968; Bell BP, 1998, J INFECT DIS, V178, P1579, DOI 10.1086/314518; Bialek SR, 2004, AM J PUBLIC HEALTH, V94, P996, DOI 10.2105/AJPH.94.6.996; *CDCP, 2004, MMWR-MORBID MORTAL W, V51, P1; *CDCP, 2004, 59 CDCP US DEP HHS; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P141; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P1155; Cotter SM, 2003, J INFECT DIS, V187, P1235, DOI 10.1086/374057; DAGAN R, 2002, INF DIS SOC AM 40 AN; Dominguez A, 2003, VACCINE, V21, P698, DOI 10.1016/S0264-410X(02)00583-2; Doyle TJ, 2002, AM J EPIDEMIOL, V155, P866, DOI 10.1093/aje/155.9.866; Kann Laura, 1996, Morbidity and Mortality Weekly Report, V45, P1; Lopalco PL, 2000, VACCINE, V19, P470, DOI 10.1016/S0264-410X(00)00193-6; Samandari T, 2004, VACCINE, V22, P4342, DOI 10.1016/j.vaccine.2004.04.014; Staes CJ, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.4.e54; *US BUR CENS, STAT POP DAT	22	166	183	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 13	2005	294	2					194	201		10.1001/jama.294.2.194	http://dx.doi.org/10.1001/jama.294.2.194			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944DO	16014593				2022-12-01	WOS:000230406100023
J	Quiroga, RQ; Reddy, L; Kreiman, G; Koch, C; Fried, I				Quiroga, RQ; Reddy, L; Kreiman, G; Koch, C; Fried, I			Invariant visual representation by single neurons in the human brain	NATURE			English	Article							MEDIAL TEMPORAL-LOBE; INFEROTEMPORAL CORTEX; OBJECT RECOGNITION; MONKEY; FACES; MEMORY; HIPPOCAMPUS; POTENTIALS; AMYGDALA; CORTICES	It takes a fraction of a second to recognize a person or an object even when seen under strikingly different conditions. How such a robust, high-level representation is achieved by neurons in the human brain is still unclear(1-6). In monkeys, neurons in the upper stages of the ventral visual pathway respond to complex images such as faces and objects and show some degree of invariance to metric properties such as the stimulus size, position and viewing angle(2,4,7-12). We have previously shown that neurons in the human medial temporal lobe (MTL) fire selectively to images of faces, animals, objects or scenes(13,14). Here we report on a remarkable subset of MTL neurons that are selectively activated by strikingly different pictures of given individuals, landmarks or objects and in some cases even by letter strings with their names. These results suggest an invariant, sparse and explicit code, which might be important in the transformation of complex visual percepts into long-term and more abstract memories.	CALTECH, Pasadena, CA 91125 USA; Univ Calif Los Angeles, Div Neurosurg, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Neuropsychiat, Los Angeles, CA 90095 USA; MIT, Cambridge, MA 02142 USA; Tel Aviv Univ, Tel Aviv Med Ctr, Funct Neurosurg Unit, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	California Institute of Technology; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Massachusetts Institute of Technology (MIT); Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Quiroga, RQ (corresponding author), Univ Leicester, Dept Engn, Leicester LE1 7RH, Leics, England.	rodri@vis.caltech.edu	Reddy, Leila/C-2181-2009	Koch, Christof/0000-0001-6482-8067				Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Fried I, 1997, NEURON, V18, P753, DOI 10.1016/S0896-6273(00)80315-3; GROSS CG, 1969, SCIENCE, V166, P1303, DOI 10.1126/science.166.3910.1303; Halgren E, 1998, ELECTROEN CLIN NEURO, V106, P156, DOI 10.1016/S0013-4694(97)00119-3; Hampson RE, 2004, P NATL ACAD SCI USA, V101, P3184, DOI 10.1073/pnas.0400162101; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Koch Christof, 2004, QUEST CONSCIOUSNESS; Konorski J, 1967, INTEGRATIVE ACTIVITY; Kreiman G, 2000, NAT NEUROSCI, V3, P946, DOI 10.1038/78868; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; LOGOTHETIS NK, 1995, CEREB CORTEX, V3, P270; MacMillan N. A, 1991, DETECTION THEORY USE; MCCARTHY G, 1989, J NEUROSCI, V9, P4253; MISHASHITA Y, 1988, NATURE, V335, P817; MIYASHITA Y, 1988, NATURE, V331, P68, DOI 10.1038/331068a0; PERRETT DI, 1982, EXP BRAIN RES, V47, P329; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Riesenhuber M, 2002, CURR OPIN NEUROBIOL, V12, P162, DOI 10.1016/S0959-4388(02)00304-5; Saleem KS, 1996, J NEUROSCI, V16, P4757; SCHWARTZ EL, 1983, P NATL ACAD SCI-BIOL, V80, P5776, DOI 10.1073/pnas.80.18.5776; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Suzuki WA, 1996, SEMIN NEUROSCI, V8, P3, DOI 10.1006/smns.1996.0002; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; YOUNG MP, 1992, SCIENCE, V256, P1327, DOI 10.1126/science.1598577	30	1013	1031	11	210	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2005	435	7045					1102	1107		10.1038/nature03687	http://dx.doi.org/10.1038/nature03687			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937ZT	15973409				2022-12-01	WOS:000229970400050
J	Dou, YL; Milne, TA; Tackett, AJ; Smith, ER; Fukuda, A; Wysocka, J; Allis, CD; Chait, BT; Hess, JL; Roeder, RG				Dou, YL; Milne, TA; Tackett, AJ; Smith, ER; Fukuda, A; Wysocka, J; Allis, CD; Chait, BT; Hess, JL; Roeder, RG			Physical association and coordinate function of the H3K4 methyltransferase MLL1 and the H4K16 acetyltransferase MOF	CELL			English	Article							HISTONE H4 ACETYLATION; CHROMATIN IN-VITRO; DOSAGE COMPENSATION; MASS-SPECTROMETRY; GENE-EXPRESSION; METHYLATION; COMPLEX; DROSOPHILA; TRANSCRIPTION; TRITHORAX	A stable complex containing MILL1 and MOF has been immunoaffinity purified from a human cell line that stably expresses an epitope-tagged WDR5 subunit. Stable interactions between MILL1 and MOF were confirmed by reciprocal immunoprecipitation, cosedimentation, and cotransfection analyses, and interaction sites were mapped to MLL1 C-terminal and MOF zinc finger domains. The purified complex has a robust MILL1-mediated histone methyltransferase activity that can effect mono-, di-, and trimethylation of H3 K4 and a MOF-mediated histone acetyltransferase activity that is specific for H4 K16. Importantly, both activities are required for optimal transcription activation on a chromatin template in vitro and on an endogenous MLL1 target gene, Hox a9, in vivo. These results indicate an activator-based mechanism for joint MILLI1 and MOF recruitment and targeted methylation and acetylation and provide a molecular explanation for the closely correlated distribution of H3 K4 methylation and H4 K16 acetylation on active genes.	Rockefeller Univ, Lab Biochem & Mol Biol, New York, NY 10021 USA; Rockefeller Univ, Lab Chromatin Biol, New York, NY 10021 USA; Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10021 USA; Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	Rockefeller University; Rockefeller University; Rockefeller University; University of Pennsylvania	Roeder, RG (corresponding author), Rockefeller Univ, Lab Biochem & Mol Biol, New York, NY 10021 USA.	roeder@mail.rockefeller.edu	Milne, Tom/E-1872-2016	Milne, Tom/0000-0002-0413-4271				Akhtar A, 2000, MOL CELL, V5, P367, DOI 10.1016/S1097-2765(00)80431-1; An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; An WJ, 2004, METHOD ENZYMOL, V377, P460; Beisel C, 2002, NATURE, V419, P857, DOI 10.1038/nature01126; Carrozza MJ, 2003, TRENDS GENET, V19, P321, DOI 10.1016/S0168-9525(03)00115-X; Corona DFV, 2002, EMBO REP, V3, P242, DOI 10.1093/embo-reports/kvf056; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dion MF, 2005, P NATL ACAD SCI USA, V102, P5501, DOI 10.1073/pnas.0500136102; Ernst P, 2001, MOL CELL BIOL, V21, P2249, DOI 10.1128/MCB.21.7.2249-2258.2001; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Fujimoto S, 1998, GENE, V209, P77, DOI 10.1016/S0378-1119(98)00014-6; Goo YH, 2003, MOL CELL BIOL, V23, P140, DOI 10.1128/MCB.23.1.140-149.2003; Hassan AH, 2001, CELL, V104, P817, DOI 10.1016/S0092-8674(01)00279-3; Hess JL, 2004, TRENDS MOL MED, V10, P500, DOI 10.1016/j.molmed.2004.08.005; Hsieh JJD, 2003, MOL CELL BIOL, V23, P186, DOI 10.1128/MCB.23.1.186-194.2003; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; JOHNSON LM, 1990, P NATL ACAD SCI USA, V87, P6286, DOI 10.1073/pnas.87.16.6286; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Krutchinsky AN, 2000, J AM SOC MASS SPECTR, V11, P493, DOI 10.1016/S1044-0305(00)00114-8; Krutchinsky AN, 2001, ANAL CHEM, V73, P5066, DOI 10.1021/ac010682o; Kundu TK, 2000, MOL CELL, V6, P551, DOI 10.1016/S1097-2765(00)00054-X; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Luger K, 1999, METHOD ENZYMOL, V304, P3; MEGEE PC, 1990, SCIENCE, V247, P841, DOI 10.1126/science.2106160; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Morales V, 2004, EMBO J, V23, P2258, DOI 10.1038/sj.emboj.7600235; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Neal KC, 2000, BBA-GENE STRUCT EXPR, V1490, P170, DOI 10.1016/S0167-4781(99)00211-0; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Owen-Hughes T, 1999, METH MOL B, V119, P319; Petruk S, 2001, SCIENCE, V294, P1331, DOI 10.1126/science.1065683; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Santos-Rosa H, 2003, MOL CELL, V12, P1325, DOI 10.1016/S1097-2765(03)00438-6; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Smith CM, 2003, ANAL BIOCHEM, V316, P23, DOI 10.1016/S0003-2697(03)00032-0; Smith ER, 2000, MOL CELL BIOL, V20, P312, DOI 10.1128/MCB.20.1.312-318.2000; Smith ER, 2001, J BIOL CHEM, V276, P31483, DOI 10.1074/jbc.C100351200; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; TURNER BM, 1992, CELL, V69, P375, DOI 10.1016/0092-8674(92)90417-B; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; VAQUERO A, 2002, SCI AGING KNOWLEDGE, pRE4; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Zhang KL, 2004, PROTEOMICS, V4, P3765, DOI 10.1002/pmic.200400819; Zhang KL, 2002, MOL CELL PROTEOMICS, V1, P500, DOI 10.1074/mcp.M200031-MCP200	51	507	549	2	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 17	2005	121	6					873	885		10.1016/j.cell.2005.04.031	http://dx.doi.org/10.1016/j.cell.2005.04.031			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	938NX	15960975	Bronze			2022-12-01	WOS:000230011200010
J	McClenahan, J				McClenahan, J			A good man	ANNALS OF INTERNAL MEDICINE			English	Editorial Material											McClenahan, J (corresponding author), 413 Stuart Circle,Apartment B2, Richmond, VA 23220 USA.								0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 7	2005	142	11					944	945		10.7326/0003-4819-142-11-200506070-00016	http://dx.doi.org/10.7326/0003-4819-142-11-200506070-00016			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	932LX	15941705				2022-12-01	WOS:000229556300012
J	Shendure, J; Porreca, GJ; Reppas, NB; Lin, XX; McCutcheon, JP; Rosenbaum, AM; Wang, MD; Zhang, K; Mitra, RD; Church, GM				Shendure, J; Porreca, GJ; Reppas, NB; Lin, XX; McCutcheon, JP; Rosenbaum, AM; Wang, MD; Zhang, K; Mitra, RD; Church, GM			Accurate multiplex polony sequencing of an evolved bacterial genome	SCIENCE			English	Article							SINGLE DNA-MOLECULES; ESCHERICHIA-COLI; AMPLIFICATION; EVOLUTION	We describe a DNA sequencing technology in which a commonly available, inexpensive epifluorescence microscope is converted to rapid nonelectrophoretic DNA sequencing automation. We apply this technology to resequence an evolved strain of Escherichia coli at less than one error per million consensus bases. A cell-free, mate-paired library provided single DNA molecules that were amplified in parallel to 1-micrometer beads by emulsion polymerase chain reaction. Millions of beads were immobilized in a polyacrylamide gel and subjected to automated cycles of sequencing by ligation and four-color imaging. Cost per base was roughly one-ninth as much as that of conventional sequencing. Our protocols were implemented with off-the-shelf instrumentation and reagents.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Washington Univ, Dept Genet, St Louis, MO 63110 USA; Washington Univ, Howard Hughes Med Inst, St Louis, MO 63110 USA	Harvard University; Harvard Medical School; Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL)	Shendure, J (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	shendure@alumni.princeton.edu; gregory_porreca@student.hms.harvard.edu	Shendure, Jay/AAU-3684-2021; Zhang, Kun/ABE-6349-2020	Zhang, Kun/0000-0002-7596-5224; Mitra, Robi/0000-0002-2680-4264; church, george/0000-0001-6232-9969; Shendure, Jay/0000-0002-1516-1865; McCutcheon, John/0000-0002-5489-6039				ADAMS CP, 1997, Patent No. 5641658; BARANY F, 1991, P NATL ACAD SCI USA, V88, P189, DOI 10.1073/pnas.88.1.189; Barker CS, 2004, J BACTERIOL, V186, P7529, DOI 10.1128/JB.186.22.7529-7537.2004; Braslavsky I, 2003, P NATL ACAD SCI USA, V100, P3960, DOI 10.1073/pnas.0230489100; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; Collins FS, 2003, SCIENCE, V300, P286, DOI 10.1126/science.1084564; Dressman D, 2003, P NATL ACAD SCI USA, V100, P8817, DOI 10.1073/pnas.1133470100; Ghadessy FJ, 2001, P NATL ACAD SCI USA, V98, P4552, DOI 10.1073/pnas.071052198; Housby JN, 1998, NUCLEIC ACIDS RES, V26, P4259, DOI 10.1093/nar/26.18.4259; Leamon JH, 2003, ELECTROPHORESIS, V24, P3769, DOI 10.1002/elps.200305646; Levene MJ, 2003, SCIENCE, V299, P682, DOI 10.1126/science.1079700; Lizardi PM, 1998, NAT GENET, V19, P225, DOI 10.1038/898; MACEVICZ SC, 1998, Patent No. 5750341; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; Mitra RD, 2003, ANAL BIOCHEM, V320, P55, DOI 10.1016/S0003-2697(03)00291-4; Mitra RD, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.24.e34; Mucke M, 2001, J MOL BIOL, V312, P687, DOI 10.1006/jmbi.2001.4998; Nakano M, 2003, J BIOTECHNOL, V102, P117, DOI 10.1016/S0168-1656(03)00023-3; PLASTERK RHA, 1985, EMBO J, V4, P237, DOI 10.1002/j.1460-2075.1985.tb02341.x; REPPAS NB, UNPUB; Ronaghi M, 1996, ANAL BIOCHEM, V242, P84, DOI 10.1006/abio.1996.0432; SANGER F, 1977, NATURE, V265, P687, DOI 10.1038/265687a0; Seo TS, 2005, P NATL ACAD SCI USA, V102, P5926, DOI 10.1073/pnas.0501965102; Shendure J, 2004, NAT REV GENET, V5, P335, DOI 10.1038/nrg1325; SHORE D, 1983, J MOL BIOL, V170, P957, DOI 10.1016/S0022-2836(83)80198-3; Tawfik DS, 1998, NAT BIOTECHNOL, V16, P652, DOI 10.1038/nbt0798-652	26	862	1373	7	208	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 9	2005	309	5741					1728	1732		10.1126/science.1117389	http://dx.doi.org/10.1126/science.1117389			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963WK	16081699				2022-12-01	WOS:000231836700046
J	Jefferson, T				Jefferson, T			Microbial challenge studies - a challenge worth accepting	LANCET			English	Editorial Material									Cochrane Vaccines Field, I-00061 Rome, Italy		Jefferson, T (corresponding author), Cochrane Vaccines Field, I-00061 Rome, Italy.	Toj1@aol.com						Academy of Medical Sciences, 2005, MICR CHALL STUD HUM; Thompson K.R., 1991, HARVARD HOSP ITS VOL; TYRRELL D, 1990, J ROY COLL PHYS LOND, V24, P137	3	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 13	2005	366	9485					531	533		10.1016/S0140-6736(05)67079-1	http://dx.doi.org/10.1016/S0140-6736(05)67079-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	955LL	16099277	Bronze, Green Published			2022-12-01	WOS:000231227300009
J	Hong, JH; Hwang, ES; McManus, MT; Amsterdam, A; Tian, Y; Kalmukova, R; Mueller, E; Benjamin, T; Spiegelman, BM; Sharp, PA; Hopkins, N; Yaffe, MB				Hong, JH; Hwang, ES; McManus, MT; Amsterdam, A; Tian, Y; Kalmukova, R; Mueller, E; Benjamin, T; Spiegelman, BM; Sharp, PA; Hopkins, N; Yaffe, MB			TAZ, a transcriptional modulator of mesenchymal stem cell differentiation	SCIENCE			English	Article							MARROW STROMAL CELLS; OSTEOBLAST DIFFERENTIATION; BONE-MARROW; PPAR-GAMMA; ADIPOSE-TISSUE; ADIPOGENESIS; OSTEOPOROSIS; CBFA1; COACTIVATOR; PATHWAY	Mesenchymal stem cells (MSCs) are a pluripotent cell type that can differentiate into several distinct lineages. Two key transcription factors, Runx2 and peroxisome proliferator-activated receptor gamma (PPAR gamma), drive MSCs to differentiate into either osteoblasts or adipocytes, respectively. How these two transcription factors are regulated in order to specify these alternate cell fates remains a pivotal question. Here we report that a 14-3-3-binding protein, TAZ (transcriptional coactivator with PDZ-binding motif), coactivates Runx2-dependent gene transcription white repressing PPAR gamma-dependent gene transcription. By modulating TAZ expression in model cell lines, mouse embryonic fibroblasts, and primary MSCs in culture and in zebrafish in vivo, we observed alterations in osteogenic versus adipogenic potential. These results indicate that TAZ functions as a molecular rheostat that modulates MSC differentiation.	MIT, Ctr Canc Res, Dept Biol, Cambridge, MA 02139 USA; Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Sch Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Yaffe, MB (corresponding author), MIT, Ctr Canc Res, Dept Biol, 77 Massachusetts Ave,E18-580, Cambridge, MA 02139 USA.	myaffe@mit.edu	mcmanus, michael/AAB-1239-2020; Hong, Jeong-Ho/T-8099-2018	mcmanus, michael/0000-0003-3013-6569; Hong, Jeong-Ho/0000-0002-8235-9855	NCI NIH HHS [CA042063] Funding Source: Medline; NIGMS NIH HHS [GM60594, GM68762] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA042063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075004, Z01DK075004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068762, R01GM060594] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; BURKHARDT R, 1987, BONE, V8, P157, DOI 10.1016/8756-3282(87)90015-9; Caplan AI, 2001, TRENDS MOL MED, V7, P259, DOI 10.1016/S1471-4914(01)02016-0; Chang SCN, 2004, J SURG RES, V119, P85, DOI 10.1016/j.jss.2003.08.003; CORNELIUS P, 1994, ANNU REV NUTR, V14, P99, DOI 10.1146/annurev.nu.14.070194.000531; Cui CB, 2003, MOL CELL BIOL, V23, P1004, DOI 10.1128/MCB.23.3.1004-1013.2003; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Gallea S, 2001, BONE, V28, P491, DOI 10.1016/S8756-3282(01)00415-X; Hong J.H., UNPUB; Kajkenova O, 1997, J BONE MINER RES, V12, P1772, DOI 10.1359/jbmr.1997.12.11.1772; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Kaplan FS, 2000, J BONE MINER RES, V15, P2084, DOI 10.1359/jbmr.2000.15.11.2084; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; MEUNIER P, 1971, CLIN ORTHOP RELAT R, P147, DOI DOI 10.1097/00003086-197110000-00021; Nakashima K, 2003, TRENDS GENET, V19, P458, DOI 10.1016/S0168-9525(03)00176-8; Nuttall ME, 2000, BONE, V27, P177, DOI 10.1016/S8756-3282(00)00317-3; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; TIAN Y, UNPUB; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Verma S, 2002, J CLIN PATHOL, V55, P693, DOI 10.1136/jcp.55.9.693; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551	28	762	819	4	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2005	309	5737					1074	1078		10.1126/science.1110955	http://dx.doi.org/10.1126/science.1110955			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955MN	16099986				2022-12-01	WOS:000231230100046
J	Gunsalus, KC; Ge, H; Schetter, AJ; Goldberg, DS; Han, JDJ; Hao, T; Berriz, GF; Bertin, N; Huang, J; Chuang, LS; Li, N; Mani, R; Hyman, AA; Sonnichsen, B; Echeverri, CJ; Roth, FP; Vidal, M; Piano, F				Gunsalus, KC; Ge, H; Schetter, AJ; Goldberg, DS; Han, JDJ; Hao, T; Berriz, GF; Bertin, N; Huang, J; Chuang, LS; Li, N; Mani, R; Hyman, AA; Sonnichsen, B; Echeverri, CJ; Roth, FP; Vidal, M; Piano, F			Predictive models of molecular machines involved in Caenorhabditis elegans early embryogenesis	NATURE			English	Article							C-ELEGANS; CENTROSOME DUPLICATION; MAPPING DATA; PROTEIN; CELL; INTERACTOME; CENTRIOLAR; NETWORK; MAP; TRANSCRIPTOME	Although numerous fundamental aspects of development have been uncovered through the study of individual genes and proteins, system-level models are still missing for most developmental processes. The first two cell divisions of Caenorhabditis elegans embryogenesis constitute an ideal test bed for a system-level approach. Early embryogenesis, including processes such as cell division and establishment of cellular polarity, is readily amenable to large-scale functional analysis. A first step toward a system-level understanding is to provide 'first-draft' models both of the molecular assemblies involved(1) and of the functional connections between them. Here we show that such models can be derived from an integrated gene/protein network generated from three different types of functional relationship(2): protein interaction(3), expression profiling similarity(4) and phenotypic profiling similarity(5), as estimated from detailed early embryonic RNA interference phenotypes systematically recorded for hundreds of early embryogenesis genes(6). The topology of the integrated network suggests that C. elegans early embryogenesis is achieved through coordination of a limited set of molecular machines. We assessed the overall predictive value of such molecular machine models by dynamic localization of ten previously uncharacterized proteins within the living embryo.	NYU, Dept Biol, Ctr Comparat Funct Genom, New York, NY 10003 USA; Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Cenix Biosci GmbH, D-01307 Dresden, Germany	New York University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Max Planck Society	Roth, FP (corresponding author), NYU, Dept Biol, Ctr Comparat Funct Genom, New York, NY 10003 USA.	fritz_roth@hms.harvard.edu; marc_vidal@dfci.harvard.edu; fp1@nyu.edu	Roth, Frederick P/H-6308-2011; Chuang, Ling-shiang/GNH-1836-2022; Hyman, Tony/F-1923-2011; Hyman, Anthony A/B-3917-2017; Bertin, Nicolas/O-9602-2019; Bertin, Nicolas/C-3025-2008	Chuang, Ling-shiang/0000-0001-5054-1305; Hyman, Anthony A/0000-0003-3664-154X; Roth, Frederick/0000-0002-6628-649X; Bertin, Nicolas/0000-0002-9835-9606				Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baas AF, 2004, TRENDS CELL BIOL, V14, P312, DOI 10.1016/j.tcb.2004.04.001; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bader JS, 2004, NAT BIOTECHNOL, V22, P78, DOI 10.1038/nbt924; Begley TJ, 2002, MOL CANCER RES, V1, P103; Boulton SJ, 2002, SCIENCE, V295, P127, DOI 10.1126/science.1065986; Brajenovic M, 2004, J BIOL CHEM, V279, P12804, DOI 10.1074/jbc.M312171200; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Dammermann A, 2004, DEV CELL, V7, P815, DOI 10.1016/j.devcel.2004.10.015; Delattre M, 2004, NAT CELL BIOL, V6, P656, DOI 10.1038/ncb1146; Ge H, 2001, NAT GENET, V29, P482, DOI 10.1038/ng776; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Jansen R, 2002, GENOME RES, V12, P37, DOI 10.1101/gr.205602; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; Kirkham M, 2003, CELL, V112, P575, DOI 10.1016/S0092-8674(03)00117-X; Kitagawa R, 2002, CURR BIOL, V12, P2118, DOI 10.1016/S0960-9822(02)01392-1; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220; Leidel S, 2003, DEV CELL, V4, P431, DOI 10.1016/S1534-5807(03)00062-5; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; O'Connell KF, 2001, CELL, V105, P547, DOI 10.1016/S0092-8674(01)00338-5; Piano F, 2002, CURR BIOL, V12, P1959, DOI 10.1016/S0960-9822(02)01301-5; Schneider SQ, 2003, ANNU REV GENET, V37, P221, DOI 10.1146/annurev.genet.37.110801.142443; Schumacher JM, 1998, DEVELOPMENT, V125, P4391; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Vidal M, 2001, CELL, V104, P333, DOI 10.1016/S0092-8674(01)00221-5; Walhout AJM, 2002, CURR BIOL, V12, P1952, DOI 10.1016/S0960-9822(02)01279-4	30	200	231	0	18	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 11	2005	436	7052					861	865		10.1038/nature03876	http://dx.doi.org/10.1038/nature03876			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953XG	16094371				2022-12-01	WOS:000231116500049
J	Posson, DJ; Ge, PH; Miller, C; Bezanilla, F; Selvin, PR				Posson, DJ; Ge, PH; Miller, C; Bezanilla, F; Selvin, PR			Small vertical movement of a K+ channel voltage sensor measured with luminescence energy transfer	NATURE			English	Article							POTASSIUM-CHANNEL; CHARYBDOTOXIN BLOCK; ELECTRIC-FIELD; GATING CHARGE; S4 SEGMENT; SHAKER; MECHANISM; PEPTIDE; PORE	Voltage-gated ion channels open and close in response to voltage changes across electrically excitable cell membranes(1). Voltage-gated potassium (Kv) channels are homotetramers with each subunit constructed from six transmembrane segments, S1 - S6 (ref. 2). The voltage-sensing domain ( segments S1 - S4) contains charged arginine residues on S4 that move across the membrane electric field(2,3), modulating channel open probability. Understanding the physical movements of this voltage sensor is of fundamental importance and is the subject of controversy. Recently, the crystal structure of the KvAP(4) channel motivated an unconventional 'paddle model' of S4 charge movement, indicating that the segments S3b and S4 might move as a unit through the lipid bilayer with a large ( 15-20-angstrom) transmembrane displacement(5). Here we show that the voltage-sensor segments do not undergo significant transmembrane translation. We tested the movement of these segments in functional Shaker K 1 channels by using luminescence resonance energy transfer to measure distances between the voltage sensors and a pore-bound scorpion toxin. Our results are consistent with a 2-angstrom vertical displacement of S4, not the large excursion predicted by the paddle model. This small movement supports an alternative model in which the protein shapes the electric field profile, focusing it across a narrow region of S4 ( ref. 6).	Univ Illinois, Dept Phys, Urbana, IL 61801 USA; Univ Illinois, Ctr Biophys, Urbana, IL 61801 USA; Brandeis Univ, Howard Hughes Med Inst, Dept Biochem, Waltham, MA 02454 USA; Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Anesthesiol, Los Angeles, CA 90095 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Brandeis University; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Selvin, PR (corresponding author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.	selvin@uiuc.edu			NIGMS NIH HHS [R01 GM030376, R01 GM074770, R37 GM030376] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074770] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; ARMSTRONG CM, 1973, NATURE, V242, P459, DOI 10.1038/242459a0; Asamoah OK, 2003, NEURON, V37, P85, DOI 10.1016/S0896-6273(02)01126-1; Baumgartner W, 1999, BIOPHYS J, V77, P1980, DOI 10.1016/S0006-3495(99)77039-6; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Blaustein RO, 2000, NAT STRUCT BIOL, V7, P309; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; Clegg Robert M., 1995, Current Opinion in Biotechnology, V6, P103, DOI 10.1016/0958-1669(95)80016-6; Cuello LG, 2004, SCIENCE, V306, P491, DOI 10.1126/science.1101373; Eriksson MAL, 2002, BIOPHYS J, V83, P2595, DOI 10.1016/S0006-3495(02)75270-3; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; GOLDSTEIN SAN, 1993, BIOPHYS J, V65, P1613, DOI 10.1016/S0006-3495(93)81200-1; GOLDSTEIN SAN, 1994, NEURON, V12, P1377, DOI 10.1016/0896-6273(94)90452-9; Hessa T, 2005, SCIENCE, V307, P1427, DOI 10.1126/science.1109176; Heyduk T, 2001, ANAL BIOCHEM, V289, P60, DOI 10.1006/abio.2000.4925; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Laine M, 2004, FEBS LETT, V564, P257, DOI 10.1016/S0014-5793(04)00273-X; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; MACKINNON R, 1988, J GEN PHYSIOL, V91, P335, DOI 10.1085/jgp.91.3.335; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; Reifenberger JG, 2003, J PHYS CHEM B, V107, P12862, DOI 10.1021/jp0357424; SELVIN PR, 1994, J AM CHEM SOC, V116, P6029, DOI 10.1021/ja00092a088; Selvin PR, 2002, ANNU REV BIOPH BIOM, V31, P275, DOI 10.1146/annurev.biophys.31.101101.140927; Selvin PR, 2000, NAT STRUCT BIOL, V7, P730, DOI 10.1038/78948; SHIMONY E, 1994, PROTEIN ENG, V7, P503, DOI 10.1093/protein/7.4.503; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270	28	158	161	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2005	436	7052					848	851		10.1038/nature03819	http://dx.doi.org/10.1038/nature03819			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953XG	16094368	Green Accepted			2022-12-01	WOS:000231116500046
J	Ihmels, J; Bergmann, S; Gerami-Nejad, M; Yanai, I; McClellan, M; Berman, J; Barkai, N				Ihmels, J; Bergmann, S; Gerami-Nejad, M; Yanai, I; McClellan, M; Berman, J; Barkai, N			Rewiring of the yeast transcriptional network through the evolution of motif usage	SCIENCE			English	Article							GENOME; DUPLICATION	Recent experiments revealed large-scale differences in the transcription programs of related species, yet little is known about the genetic basis underlying the evolution of gene expression and its contribution to phenotypic diversity. Here we describe a large-scale modulation of the yeast transcription program that is connected to the emergence of the capacity for rapid anaerobic growth. Genes coding for mitochondrial and cytoplasmic ribosomal proteins display a strongly correlated expression pattern in Candida, albicans, but this correlation is lost in the fermentative yeast Saccharomyces cerevisiae. We provide evidence that this change in gene expression is connected to the loss of a specific cis-regulatory element from dozens of genes following the apparent whole-genome duplication event. Our results shed new light on the genetic mechanisms underlying the large-scale evolution of transcriptional networks.	Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA	Weizmann Institute of Science; Weizmann Institute of Science; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Barkai, N (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	naama.barkai@weizmann.ac.il	Berman, Judith/AAS-5115-2021; Berman, Judith/ABA-8528-2021	Berman, Judith/0000-0002-8577-0084; Yanai, Itai/0000-0002-8438-2741; Bergmann, Sven/0000-0002-6785-9034	NIDCR NIH HHS [R01 DE/AI 14666] Funding Source: Medline; PHS HHS [A150562] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014666] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Bergmann S, 2004, PLOS BIOL, V2, P85, DOI 10.1371/journal.pbio.0020009; Carroll SB, 2000, CELL, V101, P577, DOI 10.1016/S0092-8674(00)80868-5; Davidson EH, 2001, GENOMIC REGULATORY S; Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781; Gasch AP, 2004, PLOS BIOL, V2, P2202, DOI 10.1371/journal.pbio.0020398; Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Piskur J, 2004, MOL MICROBIOL, V53, P381, DOI 10.1111/j.1365-2958.2004.04182.x; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; Tanay A, 2005, P NATL ACAD SCI USA, V102, P7203, DOI 10.1073/pnas.0502521102; Tavazoie S, 1998, NAT BIOTECHNOL, V16, P566, DOI 10.1038/nbt0698-566; Wolfe K, 2004, CURR BIOL, V14, pR392, DOI 10.1016/j.cub.2004.05.015; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711	14	221	231	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2005	309	5736					938	940		10.1126/science.1113833	http://dx.doi.org/10.1126/science.1113833			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953SS	16081737				2022-12-01	WOS:000231101400048
J	Almroth, L; Elmusharaf, S; El Hadi, N; Obeid, A; El Sheikh, MAA; Elfadil, SM; Bergstrom, S				Almroth, L; Elmusharaf, S; El Hadi, N; Obeid, A; El Sheikh, MAA; Elfadil, SM; Bergstrom, S			Primary infertility after genital mutilation in girlhood in Sudan: a case-control study	LANCET			English	Article							SUB-SAHARAN AFRICA; FEMALE CIRCUMCISION; HEALTH CONSEQUENCES; SCHISTOSOMIASIS; TUBERCULOSIS	Background In theory, infections that arise after female genital mutilation (FGM) in childhood might ascend to the internal genitalia, causing inflammation and scarring and subsequent tubal-factor infertility. Our aim was to investigate this possible association between FGM and primary infertility. Methods We did a hospital-based case-control study in Khartoum, Sudan, to which we enrolled women (n=99) with primary infertility not caused by hormonal or iatrogenic factors (previous abdominal surgery), or the result of malefactor infertility. These women underwent diagnostic laparoscopy. Our controls were primigravidae women (n=180) recruited from antenatal care. We used exact conditional logistic regression, stratifying for age and controlling for socioeconomic status, level of education, gonorrhoea, and chlamydia, to compare these groups with respect to FGM. Findings Of the 99 infertile women examined, 48 had adnexal pathology indicative of previous inflammation. After controlling for covariates, these women had a significantly higher risk than controls of having undergone the most extensive form of FGM, involving the labia majora (odds ratio 4.69, 95% CI 1.49-19.7). Among women with primary infertility, both those with tubal pathology and those with normal laparoscopy findings were at a higher risk than controls of extensive FGM, both with borderline significance (p=0.054 and p=0.055, respectively). The anatomical extent of FGM, rather than whether or not the vulva had been sutured or closed, was associated with primary infertility. Interpretation Our findings indicate a positive association between the anatomical extent of FGM and primary infertility. Laparoscopic postinflammatory adnexal changes are not the only explanation for this association, since cases without such pathology were also affected. The association between FGM and primary infertility is highly relevant for preventive work against this ancient practice.	Karolinska Inst, Div Int Hlth, SE-17176 Stockholm, Sweden; Univ Khartoum, Dept Obstet & Gynaecol, Khartoum, Sudan	Karolinska Institutet; University of Khartoum	Almroth, L (corresponding author), Karolinska Inst, Div Int Hlth, SE-17176 Stockholm, Sweden.	L.Almroth@telia.com						Aliyu MH, 2004, INT J FERTIL WOMEN M, V49, P123; Almroth L, 2001, INT J GYNECOL OBSTET, V74, P179, DOI 10.1016/S0020-7292(01)00392-7; BALK D, 2000, FEMALE CIRCUMCISION; BODDY J, 1982, AM ETHNOL, V9, P682, DOI 10.1525/ae.1982.9.4.02a00040; DESILVA S, 1989, EUR J OBSTET GYN R B, V32, P233, DOI 10.1016/0028-2243(89)90041-5; ELDAREER AA, 1983, TROP DOCT, V13, P41, DOI 10.1177/004947558301300114; Gruenbaum E, 1982, MED ANTHR NEWSLETTER, V13, P4, DOI DOI 10.1525/MAQ.1982.13.2.02A00020; Inhorn M C, 1993, Med Anthropol, V15, P217; Jahromi BN, 2001, INT J GYNECOL OBSTET, V75, P269, DOI 10.1016/S0020-7292(01)00494-5; Jones H, 1999, STUD FAMILY PLANN, V30, P219, DOI 10.1111/j.1728-4465.1999.00219.x; LARSEN U, 1994, POP STUD-J DEMOG, V48, P459, DOI 10.1080/0032472031000147976; Larsen U, 2002, J BIOSOC SCI, V34, P363, DOI 10.1017/S0021932002003632; Larsen U, 2000, INT J EPIDEMIOL, V29, P285, DOI 10.1093/ije/29.2.285; LARSEN UM, 1989, REPROD SOCIAL ORG SU; Lenzi E, 1970, Acta Eur Fertil, V2, P47; Morison L, 2001, TROP MED INT HEALTH, V6, P643, DOI 10.1046/j.1365-3156.2001.00749.x; NELSON WE, 2000, NELSON TXB PEDIAT, P1660; Obermeyer CM, 2003, MED ANTHROPOL Q, V17, P394, DOI 10.1525/maq.2003.17.3.394; Okonofua FE, 2002, BJOG-INT J OBSTET GY, V109, P1089, DOI 10.1111/j.1471-0528.2002.01550.x; Poggensee G, 1998, AM J TROP MED HYG, V59, P782, DOI 10.4269/ajtmh.1998.59.782; Poggensee G, 2001, ACTA TROP, V79, P193, DOI 10.1016/S0001-706X(01)00086-9; Rahman A, 2000, FEMALE GENITAL MUTIL; REIMANN K, 1987, GENITOURIN MED, V63, P250; RUSHWAN H, 1980, AM J OBSTET GYNECOL, V138, P877, DOI 10.1016/0002-9378(80)91076-5; Shandall A A, 1967, Sudan Med J, V5, P178; Talle A., 1993, CARVED FLESH CAST SE; Verzin J, 1975, TROPICAL DOCTOR, V5, P163; WHO Technical Working Group, 1996, FEM GEN MUT; World Health Organization, 1998, FEMALE GENITAL MUTIL; Yount KM, 2004, ADV GEND RES, V8, P199, DOI 10.1016/S1529-2126(04)08007-5; ZAKI AM, 1966, J OBSTET GYN BR COMM, V73, P302; 1991, SUDAN DEMOGRAPHIC HL	32	76	76	1	15	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 30	2005	366	9483					385	391		10.1016/S0140-6736(05)67023-7	http://dx.doi.org/10.1016/S0140-6736(05)67023-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	950IB	16054938				2022-12-01	WOS:000230849700025
J	Wawersik, M; Milutinovich, A; Casper, AL; Matunis, E; Williams, B; Van Doren, M				Wawersik, M; Milutinovich, A; Casper, AL; Matunis, E; Williams, B; Van Doren, M			Somatic control of germline sexual development is mediated by the JAK/STAT pathway	NATURE			English	Article							CELL SELF-RENEWAL; DROSOPHILA EMBRYOS; SIGNALING PATHWAY; PROTEIN; STAT; GENE; ACTIVATION; EXPRESSION; DIMORPHISM; MUTATIONS	Germ cells must develop along distinct male or female paths to produce the sperm or eggs required for sexual reproduction. In both mouse and Drosophila, the sexual identity of germ cells is influenced by the sex of the surrounding somatic tissue (for example, refs 1, 2, reviewed in refs 3, 4); however, little is known about how the soma controls germline sex determination. Here we show that the janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway provides a sex-specific signal from the soma to the germ line in Drosophila embryonic gonads. The somatic gonad expresses a JAK/STAT ligand, unpaired (upd), in a male-specific manner, and activates the JAK/STAT pathway in male germ cells at the time of gonad formation. Furthermore, the JAK/STAT pathway is necessary for male-specific germ cell behaviour during early gonad development, and is sufficient to activate aspects of male germ cell behaviour in female germ cells. Our findings provide direct evidence that the JAK/STAT pathway mediates a key signal from the somatic gonad that regulates male germline sexual development.	Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Van Doren, M (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.	vandoren@jhu.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD046619] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM066562, R01GM063023] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD046619] Funding Source: Medline; NIGMS NIH HHS [R01 GM063023, T32 GM007231, F32 GM066562] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agaisse H, 2003, DEV CELL, V5, P441, DOI 10.1016/S1534-5807(03)00244-2; Asaoka-Taguchi M, 1999, NAT CELL BIOL, V1, P431, DOI 10.1038/15666; Boyle M, 1997, DEVELOPMENT, V124, P971; Callus BA, 2002, ONCOGENE, V21, P4812, DOI 10.1038/sj.onc.1205618; Campos-Ortega JA., 1997, EMBRYONIC DEV DROSOP; DeFalco TJ, 2003, DEV CELL, V5, P205, DOI 10.1016/S1534-5807(03)00204-1; Harrison DA, 1998, GENE DEV, V12, P3252, DOI 10.1101/gad.12.20.3252; HARRISON DA, 1995, EMBO J, V14, P2857, DOI 10.1002/j.1460-2075.1995.tb07285.x; Hou SX, 2002, DEV CELL, V3, P765, DOI 10.1016/S1534-5807(02)00376-3; Ichiba M, 1998, J BIOL CHEM, V273, P6132, DOI 10.1074/jbc.273.11.6132; Janzer B, 2001, MECH DEVELOP, V100, P3, DOI 10.1016/S0925-4773(00)00529-3; Jinks TM, 2000, MOL CELL, V5, P581, DOI 10.1016/S1097-2765(00)80451-7; Kerkis J, 1931, GENETICS, V16, P0212; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Li JH, 2003, DEV CELL, V5, P787, DOI 10.1016/S1534-5807(03)00328-9; McLaren A, 2003, DEV BIOL, V262, P1, DOI 10.1016/S0012-1606(03)00214-8; MCLAREN A, 1981, J REPROD FERTIL, V61, P461, DOI 10.1530/jrf.0.0610461; Moore LA, 1998, DEVELOPMENT, V125, P667; NAGOSHI RN, 1990, GENE DEV, V4, P89, DOI 10.1101/gad.4.1.89; Oliver B, 2002, INT REV CYTOL, V219, P1; PATEL NH, 1994, DROSOPHILA MELANOGAS, P445; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; SCHUPBACH T, 1982, DEV BIOL, V89, P117, DOI 10.1016/0012-1606(82)90300-1; Sefton L, 2000, NATURE, V405, P970, DOI 10.1038/35016119; Sonnenblick B. P., 1941, P NATL ACAD SCI USA, V26, P373; Staab S, 1996, DEVELOPMENT, V122, P4065; STEINMANNZWICKY M, 1989, SXL CELL, V57, P157; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Van Doren M, 1998, NATURE, V396, P466, DOI 10.1038/24871; Zhang N, 1997, NATURE, V385, P64, DOI 10.1038/385064a0	30	97	100	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2005	436	7050					563	567		10.1038/nature03849	http://dx.doi.org/10.1038/nature03849			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049490	Green Accepted			2022-12-01	WOS:000230788800063
J	Sinkins, SP; Walker, T; Lynd, AR; Steven, AR; Makepeace, BL; Godfray, HCJ; Parkhill, J				Sinkins, SP; Walker, T; Lynd, AR; Steven, AR; Makepeace, BL; Godfray, HCJ; Parkhill, J			Wolbachia variability and host effects on crossing type in Culex mosquitoes	NATURE			English	Article							CYTOPLASMIC INCOMPATIBILITY; BACTERIOPHAGE-WO; PIPIENS L; POPULATIONS; DROSOPHILA; TRANSMISSION; ENDOSYMBIONT; ARTHROPODS; RESISTANCE; EVOLUTION	Wolbachia is a common maternally inherited bacterial symbiont able to induce crossing sterilities known as cytoplasmic incompatibility (CI) in insects(1,2). Wolbachia-modified sperm are unable to complete fertilization of uninfected ova, but a rescue function allows infected eggs to develop normally. By providing a reproductive advantage to infected females, Wolbachia can rapidly invade uninfected populations(3), and this could provide a mechanism for driving transgenes through pest populations(4,5). CI can also occur between Wolbachia-infected populations and is usually associated with the presence of different Wolbachia strains(1). In the Culex pipiens mosquito group ( including the filariasis vector C. quinquefasciatus) a very unusual degree of complexity of Wolbachia-induced crossing-types has been reported, with partial or complete CI that can be unidirectional or bidirectional(6-11), yet no Wolbachia strain variation was found(11). Here we show variation between incompatible Culex strains in two Wolbachia ankyrin repeat-encoding genes associated with a prophage region, one of which is sex-specifically expressed in some strains, and also a direct effect of the host nuclear genome on CI rescue.	Univ Oxford, Dept Zool, Oxford OX1 3SY, England; Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; Univ London Imperial Coll Sci Technol & Med, NERC, Ctr Populat Biol, Dept Biol Sci, Ascot SL5 7PY, Berks, England; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	University of Oxford; Liverpool School of Tropical Medicine; University of Liverpool; Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); Wellcome Trust Sanger Institute	Sinkins, SP (corresponding author), Univ Oxford, Dept Zool, Peter Medawar Bldg,S Parks Rd, Oxford OX1 3SY, England.	steven.sinkins@zoo.ox.ac.uk	Lynd, Amy/AAE-9640-2020; Parkhill, Julian/G-4703-2011; Walker, Thomas/F-6572-2013; Lynd, Amy/C-8938-2013; Walker, Thomas/B-9198-2014	Lynd, Amy/0000-0001-6054-0525; Parkhill, Julian/0000-0002-7069-5958; Walker, Thomas/0000-0003-4475-5395; Walker, Thomas/0000-0002-3545-012X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BARR AR, 1980, NATURE, V283, P71, DOI 10.1038/283071a0; Callaini G, 1997, J CELL SCI, V110, P271; Caturegli P, 2000, INFECT IMMUN, V68, P5277, DOI 10.1128/IAI.68.9.5277-5283.2000; COLLINS FH, 1987, AM J TROP MED HYG, V37, P37, DOI 10.4269/ajtmh.1987.37.37; Dobson SL, 2003, TRENDS PARASITOL, V19, P128, DOI 10.1016/S1471-4922(03)00002-3; Elfring LK, 1997, MOL BIOL CELL, V8, P583, DOI 10.1091/mbc.8.4.583; Guillemaud T, 1997, P ROY SOC B-BIOL SCI, V264, P245, DOI 10.1098/rspb.1997.0035; IRVINGBELL RJ, 1983, J MED ENTOMOL, V20, P44, DOI 10.1093/jmedent/20.1.44; Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a; LAVEN H, 1967, GENETICS INSECT VECT, P251; MAGNIN M, 1987, GENETICA, V74, P125, DOI 10.1007/BF00055223; Masui S, 2000, J MOL EVOL, V51, P491, DOI 10.1007/s002390010112; Masui S, 2001, BIOCHEM BIOPH RES CO, V283, P1099, DOI 10.1006/bbrc.2001.4906; Olson KE, 1996, SCIENCE, V272, P884, DOI 10.1126/science.272.5263.884; ONEILL SL, 1992, MED VET ENTOMOL, V6, P209, DOI 10.1111/j.1365-2915.1992.tb00608.x; ONeill SL, 1997, INFLUENTIAL PASSENGE; RAYMOND M, 1991, NATURE, V350, P151, DOI 10.1038/350151a0; ROUSSET F, 1991, J EVOLUTION BIOL, V4, P69, DOI 10.1046/j.1420-9101.1991.4010069.x; Sanogo YO, 2004, INSECT MOL BIOL, V13, P365, DOI 10.1111/j.0962-1075.2004.00498.x; Sinkins SP, 2004, P ROY SOC B-BIOL SCI, V271, P1421, DOI 10.1098/rspb.2004.2740; Sinkins SP, 2000, INSECT TRANSGENESIS, P271; Song She-Wu, 2002, Acta Entomologica Sinica, V45, P705; Tram U, 2002, SCIENCE, V296, P1124, DOI 10.1126/science.1070536; TURELLI M, 1991, NATURE, V353, P440, DOI 10.1038/353440a0; TURELLI M, 1994, EVOLUTION, V48, P1500, DOI 10.1111/j.1558-5646.1994.tb02192.x; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; WILLIAMS EH, 1993, J INVERTEBR PATHOL, V61, P206, DOI 10.1006/jipa.1993.1037; WRIGHT JD, 1978, J ULTRA MOL STRUCT R, V63, P79, DOI 10.1016/S0022-5320(78)80046-X; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	30	113	121	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 14	2005	436	7048					257	260		10.1038/nature03629	http://dx.doi.org/10.1038/nature03629			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944VR	16015330				2022-12-01	WOS:000230459500041
J	Theise, ND				Theise, ND			Now you see it, now you don't	NATURE			English	Editorial Material									Beth Israel Med Ctr, Div Digest Dis, New York, NY 10003 USA	Harvard University; Beth Israel Deaconess Medical Center	Theise, ND (corresponding author), Beth Israel Med Ctr, Div Digest Dis, 1st Ave & 16th St, New York, NY 10003 USA.							Kurakin A, 2005, DEV GENES EVOL, V215, P46, DOI 10.1007/s00427-004-0448-7; Theise ND, 2004, BLOOD CELL MOL DIS, V32, P17, DOI 10.1016/j.bcmd.2003.09.010; Theise ND, 2002, LEUKEMIA, V16, P542, DOI 10.1038/sj.leu.2402445	3	14	14	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 30	2005	435	7046					1165	1165		10.1038/4351165a	http://dx.doi.org/10.1038/4351165a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940JJ	15988502				2022-12-01	WOS:000230140500021
J	Thomas, DSG; Knight, M; Wiggs, GFS				Thomas, DSG; Knight, M; Wiggs, GFS			Remobilization of southern African desert dune systems by twenty-first century global warming	NATURE			English	Article							SOUTHWEST KALAHARI DESERT; DUNEFIELD ACTIVITY; MOBILITY; VARIABILITY; RAINFALL	Although desert dunes cover 5 per cent of the global land surface and 30 per cent of Africa, the potential impacts of twenty-first century global warming on desert dune systems are not well understood(1). The inactive Sahel and southern African dune systems, which developed in multiple arid phases since the last interglacial period(2), are used today by pastoral and agricultural systems(3,4) that could be disrupted if climate change alters twenty-first century dune dynamics. Empirical data and model simulations have established that the interplay between dune surface erodibility ( determined by vegetation cover and moisture availability) and atmospheric erosivity ( determined by wind energy) is critical for dunefield dynamics(5). This relationship between erodibility and erosivity is susceptible to climate-change impacts. Here we use simulations with three global climate models and a range of emission scenarios to assess the potential future activity of three Kalahari dunefields. We determine monthly values of dune activity by modifying and improving an established dune mobility index(6) so that it can account for global climate model data outputs. We find that, regardless of the emission scenario used, significantly enhanced dune activity is simulated in the southern dunefield by 2039, and in the eastern and northern dunefields by 2069. By 2099 all dunefields are highly dynamic, from northern South Africa to Angola and Zambia. Our results suggest that dunefields are likely to be reactivated ( the sand will become significantly exposed and move) as a consequence of twenty-first century climate warming.	Univ Oxford, Ctr Environm, Sch Geog & Environm, Oxford OX1 3QY, England; Univ Salford, Dept Earth & Life Sci, Manchester M5 4WT, Lancs, England	University of Oxford; University of Salford	Thomas, DSG (corresponding author), Univ Oxford, Ctr Environm, Sch Geog & Environm, S Parks Rd, Oxford OX1 3QY, England.	david.thomas@ouce.ox.ac.uk		Thomas, David/0000-0001-6867-5504; Wiggs, Giles/0000-0002-2131-0724				[Anonymous], 2000, IPCC SPECIAL REPORT; Bauer BO, 1998, J ARID ENVIRON, V39, P345, DOI 10.1006/jare.1998.0380; Bullard JE, 1997, EARTH SURF PROC LAND, V22, P165, DOI 10.1002/(SICI)1096-9837(199702)22:2&lt;165::AID-ESP687&gt;3.0.CO;2-9; CHEPIL W. S., 1963, ADVAN AGRON, V15, P211, DOI 10.1016/S0065-2113(08)60400-9; Hulme M., 1996, CLIMATE CHANGE SO AF; IPCC, 2001, CLIM CHANG 2001; KAR A, 1993, J ARID ENVIRON, V25, P83, DOI 10.1006/jare.1993.1044; Knight M, 2004, GEOMORPHOLOGY, V59, P197, DOI 10.1016/j.geomorph.2003.07.017; Korner C, 2000, ECOL APPL, V10, P1590, DOI 10.2307/2641226; LANCASTER N, 1988, J ARID ENVIRON, V14, P233; Lancaster N, 2000, EARTH SURF PROC LAND, V25, P197, DOI [10.1002/(SICI)1096-9837(200002)25:2&lt;197::AID-ESP82&gt;3.0.CO;2-H, 10.1002/(SICI)1096-9837(200002)25:2<197::AID-ESP82>3.0.CO;2-H]; Livingstone I., 1993, GEOLOGICAL SOC SPECI, V720, P91; Muhs D.R., 1993, J ARID ENVIRON, V25, P905; Nicholson SE, 1997, INT J CLIMATOL, V17, P117, DOI 10.1002/(SICI)1097-0088(199702)17:2<117::AID-JOC84>3.0.CO;2-O; RINGROSE S, 1991, INT J REMOTE SENS, V12, P1023, DOI 10.1080/01431169108929708; SCANLON TM, 2002, REMOTE SENS ENVIRON, V13, P419; Sporton D., 2002, SUSTAINABLE LIVELIHO; Stokes S, 1997, NATURE, V388, P154, DOI 10.1038/40596; SUMMER G, 2001, INT J CLIMATOL, V21, P211; TALBOT MR, 1984, PALAEOECOL AFR, V16, P203; Thomas DSG, 2005, GEOMORPHOLOGY, V64, P117, DOI 10.1016/j.geomorph.2004.06.004; Thomas DSG, 2002, QUATERNARY SCI REV, V21, P783, DOI 10.1016/S0277-3791(01)00127-5; THOMAS DSG, 1998, ARID ZONE GEOMORPHOL, P373; Tsoar H., 2020, AEOLIAN GEOMORPHOLOG, P75; Turner MD, 1999, J ARID ENVIRON, V41, P277, DOI 10.1006/jare.1998.0485; WASSON RJ, 1986, EARTH SURF PROCESSES, V11, P505, DOI 10.1002/esp.3290110505; WIGGS GFS, 1995, EARTH SURF PROC LAND, V20, P515, DOI 10.1002/esp.3290200604; WOODRUFF WP, 1968, J SOIL WATER CONSERV, V23, P103	28	219	234	4	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 30	2005	435	7046					1218	1221		10.1038/nature03717	http://dx.doi.org/10.1038/nature03717			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940JJ	15988522				2022-12-01	WOS:000230140500040
J	Manasse, HR				Manasse, HR			Conscientious objection and the pharmacist	SCIENCE			English	Editorial Material									Amer Soc Hlth Syst Pharmacists, Bethesda, MD 20814 USA		Manasse, HR (corresponding author), Amer Soc Hlth Syst Pharmacists, Bethesda, MD 20814 USA.	evp@ashp.org						BEAUCHAMP TL, 1989, PRINCIPLES BIOMEDICA, P389; Davey Monica, 2005, N Y Times Web, pA16	2	7	8	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2005	308	5728					1558	1559		10.1126/science.1114371	http://dx.doi.org/10.1126/science.1114371			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	936BH	15947160				2022-12-01	WOS:000229827000027
J	Ogata, J; Kanno, Y; Itoh, Y; Tsugawa, H; Suzuki, M				Ogata, J; Kanno, Y; Itoh, Y; Tsugawa, H; Suzuki, M			Anthocyanin biosynthesis in roses	NATURE			English	Editorial Material									Aomori Green BioCtr, Nogi Yamaguchi, Aomori 0300142, Japan; Tokyo Univ Agr & Technol, Fac Technol, Dept Biotechnol, Tokyo 1848588, Japan	Tokyo University of Agriculture & Technology	Ogata, J (corresponding author), Aomori Green BioCtr, Nogi Yamaguchi, Aomori 0300142, Japan.	masahiko_suzuki@ags.pref.aomori.jp						CAIRNS T, 2000, MODERN ROSES, V11; GUDIN S, 2003, ENCY ROSE SCI, V1, P25; Heller W., 1993, FLAVONOIDS ADV RES 1, P499; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; Jay M., 2003, ENCY ROSE SCI, V1, P248; Ogata J., 2004, PLANT BIOTECHNOL, V21, P367, DOI DOI 10.5511/PLANTBI0TECHN0L0GY.21.367; Springob K, 2003, NAT PROD REP, V20, P288, DOI 10.1039/b109542k; STRACK D, 1993, FLAVONOIDS ADV RES 1, P1; Tanaka Y, 2005, PLANT CELL TISS ORG, V80, P1, DOI 10.1007/s11240-004-0739-8; Yamazaki M, 1999, J BIOL CHEM, V274, P7405, DOI 10.1074/jbc.274.11.7405	10	89	119	7	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2005	435	7043					757	758		10.1038/nature435757a	http://dx.doi.org/10.1038/nature435757a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933NK	15944692				2022-12-01	WOS:000229638700038
J	Garg, V; Muth, AN; Ransom, JF; Schluterman, MK; Barnes, R; King, IN; Grossfeld, PD; Srivastava, D				Garg, V; Muth, AN; Ransom, JF; Schluterman, MK; Barnes, R; King, IN; Grossfeld, PD; Srivastava, D			Mutations in NOTCH1 cause aortic valve disease	NATURE			English	Article							NUCLEAR ACCESS; DROSOPHILA; HEART; TRANSITION; MECHANISM; CBFA1	Calcification of the aortic valve is the third leading cause of heart disease in adults(1). The incidence increases with age, and it is often associated with a bicuspid aortic valve present in 1 - 2% of the population(2). Despite the frequency, neither the mechanisms of valve calcification nor the developmental origin of a two, rather than three, leaflet aortic valve is known. Here, we show that mutations in the signalling and transcriptional regulator NOTCH1 cause a spectrum of developmental aortic valve anomalies and severe valve calcification in non-syndromic autosomal-dominant human pedigrees. Consistent with the valve calcification phenotype, Notch1 transcripts were most abundant in the developing aortic valve of mice, and Notch1 repressed the activity of Runx2, a central transcriptional regulator of osteoblast cell fate. The hairy-related family of transcriptional repressors (Hrt), which are activated by Notch1 signalling, physically interacted with Runx2 and repressed Runx2 transcriptional activity independent of histone deacetylase activity. These results suggest that NOTCH1 mutations cause an early developmental defect in the aortic valve and a later de-repression of calcium deposition that causes progressive aortic valve disease.	Univ Texas, SW Med Ctr, Dept Pediat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; Childrens Med Ctr, Dallas, TX 75235 USA; Univ Calif San Diego, Dept Pediat, Div Cardiol, San Diego, CA 92123 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Diego	Garg, V (corresponding author), Univ Texas, SW Med Ctr, Dept Pediat, 6000 Harry Hines Blvd,Room NA8-124, Dallas, TX 75390 USA.	vidu.garg@utsouthwestern.edu; dsrivastava@gladstone.ucsf.edu	Garg, Vidu/D-8240-2012; Burdine, Marie Schluterman/GLU-1812-2022; Garg, Vidu/E-3101-2011	Garg, Vidu/0000-0002-3778-5927; Burdine, Marie Schluterman/0000-0002-3940-5748; Ransom, Joshua/0000-0002-3591-0288	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL079260] Funding Source: NIH RePORTER; NHLBI NIH HHS [K08 HL079260, K08 HL079260-01] Funding Source: Medline; NICHD NIH HHS [K08 HD001382] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		[Anonymous], 2004, HEART DIS STROK STAT; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cripe L, 2004, J AM COLL CARDIOL, V44, P138, DOI 10.1016/j.jacc.2004.03.050; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Horne BD, 2004, CIRCULATION, V110, P3143, DOI 10.1161/01.CIR.0000147189.85636.C3; Iso T, 2001, MOL CELL BIOL, V21, P6080, DOI 10.1128/MCB.21.17.6080-6089.2001; Kathiriya IS, 2004, J BIOL CHEM, V279, P54937, DOI 10.1074/jbc.M409879200; Krebs LT, 2000, GENE DEV, V14, P1343; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Loffredo CA, 2004, AM J MED GENET A, V124A, P225, DOI 10.1002/ajmg.a.20366; McLarren KW, 2000, J BIOL CHEM, V275, P530, DOI 10.1074/jbc.275.1.530; Nakagawa O, 1999, DEV BIOL, V216, P72, DOI 10.1006/dbio.1999.9454; Nakagawa O, 2000, P NATL ACAD SCI USA, V97, P13655, DOI 10.1073/pnas.250485597; OBRIEN KD, 1995, CIRCULATION, V92, P2163, DOI 10.1161/01.CIR.92.8.2163; Rajamannan NM, 2003, HEART, V89, P801, DOI 10.1136/heart.89.7.801; Rajamannan NM, 2002, CIRCULATION, V105, P2660, DOI 10.1161/01.CIR.0000017435.87463.72; Sotillos S, 1997, DEVELOPMENT, V124, P4769; Steitz SA, 2001, CIRC RES, V89, P1147, DOI 10.1161/hh2401.101070; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Wen CH, 1997, DEVELOPMENT, V124, P4759; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160	30	986	1046	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2005	437	7056					270	274		10.1038/nature03940	http://dx.doi.org/10.1038/nature03940			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961YE	16025100				2022-12-01	WOS:000231696900059
J	Gasser, S; Orsulic, S; Brown, EJ; Raulet, DH				Gasser, S; Orsulic, S; Brown, EJ; Raulet, DH			The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor	NATURE			English	Article							GENOMIC INSTABILITY; NK CELLS; CHECKPOINT; ATM; TUMORIGENESIS; ACTIVATION; REPAIR; CHK1; IMMUNORECEPTOR; MACROPHAGES	Some stimulatory receptors of the innate immune system, such as the NKG2D receptor ( also called KLRK1) expressed by natural killer cells and activated CD8(+) T cells, recognize self-molecules that are upregulated in diseased cells by poorly understood mechanisms(1). Here we show that mouse and human NKG2D ligands are upregulated in non-tumour cell lines by genotoxic stress and stalled DNA replication, conditions known to activate a major DNA damage checkpoint pathway initiated by ATM ( ataxia telangiectasia, mutated) or ATR (ATM- and Rad3-related) protein kinases(2). Ligand upregulation was prevented by pharmacological or genetic inhibition of ATR, ATM or Chk1 ( a downstream transducer kinase in the pathway). Furthermore, constitutive ligand expression by a tumour cell line was inhibited by targeting short interfering RNA to ATM, suggesting that ligand expression in established tumour cells, which often harbour genomic irregularities, may be due to chronic activation of the DNA damage response pathway. Thus, the DNA damage response, previously shown to arrest the cell cycle and enhance DNA repair functions, or to trigger apoptosis, may also participate in alerting the immune system to the presence of potentially dangerous cells.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Harvard University; Massachusetts General Hospital; University of Pennsylvania	Raulet, DH (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	raulet@uclink.berkeley.edu	gasser, stephan/A-2309-2013	Raulet, David/0000-0002-1257-8649; Gasser, Stephan/0000-0002-5616-0914	NATIONAL CANCER INSTITUTE [R01CA093678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039642] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA093678] Funding Source: Medline; NIAID NIH HHS [R01 AI039642] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bignami M, 2003, EUR J CANCER, V39, P2142, DOI 10.1016/S0959-8049(03)00569-0; Brown EJ, 2000, GENE DEV, V14, P397; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Diefenbach A, 2003, EUR J IMMUNOL, V33, P381, DOI 10.1002/immu.200310012; Gonzalez S, 2003, MOL CELL BIOL, V23, P8161, DOI 10.1128/MCB.23.22.8161-8171.2003; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Hernandez-Hoyos G, 2003, IMMUNITY, V19, P83, DOI 10.1016/S1074-7613(03)00176-6; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; Krause DR, 2003, ONCOGENE, V22, P5927, DOI 10.1038/sj.onc.1206691; LANDER MR, 1978, J NATL CANCER I, V60, P477; Lodoen M, 2003, J EXP MED, V197, P1245, DOI 10.1084/jem.20021973; Mills KD, 2003, IMMUNOL REV, V194, P77, DOI 10.1034/j.1600-065X.2003.00060.x; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Osborn AJ, 2002, TRENDS CELL BIOL, V12, P509, DOI 10.1016/S0962-8924(02)02380-2; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sarkaria JN, 1999, CANCER RES, V59, P4375; Sieber OM, 2003, NAT REV CANCER, V3, P701, DOI 10.1038/nrc1170; Weitzman MD, 2004, DNA REPAIR, V3, P1165, DOI 10.1016/j.dnarep.2004.03.018; Xing DY, 2005, P NATL ACAD SCI USA, V102, P6936, DOI 10.1073/pnas.0502256102; Zhang XS, 2004, MOL CELL BIOL, V24, P9207, DOI 10.1128/MCB.24.20.9207-9220.2004; Zhou BBS, 2004, NAT REV CANCER, V4, P216, DOI 10.1038/nrc1296	27	980	1028	5	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2005	436	7054					1186	1190		10.1038/nature03884	http://dx.doi.org/10.1038/nature03884			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958AK	15995699	Green Accepted			2022-12-01	WOS:000231416600052
J	Sharp, D				Sharp, D			Novel pain relief via marine snails	LANCET			English	Editorial Material							ZICONOTIDE; DRUGS		The Lancet, London NW1 7BY, England		Sharp, D (corresponding author), The Lancet, London NW1 7BY, England.							Bonnemain B, 2005, EVID-BASED COMPL ALT, V2, P25, DOI 10.1093/ecam/neh057; COUSINS MJ, 2002, 10 WORLD C PAIN SAN; Duda TF, 2004, SCIENCE, V303, P955, DOI 10.1126/science.303.5660.955; *EUR MED EV AG, 2005, PRIALT EUR PUBL ASS; Fegan D, 1997, LANCET, V349, P1672, DOI 10.1016/S0140-6736(05)62639-6; Livett BG, 2004, CURR MED CHEM, V11, P1715, DOI 10.2174/0929867043364928; Miljanich GP, 2004, CURR MED CHEM, V11, P3029, DOI 10.2174/0929867043363884; Penn RD, 2000, PAIN, V85, P291, DOI 10.1016/S0304-3959(99)00254-7; Sollod BL, 2005, PEPTIDES, V26, P131, DOI 10.1016/j.peptides.2004.07.016; Staats PS, 2004, JAMA-J AM MED ASSOC, V291, P63, DOI 10.1001/jama.291.1.63; Stix G, 2005, SCI AM, V292, P79	11	10	10	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 6	2005	366	9484					439	440		10.1016/S0140-6736(05)67040-7	http://dx.doi.org/10.1016/S0140-6736(05)67040-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	952RD	16084239				2022-12-01	WOS:000231022300010
J	Messenger, S; Keller, LP; Lauretta, DS				Messenger, S; Keller, LP; Lauretta, DS			Supernova olivine from cometary dust	SCIENCE			English	Article							MOLECULAR-CLOUD MATERIAL; PRESOLAR SIC GRAINS; SOLAR-SYSTEM; ISOTOPIC COMPOSITIONS; ISO SPECTROSCOPY; SILICON-CARBIDE; MASSIVE STARS; CARBON; CONDENSATION; NITROGEN	An interplanetary dust particle contains a submicrometer crystalline silicate aggregate of probable supernova origin. The grain has a pronounced enrichment in O-18/O-16 (13 times the solar value) and depletions in O-17/O-16 (one-third solar) and Si-29/Si-28 (<0.8 times solar), indicative of formation from a type 11 supernova. The aggregate contains olivine (forsterite 83) grains <100 nanometers in size, with microstructures that are consistent with minimal thermal alteration. This unusually iron-rich olivine grain could have formed by equilibrium condensation from cooling supernova ejecta if several different nucleosynthetic zones mixed in the proper proportions. The supernova grain is also partially encased in nitrogen-15-rich organic matter that likely formed in a presolar cold molecular cloud.	NASA, Lyndon B Johnson Space Ctr, Robert M Walker Lab Space Sci, Houston, TX 77058 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA	National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; University of Arizona	Messenger, S (corresponding author), NASA, Lyndon B Johnson Space Ctr, Robert M Walker Lab Space Sci, Mail Code KR, Houston, TX 77058 USA.	scott.r.messenger@nasa.gov						Alexander CMO, 1998, METEORIT PLANET SCI, V33, P603, DOI 10.1111/j.1945-5100.1998.tb01667.x; ALEXANDER CMO, 1993, GEOCHIM COSMOCHIM AC, V57, P2869, DOI 10.1016/0016-7037(93)90395-D; Amari S, 2001, ASTROPHYS J, V559, P463, DOI 10.1086/322397; Amari S, 2001, ASTROPHYS J, V546, P248, DOI 10.1086/318230; ARNARI S, 1992, ASTROPHYS J, V394, P643; ARNOULD M, 1998, AIP C P, V402, P179; BERNATOWIC TJ, 1998, AIP C P, V402; Bernstein MP, 2002, ASTROPHYS J, V576, P1115, DOI 10.1086/341863; Boothroyd AI, 1999, ASTROPHYS J, V510, P232, DOI 10.1086/306546; Bradley J. P., 1988, METEORITES EARLY SOL, P861; Bradley JP, 1999, SCIENCE, V285, P1716, DOI 10.1126/science.285.5434.1716; Busso M, 2003, PUBL ASTRON SOC AUST, V20, P356, DOI 10.1071/AS03035; Charnley SB, 2002, ASTROPHYS J, V569, pL133, DOI 10.1086/340484; Choi BG, 1998, SCIENCE, V282, P1284, DOI 10.1126/science.282.5392.1284; Choi BG, 1999, ASTROPHYS J, V522, pL133, DOI 10.1086/312239; Clayton DD, 1999, SCIENCE, V283, P1290, DOI 10.1126/science.283.5406.1290; Clayton DD, 2001, ASTROPHYS J, V562, P480, DOI 10.1086/323467; CLAYTON DD, 2004, ORIGIN EVOLUTION ELE, P297; Deneault EAN, 2003, ASTROPHYS J, V594, P312, DOI 10.1086/376863; Dunne L, 2003, NATURE, V424, P285, DOI 10.1038/nature01792; Ebel DS, 2000, GEOCHIM COSMOCHIM AC, V64, P339, DOI 10.1016/S0016-7037(99)00284-7; FEDKIN AV, 2004, LUNAR PLANET SCI, V35, pA1823; Floss C, 2004, SCIENCE, V303, P1355, DOI 10.1126/science.1093283; Floss C., 2004, LUNAR PLANET SCI, VXXXV; Gibb EL, 2000, ASTROPHYS J, V536, P347, DOI 10.1086/308940; HOPPE P, 1994, ASTROPHYS J, V430, P870, DOI 10.1086/174458; Hoppe P, 1996, GEOCHIM COSMOCHIM AC, V60, P883, DOI 10.1016/0016-7037(95)00435-1; HOPPE P, 2005, LUNAR PLANET SCI, V36; Huss GR, 1997, GEOCHIM COSMOCHIM AC, V61, P5117, DOI 10.1016/S0016-7037(97)00299-8; Jones AP, 1996, ASTROPHYS J, V469, P740, DOI 10.1086/177823; Keller LP, 2004, GEOCHIM COSMOCHIM AC, V68, P2577, DOI 10.1016/j.gca.2003.10.044; Kemper F, 2004, ASTROPHYS J, V609, P826, DOI 10.1086/421339; Kemper F, 2002, ASTRON ASTROPHYS, V394, P679, DOI 10.1051/0004-6361:20021119; KOBAYASHI S, 2005, LUNAR PLANET SCI, V36; KRESTINA H, 2002, LUNAR PLANET SCI, V33; Lada CJ, 2003, ANNU REV ASTRON ASTR, V41, P57, DOI 10.1146/annurev.astro.41.011802.094844; Li AG, 1997, ASTRON ASTROPHYS, V323, P566; MARHAS KK, 2004, LUNAR PLANET SCI, V35; Meeus G, 2001, ASTRON ASTROPHYS, V365, P476, DOI 10.1051/0004-6361:20000144; Messenger S, 2003, SCIENCE, V300, P105, DOI 10.1126/science.1080576; Messenger S, 2000, NATURE, V404, P968, DOI 10.1038/35010053; Messenger S, 2002, METEORIT PLANET SCI, V37, P1491, DOI 10.1111/j.1945-5100.2002.tb00806.x; MESSENGER S, 1997, AIP C P, V402, P545; MEYER BS, 1995, METEORITICS, V30, P325, DOI 10.1111/j.1945-5100.1995.tb01131.x; Mostefaoui S, 2004, ASTROPHYS J, V613, pL149, DOI 10.1086/424842; Mouri H, 2000, ASTROPHYS J, V534, pL63, DOI 10.1086/312633; Nagashima K, 2004, NATURE, V428, P921, DOI 10.1038/nature02510; Nguyen AN, 2004, SCIENCE, V303, P1496, DOI 10.1126/science.1094389; NGUYEN AN, 2005, LUNAR PLANET SCI, V36; Nittler LR, 1998, NATURE, V393, P222, DOI 10.1038/30377; Nittler LR, 1997, ASTROPHYS J, V483, P475, DOI 10.1086/304234; Pasek MA, 2005, ICARUS, V175, P1, DOI 10.1016/j.icarus.2004.10.012; Rauscher T, 2002, ASTROPHYS J, V576, P323, DOI 10.1086/341728; STROUD RM, 2004, MET PLANET SCI, V39; Tachibana S, 2003, ASTROPHYS J, V588, pL41, DOI 10.1086/375362; Travaglio C, 1999, ASTROPHYS J, V510, P325, DOI 10.1086/306551; van Dishoeck EF, 2004, ANNU REV ASTRON ASTR, V42, P119, DOI 10.1146/annurev.astro.42.053102.134010; Waters LBFM, 1996, ASTRON ASTROPHYS, V315, pL361; WOODEN DH, 1998, AIP C P, V402, P317; WOOSLEY SE, 1995, ASTROPHYS J SUPPL S, V101, P181, DOI 10.1086/192237; Yada T., 2005, LUNAR PLANET SCI, VXXXVI; Zinner E, 2003, GEOCHIM COSMOCHIM AC, V67, P5083, DOI 10.1016/S0016-7037(03)00261-8; Zinner EK, 2005, TREATISE GEOCHEM, V1, P17	63	133	133	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2005	309	5735					737	741		10.1126/science.1109602	http://dx.doi.org/10.1126/science.1109602			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951NU	15994379				2022-12-01	WOS:000230938200040
J	Arrow, KJ; Gelband, H; Jamison, DT				Arrow, KJ; Gelband, H; Jamison, DT			Making antimalarial agents available in Africa	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Stanford Univ, Palo Alto, CA 94304 USA; Natl Acad Sci, Inst Med, Washington, DC 20418 USA; Univ Calif Los Angeles, Los Angeles, CA USA	Stanford University; National Academies of Sciences, Engineering & Medicine; University of California System; University of California Los Angeles	Arrow, KJ (corresponding author), Stanford Univ, Palo Alto, CA 94304 USA.							Arrow KJ, 2004, SAVING LIVES BUYING; *UNICEF, 2003, AFR MAL REP 2003	2	12	14	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 28	2005	353	4					333	335		10.1056/NEJMp058168	http://dx.doi.org/10.1056/NEJMp058168			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949JW	16000348				2022-12-01	WOS:000230782800003
J	Maisel, WH; Laskey, WK				Maisel, WH; Laskey, WK			Patent foramen ovalle closure devices - Moving beyond equipoise	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CRYPTOGENIC STROKE; PERCUTANEOUS CLOSURE; MEDICAL-TREATMENT		Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Cardiovasc Div, Boston, MA 02115 USA; Univ New Mexico, Sch Med, Dept Med, Div Cardiol, Albuquerque, NM 87131 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of New Mexico	Maisel, WH (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Cardiovasc Div, 185 Pilgrim Rd, Boston, MA 02115 USA.	wmaisel@bidmc.harvard.edu						*AM HEART ASS, STROK NEWS SUMM 2004; Baker SS, 2002, CATHETER CARDIO INTE, V55, P83, DOI 10.1002/ccd.10079; Blackshear JL, 2004, J AM COLL CARDIOL, V44, P759, DOI 10.1016/j.jacc.2004.06.002; *CIMIT REG AFF, 2002, AGA MED ANT FULL PMA; Donnan GA, 2004, STROKE, V35, P806, DOI 10.1161/01.STR.0000117965.15684.D3; Homma S, 2002, CIRCULATION, V105, P2625, DOI 10.1161/01.CIR.0000017498.88393.44; Homma S, 1997, STROKE, V28, P2376, DOI 10.1161/01.STR.28.12.2376; Horton SC, 2004, MAYO CLIN PROC, V79, P79, DOI 10.4065/79.1.79; *INT STROK CTR, STROK TRIALS DIR TRI; *INT STROK CTR, STROK TRIALS DIR RES; Khairy P, 2003, ANN INTERN MED, V139, P753, DOI 10.7326/0003-4819-139-9-200311040-00010; Krumsdorf U, 2004, J AM COLL CARDIOL, V43, P302, DOI 10.1016/j.jacc.2003.10.030; Landzberg MJ, 2004, HEART, V90, P219, DOI 10.1136/hrt.2003.019315; Maisel WH, 2004, ANN INTERN MED, V140, P296, DOI 10.7326/0003-4819-140-4-200402170-00012; Meissner I, 1999, MAYO CLIN PROC, V74, P862, DOI 10.4065/74.9.862; Messe SR, 2004, NEUROLOGY, V62, P1042, DOI 10.1212/01.WNL.0000119173.15878.F3; *MINN HEART I, CARDIA STAR TRIAL US; Orgera MA, 2001, SOUTHERN MED J, V94, P699; Schwerzmann M, 2004, HEART, V90, P186, DOI 10.1136/hrt.2002.003111; Sievert H, 2004, EUR HEART J, V25, P361, DOI 10.1016/j.ehj.2004.01.012; *US DEP HHS, HUM DEV EX HDE REG Q; *US DEP HHS, H990011 CARDIOSEAL S; *US DEP HHS, H000007 AMPL PFO OCC; *US SEC EXCH COMM, ANN REP FISC YEAR EN; Williams DO, 1998, CIRCULATION, V97, P309; Windecker S, 2004, J AM COLL CARDIOL, V44, P750, DOI 10.1016/j.jacc.2004.05.044; *WINDH INF INC, START UP WINDH REV E; Wu LA, 2004, ARCH INTERN MED, V164, P950, DOI 10.1001/archinte.164.9.950; 2004, FED REG, V69, P66235	29	35	35	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 20	2005	294	3					366	369		10.1001/jama.294.3.366	http://dx.doi.org/10.1001/jama.294.3.366			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946YL	16030282				2022-12-01	WOS:000230609100022
J	Decullier, E; Lheritier, V; Chapuis, F				Decullier, E; Lheritier, V; Chapuis, F			Fate of biomedical research protocols and publication bias in France: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CLINICAL-TRIALS; FOLLOW-UP; REGISTRATION; COMMITTEE	Objectives To describe the fate of protocols approved by the French research ethics committees, a national system created by the French 1988 Huriet-Serusclat Act; to assess publication bias at a national level. Design Retrospective cohort study. Setting Representative sample of 25/48 French research ethics committees in 1994. Protocols 649 research protocols approved by committees, with follow-up information. Main outcome measures Protocols' initial characteristics (design, study size, investigator) abstracted from committees' archives; follow-up information (rates of initiation, completion, and publication) obtained from mailed questionnaire to principal investigators. Results Completed questionnaires were available for 649/976 (69%) protocols. Of these, 581 (90%) studies were initiated, 501/581 (86%) were completed, and 190/501 (38%) were published. Studies with confirmatory results were more likely to be published as scientific papers than were studies with inconclusive results (adjusted odds ratio 4.59, 95% confidence interval 2.21 to 9.54). Moreover, studies with confirmatory results were published more quickly than studies with inconclusive results (hazard ratio 2.48, 1.36 to 4.55). Conclusion At a national level, too many research studies are not completed, and among those completed too many are not published. We suggest capitalising on research ethics committees to register and follow all authorised research on human participants on a systematic and prospective basis.	Hop Hotel Dieu, French Natl Confederat Res Eth Comm, F-69002 Lyon, France; Hosp Civils Lyon, DIM, Clin Res Unit, F-69424 Lyon, France; Hop Hotel Dieu, CCPPRB Lyon B, F-69002 Lyon, France	CHU Lyon; CHU Lyon; CHU Lyon	Chapuis, F (corresponding author), Hop Hotel Dieu, French Natl Confederat Res Eth Comm, F-69002 Lyon, France.	francois.chapuis@chu-lyon.fr	decullier, evelyne/AAL-5861-2021					Abbasi K, 2004, BRIT MED J, V329, P637, DOI 10.1136/bmj.329.7467.637; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; De Angelis C, 2004, MED J AUSTRALIA, V181, P293, DOI 10.5694/j.1326-5377.2004.tb06290.x; DICKERSIN K, 1992, JAMA-J AM MED ASSOC, V267, P374, DOI 10.1001/jama.267.3.374; DICKERSIN K, 1992, CONTROL CLIN TRIALS, V13, P170, DOI 10.1016/0197-2456(92)90022-R; EASTERBROOK P, 1987, BRIT MED J, V295, P1347, DOI 10.1136/bmj.295.6609.1347-a; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; EASTERBROOK PJ, 1992, J ROY SOC MED, V85, P71; GREENWALD AG, 1975, PSYCHOL BULL, V82, P1, DOI 10.1037/h0076157; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P281, DOI 10.1001/jama.279.4.281; Pich J, 2003, LANCET, V361, P1015, DOI 10.1016/S0140-6736(03)12799-7; SIMES RJ, 1986, J CLIN ONCOL, V4, P1529, DOI 10.1200/JCO.1986.4.10.1529; Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640	13	106	107	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 2	2005	331	7507					19	22		10.1136/bmj.38488.385995.8F	http://dx.doi.org/10.1136/bmj.38488.385995.8F			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	947TD	15967761	Green Published, Bronze			2022-12-01	WOS:000230668500016
J	Chao, WL; Harteneck, BD; Liddle, JA; Anderson, EH; Attwood, DT				Chao, WL; Harteneck, BD; Liddle, JA; Anderson, EH; Attwood, DT			Soft X-ray microscopy at a spatial resolution better than 15nm	NATURE			English	Article							ELECTRON-BEAM LITHOGRAPHY; MAGNETIC NANOSTRUCTURES; TRANSMISSION MICROSCOPY; WATER; TOMOGRAPHY; DOMAINS	Analytical tools that have spatial resolution at the nanometre scale are indispensable for the life and physical sciences. It is desirable that these tools also permit elemental and chemical identification on a scale of 10 nm or less, with large penetration depths. A variety of techniques(1-7) in X-ray imaging are currently being developed that may provide these combined capabilities. Here we report the achievement of sub-15-nm spatial resolution with a soft X-ray microscope - and a clear path to below 10 nm - using an overlay technique for zone plate fabrication. The microscope covers a spectral range from a photon energy of 250 eV (similar to 5 nm wavelength) to 1.8 keV (similar to 0.7 nm), so that primary K and L atomic resonances of elements such as C, N, O, Al, Ti, Fe, Co and Ni can be probed. This X-ray microscopy technique is therefore suitable for a wide range of studies: biological imaging in the water window(8,9); studies of wet environmental samples(10,11); studies of magnetic nanostructures with both elemental and spin-orbit sensitivity(12-14); studies that require viewing through thin windows, coatings or substrates ( such as buried electronic devices in a silicon chip(15)); and three-dimensional imaging of cryogenically fixed biological cells(9,16).	Univ Calif Berkeley, Lawrence Berkeley Lab, Ctr Xray Opt, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Chao, WL (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Ctr Xray Opt, 1 Cyclotron Rd,MS 2-400, Berkeley, CA 94720 USA.	wlchao@lbl.gov	Liddle, James A/A-4867-2013	Liddle, James A/0000-0002-2508-7910				Anderson EH, 2004, MICROELECTRON ENG, V73-4, P74, DOI 10.1016/j.mee.2004.02.019; Anderson EH, 2000, J VAC SCI TECHNOL B, V18, P2970, DOI 10.1116/1.1321282; Anderson EH, 1995, J VAC SCI TECHNOL B, V13, P2529, DOI 10.1116/1.588387; Attwood D., 2000, SOFT XRAYS EXTREME U; BORN M, 1999, PRINCIPLES OPTICS, P596; Chao W, 2003, J VAC SCI TECHNOL B, V21, P3108, DOI 10.1116/1.1619956; Chao WL, 2003, OPT LETT, V28, P2019, DOI 10.1364/OL.28.002019; Di Fabrizio E, 1999, NATURE, V401, P895, DOI 10.1038/44791; Eisebitt S, 2004, NATURE, V432, P885, DOI 10.1038/nature03139; Fischer P, 1996, Z PHYS B CON MAT, V101, P313, DOI 10.1007/s002570050214; Fischer P, 2002, J PHYS D APPL PHYS, V35, P2391, DOI 10.1088/0022-3727/35/19/310; Gibson EA, 2003, SCIENCE, V302, P95, DOI 10.1126/science.1088654; GOODMAN JW, 2000, STAT OPTICS, P303; Jochum E., 1995, SYNCHROTRON RAD NEWS, V8, P29; Juenger MCG, 2003, J MATER SCI LETT, V22, P1335, DOI 10.1023/A:1025731210337; Kipp L, 2001, NATURE, V414, P184, DOI 10.1038/35102526; Larabell CA, 2004, MOL BIOL CELL, V15, P957, DOI 10.1091/mbc.E03-07-0522; Larotonda MA, 2004, IEEE J SEL TOP QUANT, V10, P1363, DOI 10.1109/JSTQE.2004.838038; Marchesini S, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.140101; Meyer-Ilse W, 2001, J MICROSC-OXFORD, V201, P395, DOI 10.1046/j.1365-2818.2001.00845.x; Miao JW, 1999, NATURE, V400, P342, DOI 10.1038/22498; Miao JW, 2003, P NATL ACAD SCI USA, V100, P110, DOI 10.1073/pnas.232691299; Myneni SCB, 1999, SCIENCE, V286, P1335, DOI 10.1126/science.286.5443.1335; SCHMAHL G, 1984, XRAY MICROSCOPY; Schneider G, 2002, J VAC SCI TECHNOL B, V20, P3089, DOI 10.1116/1.1523403; Schneider G, 2002, SURF REV LETT, V9, P177, DOI 10.1142/S0218625X02001914; Stoll H, 2004, APPL PHYS LETT, V84, P3328, DOI 10.1063/1.1723698; SUSINI J, 2003, XRAY MICROSCOPY, V7; Toh K. K. H., 1987, Proceedings of the SPIE - The International Society for Optical Engineering, V772, P202, DOI 10.1117/12.967051; Vogt U, 2004, APPL PHYS B-LASERS O, V78, P53, DOI 10.1007/s00340-003-1338-9; Yasin S, 2001, APPL PHYS LETT, V78, P2760, DOI 10.1063/1.1369615	31	682	739	9	208	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 30	2005	435	7046					1210	1213		10.1038/nature03719	http://dx.doi.org/10.1038/nature03719			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940JJ	15988520				2022-12-01	WOS:000230140500038
J	Lyamin, O; Pryaslova, J; Lance, V; Siegel, J				Lyamin, O; Pryaslova, J; Lance, V; Siegel, J			Continuous activity in cetaceans after birth	NATURE			English	Editorial Material							SLEEP-DEPRIVATION; STATE; DROSOPHILA		Univ Calif Los Angeles, North Hills, CA 91343 USA; VA GLAHS, North Hills, CA 91343 USA; Utrish Dolphinarium, Moscow 119071, Russia; San Diego State Univ, San Diego, CA 92182 USA	University of California System; University of California Los Angeles; California State University System; San Diego State University	Siegel, J (corresponding author), Univ Calif Los Angeles, North Hills, CA 91343 USA.	jsiegel@ucla.edu	Lyamin, Oleg/AAO-4881-2020	Lyamin, Oleg/0000-0003-2049-0943	NINDS NIH HHS [R01 NS042947] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BONNET MH, 1989, PHYSIOL BEHAV, V45, P1049, DOI 10.1016/0031-9384(89)90236-9; FLANIGAN WF, 1975, SLEEP RES, V4, P139; HOPPENBROUWERS T, 1975, EXP NEUROL, V49, P822, DOI 10.1016/0014-4886(75)90062-X; Lyamin OI, 2004, ARCH ITAL BIOL, V142, P557; Lyamin OI, 2002, BEHAV BRAIN RES, V129, P125, DOI 10.1016/S0166-4328(01)00346-1; RECHTSCHAFFEN A, 1983, SCIENCE, V221, P182, DOI 10.1126/science.6857280; Rechtschaffen A, 2002, SLEEP, V25, P18, DOI 10.1093/sleep/25.1.18; ROFFWARG HP, 1966, SCIENCE, V152, P604, DOI 10.1126/science.152.3722.604; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a	10	94	98	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2005	435	7046					1177	1177		10.1038/4351177a	http://dx.doi.org/10.1038/4351177a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940JJ	15988513	Bronze, Green Accepted			2022-12-01	WOS:000230140500031
J	Olsen, NJ				Olsen, NJ			Tailoring arthritis therapy in the wake of the NSAID crisis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Texas, SW Med Ctr, Dallas, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Olsen, NJ (corresponding author), Univ Texas, SW Med Ctr, 5323 Harry Hines Blvd, Dallas, TX 75235 USA.								0	11	11	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 23	2005	352	25					2578	2580		10.1056/NEJMp058105	http://dx.doi.org/10.1056/NEJMp058105			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	937VJ	15972863				2022-12-01	WOS:000229953700004
J	Lu, J; Getz, G; Miska, EA; Alvarez-Saavedra, E; Lamb, J; Peck, D; Sweet-Cordero, A; Ebet, BL; Mak, RH; Ferrando, AA; Downing, JR; Jacks, T; Horvitz, HR; Golub, TR				Lu, J; Getz, G; Miska, EA; Alvarez-Saavedra, E; Lamb, J; Peck, D; Sweet-Cordero, A; Ebet, BL; Mak, RH; Ferrando, AA; Downing, JR; Jacks, T; Horvitz, HR; Golub, TR			MicroRNA expression profiles classify human cancers	NATURE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; GENE-EXPRESSION; CAENORHABDITIS-ELEGANS; STEM-CELLS; SIGNATURES; RNA; DIFFERENTIATION; IDENTIFICATION; ACCUMULATION; MICROARRAYS	Recent work has revealed the existence of a class of small non-coding RNA species, known as microRNAs ( miRNAs), which have critical functions across various biological processes(1,2). Here we use a new, bead-based flow cytometric miRNA expression profiling method to present a systematic expression analysis of 217 mammalian miRNAs from 334 samples, including multiple human cancers. The miRNA profiles are surprisingly informative, reflecting the developmental lineage and differentiation state of the tumours. We observe a general downregulation of miRNAs in tumours compared with normal tissues. Furthermore, we were able to successfully classify poorly differentiated tumours using miRNA expression profiles, whereas messenger RNA profiles were highly inaccurate when applied to the same samples. These findings highlight the potential of miRNA profiling in cancer diagnosis.	MIT, Broad Inst, Cambridge, MA 02141 USA; Harvard Univ, Broad Inst, Cambridge, MA 02141 USA; MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; MIT, Ctr Canc Res, Cambridge, MA 02139 USA; Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; St Jude Children's Research Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Golub, TR (corresponding author), MIT, Broad Inst, Cambridge, MA 02141 USA.	golub@broad.mit.edu	Ferrando, Adolfo A/Q-7026-2016; Downing, James R./N-8102-2018	Miska, Eric/0000-0002-4450-576X; Mak, Raymond/0000-0002-8754-0565				Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Babak T, 2004, RNA, V10, P1813, DOI 10.1261/rna.7119904; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Chung CH, 2002, NAT GENET, V32, P533, DOI 10.1038/ng1038; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Michael MZ, 2003, MOL CANCER RES, V1, P882; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Nelson PT, 2004, NAT METHODS, V1, P155, DOI 10.1038/NMETH717; Pavlidis N, 2003, EUR J CANCER, V39, P1990, DOI 10.1016/S0959-8049(03)00547-1; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stegmaier K, 2004, NAT GENET, V36, P257, DOI 10.1038/ng1305; Sun YQ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh186; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6	30	7623	8274	22	1484	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2005	435	7043					834	838		10.1038/nature03702	http://dx.doi.org/10.1038/nature03702			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933NK	15944708				2022-12-01	WOS:000229638700054
J	Margulies, M; Egholm, M; Altman, WE; Attiya, S; Bader, JS; Bemben, LA; Berka, J; Braverman, MS; Chen, YJ; Chen, ZT; Dewell, SB; Du, L; Fierro, JM; Gomes, XV; Godwin, BC; He, W; Helgesen, S; Ho, CH; Irzyk, GP; Jando, SC; Alenquer, MLI; Jarvie, TP; Jirage, KB; Kim, JB; Knight, JR; Lanza, JR; Leamon, JH; Lefkowitz, SM; Lei, M; Li, J; Lohman, KL; Lu, H; Makhijani, VB; McDade, KE; McKenna, MP; Myers, EW; Nickerson, E; Nobile, JR; Plant, R; Puc, BP; Ronan, MT; Roth, GT; Sarkis, GJ; Simons, JF; Simpson, JW; Srinivasan, M; Tartaro, KR; Tomasz, A; Vogt, KA; Volkmer, GA; Wang, SH; Wang, Y; Weiner, MP; Yu, PG; Begley, RF; Rothberg, JM				Margulies, M; Egholm, M; Altman, WE; Attiya, S; Bader, JS; Bemben, LA; Berka, J; Braverman, MS; Chen, YJ; Chen, ZT; Dewell, SB; Du, L; Fierro, JM; Gomes, XV; Godwin, BC; He, W; Helgesen, S; Ho, CH; Irzyk, GP; Jando, SC; Alenquer, MLI; Jarvie, TP; Jirage, KB; Kim, JB; Knight, JR; Lanza, JR; Leamon, JH; Lefkowitz, SM; Lei, M; Li, J; Lohman, KL; Lu, H; Makhijani, VB; McDade, KE; McKenna, MP; Myers, EW; Nickerson, E; Nobile, JR; Plant, R; Puc, BP; Ronan, MT; Roth, GT; Sarkis, GJ; Simons, JF; Simpson, JW; Srinivasan, M; Tartaro, KR; Tomasz, A; Vogt, KA; Volkmer, GA; Wang, SH; Wang, Y; Weiner, MP; Yu, PG; Begley, RF; Rothberg, JM			Genome sequencing in microfabricated high-density picolitre reactors	NATURE			English	Article							PYROPHOSPHATE; MOLECULES; EVOLUTION	The proliferation of large-scale DNA-sequencing projects in recent years has driven a search for alternative methods to reduce time and cost. Here we describe a scalable, highly parallel sequencing system with raw throughput significantly greater than that of state-of-the-art capillary electrophoresis instruments. The apparatus uses a novel fibre-optic slide of individual wells and is able to sequence 25 million bases, at 99% or better accuracy, in one four-hour run. To achieve an approximately 100-fold increase in throughput over current Sanger sequencing technology, we have developed an emulsion method for DNA amplification and an instrument for sequencing by synthesis using a pyrosequencing protocol optimized for solid support and picolitre-scale volumes. Here we show the utility, throughput, accuracy and robustness of this system by shotgun sequencing and de novo assembly of the Mycoplasma genitalium genome with 96% coverage at 99.96% accuracy in one run of the machine.	Life Sci Corp 454, Branford, CT 06405 USA; Univ Calif Berkeley, Berkeley, CA 94720 USA; Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA; Rothberg Inst Childhood Dis, Guilford, CT 06437 USA	University of California System; University of California Berkeley; Rockefeller University	Rothberg, JM (corresponding author), Life Sci Corp 454, 20 Commercial St, Branford, CT 06405 USA.	jrothberg@454.com	Bader, Joel/A-1818-2009; chen, qi/C-8585-2011	Bader, Joel/0000-0002-6020-4625; Tomasz, Alexander/0000-0003-1520-1983	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003562, P01HG003022] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG003562-02, P01 HG003022-020002] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BAINS W, 1988, J THEOR BIOL, V135, P303, DOI 10.1016/S0022-5193(88)80246-7; Dressman D, 2003, P NATL ACAD SCI USA, V100, P8817, DOI 10.1073/pnas.1133470100; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FAGIN B, 1993, COMPUT APPL BIOSCI, V9, P221; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Ghadessy FJ, 2001, P NATL ACAD SCI USA, V98, P4552, DOI 10.1073/pnas.071052198; JACOBSON KB, 1991, GENET ANAL-BIOMOL E, V8, P223, DOI 10.1016/1050-3862(91)90032-M; JETT JH, 1989, J BIOMOL STRUCT DYN, V7, P301, DOI 10.1080/07391102.1989.10507773; LANDER E S, 1988, Genomics, V2, P231; Leamon JH, 2003, ELECTROPHORESIS, V24, P3769, DOI 10.1002/elps.200305646; Mehta K, 1993, Biomed Sci Instrum, V29, P507; MOORE GE, 1965, ELECTRONICS, V38, P8; Myers E W, 1995, J Comput Biol, V2, P275, DOI 10.1089/cmb.1995.2.275; NYREN P, 1993, ANAL BIOCHEM, V208, P171, DOI 10.1006/abio.1993.1024; OGAWA T, 2005, INCREASED PRODUCTIVI; PROBER JM, 1987, SCIENCE, V238, P336, DOI 10.1126/science.2443975; Ronaghi M, 1996, ANAL BIOCHEM, V242, P84, DOI 10.1006/abio.1996.0432; Ronaghi M, 2001, GENOME RES, V11, P3, DOI 10.1101/gr.11.1.3; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Tawfik DS, 1998, NAT BIOTECHNOL, V16, P652, DOI 10.1038/nbt0798-652; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217	22	5460	6625	21	1005	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2005	437	7057					376	380		10.1038/nature03959	http://dx.doi.org/10.1038/nature03959			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964AS	16056220	Green Accepted, hybrid			2022-12-01	WOS:000231849100045
J	Matsumoto, T; Wu, JZ; Kanamori, H; Katayose, Y; Fujisawa, M; Namiki, N; Mizuno, H; Yamamoto, K; Antonio, BA; Baba, T; Sakata, K; Nagamura, Y; Aoki, H; Arikawa, K; Arita, K; Bito, T; Chiden, Y; Fujitsuka, N; Fukunaka, R; Hamada, M; Harada, C; Hayashi, A; Hijishita, S; Honda, M; Hosokawa, S; Ichikawa, Y; Idonuma, A; Iijima, M; Ikeda, M; Ikeno, M; Ito, K; Ito, S; Ito, T; Ito, Y; Ito, Y; Iwabuchi, A; Kamiya, K; Karasawa, W; Kurita, K; Katagiri, S; Kikuta, A; Kobayashi, H; Kobayashi, N; Machita, K; Maehara, T; Masukawa, M; Mizubayashi, T; Mukai, Y; Nagasaki, H; Nagata, Y; Naito, S; Nakashima, M; Nakama, Y; Nakamichi, Y; Nakamura, M; Meguro, A; Negishi, M; Ohta, I; Ohta, T; Okamoto, M; Ono, N; Saji, S; Sakaguchi, M; Sakai, K; Shibata, M; Shimokawa, T; Song, JY; Takazaki, Y; Terasawa, K; Tsugane, M; Tsuji, K; Ueda, S; Waki, K; Yamagata, H; Yamamoto, M; Yamamoto, S; Yamane, H; Yoshiki, S; Yoshihara, R; Yukawa, K; Zhong, HS; Yano, M; Sasaki, T; Yuan, QP; Shu, OT; Liu, J; Jones, KM; Gansberger, K; Moffat, K; Hill, J; Bera, J; Fadrosh, D; Jin, SH; Johri, S; Kim, M; Overton, L; Reardon, M; Tsitrin, T; Vuong, H; Weaver, B; Ciecko, A; Tallon, L; Jackson, J; Pai, G; Van Aken, S; Utterback, T; Reidmuller, S; Feldblyum, T; Hsiao, J; Zismann, V; Iobst, S; de Vazeille, AR; Buell, CR; Ying, K; Li, Y; Lu, TT; Huang, YC; Zhao, Q; Feng, Q; Zhang, L; Zhu, JJ; Weng, QJ; Mu, J; Lu, YQ; Fan, DL; Liu, YL; Guan, JP; Zhang, YJ; Yu, SL; Liu, XH; Zhang, Y; Hong, GF; Han, B; Choisne, N; Demange, N; Orjeda, G; Samain, S; Cattolico, L; Pelletier, E; Couloux, A; Segurens, B; Wincker, P; D'Hont, A; Scarpelli, C; Weissenbach, J; Salanoubat, M; Quetier, F; Yu, Y; Kim, HR; Rambo, T; Currie, J; Collura, K; Luo, MZ; Yang, TJ; Ammiraju, JSS; Engler, F; Soderlund, C; Wing, RA; Palmer, LE; de la Bastide, M; Spiegel, L; Nascimento, L; Zutavern, T; O'Shaughnessy, A; Dike, S; Dedhia, N; Preston, R; Balija, V; McCombie, WR; Chow, TY; Chen, HH; Chung, MC; Chen, CS; Shaw, JF; Wu, HP; Hsiao, KJ; Chao, YT; Chu, MK; Cheng, CH; Hour, AL; Lee, PF; Lin, SJ; Lin, YC; Liou, JY; Liu, SM; Hsing, YI; Raghuvanshi, S; Mohanty, A; Bharti, AK; Gaur, A; Gupta, V; Kumar, D; Ravi, V; Vij, S; Kapur, A; Khurana, P; Khurana, P; Khurana, JP; Tyagi, AK; Gaikwad, K; Singh, A; Dalal, V; Srivastava, S; Dixit, A; Pal, AK; Ghazi, IA; Yadav, M; Pandit, A; Bhargava, A; Sureshbabu, K; Batra, K; Sharma, TR; Mohapatra, T; Singh, NK; Messing, J; Nelson, AB; Fuks, G; Kavchok, S; Keizer, G; Llaca, ELV; Song, RT; Tanyolac, B; Young, S; Il, KH; Hahn, JH; Sangsakoo, G; Vanavichit, A; de Mattos, LAT; Zimmer, PD; Malone, G; Dellagostin, O; de Oliveira, AC; Bevan, M; Bancroft, I; Minx, P; Cordum, H; Wilson, R; Cheng, ZK; Jin, WW; Jiang, JM; Leong, SA; Iwama, H; Gojobori, T; Itoh, T; Niimura, Y; Fujii, Y; Habara, T; Sakai, H; Sato, Y; Wilson, G; Kumar, K; McCouch, S; Juretic, N; Hoen, D; Wright, S; Bruskiewich, R; Bureau, T; Miyao, A; Hirochika, H; Nishikawa, T; Kadowaki, K; Sugiura, M				Matsumoto, T; Wu, JZ; Kanamori, H; Katayose, Y; Fujisawa, M; Namiki, N; Mizuno, H; Yamamoto, K; Antonio, BA; Baba, T; Sakata, K; Nagamura, Y; Aoki, H; Arikawa, K; Arita, K; Bito, T; Chiden, Y; Fujitsuka, N; Fukunaka, R; Hamada, M; Harada, C; Hayashi, A; Hijishita, S; Honda, M; Hosokawa, S; Ichikawa, Y; Idonuma, A; Iijima, M; Ikeda, M; Ikeno, M; Ito, K; Ito, S; Ito, T; Ito, Y; Ito, Y; Iwabuchi, A; Kamiya, K; Karasawa, W; Kurita, K; Katagiri, S; Kikuta, A; Kobayashi, H; Kobayashi, N; Machita, K; Maehara, T; Masukawa, M; Mizubayashi, T; Mukai, Y; Nagasaki, H; Nagata, Y; Naito, S; Nakashima, M; Nakama, Y; Nakamichi, Y; Nakamura, M; Meguro, A; Negishi, M; Ohta, I; Ohta, T; Okamoto, M; Ono, N; Saji, S; Sakaguchi, M; Sakai, K; Shibata, M; Shimokawa, T; Song, JY; Takazaki, Y; Terasawa, K; Tsugane, M; Tsuji, K; Ueda, S; Waki, K; Yamagata, H; Yamamoto, M; Yamamoto, S; Yamane, H; Yoshiki, S; Yoshihara, R; Yukawa, K; Zhong, HS; Yano, M; Sasaki, T; Yuan, QP; Shu, OT; Liu, J; Jones, KM; Gansberger, K; Moffat, K; Hill, J; Bera, J; Fadrosh, D; Jin, SH; Johri, S; Kim, M; Overton, L; Reardon, M; Tsitrin, T; Vuong, H; Weaver, B; Ciecko, A; Tallon, L; Jackson, J; Pai, G; Van Aken, S; Utterback, T; Reidmuller, S; Feldblyum, T; Hsiao, J; Zismann, V; Iobst, S; de Vazeille, AR; Buell, CR; Ying, K; Li, Y; Lu, TT; Huang, YC; Zhao, Q; Feng, Q; Zhang, L; Zhu, JJ; Weng, QJ; Mu, J; Lu, YQ; Fan, DL; Liu, YL; Guan, JP; Zhang, YJ; Yu, SL; Liu, XH; Zhang, Y; Hong, GF; Han, B; Choisne, N; Demange, N; Orjeda, G; Samain, S; Cattolico, L; Pelletier, E; Couloux, A; Segurens, B; Wincker, P; D'Hont, A; Scarpelli, C; Weissenbach, J; Salanoubat, M; Quetier, F; Yu, Y; Kim, HR; Rambo, T; Currie, J; Collura, K; Luo, MZ; Yang, TJ; Ammiraju, JSS; Engler, F; Soderlund, C; Wing, RA; Palmer, LE; de la Bastide, M; Spiegel, L; Nascimento, L; Zutavern, T; O'Shaughnessy, A; Dike, S; Dedhia, N; Preston, R; Balija, V; McCombie, WR; Chow, TY; Chen, HH; Chung, MC; Chen, CS; Shaw, JF; Wu, HP; Hsiao, KJ; Chao, YT; Chu, MK; Cheng, CH; Hour, AL; Lee, PF; Lin, SJ; Lin, YC; Liou, JY; Liu, SM; Hsing, YI; Raghuvanshi, S; Mohanty, A; Bharti, AK; Gaur, A; Gupta, V; Kumar, D; Ravi, V; Vij, S; Kapur, A; Khurana, P; Khurana, P; Khurana, JP; Tyagi, AK; Gaikwad, K; Singh, A; Dalal, V; Srivastava, S; Dixit, A; Pal, AK; Ghazi, IA; Yadav, M; Pandit, A; Bhargava, A; Sureshbabu, K; Batra, K; Sharma, TR; Mohapatra, T; Singh, NK; Messing, J; Nelson, AB; Fuks, G; Kavchok, S; Keizer, G; Llaca, ELV; Song, RT; Tanyolac, B; Young, S; Il, KH; Hahn, JH; Sangsakoo, G; Vanavichit, A; de Mattos, LAT; Zimmer, PD; Malone, G; Dellagostin, O; de Oliveira, AC; Bevan, M; Bancroft, I; Minx, P; Cordum, H; Wilson, R; Cheng, ZK; Jin, WW; Jiang, JM; Leong, SA; Iwama, H; Gojobori, T; Itoh, T; Niimura, Y; Fujii, Y; Habara, T; Sakai, H; Sato, Y; Wilson, G; Kumar, K; McCouch, S; Juretic, N; Hoen, D; Wright, S; Bruskiewich, R; Bureau, T; Miyao, A; Hirochika, H; Nishikawa, T; Kadowaki, K; Sugiura, M		Int Rice Genome Sequencing Project	The map-based sequence of the rice genome	NATURE			English	Article							ORYZA-SATIVA L.; ARABIDOPSIS-THALIANA; TRANSPOSABLE ELEMENTS; DRAFT SEQUENCE; JAPONICA RICE; GENES; ANNOTATION; CENTROMERE; MICRORNAS; INDICA	Rice, one of the world's most important food plants, has important syntenic relationships with the other cereal species and is a model plant for the grasses. Here we present a map-based, finished quality sequence that covers 95% of the 389 Mb genome, including virtually all of the euchromatin and two complete centromeres. A total of 37,544 non-transposable-element-related protein-coding genes were identified, of which 71% had a putative homologue in Arabidopsis. In a reciprocal analysis, 90% of the Arabidopsis proteins had a putative homologue in the predicted rice proteome. Twenty-nine per cent of the 37,544 predicted genes appear in clustered gene families. The number and classes of transposable elements found in the rice genome are consistent with the expansion of syntenic regions in the maize and sorghum genomes. We find evidence for widespread and recurrent gene transfer from the organelles to the nuclear chromosomes. The map-based sequence has proven useful for the identification of genes underlying agronomic traits. The additional single-nucleotide polymorphisms and simple sequence repeats identified in our study should accelerate improvements in rice production.	Natl Inst Agrobiol Sci, Inst Soc Techno Innovat Agr Forestry & Fisheries, Tsukuba, Ibaraki 3058602, Japan; Inst Genome Res, Rockville, MD 20850 USA; Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai 200233, Peoples R China; Ctr Natl Sequencage, INRA URGV, CNRS UMR 8030, F-91057 Evry, France; UMR PIA, Cirad Amis, F-34398 Montpellier 05, France; Univ Arizona, Dept Plant Sci, BIO5 Inst, Tucson, AZ 85721 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11723 USA; Acad Sinica, Inst Bot, Taipei 11529, Taiwan; Natl Cheng Kung Univ, Tainan 701, Taiwan; Natl Yang Ming Univ, Taipei 112, Taiwan; Univ Delhi, Dept Plant Mol Biol, New Delhi 110021, India; Indian Agr Res Inst, Natl Res Ctr Plant Biotechnol, New Delhi 110012, India; Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA; Natl Inst Agr Sci & Technol, RDA, Suwon 441707, South Korea; Kasetsart Univ, Rice Gene Unit, Nakron Pathom 73140, Thailand; Univ Fed Pelotas, Ctr Genom & Fitomelhoramento, BR-96001970 Pelotas, RS, Brazil; John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England; Washington Univ, Genome Sequencing Ctr, St Louis, MO 63108 USA; Univ Wisconsin, Dept Hort, Madison, WI 53706 USA; Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA; Natl Inst Genet, Ctr Informat Biol, Mishima, Shizuoka 4118540, Japan; Natl Inst Genet, DNA Data Bank Japan, Mishima, Shizuoka 4118540, Japan; Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr, Koto Ku, Tokyo 1350064, Japan; Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan; Natl Inst Adv Ind Sci & Technol, Inst Med Res, Bunkyo Ku, Tokyo 1138510, Japan; Japan Biol informat Consortium, Japan Biol Informat Res Ctr, Koto Ku, Tokyo 1350064, Japan; Cornell Univ, Dept Plant Breeding, Ithaca, NY 14850 USA; McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada; Int Rice Res Inst, Biometr & Bioinformat Unit, Manila, Philippines; Nagoya City Univ, Grad Sch Nat Sci, Nagoya, Aichi 4678501, Japan; Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	National Institute of Agrobiological Sciences - Japan; J. Craig Venter Institute; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Universite Paris Saclay; CEA; CIRAD; University of Arizona; Cold Spring Harbor Laboratory; Academia Sinica - Taiwan; National Cheng Kung University; National Yang Ming Chiao Tung University; University of Delhi; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; ICAR - National Institute For Plant Biotechnology (NIPB); Rutgers State University New Brunswick; Rural Development Administration (RDA), Republic of Korea; Kasetsart University; Universidade Federal de Pelotas; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Washington University (WUSTL); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Agrobiological Sciences - Japan; National Institute of Advanced Industrial Science & Technology (AIST); Cornell University; McGill University; York University - Canada; CGIAR; International Rice Research Institute (IRRI); Nagoya City University; United States Department of Energy (DOE); Brookhaven National Laboratory	Sasaki, T (corresponding author), Natl Inst Agrobiol Sci, Inst Soc Techno Innovat Agr Forestry & Fisheries, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058602, Japan.	tsasaki@nias.affrc.go.jp	Wright, Stephen I/C-3113-2008; Leong, Sally A/I-8550-2012; Reardon, Michael/ABF-8880-2021; LIN, Yao-Cheng/B-4394-2008; Yang, Tae-Jin/AAT-5274-2020; Oliveira, Antonio/F-7508-2012; Wing, Rod A/Z-2885-2019; Singh, Nouratan/N-9377-2017; Jiang, Jiming/V-6060-2019; Wilson, Richard K./AAF-4139-2019; DHONT, Angélique/AAL-8074-2021; TYAGI, AKHILESH KUMAR/D-2649-2009; Ravi, Vydianathan/B-2759-2009; Iobst, Stacey/AAJ-9564-2020; Tanyolac, Bahattin/AAD-3762-2019; Song, Rentao/A-6544-2012; Bancroft, Ian/AAH-3831-2020; Yano, Masahiro/AAC-5441-2019; Miyao, Akio/V-7306-2019; Dellagostin, Odir/C-2331-2009; Oliveira, Antonio/K-5923-2019; Jiang, Jiming/A-9614-2009; Song, Rentao/AAG-9107-2021; Quetier, Francis/J-7923-2017; Waki, Kazunori/T-6444-2019	Wright, Stephen I/0000-0001-9973-9697; LIN, Yao-Cheng/0000-0002-9390-795X; Oliveira, Antonio/0000-0001-8835-8071; Wing, Rod A/0000-0001-6633-6226; Singh, Nouratan/0000-0002-8063-8375; Jiang, Jiming/0000-0002-6435-6140; Wilson, Richard K./0000-0002-1992-1358; Ravi, Vydianathan/0000-0003-0807-7697; Song, Rentao/0000-0003-1810-9875; Miyao, Akio/0000-0002-2822-2866; Dellagostin, Odir/0000-0003-2803-4088; Oliveira, Antonio/0000-0001-8835-8071; Jiang, Jiming/0000-0002-6435-6140; Song, Rentao/0000-0003-1810-9875; Tsugane, Mika/0000-0002-7991-5224; Quetier, Francis/0000-0003-4388-9287; Yuan, Qiaoping/0000-0002-5880-8702; Gupta, Vikrant/0000-0002-3479-8749; Buell, C Robin/0000-0002-6727-4677; Wu, Jianzhong/0000-0002-4033-852X; Chao, Ya-Ting/0000-0002-4917-2183; Messing, Joachim/0000-0001-8260-2643; Waki, Kazunori/0000-0001-7311-7208; Iobst, Stacey E./0000-0002-6954-2903; Itoh, Takeshi/0000-0002-6291-4233; Orjeda, Gisella/0000-0003-3013-5523; Cheng, Chia-Hsiung/0000-0003-0307-9650				Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Barry GF, 2001, PLANT PHYSIOL, V125, P1164, DOI 10.1104/pp.125.3.1164; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Castelli V, 2004, GENOME RES, V14, P406, DOI 10.1101/gr.1515604; CAUSSE MA, 1994, GENETICS, V138, P1251; Chen MS, 2002, PLANT CELL, V14, P537, DOI 10.1105/tpc.010485; Cheng ZK, 2002, PLANT CELL, V14, P1691, DOI 10.1105/tpc.003079; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P2369, DOI 10.1093/nar/27.11.2369; Dong FG, 1998, P NATL ACAD SCI USA, V95, P8135, DOI 10.1073/pnas.95.14.8135; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Feltus FA, 2004, GENOME RES, V14, P1812, DOI 10.1101/gr.2479404; Feng Q, 2002, NATURE, V420, P316, DOI 10.1038/nature01183; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Guyot R, 2004, GENOME, V47, P610, DOI 10.1139/G04-016; Harushima Y, 1998, GENETICS, V148, P479; Hirochika H, 1996, P NATL ACAD SCI USA, V93, P7783, DOI 10.1073/pnas.93.15.7783; Juretic N, 2004, BIOINFORMATICS, V20, P155, DOI 10.1093/bioinformatics/bth019; KAMISUGI Y, 1994, MOL GEN GENET, V245, P133, DOI 10.1007/BF00283259; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kikuchi S, 2003, SCIENCE, V301, P376, DOI 10.1126/science.1081288; Lai JS, 2004, GENOME RES, V14, P1924, DOI 10.1101/gr.2701104; Mao L, 2000, GENOME RES, V10, P982, DOI 10.1101/gr.10.7.982; McCouch SR, 2002, DNA RES, V9, P257, DOI 10.1093/dnares/9.6.257; Messing J, 2004, P NATL ACAD SCI USA, V101, P14349, DOI 10.1073/pnas.0406163101; Miyao A, 2003, PLANT CELL, V15, P1771, DOI 10.1105/tpc.012559; MOORE G, 1995, CURR BIOL, V5, P737, DOI 10.1016/S0960-9822(95)00148-5; Nagaki K, 2004, NAT GENET, V36, P138, DOI 10.1038/ng1289; Ohmido N, 2000, MOL GEN GENET, V263, P388, DOI 10.1007/s004380051182; OONO K, 1980, CHROMOSOMA, V76, P85, DOI 10.1007/BF00292228; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Peng S, 1999, CROP SCI, V39, P1552, DOI 10.2135/cropsci1999.3961552x; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; Saji S, 2001, GENOME, V44, P32, DOI 10.1139/gen-44-1-32; Salse J, 2004, PLANT J, V38, P396, DOI 10.1111/j.1365-313X.2004.02058.x; Sasaki T, 2000, CURR OPIN PLANT BIOL, V3, P138, DOI 10.1016/S1369-5266(99)00047-3; Sasaki T, 2002, NATURE, V420, P312, DOI 10.1038/nature01184; Shen YJ, 2004, PLANT PHYSIOL, V135, P1198, DOI 10.1104/pp.103.038463; Shishido R, 2000, MOL GEN GENET, V263, P586, DOI 10.1007/s004380051205; Simillion C, 2004, GENOME RES, V14, P1095, DOI 10.1101/gr.2179004; Song R, 2002, GENOME RES, V12, P1549, DOI 10.1101/gr.268302; Turcotte K, 2001, PLANT J, V25, P169, DOI 10.1046/j.1365-313x.2001.00945.x; Wang JF, 2004, NUCLEIC ACIDS RES, V32, P1688, DOI 10.1093/nar/gkh332; Wang XJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r65; Wu JZ, 2004, PLANT CELL, V16, P967, DOI 10.1105/tpc.019273; Wu JZ, 2002, PLANT CELL, V14, P525, DOI 10.1105/tpc.010274; Yamamoto K, 1997, PLANT MOL BIOL, V35, P135, DOI 10.1023/A:1005735322577; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Yu YS, 2003, SCIENCE, V300, P1566, DOI 10.1126/science.1083523; Zhang Y, 2004, NUCLEIC ACIDS RES, V32, P2023, DOI 10.1093/nar/gkh521	50	2638	6711	33	661	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2005	436	7052					793	800		10.1038/nature03895	http://dx.doi.org/10.1038/nature03895			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953XG	16100779	Bronze			2022-12-01	WOS:000231116500034
J	Phillips, LR; Milescu, M; Li-Smerin, YY; Mindell, JA; Kim, JI; Swartz, KJ				Phillips, LR; Milescu, M; Li-Smerin, YY; Mindell, JA; Kim, JI; Swartz, KJ			Voltage-sensor activation with a tarantula toxin as cargo	NATURE			English	Article							DEPENDENT K+ CHANNEL; POTASSIUM CHANNELS; GATING MODIFIER; SCORPION TOXIN; MOLECULAR DETERMINANTS; CHARGE MOVEMENT; SODIUM-CHANNELS; BINDING; HANATOXIN; FLUORESCENCE	The opening and closing of voltage-activated Na+, Ca2+ and K+ (Kv) channels underlies electrical and chemical signalling throughout biology, yet the structural basis of voltage sensing is unknown. Hanatoxin is a tarantula toxin that inhibits Kv channels by binding to voltage-sensor paddles(1-5), crucial helix-turn-helix motifs within the voltage-sensing domains that are composed of S3b and S4 helices(6). The active surface of the toxin is amphipathic(7,8), and related toxins have been shown to partition into membranes(9-12), raising the possibility that the toxin is concentrated in the membrane and interacts only weakly and transiently with the voltage sensors. Here we examine the kinetics and state dependence of the toxin - channel interaction and the physical location of the toxin in the membrane. We find that hanatoxin forms a strong and stable complex with the voltage sensors, far outlasting fluctuations of the voltage sensors between resting ( closed) conformations at negative voltages and activated ( open) conformations at positive voltages. Toxin affinity is reduced by voltage-sensor activation, explaining why the toxin stabilizes the resting conformation. We also find that when hanatoxin partitions into membranes it is localized to an interfacial region, with Trp 30 positioned about 8.5 angstrom from the centre of the bilayer. These results demonstrate that voltage-sensor paddles activate with a toxin as cargo, and suggest that the paddles traverse no more than the outer half of the bilayer during activation.	Natl Inst Neurol Disorders & Stroke, Mol Physiol & Biophys Sect, NIH, Bethesda, MD 20892 USA; Natl Inst Neurol Disorders & Stroke, Membrane Transport Biophys Unit, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA; Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju 500712, South Korea	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Gwangju Institute of Science & Technology (GIST)	Swartz, KJ (corresponding author), Natl Inst Neurol Disorders & Stroke, Mol Physiol & Biophys Sect, NIH, 35 Convent Dr,MSC 3701, Bethesda, MD 20892 USA.	swartzk@ninds.nih.gov	Mindell, Joseph/P-4461-2017	Mindell, Joseph/0000-0002-6952-8247	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002945] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA NS002945-13] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		ABRAMS FS, 1992, BIOCHEMISTRY-US, V31, P5312, DOI 10.1021/bi00138a010; Ahern CA, 2004, J GEN PHYSIOL, V123, P205, DOI 10.1085/jgp.200308993; CATTERALL WA, 1979, J GEN PHYSIOL, V74, P375, DOI 10.1085/jgp.74.3.375; CATTERALL WA, 1977, J BIOL CHEM, V252, P8660; Cuello LG, 2004, SCIENCE, V306, P491, DOI 10.1126/science.1101373; Islas LD, 2001, J GEN PHYSIOL, V117, P69, DOI 10.1085/jgp.117.1.69; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jung HJ, 2005, BIOCHEMISTRY-US, V44, P6015, DOI 10.1021/bi0477034; Ladokhin AS, 2000, ANAL BIOCHEM, V285, P235, DOI 10.1006/abio.2000.4773; Ladokhin AS, 1999, BIOPHYS J, V76, P946, DOI 10.1016/S0006-3495(99)77258-9; Ladokhin AS, 1999, ANAL BIOCHEM, V276, P65, DOI 10.1006/abio.1999.4343; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Lee HC, 2003, NEURON, V40, P527, DOI 10.1016/S0896-6273(03)00636-6; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Li-Smerin Y, 2001, J GEN PHYSIOL, V117, P205, DOI 10.1085/jgp.117.3.205; Li-Smerin Y, 2000, J GEN PHYSIOL, V115, P673, DOI 10.1085/jgp.115.6.673; McDonough SI, 1997, MOL PHARMACOL, V52, P1095, DOI 10.1124/mol.52.6.1095; MCINTOSH TJ, 1987, BIOCHEMISTRY-US, V26, P1783, DOI 10.1021/bi00380a042; Rogers JC, 1996, J BIOL CHEM, V271, P15950, DOI 10.1074/jbc.271.27.15950; Smith JJ, 2005, J BIOL CHEM, V280, P11127, DOI 10.1074/jbc.M412552200; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Suchyna TM, 2004, NATURE, V430, P235, DOI 10.1038/nature02743; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; Swartz KJ, 2004, NAT REV NEUROSCI, V5, P905, DOI 10.1038/nrn1559; SWARTZ KJ, 1995, NEURON, V15, P941, DOI 10.1016/0896-6273(95)90184-1; Swartz KJ, 1997, NEURON, V18, P665, DOI 10.1016/S0896-6273(00)80306-2; Takahashi H, 2000, J MOL BIOL, V297, P771, DOI 10.1006/jmbi.2000.3609; Wang JM, 2004, J GEN PHYSIOL, V123, P455, DOI 10.1085/jgp.200309005; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8	30	160	166	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2005	436	7052					857	860		10.1038/nature03873	http://dx.doi.org/10.1038/nature03873			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953XG	16094370				2022-12-01	WOS:000231116500048
J	Campisi, J				Campisi, J			Cancer - Suppressing cancer: The importance of being senescent	SCIENCE			English	Editorial Material							FIBROBLASTS; GROWTH; CELLS		Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; Buck Inst Age Res, Novato, CA 94945 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Buck Institute for Research on Aging	Campisi, J (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, 1 Cyclotron Rd, Berkeley, CA 94720 USA.	jcampisi@lbl.gov						Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Chang BD, 2002, P NATL ACAD SCI USA, V99, P389, DOI 10.1073/pnas.012602599; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890	8	197	214	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 5	2005	309	5736					886	887		10.1126/science.1116801	http://dx.doi.org/10.1126/science.1116801			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953SS	16081723				2022-12-01	WOS:000231101400030
J	Chendrimada, TP; Gregory, RI; Kumaraswamy, E; Norman, J; Cooch, N; Nishikura, K; Shiekhattar, R				Chendrimada, TP; Gregory, RI; Kumaraswamy, E; Norman, J; Cooch, N; Nishikura, K; Shiekhattar, R			TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing	NATURE			English	Article							RNA-BINDING-PROTEIN; MICROPROCESSOR COMPLEX; C-ELEGANS; INTERFERENCE; INITIATION; ARGONAUTE2; CELLS	MicroRNAs ( miRNAs) are generated by a two-step processing pathway to yield RNA molecules of approximately 22 nucleotides that negatively regulate target gene expression at the post-transcriptional level(1). Primary miRNAs are processed to precursor miRNAs (pre-miRNAs) by the Microprocessor complex(2-4). These pre-miRNAs are cleaved by the RNase III Dicer(5-8) to generate mature miRNAs that direct the RNA-induced silencing complex ( RISC) to messenger RNAs with complementary sequence(9). Here we show that TRBP ( the human immunodeficiency virus transactivating response RNA-binding protein(10)), which contains three double-stranded, RNA-binding domains, is an integral component of a Dicer-containing complex. Biochemical analysis of TRBP-containing complexes revealed the association of Dicer - TRBP with Argonaute 2 (Ago2)(11,12), the catalytic engine of RISC. The physical association of Dicer - TRBP and Ago2 was confirmed after the isolation of the ternary complex using Flag-tagged Ago2 cell lines. In vitro reconstitution assays demonstrated that TRBP is required for the recruitment of Ago2 to the small interfering RNA ( siRNA) bound by Dicer. Knockdown of TRBP results in destabilization of Dicer and a consequent loss of miRNA biogenesis. Finally, depletion of the Dicer - TRBP complex via exogenously introduced siRNAs diminished RISC-mediated reporter gene silencing. These results support a role of the Dicer - TRBP complex not only in miRNA processing but also as a platform for RISC assembly.	Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	The Wistar Institute	Shiekhattar, R (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	shiekhattar@wistar.org	Chan, Edward K. L./B-5671-2009	Chan, Edward K. L./0000-0003-3938-9503	NATIONAL CANCER INSTITUTE [P01CA072765] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040536] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA072765-050002, P01 CA072765] Funding Source: Medline; NHLBI NIH HHS [R01 HL070045-03, R01 HL070045] Funding Source: Medline; NIGMS NIH HHS [R01 GM040536-15, R01 GM040536] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Doi N, 2003, CURR BIOL, V13, P41, DOI 10.1016/S0960-9822(02)01394-5; GATIGNOL A, 1991, SCIENCE, V251, P1597, DOI 10.1126/science.2011739; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Sontheimer EJ, 2005, NAT REV MOL CELL BIO, V6, P127, DOI 10.1038/nrm1568; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zhong J, 1999, NAT GENET, V22, P171, DOI 10.1038/9684	19	1456	1555	2	172	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2005	436	7051					740	744		10.1038/nature03868	http://dx.doi.org/10.1038/nature03868			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951XA	15973356	Green Accepted			2022-12-01	WOS:000230964500052
J	Gulati, M; Black, HR; Shaw, LJ; Arnsdorf, MF; Merz, CNB; Lauer, MS; Marwick, TH; Pandey, DK; Wicklund, RH; Thisted, RA				Gulati, M; Black, HR; Shaw, LJ; Arnsdorf, MF; Merz, CNB; Lauer, MS; Marwick, TH; Pandey, DK; Wicklund, RH; Thisted, RA			The prognostic value of a nomogram for exercise capacity in women	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PREDICTING FUNCTIONAL-CAPACITY; CORONARY-ARTERY-DISEASE; MAXIMAL OXYGEN INTAKE; METABOLIC EQUIVALENTS; PHYSICAL-FITNESS; HEALTHY-MEN; FOLLOW-UP; MORTALITY; DEATH; AGE	BACKGROUND: Recent studies have demonstrated that exercise capacity is an independent predictor of mortality in women. Normative values of exercise capacity for age in women have not been well established. Our objectives were to construct a nomogram to permit determination of predicted exercise capacity for age in women and to assess the predictive value of the nomogram with respect to survival. METHODS: A total of 5721 asymptomatic women underwent a symptom-limited, maximal stress test. Exercise capacity was measured in metabolic equivalents (MET). Linear regression was used to estimate the mean MET achieved for age. A nomogram was established to allow the percentage of predicted exercise capacity to be estimated on the basis of age and the exercise capacity achieved. The nomogram was then used to determine the percentage of predicted exercise capacity for both the original cohort and a referral population of 4471 women with cardiovascular symptoms who underwent a symptom-limited stress test. Survival data were obtained for both cohorts, and Cox survival analysis was used to estimate the rates of death from any cause and from cardiac causes in each group. RESULTS: The linear regression equation for predicted exercise capacity (in MET) on the basis of age in the cohort of asymptomatic women was as follows: predicted MET = 14.7 - (0.13 x age). The risk of death among asymptomatic women whose exercise capacity was less than 85 percent of the predicted value for age was twice that among women whose exercise capacity was at least 85 percent of the age-predicted value (P<0.001). Results were similar in the cohort of symptomatic women. CONCLUSIONS: We have established a nomogram for predicted exercise capacity on the basis of age that is predictive of survival among both asymptomatic and symptomatic women. These findings could be incorporated into the interpretation of exercise stress tests, providing additional prognostic information for risk stratification.	Rush Univ, Med Ctr, Dept Prevent Med, Chicago, IL 60612 USA; Cedars Sinai Med Ctr, Cedars Sinai Res Inst, Dept Med, Div Cardiol, Los Angeles, CA 90048 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; Cleveland Clin Fdn, Dept Cardiol, Cleveland, OH 44195 USA; Princess Alexandra Hosp, Dept Med, Brisbane, Qld 4102, Australia; Univ Illinois, Dept Neurol, Chicago, IL USA; St James Hosp & Hlth Ctr, Div Cardiol, Chicago, IL USA	Rush University; Cedars Sinai Medical Center; University of Chicago; University of Chicago; Cleveland Clinic Foundation; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Gulati, M (corresponding author), Northwestern Univ, Bluhm Cardiovasc Inst, 201 E Huron St, Chicago, IL 60611 USA.	mgulati@nmff.org	Gulati, Martha/AAB-7722-2022; Thisted, Ronald A/B-1985-2008; Marwick, Thomas H/C-7261-2013; Lauer, Michael S/L-9656-2013	Marwick, Thomas H/0000-0001-9065-0899; Lauer, Michael S/0000-0002-9217-8177; Pandey, Dilip/0000-0001-7242-3182				BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; BRUCE RA, 1971, ANN CLIN RES, V3, P323; BRUCE RA, 1973, AM HEART J, V85, P546, DOI 10.1016/0002-8703(73)90502-4; DEHN MM, 1972, J APPL PHYSIOL, V33, P805, DOI 10.1152/jappl.1972.33.6.805; EKELUND LG, 1988, NEW ENGL J MED, V319, P1379, DOI 10.1056/NEJM198811243192104; FOSTER C, 1984, AM HEART J, V107, P1229, DOI 10.1016/0002-8703(84)90282-5; FROELICHER VF, 1974, AEROSPACE MED, V45, P310; Gulati M, 2003, CIRCULATION, V108, P1554, DOI 10.1161/01.CIR.0000091080.57509.E9; JETTE M, 1990, CLIN CARDIOL, V13, P555, DOI 10.1002/clc.4960130809; Marwick TH, 2001, CIRCULATION, V103, P2566; Marwick TH, 1999, AM J MED, V106, P172, DOI 10.1016/S0002-9343(98)00388-X; Mora S, 2003, JAMA-J AM MED ASSOC, V290, P1600, DOI 10.1001/jama.290.12.1600; MORRIS CK, 1993, J AM COLL CARDIOL, V22, P175, DOI 10.1016/0735-1097(93)90832-L; MYERS J, 1991, J AM COLL CARDIOL, V17, P1334, DOI 10.1016/S0735-1097(10)80144-5; ROBERTS JM, 1984, AM HEART J, V108, P1454, DOI 10.1016/0002-8703(84)90692-6; Shaw LJ, 2005, J AM COLL CARDIOL, V45, P1494, DOI 10.1016/j.jacc.2005.01.036; SULLIVAN M, 1984, AM HEART J, V107, P486, DOI 10.1016/0002-8703(84)90090-5; Wei M, 1999, JAMA-J AM MED ASSOC, V282, P1547, DOI 10.1001/jama.282.16.1547; WOLTHUIS RA, 1977, CIRCULATION, V55, P153, DOI 10.1161/01.CIR.55.1.153	19	285	290	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 4	2005	353	5					468	475		10.1056/NEJMoa044154	http://dx.doi.org/10.1056/NEJMoa044154			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951OB	16079370				2022-12-01	WOS:000230939000006
J	Bostwick, KS; Prum, RO				Bostwick, KS; Prum, RO			Courting bird sings with stridulating wing feathers	SCIENCE			English	Article							PIPRIDAE; AVES		Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14850 USA; Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; Yale Univ, Peabody Museum Nat Hist, New Haven, CT 06520 USA	Cornell University; Yale University; Yale University	Bostwick, KS (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14850 USA.	ksb6@cornell.edu		Prum, Richard/0000-0002-4741-7132				Bennet-Clark H.C., 1989, P227; Bostwick KS, 2000, AUK, V117, P465, DOI 10.1642/0004-8038(2000)117[0465:DBMSAE]2.0.CO;2; Bostwick KS, 2003, J EXP BIOL, V206, P3693, DOI 10.1242/jeb.00598; Darwin C., 1871, P423; Fletcher N. H., 1992, ACOUSTIC SYSTEMS BIO; Prum RO, 1998, ANIM BEHAV, V55, P977, DOI 10.1006/anbe.1997.0647	6	53	53	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 29	2005	309	5735					736	736		10.1126/science.1111701	http://dx.doi.org/10.1126/science.1111701			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951NU	16051789				2022-12-01	WOS:000230938200039
J	Huseby, ES; White, J; Crawford, F; Vass, T; Becker, D; Pinilla, C; Marrack, P; Kappler, JW				Huseby, ES; White, J; Crawford, F; Vass, T; Becker, D; Pinilla, C; Marrack, P; Kappler, JW			How the T cell repertoire becomes peptide and MHC specific	CELL			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; NEGATIVE SELECTION; POSITIVE SELECTION; CRYSTAL-STRUCTURES; THYMIC SELECTION; TRANSGENIC MICE; ANTIGEN; TOLERANCE; RECEPTOR; RESTRICTION	T cells bearing up T cell receptors (TCRs) recognize antigens in the form of peptides bound to class I or class II major histocompatibility proteins (MHC). TCRs on mature T cells are usually very specific for both peptide and MHC class and allele. They are picked out from a precursor population in the thymus by MHC-driven positive and negative selection. Here we show that the pool of T cells initially positively selected in the thymus contains many T cells that are very crossreactive for peptide and MHC and that subsequent negative selection establishes the MHC-restriction and peptide specificity of peripheral T cells. Our results also suggest that germline-encoded TCR variable elements have an inherent predisposition to react with features shared by all MHC proteins.	Natl Jewish Med & Res Ctr, Howard Hughes Med Inst, Denver, CO 80206 USA; Natl Jewish Med & Res Ctr, Integrated Dept Immunol, Denver, CO 80206 USA; Torrey Pines Inst Mol Studies, San Diego, CA 92121 USA; Univ Colorado, Ctr Hlth Sci, Dept Biochem & Mol Genet, Denver, CO 80206 USA; Univ Colorado, Ctr Hlth Sci, Dept Med, Denver, CO 80206 USA; Univ Colorado, Ctr Hlth Sci, Dept Pharmacol, Denver, CO 80206 USA	Howard Hughes Medical Institute; National Jewish Health; National Jewish Health; Torrey Pines Institute for Molecular Studies, California; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Marrack, P (corresponding author), Natl Jewish Med & Res Ctr, Howard Hughes Med Inst, Denver, CO 80206 USA.	marrackp@njc.org	Marrack, Philippa/AHE-6316-2022	Marrack, Philippa/0000-0003-1883-3687	NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI017134, R56AI017134, R37AI018785, R37AI017134, R01AI018785, R01AI052225, P01AI022295] Funding Source: NIH RePORTER; NCI NIH HHS [CA-046934] Funding Source: Medline; NIAID NIH HHS [AI-18785, AI-22295, AI-52225, AI-17134] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BERG LJ, 1989, CELL, V58, P1035, DOI 10.1016/0092-8674(89)90502-3; BEVAN MJ, 1977, NATURE, V269, P417, DOI 10.1038/269417a0; BLACKMAN M, 1986, CELL, V47, P349, DOI 10.1016/0092-8674(86)90591-X; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Crawford F, 2004, PLOS BIOL, V2, P523, DOI 10.1371/journal.pbio.0020090; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Housset D, 2003, TRENDS IMMUNOL, V24, P429, DOI 10.1016/S1471-4906(03)00180-7; Huseby ES, 2003, P NATL ACAD SCI USA, V100, P11565, DOI 10.1073/pnas.1934636100; Huseby ES, 2001, J EXP MED, V194, P669, DOI 10.1084/jem.194.5.669; Huseby ES, 2001, IMMUNITY, V14, P471, DOI 10.1016/S1074-7613(01)00127-3; Ignatowicz L, 1996, CELL, V84, P521, DOI 10.1016/S0092-8674(00)81028-4; JERNE N K, 1971, European Journal of Immunology, V1, P1, DOI 10.1002/eji.1830010102; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KATZ DH, 1975, J EXP MED, V141, P263, DOI 10.1084/jem.141.1.263; KIRBERG J, 1994, J EXP MED, V180, P25, DOI 10.1084/jem.180.1.25; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Krogsgaard M, 2005, NAT IMMUNOL, V6, P239, DOI 10.1038/ni1173; Liu XQ, 2002, P NATL ACAD SCI USA, V99, P8820, DOI 10.1073/pnas.132272099; MACDONALD HR, 1988, NATURE, V336, P471, DOI 10.1038/336471a0; Mathis D, 2004, IMMUNITY, V20, P509, DOI 10.1016/S1074-7613(04)00111-6; MATZINGER P, 1993, IMMUNOL REV, V135, P81, DOI 10.1111/j.1600-065X.1993.tb00645.x; Merkenschlager M, 1997, J EXP MED, V186, P1149, DOI 10.1084/jem.186.7.1149; PINILLA C, 1992, BIOTECHNIQUES, V13, P901; Robinson J, 2003, NUCLEIC ACIDS RES, V31, P311, DOI 10.1093/nar/GKG070; SCHILHAM MW, 1986, J IMMUNOL, V137, P2748; SCOTT B, 1989, NATURE, V338, P591, DOI 10.1038/338591a0; Sim BC, 1996, SCIENCE, V273, P963, DOI 10.1126/science.273.5277.963; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.iy.07.040189.003125; UNANUE ER, 1984, ANNU REV IMMUNOL, V2, P395, DOI 10.1146/annurev.iy.02.040184.002143; von Boehmer H, 2003, IMMUNOL REV, V191, P62, DOI 10.1034/j.1600-065X.2003.00010.x; Wise M, 1999, EUR J IMMUNOL, V29, P156, DOI 10.1002/(SICI)1521-4141(199901)29:01<156::AID-IMMU156>3.0.CO;2-K; Zerrahn J, 1997, CELL, V88, P627, DOI 10.1016/S0092-8674(00)81905-4; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	38	232	238	3	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 29	2005	122	2					247	260		10.1016/j.cell.2005.05.013	http://dx.doi.org/10.1016/j.cell.2005.05.013			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	951CR	16051149	Bronze			2022-12-01	WOS:000230907000012
J	Chiou, PY; Ohta, AT; Wu, MC				Chiou, PY; Ohta, AT; Wu, MC			Massively parallel manipulation of single cells and microparticles using optical images	NATURE			English	Article							TRAVELING-WAVE DIELECTROPHORESIS; SEPARATION; BACTERIA; BEAMS; CHIP	The ability to manipulate biological cells and micrometre-scale particles plays an important role in many biological and colloidal science applications. However, conventional manipulation techniques - including optical tweezers(1-6), electrokinetic forces (electrophoresis(7,8), dielectrophoresis(9), travelling-wave dielectrophoresis(10,11)), magnetic tweezers(12,13), acoustic traps(14) and hydrodynamic flows(15-17) - cannot achieve high resolution and high throughput at the same time. Optical tweezers offer high resolution for trapping single particles, but have a limited manipulation area owing to tight focusing requirements; on the other hand, electrokinetic forces and other mechanisms provide high throughput, but lack the flexibility or the spatial resolution necessary for controlling individual cells. Here we present an optical image-driven dielectrophoresis technique that permits high-resolution patterning of electric fields on a photoconductive surface for manipulating single particles. It requires 100,000 times less optical intensity than optical tweezers. Using an incoherent light source ( a light-emitting diode or a halogen lamp) and a digital micromirror spatial light modulator, we have demonstrated parallel manipulation of 15,000 particle traps on a 1.3 x 1.0 mm(2) area. With direct optical imaging control, multiple manipulation functions are combined to achieve complex, multi-step manipulation protocols.	Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Berkeley Sensor & Actuator Ctr, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Wu, MC (corresponding author), Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA.	wu@eecs.berkeley.edu	Chiou, Pei-Yu/D-5496-2011; Wu, Ming C/J-9906-2012	Wu, Ming C/0000-0003-4808-6686; Ohta, Aaron/0000-0003-3789-897X				ASHKIN A, 1987, NATURE, V330, P769, DOI 10.1038/330769a0; BECKER FF, 1995, P NATL ACAD SCI USA, V92, P860, DOI 10.1073/pnas.92.3.860; Cabrera CR, 2001, ELECTROPHORESIS, V22, P355, DOI 10.1002/1522-2683(200101)22:2<355::AID-ELPS355>3.0.CO;2-C; Curtis JE, 2002, OPT COMMUN, V207, P169, DOI 10.1016/S0030-4018(02)01524-9; Garces-Chavez V, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1843283; Gascoyne P, 2002, LAB CHIP, V2, P70, DOI [10.1039/b110990c, 10.1039/b110090c]; Grier DG, 2003, NATURE, V424, P810, DOI 10.1038/nature01935; Hayward RC, 2000, NATURE, V404, P56, DOI 10.1038/35003530; HERTZ HM, 1995, J APPL PHYS, V78, P4845, DOI 10.1063/1.359770; Hughes MP, 2002, ELECTROPHORESIS, V23, P2569, DOI 10.1002/1522-2683(200208)23:16<2569::AID-ELPS2569>3.0.CO;2-M; KESSLER JO, 1985, NATURE, V313, P218, DOI 10.1038/313218a0; Kremser L, 2004, ELECTROPHORESIS, V25, P2282, DOI 10.1002/elps.200305868; Krupke R, 2003, SCIENCE, V301, P344, DOI 10.1126/science.1086534; Lee GB, 2001, J MICROMECH MICROENG, V11, P654, DOI 10.1088/0960-1317/11/6/306; Lee H, 2004, APPL PHYS LETT, V85, P1063, DOI 10.1063/1.1776339; MacDonald MP, 2003, NATURE, V426, P421, DOI 10.1038/nature02144; Manaresi N, 2003, IEEE J SOLID-ST CIRC, V38, P2297, DOI 10.1109/JSSC.2003.819171; McGloin D, 2003, OPT COMMUN, V225, P215, DOI 10.1016/j.optcom.2003.07.032; Morgan H, 1997, J MICROMECH MICROENG, V7, P65, DOI 10.1088/0960-1317/7/2/004; Ozkan M, 2002, SENSOR MATER, V14, P189; PAI DM, 1993, REV MOD PHYS, V65, P163, DOI 10.1103/RevModPhys.65.163; Pethig R, 2003, IEEE ENG MED BIOL, V22, P43, DOI 10.1109/MEMB.2003.1266046; SCHWARZ R, 1993, APPL PHYS LETT, V63, P1083, DOI 10.1063/1.109840; Sundararajan N, 2004, J MICROELECTROMECH S, V13, P559, DOI 10.1109/JMEMS.2004.832196; Yan J, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.011905; Yang J, 2000, BIOPHYS J, V78, P2680, DOI 10.1016/S0006-3495(00)76812-3	26	1056	1152	19	575	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2005	436	7049					370	372		10.1038/nature03831	http://dx.doi.org/10.1038/nature03831			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	16034413				2022-12-01	WOS:000230623400037
J	Kinet, JP				Kinet, JP			A new strategy to counter allergy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RECEPTOR		Harvard Univ, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Kinet, JP (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.							Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Rivera J, 2002, CURR OPIN IMMUNOL, V14, P688, DOI 10.1016/S0952-7915(02)00396-5; SHU D, 2005, NAT MED, V11, P446; Siraganian RP, 2003, CURR OPIN IMMUNOL, V15, P639, DOI 10.1016/j.coi.2003.09.010	5	7	8	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2005	353	3					310	312		10.1056/NEJMcibr051440	http://dx.doi.org/10.1056/NEJMcibr051440			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946YH	16034020				2022-12-01	WOS:000230608700016
J	Makinoshima, H; Glickman, MS				Makinoshima, H; Glickman, MS			Regulation of Mycobacterium tuberculosis cell envelope composition and virulence by intramembrane proteolysis	NATURE			English	Article							STRESS-RESPONSE; BOVIS BCG; BIOSYNTHESIS; CLEAVAGE; MICE; IDENTIFICATION; SURVIVAL; PATHWAY; RSEA	Mycobacterium tuberculosis infection is a continuing global health crisis that kills 2 million people each year(1). Although the structurally diverse lipids of the M. tuberculosis cell envelope each have non-redundant roles in virulence or persistence(2-7), the molecular mechanisms regulating cell envelope composition in M. tuberculosis are undefined. In higher eukaryotes, membrane composition is controlled by site two protease (S2P)-mediated cleavage of sterol regulatory element binding proteins(8,9), membrane-bound transcription factors that control lipid biosynthesis. S2P is the founding member of a widely distributed family of membrane metalloproteases(10,11) that cleave substrate proteins within transmembrane segments(12). Here we show that a previously uncharacterized M. tuberculosis S2P homologue (Rv2869c) regulates M. tuberculosis cell envelope composition, growth in vivo and persistence in vivo. These results establish that regulated intramembrane proteolysis is a conserved mechanism controlling membrane composition in prokaryotes and show that this proteolysis is a proximal regulator of cell envelope virulence determinants in M. tuberculosis.	Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Immunol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Div Infect Dis, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Glickman, MS (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Immunol, 1275 York Ave, New York, NY 10021 USA.	glickmam@mskcc.org		Glickman, Michael S/0000-0001-7918-5164	NIAID NIH HHS [R01 AI053417, R01 AI080619] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053417, R01AI080619] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alba BM, 2002, GENE DEV, V16, P2156, DOI 10.1101/gad.1008902; Altincicek B, 2001, J BACTERIOL, V183, P2411, DOI 10.1128/JB.183.8.2411-2416.2001; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Chen JC, 2005, MOL MICROBIOL, V55, P1085, DOI 10.1111/j.1365-2958.2004.04443.x; Cohen-Gonsaud M, 2005, NAT STRUCT MOL BIOL, V12, P270, DOI 10.1038/nsmb905; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; CUTTING S, 1991, J MOL BIOL, V221, P1237; Dubnau E, 2000, MOL MICROBIOL, V36, P630, DOI 10.1046/j.1365-2958.2000.01882.x; Duncan EA, 1998, J BIOL CHEM, V273, P17801, DOI 10.1074/jbc.273.28.17801; Gao LY, 2003, MOL MICROBIOL, V49, P1547, DOI 10.1046/j.1365-2958.2003.03667.x; Gilleron M, 2003, J BIOL CHEM, V278, P29880, DOI 10.1074/jbc.M303446200; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Glickman MS, 2001, CELL, V104, P477, DOI 10.1016/S0092-8674(01)00236-7; Hingley-Wilson SM, 2003, NAT IMMUNOL, V4, P949, DOI 10.1038/ni981; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Kanehara K, 2002, GENE DEV, V16, P2147, DOI 10.1101/gad.1002302; Kremer L, 2002, BIOCHEM J, V363, P437, DOI 10.1042/0264-6021:3630437; Kuzuyama T, 2000, J BIOL CHEM, V275, P19928, DOI 10.1074/jbc.M001820200; Rao V, 2005, J EXP MED, V201, P535, DOI 10.1084/jem.20041668; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Rhoades E, 2003, MOL MICROBIOL, V48, P875, DOI 10.1046/j.1365-2958.2003.03473.x; Rudner DZ, 1999, P NATL ACAD SCI USA, V96, P14765, DOI 10.1073/pnas.96.26.14765; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Schaible UE, 2003, NAT MED, V9, P1039, DOI 10.1038/nm906; Schobel S, 2004, MOL MICROBIOL, V52, P1091, DOI 10.1111/j.1365-2958.2004.04031.x; Vergne I, 2004, MOL BIOL CELL, V15, P751, DOI 10.1091/mbc.E03-05-0307; Weihofen A, 2003, TRENDS CELL BIOL, V13, P71, DOI 10.1016/S0962-8924(02)00041-7; *WHO, 2004, GLOB TUB CONTR SURV	30	90	97	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2005	436	7049					406	409		10.1038/nature03713	http://dx.doi.org/10.1038/nature03713			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	16034419	Green Accepted			2022-12-01	WOS:000230623400045
J	Berriman, M; Ghedin, E; Hertz-Fowler, C; Blandin, G; Renauld, H; Bartholomeu, DC; Lennard, NJ; Caler, E; Hamlin, NE; Haas, B; Bohme, W; Hannick, L; Aslett, MA; Shallom, J; Marcello, L; Hou, LH; Wickstead, B; Alsmark, UCM; Arrowsmith, C; Atkin, RJ; Barron, AJ; Bringaud, F; Brooks, K; Carrington, M; Cherevach, I; Chillingworth, TJ; Churcher, C; Clark, LN; Corton, CH; Cronin, A; Davies, RM; Doggett, J; Djikeng, A; Feldblyum, T; Field, MC; Fraser, A; Goodhead, I; Hance, Z; Harper, D; Harris, BR; Hauser, H; Hostetter, J; Ivens, A; Jagels, K; Johnson, D; Johnson, J; Jones, K; Kerhornou, AX; Koo, H; Larke, N; Landfear, S; Larkin, C; Leech, V; Line, A; Lord, A; MacLeod, A; Mooney, PJ; Moule, S; Martin, DMA; Morgan, GW; Mungall, K; Norbertczak, H; Ormond, D; Pai, G; Peacock, CS; Peterson, J; Quail, MA; Rabbinowitsch, E; Rajandream, MA; Reitter, C; Salzberg, SL; Sanders, M; Schobel, S; Sharp, S; Simmonds, M; Simpson, AJ; Talton, L; Turner, CMR; Tait, A; Tivey, AR; Van Aken, S; Walker, D; Wanless, D; Wang, SL; White, B; White, O; Whitehead, S; Woodward, J; Wortman, J; Adams, MD; Embley, TM; Gull, K; Ullu, E; Barry, JD; Fairlamb, AH; Opperdoes, F; Barret, BG; Donelson, JE; Hall, N; Fraser, CM; Melville, SE; El-Sayed, NM				Berriman, M; Ghedin, E; Hertz-Fowler, C; Blandin, G; Renauld, H; Bartholomeu, DC; Lennard, NJ; Caler, E; Hamlin, NE; Haas, B; Bohme, W; Hannick, L; Aslett, MA; Shallom, J; Marcello, L; Hou, LH; Wickstead, B; Alsmark, UCM; Arrowsmith, C; Atkin, RJ; Barron, AJ; Bringaud, F; Brooks, K; Carrington, M; Cherevach, I; Chillingworth, TJ; Churcher, C; Clark, LN; Corton, CH; Cronin, A; Davies, RM; Doggett, J; Djikeng, A; Feldblyum, T; Field, MC; Fraser, A; Goodhead, I; Hance, Z; Harper, D; Harris, BR; Hauser, H; Hostetter, J; Ivens, A; Jagels, K; Johnson, D; Johnson, J; Jones, K; Kerhornou, AX; Koo, H; Larke, N; Landfear, S; Larkin, C; Leech, V; Line, A; Lord, A; MacLeod, A; Mooney, PJ; Moule, S; Martin, DMA; Morgan, GW; Mungall, K; Norbertczak, H; Ormond, D; Pai, G; Peacock, CS; Peterson, J; Quail, MA; Rabbinowitsch, E; Rajandream, MA; Reitter, C; Salzberg, SL; Sanders, M; Schobel, S; Sharp, S; Simmonds, M; Simpson, AJ; Talton, L; Turner, CMR; Tait, A; Tivey, AR; Van Aken, S; Walker, D; Wanless, D; Wang, SL; White, B; White, O; Whitehead, S; Woodward, J; Wortman, J; Adams, MD; Embley, TM; Gull, K; Ullu, E; Barry, JD; Fairlamb, AH; Opperdoes, F; Barret, BG; Donelson, JE; Hall, N; Fraser, CM; Melville, SE; El-Sayed, NM			The genome of the African trypanosome Trypanosoma brucei	SCIENCE			English	Article							ANTIGENIC VARIATION; LEISHMANIA-DONOVANI; PARASITIC PROTOZOA; SLEEPING SICKNESS; DRUG TARGET; CHEMOTHERAPY; METABOLISM; TELOMERES; SEQUENCE; GENES	African trypanosomes cause human sleeping sickness and livestock trypanosomiasis in sub-Saharan Africa. We present the sequence and analysis of the 11 megabase-sized chromosomes of Trypanosoma brucei. The 26-megabase genome contains 9068 predicted genes, including similar to 900 pseudogenes and similar to 1700 T. brucei-specific genes. Large subteiomeric arrays contain an archive of 806 variant surface glycoprotein (VSG) genes used by the parasite to evade the mammalian immune system. Most VSG genes are pseudogenes, which may be used to generate expressed mosaic genes by ectopic recombination. Comparisons of the cytoskeleton and endocytic trafficking systems with those of humans and other eukaryotic organisms reveal major differences. A comparison of metabolic pathways encoded by the genomes; of T. brucei, T. cruzi, and Leishmania major reveals the least overall metabolic capability in T. brucei and the greatest in L. major. Horizontal transfer of genes of, bacterial. origin has contributed to some of the metabolic differences in these, parasites, and a number of novel potential drug targets have been identified.	Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; Inst Genome Res, Rockville, MD 20850 USA; George Washington Univ, Dept Microbiol & Trop Med, Washington, DC 20052 USA; Univ Glasgow, Wellcome Ctr Mol Parasitol, Glasgow G11 6NU, Lanark, Scotland; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; Univ Newcastle Upon Tyne, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Bordeaux 2, CNRS, UMR 5162, Lab Genom Fonct Trypanosomatides, F-33076 Bordeaux, France; Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; Oregon Hlth Sci Univ, Portland, OR 97239 USA; Univ Dundee, Sch Life Sci, Wellcome Trust Bioctr, Dundee DD1 5EH, Scotland; Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AY, England; Univ Glasgow, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; Christian de Duve Inst Cellular Pathol, B-1200 Brussels, Belgium; Catholic Univ Louvain, B-1200 Brussels, Belgium; Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA	Wellcome Trust Sanger Institute; J. Craig Venter Institute; George Washington University; University of Glasgow; University of Oxford; Newcastle University - UK; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; University of Cambridge; University of Cambridge; Oregon Health & Science University; University of Dundee; Imperial College London; University of Glasgow; Case Western Reserve University; Yale University; Universite Catholique Louvain; University of Iowa	Berriman, M (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SA, England.	neisayed@tigr.org	Salzberg, Steven L/F-6162-2011; Ghedin, Elodie/Y-5654-2019; Opperdoes, Frederik R/C-8897-2018; Berriman, Matthew/A-7618-2011; Peacock, Christopher/A-4052-2012; El-Sayed, Najib M.A./K-7266-2015; Salzberg, Steven/Q-6514-2019; Simpson, Amelia/HGB-1823-2022; Donelson, John E/F-5795-2010; Field, Mark/AAD-6455-2021; Carrington, Mark/N-4892-2018; Goodhead, Ian/ABC-9200-2020; Carrington, Mark/N-3653-2019; Quail, michael/ABE-6131-2020; Bartholomeu, Daniella C./J-4714-2015; Alsmark, Cecilia/AAO-1330-2021; Martin, David/C-2984-2009; Hall, Neil/A-8717-2013; Opperdoes, Fred/N-9922-2019; Fairlamb, Alan/A-5272-2009; Blandin, Gaelle/N-9745-2013	Salzberg, Steven L/0000-0002-8859-7432; Ghedin, Elodie/0000-0002-1515-725X; Opperdoes, Frederik R/0000-0003-1984-3764; Berriman, Matthew/0000-0002-9581-0377; El-Sayed, Najib M.A./0000-0001-7970-3312; Salzberg, Steven/0000-0002-8859-7432; Carrington, Mark/0000-0002-6435-7266; Carrington, Mark/0000-0002-6435-7266; Bartholomeu, Daniella C./0000-0003-0974-7357; Hall, Neil/0000-0002-7995-3810; Opperdoes, Fred/0000-0003-1984-3764; Fairlamb, Alan/0000-0001-5134-0329; Blandin, Gaelle/0000-0003-2790-9524; Martin, David/0000-0002-8732-204X; Goodhead, Ian/0000-0002-3110-9442; Schobel, Seth/0000-0002-8967-257X; Harper, David/0000-0002-8313-3516; Field, Mark/0000-0002-4866-2885; MARCELLO, LUCIO/0000-0003-2252-1870; Ivens, Al/0000-0002-0112-3876; Hertz-Fowler, Christiane/0000-0002-0729-6479; Fraser, Claire/0000-0003-1462-2428; Djikeng, Appolinaire/0000-0001-9271-3419; Hall, Neil/0000-0003-2808-0009; Embley, Thomas Martin/0000-0002-1484-340X; Wickstead, Bill/0000-0002-4620-9091; Wortman, Jennifer/0000-0002-8713-1227; Bohme, Ulrike/0000-0002-0248-5924; Hannick, Linda/0000-0002-8018-8466; Kerhornou, Arnaud/0000-0002-2890-295X; Davies, Robert/0000-0002-9983-1378	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043062, U01AI043062] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI043062, U01 AI043062, AI43062] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome TrustEuropean Commission)		Ackers JP, 2005, MOL BIOCHEM PARASIT, V141, P89, DOI 10.1016/j.molbiopara.2005.01.017; [Anonymous], 2004, WORLD HLTH REP 2004; Arkhipova IR, 2001, P NATL ACAD SCI USA, V98, P14497, DOI 10.1073/pnas.231494798; Atwood JA, 2005, SCIENCE, V309, P473, DOI 10.1126/science.1110289; Barry JD, 2003, INT J PARASITOL, V33, P29, DOI 10.1016/S0020-7519(02)00247-3; Becker M, 2004, GENOME RES, V14, P2319, DOI 10.1101/gr.2955304; Besteiro S, 2002, J BIOL CHEM, V277, P38001, DOI 10.1074/jbc.M201759200; Borst P, 2002, CELL, V109, P5, DOI 10.1016/S0092-8674(02)00711-0; Bringaud F, 2002, EUKARYOT CELL, V1, P137, DOI 10.1128/EC.1.1.137-151.2002; CARRINGTON M, 1991, J MOL BIOL, V221, P823, DOI 10.1016/0022-2836(91)80178-W; CAZZULO JJ, 1992, FASEB J, V6, P3153, DOI 10.1096/fasebj.6.13.1397837; Comini MA, 2004, FREE RADICAL BIO MED, V36, P1289, DOI 10.1016/j.freeradbiomed.2004.02.008; CRAIG A, 2003, ANTIGENIC VARIATION, P464; DREW ME, 1995, MOL CELL BIOL, V15, P5508; El Sawalhy A, 1998, J PARASITOL, V84, P469, DOI 10.2307/3284707; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; El-Sayed NMA, 2003, NUCLEIC ACIDS RES, V31, P4856, DOI 10.1093/nar/gkg673; Fairlamb AH, 2003, TRENDS PARASITOL, V19, P488, DOI 10.1016/j.pt.2003.09.002; Ferguson MAJ, 2000, P NATL ACAD SCI USA, V97, P10673, DOI 10.1073/pnas.97.20.10673; Field MC, 2004, TRAFFIC, V5, P905, DOI 10.1111/j.1600-0854.2004.00234.x; Garcia-Salcedo JA, 2004, EMBO J, V23, P780, DOI 10.1038/sj.emboj.7600094; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gazit V, 2003, BEHAV BRAIN RES, V143, P1, DOI 10.1016/S0166-4328(03)00075-5; Ginger ML, 2001, J BIOL CHEM, V276, P11674, DOI 10.1074/jbc.M006850200; Hall N, 2003, NUCLEIC ACIDS RES, V31, P4864, DOI 10.1093/nar/gkg674; Huynh TT, 2003, J BIOL CHEM, V278, P39794, DOI 10.1074/jbc.M306306200; Irsch T, 2004, J BIOL CHEM, V279, P22209, DOI 10.1074/jbc.M401240200; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; KAMPER SM, 1992, MOL BIOCHEM PARASIT, V53, P33, DOI 10.1016/0166-6851(92)90004-4; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Landfear SM, 2004, EUKARYOT CELL, V3, P245, DOI 10.1128/EC.3.2.245-254.2004; Li F, 1998, EXP PARASITOL, V88, P255, DOI 10.1006/expr.1998.4237; LINSTEAD DJ, 1977, J GEN MICROBIOL, V101, P243, DOI 10.1099/00221287-101-2-243; LIU AYC, 1983, J MOL BIOL, V167, P57, DOI 10.1016/S0022-2836(83)80034-5; Lowell JE, 2004, J CELL SCI, V117, P5937, DOI 10.1242/jcs.01515; Melville SE, 1998, MOL BIOCHEM PARASIT, V94, P155, DOI 10.1016/S0166-6851(98)00054-1; Nihei C, 2002, BBA-MOL BASIS DIS, V1587, P234, DOI 10.1016/S0925-4439(02)00086-8; Ogbadoyi E, 2000, CHROMOSOMA, V108, P501, DOI 10.1007/s004120050402; Overath P, 2004, MOL MICROBIOL, V53, P735, DOI 10.1111/j.1365-2958.2004.04224.x; Pays E, 2004, CURR OPIN MICROBIOL, V7, P369, DOI 10.1016/j.mib.2004.05.001; Pereira CA, 2002, J EUKARYOT MICROBIOL, V49, P82, DOI 10.1111/j.1550-7408.2002.tb00346.x; Price HP, 2005, J CELL SCI, V118, P831, DOI 10.1242/jcs.01624; Roberts SC, 2004, J BIOL CHEM, V279, P23668, DOI 10.1074/jbc.M402042200; Roper JR, 2002, P NATL ACAD SCI USA, V99, P5884, DOI 10.1073/pnas.092669999; ROTH C, 1989, P NATL ACAD SCI USA, V86, P9375, DOI 10.1073/pnas.86.23.9375; Steenkamp DJ, 2002, ANTIOXID REDOX SIGN, V4, P105, DOI 10.1089/152308602753625906; STEIGER RF, 1977, J PROTOZOOL, V24, P437, DOI 10.1111/j.1550-7408.1977.tb04771.x; TURNER CMR, 1989, PARASITOLOGY, V99, P67, DOI 10.1017/S0031182000061035; Urbina JA, 2003, TRENDS PARASITOL, V19, P495, DOI 10.1016/j.pt.2003.09.001; Van Hellemond JJ, 1998, P NATL ACAD SCI USA, V95, P3036, DOI 10.1073/pnas.95.6.3036; VANDERPLOEG LH, 1982, NUCLEIC ACIDS RES, V10, P9505; Vanhamme L, 2003, NATURE, V422, P83, DOI 10.1038/nature01461; Vickers TJ, 2004, P NATL ACAD SCI USA, V101, P13186, DOI 10.1073/pnas.0402918101; Wickstead B, 2004, GENOME RES, V14, P1014, DOI 10.1101/gr.2227704; Wyllie S, 2004, J BIOL CHEM, V279, P39925, DOI 10.1074/jbc.M405635200	55	1266	1371	3	193	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2005	309	5733					416	422		10.1126/science.1112642	http://dx.doi.org/10.1126/science.1112642			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946LY	16020726				2022-12-01	WOS:000230574900036
J	Perez-Morga, D; Vanhollebeke, B; Paturiaux-Hanocq, F; Nolan, DP; Lins, L; Homble, F; Vanhamme, L; Tebabi, P; Pays, A; Poelvoorde, P; Jacquet, A; Brasseur, R; Pays, E				Perez-Morga, D; Vanhollebeke, B; Paturiaux-Hanocq, F; Nolan, DP; Lins, L; Homble, F; Vanhamme, L; Tebabi, P; Pays, A; Poelvoorde, P; Jacquet, A; Brasseur, R; Pays, E			Apolipoprotein L-1 promotes trypanosome lysis by forming pores in lysosomal membranes	SCIENCE			English	Article							HIGH-DENSITY-LIPOPROTEIN; L GENE-CLUSTER; LYTIC FACTOR; HUMAN-SERUM; LIPID-MEMBRANES; COLICIN-A; L-I; BRUCEI; IDENTIFICATION; TISSUE	Apolipoprotein L-I is the trypanolytic factor of human serum. Here we show that this protein contains a membrane pore-forming domain functionally similar to that of bacteria[ colicins, flanked by a membrane-addressing domain. In lipid bilayer membranes, apolipoprotein L-I formed anion channels. In Trypanosoma brucei, apolipoprotein L-I was targeted to the lysosomal membrane and triggered depolarization of this membrane, continuous influx of chloride, and subsequent osmotic swelling of the lysosome until the trypanosome lysed.	Univ Libre Bruxelles, IBMM, Mol Parasitol Lab, B-6041 Gosselies, Belgium; Univ Dublin Trinity Coll, Dept Biochem, Dublin 2, Ireland; Univ Gembloux, Ctr Biophys Mol Numer, Gembloux, Belgium; Univ Libre Bruxelles, B-1050 Brussels, Belgium; Univ Libre Bruxelles, IBMM, Lab Appl Genet, B-6041 Gosselies, Belgium	Universite Libre de Bruxelles; Trinity College Dublin; University of Liege; Universite Libre de Bruxelles; Universite Libre de Bruxelles	Pays, E (corresponding author), Univ Libre Bruxelles, IBMM, Mol Parasitol Lab, 12 Rue Profs Jeener & Brachet, B-6041 Gosselies, Belgium.	epays@ulb.ac.be	Jacquet, Alain/T-8611-2019; Jacquet, Alain/GQI-0546-2022; LINS, LAURENCE/Y-1661-2019; Homble, Fabrice/AAH-3780-2020	Jacquet, Alain/0000-0002-0980-9741; Jacquet, Alain/0000-0002-0980-9741; LINS, LAURENCE/0000-0001-7772-6748; Homble, Fabrice/0000-0001-6031-136X; Nolan, Derek/0000-0002-3742-4304; Perez-Morga, David/0000-0002-7168-1865; Vanhollebeke, Benoit/0000-0002-0353-365X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Duchateau PN, 2001, J LIPID RES, V42, P620; Duchateau PN, 1997, J BIOL CHEM, V272, P25576, DOI 10.1074/jbc.272.41.25576; Duche D, 2002, BIOCHIMIE, V84, P455, DOI 10.1016/S0300-9084(02)01424-4; FUKS B, 1994, BIOPHYS J, V66, P1404, DOI 10.1016/S0006-3495(94)80931-2; Green HP, 2003, J BIOL CHEM, V278, P422, DOI 10.1074/jbc.M207215200; GRINVALD A, 1984, NATURE, V308, P848, DOI 10.1038/308848a0; HAGER KM, 1994, J CELL BIOL, V126, P155, DOI 10.1083/jcb.126.1.155; Kienker PK, 2003, J GEN PHYSIOL, V122, P161, DOI 10.1085/jgp.200308852; Lazebnik Y, 2001, CURR BIOL, V11, pR767, DOI 10.1016/S0960-9822(01)00465-1; Maget-Dana R, 1999, BBA-BIOMEMBRANES, V1462, P109, DOI 10.1016/S0005-2736(99)00203-5; Monajemi H, 2002, GENOMICS, V79, P539, DOI 10.1006/geno.2002.6729; MORLON J, 1983, J MOL BIOL, V170, P271, DOI 10.1016/S0022-2836(83)80148-X; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Nardi A, 2001, J MOL BIOL, V307, P1293, DOI 10.1006/jmbi.2001.4524; Nolan DP, 2000, EUR J BIOCHEM, V267, P4615, DOI 10.1046/j.1432-1327.2000.01477.x; Page NM, 2001, GENOMICS, V74, P71, DOI 10.1006/geno.2001.6534; Poelvoorde P, 2004, MOL BIOCHEM PARASIT, V134, P155, DOI 10.1016/j.molbiopara.2003.11.006; RIFKIN MR, 1984, EXP PARASITOL, V58, P81, DOI 10.1016/0014-4894(84)90023-7; RIFKIN MR, 1991, J LIPID RES, V32, P639; Shimamura M, 2001, MOL BIOCHEM PARASIT, V115, P227, DOI 10.1016/S0166-6851(01)00292-4; Vanderheyden N, 2000, BIOCHEM J, V346, P53, DOI 10.1042/0264-6021:3460053; Vanhamme L, 2004, INT J PARASITOL, V34, P887, DOI 10.1016/j.ijpara.2004.04.008; Vanhamme L, 2003, NATURE, V422, P83, DOI 10.1038/nature01461	23	236	243	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2005	309	5733					469	472		10.1126/science.1114566	http://dx.doi.org/10.1126/science.1114566			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946LY	16020735				2022-12-01	WOS:000230574900048
J	de Ruiter, PC; Wolters, V; Moore, JC; Winemiller, KO				de Ruiter, PC; Wolters, V; Moore, JC; Winemiller, KO			Food web ecology: Playing Jenga and beyond	SCIENCE			English	Editorial Material							COMMUNITY DESCRIPTION; SPECIES ABUNDANCE; BODY-SIZE; STABILITY; BIODIVERSITY; DYNAMICS		Univ Utrecht, Dept Environm Sci, Copernicus Res Inst Sustainable Dev & Innovat, NL-3508 TC Utrecht, Netherlands; Univ Giessen, Dept Anim Ecol, D-35392 Giessen, Germany; Univ No Colorado, Sch Biol Sci, Greeley, CO 80639 USA; Texas A&M Univ, Dept Wildlife & Fisheries Sci, Sect Ecol & Evolutionary Biol, College Stn, TX 77843 USA	Utrecht University; Justus Liebig University Giessen; University of Northern Colorado; Texas A&M University System; Texas A&M University College Station	de Ruiter, PC (corresponding author), Univ Utrecht, Dept Environm Sci, Copernicus Res Inst Sustainable Dev & Innovat, NL-3508 TC Utrecht, Netherlands.	p.deruiter@geo.uu.nl; Volkmar.Wolters@allzool.bio.uni-giessen.de; john.moore@unco.edu; k-winemiller@tamu.edu	Moore, John/E-9802-2011; Wolters, Volkmar/B-4635-2010	Wolters, Volkmar/0000-0002-7556-4578; Winemiller, Kirk/0000-0003-0236-5129				Brose U, 2004, NATURE, V428, P167, DOI 10.1038/nature02297; Cohen JE, 2003, P NATL ACAD SCI USA, V100, P1781, DOI 10.1073/pnas.232715699; De Roos AM, 2002, P NATL ACAD SCI USA, V99, P12907, DOI 10.1073/pnas.192174199; DEANGELIS DL, 1992, DYNAMICS FOOD WEBS N; Downing AL, 2002, NATURE, V416, P837, DOI 10.1038/416837a; Elton C., 1927, ANIMAL ECOLOGY; Jonsson T, 2005, ADV ECOL RES, V36, P1, DOI 10.1016/S0065-2504(05)36001-6; Kondoh M, 2003, SCIENCE, V299, P1388, DOI 10.1126/science.1079154; Krause AE, 2003, NATURE, V426, P282, DOI 10.1038/nature02115; MACARTHUR R, 1955, ECOLOGY, V36, P533, DOI 10.2307/1929601; May R.M., 1973, STABILITY COMPLEXITY; McCann KS, 2005, ECOL LETT, V8, P513, DOI 10.1111/j.1461-0248.2005.00742.x; Moore JC, 2004, ECOL LETT, V7, P584, DOI 10.1111/j.1461-0248.2004.00606.x; MOORE JC, 1988, NATURE, V333, P261, DOI 10.1038/333261a0; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; Odum H.T., 1983, SYSTEMS ECOLOGY; PAINE RT, 1980, J ANIM ECOL, V49, P667; Polis G.A., 1996, FOOD WEBS INTEGRATIO; Thebault E, 2003, P NATL ACAD SCI USA, V100, P14949, DOI 10.1073/pnas.2434847100; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572	20	96	103	1	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 1	2005	309	5731					68	+		10.1126/science.1096112	http://dx.doi.org/10.1126/science.1096112			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	941KD	15994518				2022-12-01	WOS:000230212800035
J	Sun, F; Huo, X; Zhai, YJ; Wang, AJ; Xu, JX; Su, D; Bartlam, M; Rao, ZH				Sun, F; Huo, X; Zhai, YJ; Wang, AJ; Xu, JX; Su, D; Bartlam, M; Rao, ZH			Crystal structure of mitochondrial respiratory membrane protein complex II	CELL			English	Article							SUCCINATE-UBIQUINONE REDUCTASE; CYTOCHROME BC(1) COMPLEX; BOVINE HEART-MITOCHONDRIA; COLI FUMARATE REDUCTASE; ANCHORING SUBUNIT QPS3; QUINONE-BINDING-SITES; ESCHERICHIA-COLI; FAMILIAL PHEOCHROMOCYTOMA; NECK PARAGANGLIOMAS; FLAVOPROTEIN GENE	The mitochondrial respiratory Complex II or succinate: ubiquinone oxidoreductase (SQR) is an integral membrane protein complex in both the tricarboxylic acid cycle and aerobic respiration. Here we report the first crystal structure of Complex II from porcine heart at 2.4 angstrom resolution and its complex structure with inhibitors 3-nitropropionate and 2-thenoyltrifluoroacetone (TTFA) at 3.5 angstrom resolution. Complex II is comprised of two hydrophilic proteins, flavoprotein (Fp) and ironsulfur protein (Ip), and two transmembrane proteins (CybL and CybS), as well as prosthetic groups required for electron transfer from succinate to ubiquinone. The structure correlates the protein environments around prosthetic groups with their unique midpoint redox potentials. Two ubiquinone binding sites are discussed and elucidated by TTFA binding. The Complex II structure provides a bona fide model for study of the mitochondrial respiratory system and human mitochondrial diseases related to mutations in this complex.	Tsinghua Univ, Tsing Hua IBP Joint Res Grp Struct Biol, Beijing 100084, Peoples R China; Chinese Acad Sci, Inst Biophys IBP, Natl Lab Biomacromol, Beijing 100101, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Rao, ZH (corresponding author), Tsinghua Univ, Tsing Hua IBP Joint Res Grp Struct Biol, Beijing 100084, Peoples R China.	raozh@xtal.tsinghua.edu.cn	Rao, Zihe/HCH-6944-2022; Su, Dan/F-8177-2010; Sun, Fei/AAR-3186-2020; Sun, Fei/C-4190-2015	Sun, Fei/0000-0002-0351-5144; Sun, Fei/0000-0002-0351-5144; Bartlam, Mark/0000-0001-5173-5080				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Ackrell BAC, 2002, MOL ASPECTS MED, V23, P369, DOI 10.1016/S0098-2997(02)00012-2; Astuti D, 2001, LANCET, V357, P1181, DOI 10.1016/S0140-6736(00)04378-6; Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282; Bauters C, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.6.e75; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Baysal BE, 2002, J MED GENET, V39, P178, DOI 10.1136/jmg.39.3.178; Birch-Machin MA, 2000, ANN NEUROL, V48, P330, DOI 10.1002/1531-8249(200009)48:3<330::AID-ANA7>3.0.CO;2-A; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Dekker PBD, 2003, J PATHOL, V201, P480, DOI 10.1002/path.1461; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guo J, 2003, J BIOL CHEM, V278, P47629, DOI 10.1074/jbc.M306312200; Hagerhall C, 1997, BBA-BIOENERGETICS, V1320, P107, DOI 10.1016/S0005-2728(97)00019-4; INGLEDEW WJ, 1976, ARCH BIOCHEM BIOPHYS, V177, P176, DOI 10.1016/0003-9861(76)90427-6; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; Iverson TM, 1999, SCIENCE, V284, P1961, DOI 10.1126/science.284.5422.1961; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lancaster CRD, 1999, NATURE, V402, P377, DOI 10.1038/46483; Lange C, 2002, P NATL ACAD SCI USA, V99, P2800, DOI 10.1073/pnas.052704699; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE GY, 1995, J BIOL CHEM, V270, P6193, DOI 10.1074/jbc.270.11.6193; Lemos RS, 2002, BBA-BIOENERGETICS, V1553, P158, DOI 10.1016/S0005-2728(01)00239-0; Lu GG, 2000, J APPL CRYSTALLOGR, V33, P176, DOI 10.1107/S0021889899012339; Maklashina E, 1999, ARCH BIOCHEM BIOPHYS, V369, P223, DOI 10.1006/abbi.1999.1359; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Messner KR, 2002, J BIOL CHEM, V277, P42563, DOI 10.1074/jbc.M204958200; MIKI T, 1992, ARCH BIOCHEM BIOPHYS, V293, P61, DOI 10.1016/0003-9861(92)90365-4; Milunsky JM, 2001, AM J MED GENET, V100, P311, DOI 10.1002/ajmg.1270; Neumann HPH, 2002, NEW ENGL J MED, V346, P1459, DOI 10.1056/NEJMoa020152; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; OHNISHI T, 1980, J BIOL CHEM, V255, P3278; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Oyedotun KS, 2001, J BIOL CHEM, V276, P16936, DOI 10.1074/jbc.M100184200; Oyedotun KS, 1999, J BIOL CHEM, V274, P23956, DOI 10.1074/jbc.274.34.23956; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Parfait B, 2000, HUM GENET, V106, P236, DOI 10.1007/s004390051033; Rustin P, 2002, BBA-BIOENERGETICS, V1553, P117, DOI 10.1016/S0005-2728(01)00228-6; RUZICKA FJ, 1975, P NATL ACAD SCI USA, V72, P2886, DOI 10.1073/pnas.72.8.2886; SALERNO JC, 1977, FEBS LETT, V82, P179, DOI 10.1016/0014-5793(77)80579-6; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Shenoy SK, 1999, J BIOL CHEM, V274, P8717, DOI 10.1074/jbc.274.13.8717; Shenoy SK, 1997, J BIOL CHEM, V272, P17867, DOI 10.1074/jbc.272.28.17867; Taschner PEM, 2001, GENE CHROMOSOME CANC, V31, P274, DOI 10.1002/gcc.1144; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; Van Coster R, 2003, AM J MED GENET A, V120A, P13, DOI 10.1002/ajmg.a.10202; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; XU Y, 1987, BIOCHEM BIOPH RES CO, V144, P315, DOI 10.1016/S0006-291X(87)80512-0; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605; Yankovskaya V, 1996, J BIOL CHEM, V271, P21020, DOI 10.1074/jbc.271.35.21020; YU L, 1987, J BIOL CHEM, V262, P1137; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612	57	553	580	18	165	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 1	2005	121	7					1043	1057		10.1016/j.cell.2005.05.025	http://dx.doi.org/10.1016/j.cell.2005.05.025			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	944RZ	15989954	Bronze			2022-12-01	WOS:000230448000011
J	Becks, L; Hilker, FM; Malchow, H; Jurgens, K; Arndt, H				Becks, L; Hilker, FM; Malchow, H; Jurgens, K; Arndt, H			Experimental demonstration of chaos in a microbial food web	NATURE			English	Article							PREDATOR-PREY SYSTEM; LYAPUNOV EXPONENTS; DYNAMICS; CYCLES; POPULATIONS; BIFURCATION; DIVERSITY; BACTERIA	Discovering why natural population densities change over time and vary with location is a central goal of ecological and evolutional disciplines. The recognition that even simple ecological systems can undergo chaotic behaviour has made chaos a topic of considerable interest among theoretical ecologists(1-4). However, there is still a lack of experimental evidence that chaotic behaviour occurs in the real world of coexisting populations in multi-species systems. Here we study the dynamics of a defined predator - prey system consisting of a bacterivorous ciliate and two bacterial prey species. The bacterial species preferred by the ciliate was the superior competitor. Experimental conditions were kept constant with continuous cultivation in a one-stage chemostat. We show that the dynamic behaviour of such a two-prey, one-predator system includes chaotic behaviour, as well as stable limit cycles and coexistence at equilibrium. Changes in the population dynamics were triggered by changes in the dilution rates of the chemostat. The observed dynamics were verified by estimating the corresponding Lyapunov exponents. Such a defined microbial food web offers a new possibility for the experimental study of deterministic chaos in real biological systems.	Univ Cologne, Inst Zool, Dept Gen Ecol & Limnol, D-50923 Cologne, Germany; Univ Osnabruck, Inst Environm Syst Res, Dept Math & Comp Sci, D-49069 Osnabruck, Germany; Max Planck Inst Limnol, D-24302 Plon, Germany; Balt Sea Res Inst, D-18119 Rostock, Germany	University of Cologne; University Osnabruck; Max Planck Society	Arndt, H (corresponding author), Univ Cologne, Inst Zool, Dept Gen Ecol & Limnol, D-50923 Cologne, Germany.	hartmut.arndt@uni-koeln.de	Arndt, Hartmut/K-9364-2017; Hilker, Frank/B-8624-2008; Becks, Lutz/I-8256-2012	Arndt, Hartmut/0000-0003-2811-3595; Hilker, Frank/0000-0001-5470-8889; Jurgens, Klaus/0000-0002-7999-9368				Arndt H., 2000, FLAGELLATES, P240; BEGON M, 2002, ECOLOGY; CARON DA, 1982, SCIENCE, V218, P795, DOI 10.1126/science.218.4574.795; Christoffersen K, 1997, AQUAT MICROB ECOL, V13, P127, DOI 10.3354/ame013127; Costantino RF, 1997, SCIENCE, V275, P389, DOI 10.1126/science.275.5298.389; Dennis B, 1997, J ANIM ECOL, V66, P704, DOI 10.2307/5923; Eisenmann H, 1998, APPL ENVIRON MICROB, V64, P1264; ELLNER S, 1995, AM NAT, V145, P343, DOI 10.1086/285744; Fussmann GF, 2000, SCIENCE, V290, P1358, DOI 10.1126/science.290.5495.1358; GILPIN ME, 1979, AM NAT, V113, P306, DOI 10.1086/283389; HASTINGS A, 1991, ECOLOGY, V72, P896, DOI 10.2307/1940591; HEERKLOSS R, 1993, VERH INT VEREIN LIMN, V25, P995; Hegger R, 1999, CHAOS, V9, P413, DOI 10.1063/1.166424; Huisman J, 1999, NATURE, V402, P407, DOI 10.1038/46540; Jessup CM, 2004, TRENDS ECOL EVOL, V19, P189, DOI 10.1016/j.tree.2004.01.008; JOST JL, 1973, J BACTERIOL, V113, P834, DOI 10.1128/JB.113.2.834-840.1973; KANTZ H, 1994, PHYS LETT A, V185, P77, DOI 10.1016/0375-9601(94)90991-1; Kooi BW, 2003, DYNAM CONT DIS SER B, V10, P259; LUCKINBILL LS, 1978, ECOLOGY, V59, P1271, DOI 10.2307/1938241; MAY RM, 1974, SCIENCE, V186, P645, DOI 10.1126/science.186.4164.645; Nelson WA, 2005, NATURE, V433, P413, DOI 10.1038/nature03212; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Rainey PB, 2000, TRENDS ECOL EVOL, V15, P243, DOI 10.1016/S0169-5347(00)01871-1; ROSENSTEIN MT, 1993, PHYSICA D, V65, P117, DOI 10.1016/0167-2789(93)90009-P; TAKEUCHI Y, 1983, B MATH BIOL, V45, P877, DOI 10.1007/BF02458820; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; Vayenas DV, 1999, MATH BIOSCI, V162, P69, DOI 10.1016/S0025-5564(99)00044-9; Volterra V, 1926, NATURE, V118, P558, DOI 10.1038/118558a0; WOLF A, 1985, PHYSICA D, V16, P285, DOI 10.1016/0167-2789(85)90011-9; Yoshida T, 2003, NATURE, V424, P303, DOI 10.1038/nature01767	30	160	166	1	75	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 30	2005	435	7046					1226	1229		10.1038/nature03627	http://dx.doi.org/10.1038/nature03627			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940JJ	15988524				2022-12-01	WOS:000230140500042
J	Liu, JG; Diamond, J				Liu, JG; Diamond, J			China's environment in a globalizing world	NATURE			English	Article							ACID DEPOSITION; TRADE		Michigan State Univ, Dept Fisheries & Wildlife, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48824 USA; Chinese Acad Sci, Ecoenvironm Sci Res Ctr, Beijing, Peoples R China; Fudan Univ, Shanghai 200433, Peoples R China; Univ Calif Los Angeles, Dept Geog, Los Angeles, CA 90095 USA	Michigan State University; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Fudan University; University of California System; University of California Los Angeles	Liu, JG (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48824 USA.	jliu@panda.msu.edu; jdiamond@geog.ucla.edu	liang, jiwang/A-5334-2009; Liu, Jianguo/G-5211-2015	Liu, Jianguo/0000-0001-6344-0087	NICHD NIH HHS [R01 HD39789] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039789] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ADAMS M, 2001, ITTO NEWSLETTER; Brown L.R., 1995, WHO WILL FEED CHINA; Chai JCH, 2002, SUSTAIN DEV, V10, P25, DOI 10.1002/sd.174; DAI Q, 1998, RIVER DRAGON HAS COM, P3; Dean JM, 2002, CAN J ECON, V35, P819, DOI 10.1111/0008-4085.00155; *ED BOARD, 2000, ENV PROT CHIN; *ED BOARD, 2001, ATL POP ENV SUST DEV; Feng ZW, 2002, J ENVIRON SCI-CHINA, V14, P227; GUO X, 2004, CHINA ENV DEV REV, V2, P53; Holden C, 2001, SCIENCE, V294, P2457; Johnson Todd M., 1997, CLEAR WATER BLUE SKI; Liu JG, 2003, SCIENCE, V300, P1240, DOI 10.1126/science.1078868; Liu JG, 2003, NATURE, V421, P530, DOI 10.1038/nature01359; *NAT BUR STAT CHIN, 2000, CHIN STAT YB 2000; National Bureau of Statistics of China, 2004, CHIN STAT YB 2003; Pauly D, 2003, SCIENCE, V302, P1359, DOI 10.1126/science.1088667; QU G, 2000, DREAM EXPECTATION PA; *SEPA, 1999, REP CHIN EC ISS; United Nations Centre for Human Settlements, 2001, CIT GLOB WORLD GLOB; World Bank, 2001, CHIN AIR LAND WAT; Xie Y, 2001, BIODIVERS CONSERV, V10, P1317, DOI 10.1023/A:1016695609745; XIE Z, 1997, GREENING STRATEGY, P44; Xu XP, 1998, ECOSYST HEALTH, V4, P199, DOI 10.1046/j.1526-0992.1998.98096.x; Yang L, 2002, PHYTON-ANN REI BOT A, V42, P255; YE R, 2001, ENV TRADE; ZHANG P, INTRO NATURAL FOREST, P99	26	1199	1318	30	648	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2005	435	7046					1179	1186		10.1038/4351179a	http://dx.doi.org/10.1038/4351179a			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940JJ	15988514	Bronze			2022-12-01	WOS:000230140500032
J	Escher, P; Lacazette, E; Courtet, M; Blindenbacher, A; Landmann, L; Bezakova, G; Lloyd, KC; Mueller, U; Brenner, HR				Escher, P; Lacazette, E; Courtet, M; Blindenbacher, A; Landmann, L; Bezakova, G; Lloyd, KC; Mueller, U; Brenner, HR			Synapses form in skeletal muscles lacking neuregulin receptors	SCIENCE			English	Article							ACETYLCHOLINE-RECEPTOR; NEUROMUSCULAR-JUNCTION; TRANSCRIPTION FACTOR; GENE-EXPRESSION; IN-VIVO; DIFFERENTIATION; SUBUNIT; ERBB4; MICE; PROTEIN	The formation of the neuromuscular junction (NMJ) is directed by reciprocal interactions between motor neurons and muscle fibers. Neuregulin (NRG) and Agrin from motor nerve terminals are both implicated. Here, we demonstrate that NMJs can form in the absence of the NRG receptors ErbB2 and ErbB4 in mouse muscle. Postsynaptic differentiation is, however, induced by Agrin. We therefore conclude that NRG signaling to muscle is not required for NMJ formation. The effects of NRG signaling to muscle may be mediated indirectly through Schwann cells.	Univ Basel, Inst Physiol, CH-4056 Basel, Switzerland; Univ Basel, Inst Anat, Dept Clin Biol Sci, CH-4056 Basel, Switzerland; Univ Basel, Div Pharmacol, Biozentrum, CH-4056 Basel, Switzerland; Univ Calif Davis, Ctr Comparat Med, Sch Vet Med, Davis, CA 95616 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Inst Childhood & Neglected Dis, La Jolla, CA 92037 USA	University of Basel; University of Basel; University of Basel; University of California System; University of California Davis; Scripps Research Institute; Scripps Research Institute	Escher, P (corresponding author), Univ Basel, Inst Physiol, CH-4056 Basel, Switzerland.	Hans-Rudolf.Brenner@unibas.ch	Lacazette, eric/M-7168-2014	lacazette, eric/0000-0003-1234-5260				BEZAKOVA G, UNPUB; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; CHU GC, 1995, NEURON, V14, P329, DOI 10.1016/0896-6273(95)90289-9; Cossins J, 2004, HUM MOL GENET, V13, P2947, DOI 10.1093/hmg/ddh320; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; ESCHER P, UNPUB; FALLS DL, 1993, CELL, V72, P801, DOI 10.1016/0092-8674(93)90407-H; Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.3.CO;2-X; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Hashemolhosseini S, 2000, MOL CELL NEUROSCI, V16, P697, DOI 10.1006/mcne.2000.0911; JO SA, 1995, NATURE, V373, P158, DOI 10.1038/373158a0; Leu M, 2003, DEVELOPMENT, V130, P2291, DOI 10.1242/dev.00447; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Long WW, 2003, DEVELOPMENT, V130, P5257, DOI 10.1242/dev.00715; Marques MJ, 2000, J NEUROSCI, V20, P3663, DOI 10.1523/JNEUROSCI.20-10-03663.2000; MCMAHAN UJ, 1990, COLD SH Q B, V55, P407; Meier T, 1997, J NEUROSCI, V17, P6534; Missias AC, 1996, DEV BIOL, V179, P223, DOI 10.1006/dbio.1996.0253; MOSCOSO LM, 1995, DEV BIOL, V172, P158, DOI 10.1006/dbio.1995.0012; Ozaki M, 1997, NATURE, V390, P691, DOI 10.1038/37795; Rimer M, 2004, MOL CELL NEUROSCI, V26, P271, DOI 10.1016/j.mcn.2004.02.002; Sandrock AW, 1997, SCIENCE, V276, P599, DOI 10.1126/science.276.5312.599; Schaeffer L, 1998, EMBO J, V17, P3078, DOI 10.1093/emboj/17.11.3078; Schwander M, 2003, DEV CELL, V4, P673, DOI 10.1016/S1534-5807(03)00118-7; Tidcombe H, 2003, P NATL ACAD SCI USA, V100, P8281, DOI 10.1073/pnas.1436402100; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; Witzemann V, 1996, P NATL ACAD SCI USA, V93, P13286, DOI 10.1073/pnas.93.23.13286; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2	28	93	95	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2005	308	5730					1920	1923		10.1126/science.1108258	http://dx.doi.org/10.1126/science.1108258			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940BZ	15976301				2022-12-01	WOS:000230120000043
J	Solomon, SD; Zelenkofske, S; McMurray, JJV; Finn, PV; Velazquez, E; Ertl, G; Harsanyi, A; Rouleau, JL; Maggioni, A; Kober, L; White, H; Van de Werf, F; Pieper, K; Califf, RM; Pfeffer, MA				Solomon, SD; Zelenkofske, S; McMurray, JJV; Finn, PV; Velazquez, E; Ertl, G; Harsanyi, A; Rouleau, JL; Maggioni, A; Kober, L; White, H; Van de Werf, F; Pieper, K; Califf, RM; Pfeffer, MA		VALIANT Investigators	Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; CARDIAC DEATH; RISK STRATIFICATION	Background The risk of sudden death from cardiac causes is increased among survivors of acute myocardial infarction with reduced left ventricular systolic function. We assessed the risk and time course of sudden death in high-risk patients after myocardial infarction. Methods We studied 14,609 patients with left ventricular dysfunction, heart failure, or both after myocardial infarction to assess the incidence and timing of sudden unexpected death or cardiac arrest with resuscitation in relation to the left ventricular ejection fraction. Results Of 14,609 patients, 1067 (7 percent) had an event a median of 180 days after myocardial infarction: 903 died suddenly, and 164 were resuscitated after cardiac arrest. The risk was highest in the first 30 days after myocardial infarction -- 1.4 percent per month (95 percent confidence interval, 1.2 to 1.6 percent) -- and decreased to 0.14 percent per month (95 percent confidence interval, 0.11 to 0.18 percent) after 2 years. Patients with a left ventricular ejection fraction of 30 percent or less were at highest risk in this early period (rate, 2.3 percent per month; 95 percent confidence interval, 1.8 to 2.8 percent). Nineteen percent of all sudden deaths or episodes of cardiac arrest with resuscitation occurred within the first 30 days after myocardial infarction, and 83 percent of all patients who died suddenly did so in the first 30 days after hospital discharge. Each decrease of 5 percentage points in the left ventricular ejection fraction was associated with a 21 percent adjusted increase in the risk of sudden death or cardiac arrest with resuscitation in the first 30 days. Conclusions The risk of sudden death is highest in the first 30 days after myocardial infarction among patients with left ventricular dysfunction, heart failure, or both. Thus, earlier implementation of strategies for preventing sudden death may be warranted in selected patients.	Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; Novartis Pharmaceut, E Hanover, NJ USA; Univ Glasgow, Western Infirm, Dept Cardiol, Glasgow G11 6NT, Lanark, Scotland; Duke Univ, Med Ctr, Durham, NC USA; Univ Wurzburg, Wurzburg, Germany; Natl Ctr Hlth Serv, Budapest, Hungary; Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada; Assoc Nazl Med Cardiol Osped Res Ctr, Florence, Italy; Rigshosp, Dept Cardiol, DK-2100 Copenhagen, Denmark; Green Lane Hosp, Dept Cardiol, Auckland 3, New Zealand; Leuven Coordinating Ctr, Louvain, Belgium	Harvard University; Brigham & Women's Hospital; Novartis; University of Glasgow; Duke University; University of Wurzburg; Universite de Montreal; Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO); Rigshospitalet; University of Copenhagen; KU Leuven	Solomon, SD (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.	ssolomon@rics.bwh.harvard.edu	Maggioni, Aldo Pietro/AAL-5334-2020; Solomon, Scott/I-5789-2013; mcmurray, John/B-2467-2013	Maggioni, Aldo Pietro/0000-0003-2764-6779; mcmurray, John/0000-0002-6317-3975; Kober, Lars/0000-0002-6635-1466; Patt, Mitchell/0000-0001-9696-4477; Van de Werf, Frans/0000-0001-9479-7767				ALKHATIB SM, IN PRESS AM HEART J; Antman Elliott M., 2004, J Am Coll Cardiol, V44, pE1, DOI 10.1016/j.jacc.2004.07.014; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Braunwald E, 2004, NEW ENGL J MED, V351, P2058; Buxton AE, 2000, NEW ENGL J MED, V343, P1813; Buxton AE, 1999, NEW ENGL J MED, V341, P1882, DOI 10.1056/NEJM199912163412503; CALIFF RM, 1982, AM J CARDIOL, V50, P23, DOI 10.1016/0002-9149(82)90004-2; Every N, 2002, AM HEART J, V144, P390, DOI 10.1067/mhj.2002.125495; Hohnloser SH, 2000, AM HEART J, V140, P735, DOI 10.1067/mhj.2000.110088; Hohnloser SH, 2004, NEW ENGL J MED, V351, P2481, DOI 10.1056/NEJMoa041489; Huikuri HV, 2003, J AM COLL CARDIOL, V42, P652, DOI 10.1016/S0735-1097(03)00783-6; Huikuri HV, 2001, NEW ENGL J MED, V345, P1473, DOI 10.1056/NEJMra000650; KLEIGER RE, 1987, AM J CARDIOL, V59, P256, DOI 10.1016/0002-9149(87)90795-8; MOSS AJ, 1983, NEW ENGL J MED, V309, P331, DOI 10.1056/nejm198308113090602; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; MUKHARJI J, 1984, AM J CARDIOL, V54, P31, DOI 10.1016/0002-9149(84)90299-6; MYERBURG RJ, 1993, ANN INTERN MED, V119, P1187, DOI 10.7326/0003-4819-119-12-199312150-00006; Naccarella F, 2000, CURR OPIN CARDIOL, V15, P1, DOI 10.1097/00001573-200001000-00001; Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292; Savard P, 1997, CIRCULATION, V96, P202; STEINBERG JS, 1992, AM J CARDIOL, V69, P13, DOI 10.1016/0002-9149(92)90669-P; Uretsky BF, 2000, CIRCULATION, V102, P611, DOI 10.1161/01.CIR.102.6.611; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334	23	547	567	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 23	2005	352	25					2581	2588		10.1056/NEJMoa043938	http://dx.doi.org/10.1056/NEJMoa043938			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	937VJ	15972864				2022-12-01	WOS:000229953700005
J	Obermann, K				Obermann, K			When the patient comes back	LANCET			English	Editorial Material									CHD Eastern Visayas, GTZ Hlth Sector Philippines, Palo 6501, Leyte, Philippines		Obermann, K (corresponding author), CHD Eastern Visayas, GTZ Hlth Sector Philippines, Palo 6501, Leyte, Philippines.	obermannk@gmx.de							0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 18	2005	365	9477					2149	2149		10.1016/S0140-6736(05)66741-4	http://dx.doi.org/10.1016/S0140-6736(05)66741-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	936LZ	15964454				2022-12-01	WOS:000229858800035
J	Harris, GC; Wimmer, M; Aston-Jones, G				Harris, GC; Wimmer, M; Aston-Jones, G			A role for lateral hypothalamic orexin neurons in reward seeking	NATURE			English	Article							VENTRAL TEGMENTAL AREA; RECEPTOR ANTAGONIST; RAT-BRAIN; HYPOCRETIN OREXIN; FEEDING-BEHAVIOR; FOS EXPRESSION; PREFERENCE; STRESS; NEUROPEPTIDES; ENVIRONMENT	The lateral hypothalamus is a brain region historically implicated in reward and motivation(1 - 4), but the identity of the neurotransmitters involved are unknown. The orexins ( or hypocretins) are neuropeptides recently identified as neurotransmitters in lateral hypothalamus neurons(5,6). Although knockout and transgenic overexpression studies have implicated orexin neurons in arousal and sleep(7), these cells also project to reward- associated brain regions, including the nucleus accumbens and ventral tegmental area(8,9). This indicates a possible role for these neurons in reward function and motivation(3,10), consistent with previous studies implicating these neurons in feeding(6). Here we show that activation of lateral hypothalamus orexin neurons is strongly linked to preferences for cues associated with drug and food reward. In addition, we show that chemical activation of lateral hypothalamus orexin neurons reinstates an extinguished drug- seeking behaviour. This reinstatement effect was completely blocked by prior administration of an orexin A antagonist. Moreover, administration of the orexin A peptide directly into the ventral tegmental area also reinstated drug- seeking. These data reveal a new role for lateral hypothalamus orexin neurons in reward- seeking, drug relapse and addiction.	Univ Penn, Dept Psychiat, Lab Neuromodulat & Behav, Philadelphia, PA 19104 USA	University of Pennsylvania	Harris, GC (corresponding author), Univ Penn, Dept Psychiat, Lab Neuromodulat & Behav, 705 Stellar Chance 6100,422 Curie Blvd, Philadelphia, PA 19104 USA.	glenda@dolphin.upenn.edu	Wimmer, Mathieu E/P-8091-2018; Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X				ANAND BK, 1951, YALE J BIOL MED, V24, P123; Baldo BA, 2004, EUR J NEUROSCI, V19, P376, DOI 10.1111/j.1460-9568.2004.03093.x; Baldo BA, 2003, J COMP NEUROL, V464, P220, DOI 10.1002/cne.10783; Bevins RA, 2002, BEHAV BRAIN RES, V129, P41, DOI 10.1016/S0166-4328(01)00326-6; Campbell RE, 2003, J NEUROSCI, V23, P1487, DOI 10.1523/JNEUROSCI.23-04-01487.2003; Carr KD, 2002, PHYSIOL BEHAV, V76, P353, DOI 10.1016/S0031-9384(02)00759-X; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; DiLeone RJ, 2003, LIFE SCI, V73, P759, DOI 10.1016/S0024-3205(03)00408-9; Espana RA, 2003, NEUROSCIENCE, V121, P201, DOI 10.1016/S0306-4522(03)00334-8; Estabrooke IV, 2001, J NEUROSCI, V21, P1656, DOI 10.1523/JNEUROSCI.21-05-01656.2001; Fadel J, 2002, NEUROSCIENCE, V111, P379, DOI 10.1016/S0306-4522(02)00017-9; Georgescu D, 2003, J NEUROSCI, V23, P3106; Harris GC, 2003, NEUROPSYCHOPHARMACOL, V28, P865, DOI 10.1038/sj.npp.1300122; Harris GC, 2003, NEUROPSYCHOPHARMACOL, V28, P292, DOI 10.1038/sj.npp.1300037; Harris GC, 2003, NEUROPSYCHOPHARMACOL, V28, P73, DOI 10.1038/sj.npp.1300011; Haynes AC, 2000, REGUL PEPTIDES, V96, P45, DOI 10.1016/S0167-0115(00)00199-3; Herrera DG, 1996, PROG NEUROBIOL, V50, P83, DOI 10.1016/S0301-0082(96)00021-4; Korotkova TM, 2003, J NEUROSCI, V23, P7; Marcus JN, 2001, J COMP NEUROL, V435, P6, DOI 10.1002/cne.1190; OLDS J, 1954, J COMP PHYSIOL PSYCH, V47, P419, DOI 10.1037/h0058775; Petrovich GD, 2003, ANN NY ACAD SCI, V985, P251; Peyron C, 1998, J NEUROSCI, V18, P9996; Rodgers RJ, 2001, EUR J NEUROSCI, V13, P1444, DOI 10.1046/j.0953-816x.2001.01518.x; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Shalev U, 2002, PHARMACOL REV, V54, P1, DOI 10.1124/pr.54.1.1; Siegel JM, 2004, ANNU REV PSYCHOL, V55, P125, DOI 10.1146/annurev.psych.55.090902.141545; Smart D, 2001, BRIT J PHARMACOL, V132, P1179, DOI 10.1038/sj.bjp.0703953; Swanson L. W, 1992, BRAIN MAPS STRUCTURE; Trivedi P, 1998, FEBS LETT, V438, P71, DOI 10.1016/S0014-5793(98)01266-6; Wang B, 2000, NEUROREPORT, V11, P2781, DOI 10.1097/00001756-200008210-00034	31	968	1004	2	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2005	437	7058					556	559		10.1038/nature04071	http://dx.doi.org/10.1038/nature04071			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966FF	16100511				2022-12-01	WOS:000232004800051
J	LaFever, L; Drummond-Barbosa, D				LaFever, L; Drummond-Barbosa, D			Direct control of germline stem cell division and cyst growth by neural insulin in Drosophila	SCIENCE			English	Article							RECEPTOR; PEPTIDES; OVARY; FLIES	Stem cells reside in specialized niches that provide signals required for their maintenance and division. Tissue-extrinsic signals can also modify stem cell activity, although this is poorly understood. Here, we report that neural-derived Drosophila insulin-like peptides (DILPs) directly regulate germline stem cell division rate, demonstrating that signals mediating the ovarian response to nutritional input can modify stem cell activity in a niche-independent manner. We also reveal a crucial direct role of DILPs in controlling germline cyst growth and vitellogenesis.	Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37232 USA	Vanderbilt University	Drummond-Barbosa, D (corresponding author), Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, 4120B Med Res Bldg 3,465 21st Ave S, Nashville, TN 37232 USA.	daniela.drummond-barbosa@vanderbilt.edu			NICHD NIH HHS [T32 HD007502] Funding Source: Medline; NIGMS NIH HHS [R01 GM069875, GM 069875] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069875] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Cao C, 2001, CELL TISSUE RES, V304, P317, DOI 10.1007/s004410100367; Chen C, 1996, ENDOCRINOLOGY, V137, P846, DOI 10.1210/en.137.3.846; Drummond-Barbosa D, 2001, DEV BIOL, V231, P265, DOI 10.1006/dbio.2000.0135; Garofalo RS, 2002, TRENDS ENDOCRIN MET, V13, P156, DOI 10.1016/S1043-2760(01)00548-3; Goberdhan DCI, 2003, DIFFERENTIATION, V71, P375, DOI 10.1046/j.1432-0436.2003.7107001.x; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; LAFEVER L, UNPUB; Maines JZ, 2004, DEVELOPMENT, V131, P775, DOI 10.1242/dev.00932; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Spradling AC, 1997, COLD SPRING HARB SYM, V62, P25; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Wynn Arthur, 1993, Nutrition and Health (Bicester), V9, P43; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; XU T, 1993, DEVELOPMENT, V117, P1223	17	232	238	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2005	309	5737					1071	1073		10.1126/science.1111410	http://dx.doi.org/10.1126/science.1111410			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955MN	16099985				2022-12-01	WOS:000231230100045
J	O'Neal, CJ; Jobling, MG; Holmes, RK; Hol, WGJ				O'Neal, CJ; Jobling, MG; Holmes, RK; Hol, WGJ			Structural basis for the activation of cholera toxin by human ARF6-GTP	SCIENCE			English	Article							HEAT-LABILE ENTEROTOXIN; RIBOSYLATING BACTERIAL TOXINS; CRYSTAL-STRUCTURE; CLOSTRIDIUM-BOTULINUM; ADP-RIBOSYLATION; BINDING; SUBUNIT; MECHANISM; ARF; RECOGNITION	The Vibrio cholerae bacterium causes devastating diarrhea when it infects the human intestine. The key event is adenosine diphosphate (ADP)-ribosylation of the human signaling protein G(S alpha), catalyzed by the cholera toxin A1 subunit (CTA1). This reaction is ailostericaliy activated by human ADP-ribosylation factors (ARFs), a family of essential and ubiquitous G proteins. Crystal structures of a CTA1:ARF6-GTP (guanosine triphosphate) complex reveal that binding of the human activator elicits dramatic changes in CTA1 loop regions that allow nicotinamide adenine dinucleotide (NAD(+)) to bind to the active site. The extensive toxin:ARF-GTP interface surface mimics ARF-GTP recognition of normal cellular protein partners, which suggests that the toxin has evolved to exploit promiscuous binding properties of ARFs.	Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Washington, Dept Chem, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Colorado, Hlth Sci Ctr, Dept Microbiol, Aurora, CO 80045 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Colorado System; University of Colorado Anschutz Medical Campus	Hol, WGJ (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	wghol@u.washington.edu	Jobling, Michael G/AAJ-3814-2021	Jobling, Michael/0000-0001-7689-3093	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI034501, R01AI031940, R01AI034501] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-31940, R01 AI031940, AI-34501] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agren L, 1999, PROTEIN ENG, V12, P173, DOI 10.1093/protein/12.2.173; Bell CE, 1996, BIOCHEMISTRY-US, V35, P1137, DOI 10.1021/bi9520848; Biou V, 2004, BIOCHEMISTRY-US, V43, P6833, DOI 10.1021/bi049630u; Cieplak W, 1995, J BIOL CHEM, V270, P30545, DOI 10.1074/jbc.270.51.30545; de Haan L, 2004, MOL MEMBR BIOL, V21, P77, DOI 10.1080/09687680410001663267; Evans HR, 2003, J BIOL CHEM, V278, P45924, DOI 10.1074/jbc.M307719200; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Han S, 2002, INT J MED MICROBIOL, V291, P523; Han S, 1999, NAT STRUCT BIOL, V6, P932, DOI 10.1038/13300; Han SI, 2001, J MOL BIOL, V305, P95, DOI 10.1006/jmbi.2000.4292; Hanzal-Bayer M, 2002, EMBO J, V21, P2095, DOI 10.1093/emboj/21.9.2095; Jobling MG, 2001, J BACTERIOL, V183, P4024, DOI 10.1128/JB.183.13.4024-4032.2001; KAHN RA, 1986, J BIOL CHEM, V261, P7906; LEE CM, 1991, J CLIN INVEST, V87, P1780, DOI 10.1172/JCI115197; Li M, 1996, P NATL ACAD SCI USA, V93, P6902, DOI 10.1073/pnas.93.14.6902; LOBET Y, 1991, INFECT IMMUN, V59, P2870, DOI 10.1128/IAI.59.9.2870-2879.1991; Masignani V, 2000, HANDB EXP PHARM, V145, P21; MEKALANOS JJ, 1979, J BIOL CHEM, V254, P5855; Menetrey J, 2000, NAT STRUCT BIOL, V7, P466; Menetrey J, 2002, J BIOL CHEM, V277, P30950, DOI 10.1074/jbc.M201844200; Nagahama M, 2000, J BACTERIOL, V182, P2096, DOI 10.1128/JB.182.8.2096-2103.2000; NODA M, 1990, BIOCHIM BIOPHYS ACTA, V1034, P195, DOI 10.1016/0304-4165(90)90076-9; O'Neal CJ, 2004, BIOCHEMISTRY-US, V43, P3772, DOI 10.1021/bi0360152; Panic B, 2003, MOL CELL, V12, P863, DOI 10.1016/S1097-2765(03)00356-3; Pasqualato S, 2002, EMBO REP, V3, P1035, DOI 10.1093/embo-reports/kvf221; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; Shiba T, 2003, NAT STRUCT BIOL, V10, P386, DOI 10.1038/nsb920; SIXMA TK, 1991, NATURE, V351, P371, DOI 10.1038/351371a0; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Sun JJ, 2004, NAT STRUCT MOL BIOL, V11, P868, DOI 10.1038/nsmb818; Tsuge H, 2003, J MOL BIOL, V325, P471, DOI 10.1016/S0022-2836(02)01247-0; vandenAkker F, 1996, STRUCTURE, V4, P665, DOI 10.1016/S0969-2126(96)00073-1; VANDENAKKER F, 1995, BIOCHEMISTRY-US, V34, P10996, DOI 10.1021/bi00035a005; Widdus R, 2001, B WORLD HEALTH ORGAN, V79, P713; Wilde C, 2002, BIOCHEMISTRY-US, V41, P1539, DOI 10.1021/bi015809i; ZHANG RG, 1995, J MOL BIOL, V251, P563, DOI 10.1006/jmbi.1995.0456; Zhou GC, 2004, J AM CHEM SOC, V126, P5690, DOI 10.1021/ja038159+; Zhu XJ, 2001, BIOCHEMISTRY-US, V40, P4560, DOI 10.1021/bi002628s; Zhu XJ, 2001, J BIOL CHEM, V276, P25014, DOI 10.1074/jbc.M100923200	39	116	120	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2005	309	5737					1093	1096		10.1126/science.1113398	http://dx.doi.org/10.1126/science.1113398			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955MN	16099990				2022-12-01	WOS:000231230100051
J	Hemann, MT; Bric, A; Teruya-Feldstein, J; Herbst, A; Nilsson, JA; Cordon-Cardo, C; Cleveland, JL; Tansey, WP; Lowe, SW				Hemann, MT; Bric, A; Teruya-Feldstein, J; Herbst, A; Nilsson, JA; Cordon-Cardo, C; Cleveland, JL; Tansey, WP; Lowe, SW			Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants	NATURE			English	Article							BURKITT-LYMPHOMA CELLS; N-TERMINAL DOMAIN; C-MYC; TRANSACTIVATION DOMAIN; TRANSFORMING ACTIVITY; IN-VIVO; MUTATIONS; APOPTOSIS; ONCOGENE; GENE	The c-Myc oncoprotein promotes proliferation and apoptosis, such that mutations that disable apoptotic programmes often cooperate with MYC during tumorigenesis. Here we report that two common mutant MYC alleles derived from human Burkitt's lymphoma uncouple proliferation from apoptosis and, as a result, are more effective than wild-type MYC at promoting B cell lymphomagenesis in mice. Mutant MYC proteins retain their ability to stimulate proliferation and activate p53, but are defective at promoting apoptosis due to a failure to induce the BH3-only protein Bim ( a member of the B cell lymphoma 2 (Bcl2) family) and effectively inhibit Bcl2. Disruption of apoptosis through enforced expression of Bcl2, or loss of either Bim or p53 function, enables wild-type MYC to produce lymphomas as efficiently as mutant MYC. These data show how parallel apoptotic pathways act together to suppress MYC-induced transformation, and how mutant MYC proteins, by selectively disabling a p53-independent pathway, enable tumour cells to evade p53 action during lymphomagenesis.	Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; St Jude Children's Research Hospital	Lowe, SW (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	lowe@cshl.org	Nilsson, Jonas/E-5346-2013	Nilsson, Jonas/0000-0003-0346-6837	NATIONAL CANCER INSTITUTE [P01CA087497, P30CA008748] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA087497, P30 CA008748] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; ALBERT T, 1994, ONCOGENE, V9, P759; Bemark M, 2000, ONCOGENE, V19, P3404, DOI 10.1038/sj.onc.1203686; BHATIA K, 1993, NAT GENET, V5, P56, DOI 10.1038/ng0993-56; BHATIA KG, 1992, CANCER RES, V52, P4273; Chang DW, 2000, MOL CELL BIOL, V20, P4309, DOI 10.1128/MCB.20.12.4309-4319.2000; CLARK HM, 1994, CANCER RES, V54, P3383; Cole M D, 1986, Basic Life Sci, V38, P399; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; Dang CV, 1999, MOL CELL BIOL, V19, P1; DAVIS M, 1984, NATURE, V308, P286, DOI 10.1038/308286a0; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; FRYKBERG L, 1987, ONCOGENE, V1, P415; GAIDANO G, 1991, P NATL ACAD SCI USA, V88, P5413, DOI 10.1073/pnas.88.12.5413; HENRIKSSON M, 1993, ONCOGENE, V8, P3199; HOANG AT, 1995, MOL CELL BIOL, V15, P4031; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Maclean KH, 2003, MOL CELL BIOL, V23, P7256, DOI 10.1128/MCB.23.20.7256-7270.2003; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; RABBITTS TH, 1983, NATURE, V306, P760, DOI 10.1038/306760a0; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Sears RC, 2004, CELL CYCLE, V3, P1133, DOI 10.4161/cc.3.9.1145; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SPENCER CA, 1991, ADV CANCER RES, V56, P1; WESTAWAY D, 1984, P NATL ACAD SCI-BIOL, V81, P843, DOI 10.1073/pnas.81.3.843; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Yu DN, 2002, ONCOGENE, V21, P1922, DOI 10.1038/sj.onc.1205244	30	340	368	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2005	436	7052					807	811		10.1038/nature03845	http://dx.doi.org/10.1038/nature03845			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953XG	16094360	Green Accepted			2022-12-01	WOS:000231116500036
J	Long, SB; Campbell, EB; MacKinnon, R				Long, SB; Campbell, EB; MacKinnon, R			Voltage sensor of kv1.2: Structural basis of electromechanical coupling	SCIENCE			English	Article							SHAKER K+ CHANNEL; POTASSIUM-CHANNEL; CHARGE MOVEMENT; GATING CHARGE; ION CHANNELS; S4 SEGMENT; ACTIVATION GATE; PORE DOMAIN; PERSPECTIVE; MEMBRANE	Voltage-dependent ion channels contain voltage sensors that allow them to switch between nonconductive and conductive states over the narrow range of a few hundredths of a volt. We investigated the mechanism by which these channels sense cell membrane voltage by determining the x-ray crystal structure of a mammalian Shaker family potassium ion (K+) channel. The voltage-dependent K+ channel Kv1.2 grew three-dimensional crystals, with an internal arrangement that left the voltage sensors in an apparently native conformation, allowing us to reach three important conclusions. First, the voltage sensors are essentially independent domains inside the membrane. Second, they perform mechanical work on the pore through the S4-S5 linker helices, which are positioned to constrict or dilate the S6 inner helices of the pore. Third, in the open conformation, two of the four conserved Arg residues on S4 are on a lipid-facing surface and two are buried in the voltage sensor. The structure offers a simple picture of how membrane voltage influences the open probability of the channel.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10021 USA.	mackinn@rockefeller.edu			NIGMS NIH HHS [GM43949] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043949] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; Baker OS, 1998, NEURON, V20, P1283, DOI 10.1016/S0896-6273(00)80507-3; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Bezanilla F, 2002, J GEN PHYSIOL, V120, P465, DOI 10.1085/jgp.20028660; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; Cuello LG, 2004, SCIENCE, V306, P491, DOI 10.1126/science.1101373; Elinder F, 2001, BIOPHYS J, V80, P1802, DOI 10.1016/S0006-3495(01)76150-4; Elliott DJS, 2004, EMBO J, V23, P4717, DOI 10.1038/sj.emboj.7600484; Gandhi CS, 2003, NEURON, V40, P515, DOI 10.1016/S0896-6273(03)00646-9; Gandhi CS, 2002, J GEN PHYSIOL, V120, P455, DOI 10.1085/jgp.20028678; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; Gonzalez C, 2005, P NATL ACAD SCI USA, V102, P5020, DOI 10.1073/pnas.0501051102; Hackos DH, 2002, J GEN PHYSIOL, V119, P521, DOI 10.1085/jgp.20028569; Hessa T, 2005, SCIENCE, V307, P1427, DOI 10.1126/science.1109176; Horn R, 2002, J GEN PHYSIOL, V120, P449, DOI 10.1085/jgp.20028658; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Laine M, 2004, FEBS LETT, V564, P257, DOI 10.1016/S0014-5793(04)00273-X; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Lee HC, 2003, NEURON, V40, P527, DOI 10.1016/S0896-6273(03)00636-6; Li-Smerin YY, 2000, NEURON, V25, P411, DOI 10.1016/S0896-6273(00)80904-6; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; MacKinnon R, 2004, SCIENCE, V306, P1304, DOI 10.1126/science.1105528; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; RUTA V, 2005, THESIS ROCKEFELLER U; Schoppa NE, 1998, J GEN PHYSIOL, V111, P295, DOI 10.1085/jgp.111.2.295; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Sukhareva M, 2003, J GEN PHYSIOL, V122, P541, DOI 10.1085/jgp.200308905; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; Yusaf SP, 1996, PFLUG ARCH EUR J PHY, V433, P91, DOI 10.1007/s004240050253	43	769	782	3	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2005	309	5736					903	908		10.1126/science.1116270	http://dx.doi.org/10.1126/science.1116270			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953SS	16002579				2022-12-01	WOS:000231101400037
J	Kapadia, S				Kapadia, S			Spot diagnosis or misdiagnosis?	LANCET			English	Editorial Material									Sir Ganga Ram Hosp, Dept Vasc Surg, New Delhi, India		Kapadia, S (corresponding author), Sir Ganga Ram Hosp, Dept Vasc Surg, New Delhi, India.	drsumit_k@rediffmaff.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 30	2005	366	9483					425	425		10.1016/S0140-6736(05)67026-2	http://dx.doi.org/10.1016/S0140-6736(05)67026-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	950IB	16054944				2022-12-01	WOS:000230849700031
J	Beaulieu, JM; Sotnikova, TD; Marion, S; Lefkowitz, RJ; Gainetdinov, RR; Caron, MG				Beaulieu, JM; Sotnikova, TD; Marion, S; Lefkowitz, RJ; Gainetdinov, RR; Caron, MG			An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior	CELL			English	Article							PROTEIN-KINASE-B; BETA-ARRESTIN; REWARDING PROPERTIES; SYNTHASE KINASE-3; PHOSPHATASE 2A; MICE LACKING; RECEPTOR; ACTIVATION; PHOSPHORYLATION; COCAINE	Dopamine plays an important role in the etiology of schizophrenia, and D2 class dopamine receptors are the best-established target of antipsychotic drugs. Here we show that D2 class-receptor-mediated Akt regulation involves the formation of signaling complexes containing beta-arrestin 2, PP2A, and Akt. beta-arrestin 2 deficiency in mice results in reduction of dopamine-dependent behaviors, loss of Akt regulation by dopamine in the striatum, and disruption of the dopamine-dependent interaction of Akt with its negative regulator, protein phosphatase 2A. Importantly, canonical cAMP-mediated dopamine-receptor signaling is not inhibited in the absence of beta-arrestin 2. These results demonstrate that, apart from its classical function in receptor desensitization, beta-arrestin 2 also acts as a signaling intermediate through a kinase/phosphatase scaffold. Furthermore, this function of beta-arrestin 2 is important for the expression of dopamine-associated behaviors, thus implicating beta-arrestin 2 as a positive mediator of dopaminergic synaptic transmission and a potential pharmacological target for dopamine-related psychiatric disorders.	Duke Univ, Med Ctr, Inst Genome Sci & Policy, Ctr Model Human Dis,Dept Cell Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Biochem, Durham, NC 27710 USA	Duke University; Duke University; Howard Hughes Medical Institute; Duke University; Howard Hughes Medical Institute	Caron, MG (corresponding author), Duke Univ, Med Ctr, Inst Genome Sci & Policy, Ctr Model Human Dis,Dept Cell Biol, Durham, NC 27710 USA.	caron002@mc.duke.edu	Gainetdinov, Raul R/G-5875-2011; Lefkowitz, Robert/AAW-2649-2021; Beaulieu, Jean-Martin/A-7598-2008; Sotnikova, Tatyana D/T-9992-2017; soler, martha maricel m gomez/L-6025-2014	Gainetdinov, Raul R/0000-0003-2951-6038; Beaulieu, Jean-Martin/0000-0002-0446-7447; soler, martha maricel m gomez/0000-0002-4412-8108; Marion, Sebastien/0000-0002-3302-3845	NIDA NIH HHS [DA-13511] Funding Source: Medline; NIMH NIH HHS [MH-40159] Funding Source: Medline; NINDS NIH HHS [NS-19576] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH040159, P30MH040159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013511] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Bohn LM, 2003, J NEUROSCI, V23, P10265; Brami-Cherrier K, 2002, J NEUROSCI, V22, P8911; Carlsson A, 2001, SCIENCE, V294, P1021, DOI 10.1126/science.1066969; Chalecka-Franaszek E, 1999, P NATL ACAD SCI USA, V96, P8745, DOI 10.1073/pnas.96.15.8745; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Cyr M, 2003, P NATL ACAD SCI USA, V100, P11035, DOI 10.1073/pnas.1831768100; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Fienberg AA, 1998, SCIENCE, V281, P838, DOI 10.1126/science.281.5378.838; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; Gainetdinov RR, 2003, NEURON, V38, P291, DOI 10.1016/S0896-6273(03)00192-2; Gainetdinov RR, 2003, ANNU REV PHARMACOL, V43, P261, DOI 10.1146/annurev.pharmtox.43.050802.112309; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Goel R, 2002, J BIOL CHEM, V277, P18640, DOI 10.1074/jbc.M108995200; Gould TD, 2004, INT J NEUROPSYCHOPH, V7, P387, DOI 10.1017/S1461145704004535; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; Ikeda M, 2004, BIOL PSYCHIAT, V56, P698, DOI 10.1016/j.biopsych.2004.07.023; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; JESSELL TM, 1993, CELL, V72, P1, DOI 10.1016/S0092-8674(05)80025-X; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; Kang UG, 2004, FEBS LETT, V560, P115, DOI 10.1016/S0014-5793(04)00082-1; Krupnick JG, 1997, J BIOL CHEM, V272, P15011, DOI 10.1074/jbc.272.23.15011; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Li LK, 2003, MOL CELL BIOL, V23, P9389, DOI 10.1128/MCB.23.24.9389-9404.2003; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; McCluskey Adam, 2001, Mini-Reviews in Medicinal Chemistry, V1, P43, DOI 10.2174/1389557013407205; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Nair VD, 2003, J BIOL CHEM, V278, P47053, DOI 10.1074/jbc.M303364200; Nally RE, 2003, NEUROPSYCHOPHARMACOL, V28, P2055, DOI 10.1038/sj.npp.1300259; Nishi A, 1997, J NEUROSCI, V17, P8147; Povsic TJ, 2003, J BIOL CHEM, V278, P51334, DOI 10.1074/jbc.M309968200; Scheid MP, 2001, NAT REV MOL CELL BIO, V2, P760, DOI 10.1038/35096067; SNYDER SH, 1976, AM J PSYCHIAT, V133, P197; Ugi S, 2004, MOL CELL BIOL, V24, P8778, DOI 10.1128/MCB.24.19.8778-8789.2004; UNWIN N, 1993, CELL, V72, P31, DOI 10.1016/S0092-8674(05)80026-1; Valjent E, 2000, J NEUROSCI, V20, P8701; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Walsh AH, 1997, FEBS LETT, V416, P230, DOI 10.1016/S0014-5793(97)01210-6; Wang YM, 1997, NEURON, V19, P1285, DOI 10.1016/S0896-6273(00)80419-5; WILCOX RE, 1980, PHARMACOL BIOCHEM BE, V12, P29, DOI 10.1016/0091-3057(80)90411-6; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0	51	764	793	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 29	2005	122	2					261	273		10.1016/j.cell.2005.05.012	http://dx.doi.org/10.1016/j.cell.2005.05.012			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	951CR	16051150	Bronze			2022-12-01	WOS:000230907000013
J	Sengupta, S; Eavarone, D; Capila, I; Zhao, GL; Watson, N; Kiziltepe, T; Sasisekharan, R				Sengupta, S; Eavarone, D; Capila, I; Zhao, GL; Watson, N; Kiziltepe, T; Sasisekharan, R			Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system	NATURE			English	Article							ANGIOGENESIS INHIBITORS; ANTIANGIOGENIC THERAPY; HYPOXIA; VASCULATURE; GROWTH	In the continuing search for effective treatments for cancer, the emerging model is the combination of traditional chemotherapy with anti-angiogenesis agents(1) that inhibit blood vessel growth. However, the implementation of this strategy has faced two major obstacles. First, the long-term shutdown of tumour blood vessels by the anti-angiogenesis agent can prevent the tumour from receiving a therapeutic concentration of the chemotherapy agent. Second, inhibiting blood supply drives the intra-tumoural accumulation of hypoxia-inducible factor-1 alpha (HIF1-alpha); overexpression of HIF1-alpha is correlated with increased tumour invasiveness and resistance to chemotherapy(2-5). Here we report the disease-driven engineering of a drug delivery system, a 'nanocell', which overcomes these barriers unique to solid tumours. The nanocell comprises a nuclear nanoparticle within an extranuclear pegylated-lipid envelope, and is preferentially taken up by the tumour. The nanocell enables a temporal release of two drugs: the outer envelope first releases an anti-angiogenesis agent, causing a vascular shutdown; the inner nanoparticle, which is trapped inside the tumour, then releases a chemotherapy agent. This focal release within a tumour results in improved therapeutic index with reduced toxicity. The technology can be extended to additional agents, so as to target multiple signalling pathways or distinct tumour compartments, enabling the model of an 'integrative' approach in cancer therapy.	MIT, Biol Engn Div, Cambridge, MA 02139 USA; MIT, Dept Chem, Cambridge, MA 02139 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Sasisekharan, R (corresponding author), MIT, Biol Engn Div, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	rams@MIT.edu						Allen TM, 2002, NAT REV CANCER, V2, P750, DOI 10.1038/nrc903; Arap W, 2002, NAT MED, V8, P121, DOI 10.1038/nm0202-121; Blagosklonny MV, 2004, CANCER CELL, V5, P13, DOI 10.1016/S1535-6108(03)00336-2; Chabner B.A, 1996, GOODMAN GILMANS PHAR; Hanahan D, 2000, J CLIN INVEST, V105, P1045, DOI 10.1172/JCI9872; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; Kerbel RS, 2004, NAT REV CANCER, V4, P423, DOI 10.1038/nrc1369; Kieran MW, 2003, NAT MED, V9, P1104, DOI 10.1038/nm0903-1104a; MIKLOS AG, 1994, BIOMATERIALS, V15, P55; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Rofstad EK, 2002, CANCER RES, V62, P1847; Semenza GL, 2000, J CLIN INVEST, V106, P809, DOI 10.1172/JCI11223; Sengupta S, 2004, FASEB J, V18, P1565, DOI 10.1096/fj.04-1934fje; Tong RT, 2004, CANCER RES, V64, P3731, DOI 10.1158/0008-5472.CAN-04-0074; Tozer GM, 2002, INT J EXP PATHOL, V83, P21, DOI 10.1046/j.1365-2613.2002.00211.x; Tran J, 2002, P NATL ACAD SCI USA, V99, P4349, DOI 10.1073/pnas.072586399; Yoo HS, 1999, PHARMACEUT RES, V16, P1114, DOI 10.1023/A:1018908421434; Yu JL, 2002, SCIENCE, V295, P1526, DOI 10.1126/science.1068327; YUAN F, 1995, CANCER RES, V55, P3752	21	762	813	7	338	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2005	436	7050					568	572		10.1038/nature03794	http://dx.doi.org/10.1038/nature03794			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049491				2022-12-01	WOS:000230788800064
J	Berti, A; Bottini, G; Gandola, M; Pia, L; Smania, N; Stracciari, A; Castiglioni, I; Vallar, G; Paulesu, E				Berti, A; Bottini, G; Gandola, M; Pia, L; Smania, N; Stracciari, A; Castiglioni, I; Vallar, G; Paulesu, E			Shared cortical anatomy for motor, awareness and motor control	SCIENCE			English	Article							UNILATERAL NEGLECT; RIGHT-HEMISPHERE; ANOSOGNOSIA; HEMIPLEGIA; METAANALYSIS; IMAGERY; LESIONS; SYSTEM	In everyday life, the successful monitoring of behavior requires continuous updating of the effectiveness of motor acts; one crucial step is becoming aware of the movements one. is performing. We studied the anatomical distribution of lesions in right-brain-damaged hemiplegic patients, who obstinately denied their motor impairment, claiming that they could move their paralyzed limbs. Denial was associated with lesions in areas related to the programming of motor acts, particularly Brodmann's premotor areas 6 and 44, motor area 4, and the somatosensory cortex. This association suggests that monitoring systems may be implemented within the same cortical network that is responsible for the primary function that has to be monitored.	Univ Turin, Dept Psychol, I-10123 Turin, Italy; Univ Turin, Ctr Cognit Sci, I-10123 Turin, Italy; Univ Pavia, Dept Psychol, I-27100 Pavia, Italy; GB Rossi Univ Hosp, Rehabil Unit, I-37134 Verona, Italy; St Orsola Marcello Malpighi Hosp, Neurol Unit, I-40138 Bologna, Italy; CNR, Bioimaging & Mol Physiol Inst, I-20090 Milan, Italy; Univ Milano Bicocca, Dept Psychol, I-20126 Milan, Italy	University of Turin; University of Turin; University of Pavia; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Consiglio Nazionale delle Ricerche (CNR); University of Milano-Bicocca	Berti, A (corresponding author), Univ Turin, Dept Psychol, Via Po 14, I-10123 Turin, Italy.	berti@psych.unito.it	Castiglioni, Isabella/AAC-4949-2022; Gandola, Martina/GVR-2848-2022; Pia, Lorenzo/R-5263-2016; Gandola, Martina/AAC-1405-2019; Vallar, Giuseppe/K-8443-2012; PAULESU, ERALDO/C-2737-2017	Pia, Lorenzo/0000-0002-0360-3152; Gandola, Martina/0000-0002-0537-586X; Vallar, Giuseppe/0000-0001-7015-0117; BOTTINI, GABRIELLA/0000-0003-4683-6420; PAULESU, ERALDO/0000-0002-9224-754X; Castiglioni, Isabella/0000-0001-7191-5417; stracciari, andrea/0000-0002-7058-4772				Babinski J, 1914, REV NEUROL, V27, P845; Berti A, 1996, J Int Neuropsychol Soc, V2, P426; BERTI A, 1992, J COGNITIVE NEUROSCI, V4, P345, DOI 10.1162/jocn.1992.4.4.345; Berti A., 1998, ANOSOGNOSIA MOTOR IM, V3, P21, DOI DOI 10.1080/135468098396233; BISIACH E, 1986, NEUROPSYCHOLOGIA, V24, P471, DOI 10.1016/0028-3932(86)90092-8; Bisiach E., 1999, HDB CLIN EXPT NEUROP, P479; BISIACH E, 1995, COGNITIVE NEUROSCIEN, P1131; Bisiach E., 1991, AWARENESS DEFICIT BR, P17; BOTTINI G, 1995, NATURE, V376, P778, DOI 10.1038/376778a0; Dauriac-Le Masson V, 2002, REV NEUROL-FRANCE, V158, P427; Frith CD, 2000, PHILOS T R SOC B, V355, P1771, DOI 10.1098/rstb.2000.0734; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; Jackson PL, 2004, CURR OPIN NEUROBIOL, V14, P259, DOI 10.1016/j.conb.2004.01.020; JEANNEROD M, 1994, BEHAV BRAIN SCI, V17, P187, DOI 10.1017/S0140525X00034026; Karnath HO, 2001, NATURE, V411, P950, DOI 10.1038/35082075; McGuire PK, 1996, BRIT J PSYCHIAT, V169, P148, DOI 10.1192/bjp.169.2.148; Mort DJ, 2003, BRAIN, V126, P1986, DOI 10.1093/brain/awg200; Pia L, 2004, CORTEX, V40, P367, DOI 10.1016/S0010-9452(08)70131-X; Rizzolatti G, 1998, ELECTROEN CLIN NEURO, V106, P283, DOI 10.1016/S0013-4694(98)00022-4; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Roth R, 1996, NEUROREPORT, V7, P1280, DOI 10.1097/00001756-199605170-00012; Small M, 1996, EUR NEUROL, V36, P353, DOI 10.1159/000117293; Tanji J, 1996, CURR OPIN NEUROBIOL, V6, P782, DOI 10.1016/S0959-4388(96)80028-6; VALLAR G, 1986, NEUROPSYCHOLOGIA, V24, P609, DOI 10.1016/0028-3932(86)90001-1	24	249	249	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2005	309	5733					488	491		10.1126/science.1110625	http://dx.doi.org/10.1126/science.1110625			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946LY	16020740				2022-12-01	WOS:000230574900053
J	Dupuy, AJ; Akagi, K; Largaespada, DA; Copeland, NG; Jenkins, NA				Dupuy, AJ; Akagi, K; Largaespada, DA; Copeland, NG; Jenkins, NA			Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system	NATURE			English	Article							CHROMOSOMAL TRANSPOSITION; MLV INTEGRATION; HUMAN-CELLS; GENE; MOUSE; DROSOPHILA; GENOME; MICE; DISRUPTION; EXPRESSION	Transposons have provided important genetic tools for functional genomic screens in lower eukaryotes but have proven less useful in higher eukaryotes because of their low transposition frequency. Here we show that Sleeping Beauty (SB), a member of the Tc1/mariner class of transposons, can be mobilized in mouse somatic cells at frequencies high enough to induce embryonic death and cancer in wild-type mice. Tumours are aggressive, with some animals developing two or even three different types of cancer within a few months of birth. The tumours result from SB insertional mutagenesis of cancer genes, thus facilitating the identification of genes and pathways that induce disease. SB transposition can easily be controlled to mutagenize any target tissue and can therefore, in principle, be used to induce many of the cancers affecting humans, including those for which little is known about the aetiology. The uses of SB are also not restricted to the mouse and could potentially be used for forward genetic screens in any higher eukaryote in which transgenesis is possible.	NCI, Ctr Canc Res, Mouse Canc Genet Program, Frederick, MD 21702 USA; Univ Minnesota, Ctr Canc, Dept Genet Cell Biol & Dev, Arnold & Mabel Beckman Ctr Transposon Res, Minneapolis, MN 55455 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Minnesota System; University of Minnesota Twin Cities	Jenkins, NA (corresponding author), NCI, Ctr Canc Res, Mouse Canc Genet Program, Frederick, MD 21702 USA.	jenkins@ncifcrf.gov	Largaespada, David/C-9832-2014; Wilson, Matthew H/K-3193-2013	Dupuy, Adam/0000-0002-8561-4911	DIVISION OF BASIC SCIENCES - NCI [Z01BC010556] Funding Source: NIH RePORTER	DIVISION OF BASIC SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barnes DE, 1998, CURR BIOL, V8, P1395, DOI 10.1016/S0960-9822(98)00021-9; BELLEN HJ, 1989, GENE DEV, V3, P1288, DOI 10.1101/gad.3.9.1288; Beverly LJ, 2003, CANCER CELL, V3, P551, DOI 10.1016/S1535-6108(03)00137-5; Carlson CM, 2003, GENETICS, V165, P243; Cui ZB, 2002, J MOL BIOL, V318, P1221, DOI 10.1016/S0022-2836(02)00237-1; Davidson AE, 2003, DEV BIOL, V263, P191, DOI 10.1016/j.ydbio.2003.07.013; Dupuy AJ, 2001, GENESIS, V30, P82, DOI 10.1002/gene.1037; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Fischer SEJ, 2001, P NATL ACAD SCI USA, V98, P6759, DOI 10.1073/pnas.121569298; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; Geurts AM, 2003, MOL THER, V8, P108, DOI 10.1016/S1525-0016(03)00099-6; Grabher C, 2003, GENE, V322, P57, DOI 10.1016/j.gene.2003.09.009; Horie K, 2003, MOL CELL BIOL, V23, P9189, DOI 10.1128/MCB.23.24.9189-9207.2003; Horie K, 2001, P NATL ACAD SCI USA, V98, P9191, DOI 10.1073/pnas.161071798; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Luo GB, 1998, P NATL ACAD SCI USA, V95, P10769, DOI 10.1073/pnas.95.18.10769; OSBORNE BI, 1995, CURR OPIN CELL BIOL, V7, P406, DOI 10.1016/0955-0674(95)80097-2; Plasterk RHA, 1996, CURR TOP MICROBIOL, V204, P125; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SPRADLING AC, 1995, P NATL ACAD SCI USA, V92, P10824, DOI 10.1073/pnas.92.24.10824; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Yant SR, 2005, MOL CELL BIOL, V25, P2085, DOI 10.1128/MCB.25.6.2085-2094.2005	24	394	417	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2005	436	7048					221	226		10.1038/nature03691	http://dx.doi.org/10.1038/nature03691			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944VR	16015321				2022-12-01	WOS:000230459500032
J	Pascal, AA; Liu, ZF; Broess, K; van Oort, B; van Amerongen, H; Wang, C; Horton, P; Robert, B; Chang, WR; Ruban, A				Pascal, AA; Liu, ZF; Broess, K; van Oort, B; van Amerongen, H; Wang, C; Horton, P; Robert, B; Chang, WR; Ruban, A			Molecular basis of photoprotection and control of photosynthetic light-harvesting	NATURE			English	Article							CHLOROPHYLL-PROTEIN COMPLEX; TIME-RESOLVED FLUORESCENCE; GREEN PLANTS; EXCITATION-ENERGY; BINDING; LHCII; MECHANISM; XANTHOPHYLLS; ZEAXANTHIN; MEMBRANES	In order to maximize their use of light energy in photosynthesis, plants have molecules that act as light-harvesting antennae, which collect light quanta and deliver them to the reaction centres, where energy conversion into a chemical form takes place. The functioning of the antenna responds to the extreme changes in the intensity of sunlight encountered in nature(1-3). In shade, light is efficiently harvested in photosynthesis. However, in full sunlight, much of the energy absorbed is not needed and there are vitally important switches to specific antenna states, which safely dissipate the excess energy as heat(2,3). This is essential for plant survival(4), because it provides protection against the potential photo-damage of the photosynthetic membrane(5). But whereas the features that establish high photosynthetic efficiency have been highlighted(6), almost nothing is known about the molecular nature of the dissipative states. Recently, the atomic structure of the major plant light-harvesting antenna protein, LHCII, has been determined by X-ray crystallography(7). Here we demonstrate that this is the structure of a dissipative state of LHCII. We present a spectroscopic analysis of this crystal form, and identify the specific changes in configuration of its pigment population that give LHCII the intrinsic capability to regulate energy flow. This provides a molecular basis for understanding the control of photosynthetic light-harvesting.	Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; CNRS, URA 2096, Serv Biophys Fonct Membranaires, F-91191 Gif Sur Yvette, France; CEA Saclay, DBJC, F-91191 Gif Sur Yvette, France; Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; Univ Wageningen & Res Ctr, Biophys Lab, NL-6700 ET Wageningen, Netherlands	University of Sheffield; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Chinese Academy of Sciences; Institute of Biophysics, CAS; Wageningen University & Research	Horton, P (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Western Bank, Sheffield S10 2TN, S Yorkshire, England.	p.horton@sheffield.ac.uk; robert@dsvidf.cea.fr	Robert, Bruno/D-1264-2012; van Amerongen, Herbert/J-9483-2016; Horton, Peter/A-3958-2012; pascal, andrew a/B-6186-2014; van Oort, Bart/C-4674-2008	Robert, Bruno/0000-0001-5999-4538; van Amerongen, Herbert/0000-0002-9783-2895; Horton, Peter/0000-0002-6095-1460; pascal, andrew a/0000-0002-1844-6065; van Oort, Bart/0000-0002-5470-1545; liu, zhen feng/0000-0001-5502-9474				BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; Barzda V, 2001, BIOPHYS J, V81, P538, DOI 10.1016/S0006-3495(01)75720-7; BEDDARD GS, 1976, NATURE, V260, P366, DOI 10.1038/260366a0; Croce R, 1999, FEBS LETT, V456, P1, DOI 10.1016/S0014-5793(99)00907-2; Demmig-Adams B, 2002, SCIENCE, V298, P2149, DOI 10.1126/science.1078002; DEMMIGADAMS B, 1990, BIOCHIM BIOPHYS ACTA, V1020, P1, DOI 10.1016/0005-2728(90)90088-L; Finazzi G, 2004, P NATL ACAD SCI USA, V101, P12375, DOI 10.1073/pnas.0404798101; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Horton P, 2005, J EXP BOT, V56, P365, DOI 10.1093/jxb/eri023; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; HORTON P, 1991, FEBS LETT, V292, P1, DOI 10.1016/0014-5793(91)80819-O; Kulheim C, 2002, SCIENCE, V297, P91, DOI 10.1126/science.1072359; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Moya I, 2001, BIOCHEMISTRY-US, V40, P12552, DOI 10.1021/bi010342x; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; MULLET JE, 1980, BIOCHIM BIOPHYS ACTA, V589, P100, DOI 10.1016/0005-2728(80)90135-8; MULLINEAUX CW, 1993, BIOCHIM BIOPHYS ACTA, V1141, P23, DOI 10.1016/0005-2728(93)90184-H; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Remelli R, 1999, J BIOL CHEM, V274, P33510, DOI 10.1074/jbc.274.47.33510; Robert B, 2004, TRENDS PLANT SCI, V9, P385, DOI 10.1016/j.tplants.2004.06.006; Ruban AV, 2000, FEBS LETT, V477, P181, DOI 10.1016/S0014-5793(00)01799-3; Ruban AV, 1999, J BIOL CHEM, V274, P10458, DOI 10.1074/jbc.274.15.10458; RUBAN AV, 1992, BIOCHIM BIOPHYS ACTA, V1102, P30, DOI 10.1016/0167-4838(92)90495-Y; RUBAN AV, 1995, BIOCHEMISTRY-US, V34, P2333, DOI 10.1021/bi00007a029; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; van Amerongen H, 2001, J PHYS CHEM B, V105, P604, DOI 10.1021/jp0028406; Wentworth M, 2003, J BIOL CHEM, V278, P21845, DOI 10.1074/jbc.M302586200	29	503	517	10	186	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2005	436	7047					134	137		10.1038/nature03795	http://dx.doi.org/10.1038/nature03795			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942QJ	16001075				2022-12-01	WOS:000230296600053
J	Rothwell, PM; Giles, MF; Flossmann, E; Lovelock, CE; Redgrave, JNE; Warlow, CP; Mehta, Z				Rothwell, PM; Giles, MF; Flossmann, E; Lovelock, CE; Redgrave, JNE; Warlow, CP; Mehta, Z			A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack	LANCET			English	Article							SYMPTOMATIC CAROTID STENOSIS; ACUTE CORONARY SYNDROMES; PROGNOSIS; OXFORDSHIRE; ENDARTERECTOMY; CLOPIDOGREL; PREVENTION; MANAGEMENT; SUBGROUPS; MORTALITY	Background Effective early management of patients with transient ischaemic attacks (TIA) is undermined by an inability to predict who is at highest early risk of stroke. Methods We derived a score for 7-day risk of stroke in a population-based cohort of patients (n=209) with a probable or definite TIA (Oxfordshire Community Stroke Project; OCSP), and validated the score in a similar population-based cohort (Oxford Vascular Study; OXVASC, n=190). We assessed likely clinical usefulness to front-line health services by using the score to stratify all patients with suspected TIA referred to OXVASC (n=378, outcome: 7-day risk of stroke) and to a hospital-based weekly TIA clinic (n=210; outcome: risk of stroke before appointment) Results A six-point score derived in the OCSP (age [>= 60 years=1], blood pressure [systolic >140 mm Hg and/or diastolic >= 90 mm Hg=1], clinical features [unilateral weakness=2, speech disturbance without weakness=1, other=0], and duration of symptoms in min [>= 60=2,10-59=1, <10=0]; ABCD) was highly predictive of 7-day risk of stroke in OXVASC patients with probable or definite TIA (p<0.0001), in the OXVASC population-based cohort of all referrals with suspected TIA (p<0.0001), and in the hospital-based weekly TIA clinic-referred cohort (p=0.006). In the OXVASC suspected TIA cohort, 19 of 20 (95%) strokes occurred in 101 (27%) patients with a score of 5 or greater: 7-day risk was 0.4% (95% CI 0-1.1) in 274 (73%) patients with a score less than 5, 12.1% (4.2-20.0) in 66 (18%) with a score of 5, and 31.4% (16.0-46.8) in 35 (9%) with a score of 6. In the hospital-referred clinic cohort, 14 (7.5%) patients had a stroke before their scheduled appointment, all with a score of 4 or greater. Conclusions Risk of stroke during the 7 days after TIA seems to be highly predictable. Although further validations and refinements are needed, the ABCD score can be used in routine clinical practice to identify high-risk individuals who need emergency investigation and treatment.	Univ Oxford, Radcliffe Infirm, Dept Clin Neurol, Stroke Prevent Res Unit, Oxford OX2 6HE, England; Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh, Midlothian, Scotland	Radcliffe Infirmary; University of Oxford; University of Edinburgh	Rothwell, PM (corresponding author), Univ Oxford, Radcliffe Infirm, Dept Clin Neurol, Stroke Prevent Res Unit, Oxford OX2 6HE, England.	peter.rothwell@clneuro.ox.ac.uk	Rothwell, Peter/ABE-5913-2020	Rothwell, Peter/0000-0001-9739-9211	Medical Research Council [G0500987] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5; Bond R, 2003, STROKE, V34, P2290, DOI 10.1161/01.STR.0000087785.01407.CC; Coull AJ, 2004, STROKE, V35, P2041, DOI 10.1161/01.STR.0000137605.48864.2f; Coull AJ, 2004, STROKE, V35, P1925, DOI 10.1161/01.STR.0000133129.58126.67; Coull AJ, 2004, BMJ-BRIT MED J, V328, P326, DOI 10.1136/bmj.37991.635266.44; DENNIS M, 1990, STROKE, V21, P848, DOI 10.1161/01.STR.21.6.848; DENNIS MS, 1989, STROKE, V20, P333, DOI 10.1161/01.STR.20.3.333; GILES MF, 2004, CEREBROVASC DIS, V17, P6; Gladstone DJ, 2002, STROKE, V33, P2123, DOI 10.1161/01.STR.0000025518.34157.51; Goldstein LB, 2000, ARCH INTERN MED, V160, P2941, DOI 10.1001/archinte.160.19.2941; Gubitz G, 1999, CEREBROVASC DIS, V9, P210, DOI 10.1159/000015957; Hacke W, 2004, LANCET, V363, P768; HANKEY GJ, 1992, J NEUROL NEUROSUR PS, V55, P640, DOI 10.1136/jnnp.55.8.640; HATANO S, 1976, B WORLD HEALTH ORGAN, V56, P541; Hill MD, 2004, NEUROLOGY, V62, P2015, DOI 10.1212/01.WNL.0000129482.70315.2F; *INT STROK TRIAL C, 1977, LANCET, V349, P1569; Intercollegiate working Party for Stroke, 2004, NAT CLIN GUID STROK; Johnston SC, 2003, NEUROLOGY, V60, P1429, DOI 10.1212/01.WNL.0000063309.41867.0F; Johnston SC, 1999, EUR NEUROL, V42, P105, DOI 10.1159/000069419; Johnston SC, 2000, JAMA-J AM MED ASSOC, V284, P2901, DOI 10.1001/jama.284.22.2901; KENNEDY J, 2003, SEMIN CEREBROVASC DI, V3, P25; Kernan WN, 2000, STROKE, V31, P456, DOI 10.1161/01.STR.31.2.456; KOUDSTAAL PJ, 1993, LANCET, V342, P1255; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lisabeth LD, 2004, STROKE, V35, P1842, DOI 10.1161/01.STR.0000134416.89389.9d; Lovett JK, 2004, NEUROLOGY, V62, P569, DOI 10.1212/01.WNL.0000110311.09970.83; Lovett JK, 2003, STROKE, V34, pE138, DOI 10.1161/01.STR.0000080935.01264.91; Markus HS, 2005, CIRCULATION, V111, P2233, DOI 10.1161/01.CIR.0000163561.90680.1C; Ovbiagele B, 2004, STROKE, V35, P2879, DOI 10.1161/01.STR.0000147967.49567.d6; Pearce LA, 2000, AM J MED, V109, P45, DOI 10.1016/S0002-9343(00)00440-X; Purroy F, 2004, STROKE, V35, P2313, DOI 10.1161/01.STR.0000141703.21173.91; Rothwell PM, 2004, LANCET, V363, P915, DOI 10.1016/S0140-6736(04)15785-1; Rothwell PM, 2005, NEUROLOGY, V64, P817, DOI 10.1212/01.WNL.0000152985.32732.EE; Rothwell PM, 2003, CEREBROVASC DIS, V16, P2, DOI 10.1159/000070271; Rothwell PM, 2005, LANCET, V365, P256; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711; Wolf PA, 1999, STROKE, V30, P1991, DOI 10.1161/01.STR.30.9.1991; Yusuf S, 2001, NEW ENGL J MED, V345, P494	39	436	495	3	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 2	2005	366	9479					29	36		10.1016/S0140-6736(05)66702-5	http://dx.doi.org/10.1016/S0140-6736(05)66702-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942JB	15993230				2022-12-01	WOS:000230277600031
J	Gardner, MJ; Bishop, R; Shah, T; de Villiers, EP; Carlton, JM; Hall, N; Ren, QH; Paulsen, IT; Pain, A; Berriman, M; Wilson, RJM; Sato, S; Ralph, SA; Mann, DJ; Xiong, ZK; Shallom, SJ; Weidman, J; Jiang, LX; Lynn, J; Weaver, B; Shoaibi, A; Domingo, AR; Wasawo, D; Crabtree, J; Wortman, JR; Haas, B; Angiuoli, SV; Creasy, TH; Lu, C; Suh, B; Silva, JC; Utterback, TR; Feldblyum, TV; Pertea, M; Allen, J; Nierman, WC; Taracha, ELN; Salzberg, SL; White, OR; Fitzhugh, HA; Morzaria, S; Venter, JC; Fraser, CM; Nene, V				Gardner, MJ; Bishop, R; Shah, T; de Villiers, EP; Carlton, JM; Hall, N; Ren, QH; Paulsen, IT; Pain, A; Berriman, M; Wilson, RJM; Sato, S; Ralph, SA; Mann, DJ; Xiong, ZK; Shallom, SJ; Weidman, J; Jiang, LX; Lynn, J; Weaver, B; Shoaibi, A; Domingo, AR; Wasawo, D; Crabtree, J; Wortman, JR; Haas, B; Angiuoli, SV; Creasy, TH; Lu, C; Suh, B; Silva, JC; Utterback, TR; Feldblyum, TV; Pertea, M; Allen, J; Nierman, WC; Taracha, ELN; Salzberg, SL; White, OR; Fitzhugh, HA; Morzaria, S; Venter, JC; Fraser, CM; Nene, V			Genome sequence of Theileria parva, a bovine pathogen that transforms lymphocytes	SCIENCE			English	Article							PARASITE PLASMODIUM-FALCIPARUM; PYRUVATE-DEHYDROGENASE COMPLEX; OPEN READING FRAMES; ENCODED PROTEINS; MALARIA; GENES; DNA; APICOMPLEXAN; MITOCHONDRIA; TELOMERES	We report the genome sequence of Theileria parva, an apicomplexan pathogen causing economic losses to smallholder farmers in Africa. The parasite chromosomes exhibit limited conservation of gene synteny with Plasmodium falciparum, and its plastid-like genome represents the first example where all apicoplast genes are encoded on one DNA strand. We tentatively identify proteins that facilitate parasite segregation during host cell cytokinesis and contribute to persistent infection of transformed host cells. Several biosynthetic pathways are incomplete or absent, suggesting substantial metabolic dependence on the host cell. One protein family that may generate parasite antigenic diversity is not telomere-associated.	Inst Genom Res TIGR, Rockville, MD 20850 USA; Int Livestock Res Inst, Nairobi, Kenya; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Natl Inst Med Res, London NW7 1AA, England; Inst Pasteur, F-75724 Paris, France; Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AZ, England; Venter Inst, Rockville, MD 20850 USA	J. Craig Venter Institute; CGIAR; International Livestock Research Institute (ILRI); Wellcome Trust Sanger Institute; MRC National Institute for Medical Research; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Imperial College London; J. Craig Venter Institute	Gardner, MJ (corresponding author), Inst Genom Res TIGR, 9712 Med Ctr Dr, Rockville, MD 20850 USA.	gardner@tigr.org	Pertea, Mihaela/AAT-2705-2021; Berriman, Matthew/A-7618-2011; Pain, Arnab/L-5766-2015; Hall, Neil/A-8717-2013; Salzberg, Steven L/F-6162-2011; Salzberg, Steven/Q-6514-2019; Silva, Joana/GYQ-9526-2022; Paulsen, Ian T/K-3832-2012; Angiuoli, Samuel V/H-7340-2014; Silva, Joana/GVT-6441-2022; Sato, Shigeharu/K-9464-2013; Ralph, Stuart/C-8590-2014	Pertea, Mihaela/0000-0003-0762-8637; Berriman, Matthew/0000-0002-9581-0377; Pain, Arnab/0000-0002-1755-2819; Hall, Neil/0000-0002-7995-3810; Salzberg, Steven L/0000-0002-8859-7432; Salzberg, Steven/0000-0002-8859-7432; Paulsen, Ian T/0000-0001-9015-9418; Fraser, Claire/0000-0003-1462-2428; Hall, Neil/0000-0003-2808-0009; de Villiers, Etienne/0000-0001-9878-1009; Nene, Vishvanath/0000-0001-7066-4169; Wortman, Jennifer/0000-0002-8713-1227; Sato, Shigeharu/0000-0001-9559-7580; Shah, Trushar/0000-0002-0091-7981; Ralph, Stuart/0000-0003-0114-7808; Sato, Shigeharu/0000-0003-2738-430X; Gardner, Malcolm/0000-0003-2180-5089; Angiuoli, Samuel/0000-0001-9525-4350; Allen, Jonathan/0000-0002-4359-8263				Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; ANDERS RF, 1986, PARASITE IMMUNOL, V8, P529, DOI 10.1111/j.1365-3024.1986.tb00867.x; Barry JD, 2003, INT J PARASITOL, V33, P29, DOI 10.1016/S0020-7519(02)00247-3; BAYLIS HA, 1991, MOL BIOCHEM PARASIT, V49, P133, DOI 10.1016/0166-6851(91)90136-T; Bishop R, 1997, MOL CELL BIOL, V17, P1666, DOI 10.1128/MCB.17.3.1666; Bishop R, 2000, MOL BIOCHEM PARASIT, V110, P359, DOI 10.1016/S0166-6851(00)00291-7; BISHOP R, UNPUB; Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; Cheeseman IM, 2004, CURR BIOL, V14, pR70, DOI 10.1016/j.cub.2003.12.048; ESCALANTE AA, 1995, P NATL ACAD SCI USA, V92, P5793, DOI 10.1073/pnas.92.13.5793; Foth BJ, 2005, MOL MICROBIOL, V55, P39, DOI 10.1111/j.1365-2958.2004.04407.x; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Goedert M, 2004, SEMIN CELL DEV BIOL, V15, P45, DOI 10.1016/j.semcdb.2003.12.015; GRAHAM SV, UNPUB; GUNDERSON JH, 1987, SCIENCE, V238, P933, DOI 10.1126/science.3672135; KAIRO A, 1994, EMBO J, V13, P898, DOI 10.1002/j.1460-2075.1994.tb06333.x; Leon S, 2003, BIOCHEM J, V371, P823, DOI 10.1042/BJ20021946; MCCOLM AA, 1984, ANN TROP MED PARASIT, V78, P345, DOI 10.1080/00034983.1984.11811831; Norval R.A.I., 1992, EPIDEMIOLOGY THEILER, P481; Pain A, 2005, SCIENCE, V309, P131, DOI 10.1126/science.1110418; Ralph SA, 2005, MOL MICROBIOL, V55, P1, DOI 10.1111/j.1365-2958.2004.04314.x; Seeber F, 2002, INT J PARASITOL, V32, P1207, DOI 10.1016/S0020-7519(02)00022-X; Sohanpal B, 2000, GENE, V255, P401, DOI 10.1016/S0378-1119(00)00284-5; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; Walter RF, 2005, CURR ISSUES MOL BIOL, V7, P57, DOI 10.21775/cimb.007.057; Wilson RJM, 1996, J MOL BIOL, V261, P155, DOI 10.1006/jmbi.1996.0449; Xu XM, 2004, P NATL ACAD SCI USA, V101, P9143, DOI 10.1073/pnas.0400799101	29	255	308	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2005	309	5731					134	137		10.1126/science.1110439	http://dx.doi.org/10.1126/science.1110439			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	941KD	15994558	Bronze			2022-12-01	WOS:000230212800076
J	Maeda, S; Kamata, H; Luo, JL; Leffert, H; Karin, M				Maeda, S; Kamata, H; Luo, JL; Leffert, H; Karin, M			IKK beta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis	CELL			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; HEPATOCELLULAR-CARCINOMA; NUCLEAR-FACTOR; TRANSGENIC MICE; LIVER-REGENERATION; JNK ACTIVATION; MOUSE-LIVER; CELL-DEATH; TNF-ALPHA	I kappa B kinase beta (IKK beta), required for NF-kappa B activation, links chronic inflammation with carcinogenesis. We investigated whether IKK beta is involved in chemically induced liver cancer, a model not involving overt inflammation. Surprisingly, mice lacking IKK beta only in hepatocytes (Ikk beta(Delta hep) mice) exhibited a marked increase in hepatocarcinogenesis caused by diethylnitrosamine (DEN). This correlated with enhanced reactive oxygen species (ROS) production, increased JNK activation, and hepatocyte death, giving rise to augmented compensatory proliferation of surviving hepatocytes. Brief oral administration of an antioxidant around the time of DEN exposure blocked prolonged JNK activation and compensatory proliferation and prevented excessive DEN-induced carcinogenesis in Ikk beta(Delta hep) mice. Decreased hepatocarcinogenesis was also found in mice lacking IKKP in both hepatocytes and hematopoietic-derived Kupffer cells. These mice exhibited reduced hepatocyte regeneration and diminished induction of hepatomitogens, which were unaltered in Ikk beta(Delta hep) mice. IKK beta, therefore, orchestrates inflammatory crosstalk between hepatocytes and hematopoietic-derived cells that promotes chemical hepatocarcinogenesis.	Univ Calif San Diego, Sch Med, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Lab Gene Regulat & Signal Transduct, 9500 Gilman Dr,MC 0723, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Kamata, Hideaki/N-3907-2017	Luo, Jun-Li/0000-0002-7625-4766	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES006376, P42ES010337] Funding Source: NIH RePORTER; NIAID NIH HHS [AI43477] Funding Source: Medline; NIEHS NIH HHS [ES010337, ES06376] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; BERENBLUM I, 1954, ADV CANCER RES, V2, P129, DOI 10.1016/S0065-230X(08)60493-5; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Cavin LG, 2004, CANCER RES, V64, P7030, DOI 10.1158/0008-5472.CAN-04-1647; CHISARI FV, 1995, HEPATOLOGY, V22, P1316, DOI 10.1016/0270-9139(95)90645-2; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; DYROFF MC, 1986, CARCINOGENESIS, V7, P241, DOI 10.1093/carcin/7.2.241; Eferl R, 2003, CELL, V112, P181, DOI 10.1016/S0092-8674(03)00042-4; ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407; Factor VM, 2000, P NATL ACAD SCI USA, V97, P2196, DOI 10.1073/pnas.040428797; FARBER J L, 1984, Pharmacological Reviews, V36, p71S; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; Fausto N, 1999, SEMIN LIVER DIS, V19, P243, DOI 10.1055/s-2007-1007114; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hara A, 2000, BRIT J CANCER, V82, P467; HARDONK MJ, 1992, J LEUKOCYTE BIOL, V52, P296, DOI 10.1002/jlb.52.3.296; Horiguchi N, 2002, ONCOGENE, V21, P1791, DOI 10.1038/sj.onc.1205248; Hsu LC, 2004, NATURE, V428, P341, DOI 10.1038/nature02405; Im YH, 2001, CANCER RES, V61, P6665; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; KLEIN G, 1985, NATURE, V315, P190, DOI 10.1038/315190a0; Kobayashi A, 2004, METHOD ENZYMOL, V378, P273; KORSMEYER SJ, 1992, BLOOD, V80, P879; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; LIAO WSL, 1980, J BIOL CHEM, V255, P36; Lieber A, 1997, J VIROL, V71, P8798, DOI 10.1128/JVI.71.11.8798-8807.1997; Maeda S, 2003, IMMUNITY, V19, P725, DOI 10.1016/S1074-7613(03)00301-7; MAUAD TH, 1994, AM J PATHOL, V145, P1237; Philip M, 2004, SEMIN CANCER BIOL, V14, P433, DOI 10.1016/j.semcancer.2004.06.006; Pierce RH, 2002, AM J PATHOL, V160, P1555, DOI 10.1016/S0002-9440(10)61101-7; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Sakon S, 2003, EMBO J, V22, P3898, DOI 10.1093/emboj/cdg379; SARMA DSR, 1986, CANCER SURV, V5, P781; Satoh K, 2002, CARCINOGENESIS, V23, P457, DOI 10.1093/carcin/23.3.457; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schirmacher P, 1993, EXS, V65, P285; SELL S, 1982, HEPATOLOGY, V2, P77; Tai DI, 2000, CANCER, V89, P2274, DOI 10.1002/1097-0142(20001201)89:11<2274::AID-CNCR16>3.3.CO;2-U; TALBOT D, 1994, NUCLEIC ACIDS RES, V22, P756, DOI 10.1093/nar/22.5.756; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Thorgeirsson SS, 2000, TOXICOL LETT, V112, P553, DOI 10.1016/S0378-4274(99)00224-6; Verna L, 1996, PHARMACOL THERAPEUT, V71, P57, DOI 10.1016/0163-7258(96)00062-9; WILLIAMS GM, 1993, TOXICOL IND HEALTH, V9, P303, DOI 10.1177/0748233793009001-222; WONG GHW, 1988, SCIENCE, V242, P941, DOI 10.1126/science.3263703; Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441; Zhang JY, 2004, GENE DEV, V18, P17, DOI 10.1101/gad.1160904; Zhou ZX, 2004, AM J PATHOL, V164, P1547, DOI 10.1016/S0002-9440(10)63713-3	54	913	957	5	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 1	2005	121	7					977	990		10.1016/j.cell.2005.04.014	http://dx.doi.org/10.1016/j.cell.2005.04.014			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	944RZ	15989949	Bronze			2022-12-01	WOS:000230448000006
J	Biswas, T; Aihara, H; Radman-Livaja, M; Filman, D; Landy, A; Ellenberger, T				Biswas, T; Aihara, H; Radman-Livaja, M; Filman, D; Landy, A; Ellenberger, T			A structural basis for allosteric control of DNA recombination by lambda integrase	NATURE			English	Article							SITE-SPECIFIC RECOMBINATION; CRYSTAL-STRUCTURE; INT PROTEIN; COMPLEX; ORDER; IHF; ARCHITECTURE; FLEXIBILITY; MUTATIONS; VANADATE	Site-specific DNA recombination is important for basic cellular functions including viral integration, control of gene expression, production of genetic diversity and segregation of newly replicated chromosomes, and is used by bacteriophage lambda to integrate or excise its genome into and out of the host chromosome. lambda recombination is carried out by the bacteriophage-encoded integrase protein (lambda-int) together with accessory DNA sites and associated bending proteins that allow regulation in response to cell physiology. Here we report the crystal structures of lambda-int in higher-order complexes with substrates and regulatory DNAs representing different intermediates along the reaction pathway. The structures show how the simultaneous binding of two separate domains of lambda-int to DNA facilitates synapsis and can specify the order of DNA strand cleavage and exchange. An intertwined layer of amino-terminal domains bound to accessory (arm) DNAs shapes the recombination complex in a way that suggests how arm binding shifts the reaction equilibrium in favour of recombinant products.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Brown Univ, Div Biol & Med, Providence, RI 02912 USA	Harvard University; Harvard Medical School; Brown University	Ellenberger, T (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	tome@hms.harvard.edu		filman, david/0000-0002-8714-1644; Radman-Livaja, Marta/0000-0003-4987-0608	NIGMS NIH HHS [R01 GM062723, R01 GM033928] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033928, R01GM062723] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aihara H, 2003, MOL CELL, V12, P187, DOI 10.1016/S1097-2765(03)00268-5; Azaro MA, 1997, EMBO J, V16, P3744, DOI 10.1093/emboj/16.12.3744; Azaro MA., 2002, MOBILE DNA-UK, P118, DOI DOI 10.1128/9781555817954.CH7; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bankhead TM, 2003, J BACTERIOL, V185, P2653, DOI 10.1128/JB.185.8.2653-2666.2003; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUSHMAN W, 1985, SCIENCE, V230, P906, DOI 10.1126/science.2932798; Chen Y, 2000, MOL CELL, V6, P885, DOI 10.1016/S1097-2765(05)00088-2; Chen Y, 2003, ANNU REV BIOPH BIOM, V32, P135, DOI 10.1146/annurev.biophys.32.110601.141732; Crisona NJ, 1999, J MOL BIOL, V289, P747, DOI 10.1006/jmbi.1999.2771; Davies DR, 2003, CHEM BIOL, V10, P139, DOI 10.1016/S1074-5521(03)00021-8; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DEVARGAS LM, 1989, SCIENCE, V244, P1457; FRANZ B, 1995, EMBO J, V14, P397, DOI 10.1002/j.1460-2075.1995.tb07014.x; Gopaul DN, 1998, EMBO J, V17, P4175, DOI 10.1093/emboj/17.14.4175; Guo F, 1997, NATURE, V389, P40, DOI 10.1038/37925; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kazmierczak RA, 2002, NUCLEIC ACIDS RES, V30, P5193, DOI 10.1093/nar/gkf652; KIM S, 1992, SCIENCE, V256, P198, DOI 10.1126/science.1533056; KITTS PA, 1988, J MOL BIOL, V204, P95, DOI 10.1016/0022-2836(88)90602-X; Kwon HJ, 1997, SCIENCE, V276, P126, DOI 10.1126/science.276.5309.126; LANDY A, 1989, ANNU REV BIOCHEM, V58, P913, DOI 10.1146/annurev.biochem.58.1.913; Martin SS, 2003, BIOCHEM BIOPH RES CO, V308, P529, DOI 10.1016/S0006-291X(03)01437-2; MIZUUCHI K, 1978, J MOL BIOL, V121, P375, DOI 10.1016/0022-2836(78)90370-4; NASH HA, 1996, CELLULAR MOL BIOL, P2263; NUMRYCH TE, 1990, NUCLEIC ACIDS RES, V18, P3953, DOI 10.1093/nar/18.13.3953; NUNESDUBY SE, 1987, CELL, V50, P779, DOI 10.1016/0092-8674(87)90336-9; NUNESDUBY SE, 1995, CURR BIOL, V5, P139, DOI 10.1016/S0960-9822(95)00035-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Radman-Livaja M, 2005, P NATL ACAD SCI USA, V102, P3913, DOI 10.1073/pnas.0500844102; Radman-Livaja M, 2003, MOL CELL, V11, P783, DOI 10.1016/S1097-2765(03)00111-4; Rice PA, 1996, CELL, V87, P1295, DOI 10.1016/S0092-8674(00)81824-3; RICHET E, 1988, CELL, V52, P9, DOI 10.1016/0092-8674(88)90526-0; ROSS W, 1979, CELL, V18, P297, DOI 10.1016/0092-8674(79)90049-7; ROSS W, 1982, P NATL ACAD SCI-BIOL, V79, P7724, DOI 10.1073/pnas.79.24.7724; Sam MD, 2004, J MOL BIOL, V338, P229, DOI 10.1016/j.jmb.2004.02.053; Sarkar D, 2002, J MOL BIOL, V324, P775, DOI 10.1016/S0022-2836(02)01199-3; Segall AM, 1996, GENES CELLS, V1, P453, DOI 10.1046/j.1365-2443.1996.d01-254.x; Sherratt DJ, 1998, CELL, V93, P149, DOI 10.1016/S0092-8674(00)81566-4; Subramanya HS, 1997, EMBO J, V16, P5178, DOI 10.1093/emboj/16.17.5178; Swinger KK, 2004, CURR OPIN STRUC BIOL, V14, P28, DOI 10.1016/j.sbi.2003.12.003; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P1937, DOI 10.1107/S0907444902016438; THOMPSON JF, 1987, J MOL BIOL, V195, P481, DOI 10.1016/0022-2836(87)90177-X; THOMPSON JF, 1988, NUCLEIC ACIDS RES, V16, P9687, DOI 10.1093/nar/16.20.9687; Tirumalai RS, 1998, J MOL BIOL, V279, P513, DOI 10.1006/jmbi.1998.1786; Van Duyne GD, 2001, ANNU REV BIOPH BIOM, V30, P87, DOI 10.1146/annurev.biophys.30.1.87; Warren D, 2005, MOL MICROBIOL, V55, P1104, DOI 10.1111/j.1365-2958.2004.04447.x; Wojciak JM, 2002, P NATL ACAD SCI USA, V99, P3434, DOI 10.1073/pnas.052017999	48	131	137	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2005	435	7045					1059	1066		10.1038/nature03657	http://dx.doi.org/10.1038/nature03657			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937ZT	15973401	Green Accepted			2022-12-01	WOS:000229970400040
J	Reguera, G; McCarthy, KD; Mehta, T; Nicoll, JS; Tuominen, MT; Lovley, DR				Reguera, G; McCarthy, KD; Mehta, T; Nicoll, JS; Tuominen, MT; Lovley, DR			Extracellular electron transfer via microbial nanowires	NATURE			English	Article							INSOLUBLE FE(III) OXIDE; GEOBACTER-METALLIREDUCENS; PSEUDOMONAS-AERUGINOSA; IV PILI; REDUCTION; SULFURREDUCENS; RESPIRATION; BIOGENESIS; METABOLISM; MOTILITY	Microbes that can transfer electrons to extracellular electron acceptors, such as Fe(III) oxides, are important in organic matter degradation and nutrient cycling in soils and sediments(1,2). Previous investigations on electron transfer to Fe(III) have focused on the role of outer-membrane c-type cytochromes(1,3). However, some Fe(III) reducers lack c-cytochromes(4). Geobacter species, which are the predominant Fe(III) reducers in many environments(1), must directly contact Fe(III) oxides to reduce them(5), and produce monolateral pili(6) that were proposed(1,2), on the basis of the role of pili in other organisms(7,8), to aid in establishing contact with the Fe(III) oxides. Here we report that a pilus-deficient mutant of Geobacter sulfurreducens could not reduce Fe(III) oxides but could attach to them. Conducting-probe atomic force microscopy revealed that the pili were highly conductive. These results indicate that the pili of G. sulfurreducens might serve as biological nanowires, transferring electrons from the cell surface to the surface of Fe(III) oxides. Electron transfer through pili indicates possibilities for other unique cell-surface and cell-cell interactions, and for bioengineering of novel conductive materials.	Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA; Univ Massachusetts, Dept Phys, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Lovley, DR (corresponding author), Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA.	dlovley@microbio.umass.edu	Tuominen, Mark/A-6129-2012; Reguera, Gemma/AAZ-5864-2020	Reguera, Gemma/0000-0003-4317-7933				AHO EL, 1987, INFECT IMMUN, V55, P1009, DOI 10.1128/IAI.55.4.1009-1013.1987; Alm RA, 1997, GENE, V192, P89, DOI 10.1016/S0378-1119(96)00805-0; BUTLER JE, UNPUB J BACTERIOL; Childers SE, 2002, NATURE, V416, P767, DOI 10.1038/416767a; CHILDERS SE, 2003, 103 GEN M, P361; Coppi MV, 2001, APPL ENVIRON MICROB, V67, P3180, DOI 10.1128/AEM.67.7.3180-3187.2001; Davis JJ, 2003, PHILOS T R SOC A, V361, P2807, DOI 10.1098/rsta.2003.1270; DOIG P, 1988, INFECT IMMUN, V56, P1641, DOI 10.1128/IAI.56.6.1641-1646.1988; Holmes DE, 2004, INT J SYST EVOL MICR, V54, P1591, DOI 10.1099/ijs.0.02958-0; Lonergan DJ, 1996, J BACTERIOL, V178, P2402, DOI 10.1128/jb.178.8.2402-2408.1996; Lovley DR, 2003, NAT REV MICROBIOL, V1, P35, DOI 10.1038/nrmicro731; LOVLEY DR, 1995, APPL ENVIRON MICROB, V61, P2132, DOI 10.1128/AEM.61.6.2132-2138.1995; LOVLEY DR, 1988, APPL ENVIRON MICROB, V54, P1472, DOI 10.1128/AEM.54.6.1472-1480.1988; Lovley DR, 1996, NATURE, V382, P445, DOI 10.1038/382445a0; LOVLEY DR, 2004, ADV MICROBIAL PHYSL, V49; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; Methe BA, 2003, SCIENCE, V302, P1967, DOI 10.1126/science.1088727; Nassif X, 1997, GENE, V192, P149, DOI 10.1016/S0378-1119(96)00802-5; Nevin KP, 2000, APPL ENVIRON MICROB, V66, P2248, DOI 10.1128/AEM.66.5.2248-2251.2000; PARGE HE, 1995, NATURE, V378, P32, DOI 10.1038/378032a0; Richardson DJ, 2000, MICROBIOL-SGM, V146, P551, DOI 10.1099/00221287-146-3-551; Sahu SN, 2003, MOL CELL BIOCHEM, V253, P167, DOI 10.1023/A:1026028930203; Sayler GS, 2004, CURR OPIN MICROBIOL, V7, P267, DOI 10.1016/j.mib.2004.04.003; STROM MS, 1993, ANNU REV MICROBIOL, V47, P565, DOI 10.1146/annurev.micro.47.1.565; Wall D, 1999, MOL MICROBIOL, V32, P1, DOI 10.1046/j.1365-2958.1999.01339.x	25	1701	1844	76	1277	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2005	435	7045					1098	1101		10.1038/nature03661	http://dx.doi.org/10.1038/nature03661			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937ZT	15973408				2022-12-01	WOS:000229970400049
J	Hargreaves, EL; Rao, G; Lee, I; Knierim, JJ				Hargreaves, EL; Rao, G; Lee, I; Knierim, JJ			Major dissociation between medial and lateral entorhinal input to dorsal hippocampus	SCIENCE			English	Article							POSITIONAL FIRING PROPERTIES; FREELY MOVING RATS; HEAD-DIRECTION CELLS; PLACE CELLS; POSTRHINAL CORTEX; PERIRHINAL CORTEX; MEMORY; PARASUBICULUM; NEURONS; PRESUBICULUM	Hippocampal place cells are a model system of how the brain constructs cognitive representations and of how these representations support complex behavior, teaming, and memory. There is, however, a lack of detailed knowledge about the properties of hippocampal afferents. We recorded multiple single units from the hippocampus and the medial and lateral entorhinal areas of behaving rats. Although many medial entorhinal neurons had highly specific place fields, Lateral entorhinal neurons displayed weak spatial specificity. This finding demonstrates a fundamental dissociation between the information conveyed to the hippocampus by its major input streams, with spatial information represented by the medial and nonspatial information represented by the lateral entorhinal cortex.	Univ Texas, Med Sch Houston, WM Keck Ctr Neurobiol Learning & Memory, Dept Neurobiol & Anat, Houston, TX 77225 USA; NYU, Ctr Neural Sci, New York, NY 10003 USA	University of Texas System; University of Texas Health Science Center Houston; New York University	Knierim, JJ (corresponding author), Univ Texas, Med Sch Houston, WM Keck Ctr Neurobiol Learning & Memory, Dept Neurobiol & Anat, POB 20708, Houston, TX 77225 USA.	james.j.knierim@uth.tmc.edu	Hargreaves, Eric/H-4891-2011	Hargreaves, Eric/0000-0001-5311-9804	NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH063297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039456] Funding Source: NIH RePORTER; NIMH NIH HHS [K02 MH63297] Funding Source: Medline; NINDS NIH HHS [R01 NS039456] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARNES CA, 1990, PROG BRAIN RES, V83, P287; Burwell RD, 1998, NEUROREPORT, V9, P3013, DOI 10.1097/00001756-199809140-00017; Burwell RD, 2003, NEUROSCIENCE, V119, P577, DOI 10.1016/S0306-4522(03)00160-X; Burwell RD, 2000, ANN NY ACAD SCI, V911, P25; CABALLEROBLEDA M, 1993, J COMP NEUROL, V328, P115, DOI 10.1002/cne.903280109; CHEN LL, 1994, EXP BRAIN RES, V101, P8, DOI 10.1007/BF00243212; Davachi L, 2003, P NATL ACAD SCI USA, V100, P2157, DOI 10.1073/pnas.0337195100; Dolorfo CL, 1998, J COMP NEUROL, V398, P25; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Gaffan D, 1998, EXP BRAIN RES, V123, P201, DOI 10.1007/s002210050562; JUNG MW, 1994, J NEUROSCI, V14, P7347; MIZUMORI SJY, 1992, BRAIN RES, V570, P188, DOI 10.1016/0006-8993(92)90581-S; Moita MAP, 2003, NEURON, V37, P485, DOI 10.1016/S0896-6273(03)00033-3; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; Muller R, 1996, NEURON, V17, P813, DOI 10.1016/S0896-6273(00)80214-7; Norman G, 2005, BEHAV NEUROSCI, V119, P557, DOI 10.1037/0735-7044.119.2.557; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1976, EXP NEUROL, V51, P78, DOI 10.1016/0014-4886(76)90055-8; QUIRK GJ, 1992, J NEUROSCI, V12, P1945; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Suzuki WA, 1997, J NEUROPHYSIOL, V78, P1062, DOI 10.1152/jn.1997.78.2.1062; Taube JS, 1995, HIPPOCAMPUS, V5, P569, DOI 10.1002/hipo.450050608; TAUBE JS, 1995, J NEUROSCI, V15, P70; VANGROEN T, 1990, BRAIN RES, V518, P227, DOI 10.1016/0006-8993(90)90976-I; Witter MP, 2004, RAT NERVOUS SYSTEM, P635, DOI [DOI 10.1016/B978-012547638-6/50022-5, 10.1016/B978-012547638-6/50022-5]; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605	28	446	455	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2005	308	5729					1792	1794		10.1126/science.1110449	http://dx.doi.org/10.1126/science.1110449			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937LY	15961670				2022-12-01	WOS:000229926800056
J	Cardillo, M; Mace, GM; Jones, KE; Bielby, J; Bininda-Emonds, ORP; Sechrest, W; Orme, CDL; Purvis, A				Cardillo, M; Mace, GM; Jones, KE; Bielby, J; Bininda-Emonds, ORP; Sechrest, W; Orme, CDL; Purvis, A			Multiple causes of high extinction risk in large mammal species	SCIENCE			English	Article							BODY-SIZE; CONSERVATION BIOLOGY; POPULATION-DENSITY; SELECTIVITY; HISTORY; LIFE	Many large animal species have a high risk of extinction. This is usually thought to result simply from the way that species traits associated with vulnerability, such as low reproductive rates, scale with body size. In a broad-scale analysis of extinction risk in mammals, we find two additional patterns in the size selectivity of extinction risk. First, impacts of both intrinsic and environmental factors increase sharply above a threshold body mass around 3 kilograms. Second, whereas extinction risk in smaller species is driven by environmental factors, in larger species it is driven by a combination of environmental factors and intrinsic traits. Thus, the disadvantages of large size are greater than generally recognized, and future loss of large mammal biodiversity could be far more rapid than expected.	Univ London Imperial Coll Sci Technol & Med, Div Biol, Ascot SL5 7PY, Berks, England; Zool Soc London, Inst Zool, London NW1 4RY, England; Univ London Imperial Coll Sci Technol & Med, NERC, Ctr Populat Biol, Ascot SL5 7PY, Berks, England; Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA; Tech Univ Munich, Lehrstuhl Tierzucht, D-85354 Freising Weihenstephan, Germany	Imperial College London; Zoological Society of London; Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of Virginia; Technical University of Munich	Cardillo, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Biol, Silwood Pk, Ascot SL5 7PY, Berks, England.	m.cardillo@imperial.ac.uk	Bielby, Jon/D-5051-2011; Cardillo, Marcel/C-9396-2009; Purvis, Andy/A-7529-2008; Jones, Kate E/G-4768-2010; Jones, Kate/Y-3317-2019; Bininda-Emonds, Olaf/P-6718-2019; Mace, Georgina M/I-3072-2016; Bininda-Emonds, Olaf R.P:/C-5405-2008	Cardillo, Marcel/0000-0001-9855-0817; Purvis, Andy/0000-0002-8609-6204; Jones, Kate E/0000-0001-5231-3293; Jones, Kate/0000-0001-5231-3293; Mace, Georgina M/0000-0001-8965-5211; Bininda-Emonds, Olaf R.P:/0000-0003-4432-224X; Bielby, Jon/0000-0003-4586-0429	Natural Environment Research Council [NE/B503492/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Balmford A, 1996, TRENDS ECOL EVOL, V11, P193, DOI 10.1016/0169-5347(96)10026-4; Bennett PM, 1997, P ROY SOC B-BIOL SCI, V264, P401, DOI 10.1098/rspb.1997.0057; Bodmer RE, 1997, CONSERV BIOL, V11, P460, DOI 10.1046/j.1523-1739.1997.96022.x; Bruegmann MM., 2003, IUCN RED LIST THREAT, p4412810862276; Cardillo M, 2004, PLOS BIOL, V2, P909, DOI 10.1371/journal.pbio.0020197; Cardillo M, 2001, CONSERV BIOL, V15, P1435, DOI 10.1046/j.1523-1739.2001.00286.x; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; DAMUTH J, 1981, NATURE, V290, P699, DOI 10.1038/290699a0; FENSCHEL T, 1974, OECOLOGIA, V14, P317; Fisher DO, 2004, TRENDS ECOL EVOL, V19, P391, DOI 10.1016/j.tree.2004.05.004; Jernvall J, 1998, P NATL ACAD SCI USA, V95, P11279, DOI 10.1073/pnas.95.19.11279; Jerozolimski A, 2003, BIOL CONSERV, V111, P415, DOI 10.1016/S0006-3207(02)00310-5; Johnson CN, 2002, P ROY SOC B-BIOL SCI, V269, P2221, DOI 10.1098/rspb.2002.2130; Jones KE, 2003, AM NAT, V161, P601, DOI 10.1086/368289; Lawton John H., 1995, P147; Mace GM, 2003, SCIENCE, V300, P1707, DOI 10.1126/science.1085510; Martin P. S., 1967, P75; McKinney ML, 1998, ANIM CONSERV, V1, P159, DOI 10.1111/j.1469-1795.1998.tb00024.x; McKinney ML, 1997, ANNU REV ECOL SYST, V28, P495, DOI 10.1146/annurev.ecolsys.28.1.495; Peres CA, 2001, CONSERV BIOL, V15, P1490, DOI 10.1046/j.1523-1739.2001.01089.x; Pimm S.L., 1991, BALANCE NATURE; PIMM SL, 1988, AM NAT, V132, P757, DOI 10.1086/284889; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; Raup D.M., 1993, EXTINCTION BAD GENES; Russell GJ, 1998, CONSERV BIOL, V12, P1365, DOI 10.1046/j.1523-1739.1998.96332.x; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126	27	812	844	14	396	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 19	2005	309	5738					1239	1241		10.1126/science.1116030	http://dx.doi.org/10.1126/science.1116030			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	957TE	16037416	Green Submitted			2022-12-01	WOS:000231395400045
J	Ashikari, M; Sakakibara, H; Lin, SY; Yamamoto, T; Takashi, T; Nishimura, A; Angeles, ER; Qian, Q; Kitano, H; Matsuoka, M				Ashikari, M; Sakakibara, H; Lin, SY; Yamamoto, T; Takashi, T; Nishimura, A; Angeles, ER; Qian, Q; Kitano, H; Matsuoka, M			Cytokinin oxidase regulates rice grain production	SCIENCE			English	Article							QUANTITATIVE TRAIT LOCUS; ORYZA-SATIVA L.; GREEN-REVOLUTION; PHOTOPERIOD SENSITIVITY; DRAFT SEQUENCE; FLOWERING TIME; ARABIDOPSIS; MAIZE; GENES; YIELD	Most agriculturally important traits are regulated by genes known as quantitative trait loci (QTLs) derived from natural allelic variations. We here show that a QTL that increases grain productivity in rice, Gn1a, is a gene for cytokinin oxidase/ dehydrogenase (OsCKX2), an enzyme that degrades the phytohormone cytokinin. Reduced expression of OsCKX2 causes cytokinin accumulation in inflorescence meristems and increases the number of reproductive organs, resulting in enhanced grain yield. QTL pyramiding to combine loci for grain number and plant height in the same genetic background generated lines exhibiting both beneficial traits. These results provide a strategy for tailormade crop improvement.	Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan; RIKEN, Plant Sci Ctr, Yokohama, Kanagawa 2300045, Japan; Honda Res Inst Japan Co Ltd, Chiba 2920818, Japan; China Natl Rice Res Inst, Hangzhou 310006, Peoples R China	Nagoya University; RIKEN; Honda Motor Company; Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS	Matsuoka, M (corresponding author), Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan.	makoto@agr.nagoya-u.ac.jp	Ding, Cheng-Qiang/B-6287-2011; Yamamoto, Toshio/AAX-7146-2020; qian, qian/AAH-8708-2021; Sakakibara, Hitoshi/A-6040-2010	Yamamoto, Toshio/0000-0002-5209-7735; Sakakibara, Hitoshi/0000-0001-5449-6492				ARMSTRONG D, 1994, CYTOKININ CHEM ACTIV, pCH11; ASHIKARI M, 2002, BREED SCI; Austin DF, 2000, CROP SCI, V40, P30, DOI 10.2135/cropsci2000.40130x; BERNIER G, 1993, PLANT CELL, V5, P1147, DOI 10.1105/tpc.5.10.1147; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; El-Assal SED, 2001, NAT GENET, V29, P435, DOI 10.1038/ng767; *FAO, STAT FOOD INS WORLD; Feng Q, 2002, NATURE, V420, P316, DOI 10.1038/nature01183; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Fridman E, 2000, P NATL ACAD SCI USA, V97, P4718, DOI 10.1073/pnas.97.9.4718; Gale MD, 1998, P NATL ACAD SCI USA, V95, P1971, DOI 10.1073/pnas.95.5.1971; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Ho JC, 2002, THEOR APPL GENET, V105, P440, DOI 10.1007/s00122-002-0945-x; Khush G, 2003, NUTR REV, V61, pS114, DOI 10.1301/nr.2003.jun.S114-S116; Khush GS, 2001, P NUTR SOC, V60, P15, DOI 10.1079/PNS200075; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Liu JP, 2002, P NATL ACAD SCI USA, V99, P13302, DOI 10.1073/pnas.162485999; MILLER CO, 1955, J AM CHEM SOC, V77, P1392, DOI 10.1021/ja01610a105; Mok DWS, 2001, ANNU REV PLANT PHYS, V52, P89, DOI 10.1146/annurev.arplant.52.1.89; MOK MC, 1994, CYTOKININ CHEM ACTIV, pCH12; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; *RIC CHROM 10 SEQ, 2003, SCIENCE NEW YORK NY, V0300; Salse J, 2004, PLANT J, V38, P396, DOI 10.1111/j.1365-313X.2004.02058.x; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Sasaki T, 2005, PLANT CELL PHYSIOL, V46, P3, DOI 10.1093/pcp/pci503; Sasaki T, 2002, NATURE, V420, P312, DOI 10.1038/nature01184; Schmulling T, 2003, J PLANT RES, V116, P241, DOI 10.1007/s10265-003-0096-4; Spielmeyer W, 2002, P NATL ACAD SCI USA, V99, P9043, DOI 10.1073/pnas.132266399; Takahashi Y, 2001, P NATL ACAD SCI USA, V98, P7922, DOI 10.1073/pnas.111136798; *UN POP FUND, 2004, STAT WORLD POP; Veldboom LR, 1996, CROP SCI, V36, P1310, DOI 10.2135/cropsci1996.0011183X003600050040x; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928; Werner T, 2001, P NATL ACAD SCI USA, V98, P10487, DOI 10.1073/pnas.171304098; Yano M, 2001, CURR OPIN PLANT BIOL, V4, P130, DOI 10.1016/S1369-5266(00)00148-5; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037	37	1146	1403	33	541	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2005	309	5735					741	745		10.1126/science.1113373	http://dx.doi.org/10.1126/science.1113373			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951NU	15976269				2022-12-01	WOS:000230938200041
J	Didkowska, J; Manczuk, M; McNeill, A; Powles, J; Zatonski, W				Didkowska, J; Manczuk, M; McNeill, A; Powles, J; Zatonski, W			Lung cancer mortality at ages 35-54 in the European Union: ecological study of evolving tobacco epidemics	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Ctr Canc, Inst Oncol, Canc Epidemiol & Prevent Div, PL-02781 Warsaw, Poland; UCL, London WC1E 6BT, England; Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB2 2SR, England	Maria Sklodowska-Curie National Research Institute of Oncology; University of London; University College London; University of Cambridge	Zatonski, W (corresponding author), Ctr Canc, Inst Oncol, Canc Epidemiol & Prevent Div, 5 Roentgena Str, PL-02781 Warsaw, Poland.	canepid@coi.waw.pl	Manczuk, Marta/S-5900-2016; Manczuk, Marta/GPK-8403-2022	Manczuk, Marta/0000-0002-4319-6424; Manczuk, Marta/0000-0002-4319-6424; McNeill, Ann/0000-0002-6223-4000; Powles, John/0000-0002-0766-7989				Brennan P, 2002, BRIT J CANCER, V87, P43, DOI 10.1038/sj.bjc.6600352; LOPEZ AD, 1994, TOB CONTROL, V3, P243; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; Peto R, 1994, MORTALITY SMOKING DE; [No title captured]	5	34	36	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	2005	331	7510					189	191		10.1136/bmj.331.7510.189	http://dx.doi.org/10.1136/bmj.331.7510.189			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951EA	16037450	Green Published, Bronze			2022-12-01	WOS:000230910700019
J	Kern, J; Strnad, M; Coric, T; Vuletic, S				Kern, J; Strnad, M; Coric, T; Vuletic, S			Cardiovascular risk factors in Croatia: struggling to provide the evidence for developing policy recommendations	BRITISH MEDICAL JOURNAL			English	Article							MEDITERRANEAN DIET; SURVIVAL		Univ Zagreb, Sch Med, Andrija Stampar Sch Publ Hlth, Zagreb 10000, Croatia; Croatian Publ Hlth Inst, Social Med Serv, Zagreb 10000, Croatia	University of Zagreb; University of Zagreb, School of Dental Medicine	Kern, J (corresponding author), Univ Zagreb, Sch Med, Andrija Stampar Sch Publ Hlth, Rockefellerova 4, Zagreb 10000, Croatia.	jkern@snz.hr	, jkern@snz.hr/AAR-8708-2021	KERN, JOSIPA/0000-0002-0896-3018				Bautista Marita C, 2005, Prog Cardiovasc Nurs, V20, P70, DOI 10.1111/j.0889-7204.2005.04558.x; BELAND Y, 2004, P AM STAT ASS M SURV; *CROAT CENTR BUR S, 2004, STAT YB 2004; Kern Josipa, 2004, Med Arh, V58, P351; McKee M, 2004, BRIT MED J, V329, P1355, DOI 10.1136/bmj.329.7479.1355; Trichopoulou A, 2005, ARCH INTERN MED, V165, P929, DOI 10.1001/archinte.165.8.929; Trichopoulou A, 2005, BMJ-BRIT MED J, V330, P991, DOI 10.1136/bmj.38415.644155.8F	7	47	52	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 23	2005	331	7510					208	210		10.1136/bmj.331.7510.208	http://dx.doi.org/10.1136/bmj.331.7510.208			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951EA	16037458	Green Published, Bronze			2022-12-01	WOS:000230910700027
J	Masumoto, H; Hawke, D; Kobayashi, R; Verreault, A				Masumoto, H; Hawke, D; Kobayashi, R; Verreault, A			A role for cell-cycle-regulated histone H3 lysine 56 acetylation in the DNA damage response	NATURE			English	Article							NUCLEOSOME CORE PARTICLE; REPLICATION FORKS; H4; COMPLEXES; MECHANISM; REPAIR; H2A	DNA breaks are extremely harmful lesions that need to be repaired efficiently throughout the genome. However, the packaging of DNA into nucleosomes is a significant barrier to DNA repair, and the mechanisms of repair in the context of chromatin are poorly understood(1). Here we show that lysine 56 (K56) acetylation is an abundant modification of newly synthesized histone H3 molecules that are incorporated into chromosomes during S phase. Defects in the acetylation of K56 in histone H3 result in sensitivity to genotoxic agents that cause DNA strand breaks during replication. In the absence of DNA damage, the acetylation of histone H3 K56 largely disappears in G2. In contrast, cells with DNA breaks maintain high levels of acetylation, and the persistence of the modification is dependent on DNA damage checkpoint proteins. We suggest that the acetylation of histone H3 K56 creates a favourable chromatin environment for DNA repair and that a key component of the DNA damage response is to preserve this acetylation.	Canc Res UK, London Res Inst, Clare Hall Labs, Chromosome Dynam Lab, S Mimms EN6 3LD, Herts, England; Univ Texas, MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA	Cancer Research UK; University of Texas System; UTMD Anderson Cancer Center	Verreault, A (corresponding author), Canc Res UK, London Res Inst, Clare Hall Labs, Chromosome Dynam Lab, Blanche Lane, S Mimms EN6 3LD, Herts, England.	alain.verreault@cancer.org.uk		Hawke, David/0000-0002-6102-7843				Bird AW, 2002, NATURE, V419, P411, DOI 10.1038/nature01035; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Downs JA, 2004, MOL CELL, V16, P979, DOI 10.1016/j.molcel.2004.12.003; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Gunjan A, 2003, CELL, V115, P537, DOI 10.1016/S0092-8674(03)00896-1; Haber JE, 2000, TRENDS GENET, V16, P259, DOI 10.1016/S0168-9525(00)02022-9; HSIANG YH, 1989, CANCER RES, V49, P5077; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Nitiss JL, 1996, MOL PHARMACOL, V50, P1095; NORTON VG, 1989, CELL, V57, P449, DOI 10.1016/0092-8674(89)90920-3; Peterson CL, 2004, GENE DEV, V18, P602, DOI 10.1101/gad.1182704; Pilch DR, 2003, BIOCHEM CELL BIOL, V81, P123, DOI 10.1139/o03-042; Pommier Y, 2003, MUTAT RES-FUND MOL M, V532, P173, DOI 10.1016/j.mrfmmm.2003.08.016; Redon C, 2003, EMBO REP, V4, P678, DOI 10.1038/sj.embor.embor871; Sklenar Amy R., 2004, BMC Biochemistry, V5, P11, DOI 10.1186/1471-2091-5-11; SOGO JM, 1986, J MOL BIOL, V189, P189, DOI 10.1016/0022-2836(86)90390-6; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; Wechser MA, 1997, EMBO J, V16, P2086, DOI 10.1093/emboj/16.8.2086; Ye JX, 2005, MOL CELL, V18, P123, DOI 10.1016/j.molcel.2005.02.031	21	473	478	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2005	436	7048					294	298		10.1038/nature03714	http://dx.doi.org/10.1038/nature03714			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944VR	16015338				2022-12-01	WOS:000230459500049
J	Riedel, IH; Kruse, K; Howard, J				Riedel, IH; Kruse, K; Howard, J			A self-organized vortex array of hydrodynamically entrained sperm cells	SCIENCE			English	Article							MOTILITY; MICROTUBULES; SPERMATOZOA	Many patterns in biological systems depend on the exchange of chemical signals between cells. We report a spatiotemporal pattern mediated by hydrodynamic interactions. At planar surfaces, spermatozoa self-organized into dynamic vortices resembling quantized rotating waves. These vortices formed an array with local hexagonal order. Introducing an order parameter that quantifies cooperativity, we found that the array appeared only above a critical sperm density. Using a model, we estimated the hydrodynamic interaction force between spermatozoa to be similar to 0.03 piconewtons. Thus, large-scale coordination of cells can be regulated hydrodynamically, and chemical signals are not required.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Max Planck Inst Phys Complex Syst, D-01187 Dresden, Germany	Max Planck Society; Max Planck Society	Riedel, IH (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	riedel@mpi-cbg.de; howard@mpi-cbg.de	Howard, Jonathon/D-4229-2011; Howard, Jonathon/J-7492-2016; Riedel-Kruse, Ingmar/B-8818-2008; Kruse, Karsten/GOG-8298-2022	Howard, Jonathon/0000-0003-0086-1196; Howard, Jonathon/0000-0003-0086-1196; Kruse, Karsten/0000-0001-8665-2349; Riedel-Kruse, Ingmar/0000-0002-6068-5561				[Anonymous], 1987, FLUID MECH-SOV RES; Berg, 2018, RANDOM WALKS BIOL; Darnton N, 2004, BIOPHYS J, V86, P1863, DOI 10.1016/S0006-3495(04)74253-8; Dombrowski C, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098103; FAUCI LJ, 1995, B MATH BIOL, V57, P679, DOI 10.1007/bf02461846; Gibbons I.R., 1981, Journal of Cell Biology, V91, P107; GRAY J, 1955, J EXP BIOL, V32, P802; Gray J., 1928, CILIARY MOVEMENT; Gueron S, 1998, BIOPHYS J, V74, P1658, DOI 10.1016/S0006-3495(98)77879-8; HOELLDOBLER B, 1990, ANTS; Howard J., 2001, MECH MOTOR PROTEINS; Lenz P, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.108104; Misteli T, 2001, J CELL BIOL, V155, P181, DOI 10.1083/jcb.200108110; Moore H, 2002, NATURE, V418, P174, DOI 10.1038/nature00832; Nedelec FJ, 1997, NATURE, V389, P305, DOI 10.1038/38532; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; OKAMOTO K, 1994, J EXP BIOL, V192, P61; PRIGOGINE I, 1967, J CHEM PHYS, V46, P3542, DOI 10.1063/1.1841255; Sleigh M.A., 1974, CILIA FLAGELLA; Strogatz S.H., 2000, J STAT PHYS, V78, P1635; TAYLOR G, 1951, PROC R SOC LON SER-A, V209, P447, DOI 10.1098/rspa.1951.0218; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Woolley DM, 2003, REPRODUCTION, V126, P259, DOI 10.1530/rep.0.1260259; Wu XL, 2000, PHYS REV LETT, V84, P3017, DOI 10.1103/PhysRevLett.84.3017; Zahn K, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.115502; Zahn K, 1999, PHYS REV LETT, V82, P2721, DOI 10.1103/PhysRevLett.82.2721	26	393	393	6	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2005	309	5732					300	303		10.1126/science.1110329	http://dx.doi.org/10.1126/science.1110329			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944SP	16002619				2022-12-01	WOS:000230449800045
J	Schalch, T; Duda, S; Sargent, DF; Richmond, TJ				Schalch, T; Duda, S; Sargent, DF; Richmond, TJ			X-ray structure of a tetranucleosome and its implications for the chromatin fibre	NATURE			English	Article							HIGHER-ORDER STRUCTURE; NUCLEOSOME CORE; REPEAT LENGTH; LINKER LENGTH; IN-SITU; DIAMETER; DNA; ORGANIZATION; FILAMENT; RIBBON	DNA in eukaryotic chromosomes is organized in arrays of nucleosomes compacted into chromatin fibres. This higher-order structure of nucleosomes is the substrate for DNA replication, recombination, transcription and repair. Although the structure of the nucleosome core is known at near-atomic resolution(1), even the most fundamental information about the organization of nucleosomes in the fibre is controversial. Here we report the crystal structure of an oligonucleosome (a compact tetranucleosome) at 9 angstrom resolution, solved by molecular replacement using the nucleosome core structure. The structure shows that linker DNA zigzags back and forth between two stacks of nucleosome cores, which forma truncated two-start helix, and does not follow a path compatible with a one-start solenoidal helix(2). The length of linker DNA is most probably buffered by stretching of the DNA contained in the nucleosome cores. We have built continuous fibre models by successively stacking tetranucleosomes one on another. The resulting models are nearly fully compacted and most closely resemble the previously described crossed-linker model(3). They suggest that the interfaces between nucleosomes along a single helix start are polymorphic.	ETH Honggerberg, ETH Zurich, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Richmond, TJ (corresponding author), ETH Honggerberg, ETH Zurich, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.	richmond@mol.biol.ethz.ch	Schalch, Thomas/E-7507-2010; Schalch, Thomas/A-6007-2014	Schalch, Thomas/0000-0002-0758-3013				ALLAN J, 1984, J CELL BIOL, V98, P1320, DOI 10.1083/jcb.98.4.1320; ATHEY BD, 1990, J CELL BIOL, V111, P795, DOI 10.1083/jcb.111.3.795; BLANK TA, 1995, J MOL BIOL, V252, P305, DOI 10.1006/jmbi.1995.0498; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUTLER PJG, 1980, J MOL BIOL, V140, P505, DOI 10.1016/0022-2836(80)90268-5; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; FINCH JT, 1976, P NATL ACAD SCI USA, V73, P1897, DOI 10.1073/pnas.73.6.1897; GERCHMAN SE, 1987, P NATL ACAD SCI USA, V84, P7802, DOI 10.1073/pnas.84.22.7802; GRAZIANO V, 1994, NATURE, V368, P351, DOI 10.1038/368351a0; HOROWITZ RA, 1994, J CELL BIOL, V125, P1, DOI 10.1083/jcb.125.1.1; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Korber P, 2004, J BIOL CHEM, V279, P35113, DOI 10.1074/jbc.M405446200; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; MCGHEE JD, 1983, CELL, V33, P831, DOI 10.1016/0092-8674(83)90025-9; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OUDET P, 1975, CELL, V4, P281, DOI 10.1016/0092-8674(75)90149-X; PEHRSON JR, 1989, P NATL ACAD SCI USA, V86, P9149, DOI 10.1073/pnas.86.23.9149; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; RIS H, 1979, CELL BIOL COMPREHENS, P268; SEN D, 1986, BIOCHEMISTRY-US, V25, P3441, DOI 10.1021/bi00359a052; THOMA F, 1977, CELL, V12, P101, DOI 10.1016/0092-8674(77)90188-X; THOMAS JO, 1976, FEBS LETT, V66, P274, DOI 10.1016/0014-5793(76)80521-2; WIDOM J, 1985, CELL, V43, P207, DOI 10.1016/0092-8674(85)90025-X; WIDOM J, 1985, EMBO J, V4, P3189, DOI 10.1002/j.1460-2075.1985.tb04064.x; WILLIAMS SP, 1986, BIOPHYS J, V49, P233, DOI 10.1016/S0006-3495(86)83637-2; WOODCOCK CL, 1994, J CELL BIOL, V125, P11, DOI 10.1083/jcb.125.1.11; WOODCOCK CLF, 1984, J CELL BIOL, V99, P42, DOI 10.1083/jcb.99.1.42	30	557	582	2	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2005	436	7047					138	141		10.1038/nature03686	http://dx.doi.org/10.1038/nature03686			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942QJ	16001076				2022-12-01	WOS:000230296600054
J	Kamphuis, S; Kuis, W; de Jager, W; Teklenburg, G; Massa, M; Gordon, G; Boerhof, M; Rijkers, GT; Uiterwaal, CS; Otten, HG; Sette, A; Albani, S; Prakken, BJ				Kamphuis, S; Kuis, W; de Jager, W; Teklenburg, G; Massa, M; Gordon, G; Boerhof, M; Rijkers, GT; Uiterwaal, CS; Otten, HG; Sette, A; Albani, S; Prakken, BJ			Tolerogenic immune responses to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis	LANCET			English	Article							HEAT-SHOCK PROTEINS; RHEUMATOID-ARTHRITIS; VACCINE DESIGN; HUMAN HSP60; INTERLEUKIN-10; AUTOIMMUNITY; RECOGNITION; REMISSION; TOOLS	Background juvenile idiopathic arthritis is a heterogeneous autoimmune disease characterised by chronic inflammation of one or more joints. In patients with this disease, T-cell reactivity to autologous heat-shock protein 60 (HSP60) is associated with a favourable prognosis. We sought to identify HSP60 T-cell epitopes to find potential targets for HSP60 immunotherapy and to assess whether immune responses to these epitopes contribute to the distinct clinical outcome of this disease. Methods We identified eight potential epitopes using a computer algorithm from both self and microbial HSP60 binding to many HLA-DR molecules. We analysed the pattern of T-cell responses induced by these HSP60 peptides in peripheral-blood mononuclear cells (PBMC) of 57 patients with juvenile idiopathic arthritis, 27 healthy controls, and 20 disease controls. We undertook in-vitro MHC binding studies with the identified peptides, and HLA class II typing of a subset of patients with juvenile idiopathic arthritis. Findings Five of the eight peptides identified yielded proliferative T-cell responses in 50-70% of PBMC from patients with juvenile idiopathic arthritis irrespective of MHC genotype, but not in PBMC from healthy or disease controls. Although PBMC from both patients with juvenile idiopathic arthritis and healthy controls produced interferon gamma in response to these peptides, only PBMC from patients with the disease produced interleukin 10. Interpretation The recorded T-cell-induction in juvenile idiopathic arthritis is tolerogenic. In patients with oligoarticular disease, the immune responses to the HSP60 epitopes identified could contribute to disease remission. Relevance to practice The broad recognition of these HSP60 epitopes in a population of patients with polymorphic MHC genotypes opens the way for HSP60-peptide immunotherapy, representing a novel treatment option to specifically modulate the immune system in patients with juvenile idiopathic arthritis.	Univ Med Ctr Utrecht, Dept Paediat Immunol, NL-3508 AB Utrecht, Netherlands; Univ Med Ctr Utrecht, IACOPO Inst Translat Med, NL-3508 AB Utrecht, Netherlands; Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 AB Utrecht, Netherlands; IRCCS San Matteo, Biotechnol Lab, Pavia, Italy; La Jolla Inst Allergy & Immunol, La Jolla, CA USA; Univ Calif San Diego, Dept Med & Paediat, San Diego, CA 92103 USA; Univ Calif San Diego, IACOPO Inst Translat Med, San Diego, CA 92103 USA; Androclus Therapeut, Milan, Italy	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; IRCCS Fondazione San Matteo; La Jolla Institute for Immunology; University of California System; University of California San Diego; University of California System; University of California San Diego	Prakken, BJ (corresponding author), Univ Med Ctr Utrecht, Dept Paediat Immunol, KC-03-063-0,POB 85090, NL-3508 AB Utrecht, Netherlands.	b.prakken@wkz.azu.nl	Rijkers, Ger/R-7236-2019; Kamphuis, Sylvia/AAJ-8195-2020; Massa, Margherita/K-4682-2016; Sette, Alessandro/AFO-8916-2022; Rijkers, Ger/AAW-6143-2020	Rijkers, Ger/0000-0001-6948-6123; Massa, Margherita/0000-0001-8037-0439; de Jager, Wilco/0000-0002-0014-0682				Abulafia-Lapid R, 1999, J AUTOIMMUN, V12, P121, DOI 10.1006/jaut.1998.0262; ALBANI S, 1995, NAT MED, V1, P448, DOI 10.1038/nm0595-448; Bason C, 2003, LANCET, V362, P1971, DOI 10.1016/S0140-6736(03)15016-7; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Cohen IR, 2004, J CLIN INVEST, V114, P1227, DOI 10.1172/JCI200422396; COHEN IR, 1991, IMMUNOL TODAY, V12, P105, DOI 10.1016/0167-5699(91)90093-9; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; de Kleer IM, 2003, ARTHRITIS RHEUM, V48, P2001, DOI 10.1002/art.11174; DEGRAEFFMEEDER ER, 1995, J CLIN INVEST, V95, P934, DOI 10.1172/JCI117801; DEGRAEFFMEEDER ER, 1991, LANCET, V337, P1368, DOI 10.1016/0140-6736(91)93057-G; Gaston JSH, 1997, AUTOIMMUNITY, V26, P33, DOI 10.3109/08916939709009548; Lillicrap MS, 2004, INT IMMUNOL, V16, P405, DOI 10.1093/intimm/dxh032; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Nepom GT, 2002, ARTHRITIS RHEUM, V46, P5, DOI 10.1002/1529-0131(200201)46:1<5::AID-ART10063>3.0.CO;2-S; Petty RE, 2004, J RHEUMATOL, V31, P390; Pockley AG, 2003, LANCET, V362, P469, DOI 10.1016/S0140-6736(03)14075-5; Prakken ABJ, 1996, ARTHRITIS RHEUM-US, V39, P1826, DOI 10.1002/art.1780391108; Prakken B, 2000, NAT MED, V6, P1406, DOI 10.1038/82231; Prakken BJ, 2004, P NATL ACAD SCI USA, V101, P4228, DOI 10.1073/pnas.0400061101; Prakken BJ, 2003, SPRINGER SEMIN IMMUN, V25, P47, DOI 10.1007/s00281-003-0128-7; Raz I, 2001, LANCET, V358, P1749, DOI 10.1016/S0140-6736(01)06801-5; Sette A, 2000, SCIENCE, V290, P2074; Sette A, 2003, CURR OPIN IMMUNOL, V15, P461, DOI 10.1016/S0952-7915(03)00083-9; Southwood S, 1998, J IMMUNOL, V160, P3363; van Eden W, 2005, NAT REV IMMUNOL, V5, P318, DOI 10.1038/nri1593; VANDERZEE R, 1995, PEPTIDES 1994, P841; vanRoon JAG, 1997, J CLIN INVEST, V100, P459, DOI 10.1172/JCI119553; Woo P, 1998, LANCET, V351, P969	28	130	140	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 2	2005	366	9479					50	56		10.1016/S0140-6736(05)66827-4	http://dx.doi.org/10.1016/S0140-6736(05)66827-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942JB	15993233				2022-12-01	WOS:000230277600034
J	Peters, CJ				Peters, CJ			Marburg and ebola - Arming ourselves against the deadly filoviruses	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Texas, Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77550 USA	University of Texas System; University of Texas Medical Branch Galveston	Peters, CJ (corresponding author), Univ Texas, Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77550 USA.								0	29	30	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 23	2005	352	25					2571	2573		10.1056/NEJMp058109	http://dx.doi.org/10.1056/NEJMp058109			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	937VJ	15972860	Bronze			2022-12-01	WOS:000229953700001
J	Poh, M; Boyer, M; Solan, A; Dahl, SLM; Pedrotty, D; Banik, SSR; McKee, JA; Klinger, RY; Counter, CM; Niklason, LE				Poh, M; Boyer, M; Solan, A; Dahl, SLM; Pedrotty, D; Banik, SSR; McKee, JA; Klinger, RY; Counter, CM; Niklason, LE			Blood vessels engineered from human cells	LANCET			English	Article							IN-VITRO	Tissue engineering has made considerable progress in the past decade, but advances have stopped short of clinical application for most tissues. We postulated that an obstacle in engineering human tissues is the limited replicative capacity of adult somatic cells. To test this hypothesis, the effectiveness of telomerase expression to extend cellular lifespan was assessed in a model of human vascular tissue engineering. Telomerase expression in vascular cells isolated from elderly patients enabled the successful culture of engineered autologous blood vessels. Engineered vessels may one day provide a source of bypass conduit for patients with atherosclerotic disease.	Duke Univ, Med Ctr, Dept Anesthesia, Durham, NC 27708 USA; Duke Univ, Med Ctr, Dept Biomed Engn, Durham, NC 27708 USA; Duke Univ, Med Ctr, Dept Surg, Durham, NC 27708 USA; Univ Pittsburgh, Pittsburgh, PA USA	Duke University; Duke University; Duke University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Niklason, LE (corresponding author), Duke Univ, Med Ctr, Dept Anesthesia, CIEMAS Room 1395,100 Sci Dr, Durham, NC 27708 USA.	nikla001@mc.duke.edu		Boyer, Matthew/0000-0002-8970-2046; Counter, Christopher M/0000-0003-0748-3079	NCI NIH HHS [CA-82481] Funding Source: Medline; NHLBI NIH HHS [F32-HL-71407, HL-63766] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA082481] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063766, F32HL071407] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Counter CM, 2003, LANCET, V361, P1345, DOI 10.1016/S0140-6736(03)13042-5; Dahl SLM, 2003, CELL TRANSPLANT, V12, P659, DOI 10.3727/000000003108747136; Jiang XR, 1999, NAT GENET, V21, P111, DOI 10.1038/5056; McKee JA, 2003, EMBO REP, V4, P633, DOI 10.1038/sj.embor.embor847; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489	6	166	177	0	23	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 18	2005	365	9477					2122	2124		10.1016/S0140-6736(05)66735-9	http://dx.doi.org/10.1016/S0140-6736(05)66735-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	936LZ	15964449				2022-12-01	WOS:000229858800029
J	Smith, C				Smith, C			Getting down to details	NATURE			English	Article																			0	13	16	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 16	2005	435	7044					991	996		10.1038/435991a	http://dx.doi.org/10.1038/435991a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935RN	15959523	Bronze			2022-12-01	WOS:000229799700056
J	Greenberger, MD; Vogelstein, R				Greenberger, MD; Vogelstein, R			Pharmacist refusals: A threat to women's health	SCIENCE			English	Editorial Material									Natl Womens Law Ctr, Washington, DC 20036 USA		Greenberger, MD (corresponding author), Natl Womens Law Ctr, Washington, DC 20036 USA.	riaser@nwlc.org						*AMWA, 2005, STAT AMWA SUPP PHARM; *APHA, 2003, POL STAT 2003 15; WINCKLER SC, 2004, UNPUB COMMUNICA 0701; 2005, N CAROLINA BOARD PHA, V26, P1; 2005, SUNDAY MIRROR   0227; 2005, FINANCIAL TIMES 0331	6	6	7	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2005	308	5728					1557	1558		10.1126/science.1114466	http://dx.doi.org/10.1126/science.1114466			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	936BH	15947159				2022-12-01	WOS:000229827000026
J	Pai, M; Gokhale, K; Joshi, R; Dogra, S; Kalantri, S; Mendiratta, DK; Narang, P; Daley, CL; Granich, RM; Mazurek, GH; Reingold, AL; Riley, LW; Colford, JM				Pai, M; Gokhale, K; Joshi, R; Dogra, S; Kalantri, S; Mendiratta, DK; Narang, P; Daley, CL; Granich, RM; Mazurek, GH; Reingold, AL; Riley, LW; Colford, JM			Mycobacterium tuberculosis infection in health care workers in rural India - Comparison of a whole-blood interferon gamma assay with tuberculin skin testing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	101st International Conference of the American-Thoracic-Society	MAY 20-25, 2005	San Diego, CA	Amer Thorac Soc, Fogarty AIDS Int Training & Res Program			ANNUAL RISK; PREVALENCE; DIAGNOSIS; ESAT-6; REACTIVITY; RESPONSES	Context Mycobacterium tuberculosis infection in health care workers has not been adequately studied in developing countries using newer diagnostic tests. Objectives To estimate latent tuberculosis infection prevalence in healthcare workers using the tuberculin skin test (TST) and a whole-blood interferon gamma (IFN-gamma) assay; to determine agreement between the tests; and to compare their correlation with risk factors. Design, Setting, and Participants A cross-sectional comparison study of 726 health care workers aged 18 to 61 years (median age, 22 years) with no history of active tuberculosis conducted from January to May 2004, at a rural medical school in India. A total of 493 (68%) of the health care workers had direct contact with patients with tuberculosis and 514 (71%) had BCG vaccine scars. Interventions Tuberculin skin testing was performed using 1-TU dose of purified protein derivative RT23, and the IFN-gamma assay was performed by measuring IFN-gamma response to early secreted antigenic target 6, culture filtrate protein 10, and a portion of tuberculosis antigen TB7.7. Main Outcome Measures Agreement between TST and the IFN-gamma assay, and comparison of the tests with respect to their association with risk factors. Results A large proportion of the health care workers were latently infected; 360 (50%) were positive by either TST or IFN-gamma assay, and 226 (31%) were positive by both tests. The prevalence estimates of TST and IFN-gamma assay positivity were comparable (41%; 95% confidence interval[CI], 38%-45% and 40%; 95% Cl, 37%-43%, respectively). Agreement between the tests was high (81.4%; kappa=0.61; 95% Cl, 0.56-0.67). Increasing age and years in the health profession were significant risk factors for both IFN-gamma assay and TST positivity. BCG vaccination had little impact on TST and IFN-gamma assay results. Conclusions Our study showed high latent tuberculosis infection prevalence in Indian health care workers, high agreement between TST and IFN-gamma assay, and similar association between positive test results and risk factors. Although TST and IFN-gamma assay appear comparable in this population, they have different performance and operational characteristics; therefore, the decision to select one test over the other will depend on the population, purpose of testing, and resource availability.	Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis, Berkeley, CA 94720 USA; Mahatma Gandi Inst Med Sci, Dept Med, Sevagram, India; Mahatma Gandi Inst Med Sci, Dept Microbiol, Sevagram, India; Univ Calif San Francisco, Dept Med, San Francisco, CA USA; Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA; Off WHO Representat India, New Delhi, India	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Mahatma Gandhi Institute of Medical Sciences, Sevagram; Mahatma Gandhi Institute of Medical Sciences, Sevagram; University of California System; University of California San Francisco; Centers for Disease Control & Prevention - USA; World Health Organization	Pai, M (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, 140 Warren Hall, Berkeley, CA 94720 USA.	madhupai@berkeley.edu	Kalantri, Shriprakash/ABG-9318-2021; PAL, MRINAL/ABG-9676-2020; Daley, Charles L./AAC-3231-2021; Pai, Madhukar/AAX-9901-2021	Kalantri, Shriprakash/0000-0002-1633-1029; PAL, MRINAL/0000-0002-1032-272X; Pai, Madhukar/0000-0003-3667-4536; Joshi, Rajnish/0000-0002-4702-0522; Colford, John/0000-0002-3288-6956; Narang, Pratibha/0000-0001-6135-1857	FIC NIH HHS [1-D43-TW00003-16] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [D43TW000003] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Alonso-Echanove J, 2001, CLIN INFECT DIS, V33, P589, DOI 10.1086/321892; *AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, pS221, DOI DOI 10.1164/AJRCCM.161.SUPPLEMENT_; Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; [Anonymous], GUID PREV TUB HLTH C; [Anonymous], 1999, EPIDEMIOLOGIC BASIS; Arend SM, 2002, J INFECT DIS, V186, P1797, DOI 10.1086/345760; Brock L, 2004, AM J RESP CRIT CARE, V170, P65, DOI 10.1164/rccm.200402-232OC; Chadha V. K., 2004, Indian Journal of Pediatrics, V71, P1063, DOI 10.1007/BF02829815; Chadha V K, 2003, J Indian Med Assoc, V101, P144; Chadha V. K., 2003, Indian Journal of Tuberculosis, V50, P125; Chadha V. K., 2000, Indian Journal of Tuberculosis, V47, P139; Chadha Vineet K., 2001, Indian Journal of Pediatrics, V68, P53, DOI 10.1007/BF02728860; Chadha VK, 2005, INT J TUBERC LUNG D, V9, P116; Chadha VK, 2004, INT J TUBERC LUNG D, V8, P1437; Chadha VK, 2003, INT J TUBERC LUNG D, V7, P172; CHAKRABORTY AK, 1976, INDIAN J MED RES, V64, P639; David W, 2000, APPL LOGISTIC REGRES, P26, DOI 10.1002/0471722146; Do AN, 1999, INT J TUBERC LUNG D, V3, P377; Doherty TM, 2002, J CLIN MICROBIOL, V40, P704, DOI 10.1128/JCM.40.2.704-706.2002; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; Geluk A, 2002, INFECT IMMUN, V70, P2544, DOI 10.1128/IAI.70.5.2544-2548.2002; Gopi PG, 2003, INT J TUBERC LUNG D, V7, P1154; Gopinath KG, 2004, J HOSP INFECT, V57, P339, DOI 10.1016/j.jhin.2004.03.029; GRANICH R, 2003, J INDIAN MED ASSOC, V101, P156; Granich Reuben, 2003, J Indian Med Assoc, V101, P150; Hill PC, 2004, CLIN INFECT DIS, V38, P966, DOI 10.1086/382362; HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968; Kassim S, 2000, INT J TUBERC LUNG D, V4, P321; Khatri GR, 2002, NEW ENGL J MED, V347, P1420, DOI 10.1056/NEJMsa020098; Lalvani A, 2003, THORAX, V58, P916, DOI 10.1136/thorax.58.11.916; Lalvani A, 2001, J INFECT DIS, V183, P469, DOI 10.1086/318081; Mazurek Gerald H, 2003, MMWR Recomm Rep, V52, P15; Mazurek GH, 2001, JAMA-J AM MED ASSOC, V286, P1740, DOI 10.1001/jama.286.14.1740; Menzies D, 2003, AM J RESP CRIT CARE, V167, P599, DOI 10.1164/rccm.200208-873BC; MENZIES RI, 2000, LUNG BIOL HEALTH DIS, V144, P279; Mori T, 2004, AM J RESP CRIT CARE, V170, P59, DOI 10.1164/rccm.200402-179OC; Narang P, 1999, INT J TUBERC LUNG D, V3, P478; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Rao KG, 2004, INT J TUBERC LUNG D, V8, P1392; *REV NAT TUB CONTR, 1997, TECHN GUID TUB CONTR; Richeldi L, 2004, AM J RESP CRIT CARE, V170, P288, DOI 10.1164/rccm.200403-307OC; Sepkowitz KA, 1996, TUBERCLE LUNG DIS, V77, P81, DOI 10.1016/S0962-8479(96)90081-7; Wang L, 2002, THORAX, V57, P804, DOI 10.1136/thorax.57.9.804; Watkins RE, 2000, INT J TUBERC LUNG D, V4, P895	45	275	281	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	2005	293	22					2746	2755		10.1001/jama.293.22.2746	http://dx.doi.org/10.1001/jama.293.22.2746			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	933OV	15941804	Bronze			2022-12-01	WOS:000229643700023
J	Dalton, R				Dalton, R			California stem-cell institute fights legal challenges	NATURE			English	News Item								The Californian stem-cell institute, California Institute for Regenerative Medicine, fights legal challenges.										2005, NATURE, V434, P427	1	0	0	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 2	2005	435	7042					544	544						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931HK	15957195				2022-12-01	WOS:000229476200008
J	Basu, P				Basu, P			Vaccines on trial	NATURE			English	Article																			0	3	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 28	2005	436	7050					484	484		10.1038/436484a	http://dx.doi.org/10.1038/436484a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049470				2022-12-01	WOS:000230788800039
J	Zatonski, WA; Willett, W				Zatonski, WA; Willett, W			Changes in dietary fat and declining coronary heart disease in Poland: population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK; MORTALITY		Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Ctr Canc, PL-02781 Warsaw, Poland; Inst Oncol, PL-02781 Warsaw, Poland	Harvard University; Harvard T.H. Chan School of Public Health; Maria Sklodowska-Curie National Research Institute of Oncology	Willett, W (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	walter.willett@channing.harvard.edu						DWYER T, 1980, INT J EPIDEMIOL, V9, P65, DOI 10.1093/ije/9.1.65; Hu FB, 1999, AM J CLIN NUTR, V70, P1001; Hu FB, 2002, JAMA-J AM MED ASSOC, V288, P2569, DOI 10.1001/jama.288.20.2569; Joshipura KJ, 2001, ANN INTERN MED, V134, P1106, DOI 10.7326/0003-4819-134-12-200106190-00010; Zatonski WA, 1998, BMJ-BRIT MED J, V316, P1047	5	107	112	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	2005	331	7510					187	188		10.1136/bmj.331.7510.187	http://dx.doi.org/10.1136/bmj.331.7510.187			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951EA	16037448	Green Published, Bronze			2022-12-01	WOS:000230910700017
J	Diaconu, M; Kothe, U; Schlunzen, F; Fischer, N; Harms, JM; Tonevitsky, AG; Stark, H; Rodnina, MV; Wahl, MC				Diaconu, M; Kothe, U; Schlunzen, F; Fischer, N; Harms, JM; Tonevitsky, AG; Stark, H; Rodnina, MV; Wahl, MC			Structural basis for the function of the ribosomal L7/12 stalk in factor binding and GTPase activation	CELL			English	Article							ELONGATION-FACTOR TU; AMINOACYL-TRANSFER-RNA; PROTEIN L7/L12; CODON-RECOGNITION; SUBUNIT; SITE; VISUALIZATION; TRANSLOCATION; LOCALIZATION; TRANSLATION	The L7/12 stalk of the large subunit of bacterial ribosomes encompasses protein L10 and multiple copies of L7/12. We present crystal structures of Thermotoga maritima L10 in complex with three L7/12 N-terminaldomain dimers, refine the structure of an archaeal L10E N-terminal domain on the 50S subunit, and identify these elements in cryo-electron-microscopic reconstructions of Escherichia coli ribosomes. The mobile C-terminal helix alpha 8 of L10 carries three L7/12 dimers in T maritima and two in E. coli, in concordance with the different length of helix alpha 8 of L10 in these organisms. The stalk is organized into three elements (stalk base, L10 helix alpha 8-L7/12 N-terminaldomain complex, and L7/12 C-terminal domains) linked by flexible connections. Highly mobile L7/12 C-terminal domains promote recruitment of translation factors to the ribosome and stimulate GTP hydrolysis by the ribosome bound factors through stabilization of their active GTPase conformation.	Max Planck Inst Biophys Chem, Rontgenkristallog, D-37077 Gottingen, Germany; Max Planck Inst Biophys Chem, 3D Kryoelektr Mikroskopie, D-37077 Gottingen, Germany; Univ Witten Herdecke, Inst Phys Biochem, D-58448 Witten, Germany; DESY, Max Planck Arbeitsgrppen Strukt Mol Biol, D-22607 Hamburg, Germany; Moscow MV Lomonosov State Univ, Dept Biol, Moscow 119899, Russia	Max Planck Society; Max Planck Society; Witten Herdecke University; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Max Planck Society; Lomonosov Moscow State University	Wahl, MC (corresponding author), Max Planck Inst Biophys Chem, Rontgenkristallog, Fassberg 11, D-37077 Gottingen, Germany.	mwahl@gwdg.de	Diaconu, Mihaela Stefania/C-3644-2012; Tonevitsky, Alexander G/F-8640-2014; Rodnina, Marina V./AAD-4667-2019; Schluenzen, Frank/H-6274-2014; Harms, Joerg/K-8786-2012; Kothe, Ute/K-5568-2019; Fischer, Niels/ABA-5342-2021; Schluenzen, Frank/P-9177-2019; Tonevitsky, Alexander/R-5596-2019; Wahl, Markus C./D-6365-2017	Diaconu, Mihaela Stefania/0000-0002-1144-338X; Rodnina, Marina V./0000-0003-0105-3879; Schluenzen, Frank/0000-0003-2849-0542; Harms, Joerg/0000-0002-9442-8264; Kothe, Ute/0000-0002-2744-7334; Fischer, Niels/0000-0002-4609-4052; Schluenzen, Frank/0000-0003-2849-0542; Wahl, Markus C./0000-0002-2811-5307; Holger, Stark/0000-0002-6161-1118				Agrawal RK, 1998, P NATL ACAD SCI USA, V95, P6134, DOI 10.1073/pnas.95.11.6134; Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; Agrawal RK, 2001, J MOL BIOL, V311, P777, DOI 10.1006/jmbi.2001.4907; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BEAUCLERK AAD, 1984, J BIOL CHEM, V259, P6559; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; Bocharov EV, 2004, J BIOL CHEM, V279, P17697, DOI 10.1074/jbc.M313384200; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Dey D, 1998, J BIOL CHEM, V273, P1670, DOI 10.1074/jbc.273.3.1670; Gonzalo P, 2003, BIOL CELL, V95, P179, DOI 10.1016/S0248-4900(03)00034-0; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; Klaholz BP, 2004, NATURE, V427, P862, DOI 10.1038/nature02332; Kothe U, 2004, J MOL BIOL, V336, P1011, DOI 10.1016/j.jmb.2003.12.080; LILJAS A, 1987, BIOCHIMIE, V69, P1043, DOI 10.1016/0300-9084(87)90004-6; Mohr D, 2000, EMBO J, V19, P3458, DOI 10.1093/emboj/19.13.3458; Mohr D, 2002, BIOCHEMISTRY-US, V41, P12520, DOI 10.1021/bi026301y; Montesano-Roditis L, 2001, J BIOL CHEM, V276, P14117, DOI 10.1074/jbc.M008430200; Mulder FAA, 2004, BIOCHEMISTRY-US, V43, P5930, DOI 10.1021/bi0495331; OLEINIKOV AV, 1993, J BIOL CHEM, V268, P917; Pape T, 1998, EMBO J, V17, P7490, DOI 10.1093/emboj/17.24.7490; Rawat UBS, 2003, NATURE, V421, P87, DOI 10.1038/nature01224; RODNINA MV, 1995, P NATL ACAD SCI USA, V92, P1945, DOI 10.1073/pnas.92.6.1945; Rodnina MV, 1996, J BIOL CHEM, V271, P646, DOI 10.1074/jbc.271.2.646; ROSENDAHL G, 1993, J MOL BIOL, V234, P1013, DOI 10.1006/jmbi.1993.1655; Savelsbergh A, 2000, J BIOL CHEM, V275, P890, DOI 10.1074/jbc.275.2.890; Savelsbergh A, 2003, MOL CELL, V11, P1517, DOI 10.1016/S1097-2765(03)00230-2; Stark H, 2002, NAT STRUCT BIOL, V9, P849, DOI 10.1038/nsb859; Stark H, 2000, CELL, V100, P301, DOI 10.1016/S0092-8674(00)80666-2; SUBRAMANIAN AR, 1975, J MOL BIOL, V95, P1, DOI 10.1016/0022-2836(75)90330-7; Valle M, 2003, NAT STRUCT BIOL, V10, P899, DOI 10.1038/nsb1003; Vetter IR, 1999, Q REV BIOPHYS, V32, P1, DOI 10.1017/S0033583599003480; Vila-Sanjurjo A, 2003, P NATL ACAD SCI USA, V100, P8682, DOI 10.1073/pnas.1133380100; Wahl MC, 2000, EMBO J, V19, P174, DOI 10.1093/emboj/19.2.174; Wahl MC, 2002, CURR PROTEIN PEPT SC, V3, P93, DOI 10.2174/1389203023380756; Wieden HJ, 2001, J MOL EVOL, V52, P129, DOI 10.1007/s002390010141; Wimberly BT, 1999, CELL, V97, P491, DOI 10.1016/S0092-8674(00)80759-X; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	37	307	317	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 1	2005	121	7					991	1004		10.1016/j.cell.2005.04.015	http://dx.doi.org/10.1016/j.cell.2005.04.015			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	944RZ	15989950	Green Published, Bronze			2022-12-01	WOS:000230448000007
J	Nudleman, E; Wall, D; Kaiser, D				Nudleman, E; Wall, D; Kaiser, D			Cell-to-cell transfer of bacterial outer membrane lipoproteins	SCIENCE			English	Article							MYXOCOCCUS-XANTHUS; GLIDING MOTILITY; IV PILI; MOVEMENT; MYXOBACTERIA; STIMULATION	Myxococcus xanthus cells can glide forward by retracting type IV pili. Tgl, an outer membrane lipoprotein, is necessary to assemble pili. Tgl(+) mutants can be transiently "stimulated" if brought into end-to-end contact with tgl(+) donor cells. By separating the stimulated recipient cells from donor cells, we found that Tgl protein was transferred from the donors to the rescued recipient cells. Mutants lacking CglB lipoprotein, which is part of a second gliding engine, could also be stimulated, and CglB protein was transferred from donor to recipient cells. The high transfer efficiency of Tgl and CglB proteins suggests that donor and recipient cells briefly fuse their outer membranes.	Stanford Univ, Dept Dev Biol, Sch Med, Beckman Ctr B300, Stanford, CA 94305 USA; Stanford Univ, Dept Biochem, Sch Med, Beckman Ctr B300, Stanford, CA 94305 USA	Stanford University; Stanford University	Kaiser, D (corresponding author), Albert Einstein Coll Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	kaiser@cmgm.stanford.edu		Wall, Daniel/0000-0002-0273-1371	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM023441, R01GM023441] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM23441] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Hardie KR, 1996, MOL MICROBIOL, V22, P967, DOI 10.1046/j.1365-2958.1996.01539.x; HODGKIN J, 1977, P NATL ACAD SCI USA, V74, P2938, DOI 10.1073/pnas.74.7.2938; HODGKIN J, 1979, MOL GEN GENET, V171, P177, DOI 10.1007/BF00270004; KAISER D, 1983, CELL MOTIL CYTOSKEL, V3, P227, DOI 10.1002/cm.970030304; KAISER D, 1979, P NATL ACAD SCI USA, V76, P5952, DOI 10.1073/pnas.76.11.5952; Kaiser D, 2005, CURR OPIN MICROBIOL, V8, P216, DOI 10.1016/j.mib.2005.02.002; Kaiser D, 2003, NAT REV MICROBIOL, V1, P45, DOI 10.1038/nrmicro733; MACRAE TH, 1976, CAN J MICROBIOL, V22, P1589, DOI 10.1139/m76-234; McBride MJ, 2001, ANNU REV MICROBIOL, V55, P49, DOI 10.1146/annurev.micro.55.1.49; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; Nouwen N, 1999, P NATL ACAD SCI USA, V96, P8173, DOI 10.1073/pnas.96.14.8173; Nudleman E, 2004, J MOL MICROB BIOTECH, V7, P52, DOI 10.1159/000077869; NUDLEMAN E, UNPUB; Rodriguez AM, 1999, J BACTERIOL, V181, P4381, DOI 10.1128/JB.181.14.4381-4390.1999; Thanassi DG, 2002, J MOL MICROB BIOTECH, V4, P11; Wall D, 1998, J BACTERIOL, V180, P759, DOI 10.1128/JB.180.3.759-761.1998; Wall D, 1999, J BACTERIOL, V181, P24, DOI 10.1128/JB.181.1.24-33.1999; Wolgemuth C, 2002, CURR BIOL, V12, P369, DOI 10.1016/S0960-9822(02)00716-9; WU SS, 1995, MOL MICROBIOL, V18, P547, DOI 10.1111/j.1365-2958.1995.mmi_18030547.x	19	120	123	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2005	309	5731					125	127		10.1126/science.1112440	http://dx.doi.org/10.1126/science.1112440			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	941KD	15994555				2022-12-01	WOS:000230212800073
J	Ninis, N; Phillips, C; Bailey, L; Pollock, JI; Nadel, S; Britto, J; Maconochie, I; Winrow, A; Coen, PG; Booy, R; Levin, M				Ninis, N; Phillips, C; Bailey, L; Pollock, JI; Nadel, S; Britto, J; Maconochie, I; Winrow, A; Coen, PG; Booy, R; Levin, M			The role of healthcare delivery in the outcome of meningococcal disease in children: case-control study of fatal and non-fatal cases	BRITISH MEDICAL JOURNAL			English	Article							SEPTICEMIA; MANAGEMENT	Objective To determine whether suboptimal management in hospital could contribute to poor outcome in children admitted with meningococcal disease. Design Case-control study of childhood deaths from meningococcal disease, comparing hospital care in fatal mid non-fatal cases. Setting National statistics and hospital records. Subjects All children under 17 years who died from meningococcal disease (cases) matched by age with three survivors (controls) from the same region of the country. Main outcome measures Predefined criteria defined optimal management. A panel of paediatricians blinded to the outcome assessed case records using a standardised form and scored patients for suboptimal management. Results We identified 143 cases and 355 controls. Departures from optimal (per protocol) management occurred more frequently in the fatal cases than in the survivors. Multivariate analysis identified three factors independently associated with an increased risk of death: failure to be looked after by a paediatrician, failure of sufficient supervision of junior staff, and failure of staff to administer adequate inotropes. Failure to recognise complications of the disease was a significant risk factor for death, although not independently of absence of paediatric care (P=0.002). The odds ratio for death was 8.7 (95% confidence interval 2.3 to 33) with two failures, increasing with multiple failures. Conclusions Suboptimal healthcare delivery significantly reduces the likelihood of survival in children with meningococcal disease. Improved training of medical and nursing staff, adherence to published protocols, and increased supervision by consultants may improve the outcome for these children and also those with other life threatening illnesses.	Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Paediat, Infect Dis Unit, London W2 1PG, England; Royal Coll Paediat & Child Hlth, Res Unit, London W1W 6DE, England; Univ W England, Fac Hlth & Social Care, Bristol BS16 1DD, Avon, England; St Marys Hosp, Paediat Intens Care Unit, London W2 1PG, England; St Marys Hosp, Paediat Accid & Emergency Dept, London W2 1PG, England; Kingston Hosp, Dept Paediat, Kingston upon Thames KT2 7QB, Surrey, England; Univ London, Queen Marys Sch Med & Dent, London E1 1BB, England	Imperial College London; University of West England; Imperial College London; Imperial College London; University of London; Queen Mary University London	Ninis, N (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Paediat, Infect Dis Unit, London W2 1PG, England.	ninisn@gosh.nhs.uk	Booy, Robert/D-4188-2011	Levin, Michael/0000-0003-2767-6919; Maconochie, Ian/0000-0001-6319-8550				*ADV LIF SUPP GROU, 2001, ADV PAED LIF SUPP MA; Booy R, 2001, ARCH DIS CHILD, V85, P386, DOI 10.1136/adc.85.5.386; Hosmer DW, 2000, APPL LOGISTIC REGRES, V2nd; JONES D, 1995, MENINGOCOCCAL DIS, P147; Nadel S, 1998, J ACCID EMERG MED, V15, P298; NADEL S, 1995, MENINGOCOCCAL DIS, P207; *OFF NAT STAT, 2000, MORT STAT DH2, V26; Pathan N, 2000, J ROY COLL PHYS LOND, V34, P436; Pollard AJ, 1999, ARCH DIS CHILD, V80, P290, DOI 10.1136/adc.80.3.290; Ramsay M, 1997, Commun Dis Rep CDR Rev, V7, pR49; Stuart J M, 1997, Commun Dis Rep CDR Rev, V7, pR3; THOMSON APJ, 1991, CRIT CARE MED, V19, P26, DOI 10.1097/00003246-199101000-00010; Thorburn K, 2001, ARCH DIS CHILD, V85, P382, DOI 10.1136/adc.85.5.382; Thornhill J, 2000, BJU INT, V85, P382	14	112	120	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 25	2005	330	7506					1475	1478		10.1136/bmj.330.7506.1475	http://dx.doi.org/10.1136/bmj.330.7506.1475			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942NR	15976421	Green Published, Bronze			2022-12-01	WOS:000230289600017
J	Kalo, P; Gleason, C; Edwards, A; Marsh, J; Mitra, RM; Hirsch, S; Jakab, J; Sims, S; Long, SR; Rogers, J; Kiss, GB; Downie, JA; Oldroyd, GED				Kalo, P; Gleason, C; Edwards, A; Marsh, J; Mitra, RM; Hirsch, S; Jakab, J; Sims, S; Long, SR; Rogers, J; Kiss, GB; Downie, JA; Oldroyd, GED			Nodulation signaling in legumes requires NSP2, a member of the GRAS family of transcriptional regulators	SCIENCE			English	Article							MEDICAGO-TRUNCATULA; CALCIUM SPIKING; NOD FACTORS; MUTANTS; IDENTIFICATION; TRANSDUCTION; SYMBIOSIS; GENE	Rhizobial bacteria enter a symbiotic interaction with legumes, activating diverse responses in roots through the lipochito oligosaccharide signaling molecule Nod factor. Here, we show that NSP2 from Medicago truncatula encodes a GRAS protein essential for Nod-factor signaling. NSP2 functions downstream of Nod-factor-induced calcium spiking and a calcium/calmodulin-dependent protein kinase. We show that NSP2-GFP expressed from a constitutive promoter is localized to the endoplasmic reticulum/nuclear envelope and relocalizes to the nucleus after Nod-factor elicitation. This work provides evidence that a GRAS protein transduces calcium signals in plants and provides a possible regulator of Nod-factor-inducible gene expression.	John Innes Ctr, Dept Dis & Stress Biol, Norwich NR4 7UH, Norfolk, England; John Innes Ctr, Dept Mol Microbiol, Norwich NR4 7UH, Norfolk, England; Agr Biotechnol Ctr, Inst Genet, H-2100 Godollo, Hungary; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Wellcome Trust Sanger Institute; Stanford University	Oldroyd, GED (corresponding author), John Innes Ctr, Dept Dis & Stress Biol, Norwich NR4 7UH, Norfolk, England.	giles.oldroyd@bbsrc.ac.uk	Kalo, Peter/A-3919-2012; Oldroyd, Giles/ABA-7501-2020; Oldroyd, Giles/ABD-8143-2021; Mitra, Raka/GQA-9960-2022; Downie, Allan/I-3487-2012	Kalo, Peter/0000-0002-0404-8904; Oldroyd, Giles/0000-0002-5245-6355; Downie, Allan/0000-0003-1011-4960; Mitra, Raka/0000-0002-2798-2038				Ben Amor B, 2003, PLANT J, V34, P495, DOI 10.1046/j.1365-313X.2003.01743.x; Bolle C, 2004, PLANTA, V218, P683, DOI 10.1007/s00425-004-1203-z; Catoira R, 2000, PLANT CELL, V12, P1647, DOI 10.1105/tpc.12.9.1647; Ehrhardt DW, 1996, CELL, V85, P673, DOI 10.1016/S0092-8674(00)81234-9; Kalo P, 2004, MOL GENET GENOMICS, V272, P235, DOI 10.1007/s00438-004-1055-z; Levy J, 2004, SCIENCE, V303, P1361, DOI 10.1126/science.1093038; Long SR, 1996, PLANT CELL, V8, P1885, DOI 10.1105/tpc.8.10.1885; Mitra RM, 2004, P NATL ACAD SCI USA, V101, P10217, DOI 10.1073/pnas.0402186101; Mitra RM, 2004, P NATL ACAD SCI USA, V101, P4701, DOI 10.1073/pnas.0400595101; Oldroyd GED, 2004, NAT REV MOL CELL BIO, V5, P566, DOI 10.1038/nrm1424; Oldroyd GED, 2003, PLANT PHYSIOL, V131, P1027, DOI 10.1104/pp.102.010710; Smit P, 2005, SCIENCE, V308, P1789, DOI 10.1126/science.1111025; Wais RJ, 2000, P NATL ACAD SCI USA, V97, P13407, DOI 10.1073/pnas.230439797; Walker SA, 2000, P NATL ACAD SCI USA, V97, P13413, DOI 10.1073/pnas.230440097	14	396	425	3	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2005	308	5729					1786	1789		10.1126/science.1110951	http://dx.doi.org/10.1126/science.1110951			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937LY	15961668				2022-12-01	WOS:000229926800054
J	Kowalewski, M; Hoffmeister, AP; Baumiller, TK; Bambach, RK				Kowalewski, M; Hoffmeister, AP; Baumiller, TK; Bambach, RK			Secondary evolutionary escalation between brachiopods and enemies of other prey	SCIENCE			English	Article							MESOZOIC MARINE REVOLUTION; DRILLING PREDATION; FOSSIL RECORD; COMPETITION; BEHAVIOR; MUSSELS; SNAILS	The fossil record of predation indicates that attacks on Paleozoic brachiopods were very rare, especially compared to those on post-Pateozoic mollusks, yet stratigraphically and geographically widespread. Drilling frequencies were very tow in the early Paleozoic (<<1%) and went up slightly in the mid-to-late Paleozoic. Present-day brachiopods revealed frequencies only slightly higher. The persistent rarity of drilling suggests that brachiopods were the secondary casualties of mistaken or opportunistic attacks by the enemies of other taxa. Such sporadic attacks became slightly more frequent as trophic systems escalated and predators diversified. Some evolutionarily persistent biotic interactions may be incidental rather than coevolutionary or escalatory in nature.	Virginia Polytech Inst & State Univ, Dept Geosci, Blacksburg, VA 24061 USA; Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA; Harvard Univ, Bot Museum, Cambridge, MA 02138 USA	Virginia Polytechnic Institute & State University; University of Michigan System; University of Michigan; Harvard University	Kowalewski, M (corresponding author), Virginia Polytech Inst & State Univ, Dept Geosci, Blacksburg, VA 24061 USA.	michalk@vt.edu	Kowalewski, Michal/B-4263-2008; Baumiller, Tomasz K/C-3596-2012	Kowalewski, Michal/0000-0002-8575-4711; Baumiller, Tomasz K/0000-0002-4506-9330				AUSICH WI, 1979, J PALEONTOL, V53, P335; Bambach RK, 1999, GEOBIOS-LYON, V32, P131, DOI 10.1016/S0016-6995(99)80025-4; Baumiller TK, 1999, PALAEOGEOGR PALAEOCL, V147, P283, DOI 10.1016/S0031-0182(98)00165-5; Baumiller TK, 2004, PALAEOGEOGR PALAEOCL, V214, P85, DOI 10.1016/j.palaeo.2004.07.023; Baumiller TK, 2004, SCIENCE, V305, P1453, DOI 10.1126/science.1101009; Brett Carlton E., 2002, Paleontological Society Papers, V8, P93; Brett CE, 2003, T GEOBIOL, V20, P401; CADEE GC, 1984, LETHAIA, V17, P289, DOI 10.1111/j.1502-3931.1984.tb00674.x; Delance JH, 2004, PALAEOGEOGR PALAEOCL, V208, P23, DOI 10.1016/j.palaeo.2004.02.025; Dietl GP, 2004, SCIENCE, V306, P2229, DOI 10.1126/science.1106182; Harper EM, 2003, PALAEOGEOGR PALAEOCL, V210, P185, DOI 10.1016/S0031-0182(03)00624-2; Harper EM, 1998, PALAIOS, V13, P352, DOI 10.2307/3515323; Harper EM, 2000, PALAEOGEOGR PALAEOCL, V158, P15, DOI 10.1016/S0031-0182(99)00164-9; Harper EM, 2003, POLAR BIOL, V26, P208, DOI 10.1007/s00300-002-0455; Hoffmeister AP, 2004, ACTA PALAEONTOL POL, V49, P443; Hoffmeister AP, 2003, LETHAIA, V36, P107, DOI 10.1080/00241160310000408; HUGHES RN, 1984, J EXP MAR BIOL ECOL, V77, P45, DOI 10.1016/0022-0981(84)90050-9; KELLEY PH, 1993, PALAIOS, V8, P358, DOI 10.2307/3515266; Kelley PH, 1996, GEOL SOC SP, P373, DOI 10.1144/GSL.SP.1996.001.01.27; Kowalewski M, 1998, GEOLOGY, V26, P1091, DOI 10.1130/0091-7613(1998)026<1091:AFRFOH>2.3.CO;2; LABARBERA M, 1981, PALEOBIOLOGY, V7, P510, DOI 10.1017/S0094837300025550; Leighton LR, 2003, PALAEOGEOGR PALAEOCL, V210, P221, DOI 10.1016/S0031-0182(03)00627-8; Nebelsick JH, 1999, PALAIOS, V14, P127, DOI 10.2307/3515369; Rilov G, 2002, MAR ENVIRON RES, V54, P85, DOI 10.1016/S0141-1136(02)00096-X; SIGNOR PW, 1984, PALEOBIOLOGY, V10, P229, DOI 10.1017/S0094837300008174; SMITH SA, 1985, SCIENCE, V230, P1033, DOI 10.1126/science.230.4729.1033; Steer MA, 2003, J EXP MAR BIOL ECOL, V290, P165, DOI 10.1016/S0022-0981(03)00076-5; THAYER CW, 1985, SCIENCE, V228, P1527, DOI 10.1126/science.228.4707.1527; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; VERMEIJ G J, 1977, Paleobiology, V3, P245; Vermeij G.J, 1987, EVOLUTION ESCALATION; VERMEIJ GJ, 1981, SCIENCE, V214, P1024, DOI 10.1126/science.214.4524.1024; WALKER SE, 1993, PALAEONTOLOGY, V36, P735; WAREN A, 1994, VELIGER, V37, P141	34	70	72	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2005	308	5729					1774	1777		10.1126/science.1113408	http://dx.doi.org/10.1126/science.1113408			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937LY	15961667				2022-12-01	WOS:000229926800051
J	Somesh, BP; Reid, J; Liu, WF; Sogaard, TMM; Erdjument-Bromage, H; Tempst, P; Svejstrup, JQ				Somesh, BP; Reid, J; Liu, WF; Sogaard, TMM; Erdjument-Bromage, H; Tempst, P; Svejstrup, JQ			Multiple mechanisms confining RNA polymerase II ubiquitylation to polymerases undergoing transcriptional arrest	CELL			English	Article							TERMINAL REPEAT DOMAIN; LARGE SUBUNIT; STRUCTURAL BASIS; DNA-REPAIR; PROTEIN; UBIQUITIN; ELONGATION; COMPLEX; KINASE; GENE	In order to study mechanisms and regulation of RNA polymerase II (RNAPII) ubiquitylation and degradation, highly purified factors were used to reconstitute RNAPII ubiquitylation in vitro. We show that arrested RNAPII elongation complexes are the preferred substrates for ubiquitylation. Accordingly, not only DNA-damage-dependent but also DNA-damage-independent transcriptional arrest results in RNAPII ubiquitylation in vivo. Def1, known to be required for damage-induced degradation of RNAPII, stimulates ubiquitylation of RNAPII only in an elongation complex. Ubiquitylation of RNAPII is dependent on its C-terminal repeat domain (CTD). Moreover, CTD phosphorylation at serine 5, a hallmark of the initiating polymerase, but not at serine 2, a hallmark of the elongating polymerase, completely inhibits ubiqultylation. In agreement with this, ubiquitylated RNAPII is hypophosphorylated at serine 5 in vivo, and mutation of the serine 5 phosphatase SSU72 inhibits RNAPII degradation. These results identify several mechanisms that confine ubiquitylation of RNAPII to the forms of the enzyme that arrest during elongation.	Canc Res UK, London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	Cancer Research UK; Memorial Sloan Kettering Cancer Center	Svejstrup, JQ (corresponding author), Canc Res UK, London Res Inst, Clare Hall Labs, Blanche Lane, S Mimms EN6 3LD, Herts, England.	j.svejstrup@cancer.org.uk		Erdjument-Bromage, Hediye/0000-0003-0224-3594; Tempst, Paul/0000-0002-6680-3987; Svejstrup, Jesper/0000-0003-4964-6147; Sogaard, Teit Max Moscote/0000-0001-6224-4818				Arndt KM, 2003, TRENDS GENET, V19, P543, DOI 10.1016/j.tig.2003.08.008; Awrey DE, 1997, J BIOL CHEM, V272, P14747, DOI 10.1074/jbc.272.23.14747; Beaudenon SL, 1999, MOL CELL BIOL, V19, P6972; BOHR VA, 1985, CELL, V40, P359, DOI 10.1016/0092-8674(85)90150-3; Bregman DB, 1996, P NATL ACAD SCI USA, V93, P11586, DOI 10.1073/pnas.93.21.11586; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; EDWARDS AM, 1990, P NATL ACAD SCI USA, V87, P2122, DOI 10.1073/pnas.87.6.2122; FEAVER WJ, 1991, CELL, V67, P1223, DOI 10.1016/0092-8674(91)90298-D; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; Gavva NR, 1997, J BIOL CHEM, V272, P24105, DOI 10.1074/jbc.272.39.24105; Gillette TG, 2004, P NATL ACAD SCI USA, V101, P5904, DOI 10.1073/pnas.0305411101; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; HANSSON J, 1989, J BIOL CHEM, V264, P21788; HENNING KA, 1995, CELL, V82, P555, DOI 10.1016/0092-8674(95)90028-4; Huibregtse JM, 1997, P NATL ACAD SCI USA, V94, P3656, DOI 10.1073/pnas.94.8.3656; Jones JC, 2004, J BIOL CHEM, V279, P24957, DOI 10.1074/jbc.M402218200; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; Kobor MS, 1999, MOL CELL, V4, P55, DOI 10.1016/S1097-2765(00)80187-2; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Krishnamurthy S, 2004, MOL CELL, V14, P387, DOI 10.1016/S1097-2765(04)00235-7; Lee KB, 2002, P NATL ACAD SCI USA, V99, P4239, DOI 10.1073/pnas.072068399; LI Y, 1994, P NATL ACAD SCI USA, V91, P2362, DOI 10.1073/pnas.91.6.2362; Luo ZH, 2001, MUTAT RES-DNA REPAIR, V486, P259, DOI 10.1016/S0921-8777(01)00097-0; Mitsui A, 1999, P NATL ACAD SCI USA, V96, P6054, DOI 10.1073/pnas.96.11.6054; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Ratner JN, 1998, J BIOL CHEM, V273, P5184, DOI 10.1074/jbc.273.9.5184; Reid J, 2004, J BIOL CHEM, V279, P29875, DOI 10.1074/jbc.C400185200; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; SHERMAN F, 1991, P3; Spence J, 2000, CELL, V102, P67, DOI 10.1016/S0092-8674(00)00011-8; Svejstrup JQ, 2004, BBA-GENE STRUCT EXPR, V1677, P64, DOI 10.1016/j.bbaexp.2003.10.012; Svejstrup JQ, 2003, J CELL SCI, V116, P447, DOI 10.1242/jcs.00271; Svejstrup JQ, 2002, NAT REV MOL CELL BIO, V3, P21, DOI 10.1038/nrm703; Trigon S, 1998, J BIOL CHEM, V273, P6769, DOI 10.1074/jbc.273.12.6769; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; VANGOOL AJ, 1994, EMBO J, V13, P5361, DOI 10.1002/j.1460-2075.1994.tb06871.x; Winkler GS, 2002, METHODS, V26, P260, DOI 10.1016/S1046-2023(02)00030-0; Woudstra EC, 2002, NATURE, V415, P929, DOI 10.1038/415929a	43	177	185	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 17	2005	121	6					913	923		10.1016/j.cell.2005.04.010	http://dx.doi.org/10.1016/j.cell.2005.04.010			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	938NX	15960978	Bronze			2022-12-01	WOS:000230011200013
J	Blanford, S; Chan, BHK; Jenkins, N; Sim, D; Turner, RJ; Read, AF; Thomas, MB				Blanford, S; Chan, BHK; Jenkins, N; Sim, D; Turner, RJ; Read, AF; Thomas, MB			Fungal pathogen reduces potential for malaria transmission	SCIENCE			English	Article							METARHIZIUM-FLAVOVIRIDE; ENTOMOPATHOGENIC FUNGUS; BIOLOGICAL-CONTROL; MYCOINSECTICIDE; INSECTICIDES; LOCUSTS	Using a rodent malaria model, we found that exposure to surfaces treated with fungal entornopathogens following an infectious blood meal reduced the number of mosquitoes able to transmit malaria by a factor of about 80. Fungal infection, achieved through contact with both solid surfaces and netting for durations well within the typical post-feed resting periods, was sufficient to cause >90% mortality. Daily mortality rates escalated dramatically around the time of sporozoite maturation, and infected mosquitoes showed reduced propensity to blood feed. Residual sprays of fungal biopesticides might replace or supplement chemical insecticides for malaria control, particularly in areas of high insecticide resistance.	Univ London Imperial Coll Sci Technol & Med, Div Biol, Wye TN25 5AH, Kent, England; Univ London Imperial Coll Sci Technol & Med, NERC, Ctr Populat Biol, Wye TN25 5AH, Kent, England; Univ Edinburgh, Inst Evolut, Sch Biol Sci, Ashworth Labs, Edinburgh EH9 3JT, Midlothian, Scotland; Univ Edinburgh, Inst Immunol, Sch Biol Sci, Ashworth Labs, Edinburgh EH9 3JT, Midlothian, Scotland; Univ Edinburgh, Inst Infect Res, Sch Biol Sci, Ashworth Labs, Edinburgh EH9 3JT, Midlothian, Scotland; Univ London Imperial Coll Sci Technol & Med, CABI Biosci, Dept Agr Sci, Wye TN25 5AH, Kent, England	Imperial College London; Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of Edinburgh; University of Edinburgh; University of Edinburgh; Imperial College London	Thomas, MB (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Biol, Wye Campus, Wye TN25 5AH, Kent, England.	m.thomas@imperial.ac.uk		Chan, Brian/0000-0002-9451-4621	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BATEMAN RP, 1993, ANN APPL BIOL, V122, P145, DOI 10.1111/j.1744-7348.1993.tb04022.x; Brooke BD, 2001, B ENTOMOL RES, V91, P265, DOI 10.1079/BER2001108; Carucci D, 2004, NATURE, V430, P944, DOI 10.1038/430944a; Charlwood JD, 1997, AFR ENTOMOL, V5, P93; GELFAND H. M., 1955, TRANS ROY SOC TROP MED AND HYG, V49, P508, DOI 10.1016/0035-9203(55)90023-7; GILLIES MT, 1954, B ENTOMOL RES, V45, P375, DOI 10.1017/S000748530002719X; Greenwood B, 2004, NATURE, V430, P926, DOI 10.1038/430926a; Hargreaves K, 2000, MED VET ENTOMOL, V14, P181, DOI 10.1046/j.1365-2915.2000.00234.x; Hemingway J, 2004, NATURE, V430, P936, DOI 10.1038/430936a; Hemingway J, 2004, SCIENCE, V303, P1984, DOI 10.1126/science.1096548; LACEY LA, 1986, ANNU REV ENTOMOL, V31, P265, DOI 10.1146/annurev.en.31.010186.001405; Lomer CJ, 2001, ANNU REV ENTOMOL, V46, P667, DOI 10.1146/annurev.ento.46.1.667; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Osta MA, 2004, SCIENCE, V303, P2030, DOI 10.1126/science.1091789; Rishikesh N., 1988, P1227; Scholte EJ, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.19; Scholte EJ, 2005, SCIENCE, V308, P1641, DOI 10.1126/science.1108639; Scholte EJ, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-29; SCHOLTE EJ, IN PRESS J INVERTEBR; Scholte Ernst-Jan, 2003, Proceedings of the Section Experimental and Applied Entomology of the Netherlands Entomological Society (N.E.V.), V14, P25; StLeger RJ, 1996, P NATL ACAD SCI USA, V93, P6349, DOI 10.1073/pnas.93.13.6349; Thomas MB, 1998, ENTOMOL EXP APPL, V87, P93, DOI 10.1023/A:1003298103716; Thomas MB, 1997, PESTIC SCI, V49, P47, DOI 10.1002/(SICI)1096-9063(199701)49:1&lt;47::AID-PS471&gt;3.0.CO;2-O; THOMAS MB, 2004, BIOCONTROL NEWS INFO, V25, pN47; Zaim M, 2002, TRENDS PARASITOL, V18, P161, DOI 10.1016/S1471-4922(01)02220-6	25	247	262	4	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2005	308	5728					1638	1641		10.1126/science.1108423	http://dx.doi.org/10.1126/science.1108423			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	936BH	15947189				2022-12-01	WOS:000229827000060
J	Todorov, A; Mandisodza, AN; Goren, A; Hall, CC				Todorov, A; Mandisodza, AN; Goren, A; Hall, CC			Inferences of competence from faces predict election outcomes	SCIENCE			English	Article							PERSON PERCEPTION; BEHAVIOR	We show that inferences of competence based solely on facial appearance predicted the outcomes of U.S. congressional elections better than chance (e.g., 68.8% of the Senate races in 2004) and also were linearly related to the margin of victory. These inferences were specific to competence and occurred within a 1-second exposure to the faces of the candidates. The findings suggest that rapid, unreflective trait inferences can contribute to voting choices, which are widely assumed to be based primarily on rational and, deliberative considerations.	Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA	Princeton University; Princeton University	Todorov, A (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA.	atodorov@princeton.edu						Ambady N, 2000, ADV EXP SOC PSYCHOL, V32, P201, DOI 10.1016/S0065-2601(00)80006-4; Bartels LM, 2000, AM J POLIT SCI, V44, P35, DOI 10.2307/2669291; BUDESHEIM TL, 1994, PERS SOC PSYCHOL B, V20, P339, DOI 10.1177/0146167294204001; Chen S, 1999, DUAL-PROCESS THEORIES IN SOCIAL PSYCHOLOGY, P73; COVER AD, 1977, AM J POLIT SCI, V21, P523, DOI 10.2307/2110580; DARWIN F, 1950, C DARWINS AUTOBIOGRA, P36; GILBERT D T, 1989, P189; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Hassin R, 2000, J PERS SOC PSYCHOL, V78, P837, DOI 10.1037/0022-3514.78.5.837; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; Keating CF, 1999, POLIT PSYCHOL, V20, P593, DOI 10.1111/0162-895X.00158; Kelley CM, 1998, ACTA PSYCHOL, V98, P127, DOI 10.1016/S0001-6918(97)00039-5; KELLEY HH, 1950, J PERS, V18, P431, DOI 10.1111/j.1467-6494.1950.tb01260.x; KINDER DR, 1980, POLITICAL BEHAV, V0002; MARTIN DS, 1978, AUST J PSYCHOL, V30, P255, DOI 10.1080/00049537808256378; Montepare JM, 1998, ADV EXP SOC PSYCHOL, V30, P93, DOI 10.1016/S0065-2601(08)60383-4; Mueller U, 1996, SOC FORCES, V74, P823, DOI 10.2307/2580383; QUATTRONE GA, 1988, AM POLIT SCI REV, V82, P719, DOI 10.2307/1962487; Todorov A, 2003, J EXP SOC PSYCHOL, V39, P549, DOI 10.1016/S0022-1031(03)00059-3; Winston JS, 2002, NAT NEUROSCI, V5, P277, DOI 10.1038/nn816; Zaller J., 1992, NATURE ORIGINS MASS; Zebrowitz LA, 2002, PERS SOC PSYCHOL B, V28, P238, DOI 10.1177/0146167202282009; ZEBROWITZ LA, 1999, READING FACES WINDOW	24	840	846	3	195	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2005	308	5728					1623	1626		10.1126/science.1110589	http://dx.doi.org/10.1126/science.1110589			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	936BH	15947187				2022-12-01	WOS:000229827000056
J	Bloche, MG				Bloche, MG			Managing conflict at the end of life	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Georgetown Univ, Washington, DC 20057 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Georgetown University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Bloche, MG (corresponding author), Georgetown Univ, Washington, DC 20057 USA.							Bercovitch Jacob, 1989, MEDIATION RES PROCES; Bloche MG, 2002, STANFORD LAW REV, V55, P919, DOI 10.2307/1229676; Dubler N.N., 2004, BIOETHICS MEDIATION; Frey B.S., 1999, EC VALUES ORG, P437; LYNCH RN, 2005, COMMUNICATION   0228	5	32	33	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 9	2005	352	23					2371	2373		10.1056/NEJMp058104	http://dx.doi.org/10.1056/NEJMp058104			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933NL	15944420				2022-12-01	WOS:000229638900001
J	Menetrey, J; Bahloul, A; Wells, AL; Yengo, CM; Morris, CA; Sweeney, HL; Houdusse, A				Menetrey, J; Bahloul, A; Wells, AL; Yengo, CM; Morris, CA; Sweeney, HL; Houdusse, A			The structure of the myosin VI motor reveals the mechanism of directionality reversal	NATURE			English	Article							KINETIC MECHANISM; LEVER ARM; CALMODULIN; PROTEIN; PROCESSIVITY; BINDING; DOMAIN; MODEL	Here we solve a 2.4-angstrom structure of a truncated version of the reverse-direction myosin motor, myosin VI, that contains the motor domain and binding sites for two calmodulin molecules. The structure reveals only minor differences in the motor domain from that in plus-end directed myosins, with the exception of two unique inserts. The first is near the nucleotide-binding pocket and alters the rates of nucleotide association and dissociation. The second unique insert forms an integral part of the myosin VI converter domain along with a calmodulin bound to a novel target motif within the insert. This serves to redirect the effective 'lever arm' of myosin VI, which includes a second calmodulin bound to an 'IQ motif', towards the pointed ( minus) end of the actin filament. This repositioning largely accounts for the reverse directionality of this class of myosin motors. We propose a model incorporating a kinesin-like uncoupling/docking mechanism to provide a full explanation of the movements of myosin VI.	CNRS, Inst Curie, F-75248 Paris, France; Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Cite; University of Pennsylvania	Houdusse, A (corresponding author), CNRS, Inst Curie, 26 Rue Ulm, F-75248 Paris, France.	lsweeney@mail.med.upenn.edu; anne.houdusse@curie.fr	Ménétrey, Julie/AAM-6408-2021; Sweeney, H Lee/F-1862-2010	BAHLOUL, Amel/0000-0001-7042-4616	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048931] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR048931-03, R01 AR048931] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Altman D, 2004, CELL, V116, P737, DOI 10.1016/S0092-8674(04)00211-9; Bahloul A, 2004, P NATL ACAD SCI USA, V101, P4787, DOI 10.1073/pnas.0306892101; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buss F, 2004, ANNU REV CELL DEV BI, V20, P649, DOI 10.1146/annurev.cellbio.20.012103.094243; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Coureux PD, 2003, NATURE, V425, P419, DOI 10.1038/nature01927; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; De la Cruz EM, 2001, J BIOL CHEM, V276, P32373, DOI 10.1074/jbc.M104136200; Fallon JL, 2003, STRUCTURE, V11, P1303, DOI 10.1016/j.str.2003.09.004; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; Geisbrecht ER, 2002, NAT CELL BIOL, V4, P616, DOI 10.1038/ncb830; Hasson T, 2003, J CELL SCI, V116, P3453, DOI 10.1242/jcs.00669; Holmes KC, 2004, PHILOS T ROY SOC B, V359, P1819, DOI 10.1098/rstb.2004.1566; Homma K, 2001, NATURE, V412, P831, DOI 10.1038/35090597; Houdusse A, 2000, P NATL ACAD SCI USA, V97, P11238, DOI 10.1073/pnas.200376897; Houdusse A, 1999, CELL, V97, P459, DOI 10.1016/S0092-8674(00)80756-4; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Millo H, 2004, MECH DEVELOP, V121, P1335, DOI 10.1016/j.mod.2004.06.007; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nishikawa S, 2002, BIOCHEM BIOPH RES CO, V290, P311, DOI 10.1006/bbrc.2001.6142; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Purcell TJ, 2002, P NATL ACAD SCI USA, V99, P14159, DOI 10.1073/pnas.182539599; Reubold TF, 2003, NAT STRUCT BIOL, V10, P826, DOI 10.1038/nsb987; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Robblee JP, 2004, J BIOL CHEM, V279, P38608, DOI 10.1074/jbc.M403504200; Rock RS, 2005, MOL CELL, V17, P603, DOI 10.1016/j.molcel.2005.01.015; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; Rosenfeld SS, 2005, J BIOL CHEM, V280, P6072, DOI 10.1074/jbc.M412717200; Rosenfeld SS, 2003, J BIOL CHEM, V278, P18550, DOI 10.1074/jbc.M300849200; ROUSSEL A, 1989, SILICON GRAPHICS GEO, P77; Ruff C, 2001, NAT STRUCT BIOL, V8, P226, DOI 10.1038/84962; Sakamoto T, 2003, J BIOL CHEM, V278, P29201, DOI 10.1074/jbc.M303662200; Sasaki N, 2003, BIOCHEMISTRY-US, V42, P90, DOI 10.1021/bi026051l; Sweeney HL, 2004, PHILOS T R SOC B, V359, P1829, DOI 10.1098/rstb.2004.1576; Tsiavaliaris G, 2004, NATURE, V427, P558, DOI 10.1038/nature02303; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; Yildiz A, 2004, J BIOL CHEM, V279, P37223, DOI 10.1074/jbc.C400252200	42	164	169	2	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2005	435	7043					779	785		10.1038/nature03592	http://dx.doi.org/10.1038/nature03592			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933NK	15944696	Green Accepted			2022-12-01	WOS:000229638700042
J	O'Donnell, KA; Wentzel, EA; Zeller, KI; Dang, CV; Mendell, JT				O'Donnell, KA; Wentzel, EA; Zeller, KI; Dang, CV; Mendell, JT			c-Myc-regulated microRNAs modulate E2F1 expression	NATURE			English	Article							TRANSCRIPTION FACTOR; GENOMIC TARGETS; IDENTIFICATION; GENES; LYMPHOMA; MECHANISM	MicroRNAs ( miRNAs) are 21 - 23 nucleotide RNA molecules that regulate the stability or translational efficiency of target messenger RNAs1. miRNAs have diverse functions, including the regulation of cellular differentiation, proliferation and apoptosis(2). Although strict tissue- and developmental-stage-specific expression is critical for appropriate miRNA function, mammalian transcription factors that regulate miRNAs have not yet been identified. The proto-oncogene c-MYC encodes a transcription factor that regulates cell proliferation, growth and apoptosis(3). Dysregulated expression or function of c-Myc is one of the most common abnormalities in human malignancy(4). Here we show that c-Myc activates expression of a cluster of six miRNAs on human chromosome 13. Chromatin immunoprecipation experiments show that c-Myc binds directly to this locus. The transcription factor E2F1 is an additional target of c-Myc that promotes cell cycle progression(5-7). We find that expression of E2F1 is negatively regulated by two miRNAs in this cluster, miR-17-5p and miR-20a. These findings expand the known classes of transcripts within the c-Myc target gene network, and reveal a mechanism through which c-Myc simultaneously activates E2F1 transcription and limits its translation, allowing a tightly controlled proliferative signal.	Johns Hopkins Univ, Sch Med, Program Human Genet & Mol Biol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Mendell, JT (corresponding author), Johns Hopkins Univ, Sch Med, Program Human Genet & Mol Biol, Baltimore, MD 21205 USA.	jmendell@jhmi.edu	Jackson, Benjamin L/C-4297-2012; Dang, Chi/Y-3375-2019	Dang, Chi/0000-0002-4031-2522				Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Cole MD, 1999, ONCOGENE, V18, P2916, DOI 10.1038/sj.onc.1202748; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Guo QM, 2000, CANCER RES, V60, P5922; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Leone G, 1997, NATURE, V387, P422, DOI 10.1038/387422a0; Levens D, 2002, P NATL ACAD SCI USA, V99, P5757, DOI 10.1073/pnas.102173199; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lin YW, 1999, EUR J CANCER, V35, P1730, DOI 10.1016/S0959-8049(99)00205-1; Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039; Matsumura I, 2003, CELL CYCLE, V2, P333, DOI 10.4161/cc.2.4.428; McManus MT, 2003, SEMIN CANCER BIOL, V13, P253, DOI 10.1016/S1044-579X(03)00038-5; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Orian A, 2003, GENE DEV, V17, P1101, DOI 10.1101/gad.1066903; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Pajic A, 2000, INT J CANCER, V87, P787, DOI 10.1002/1097-0215(20000915)87:6<787::AID-IJC4>3.0.CO;2-6; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69; Zeller KI, 2001, J BIOL CHEM, V276, P48285, DOI 10.1074/jbc.M108506200	30	2257	2462	3	204	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2005	435	7043					839	843		10.1038/nature03677	http://dx.doi.org/10.1038/nature03677			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933NK	15944709				2022-12-01	WOS:000229638700055
J	Dye, C; Watt, CJ; Bleed, DM; Hosseini, SM; Raviglione, MC				Dye, C; Watt, CJ; Bleed, DM; Hosseini, SM; Raviglione, MC			Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ISONIAZID PREVENTIVE THERAPY; PULMONARY TUBERCULOSIS; RESISTANT TUBERCULOSIS; COST-EFFECTIVENESS; HIV; CHEMOTHERAPY; TRANSMISSION; INFECTION; MORTALITY; EFFICACY	Context The United Nations Millennium Development Goals (MDGs) are stimulating more rigorous evaluations of the impact of DOTS (the WHO-recommended approach to tuberculosis control based on 5 essential elements) and other possible strategies for tuberculosis (TB) control. Objective To evaluate the prospects for detecting 70% of new sputum smear-positive cases and successfully treating 85% of these by the end of 2005, for reducing TB incidence, and for halving TB prevalence and deaths globally between 1990 and 2015, as specified by the MDGs. Data Sources TB case notifications (1980-2003) from DOTS and non-DOTS programs and cohort treatment outcomes (1994-2002) reported annually to the World Health Organization (WHO) by up to 200 countries, TB death registrations, and prevalence surveys of infection and disease. Study Selection Case notification series that reflect trends in incidence, treatment outcomes from DOTS cohorts, death statistics from countries with WHO-validated vital registration systems, and national prevalence surveys of infection and disease. Data Extraction Case reports, treatment outcomes, prevalence surveys - and death registrations from WHO's global TB database covering 1990-2003 to estimate TB incidence, prevalence, and death rates through 2015 for 9 epidemiologically different world regions. Data Synthesis TB incidence increased globally in 2003, but incidence, prevalence, and death rates were approximately stable or decreased in 7 of 9 regions. The exceptions were regions of Africa with low (<4% in adults 15-49 years) and high rates (>= 4%) of HIV infection. The global detection rate of new smear-positive cases by DOTS programs increased from 11% in 1995 to 45% in 2003 (with the lowest case-detection rates in Eastern Europe and the highest rates in the Western Pacific) and could reach 60% by 2005. More than 17 million patients were treated in DOTS programs between 1994 and 2003, with overall treatment success rates more than 80% since 1998. In 2003, overall reported treatment success was 82%, with much variation among regions. The highest rates were reported in the Western Pacific region (89%) and lowest rates in African countries with high and low HIV infection rates (71% and 74%, respectively), in established market economies (77%), and in Eastern Europe (75%). To halve the prevalence rate by 2015, TB control programs must reach global targets for detection (70%) and treatment success (85%) and also reduce the incidence rate by at least 2% annually. To halve the death rate, incidence must decrease more steeply, by at least 5% to 6% annually. Conclusion Reduction of TB incidence, prevalence, and deaths by 2015 could be achieved in most of the world, but the challenge will be greatest in Africa and Eastern Europe.	WHO, Stop TB Dept, CH-1211 Geneva, Switzerland	World Health Organization	Dye, C (corresponding author), WHO, Stop TB Dept, CH-1211 Geneva, Switzerland.	dyec@who.int	Dye, Christopher/AIC-4659-2022	Dye, Christopher/0000-0002-2957-1793; RAVIGLIONE, Mario/0000-0002-9331-2067				AISU T, 1995, AIDS, V9, P267, DOI 10.1097/00002030-199509030-00008; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; [Anonymous], 1999, EPIDEMIOLOGIC BASIS; BARNUM HN, 1986, SOC SCI MED, V23, P847, DOI 10.1016/0277-9536(86)90212-1; Barry C, 2001, TUBERCULOSIS, V81, P1, DOI 10.1054/tube.2001.0288; BLOWER SM, 1995, NAT MED, V1, P815, DOI 10.1038/nm0895-815; Borgdorff MW, 2004, EMERG INFECT DIS, V10, P1523, DOI 10.3201/eid1009.040349; Borgdorff MW, 2002, B WORLD HEALTH ORGAN, V80, P217; Chen XY, 2004, LANCET, V364, P417; Churchyard GJ, 2003, AIDS, V17, P2063, DOI 10.1097/00002030-200309260-00007; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Corbett EL, 2004, AM J RESP CRIT CARE, V170, P673, DOI 10.1164/rccm.200405-590OC; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Dye C, 1998, LANCET, V352, P1886, DOI 10.1016/S0140-6736(98)03199-7; DYE C, IN PRESS DIS CONTROL; DYE C, 2003, CLIN TUBERCULOSIS; Elzinga G, 2004, LANCET, V363, P814, DOI 10.1016/S0140-6736(04)15698-5; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Frieden T, 2004, TOMANS TUBERCULOSIS; Harries AD, 2001, INT J TUBERC LUNG D, V5, P1109; IRAWATI SR, 2004, INT J TUBERC LUNG S1, V11, pS98; Jamison D.T., 1993, DIS CONTROL PRIORITI; Johnson JL, 2001, AIDS, V15, P2137, DOI 10.1097/00002030-200111090-00009; Kim SJ, 1995, TUBERCLE LUNG DIS, V76, P534, DOI 10.1016/0962-8479(95)90530-8; Lietman T, 2000, CLIN INFECT DIS, V30, pS316, DOI 10.1086/313881; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; MURRAY CJL, 1991, LANCET, V338, P1305, DOI 10.1016/0140-6736(91)92600-7; Quigley MA, 2001, AIDS, V15, P215, DOI 10.1097/00002030-200101260-00011; Radhakrishna S, 2001, INT J TUBERC LUNG D, V5, P142; Raviglione M, 2001, INT J TUBERC LUNG D, V5, P213; STOP TB, M 2 AD HOC COMM TB E; Styblo K, 1991, TUBERCULOSIS CAN BE, V2, P60; Styblo K, 1991, EPIDEMIOLOGY TUBERCU; Suarez PG, 2002, LANCET, V359, P1980, DOI 10.1016/S0140-6736(02)08830-X; Suarez PG, 2001, J INFECT DIS, V184, P473, DOI 10.1086/322777; UN Millennium Project 2005, 2005, INV STRAT REV GLOB I; *UN STAT DIV, MILL IND DAT; Volmink J, 1997, BMJ-BRIT MED J, V315, P1403, DOI 10.1136/bmj.315.7120.1403; VOLMINK J, 2003, COCHRANE DATABASE SY; *WHO, 2004, INT POL COLL TB HIV; *WHO, 2005, WHOHTMTB2005349; *WHO, STOP TB DEP TUB; *WHO, 2000, 53 WORLD HLTH ASS ST; *WHO, 2004, 3 WHO; Williams BG, 2003, SCIENCE, V301, P1535, DOI 10.1126/science.1086845; World Bank, 1993, WORLD DEV REP 1993 I, V1; World Health Organization, 2002, WHOCDSTB2002297; World Health Organization, 1991, WHA441991REC1 WHO; World Hlth Org, 2002, INT J TUBERC LUNG D, V6, P378; Zachariah R, 2003, INT J TUBERC LUNG D, V7, P1033; FIND DIAGNOSTICS	51	361	377	1	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	2005	293	22					2767	2775		10.1001/jama.293.22.2767	http://dx.doi.org/10.1001/jama.293.22.2767			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933OV	15941807				2022-12-01	WOS:000229643700026
J	Higgins, LJ; Yan, F; Liu, PH; Liu, HW; Drennan, CL				Higgins, LJ; Yan, F; Liu, PH; Liu, HW; Drennan, CL			Structural insight into antibiotic fosfomycin biosynthesis by a mononuclear iron enzyme	NATURE			English	Article							(S)-2-HYDROXYPROPYLPHOSPHONIC ACID EPOXIDASE; SUBSTRATE; COMPLEX; CUPINS; TAUD	The biosynthetic pathway of the clinically important antibiotic fosfomycin uses enzymes that catalyse reactions without precedent in biology. Among these is hydroxypropylphosphonic acid epoxidase, which represents a new subfamily of non-haem mononuclear iron enzymes. Here we present six X-ray structures of this enzyme: the apoenzyme at 2.0 angstrom resolution; a native Fe(II)-bound form at 2.4 angstrom resolution; a tris( hydroxymethyl) aminomethane - Co( II)- enzyme complex structure at 1.8 angstrom resolution; a substrate - Co( II)- enzyme complex structure at 2.5 angstrom resolution; and two substrate - Fe( II)enzyme complexes at 2.1 and 2.3 angstrom resolution. These structural data lead us to suggest how this enzyme is able to recognize and respond to its substrate with a conformational change that protects the radical-based intermediates formed during catalysis. Comparisons with other family members suggest why substrate binding is able to prime iron for dioxygen binding in the absence of alpha-ketoglutarate ( a co-substrate required by many mononuclear iron enzymes), and how the unique epoxidation reaction of hydroxypropylphosphonic acid epoxidase may occur.	MIT, Dept Chem, Cambridge, MA 02139 USA; Univ Texas, Dept Chem & Biochem, Austin, TX 78712 USA	Massachusetts Institute of Technology (MIT); University of Texas System; University of Texas Austin	Higgins, LJ (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.							Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cassone M, 2004, MICROB DRUG RESIST, V10, P43, DOI 10.1089/107662904323047790; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Dunwell JM, 2004, PHYTOCHEMISTRY, V65, P7, DOI 10.1016/j.phytochem.2003.08.016; Dunwell JM, 2001, TRENDS BIOCHEM SCI, V26, P740, DOI 10.1016/S0968-0004(01)01981-8; Dunwell JM, 1998, BIOTECHNOL GENET ENG, V15, P1; Guengerich FP, 2003, ARCH BIOCHEM BIOPHYS, V409, P59; HAMMERSCHMIDT F, 1991, J CHEM SOC P1, V8, P1993; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Hegg EL, 1997, EUR J BIOCHEM, V250, P625, DOI 10.1111/j.1432-1033.1997.t01-1-00625.x; HIDAKA T, 1995, MOL GEN GENET, V249, P274, DOI 10.1007/BF00290527; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu PH, 2001, J AM CHEM SOC, V123, P4619, DOI 10.1021/ja004153y; Liu PH, 2004, J AM CHEM SOC, V126, P10306, DOI 10.1021/ja0475050; Liu PH, 2003, BIOCHEMISTRY-US, V42, P11577, DOI 10.1021/bi030140w; Lobel B, 2003, INT J ANTIMICROB AG, V22, pS85, DOI 10.1016/S0924-8579(03)00237-1; Nakazawa Hiroaki, 2003, Journal of Infection and Chemotherapy, V9, P304, DOI 10.1007/s10156-003-0266-2; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Price JC, 2003, BIOCHEMISTRY-US, V42, P7497, DOI 10.1021/bi030011f; Roach PL, 1996, EUR J BIOCHEM, V242, P736, DOI 10.1111/j.1432-1033.1996.0736r.x; Roach PL, 1997, NATURE, V387, P827, DOI 10.1038/42990; ROACH PL, 1995, PROTEIN SCI, V4, P1007; Ryle MJ, 2003, BIOCHEMISTRY-US, V42, P1854, DOI 10.1021/bi026832m; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Valegard K, 2004, NAT STRUCT MOL BIOL, V11, P95, DOI 10.1038/nsmb712; Zhao ZB, 2002, ANGEW CHEM INT EDIT, V41, P4529, DOI 10.1002/1521-3773(20021202)41:23<4529::AID-ANIE4529>3.0.CO;2-2; Zhou J, 2001, J AM CHEM SOC, V123, P7388, DOI 10.1021/ja004025+	31	97	101	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 6	2005	437	7060					838	844		10.1038/nature03924	http://dx.doi.org/10.1038/nature03924			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	970VB	16015285				2022-12-01	WOS:000232338600036
J	Packer, C; Ikanda, D; Kissui, B; Kushnir, H				Packer, C; Ikanda, D; Kissui, B; Kushnir, H			Lion attacks on humans in Tanzania - Understanding the timing and distribution of attacks on rural communities will help to prevent them.	NATURE			English	Editorial Material							HUMAN-CARNIVORE CONFLICT; PANTHERA-LEO; LIVESTOCK; PREDATION		Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; Tanzania Wildlife Res Inst, Arusha, Tanzania	University of Minnesota System; University of Minnesota Twin Cities	Packer, C (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	packer@cbs.umn.edu						Bauer H, 2004, ORYX, V38, P26, DOI 10.1017/S0030605304000055; CARDONNET P, 2002, CONSERVATION AFRICAN; Kellert SR, 1996, CONSERV BIOL, V10, P977, DOI 10.1046/j.1523-1739.1996.10040977.x; KERBISPETERHANS JC, 2002, E AFRIC NAT HIST, V90, P1; Loe J, 2004, AMBIO, V33, P283, DOI 10.1639/0044-7447(2004)033[0283:LCAHSA]2.0.CO;2; NICHOLSON B, 2001, LAST OLD AFRICA; Ogada MO, 2003, CONSERV BIOL, V17, P1521, DOI 10.1111/j.1523-1739.2003.00061.x; Patterson BD, 2004, BIOL CONSERV, V119, P507, DOI 10.1016/j.biocon.2004.01.013; RUSHBY GG, 1965, NO MORE TUSKER; *TRAFFIC, 1998, FOOD THOUGHT UT WILD; Treves A, 2004, CONSERV BIOL, V18, P114, DOI 10.1111/j.1523-1739.2004.00189.x; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Wilson CJ, 2004, MAMMAL REV, V34, P211, DOI 10.1111/j.1365-2907.2004.00038.x	13	135	144	1	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 18	2005	436	7053					927	928		10.1038/436927a	http://dx.doi.org/10.1038/436927a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955XQ	16107828				2022-12-01	WOS:000231263900030
J	Johnson, CM; Beard, BL				Johnson, CM; Beard, BL			Biogeochemical cycling of iron isotopes	SCIENCE			English	Editorial Material							FE ISOTOPE; FRACTIONATION; CONSTRAINTS; EARTH; ROCKS		Univ Wisconsin, Dept Geol & Geophys, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Johnson, CM (corresponding author), Univ Wisconsin, Dept Geol & Geophys, 1215 W Dayton St, Madison, WI 53706 USA.	clarkj@geology.wisc.edu						Anbar AD, 2005, GEOCHIM COSMOCHIM AC, V69, P825, DOI 10.1016/j.gca.2004.06.012; Beard BL, 2004, REV MINERAL GEOCHEM, V55, P319, DOI 10.2138/gsrmg.55.1.319; Beard BL, 1999, SCIENCE, V285, P1889, DOI 10.1126/science.285.5435.1889; Beard BL, 2004, GEOCHIM COSMOCHIM AC, V68, P4727, DOI 10.1016/j.gca.2004.04.023; Brantley SL, 2004, GEOCHIM COSMOCHIM AC, V68, P3189, DOI 10.1016/j.gca.2004.01.023; Bullen TD, 2001, GEOLOGY, V29, P699, DOI 10.1130/0091-7613(2001)029<0699:DOSAII>2.0.CO;2; Butler IB, 2005, EARTH PLANET SC LETT, V236, P430, DOI 10.1016/j.epsl.2005.05.022; Croal LR, 2004, GEOCHIM COSMOCHIM AC, V68, P1227, DOI 10.1016/j.gca.2003.09.011; Fantle MS, 2004, EARTH PLANET SC LETT, V228, P547, DOI 10.1016/j.epsl.2004.10.013; Johnson C. M, 2004, REV MINERAL GEOCHEM, V55; Johnson CM, 2005, GEOCHIM COSMOCHIM AC, V69, P963, DOI 10.1016/j.gca.2004.06.043; Johnson CM, 2003, CONTRIB MINERAL PETR, V144, P523, DOI 10.1007/s00410-002-0418-x; Kump L, 2005, SCIENCE, V307, P1058, DOI 10.1126/science.1107482; Levasseur S, 2004, EARTH PLANET SC LETT, V224, P91, DOI 10.1016/j.epsl.2004.05.010; Rouxel OJ, 2005, SCIENCE, V307, P1088, DOI 10.1126/science.1105692; Schauble EA, 2004, REV MINERAL GEOCHEM, V55, P65, DOI 10.2138/gsrmg.55.1.65; Sevenet N, 2003, CLIN EXP MED, V3, P1, DOI 10.1007/s102380300008; Skulan JL, 2002, GEOCHIM COSMOCHIM AC, V66, P2995, DOI 10.1016/S0016-7037(02)00902-X; Welch SA, 2003, GEOCHIM COSMOCHIM AC, V67, P4231, DOI 10.1016/S0016-7037(03)00266-7; Yamaguchi KE, 2005, CHEM GEOL, V218, P135, DOI 10.1016/j.chemgeo.2005.01.020	20	46	51	1	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2005	309	5737					1025	1027		10.1126/science.1112552	http://dx.doi.org/10.1126/science.1112552			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955MN	16099969				2022-12-01	WOS:000231230100029
J	Chanda, B; Asamoah, OK; Blunck, R; Roux, B; Bezanilla, F				Chanda, B; Asamoah, OK; Blunck, R; Roux, B; Bezanilla, F			Gating charge displacement in voltage-gated ion channels involves limited transmembrane movement	NATURE			English	Article							SHAKER K+ CHANNEL; POTASSIUM CHANNEL; SODIUM-CHANNELS; ELECTRIC-FIELD; FREE-ENERGY; S4 SEGMENT; SENSOR; PORE; ELECTROSTATICS; MELITTIN	Voltage-gated ion channels are responsible for generating electrical impulses in nerves and other excitable cells. The fourth transmembrane helix (S4) in voltage-gated channels is the primary voltage-sensing unit that mediates the response to a changing membrane electric field(1,2). The molecular mechanism of voltage sensing, particularly with respect to the magnitude of the transmembrane movement of S4, remains controversial(3-5). To determine the extent of this transmembrane movement, we use fluorescent resonance energy transfer between the S4 domain and a reference point in the lipid bilayer. The lipophilic ion dipicrylamine distributes on either side of the lipid bilayer depending on the membrane potential, and is used here as a resonance-energy-transfer acceptor from donor molecules attached to several positions in the Shaker K+ channel. A voltage-driven transmembrane movement of the donor should produce a transient fluorescence change because the acceptor also translocates as a function of voltage. In Shaker K+ channels no such transient fluorescence is observed, indicating that the S4 segment does not translocate across the lipid bilayer. Based on these observations, we propose a molecular model of voltage gating that can account for the observed 13e gating charge with limited transmembrane S4 movement.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90025 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol, Los Angeles, CA 90025 USA; Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; Ctr Estudios Cient, Valdivia, Chile	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cornell University	Bezanilla, F (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, 650 Charles E Young Dr S, Los Angeles, CA 90025 USA.	fbezanil@ucla.edu	Blunck, Rikard/L-4226-2013; Blunck, Rikard/AAM-3078-2020	Blunck, Rikard/0000-0003-4484-2907; Blunck, Rikard/0000-0003-4484-2907; Chanda, Baron/0000-0003-4954-7034				Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Ahern CA, 2004, TRENDS NEUROSCI, V27, P303, DOI 10.1016/j.tins.2004.03.008; Asamoah OK, 2003, NEURON, V37, P85, DOI 10.1016/S0896-6273(02)01126-1; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; BOLAND LM, 1994, BIOPHYS J, V66, P694, DOI 10.1016/S0006-3495(94)80843-4; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.bi.55.070186.004513; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; Cha A, 1998, J GEN PHYSIOL, V112, P391, DOI 10.1085/jgp.112.4.391; Chanda B, 2002, J GEN PHYSIOL, V120, P629, DOI 10.1085/jgp.20028679; Cuello LG, 2004, SCIENCE, V306, P491, DOI 10.1126/science.1101373; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; Gonzalez C, 2001, P NATL ACAD SCI USA, V98, P9617, DOI 10.1073/pnas.171306298; GONZALEZ JE, 1995, BIOPHYS J, V69, P1272, DOI 10.1016/S0006-3495(95)80029-9; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; Islas LD, 2001, J GEN PHYSIOL, V117, P69, DOI 10.1085/jgp.117.1.69; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; KEMPF C, 1982, J BIOL CHEM, V257, P2469; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; LONG SB, 2000, SCIENCE         0707; Nina M, 1997, J PHYS CHEM B, V101, P5239, DOI 10.1021/jp970736r; Roux B, 1997, BIOPHYS J, V73, P2980, DOI 10.1016/S0006-3495(97)78327-9; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Starace DM, 1997, NEURON, V19, P1319, DOI 10.1016/S0896-6273(00)80422-5; TOSTESON MT, 1981, BIOPHYS J, V36, P109, DOI 10.1016/S0006-3495(81)84719-4; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	31	217	225	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2005	436	7052					852	856		10.1038/nature03888	http://dx.doi.org/10.1038/nature03888			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953XG	16094369				2022-12-01	WOS:000231116500047
J	Sharland, M; Kendall, H; Yeates, D; Randall, A; Hughes, G; Glasziou, P; Mant, D				Sharland, M; Kendall, H; Yeates, D; Randall, A; Hughes, G; Glasziou, P; Mant, D			Antibiotic prescribing in general practice and hospital admissions for peritonsillar abscess, mastoiditis, and rheumatic fever in children: time trend analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RESPIRATORY-TRACT INFECTIONS		Univ Oxford, Div Publ Hlth & Primary Care, Hlth Care Epidemiol Unit, Oxford OX3 7LF, England; Univ London St Georges Hosp, Paediat Infect Dis Unit, London SW17 0QT, England; Prescript Pricing Author, Pharmaceut Directorate, Newcastle Upon Tyne NE1 6SN, Tyne & Wear, England; Med & Healthcare Prod Regulatory Agcy, GPRD Div, London SW8 5NQ, England	University of Oxford; St Georges University London; The Medicines & Healthcare Products Regulatory Agency	Mant, D (corresponding author), Univ Oxford, Div Publ Hlth & Primary Care, Hlth Care Epidemiol Unit, Oxford OX3 7LF, England.	david.mant@dphpc.ox.ac.uk	Mant, David CA/C-7763-2009; Glasziou, Paul/A-7832-2008	Glasziou, Paul/0000-0001-7564-073X; Hughes, Gwenda/0000-0003-2090-7702; sharland, mike/0000-0001-8626-8291	MRC [G0000340] Funding Source: UKRI; Medical Research Council [G0000340] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Arroll B, 2003, BRIT J GEN PRACT, V53, P871; *DEP HLTH STAND ME, 2000, PATH LEAST RES MAIN; Little P, 2002, BRIT J GEN PRACT, V52, P187; Majeed A, 2004, BRIT MED J, V329, P879, DOI 10.1136/bmj.329.7471.879; Van Zuijlen DA, 2001, PEDIATR INFECT DIS J, V20, P140, DOI 10.1097/00006454-200102000-00004	5	110	110	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 6	2005	331	7512					328	329		10.1136/bmj.38503.706887.AE1	http://dx.doi.org/10.1136/bmj.38503.706887.AE1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	955WZ	15967760	Green Published, Bronze, Green Submitted			2022-12-01	WOS:000231259800020
J	Schenkl, S; van Mourik, F; van der Zwan, G; Haacke, S; Chergui, M				Schenkl, S; van Mourik, F; van der Zwan, G; Haacke, S; Chergui, M			Probing the ultrafast charge translocation of photoexcited retinal in bacteriorhodopsin	SCIENCE			English	Article							SPECTROSCOPY; CHROMOPHORE; DYNAMICS; ISOMERIZATION; STATE; TRANSITIONS; EXCITATION; RESOLUTION; PROTEINS; EVENTS	The ultrafast evolution of the electric field within bacteriorhodopsin was measured by monitoring the absorption changes of a tryptophan residue after excitation of retinal. The Trp absorption decreases within the first 200 femtoseconds and then recovers on time scales typical for retinal isomerization and vibrational relaxation. A model of excitonic coupling between retinal and tryptophans shows that the signal reflects a gradual rise of the retinal difference dipole moment, which precedes and probably drives isomerization. The results suggest an intimate connection between the progressive dipole moment change and the retinal skeletal changes reported over the same time scale.	Ecole Polytech Fed Lausanne, Lab Ultrafast Spect, Inst Sci & Ingn Chim, FSB BSP, CH-1015 Lausanne, Switzerland; Vrije Univ Amsterdam, Fac Sci, NL-1081 HV Amsterdam, Netherlands	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Vrije Universiteit Amsterdam	Chergui, M (corresponding author), Ecole Polytech Fed Lausanne, Lab Ultrafast Spect, Inst Sci & Ingn Chim, FSB BSP, CH-1015 Lausanne, Switzerland.	majed.chergui@epfl.ch	Haacke, Stefan/B-5554-2013	Haacke, Stefan/0000-0002-6969-4667				Callis PR, 1997, METHOD ENZYMOL, V278, P113; DOBLER J, 1988, CHEM PHYS LETT, V144, P215, DOI 10.1016/0009-2614(88)87120-3; DOIG SJ, 1991, J PHYS CHEM-US, V95, P6372, DOI 10.1021/j100169a054; EFTINK MR, 1990, J PHYS CHEM-US, V94, P3469, DOI 10.1021/j100372a022; Gonzalez-Luque R, 2000, P NATL ACAD SCI USA, V97, P9379, DOI 10.1073/pnas.97.17.9379; Groma GI, 2004, P NATL ACAD SCI USA, V101, P7971, DOI 10.1073/pnas.0306789101; Herbst J, 2002, SCIENCE, V297, P822, DOI 10.1126/science.1072144; HORNG ML, 1995, J PHYS CHEM-US, V99, P17311, DOI 10.1021/j100048a004; HUANG JY, 1989, J PHYS CHEM-US, V93, P3314, DOI 10.1021/j100345a086; Kennis JTM, 2002, J PHYS CHEM B, V106, P6067, DOI 10.1021/jp014681b; Kobayashi T, 2001, NATURE, V414, P531, DOI 10.1038/35107042; LEWIS A, 1978, P NATL ACAD SCI USA, V75, P549, DOI 10.1073/pnas.75.2.549; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; MATHIES R, 1976, P NATL ACAD SCI USA, V73, P2169, DOI 10.1073/pnas.73.7.2169; MATHIES RA, 1988, SCIENCE, V240, P777, DOI 10.1126/science.3363359; PebayPeyroula E, 1997, SCIENCE, V277, P1676, DOI 10.1126/science.277.5332.1676; SALEM L, 1975, NATURE, V258, P526, DOI 10.1038/258526a0; TSUDA M, 1980, NATURE, V287, P351, DOI 10.1038/287351a0; WALD G, 1968, SCIENCE, V162, P230, DOI 10.1126/science.162.3850.230; WARSHEL A, 1981, ACCOUNTS CHEM RES, V14, P284, DOI 10.1021/ar00069a004; Xu D, 1996, BIOPHYS J, V70, P453, DOI 10.1016/S0006-3495(96)79588-7; Zhong Q, 1996, J AM CHEM SOC, V118, P12828, DOI 10.1021/ja961058+	22	118	120	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 5	2005	309	5736					917	920		10.1126/science.1111482	http://dx.doi.org/10.1126/science.1111482			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953SS	16081732				2022-12-01	WOS:000231101400041
J	Brem, RB; Storey, JD; Whittle, J; Kruglyak, L				Brem, RB; Storey, JD; Whittle, J; Kruglyak, L			Genetic interactions between polymorphisms that affect gene expression in yeast	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; COMPLEX TRAIT; EPISTASIS; DROSOPHILA	Interactions between polymorphisms at different quantitative trait loci (QTLs) are thought to contribute to the genetics of many traits, and can markedly affect the power of genetic studies to detect QTLs(1). Interacting loci have been identified in many organisms(1-5). However, the prevalence of interactions(6-8), and the nucleotide changes underlying them(9,10), are largely unknown. Here we search for naturally occurring genetic interactions in a large set of quantitative phenotypes - the levels of all transcripts in a cross between two strains of Saccharomyces cerevisiae(7). For each transcript, we searched for secondary loci interacting with primary QTLs detected by their individual effects. Such locus pairs were estimated to be involved in the inheritance of 57% of transcripts; statistically significant pairs were identified for 225 transcripts. Among these, 67% of secondary loci had individual effects too small to be significant in a genome-wide scan. Engineered polymorphisms in isogenic strains confirmed an interaction between the mating-type locus MAT and the pheromone response gene GPA1. Our results indicate that genetic interactions are widespread in the genetics of transcript levels, and that many QTLs will be missed by single-locus tests but can be detected by two-stage tests that allow for interactions.	Fred Hutchinson Canc Res Ctr, Program Computat Biol, Seattle, WA 98109 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Infect Dis Res Inst, Seattle, WA 98104 USA; Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; Princeton Univ, Dept Ecol & Evolutionary Biol, Carl Icahn Lab, Princeton, NJ 08544 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Princeton University; Princeton University	Brem, RB (corresponding author), Fred Hutchinson Canc Res Ctr, Program Computat Biol, 1100 Fairview Ave N,M2-B876, Seattle, WA 98109 USA.	rbrem@fhcrc.org; leonid@genomics.princeton.edu	Storey, John/B-5282-2011	Storey, John/0000-0001-5992-402X	NHGRI NIH HHS [R01 HG002913] Funding Source: Medline; NIMH NIH HHS [R37 MH059520] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH059520] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BARDWELL L, 1994, DEV BIOL, V166, P363, DOI 10.1006/dbio.1994.1323; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Caicedo AL, 2004, P NATL ACAD SCI USA, V101, P15670, DOI 10.1073/pnas.0406232101; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Csank C, 2002, METHOD ENZYMOL, V350, P347, DOI 10.1016/S0076-6879(02)50973-3; Gibson G, 2004, GENETICS, V167, P1791, DOI 10.1534/genetics.104.026583; HAGEN DC, 1984, J MOL BIOL, V178, P835, DOI 10.1016/0022-2836(84)90314-0; Kroymann J, 2005, NATURE, V435, P95, DOI 10.1038/nature03480; Leamy LJ, 2005, HEREDITY, V94, P316, DOI 10.1038/sj.hdy.6800637; Lynch M., 1998, AM J HUM GENET; Montooth KL, 2003, GENETICS, V165, P623; Rawson PD, 2002, P NATL ACAD SCI USA, V99, P12955, DOI 10.1073/pnas.202335899; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Shook DR, 1999, GENETICS, V153, P1233; Storey JD, 2005, PLOS BIOL, V3, P1380, DOI 10.1371/journal.pbio.0030267; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Sudarsanam P, 2000, P NATL ACAD SCI USA, V97, P3364, DOI 10.1073/pnas.050407197; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Velculescu VE, 1997, CELL, V88, P243, DOI 10.1016/S0092-8674(00)81845-0; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222; Zeitlinger J, 2003, CELL, V113, P395, DOI 10.1016/S0092-8674(03)00301-5	25	243	252	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2005	436	7051					701	703		10.1038/nature03865	http://dx.doi.org/10.1038/nature03865			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951XA	16079846	Green Accepted			2022-12-01	WOS:000230964500044
J	Eisen, GM; Weinberg, DS				Eisen, GM; Weinberg, DS			Narative review: Screening for colorectal cancer in patients with a first-degree relative with colonic neoplasia	ANNALS OF INTERNAL MEDICINE			English	Review							COMPUTED TOMOGRAPHIC COLONOGRAPHY; FECAL-OCCULT-BLOOD; VIRTUAL COLONOSCOPY; FAMILY-HISTORY; BARIUM ENEMA; AVERAGE-RISK; ASYMPTOMATIC ADULTS; DISEASE PREVENTION; RANDOMIZED-TRIAL; CT COLONOGRAPHY	Many patients and providers are aware that colorectal cancer (CRC) "runs in families." A patient with 1 first-degree relative with CRC has approximately twice the personal risk for CRC as a similar person without this family history. Colorectal cancer is the third most common type of cancer in the United States. When providers neglect to collect information on family history, they may fail to appropriately tailor recommendations for screening for CRC for many patients. This review considers the existing data and summarizes an evidence-based approach to the common clinical problem of how and when to implement screening for CRC in a patient with a family history of colonic neoplasia. The authors discuss the varying risks for CRC given the patient's age, health habits, and personal and family histories. In the context of a clinical case that focuses on the effect of a single affected first-degree relative, the authors weigh the risks and benefits of various screening alternatives; and briefly address chemoprevention, genetic testing, and future directions in screening for CRC.	Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; Oregon Hlth & Sci Univ, Portland, OR USA	Fox Chase Cancer Center; Oregon Health & Science University	Weinberg, DS (corresponding author), Fox Chase Canc Ctr, 333 Cottman Ave, Philadelphia, PA 19111 USA.	david.weinberg@fccc.edu						Ahlquist DA, 2000, GASTROENTEROLOGY, V119, P1219, DOI 10.1053/gast.2000.19580; Alberts DS, 2000, NEW ENGL J MED, V342, P1156, DOI 10.1056/NEJM200004203421602; Arguedas MR, 2001, ALIMENT PHARM THER, V15, P631, DOI 10.1046/j.1365-2036.2001.00969.x; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; Barrison AF, 2003, AM J GASTROENTEROL, V98, P1410, DOI 10.1016/S0002-9270(03)00256-9; Berg AO, 2002, ANN INTERN MED, V137, P834, DOI 10.7326/0003-4819-137-10-200211190-00013; Blakeborough A, 1997, CLIN RADIOL, V52, P142, DOI 10.1016/S0009-9260(97)80108-0; Bond JH, 2000, AM J GASTROENTEROL, V95, P3053; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Burt RW, 1996, PREVENTION EARLY DET, P171; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Chung DC, 2003, ANN INTERN MED, V138, P560, DOI 10.7326/0003-4819-138-7-200304010-00012; Cotton PB, 2004, JAMA-J AM MED ASSOC, V291, P1713, DOI 10.1001/jama.291.14.1713; Cram P, 2003, ARCH INTERN MED, V163, P1601, DOI 10.1001/archinte.163.13.1601; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; Dong SM, 2001, J NATL CANCER I, V93, P858, DOI 10.1093/jnci/93.11.858; Eisen GM, 2000, GASTROINTEST ENDOSC, V51, P777, DOI 10.1053/ge.2000.v51.age516777; Fletcher RH, 2002, JAMA-J AM MED ASSOC, V287, P3127, DOI 10.1001/jama.287.23.3127; FUCHS CS, 1994, NEW ENGL J MED, V331, P1669, DOI 10.1056/NEJM199412223312501; Giardiello FM, 1997, JAMA-J AM MED ASSOC, V278, P1278, DOI 10.1001/jama.278.15.1278; Giardiello FM, 2001, GASTROENTEROLOGY, V121, P198, DOI 10.1053/gast.2001.25581; Giovannucci E, 1998, ANN INTERN MED, V129, P517, DOI 10.7326/0003-4819-129-7-199810010-00002; Hardcastle JD, 1996, LANCET, V348, P1472, DOI 10.1016/S0140-6736(96)03386-7; Houlston RS, 2001, GASTROENTEROLOGY, V121, P282, DOI 10.1053/gast.2001.26265; Howe GR, 1997, CANCER CAUSE CONTROL, V8, P215, DOI 10.1023/A:1018476414781; Hyman J, 1998, CANCER EPIDEM BIOMAR, V7, P291; Iannaccone R, 2004, GASTROENTEROLOGY, V127, P1300, DOI 10.1053/j.gastro.2004.08.025; Imperiale TF, 2000, NEW ENGL J MED, V343, P169, DOI 10.1056/NEJM200007203430302; Imperiale TF, 2004, NEW ENGL J MED, V351, P2704, DOI 10.1056/NEJMoa033403; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Johnson CD, 2003, GASTROENTEROLOGY, V125, P311, DOI 10.1016/S0016-5085(03)00894-1; Kinzler KW, 1998, GENETIC BASIS HUMAN, P565; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Ladabaum U, 2004, CLIN GASTROENTEROL H, V2, P554, DOI 10.1016/S1542-3565(04)00247-2; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Martinez ME, 1998, CANCER EPIDEM BIOMAR, V7, P163; McCullough ML, 2003, CANCER CAUSE CONTROL, V14, P1, DOI 10.1023/A:1022591007673; MULLER AD, 1995, ARCH INTERN MED, V155, P1741, DOI 10.1001/archinte.155.16.1741; Murff HJ, 2004, AM J PREV MED, V27, P239, DOI 10.1016/j.amepre.2004.05.003; Mysliwiec PA, 2004, ANN INTERN MED, V141, P264, DOI 10.7326/0003-4819-141-4-200408170-00006; Nanda K, 1999, OBSTET GYNECOL, V93, P880, DOI 10.1016/S0029-7844(98)00424-4; *NAT COMPR CANC NE, COL CANC SCREEN GUID; Noshirwani KC, 2000, GASTROINTEST ENDOSC, V51, P433, DOI 10.1016/S0016-5107(00)70444-5; Patterson RE, 1997, CANCER CAUSE CONTROL, V8, P786, DOI 10.1023/A:1018443724293; Pickhardt PJ, 2003, AM J ROENTGENOL, V181, P799, DOI 10.2214/ajr.181.3.1810799; Pickhardt PJ, 2004, ANN INTERN MED, V141, P352, DOI 10.7326/0003-4819-141-5-200409070-00009; Pickhardt PJ, 2003, NEW ENGL J MED, V349, P2191, DOI 10.1056/NEJMoa031618; Pignone M, 2002, ANN INTERN MED, V137, P132, DOI 10.7326/0003-4819-137-2-200207160-00015; Pineau BC, 2003, GASTROENTEROLOGY, V125, P304, DOI 10.1016/S0016-5085(03)00885-0; Rex DK, 1997, GASTROENTEROLOGY, V112, P17, DOI 10.1016/S0016-5085(97)70213-0; RIS LA, 1994, NIH PUB, V94; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Sandler RS, 2003, NEW ENGL J MED, V348, P883, DOI 10.1056/NEJMoa021633; Sandler RS, 2004, ANN INTERN MED, V140, P224, DOI 10.7326/0003-4819-140-3-200402030-00014; Schatzkin A, 2000, NEW ENGL J MED, V342, P1149, DOI 10.1056/NEJM200004203421601; Schroy PC, 2002, AM J GASTROENTEROL, V97, P1031, DOI 10.1111/j.1572-0241.2002.05624.x; Schroy PC, 2005, J CLIN GASTROENTEROL, V39, P298, DOI 10.1097/01.mcg.0000155129.31208.0d; Seeff LC, 2004, CANCER-AM CANCER SOC, V100, P2093, DOI 10.1002/cncr.20276; SIDRANSKY D, 1992, SCIENCE, V256, P102, DOI 10.1126/science.1566048; Slattery ML, 2004, PREV MED, V38, P276, DOI 10.1016/j.ypmed.2003.11.009; Smith RA, 2004, CA-CANCER J CLIN, V54, P41, DOI 10.3322/canjclin.54.1.41; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405; Sonnenberg A, 1999, AM J GASTROENTEROL, V94, P2268; STRYKER SJ, 1987, GASTROENTEROLOGY, V93, P1009, DOI 10.1016/0016-5085(87)90563-4; Suleiman S, 2002, GASTROENTEROLOGY, V122, P78, DOI 10.1053/gast.2002.29689; Tagore Kuldeep S, 2003, Clin Colorectal Cancer, V3, P47, DOI 10.3816/CCC.2003.n.011; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; Wagner JL, 1996, PREVENTION EARLY DET, P321; Weisburger JH, 2002, EUR J CANCER PREV, V11, pS1; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; Winawer SJ, 1996, NEW ENGL J MED, V334, P82, DOI 10.1056/NEJM199601113340204; WINAWER SJ, 1993, NEW ENGL J MED, V328, P901, DOI 10.1056/NEJM199304013281301; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Winawer SJ, 2000, NEW ENGL J MED, V342, P1766, DOI 10.1056/NEJM200006153422401	76	11	12	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 2	2005	143	3					190	198		10.7326/0003-4819-143-3-200508020-00005	http://dx.doi.org/10.7326/0003-4819-143-3-200508020-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951TM	16061917				2022-12-01	WOS:000230953900004
J	Reisz, RR; Scott, D; Sues, HD; Evans, DC; Raath, MA				Reisz, RR; Scott, D; Sues, HD; Evans, DC; Raath, MA			Embryos of an Early Jurassic prosauropod dinosaur and their evolutionary significance	SCIENCE			English	Article							SAUROPOD DINOSAURS; LOCOMOTION	Articulated embryos from the Lower Jurassic Elliot Formation of South Africa are referable to the prosauropod Massospondylus carinatus and, together with other material, provide substantial insights into the ontogenetic development in this early dinosaur. The large forelimbs and head and the horizontally held neck indicate that the hatchlings were obligate quadrupeds. In contrast, adult Massospondylus were at least facultatively bipedal. This suggests that the quadrupedal gait of giant sauropods may have evolved by retardation of postnatal negative allometry of the forelimbs. Embryonic body proportions and an absence of well-developed teeth suggest that hatchlings of this dinosaur may have required parental care.	Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada; Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20013 USA; Univ Witwatersrand, Bernard Price Inst Palaeontol Res, ZA-2050 Wits, Johannesburg, South Africa	University of Toronto; University Toronto Mississauga; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Witwatersrand	Reisz, RR (corresponding author), Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada.	rreisz@utm.utoronto.ca						BONAPARTE J F, 1979, Ameghiniana, V16, P173; Bonnan MF, 2003, J VERTEBR PALEONTOL, V23, P595, DOI 10.1671/A1108; Carrano MT, 2000, PALEOBIOLOGY, V26, P489, DOI 10.1666/0094-8373(2000)026<0489:HATEOD>2.0.CO;2; COOPER M R, 1981, Occasional Papers of the National Museums and Monuments of Rhodesia Series B Natural Sciences, V6, P689; Currie PJ, 2003, CAN J EARTH SCI, V40, P651, DOI 10.1139/E02-083; Ferguson M.W.J., 1985, Biology of Reptilia, V14, P329; Galton PM, 2004, DINOSAURIA, 2ND EDITION, P232; KITCHING J W, 1984, Palaeontologia Africana, V25, P111; KITCHING J W, 1979, Palaeontologia Africana, V22, P41; Langer MC, 1999, CR ACAD SCI II A, V329, P511, DOI 10.1016/S1251-8050(00)80025-7; SERENO PC, 1991, MEMOIRS SOC VERTEBRA, V2, P1, DOI DOI 10.2307/3889336; Starck J.M., 1998, AVIAN GROWTH DEV EVO, P3; Starck J.M., 1998, AVIAN GROWTH DEV EVO, P59; Stevens KA, 1999, SCIENCE, V284, P798, DOI 10.1126/science.284.5415.798; Sues HD, 2004, ANN CARNEGIE MUS, V73, P239; WILSON JA, 1998, MEMOIR SOC VERTEBRAT, V5, P1, DOI DOI 10.2307/3889325; Yates Adam M., 2003, Journal of Systematic Palaeontology, V1, P1, DOI 10.1017/S1477201903001007; Yates AM, 2003, P ROY SOC B-BIOL SCI, V270, P1753, DOI 10.1098/rspb.2003.2417	18	102	113	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 29	2005	309	5735					761	764		10.1126/science.1114942	http://dx.doi.org/10.1126/science.1114942			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951NU	16051793	Green Submitted			2022-12-01	WOS:000230938200047
J	Bernays, EA; Singer, MS				Bernays, EA; Singer, MS			Taste alteration and endoparasites	NATURE			English	Editorial Material							PYRROLIZIDINE ALKALOIDS; POLYPHAGOUS CATERPILLAR; GALEAL SENSILLUM; FOOD QUALITY; SUBSTANCES; SELECTION; NEURON; PLANTS		Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; Univ Arizona, Arizona Res Labs, Div Neurobiol, Tucson, AZ 85721 USA; Wesleyan Univ, Dept Biol, Middletown, CT 06459 USA	University of Arizona; University of Arizona; Wesleyan University	Bernays, EA (corresponding author), Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA.							Bernays EA, 2002, PHYSIOL ENTOMOL, V27, P312, DOI 10.1046/j.1365-3032.2002.00304.x; Bernays EA, 2002, J COMP PHYSIOL A, V188, P715, DOI 10.1007/s00359-002-0345-3; Bernays EA, 2000, J COMP PHYSIOL A, V186, P13, DOI 10.1007/s003590050002; Bezzerides A, 2004, P NATL ACAD SCI USA, V101, P9029, DOI 10.1073/pnas.0402480101; Bowers M. Deane, 1993, P331; Hartmann T, 2004, J CHEM ECOL, V30, P229, DOI 10.1023/B:JOEC.0000017975.16399.c3; Nishida R, 2002, ANNU REV ENTOMOL, V47, P57, DOI 10.1146/annurev.ento.47.091201.145121; ROTHSCHILD M, 1979, BIOL J LINN SOC, V12, P305, DOI 10.1111/j.1095-8312.1979.tb00062.x; SIMPSON SJ, 1991, APPETITE, V17, P141, DOI 10.1016/0195-6663(91)90069-5; Singer MS, 2004, ECOLOGY, V85, P2747, DOI 10.1890/03-0827; Singer MS, 2003, OIKOS, V100, P554, DOI 10.1034/j.1600-0706.2003.11720.x; Singer MS, 2004, AM NAT, V164, P423, DOI 10.1086/423152; Stireman JO, 2003, ECOLOGY, V84, P296, DOI 10.1890/0012-9658(2003)084[0296:DOPHAI]2.0.CO;2	13	63	65	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 28	2005	436	7050					476	476		10.1038/436476a	http://dx.doi.org/10.1038/436476a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049466				2022-12-01	WOS:000230788800033
J	Birnie, A; Varma, S				Birnie, A; Varma, S			Adenocarcinoma of the breast in a man	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Queens Med Ctr, Nottingham NG7 2UH, England	University of Nottingham	Birnie, A (corresponding author), Queens Med Ctr, Nottingham NG7 2UH, England.								0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2005	353	3					286	286		10.1056/NEJMicm040548	http://dx.doi.org/10.1056/NEJMicm040548			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946YH	16034014				2022-12-01	WOS:000230608700009
J	Ingelsson, E; Sundstrom, J; Arnlov, J; Zethelius, B; Lind, L				Ingelsson, E; Sundstrom, J; Arnlov, J; Zethelius, B; Lind, L			Insulin resistance and risk of congestive heart failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; CARDIAC STRUCTURE; ANGIOTENSIN-II; GLUCOSE; POPULATION; HYPERINSULINEMIA; HYPERTENSION; PREDICTORS; ACTIVATION; IMPACT	Context Diabetes and obesity are established risk factors for-congestive heart failure (CHF) and are both associated with insulin resistance. Objective To explore if insulin resistance may predict CHF and may provide the link between obesity and CHF. Design, Setting, and Participants The Uppsala Longitudinal Study of Adult Men, a prospective, community-based, observational cohort in Uppsala, Sweden. We investigated 1187 elderly ( >= 70 years) men free from CHF and valvular disease at baseline between 1990 and 1995, with follow-up until the end of 2002. Variables reflecting insulin sensitivity (including euglycemic insulin clamp glucose disposal rate) and obesity were analyzed together with established risk factors (prior myocardial infarction, hypertension, diabetes, electrocardiographic left ventricular hypertrophy, smoking, and serum cholesterol level) as predictors of subsequent incidence of CHF, using Cox proportional hazards analyses. Main Outcome Measure First hospitalization for heart failure. Results One hundred four men developed CHF during a median follow-up of 8.9 (range, 0.01-11.4) years. In multivariable Cox proportional hazards models adjusted for established risk factors for CHF, increased risk of CHF was associated with a 1-SD increase in the 2-hour glucose value of an oral glucose tolerance test (hazard ratio [HR], 1.44; 95% confidence interval [CI], 1.08-1.93), fasting serum proinsulin level (HR, 1.29; 95% Cl, 1.02-1.64), body mass index (HR, 1.35; 95% Cl, 1.11-1.65), and waist circumference (HR, 1.36; 95% Cl, 1.10-1.69), whereas a 1-SD increase in clamp glucose disposal rate decreased the risk (HR, 0.66; 95% Cl, 0.51-0.86). When adding clamp glucose disposal rate to these models as a covariate, the obesity variables were no longer significant predictors of subsequent CHF. Conclusions Insulin resistance predicted CHF incidence independently of established risk factors including diabetes in our large community-based sample of elderly men. The previously described association between obesity and subsequent CHF may be mediated largely by insulin resistance.	Uppsala Univ, Dept Publ Hlth & Caring Sci, Sect Geriatr, SE-75125 Uppsala, Sweden; Uppsala Univ, Dept Med Sci, SE-75125 Uppsala, Sweden; AstraZeneca R&D, Molndal, Sweden	Uppsala University; Uppsala University; AstraZeneca	Ingelsson, E (corresponding author), Uppsala Univ, Dept Publ Hlth & Caring Sci, Sect Geriatr, Box 609, SE-75125 Uppsala, Sweden.	erik.ingelsson@pubcare.uu.se	Ärnlöv, Johan/AAF-2746-2019; Sundström, Johan/A-6286-2009; Sundstrom, Johan/R-2139-2019	Ärnlöv, Johan/0000-0002-6933-4637; Sundström, Johan/0000-0003-2247-8454; Sundstrom, Johan/0000-0003-2247-8454				ANDERSON EA, 1991, J CLIN INVEST, V87, P2246, DOI 10.1172/JCI115260; Arnlov J, 2001, AM HEART J, V142, P720, DOI 10.1067/mhj.2001.116957; ARNLOV J, IN PRESS NUTR METAB; Basta G, 2004, CARDIOVASC RES, V63, P582, DOI 10.1016/j.cardiores.2004.05.001; Bell DSH, 2003, DIABETES CARE, V26, P2433, DOI 10.2337/diacare.26.8.2433; Chen YT, 1999, AM J MED, V106, P605, DOI 10.1016/S0002-9343(99)00126-6; CLELAND JG, 1995, EUR HEART J, V16, P741; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; DEFRONZO RA, 1975, J CLIN INVEST, V55, P845, DOI 10.1172/JCI107996; Devereux RB, 2000, CIRCULATION, V101, P2271, DOI 10.1161/01.CIR.101.19.2271; ERIKSSON H, 1989, EUR HEART J, V10, P647, DOI 10.1093/oxfordjournals.eurheartj.a059542; Ferrannini E, 1997, J CLIN INVEST, V100, P1166, DOI 10.1172/JCI119628; GABOURY CL, 1994, J CLIN INVEST, V94, P2295, DOI 10.1172/JCI117593; Gavin JR, 1999, DIABETES CARE, V22, pS5; Hammar N, 2001, INT J EPIDEMIOL, V30, pS30, DOI 10.1093/ije/30.suppl_1.S30; He J, 2001, ARCH INTERN MED, V161, P996, DOI 10.1001/archinte.161.7.996; Hedstrand H, 1975, Ups J Med Sci Suppl, V19, P1; Holmang A, 1996, EUR J CLIN INVEST, V26, P973, DOI 10.1046/j.1365-2362.1996.2880577.x; INGELSSON E, IN PRESS EUR J HEART; Jyothirmayi, 1998, J Cardiovasc Pharmacol Ther, V3, P319, DOI 10.1177/107424849800300407; KANNEL WB, 1991, AM HEART J, V121, P951, DOI 10.1016/0002-8703(91)90225-7; KANNEL WB, 1974, AM J CARDIOL, V34, P29, DOI 10.1016/0002-9149(74)90089-7; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; LINDBLAD U, 1993, SCAND J SOC MED, V21, P3, DOI 10.1177/140349489302100102; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Paolisso G, 1999, AM J CARDIOL, V83, P1338, DOI 10.1016/S0002-9149(99)00097-1; POLLARE T, 1991, ARTERIOSCLER THROMB, V11, P1192, DOI 10.1161/01.ATV.11.5.1192; PRINEAS RJ, 1982, MINNESOTA CODE MANUA, P239; Rutter MK, 2003, CIRCULATION, V107, P448, DOI 10.1161/01.CIR.0000045671.62860.98; Sartori M, 2004, AM J HYPERTENS, V17, P604, DOI 10.1016/j.amjhyper.2004.02.017; SOBEY WJ, 1989, BIOCHEM J, V260, P535, DOI 10.1042/bj2600535; Sundstrom J, 2000, CIRCULATION, V101, P2595, DOI 10.1161/01.CIR.101.22.2595; Suskin N, 2000, EUR HEART J, V21, P1368, DOI 10.1053/euhj.1999.2043; Swan JW, 1997, J AM COLL CARDIOL, V30, P527, DOI 10.1016/S0735-1097(97)00185-X; Wong CY, 2004, CIRCULATION, V110, P3081, DOI 10.1161/01.CIR.0000147184.13872.0F; Zethelius B, 2004, DIABETES CARE, V27, P1433, DOI 10.2337/diacare.27.6.1433	37	394	411	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 20	2005	294	3					334	341		10.1001/jama.294.3.334	http://dx.doi.org/10.1001/jama.294.3.334			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946YL	16030278	Bronze			2022-12-01	WOS:000230609100018
J	Carroll, JS; Liu, XS; Brodsky, AS; Li, W; Meyer, CA; Szary, AJ; Eeckhoute, J; Shao, WL; Hestermann, EV; Geistlinger, TR; Fox, EA; Silver, PA; Brown, M				Carroll, JS; Liu, XS; Brodsky, AS; Li, W; Meyer, CA; Szary, AJ; Eeckhoute, J; Shao, WL; Hestermann, EV; Geistlinger, TR; Fox, EA; Silver, PA; Brown, M			Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1	CELL			English	Article							BREAST-CANCER CELLS; BETA-GLOBIN LOCUS; TRANSCRIPTION FACTOR; CHROMATIN-IMMUNOPRECIPITATION; RESPONSIVE ELEMENT; GENE-EXPRESSION; ALPHA; ACTIVATION; IDENTIFICATION; MICROARRAY	Estrogen plays an essential physiologic role in reproduction and a pathologic one in breast cancer. The completion of the human genome has allowed the identification of the expressed regions of protein-coding genes; however, little is known concerning the organization of their cis-regulatory elements. We have mapped the association of the estrogen receptor (ER) with the complete nonrepetitive sequence of human chromosomes 21 and 22 by combining chromatin immunoprecipitation (ChIP) with tiled microarrays. ER binds selectively to a limited number of sites, the majority of which are distant from the transcription start sites of regulated genes. The unbiased sequence interrogation of the genuine chromatin binding sites suggests that direct ER binding requires the presence of Forkhead factor binding in close proximity. Furthermore, knockdown of FoxA1 expression blocks the association of ER with chromatin and estrogen-induced gene expression demonstrating the necessity of FoxA1 in mediating an estrogen response in breast cancer cells.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Sch Publ Hlth, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; Furman Univ, Dept Biol, Greenville, SC 29613 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Brown, M (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	myles_brown@dfci.harvard.edu	Brown, Myles/B-6906-2008; Brown, Myles/AAX-5332-2021; Li, Wei/A-8544-2009; Eeckhoute, Jerome/AAN-8219-2021	Brown, Myles/0000-0002-8213-1658; Eeckhoute, Jerome/0000-0002-7222-9264; Li, Wei/0000-0001-9931-5990; Carroll, Jason/0000-0003-3643-0080	NATIONAL CANCER INSTITUTE [F32CA108380] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K22HG002488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T90DK070078] Funding Source: NIH RePORTER; NCI NIH HHS [F32 CA108380-02] Funding Source: Medline; NHGRI NIH HHS [K22 HG02488-01A1] Funding Source: Medline; NIDDK NIH HHS [T90 DK070078-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AUGEREAU P, 1994, MOL ENDOCRINOL, V8, P693, DOI 10.1210/me.8.6.693; Bajic VB, 2003, NUCLEIC ACIDS RES, V31, P3560, DOI 10.1093/nar/gkg570; Beck S, 1999, DNA CELL BIOL, V18, P157, DOI 10.1089/104454999315547; BECKMAN JS, 1993, NATURE, V364, P584, DOI 10.1038/364584a0; BERRY M, 1989, P NATL ACAD SCI USA, V86, P1218, DOI 10.1073/pnas.86.4.1218; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bourdeau V, 2004, MOL ENDOCRINOL, V18, P1411, DOI 10.1210/me.2003-0441; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Bulger M, 2002, CURR OPIN GENET DEV, V12, P170, DOI 10.1016/S0959-437X(02)00283-6; Carroll JS, 2000, J BIOL CHEM, V275, P38221, DOI 10.1074/jbc.M004424200; CAVAILLES V, 1995, EMBO J, V14, P3741, DOI 10.1002/j.1460-2075.1995.tb00044.x; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Cirillo LA, 1998, EMBO J, V17, P244, DOI 10.1093/emboj/17.1.244; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; DUBIK D, 1992, ONCOGENE, V7, P1587; Giamarchi C, 1999, ONCOGENE, V18, P533, DOI 10.1038/sj.onc.1202317; HALACHMI S, 1994, SCIENCE, V264, P1455, DOI 10.1126/science.8197458; Holmqvist PH, 2005, EXP CELL RES, V304, P593, DOI 10.1016/j.yexcr.2004.12.002; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Ikeda K, 2000, BIOCHEM BIOPH RES CO, V273, P654, DOI 10.1006/bbrc.2000.2920; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Katsanis N, 1998, HUM GENET, V102, P221, DOI 10.1007/s004390050682; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Kuang SQ, 2004, CANCER RES, V64, P1875, DOI 10.1158/0008-5472.CAN-03-3745; Lacroix M, 2004, MOL CELL ENDOCRINOL, V219, P1, DOI 10.1016/j.mce.2004.02.021; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Pedram A, 2002, J BIOL CHEM, V277, P50768, DOI 10.1074/jbc.M210106200; Petz LN, 2002, ENDOCRINOLOGY, V143, P4583, DOI 10.1210/en.2002-220369; Porter W, 1996, MOL ENDOCRINOL, V10, P1371, DOI 10.1210/me.10.11.1371; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Robyr D, 2000, J BIOL CHEM, V275, P28291; Sawado T, 2003, GENE DEV, V17, P1009, DOI 10.1101/gad.1072303; Schiff R, 2000, J NATL CANCER I, V92, P1926, DOI 10.1093/jnci/92.23.1926; Schuur ER, 2001, J BIOL CHEM, V276, P33554, DOI 10.1074/jbc.M105555200; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Singh RJ, 1998, P NATL ACAD SCI USA, V95, P6675, DOI 10.1073/pnas.95.12.6675; TENG CT, 1992, MOL ENDOCRINOL, V6, P1969, DOI 10.1210/me.6.11.1969; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; UMAYAHARA Y, 1994, J BIOL CHEM, V269, P16433; Vyhlidal C, 2000, J MOL ENDOCRINOL, V24, P329, DOI 10.1677/jme.0.0240329; Wang DY, 2004, MOL ENDOCRINOL, V18, P402, DOI 10.1210/me.2003-0202; Weinmann AS, 2002, GENE DEV, V16, P235, DOI 10.1101/gad.943102; WEISZ A, 1990, NUCLEIC ACIDS RES, V18, P5097, DOI 10.1093/nar/18.17.5097	50	1043	1070	1	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 15	2005	122	1					33	43		10.1016/j.cell.2005.05.008	http://dx.doi.org/10.1016/j.cell.2005.05.008			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	950EC	16009131	Bronze			2022-12-01	WOS:000230839400009
J	Barna, M; Pandolfi, PP; Niswander, L				Barna, M; Pandolfi, PP; Niswander, L			Gli3 and Plzf cooperate in proximal limb patterning at early stages of limb development	NATURE			English	Article							VERTEBRATE LIMB; GENE-EXPRESSION; MOUSE LIMB; CHICK LIMB; DIFFERENTIATION; CHONDROGENESIS; ROLES; CONDENSATIONS; EVOLUTION; HEDGEHOG	The vertebrate limb initially develops as a bud of mesenchymal cells that subsequently aggregate in a proximal to distal (P - D) sequence to give rise to cartilage condensations that prefigure all limb skeletal components(1). Of the three cardinal limb axes, the mechanisms that lead to establishment and patterning of skeletal elements along the P - D axis are the least understood. Here we identify a genetic interaction between Gli3 (GLI-Kruppel family member 3) and Plzf ( promyelocytic leukaemia zinc finger, also known as Zbtb16 and Zfp145), which is required specifically at very early stages of limb development for all proximal cartilage condensations in the hindlimb ( femur, tibia, fibula). Notably, distal condensations comprising the foot are relatively unperturbed in Gli3(-/-); Plzf(-/-) mouse embryos. We demonstrate that the cooperative activity of Gli3 and Plzf establishes the correct temporal and spatial distribution of chondrocyte progenitors in the proximal limb-bud independently of known P - D patterning markers and overall limb-bud size. Moreover, the limb defects in Gli3(-/-); Plzf(-/-) embryos correlate with the transient death of a specific subset of proximal mesenchymal cells that express bone morphogenetic protein receptor, type 1B (Bmpr1b) at the onset of limb development. These findings suggest that the development of proximal and distal skeletal elements is distinctly regulated early during limb-bud formation. The initial division of the vertebrate limb into two distinct molecular domains is consistent with fossil evidence indicating that the upper and lower extremities of the limb have different evolutionary origins(2).	Sloan Kettering Inst, Dev Biol Program, New York, NY 10021 USA; Sloan Kettering Inst, Canc Biol & Genet Program, New York, NY 10021 USA; Sloan Kettering Inst, Dept Pathol, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, Program Mol Biol, New York, NY 10021 USA; Univ Colorado, Hlth Sci Ctr, Howard Hughes Med Inst, Aurora, CO 80045 USA; Univ Colorado, Hlth Sci Ctr, Dept Pediat, Sect Dev Biol, Aurora, CO 80045 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Niswander, L (corresponding author), Sloan Kettering Inst, Dev Biol Program, New York, NY 10021 USA.	Lee.Niswander@uchsc.edu	Niswander, Lee/D-3976-2013	Niswander, Lee/0000-0002-9959-0594				Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; AVANTAGGIATO V, 1995, J NEUROSCI, V15, P4927; Barna M, 2002, DEV CELL, V3, P499, DOI 10.1016/S1534-5807(02)00289-7; Barna M, 2000, NAT GENET, V25, P166, DOI 10.1038/76014; Boulet AM, 2004, DEVELOPMENT, V131, P299, DOI 10.1242/dev.00936; Buscher D, 1997, MECH DEVELOP, V62, P175, DOI 10.1016/S0925-4773(97)00656-4; Cohn MJ, 2002, BIOESSAYS, V24, P460, DOI 10.1002/bies.10088; DAVIS AP, 1995, NATURE, V375, P791, DOI 10.1038/375791a0; Dudley AT, 2002, NATURE, V418, P539, DOI 10.1038/nature00945; Hall BK, 2000, BIOESSAYS, V22, P138, DOI 10.1002/(SICI)1521-1878(200002)22:2<138::AID-BIES5>3.0.CO;2-4; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; Masuya H, 1997, DEV BIOL, V182, P42, DOI 10.1006/dbio.1996.8457; Mercader N, 2000, DEVELOPMENT, V127, P3961; OSTER GF, 1988, EVOLUTION, V42, P862, DOI 10.1111/j.1558-5646.1988.tb02508.x; Pizette S, 2000, DEV BIOL, V219, P237, DOI 10.1006/dbio.2000.9610; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; SUMMERBELL D, 1974, J EMBRYOL EXP MORPH, V32, P651; Sun X, 2002, NATURE, V418, P501, DOI 10.1038/nature00902; Wakamatsu Y, 1998, DEVELOPMENT, V125, P4205; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Welscher PT, 2002, SCIENCE, V298, P827, DOI 10.1126/science.1075620; WOLPERT L, 1979, J EMBRYOL EXP MORPH, V50, P175; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; Yi SE, 2000, DEVELOPMENT, V127, P621; Zou HY, 1997, GENE DEV, V11, P2191, DOI 10.1101/gad.11.17.2191	26	77	83	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2005	436	7048					277	281		10.1038/nature03801	http://dx.doi.org/10.1038/nature03801			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944VR	16015334				2022-12-01	WOS:000230459500045
J	Tarnopolsky, A; Fletcher, N; Hollenberg, L; Lange, B; Smith, J; Wolfe, J				Tarnopolsky, A; Fletcher, N; Hollenberg, L; Lange, B; Smith, J; Wolfe, J			Acoustics: The vocal tract and the sound of a didgeridoo	NATURE			English	Editorial Material									Univ New S Wales, Sch Phys, Sydney, NSW 2052, Australia; Australian Natl Univ, Res Sch Phys Sci, Canberra, ACT 0200, Australia; Univ Melbourne, Sch Phys, Parkville, Vic 3010, Australia	University of New South Wales Sydney; Australian National University; University of Melbourne	Tarnopolsky, A (corresponding author), Univ New S Wales, Sch Phys, Sydney, NSW 2052, Australia.	j.wolfe@unsw.edu.au	Hollenberg, Lloyd/B-2296-2010	Wolfe, Joe/0000-0001-8030-0561; HOLLENBERG, LLOYD/0000-0001-7672-6965				Epps J, 1997, MEAS SCI TECHNOL, V8, P1112, DOI 10.1088/0957-0233/8/10/012; Fletcher N., 1983, AUSTR ABORIGINAL STU, V1, P28; Fletcher N.H., 1998, PHYS MUSICAL INSTRUM; Mukai S, 1989, J OTOLARYNGOL JPN, V92, P260; Smith J. R., 1997, P I ACOUSTICS, V19, P315; Sundberg J., 1987, SCI SINGING VOICE; Wolfe J, 2003, P STOCKH MUS AC C SM, P307	7	22	22	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2005	436	7047					39	39		10.1038/43639a	http://dx.doi.org/10.1038/43639a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942QJ	16001056	Bronze, Green Published, Green Submitted			2022-12-01	WOS:000230296600032
J	Cadwell, K; Coscoy, L				Cadwell, K; Coscoy, L			Ubiquitination on nonlysine residues by a viral E3 ubiquitin ligase	SCIENCE			English	Article							MHC CLASS-I; COMPLEX CLASS-I; DOWN-REGULATION; HERPESVIRUS K3; IMMUNE EVASION; PROTEINS; ENDOCYTOSIS	Ubiquitination controls a broad range of cellular functions. The last step of the ubiquitination pathway is regulated by enzyme type 3 (E3) ubiquitin ligases. E3 enzymes are responsible for substrate specificity and catalyze the formation of an isopeptide bond between a lysine residue of the substrate (or the N terminus of the substrate) and ubiquitin. MIR1 and MIR2 are two E3 ubiquitin ligases encoded by Kaposi's sarcoma-associated herpesvirus that mediate the ubiquitination of major histocompatibility complex class I (MHC 1) molecules and subsequent internalization. Here, we found that MIR1, but not MIR2, promoted down-regulation of MHC I molecules lacking lysine residues in their intracytoplasmic domain. In the presence of MIR1, these MHC I molecules were ubiquitinated, and their association with ubiquitin was sensitive to P beta(2)-mercaptoethanol, unlike lysine-ubiquitin bonds. This form of ubiquitination required a cysteine residue in the intracytoplasmic tail of MHC I molecules. An MHC I molecule containing a single cysteine residue in an artificial glycine and atanine intracytoplasmic domain was endocytosed and degraded in the presence of MIR1. Thus, ubiquitination can occur on proteins lacking accessible lysines or an accessible N terminus.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Coscoy, L (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 142 Life Sci Addit Room 3200, Berkeley, CA 94720 USA.	lcoscoy@berkeley.edu		Cadwell, Ken/0000-0002-5860-0661	NCI NIH HHS [1R01CA108447-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA108447] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Boname JM, 2001, IMMUNITY, V15, P627, DOI 10.1016/S1074-7613(01)00213-8; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; Coscoy L, 2000, P NATL ACAD SCI USA, V97, P8051, DOI 10.1073/pnas.140129797; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; Coscoy L, 2001, J CLIN INVEST, V107, P1599, DOI 10.1172/JCI12432; Fruh K, 2002, VIRUS RES, V88, P55, DOI 10.1016/S0168-1702(02)00120-X; Furman MH, 2002, J CLIN INVEST, V110, P875, DOI 10.1172/JCI200216831; Hewitt EW, 2002, EMBO J, V21, P2418, DOI 10.1093/emboj/21.10.2418; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Ishido S, 2000, J VIROL, V74, P5300, DOI 10.1128/JVI.74.11.5300-5309.2000; Lorenzo ME, 2002, J VIROL, V76, P5522, DOI 10.1128/JVI.76.11.5522-5531.2002; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Sanchez DJ, 2002, J BIOL CHEM, V277, P6124, DOI 10.1074/jbc.M110265200; Stevenson PG, 2000, P NATL ACAD SCI USA, V97, P8455, DOI 10.1073/pnas.150240097	15	298	311	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2005	309	5731					127	130		10.1126/science.1110340	http://dx.doi.org/10.1126/science.1110340			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	941KD	15994556				2022-12-01	WOS:000230212800074
J	Henshaw, D				Henshaw, D			Tension pneumothoraces	LANCET			English	Editorial Material									Kalgoorlie Reg Hosp, Kalgoorlie, WA 6430, Australia		Henshaw, D (corresponding author), Kalgoorlie Reg Hosp, Kalgoorlie, WA 6430, Australia.	David.Henshaw@health.wa.gov.au							0	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 25	2005	365	9478					2243	2243		10.1016/S0140-6736(05)66784-0	http://dx.doi.org/10.1016/S0140-6736(05)66784-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	938WT	15978934				2022-12-01	WOS:000230034800036
J	Mirica, LM; Vance, M; Rudd, DJ; Hedman, B; Hodgson, KO; Solomon, EI; Stack, TDP				Mirica, LM; Vance, M; Rudd, DJ; Hedman, B; Hodgson, KO; Solomon, EI; Stack, TDP			Tyrosinase reactivity in a model complex: An alternative hydroxylation mechanism	SCIENCE			English	Article							SIDE-ON PEROXO; <CU-2(MU-O)(2)>(2+) CORE; PHENOLASE ACTIVITY; DIOXYGEN; OXYGENATION; BINDING; LIGAND; INTERMEDIATE; REDUCTION; CHEMISTRY	The binuclear copper enzyme tyrosinase activates O-2 to form a mu-eta(2):eta(2)-peroxodicopper(II) complex, which oxidizes phenols to catechols. Here, a synthetic mu-eta(2):eta(2)-peroxodicopper(II) complex, with an absorption spectrum similar to that of the enzymatic active oxidant, is reported to rapidly hydroxylate phenolates at -80 degrees C. Upon phenolate addition at extreme temperature in solution (-120 degrees C), a reactive intermediate consistent with a bis-mu-oxodicopper(III)phenolate complex, with the O-O bond fully cleaved, is observed experimentally. The subsequent hydroxylation step has the hallmarks of an electrophilic aromatic substitution mechanism, similar to tyrosinase. Overall, the evidence for sequential O-O bond cleavage and C-O bond formation in this synthetic complex suggests an alternative intimate mechanism to the concerted or late stage O-O bond scission generally accepted for the phenol hydroxylation reaction performed by tyrosinase.	Stanford Univ, Dept Chem, Stanford, CA 94305 USA; Stanford Linear Accelerator Ctr, Stanford Synchrotron Radiat Lab, Stanford, CA 94309 USA	Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Hedman, B (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	hedman@ssrl.slac.stanford.edu; hodgson@ssrl.slac.stanford.edu; edward.solomon@stanford.edu; stack@stanford.edu	Mirica, Liviu M./R-1978-2017	Mirica, Liviu M./0000-0003-0584-9508; Solomon, Edward/0000-0003-0291-3199	NCRR NIH HHS [RR01209] Funding Source: Medline; NIDDK NIH HHS [DK31450] Funding Source: Medline; NIGMS NIH HHS [GM50730] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031450, R37DK031450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050730, R29GM050730] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chen P, 2002, J INORG BIOCHEM, V88, P368, DOI 10.1016/S0162-0134(01)00349-X; Decker H, 2000, ANGEW CHEM INT EDIT, V39, P1591, DOI 10.1002/(SICI)1521-3773(20000502)39:9<1591::AID-ANIE1591>3.0.CO;2-H; DuBois JL, 1997, J AM CHEM SOC, V119, P8578, DOI 10.1021/ja9717673; DuBois JL, 2000, J AM CHEM SOC, V122, P5775, DOI 10.1021/ja993134p; Green MT, 2004, SCIENCE, V304, P1653, DOI 10.1126/science.1096897; Halfen JA, 1996, SCIENCE, V271, P1397, DOI 10.1126/science.271.5254.1397; Henson MJ, 1999, J AM CHEM SOC, V121, P10332, DOI 10.1021/ja9918425; Holland PL, 1999, ANGEW CHEM INT EDIT, V38, P1139, DOI 10.1002/(SICI)1521-3773(19990419)38:8<1139::AID-ANIE1139>3.0.CO;2-0; Itoh S, 2001, J AM CHEM SOC, V123, P6708, DOI 10.1021/ja015702i; Kim M, 2002, NAT STRUCT BIOL, V9, P591, DOI 10.1038/nsb824; Lewis EA, 2004, CHEM REV, V104, P1047, DOI 10.1021/cr020633r; Mahadevan V, 2000, J AM CHEM SOC, V122, P10249, DOI 10.1021/ja002527h; Mahadevan V, 1997, J AM CHEM SOC, V119, P11996, DOI 10.1021/ja972946n; Mahapatra S, 1997, ANGEW CHEM INT EDIT, V36, P130, DOI 10.1002/anie.199701301; Mandal S, 2000, J ORG CHEM, V65, P4804, DOI 10.1021/jo991625m; Mirica LM, 2004, CHEM REV, V104, P1013, DOI 10.1021/cr020632z; Mirica LM, 2002, J AM CHEM SOC, V124, P9332, DOI 10.1021/ja026905p; Pidcock E, 1998, J AM CHEM SOC, V120, P7841, DOI 10.1021/ja980687b; Price JC, 2003, BIOCHEMISTRY-US, V42, P7497, DOI 10.1021/bi030011f; Santagostini L, 2000, CHEM-EUR J, V6, P519, DOI 10.1002/(SICI)1521-3765(20000204)6:3<519::AID-CHEM519>3.0.CO;2-I; SCOTT RA, 1985, METHOD ENZYMOL, V117, P414; Siegbahn PEM, 2003, J BIOL INORG CHEM, V8, P567, DOI 10.1007/s00775-003-0449-4; Solomon EI, 2001, ANGEW CHEM INT EDIT, V40, P4570, DOI 10.1002/1521-3773(20011217)40:24<4570::AID-ANIE4570>3.0.CO;2-4; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; WILCOX DE, 1985, J AM CHEM SOC, V107, P4015, DOI 10.1021/ja00299a043; Yamazaki S, 2003, J AM CHEM SOC, V125, P13034, DOI 10.1021/ja036425d	26	255	258	4	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2005	308	5730					1890	1892		10.1126/science.1112081	http://dx.doi.org/10.1126/science.1112081			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	940BZ	15976297				2022-12-01	WOS:000230120000034
J	Cote, ML; Kardia, SLR; Wenzlaff, AS; Ruckdeschel, JC; Schwartz, AG				Cote, ML; Kardia, SLR; Wenzlaff, AS; Ruckdeschel, JC; Schwartz, AG			Risk of lung cancer among white and black relatives of individuals with early-onset lung cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; AIR-FLOW OBSTRUCTION; CHRONIC-BRONCHITIS; FAMILIAL RISK; AGE; AGGREGATION; INFORMATION	Context Evidence exists that lung cancer aggregates in families and recent findings of a chromosomal region linked to lung cancer susceptibility support a genetic component to risk. Family studies of early-onset lung cancer patients offer a unique opportunity to evaluate lifetime risk of lung cancer in relatives. Objective To measure lung cancer aggregation and estimate lifetime risk among relatives of early-onset cases and population-based controls. Design and Setting Familial aggregation and cumulative risk estimates from interview data of incident cases and concurrently ascertained controls between 1990 and 2003 in metropolitan Detroit, Mich. Participants The study included 7576 biological mothers, fathers, and siblings of 692 early-onset cases and 773 frequency-matched controls. One third of the population was black. Main Outcome Measures Cumulative lifetime risk of lung cancer, stratified by race and smoking behavior in relatives of early-onset cases and controls. Results Smokers with a family history of early-onset lung cancer in a first-degree relative had a higher risk of developing lung cancer with increasing age than smokers without a family history. An increase in risk occurs after age 60 years in these individuals, with 17.1% (SE 2.4%) of white case relatives and 25.1% (SE 5.8%) of black case relatives diagnosed with lung cancer by age 70 years. Relatives of black cases were at statistically significant increased risk of lung cancer compared with relatives of white cases (odds ratio, 2.07, 95% confidence interval, 1.29-3.32) after adjusting for age, sex, pack-years, pneumonia, and chronic obstructive lung disease. Conclusions First-degree relatives of black individuals with early-onset lung cancer have greater risk of lung cancer than their white counterparts, and these risks are further amplified by cigarette smoking. These data provide estimates of lung cancer risk that can be used to offer counseling to family members of patients with early-onset lung cancer.	Wayne State Univ, Karmanos Canc Inst, Populat Studies & Prevent Program, Detroit, MI USA; Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; University of Michigan System; University of Michigan	Cote, ML (corresponding author), 110 E Warren Ave, Detroit, MI 48201 USA.	cotem@med.wayne.edu	Ruckdeschel, John/AAU-2137-2020	Ruckdeschel, John/0000-0002-7977-4257	NATIONAL CANCER INSTITUTE [R01CA060691] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA60691, N01 CN65064] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		*AM CANC SOC, WHAT ARE KEY STAT LU; Bailey-Wilson JE, 2004, AM J HUM GENET, V75, P460, DOI 10.1086/423857; Bromen K, 2000, AM J EPIDEMIOL, V152, P497, DOI 10.1093/aje/152.6.497; CUPPLES LA, 1991, AM J HUM GENET, V49, P76; DOLL R, 1952, BMJ-BRIT MED J, V2, P1271, DOI 10.1136/bmj.2.4797.1271; Etzel CJ, 2003, CANCER RES, V63, P8531; Gauderman WJ, 2000, AM J EPIDEMIOL, V151, P41, DOI 10.1093/oxfordjournals.aje.a010120; Kreuzer M, 1998, AM J EPIDEMIOL, V147, P1028; Li XJ, 2004, INT J CANCER, V112, P451, DOI 10.1002/ijc.20436; Mayne ST, 1999, CANCER EPIDEM BIOMAR, V8, P1065; McLaughlin J K, 1990, Epidemiology, V1, P408, DOI 10.1097/00001648-199009000-00013; Murff HJ, 2004, JAMA-J AM MED ASSOC, V292, P1480, DOI 10.1001/jama.292.12.1480; OOI WL, 1986, J NATL CANCER I, V76, P217; PICKLE LW, 1983, AM J EPIDEMIOL, V118, P99, DOI 10.1093/oxfordjournals.aje.a113621; Ries LAG., SEER CANC STAT REV 1; *SAS I INC, 1999, SAS SYST WIND COMP P; Schwartz AG, 1996, AM J EPIDEMIOL, V144, P554, DOI 10.1093/oxfordjournals.aje.a008965; Schwartz AG, 1999, GENET EPIDEMIOL, V17, P1, DOI 10.1002/(SICI)1098-2272(1999)17:1<1::AID-GEPI1>3.0.CO;2-C; Silverman EK, 1998, AM J RESP CRIT CARE, V157, P1770, DOI 10.1164/ajrccm.157.6.9706014; Silverman EK, 2002, HUM MOL GENET, V11, P623, DOI 10.1093/hmg/11.6.623; SKILLRUD DM, 1986, ANN INTERN MED, V105, P503, DOI 10.7326/0003-4819-105-4-503; Sullivan F, 1999, COMPUT SCI ENG, V1, P2; TAGER I, 1978, INT J EPIDEMIOL, V7, P55, DOI 10.1093/ije/7.1.55; Theis B, 1994, Eur J Cancer Prev, V3, P321, DOI 10.1097/00008469-199407000-00004; TOCKMAN MS, 1987, ANN INTERN MED, V106, P512, DOI 10.7326/0003-4819-106-4-512; TOKUHATA GEORGE K., 1963, JOUR NATL CANCER INST, V30, P289; Vink JM, 2003, ADDICTION, V98, P923, DOI 10.1046/j.1360-0443.2003.00405.x; Yang P, 1999, GENET EPIDEMIOL, V17, P253, DOI 10.1002/(SICI)1098-2272(199911)17:4<253::AID-GEPI2>3.3.CO;2-B; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	29	70	77	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	2005	293	24					3036	3042		10.1001/jama.293.24.3036	http://dx.doi.org/10.1001/jama.293.24.3036			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	937SG	15972566	Bronze			2022-12-01	WOS:000229945200019
J	Wysocka, J; Swigut, T; Milne, TA; Dou, YL; Zhang, X; Burlingame, AL; Roeder, RG; Brivanlou, AH; Allis, CD				Wysocka, J; Swigut, T; Milne, TA; Dou, YL; Zhang, X; Burlingame, AL; Roeder, RG; Brivanlou, AH; Allis, CD			WDR5 associates with histone H3 methylated at K4 and is essential for H3K4 methylation and vertebrate development	CELL			English	Article							METHYLTRANSFERASE COMPLEX; SACCHAROMYCES-CEREVISIAE; LYSINE-4 METHYLATION; PROTEINS; HETEROCHROMATIN; RECOGNITION; MAINTENANCE; BINDING; GROWTH; MENIN	Histone H3 lysine 4 (K4) methylation has been linked to the transcriptional activation in a variety of eukaryotic species. Here we show that a common component of MLL1, MLL2, and hSetl H3 K4 methyltransferase complexes, the WD40-repeat protein WDR5, directly associates with histone H3 di- and trimethylated at K4 and with H3-K4-dimethylated nucleosomes. WDR5 is required for binding of the methyltransferase complex to the K4-dimethylated H3 tail as well as for global H3 K4 trimethylation and HOX gene activation in human cells. WDR5 is essential for vertebrate development, in that WDR5-depleted X. laevis tadpoles exhibit a variety of developmental defects and abnormal spatial Hox gene expression. Our results are the first demonstration that a WD40-repeat protein acts as a module for recognition of a specific histone modification and suggest a mechanism for reading and writing an epigenetic mark for gene activation.	Rockefeller Univ, Lab Chromatin Biol, New York, NY 10021 USA; Rockefeller Univ, Lab Mol Vertebrate Embryol, New York, NY 10021 USA; Rockefeller Univ, Lab Biochem & Mol Biol, New York, NY 10021 USA; Univ Calif San Francisco, Mass Spectrometry Facil, San Francisco, CA 94143 USA	Rockefeller University; Rockefeller University; Rockefeller University; University of California System; University of California San Francisco	Allis, CD (corresponding author), Rockefeller Univ, Lab Chromatin Biol, New York, NY 10021 USA.	alliscd@rockefeller.edu	Milne, Tom/E-1872-2016	Milne, Tom/0000-0002-0413-4271; Swigut, Tomek/0000-0002-7649-6781	NCRR NIH HHS [RR001614, RR015804] Funding Source: Medline; NIGMS NIH HHS [GM 53512, R01 GM066977] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614, S10RR015804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM053512, R01GM053512, R01GM066977] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; BRIVANLOU AH, 1989, DEVELOPMENT, V106, P611; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Elgin SCR, 2003, CURR BIOL, V13, pR895, DOI 10.1016/j.cub.2003.11.006; Francis NJ, 2001, NAT REV MOL CELL BIO, V2, P409, DOI 10.1038/35073039; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Goo YH, 2003, MOL CELL BIOL, V23, P140, DOI 10.1128/MCB.23.1.140-149.2003; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hollmann M, 2002, MOL GENET GENOMICS, V268, P425, DOI 10.1007/s00438-002-0768-0; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Ko C, 2003, BIOCHEM BIOPH RES CO, V300, P9, DOI 10.1016/S0006-291X(02)02699-2; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Loyola A, 2004, BBA-GENE STRUCT EXPR, V1677, P3, DOI 10.1016/j.bbaexp.2003.09.012; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; R Development Core Team, 2004, LANG ENV STAT COMP; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Sive H. L., 2000, EARLY DEV XENOPUS LA; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Wysocka J, 2001, MOL CELL BIOL, V21, P3820, DOI 10.1128/MCB.21.11.3820-3829.2001; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004	32	617	641	3	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 17	2005	121	6					859	872		10.1016/j.cell.2005.03.036	http://dx.doi.org/10.1016/j.cell.2005.03.036			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	938NX	15960974	Bronze			2022-12-01	WOS:000230011200009
J	Ihee, H; Lorenc, M; Kim, TK; Kong, QY; Cammarata, M; Lee, JH; Bratos, S; Wulff, M				Ihee, H; Lorenc, M; Kim, TK; Kong, QY; Cammarata, M; Lee, JH; Bratos, S; Wulff, M			Ultrafast x-ray diffraction of transient molecular structures in solution	SCIENCE			English	Article							RADICALS; CRYSTALLOGRAPHY	We report direct structural evidence of the bridged radical (CH(2)ICH(2)center dot) in a polar solution, obtained using time-resolved liquid-phase x-ray diffraction. This transient intermediate has long been hypothesized to explain stereochemical control in many association and/or dissociation reactions involving haloalkanes. Ultrashort optical pulses were used to dissociate an iodine atom from the haloethane molecule (C2H4I2) dissolved in methanol, and the diffraction of picosecond x-ray pulses from a synchrotron supports the following structural dynamics, with similar to 0.01 angstrom spatial resolution and similar to 100 picosecond time resolution: The loss of one iodine atom from C2H4I2 leads to the C-I-C triangular geometry of CH(2)ICH(2)center dot. This transient C2H4I then binds to an iodine atom to form a new species, the C2H4I-I isomer, which eventually decays into C2H4+I-2. Solvent dynamics were also extracted from the data, revealing a change in the solvent cage geometry, heating, and thermal expansion.	Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea; Korea Adv Inst Sci & Technol, Sch Mol Sci BK21, Taejon 305701, South Korea; European Synchrotron Radiat Facil, F-38043 Grenoble, France; Natl Inst Phys Matter, I-90123 Palermo, Italy; Dept Phys & Astron Sci, I-90123 Palermo, Italy; Univ Paris 06, Phys Theor Liquides Lab, F-75252 Paris, France	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); European Synchrotron Radiation Facility (ESRF); Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); UDICE-French Research Universities; Sorbonne Universite	Ihee, H (corresponding author), Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea.	hyotcherl_ihee@kaist.ac.kr	Ihee, Hyotcherl/C-1614-2011; KIM, TAE KYU/A-8737-2016; Cammarata, Marco/C-2322-2008; Lorenc, Maciej/N-7594-2014	KIM, TAE KYU/0000-0002-9578-5722; Cammarata, Marco/0000-0003-3013-1186; 				ADITYA S, 1957, J AM CHEM SOC, V79, P2680, DOI 10.1021/ja01568a005; Allen M. P., 1989, COMPUTER SIMULATION; BECKWITH ALJ, 1980, REARRANGEMENTS GROUN, V1, P273; Bernardi F., 1988, J MOL STRUC-THEOCHEM, V180, P79; Bowles AJ, 1970, CHEM PHYS LETT, V5, P552, DOI 10.1016/0009-2614(70)85043-6; Bratos S, 2004, CHEM PHYS, V304, P245, DOI 10.1016/j.chemphys.2004.06.065; Dudek RC, 2001, J PHYS CHEM A, V105, P4167, DOI 10.1021/jp010122t; EDGE DJ, 1972, J AM CHEM SOC, V94, P6485, DOI 10.1021/ja00773a036; ENGELS B, 1986, J MOL STRUC-THEOCHEM, V138, P59; Fossey J, 1995, FREE RADICALS ORGANI; Gnanakaran S, 2001, J AM CHEM SOC, V123, P12886, DOI 10.1021/ja011088z; GOERING HL, 1952, J AM CHEM SOC, V74, P3588, DOI 10.1021/ja01134a035; Ihee H, 2001, SCIENCE, V291, P458, DOI 10.1126/science.291.5503.458; Ihee H, 1999, J PHYS CHEM A, V103, P6638, DOI 10.1021/jp990867n; Kochi J. K., 1973, FREE RADICALS, VII; Paul Maj S., 1984, CHEM COMMUN, P561; Plech A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.125505; Rasmusson M, 2002, J PHYS CHEM A, V106, P7090, DOI 10.1021/jp020720n; Rischel C, 1997, NATURE, V390, P490, DOI 10.1038/37317; Rose-Petruck C, 1999, NATURE, V398, P310, DOI 10.1038/18631; Ruan CY, 2004, SCIENCE, V304, P80, DOI 10.1126/science.1094818; Schotte F, 2003, SCIENCE, V300, P1944, DOI 10.1126/science.1078797; Siders CW, 1999, SCIENCE, V286, P1340, DOI 10.1126/science.286.5443.1340; Siwick BJ, 2003, SCIENCE, V302, P1382, DOI 10.1126/science.1090052; SKELL PS, 1963, J AM CHEM SOC, V85, P2849, DOI 10.1021/ja00901a038; THALER W, 1963, J AM CHEM SOC, V85, P2607, DOI 10.1021/ja00900a019; Tomov IV, 1999, J PHYS CHEM B, V103, P7081, DOI 10.1021/jp9908449; Vakhtin AB, 2003, J PHYS CHEM A, V107, P10055, DOI 10.1021/jp030230a	28	195	197	0	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 19	2005	309	5738					1223	1227		10.1126/science.1114782	http://dx.doi.org/10.1126/science.1114782			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	957TE	16020695				2022-12-01	WOS:000231395400040
J	Potter, JD				Potter, JD			Vegetables, fruit, and cancer	LANCET			English	Editorial Material							IOWA-WOMENS-HEALTH; LUNG-CANCER; COLON-CANCER; BREAST-CANCER; VITAMIN-C; PROSPECTIVE COHORT; GASTRIC-CANCER; DIETARY FIBER; FOLLOW-UP; RISK		Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Potter, JD (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA.	jpotter@fhcrc.org		Potter, John/0000-0001-5439-1500				Collins FS, 2004, NATURE, V429, P475, DOI 10.1038/nature02628; Feskanich D, 2000, JNCI-J NATL CANCER I, V92, P1812, DOI 10.1093/jnci/92.22.1812; Flood A, 2002, AM J CLIN NUTR, V75, P936, DOI 10.1093/ajcn/75.5.936; FRASER GE, 1991, AM J EPIDEMIOL, V133, P683, DOI 10.1093/oxfordjournals.aje.a115943; GIOVANNUCCI E, 1994, ANN MED, V26, P443, DOI 10.3109/07853899409148367; Giovannucci E, 1998, CANCER RES, V58, P442; GIOVANNUCCI E, 1994, CANCER RES, V54, P2390; Holmes MD, 1999, JAMA-J AM MED ASSOC, V281, P914, DOI 10.1001/jama.281.10.914; Hung HC, 2004, JNCI-J NATL CANCER I, V96, P1577, DOI 10.1093/jnci/djh296; HUNTER DJ, 1993, NEW ENGL J MED, V329, P234, DOI 10.1056/NEJM199307223290403; Joshipura KJ, 1999, JAMA-J AM MED ASSOC, V282, P1233, DOI 10.1001/jama.282.13.1233; Joshipura KJ, 2001, ANN INTERN MED, V134, P1106, DOI 10.7326/0003-4819-134-12-200106190-00010; KATO I, 1992, JPN J CANCER RES, V83, P568, DOI 10.1111/j.1349-7006.1992.tb00127.x; Kobayashi M, 2002, INT J CANCER, V102, P39, DOI 10.1002/ijc.10659; KROMHOUT D, 1987, AM J CLIN NUTR, V45, P1361, DOI 10.1093/ajcn/45.5.1361; KVALE G, 1983, INT J CANCER, V31, P397, DOI 10.1002/ijc.2910310402; Liu Y, 2004, CANCER CAUSE CONTROL, V15, P349, DOI 10.1023/B:CACO.0000027507.22124.20; Michaud DS, 1999, JNCI-J NATL CANCER I, V91, P605, DOI 10.1093/jnci/91.7.605; Michels KB, 2000, JNCI-J NATL CANCER I, V92, P1740, DOI 10.1093/jnci/92.21.1740; Miller AB, 2004, INT J CANCER, V108, P269, DOI 10.1002/ijc.11559; NOMURA AMY, 1995, JPN J CANCER RES, V86, P916, DOI 10.1111/j.1349-7006.1995.tb03001.x; POTTER JD, 1995, CANCER EPIDEM BIOMAR, V4, P319; Potter JD, 2004, CANCER EPIDEM BIOMAR, V13, P895; ROHAN TE, 1993, CANCER CAUSE CONTROL, V4, P29, DOI 10.1007/BF00051711; SHIBATA A, 1992, BRIT J CANCER, V66, P673, DOI 10.1038/bjc.1992.336; Slattery ML, 2000, J NATL CANCER I, V92, P1831, DOI 10.1093/jnci/92.22.1831; Smith-Warner SA, 2001, INT J CANCER, V92, P767, DOI 10.1002/1097-0215(20010601)92:5&lt;767::AID-IJC1247&gt;3.0.CO;2-0; STEINMETZ KA, 1991, CANCER CAUSE CONTROL, V2, P325, DOI 10.1007/BF00051672; STEINMETZ KA, 1991, CANCER CAUSE CONTROL, V2, P427, DOI 10.1007/BF00054304; STEINMETZ KA, 1994, AM J EPIDEMIOL, V139, P1; STEINMETZ KA, 1993, CANCER RES, V53, P536; Terry P, 2001, JNCI-J NATL CANCER I, V93, P525, DOI 10.1093/jnci/93.7.525; THUN MJ, 1992, JNCI-J NATL CANCER I, V84, P1491, DOI 10.1093/jnci/84.19.1491; Voorrips LE, 2000, AM J EPIDEMIOL, V152, P1081, DOI 10.1093/aje/152.11.1081; WANG LD, 1985, CHINESE MED J-PEKING, V98, P206; WILLETT WC, 1990, NEW ENGL J MED, V323, P1664, DOI 10.1056/NEJM199012133232404; WILLETT WC, 1987, NEW ENGL J MED, V316, P22, DOI 10.1056/NEJM198701013160105; World Cancer Research Fund & American Institute for Cancer Research, 1997, FOOD NUTR PREV CANC; Zhang SM, 1999, JNCI-J NATL CANCER I, V91, P547, DOI 10.1093/jnci/91.6.547; Zhang SMM, 2000, CANCER EPIDEM BIOMAR, V9, P477	40	47	51	3	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 13	2005	366	9485					527	530		10.1016/S0140-6736(05)67077-8	http://dx.doi.org/10.1016/S0140-6736(05)67077-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	955LL	16099275				2022-12-01	WOS:000231227300007
J	Michaloglou, C; Vredeveld, LCW; Soengas, MS; Denoyelle, C; Kuilman, T; van der Horst, CMAM; Majoor, DM; Shay, JW; Mooi, WJ; Peeper, DS				Michaloglou, C; Vredeveld, LCW; Soengas, MS; Denoyelle, C; Kuilman, T; van der Horst, CMAM; Majoor, DM; Shay, JW; Mooi, WJ; Peeper, DS			BRAF(E600)-associated senescence-like cell cycle arrest of human naevi	NATURE			English	Article							MALIGNANT-MELANOMA; TUMOR SUPPRESSION; BRAF MUTATIONS; CANCER; P53; P16; TRANSFORMATION; ONCOGENE; GENES	Most normal mammalian cells have a finite lifespan(1), thought to constitute a protective mechanism against unlimited proliferation(2-4). This phenomenon, called senescence, is driven by telomere attrition, which triggers the induction of tumour suppressors including p16(INK4a) (ref. 5). In cultured cells, senescence can be elicited prematurely by oncogenes(6); however, whether such oncogene-induced senescence represents a physiological process has long been debated. Human naevi ( moles) are benign tumours of melanocytes that frequently harbour oncogenic mutations ( predominantly V600E, where valine is substituted for glutamic acid) in BRAF(7), a protein kinase and downstream effector of Ras. Nonetheless, naevi typically remain in a growth-arrested state for decades and only rarely progress into malignancy (melanoma)(8-10). This raises the question of whether naevi undergo BRAF(V600E)- induced senescence. Here we show that sustained BRAF(V600E) expression in human melanocytes induces cell cycle arrest, which is accompanied by the induction of both p16(INK4a) and senescence- associated acidic beta-galactosidase (SA-beta-Gal) activity, a commonly used senescence marker. Validating these results in vivo, congenital naevi are invariably positive for SA-beta-Gal, demonstrating the presence of this classical senescence-associated marker in a largely growth-arrested, neoplastic human lesion. In growth-arrested melanocytes, both in vitro and in situ, we observed a marked mosaic induction of p16(INK4a), suggesting that factors other than p16(INK4a) contribute to protection against BRAF(V600E)- driven proliferation. Naevi do not appear to suffer from telomere attrition, arguing in favour of an active oncogene-driven senescence process, rather than a loss of replicative potential. Thus, both in vitro and in vivo, BRAF(V600E)-expressing melanocytes display classical hallmarks of senescence, suggesting that oncogene-induced senescence represents a genuine protective physiological process.	Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Div Pathol, NL-1066 CX Amsterdam, Netherlands; Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; Univ Amsterdam, Acad Med Ctr, Dept Plast Reconstruct & Hand Surg, NL-1100 AZ Amsterdam, Netherlands; Univ Texas, SW Med Ctr, Dept Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Harold Simmons Canc Ctr, Dallas, TX 75390 USA; Free Univ Amsterdam, Med Ctr, Dept Pathol, NL-1081 HV Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Amsterdam; Academic Medical Center Amsterdam; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Vrije Universiteit Amsterdam	Peeper, DS (corresponding author), Netherlands Canc Inst, Div Mol Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	wj.mooi@vumc.nl; d.peeper@nki.nl	Peeper, Daniel/AAA-2430-2020; Shay, Jerry W/F-7878-2011; Soengas, Maria S/H-6455-2015; DENOYELLE, Christophe CD/K-6205-2015	Soengas, Maria S/0000-0003-0612-6299; DENOYELLE, Christophe CD/0000-0001-7153-8826				Bandyopadhyay D, 2001, EXP GERONTOL, V36, P1265, DOI 10.1016/S0531-5565(01)00098-5; Bastian BC, 2003, ONCOGENE, V22, P3081, DOI 10.1038/sj.onc.1206463; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Bennett DC, 2003, ONCOGENE, V22, P3063, DOI 10.1038/sj.onc.1206446; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Chin L, 1998, GENE DEV, V12, P3467, DOI 10.1101/gad.12.22.3467; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; GRUIS NA, 1995, NAT GENET, V10, P351, DOI 10.1038/ng0795-351; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Hingorani SR, 2003, CANCER RES, V63, P5198; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; KUWATA T, 1993, VIRCHOWS ARCH A, V423, P359, DOI 10.1007/BF01607148; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Mathon NE, 2001, NAT REV CANCER, V1, P203, DOI 10.1038/35106045; Miracco C, 2002, BRIT J DERMATOL, V146, P399, DOI 10.1046/j.1365-2133.2002.04600.x; MOOI WJ, 1992, BIOPSY PATHOLOGY MEL, P56; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Patton EE, 2005, CURR BIOL, V15, P249, DOI 10.1016/j.cub.2005.01.031; Peeper DS, 2002, NAT CELL BIOL, V4, P148, DOI 10.1038/ncb742; PEEPER DS, 2002, HISTOPATHOLOGY, V41, pS139; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Robinson WA, 1998, MELANOMA RES, V8, P499, DOI 10.1097/00008390-199812000-00004; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sharpless NE, 2003, ONCOGENE, V22, P3092, DOI 10.1038/sj.onc.1206461; Shay JW, 2004, ONCOGENE, V23, P2919, DOI 10.1038/sj.onc.1207518; Wang YL, 1996, BRIT J DERMATOL, V134, P269; Wellbrock C, 2004, CANCER RES, V64, P2338, DOI 10.1158/0008-5472.CAN-03-3433; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	30	1589	1638	4	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2005	436	7051					720	724		10.1038/nature03890	http://dx.doi.org/10.1038/nature03890			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951XA	16079850	Green Published			2022-12-01	WOS:000230964500048
J	Johnson, J; Bagley, J; Skaznik-Wikiel, M; Lee, HJ; Adams, GB; Niikura, Y; Tschudy, KS; Tilly, JC; Cortes, ML; Forkert, R; Spitzer, T; Iacomini, J; Scadden, DT; Tilly, JL				Johnson, J; Bagley, J; Skaznik-Wikiel, M; Lee, HJ; Adams, GB; Niikura, Y; Tschudy, KS; Tilly, JC; Cortes, ML; Forkert, R; Spitzer, T; Iacomini, J; Scadden, DT; Tilly, JL			Oocyte generation in adult mammalian ovaries by putative germ cells in bone marrow and peripheral blood	CELL			English	Article							HEMATOPOIETIC STEM-CELLS; MURINE HOMOLOG; PROPHASE I; MOUSE; EXPRESSION; GENE; MICE; FOLLICULOGENESIS; DEFICIENCY; PLASTICITY	It has been suggested that germline stem cells maintain oogenesis in postnatal mouse ovaries. Here we show that adult mouse ovaries rapidly generate hundreds of oocytes, despite a small premeiotic germ cell pool. In considering the possibility of an extragonadal source of germ cells, we show expression of germline markers in bone marrow (BM). Further, BM transplantation restores oocyte production in wild-type mice sterilized by chemotherapy, as well as in ataxia telangiectasia-mutated gene-deficient mice, which are otherwise incapable of making oocytes. Donor-derived oocytes are also observed in female mice following peripheral blood transplantation. Although the fertilizability and developmental competency of the BM and peripheral blood-derived oocytes remain to be established, their morphology, enclosure within follicles, and expression of germ-cell- and oocyte-specific markers collectively support that these cells are bona fide oocytes. These results identify BM as a potential source of germ cells that could sustain oocyte production in adulthood.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Vincent Ctr Reprod Biol,Vincent Obstetr & Gynecol, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Regenerat Med & Technol, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, MGH Canc Ctr, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Tilly, JL (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Vincent Ctr Reprod Biol,Vincent Obstetr & Gynecol, Boston, MA 02114 USA.	jtilly@partners.org	Johnson, Johnson/HDL-9124-2022; Niikura, Yuichi/AAQ-5935-2020	Skaznik-Wikiel, Malgorzata/0000-0002-5248-6909; Johnson, Joshua/0000-0002-6016-8089	NIA NIH HHS [R01-AG012279, R01-AG024999] Funding Source: Medline; NICHD NIH HHS [L50 HD048367] Funding Source: Medline; NIEHS NIH HHS [R01-ES08430] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024999, R01AG012279] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Allen E, 1923, AM J ANAT, V31, P439, DOI 10.1002/aja.1000310502; Barlow C, 1998, DEVELOPMENT, V125, P4007; Benson DA, 2004, NUCLEIC ACIDS RES, V32, pD23, DOI 10.1093/nar/gkh045; Brinster CJ, 2003, BIOL REPROD, V69, P412, DOI 10.1095/biolreprod.103.016519; Brinster RL, 2002, SCIENCE, V296, P2174, DOI 10.1126/science.1071607; Canning J, 2003, ENDOCRINOLOGY, V144, P9, DOI 10.1210/en.2002-220988; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Cohen PE, 2001, BIOESSAYS, V23, P996, DOI 10.1002/bies.1145; Cooke HJ, 1996, HUM MOL GENET, V5, P513, DOI 10.1093/hmg/5.4.513; Cooper R., 1993, METHODS TOXICOLOGY B, P45; Deng W, 2001, INT REV CYTOL, V203, P93; Di Giacomo M, 2005, P NATL ACAD SCI USA, V102, P737, DOI 10.1073/pnas.0406212102; DIALYNAS DP, 1983, J IMMUNOL, V131, P2445; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; Erickson GF, 2000, TRENDS ENDOCRIN MET, V11, P193, DOI 10.1016/S1043-2760(00)00249-6; FUJIWARA Y, 1994, P NATL ACAD SCI USA, V91, P12258, DOI 10.1073/pnas.91.25.12258; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; GOSDEN RG, 1983, BIOL REPROD, V28, P255, DOI 10.1095/biolreprod28.2.255; Gosden RG, 2004, HUM REPROD UPDATE, V10, P193, DOI 10.1093/humupd/dmh023; GREEN EL, 1970, INT J RADIAT BIOL RE, V17, P87, DOI 10.1080/09553007014550091; Grove JE, 2004, STEM CELLS, V22, P487, DOI 10.1634/stemcells.22-4-487; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Heike T, 2004, INT J HEMATOL, V79, P7, DOI 10.1007/BF02983527; Herzog EL, 2003, BLOOD, V102, P3483, DOI 10.1182/blood-2003-05-1664; HIRSHFIELD AN, 1991, INT REV CYTOL, V124, P43; Johnson J, 2004, NATURE, V428, P145, DOI 10.1038/nature02316; LAWSON KA, 1994, CIBA F SYMP, V182, P68; MARANI E, 1986, ACTA MORPHOL NEER SC, V24, P103; Matzuk MM, 2002, SCIENCE, V296, P2178, DOI 10.1126/science.1071965; MCGRATH SA, 1995, MOL ENDOCRINOL, V9, P131, DOI 10.1210/me.9.1.131; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Meirelles LD, 2003, BRIT J HAEMATOL, V123, P702, DOI 10.1046/j.1365-2141.2003.04669.x; Molyneaux K, 2004, INT J DEV BIOL, V48, P537, DOI 10.1387/ijdb.041833km; Morita Y, 2000, NAT MED, V6, P1109, DOI 10.1038/80442; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cellbio.11.1.35; Neto ED, 2000, P NATL ACAD SCI USA, V97, P3491; Noce T, 2001, CELL STRUCT FUNCT, V26, P131, DOI 10.1247/csf.26.131; OKADA S, 1991, BLOOD, V78, P1706; OKADA S, 1992, BLOOD, V80, P3044; Perez GI, 1999, NAT GENET, V21, P200, DOI 10.1038/5985; Perez GI, 1997, NAT MED, V3, P1228, DOI 10.1038/nm1197-1228; PETERS H, 1969, ACTA ENDOCRINOL-COP, V62, P98, DOI 10.1530/acta.0.0620098; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PHILPOTT CC, 1987, DEV BIOL, V121, P568, DOI 10.1016/0012-1606(87)90192-8; Rajkovic A, 2004, SCIENCE, V305, P1157, DOI 10.1126/science.1099755; RICH IN, 1995, BLOOD, V86, P463, DOI 10.1182/blood.V86.2.463.bloodjournal862463; RICHARDSON SJ, 1987, J CLIN ENDOCR METAB, V65, P1231, DOI 10.1210/jcem-65-6-1231; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; SARMIENTO M, 1980, J IMMUNOL, V125, P2665; SCHOLER HR, 1989, EMBO J, V8, P2543, DOI 10.1002/j.1460-2075.1989.tb08392.x; Sette C, 2000, INT J DEV BIOL, V44, P599; SHIROMIZU K, 1984, PEDIATR PHARMACOL, V4, P213; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; SPANGRUDE GJ, 1990, EXP HEMATOL, V18, P920; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suzumori N, 2002, MECH DEVELOP, V111, P137, DOI 10.1016/S0925-4773(01)00620-7; Szabo PE, 2002, MECH DEVELOP, V115, P157, DOI 10.1016/S0925-4773(02)00087-4; Tilly JL, 2001, NAT REV MOL CELL BIO, V2, P838, DOI 10.1038/35099086; Tilly Jonathan L, 2003, Reprod Biol Endocrinol, V1, P11, DOI 10.1186/1477-7827-1-11; VANDERIJN M, 1989, P NATL ACAD SCI USA, V86, P4634; Wognum AW, 2003, ARCH MED RES, V34, P461, DOI 10.1016/j.arcmed.2003.09.008; Yeom YI, 1996, DEVELOPMENT, V122, P881; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; ZUCKERMAN S, 1951, RECENT PROG HORM RES, V6, P63; Zuckerman S., 1977, OVARY, V1, P41	65	515	563	1	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 29	2005	122	2					303	315		10.1016/j.cell.2005.06.031	http://dx.doi.org/10.1016/j.cell.2005.06.031			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	951CR	16051153	Bronze			2022-12-01	WOS:000230907000016
J	Kerner, MJ; Naylor, DJ; Ishihama, Y; Maier, T; Chang, HC; Stines, AP; Georgopoulos, C; Frishman, D; Hayer-Hartl, M; Mann, M; Hartl, FU				Kerner, MJ; Naylor, DJ; Ishihama, Y; Maier, T; Chang, HC; Stines, AP; Georgopoulos, C; Frishman, D; Hayer-Hartl, M; Mann, M; Hartl, FU			Proteome-wide analysis of chaperonin-dependent protein folding in Escherichia coli	CELL			English	Article							TRIGGER FACTOR; IN-VIVO; MOLECULAR CHAPERONES; CRYSTAL-STRUCTURE; POLYPEPTIDE FLUX; GROEL; DNAK; SYSTEM; CELL; INTERMEDIATE	The E. coli chaperonin GroEL and its cofactor GroES promote protein folding by sequestering nonnative polypeptides in a cage-like structure. Here we define the contribution of this system to protein folding across the entire E. coli proteome. Approximately 250 different proteins interact with GroEL, but most of these can utilize either GroEL or the upstream chaperones trigger factor (TF) and DnaK for folding. Obligate GroEL-dependence is limited to only similar to 85 substrates, including 13 essential proteins, and occupying more than 75% of GroEL capacity. These proteins appear to populate kinetically trapped intermediates during folding; they are stabilized by TF/DnaK against aggregation but reach native state only upon transfer to GroEL/GroES. Interestingly, substantially enriched among the GroEL substrates are proteins with (beta alpha)(8) TIM-barrel domains. We suggest that the chaperonin system may have facilitated the evolution of this fold into a versatile platform for the implementation of numerous enzymatic functions.	Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany; Univ So Denmark, Ctr Expt Bioinformat, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark; Ctr Med Univ Geneva, Dept Microbiol & Med Mol, CH-1211 Geneva, Switzerland; GSF Natl Res Ctr Environm & Hlth, Inst Bioinformat, D-85764 Neuherberg, Germany; Tech Univ Munich, Wissensch Zentrum Weihenstephan, Dept Genome Oriented Bioinformat, D-85354 Freising Weihenstephan, Germany	Max Planck Society; University of Southern Denmark; University of Geneva; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Hartl, FU (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	uhartl@biochem.mpg.de	Hartl, F. Ulrich/Y-8206-2019; Frishman, Dmitrij/AAT-7815-2020; Mann, Matthias/A-3454-2013; Ishihama, Yasushi/B-3101-2016; Hayer-Hartl, Manajit/V-8078-2017	Mann, Matthias/0000-0003-1292-4799; Ishihama, Yasushi/0000-0001-7714-203X; Hayer-Hartl, Manajit/0000-0001-8213-6742; zhang, hong jun/0000-0003-0030-8323				Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; Chaudhuri TK, 2001, CELL, V107, P235, DOI 10.1016/S0092-8674(01)00523-2; Chiti F, 2002, P NATL ACAD SCI USA, V99, P16419, DOI 10.1073/pnas.212527999; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Dobson CM, 1998, ANGEW CHEM INT EDIT, V37, P868, DOI 10.1002/(SICI)1521-3773(19980420)37:7<868::AID-ANIE868>3.0.CO;2-H; Ellis RJ, 1996, FASEB J, V10, P20, DOI 10.1096/fasebj.10.1.8566542; Ewalt KL, 1997, CELL, V90, P491, DOI 10.1016/S0092-8674(00)80509-7; FAYET O, 1989, J BACTERIOL, V171, P1379, DOI 10.1128/JB.171.3.1379-1385.1989; Fenton WA, 2003, Q REV BIOPHYS, V36, P229, DOI 10.1017/S0033583503003883; Ferguson N, 1999, J MOL BIOL, V286, P1597, DOI 10.1006/jmbi.1998.2548; Figueiredo L, 2004, J BIOL CHEM, V279, P1090, DOI 10.1074/jbc.M310914200; Frishman D, 2003, NUCLEIC ACIDS RES, V31, P207, DOI 10.1093/nar/gkg005; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Genevaux P, 2004, EMBO REP, V5, P195, DOI 10.1038/sj.embor.7400067; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Gromiha MM, 2004, PROG BIOPHYS MOL BIO, V86, P235, DOI 10.1016/j.pbiomolbio.2003.09.003; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HORWICH AL, 1993, CELL, V74, P909, DOI 10.1016/0092-8674(93)90470-B; Houry WA, 1999, NATURE, V402, P147, DOI 10.1038/45977; Jewett AI, 2004, P NATL ACAD SCI USA, V101, P13192, DOI 10.1073/pnas.0400720101; Klunker D, 2003, J BIOL CHEM, V278, P33256, DOI 10.1074/jbc.M302018200; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Lin Z, 2004, MOL CELL, V16, P23, DOI 10.1016/j.molcel.2004.09.003; Lo Conte L, 2002, NUCLEIC ACIDS RES, V30, P264; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; McLennan N, 1998, NATURE, V392, P139, DOI 10.1038/32317; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Nobelmann B, 1996, J BACTERIOL, V178, P6790, DOI 10.1128/jb.178.23.6790-6795.1996; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Teter SA, 1999, CELL, V97, P755, DOI 10.1016/S0092-8674(00)80787-4; Thirumalai D, 2003, P NATL ACAD SCI USA, V100, P11195, DOI 10.1073/pnas.2035072100; Ullers RS, 2004, P NATL ACAD SCI USA, V101, P7583, DOI 10.1073/pnas.0402398101; Vorderwulbecke S, 2004, FEBS LETT, V559, P181, DOI 10.1016/S0014-5793(04)00052-3; Wang JD, 2002, CELL, V111, P1027, DOI 10.1016/S0092-8674(02)01198-4; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944	40	480	488	0	45	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 29	2005	122	2					209	220		10.1016/j.cell.2005.05.028	http://dx.doi.org/10.1016/j.cell.2005.05.028			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	951CR	16051146	hybrid			2022-12-01	WOS:000230907000009
J	Magill, A; Panosian, C				Magill, A; Panosian, C			Making antibacterial agents available in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Walter Reed Army Inst Res, Silver Spring, MD 20910 USA; Univ Calif Los Angeles, Med Ctr, Los Angeles, CA 90024 USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Magill, A (corresponding author), Walter Reed Army Inst Res, Silver Spring, MD 20910 USA.							Arrow KJ, 2004, SAVING LIVES BUYING; Wallace MR, 1996, AM J MED, V100, P49, DOI 10.1016/S0002-9343(96)90011-X; ZAKIN S, 2005, LOS ANGELES TIM 0612, pM1; 2000, MMWR MORB MORTAL WKL, V49, P1138	4	7	7	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 28	2005	353	4					335	337		10.1056/NEJMp058167	http://dx.doi.org/10.1056/NEJMp058167			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949JW	16000347				2022-12-01	WOS:000230782800004
J	Iqbal, MB; Sharma, R; Underwood, SR; Kaddoura, S				Iqbal, MB; Sharma, R; Underwood, SR; Kaddoura, S			Radioisotopes and airport security	LANCET			English	Editorial Material									Royal Brompton Hosp, Dept Nucl Med, London SW3 6NP, England; Royal Brompton Hosp, Dept Cardiol, London SW3 6NP, England	Royal Brompton Hospital; Royal Brompton Hospital	Underwood, SR (corresponding author), Royal Brompton Hosp, Dept Nucl Med, London SW3 6NP, England.	r.underwood@imperial.ac.uk		Underwood, Stephen Richard/0000-0002-5777-1442				ATKINS HL, 1977, J NUCL MED, V18, P133; LEVIN ME, 1988, NEW ENGL J MED, V319, P587; TOLTZIS RJ, 1986, NEW ENGL J MED, V315, P836; 2004, RSNA NEWS, V14, P6	4	13	13	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2005	366	9482					342	342		10.1016/S0140-6736(05)66994-2	http://dx.doi.org/10.1016/S0140-6736(05)66994-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	948RJ	16039341				2022-12-01	WOS:000230733100037
J	Sibly, RM; Barker, D; Denham, MC; Hone, J; Pagel, M				Sibly, RM; Barker, D; Denham, MC; Hone, J; Pagel, M			On the regulation of populations of mammals, birds, fish, and insects	SCIENCE			English	Article							DENSITY-DEPENDENCE; GROWTH; HERBIVORES	A key unresolved question in population ecology concerns the relationship between a population's size and its growth rate. We estimated this relationship for 1780 time series of mammals, birds, fish, and insects. We found that rates of population growth are high at low population densities but, contrary to previous predictions, decline rapidly with increasing population size and then flatten out, for all four taxa. This produces a strongly concave relationship between a population's growth rate and its size. These findings have fundamental implications for our understanding of animals' lives, suggesting in particular that many animals in these taxa will be found living at densities above the carrying capacity of their environments.	Univ Reading, Sch Anim & Microbial Sci, Reading RG6 6AJ, Berks, England; GlaxoSmithKline Res & Dev Ltd, Stat Sci Europe, Harlow CM19 5AW, Essex, England; Univ Canberra, Inst Appl Ecol, Canberra, ACT 2601, Australia	University of Reading; GlaxoSmithKline; University of Canberra	Sibly, RM (corresponding author), Univ Reading, Sch Anim & Microbial Sci, Reading RG6 6AJ, Berks, England.	r.m.sibly@reading.ac.uk	Barker, David JP/A-5671-2013	Sibly, Richard/0000-0001-6828-3543; Hone, Jim/0000-0002-8104-8852				ANDERSON R M, 1991; Bayliss P, 2002, PHILOS T ROY SOC B, V357, P1233, DOI 10.1098/rstb.2002.1124; Beissinger S.R., 2002, POPULATION VIABILITY; Caughley G., 1994, WILDLIFE ECOLOGY MAN; CluttonBrock TH, 1997, AM NAT, V149, P195, DOI 10.1086/285987; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; FOWLER CW, 1981, ECOLOGY, V62, P602, DOI 10.2307/1937727; GILPIN ME, 1973, P NATL ACAD SCI USA, V70, P3590, DOI 10.1073/pnas.70.12.3590; Halley J, 2002, OIKOS, V99, P518, DOI 10.1034/j.1600-0706.2002.11962.x; Jennings S., 2001, MARINE FISHERIES ECO; Krebs CJ, 2002, PHILOS T ROY SOC B, V357, P1211, DOI 10.1098/rstb.2002.1122; Lande R, 1997, ECOLOGY, V78, P1341; Lande R., 2003, STOCHASTIC POPULATIO; Lindstrom J, 2002, ECOL LETT, V5, P338, DOI 10.1046/j.1461-0248.2002.00317.x; NERC Centre for Population Biology IC, 2010, GLOB POP DYN DAT; Pastorok R. A., 2002, ECOLOGICAL MODELING; Royama T., 1992, ANAL POPULATION ECOL; Saether BE, 1997, TRENDS ECOL EVOL, V12, P143, DOI 10.1016/S0169-5347(96)10068-9; Saether BE, 1996, OIKOS, V77, P217, DOI 10.2307/3546060; Saether BE, 2002, SCIENCE, V295, P2070; Shenk TM, 1998, ECOL MONOGR, V68, P445, DOI 10.1890/0012-9615(1998)068[0445:SVEODD]2.0.CO;2; Sibly RM, 2002, PHILOS T R SOC B, V357, P1153, DOI 10.1098/rstb.2002.1117; Sinclair A.R.E., 1989, P197; Sinclair ARE, 2003, PHILOS T R SOC B, V358, P1729, DOI 10.1098/rstb.2003.1359; Sinclair ARE, 1996, FRONTIERS OF POPULATION ECOLOGY, P127; Sinclair ARE, 2002, PHILOS T ROY SOC B, V357, P1221, DOI 10.1098/rstb.2002.1123; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; Tsoularis A, 2002, MATH BIOSCI, V179, P21, DOI 10.1016/S0025-5564(02)00096-2; Turchin P, 1999, OIKOS, V84, P153, DOI 10.2307/3546876; Turchin Peter, 2003, Monographs in Population Biology, V35, pi	30	306	316	4	210	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2005	309	5734					607	610		10.1126/science.1110760	http://dx.doi.org/10.1126/science.1110760			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SE	16040705				2022-12-01	WOS:000230735200047
J	Matsuoka, T; Ahlberg, PE; Kessaris, N; Iannarelli, P; Dennehy, U; Richardson, WD; McMahon, AP; Koentges, G				Matsuoka, T; Ahlberg, PE; Kessaris, N; Iannarelli, P; Dennehy, U; Richardson, WD; McMahon, AP; Koentges, G			Neural crest origins of the neck and shoulder	NATURE			English	Article							EXPRESSION; MUSCLES; GENES; EVOLUTION; MIGRATION; SUGGEST; GROWTH; FATE	The neck and shoulder region of vertebrates has undergone a complex evolutionary history. To identify its underlying mechanisms we map the destinations of embryonic neural crest and mesodermal stem cells using Cre- recombinase-mediated transgenesis. The single-cell resolution of this genetic labelling reveals cryptic cell boundaries traversing the seemingly homogeneous skeleton of the neck and shoulders. Within this assembly of bones and muscles we discern a precise code of connectivity that mesenchymal stem cells of both neural crest and mesodermal origin obey as they form muscle scaffolds. The neural crest anchors the head onto the anterior lining of the shoulder girdle, while a Hox-gene-controlled mesoderm links trunk muscles to the posterior neck and shoulder skeleton. The skeleton that we identify as neural crest-derived is specifically affected in human Klippel - Feil syndrome, Sprengel's deformity and Arnold - Chiari I/II malformation, providing insights into their likely aetiology. We identify genes involved in the cellular modularity of the neck and shoulder skeleton and propose a new method for determining skeletal homologies that is based on muscle attachments. This has allowed us to trace the whereabouts of the cleithrum, the major shoulder bone of extinct land vertebrate ancestors, which seems to survive as the scapular spine in living mammals.	UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; UCL, Lab Funct Genom, London WC1E 6BT, England; UCL, Dept Biol, London WC1E 6BT, England; Uppsala Univ, Dept Physiol & Dev Biol, Subdept Evolutionary Organismal Biol, S-75236 Uppsala, Sweden; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	University of London; University College London; University of London; University College London; University of London; University College London; Uppsala University; Harvard University	Koentges, G (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England.	g.koentges@ucl.ac.uk	Kessaris, Nicoletta/AAD-6774-2019; Campbell, Chris/J-7596-2013; McMahon, Andrew P/ABE-7520-2020; Richardson FMedSci FRS, William D/C-1762-2008	Kessaris, Nicoletta/0000-0003-1191-6009; Campbell, Chris/0000-0001-7749-8538; Richardson FMedSci FRS, William D/0000-0001-7261-2485; Ahlberg, Per/0000-0001-9054-2900	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033642] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS033642] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission)		Alvares LE, 2003, DEV CELL, V5, P379, DOI 10.1016/S1534-5807(03)00263-6; Barrow JR, 1999, DEVELOPMENT, V126, P5011; Baylies MK, 1998, CELL, V93, P921, DOI 10.1016/S0092-8674(00)81198-8; BURKE AC, 1995, DEVELOPMENT, V121, P333; CLACK JA, 2005, J SYSTEMATIC PALAEON, V2, P311, DOI DOI 10.1017/S1477201904001506; Clarke RA, 1998, PEDIATR RADIOL, V28, P967, DOI 10.1007/s002470050511; CONDIE BG, 1994, NATURE, V370, P304, DOI 10.1038/370304a0; COULY GF, 1992, DEVELOPMENT, V114, P1; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; DIETRICH S, 1995, DEV BIOL, V167, P529, DOI 10.1006/dbio.1995.1047; Edgeworth F, 1935, CRANIAL MUSCLES VERT; Ferguson CA, 2004, DEV BIOL, V269, P70, DOI 10.1016/j.ydbio.2004.01.013; Graham D. I., 2002, GREENFIELDS NEUROPAT; Hall BK, 2001, J EXP ZOOL, V289, P153, DOI 10.1002/1097-010X(20010215)289:3<153::AID-JEZ1>3.0.CO;2-O; HORWITZ AE, 1908, AM J ORTHOP SURG, V6, P260; Huang LF, 1997, DEV DYNAM, V210, P33, DOI 10.1002/(SICI)1097-0177(199709)210:1<33::AID-AJA4>3.0.CO;2-2; Huang RJ, 2000, ANAT EMBRYOL, V202, P375, DOI 10.1007/s004290000131; Huang RJ, 2000, DEVELOPMENT, V127, P3789; Jaekel O., 1918, Palaeontologische Zeitschrift Berlin, V2, P88; JANVIER P., 1996, EARLY VERTEBRATES; Jarvik E., 1980, BASIC STRUCTURE EVOL, V1; Jiang XB, 2002, DEV BIOL, V241, P106, DOI 10.1006/dbio.2001.0487; Johanson Z, 2003, J VERTEBR PALEONTOL, V23, P735, DOI 10.1671/2; Joyce W, 2003, J VERTEBR PALEONTOL, V23, p66A; Kjaer I, 1999, AM J MED GENET, V82, P6, DOI 10.1002/(SICI)1096-8628(19990101)82:1<6::AID-AJMG2>3.0.CO;2-#; Kontges G, 1996, DEVELOPMENT, V122, P3229; Le Douarin N.M., 1999, NEURAL CREST; LEBEDEV OA, 2005, ACTA U LATVIENSIS, V679, P79; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; LUMSDEN A, 1991, DEVELOPMENT, V113, P1281; Mao XH, 2001, BLOOD, V97, P324, DOI 10.1182/blood.V97.1.324; Motta PJ, 2001, ENVIRON BIOL FISH, V60, P131, DOI 10.1023/A:1007649900712; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Peters H, 1999, DEVELOPMENT, V126, P5399; Prols F, 2004, DEV BIOL, V275, P315, DOI 10.1016/j.ydbio.2004.08.003; Reisz R.R., 1984, Journal of Vertebrate Paleontology, V4, P57; SAUNDERS JW, 1948, J EXP ZOOL, V108, P363, DOI 10.1002/jez.1401080304; Schoch Rainer R., 1999, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V278, P1; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Selleri L, 2001, DEVELOPMENT, V128, P3543; Shearman RM, 2005, J MORPHOL, V264, P94, DOI 10.1002/jmor.10322; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; Smith A, 1997, CURR BIOL, V7, P561, DOI 10.1016/S0960-9822(06)00255-7; SMITH MM, 1990, BIOL REV, V65, P277, DOI 10.1111/j.1469-185X.1990.tb01427.x; SMITH MM, 1993, EVOL BIOL, V27, P387; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sumida Stuart S., 1997, P353, DOI 10.1016/B978-012676460-4/50012-3; Takio Y, 2004, NATURE, V429, DOI 10.1038/nature02616; WINTERBOTTOM R, 1974, P ACAD NAT SCI PHILA, V125, P225; Zhang F, 1997, MECH DEVELOP, V67, P49, DOI 10.1016/S0925-4773(97)00104-4	50	339	351	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2005	436	7049					347	355		10.1038/nature03837	http://dx.doi.org/10.1038/nature03837			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	16034409	Green Accepted			2022-12-01	WOS:000230623400033
J	Hahn, J; Maier, B; Haijema, BJ; Sheetz, M; Dubnau, D				Hahn, J; Maier, B; Haijema, BJ; Sheetz, M; Dubnau, D			Transformation proteins and DNA uptake localize to the cell poles in Bacillus subtilis	CELL			English	Article							BINDING-SITE; COMPETENCE; DIVISION; SPORULATION; EXPRESSION; MOVEMENT; PATTERNS; BACTERIA; DISTINCT; SEPTUM	The Gram-positive, rod-forming bacterium Bacillus subtilis efficiently binds and internalizes transforming DNA. The localization of several competence proteins, required for DNA uptake, has been studied using fluorescence microscopy. At least three proteins (ComGA, ComFA, and YwpH) are preferentially associated with the cell poles and appear to colocalize. This association is dynamic; the proteins accumulate at the poles as transformability develops and then delocalize as transformability wanes. DNA binding and uptake also occur preferentially at the cell poles, as shown using fluorescent DNA and in single-molecule experiments with laser tweezers. In addition to the prominent polar sites, the competence proteins also localize as foci in association with the lateral cell membrane, but this distribution does not exhibit the same temporal changes as the polar accumulation. The results suggest the regulated assembly and disassembly of a DNA-uptake machine at the cell poles.	Publ Hlth Res Inst, Newark, NJ 07103 USA; Columbia Univ, Dept Sci Biol, New York, NY 10027 USA	Columbia University	Dubnau, D (corresponding author), Publ Hlth Res Inst, 225 Warren St, Newark, NJ 07103 USA.	dubnau@phri.org	Maier, Berenike/B-2350-2016	Maier, Berenike/0000-0001-6971-9927	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043756, R01GM057720] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM057720, GM43756, GM57720, GM3677, R01 GM043756] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBANO M, 1987, J BACTERIOL, V169, P3110, DOI 10.1128/jb.169.7.3110-3117.1987; ALBANO M, 1989, J BACTERIOL, V171, P5386, DOI 10.1128/jb.171.10.5386-5404.1989; Ben-Yehuda S, 2002, CELL, V109, P257, DOI 10.1016/S0092-8674(02)00698-0; Berge M, 2003, MOL MICROBIOL, V50, P527, DOI 10.1046/j.1365-2958.2003.03702.x; Berka RM, 2002, MOL MICROBIOL, V43, P1331, DOI 10.1046/j.1365-2958.2002.02833.x; Campo N, 2004, MOL MICROBIOL, V53, P1583, DOI 10.1111/j.1365-2958.2004.04278.x; CHUNG YS, 1995, MOL MICROBIOL, V15, P543, DOI 10.1111/j.1365-2958.1995.tb02267.x; Chung YS, 1998, MOL MICROBIOL, V29, P905, DOI 10.1046/j.1365-2958.1998.00989.x; Chung YS, 1998, J BACTERIOL, V180, P41, DOI 10.1128/JB.180.1.41-45.1998; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; Draskovic I, 2005, MOL MICROBIOL, V55, P881, DOI 10.1111/j.1365-2958.2004.04430.x; DRASKOVIC I, 2005, COMPETENCE GENETIC T; DUBNAU D, 1971, J MOL BIOL, V56, P209, DOI 10.1016/0022-2836(71)90460-8; DUBNAU D, 1972, J MOL BIOL, V64, P31, DOI 10.1016/0022-2836(72)90319-1; DUBNAU D, 2001, BACILLUS SUBTILIS IT, P453; Edwards DH, 1997, MOL MICROBIOL, V24, P905, DOI 10.1046/j.1365-2958.1997.3811764.x; HAHN J, 1987, J BACTERIOL, V169, P3104, DOI 10.1128/jb.169.7.3104-3109.1987; Haijema BJ, 2001, MOL MICROBIOL, V40, P52, DOI 10.1046/j.1365-2958.2001.02363.x; Hamoen LW, 2002, NUCLEIC ACIDS RES, V30, P5517, DOI 10.1093/nar/gkf698; HARRY EJ, 1995, J BACTERIOL, V177, P3386, DOI 10.1128/jb.177.12.3386-3393.1995; Hoa TT, 2002, MOL MICROBIOL, V43, P15, DOI 10.1046/j.1365-2958.2002.02727.x; INAMINE GS, 1995, J BACTERIOL, V177, P3045, DOI 10.1128/jb.177.11.3045-3051.1995; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Kidane D, 2005, CELL, V122, P73, DOI 10.1016/j.cell.2005.04.036; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVIN PA, 1994, J BACTERIOL, V176, P1451, DOI 10.1128/jb.176.5.1451-1459.1994; Levin PA, 1997, MOL MICROBIOL, V25, P839; Levin PA, 1996, GENE DEV, V10, P478, DOI 10.1101/gad.10.4.478; LONDONOVALLEJO JA, 1994, MOL MICROBIOL, V13, P197, DOI 10.1111/j.1365-2958.1994.tb00415.x; LONDONOVALLEJO JA, 1994, J BACTERIOL, V176, P4642; Maier B, 2004, NAT STRUCT MOL BIOL, V11, P643, DOI 10.1038/nsmb783; Meima R, 2002, J BIOL CHEM, V277, P6994, DOI 10.1074/jbc.M111380200; Ogura M, 2002, J BACTERIOL, V184, P2344, DOI 10.1128/JB.184.9.2344-2351.2002; Provvedi R, 1999, MOL MICROBIOL, V31, P271, DOI 10.1046/j.1365-2958.1999.01170.x; SANSONETTI P, 2002, COMEA DNA RECEPTOR; Scheffers DJ, 2004, MOL MICROBIOL, V51, P749, DOI 10.1046/j.1365-2958.2003.03854.x; Shapiro L, 2002, SCIENCE, V298, P1942, DOI 10.1126/science.1072163; Shih YL, 2003, P NATL ACAD SCI USA, V100, P7865, DOI 10.1073/pnas.1232225100; SINGH RN, 1972, J BACTERIOL, V110, P266, DOI 10.1128/JB.110.1.266-272.1972; Soufo HJD, 2004, EMBO REP, V5, P789, DOI 10.1038/sj.embor.7400209; SPIZIZEN J, 1958, P NATL ACAD SCI USA, V44, P1072, DOI 10.1073/pnas.44.10.1072; Thanedar S, 2004, CURR BIOL, V14, P1167, DOI 10.1016/j.cub.2004.06.048	42	111	117	4	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 15	2005	122	1					59	71		10.1016/j.cell.2005.04.035	http://dx.doi.org/10.1016/j.cell.2005.04.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	950EC	16009133	Bronze, Green Accepted			2022-12-01	WOS:000230839400011
J	Hoepfner, D; Schildknegt, D; Braakman, I; Philippsen, P; Tabak, HF				Hoepfner, D; Schildknegt, D; Braakman, I; Philippsen, P; Tabak, HF			Contribution of the endoplasmic reticulum to peroxisome formation	CELL			English	Article							MEMBRANE-PROTEINS; BIOGENESIS; IMPORT; PEX19P; INHERITANCE; COMPONENTS; TRANSPORT; MULTIPLE; DYNAMICS; MODULES	How peroxisomes are formed in eukaryotic cells is unknown but important for insight into a variety of diseases. Both human and yeast cells lacking peroxisomes due to mutations in PEX3 or PEX19 genes regenerate the organelles upon reintroduction of the corresponding wild-type version. To evaluate how and from where new peroxisomes are formed, we followed the trafficking route of newly made YFP-tagged Pex3 and Pex19 proteins by real-time fluorescence microscopy in Saccharomyces cerevisiae. Remarkably, Pex3 (an integral membrane protein) could first be observed in the endoplasmic reticulum (ER), where it concentrates in foci that then bud off in a Pex19-dependent manner and mature into fully functional peroxisomes. Pex19 (a farnesylated, mostly cytosolic protein) enriches first at the Pex3 foci on the ER and then on the maturing peroxisomes. This trafficking route of Pex3-YFP is the same in wild-type cells. These results demonstrate that peroxisomes are generated from domains in the ER.	Univ Utrecht, Dept Cellular Prot Chem, NL-3548 CH Utrecht, Netherlands; Univ Basel, Bioctr, Lehrstuhl Angewandte Mikrobiol, CH-4056 Basel, Switzerland; Univ Utrecht, Med Ctr, Cell Biol Lab, NL-3584 CX Utrecht, Netherlands; Univ Utrecht, Acad Biomed Ctr, NL-3548 CL Utrecht, Netherlands	Utrecht University; University of Basel; Utrecht University; Utrecht University	Tabak, HF (corresponding author), Univ Utrecht, Dept Cellular Prot Chem, Padualaan 8, NL-3548 CH Utrecht, Netherlands.	h.f.tabak@chem.uu.nl		Braakman, Ineke/0000-0003-1592-4364				Alberts B., 2002, MOL BIOL CELL; Bascom RA, 2003, MOL BIOL CELL, V14, P939, DOI 10.1091/mbc.E02-10-0633; Borgese N, 2003, J CELL BIOL, V161, P1013, DOI 10.1083/jcb.200303069; Daum G, 1997, PROG LIPID RES, V36, P103, DOI 10.1016/S0163-7827(97)00006-4; deDuve C, 1996, SCI AM, V274, P50, DOI 10.1038/scientificamerican0496-50; ERDMANN R, 1989, P NATL ACAD SCI USA, V86, P5419, DOI 10.1073/pnas.86.14.5419; Fang Y, 2004, J CELL BIOL, V164, P863, DOI 10.1083/jcb.200311131; Fehrenbacher KL, 2002, MOL BIOL CELL, V13, P854, DOI 10.1091/mbc.01-04-0184; FELDHEIM D, 1992, MOL CELL BIOL, V12, P3288, DOI 10.1128/MCB.12.7.3288; Geuze HJ, 2003, MOL BIOL CELL, V14, P2900, DOI 10.1091/mbc.E02-11-0734; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Gotte K, 1998, MOL CELL BIOL, V18, P616; Hettema EH, 2000, EMBO J, V19, P223, DOI 10.1093/emboj/19.2.223; Hettema EH, 1998, J CELL BIOL, V142, P421, DOI 10.1083/jcb.142.2.421; Hoepfner D, 2001, J CELL BIOL, V155, P979, DOI 10.1083/jcb.200107028; HOHFELD J, 1991, J CELL BIOL, V114, P1167, DOI 10.1083/jcb.114.6.1167; HUXLEY C, 1990, TRENDS GENET, V6, P236, DOI 10.1016/0168-9525(90)90190-H; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jones SC, 2004, HEALTH EDUC RES, V19, P1, DOI 10.1093/her/cyg002; Kikuchi M, 2004, J BIOL CHEM, V279, P421, DOI 10.1074/jbc.M305623200; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; Lazarow PB, 2003, CURR OPIN CELL BIOL, V15, P489, DOI 10.1016/S0955-0674(03)00082-6; Lisenbee CS, 2003, TRAFFIC, V4, P491, DOI 10.1034/j.1600-0854.2003.00107.x; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Marelli M, 2004, J CELL BIOL, V167, P1099, DOI 10.1083/jcb.200404119; Monosov EZ, 1996, J HISTOCHEM CYTOCHEM, V44, P581, DOI 10.1177/44.6.8666743; NOVIKOFF PM, 1972, J CELL BIOL, V53, P532, DOI 10.1083/jcb.53.2.532; Nunnari J, 1996, CELL, V84, P389, DOI 10.1016/S0092-8674(00)81283-0; Otte S, 2001, J CELL BIOL, V152, P503, DOI 10.1083/jcb.152.3.503; Phillips GN, 1997, CURR OPIN STRUC BIOL, V7, P821, DOI 10.1016/S0959-440X(97)80153-4; Roberg KJ, 1997, J CELL BIOL, V137, P1469, DOI 10.1083/jcb.137.7.1469; Rottensteiner H, 2004, MOL BIOL CELL, V15, P3406, DOI 10.1091/mbc.E04-03-0188; Sacksteder KA, 2000, J CELL BIOL, V148, P931, DOI 10.1083/jcb.148.5.931; Schliebs W, 2004, CURR BIOL, V14, pR397, DOI 10.1016/j.cub.2004.05.017; Snyder WB, 2000, J CELL BIOL, V149, P1171, DOI 10.1083/jcb.149.6.1171; South ST, 2001, P NATL ACAD SCI USA, V98, P12027, DOI 10.1073/pnas.221289498; Subramani S, 1998, PHYSIOL REV, V78, P171, DOI 10.1152/physrev.1998.78.1.171; Tabak HF, 2003, TRAFFIC, V4, P512, DOI 10.1034/j.1600-0854.2003.00110.x; Titorenko VI, 1997, MOL CELL BIOL, V17, P5210, DOI 10.1128/MCB.17.9.5210; VANDENBOSCH H, 1992, ANNU REV BIOCHEM, V61, P157, DOI 10.1146/annurev.bi.61.070192.001105; Voelker DR, 2000, BBA-MOL CELL BIOL L, V1486, P97, DOI 10.1016/S1388-1981(00)00051-2; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Warren G, 1996, CELL, V84, P395, DOI 10.1016/S0092-8674(00)81284-2; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	45	354	361	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 15	2005	122	1					85	95		10.1016/j.cell.2005.04.025	http://dx.doi.org/10.1016/j.cell.2005.04.025			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	950EC	16009135	Green Published, Bronze			2022-12-01	WOS:000230839400013
J	Sergio, F; Newton, I; Marchesi, L				Sergio, F; Newton, I; Marchesi, L			Top predators and biodiversity	NATURE			English	Editorial Material							CONSERVATION		CSIC, Estac Biol Donana, Dept Conservat Biol, Seville 41013, Spain; Trento Museum Nat Sci, Raptor Conservat Res Unit, I-38100 Trento, Italy; Ctr Ecol & Hydrol, Huntingdon PE28 2LS, Cambs, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); UK Centre for Ecology & Hydrology (UKCEH)	Sergio, F (corresponding author), CSIC, Estac Biol Donana, Dept Conservat Biol, Seville 41013, Spain.	fsergio@ebd.csic.es	Sergio, Fabrizio/B-3952-2015; Newton, Ian/AAV-5830-2021	Sergio, Fabrizio/0000-0002-8024-1773; Newton, Ian/0000-0002-7757-4008				Andelman SJ, 2000, P NATL ACAD SCI USA, V97, P5954, DOI 10.1073/pnas.100126797; [Anonymous], 2001, CARNIVORE CONSERVATI; Carroll C, 2001, ECOL APPL, V11, P961, DOI 10.1890/1051-0761(2001)011[0961:CAFSFC]2.0.CO;2; Entwistle A, 2000, PRIORITIES CONSERVAT; JEGGINS MD, 2000, LANDSCAPE ECOL, V15, P5; Kerr JT, 1997, CONSERV BIOL, V11, P1094, DOI 10.1046/j.1523-1739.1997.96089.x; MURPHY DD, 1992, ECOL APPL, V2, P3, DOI 10.2307/1941885; White PCL, 1997, BIOL CONSERV, V82, P345, DOI 10.1016/S0006-3207(97)00036-0	8	203	226	4	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 14	2005	436	7048					192	192		10.1038/436192a	http://dx.doi.org/10.1038/436192a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944VR	16015318	Bronze, Green Submitted			2022-12-01	WOS:000230459500027
J	Caine, A; Maltby, AE; Parkin, CA; Waters, JJ; Crolla, JA				Caine, A; Maltby, AE; Parkin, CA; Waters, JJ; Crolla, JA		UK ACC	Prenatal detection of Down's syndrome by rapid aneuploidy testing for chromosomes 13,18, and 21 by FISH or PCR without a full karyotype: a cytogenetic risk assessment	LANCET			English	Article							IN-SITU HYBRIDIZATION; FETAL NUCHAL-TRANSLUCENCY; QF-PCR; DIAGNOSIS; EXPERIENCE; ULTRASOUND; TRISOMY; PROBES; 1ST	Background In 2004, the UK National Screening Committee (UKNSC) recommended that new screening programmes for Down's syndrome need not include karyotyping and can offer prenatal diagnosis for the syndrome with FISH (fluorescence in-situ hybridisation) or PCR as rapid diagnostic tests. The UKNSC also recommended that FISH or PCR tests should only include trisomies 13, 18, and 21. We undertook a retrospective cytogenetic audit to assess the probable clinical effect of these proposed policy changes. Methods 23 prenatal cytogenetic laboratories from the UK public sector submitted data for amniotic fluid or chorionic villus samples referred from April, 1999, to March, 2004. We obtained data for the details of all abnormal karyotypes by reason for referral and assessed the efficiency of FISH and PCR rapid tests for the detection of chromosome abnormalities. Findings Of 119 528 amniotic fluid and 23 077 chorionic villus samples, rapid aneuploidy testing replacement of karyotyping would have resulted in about one in 100 and one in 40 samples having an undetected abnormal karyotype, respectively. Of these missed results, 293 (30%) of 1006 amniotic fluid samples and 152 (45%) of 327 chorionic villus samples were associated with a substantial risk of an abnormal phenotypic outcome. Of 34 995 amniotic fluid and 3049 chorionic villus samples that had karyotyping and a rapid test on the same sample, none of the three technologies was completely reliable to detect an abnormal karyotype, but the best protocol for an interpretable result was PCR and karyotyping or FISH and karyotyping. Interpretation Replacement of full karyotyping with rapid testing for trisomies 13, 18, and 21 after a positive screen for Down's syndrome will result in substantial numbers of liveborn children with hitherto preventable mental or physical handicaps, and represents a substantial change in the outcome quality of prenatal testing offered to couples in the UK.	Salisbury Dist Hosp, Wessex Reg Genet Lab, Salisbury SP2 8BJ, Wilts, England; St James Univ Hosp, Reg Cytogenet Unit, Leeds LS9 7TF, W Yorkshire, England; Sheffield Childrens NHS Trust, Sheffield, S Yorkshire, England; City Hosp Nottingham, Ctr Med Genet, Nottingham, England; Great Ormond St Hosp Children, NE London Reg Cytogenet Lab, London WC1N 3JH, England	Salisbury District Hospital; Saint James's University Hospital; Sheffield Children's NHS Foundation Trust; Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Crolla, JA (corresponding author), Salisbury Dist Hosp, Wessex Reg Genet Lab, Salisbury SP2 8BJ, Wilts, England.	john.crolla@salisbury.nhs.uk						Cirigliano V, 2004, MOL HUM REPROD, V10, P839, DOI 10.1093/molehr/gah108; Evans MI, 1999, HUM REPROD, V14, P1213, DOI 10.1093/humrep/14.5.1213; Grimshaw G M, 2003, Health Technol Assess, V7, P1; HADDOW JE, 1992, NEW ENGL J MED, V327, P588, DOI 10.1056/NEJM199208273270902; HASSOLD T, 1993, CURR OPIN GENET DEV, V3, P398, DOI 10.1016/0959-437X(93)90111-2; Hulten MA, 2003, REPRODUCTION, V126, P279, DOI 10.1530/reprod/126.3.279; KALOUSEK DK, 1987, HUM GENET, V77, P163, DOI 10.1007/BF00272385; Levett LJ, 2001, ULTRASOUND OBST GYN, V17, P115, DOI 10.1046/j.1469-0705.2001.00340.x; Lewin P, 2000, PRENATAL DIAG, V20, P1; Mann K, 2004, EUR J HUM GENET, V12, P907, DOI 10.1038/sj.ejhg.5201224; NICOLAIDES KH, 1992, BRIT MED J, V304, P867, DOI 10.1136/bmj.304.6831.867; Snijders RJM, 1998, LANCET, V352, P343, DOI 10.1016/S0140-6736(97)11280-6; Spencer K, 2003, BJOG-INT J OBSTET GY, V110, P281, DOI 10.1016/S1470-0328(03)02946-X; Thein ATA, 2000, PRENATAL DIAG, V20, P275, DOI 10.1002/(SICI)1097-0223(200004)20:4<275::AID-PD799>3.0.CO;2-Z; Thilaganathan B, 2000, BRIT J OBSTET GYNAEC, V107, P262, DOI 10.1111/j.1471-0528.2000.tb11698.x; United Kingdom Department of Health, 2003, OUR INH OUR FUT REAL; Verma L, 1998, LANCET, V352, P9, DOI 10.1016/S0140-6736(97)11090-X; Wald N J, 1997, J Med Screen, V4, P181; Wald NJ, 1999, NEW ENGL J MED, V341, P461, DOI 10.1056/NEJM199908123410701; WARBURTON D, 1991, AM J HUM GENET, V49, P995; WARD BE, 1993, AM J HUM GENET, V52, P854; WATSON MS, 2000, GENET MED, V2, P356	22	89	122	0	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 9	2005	366	9480					123	128		10.1016/S0140-6736(05)66790-6	http://dx.doi.org/10.1016/S0140-6736(05)66790-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	943JH	16005334				2022-12-01	WOS:000230349200030
J	Dezawa, M; Ishikawa, H; Itokazu, Y; Yoshihara, T; Hoshino, M; Takeda, S; Ide, C; Nabeshima, Y				Dezawa, M; Ishikawa, H; Itokazu, Y; Yoshihara, T; Hoshino, M; Takeda, S; Ide, C; Nabeshima, Y			Bone marrow stromal cells generate muscle cells and repair muscle degeneration	SCIENCE			English	Article							STEM-CELLS; MYOGENIC SPECIFICATION; REGULATORY GENE; EXPRESSION; DIFFERENTIATION; REGENERATION; QUIESCENT	Bone marrow stromal cells (MSCs) have great potential as therapeutic agents. We report a method for inducing skeletal muscle lineage cells from human and rat general adherent MSCs with an efficiency of 89%. Induced cells differentiated into muscle fibers upon transplantation into degenerated muscles of rats and mdx-nude mice. The induced population contained Pax7-positive cells that contributed to subsequent regeneration of muscle upon repetitive damage without additional transplantation of cells. These MSCs represent a more ready supply of myogenic cells than do the rare myogenic stem cells normally found in muscle and bone marrow.	Kyoto Univ, Grad Sch Med, Dept Anat & Neurobiol, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Sakyo Ku, Kyoto 6068501, Japan; Natl Ctr Neurol & Psychiat, Dept Mol Therapy, Tokyo 1878502, Japan	Kyoto University; Kyoto University; National Center for Neurology & Psychiatry - Japan	Dezawa, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Anat & Neurobiol, Sakyo Ku, Kyoto 6068501, Japan.	dezawa@anat2.med.kyoto-u.ac.jp	谭, 德华 德/D-1910-2009	Ishikawa, Hiroto/0000-0003-0760-7203				Andres V, 1996, J CELL BIOL, V132, P657, DOI 10.1083/jcb.132.4.657; Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Bischoff R., 1994, MYOLOGY, VVolume 1, P97; BOBER E, 1991, J CELL BIOL, V113, P1255, DOI 10.1083/jcb.113.6.1255; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; Dezawa M, 2004, J CLIN INVEST, V113, P1701, DOI 10.1172/JCI200420935; DEZAWA M, UNPUB; Dreyfus PA, 2004, AM J PATHOL, V164, P773, DOI 10.1016/S0002-9440(10)63165-3; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Fukada S, 2002, J CELL SCI, V115, P1285; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; Qu Z, 2000, GENE THER, V7, P428, DOI 10.1038/sj.gt.3301103; ROHWEDEL J, 1994, DEV BIOL, V164, P87, DOI 10.1006/dbio.1994.1182; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Suva D, 2004, J CELL PHYSIOL, V198, P110, DOI 10.1002/jcp.10396; Torrente Y, 2003, J CELL BIOL, V162, P511, DOI 10.1083/jcb.200210006; Wada MR, 2002, DEVELOPMENT, V129, P2987; Yoshida N, 1998, J CELL SCI, V111, P769	21	458	525	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2005	309	5732					314	317		10.1126/science.1110364	http://dx.doi.org/10.1126/science.1110364			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944SP	16002622				2022-12-01	WOS:000230449800050
J	Kawaoka, Y				Kawaoka, Y			Clinical implications of basic research: How ebola virus infects cells	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Tokyo, Int Res Ctr Infect Dis, Tokyo, Japan; Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol, Tokyo, Japan; Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA	University of Tokyo; University of Tokyo; University of Wisconsin System; University of Wisconsin Madison	Kawaoka, Y (corresponding author), Univ Tokyo, Int Res Ctr Infect Dis, Tokyo, Japan.							CHANDRAN K, IN PRESS SCIENCE; DOMS RW, 1985, J BIOL CHEM, V260, P2973; Geisbert TW, 2003, LANCET, V362, P1953, DOI 10.1016/S0140-6736(03)15012-X; Jones PLS, 1998, J BIOL CHEM, V273, P404, DOI 10.1074/jbc.273.1.404; Sullivan NJ, 2003, NATURE, V424, P681, DOI 10.1038/nature01876	5	16	21	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 23	2005	352	25					2645	2646		10.1056/NEJMcibr051754	http://dx.doi.org/10.1056/NEJMcibr051754			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	937VJ	15972874				2022-12-01	WOS:000229953700016
J	Lee, CS; Friedman, JR; Fulmer, JT; Kaestner, KH				Lee, CS; Friedman, JR; Fulmer, JT; Kaestner, KH			The initiation of liver development is dependent on Foxa transcription factors	NATURE			English	Article							GUT ENDODERM; GLUCOSE-HOMEOSTASIS; GENE; DIFFERENTIATION; CHROMATIN; HNF3; ORGANOGENESIS; NUCLEOSOME; EXPRESSION; HNF-3-BETA	The specification of the vertebrate liver is thought to occur in a two-step process, beginning with the establishment of competence within the foregut endoderm for responding to organ-specific signals, followed by the induction of liver-specific genes. On the basis of expression and in vitro studies, it has been proposed that the Foxa transcription factors establish competence by opening compacted chromatin structures within liver-specific target genes(1). Here we show that Foxa1 and Foxa2 (forkhead box proteins A1 and A2) are required in concert for hepatic specification in mouse. In embryos deficient for both genes in the foregut endoderm, no liver bud is evident and expression of the hepato-blast marker alpha-fetoprotein (Afp) is lost. Furthermore, Foxa1/Foxa2-deficient endoderm cultured in the presence of exogenous fibroblast growth factor 2 (FGF2) fails to initiate expression of the liver markers albumin and transthyretin. Thus, Foxa1 and Foxa2 are required for the establishment of competence within the foregut endoderm and the onset of hepatogenesis.	Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Kaestner, KH (corresponding author), Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA.	kaestner@mail.med.upenn.edu	Friedman, Joshua/Q-9367-2019	Friedman, Joshua/0000-0001-9382-8429				ANG SL, 1994, CELL, V78, P561, DOI 10.1016/0092-8674(94)90522-3; Barbera JPM, 2000, DEVELOPMENT, V127, P2433; Bort R, 2004, DEVELOPMENT, V131, P797, DOI 10.1242/dev.00965; Bossard P, 2000, DEVELOPMENT, V127, P4915; Bossard P, 1998, DEVELOPMENT, V125, P4909; Cirillo LA, 1999, MOL CELL, V4, P961, DOI 10.1016/S1097-2765(00)80225-7; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Cirillo LA, 1998, EMBO J, V17, P244, DOI 10.1093/emboj/17.1.244; Clotman F, 2002, DEVELOPMENT, V129, P1819; Coffinier C, 2002, DEVELOPMENT, V129, P1829; COSTA RH, 1989, MOL CELL BIOL, V9, P1415, DOI 10.1128/MCB.9.4.1415; Crowe AJ, 1999, J BIOL CHEM, V274, P25113, DOI 10.1074/jbc.274.35.25113; Deutsch G, 2001, DEVELOPMENT, V128, P871; Gualdi R, 1996, GENE DEV, V10, P1670, DOI 10.1101/gad.10.13.1670; Holmqvist PH, 2005, EXP CELL RES, V304, P593, DOI 10.1016/j.yexcr.2004.12.002; Jung JN, 1999, SCIENCE, V284, P1998, DOI 10.1126/science.284.5422.1998; Kaestner KH, 2000, TRENDS ENDOCRIN MET, V11, P281, DOI 10.1016/S1043-2760(00)00271-X; Kaestner KH, 1999, GENE DEV, V13, P495, DOI 10.1101/gad.13.4.495; Keng VW, 2000, BIOCHEM BIOPH RES CO, V276, P1155, DOI 10.1006/bbrc.2000.3548; LAI E, 1990, GENE DEV, V4, P1427, DOI 10.1101/gad.4.8.1427; LAI E, 1991, GENE DEV, V5, P416, DOI 10.1101/gad.5.3.416; Lee CS, 2005, DEV BIOL, V278, P484, DOI 10.1016/j.ydbio.2004.10.012; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Shen W, 2001, J BIOL CHEM, V276, P42812, DOI 10.1074/jbc.M106344200; WEINSTEIN DC, 1994, CELL, V78, P575, DOI 10.1016/0092-8674(94)90523-1; Wilkinson DG, 1992, SITU HYBRIDIZATION P; Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837	27	413	432	2	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2005	435	7044					944	947		10.1038/nature03649	http://dx.doi.org/10.1038/nature03649			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935RN	15959514				2022-12-01	WOS:000229799700047
J	Hammock, EAD; Young, LJ				Hammock, EAD; Young, LJ			Microsatellite instability generates diversity in brain and sociobehavioral traits	SCIENCE			English	Article							PAIR-BOND FORMATION; PRAIRIE VOLES; MICROTUS-OCHROGASTER; SOCIAL RECOGNITION; ARGININE-VASOPRESSIN; PARTNER PREFERENCE; OLFACTORY-BULB; MATING SYSTEM; RECEPTOR; PATTERNS	Repetitive microsatellites mutate at relatively high rates and may contribute to the rapid evolution of species-typical traits. We show that individual alleles of a repetitive polymorphic microsatellite in the 5' region of the prairie vole vasopressin 1a receptor (avpr1a) gene modify gene expression in vitro. In vivo, we observe that this regulatory polymorphism predicts both individual differences in receptor distribution patterns and socio-behavioral traits. These data suggest that individual differences in gene expression patterns may be conferred via polymorphic microsatellites in the cis-regulatory regions of genes and may contribute to normal variation in behavioral traits.	Emory Univ, Yerkes Natl Primate Res Ctr, Ctr Behav Neurosci, Dept Psychiat & Behav Sci, Atlanta, GA 30329 USA	Emory University	Young, LJ (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, Ctr Behav Neurosci, Dept Psychiat & Behav Sci, Atlanta, GA 30329 USA.	Edunn2@emory.edu; Lyoun03@emory.edu	Hammock, Elizabeth/G-1897-2011		NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH056897, F31MH067397, K02MH064692, R01MH056897] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00165] Funding Source: Medline; NIMH NIH HHS [MH67397, MH56897, MH64692] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bielsky IF, 2004, PEPTIDES, V25, P1565, DOI 10.1016/j.peptides.2004.05.019; Bielsky IF, 2004, NEUROPSYCHOPHARMACOL, V29, P483, DOI 10.1038/sj.npp.1300360; DEWAAL FBM, 1988, BEHAVIOUR, V106, P183, DOI 10.1163/156853988X00269; Dluzen DE, 1998, PEPTIDES, V19, P999, DOI 10.1016/S0196-9781(98)00047-3; ENGELMANN M, 1994, PHYSIOL BEHAV, V55, P145, DOI 10.1016/0031-9384(94)90022-1; Fondon JW, 2004, P NATL ACAD SCI USA, V101, P18058, DOI 10.1073/pnas.0408118101; Francis D, 1999, SCIENCE, V286, P1155, DOI 10.1126/science.286.5442.1155; *GENBANK, NW114825 GENBANK; *GENBANK, AF208541 GENBANK; GETZ LL, 1981, BEHAV ECOL SOCIOBIOL, V8, P189, DOI 10.1007/BF00299829; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; HAMMOCK E, IN PRESS GENES BRAIN; Hammock EAD, 2004, MOL BIOL EVOL, V21, P1057, DOI 10.1093/molbev/msh104; Hammock EAD, 2002, EUR J NEUROSCI, V16, P399, DOI 10.1046/j.1460-9568.2002.02083.x; INSEL TR, 1994, J NEUROSCI, V14, P5381; JANNETT FJ, 1982, J MAMMAL, V63, P495, DOI 10.2307/1380450; Kashi Y, 1997, TRENDS GENET, V13, P74, DOI 10.1016/S0168-9525(97)01008-1; Kim SJ, 2002, MOL PSYCHIATR, V7, P503, DOI 10.1038/sj.mp.4001125; KING DG, 1994, SCIENCE, V263, P595, DOI 10.1126/science.263.5147.595-b; KIRKPATRICK B, 1994, PHYSIOL BEHAV, V55, P885, DOI 10.1016/0031-9384(94)90075-2; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Lim MM, 2004, NATURE, V429, P754, DOI 10.1038/nature02539; Lim MM, 2004, NEUROSCIENCE, V125, P35, DOI 10.1016/j.neuroscience.2003.12.008; Liu Y, 2001, BEHAV NEUROSCI, V115, P910, DOI 10.1037//0735-7044.115.4.910; Phelps SM, 2003, J COMP NEUROL, V466, P564, DOI 10.1002/cne.10902; Pitkow LJ, 2001, J NEUROSCI, V21, P7392, DOI 10.1523/JNEUROSCI.21-18-07392.2001; Roberts RL, 1998, ANIM BEHAV, V55, P1131, DOI 10.1006/anbe.1997.0659; SHAPIRO LE, 1990, J COMP PSYCHOL, V104, P268, DOI 10.1037/0735-7036.104.3.268; Thibonnier M, 2000, J MOL CELL CARDIOL, V32, P557, DOI 10.1006/jmcc.2000.1108; THOMAS JA, 1979, BEHAV ECOL SOCIOBIOL, V5, P171, DOI 10.1007/BF00293304; WANG ZX, 1994, P NATL ACAD SCI USA, V91, P400, DOI 10.1073/pnas.91.1.400; Wassink TH, 2004, MOL PSYCHIATR, V9, P968, DOI 10.1038/sj.mp.4001503; WILLIAMS JR, 1992, PHYSIOL BEHAV, V52, P635, DOI 10.1016/0031-9384(92)90390-N; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; Young LJ, 1999, NATURE, V400, P766, DOI 10.1038/23475; Young LJ, 1997, BEHAV NEUROSCI, V111, P599, DOI 10.1037/0735-7044.111.3.599; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	38	385	396	1	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2005	308	5728					1630	1634		10.1126/science.1111427	http://dx.doi.org/10.1126/science.1111427			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	936BH	15947188				2022-12-01	WOS:000229827000058
J	Huang, JB; Wu, S; Barrera, J; Matthews, K; Pan, DJ				Huang, JB; Wu, S; Barrera, J; Matthews, K; Pan, DJ			The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP	CELL			English	Article							YES-ASSOCIATED PROTEIN; MYOTONIC-DYSTROPHY KINASE; TUMOR-SUPPRESSOR; PROMOTES APOPTOSIS; CYCLE EXIT; GROWTH; SALVADOR; ENCODES; FAMILY; DOMAIN	Coordination between cell proliferation and cell death is essential to maintain homeostasis in multicellular organisms. In Drosophila, these two processes are regulated by a pathway involving the Ste20-like kinase Hippo (Hpo) and the NDR family kinase Warts (Wts; also called Lats). Hpo phosphorylates and activates Wts, which in turn, through unknown mechanisms, negatively regulates the transcription of cell-cycle and cell-death regulators such as cycE and diap1. Here we identify Yorkie (Yki), the Drosophila ortholog of the mammalian transcriptional coactivator yes-associated protein (YAP), as a missing link between Wts and transcriptional regulation. Yki is required for normal tissue growth and diapl transcription and is phosphorylated and inactivated by Wts. Overexpression of yki phenocopies loss-of-function mutations of hpo or wts, including elevated transcription of cycE and diapl, increased proliferation, defective apoptosis, and tissue overgrowth. Thus, Yki Is a critical target of the Wts/Lats protein kinase and a potential oncogene.	Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Pan, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	djpan@jhmi.edu		Wu, Shian/0000-0003-4990-6594				Aronheim A, 1997, MOL CELL BIOL, V17, P3094, DOI 10.1128/MCB.17.6.3094; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Guertin DA, 2000, EMBO J, V19, P1803, DOI 10.1093/emboj/19.8.1803; Hafen E, 2003, CURR TOP MICROBIOL, V279, P153; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Hay BA, 2003, DEV CELL, V5, P361, DOI 10.1016/S1534-5807(03)00270-3; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; Hipfner DR, 2004, NAT REV MOL CELL BIO, V5, P805, DOI 10.1038/nrm1491; Hirota T, 2000, J CELL BIOL, V149, P1073, DOI 10.1083/jcb.149.5.1073; Jia JH, 2003, GENE DEV, V17, P2514, DOI 10.1101/gad.1134003; Jones L, 2000, DEVELOPMENT, V127, P4619; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kango-Singh M, 2002, DEVELOPMENT, V129, P5719, DOI 10.1242/dev.00168; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; Mah AS, 2001, P NATL ACAD SCI USA, V98, P7325, DOI 10.1073/pnas.141098998; Newsome TP, 2000, DEVELOPMENT, V127, P851; Pan DJ, 2004, TRENDS CELL BIOL, V14, P78, DOI 10.1016/j.tcb.2003.12.006; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Pignoni F, 1997, DEVELOPMENT, V124, P271; Ryoo HD, 2003, NAT CELL BIOL, V5, P853, DOI 10.1038/ncb1003-853; St John MAR, 1999, NAT GENET, V21, P182, DOI 10.1038/5965; Strano S, 2001, J BIOL CHEM, V276, P15164, DOI 10.1074/jbc.M010484200; SUDOL M, 1994, ONCOGENE, V9, P2145; Tamaskovic R, 2003, FEBS LETT, V546, P73, DOI 10.1016/S0014-5793(03)00474-5; Tao WF, 1999, NAT GENET, V21, P177, DOI 10.1038/5960; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Verde F, 1998, P NATL ACAD SCI USA, V95, P7526, DOI 10.1073/pnas.95.13.7526; Wolff Tanya, 1993, P1277; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; XU TA, 1995, DEVELOPMENT, V121, P1053; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Yang XL, 2004, NAT CELL BIOL, V6, P609, DOI 10.1038/ncb1140	39	1287	1339	6	139	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 12	2005	122	3					421	434		10.1016/j.cell.2005.06.007	http://dx.doi.org/10.1016/j.cell.2005.06.007			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	955UZ	16096061	Bronze			2022-12-01	WOS:000231254400013
J	Kritchevsky, SB; Nicklas, BJ; Visser, M; Simonsick, EM; Newman, AB; Harris, TB; Lange, EM; Penninx, BW; Goodpaster, BH; Satterfield, S; Colbert, LH; Rubin, SM; Pahor, M				Kritchevsky, SB; Nicklas, BJ; Visser, M; Simonsick, EM; Newman, AB; Harris, TB; Lange, EM; Penninx, BW; Goodpaster, BH; Satterfield, S; Colbert, LH; Rubin, SM; Pahor, M			Angiotensin-converting enzyme insertion/deletion genotype, exercise, and physical decline	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN SKELETAL-MUSCLE; ACE GENE; OLDER PERSONS; DELETION POLYMORPHISM; I/D POLYMORPHISM; BODY-COMPOSITION; BLOOD-PRESSURE; I ALLELE; PERFORMANCE; STRENGTH	Context Physical performance in response to exercise appears to be influenced by the angiotensin-converting enzyme (ACE) insertion (I)/deletion (D) genotype in young adults, but whether this relationship could help explain variation in older individuals' response to exercise has not been well studied. Objective To determine whether the ACE genotype interacts with significant physical activity to affect the incidence of mobility limitation in well-functioning older adults. Design, Setting, and Participants The Health Aging and Body Composition (Health ABC) Cohort Study, conducted in the metropolitan areas of Memphis, Tenn, and Pittsburgh, Pa. A total of 3075 well-functioning community-dwelling adults aged 70 through 79 years were enrolled from 1997 to 1998 and had a mean of 4.1 years of follow-up. Main Outcome Measure Incident mobility limitation defined as the report of difficulty walking a quarter of a mile (0.4 km) or walking up 10 steps on 2 consecutive semiannual interviews (n=1204). Results Physically active participants (those reporting expending >= 1000 kcal/wk in exercise, walking, and stair climbing) were less likely to develop mobility limitation regardless of genotype. However, activity level interacted significantly with the ACE genotype (P=.002). In the inactive group, the ACE genotype was not associated with limitation (P=.46). In the active group, those with the II genotype were more likely to develop mobility limitation after adjusting for potential confounders compared with those with ID/DD genotypes (adjusted rate ratio, 1.45, 95% confidence interval, 1.08-1.94). The gene association was especially strong among participants reporting weightlifting. Exploration of possible physiological correlates revealed that among active participants, those with the II genotype had higher percentage of body fat (P=.02) and more intermuscular thigh fat (P=.02) but had similar quadriceps strength as those with ID/DD. Conclusions Among older individuals who exercised, those with the ACE DD or ID genotypes were less likely to develop mobility limitation than those with the II genotype. Regardless of genotype, individuals who exercised were less likely to develop mobility limitation than those who did not exercise.	Wake Forest Univ, Bowman Gray Sch Med,Sticht Ctr Aging, Dept Internal Med, Sect Gerontol & Geriatr Med, Winston Salem, NC 27157 USA; Wake Forest Univ, Bowman Gray Sch Med, Ctr Human Genom, Dept Internal Med, Winston Salem, NC 27157 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Publ Hlth Sci, Winston Salem, NC 27157 USA; Vrije Univ Amsterdam, Dept Psychiat, Amsterdam, Netherlands; Vrije Univ Amsterdam, Inst Hlth Sci, Amsterdam, Netherlands; NIA, Gerontol Res Ctr, Baltimore, MD 21224 USA; Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; NIA, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; Univ Tennessee, Dept Prevent Med, Memphis, TN USA; Univ Wisconsin, Dept Kinesiol, Madison, WI USA; Univ Calif San Francisco, Prevent Sci Grp, San Francisco, CA 94143 USA; Univ Florida, Dept Aging & Geriatr Res, Gainesville, FL USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Tennessee System; University of Tennessee Health Science Center; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California San Francisco; State University System of Florida; University of Florida	Kritchevsky, SB (corresponding author), Wake Forest Univ, Bowman Gray Sch Med,Sticht Ctr Aging, Dept Internal Med, Sect Gerontol & Geriatr Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.	skritche@wfubmc.edu	Visser, Marjolein/AAP-3224-2020; Simonsick, Eleanor/W-6864-2019; Nicklas, Barbara/AAA-2781-2020; Newman, Anne B./C-6408-2013; Penninx, Brenda WJH/S-7627-2017	Newman, Anne B./0000-0002-0106-1150; Penninx, Brenda WJH/0000-0001-7779-9672; Visser, Marjolein/0000-0002-5136-298X; Kritchevsky, Stephen/0000-0003-3336-6781	NIA NIH HHS [N01-AG-6-2106, N01-AG-6-2103, N01-AG-6-2101, P30 AG-021332, R01 AG-18702] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [N01AG062103, P30AG021332, R01AG018702, N01AG062101, Z01AG007390, N01AG062106] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ades PA, 1996, ANN INTERN MED, V124, P568, DOI 10.7326/0003-4819-124-6-199603150-00005; AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; An P, 2003, INT J SPORTS MED, V24, P492; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Bean JF, 2003, J GERONTOL A-BIOL, V58, P728; Blais C, 1999, J APPL PHYSIOL, V87, P1197, DOI 10.1152/jappl.1999.87.3.1197; Boppart MD, 1999, J APPL PHYSIOL, V87, P1668, DOI 10.1152/jappl.1999.87.5.1668; Bouchard C, 2001, MED SCI SPORT EXER, V33, pS446, DOI 10.1097/00005768-200106001-00013; Broadwin J, 2001, J AM GERIATR SOC, V49, P1641, DOI 10.1046/j.1532-5415.2001.t01-1-49273.x; Carter CS, 2004, J GERONTOL A-BIOL, V59, P416; Clark DO, 1996, AM J PUBLIC HEALTH, V86, P57, DOI 10.2105/AJPH.86.1.57; Coates D, 2003, INT J BIOCHEM CELL B, V35, P769, DOI 10.1016/S1357-2725(02)00309-6; Cress ME, 1999, J GERONTOL A-BIOL, V54, pM242, DOI 10.1093/gerona/54.5.M242; Di Bari M, 2004, J AM GERIATR SOC, V52, P961, DOI 10.1111/j.1532-5415.2004.52265.x; Ding JZ, 2004, AM J HYPERTENS, V17, P971, DOI 10.1016/j.amjhyper.2004.05.001; Foldvari M, 2000, J GERONTOL A-BIOL, V55, pM192, DOI 10.1093/gerona/55.4.M192; Folland J, 2000, EXP PHYSIOL, V85, P575, DOI 10.1017/S0958067000020571; Frederiksen H, 2003, AGING CLIN EXP RES, V15, P284; Frederiksen H, 2003, SCAND J MED SCI SPOR, V13, P9, DOI 10.1034/j.1600-0838.2003.20219.x; Frederiksen H, 2003, ANN EPIDEMIOL, V13, P57, DOI 10.1016/S1047-2797(02)00254-5; Gayagay G, 1998, HUM GENET, V103, P48, DOI 10.1007/s004390050781; Goodpaster BH, 2004, PEDIATR DIABETES, V5, P219, DOI 10.1111/j.1399-543X.2004.00071.x; Goodpaster BH, 2001, J APPL PHYSIOL, V90, P2157, DOI 10.1152/jappl.2001.90.6.2157; Gordon SE, 2001, AM J PHYSIOL-ENDOC M, V280, pE150, DOI 10.1152/ajpendo.2001.280.1.E150; Hirvensalo M, 2000, J AM GERIATR SOC, V48, P493, DOI 10.1111/j.1532-5415.2000.tb04994.x; Jones A, 2002, EXERC SPORT SCI REV, V30, P184, DOI 10.1097/00003677-200210000-00008; KNOWLER WC, 1988, AM J HUM GENET, V43, P520; Kohlstedt K, 2004, CIRC RES, V94, P60, DOI 10.1161/01.RES.0000107195.13573.E4; LEE IM, 1992, AM J EPIDEMIOL, V135, P915, DOI 10.1093/oxfordjournals.aje.a116387; LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3; Martinez E, 2000, J HUM HYPERTENS, V14, P131, DOI 10.1038/sj.jhh.1000958; MILLER B, 1993, ANAL EPIDEMIOLOGIC S, V27, P41; Montgomery HE, 1997, CIRCULATION, V96, P741; Myerson S, 1999, J APPL PHYSIOL, V87, P1313, DOI 10.1152/jappl.1999.87.4.1313; Myerson SG, 2001, CIRCULATION, V103, P226; Nagi SZ, 1991, DISABILITY AM NATL A, P309, DOI DOI 10.17226/1579; NAKAI K, 1994, CIRCULATION, V90, P2199, DOI 10.1161/01.CIR.90.5.2199; Nazarov IB, 2001, EUR J HUM GENET, V9, P797, DOI 10.1038/sj.ejhg.5200711; Newman AB, 2003, J GERONTOL A-BIOL, V58, P715; Onder G, 2002, LANCET, V359, P926, DOI 10.1016/S0140-6736(02)08024-8; Penninx BWJH, 2001, ARCH INTERN MED, V161, P2309, DOI 10.1001/archinte.161.19.2309; Perusse L, 2003, MED SCI SPORT EXER, V35, P1248, DOI 10.1249/01.MSS.0000078938.84161.22; Rantanen T, 1997, J AM GERIATR SOC, V45, P1439, DOI 10.1111/j.1532-5415.1997.tb03193.x; RENELAND R, 1994, SCAND J CLIN LAB INV, V54, P105, DOI 10.3109/00365519409086516; Resnick HE, 2001, J CLIN EPIDEMIOL, V54, P869, DOI 10.1016/S0895-4356(01)00359-6; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; Singh MAF, 2002, J GERONTOL A-BIOL, V57, pM262, DOI 10.1093/gerona/57.5.M262; STEBBINS CL, 1990, J APPL PHYSIOL, V69, P1225, DOI 10.1152/jappl.1990.69.4.1225; Strazzullo P, 2003, ANN INTERN MED, V138, P17, DOI 10.7326/0003-4819-138-1-200301070-00007; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0; Suehiro T, 2004, HUM GENET, V115, P91, DOI 10.1007/s00439-004-1136-4; Thomis MAI, 1998, MED SCI SPORT EXER, V30, P724, DOI 10.1097/00005768-199805000-00013; van Loon LJC, 2004, J APPL PHYSIOL, V97, P1170, DOI 10.1152/japplphysiol.00368.2004; Visser M, 2005, J GERONTOL A-BIOL, V60, P324, DOI 10.1093/gerona/60.3.324; Visser M, 2005, J AM GERIATR SOC, V53, P762, DOI 10.1111/j.1532-5415.2005.53257.x; Visser M, 1998, J GERONTOL A-BIOL, V53, pM214, DOI 10.1093/gerona/53A.3.M214; Visser M, 2002, J AM GERIATR SOC, V50, P897, DOI 10.1046/j.1532-5415.2002.50217.x; WASHBURN RA, 1991, J CLIN EPIDEMIOL, V44, P1319, DOI 10.1016/0895-4356(91)90093-O; Williams AG, 2000, NATURE, V403, P614, DOI 10.1038/35001141; Wu SC, 1999, J AM GERIATR SOC, V47, P1082, DOI 10.1111/j.1532-5415.1999.tb05231.x; Zamboni M, 1999, J AM GERIATR SOC, V47, P1403, DOI 10.1111/j.1532-5415.1999.tb01557.x; Zhang B, 2003, CLIN GENET, V63, P139, DOI 10.1034/j.1399-0004.2003.00029.x	62	76	77	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 10	2005	294	6					691	698		10.1001/jama.294.6.691	http://dx.doi.org/10.1001/jama.294.6.691			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	953IA	16091571	Bronze			2022-12-01	WOS:000231068600022
J	Stewart, ML; Krishna, S; Burchmore, RJS; Brun, R; de Koning, HP; Boykin, DW; Tidwell, RR; Hall, JE; Barrett, MP				Stewart, ML; Krishna, S; Burchmore, RJS; Brun, R; de Koning, HP; Boykin, DW; Tidwell, RR; Hall, JE; Barrett, MP			Detection of arsenical drug resistance in Trypanosoma brucei with a simple fluorescence test	LANCET			English	Article								The resurgence of human African trypanosomiasis (HAT), coupled with an increased incidence of drug resistance, is of concern. We report a quick, simple, and sensitive test for identification of parasites resistant to melarsoprol, the main drug used to treat late stage HAT. Resistant parasites are defective in a plasma membrane transporter responsible for drug uptake. The same transporter carries the fluorescent diamidine DB99 (2,5-bis-(4-amidinophenyl)-3,4-dimethylfuran) into trypanosomes. The two DNA-containing structures in the trypanosome the nucleus and the kinetoplast-begin to fluoresce within 1 min of introduction of DB99, unless drug resistant.	Univ London St Georges Hosp, Sch Med, Dept Cellular & Mol Med Infect Dis, London SW17 0RE, England; Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA; Univ N Carolina, Sch Pharm, Div Med Chem & Nat Prod, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA; Swiss Trop Inst, CH-4002 Basel, Switzerland	St Georges University London; University System of Georgia; Georgia State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Basel; Swiss Tropical & Public Health Institute	Barrett, MP (corresponding author), Univ Glasgow, Div Infect & Immun, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland.	m.barrett@bio.gla.ac.uk	Burchmore, Richard/A-1896-2011	Krishna, Sanjeev/0000-0003-0066-0634; De Koning, Harry/0000-0002-9963-1827; Barrett, Mike/0000-0001-9447-3519; Burchmore, Richard/0000-0003-1663-9004	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Brun R, 2001, TROP MED INT HEALTH, V6, P906, DOI 10.1046/j.1365-3156.2001.00775.x; CARTER NS, 1993, NATURE, V361, P173, DOI 10.1038/361173a0; Matovu E, 2003, EUKARYOT CELL, V2, P1003, DOI 10.1128/EC.2.5.1003-1008.2003; Scott AG, 1996, ACTA TROP, V60, P251, DOI 10.1016/0001-706X(96)00131-3	5	39	40	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 6	2005	366	9484					486	487		10.1016/S0140-6736(05)66793-1	http://dx.doi.org/10.1016/S0140-6736(05)66793-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	952RD	16084257				2022-12-01	WOS:000231022300030
J	Li, CR; Zhang, XN; Cao, ZX				Li, CR; Zhang, XN; Cao, ZX			Triangular and Fibonacci number patterns driven by stress on core/shell microstructures	SCIENCE			English	Article							THIN-FILMS; SILICON; GROWTH	Fibonacci number patterns and triangular patterns with intrinsic defects occur frequently on nonplanar surfaces in nature, particularly in plants. By controlling the geometry and the stress upon cooling, these patterns can be reproduced on the surface of microstructures about 10 micrometers in diameter. Spherules of the Ag core/SiO(x) shell structure, possessing markedly uniform size and shape, self-assembled into the Fibonacci number patterns (5 by 8 and 13 by 21) or the triangular pattern, depending on the geometry of the primary supporting surface. Under proper geometrical constraints, the patterns developed through self-assembly in order to minimize the total strain energy. This demonstrates that highly ordered microstructures can be prepared simultaneously across large areas by stress engineering.	Chinese Acad Sci, Inst Phys, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Institute of Physics, CAS	Cao, ZX (corresponding author), Chinese Acad Sci, Inst Phys, POB 603, Beijing 100080, Peoples R China.	zxcao@aphy.iphy.ac.cn						Adelung R, 2004, NAT MATER, V3, P375, DOI 10.1038/nmat1128; Adler I, 1997, ANN BOT-LONDON, V80, P231, DOI 10.1006/anbo.1997.0422; Aggarwal S, 2000, SCIENCE, V287, P2235, DOI 10.1126/science.287.5461.2235; Altschuler EL, 1997, PHYS REV LETT, V78, P2681, DOI 10.1103/PhysRevLett.78.2681; Bowden N, 1998, NATURE, V393, P146, DOI 10.1038/30193; Bowick M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.185502; Chen X, 2004, SCRIPTA MATER, V50, P797, DOI 10.1016/j.scriptamat.2003.11.035; Cromwell P.R., 1997, POLYHEDRA; Hanbucken M., 2001, STRESS STRAIN EPITAX; Hill JP, 2004, SCIENCE, V304, P1481, DOI 10.1126/science.1097789; Kaye GWC., 1986, TABLES PHYS CHEM CON, V15th; Lee H, 2001, APPL PHYS LETT, V78, P105, DOI 10.1063/1.1336554; Su PY, 2004, APPL PHYS LETT, V84, P3480, DOI 10.1063/1.1737797; Timoshenko S., 1970, THEORY ELASTIC STABI; Vlasov YA, 2001, NATURE, V414, P289, DOI 10.1038/35104529; Weyl Hermann, 1952, SYMMETRY; Yin YD, 2004, SCIENCE, V304, P711, DOI 10.1126/science.1096566; Zhang XN, 2004, MATER LETT, V58, P1917, DOI 10.1016/j.matlet.2003.11.027	18	89	96	6	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 5	2005	309	5736					909	911		10.1126/science.1113412	http://dx.doi.org/10.1126/science.1113412			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953SS	16081729				2022-12-01	WOS:000231101400038
J	Lee, BC; Kim, MK; Jang, G; Oh, HJ; Yuda, F; Kim, HJ; Shamim, MH; Kim, JJ; Kang, SK; Schatten, G; Hwang, WS				Lee, BC; Kim, MK; Jang, G; Oh, HJ; Yuda, F; Kim, HJ; Shamim, MH; Kim, JJ; Kang, SK; Schatten, G; Hwang, WS			Dogs cloned from adult somatic cells	NATURE			English	Editorial Material							DISEASE		Seoul Natl Univ, Coll Vet Med, Dept Theriogenol & Biotechnol, Seoul 151742, South Korea; Univ Pittsburgh, Sch Med, Magee Womens Res Inst, Pittsburgh Dev Ctr,Dept Obstet Gynecol Reprod Sci, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Magee Womens Res Inst, Pittsburgh Dev Ctr,Dept Cell Biol Physiol, Pittsburgh, PA 15213 USA	Seoul National University (SNU); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute	Lee, BC (corresponding author), Seoul Natl Univ, Coll Vet Med, Dept Theriogenol & Biotechnol, Seoul 151742, South Korea.	hwangws@snu.ac.kr	Fibrianto, Yuda Heru/GOV-3784-2022; Schatten, Gerald/B-3253-2009	Fibrianto, Yuda Heru/0000-0002-5886-6697; Schatten, Gerald/0000-0001-5206-7782				Galli C, 2003, NATURE, V424, P635, DOI 10.1038/424635a; Lohi H, 2005, SCIENCE, V307, P81, DOI 10.1126/science.1102832; Modiano JF, 2005, CANCER RES, V65, P5654, DOI 10.1158/0008-5472.CAN-04-4613; Ostrander EA, 1997, AM J HUM GENET, V61, P475, DOI 10.1086/515522; Shin T, 2002, NATURE, V415, P859, DOI 10.1038/nature723; Sutter NB, 2004, NAT REV GENET, V5, P900, DOI 10.1038/nrg1492; Westhusin ME, 2001, J REP FER S, P287; Woods GL, 2003, SCIENCE, V301, P1063, DOI 10.1126/science.1086743; Zhou Q, 2003, SCIENCE, V302, P1179, DOI 10.1126/science.1088313	9	327	373	1	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2005	436	7051					641	641		10.1038/436641a	http://dx.doi.org/10.1038/436641a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951XA	16079832				2022-12-01	WOS:000230964500029
J	Wang, H; Nussbaum-Wagler, T; Li, BL; Zhao, Q; Vigouroux, Y; Faller, M; Bomblies, K; Lukens, L; Doebley, JF				Wang, H; Nussbaum-Wagler, T; Li, BL; Zhao, Q; Vigouroux, Y; Faller, M; Bomblies, K; Lukens, L; Doebley, JF			The origin of the naked grains of maize	NATURE			English	Article							MOLECULAR EVOLUTION; FRUIT SIZE; GENE; DOMESTICATION; SELECTION; TEOSINTE; LOCUS	The most critical step in maize (Zea mays ssp. mays) domestication was the liberation of the kernel from the hardened, protective casing that envelops the kernel in the maize progenitor, teosinte(1). This evolutionary step exposed the kernel on the surface of the ear, such that it could readily be used by humans as a food source. Here we show that this key event in maize domestication is controlled by a single gene ( teosinte glume architecture or tga1), belonging to the SBP-domain family(2) of transcriptional regulators. The factor controlling the phenotypic difference between maize and teosinte maps to a 1-kilobase region, within which maize and teosinte show only seven fixed differences in their DNA sequences. One of these differences encodes a non-conservative amino acid substitution and may affect protein function, and the other six differences potentially affect gene regulation. Molecular evolution analyses show that this region was the target of selection during maize domestication. Our results demonstrate that modest genetic changes in single genes can induce dramatic changes in phenotype during domestication and evolution.	Univ Wisconsin, Genet Lab, Madison, WI 53706 USA; DuPont Crop Genet, Wilmington, DE 19880 USA; Univ Guelph, Dept Plant Agr, Guelph, ON N1G 2W1, Canada	University of Wisconsin System; University of Wisconsin Madison; DuPont; University of Guelph	Doebley, JF (corresponding author), Univ Wisconsin, Genet Lab, Madison, WI 53706 USA.	jdoebley@wisc.edu	vigouroux, Yves/A-9056-2011	vigouroux, Yves/0000-0002-8361-6040; Bomblies, Kirsten/0000-0002-2434-3863; Lukens, Lewis/0000-0003-3963-2008	NIGMS NIH HHS [R01 GM058816] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058816] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beadle GW, 1939, J HERED, V30, P245, DOI 10.1093/oxfordjournals.jhered.a104728; Clark RM, 2004, P NATL ACAD SCI USA, V101, P700, DOI 10.1073/pnas.2237049100; Cong B, 2002, P NATL ACAD SCI USA, V99, P13606, DOI 10.1073/pnas.172520999; Darwin C., 1859, ORIGIN SPECIES MEANS; Doebley J, 2004, ANNU REV GENET, V38, P37, DOI 10.1146/annurev.genet.38.072902.092425; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; DOEBLEY J, 1993, GENETICS, V134, P559; DORWEILER J, 1993, SCIENCE, V262, P233, DOI 10.1126/science.262.5131.233; Dorweiler JE, 1997, AM J BOT, V84, P1313, DOI 10.2307/2446130; GOTTLIEB LD, 1984, AM NAT, V123, P681, DOI 10.1086/284231; HUDSON RR, 1987, GENETICS, V116, P153; Jackson DP., 1992, MOL PLANT PATHOLOGY, P163; Kim Y, 2002, GENETICS, V160, P765; Klein J, 1996, MOL GEN GENET, V250, P7, DOI 10.1007/s004380050046; LANDE R, 1983, HEREDITY, V50, P47, DOI 10.1038/hdy.1983.6; Mangelsdorf PC, 1938, P NATL ACAD SCI USA, V24, P303, DOI 10.1073/pnas.24.8.303; Nesbitt TC, 2002, GENETICS, V162, P365; Przeworski M, 2003, GENETICS, V164, P1667; Purugganan MD, 2000, GENETICS, V155, P855; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; SMITH JM, 1981, NATURE, V289, P13, DOI 10.1038/289013a0; TAJIMA F, 1989, GENETICS, V123, P585; Tenaillon MI, 2004, MOL BIOL EVOL, V21, P1214, DOI 10.1093/molbev/msh102; White SE, 1999, GENETICS, V153, P1455; WILKES HG, 1967, TEOSINTE CLOSET RELA	25	392	446	4	156	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2005	436	7051					714	719		10.1038/nature03863	http://dx.doi.org/10.1038/nature03863			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951XA	16079849	Green Accepted			2022-12-01	WOS:000230964500047
J	Tolia, NH; Enemark, EJ; Sim, BKL; Joshua-Tor, L				Tolia, NH; Enemark, EJ; Sim, BKL; Joshua-Tor, L			Structural basis for the EBA-175 erythrocyte invasion pathway of the malaria parasite Plasmodium falciparum	CELL			English	Article							BINDING ANTIGEN; MEROZOITE PROTEINS; RECEPTOR; ACID; EXPRESSION; GENES; VIVAX; PROGRAM; SURFACE; FAMILY	Erythrocyte binding antigen 175 (EBA-175) is a P. falciparum protein that binds the major glycoprotein found on human erythrocytes, glycophorin A, during invasion. Here we present the crystal structure of the erythrocyte binding domain of EBA-175, RII, which has been established as a vaccine candidate. Binding sites for the heavily sialylated receptor glycophorin A are proposed based on a complex of RII with a glycan that contains the essential components required for binding. The dimeric organization of RII displays two prominent channels that contain four of the six observed glycan binding sites. Each monomer consists of two Duffy binding-like (DBL) domains (F1 and F2). F2 more prominently lines the channels and makes the majority of the glycan contacts, underscoring its role in cytoadherence and in antigenic variation in malaria. Our studies provide insight into the mechanism of erythrocyte invasion by the malaria parasite and aid in rational drug design and vaccines.	Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; Cold Spring Harbor Lab, Keck Struct Biol Lab, Cold Spring Harbor, NY 11724 USA; Prot Potential, Gaithersburg, MD 20878 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory	Sim, BKL (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	ksim@protpot.com; leemor@cshl.edu	Enemark, Eric/N-8086-2018; Tolia, Niraj H/D-2332-2014	Tolia, Niraj H/0000-0002-2689-1337; Joshua-Tor, Leemor/0000-0001-8185-8049				ADAMS JH, 1992, P NATL ACAD SCI USA, V89, P7085, DOI 10.1073/pnas.89.15.7085; Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7; BACON D, 1988, J MOL GRAPHICS, V6, P219, DOI 10.1016/S0263-7855(98)80030-1; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Blair PL, 2002, MOL BIOCHEM PARASIT, V122, P35, DOI 10.1016/S0166-6851(02)00067-1; Breman JG, 2001, AM J TROP MED HYG, V64, pIV, DOI 10.4269/ajtmh.2001.64.iv; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAMUS D, 1985, SCIENCE, V230, P553, DOI 10.1126/science.3901257; CHITNIS CE, 1994, J EXP MED, V180, P497, DOI 10.1084/jem.180.2.497; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; Duraisingh MT, 2003, P NATL ACAD SCI USA, V100, P4796, DOI 10.1073/pnas.0730883100; Duraisingh MT, 2003, EMBO J, V22, P1047, DOI 10.1093/emboj/cdg096; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037; Gilberger TW, 2003, J CELL BIOL, V162, P317, DOI 10.1083/jcb.200301046; Gilberger TW, 2003, J BIOL CHEM, V278, P14480, DOI 10.1074/jbc.M211446200; Gowda DC, 1999, PARASITOL TODAY, V15, P147, DOI 10.1016/S0169-4758(99)01412-X; Guzman F, 2002, LIFE SCI, V71, P2773, DOI 10.1016/S0024-3205(02)02108-2; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Jones TR, 2001, J INFECT DIS, V183, P303, DOI 10.1086/317933; Kaneko O, 2002, MOL BIOCHEM PARASIT, V121, P275, DOI 10.1016/S0166-6851(02)00042-7; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P1878, DOI 10.1107/S0907444999010495; KLOTZ FW, 1992, MOL BIOCHEM PARASIT, V51, P49, DOI 10.1016/0166-6851(92)90199-T; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Liang H, 1997, MOL BIOCHEM PARASIT, V84, P241, DOI 10.1016/S0166-6851(96)02791-0; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; MARCHESI VT, 1972, P NATL ACAD SCI USA, V69, P1445, DOI 10.1073/pnas.69.6.1445; Mayer DCG, 2001, P NATL ACAD SCI USA, V98, P5222, DOI 10.1073/pnas.081075398; Mayor A, 2005, BLOOD, V105, P2557, DOI 10.1182/blood-2004-05-1722; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Narum DL, 2002, MOL BIOCHEM PARASIT, V119, P159, DOI 10.1016/S0166-6851(01)00428-5; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; ORLANDI PA, 1992, J CELL BIOL, V116, P901, DOI 10.1083/jcb.116.4.901; Rayner JC, 2001, J EXP MED, V194, P1571, DOI 10.1084/jem.194.11.1571; Rayner JC, 2000, P NATL ACAD SCI USA, V97, P9648, DOI 10.1073/pnas.160469097; Reed MB, 2000, P NATL ACAD SCI USA, V97, P7509, DOI 10.1073/pnas.97.13.7509; Rodriguez LE, 2000, PARASITOLOGY, V120, P225, DOI 10.1017/S003118209900551X; SHELDRICK GM, 1993, ACTA CRYSTALLOGR D, V49, P18, DOI 10.1107/S0907444992007364; SIM BKL, 1990, J CELL BIOL, V111, P1877, DOI 10.1083/jcb.111.5.1877; Sim BKL, 2001, MOL MED, V7, P247, DOI 10.1007/BF03401844; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Snow RW, 1999, B WORLD HEALTH ORGAN, V77, P624; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Taylor HM, 2002, INFECT IMMUN, V70, P5779, DOI 10.1128/IAI.70.10.5779-5789.2002; TEWILLIGER TC, 2000, ACTA CRYSTALLOGR D, V56, P965; Thompson JK, 2001, MOL MICROBIOL, V41, P47, DOI 10.1046/j.1365-2958.2001.02484.x; Triglia T, 2005, MOL MICROBIOL, V55, P162, DOI 10.1111/j.1365-2958.2004.04388.x; Triglia T, 2001, MOL BIOCHEM PARASIT, V116, P55, DOI 10.1016/S0166-6851(01)00303-6; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; Word JM, 1999, J MOL BIOL, V285, P1711, DOI 10.1006/jmbi.1998.2400	59	250	254	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 29	2005	122	2					183	193		10.1016/j.cell.2005.05.033	http://dx.doi.org/10.1016/j.cell.2005.05.033			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	951CR	16051144	Bronze			2022-12-01	WOS:000230907000007
J	Burdyga, T; Wray, S				Burdyga, T; Wray, S			Action potential refractory period in ureter smooth muscle is set by Ca sparks and BK channels	NATURE			English	Article							GUINEA-PIG URETER; CA2+-ACTIVATED K+ CHANNELS; SARCOPLASMIC-RETICULUM; CALCIUM SPARKS; INTRACELLULAR CA2+; CURRENTS; CELLS; RYANODINE; RELEASE; RAT	In excitable tissues the refractory period is a critical control mechanism preventing hyperactivity and undesirable tetani, by preventing subsequent stimuli eliciting action potentials and Ca2+ entry. In ureteric smooth muscle, peristaltic waves that occur as invading pacemaker potentials produce long-lasting action potentials (300-800 ms) and extraordinarily long ( more than 10 s) refractory periods(1-6), which prevent urine reflux and kidney damage(2). For smooth muscles neither the mechanisms underlying the refractory period nor the link between excitability and refractoriness are properly understood. Here we show that a negative feedback process, which depends on Ca2+ loading the sarcoplasmic reticulum (SR) during the action potential and on the subsequent activation of local releases of Ca2+ from the SR (sparks(7)), stimulating plasmalemmal Ca2+-sensitive K+ (BK) channels, determines the refractory period of the action potential. As sparks gradually reduce the Ca2+ load in the SR, electrical inhibition is released, the refractory period is terminated and peristaltic contractions occur again. The refractory period can be manipulated, for example from 10 s to 100 s, by altering the Ca2+ content of the SR or release mechanism or by inhibiting BK channels. This insight into the control of excitability and hence function provides a focus for therapies directed at pathologies of smooth muscle.	Univ Liverpool, Dept Physiol, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Burdyga, T (corresponding author), Univ Liverpool, Dept Physiol, Liverpool L69 3BX, Merseyside, England.	burdyga@liv.ac.uk	wray, susan/B-1197-2009	Wray, Susan/0000-0002-0086-1359; Burdyga, Theodor/0000-0002-6312-1550				BENHAM CD, 1986, J PHYSIOL-LONDON, V381, P385, DOI 10.1113/jphysiol.1986.sp016333; Bogdanov KY, 2001, CIRC RES, V88, P1254, DOI 10.1161/hh1201.092095; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Burdyga T, 1997, PFLUG ARCH EUR J PHY, V435, P182, DOI 10.1007/s004240050499; Burdyga TV, 1998, BBA-MOL CELL RES, V1402, P109, DOI 10.1016/S0167-4889(97)00149-3; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Cheranov SY, 2002, J PHYSIOL-LONDON, V544, P71, DOI 10.1113/jphysiol.2002.025197; Cuthbert A W, 1965, J Physiol, V180, P225; Exintaris B, 1999, UROL RES, V27, P319; Gordienko DV, 2001, CELL CALCIUM, V29, P13, DOI 10.1054/ceca.2000.0180; Heppner TJ, 1997, AM J PHYSIOL-CELL PH, V273, pC110; Hove-Madsen L, 2004, CIRCULATION, V110, P1358, DOI 10.1161/01.CIR.0000141296.59876.87; IMAIZUMI Y, 1989, J PHYSIOL-LONDON, V411, P131, DOI 10.1113/jphysiol.1989.sp017565; Kotlikoff MI, 2003, PROG BIOPHYS MOL BIO, V83, P171, DOI 10.1016/S0079-6107(03)00056-7; KURIYAMA H, 1967, J PHYSIOL-LONDON, V191, P225, DOI 10.1113/jphysiol.1967.sp008247; LANG RJ, 1989, J PHYSIOL-LONDON, V412, P375, DOI 10.1113/jphysiol.1989.sp017622; MAGGI CA, 1994, N-S ARCH PHARMACOL, V349, P510, DOI 10.1007/BF00169141; MAGGI CA, 1995, BRIT J PHARMACOL, V114, P127, DOI 10.1111/j.1476-5381.1995.tb14916.x; Matthew A, 2004, J SOC GYNECOL INVEST, V11, P207, DOI 10.1016/j.jsgi.2003.10.009; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; Shabir S, 2004, J PHYSIOL-LONDON, V560, P839, DOI 10.1113/jphysiol.2004.070615; Weiss R. M., 1986, CAMPBELLS UROLOGY, P94; Wellman GC, 2001, AM J PHYSIOL-CELL PH, V281, pC1029, DOI 10.1152/ajpcell.2001.281.3.C1029; WEMYSSHOLDEN GD, 1993, BRIT J UROL, V71, P156, DOI 10.1111/j.1464-410X.1993.tb15909.x; ZhuGe RH, 2004, AM J PHYSIOL-CELL PH, V287, pC1577, DOI 10.1152/ajpcell.00153.2004; Zima AV, 2004, J PHYSIOL-LONDON, V555, P607, DOI 10.1113/jphysiol.2003.058529	26	75	78	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 28	2005	436	7050					559	562		10.1038/nature03834	http://dx.doi.org/10.1038/nature03834			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049489				2022-12-01	WOS:000230788800062
J	Carulla, N; Caddy, GL; Hall, DR; Zurdo, J; Gairi, M; Feliz, M; Giralt, E; Robinson, CV; Dobson, CM				Carulla, N; Caddy, GL; Hall, DR; Zurdo, J; Gairi, M; Feliz, M; Giralt, E; Robinson, CV; Dobson, CM			Molecular recycling within amyloid fibrils	NATURE			English	Article							PROTEIN AGGREGATION; CORE; MICROSCOPY; RESISTANT; POSSESS; PRIONS; MODEL	Amyloid fibrils are thread-like protein aggregates with a core region formed from repetitive arrays of beta-sheets oriented parallel to the fibril axis(1,2). Such structures were first recognized in clinical disorders(1,3), but more recently have also been linked to a variety of non-pathogenic phenomena ranging from the transfer of genetic information to synaptic changes associated with memory(4-7). The observation that many proteins can convert into similar structures in vitro has suggested that this ability is a generic feature of polypeptide chains(1,8). Here we have probed the nature of the amyloid structure by monitoring hydrogen/deuterium exchange in fibrils formed from an SH3 domain(9-12) using a combination of nuclear magnetic resonance spectroscopy and electrospray ionization mass spectrometry. The results reveal that under the conditions used in this study, exchange is dominated by a mechanism of dissociation and re-association that results in the recycling of molecules within the fibril population. This insight into the dynamic nature of amyloid fibrils, and the ability to determine the parameters that define this behaviour, have important implications for the design of therapeutic strategies directed against amyloid disease.	Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; Serv Cient Tecn, Barcelona 08028, Spain; Inst Recerca Biomed Barcelona, Barcelona 08028, Spain; Univ Barcelona, Dept Quim Organ, E-08028 Barcelona, Spain	University of Cambridge; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona	Dobson, CM (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	cvr24@cam.ac.uk; cmd44@cam.ac.uk	Hall, Damien/AGY-5341-2022; Feliz, Miguel/F-3792-2016; Zurdo, Jesús/C-3110-2015; Hall, Damien/D-9927-2012; Gairi, Margarida/E-9800-2016; giralt, ernest/N-1669-2014	Hall, Damien/0000-0003-1538-7618; Feliz, Miguel/0000-0002-7676-3309; Zurdo, Jesús/0000-0001-5186-8633; Hall, Damien/0000-0003-1538-7618; Gairi, Margarida/0000-0003-3560-5897; giralt, ernest/0000-0001-8381-1797; robinson, carol/0000-0001-7829-5505; Carulla, Natalia/0000-0002-3787-978X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ban T, 2003, J BIOL CHEM, V278, P16462, DOI 10.1074/jbc.C300049200; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; de Laureto PP, 2003, J MOL BIOL, V334, P129, DOI 10.1016/j.jmb.2003.09.024; Dobson CM, 2004, SCIENCE, V304, P1259, DOI 10.1126/science.1093078; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Englander SW, 2001, NAT STRUCT BIOL, V8, P741, DOI 10.1038/nsb0901-741; Goldsbury C, 1999, J MOL BIOL, V285, P33, DOI 10.1006/jmbi.1998.2299; Hall D, 2004, J MOL BIOL, V336, P775, DOI 10.1016/j.jmb.2003.12.004; Hamada D, 2004, TRENDS BIOTECHNOL, V22, P93, DOI 10.1016/j.tibtech.2003.12.003; Hammarstrom P, 2003, SCIENCE, V299, P713, DOI 10.1126/science.1079589; Hoshino M, 2002, NAT STRUCT BIOL, V9, P332, DOI 10.1038/nsb792; Jimenez JL, 1999, EMBO J, V18, P815, DOI 10.1093/emboj/18.4.815; Kelly JW, 2003, J CELL BIOL, V161, P461, DOI 10.1083/jcb.200304074; Kheterpal I, 2003, BIOCHEMISTRY-US, V42, P14092, DOI 10.1021/bi0357816; Kheterpal I, 2000, P NATL ACAD SCI USA, V97, P13597, DOI 10.1073/pnas.250288897; MacPhee CE, 2004, CURR OPIN SOLID ST M, V8, P141, DOI 10.1016/j.cossms.2004.01.010; MIRANKER A, 1993, SCIENCE, V262, P896, DOI 10.1126/science.8235611; Olofsson A, 2004, J BIOL CHEM, V279, P5699, DOI 10.1074/jbc.M310605200; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Sunde M, 1997, ADV PROTEIN CHEM, V50, P123, DOI 10.1016/S0065-3233(08)60320-4; Ventura S, 2004, P NATL ACAD SCI USA, V101, P7258, DOI 10.1073/pnas.0308249101; Wickner RB, 2004, GENE DEV, V18, P470, DOI 10.1101/gad.1177104; Yamaguchi KI, 2004, J MOL BIOL, V338, P559, DOI 10.1016/j.jmb.2004.02.067; Zurdo J, 2001, J MOL BIOL, V311, P325, DOI 10.1006/jmbi.2001.4858; Zurdo J, 2001, J AM CHEM SOC, V123, P8141, DOI 10.1021/ja016229b	30	288	288	0	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2005	436	7050					554	558		10.1038/nature03986	http://dx.doi.org/10.1038/nature03986			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049488				2022-12-01	WOS:000230788800061
J	D'Amico, AV; Renshaw, AA; Sussman, B; Chen, MH				D'Amico, AV; Renshaw, AA; Sussman, B; Chen, MH			Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							III RANDOMIZED TRIAL; RADICAL PROSTATECTOMY; ANDROGEN SUPPRESSION; ANTIGEN LEVELS; TRENDS	Context Men with localized prostate cancer and a preoperative prostate-specific antigen (PSA) velocity greater than 2.0 ng/mL per year experience a 10-fold increase in prostate cancer-specific mortality despite surgery. Objective To assess whether a greater than 2.0-ng/mL increase in PSA level during the year prior to diagnosis was significantly associated with prostate cancer-specific mortality following radiation therapy (RT). Design, Setting, and Patients Between January 1, 1989, and December 1, 2002, 358 men treated with RT for localized prostate cancer formed the study cohort (median age at treatment, 71.2 (range, 43.2-83.5] years). A Cox regression multivariable analysis was used to evaluate whether a PSA velocity greater than 2.0 ng/mL per year was significantly associated with prostate cancer-specific mortality and all-cause mortality after controlling for prognostic factors available at diagnosis. Main Outcome Measure Time to prostate cancer-specific mortality for the 125 men with low-risk prostate cancer (clinical tumor category T1c or T2a and PSA level <10.0 ng/mL and Gleason score :56) and the 233 men with higher-risk disease, stratified by the PSA velocity. Results A PSA velocity greater than 2.0 ng/mL per year was significantly associated with a shorter time to prostate cancer-specific mortality (adjusted hazard ratio [HR], 12.0; 95% confidence interval [CI], 3.0-54.0; P=.001) and all-cause mortality (adjusted HR, 2.1; 95% Cl, 1.3-3.6; P=.005) when compared with men whose PSA velocity was 2.0 ng/mL per year or less. Men presenting with low-risk disease and a PSA velocity greater than 2.0 ng/mL per year had a 7-year estimate of prostate cancer-specific mortality of 19% (95% Cl, 2%-39%) compared with 0% for men whose PSA velocity was 2.0 ng/mL per year or less. The corresponding values for men with higher-risk disease were 24% (95% Cl, 12%-37%) and 4% (95% Cl, 0%-11%), respectively. Conclusions A greater than 2.0-ng/mL increase in PSA level during the year prior to diagnosis is associated with a significantly higher risk of death due to prostate cancer following RT despite having low-risk disease. Such men who are planning to undergo RT and are in good health could be considered for RT combined with androgen suppression therapy because this approach improves survival in men with higher-risk disease.	Brigham & Womens Hosp, Dept Radiat Oncol, Boston, MA 02215 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02215 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Univ Connecticut, Dept Stat, Storrs, CT 06269 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; University of Connecticut	D'Amico, AV (corresponding author), Brigham & Womens Hosp, Dept Radiat Oncol, 75 Francis St,L-2 Level, Boston, MA 02215 USA.	adamico@lroc.harvard.edu						Andriole GL, 2004, UROL ONCOL-SEMIN ORI, V22, P358, DOI 10.1016/j.urolonc.2004.04.013; Bolla M, 2002, LANCET, V360, P103, DOI 10.1016/S0140-6736(02)09408-4; CARTER HB, 1992, JAMA-J AM MED ASSOC, V267, P2215, DOI 10.1001/jama.267.16.2215; CATALONA WJ, 1993, JAMA-J AM MED ASSOC, V270, P948, DOI 10.1001/jama.270.8.948; Cooperberg MR, 2004, J CLIN ONCOL, V22, P2141, DOI 10.1200/JCO.2004.10.062; Cooperberg MR, 2003, J UROLOGY, V170, pS21, DOI 10.1097/01.ju.0000095025.03331.c6; Cox JD, 1999, J CLIN ONCOL, V17, P1155; D'Amico AV, 2002, J CLIN ONCOL, V20, P4567, DOI 10.1200/JCO.2002.03.061; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; D'Amico AV, 2003, J NATL CANCER I, V95, P1376, DOI 10.1093/jnci/djg043; D'Amico AV, 2004, JAMA-J AM MED ASSOC, V292, P821, DOI 10.1001/jama.292.7.821; D'Amico AV, 2004, NEW ENGL J MED, V351, P125, DOI 10.1056/NEJMoa032975; GAYNOR JJ, 1993, J AM STAT ASSOC, V88, P400, DOI 10.2307/2290318; Goluboff ET, 1997, J UROLOGY, V158, P1876, DOI 10.1016/S0022-5347(01)64154-5; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KLEIN JP, 1977, SURVIVAL ANAL TECHNI; PARTIN AW, 2004, P 2004 ANN M AM UR A; Pollack A, 2002, INT J RADIAT ONCOL, V53, P1097, DOI 10.1016/S0360-3016(02)02829-8; Roach M, 2003, J CLIN ONCOL, V21, P1904, DOI 10.1200/JCO.2003.05.004; Roobol MJ, 2003, BJU INT, V92, P117, DOI 10.1111/j.1464-410X.2003.4698x.x; Wilt T J, 1997, Oncology (Williston Park), V11, P1133; ZIETMAN AL, 2004, P 46 ANN M AM SOC TH	22	250	257	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 27	2005	294	4					440	447		10.1001/jama.294.4.440	http://dx.doi.org/10.1001/jama.294.4.440			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	948RM	16046650	Bronze			2022-12-01	WOS:000230733400018
J	Rubinoff, D; Haines, WP				Rubinoff, D; Haines, WP			Web-spinning caterpillar stalks snails	SCIENCE			English	Article									Univ Hawaii, Dept Plant & Environm Protect Sci, Honolulu, HI 96822 USA	University of Hawaii System	Rubinoff, D (corresponding author), Univ Hawaii, Dept Plant & Environm Protect Sci, 310 Gilmore Hall,3050 Maile Way, Honolulu, HI 96822 USA.	rubinoff@hawaii.edu						GILLESPIE RG, 1992, NATURE, V355, P212, DOI 10.1038/355212b0; KRISTENSEN NP, 1999, LEIPDOPTERA MOTHS BU, pCH2; MONTGOMERY SL, 1982, ENTOMOL GEN, V8, P27; Pierce Naomi E., 1995, Journal of the Lepidopterists' Society, V49, P412; Zimmerman EC, 1948, INSECTS HAWAII, V2; Zimmerman EC, 1978, MICROLEPIDOPTERA 2, V9, P883	6	23	24	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 22	2005	309	5734					575	575		10.1126/science.1110397	http://dx.doi.org/10.1126/science.1110397			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SE	16040699				2022-12-01	WOS:000230735200037
J	Cyranoski, D				Cyranoski, D			Malaysia plans 'red book' in its attempts to go green	NATURE			English	News Item								Malaysia is one of the most biologically diverse countries in the world, yet in recent decades has been accused of clearing rainforests and draining peat swamps in order to grow palm trees for the production of palm oil. The international Convention on Biological Diversity has been pressurizing Malaysia to implement conservation strategies. Whilst the new government is said to be in favor, the resources might not yet be in place.											0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 21	2005	436	7049					313	313		10.1038/436313b	http://dx.doi.org/10.1038/436313b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	16034382	Bronze			2022-12-01	WOS:000230623400008
J	Lichtenstein, AH; Russell, RM				Lichtenstein, AH; Russell, RM			Essential nutrients: Food or supplements? Where should the emphasis be?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CORONARY-HEART-DISEASE; LONG-TERM SUPPLEMENTATION; BETA-CAROTENE SUPPLEMENTS; VITAMIN-E SUPPLEMENTATION; CARDIOVASCULAR-DISEASE; ALPHA-TOCOPHEROL; ARTERY-DISEASE; LUNG-CANCER; MYOCARDIAL-INFARCTION; ANTIOXIDANT VITAMINS	The consumption of adequate levels and proper balance of essential nutrients is critical for maintaining health. The identification, isolation, and purification of nutrients in the early 20th century raised the possibility that optimal health outcomes could be realized through nutrient supplementation. Recent attempts using this approach for cardiovascular disease and lung cancer have been disappointing, as demonstrated with vitamin E and beta carotene. Moreover, previously unrecognized risks caused by nutrient toxicity and nutrient interactions have surfaced during intervention studies. The most promising data in the area of nutrition and positive health outcomes relate to dietary patterns, not nutrient supplements. These data suggest that other factors in food or the relative presence of some foods and the absence of other foods are more important than the level of individual nutrients consumed. Finally, unknown are the implications on public health behavior of shifting the emphasis away from food toward nutrient supplements. Notwithstanding the justification for targeting recommendations for nutrient supplements to certain segments of the population (eg, the elderly), there are insufficient data to justify an alteration in public health policy from one that emphasizes food and diet to one that emphasizes nutrient supplements.	Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA	Tufts University; United States Department of Agriculture (USDA)	Lichtenstein, AH (corresponding author), Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, 711 Washington St, Boston, MA 02111 USA.	alice.lichtenstein@tufts.edu						Al-Delaimy WK, 2004, STROKE, V35, P1259, DOI 10.1161/01.STR.0000127813.12854.9c; Alberts DS, 2000, NEW ENGL J MED, V342, P1156, DOI 10.1056/NEJM200004203421602; Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; *AM AC PED DENT, 2004, PEDIAT DENT S, V26, P87; [Anonymous], 1991, Lancet, V338, P131, DOI 10.1016/0140-6736(91)90133-A; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Bazzano LA, 2002, STROKE, V33, P1183, DOI 10.1161/01.STR.0000014607.90464.88; BLANK S, 1995, AM J PUBLIC HEALTH, V85, P656, DOI 10.2105/AJPH.85.5.656; Boaz M, 2000, LANCET, V356, P1213, DOI 10.1016/S0140-6736(00)02783-5; Boileau TWM, 2003, JNCI-J NATL CANCER I, V95, P1578, DOI 10.1093/jnci/djg081; Braam L, 2004, J AM DIET ASSOC, V104, P1410, DOI 10.1016/j.jada.2004.06.021; Brilakis ES, 2002, ATHEROSCLEROSIS, V165, P375, DOI 10.1016/S0021-9150(02)00303-9; Brown BG, 2001, NEW ENGL J MED, V345, P1583, DOI 10.1056/NEJMoa011090; Brown BG, 2002, ARTERIOSCL THROM VAS, V22, P1535, DOI 10.1161/01.ATV.0000034706.24149.95; BROWN ED, 1989, AM J CLIN NUTR, V49, P1258, DOI 10.1093/ajcn/49.6.1258; Brown MJ, 2004, AM J CLIN NUTR, V80, P396, DOI 10.1093/ajcn/80.2.396; CARPENTER TO, 1987, J PEDIATR-US, V111, P507, DOI 10.1016/S0022-3476(87)80109-9; CARTER EGA, 1982, AM J CLIN NUTR, V36, P855, DOI 10.1093/ajcn/36.5.855; Carter H, 2004, Morbidity and Mortality Weekly Report, V53, P847; Castenmiller JJM, 1999, J NUTR, V129, P349, DOI 10.1093/jn/129.2.349; Chung HY, 2004, J NUTR, V134, P1887, DOI 10.1093/jn/134.8.1887; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; CORRIGAN JJ, 1981, AM J CLIN NUTR, V34, P1701, DOI 10.1093/ajcn/34.9.1701; DAWSON DW, 1984, BRIT MED J, V288, P675, DOI 10.1136/bmj.288.6418.675; Dhar M, 2003, NEW ENGL J MED, V348, P2204, DOI 10.1056/NEJMoa022639; DISLER PB, 1975, GUT, V16, P193, DOI 10.1136/gut.16.3.193; Dragsted LO, 2004, AM J CLIN NUTR, V79, P1060; Eidelman RS, 2004, ARCH INTERN MED, V164, P1552, DOI 10.1001/archinte.164.14.1552; Eikelboom JW, 1999, ANN INTERN MED, V131, P363, DOI 10.7326/0003-4819-131-5-199909070-00008; Erkkila AT, 2005, EUR J CLIN NUTR, V59, P196, DOI 10.1038/sj.ejcn.1602058; Feskanich D, 2002, JAMA-J AM MED ASSOC, V287, P47, DOI 10.1001/jama.287.1.47; Fletcher RH, 2002, JAMA-J AM MED ASSOC, V287, P3127, DOI 10.1001/jama.287.23.3127; Gibbons RJ, 2003, CIRCULATION, V107, P149, DOI 10.1161/01.CIR.0000047041.66447.29; Girelli D, 2003, J NUTR, V133, P1281; Greenberg ER, 1996, JAMA-J AM MED ASSOC, V275, P699, DOI 10.1001/jama.275.9.699; Greger JL, 1999, J NUTR, V129, p1434S, DOI 10.1093/jn/129.7.1434S; HALLBERG L, 1991, AM J CLIN NUTR, V53, P112, DOI 10.1093/ajcn/53.1.112; Hannon-Fletcher MP, 2004, AM J CLIN NUTR, V80, P911, DOI 10.1093/ajcn/80.4.911; HARKER LA, 1974, NEW ENGL J MED, V291, P537, DOI 10.1056/NEJM197409122911101; HARKER LA, 1976, J CLIN INVEST, V58, P731, DOI 10.1172/JCI108520; Haskell MJ, 2004, AM J CLIN NUTR, V80, P705; Hennekens CH, 1996, NEW ENGL J MED, V334, P1145, DOI 10.1056/NEJM199605023341801; Herbert V, 1998, JAMA-J AM MED ASSOC, V279, P505; Hodis HN, 2002, CIRCULATION, V106, P1453, DOI 10.1161/01.CIR.0000029092.99946.08; Hu FB, 2000, AM J CLIN NUTR, V72, P912; Huang HY, 2003, J NUTR, V133, P3137, DOI 10.1093/jn/133.10.3137; Hung J, 2003, BRIT MED J, V326, P131, DOI 10.1136/bmj.326.7381.131; *I MED, 1997, DIET REF INT CALC VI; *I MED, 2001, DIET REF INT ZINC; *I MED, 1998, DIET REF INT B12; Institute of Medicine, 1994, SHOULD REC DIET ALL; JACOBUS CH, 1992, NEW ENGL J MED, V326, P1173, DOI 10.1056/NEJM199204303261801; Jacques PF, 1999, NEW ENGL J MED, V340, P1449, DOI 10.1056/NEJM199905133401901; Jasti S, 2003, J NUTR, V133, p2010S, DOI 10.1093/jn/133.6.2010S; JIALAL I, 1992, J LIPID RES, V33, P899; Katz DL, 2004, J AM COLL NUTR, V23, P397, DOI 10.1080/07315724.2004.10719384; KOPLAN JP, 1986, AM J PUBLIC HEALTH, V76, P287, DOI 10.2105/AJPH.76.3.287; KOSTIC D, 1995, AM J CLIN NUTR, V62, P604, DOI 10.1093/ajcn/62.3.604; Kris-Etherton PM, 2004, CIRCULATION, V110, P637, DOI 10.1161/01.CIR.0000137822.39831.F1; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; Kruger WD, 2000, MOL GENET METAB, V70, P53, DOI 10.1006/mgme.2000.2993; Lampe JW, 1999, AM J CLIN NUTR, V70, p475S, DOI 10.1093/ajcn/70.3.475s; Lange H, 2004, NEW ENGL J MED, V350, P2673, DOI 10.1056/NEJMoa032845; Law MR, 1998, EUR J CLIN NUTR, V52, P549, DOI 10.1038/sj.ejcn.1600603; LEVY AS, 1987, J AM DIET ASSOC, V87, P754; Livny O, 2003, EUR J NUTR, V42, P338, DOI 10.1007/s00394-003-0430-6; Lonn E, 2002, DIABETES CARE, V25, P1919, DOI 10.2337/diacare.25.11.1919; Lonn E, 2005, JAMA-J AM MED ASSOC, V293, P1338, DOI 10.1001/jama.293.11.1338; Lu QJ, 2003, BIOMED ENVIRON SCI, V16, P237; MACLAUGHLIN J, 1985, J CLIN INVEST, V76, P1536, DOI 10.1172/JCI112134; Malinow MR, 1999, CIRCULATION, V99, P178, DOI 10.1161/01.CIR.99.1.178; Mayne ST, 1996, FASEB J, V10, P690, DOI 10.1096/fasebj.10.7.8635686; MCCAY PB, 1985, ANNU REV NUTR, V5, P323, DOI 10.1146/annurev.nu.05.070185.001543; Meydani SN, 2004, JAMA-J AM MED ASSOC, V292, P828, DOI 10.1001/jama.292.7.828; Michaud DS, 2000, AM J CLIN NUTR, V72, P990; Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110; Milman N, 2004, ANN HEMATOL, V83, P423, DOI 10.1007/s00277-003-0830-y; Molldrem KL, 2004, AM J CLIN NUTR, V80, P131; Morris CD, 2003, ANN INTERN MED, V139, P56, DOI 10.7326/0003-4819-139-1-200307010-00014; Morris MC, 2005, ARCH NEUROL-CHICAGO, V62, P641, DOI 10.1001/archneur.62.4.641; Ness AR, 1997, INT J EPIDEMIOL, V26, P1, DOI 10.1093/ije/26.1.1; Odeberg JM, 2003, EUR J PHARM SCI, V19, P299, DOI 10.1016/S0928-0987(03)00135-0; Olmedilla B, 2002, CLIN SCI, V102, P447, DOI 10.1042/CS20010159; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Ordovas JM, 2004, ANNU REV GENOM HUM G, V5, P71, DOI 10.1146/annurev.genom.5.061903.180008; Osganian SK, 2003, J AM COLL CARDIOL, V42, P246, DOI 10.1016/S0735-1097(03)00575-8; Osganian SK, 2003, AM J CLIN NUTR, V77, P1390, DOI 10.1093/ajcn/77.6.1390; Pallast EG, 1999, AM J CLIN NUTR, V69, P1273; Pan MH, 2004, J CLIN INVEST, V113, P1277, DOI 10.1172/JCI200419197; PELLETIER DL, 1997, FAMILY EC NUTR REV, V10, P32; PETO R, 1981, NATURE, V290, P201, DOI 10.1038/290201a0; Rapola JM, 1997, LANCET, V349, P1715, DOI 10.1016/S0140-6736(97)01234-8; REAVEN PD, 1993, ARTERIOSCLER THROMB, V13, P590, DOI 10.1161/01.ATV.13.4.590; REINHOLD JG, 1974, J NUTR, V104, P976, DOI 10.1093/jn/104.8.976; RIMM EB, 1993, NEW ENGL J MED, V328, P1450, DOI 10.1056/NEJM199305203282004; Roodenburg AJC, 2000, AM J CLIN NUTR, V71, P1187; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Sanderson P, 2003, BRIT J NUTR, V90, P473, DOI 10.1079/BJN2003889; Schatzkin A, 2000, NEW ENGL J MED, V342, P1149, DOI 10.1056/NEJM200004203421601; Shekelle PG, 2004, J GEN INTERN MED, V19, P380, DOI 10.1111/j.1525-1497.2004.30090.x; Sies H, 1998, P SOC EXP BIOL MED, V218, P121, DOI 10.3181/00379727-218-44285a; SLESINSKI MJ, 1995, J AM DIET ASSOC, V95, P921, DOI 10.1016/S0002-8223(95)00255-3; SOLOMONS NW, 1982, J AM DIET ASSOC, V80, P115; STAHL W, 1992, J NUTR, V122, P2161, DOI 10.1093/jn/122.11.2161; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P756, DOI 10.1056/NEJM199109123251102; STAMPFER MJ, 1993, NEW ENGL J MED, V328, P1444, DOI 10.1056/NEJM199305203282003; Steinmetz KA, 1996, J AM DIET ASSOC, V96, P1027, DOI 10.1016/S0002-8223(96)00273-8; Stephens NG, 1996, LANCET, V347, P781, DOI 10.1016/S0140-6736(96)90866-1; Strandhagen E, 2000, EUR J CLIN NUTR, V54, P337, DOI 10.1038/sj.ejcn.1600959; Tang G, 1999, AM J CLIN NUTR, V70, P1069; Teucher B, 2004, INT J VITAM NUTR RES, V74, P403, DOI 10.1024/0300-9831.74.6.403; Tognoni G, 2001, LANCET, V357, P89, DOI 10.1016/S0140-6736(00)03539-X; Toole JF, 2004, JAMA-J AM MED ASSOC, V291, P565, DOI 10.1001/jama.291.5.565; US Department of Health Human Services US Department of Agriculture, 2005, DIET GUID AM 2005; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Virtamo J, 1998, ARCH INTERN MED, V158, P668, DOI 10.1001/archinte.158.6.668; Voutilainen S, 2004, AM J CLIN NUTR, V80, P317, DOI 10.1093/ajcn/80.2.317; Wang XD, 1999, J NATL CANCER I, V91, P60, DOI 10.1093/jnci/91.1.60; Willcox JK, 2003, CRIT REV FOOD SCI, V43, P1, DOI 10.1080/10408690390826437; Yeum KJ, 2004, ARCH BIOCHEM BIOPHYS, V430, P97, DOI 10.1016/j.abb.2004.03.006; Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302; YUZBASIYANGURKAN V, 1992, J LAB CLIN MED, V120, P380; Ziegler RG, 1996, CANCER CAUSE CONTROL, V7, P157, DOI 10.1007/BF00115646; 1983, MMWR MORB MORTAL WKL, V32, P305	124	74	79	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 20	2005	294	3					351	358		10.1001/jama.294.3.351	http://dx.doi.org/10.1001/jama.294.3.351			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946YL	16030280				2022-12-01	WOS:000230609100020
J	Atwood, JA; Weatherly, DB; Minning, TA; Bundy, B; Cavola, C; Opperdoes, FR; Orlando, R; Tarleton, RL				Atwood, JA; Weatherly, DB; Minning, TA; Bundy, B; Cavola, C; Opperdoes, FR; Orlando, R; Tarleton, RL			The Trypanosoma cruzi proteome	SCIENCE			English	Article							GENE-EXPRESSION; RHODNIUS-PROLIXUS; DNA-MICROARRAY; LIFE-CYCLE; TRYPOMASTIGOTE; HISTIDINE; PROTEINS; BRUCEI; GENOME	To complement the sequencing of the three kinetoplastid genomes reported in this issue, we have undertaken a whole-organism, proteomic analysis of the four life-cycle stages of Trypanosoma cruzi. Peptides mapping to 2784 proteins in 1168 protein groups from the annotated T. cruzi genome were identified across the four life-cycte stages. Protein products were identified from >1000 genes annotated as "hypothetical" in the sequenced genome, including members of a newly defined gene family annotated, as mucin-associated surface proteins. The four parasite stages appear to use distinct energy sources, including histidine for stages present in the insect vectors and fatty acids by intracellular amastigotes.	Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; Catholic Univ Louvain, Brussels, Belgium; Christian de Duve Inst Cellular Pathol, Trop Dis Res Unit, Brussels, Belgium; Christian de Duve Inst Cellular Pathol, Biochem Lab, Brussels, Belgium	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Universite Catholique Louvain	Tarleton, RL (corresponding author), Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA.	tarleton@cb.uga.edu	Opperdoes, Fred/N-9922-2019; Opperdoes, Frederik R/C-8897-2018	Opperdoes, Fred/0000-0003-1984-3764; Opperdoes, Frederik R/0000-0003-1984-3764; Tarleton, Rick/0000-0002-9589-5243	NIAID NIH HHS [P01 AI044979] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI044979] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akopyants NS, 2001, MOL BIOCHEM PARASIT, V113, P337, DOI 10.1016/S0166-6851(01)00227-4; Almeida R, 2004, MOL BIOCHEM PARASIT, V136, P87, DOI 10.1016/j.molbiopara.2004.03.004; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; Diehl S, 2002, MOL BIOCHEM PARASIT, V123, P115, DOI 10.1016/S0166-6851(02)00138-X; Duncan R, 2004, TRENDS PARASITOL, V20, P211, DOI 10.1016/j.pt.2004.02.008; ELSAYED NMA, 2005, SCIENCE, V309; EVANS DA, 1972, J PROTOZOOL, V19, P686, DOI 10.1111/j.1550-7408.1972.tb03561.x; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Frasch ACC, 2000, PARASITOL TODAY, V16, P282, DOI 10.1016/S0169-4758(00)01698-7; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; HARINGTON JS, 1961, PARASITOLOGY, V51, P309, DOI 10.1017/S0031182000070554; HARINGTON JS, 1956, NATURE, V178, P268, DOI 10.1038/178268a0; LOW HP, 1997, MOL BIOCHEM PARASIT, V160, P1817; Martin D, 2004, IMMUNOL REV, V201, P304, DOI 10.1111/j.0105-2896.2004.00183.x; Martinez-Calvillo S, 2003, MOL CELL, V11, P1291, DOI 10.1016/S1097-2765(03)00143-6; Minning TA, 2003, MOL BIOCHEM PARASIT, V131, P55, DOI 10.1016/S0166-6851(03)00189-0; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Resing KA, 2004, ANAL CHEM, V76, P3556, DOI 10.1021/ac035229m; TOMLINSON S, 1995, PARASITOLOGY, V110, P547, DOI 10.1017/S0031182000065264; Torres C, 2004, MOL MICROBIOL, V54, P632, DOI 10.1111/j.1365-2958.2004.04304.x; Vickery HB, 1942, J BIOL CHEM, V144, P719; Weatherly DB, 2005, MOL CELL PROTEOMICS, V4, P762, DOI 10.1074/mcp.M400215-MCP200; Wilkinson SR, 2002, P NATL ACAD SCI USA, V99, P13453, DOI 10.1073/pnas.202422899; Worthey EA, 2003, NUCLEIC ACIDS RES, V31, P4201, DOI 10.1093/nar/gkg469	24	322	334	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2005	309	5733					473	476		10.1126/science.1110289	http://dx.doi.org/10.1126/science.1110289			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946LY	16020736				2022-12-01	WOS:000230574900049
J	Ivens, AC; Peacock, CS; Worthey, EA; Murphy, L; Aggarwal, G; Berriman, M; Sisk, E; Rajandream, MA; Adlem, E; Aert, R; Anupama, A; Apostolou, Z; Attipoe, P; Bason, N; Bauser, C; Beck, A; Beverley, SM; Bianchettin, G; Borzym, K; Bothe, G; Bruschi, CV; Collins, M; Cadag, E; Ciarloni, L; Clayton, C; Coulson, RMR; Cronin, A; Cruz, AK; Davies, RM; De Gaudenzi, J; Dobson, DE; Duesterhoeft, A; Fazelina, G; Fosker, N; Frasch, AC; Fraser, A; Fuchs, M; Gabel, C; Goble, A; Goffeau, A; Harris, D; Hertz-Fowler, C; Hilbert, H; Horn, D; Huang, YT; Klages, S; Knights, A; Kube, M; Larke, N; Litvin, L; Lord, A; Louie, T; Marra, M; Masuy, D; Matthews, K; Michaeli, S; Mottram, JC; Muller-Auer, S; Munden, H; Nelson, S; Norbertczak, H; Oliver, K; O'Neil, S; Pentony, M; Pohl, TM; Price, C; Purnelle, B; Quail, MA; Rabbinowitsch, E; Reinhardt, R; Rieger, M; Rinta, J; Robben, J; Robertson, L; Ruiz, JC; Rutter, S; Saunders, D; Schafer, M; Schein, J; Schwartz, DC; Seeger, K; Seyler, A; Sharp, S; Shin, H; Sivam, D; Squares, R; Squares, S; Tosato, V; Vogt, C; Volckaert, G; Wambutt, R; Warren, T; Wedler, H; Woodward, J; Zhou, SG; Zimmermann, W; Smith, DF; Blackwell, JM; Stuart, KD; Barrell, B; Myler, PJ				Ivens, AC; Peacock, CS; Worthey, EA; Murphy, L; Aggarwal, G; Berriman, M; Sisk, E; Rajandream, MA; Adlem, E; Aert, R; Anupama, A; Apostolou, Z; Attipoe, P; Bason, N; Bauser, C; Beck, A; Beverley, SM; Bianchettin, G; Borzym, K; Bothe, G; Bruschi, CV; Collins, M; Cadag, E; Ciarloni, L; Clayton, C; Coulson, RMR; Cronin, A; Cruz, AK; Davies, RM; De Gaudenzi, J; Dobson, DE; Duesterhoeft, A; Fazelina, G; Fosker, N; Frasch, AC; Fraser, A; Fuchs, M; Gabel, C; Goble, A; Goffeau, A; Harris, D; Hertz-Fowler, C; Hilbert, H; Horn, D; Huang, YT; Klages, S; Knights, A; Kube, M; Larke, N; Litvin, L; Lord, A; Louie, T; Marra, M; Masuy, D; Matthews, K; Michaeli, S; Mottram, JC; Muller-Auer, S; Munden, H; Nelson, S; Norbertczak, H; Oliver, K; O'Neil, S; Pentony, M; Pohl, TM; Price, C; Purnelle, B; Quail, MA; Rabbinowitsch, E; Reinhardt, R; Rieger, M; Rinta, J; Robben, J; Robertson, L; Ruiz, JC; Rutter, S; Saunders, D; Schafer, M; Schein, J; Schwartz, DC; Seeger, K; Seyler, A; Sharp, S; Shin, H; Sivam, D; Squares, R; Squares, S; Tosato, V; Vogt, C; Volckaert, G; Wambutt, R; Warren, T; Wedler, H; Woodward, J; Zhou, SG; Zimmermann, W; Smith, DF; Blackwell, JM; Stuart, KD; Barrell, B; Myler, PJ			The genome of the kinetoplastid parasite, Leishmania major	SCIENCE			English	Article							FAMILY ENCODING AMASTIN; PRE-MESSENGER-RNA; TRYPANOSOMA-BRUCEI; FRIEDLIN CHROMOSOME-1; AFRICAN TRYPANOSOME; GENE; TRANSCRIPTION; CRUZI; DIFFERENTIATION; SEQUENCE	Leishmania species cause a spectrum of human diseases in tropical and subtropical regions of the world. We have sequenced the 36 chromosomes of the 32.8-megabase haploid genome of Leishmania major (Friedlin strain) and predict 911 RNA genes, 39 pseudogenes, and 8272 protein-coding genes, of which 36% can be ascribed a putative function. These include genes involved in host-pathogen interactions, such as proteolytic enzymes, and extensive machinery for synthesis of complex surface glycoconjugates. The organization of protein-coding genes into long strand-specific, polycistronic clusters and lack of general transcription factors in the L. major, Trypanosoma brucei, and Trypanosoma cruzi (Tritryp) genomes suggest that the mechanisms regulating RNA polymerase II-directed transcription are distinct from those operating in other eukaryotes, although the trypanosomatids appear capable of chromatin remodeling. Abundant RNA-binding proteins are encoded in the Tritryp genomes, consistent with active posttranscriptional regulation of gene expression.	Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; Seattle Biomed Res Inst, Seattle, WA 98109 USA; Katholieke Univ Leuven, Lab Gene Technol, B-3001 Louvain, Belgium; GENOTYPE GmbH, D-69259 Wilhelmsfeld, Germany; GATC Biotech AG, D-78467 Constance, Germany; Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; Univ Trieste, Dept Biol, Genom Grp, Genet Lab, I-34148 Trieste, Italy; Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy; Zentrum Mol Biol, D-69120 Heidelberg, Germany; European Mol Biol Lab, European Bioinformat Inst, Cambridge CB10 1SD, England; Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, BR-14049900 Ribeirao Preto, SP, Brazil; Univ San Martin, Inst Invest Biotecnol, INTECH, RA-1650 Buenos Aires, DF, Argentina; Consejo Nacl Invest Cient & Tecn, Natl Res Council, RA-1650 Buenos Aires, DF, Argentina; QIAGEN GmbH, D-40724 Hilden, Germany; Catholic Univ Louvain, Inst Sci Vie, Unite Biochim Physiol, B-1348 Louvain, Belgium; Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; British Columbia Canc Agcy, Genome Sci Ctr, Genome Sequence Ctr, Vancouver, BC V5Z 4E6, Canada; Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh EH9 3JT, Midlothian, Scotland; Bar Ilan Univ, Fac Life Sci, IL-52900 Ramat Gan, Israel; Univ Glasgow, Wellcome Ctr Mol Parasitol, Glasgow G11 6NU, Lanark, Scotland; Univ Wisconsin, UW Biotechnol Ctr, Lab Mol & Computat Genom, Madison, WI 53706 USA; Agowa GmbH, D-12489 Berlin, Germany; Univ York, Dept Biol, Immunol & Infect Unit, York YO10 5YW, N Yorkshire, England; Cambridge Inst Med Res, Cambridge CB2 2XY, England; Univ Washington, Dept Pathobiol, Seattle, WA 98195 USA; Univ Washington, Dept Biomed & Hlth Informat, Seattle, WA 98195 USA	Wellcome Trust Sanger Institute; Center for Infectious Disease Research; KU Leuven; Max Planck Society; Washington University (WUSTL); University of Trieste; International Center for Genetic Engineering & Biotechnology (ICGEB); Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); Universidade de Sao Paulo; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); QIAGEN GmbH; Universite Catholique Louvain; University of London; London School of Hygiene & Tropical Medicine; British Columbia Cancer Agency; University of Edinburgh; Bar Ilan University; University of Glasgow; University of Wisconsin System; University of Wisconsin Madison; University of York - UK; University of Cambridge; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Ivens, AC (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SA, Cambs, England.	aticat@sanger.ac.uk; peter.myler@sbri.org	Myler, Peter John/AAR-9535-2021; Peacock, Christopher/A-4052-2012; Schein, Jacquie E/G-3674-2015; Ruiz, Jeronimo/D-2511-2011; Cruz, Angela Kaysel/N-8445-2014; Marra, Marco A/B-5987-2008; Zhou, Shiguo/B-3832-2011; Clayton, Christine/K-7700-2019; Michaeli, Shulamit/AAC-8255-2022; Quail, michael/ABE-6131-2020; Blackwell, Jenefer M/H-3015-2015; Berriman, Matthew/A-7618-2011	Cruz, Angela Kaysel/0000-0002-4260-4713; Marra, Marco A/0000-0001-7146-7175; Zhou, Shiguo/0000-0001-7421-2506; Berriman, Matthew/0000-0002-9581-0377; Mottram, Jeremy/0000-0001-5574-3766; Ivens, Al/0000-0002-0112-3876; Beverley, Stephen/0000-0001-5319-0811; Matthews FRS FMedSci FRSE, Professor Keith/0000-0003-0309-9184; Clayton, Christine/0000-0002-6384-0731; Myler, Peter/0000-0002-0056-0513; Ciarloni, Laura/0000-0003-4185-016X; Reinhardt, Richard/0000-0001-9376-2132; /0000-0002-1361-9721; Davies, Robert/0000-0002-9983-1378; Schofield, Ellen/0000-0003-0648-1418; Horn, David/0000-0001-5173-9284; Murphy, Lee/0000-0001-6467-7449; Hertz-Fowler, Christiane/0000-0002-0729-6479; Frasch, Alberto Carlos/0000-0001-7532-653X	NIAID NIH HHS [R01 AI053667, R01 AI040599] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053667, U01AI040599, R01AI040599] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALEXANDER J, 1992, ADV PARASIT, V31, P175, DOI 10.1016/S0065-308X(08)60022-6; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Besteiro S, 2004, MOL MICROBIOL, V54, P1224, DOI 10.1111/j.1365-2958.2004.04355.x; Britto C, 1998, GENE, V222, P107, DOI 10.1016/S0378-1119(98)00472-7; Burleigh BA, 2002, CELL MICROBIOL, V4, P701, DOI 10.1046/j.1462-5822.2002.00226.x; Chiurillo MA, 2000, EXP PARASITOL, V94, P248, DOI 10.1006/expr.2000.4499; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; Couvreur B, 2002, MOL BIOL EVOL, V19, P2110, DOI 10.1093/oxfordjournals.molbev.a004036; Denny PW, 2004, MOL MICROBIOL, V52, P313, DOI 10.1111/j.1365-2958.2003.03975.x; Dobson DE, 2003, J BIOL CHEM, V278, P15523, DOI 10.1074/jbc.M301568200; DOBSON DE, UNPUB; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; El-Sayed NMA, 2003, NUCLEIC ACIDS RES, V31, P4856, DOI 10.1093/nar/gkg673; Estevez AM, 2001, EMBO J, V20, P3831, DOI 10.1093/emboj/20.14.3831; EVERS R, 1989, CELL, V56, P585, DOI 10.1016/0092-8674(89)90581-3; Falcone FH, 2001, J IMMUNOL, V167, P5348, DOI 10.4049/jimmunol.167.9.5348; Garami A, 2001, EMBO J, V20, P3657, DOI 10.1093/emboj/20.14.3657; Geiduschek EP, 2000, NAT STRUCT BIOL, V7, P437, DOI 10.1038/75820; Hall N, 2003, NUCLEIC ACIDS RES, V31, P4864, DOI 10.1093/nar/gkg674; Huang Y, 2001, NUCLEIC ACIDS RES, V29, P2675, DOI 10.1093/nar/29.13.2675; Ingram AK, 2002, MOL MICROBIOL, V45, P89, DOI 10.1046/j.1365-2958.2002.03018.x; Juttner S, 1998, J IMMUNOL, V161, P2383; Liang XH, 2003, EUKARYOT CELL, V2, P830, DOI 10.1128/EC.2.5.830-840.2003; Liu L, 2003, J BIOL CHEM, V278, P18271, DOI 10.1074/jbc.M209215200; Mair G, 2000, RNA, V6, P163, DOI 10.1017/S135583820099229X; Martinez-Calvillo S, 2003, MOL CELL, V11, P1291, DOI 10.1016/S1097-2765(03)00143-6; Martinez-Calvillo S, 2004, EUKARYOT CELL, V3, P506, DOI 10.1128/EC.3.2.506-517.2004; MATTHEWS KR, 1994, GENE DEV, V8, P491, DOI 10.1101/gad.8.4.491; Myler PJ, 1999, P NATL ACAD SCI USA, V96, P2902, DOI 10.1073/pnas.96.6.2902; Numata O, 2000, J BIOCHEM, V127, P51, DOI 10.1093/oxfordjournals.jbchem.a022583; Obado SO, 2005, GENOME RES, V15, P36, DOI 10.1101/gr.2895105; Ravel C, 1999, NUCLEIC ACIDS RES, V27, P2473, DOI 10.1093/nar/27.12.2473; Rawlings ND, 2004, NUCLEIC ACIDS RES, V32, pD160, DOI 10.1093/nar/gkp971; Rochette A, 2005, MOL BIOCHEM PARASIT, V140, P205, DOI 10.1016/j.molbiopara.2005.01.006; Ruan JP, 2004, MOL CELL BIOL, V24, P9610, DOI 10.1128/MCB.24.21.9610-9618.2004; Santos CC, 2005, J CELL SCI, V118, P901, DOI 10.1242/jcs.01677; Sunkin SM, 2000, MOL BIOCHEM PARASIT, V109, P1, DOI 10.1016/S0166-6851(00)00215-2; TEIXEIRA SMR, 1994, J BIOL CHEM, V269, P20509; Tosato V, 2001, CURR GENET, V40, P186, DOI 10.1007/s002940100246; ULLU E, COMMUNICATION; van Leeuwen F, 2003, CELL, V112, P591, DOI 10.1016/S0092-8674(03)00152-1; Vickers TJ, 2004, J BIOL CHEM, V279, P49003, DOI 10.1074/jbc.M407958200; Wang CC, 2003, J BIOL CHEM, V278, P15800, DOI 10.1074/jbc.M300195200; *WHO TDR, SPEC PROGR RES TRAIN; Wincker P, 1996, NUCLEIC ACIDS RES, V24, P1688, DOI 10.1093/nar/24.9.1688; Worthey EA, 2003, NUCLEIC ACIDS RES, V31, P4201, DOI 10.1093/nar/gkg469; Yao CQ, 2003, MOL BIOCHEM PARASIT, V132, P1, DOI 10.1016/S0166-6851(03)00211-1; Zangger H, 2002, CELL DEATH DIFFER, V9, P1126, DOI 10.1038/sj.cdd.4401071; Zhang K, 2005, MOL MICROBIOL, V55, P1566, DOI 10.1111/j.1365-2958.2005.04493.x; Zhou SG, 2004, MOL BIOCHEM PARASIT, V138, P97, DOI 10.1016/j.molbiopara.2004.08.002; Zurita M, 2003, TRENDS GENET, V19, P578, DOI 10.1016/j.tig.2003.08.005	52	1076	1168	1	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2005	309	5733					436	442		10.1126/science.1112680	http://dx.doi.org/10.1126/science.1112680			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946LY	16020728	Green Submitted, Green Accepted, Green Published			2022-12-01	WOS:000230574900038
J	Zuo, Y; Yang, G; Kwon, E; Gan, WB				Zuo, Y; Yang, G; Kwon, E; Gan, WB			Long-term sensory deprivation prevents dendritic spine loss in primary somatosensory cortex	NATURE			English	Article							VISUAL-CORTEX; NMDA RECEPTOR; CEREBRAL-CORTEX; SYNAPTIC PLASTICITY; OCULAR DOMINANCE; DIVERSE REGIONS; ADULT CORTEX; SYNAPSES; SYNAPTOGENESIS; POTENTIATION	A substantial decrease in the number of synapses occurs in the mammalian brain from the late postnatal period until the end of life(1-5). Although experience plays an important role in modifying synaptic connectivity(6-17), its effect on this nearly lifelong synapse loss remains unknown. Here we used transcranial two-photon microscopy to visualize postsynaptic dendritic spines in layer I of the barrel cortex in transgenic mice expressing yellow fluorescent protein. We show that in young adolescent mice, long-term sensory deprivation through whisker trimming prevents net spine loss by preferentially reducing the rate of ongoing spine elimination, not by increasing the rate of spine formation. This effect of deprivation diminishes as animals mature but still persists in adulthood. Restoring sensory experience after adolescent deprivation accelerates spine elimination. Similar to sensory manipulation, the rate of spine elimination decreases after chronic blockade of NMDA (N-methyl-D-aspartate) receptors with the antagonist MK801, and accelerates after drug withdrawal. These studies of spine dynamics in the primary somatosensory cortex suggest that experience plays an important role in the net loss of synapses over most of an animal's lifespan, particularly during adolescence.	NYU, Sch Med, Skirball Inst,Dept Physiol & Neurosci, Mol Neurobiol Program, New York, NY 10016 USA	New York University	Zuo, Y (corresponding author), NYU, Sch Med, Skirball Inst,Dept Physiol & Neurosci, Mol Neurobiol Program, 540 1st Ave, New York, NY 10016 USA.			Zuo, Yi/0000-0001-9020-0003; Yang, Guang/0000-0002-5739-9126				BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BALICEGORDON RJ, 1994, NATURE, V372, P519, DOI 10.1038/372519a0; Bock J, 1999, P NATL ACAD SCI USA, V96, P2485, DOI 10.1073/pnas.96.5.2485; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; CHANGEUX JP, 1976, NATURE, V264, P705, DOI 10.1038/264705a0; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Grossman AW, 2002, PROG BRAIN RES, V138, P91, DOI 10.1016/S0079-6123(02)38073-7; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; MARKUS EJ, 1987, EXP NEUROL, V96, P262, DOI 10.1016/0014-4886(87)90045-8; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MICHEVA KD, 1995, P NATL ACAD SCI USA, V92, P11834, DOI 10.1073/pnas.92.25.11834; Nicoll RA, 1999, ANN NY ACAD SCI, V868, P515, DOI 10.1111/j.1749-6632.1999.tb11320.x; RAKIC P, 1986, SCIENCE, V232, P232, DOI 10.1126/science.3952506; Sadaka Y, 2003, J COMP NEUROL, V457, P75, DOI 10.1002/cne.10518; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; VALVERDE F, 1971, BRAIN RES, V33, P1, DOI 10.1016/0006-8993(71)90302-7; Winkelmann E, 1977, J Hirnforsch, V18, P21; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	30	326	333	2	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 14	2005	436	7048					261	265		10.1038/nature03715	http://dx.doi.org/10.1038/nature03715			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944VR	16015331				2022-12-01	WOS:000230459500042
J	Ali, M; Emch, M; von Seidlein, L; Yunus, M; Sack, DA; Rao, M; Holmgren, J; Clemens, JD				Ali, M; Emch, M; von Seidlein, L; Yunus, M; Sack, DA; Rao, M; Holmgren, J; Clemens, JD			Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis	LANCET			English	Article							FIELD TRIAL; IMMUNIZATION	Background Decisions about the use of killed oral cholera vaccines, which confer moderate levels of direct protection to vaccinees, can depend on whether the vaccines also provide indirect (herd) protection when high levels of vaccine coverage are attained. We reanalysed data from a field trial in Bangladesh to ascertain whether there is evidence of indirect protection from killed oral cholera vaccines. Methods We analysed the first year of surveillance data from a placebo-controlled trial of B subunit-killed whole-cell and killed whole-cell-only oral cholera vaccines in children and adult women in Bangladesh. We calculated whether there was an inverse, monotonic trend for the relation between the level of vaccine coverage in a residential cluster and the incidence of cholera in individual vaccine recipients or placebo recipients residing in the cluster after controlling for potential confounding variables. Findings Vaccine coverage of the targeted population ranged from 4% to 65%. Incidence rates of cholera among placebo recipients were inversely related to levels of vaccine coverage (7.01 cases per 1000 in the lowest quintile of coverage vs 1.47 cases per 1000 in the highest quintile; p<0.0001 for trend). Receipt of vaccine by an individual and the level of vaccine coverage of the individual's cluster were independently related to a reduced risk of cholera. Moreover, after adjustment for the level of vaccine coverage of the cluster, vaccine protective efficacy remained significant (55% [95% CI 41-66], p<0.0001). Interpretation in addition to providing direct protection to vaccine recipients, killed oral cholera vaccines confer significant herd protection to neighbouring non-vaccinated individuals. Use of these vaccines could have a major effect on the burden of cholera in endemic settings.	Int Vaccine Inst, Seoul 151818, South Korea; Portland State Univ, Dept Geog, Portland, OR 97207 USA; ICDDR B, Ctr Hlth & Populat Res, Dhaka, Bangladesh; NIAID, NIH, Bethesda, MD 20892 USA; Univ Gothenburg, Dept Med Microbiol & Immunol, Gothenburg, Sweden; NICHHD, Bethesda, MD 20892 USA	International Vaccine Institute; Portland State University; International Centre for Diarrhoeal Disease Research (ICDDR); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Gothenburg; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Clemens, JD (corresponding author), Int Vaccine Inst, SNU Res Pk,San 4-8 Bongcheon 7 Dong, Seoul 151818, South Korea.	jclemens@ivi.int	Ali, Mohammad/E-2365-2017	Ali, Mohammad/0000-0003-1410-388X; Holmgren, Jan/0000-0003-1784-5918	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI053214] Funding Source: NIH RePORTER; NIAID NIH HHS [1R03AI53214-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ali M, 2001, J HEALTH POPUL NUTR, V19, P100; Anderson R M, 1990, Lancet, V335, P641; BLACK RE, 1987, INFECT IMMUN, V55, P1116, DOI 10.1128/IAI.55.5.1116-1120.1987; CLEMENS JD, 1986, LANCET, V2, P124; CLEMENS JD, 1987, J INFECT DIS, V155, P79, DOI 10.1093/infdis/155.1.79; CLEMENS JD, 1992, AM J EPIDEMIOL, V135, P865, DOI 10.1093/oxfordjournals.aje.a116382; CLEMENS JD, 1990, LANCET, V335, P270, DOI 10.1016/0140-6736(90)90080-O; CLEMENS JD, 1988, J INFECT DIS, V158, P60, DOI 10.1093/infdis/158.1.60; CLEMENS JD, 1990, AM J EPIDEMIOL, V131, P400, DOI 10.1093/oxfordjournals.aje.a115515; CLEMENS JD, 1992, J INFECT DIS, V166, P1029, DOI 10.1093/infdis/166.5.1029; Cox D.R., 1958, PLANNING EXPT; FINE PEM, 1993, EPIDEMIOL REV, V15, P265, DOI 10.1093/oxfordjournals.epirev.a036121; FOX JP, 1995, AM J EPIDEMIOL, V141, P187, DOI 10.1093/oxfordjournals.aje.a117420; GLASS RI, 1985, J INFECT DIS, V151, P236, DOI 10.1093/infdis/151.2.236; GLASS RI, 1982, AM J EPIDEMIOL, V116, P959, DOI 10.1093/oxfordjournals.aje.a113498; GREENLAND S, 1988, INT J EPIDEMIOL, V17, P456, DOI 10.1093/ije/17.2.456; Longini IM, 2002, STAT MED, V21, P481, DOI 10.1002/sim.994; MURPHY TV, 1993, JAMA-J AM MED ASSOC, V269, P246, DOI 10.1001/jama.269.2.246; Snedecor GW, 1980, STAT METHODS; *WHO GLOB TASK FOR, 2002, WHO M 10 11 DEC 2002; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	21	228	236	1	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 2	2005	366	9479					44	49		10.1016/S0140-6736(05)66550-6	http://dx.doi.org/10.1016/S0140-6736(05)66550-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942JB	15993232				2022-12-01	WOS:000230277600033
J	Kim, J; Wu, HH; Lander, AD; Lyons, KM; Matzuk, MM; Calof, AL				Kim, J; Wu, HH; Lander, AD; Lyons, KM; Matzuk, MM; Calof, AL			GDF11 controls the timing of progenitor cell competence in developing retina	SCIENCE			English	Article							GANGLION-CELLS; RAT RETINA; NEURAL RETINA; FROG RETINA; BHLH GENES; DIFFERENTIATION; MOUSE; AUTOREGULATION; RETINOGENESIS; EXPRESSION	The orderly generation of cell types in the developing retina is thought to be regulated by changes in the competence of multipotent progenitors. Here, we show that a secreted factor, growth and differentiation factor 11 (GDF11), controls the numbers of retinal ganglion cells (RGCs), as well as amacrine and photoreceptor cells, that form during development. GDF11 does not affect proliferation of progenitors-a major mode of GDF11 action in other tissues-but instead controls duration of expression of Maths, a gene that confers competence for RGC genesis, in progenitor cells. Thus, GDF11 governs the temporal windows during which multipotent progenitors retain competence to produce distinct neural progeny.	Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA; Univ Calif Irvine, Ctr Dev Biol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; Univ Calif Los Angeles, Dept Mol Cellular & Dev Biol, Los Angeles, CA 90095 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Los Angeles; Baylor College of Medicine	Calof, AL (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA.	alcalof@uci.edu	Lander, Arthur D/C-9008-2011; Calof, Anne/A-8644-2013; Kim, Joon/C-1833-2011; Lander, Arthur/L-2827-2019	Lander, Arthur D/0000-0002-4380-5525; Calof, Anne/0000-0003-3676-2499; Lander, Arthur/0000-0002-4380-5525	NIAMS NIH HHS [AR44528] Funding Source: Medline; NICHD NIH HHS [HD38761, HD32067] Funding Source: Medline; NIDCD NIH HHS [DC03583] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD032067] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD038761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003583] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BARNSTABLE CJ, 1985, DEV BRAIN RES, V20, P286, DOI 10.1016/0165-3806(85)90116-6; Belliveau MJ, 1999, DEVELOPMENT, V126, P555; Brown NL, 2001, DEVELOPMENT, V128, P2497; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; Dyer MA, 2003, NAT GENET, V34, P53, DOI 10.1038/ng1144; Federman SM, 2000, J BONE MINER RES, V15, pS463; Gamer LW, 1999, DEV BIOL, V208, P222, DOI 10.1006/dbio.1998.9191; Gan L, 1996, P NATL ACAD SCI USA, V93, P3920, DOI 10.1073/pnas.93.9.3920; Gonzalez-Hoyuela M, 2001, DEVELOPMENT, V128, P117; Hatakeyama J, 2001, DEVELOPMENT, V128, P1313; Kanekar S, 1997, NEURON, V19, P981, DOI 10.1016/S0896-6273(00)80391-8; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Liu W, 2000, DEV DYNAM, V217, P320, DOI 10.1002/(SICI)1097-0177(200003)217:3<320::AID-DVDY10>3.0.CO;2-F; Marquardt T, 2002, TRENDS NEUROSCI, V25, P32, DOI 10.1016/S0166-2236(00)02028-2; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Morrow EM, 1999, DEVELOPMENT, V126, P23; Nakashima M, 1999, MECH DEVELOP, V80, P185, DOI 10.1016/S0925-4773(98)00205-6; Oh SP, 2002, GENE DEV, V16, P2749, DOI 10.1101/gad.1021802; Rapaport DH, 2001, J NEUROBIOL, V49, P129, DOI 10.1002/neu.1070; Rapaport DH, 2004, J COMP NEUROL, V474, P304, DOI 10.1002/cne.20134; REH TA, 1986, DEV BIOL, V114, P463, DOI 10.1016/0012-1606(86)90210-1; SPARROW JR, 1990, DEV BRAIN RES, V51, P69, DOI 10.1016/0165-3806(90)90259-2; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; Vetter ML, 2001, SEMIN CELL DEV BIOL, V12, P491, DOI 10.1006/scdb.2001.0273; WAID DK, 1995, NEURON, V14, P117, DOI 10.1016/0896-6273(95)90245-7; Waid DK, 1998, DEVELOPMENT, V125, P1059; WATANABE T, 1990, NEURON, V4, P461, DOI 10.1016/0896-6273(90)90058-N; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; Wu HH, 2003, NEURON, V37, P197, DOI 10.1016/S0896-6273(02)01172-8; XIANG MQ, 1993, NEURON, V11, P689, DOI 10.1016/0896-6273(93)90079-7; Yang ZY, 2003, DEV BIOL, V264, P240, DOI 10.1016/j.ydbio.2003.08.005; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215	32	168	184	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2005	308	5730					1927	1930		10.1126/science.1110175	http://dx.doi.org/10.1126/science.1110175			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940BZ	15976303	Green Submitted			2022-12-01	WOS:000230120000045
J	Shenfield, F				Shenfield, F			Semantics and ethics of human embryonic stem-cell research	LANCET			English	Editorial Material									UCL Hosp, Reprod Med Unit, London WC1E 6AY, England	University College London Hospitals NHS Foundation Trust; University of London; University College London	Shenfield, F (corresponding author), UCL Hosp, Reprod Med Unit, London WC1E 6AY, England.	mfi@easynet.co.uk						*DEP HLTH, 2000, STEM CELL RES MED PR; *EUR COUNC EUR, 1996, CONV PROT HUM RIGHTS; *EUR GROUP ETH SCI, 2002, AD OP ETH ASP HUM CE; Shenfield F, 2002, HUM REPROD, V17, P1409; Shenfield F, 2001, HUM REPROD, V16, P1046; SHENFIELD F, 1995, HUM REPROD, V10, P253, DOI 10.1093/oxfordjournals.humrep.a135924; Shenfield F., 2002, ETHICAL DILEMMAS REP; WARNOCK M, 1984, REPORT COMMITTEE ENQ	8	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 18	2005	365	9477					2071	2073		10.1016/S0140-6736(05)66555-5	http://dx.doi.org/10.1016/S0140-6736(05)66555-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	936LZ	15964431				2022-12-01	WOS:000229858800008
J	Ogilvie, D; Gruer, L; Haw, S				Ogilvie, D; Gruer, L; Haw, S			Young people's access to tobacco, alcohol, and other drugs	BMJ-BRITISH MEDICAL JOURNAL			English	Review							YOUTH ACCESS; SUBSTANCE-ABUSE; PRICE; HEROIN; AVAILABILITY; SMOKING; POLICY; INTERVENTIONS; PREVENTION; REDUCTION		Univ Glasgow, MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland; NHS Hlth Scotland, Glasgow G3 7LS, Lanark, Scotland; NHS Hlth Scotland, Edinburgh EH10 4SG, Midlothian, Scotland	MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow	Ogilvie, D (corresponding author), Univ Glasgow, MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland.	d.ogilvie@msoc.mrc.gla.ac.uk	Ogilvie, David/B-2444-2012	Ogilvie, David/0000-0002-0270-4672				*AC MED SCI, 2004, CALL TIM NAT DRINK H; [Anonymous], 2002, WORLD HLTH REP 2002; *ASH SCOTL, 2001, TOB TAX SMUGGL SCOTL; Aust R, 2002, PREVALENCE DRUG USE; Babor T., 2003, ALCOHOL NO ORDINARY; BOREHAM R, 2001, SMOKING DRINKING DRU; BOREHAM R, 2002, DRUG USE SMOKING DRI; BOREHAM R, 2004, SMOKING DRINKING DRU; BRADSHAW P, 2003, UNDERAGE DRINKING IL; Bucke T., 2002, POLICE J, V75, P15; Caulkins JP, 2001, AM J PUBLIC HEALTH, V91, P1446, DOI 10.2105/AJPH.91.9.1446; Caulkins JP, 1998, J DRUG ISSUES, V28, P593, DOI 10.1177/002204269802800302; Chaloupka FJ., 2000, TOBACCO CONTROL DEV; Coope S., 2004, REDUCING IMPACT LOCA; Croghan E, 2003, TOB CONTROL, V12, P67, DOI 10.1136/tc.12.1.67; CROME IB, 2004, YOUNG PEOPLE SUBSTAN; CURRIE C, 2004, SCOTTISH SCH ADOLESC; CURRIE C, 2003, SCOTTISH SCH ADOLESC; Day C, 2003, ADDICTION, V98, P93, DOI 10.1046/j.1360-0443.2003.00266.x; DiFranza JR, 2000, TOB CONTROL, V9, P120, DOI 10.1136/tc.9.2.120; ESMAIL A, 1992, BRIT MED J, V305, P692, DOI 10.1136/bmj.305.6855.692; *EUR MON CTR DRUGS, 2003, STAT DRUGS PROBL EUR; *EUR OP RES GROUP, 2002, ATT OP YOUNG PEOPL E; FIELDSMITH M, 2004, 17 ST GEORG HOSP MED; Forman RF, 2003, JAMA-J AM MED ASSOC, V290, P889, DOI 10.1001/jama.290.7.889; Forster JL, 1998, ANNU REV PUBL HEALTH, V19, P203, DOI 10.1146/annurev.publhealth.19.1.203; Guindon GE, 2002, TOB CONTROL, V11, P35, DOI 10.1136/tc.11.1.35; Halpern JH, 2001, AM J PSYCHIAT, V158, P481, DOI 10.1176/appi.ajp.158.3.481; Hayward B., 2003, YOUNG PEOPLE ICT 200; HIBELL B, 2004, 2003 ESPAD REP ALC O; Higgins K, 2004, J SOC ISSUES, V60, P485, DOI 10.1111/j.0022-4537.2004.00368.x; *HM CUST EXC, 2002, MEAS IND TAX LOSS; *HM CUST EXC, 2003, MEAS TACKL IND TAX L; Hopkins DP, 2001, AM J PREV MED, V20, P16, DOI 10.1016/S0749-3797(00)00297-X; *HOUS COMM NO IR A, 2003, ILL DRUGS TRAD DRUG; *IND DRUG MON UN, DRUG PRIC; Jha P, 1999, CURBING EPIDEMIC GOV; Joossens L, 2000, BRIT MED J, V321, P947, DOI 10.1136/bmj.321.7266.947; Joossens L, 1999, SMUGGLING CROSS BORD; KETELAARS T, 2002, REPORT EMCDDA REITOX; Lantz PM, 2000, TOB CONTROL, V9, P47, DOI 10.1136/tc.9.1.47; Levy DT, 2002, DRUG-EDUC PREV POLIC, V9, P285, DOI 10.1080/09687630210129538; LUDBROOK A, 2001, EFFECTIVE COST EFFEC; Lupton R., 2002, ROCK HARD PLACE DRUG; MacCoun R, 2001, BRIT J PSYCHIAT, V178, P123, DOI 10.1192/bjp.178.2.123; MAKELA P, 2002, EFFECTS NORDIC ALCOH; Marmot MG, 2004, BRIT MED J, V328, P906, DOI 10.1136/bmj.328.7445.906; MAY T, 2000, SERVING IMPACT LAW L; McArdle P, 2004, ARCH DIS CHILD, V89, P701, DOI 10.1136/adc.2003.040584; McKeganey N, 2004, DRUG-EDUC PREV POLIC, V11, P315, DOI 10.1080/09687630410001687888; MCMULLAN S, 2003, EXPERIENCE DRUG MISU; Moller L., 2002, EFFECTS NORDIC ALCOH; MOSKOWITZ JM, 1989, J STUD ALCOHOL, V50, P54, DOI 10.15288/jsa.1989.50.54; *NAT CTR ADD SUBST, 2004, YOUV GOT DRUGS PRESC; *NAT CTR SOC RES, 2004, DRUG US SMOK DRINK Y; *NAT DRUG INT CTR, 2000, NAT DRUG THREAT ASS; National Criminal Intelligence Service, 2003, UK THREAT ASS THREAT; National Drug Intelligence Centre, 2002, INF B DRUGS YOUTH IN; *OFF NAT STAT, 2004, SOC TRENDS, V34; *OFF NAT STAT, 2004, CONS PRIC IND MAY 20; Prime Minister's Strategy Unit, 2003, STRAT UN ALC HARM RE; PUDNEY S, 2002, ROAD RUIN SEQUENCES; Rehn N, 2001, ALCOHOL EUROPEAN REG; Reinarman C, 2004, AM J PUBLIC HEALTH, V94, P836, DOI 10.2105/AJPH.94.5.836; Room R, 2005, LANCET, V365, P519, DOI 10.1016/S0140-6736(05)70276-2; *SECR HLTH HUM SER, 2000, 10 US DEP HHS US C A; SEWEL K, 2002, INT ALCOHOL POLICIES; Shults RA, 2001, AM J PREV MED, V21, P66, DOI 10.1016/S0749-3797(01)00381-6; SMART RG, 1977, J STUD ALCOHOL, V38, P1313, DOI 10.15288/jsa.1977.38.1313; Smith D.J., 2001, EDINBURGH STUDY YOUT; Smithson M, 2004, ADDICTION, V99, P340, DOI 10.1046/j.1360-0443.2003.00603.x; STEAD LF, 2005, COCHRANE DB SYST REV, V25; Stolzenberg L, 2003, J CRIM JUST, V31, P185, DOI 10.1016/S0047-2352(02)00224-6; TAURAS JA, 2001, EFFECTS PRICE ACCESS; Topp L, 2003, DRUG ALCOHOL DEPEN, V70, P275, DOI 10.1016/S0376-8716(03)00013-9; TOWNSEND J, 1994, BMJ-BRIT MED J, V309, P923, DOI 10.1136/bmj.309.6959.923; Townsend J, 1996, BRIT MED BULL, V52, P132, DOI 10.1093/oxfordjournals.bmb.a011521; Turner KM, 2004, HEALTH PROMOT INT, V19, P428, DOI 10.1093/heapro/dah404; U.S. Department of Health and Human Services, 2000, RED TOB US REP SURG; Viner R, 2005, BRIT MED J, V330, P527, DOI 10.1136/bmj.330.7490.527; Wagenaar AC, 2002, J STUD ALCOHOL, P206, DOI 10.15288/jsas.2002.s14.206; Weatherburn D, 2003, ADDICTION, V98, P83, DOI 10.1046/j.1360-0443.2003.00248.x; WEST P, 2002, REV YOUNG PEOPL HLTH; Williams J, 2004, HEALTH ECON, V13, P123, DOI 10.1002/hec.796; Wood E, 2003, CAN MED ASSOC J, V168, P165; WOOLLERY T, 2000, TOBACCO CONTROL DEV; [No title captured]	87	26	28	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 13	2005	331	7513					393	396E		10.1136/bmj.331.7513.393	http://dx.doi.org/10.1136/bmj.331.7513.393			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	956SK	16096309	Green Accepted, Green Published			2022-12-01	WOS:000231319900020
J	Rai, VK; Jackson, TL; Thiemens, MH				Rai, VK; Jackson, TL; Thiemens, MH			Photochemical mass-independent sulfur isotopes in achondritic meteorites	SCIENCE			English	Article							SOLAR NEBULA; OXYGEN; CHONDRITES; ATMOSPHERE; CHEMISTRY; FRACTIONATION; EXPLOSION; ENSTATITE; ABUNDANCE; COMPONENT	Sulfides from four achondrite meteorite groups are enriched in S-33 (up to 0.040 per mil) as compared with primitive chondrites and terrestrial standards. Stellar nucleosynthesis and cosmic ray spallation are ruled out as causes of the anomaly, but photochemical reactions in the early solar nebula could produce the isotopic composition. The large S-33 excess present in oldhamite from the Norton County aubrite (0.161 per mil) suggests that refractory sulfide minerals condensed from a nebular gas with an enhanced carbon-oxygen ratio, but otherwise solar composition is the carrier. The presence of a mass-independent sulfur effect in meteorites argues for a similar process that could account for oxygen isotopic anomalies observed in refractory inclusions in primitive chondrites.	Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Rai, VK (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	rai@chem.ucsd.edu		Rai, Vinai K/0000-0003-4838-7630				Chin YN, 1996, ASTRON ASTROPHYS, V305, P960; CLAYTON RN, 1973, SCIENCE, V182, P485, DOI 10.1126/science.182.4111.485; Colman JJ, 1996, SCIENCE, V273, P774, DOI 10.1126/science.273.5276.774; Cooper GW, 1997, SCIENCE, V277, P1072, DOI 10.1126/science.277.5329.1072; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Farquhar J, 2000, GEOCHIM COSMOCHIM AC, V64, P1819, DOI 10.1016/S0016-7037(00)00356-2; Farquhar J, 2000, NATURE, V404, P50, DOI 10.1038/35003517; Farquhar J, 1998, SCIENCE, V280, P1580, DOI 10.1126/science.280.5369.1580; Farquhar J, 2002, SCIENCE, V298, P2369, DOI 10.1126/science.1078617; Farquhar J, 2001, J GEOPHYS RES-PLANET, V106, P32829, DOI 10.1029/2000JE001437; GAO X, 1993, GEOCHIM COSMOCHIM AC, V57, P3159, DOI 10.1016/0016-7037(93)90300-L; GAO X, 1993, GEOCHIM COSMOCHIM AC, V57, P3171, DOI 10.1016/0016-7037(93)90301-C; Gao X., 1991, GEOCHIM COSMOCHIM AC, V55, P2671, DOI DOI 10.1016/0016-7037(91)90381-E; Gao YQ, 2001, SCIENCE, V293, P259, DOI 10.1126/science.1058528; GROSSMAN L, 1972, GEOCHIM COSMOCHIM AC, V36, P597, DOI 10.1016/0016-7037(72)90078-6; Krot A. N., 2000, Protostars and planets 4, P1019; LARIMER JW, 1979, GEOCHIM COSMOCHIM AC, V43, P1455, DOI 10.1016/0016-7037(79)90140-6; LODDERS K, 1993, EARTH PLANET SC LETT, V117, P125, DOI 10.1016/0012-821X(93)90122-P; Mauersberger R, 2004, ASTRON ASTROPHYS, V426, P219, DOI 10.1051/0004-6361:20040451; Miller MF, 2002, P NATL ACAD SCI USA, V99, P10988, DOI 10.1073/pnas.172378499; Nakano H, 2003, ASTROPHYS J, V592, P1252, DOI 10.1086/375856; Nittler LR, 2003, GEOCHIM COSMOCHIM AC, V67, P4961, DOI 10.1016/S0016-7037(03)00485-X; Pasek MA, 2005, ICARUS, V175, P1, DOI 10.1016/j.icarus.2004.10.012; Ramdohr P., 1972, Meteoritics, V7, P565, DOI 10.1111/j.1945-5100.1972.tb00138.x; REES CE, 1977, GEOCHIM COSMOCHIM AC, V41, P1679, DOI 10.1016/0016-7037(77)90177-6; Shu FH, 1996, SCIENCE, V271, P1545, DOI 10.1126/science.271.5255.1545; Shu FH, 1997, SCIENCE, V277, P1475, DOI 10.1126/science.277.5331.1475; THIEMENS MH, 1983, SCIENCE, V219, P1073, DOI 10.1126/science.219.4588.1073; Thiemens MH, 1999, SCIENCE, V283, P341, DOI 10.1126/science.283.5400.341; Thiemens MH, 2001, ACCOUNTS CHEM RES, V34, P645, DOI 10.1021/ar960224f; Thiemens MH, 2003, TREATISE GEOCHEMISTR, V4, P159; WOOSLEY SE, 1995, ASTROPHYS J SUPPL S, V101, P181, DOI 10.1086/192237; Woosley SE, 2002, REV MOD PHYS, V74, P1015, DOI 10.1103/RevModPhys.74.1015	33	51	52	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2005	309	5737					1062	1065		10.1126/science.1112954	http://dx.doi.org/10.1126/science.1112954			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955MN	16099982				2022-12-01	WOS:000231230100042
J	Foerch, C; Misselwitz, B; Sitzer, M; Berger, K; Steinmetz, H; Neumann-Haefelin, T				Foerch, C; Misselwitz, B; Sitzer, M; Berger, K; Steinmetz, H; Neumann-Haefelin, T		Arbetisgrp Schlanganfall Hessen	Difference in recognition of right and left hemispheric stroke	LANCET			English	Article								Symptoms of cerebrovascular events differ depending on the hemisphere in which the lesion arises, thereby affecting disease recognition and management. We aimed to establish whether left and right hemispheric strokes are unequally distributed in inpatients. We obtained data from a large hospital-based stroke registry in Germany. 11 328 patients (56%) had left hemispheric events and 8769 (44%) had right-sided lesions (p<0.0001). Age, stroke severity, and time from symptom onset to admission were significantly associated with left hemispheric stroke, suggesting a selection effect. Difficulties in recognition of symptoms due to right hemispheric stroke challenge efforts to optimise stroke management, particularly in the critical early hours of stroke.	Goethe Univ Frankfurt, Dept Neurol, D-60528 Frankfurt, Germany; Geschaeftsstelle Qual Sicherung Hessen, Eschborn, Germany; Univ Munster, Inst Epidemiol & Social Med, Munster, Germany	Goethe University Frankfurt; University of Munster	Foerch, C (corresponding author), Goethe Univ Frankfurt, Dept Neurol, Schleusenweg 2-16, D-60528 Frankfurt, Germany.	foerch@em.uni-frankfurt.de	Neumann-Haefelin, Tobias/AAC-3915-2020					ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; BROTT T, 1994, STROKE, V25, P1122, DOI 10.1161/01.STR.25.6.1122; Farrell B, 1998, LANCET, V351, P1379, DOI 10.1016/s0140-6736(97)09292-1; Hernandez SAR, 2003, HYPERTENSION, V42, P56, DOI 10.1161/01.HYP.0000077983.66161.6F; vanLatum JC, 1996, NEUROLOGY, V46, P159; Woo D, 1999, STROKE, V30, P2355, DOI 10.1161/01.STR.30.11.2355	7	115	119	1	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 30	2005	366	9483					392	393		10.1016/S0140-6736(05)67024-9	http://dx.doi.org/10.1016/S0140-6736(05)67024-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	950IB	16054939				2022-12-01	WOS:000230849700026
J	Kocer, A; Walko, M; Meijberg, W; Feringa, BL				Kocer, A; Walko, M; Meijberg, W; Feringa, BL			A light-actuated nanovalve derived from a channel protein	SCIENCE			English	Article							MECHANOSENSITIVE ION-CHANNEL; ESCHERICHIA-COLI-CELLS; OSMOTIC DOWNSHOCK; LARGE-CONDUCTANCE; GATING MECHANISM; SINGLE RESIDUE; MSCL; ACTIVATION; MUTATIONS	Toward the realization of nanoscale device control, we report a molecular valve embedded in a membrane that can be opened by illumination with long-wavelength ultraviolet (366 nanometers) tight and then resealed by visible irradiation. The valve consists of a channel protein, the mechanosensitive channel of large conductance (MscL) from Escherichia coli, modified by attachment of synthetic compounds that undergo tight-induced charge separation to reversibly open and close a 3-nanometer pore. The system is compatible with a classical encapsulation system, the liposome, and external photochemical control over transport through the channel is achieved.	BiOMaDe Technol Fdn, NL-9747 AG Groningen, Netherlands; Univ Groningen, Stratingh Inst, Dept Organ & Mol Inorgan Chem, NL-9747 AG Groningen, Netherlands; Univ Groningen, Ctr Mat Sci, NL-9747 AG Groningen, Netherlands	University of Groningen; University of Groningen	Feringa, BL (corresponding author), BiOMaDe Technol Fdn, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	meijberg@biomade.nl; B.L.Feringa@rug.nt	Kocer, A/M-6371-2013; Feringa, Ben L./C-1665-2013					Ajouz B, 1998, J BIOL CHEM, V273, P26670, DOI 10.1074/jbc.273.41.26670; Alfimov MV, 2003, J PHOTOCH PHOTOBIO A, V158, P183, DOI 10.1016/S1010-6030(03)00033-9; Anishkin A, 2005, J GEN PHYSIOL, V125, P155, DOI 10.1085/jgp.200409118; Berrier C, 2000, J BACTERIOL, V182, P248, DOI 10.1128/JB.182.1.248-251.2000; Bertarelli C, 2004, ADV FUNCT MATER, V14, P357, DOI 10.1002/adfm.200304414; Blount P, 1996, P NATL ACAD SCI USA, V93, P11652, DOI 10.1073/pnas.93.21.11652; Blount P, 1997, J BIOL CHEM, V272, P32150, DOI 10.1074/jbc.272.51.32150; Bochet CG, 2002, J CHEM SOC PERK T 1, P125, DOI 10.1039/b009522m; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Cruickshank CC, 1997, BIOPHYS J, V73, P1925, DOI 10.1016/S0006-3495(97)78223-7; FERINGA BL, 2001, MOL SWITCHES; Folgering JHA, 2004, LANGMUIR, V20, P6985, DOI 10.1021/la048942v; Gullingsrud J, 2003, BIOPHYS J, V85, P2087, DOI 10.1016/S0006-3495(03)74637-2; Hase CC, 1997, J MEMBRANE BIOL, V157, P17, DOI 10.1007/s002329900212; Ichimura K, 2000, SCIENCE, V288, P1624, DOI 10.1126/science.288.5471.1624; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; New R.R.C., 1990, LIPOSOMES PRACTICAL, P105; Ou XR, 1998, P NATL ACAD SCI USA, V95, P11471, DOI 10.1073/pnas.95.19.11471; Perozo E, 2001, J GEN PHYSIOL, V118, P193, DOI 10.1085/jgp.118.2.193; Perozo E, 2002, NATURE, V418, P942, DOI 10.1038/nature00992; Reinhard R, 1998, J ORG CHEM, V63, P2434, DOI 10.1021/jo961861m; Sukharev S, 2004, TRENDS NEUROSCI, V27, P345, DOI 10.1016/j.tins.2004.04.006; Sukharev S, 2001, NATURE, V409, P720, DOI 10.1038/35055559; Sukhareva M, 2003, J GEN PHYSIOL, V122, P541, DOI 10.1085/jgp.200308905; Willner I, 1996, ANGEW CHEM INT EDIT, V35, P367, DOI 10.1002/anie.199603671; Yoshimura K, 1999, BIOPHYS J, V77, P1960, DOI 10.1016/S0006-3495(99)77037-2; Yoshimura K, 2001, BIOPHYS J, V80, P2198, DOI 10.1016/S0006-3495(01)76192-9	27	408	421	2	163	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2005	309	5735					755	758		10.1126/science.1114760	http://dx.doi.org/10.1126/science.1114760			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951NU	16051792				2022-12-01	WOS:000230938200045
J	Eathiraj, S; Pan, XJ; Ritacco, C; Lambright, DG				Eathiraj, S; Pan, XJ; Ritacco, C; Lambright, DG			Structural basis of family-wide Rab GTPase recognition by rabenosyn-5	NATURE			English	Article							ENDOCYTIC COMPARTMENTS; MEMBRANE TRAFFICKING; BINDING-PROTEINS; EARLY ENDOSOMES; TRANS-GOLGI; SPECIFICITY; EFFECTOR; COMPLEX; LOCALIZATION; DISSOCIATION	Rab GTPases regulate all stages of membrane trafficking, including vesicle budding, cargo sorting, transport, tethering and fusion(1,2). In the inactive (GDP-bound) conformation, accessory factors facilitate the targeting of Rab GTPases to intracellular compartments(3-8). After nucleotide exchange to the active (GTP-bound) conformation, Rab GTPases interact with functionally diverse effectors including lipid kinases, motor proteins and tethering complexes. How effectors distinguish between homologous Rab GTPases represents an unresolved problem with respect to the specificity of vesicular trafficking. Using a structural proteomic approach, we have determined the specificity and structural basis underlying the interaction of the multivalent effector rabenosyn-5 with the Rab family. The results demonstrate that even the structurally similar effector domains in rabenosyn-5 can achieve highly selective recognition of distinct subsets of Rab GTPases exclusively through interactions with the switch and interswitch regions. The observed specificity is determined at a family-wide level by structural diversity in the active conformation, which governs the spatial disposition of critical conserved recognition determinants, and by a small number of both positive and negative sequence determinants that allow further discrimination between Rab GTPases with similar switch conformations.	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Lambright, DG (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	David.Lambright@umassmed.edu			NIAID NIH HHS [P30 AI042845] Funding Source: Medline; NIGMS NIH HHS [R01 GM056324] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056324] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Calero M, 2003, MOL BIOL CELL, V14, P1852, DOI 10.1091/mbc.E02-11-0707; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Chen D, 1996, GENE, V174, P129, DOI 10.1016/0378-1119(96)00509-4; De Renzis S, 2002, NAT CELL BIOL, V4, P124, DOI 10.1038/ncb744; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Fouraux MA, 2004, MOL BIOL CELL, V15, P611, DOI 10.1091/mbc.E03-05-0343; Fukuda M, 2003, J BIOL CHEM, V278, P15373, DOI 10.1074/jbc.M212341200; Heo WD, 2003, CELL, V113, P315; Junutula JR, 2004, MOL BIOL CELL, V15, P2218, DOI 10.1091/mbc.E03-10-0777; Kauppi M, 2002, J CELL SCI, V115, P899; LOMBARDI D, 1993, EMBO J, V12, P677, DOI 10.1002/j.1460-2075.1993.tb05701.x; Merithew E, 2001, J BIOL CHEM, V276, P13982, DOI 10.1074/jbc.M009771200; Mesa R, 2001, J CELL SCI, V114, P4041; Ostermeier C, 1999, CELL, V96, P363, DOI 10.1016/S0092-8674(00)80549-8; Panic B, 2003, MOL CELL, V12, P863, DOI 10.1016/S1097-2765(03)00356-3; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Pereira-Leal JB, 2000, J MOL BIOL, V301, P1077, DOI 10.1006/jmbi.2000.4010; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Pfeffer SR, 2005, J BIOL CHEM, V280, P15485, DOI 10.1074/jbc.R500003200; Rak A, 2004, CELL, V117, P749, DOI 10.1016/j.cell.2004.05.017; Rak A, 2003, SCIENCE, V302, P646, DOI 10.1126/science.1087761; Rodriguez-Gabin AG, 2001, J NEUROSCI RES, V66, P1149, DOI 10.1002/jnr.1253.abs; Seabra MC, 2004, CURR OPIN CELL BIOL, V16, P451, DOI 10.1016/j.ceb.2004.06.014; Simpson JC, 2004, J CELL SCI, V117, P6297, DOI 10.1242/jcs.01560; Sivars U, 2003, NATURE, V425, P856, DOI 10.1038/nature02057; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vitale G, 1998, EMBO J, V17, P1941, DOI 10.1093/emboj/17.7.1941; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhu GY, 2004, NAT STRUCT MOL BIOL, V11, P975, DOI 10.1038/nsmb832	30	170	184	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2005	436	7049					415	419		10.1038/nature03798	http://dx.doi.org/10.1038/nature03798			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	16034420	Green Accepted			2022-12-01	WOS:000230623400047
J	Steinbrook, R				Steinbrook, R			The controversy over Guidant's implantable defibrillators	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SUDDEN-DEATH											Gornick CC, 2005, HEART RHYTHM, V2, P681, DOI 10.1016/j.hrthm.2005.05.014; GORSETT A, 2005, URGENT MED DEVICE SA; Maron BJ, 2000, NEW ENGL J MED, V342, P365, DOI 10.1056/NEJM200002103420601; MEIER B, 2005, NY TIMES        0524	4	39	39	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2005	353	3					221	224		10.1056/NEJMp058158	http://dx.doi.org/10.1056/NEJMp058158			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946YH	16034006				2022-12-01	WOS:000230608700001
J	Sakaba, T; Stein, A; Jahn, R; Neher, E				Sakaba, T; Stein, A; Jahn, R; Neher, E			Distinct kinetic changes in neurotransmitter release after SNARE protein cleavage	SCIENCE			English	Article							SYNAPTIC TRANSMISSION; BOTULINUM TOXIN; VESICLE FUSION; EXOCYTOSIS; CA2+; CALYX; NEUROEXOCYTOSIS; PROBABILITY; SENSITIVITY; MODULATION	Neurotransmitter release is triggered by calcium ions and depends critically on the correct function of three types of SNARE [soluble N-ethylmaleimide-sensitive factor attachment protein (SNAP) receptor] proteins. With use of the large calyx of Held presynaptic terminal from rats, we found that cleavage of different SNARE proteins by clostridial neurotoxins caused distinct kinetic changes in neurotransmitter release. When elevating calcium ion concentration directly at the presynaptic terminal with the use of caged calcium, cleavage of SNAP-25 by botulinum toxin A (BoNT/A) produced a strong reduction in the calcium sensitivity for release, whereas cleavage of syntaxin using BoNT/C1 and synaptobrevin using tetanus toxin (TeNT) produced an all-or-nothing block without changing the kinetics of remaining vesicles, When stimulating release by calcium influx through channels, a difference between BoNT/C1 and TeNT emerged, which suggests that cleavage of synaptobrevin modifies the coupling between channels and release-competent vesicles.	Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany; Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany	Max Planck Society; Max Planck Society	Neher, E (corresponding author), Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany.	tsakaba@gwdg.de; eneher@gwdg.de	Stein, Alexander/I-4950-2012; Neher, Erwin/A-2109-2013	Stein, Alexander/0000-0002-2696-0611; Jahn, Reinhard/0000-0003-1542-3498; Sakaba, Takeshi/0000-0003-0688-7717				Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Borst JGG, 1995, J PHYSIOL-LONDON, V489, P825, DOI 10.1113/jphysiol.1995.sp021095; Capogna M, 1997, J NEUROSCI, V17, P7190; Chen XM, 2001, EMBO REP, V2, P68, DOI 10.1093/embo-reports/kve005; CULLCANDY SG, 1976, J PHYSIOL-LONDON, V260, P177, DOI 10.1113/jphysiol.1976.sp011510; Deak F, 2004, NAT CELL BIOL, V6, P1102, DOI 10.1038/ncb1185; Finley MFA, 2002, J NEUROSCI, V22, P1266, DOI 10.1523/JNEUROSCI.22-04-01266.2002; Humeau Y, 2000, BIOCHIMIE, V82, P427, DOI 10.1016/S0300-9084(00)00216-9; Jarvis SE, 2001, TRENDS PHARMACOL SCI, V22, P519, DOI 10.1016/S0165-6147(00)01800-9; Lou XL, 2005, NATURE, V435, P497, DOI 10.1038/nature03568; Neher E, 2001, J NEUROSCI, V21, P444, DOI 10.1523/JNEUROSCI.21-02-00444.2001; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; NEHER E, 2002, SOC NEUR ABSTR, V32; Sakaba T, 2001, NEURON, V32, P1119, DOI 10.1016/S0896-6273(01)00543-8; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Stewart BA, 2000, P NATL ACAD SCI USA, V97, P13955, DOI 10.1073/pnas.250491397; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Takahashi T, 1996, SCIENCE, V274, P594, DOI 10.1126/science.274.5287.594; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Wu LG, 1999, NEURON, V23, P821, DOI 10.1016/S0896-6273(01)80039-8; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642; Young SM, 2005, P NATL ACAD SCI USA, V102, P2614, DOI 10.1073/pnas.0409656102; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	26	108	116	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2005	309	5733					491	494		10.1126/science.1112645	http://dx.doi.org/10.1126/science.1112645			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946LY	16020741	Green Published			2022-12-01	WOS:000230574900054
J	Pelkmans, L; Zerial, M				Pelkmans, L; Zerial, M			Kinase-regulated quantal assemblies and kiss-and-run recycling of caveolae	NATURE			English	Article							ENDOCYTOSIS; INTERNALIZATION; DYNAMIN; TRAFFICKING; TRANSPORT; RELEASE; DOMAINS; PATHWAY	A functional genomics approach has revealed that caveolae/raft-mediated endocytosis is subject to regulation by a large number of kinases(1). Here we explore the role of some of these kinases in caveolae dynamics. We discover that caveolae operate using principles different from classical membrane trafficking. First, each caveolar coat contains a set number (one 'quantum') of caveolin-1 molecules. Second, caveolae are either stored as in stationary multi-caveolar structures at the plasma membrane, or undergo continuous cycles of fission and fusion with the plasma membrane in a small volume beneath the surface, without disassembling the caveolar coat. Third, a switch mechanism shifts caveolae from this localized cycle to long-range cytoplasmic transport. We have identified six kinases that regulate different steps of the caveolar cycle. Our observations reveal new principles in caveolae trafficking and suggest that the dynamic properties of caveolae and their transport competence are regulated by different kinases operating at several levels.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Pelkmans, L (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	pelkmans@mpi-cbg.de		Pelkmans, Lucas/0000-0002-6754-9730				AXELROD D, 1984, ANNU REV BIOPHYS BIO, V13, P247, DOI 10.1146/annurev.bb.13.060184.001335; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Frolov VA, 2003, P NATL ACAD SCI USA, V100, P8698, DOI 10.1073/pnas.1432962100; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; KATZ B, 1971, SCIENCE, V173, P123, DOI 10.1126/science.173.3992.123; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Minshall RD, 2000, J CELL BIOL, V150, P1057, DOI 10.1083/jcb.150.5.1057; Mundy DI, 2002, J CELL SCI, V115, P4327, DOI 10.1242/jcs.00117; PARTON RG, 1994, J CELL BIOL, V127, P1199, DOI 10.1083/jcb.127.5.1199; PARTON RG, 1994, J HISTOCHEM CYTOCHEM, V42, P155, DOI 10.1177/42.2.8288861; Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Pelkmans L, 2003, CURR OPIN CELL BIOL, V15, P414, DOI 10.1016/S0955-0674(03)00081-4; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Ryan TA, 1997, NATURE, V388, P478, DOI 10.1038/41335; Salim K, 1996, EMBO J, V15, P6241, DOI 10.1002/j.1460-2075.1996.tb01014.x; Shajahan AN, 2004, J BIOL CHEM, V279, P20392, DOI 10.1074/jbc.M308710200; Sharma DK, 2004, MOL BIOL CELL, V15, P3114, DOI 10.1091/mbc.E04-03-0189; Thomsen P, 2002, MOL BIOL CELL, V13, P238, DOI 10.1091/mbc.01-06-0317; Toomre D, 2000, J CELL BIOL, V149, P33, DOI 10.1083/jcb.149.1.33	22	274	279	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2005	436	7047					128	133		10.1038/nature03866	http://dx.doi.org/10.1038/nature03866			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942QJ	16001074				2022-12-01	WOS:000230296600052
J	Geng, E; Kreiswirth, B; Burzynski, J; Schluger, NW				Geng, E; Kreiswirth, B; Burzynski, J; Schluger, NW			Clinical and radiographic correlates of primary and reactivation tuberculosis - A molecular epidemiology study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NEW-YORK-CITY; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; COMPLEX STRAINS; SAN-FRANCISCO; TRANSMISSION; INFECTION; MANIFESTATIONS; IS6110	Context The traditional teaching that pulmonary tuberculosis characterized by lymphadencipathy, effusions, and lower or mid lung zone infiltrates on chest radiography represents "primary" disease from recently acquired infection, whereas upper lobe infiltrates and cavities represent secondary or reactivation disease acquired in the more distant past, is not based on well-established clinical evidence. Furthermore, it is not known whether the atypical radiograph common in human immunodeficiency virus (HIV)-associated tuberculosis is due to a preponderance of primary progressive disease or altered immunity. Objective To analyze the relationship between recently acquired and remotely acquired pulmonary tuberculosis, clinical and demographic variables, and radiographic features by using molecular fingerprinting and conventional epidemiology. Design, Setting, and Population A retrospective, hospital-based series of 456 patients treated at a New York City medical center between 1990 and 1999. Eligible patients had to have had at least 1 positive respiratory culture for Mycobacterium tuberculosis and available radiographic data. Main Outcome Measures Radiographic appearance as measured by the presence or absence of 6 features: upper lobe infiltrate, cavitary lesion, adenopathy, effusions, lower or mid lung zone infiltrate, and miliary pattern. Radiographs were considered typical if they had an upper lobe infiltrate or cavity whether or not other features were present. Atypical radiographs were those that had adenopathy, effusion, or mid lower lung zone infiltrates or had none of the above features. Results Human immunodeficiency virus infection was most commonly associated with an atypical radiographic appearance on chest radiograph with an odds ratio of 0.20 (95% confidence interval, 0.13-0.31). Although a clustered fingerprint, representing recently acquired disease, was associated with typical radiograph in univariate analysis (odds ratio, 0.68; 95% confidence interval, 0.47-0.99), the association was lost when adjusted for HIV status. Conclusions Time from acquisition of infection to development of clinical disease does not reliably predict the, radiographic appearance of tuberculosis. Human immunodeficiency virus status, a probable surrogate for the integrity of the host immune response, is the only independent predictor of radiographic appearance. The altered radiographic appearance of pulmonary tuberculosis in HIV is due to altered immunity rather than recent acquisition of infection and progression to active disease.	Columbia Univ, Med Ctr, Div Pulm Allergy & Crit Care Med, Coll Phys & Surg, New York, NY 10032 USA; Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10032 USA; Publ Hlth Res Inst, Newark, NJ USA; New York City Dept Hlth, TB Control Program, New York, NY 10013 USA	Columbia University; Columbia University; New York City Department of Health & Mental Hygiene	Schluger, NW (corresponding author), Columbia Univ, Med Ctr, Div Pulm Allergy & Crit Care Med, Coll Phys & Surg, 630 W 168th St PH-8 E, New York, NY 10032 USA.	ns311@columbia.edu			NHLBI NIH HHS [K24 HL004074] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL004074] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALLAND D, 1994, NEW ENGL J MED, V330, P1710, DOI 10.1056/NEJM199406163302403; Barnes PF, 2003, NEW ENGL J MED, V349, P1149, DOI 10.1056/NEJMra021964; BASS JB, 1990, AM REV RESPIR DIS, V142, P725; Bauer J, 1999, J CLIN MICROBIOL, V37, P2602, DOI 10.1128/JCM.37.8.2602-2606.1999; Burgos M, 2003, J INFECT DIS, V188, P1878, DOI 10.1086/379895; CHOYKE PL, 1983, RADIOLOGY, V148, P357, DOI 10.1148/radiology.148.2.6867325; Daley CL, 1995, TUBERCLE LUNG DIS, V76, P475, DOI 10.1016/0962-8479(95)90520-0; DALEY CL, 1992, NEW ENGL J MED, V326, P231, DOI 10.1056/NEJM199201233260404; FARMAN DP, 1986, CHEST, V89, P75, DOI 10.1378/chest.89.1.75; FRASER RS, 1999, FRASER PARES DIAGNOS, P798; Garcia-Garcia MD, 2000, ARCH INTERN MED, V160, P630, DOI 10.1001/archinte.160.5.630; Geng E, 2002, NEW ENGL J MED, V346, P1453, DOI 10.1056/NEJMoa012972; Glynn JR, 1999, INT J TUBERC LUNG D, V3, P1055; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; JONES BE, 1993, AM REV RESPIR DIS, V148, P1292, DOI 10.1164/ajrccm/148.5.1292; Jones BE, 1997, AM J RESP CRIT CARE, V156, P1270, DOI 10.1164/ajrccm.156.4.9609143; Kremer K, 1999, J CLIN MICROBIOL, V37, P2607, DOI 10.1128/JCM.37.8.2607-2618.1999; Murray M, 2002, AM J EPIDEMIOL, V155, P565, DOI 10.1093/aje/155.6.565; Ong A, 2004, CLIN INFECT DIS, V38, P25, DOI 10.1086/380448; Perlman DC, 1997, CLIN INFECT DIS, V25, P242, DOI 10.1086/514546; Post FA, 1995, TUBERCLE LUNG DIS, V76, P518, DOI 10.1016/0962-8479(95)90527-8; Rizzi EB, 2004, EUR J RADIOL, V52, P170, DOI 10.1016/j.ejrad.2004.04.007; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; Soini H, 2001, J CLIN MICROBIOL, V39, P217, DOI 10.1128/JCM.39.1.217-221.2001; van Soolingen D, 2001, J INTERN MED, V249, P1, DOI 10.1046/j.1365-2796.2001.00772.x; WOODRING JH, 1986, AM J ROENTGENOL, V146, P497, DOI 10.2214/ajr.146.3.497	26	125	130	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	2005	293	22					2740	2745		10.1001/jama.293.22.2740	http://dx.doi.org/10.1001/jama.293.22.2740			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933OV	15941803	Bronze			2022-12-01	WOS:000229643700022
J	Unal, B; Critchley, JA; Capewell, S				Unal, B; Critchley, JA; Capewell, S			Modelling the decline in coronary heart disease deaths in England and Wales, 1981-2000: comparing contributions from primary prevention and secondary prevention	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK-FACTOR CHANGES; MORTALITY; POPULATION; SCOTLAND; SMOKING; TRENDS; CARE	Objective To investigate whether population based primary prevention (risk factor reduction in apparently healthy people) might be more powerful than current government initiatives favouring risk factor reduction in patients with coronary heart disease (CHD) (secondary prevention). Design, setting, and participants The IMPACT model was used to synthesise data for England and Wales describing CHD patient numbers, uptake of specific treatments, trends in major cardiovascular risk factors, and the mortality benefits of these specific risk factor changes in healthy people and in CHD patients. Results Between 1981 and 2000, CHD mortality rates fell by 54%, resulting in 68 230 fewer deaths in 2000. Overall smoking prevalence declined by 35% between 1981 and 2000, resulting in approximately 29 715 (minimum estimate 20 035, maximum estimate 44 6,75) fewer deaths attributable to smoking cessation: approximately 5035 in known CHD patients and approximately 24 680 in healthy people. Population total cholesterol concentrations fell by 4.2%, resulting in approximately 5770 fewer deaths attributable to dietary changes (1205 in CHD patients and 4565 in healthy people) plus 2135 fewer deaths attributable to statin treatment (1990 in CHD patients, 145 in people without CHD). Mean population blood pressure fell by 7.7%, resulting in approximately 5870 fewer deaths attributable to secular falls in blood pressure (520 in CHD patients and 5345 in healthy people) plus approximately 1890 fewer deaths attributable to antihypertensive treatments in people without CHD. Approximately 45 370 fewer deaths were thus attributable to reductions in the three major risk factors in the population: some 36 625 (81%) in people without recognised CHD and 8745 (19%) in CHD patients. Conclusions Compared with secondary prevention, primary prevention achieved a fourfold larger reduction in deaths. Future CHD policies should prioritise population-wide tobacco control and healthier diets.	Dokuz Eylul Univ, Sch Med, Dept Publ Hlth, TR-35340 Izmir, Turkey; Univ Liverpool, Liverpool Sch Trop Med, Int Hlth Grp, Liverpool L3 5QA, Merseyside, England; Univ Liverpool, Div Publ Hlth, Liverpool L69 3GB, Merseyside, England	Dokuz Eylul University; Liverpool School of Tropical Medicine; University of Liverpool; University of Liverpool	Unal, B (corresponding author), Dokuz Eylul Univ, Sch Med, Dept Publ Hlth, TR-35340 Izmir, Turkey.	belgin.unal@deu.edu.tr	Shao, Ruitai/AAU-7642-2021; Unal, Belgin/E-7064-2017	Unal, Belgin/0000-0002-4354-8266; Critchley, Julia/0000-0002-5248-4188				Bonow RO, 2002, CIRCULATION, V106, P3140, DOI 10.1161/01.CIR.0000048067.86569.E1; Boyle R, 2004, HEART, V90, P3, DOI 10.1136/hrt.2004.037523; BRIGGS A, 1994, HEALTH ECON, V3, P95, DOI 10.1002/hec.4730030206; *BRIT HEART FDN ST, 2005, COR HEART DIS STAT; *CA DEP HLTH TOB C, CAL TOB CONTR UPD; Capewell S, 1999, HEART, V81, P380, DOI 10.1136/hrt.81.4.380; Capewell S, 2001, LANCET, V358, P1213, DOI 10.1016/S0140-6736(01)06343-7; Capewell S, 2000, CIRCULATION, V102, P1511, DOI 10.1161/01.CIR.102.13.1511; Critchley J, 2004, CIRCULATION, V110, P1236, DOI 10.1161/01.CIR.0000140668.91896.AE; Critchley JA, 2003, JAMA-J AM MED ASSOC, V290, P86, DOI 10.1001/jama.290.1.86; *DEP HLTH ENGL, 2004, CHOOS HLTH MAK HLTH; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; DOWSE GK, 1995, BRIT MED J, V311, P1255, DOI 10.1136/bmj.311.7015.1255; EBRAHIM S, 1999, COCHRANE DB SYST REV; Emberson J, 2004, EUR HEART J, V25, P484, DOI 10.1016/j.ehj.2003.11.012; Hunink MGM, 1997, JAMA-J AM MED ASSOC, V277, P535, DOI 10.1001/jama.277.7.535; Kendall Cyril W C, 2004, Curr Atheroscler Rep, V6, P492, DOI 10.1007/s11883-004-0091-9; Law M, 1999, BRIT MED J, V318, P1471, DOI 10.1136/bmj.318.7196.1471; Rose G., 1992, STRATEGY PREVENTIVE; Unal B, 2005, AM J PUBLIC HEALTH, V95, P103, DOI 10.2105/AJPH.2003.029579; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; UNAL B, APPENDICES IMPACT CH; *US DEP HHS, 2000, HLTH PEOPL 2010, V1; Vartiainen E, 2000, INT J EPIDEMIOL, V29, P49, DOI 10.1093/ije/29.1.49	24	195	203	1	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 17	2005	331	7517					614	617		10.1136/bmj.38561.633345.8F	http://dx.doi.org/10.1136/bmj.38561.633345.8F			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	967EK	16107431	Bronze, Green Published, Green Accepted			2022-12-01	WOS:000232074100022
J	Johnson, D; Krsek, M; Wellington, EMH; Stott, AW; Cole, L; Bardgett, RD; Read, DJ; Leake, JR				Johnson, D; Krsek, M; Wellington, EMH; Stott, AW; Cole, L; Bardgett, RD; Read, DJ; Leake, JR			Soil invertebrates disrupt carbon flow through fungal networks	SCIENCE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI		Univ Aberdeen, Sch Biol Sci, Aberdeen AB24 3UU, Scotland; Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; NERC, Life Sci Mass Spectrometry Facil, Lancaster Environm Ctr, Lancaster LA1 4AP, England; Ctr Ecol & Hydrol, Banchory AB31 4BW, Kincardine, Scotland; Univ Lancaster, Inst Environm & Nat Sci, Lancaster LA1 4YQ, England; Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Aberdeen; University of Warwick; Lancaster University; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); UK Centre for Ecology & Hydrology (UKCEH); Lancaster University; University of Sheffield	Johnson, D (corresponding author), Univ Aberdeen, Sch Biol Sci, Aberdeen AB24 3UU, Scotland.	D.Johnson@abdn.ac.uk	Read, David/C-2454-2013; STOTT, ANDREW/I-7920-2012; Johnson, David/N-3193-2013	Wellington, ELizabeth/0000-0002-4329-0699; Leake, Jonathan/0000-0001-8364-7616	Natural Environment Research Council [NER/J/S/2002/00652] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Gange A, 2000, TRENDS ECOL EVOL, V15, P369, DOI 10.1016/S0169-5347(00)01940-6; Leake JR, 2004, CAN J BOT, V82, P1016, DOI [10.1139/b04-060, 10.1139/B04-060]; MCGONIGLE TP, 1988, P R SOC EDINB B, V94, P2; OLSSON PA, 1995, MYCOL RES, V99, P623, DOI 10.1016/S0953-7562(09)80723-5; Staddon PL, 2003, SCIENCE, V300, P1138, DOI 10.1126/science.1084269; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932	6	113	124	5	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 12	2005	309	5737					1047	1047		10.1126/science.1114769	http://dx.doi.org/10.1126/science.1114769			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955MN	16099977				2022-12-01	WOS:000231230100037
J	Lu, YH; Conrad, R				Lu, YH; Conrad, R			In situ stable isotope probing of methanogenic archaea in the rice rhizosphere	SCIENCE			English	Article							MICROBIAL COMMUNITY DYNAMICS; FIELD SOIL; PADDY FIELDS; CARBON FLOW; ROOTS; METHANE; LINKING; CH4; MICROORGANISMS; PHOTOSYNTHATES	Microorganisms living in anoxic rice soils contribute 10 to 25% of global methane emissions. The most important carbon source for CH4 production is plant-derived carbon that enters soil as root exudates and debris. Pulse labeling of rice plants with (CO2)-C-13 resulted in incorporation of C-13 into the ribosomal RNA of Rice Cluster I Archaea in the soil, indicating that this archaeal group plays a key role in CH4 production from plant-derived carbon. This group of microorganisms has not yet been isolated but appears to be of global environmental importance.	China Agr Univ, Coll Resources & Environm Sci, Beijing 100094, Peoples R China; Max Planck Inst Terr Microbiol, Karl von Frisch Str, D-35043 Marburg, Germany	China Agricultural University; Max Planck Society	Conrad, R (corresponding author), Max Planck Inst Terr Microbiol, Karl von Frisch Str, D-35043 Marburg, Germany.	conrad@staff.uni-marburg.de	Lu, Yahai/A-5030-2013	Lu, Yahai/0000-0002-1702-9868				Bodelier PLE, 2000, NATURE, V403, P421, DOI 10.1038/35000193; Boschker HTS, 1998, NATURE, V392, P801, DOI 10.1038/33900; Butler JL, 2003, APPL ENVIRON MICROB, V69, P6793, DOI 10.1128/AEM.69.11.6793-6800.2003; Chin KJ, 1999, APPL ENVIRON MICROB, V65, P2341; Conrad R, 1999, FEMS MICROBIOL ECOL, V30, P147, DOI 10.1111/j.1574-6941.1999.tb00643.x; Erkel C, 2005, FEMS MICROBIOL ECOL, V53, P187, DOI 10.1016/j.femsec.2004.12.004; Griffiths RI, 2004, J MICROBIOL METH, V58, P119, DOI 10.1016/j.mimet.2004.03.011; Grosskopf R, 1998, APPL ENVIRON MICROB, V64, P4983; Hogberg P, 2001, NATURE, V411, P789, DOI 10.1038/35081058; Inubushi K, 2003, GLOBAL CHANGE BIOL, V9, P1458, DOI 10.1046/j.1365-2486.2003.00665.x; Jeon CO, 2003, P NATL ACAD SCI USA, V100, P13591, DOI 10.1073/pnas.1735529100; King JY, 2002, SOIL BIOL BIOCHEM, V34, P173, DOI 10.1016/S0038-0717(01)00164-X; Lehmann-Richter S, 1999, ENVIRON MICROBIOL, V1, P159; Lelieveld J, 1998, TELLUS B, V50, P128, DOI 10.1034/j.1600-0889.1998.t01-1-00002.x; Lu YH, 2004, FEMS MICROBIOL ECOL, V48, P179, DOI 10.1016/j.femsec.2004.01.004; Lu YH, 2005, ENVIRON MICROBIOL, V7, P326, DOI 10.1111/j.1462-2920.2005.00697.x; Lueders T, 2004, ENVIRON MICROBIOL, V6, P60, DOI 10.1046/j.1462-2920.2003.00535.x; Lueders T, 2001, ENVIRON MICROBIOL, V3, P194, DOI 10.1046/j.1462-2920.2001.00179.x; LYNCH JM, 1990, PLANT SOIL, V129, P1, DOI 10.1007/BF00011685; Manefield M, 2002, APPL ENVIRON MICROB, V68, P5367, DOI 10.1128/AEM.68.11.5367-5373.2002; Minoda T, 1996, J GEOPHYS RES-ATMOS, V101, P21091, DOI 10.1029/96JD01710; Paustian K, 1997, GEODERMA, V79, P227, DOI 10.1016/S0016-7061(97)00043-8; Radajewski S, 2000, NATURE, V403, P646, DOI 10.1038/35001054; Rangel-Castro JI, 2005, ENVIRON MICROBIOL, V7, P828, DOI 10.1111/j.1462-2920.2005.00756.x; Singh BK, 2004, TRENDS MICROBIOL, V12, P386, DOI 10.1016/j.tim.2004.06.008; Treonis AM, 2004, SOIL BIOL BIOCHEM, V36, P533, DOI 10.1016/j.soilbio.2003.10.015; van der Gon HACD, 2002, P NATL ACAD SCI USA, V99, P12021, DOI 10.1073/pnas.192276599; Wang JS, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002180; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875	29	224	267	17	430	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2005	309	5737					1088	1090		10.1126/science.1113435	http://dx.doi.org/10.1126/science.1113435			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955MN	16099988				2022-12-01	WOS:000231230100049
J	Mervis, J				Mervis, J			Inside the pipeline: Pharma goes to work - Introduction	SCIENCE			English	Editorial Material																			0	3	3	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 29	2005	309	5735					721	721		10.1126/science.309.5735.721	http://dx.doi.org/10.1126/science.309.5735.721			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951NU	16051780				2022-12-01	WOS:000230938200032
J	Mayorga, E; Aufdenkampe, AK; Masiello, CA; Krusche, AV; Hedges, JI; Quay, PD; Richey, JE; Brown, TA				Mayorga, E; Aufdenkampe, AK; Masiello, CA; Krusche, AV; Hedges, JI; Quay, PD; Richey, JE; Brown, TA			Young organic matter as a source of carbon dioxide outgassing from Amazonian rivers	NATURE			English	Article							C-14; FRACTIONATION; GEOCHEMISTRY; RADIOCARBON; STREAM; AGE	Rivers are generally supersaturated with respect to carbon dioxide, resulting in large gas evasion fluxes that can be a significant component of regional net carbon budgets(1,2). Amazonian rivers were recently shown to outgas more than ten times the amount of carbon exported to the ocean in the form of total organic carbon or dissolved inorganic carbon(1). High carbon dioxide concentrations in rivers originate largely from in situ respiration of organic carbon(1-3), but little agreement exists about the sources or turnover times of this carbon(2,4,5). Here we present results of an extensive survey of the carbon isotope composition (C-13 and C-14) of dissolved inorganic carbon and three size-fractions of organic carbon across the Amazonian river system. We find that respiration of contemporary organic matter (less than five years old) originating on land and near rivers is the dominant source of excess carbon dioxide that drives outgassing in medium to large rivers, although we find that bulk organic carbon fractions transported by these rivers range from tens to thousands of years in age. We therefore suggest that a small, rapidly cycling pool of organic carbon is responsible for the large carbon fluxes from land to water to atmosphere in the humid tropics.	Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; Stroud Water Res Ctr, Avondale, PA 19311 USA; Rice Univ, Dept Earth Sci, Houston, TX 77005 USA; Univ Sao Paulo, CENA, Lab Ecol Isotop, BR-13400970 Piracicaba, SP, Brazil; Lawrence Livermore Natl Lab, Ctr Accelerator Mass Spectrometry, Livermore, CA 94551 USA	University of Washington; University of Washington Seattle; Rice University; Universidade de Sao Paulo; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Mayorga, E (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	emiliomayorga@alum.mit.edu	Krusche, Alex V/H-8988-2012; Masiello, Caroline/A-2653-2011	Masiello, Caroline/0000-0003-2102-6229; Brown, Tom/0000-0001-9984-7647; Mayorga, Emilio/0000-0003-2574-4623; Krusche, Alex/0000-0001-7094-5577; Aufdenkampe, Anthony/0000-0002-5811-6458				Aufdenkampe AK, 2001, LIMNOL OCEANOGR, V46, P1921, DOI 10.4319/lo.2001.46.8.1921; AUFDENKAMPE AK, IN PRESS ORG GEOCHEM; Bernardes MC, 2004, ECOL APPL, V14, pS263; Clark I.D., 1997, ENV ISOTOPES HYDROGE; Cole JJ, 2001, MAR FRESHWATER RES, V52, P101, DOI 10.1071/MF00084; Devol A. H., 2001, BIOGEOCHEMISTRY AMAZ, P275; GESCH DB, 1999, EOS, V80, P70; GIBBS RJ, 1967, GEOL SOC AM BULL, V78, P1203, DOI 10.1130/0016-7606(1967)78[1203:TGOTAR]2.0.CO;2; Grimm NB, 2003, OECOLOGIA, V137, P485, DOI 10.1007/s00442-003-1382-5; HEDGES JI, 1986, SCIENCE, V231, P1129, DOI 10.1126/science.231.4742.1129; Hedges JI, 2000, LIMNOL OCEANOGR, V45, P1449, DOI 10.4319/lo.2000.45.7.1449; HEDGES JI, 1986, LIMNOL OCEANOGR, V31, P717, DOI 10.4319/lo.1986.31.4.0717; Jones JB, 1998, ECOSYSTEMS, V1, P183; Kerrick DM, 2001, REV GEOPHYS, V39, P565, DOI 10.1029/2001RG000105; KORNER C, 1991, OECOLOGIA, V88, P30, DOI 10.1007/BF00328400; Levin I, 2000, RADIOCARBON, V42, P69, DOI 10.1017/S0033822200053066; Levin I, 2004, RADIOCARBON, V46, P1261, DOI 10.1017/S0033822200033130; MAYORGA E, IN PRESS J HYDROL; Melack J.M., 2001, BIOGEOCHEMISTRY AMAZ, P235; Mulholland PJ, 2001, FRESHWATER BIOL, V46, P1503, DOI 10.1046/j.1365-2427.2001.00773.x; QUAY PD, 1992, LIMNOL OCEANOGR, V37, P857, DOI 10.4319/lo.1992.37.4.0857; Randerson JT, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001876; Raymond PA, 2001, NATURE, V409, P497, DOI 10.1038/35054034; Raymond PA, 2003, ECOSYSTEMS, V6, P694, DOI 10.1007/s10021-002-0213-6; Richey JE, 2002, NATURE, V416, P617, DOI 10.1038/416617a; STALLARD RF, 1983, J GEOPHYS RES-OCEANS, V88, P9671, DOI 10.1029/JC088iC14p09671; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Trumbore S, 2000, ECOL APPL, V10, P399, DOI 10.1890/1051-0761(2000)010[0399:AOSOMA]2.0.CO;2; VOGEL JS, 1987, RADIOCARBON, V29, P323; ZHANG J, 1995, GEOCHIM COSMOCHIM AC, V59, P107, DOI 10.1016/00167-0379(59)1550D-	30	422	444	12	242	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 28	2005	436	7050					538	541		10.1038/nature03880	http://dx.doi.org/10.1038/nature03880			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049484	Green Submitted			2022-12-01	WOS:000230788800057
J	Schwarz, D; Matta, BM; Shakir-Botteri, NL; McPheron, BA				Schwarz, D; Matta, BM; Shakir-Botteri, NL; McPheron, BA			Host shift to an invasive plant triggers rapid animal hybrid speciation	NATURE			English	Article							APPLE MAGGOT FLY; RHAGOLETIS-POMONELLA; SYMPATRIC SPECIATION; HYBRIDIZATION; COMPILATION; EVOLUTION; ALLOZYMES; RADIATION; INFERENCE; LINKAGE	Speciation in animals is almost always envisioned as the split of an existing lineage into an ancestral and a derived species. An alternative speciation route is homoploid hybrid speciation(1) in which two ancestral taxa give rise to a third, derived, species by hybridization without a change in chromosome number. Although theoretically possible it has been regarded as rare(1) and hence of little importance in animals. On the basis of molecular and chromosomal evidence, hybridization is the best explanation for the origin of a handful of extant diploid bisexual animal taxa(2-6). Here we report the first case in which hybridization between two host-specific animals (tephritid fruitflies) is clearly associated with the shift to a new resource. Such a hybrid host shift presents an ecologically robust scenario for animal hybrid speciation because it offers a potential mechanism for reproductive isolation through differential adaptation to a new ecological niche(7). The necessary conditions for this mechanism of speciation(7) are common in parasitic animals, which represent much of animal diversity(8). The frequency of homoploid hybrid speciation in animals may therefore be higher than previously assumed.	Penn State Univ, Dept Entomol, University Pk, PA 16803 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Schwarz, D (corresponding author), Penn State Univ, Dept Entomol, 501 ASI Bldg, University Pk, PA 16803 USA.	dxs332@psu.edu	TATSUTA, HARUKI/F-2997-2010	McPheron, Bruce/0000-0001-9623-5100				Anderson EC, 2002, GENETICS, V160, P1217; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Berlocher SH, 2002, ANNU REV ENTOMOL, V47, P773, DOI 10.1146/annurev.ento.47.091201.145312; Berlocher SH, 2000, EVOLUTION, V54, P543, DOI 10.1111/j.0014-3820.2000.tb00057.x; Buerkle CA, 2000, HEREDITY, V84, P441, DOI 10.1046/j.1365-2540.2000.00680.x; Coyne J. A., 2004, SPECIATION, P337; Dowling TE, 1997, ANNU REV ECOL SYST, V28, P593, DOI 10.1146/annurev.ecolsys.28.1.593; Falush D, 2003, GENETICS, V164, P1567; Feder JL, 2003, GENETICS, V163, P939; Feder JL, 1999, ENTOMOL EXP APPL, V90, P9, DOI 10.1023/A:1003512607608; FLOATE KD, 1993, AM NAT, V141, P651, DOI 10.1086/285497; Fonseca DM, 2004, SCIENCE, V303, P1535, DOI 10.1126/science.1094247; FOOTE RH, 1993, HDB FRUIT FLIES DIPT, P322; Hirai H, 2000, INT J PARASITOL, V30, P441, DOI 10.1016/S0020-7519(99)00186-1; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; MCPHERON BA, 1985, J HERED, V76, P218, DOI 10.1093/oxfordjournals.jhered.a110075; Niu TH, 2002, AM J HUM GENET, V70, P157, DOI 10.1086/338446; Pialek J, 2001, MOL ECOL, V10, P613, DOI 10.1046/j.1365-294x.2001.01209.x; Price P.W., 1980, EVOLUTIONARY BIOL PA; REHDER A, 1947, MANUAL CULTIVATED TR, P852; Rieseberg LH, 2003, SCIENCE, V301, P1211, DOI 10.1126/science.1086949; Roethele JB, 2001, ANN ENTOMOL SOC AM, V94, P936, DOI 10.1603/0013-8746(2001)094[0936:EFBSCO]2.0.CO;2; Salzburger W, 2002, MOL ECOL, V11, P619, DOI 10.1046/j.0962-1083.2001.01438.x; Schneider S., 2000, ARLEQUIN SOFTWARE PO; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; SHAW CR, 1970, BIOCHEM GENET, V4, P297, DOI 10.1007/BF00485780; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Smith JJ, 2000, FRUIT FLIES (TEPHRITIDAE): PHYLOGENY AND EVOLUTION OF BEHAVIOR, P187; Taylor DJ, 1996, MOL PHYLOGENET EVOL, V5, P495, DOI 10.1006/mpev.1996.0045; *USDA, 2005, PLANTS DAT	30	186	192	0	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2005	436	7050					546	549		10.1038/nature03800	http://dx.doi.org/10.1038/nature03800			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049486				2022-12-01	WOS:000230788800059
J	Alarcon, WA; Calvert, GM; Blondell, JM; Mehler, LN; Sievert, J; Propeck, M; Tibbetts, DS; Becker, A; Lackovic, M; Soileau, SB; Das, R; Beckman, J; Male, DP; Thomsen, CL; Stanbury, M				Alarcon, WA; Calvert, GM; Blondell, JM; Mehler, LN; Sievert, J; Propeck, M; Tibbetts, DS; Becker, A; Lackovic, M; Soileau, SB; Das, R; Beckman, J; Male, DP; Thomsen, CL; Stanbury, M			Acute illnesses associated with pesticide exposure at schools	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMMUNITIES	Context Pesticides continue to be used on school property, and some schools are at risk of pesticide drift exposure from neighboring farms, which leads to pesticide exposure among students and school employees. However, information on the magnitude of illnesses and risk factors associated with these pesticide exposures is not available. Objective To estimate the magnitude of and associated risk factors for pesticide-related illnesses at schools. Design, Setting, and Participants Analysis of surveillance data from 1998 to 2002 of 2593 persons with acute pesticide- related illnesses associated with exposure at schools. Nationwide information on pesticide- related illnesses is routinely collected by 3 national pesticide surveillance systems: the National Institute for Occupational Safety and Health's Sentinel Event Notification System for Occupational Risks pesticides program, the California Department of Pesticide Regulation, and the Toxic Exposure Surveillance System. Main Outcome Measures Incidence rates and severity of acute pesticide- related illnesses. Results Incidence rates for 1998-2002 were 7.4 cases per million children and 27.3 cases per million school employee full-time equivalents. The incidence rates among children increased significantly from 1998 to 2002. Illness of high severity was found in 3 cases (0.1 %), moderate severity in 275 cases (11 %), and low severity in 2315 cases (89%). Most illnesses were associated with insecticides (n=895, 35%), disinfectants (n=830, 32%), repellents (n=335,13%), or herbicides (n=279, 11 %). Among 406 cases with detailed information on the source of pesticide exposure, 281 (69%) were associated with pesticides used at schools and 125 (31 %) were associated with pesticide drift exposure from farmland. Conclusions Pesticide exposure at schools produces acute illnesses among school employees and students. To prevent pesticide- related illnesses at schools, implementation of integrated pest management programs in schools, practices to reduce pesticide drift, and adoption of pesticide spray buffer zones around schools are recommended.	NIOSH, US Ctr Dis Control & Prevent, Cincinnati, OH 45226 USA; US EPA, Off Pesticide Programs, Washington, DC 20460 USA; Calif Environm Protect Agcy, Dept Pesticide Regulat, Sacramento, CA USA; Texas Dept State Hlth Serv, Environm & Injury Epidemiol & Toxicol Branch, Austin, TX USA; Washington Dept Hlth, Pesticides & Surveillance Sect, Olympia, WA USA; Florida Dept Hlth, Bur Community Environm Hlth, Tallahassee, FL USA; Louisiana Dept Hlth & Hosp, Sect Environm Epidemiol & Toxicol, New Orleans, LA USA; Calif Dept Hlth Serv, Occupat Hlth Branch, Oakland, CA USA; Inst Publ Hlth, Oakland, CA USA; New York State Dept Hlth, Bur Occupat Hlth, Troy, NY USA; Oregon Dept Human Serv Hlth Serv, Portland, OR USA; Michigan Dept Community Hlth, Div Environm & Occupat Epidemiol, Lansing, MI USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); United States Environmental Protection Agency; California Environmental Protection Agency; Texas Department of State Health Services; Florida Department of Health; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; California Department of Health Care Services; Public Health Institute; MDHHS - Michigan Department of Health & Human Services	Alarcon, WA (corresponding author), NIOSH, US Ctr Dis Control & Prevent, 4676 Columbia Pkwy,Mail Stop R-17, Cincinnati, OH 45226 USA.	walarcon@cdc.gov	Alarcon, Walter/C-4470-2008	Alarcon, Walter/0000-0002-4907-4380; Becker, alan/0000-0001-6464-4444				*AM ASS POIS CONTR, TOX EXP SURV SYST TE; *AM ASS POIS CONTR, 2001, TOX EXP SURV SYST TE, P1; Ames RG, 2002, INT J TOXICOL, V21, P397, DOI 10.1080/10915810290096621; *CA DEP PEST REG, 2002, SCH INT PEST MAN PRO; *CA DEP PEST REG, PEST ILLN SURV PROGR; Calvert GM, 2003, AM J PUBLIC HEALTH, V93, P605, DOI 10.2105/AJPH.93.4.605; CALVERT GM, 2001, HDB PESTICIDE TOXICO, P603; *CDCP, SENSOR PEST ILLN INJ; Fenske RA, 2000, J EXPO ANAL ENV EPID, V10, P662, DOI 10.1038/sj.jea.7500116; Greene A, 2002, J ECON ENTOMOL, V95, P1, DOI 10.1603/0022-0493-95.1.1; Koch D, 2002, ENVIRON HEALTH PERSP, V110, P829, DOI 10.1289/ehp.02110829; Lu CS, 2000, ENVIRON RES, V84, P290, DOI 10.1006/enrs.2000.4076; *NAT CTR MAN SCI, 1997, LEAD FREE SOLD PROJ, P1; *NAT ENV ED TRAIN, PEST NAT STRAT HLTH; National Intelligent Transport System Architecture Focus Groups, 2003, NAT INT TRANSP SYST, P1; OWENS K, 2002, SCH STATE PESTICIDE; PIPER C, 2002, PESTIC YOU, V22, P11; Quandt SA, 2004, ENVIRON HEALTH PERSP, V112, P382, DOI 10.1289/ehp.6554; Reigart J. R., 1999, RECOGNITION MANAGEME; Reigart JR, 2001, PEDIATR CLIN N AM, V48, P1185, DOI 10.1016/S0031-3955(05)70368-0; *US BUR LAB STAT, 2003, CURR POP SURV 1998 2; *US CENS BUR, 2003, PRIM CHILD CAR ARR U; *US CENS BUR, 2003, NAT POP DAT POP EST; US Environmental Protection Agency, INT PEST MAN IPM SCH; *US EPA, RER EL DEC RED GLYPH; *US EPA, INT RER EL DEC DIAZ; *US EPA, MAL RER EL DOC ENV F; *US EPA, INT RER EL DEC CHLOR; US General Accounting Office, 1999, PEST US EFF ALT PEST; OHIO SCH PEST MANAGE; PESTICIDES SCH PESTI	31	59	64	1	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 27	2005	294	4					455	465		10.1001/jama.294.4.455	http://dx.doi.org/10.1001/jama.294.4.455			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	948RM	16046652	Bronze			2022-12-01	WOS:000230733400020
J	Rosen, AB; Hamel, MB; Weinstein, MC; Cutler, DM; Fendrick, AM; Vijan, S				Rosen, AB; Hamel, MB; Weinstein, MC; Cutler, DM; Fendrick, AM; Vijan, S			Cost-effectiveness of full medicare coverage of angiotensin-converting enzyme inhibitors for beneficiaries with diabetes	ANNALS OF INTERNAL MEDICINE			English	Article							PLACEBO-CONTROLLED TRIAL; CORONARY-HEART-DISEASE; PRESCRIPTION DRUGS; MYOCARDIAL-INFARCTION; NORMOALBUMINURIC PATIENTS; CARDIOVASCULAR EVENTS; RISK-FACTORS; HEALTH; NEPHROPATHY; MELLITUS	Background: Angiotensin-converting enzyme (ACE) inhibitors slow renal disease progression and reduce cardiac morbidity and mortality in patients with diabetes. Patients' out-of-pocket costs pose a barrier to using this effective therapy. Objective: To estimate the cost-effectiveness to Medicare of first-dollar coverage (no cost sharing) of ACE inhibitors for beneficiaries with diabetes. Design: Markov model with costs and benefits discounted at 3%. Data Sources: Published literature and Medicare claims data. Target Population: 65-year-old Medicare beneficiary with diabetes. Time Horizon: Lifetime. Perspective: Medicare and societal. Interventions: we evaluated Medicare first-dollar coverage of ACE inhibitors compared with current practice (no coverage) and the new Medicare drug benefit. Outcome Measures: Costs (2003 U.S. dollars), quality-adjusted life-years (QALYs), life-years, and incremental cost-effectiveness. Results of Base-Case Analysis: Compared with current practice, first-dollar coverage of ACE inhibitors saved both lives and money (0.23 QALYs gained and $1606 saved per Medicare beneficiary). Compared with the new Medicare drug benefit, first-dollar coverage remained a dominant strategy (0.15 QALYs gained, $922 saved). Results of Sensitivity Analysis: Results were most sensitive to our estimate of increase in ACE inhibitor use; however, if ACE inhibitor use increased by only 7.2% (from 40% to 47.2%), first-dollar coverage would remain life-saving at no net cost to Medicare. In analyses conducted from the societal perspective, benefits were similar and cost savings were larger. Limitations: Results depend on accuracy of the underlying data and assumptions. The effect of more generous drug coverage on medication adherence is uncertain. Conclusions: Medicare first-dollar coverage of ACE inhibitors for beneficiaries with diabetes appears to extend life and reduce Medicare program costs. A reduction in program costs may result in more money to spend on other health care needs of the elderly.	Univ Michigan, Div Gen Med, Ann Arbor, MI 48109 USA; Ann Arbor Vet Affairs Med Ctr, Ann Arbor, MI USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Harvard Univ, Cambridge, MA 02138 USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Rosen, AB (corresponding author), Univ Michigan, Div Gen Med, 300 N Ingalls,Suite 7E10, Ann Arbor, MI 48109 USA.	abrosen@umich.edu		Cutler, David/0000-0002-4949-8917	AHRQ HHS [5 T32 HS00020-16] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000020] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Ahmad J, 1997, DIABETES CARE, V20, P1576, DOI 10.2337/diacare.20.10.1576; Arias Elizabeth, 2002, Natl Vital Stat Rep, V51, P1; Artz MB, 2002, AM J PUBLIC HEALTH, V92, P1257, DOI 10.2105/AJPH.92.8.1257; Bertoni AG, 2002, DIABETES CARE, V25, P471, DOI 10.2337/diacare.25.3.471; Brown GC, 2000, J DIABETES COMPLICAT, V14, P18, DOI 10.1016/S1056-8727(00)00061-1; Chaturvedi N, 2001, ANN INTERN MED, V134, P370, DOI 10.7326/0003-4819-134-5-200103060-00009; Chaturvedi N, 1998, LANCET, V351, P28, DOI 10.1016/S0140-6736(97)06209-0; Clark WF, 2000, CAN MED ASSOC J, V162, P195; *CTR MED MED SERV, 2003, MED MOD ACT; CULYER A, 2000, HDB HLTH EC, P119; Dunn EJ, 1999, QJM-INT J MED, V92, P443, DOI 10.1093/qjmed/92.8.443; Ellis JJ, 2004, J GEN INTERN MED, V19, P638, DOI 10.1111/j.1525-1497.2004.30516.x; Federman AD, 2001, JAMA-J AM MED ASSOC, V286, P1732, DOI 10.1001/jama.286.14.1732; Fendrick AM, 2001, AM J MANAG CARE, V7, P861; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Gerstein HC, 2000, LANCET, V355, P253; Golan L, 1999, ANN INTERN MED, V131, P660, DOI 10.7326/0003-4819-131-9-199911020-00005; Gold J A, 1996, Wis Med J, V95, P588; GOLD MR, 1996, COST EFFECTIVENESS; Goldman DP, 2004, JAMA-J AM MED ASSOC, V291, P2344, DOI 10.1001/jama.291.19.2344; Gordian M E, 1998, Alaska Med, V40, P51; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Hagihara A, 2001, HEALTH POLICY, V58, P231, DOI 10.1016/S0168-8510(01)00171-3; Haider A, 2000, Can J Clin Pharmacol, V7, P115; HARRIS BL, 1990, MED CARE, V28, P907, DOI 10.1097/00005650-199010000-00005; *HARV CTR RISK AN, 2003, COMPR TABL COST UT R; Herman WH, 2003, DIABETES CARE, V26, P683, DOI 10.2337/diacare.26.3.683; Hillen T, 2003, STROKE, V34, P1457, DOI 10.1161/01.STR.0000072985.24967.7F; Huskamp HA, 2003, NEW ENGL J MED, V349, P2224, DOI 10.1056/NEJMsa030954; Johnson RE, 1997, HEALTH SERV RES, V32, P103; JOHNSTON M, 1991, EC HLTH 1990, P46; Joyce GF, 2002, JAMA-J AM MED ASSOC, V288, P1733, DOI 10.1001/jama.288.14.1733; *KAIS FAM FDN, 2003, MED PRESCR DRUGS FA; *KAIS FAM FDN, 2004, PUBL KAIS FAM FDN; Kvetny J, 2001, QJM-INT J MED, V94, P89, DOI 10.1093/qjmed/94.2.89; Langa KM, 2002, J GERONTOL B-PSYCHOL, V57, pS177, DOI 10.1093/geronb/57.3.S177; LAWRENCE WF, 1995, AM J KIDNEY DIS, V25, P701, DOI 10.1016/0272-6386(95)90545-6; LEIBOWITZ A, 1985, SOC SCI MED, V21, P1063, DOI 10.1016/0277-9536(85)90161-3; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Malik RA, 1998, LANCET, V352, P1978, DOI 10.1016/S0140-6736(98)02478-7; Marre M, 2004, BRIT MED J, V328, P495, DOI 10.1136/bmj.37970.629537.0D; Mathias SD, 1997, STROKE, V28, P1888, DOI 10.1161/01.STR.28.10.1888; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; Mokdad AH, 2000, DIABETES CARE, V23, P1278, DOI 10.2337/diacare.23.9.1278; *NAT CTR HLTH STAT, 2004, NHANES 1999 200 PUB; Nathan DM, 1996, JAMA-J AM MED ASSOC, V276, P1409; National Center for Health Statistics, 2003, HLTH US 2003 CHARTB; NEWHOUSE JB, 2001, NATL BUREAU EC RES W, V8168; Niskanen L, 2001, DIABETES CARE, V24, P2091, DOI 10.2337/diacare.24.12.2091; O'Hare JP, 2000, DIABETES CARE, V23, P1823, DOI 10.2337/diacare.23.12.1823; OBRIEN B, 1989, J HEALTH ECON, V8, P109, DOI 10.1016/0167-6296(89)90011-8; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Phillips KA, 2000, JAMA-J AM MED ASSOC, V284, P2748, DOI 10.1001/jama.284.21.2748; Piette JD, 2004, MED CARE, V42, P102, DOI 10.1097/01.mlr.0000108742.26446.17; Pope GC, 2004, HEALTH CARE FINANC R, V25, P119; Ravid M, 1998, ANN INTERN MED, V128, P982, DOI 10.7326/0003-4819-128-12_Part_1-199806150-00004; Ravid M, 1996, ARCH INTERN MED, V156, P286, DOI 10.1001/archinte.156.3.286; REJA A, 1995, DIABETIC MED, V12, P307, DOI 10.1111/j.1464-5491.1995.tb00482.x; RETTENMAIER AJ, 2004, MEDICARE PRESCRIPTIO; Rodby RA, 1996, DIABETES CARE, V19, P1051, DOI 10.2337/diacare.19.10.1051; Rosen AB, 2004, J GEN INTERN MED, V19, P210; Rosen AB, 2004, J GEN INTERN MED, V19, P669, DOI 10.1111/j.1525-1497.2004.30264.x; Scarsi KK, 2000, ANN PHARMACOTHER, V34, P1002; Sisk JE, 1997, JAMA-J AM MED ASSOC, V278, P1333, DOI 10.1001/jama.278.16.1333; SMITH DG, 1993, INQUIRY-J HEALTH CAR, V30, P189; SOUMERAI SB, 1987, NEW ENGL J MED, V317, P550, DOI 10.1056/NEJM198708273170906; Stuart B, 1999, HEALTH AFFAIR, V18, P201, DOI 10.1377/hlthaff.18.2.201; Tamblyn R, 2001, JAMA-J AM MED ASSOC, V285, P421, DOI 10.1001/jama.285.4.421; TSEVAT J, 1993, MED DECIS MAKING, V13, P161, DOI 10.1177/0272989X9301300210; *US BUR LAB STAT, 2005, CONS PRIC IND ALL UR; *US REN DAT SYST, 2003, USRDS 2003 ANN DAT R; Valmadrid CT, 2000, ARCH INTERN MED, V160, P1093, DOI 10.1001/archinte.160.8.1093; VIBERTI G, 1994, JAMA-J AM MED ASSOC, V271, P275, DOI 10.1001/jama.271.4.275; Yusuf S, 2000, NEW ENGL J MED, V342, P145; 2003, 2003 DRUG TOPICS RED	76	104	106	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 19	2005	143	2					89	99		10.7326/0003-4819-143-2-200507190-00007	http://dx.doi.org/10.7326/0003-4819-143-2-200507190-00007			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	946YG	16027450				2022-12-01	WOS:000230608600001
J	Duerr, A; Hurst, S; Kourtis, AP; Rutenberg, N; Jamieson, DJ				Duerr, A; Hurst, S; Kourtis, AP; Rutenberg, N; Jamieson, DJ			Integrating family planning and prevention of mother-to-child HIV transmission in resource-limited settings	LANCET			English	Editorial Material							INFECTION; MORTALITY; WOMEN; CARE		Fred Hutchinson Canc Res Ctr, HIV Vaccine Trials Network, Seattle, WA 98109 USA; Ctr Dis Control & Prevent, Atlanta, GA USA; Assoc Sch Publ Hlth, Washington, DC USA; Populat Council, Washington, DC USA	Fred Hutchinson Cancer Center; Centers for Disease Control & Prevention - USA; Population Council	Duerr, A (corresponding author), Fred Hutchinson Canc Res Ctr, HIV Vaccine Trials Network, LE 500,POB 19024, Seattle, WA 98109 USA.	aduerr@hvtn.org		Jamieson, Denise/0000-0003-2597-1201; Hurst, Stacey/0000-0002-3338-9708; Kourtis, Athena/0000-0003-1585-1310				Brocklehurst P, 1998, BRIT J OBSTET GYNAEC, V105, P836, DOI 10.1111/j.1471-0528.1998.tb10227.x; *CENTR BUR STAT, 1999, KEN DEM HLTH SURV 19; *CENTR BUR STAT, 2003, ZAMB DEM HLTH SURV 2; Crampin AC, 2003, AIDS, V17, P389, DOI 10.1097/00002030-200302140-00013; Desgrees-du-Lou A, 2002, INT J STD AIDS, V13, P462, DOI 10.1258/09564620260079617; *FAM HLTH INT, 2004, NETWORK, V23, P16; FOSTER G, 1995, AIDS CARE, V7, P3, DOI 10.1080/09540129550126911; Kilewo C, 2001, J ACQ IMMUN DEF SYND, V28, P458, DOI 10.1097/00042560-200112150-00009; KING RWP, 1995, J ELECTROMAGNET WAVE, V9, P1, DOI 10.1163/156939395X00226; McIntyre J, 2003, BRIT MED BULL, V67, P127, DOI 10.1093/bmb/ldg012; Nakiyingi JS, 2003, AIDS, V17, P1827, DOI 10.1097/00002030-200308150-00012; Peck R, 2003, JAIDS-J ACQ IMM DEF, V33, P470, DOI 10.1097/00126334-200308010-00007; RYDER RW, 1994, AIDS, V8, P673, DOI 10.1097/00002030-199405000-00015; Sewankambo NK, 2000, AIDS, V14, P2391, DOI 10.1097/00002030-200010200-00021; Strachan M, 2004, ANAL FAMILY PLANNING; Sweat MD, 2004, AIDS, V18, P1661, DOI 10.1097/01.aids.0000131353.06784.8f; *UN POP FUND, 2004, NEW YORK CALL COMM L; *US DEP HHS, 2004, GUID US ANT AG HIV 1; WHO, 2004, MED EL CRIT CONTR US, V3; WHO, 2004, GLION CALL ACT FAM P; *WHO, 2003, AIDS EP UPD; World Health Organization, 2002, PREV HIV INF YOUNG C	22	38	38	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 16	2005	366	9481					261	263		10.1016/S0140-6736(05)66917-6	http://dx.doi.org/10.1016/S0140-6736(05)66917-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	945RG	16023518				2022-12-01	WOS:000230519200036
J	Coggan, JS; Bartol, TM; Esquenazi, E; Stiles, JR; Lamont, S; Martone, ME; Berg, DK; Ellisman, MH; Sejnowski, TJ				Coggan, JS; Bartol, TM; Esquenazi, E; Stiles, JR; Lamont, S; Martone, ME; Berg, DK; Ellisman, MH; Sejnowski, TJ			Evidence for ectopic neurotransmission at a neuronal synapse	SCIENCE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; CHICK CILIARY GANGLION; BUNGAROTOXIN BINDING-SITES; QUANTAL VARIABILITY; MULTIPLE CLASSES; MOLECULAR-FORMS; TRANSMISSION; LOCALIZATION; RECORDINGS; EXPRESSION	Neurotransmitter release is well known to occur at specialized synaptic regions that include presynaptic active zones and postsynaptic densities. At cholinergic synapses in the chick ciliary ganglion, however, membrane formations and physiological measurements suggest that release distant from postsynaptic densities can activate the predominantly extrasynaptic alpha 7 nicotinic receptor subtype. We explored such ectopic neurotransmission with a novel model synapse that combines Monte Carlo simulations with high-resolution serial electron microscopic tomography. Simulated synaptic activity is consistent with experimental recordings of miniature excitatory postsynaptic currents only when ectopic transmission is included in the model, broadening the possibilities for mechanisms of neuronal communication.	Salk Inst Biol Studies, Computat Neurobiol Lab, La Jolla, CA 92037 USA; Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; Carnegie Mellon Univ, Pittsburgh Supercomp Ctr, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA; Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA	Salk Institute; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Diego	Sejnowski, TJ (corresponding author), Salk Inst Biol Studies, Computat Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	terry@salk.edu	Sejnowski, Terrence/AAV-5558-2021	Coggan, Jay S/0000-0002-2270-1989	Howard Hughes Medical Institute Funding Source: Medline; NCRR NIH HHS [P41-RR06009, P41 RR004050, RR04050, P41 RR006009] Funding Source: Medline; NIDCD NIH HHS [DC03192] Funding Source: Medline; NIGMS NIH HHS [R01 GM068630, P20-GM065805, P20 GM065805, GM068630] Funding Source: Medline; NINDS NIH HHS [NS12601, P01 NS044306, NS35469, R01 NS012601, R01 NS035469, P01-NS044306] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050, P41RR006009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068630, P20GM065805] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS012601, R01NS035469, P01NS044306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003192] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ANGLISTER L, 1994, NEURON, V12, P783, DOI 10.1016/0896-6273(94)90331-X; BARTOL TM, 1991, BIOPHYS J, V59, P1290, DOI 10.1016/S0006-3495(91)82344-X; Bennett MR, 1997, BIOPHYS J, V72, P1595, DOI 10.1016/S0006-3495(97)78806-4; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Chang KT, 1999, J NEUROSCI, V19, P3701; Chang KT, 2001, NEURON, V32, P855, DOI 10.1016/S0896-6273(01)00516-5; CONROY WG, 1995, J BIOL CHEM, V270, P4424, DOI 10.1074/jbc.270.9.4424; COURAUD JY, 1980, J NEUROCHEM, V34, P1209, DOI 10.1111/j.1471-4159.1980.tb09961.x; Diamond JS, 2001, J NEUROSCI, V21, P8328, DOI 10.1523/JNEUROSCI.21-21-08328.2001; DiGregorio DA, 2002, NEURON, V35, P521, DOI 10.1016/S0896-6273(02)00787-0; FABER DS, 1992, SCIENCE, V258, P1494, DOI 10.1126/science.1279813; Franks KM, 2003, J NEUROSCI, V23, P3186; Franks KM, 2002, BIOPHYS J, V83, P2333, DOI 10.1016/S0006-3495(02)75248-X; FRERKING M, 1995, NEURON, V15, P885, DOI 10.1016/0896-6273(95)90179-5; Horch HLW, 1995, J NEUROSCI, V15, P7778; JACOB MH, 1983, J NEUROSCI, V3, P260; Kruk PJ, 1997, BIOPHYS J, V73, P2874, DOI 10.1016/S0006-3495(97)78316-4; Lenzi D, 1999, J NEUROSCI, V19, P119, DOI 10.1523/JNEUROSCI.19-01-00119.1999; Lorensen WE., 1987, COMPUT GRAPH, V21, P163, DOI [10.1145/37402.37422, DOI 10.1145/37402.37422]; LORING RH, 1985, NEUROSCIENCE, V14, P645, DOI 10.1016/0306-4522(85)90316-1; MARGIOTTA JF, 1987, J NEUROSCI, V7, P3612; McNerney ME, 2000, J NEUROPHYSIOL, V84, P1314, DOI 10.1152/jn.2000.84.3.1314; Momiyama A, 2003, J PHYSIOL-LONDON, V549, P75, DOI 10.1113/jphysiol.2002.033472; Nguyen D, 2002, J COMP NEUROL, V448, P128, DOI 10.1002/cne.10237; Nusser Z, 1997, NEURON, V19, P697, DOI 10.1016/S0896-6273(00)80382-7; Shoop RD, 2001, J NEUROSCI, V21, P771, DOI 10.1523/JNEUROSCI.21-03-00771.2001; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; Soto G E, 1994, Neuroimage, V1, P230, DOI 10.1006/nimg.1994.1008; Stiles JR, 2001, METH NE FRO NEUROSCI, P87; Stiles JR, 1999, BIOPHYS J, V77, P1177, DOI 10.1016/S0006-3495(99)76969-9; Stiles JR, 1996, P NATL ACAD SCI USA, V93, P5747, DOI 10.1073/pnas.93.12.5747; Taschenberger H, 2002, NEURON, V36, P1127, DOI 10.1016/S0896-6273(02)01137-6; Ullian EM, 1997, J NEUROSCI, V17, P7210; VIGNY M, 1978, EUR J BIOCHEM, V85, P317, DOI 10.1111/j.1432-1033.1978.tb12241.x; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500; Zhang ZW, 1996, NEURON, V17, P1231, DOI 10.1016/S0896-6273(00)80253-6	36	138	154	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2005	309	5733					446	451		10.1126/science.1108239	http://dx.doi.org/10.1126/science.1108239			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946LY	16020730	Green Accepted			2022-12-01	WOS:000230574900040
J	Gewin, V				Gewin, V			Industry lured by the gains of going green	NATURE			English	Editorial Material																			0	15	18	3	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 14	2005	436	7048					173	173		10.1038/436173a	http://dx.doi.org/10.1038/436173a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944VR	16015302	Bronze			2022-12-01	WOS:000230459500012
J	Guo, FZ; Guo, AK				Guo, FZ; Guo, AK			Crossmodal interactions between olfactory and visual learning in Drosophila	SCIENCE			English	Article							FLIGHT; MELANOGASTER; INSIGHTS; REQUIRES; MEMORY; SMELLS; BRAIN	Different modalities of sensation interact in a synergistic or antagonistic manner during sensory perception, but whether there is also interaction during memory acquisition is largely unknown. In Drosophila reinforcement learning we found that conditioning with concurrent visual and olfactory cues reduced the threshold for unimodal memory retrieval. Furthermore, bimodal preconditioning followed by unimodal conditioning with either a visual or olfactory cue led to crossmodal memory transfer. Crossmodal memory acquisition in Drosophila may contribute significantly to learning in a natural environment.	Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Neurobiol, Inst Neurosci, Shanghai 200031, Peoples R China; Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Guo, AK (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Neurobiol, Inst Neurosci, Shanghai 200031, Peoples R China.	akguo@ion.ac.cn						Brembs B, 2001, J EXP BIOL, V204, P2849; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; Davis RL, 2004, NEURON, V44, P31, DOI 10.1016/j.neuron.2004.09.008; Dubnau J, 1998, ANNU REV NEUROSCI, V21, P407, DOI 10.1146/annurev.neuro.21.1.407; Frye MA, 2004, J EXP BIOL, V207, P123, DOI 10.1242/jeb.00725; Frye MA, 2003, J EXP BIOL, V206, P843, DOI 10.1242/jeb.00175; Gottfried JA, 2003, NEURON, V39, P375, DOI 10.1016/S0896-6273(03)00392-1; GREENSPAN RJ, 1995, NEURON, V15, P747, DOI 10.1016/0896-6273(95)90165-5; Guo A, 1996, LEARN MEMORY, V3, P49, DOI 10.1101/lm.3.1.49; Hall G, 1996, ANIM LEARN BEHAV, V24, P233, DOI 10.3758/BF03198973; Heisenberg M, 2001, LEARN MEMORY, V8, P1, DOI 10.1101/lm.8.1.1; Liu L, 1999, NATURE, V400, P753, DOI 10.1038/23456; Srinivasan MV, 1998, NATURE, V396, P637, DOI 10.1038/25272; Stein BE., 1993, MERGING SENSES; Tang SM, 2004, SCIENCE, V305, P1020, DOI 10.1126/science.1099839; Tang SM, 2001, SCIENCE, V294, P1543, DOI 10.1126/science.1058237; van Swinderen B, 2003, NAT NEUROSCI, V6, P579, DOI 10.1038/nn1054; Waddell S, 2001, TRENDS GENET, V17, P719, DOI 10.1016/S0168-9525(01)02526-4	18	88	101	3	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2005	309	5732					307	310		10.1126/science.1111280	http://dx.doi.org/10.1126/science.1111280			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944SP	16002621				2022-12-01	WOS:000230449800047
J	Haddock, SHD; Dunn, CW; Pugh, PR; Schnitzler, CE				Haddock, SHD; Dunn, CW; Pugh, PR; Schnitzler, CE			Bioluminescent and red-fluorescent lures in a deep-sea siphonophore	SCIENCE			English	Article							MEDUSAE		Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; Yale Univ, New Haven, CT 06520 USA; Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England	Monterey Bay Aquarium Research Institute; Yale University; NERC National Oceanography Centre	Haddock, SHD (corresponding author), Monterey Bay Aquarium Res Inst, 7700 Sandholdt Rd, Moss Landing, CA 95039 USA.	haddock@mbari.org	Schnitzler, Christine/G-8733-2013	Dunn, Casey/0000-0003-0628-5150; Schnitzler, Christine/0000-0002-5001-6524				BONNETT R, 1979, J MAR BIOL ASSOC UK, V59, P565, DOI 10.1017/S0025315400045574; DOUGLAS RH, 2002, BIOLUMINESCENCE CHEM, P391; Haddock SHD, 1999, MAR BIOL, V133, P571, DOI 10.1007/s002270050497; HERRING PJ, 1971, COMP BIOCHEM PHYSIOL, V39, P739, DOI 10.1016/0305-0491(71)90099-X; HERRING PJ, 1977, S ZOOL SOC LOND, V38, P127; Pugh P.R., 2001, Bulletin of the Natural History Museum Zoology Series, V67, P169; Shagin DA, 2004, MOL BIOL EVOL, V21, P841, DOI 10.1093/molbev/msh079	7	75	79	0	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 8	2005	309	5732					263	263		10.1126/science.1110441	http://dx.doi.org/10.1126/science.1110441			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944SP	16002609				2022-12-01	WOS:000230449800033
J	Franklyn, JA; Sheppard, MC; Maisonneuve, P				Franklyn, JA; Sheppard, MC; Maisonneuve, P			Thyroid function and mortality in patients treated for hyperthyroidism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-ARTERY-DISEASE; ISCHEMIC-HEART-DISEASE; RISK-FACTOR; FOLLOW-UP; ATRIAL-FIBRILLATION; ALL-CAUSE; HYPOTHYROIDISM; WOMEN; TSH	Context Hyperthyroidism has been reported to cause excess all-cause and circulatory mortality. Whether this can be reversed is unknown, as is the influence of mild persisting thyroid dysfunction and treatment-induced hypothyroidism. Objectives To determine whether radioiodine treatment is associated with increased mortality and to determine the influences of mild thyroid dysfunction and the development of overt hypothyroidism treated with thyroxine (T-4). Design, Setting, and Participants A population -based study of 2668 individuals aged 40 years or older treated for overt hyperthyroidism with radioiodine in the West Midlands region of England from 1984-2002. Main Outcome Measures Cause of death compared with age- and period-specific mortality in England and Wales and assessment of the influence of T-4 therapy for radioiodine-induced hypothyroidism and subclinical thyroid dysfunction on mortality. Results In 15 968 person -years of follow-up, 554 died vs 487 expected deaths (standardized mortality ratio [SMR], 1.14; 95% confidence interval [CI], 1.04-1.24, P=.002). Increased risks of all-cause and circulatory deaths vs age- and period-specific mortality were observed in follow-up in those not requiring, or prior to, T-4 therapy. These increased risks were not observed during follow-up on T-4 therapy (circulatory disease SMR prior to T-4, 1.33; 95% Cl, 1.14-1.53 vs SMR, 0.91; 95% Cl, 0.70-1.17 during T-4)- Patients receiving T-4 had decreased risk of mortality vs risk in the period not requiring, or prior to, T-4 therapy (all-cause mortality hazard ratio [HR], 0.65; 95 % Cl, 0.54-0.79; circulatory mortality HR, 0.65; 95% Cl, 0.48-0.87). Increased all-cause mortality vs the background population was observed in the period prior to T-4 therapy in follow-up associated with low, normal, and high serum thyrotropin. The SMR for ischemic heart disease increased slightly when analyzed by serum thyrotropin, high serum thyrotropin being the highest SMR (low thyrotropin SMR, 1.06; 95% Cl, 0.75-1.45; normal thyrotropin SMR, 1.17; 95% Cl, 0.76-1.71; high thyrotropin SMR, 1.48; 95% Cl, 0.86-2.37). Comparison within the cohort showed that mild hypothyroidism prior to T-4 therapy was associated with increased risk of mortality from ischemic heart disease vs biochemical euthyroidism (HR, 2.08; 95% Cl, 1.04-4.19). Conclusions Patients treated with radioiodine for hyperthyroidism had increased mortality vs age- and period-specific mortality in England and Wales, a finding no longer evident during T-4 therapy. This supports treating hyperthyroidism with doses of radioiodine sufficient to induce overt hypothyroidism. The association within the cohort of mortality from ischemic heart disease with subclinical hypothyroidism suggests T-4 replacement should be considered should this biochemical abnormality develop after radioiodine therapy.	Univ Birmingham, Sch Med, Inst Biomed Res,Dept Med, Div Med Sci, Birmingham B15 2TT, W Midlands, England; European Inst Oncol, Div Epidemiol & Biostat, Milan, Italy	University of Birmingham; IRCCS European Institute of Oncology (IEO)	Franklyn, JA (corresponding author), Univ Birmingham, Sch Med, Inst Biomed Res,Dept Med, Div Med Sci, Birmingham B15 2TT, W Midlands, England.	j.a.franklyn@bham.ac.uk	Maisonneuve, Patrick/U-9789-2018	Maisonneuve, Patrick/0000-0002-5309-4704				Auer J, 2001, AM HEART J, V142, P838, DOI 10.1067/mhj.2001.119370; BARBER SG, 1977, LANCET, V2, P967; Canaris GJ, 2000, ARCH INTERN MED, V160, P526, DOI 10.1001/archinte.160.4.526; Cappola AR, 2003, J CLIN ENDOCR METAB, V88, P2438, DOI 10.1210/jc.2003-030398; Danese ND, 2000, J CLIN ENDOCR METAB, V85, P2993, DOI 10.1210/jcem.85.9.6841; DELIT C, 1961, JAMA-J AM MED ASSOC, V176, P262, DOI 10.1001/jama.1961.03040170008003; Fisher LD, 1999, ANNU REV PUBL HEALTH, V20, P145, DOI 10.1146/annurev.publhealth.20.1.145; FRANKLYN JA, 1991, CLIN ENDOCRINOL, V34, P71, DOI 10.1111/j.1365-2265.1991.tb01738.x; Franklyn JA, 1998, NEW ENGL J MED, V338, P712, DOI 10.1056/NEJM199803123381103; GOLDMAN MB, 1990, CANCER RES, V50, P2283; Gussekloo J, 2004, JAMA-J AM MED ASSOC, V292, P2591, DOI 10.1001/jama.292.21.2591; Hak AE, 2000, ANN INTERN MED, V132, P270, DOI 10.7326/0003-4819-132-4-200002150-00004; HALL P, 1993, ACTA ENDOCRINOL-COP, V128, P230, DOI 10.1530/acta.0.1280230; Imaizumi M, 2004, J CLIN ENDOCR METAB, V89, P3365, DOI 10.1210/jc.2003-031089; KEATING FR, 1961, PROG CARDIOVASC DIS, V3, P364, DOI 10.1016/S0033-0620(61)90004-4; Klein I, 2001, NEW ENGL J MED, V344, P501, DOI 10.1056/NEJM200102153440707; LEESE GP, 1992, CLIN ENDOCRINOL, V37, P500, DOI 10.1111/j.1365-2265.1992.tb01480.x; Parle JV, 2001, LANCET, V358, P861, DOI 10.1016/S0140-6736(01)06067-6; PARLE JV, 1991, CLIN ENDOCRINOL, V34, P77; Ringel MD, 2005, J CLIN ENDOCR METAB, V90, P588, DOI 10.1210/jc.2004-2173; SAWIN CT, 1994, NEW ENGL J MED, V331, P1249, DOI 10.1056/NEJM199411103311901; STEINBERG AD, 1968, ANN INTERN MED, V68, P338, DOI 10.7326/0003-4819-68-2-338; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; TUNBRIDGE WMG, 1977, CLIN ENDOCRINOL, V7, P481, DOI 10.1111/j.1365-2265.1977.tb01340.x; Vanderpump MPJ, 1996, THYROID, V6, P155; VANHAELST L, 1967, LANCET, V2, P800, DOI 10.1016/S0140-6736(67)92235-0; YAMAMOTO M, 1992, ENDOCRINOL JAPON, V39, P223	27	109	120	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 6	2005	294	1					71	80		10.1001/jama.294.1.71	http://dx.doi.org/10.1001/jama.294.1.71			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	941JD	15998893				2022-12-01	WOS:000230210200027
J	Fox, RC; Scott, CS				Fox, RC; Scott, CS			First evidence of a venom delivery apparatus in extinct mammals	NATURE			English	Article								Numerous non-mammalian vertebrates have evolved lethal venoms to aid either in securing prey or as protection from predators, but modern mammals that use venoms in these ways are rare, including only the duck-billed platypus (Ornithorhynchus), the Caribbean Solenodon, and a few shrews (Soricidae) (Order Insectivora)(1). Here we report evidence of a venom delivery apparatus in extinct mammals, documented by well-preserved specimens recovered from late Palaeocene rocks in Alberta, Canada(2,3). Although classified within Eutheria, these mammals are phylogenetically remote from modern Insectivora(4) and have evolved specialized teeth as salivary venom delivery systems (VDSs) that differ markedly from one another and from those of Solenodon and shrews. Our discoveries therefore show that mammals have been much more flexible in the evolution of VDSs than previously believed, contradicting currently held notions that modern insectivorans are representative of the supposedly limited role of salivary venoms in mammalian history. Evidently, small predatory eutherians have paralleled colubroid snakes(5) in evolving salivary venoms and their delivery systems several times independently.	Univ Alberta, Dept Biol Sci, Paleontol Vertebres Lab, Edmonton, AB T6G 2E9, Canada	University of Alberta	Fox, RC (corresponding author), Univ Alberta, Dept Biol Sci, Paleontol Vertebres Lab, Edmonton, AB T6G 2E9, Canada.	richard.fox@ualberta.ca						BELLAIRS AD, 1957, REPTILES LIFE HIST E; DUFTON MJ, 1992, PHARMACOL THERAPEUT, V53, P199, DOI 10.1016/0163-7258(92)90009-O; FOX RC, 1990, DAWN AGE MAMMALS NO, P51; Gazin C. L., 1956, SMITHSONIAN MISCELLA, V131, P1; GINGERICH P D, 1983, Contributions from the Museum of Paleontology University of Michigan, V26, P227; GOIN CJ, 1972, INTRO HERPETOLOGY; Jackson K, 2003, ZOOL J LINN SOC-LOND, V137, P337, DOI 10.1046/j.1096-3642.2003.00052.x; Kita M, 2004, P NATL ACAD SCI USA, V101, P7542, DOI 10.1073/pnas.0402517101; Lake AR, 1996, S AFR J SCI, V92, P167; Lofgren Donald L., 2004, P43; Macdonald DW., 1984, ENCY MAMMALS, P304; MCDOWELL SAMUEL BOOKER, 1958, BULL AMER MUS NAT HIST, V115, P113; McKenna MC, 1997, CLASSIFICATION MAMMA; Rabb G.B., 1959, NAT HIST MISC, V170, P1; Scott C, 2004, J VERTEBR PALEONTOL, V24, p111A	15	37	39	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2005	435	7045					1091	1093		10.1038/nature03646	http://dx.doi.org/10.1038/nature03646			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937ZT	15973406				2022-12-01	WOS:000229970400047
J	Erwin, DH				Erwin, DH			Seeds of diversity	SCIENCE			English	Editorial Material							ECOSYSTEM ENGINEERS; ORGANISMS		Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20013 USA	Smithsonian Institution; Smithsonian National Museum of Natural History	Erwin, DH (corresponding author), Natl Museum Nat Hist, Dept Paleobiol, MRC-121,POB 37012, Washington, DC 20013 USA.	erwind@si.edu	Erwin, Douglas H/A-9668-2009	Erwin, Douglas/0000-0003-2518-5614				[Anonymous], 2013, NICHE CONSTRUCTION N; Dawkins R, 2004, BIOL PHILOS, V19, P377, DOI 10.1023/B:BIPH.0000036180.14904.96; Dawkins R., 1982, pi; Emerson BC, 2005, NATURE, V434, P1015, DOI 10.1038/nature03450; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Lewontin R.C., 1983, P273; MAC ARTHUR ROBERT H., 1967; SIGNOR PW, 1994, PALEOBIOLOGY, V20, P297, DOI 10.1017/S0094837300012793; STANLEY SM, 1990, PALEOBIOLOGY, V16, P401, DOI 10.1017/S0094837300010150; Webby B.D., 2004, GREAT ORDOVICIAN BIO	11	36	36	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 17	2005	308	5729					1752	1753		10.1126/science.1113416	http://dx.doi.org/10.1126/science.1113416			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937LY	15961660				2022-12-01	WOS:000229926800042
J	Hopkins, DS; Pekker, D; Goldbart, PM; Bezryadin, A				Hopkins, DS; Pekker, D; Goldbart, PM; Bezryadin, A			Quantum interference device made by DNA templating of superconducting nanowires	SCIENCE			English	Article								The application of single molecules as templates for nanodevices is a promising direction for nanotechnology. We used a pair of suspended DNA molecules as templates for superconducting two-nanowire devices. Because the resulting wires are very thin, comparable to the DNA molecules themselves, they are susceptible to thermal fluctuations typical for one-dimensional superconductors and exhibit a nonzero resistance over a broad temperature range. We observed resistance oscillations in these two-nanowire structures that are different from the usual Little-Parks oscillations. Here, we provide a quantitative explanation for the observed quantum interference phenomenon, which takes into account strong phase gradients created in the leads by the applied magnetic field.	Univ Illinois, Dept Phys, Urbana, IL 61801 USA; Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Bezryadin, A (corresponding author), Univ Illinois, Dept Phys, Urbana, IL 61801 USA.	bezryadi@uiuc.edu	Bezryadin, Alexey/H-1815-2016	Bezryadin, Alexey/0000-0002-4822-6960				Bezryadin A, 2000, NATURE, V404, P971, DOI 10.1038/35010060; Braun E, 1998, NATURE, V391, P775, DOI 10.1038/35826; Braun E, 2004, ADV PHYS, V53, P441, DOI 10.1080/00018730412331294688; CLEM JR, 1972, B AM PHYS SOC, V43, P411; JAKLEVIC RC, 1964, PHYS REV LETT, V12, P159, DOI 10.1103/PhysRevLett.12.159; LANGER JS, 1967, PHYS REV, V164, P498, DOI 10.1103/PhysRev.164.498; LIKHAREV KK, 1973, SOV RADIOPHYS, V14, P722; LITTLE WA, 1967, PHYS REV, V156, P396, DOI 10.1103/PhysRev.156.396; Maksimova GM, 1998, PHYS SOLID STATE+, V40, P1607, DOI 10.1134/1.1130618; MCCUMBER DE, 1970, PHYS REV B-SOLID ST, V1, P1054, DOI 10.1103/PhysRevB.1.1054; Mertig M, 2002, NANO LETT, V2, P841, DOI 10.1021/nl025612r; Richter J, 2001, APPL PHYS LETT, V78, P536, DOI 10.1063/1.1338967; Richter J, 2002, APPL PHYS A-MATER, V74, P725, DOI 10.1007/s003390201289; Seeman NC, 1998, ANGEW CHEM INT EDIT, V37, P3220, DOI 10.1002/(SICI)1521-3773(19981217)37:23<3220::AID-ANIE3220>3.0.CO;2-C; Stan G, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.097003; Tinkham M, 2002, APPL PHYS LETT, V80, P2946, DOI 10.1063/1.1473232; Tinkham M., 2004, INTRO SUPERCONDUCTIV; Watanabe H, 2001, APPL PHYS LETT, V79, P2462, DOI 10.1063/1.1408604; Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389	19	129	131	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2005	308	5729					1762	1765		10.1126/science.1111307	http://dx.doi.org/10.1126/science.1111307			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937LY	15961664				2022-12-01	WOS:000229926800047
J	Fre, S; Huyghe, M; Mourikis, P; Robine, S; Louvard, D; Artavanis-Tsakonas, S				Fre, S; Huyghe, M; Mourikis, P; Robine, S; Louvard, D; Artavanis-Tsakonas, S			Notch signals control the fate of immature progenitor cells in the intestine	NATURE			English	Article							VILLIN GENE; EPITHELIAL-CELLS; STEM-CELLS; EXPRESSION; DIFFERENTIATION; MICE; PROLIFERATION; NEUROGENIN3; MATH1; HES5	The Notch signalling pathway plays a crucial role in specifying cellular fates in metazoan development by regulating communication between adjacent cells(1,2). Correlative studies suggested an involvement of Notch in intestinal development. Here, by modulating Notch activity in the mouse intestine, we directly implicate Notch signals in intestinal cell lineage specification. We also show that Notch activation is capable of amplifying the intestinal progenitor pool while inhibiting cell differentiation. We conclude that Notch activity is required for the maintenance of proliferating crypt cells in the intestinal epithelium.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Canc Ctr,Dept Cell Biol, Charlestown, MA 02129 USA; Inst Curie, CNRS, F-75231 Paris, France; Univ Paris 11, Fac Sci Orsay, F-91405 Orsay, France; Coll France, F-75231 Paris, France	Harvard University; Massachusetts General Hospital; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; College de France	Artavanis-Tsakonas, S (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Canc Ctr,Dept Cell Biol, Charlestown, MA 02129 USA.	tsakonas@helix.mgh.harvard.edu	Fre, Silvia/C-7540-2017; Mourikis, Philippos/AAM-2458-2020	Fre, Silvia/0000-0002-7209-7636; Mourikis, Philippos/0000-0003-3164-7109; huyghe, mathilde/0000-0002-8473-2924				Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; BRY L, 1994, P NATL ACAD SCI USA, V91, P10335, DOI 10.1073/pnas.91.22.10335; Capobianco AJ, 1997, MOL CELL BIOL, V17, P6265, DOI 10.1128/MCB.17.11.6265; Crosnier C, 2005, DEVELOPMENT, V132, P1093, DOI 10.1242/dev.01644; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; FATH KR, 1990, DEVELOPMENT, V109, P449; Galceran J, 2004, GENE DEV, V18, P2718, DOI 10.1101/gad.1249504; GERDES J, 1983, INT J CANCER, V31, P13, DOI 10.1002/ijc.2910310104; Go MJ, 1998, DEVELOPMENT, V125, P2031; Greenwald I, 1998, GENE DEV, V12, P1751, DOI 10.1101/gad.12.12.1751; Hofer D, 1996, HISTOCHEM CELL BIOL, V105, P405, DOI 10.1007/BF01463662; Ito T, 2000, DEVELOPMENT, V127, P3913; Jenny M, 2002, EMBO J, V21, P6338, DOI 10.1093/emboj/cdf649; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Kimble J, 1997, ANNU REV CELL DEV BI, V13, P333, DOI 10.1146/annurev.cellbio.13.1.333; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Lee JC, 2001, DIABETES, V50, P928, DOI 10.2337/diabetes.50.5.928; LOUVARD D, 1992, ANNU REV CELL BIOL, V8, P157, DOI 10.1146/annurev.cellbio.8.1.157; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; MAUNOURY R, 1988, EMBO J, V7, P3321, DOI 10.1002/j.1460-2075.1988.tb03203.x; MAUNOURY R, 1992, DEVELOPMENT, V115, P717; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Pinto D, 1999, J BIOL CHEM, V274, P6476, DOI 10.1074/jbc.274.10.6476; Sancho E, 2003, CURR OPIN CELL BIOL, V15, P763, DOI 10.1016/j.ceb.2003.10.012; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Varnum-Finney B, 2000, NAT MED, V6, P1278, DOI 10.1038/81390; Weinmaster G, 1997, MOL CELL NEUROSCI, V9, P91, DOI 10.1006/mcne.1997.0612; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Zine A, 2002, HEARING RES, V170, P22, DOI 10.1016/S0378-5955(02)00449-5	30	674	725	1	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2005	435	7044					964	968		10.1038/nature03589	http://dx.doi.org/10.1038/nature03589			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935RN	15959516				2022-12-01	WOS:000229799700051
J	He, L; Thomson, JM; Hemann, MT; Hernando-Monge, E; Mu, D; Goodson, S; Powers, S; Cordon-Cardo, C; Lowe, SW; Hannon, GJ; Hammond, SM				He, L; Thomson, JM; Hemann, MT; Hernando-Monge, E; Mu, D; Goodson, S; Powers, S; Cordon-Cardo, C; Lowe, SW; Hannon, GJ; Hammond, SM			A microRNA polycistron as a potential human oncogene	NATURE			English	Article							CAENORHABDITIS-ELEGANS; DEVELOPMENTAL SWITCH; IN-VIVO; GENE; RNA; SUPPRESSION; EXPRESSION; LYMPHOMA; ENCODES; TARGET	To date, more than 200 microRNAs have been described in humans; however, the precise functions of these regulatory, noncoding RNAs remains largely obscure. One cluster of microRNAs, the mir-17-92 polycistron, is located in a region of DNA that is amplified in human B-cell lymphomas(1). Here we compared B-cell lymphoma samples and cell lines to normal tissues, and found that the levels of the primary or mature microRNAs derived from the mir-17-92 locus are often substantially increased in these cancers. Enforced expression of the mir-17-92 cluster acted with c-myc expression to accelerate tumour development in a mouse B-cell lymphoma model. Tumours derived from haematopoietic stem cells expressing a subset of the mir- 17 - 92 cluster and c-myc could be distinguished by an absence of apoptosis that was otherwise prevalent in c-myc-induced lymphomas. Together, these studies indicate that non-coding RNAs, specifically microRNAs, can modulate tumour formation, and implicate the mir- 17 - 92 cluster as a potential human oncogene.	Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; Mem Sloan Kettering Canc Ctr, Div Mol Pathol, New York, NY 10021 USA	Cold Spring Harbor Laboratory; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Memorial Sloan Kettering Cancer Center	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.edu; hammond@med.unc.edu	Hannon, Gregory/AAB-3568-2019; Mu, David/E-8933-2011	Mu, David/0000-0002-7762-0182; Hernando, Eva/0000-0003-1023-0312; Powers, Scott/0000-0003-2769-1932	NATIONAL CANCER INSTITUTE [P01CA087497, P30CA008748] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA087497, P30 CA008748] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; AMBROS V, 1989, CELL, V57, P49, DOI 10.1016/0092-8674(89)90171-2; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Chang S, 2004, NATURE, V430, P785, DOI 10.1038/nature02752; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Di Cristofano A, 2001, NAT GENET, V27, P222, DOI 10.1038/84879; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hemann MT, 2004, P NATL ACAD SCI USA, V101, P9333, DOI 10.1073/pnas.0403286101; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Knuutila S, 1998, AM J PATHOL, V152, P1107; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Metzler M, 2004, GENE CHROMOSOME CANC, V39, P167, DOI 10.1002/gcc.10316; Michael MZ, 2003, MOL CANCER RES, V1, P882; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; RUVKUN G, 1989, NATURE, V338, P313, DOI 10.1038/338313a0; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369	28	2912	3225	4	262	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2005	435	7043					828	833		10.1038/nature03552	http://dx.doi.org/10.1038/nature03552			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933NK	15944707	Green Accepted, Green Submitted			2022-12-01	WOS:000229638700053
J	Cyranoski, D				Cyranoski, D			Masking our ignorance	NATURE			English	News Item																			0	2	2	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 26	2005	435	7041					408	408						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929IF	15952257				2022-12-01	WOS:000229337800018
J	Ferguson, NM; Cummings, DAT; Cauchemez, S; Fraser, C; Riley, S; Meeyai, A; Iamsirithaworn, S; Burke, DS				Ferguson, NM; Cummings, DAT; Cauchemez, S; Fraser, C; Riley, S; Meeyai, A; Iamsirithaworn, S; Burke, DS			Strategies for containing an emerging influenza pandemic in Southeast Asia	NATURE			English	Article							VIRUS INFECTIONS; ANTIVIRAL DRUG; TRANSMISSION; OSELTAMIVIR; HOUSEHOLD; RISK; RESISTANT; EPIDEMIC; OUTBREAK; DISEASES	Highly pathogenic H5N1 influenza A viruses are now endemic in avian populations in Southeast Asia, and human cases continue to accumulate. Although currently incapable of sustained human-to-human transmission, H5N1 represents a serious pandemic threat owing to the risk of a mutation or reassortment generating a virus with increased transmissibility. Identifying public health interventions that might be able to halt a pandemic in its earliest stages is therefore a priority. Here we use a simulation model of influenza transmission in Southeast Asia to evaluate the potential effectiveness of targeted mass prophylactic use of antiviral drugs as a containment strategy. Other interventions aimed at reducing population contact rates are also examined as reinforcements to an antiviral-based containment policy. We show that elimination of a nascent pandemic may be feasible using a combination of geographically targeted prophylaxis and social distancing measures, if the basic reproduction number of the new virus is below 1.8. We predict that a stockpile of 3 million courses of antiviral drugs should be sufficient for elimination. Policy effectiveness depends critically on how quickly clinical cases are diagnosed and the speed with which antiviral drugs can be distributed.	Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, London W2 1PG, England; Univ London Imperial Coll Sci Technol & Med, Inst Math Sci, London SW7 2PG, England; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; INSERM, U707, F-75571 Paris, France; Univ Hong Kong, Dept Community Med, Hong Kong, Hong Kong, Peoples R China; Minist Publ Hlth, Dept Dis Control, Bur Epidemiol, Nonthaburi 11000, Thailand	Imperial College London; Imperial College London; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Hong Kong; Ministry of Public Health - Thailand	Ferguson, NM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, St Marys Campus,Norfolk Pl, London W2 1PG, England.	neil.ferguson@imperial.ac.uk	Ferguson, Neil/B-8578-2008; Fraser, Christophe/A-8109-2008; Riley, Steven/C-4384-2009	Ferguson, Neil/0000-0002-1154-8093; Fraser, Christophe/0000-0003-2399-9657; Riley, Steven/0000-0001-7904-4804; /0000-0002-5704-8094				Abbott A, 2004, NATURE, V427, P472, DOI 10.1038/427472a; ANDERSON R M, 1991; Axtell RL, 2001, SCIENCE, V293, P1818, DOI 10.1126/science.1062081; Brooks MJ, 2004, CURR OPIN PULM MED, V10, P197, DOI 10.1097/00063198-200405000-00009; Carrat F, 2002, ARCH INTERN MED, V162, P1842, DOI 10.1001/archinte.162.16.1842; Cauchemez S, 2004, STAT MED, V23, P3469, DOI 10.1002/sim.1912; CHAMRATRITHIRON.A, 1995, NATL MIGRATION SURVE; Coombes R, 2005, BRIT MED J, V330, P495, DOI 10.1136/bmj.330.7490.495; ELVEBACK LR, 1976, AM J EPIDEMIOL, V103, P152, DOI 10.1093/oxfordjournals.aje.a112213; Ferguson NM, 2004, SCIENCE, V304, P968, DOI 10.1126/science.1096898; Ferguson NM, 2003, J ANTIMICROB CHEMOTH, V51, P977, DOI 10.1093/jac/dkg136; FLAHAULT A, 1988, STAT MED, V7, P1147, DOI 10.1002/sim.4780071107; Fleming DM, 1999, EUR J EPIDEMIOL, V15, P467, DOI 10.1023/A:1007525402861; FOX JP, 1982, AM J EPIDEMIOL, V116, P212, DOI 10.1093/oxfordjournals.aje.a113407; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Hayden FG, 1999, JAMA-J AM MED ASSOC, V282, P1240, DOI 10.1001/jama.282.13.1240; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Herlocher ML, 2004, J INFECT DIS, V190, P1627, DOI 10.1086/424572; Heymann A, 2004, PEDIATR INFECT DIS J, V23, P675, DOI 10.1097/01.inf.0000128778.54105.06; Leneva IA, 2000, ANTIVIR RES, V48, P101, DOI 10.1016/S0166-3542(00)00123-6; LONGINI IM, 1988, AM J EPIDEMIOL, V128, P845, DOI 10.1093/oxfordjournals.aje.a115038; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; *MIN LAB THAIL, 2003, YB LAB STAT; MOSER MR, 1979, AM J EPIDEMIOL, V110, P1; *NAT STAT OFF THAI, 1999, NAT MIGR SURV; *NAT STAT OFF THAI, 2000, POP CENS 2000; *OAKR NAT LAB, 2003, LANDSC GLOB POP DAT; Principi N, 2004, ARCH DIS CHILD, V89, P1002, DOI 10.1136/adc.2003.045401; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; SPICER CC, 1984, J HYG-CAMBRIDGE, V93, P105, DOI 10.1017/S0022172400060988; Stohr K, 2004, SCIENCE, V306, P2195, DOI 10.1126/science.1108165; Viboud C, 2004, BRIT J GEN PRACT, V54, P684; *WHO, 2005, WHO INT CONS INFL A; World Health Organization, 2005, AV INFL ASS PAND THR; YANG Y, 2004, 0409 EM U DEP BIOST	36	1267	1313	4	264	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2005	437	7056					209	214		10.1038/nature04017	http://dx.doi.org/10.1038/nature04017			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961YE	16079797	Green Submitted, Bronze			2022-12-01	WOS:000231696900046
J	Thingstad, TF; Krom, MD; Mantoura, RFC; Flaten, GAF; Groom, S; Herut, B; Kress, N; Law, CS; Pasternak, A; Pitta, P; Psarra, S; Rassoulzadegan, F; Tanaka, T; Tselepides, A; Wassmann, P; Woodward, EMS; Riser, CW; Zodiatis, G; Zohary, T				Thingstad, TF; Krom, MD; Mantoura, RFC; Flaten, GAF; Groom, S; Herut, B; Kress, N; Law, CS; Pasternak, A; Pitta, P; Psarra, S; Rassoulzadegan, F; Tanaka, T; Tselepides, A; Wassmann, P; Woodward, EMS; Riser, CW; Zodiatis, G; Zohary, T			Nature of phosphorus limitation in the ultraoligotrophic eastern Mediterranean	SCIENCE			English	Article							NITROGEN-FIXATION; ATLANTIC-OCEAN; NORTH-ATLANTIC; SEA; STOICHIOMETRY; CYANOBACTERIUM; SYNECHOCOCCUS; PRODUCTIVITY; COMPETITION; NUTRIENTS	Phosphate addition to surface waters of the ultraoligotrophic, phosphorus-starved eastern Mediterranean in a Lagrangian experiment caused unexpected ecosystem responses. The system exhibited a decline in chlorophyll and an increase in bacterial production and copepod egg abundance. Although nitrogen and phosphorus colimitation hindered phytoplankton growth, phosphorous may have been transferred through the microbial food web to copepods via two, not mutually exclusive, pathways: (i) bypass of the phytoplankton compartment by phosphorus uptake in heterotrophic bacteria and (ii) tunnelling, whereby phosphate luxury consumption rapidly shifts the stoichiometric composition of copepod prey. Copepods may thus be coupled to lower trophic levels through interactions not usually considered.	Univ Bergen, Dept Biol, Bergen, Norway; Univ Leeds, Sch Earth & Environm Sci, Leeds, W Yorkshire, England; Univ Leeds, Earth & Biosphere Inst, Leeds, W Yorkshire, England; Plymouth Marine Lab, Plymouth, Devon, England; IAEA, Marine Environm Lab, Monaco, Monaco; Israel Oceanog & Limnol Res, Natl Inst Oceanog, Haifa, Israel; Natl Inst Water & Atmospher Res, Wellington, New Zealand; Univ Tromso, Norwegian Coll Fishery Sci, Tromso, Norway; Hellen Ctr Marine Res, Iraklion, Crete, Greece; Stn Zool, Villefranche Sur Mer, France; Univ Cyprus, Oceanog Ctr, Nicosia, Cyprus; IOLR, Kinneret Limnol Lab, Tiberias, Israel	University of Bergen; University of Leeds; University of Leeds; Plymouth Marine Laboratory; Israel Oceanographic & Limnological Research Institute; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; UiT The Arctic University of Tromso; Hellenic Centre for Marine Research; UDICE-French Research Universities; Sorbonne Universite; University of Cyprus	Thingstad, TF (corresponding author), Univ Bergen, Dept Biol, Bergen, Norway.	frede.thingstad@bio.uib.no	Krom, Michael D/I-5076-2012; Thingstad, Tron Frede/B-2254-2008; Groom, Steve/A-1355-2012; Woodward, Ernest M S/D-5755-2016; Tanaka, Tsuneo/G-3751-2011; Pasternak, Anna F/E-6121-2014; Rassoulzadegan, Fereidoun/A-2650-2012; Tselepides, Anastasios/AAO-3965-2021	Thingstad, Tron Frede/0000-0002-5593-819X; Woodward, Ernest M S/0000-0002-7187-6689; Pasternak, Anna F/0000-0003-0317-5861; Law, Cliff/0000-0002-7669-2475; Pitta, Paraskevi/0000-0003-3557-0575; Herut, Barak/0000-0002-7093-8753; Tselepides, Anastasios/0000-0002-7880-9091				Ammerman J.W., 2003, EOS T AM GEOPHYS UN, V84, P165, DOI [10.1029/2003-o180001, DOI 10.1029/2003EO180001, DOI 10.1029/2003-O180001]; Andersen T, 2004, ECOL LETT, V7, P884, DOI 10.1111/j.1461-0248.2004.00646.x; Bertilsson S, 2003, LIMNOL OCEANOGR, V48, P1721, DOI 10.4319/lo.2003.48.5.1721; Bethoux JP, 2002, DEEP-SEA RES PT II, V49, P2007, DOI 10.1016/S0967-0645(02)00024-3; BONIN DJ, 1989, AQUAT SCI, V51, P129, DOI 10.1007/BF00879299; Ducobu H, 1998, J PHYCOL, V34, P467, DOI 10.1046/j.1529-8817.1998.340467.x; Jeffrey SW, 1999, MAR ECOL PROG SER, V189, P35, DOI 10.3354/meps189035; Jickells T, 2002, GLOB CHANGE IGBP SER, P93; Karl DM, 2001, DEEP-SEA RES PT II, V48, P1529, DOI 10.1016/S0967-0645(00)00152-1; Kress N, 2001, DEEP-SEA RES PT I, V48, P2347, DOI 10.1016/S0967-0637(01)00022-X; KROM MD, 1991, LIMNOL OCEANOGR, V36, P424, DOI 10.4319/lo.1991.36.3.0424; Mills MM, 2004, NATURE, V429, P292, DOI 10.1038/nature02550; Moutin T, 2002, LIMNOL OCEANOGR, V47, P1562, DOI 10.4319/lo.2002.47.5.1562; Redfield AC., 1963, SEA, DOI DOI 10.1016/J.ORGGEOCHEM.2014.06.002; Sanudo-Wilhelmy SA, 2004, NATURE, V432, P897, DOI 10.1038/nature03125; Sanudo-Wilhelmy SA, 2001, NATURE, V411, P66, DOI 10.1038/35075041; Struck U, 2001, GEOCHIM COSMOCHIM AC, V65, P3249, DOI 10.1016/S0016-7037(01)00668-8; Sundareshwar PV, 2003, SCIENCE, V299, P563, DOI 10.1126/science.1079100; Thingstad TF, 2005, LIMNOL OCEANOGR-METH, V3, P94, DOI 10.4319/lom.2005.3.94; Thingstad TF, 1999, PROG OCEANOGR, V44, P271, DOI 10.1016/S0079-6611(99)00029-4; Vadstein O, 1998, AQUAT MICROB ECOL, V14, P119, DOI 10.3354/ame014119; Van Wambeke F, 2002, MICROB ECOL, V43, P119, DOI 10.1007/s00248-001-0038-4; Wu JF, 2000, SCIENCE, V289, P759, DOI 10.1126/science.289.5480.759; Zohary T, 1998, LIMNOL OCEANOGR, V43, P387, DOI 10.4319/lo.1998.43.3.0387	24	365	378	5	164	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2005	309	5737					1068	1071		10.1126/science.1112632	http://dx.doi.org/10.1126/science.1112632			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955MN	16099984				2022-12-01	WOS:000231230100044
J	Demma, LJ; Traeger, MS; Nicholson, WL; Paddock, CD; Blau, DM; Eremeeva, ME; Dasch, GA; Levin, ML; Singleton, JJ; Zaki, SR; Cheek, JE; Swerdlow, DL; McQuiston, JH				Demma, LJ; Traeger, MS; Nicholson, WL; Paddock, CD; Blau, DM; Eremeeva, ME; Dasch, GA; Levin, ML; Singleton, JJ; Zaki, SR; Cheek, JE; Swerdlow, DL; McQuiston, JH			Rocky mountain spotted fever from an unexpected tick vector in Arizona	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BROWN DOG TICK; RHIPICEPHALUS-SANGUINEUS ACARI; RICKETTSIA-RICKETTSII; HUMAN PARASITISM; INFECTED TICKS; SUSCEPTIBILITY; PREVALENCE; ANTIBODIES; HUMANS; DNA	BACKGROUND: Rocky Mountain spotted fever is a life-threatening, tick-borne disease caused by Rickettsia rickettsii. This disease is rarely reported in Arizona, and the principal vectors, Dermacentor species ticks, are uncommon in the state. From 2002 through 2004, a focus of Rocky Mountain spotted fever was investigated in rural eastern Arizona. METHODS: We obtained blood and tissue specimens from patients with suspected Rocky Mountain spotted fever and ticks from patients' homesites. Serologic, molecular, immunohistochemical, and culture assays were performed to identify the causative agent. On the basis of specific laboratory criteria, patients were classified as having confirmed or probable Rocky Mountain spotted fever infection. RESULTS: A total of 16 patients with Rocky Mountain spotted fever infection (11 with confirmed and 5 with probable infection) were identified. Of these patients, 13 (81 percent) were children 12 years of age or younger, 15 (94 percent) were hospitalized, and 2 (12 percent) died. Dense populations of Rhipicephalus sanguineus ticks were found on dogs and in the yards of patients' homesites. All patients with confirmed Rocky Mountain spotted fever had contact with tick-infested dogs, and four had a reported history of tick bite preceding the illness. R. rickettsii DNA was detected in nonengorged R. sanguineus ticks collected at one home, and R. rickettsii isolates were cultured from these ticks. CONCLUSIONS: This investigation documents the presence of Rocky Mountain spotted fever in eastern Arizona, with common brown dog ticks (R. sanguineus) implicated as a vector of R. rickettsii. The broad distribution of this common tick raises concern about its potential to transmit R. rickettsii in other settings.	Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Div Viral & Rickettsial Dis, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Epidem Intelligence Serv, Off Workforce & Career Dev, Atlanta, GA 30333 USA; Indian Hlth Serv, Whiteriver Serv Unit, Whiteriver, AZ USA; Indian Hlth Serv, Natl Epidemiol Program, Albuquerque, NM USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Demma, LJ (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Div Viral & Rickettsial Dis, 1600 Clifton Rd,MS D63, Atlanta, GA 30333 USA.	ldemma@cdc.gov		Dasch, Gregory/0000-0001-6090-1810				Badger LF, 1933, PUBLIC HEALTH REP, V48, P791, DOI 10.2307/4580839; Bustamante M. E., 1947, REV INST SALUBRIDAD Y ENFERM TROP, V8, P139; Bustamante M. E., 1946, REV INST SALUBRIDAD Y ENFERM TROP, V7, P39; CARPENTER TL, 1990, J MED ENTOMOL, V27, P1065, DOI 10.1093/jmedent/27.6.1065; Cooley R.A., 1938, NATL I HLTH B, V171, P1; DALTON MJ, 1995, AM J TROP MED HYG, V52, P405, DOI 10.4269/ajtmh.1995.52.405; Dasch G. A., 1992, The Prokaryotes. A handbook on the biology of bacteria: ecophysiology, isolation, identification, applications. Volume III.., P2407; Elchos BN, 2003, J AM VET MED ASSOC, V223, P1450, DOI 10.2460/javma.2003.223.1450; ELLIOTT LB, 1990, ANN NY ACAD SCI, V590, P221, DOI 10.1111/j.1749-6632.1990.tb42223.x; Eremeeva ME, 2003, J CLIN MICROBIOL, V41, P5466, DOI 10.1128/JCM.41.12.5466-5472.2003; Eremeeva ME, 2003, ANN NY ACAD SCI, V990, P717, DOI 10.1111/j.1749-6632.2003.tb07449.x; EREMEEVA ME, 2001, MOL MED MICROBIOLOGY, P2175; Felz MW, 1996, J PARASITOL, V82, P505, DOI 10.2307/3284095; FOX MT, 1985, VET REC, V116, P661, DOI 10.1136/vr.116.25.661; GODDARD J, 1989, J MED ENTOMOL, V26, P628, DOI 10.1093/jmedent/26.6.628; GORDON JC, 1984, AM J TROP MED HYG, V33, P1026, DOI 10.4269/ajtmh.1984.33.1026; Harrison BA, 1997, J VECTOR ECOL, V22, P6; KEENAN KP, 1977, J INFECT DIS, V135, P911, DOI 10.1093/infdis/135.6.911; LORD CC, 2001, U FLORIDA PUBLICATIO; MAGNARELLI LA, 1982, AM J VET RES, V43, P656; Mannelli A, 2003, PREV VET MED, V60, P13, DOI 10.1016/S0167-5877(03)00079-5; NORMENT BR, 1984, AM J VET RES, V45, P1706; Paddock CD, 1999, J INFECT DIS, V179, P1469, DOI 10.1086/314776; Paddock CD, 2002, AM J TROP MED HYG, V66, P197, DOI 10.4269/ajtmh.2002.66.197; PARKER R. R., 1933, AMER JOUR TROP MED, V13, P341; PHILIP RN, 1976, J CLIN MICROBIOL, V3, P51; RAOULT D, 1993, AM J TROP MED HYG, V48, P249, DOI 10.4269/ajtmh.1993.48.249; Raoult D, 1997, CLIN MICROBIOL REV, V10, P694, DOI 10.1128/CMR.10.4.694; Roux V, 1996, J CLIN MICROBIOL, V34, P2058, DOI 10.1128/JCM.34.9.2058-2065.1996; Schriefer Martin E., 1994, P314; SEXTON DJ, 1976, AM J EPIDEMIOL, V103, P192, DOI 10.1093/oxfordjournals.aje.a112217; Treadwell TA, 2000, AM J TROP MED HYG, V63, P21, DOI 10.4269/ajtmh.2000.63.21; TZIANABOS T, 1989, J CLIN MICROBIOL, V27, P2866, DOI 10.1128/JCM.27.12.2866-2868.1989; Uspensky I, 2002, INT J MED MICROBIOL, V291, P156, DOI 10.1016/S1438-4221(02)80030-3	34	275	297	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 11	2005	353	6					587	594		10.1056/NEJMoa050043	http://dx.doi.org/10.1056/NEJMoa050043			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	953ST	16093467				2022-12-01	WOS:000231101500009
J	Kravchenko, JE; Rogozin, IB; Koonin, EV; Chumakov, PM				Kravchenko, JE; Rogozin, IB; Koonin, EV; Chumakov, PM			Transcription of mammalian messenger RNAs by a nuclear RNA polymerase of mitochondrial origin	NATURE			English	Article							DNA; CELLS; MTDNA; TOOL; SEQUENCES; ALIGNMENT; PATTERNS; B1	Transcription of eukaryotic genes is performed by three nuclear RNA polymerases, of which RNA polymerase II is thought to be solely responsible for the synthesis of messenger RNAs1. Here we show that transcription of some mRNAs in humans and rodents is mediated by a previously unknown single-polypeptide nuclear RNA polymerase (spRNAP-IV). spRNAP-IV is expressed from an alternative transcript of the mitochondrial RNA polymerase gene (POLRMT). The spRNAP-IV lacks 262 amino-terminal amino acids of mitochondrial RNA polymerase, including the mitochondrial-targeting signal, and localizes to the nucleus. Transcription by spRNAP-IV is resistant to the RNA polymease II inhibitor alpha-amanitin but is sensitive to short interfering RNA specific for the POLRMT gene. The promoters for spRNAP-IV differ substantially from those used by RNA polymerase II, do not respond to transcriptional enhancers and contain a common functional sequence motif.	Cleveland Clin Fdn, Lerner Res Inst, Cleveland, OH 44195 USA; VA Engelhardt Mol Biol Inst, Moscow 119991, Russia; Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA	Cleveland Clinic Foundation; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Chumakov, PM (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	chumakp@ccf.org		Rogozin, Igor/0000-0003-0802-4851; Chumakov, Peter/0000-0002-8078-2908	NATIONAL CANCER INSTITUTE [R01CA104903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025278] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA104903] Funding Source: Medline; NIA NIH HHS [R01 AG025278, R01 AG025278-01A1] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Gabaldon T, 2003, SCIENCE, V301, P609, DOI 10.1126/science.1085463; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gray MW, 1998, TRENDS MICROBIOL, V6, P1, DOI 10.1016/S0966-842X(97)01182-7; Grundy WN, 1996, COMPUT APPL BIOSCI, V12, P303; HARLOW E, 1999, USING ANTIBODIES LAB, P276; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Kaeser MD, 2002, P NATL ACAD SCI USA, V99, P95, DOI 10.1073/pnas.012283399; Keich U, 2002, BIOINFORMATICS, V18, P1382, DOI 10.1093/bioinformatics/18.10.1382; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; King M P, 1996, Methods Enzymol, V264, P304, DOI 10.1016/S0076-6879(96)64029-4; KING MP, 1988, CELL, V52, P811, DOI 10.1016/0092-8674(88)90423-0; Kurland CG, 2000, MICROBIOL MOL BIOL R, V64, P786, DOI 10.1128/MMBR.64.4.786-820.2000; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; LEWIN B, 2004, GENES, V8, P597; MASTERS BS, 1987, CELL, V51, P89, DOI 10.1016/0092-8674(87)90013-4; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; McCulloch V, 2003, MOL CELL BIOL, V23, P5816, DOI 10.1128/MCB.23.16.5816-5824.2003; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Paule MR, 2000, NUCLEIC ACIDS RES, V28, P1283, DOI 10.1093/nar/28.6.1283; Pfeifer A, 2002, P NATL ACAD SCI USA, V99, P2140, DOI 10.1073/pnas.251682798; Rantanen A, 2001, MAMM GENOME, V12, P787, DOI 10.1007/s00335-001-2052-8; SCHULER GD, 1990, PROTEIN-STRUCT FUNCT, V9, P180; Seidel-Rogol BL, 2002, NUCLEIC ACIDS RES, V30, P1929, DOI 10.1093/nar/30.9.1929; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; TARONI F, 1991, J BIOL CHEM, V266, P13267; Tiranti V, 1997, HUM MOL GENET, V6, P615, DOI 10.1093/hmg/6.4.615	30	44	48	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2005	436	7051					735	739		10.1038/nature03848	http://dx.doi.org/10.1038/nature03848			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951XA	16079853	Green Accepted			2022-12-01	WOS:000230964500051
J	Wright, AA; Katz, IT				Wright, AA; Katz, IT			Bar coding for patient safety	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ADVERSE DRUG EVENTS; HOSPITALIZED-PATIENTS		Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Wright, AA (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.		Wright, Alexi/T-5793-2019	Katz, Ingrid/0000-0002-3014-238X				Bates DW, 1997, JAMA-J AM MED ASSOC, V277, P307, DOI 10.1001/jama.277.4.307; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; LEAPE LL, 1995, JAMA-J AM MED ASSOC, V274, P35, DOI 10.1001/jama.1995.03530010049034; POON EG, 2005, SOC GEN INT MED 28 A; Rothschild JM, 2005, CRIT CARE MED, V33, P533, DOI 10.1097/01.ccm.0000155912.73313.cd	5	38	39	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 28	2005	353	4					329	331		10.1056/NEJMp058101	http://dx.doi.org/10.1056/NEJMp058101			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949JW	16049205				2022-12-01	WOS:000230782800001
J	Rohaly, G; Chemnitz, J; Dehde, S; Nunez, AM; Heukeshoven, J; Deppert, W; Dornreiter, I				Rohaly, G; Chemnitz, J; Dehde, S; Nunez, AM; Heukeshoven, J; Deppert, W; Dornreiter, I			A novel human p53 isoform is an essential element of the ATR-intra-S phase checkpoint	CELL			English	Article							ALTERNATIVELY SPLICED FORM; DNA-DAMAGE; ACTIVATION; CELLS; RNA; RECRUITMENT; EXPRESSION; MUTANTS; BINDING; CANCER	The archetypal human tumor suppressor p53 is considered to have unique transactivation properties. The assumption is based on the fact that additionally identified human p53 isoforms lack transcriptional activity. However, we provide evidence for the existence of an alternatively spliced p53 isoform (Delta p53) that exerts its transcriptional activity independent from p53. In contrast to p53, Delta p53 transactivates the endogenous p21 and 14-3-3 sigma but not the mdm2, bax, and PIG3 promoter. Cell cycle studies showed that Delta p53 displays its differential transcriptional activity only in damaged S phase cells. Upon activation of the ATR-intra-S phase checkpoint, Ap53, but not p53, transactivates the Cdk inhibitor p21. Induction of p21 results in downregulation of cyclin A-Cdk activity and accordingly attenuation of S phase progression. Data demonstrate that the Delta p53-p21-cyclin A-Cdk pathway is crucial to facilitate uncoupling of repair and replication events, indicating that Delta p53 is an essential element of the ATR-intra-S phase checkpoint.	Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, D-20251 Hamburg, Germany	Heinrich Pette Institute; University of Hamburg	Dornreiter, I (corresponding author), Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, Martinistr 52, D-20251 Hamburg, Germany.	irene.dornreiter@hpi.uni-hamburg.de						Alberts AS, 1998, CELL, V92, P475, DOI 10.1016/S0092-8674(00)80941-1; An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; ARAI N, 1986, MOL CELL BIOL, V6, P3232, DOI 10.1128/MCB.6.9.3232; Aurelio ON, 2000, MOL CELL BIOL, V20, P770, DOI 10.1128/MCB.20.3.770-778.2000; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; BARTEV NA, 2004, NAT REV MOL CELL BIO, V5, P792; Baus F, 2003, EMBO J, V22, P3992, DOI 10.1093/emboj/cdg387; Chehab NH, 2000, GENE DEV, V14, P278; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cooley BC, 2001, ARCH BIOCHEM BIOPHYS, V390, P71, DOI 10.1006/abbi.2001.2347; Dehde S, 2001, MOL CELL BIOL, V21, P2581, DOI 10.1128/MCB.21.7.2581-2593.2001; El-Deiry WS, 1998, SEMIN CANCER BIOL, V8, P345, DOI 10.1006/scbi.1998.0097; Espinosa JM, 2001, MOL CELL, V8, P57, DOI 10.1016/S1097-2765(01)00283-0; Ghosh A, 2004, MOL CELL BIOL, V24, P7987, DOI 10.1128/MCB.24.18.7987-7997.2004; Gottifredi V, 2001, P NATL ACAD SCI USA, V98, P1036, DOI 10.1073/pnas.021282898; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; Kong XT, 2001, J BIOL CHEM, V276, P32990, DOI 10.1074/jbc.M103681200; KULESZMARTIN MF, 1994, MOL CELL BIOL, V14, P1698, DOI 10.1128/MCB.14.3.1698; OLIVE PL, 1992, J NATL CANCER I, V84, P707, DOI 10.1093/jnci/84.9.707; Rehberger PA, 1997, CELL GROWTH DIFFER, V8, P851; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; WATERMAN JLF, 1995, EMBO J, V14, P512, DOI 10.1002/j.1460-2075.1995.tb07027.x; WILL K, 1995, NUCLEIC ACIDS RES, V23, P4023, DOI 10.1093/nar/23.20.4023	26	118	121	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 15	2005	122	1					21	32		10.1016/j.cell.2005.04.032	http://dx.doi.org/10.1016/j.cell.2005.04.032			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	950EC	16009130	Bronze			2022-12-01	WOS:000230839400008
J	Chen, H; Smith, GJD; Zhang, SY; Qin, K; Wang, J; Li, KS; Webster, RG; Peiris, JSM; Guan, Y				Chen, H; Smith, GJD; Zhang, SY; Qin, K; Wang, J; Li, KS; Webster, RG; Peiris, JSM; Guan, Y			H5N1 virus outbreak in migratory waterfowl	NATURE			English	Editorial Material							INFLUENZA		Shantou Univ Med Coll, Joint Influenza Res Ctr SUMC & HKU, Shantou 515031, Peoples R China; Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; Chinese Acad Sci, Inst Zool, Beijing 100080, Peoples R China; St Jude Childrens Res Hosp, Dept Infect Dis, Div Virol, Memphis, TN 38105 USA	University of Hong Kong; Chinese Academy of Sciences; Institute of Zoology, CAS; St Jude Children's Research Hospital	Chen, H (corresponding author), Shantou Univ Med Coll, Joint Influenza Res Ctr SUMC & HKU, Shantou 515031, Peoples R China.	yguan@hkucc.hku.hk	Zhang, Shuyi/B-5117-2011; Chen, Honglin/C-4224-2009; Peiris, Joseph Sriyal Malik/C-4380-2009	Chen, Honglin/0000-0001-5108-8338; Li, Kangsheng/0000-0002-6981-9263; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; Smith, Gavin JD/0000-0001-5031-468X; Guan, Yi/0000-0001-6057-9243				CLEMENTS JF, 2000, BIRDS WORLDS CHECKLI; Ellis TM, 2004, AVIAN PATHOL, V33, P492, DOI 10.1080/03079450400003601; *FOOD AGR ORG UN, 2005, AV INFL DIS EM B, V30; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; *WHO, 2005, INT COUNTR CONS INFL	6	588	687	3	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2005	436	7048					191	192		10.1038/nature03974	http://dx.doi.org/10.1038/nature03974			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944VR	16007072				2022-12-01	WOS:000230459500026
J	Pluchino, S; Zanotti, L; Rossi, B; Brambilla, E; Ottoboni, L; Salani, G; Martinello, M; Cattalini, A; Bergami, A; Furlan, R; Comi, G; Constantin, G; Martino, G				Pluchino, S; Zanotti, L; Rossi, B; Brambilla, E; Ottoboni, L; Salani, G; Martinello, M; Cattalini, A; Bergami, A; Furlan, R; Comi, G; Constantin, G; Martino, G			Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism	NATURE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; NITRIC-OXIDE; APOPTOSIS; BRAIN; INDUCTION; TRANSPLANTATION; EXPRESSION; MIGRATION	In degenerative disorders of the central nervous system (CNS), transplantation of neural multipotent ( stem) precursor cells (NPCs) is aimed at replacing damaged neural cells(1,2). Here we show that in CNS inflammation, NPCs are able to promote neuroprotection by maintaining undifferentiated features and exerting unexpected immune-like functions. In a mouse model of chronic CNS inflammation, systemically injected adult syngeneic NPCs use constitutively activated integrins and functional chemokine receptors to selectively enter the inflamed CNS. These undifferentiated cells survive repeated episodes of CNS inflammation by accumulating within perivascular areas where reactive astrocytes, inflamed endothelial cells and encephalitogenic T cells produce neurogenic and gliogenic regulators. In perivascular CNS areas, surviving adult NPCs induce apoptosis of blood-borne CNS-infiltrating encephalitogenic T cells, thus protecting against chronic neural tissue loss as well as disease-related disability. These results indicate that undifferentiated adult NPCs have relevant therapeutic potential in chronic inflammatory CNS disorders because they display immune-like functions that promote long-lasting neuroprotection.	Vita Salute Univ, Hosp San Raffaele, Neuroimmunol Unit DIBIT, I-20132 Milan, Italy; Vita Salute Univ, Hosp San Raffaele, Dept Neurol, I-20132 Milan, Italy; Vita Salute Univ, Hosp San Raffaele, Dept Neurophysiol, I-20132 Milan, Italy; Univ Verona, Dept Pathol, Sect Gen Pathol, I-37134 Verona, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Verona	Martino, G (corresponding author), Vita Salute Univ, Hosp San Raffaele, Neuroimmunol Unit DIBIT, Via Olgettina 58, I-20132 Milan, Italy.	martino.gianvito@hsr.it	Martinello, Marianna/AAE-3863-2021; Furlan, Roberto/N-5224-2019; Ottoboni, Linda/AAC-4508-2022; martino, gianvito/AAL-2682-2020; BRAMBILLA, ELENA/AAN-3742-2020; Pluchino, Stefano/AAE-9037-2019; Cattalini, Alessandro/K-4722-2016; Zanotti, Lucia/AAB-1484-2020; Furlan, Roberto/J-9177-2016	Furlan, Roberto/0000-0001-7376-9425; Ottoboni, Linda/0000-0001-5412-7785; martino, gianvito/0000-0003-1295-9131; BRAMBILLA, ELENA/0000-0003-1399-2128; Pluchino, Stefano/0000-0002-6267-9472; Cattalini, Alessandro/0000-0002-9833-6869; Furlan, Roberto/0000-0001-7376-9425; ROSSI, Barbara/0000-0003-4711-1528; Martinello, Marianna/0000-0001-9811-6308; Constantin, Gabriela/0000-0001-8978-3539; cattalini, alessandro/0000-0001-7585-1780				Akiyama Y, 2001, EXP NEUROL, V167, P27, DOI 10.1006/exnr.2000.7539; Alt C, 2002, EUR J IMMUNOL, V32, P2133, DOI 10.1002/1521-4141(200208)32:8<2133::AID-IMMU2133>3.0.CO;2-W; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Chu K, 2003, NEUROSCI LETT, V343, P129, DOI 10.1016/S0304-3940(03)00174-5; Constantin G, 1999, J IMMUNOL, V162, P1144; Constantin G, 1997, J IMMUNOL METHODS, V203, P35, DOI 10.1016/S0022-1759(97)00009-4; Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1; Fukuda S, 2003, J NEUROSCI, V23, P9357; Furlan R, 2001, J IMMUNOL, V167, P1821, DOI 10.4049/jimmunol.167.3.1821; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Karpus WJ, 1997, J LEUKOCYTE BIOL, V62, P681, DOI 10.1002/jlb.62.5.681; Lazarini F, 2000, EUR J NEUROSCI, V12, P117, DOI 10.1046/j.1460-9568.2000.00894.x; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; Marsden VS, 2003, ANNU REV IMMUNOL, V21, P71, DOI 10.1146/annurev.immunol.21.120601.141029; MCRAE BL, 1992, J NEUROIMMUNOL, V38, P229, DOI 10.1016/0165-5728(92)90016-E; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Pender MP, 2001, GLIA, V36, P137, DOI 10.1002/glia.1103; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Ricci-Vitiani L, 2004, J EXP MED, V200, P1257, DOI 10.1084/jem.20040921; Schere-Levy C, 2003, EXP CELL RES, V282, P35, DOI 10.1006/excr.2002.5666; Tarrant TK, 1999, J EXP MED, V189, P219, DOI 10.1084/jem.189.2.219; Vandenbark AA, 2000, INT IMMUNOL, V12, P57, DOI 10.1093/intimm/12.1.57; Weishaupt A, 2000, J IMMUNOL, V165, P7157, DOI 10.4049/jimmunol.165.12.7157; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Zhang XH, 1997, J EXP MED, V185, P1837, DOI 10.1084/jem.185.10.1837	27	604	632	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2005	436	7048					266	271		10.1038/nature03889	http://dx.doi.org/10.1038/nature03889			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944VR	16015332				2022-12-01	WOS:000230459500043
J	Miller, GH; Fogel, ML; Magee, JW; Gagan, MK; Clarke, SJ; Johnson, BJ				Miller, GH; Fogel, ML; Magee, JW; Gagan, MK; Clarke, SJ; Johnson, BJ			Ecosystem collapse in pleistocene Australia and a human role in megafaunal extinction	SCIENCE			English	Article							HUMAN OCCUPATION; NORTHERN AUSTRALIA; CLIMATIC-CHANGE; CONTINENT; TURNOVER; MONSOON; RECORD; CARBON; AGES	Most of Australia's largest mammals became extinct 50,000 to 45,000 years ago, shortly after humans colonized the continent. Without exceptional climate change at that time, a human cause is inferred, but a mechanism remains elusive. A 140,000-year record of dietary delta(13)C documents a permanent reduction in food sources available to the Australian emu, beginning about the time of human colonization; a change replicated at three widely separated sites and in the marsupial wombat. We speculate that human firing of landscapes rapidly converted a drought-adapted mosaic of trees, shrubs, and nutritious grasslands to the modern fire-adapted desert scrub. Animals that could adapt survived; those that could not, became extinct.	Univ Colorado, INSTAAR & Geol Sci, Boulder, CO 80309 USA; Carnegie Inst Washington, Geophys Lab, Washington, DC 20015 USA; Australian Natl Univ, Res Sch Earth Sci, Dept Earth & Marine Sci, Canberra, ACT 0200, Australia; Charles Sturt Univ, Wagga Wagga, NSW 2678, Australia; Bates Coll, Dept Geol, Lewiston, ME 04240 USA	University of Colorado System; University of Colorado Boulder; Carnegie Institution for Science; Australian National University; Charles Sturt University	Miller, GH (corresponding author), Univ Colorado, INSTAAR & Geol Sci, Boulder, CO 80309 USA.		Gagan, Michael/L-5014-2018; Fogel, Marilyn L/M-2395-2015	Gagan, Michael/0000-0002-8279-323X; Fogel, Marilyn L/0000-0002-1176-3818				Barrett DJ, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001860; Bowler JM, 2003, NATURE, V421, P837, DOI 10.1038/nature01383; Hesse PP, 2004, QUATERN INT, V118, P87, DOI 10.1016/S1040-6182(03)00132-0; HOBSON KA, 1995, CONDOR, V97, P752, DOI 10.2307/1369183; Johnson BJ, 1999, SCIENCE, V284, P1150, DOI 10.1126/science.284.5417.1150; Johnson BJ, 1998, GEOCHIM COSMOCHIM AC, V62, P2451, DOI 10.1016/S0016-7037(98)00175-6; Johnson CN, 2004, AUSTRAL ECOL, V29, P553, DOI 10.1111/j.1442-9993.2004.01389.x; KERSHAW AP, 1986, NATURE, V322, P47, DOI 10.1038/322047a0; Kershaw P, 2003, FRESHWATER BIOL, V48, P1274, DOI 10.1046/j.1365-2427.2003.01085.x; Koch P.L., 1994, P63; Magee JW, 2004, GEOLOGY, V32, P885, DOI 10.1130/G20672.1; Miller GH, 1999, SCIENCE, V283, P205, DOI 10.1126/science.283.5399.205; Miller GH, 2000, PERSPECTIVES AMINO A, P161; O'Connell JF, 2004, J ARCHAEOL SCI, V31, P835, DOI 10.1016/j.jas.2003.11.005; Roberts R, 1998, NATURE, V393, P358, DOI 10.1038/30718; Roberts RG, 2001, SCIENCE, V292, P1888, DOI 10.1126/science.1060264; ROBERTS RG, 1990, NATURE, V345, P153, DOI 10.1038/345153a0; Turney CSM, 2001, J QUATERNARY SCI, V16, P767, DOI 10.1002/jqs.643; Turney CSM, 2001, QUATERNARY RES, V55, P3, DOI 10.1006/qres.2000.2195; van der Kaars S, 2002, REV PALAEOBOT PALYNO, V120, P17, DOI 10.1016/S0034-6667(02)00075-1	20	258	267	5	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 8	2005	309	5732					287	290		10.1126/science.1111288	http://dx.doi.org/10.1126/science.1111288			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944SP	16002615				2022-12-01	WOS:000230449800041
J	Cohen, J; Schleifer, R; Tate, T				Cohen, J; Schleifer, R; Tate, T			AIDS in Uganda: the human-rights dimension	LANCET			English	Editorial Material									HIV AIDS & Human Rights Programme, New York, NY 10118 USA; Childrens Rights Div Human Rights Watch, New York, NY 10118 USA		Cohen, J (corresponding author), HIV AIDS & Human Rights Programme, New York, NY 10118 USA.	cohenj@hrw.org						ANGELO I, 2004, MONITOR         1129; Bruckner H, 2005, J ADOLESCENT HEALTH, V36, P271, DOI 10.1016/j.jadohealth.2005.01.005; COHEN J, 2005, HUMAN RIGHTS WAT MAR, P29; Hauser T., 2004, 42 AIAA AER SCI M EX, P1088; *HIV AIDS INT MOD, 2004, 4 PRES DIAL YOUNG LE, P19; *I MED COMM HIV PR, 2001, NO TIM LOS GETT MOR, P118; KARANJA L, 2003, HUMAN RIGHTS WAT AUG, P15; KEMPNER ME, 2001, SEXUALLY HLTH AM ABS; KIRBY D, 2001, EMERGING ANSWERS RES, P5; Manlove J., 2004, NOT YET PROGRAMS DEL; SCHLEIFER R, 2002, HUMAN RIGHTS WAT SEP, P19; *UG MIN ED SPORTS, 2004, IN PRESS PIASCY HDB, P22; *US HR COMM GOV RE, 2004, CONT FED FUND ABST O	13	14	15	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 18	2005	365	9477					2075	2076		10.1016/S0140-6736(05)66716-5	http://dx.doi.org/10.1016/S0140-6736(05)66716-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	936LZ	15964433				2022-12-01	WOS:000229858800010
J	Douglass, AD; Vale, RD				Douglass, AD; Vale, RD			Single-molecule microscopy reveals plasma membrane microdomains created by protein-protein networks that exclude or trap signaling molecules in T cells	CELL			English	Article							IMMUNOLOGICAL SYNAPSE FORMATION; GPI-ANCHORED PROTEINS; LIPID RAFTS; BACTERIAL CHEMOTAXIS; DYNAMIC RECRUITMENT; TYROSINE KINASES; LIVING CELLS; ACTIVATION; RECEPTOR; LAT	Membrane subdomains have been implicated in T cell signaling, although their properties and mechanisms of formation remain controversial. Here, we have used single-molecule and scanning confocal imaging to characterize the behavior of GFP-tagged signaling proteins in Jurkat T cells. We show that the coreceptor CD2, the adaptor protein LAT, and tyrosine kinase Lck cocluster in discrete microdomains in the plasma membrane of signaling T cells. These microdomains require protein-protein interactions mediated through phosphorylation of LAT and are not maintained by interactions with actin or lipid rafts. Using a two color imaging approach that allows tracking of single molecules relative to the CD2/LAT/Lck clusters, we demonstrate that these microdomains exclude and limit the free diffusion of molecules in the membrane but also can trap and immobilize specific proteins. Our data suggest that diffusional trapping through protein-protein interactions creates microdomains that concentrate or exclude cell surface proteins to facilitate T cell signaling.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94107 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94107 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Vale, RD (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94107 USA.	vale@cmp.ucsf.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038499] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM038499, R01 GM038499-16] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Axelrod D, 2003, METHOD ENZYMOL, V361, P1; Bachmann MF, 1999, J EXP MED, V190, P1383, DOI 10.1084/jem.190.10.1383; Badour K, 2003, IMMUNITY, V18, P141, DOI 10.1016/S1074-7613(02)00516-2; Bierer B E, 1993, Semin Immunol, V5, P249, DOI 10.1006/smim.1993.1029; Bonello G, 2004, J CELL SCI, V117, P1009, DOI 10.1242/jcs.00968; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Calvert PD, 2001, NATURE, V411, P90, DOI 10.1038/35075083; Delon J, 2001, IMMUNITY, V15, P691, DOI 10.1016/S1074-7613(01)00231-X; Dietrich C, 2002, BIOPHYS J, V82, P274, DOI 10.1016/S0006-3495(02)75393-9; Dustin ML, 1997, J BIOL CHEM, V272, P30889, DOI 10.1074/jbc.272.49.30889; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; Ehrlich LIR, 2002, IMMUNITY, V17, P809, DOI 10.1016/S1074-7613(02)00481-8; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Glebov OO, 2004, NAT CELL BIOL, V6, P238, DOI 10.1038/ncb1103; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Green JM, 2000, J IMMUNOL, V164, P3591, DOI 10.4049/jimmunol.164.7.3591; Harder T, 2000, J CELL BIOL, V151, P199, DOI 10.1083/jcb.151.2.199; Hartgroves LC, 2003, J BIOL CHEM, V278, P20389, DOI 10.1074/jbc.M301212200; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Hermiston ML, 2002, J CLIN INVEST, V109, P9; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Ike H, 2003, CHEMPHYSCHEM, V4, P620, DOI 10.1002/cphc.200300670; Jacobelli J, 2004, NAT IMMUNOL, V5, P531, DOI 10.1038/ni1065; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Johnson KG, 2000, P NATL ACAD SCI USA, V97, P10138, DOI 10.1073/pnas.97.18.10138; Kabouridis PS, 1997, EMBO J, V16, P4983, DOI 10.1093/emboj/16.16.4983; Kenworthy AK, 2004, J CELL BIOL, V165, P735, DOI 10.1083/jcb.200312170; KILLEEN N, 1992, EMBO J, V11, P4329, DOI 10.1002/j.1460-2075.1992.tb05532.x; Klopfenstein DR, 2002, CELL, V109, P347, DOI 10.1016/S0092-8674(02)00708-0; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Lee SJE, 2002, TRENDS IMMUNOL, V23, P492, DOI 10.1016/S1471-4906(02)02285-8; Leupin O, 2000, CURR BIOL, V10, P277, DOI 10.1016/S0960-9822(00)00362-6; Lin J, 1999, J BIOL CHEM, V274, P28861, DOI 10.1074/jbc.274.41.28861; Lin J, 2001, J BIOL CHEM, V276, P29588, DOI 10.1074/jbc.M102221200; Lommerse PHM, 2004, BIOPHYS J, V86, P609, DOI 10.1016/S0006-3495(04)74139-9; Mello BA, 2004, BIOPHYS J, V87, P1578, DOI 10.1529/biophysj.104.042739; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Nakada C, 2003, NAT CELL BIOL, V5, P626, DOI 10.1038/ncb1009; Qi SY, 2001, P NATL ACAD SCI USA, V98, P6548, DOI 10.1073/pnas.111536798; Rietveld A, 1998, BBA-REV BIOMEMBRANES, V1376, P467, DOI 10.1016/S0304-4157(98)00019-7; Roose JP, 2003, PLOS BIOL, V1, P271, DOI 10.1371/journal.pbio.0000053; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Schutz GJ, 1997, BIOPHYS J, V73, P1073, DOI 10.1016/S0006-3495(97)78139-6; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; SHENOYSCARIA AM, 1994, J CELL BIOL, V126, P353, DOI 10.1083/jcb.126.2.353; Tanimura N, 2003, J CELL BIOL, V160, P125, DOI 10.1083/jcb.200207096; Trautmann A, 2003, CURR OPIN IMMUNOL, V15, P249, DOI 10.1016/S0952-7915(03)00040-2; TURING AM, 1990, B MATH BIOL, V52, P153, DOI 10.1016/S0092-8240(05)80008-4; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Weis RM, 2003, J BACTERIOL, V185, P3636, DOI 10.1128/JB.185.12.3636-3643.2003; Weiss M, 2004, TRENDS CELL BIOL, V14, P267, DOI 10.1016/j.tcb.2004.03.012; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Yang HL, 2001, J BIOL CHEM, V276, P18775, DOI 10.1074/jbc.M009852200; YURCHAK LK, 1995, MOL CELL BIOL, V15, P6914, DOI 10.1128/mcb.15.12.6914; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; Zhu MH, 2005, J IMMUNOL, V174, P31, DOI 10.4049/jimmunol.174.1.31	65	596	615	3	82	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 17	2005	121	6					937	950		10.1016/j.cell.2005.04.009	http://dx.doi.org/10.1016/j.cell.2005.04.009			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	938NX	15960980	Green Accepted, Bronze			2022-12-01	WOS:000230011200015
J	Turvey, ST; Green, OR; Holdaway, RN				Turvey, ST; Green, OR; Holdaway, RN			Cortical growth marks reveal extended juvenile development in New Zealand moa	NATURE			English	Article							BONE MICROSTRUCTURE; PERIOSTEAL BONE; LIFE-HISTORY; EVOLUTION; AGE; EXTINCTION; SEQUENCES; DINOSAURS; RATES; BIRDS	Cyclical growth marks in cortical bone, deposited before attainment of adult body size, reflect osteogenetic changes caused by annual rhythms and are a general phenomenon in non-avian ectothermic and endothermic tetrapods(1). However, the growth periods of ornithurines (the theropod group including all modern birds) are usually apomorphically shortened to less than a year(2,3), so annual growth marks are almost unknown in this group(4-6). Here we show that cortical growth marks are frequent in long bones of New Zealand's moa (Aves: Dinornithiformes), a recently extinct ratite order. Moa showed the exaggerated K-selected life-history strategy formerly common in the New Zealand avifauna, and in some instances took almost a decade to attain skeletal maturity. This indicates that reproductive maturity in moa was extremely delayed relative to all extant birds. The two presently recognized moa families (Dinornithidae and Emeidae) also showed different postnatal growth rates, which were associated with their relative differences in body size. Both species of giant Dinornis moa attained their massive stature (up to 240 kg live mass) by accelerating their juvenile growth rate compared to the smaller emeid moa species, rather than by extending the skeletal growth period.	Univ Canterbury, Sch Biol Sci, Christchurch 8020, New Zealand; Zool Soc London, Inst Zool, London NW1 4RY, England; Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England; Palaecol Res Ltd, Christchurch 8004, New Zealand	University of Canterbury; Zoological Society of London; University of Oxford	Turvey, ST (corresponding author), Univ Canterbury, Sch Biol Sci, Private Bag 4800, Christchurch 8020, New Zealand.	samuel.turvey@ioz.ac.uk						Amprino R., 1947, ARCH BIOL, V58, P315; Bennett P.M., 2002, EVOL ECOL; Broughton JM, 2002, IBIS, V144, P143, DOI 10.1046/j.0019-1019.2001.00004.x; Bunce M, 2003, NATURE, V425, P172, DOI 10.1038/nature01871; Castanet J, 2000, CR ACAD SCI III-VIE, V323, P543, DOI 10.1016/S0764-4469(00)00181-5; Castanet J, 1996, CR ACAD SCI III-VIE, V319, P301; Chinsamy A, 1998, J VERTEBR PALEONTOL, V18, P385, DOI 10.1080/02724634.1998.10011066; CHINSAMY A, 1995, SENCKENBERG, V181, P317; Chinsamy Anusuya, 2002, P421; Cooper A, 2001, NATURE, V409, P704, DOI 10.1038/35055536; CRACRAFT J, 1974, IBIS, V116, P494, DOI 10.1111/j.1474-919X.1974.tb07648.x; Davies S.J.J.F., 2002, RATITES TINAMOUS; de Margerie E, 2004, J EXP BIOL, V207, P869, DOI 10.1242/jeb.00841; de Ricqles A, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P411; Enlow D. H., 1957, Texas Journal of Science, V9, P186; Erickson GM, 2004, NATURE, V430, P772, DOI 10.1038/nature02699; HALL BK, 1993, BONE, V7; Holdaway RN, 2000, SCIENCE, V287, P2250, DOI 10.1126/science.287.5461.2250; Horner JR, 1999, PALEOBIOLOGY, V25, P295, DOI 10.1017/S0094837300021308; HOUDE P, 1987, AUK, V104, P125, DOI 10.2307/4087243; Huynen L, 2003, NATURE, V425, P175, DOI 10.1038/nature01838; Johnson CN, 2002, P ROY SOC B-BIOL SCI, V269, P2221, DOI 10.1098/rspb.2002.2130; KLOMP NI, 1992, IBIS, V134, P245, DOI 10.1111/j.1474-919X.1992.tb03806.x; Lydekker R., 1891, CATALOGUE FOSSIL BIR; Owens IPF, 2000, P NATL ACAD SCI USA, V97, P12144, DOI 10.1073/pnas.200223397; Padian K, 2004, J VERTEBR PALEONTOL, V24, P555, DOI 10.1671/0272-4634(2004)024[0555:GISDAP]2.0.CO;2; Padian K, 2001, NATURE, V412, P405, DOI 10.1038/35086500; Sander PM, 2004, ORG DIVERS EVOL, V4, P165, DOI 10.1016/j.ode.2003.12.002; Starck JM, 2002, J MORPHOL, V254, P232, DOI 10.1002/jmor.10029; Worthy TH, 2002, LOST WORLD MOA	30	67	70	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2005	435	7044					940	943		10.1038/nature03635	http://dx.doi.org/10.1038/nature03635			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935RN	15959513				2022-12-01	WOS:000229799700046
J	Bix, M; Kim, S; Rao, A				Bix, M; Kim, S; Rao, A			Opposites attract in differentiating T cells	SCIENCE			English	Editorial Material							LOCUS-CONTROL REGION; RANGE INTRACHROMOSOMAL INTERACTIONS; TH2 CYTOKINE LOCUS; ENHANCER; BET		Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; CBR Inst Biomed Res, Boston, MA 02115 USA	University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	Bix, M (corresponding author), Univ Washington, Sch Med, Dept Immunol, 1959 NE Pacific St,HSC I6071, Seattle, WA 98195 USA.	arao@cbr.med.harvard.edu		Bix, Mark/0000-0003-4617-0497	NHLBI NIH HHS [P01 HL67664] Funding Source: Medline; NIAID NIH HHS [R01 AI44432, R01 AI48636] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL067664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044432, R01AI048636] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ansel KM, 2004, NAT IMMUNOL, V5, P1251, DOI 10.1038/ni1135; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Fields PE, 2004, IMMUNITY, V21, P865, DOI 10.1016/j.immuni.2004.10.015; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Lee DU, 2004, P NATL ACAD SCI USA, V101, P16010, DOI 10.1073/pnas.0407031101; Lee DU, 2004, J BIOL CHEM, V279, P4802, DOI 10.1074/jbc.M307904200; Lee GR, 2005, NAT IMMUNOL, V6, P42, DOI 10.1038/ni1148; Lee GR, 2003, IMMUNITY, V19, P145, DOI 10.1016/S1074-7613(03)00179-1; Miller AT, 2004, IMMUNITY, V21, P67, DOI 10.1016/j.immuni.2004.06.009; Nardone J, 2004, NAT IMMUNOL, V5, P768, DOI 10.1038/ni0804-768; Shnyreva M, 2004, P NATL ACAD SCI USA, V101, P12622, DOI 10.1073/pnas.0400849101; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; SPILIANAKIS CG, 2005, NATURE          0508; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5	16	5	6	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2005	308	5728					1563	1565		10.1126/science.1114167	http://dx.doi.org/10.1126/science.1114167			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	936BH	15947163				2022-12-01	WOS:000229827000030
J	Robison, BH; Reisenbichler, KR; Sherlock, RE				Robison, BH; Reisenbichler, KR; Sherlock, RE			Giant larvacean houses: Rapid carbon transport to the deep sea floor	SCIENCE			English	Article							PARTICULATE ORGANIC-MATTER; BENTHIC BOUNDARY-LAYER; EASTERN NORTH PACIFIC; ABYSSAL NE PACIFIC; MONTEREY-BAY; CENTRAL CALIFORNIA; OCEAN; FOOD; FLUX; DISCREPANCY	An unresolved issue in ocean science is the discrepancy between the food requirements of the animals living on the deep sea floor and their food supply, as measured by sediment traps. A 10-year time-series study of the water column off Monterey Bay, California, revealed that the discarded mucus feeding structures of giant larvaceans carry a substantial portion of the upper ocean's productivity to the deep seabed. These abundant, rapidly sinking, carbon-rich vectors are not detected by conventional,sampling methods and thus have not been included in calculations of vertical nutrient flux or in oceanic carbon budgets.	Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA	Monterey Bay Aquarium Research Institute	Robison, BH (corresponding author), Monterey Bay Aquarium Res Inst, 7700 Sandholdt Rd, Moss Landing, CA 95039 USA.	robr@mbari.org						AGASSIZ A, 1888, 3 CRUISES US COAST G, V1; ALLDREDGE AL, 1976, LIMNOL OCEANOGR, V21, P14, DOI 10.4319/lo.1976.21.1.0014; ALLDREDGE AL, 1988, PROG OCEANOGR, V20, P41, DOI 10.1016/0079-6611(88)90053-5; ALLDREDGE AL, 1972, SCIENCE, V177, P885, DOI 10.1126/science.177.4052.885; Baldwin RJ, 1998, DEEP-SEA RES PT II, V45, P643, DOI 10.1016/S0967-0645(97)00097-0; BARHAM EG, 1979, SCIENCE, V205, P1129, DOI 10.1126/science.205.4411.1129; Beaulieu SE, 1998, DEEP-SEA RES PT II, V45, P781, DOI 10.1016/S0967-0645(98)00003-4; Berelson W., 2001, OCEANOGRAPHY, V14, P59, DOI DOI 10.5670/0CEAN0G.2001.07; BURD AB, 2002, EOS, V83, P573; Chavez FP, 2002, PROG OCEANOGR, V54, P205, DOI 10.1016/S0079-6611(02)00050-2; DAVOLL PJ, 1990, DEEP-SEA RES, V37, P285, DOI 10.1016/0198-0149(90)90128-I; DEIBEL D, 1986, MAR BIOL, V93, P429, DOI 10.1007/BF00401110; Druffel ERM, 1999, SCIENCE, V284, P1139, DOI 10.1126/science.284.5417.1139; FENAUX R, 1998, BIOL PELAGIC TUNICAT, pCH15; FRANCOIS R, 2001, OCEANOGRAPHY, V14, P65; GALT CP, 1979, FISH B-NOAA, V77, P514; HAMNER WM, 1992, DEEP-SEA RES, V39, P1299, DOI 10.1016/0198-0149(92)90070-A; Hopcroft RR, 1999, J PLANKTON RES, V21, P1923, DOI 10.1093/plankt/21.10.1923; Hunt James C., 1999, Plankton Biology and Ecology, V46, P75; MARTIN JH, 1987, DEEP-SEA RES, V34, P267, DOI 10.1016/0198-0149(87)90086-0; McGowan JA, 1998, SCIENCE, V281, P210, DOI 10.1126/science.281.5374.210; Pilskaln CH, 1996, J MAR RES, V54, P1149, DOI 10.1357/0022240963213772; Reimers CE, 1992, GLOBAL BIOGEOCHEM CY, V6, P199, DOI 10.1029/92GB00105; ROEMMICH D, 1995, SCIENCE, V267, P1324, DOI 10.1126/science.267.5202.1324; ROEMMICH D, 1995, SCIENCE, V268, P352, DOI 10.1126/science.268.5209.352-b; Silver MW, 1998, LIMNOL OCEANOGR, V43, P498, DOI 10.4319/lo.1998.43.3.0498; Smith KL, 1999, SCIENCE, V284, P1174, DOI 10.1126/science.284.5417.1174; Smith KL, 2002, DEEP-SEA RES PT I, V49, P971, DOI 10.1016/S0967-0637(02)00006-7; SMITH KL, 1994, LIMNOL OCEANOGR, V39, P1101, DOI 10.4319/lo.1994.39.5.1101; SMITH KL, 1987, LIMNOL OCEANOGR, V32, P201, DOI 10.4319/lo.1987.32.1.0201; Volkman JK, 2002, J OCEANOGR, V58, P265, DOI 10.1023/A:1015809708632	31	123	129	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2005	308	5728					1609	1611		10.1126/science.1109104	http://dx.doi.org/10.1126/science.1109104			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	936BH	15947183				2022-12-01	WOS:000229827000051
J	Krishnan, R; Lindquist, SL				Krishnan, R; Lindquist, SL			Structural insights into a yeast prion illuminate nucleation and strain diversity	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; GENETIC-VARIATION; NEURONAL ISOFORM; SPECIES BARRIER; PSI+ PRIONS; BETA-HELIX; SUP35 GENE; PROTEIN; INHERITANCE; FIBERS	Self-perpetuating changes in the conformations of amyloidogenic proteins play vital roles in normal biology and disease. Despite intense research, the architecture and conformational conversion of amyloids remain poorly understood. Amyloid conformers of Sup35 are the molecular embodiment of the yeast prion known as [ PSI], which produces heritable changes in phenotype through self-perpetuating changes in protein folding. Here we determine the nature of Sup35' s cooperatively folded amyloid core, and use this information to investigate central questions in prion biology. Specific segments of the amyloid core form intermolecular contacts in a 'Head-to-Head', 'Tail-to-Tail' fashion, but the 'Central Core' is sequestered through intramolecular contacts. The Head acquires productive interactions first, and these nucleate assembly. Variations in the length of the amyloid core and the nature of intermolecular interfaces form the structural basis of distinct prion 'strains', which produce variant phenotypes in vivo. These findings resolve several problems in yeast prion biology and have broad implications for other amyloids.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Lindquist, SL (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	Lindquist_admin@wi.mit.edu	Krishnan, Rajaraman/R-4874-2019	Krishnan, Rajaraman/0000-0002-5189-4097	NIGMS NIH HHS [R37 GM025874, R01 GM025874] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM025874, R01GM025874] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Balbirnie M, 2001, P NATL ACAD SCI USA, V98, P2375, DOI 10.1073/pnas.041617698; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; Bradley ME, 2004, MOL MICROBIOL, V51, P1649, DOI 10.1111/j.1365-2958.2003.03955.x; Bradley ME, 2002, P NATL ACAD SCI USA, V99, P16392, DOI 10.1073/pnas.152330699; Caughey B, 2000, NAT MED, V6, P751, DOI 10.1038/77476; CHERNOFF YO, 1993, CURR GENET, V24, P268, DOI 10.1007/BF00351802; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; Chien P, 2003, NATURE, V424, P948, DOI 10.1038/nature01894; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; DePace AH, 2002, NAT STRUCT BIOL, V9, P389, DOI 10.1038/nsb786; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Derkatch IL, 2004, P NATL ACAD SCI USA, V101, P12934, DOI 10.1073/pnas.0404968101; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Eaglestone SS, 1999, EMBO J, V18, P1974, DOI 10.1093/emboj/18.7.1974; Eakin CM, 2004, BIOCHEMISTRY-US, V43, P7808, DOI 10.1021/bi049792q; Garzon-Rodriguez W, 2000, J BIOL CHEM, V275, P22645, DOI 10.1074/jbc.M000756200; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Hwang W, 2004, P NATL ACAD SCI USA, V101, P12916, DOI 10.1073/pnas.0402634101; Jensen MA, 2001, GENETICS, V159, P527; Kajava AV, 2004, P NATL ACAD SCI USA, V101, P7885, DOI 10.1073/pnas.0402427101; Kamen DE, 2000, BIOCHEMISTRY-US, V39, P15932, DOI 10.1021/bi001900v; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; King CY, 2001, J MOL BIOL, V307, P1247, DOI 10.1006/jmbi.2001.4542; Kishimoto A, 2004, BIOCHEM BIOPH RES CO, V315, P739, DOI 10.1016/j.bbrc.2004.01.117; KUSHNIROV VV, 1990, YEAST, V6, P461, DOI 10.1002/yea.320060603; Lee S, 2003, NAT STRUCT BIOL, V10, P725, DOI 10.1038/nsb961; Li LM, 2000, SCIENCE, V287, P661, DOI 10.1126/science.287.5453.661; Liu JJ, 2002, P NATL ACAD SCI USA, V99, P16446, DOI 10.1073/pnas.252652099; Liu JJ, 1999, NATURE, V400, P573, DOI 10.1038/23048; Nakayashiki T, 2001, MOL CELL, V7, P1121, DOI 10.1016/S1097-2765(01)00259-3; Osherovich LZ, 2004, PLOS BIOL, V2, P442, DOI 10.1371/journal.pbio.0020086; Parham SN, 2001, EMBO J, V20, P2111, DOI 10.1093/emboj/20.9.2111; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; Scheibel T, 2004, P NATL ACAD SCI USA, V101, P2287, DOI 10.1073/pnas.0308754101; Scheibel T, 2001, CURR BIOL, V11, P366, DOI 10.1016/S0960-9822(01)00099-9; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2005, CELL, V121, P49, DOI 10.1016/j.cell.2005.03.008; TERAVANESYAN MD, 1993, MOL MICROBIOL, V7, P683, DOI 10.1111/j.1365-2958.1993.tb01159.x; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; Tuite MF, 2003, NAT REV MOL CELL BIO, V4, P878, DOI 10.1038/nrm1247; Uptain SM, 2002, ANNU REV MICROBIOL, V56, P703, DOI 10.1146/annurev.micro.56.013002.100603; Wille H, 2002, P NATL ACAD SCI USA, V99, P3563, DOI 10.1073/pnas.052703499	51	402	408	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2005	435	7043					765	772		10.1038/nature03679	http://dx.doi.org/10.1038/nature03679			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933NK	15944694	Green Accepted			2022-12-01	WOS:000229638700040
J	Yamashita, A; Singh, SK; Kawate, T; Jin, Y; Gouaux, E				Yamashita, A; Singh, SK; Kawate, T; Jin, Y; Gouaux, E			Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters	NATURE			English	Article							GAMMA-AMINOBUTYRIC-ACID; SEROTONIN TRANSPORTER; DOPAMINE TRANSPORTER; GABA TRANSPORTER; TRANSMEMBRANE DOMAIN; ION-BINDING; RAT-BRAIN; RESIDUES; PERMEATION; SUBSTRATE	Na+/Cl--dependent transporters terminate synaptic transmission by using electrochemical gradients to drive the uptake of neurotransmitters, including the biogenic amines, from the synapse to the cytoplasm of neurons and glia. These transporters are the targets of therapeutic and illicit compounds, and their dysfunction has been implicated in multiple diseases of the nervous system. Here we present the crystal structure of a bacterial homologue of these transporters from Aquifex aeolicus, in complex with its substrate, leucine, and two sodium ions. The protein core consists of the first ten of twelve transmembrane segments, with segments 1 - 5 related to 6 - 10 by a pseudo-two-fold axis in the membrane plane. Leucine and the sodium ions are bound within the protein core, halfway across the membrane bilayer, in an occluded site devoid of water. The leucine and ion binding sites are defined by partially unwound transmembrane helices, with main-chain atoms and helix dipoles having key roles in substrate and ion binding. The structure reveals the architecture of this important class of transporter, illuminates the determinants of substrate binding and ion selectivity, and defines the external and internal gates.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Howard Hughes Medical Institute	Gouaux, E (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 650 W 168th St, New York, NY 10032 USA.	jeg52@columbia.edu	Gouaux, Eric/Y-4370-2019; Yamashita, Atsuko/H-5566-2017	Gouaux, Eric/0000-0002-8549-2360; Yamashita, Atsuko/0000-0002-8001-4642				Amara SG, 1998, DRUG ALCOHOL DEPEN, V51, P87, DOI 10.1016/S0376-8716(98)00068-4; Androutsellis-Theotokis A, 2003, J BIOL CHEM, V278, P12703, DOI 10.1074/jbc.M206563200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARKER EL, 2000, PSYCHOPHARMACOLOGY 4; Bennett ER, 2000, J BIOL CHEM, V275, P34106, DOI 10.1074/jbc.M004229200; Bismuth Y, 1997, J BIOL CHEM, V272, P16096, DOI 10.1074/jbc.272.26.16096; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cao YW, 1998, J NEUROSCI, V18, P7739; Chen JG, 1997, BIOCHEMISTRY-US, V36, P1479, DOI 10.1021/bi962256g; Chen JG, 1997, J BIOL CHEM, V272, P28321, DOI 10.1074/jbc.272.45.28321; Chen JG, 1998, J BIOL CHEM, V273, P12675, DOI 10.1074/jbc.273.20.12675; Chen NH, 2003, EUR J PHARMACOL, V479, P213, DOI 10.1016/j.ejphar.2003.08.070; GUASTELLA J, 1990, SCIENCE, V249, P1303, DOI 10.1126/science.1975955; Guerrero SA, 2001, APPL MICROBIOL BIOT, V56, P718, DOI 10.1007/s002530100690; Hahn M. K., 2002, Pharmacogenomics Journal, V2, P217, DOI 10.1038/sj.tpj.6500106; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Hirai T, 2002, NAT STRUCT BIOL, V9, P597, DOI 10.1038/nsb821; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Just H, 2004, J BIOL CHEM, V279, P6650, DOI 10.1074/jbc.M306092200; KAVANAUGH MP, 1992, J BIOL CHEM, V267, P22007; KESHET GI, 1995, FEBS LETT, V371, P39, DOI 10.1016/0014-5793(95)00859-8; Krogsgaard-Larsen P, 2000, CURR PHARM DESIGN, V6, P1193, DOI 10.2174/1381612003399608; Loland CJ, 2004, J BIOL CHEM, V279, P3228, DOI 10.1074/jbc.M304755200; Loland CJ, 2002, P NATL ACAD SCI USA, V99, P1683, DOI 10.1073/pnas.032386299; Lopez-Corcuera B, 2001, J BIOL CHEM, V276, P43463, DOI 10.1074/jbc.M107438200; Mager S, 1996, J NEUROSCI, V16, P5405; Mari SA, 2004, CELL MOL LIFE SCI, V61, P243, DOI 10.1007/s00018-003-3367-2; Masson J, 1999, PHARMACOL REV, V51, P439; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Nayal M, 1996, J MOL BIOL, V256, P228, DOI 10.1006/jmbi.1996.0081; Nelson N, 1998, J NEUROCHEM, V71, P1785; PANTANOWITZ S, 1993, J BIOL CHEM, V268, P3222; Penado KMY, 1998, J BIOL CHEM, V273, P28098, DOI 10.1074/jbc.273.43.28098; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Ponce J, 2000, J BIOL CHEM, V275, P13856, DOI 10.1074/jbc.275.18.13856; Richerson GB, 2004, ADV EXP MED BIOL, V548, P76; Roux MJ, 2000, NEURON, V25, P373, DOI 10.1016/S0896-6273(00)80901-0; Rudnick Gary, 2002, P25; Sato Y, 2004, J BIOL CHEM, V279, P22926, DOI 10.1074/jbc.M312194200; Sitte HH, 2004, MOL INTERV, V4, P38, DOI 10.1124/mi.4.1.38; Smicun Y, 1999, J BIOL CHEM, V274, P36058, DOI 10.1074/jbc.274.51.36058; Stephan MM, 1997, BIOCHEMISTRY-US, V36, P1322, DOI 10.1021/bi962150l; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Vanhatalo S, 1998, ANN MED, V30, P151; WANG JB, 1995, J NEUROCHEM, V64, P1416; Yernool D, 2003, BIOCHEMISTRY-US, V42, P12981, DOI 10.1021/bi030161q; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018	50	1304	1320	1	167	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2005	437	7056					215	223		10.1038/nature03978	http://dx.doi.org/10.1038/nature03978			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961YE	16041361				2022-12-01	WOS:000231696900047
J	Berken, A; Thomas, C; Wittinghofer, A				Berken, A; Thomas, C; Wittinghofer, A			A new family of RhoGEFs activates the Rop molecular switch in plants	NATURE			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; SALMONELLA-TYPHIMURIUM; GTPASE; DOMAIN; RAS; FLUORESCENCE; SUPERFAMILY; INHIBITOR; GUANOSINE; REGION	In plants, the small GTP-binding proteins called Rops work as signalling switches that control growth, development and plant responses to various environmental stimuli(1-3). Rop proteins ( Rho of plants, Rac-like and AtRac in Arabidopsis thaliana) belong to the Rho family of Ras-related GTP-binding proteins that turn on signalling pathways by switching from a GDP-bound inactive to a GTP-bound active conformation(4,5). Activation depends on guanine nucleotide exchange factors ( GEFs) that catalyse the otherwise slow GDP dissociation for subsequent GTP binding(6). Although numerous RhoGEFs exist in animals and yeasts(7), no Rop-specific GEFs have yet been identified in plants and so Rop activation has remained elusive(1-3,8). Here we describe a new family of RhoGEF proteins that are exclusive to plants. We define a unique domain within these RopGEFs, termed PRONE (plant-specific Rop nucleotide exchanger), which is exclusively active towards members of the Rop subfamily. It increases nucleotide dissociation from Rop more than a thousand-fold and forms a tight complex with nucleotide-free Rop. RopGEFs may represent the missing link in signal transduction from receptor kinases to Rops and their identification has implications for the evolution of the Rho molecular switch.	Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany	Max Planck Society	Berken, A (corresponding author), Max Planck Inst Mol Physiol, Otto Hahn Str 11, D-44227 Dortmund, Germany.	antje.berken@mpi-dortmund.mpg.de		Thomas, Christoph/0000-0001-7441-1089				Baldauf SL, 2003, SCIENCE, V300, P1703, DOI 10.1126/science.1085544; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Cherfils J, 1999, TRENDS BIOCHEM SCI, V24, P306, DOI 10.1016/S0968-0004(99)01429-2; Cool RH, 1999, MOL CELL BIOL, V19, P6297; Fan HY, 1997, PLANT J, V12, P999, DOI 10.1046/j.1365-313X.1997.12050999.x; Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD222, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Haeusler LC, 2003, FEBS LETT, V555, P556, DOI 10.1016/S0014-5793(03)01351-6; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; HARPER JW, 1993, CELL, V75, P805; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; Kaothien P, 2005, PLANT J, V42, P492, DOI 10.1111/j.1365-313X.2005.02388.x; Karnoub AE, 2001, NAT STRUCT BIOL, V8, P1037, DOI 10.1038/nsb719; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LENZEN C, 1995, METHOD ENZYMOL, V255, P95; Lenzen C, 1998, BIOCHEMISTRY-US, V37, P7420, DOI 10.1021/bi972621j; Meller N, 2002, NAT CELL BIOL, V4, P639, DOI 10.1038/ncb835; Qiu JL, 2002, PLANT CELL, V14, P101, DOI 10.1105/tpc.010346; Robbe K, 2003, J BIOL CHEM, V278, P4756, DOI 10.1074/jbc.M210412200; ROSS MD, 1980, CLIN ONCOL, V6, P167; Rudolph MG, 1999, J BIOL CHEM, V274, P30501, DOI 10.1074/jbc.274.43.30501; Schmidt G, 1996, ONCOGENE, V12, P87; Valster AH, 2000, TRENDS CELL BIOL, V10, P141, DOI 10.1016/S0962-8924(00)01728-1; Vernoud V, 2003, PLANT PHYSIOL, V131, P1191, DOI 10.1104/pp.013052; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Yang ZB, 2002, PLANT CELL, V14, pS375, DOI 10.1105/tpc.001065; Zheng ZL, 2000, PLANT MOL BIOL, V44, P1, DOI 10.1023/A:1006402628948	30	193	224	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2005	436	7054					1176	1180		10.1038/nature03883	http://dx.doi.org/10.1038/nature03883			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958AK	15980860				2022-12-01	WOS:000231416600050
J	Okie, S				Okie, S			Medical marijuana and the Supreme Court	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Abrams DI, 2003, ANN INTERN MED, V139, P258, DOI 10.7326/0003-4819-139-4-200308190-00008; BINZ S, 2005, SAN FRANCISCO C 0624, pB4; Joy JE, 1999, MARIJUANA MED ASSESS	3	16	16	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 18	2005	353	7					648	651		10.1056/NEJMp058165	http://dx.doi.org/10.1056/NEJMp058165			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	955UW	16107619				2022-12-01	WOS:000231254100002
J	Baldini, G; Cannone, F; Chirico, G				Baldini, G; Cannone, F; Chirico, G			Pre-unfolding resonant oscillations of single green fluorescent protein molecules	SCIENCE			English	Article							GEL SILICA GLASS; ENERGY-TRANSFER; DYNAMICS; FLUCTUATIONS; SPECTROSCOPY; LANDSCAPES; MICROSCOPY; KINETICS; STATES; LIGHT	Fluorescence spectroscopy of a green fluorescent protein mutant at single-molecule resolution has revealed a remarkable oscillatory behavior that can also be driven by applied fields. We show that immediately before unfolding, several periodic oscillations among the chemical substates of the protein chromophore occur. We also show that applied alternating electric or acoustic fields, when tuned to the protein characteristic frequencies, give rise to strong resonance effects.	Univ Milano Bicocca, INFM, CNR, I-20126 Milan, Italy; Univ Milano Bicocca, Dept Phys, Lab Adv Biospectroscopy, I-20126 Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); University of Milano-Bicocca; University of Milano-Bicocca	Baldini, G (corresponding author), Univ Milano Bicocca, Dept Phys, Lab Adv Biospectroscopy, I-20126 Milan, Italy.	baldini@mib.infn.it		CHIRICO, Giuseppe/0000-0001-6578-6460				Abbruzzetti S, 2005, J AM CHEM SOC, V127, P626, DOI 10.1021/ja045400r; Badjic JD, 1999, CHEM MATER, V11, P3671, DOI 10.1021/cm990507c; BENAVRAHAM D, 1993, PHYS REV B, V47, P14559, DOI 10.1103/PhysRevB.47.14559; BETTATI S, 2004, ENCY NANOSCIENCE NAN, V9, P81; Campanini B, 2005, PROTEIN SCI, V14, P1125, DOI 10.1110/ps.041190805; Cannone F, 2004, MICROSC RES TECHNIQ, V65, P186, DOI 10.1002/jemt.20125; Chattoraj M, 1996, P NATL ACAD SCI USA, V93, P8362, DOI 10.1073/pnas.93.16.8362; Chirico G, 2002, PROTEIN SCI, V11, P1152, DOI 10.1110/ps.4490102; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Creemers TMH, 2000, P NATL ACAD SCI USA, V97, P2974, DOI 10.1073/pnas.050365997; CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; Deniz AA, 2000, P NATL ACAD SCI USA, V97, P5179, DOI 10.1073/pnas.090104997; Dickson RM, 1997, NATURE, V388, P355, DOI 10.1038/41048; Edman L, 1996, P NATL ACAD SCI USA, V93, P6710, DOI 10.1073/pnas.93.13.6710; Edman L, 2000, P NATL ACAD SCI USA, V97, P8266, DOI 10.1073/pnas.130589397; Eggers DK, 2001, J MOL BIOL, V314, P911, DOI 10.1006/jmbi.2001.5166; Eggers DK, 2001, PROTEIN SCI, V10, P250, DOI 10.1110/ps.36201; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; FRAUENFELDER H, 1988, ANNU REV BIOPHYS BIO, V17, P451; FUNATSU T, 1995, NATURE, V374, P555, DOI 10.1038/374555a0; Garcia-Parajo MF, 2000, P NATL ACAD SCI USA, V97, P7237, DOI 10.1073/pnas.97.13.7237; Ha TJ, 1999, P NATL ACAD SCI USA, V96, P893, DOI 10.1073/pnas.96.3.893; Haupts U, 1998, P NATL ACAD SCI USA, V95, P13573, DOI 10.1073/pnas.95.23.13573; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; Lim MH, 1998, P NATL ACAD SCI USA, V95, P15315, DOI 10.1073/pnas.95.26.15315; Liphardt J, 2001, SCIENCE, V292, P733, DOI 10.1126/science.1058498; Lipman EA, 2003, SCIENCE, V301, P1233, DOI 10.1126/science.1085399; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Moerner WE, 2003, REV SCI INSTRUM, V74, P3597, DOI 10.1063/1.1589587; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Scharnagl C, 1999, BIOPHYS J, V77, P1839, DOI 10.1016/S0006-3495(99)77028-1; Shen CY, 1997, J AM CHEM SOC, V119, P1304, DOI 10.1021/ja961867t; Silvano D, 2002, MICROSC RES TECHNIQ, V59, P536, DOI 10.1002/jemt.10235; Talaga DS, 2000, P NATL ACAD SCI USA, V97, P13021, DOI 10.1073/pnas.97.24.13021; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Viappiani C, 2004, P NATL ACAD SCI USA, V101, P14414, DOI 10.1073/pnas.0405987101; Vlad MO, 2002, P NATL ACAD SCI USA, V99, P12548, DOI 10.1073/pnas.192439099; Weber W, 1999, P NATL ACAD SCI USA, V96, P6177, DOI 10.1073/pnas.96.11.6177; Xie XS, 1998, ANNU REV PHYS CHEM, V49, P441, DOI 10.1146/annurev.physchem.49.1.441; Xie Z, 2004, P NATL ACAD SCI USA, V101, P534, DOI 10.1073/pnas.2636333100; Zimmer M, 2002, CHEM REV, V102, P759, DOI 10.1021/cr010142r; [No title captured]	42	51	51	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2005	309	5737					1096	1100		10.1126/science.1115001	http://dx.doi.org/10.1126/science.1115001			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955MN	16099991				2022-12-01	WOS:000231230100052
J	Hafting, T; Fyhn, M; Molden, S; Moser, MB; Moser, EI				Hafting, T; Fyhn, M; Molden, S; Moser, MB; Moser, EI			Microstructure of a spatial map in the entorhinal cortex	NATURE			English	Article							HEAD-DIRECTION CELLS; HIPPOCAMPAL ENSEMBLE CODE; PATH-INTEGRATION; PLACE CELLS; FUNCTIONAL-ORGANIZATION; NEURONS; RAT; MEMORY; CA3; INFORMATION	The ability to find one's way depends on neural algorithms that integrate information about place, distance and direction, but the implementation of these operations in cortical microcircuits is poorly understood. Here we show that the dorsocaudal medial entorhinal cortex ( dMEC) contains a directionally oriented, topographically organized neural map of the spatial environment. Its key unit is the 'grid cell', which is activated whenever the animal's position coincides with any vertex of a regular grid of equilateral triangles spanning the surface of the environment. Grids of neighbouring cells share a common orientation and spacing, but their vertex locations ( their phases) differ. The spacing and size of individual fields increase from dorsal to ventral dMEC. The map is anchored to external landmarks, but persists in their absence, suggesting that grid cells may be part of a generalized, path-integration-based map of the spatial environment.	Norwegian Univ Sci & Technol, Ctr Biol Memory, N-7489 Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Moser, EI (corresponding author), Norwegian Univ Sci & Technol, Ctr Biol Memory, N-7489 Trondheim, Norway.	edvard.moser@ntnu.no		Hafting, Torkel/0000-0002-0928-3487				[Anonymous], 1998, NEURAL NETWORKS BRAI; Biegler R, 2000, ANIM LEARN BEHAV, V28, P257, DOI 10.3758/BF03200260; Bostock E, 1991, Hippocampus, V1, P193, DOI 10.1002/hipo.450010207; Dhillon A, 2000, NEUROSCIENCE, V99, P413, DOI 10.1016/S0306-4522(00)00225-6; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; Etienne AS, 2004, HIPPOCAMPUS, V14, P180, DOI 10.1002/hipo.10173; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Fyhn M, 2002, NEURON, V35, P555, DOI 10.1016/S0896-6273(02)00784-5; GALLISTER CR, 1990, ORG LEARNING; GERMROTH P, 1991, J COMP NEUROL, V305, P215, DOI 10.1002/cne.903050205; GOODRIDGE JP, 1995, BEHAV NEUROSCI, V109, P49, DOI 10.1037/0735-7044.109.1.49; Gothard KM, 1996, J NEUROSCI, V16, P8027; Iijima T, 1996, SCIENCE, V272, P1176, DOI 10.1126/science.272.5265.1176; IKEDA J, 1989, BRAIN RES, V505, P176, DOI 10.1016/0006-8993(89)90134-0; Jeffery KJ, 1997, EXP BRAIN RES, V117, P131, DOI 10.1007/s002210050206; KNIERIM JJ, 1995, J NEUROSCI, V15, P1648, DOI 10.1523/JNEUROSCI.15-03-01648.1995; Lee I, 2004, NATURE, V430, P456, DOI 10.1038/nature02739; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; LINGENHOHL K, 1991, EXP BRAIN RES, V84, P57; Lorincz A, 2000, ANN NY ACAD SCI, V911, P83; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; McNaughton BL, 1996, J EXP BIOL, V199, P173; MITTELSTAEDT ML, 1980, NATURWISSENSCHAFTEN, V67, P566, DOI 10.1007/BF00450672; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; MULLER RU, 1987, J NEUROSCI, V7, P1951; Nadel L., 1991, Hippocampus, V1, P221, DOI 10.1002/hipo.450010302; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; OKEEFE J, 1978, EXP BRAIN RES, V31, P573; Parron C, 2004, EXP BRAIN RES, V159, P349, DOI 10.1007/s00221-004-1960-8; QUIRK GJ, 1992, J NEUROSCI, V12, P1945; Redish A. D., 1999, COGNITIVE MAP PLACE, DOI DOI 10.1038/nature14445; Redish AD, 1997, HIPPOCAMPUS, V7, P15; Rockland KS, 2004, EXP BRAIN RES, V158, P265, DOI 10.1007/s00221-004-2024-9; Samsonovich A, 1997, J NEUROSCI, V17, P5900; SARGOLINI F, 2004, SOC NEUR ABSTR, V30; SHARP PE, 1995, J NEUROSCI, V15, P173; Sharp PE, 1999, HIPPOCAMPUS, V9, P432, DOI 10.1002/(SICI)1098-1063(1999)9:4<432::AID-HIPO9>3.3.CO;2-G; Skaggs W E, 1995, Adv Neural Inf Process Syst, V7, P173; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Steffenach HA, 2005, NEURON, V45, P301, DOI 10.1016/j.neuron.2004.12.044; Taube JS, 1998, PROG NEUROBIOL, V55, P225, DOI 10.1016/S0301-0082(98)00004-5; TAUBE JS, 1990, J NEUROSCI, V10, P436; vanHaeften T, 1997, J NEUROSCI, V17, P862; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Witter M. P., 2004, RAT NERVOUS SYSTEM, V3rd, P637; WITTER MP, 1989, PROG NEUROBIOL, V33, P161, DOI 10.1016/0301-0082(89)90009-9; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4	50	2139	2223	21	519	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2005	436	7052					801	806		10.1038/nature03721	http://dx.doi.org/10.1038/nature03721			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953XG	15965463				2022-12-01	WOS:000231116500035
J	Christenson, LJ; Borrowman, TA; Vachon, CM; Tollefson, MM; Otley, CC; Weaver, AL; Roenigk, RK				Christenson, LJ; Borrowman, TA; Vachon, CM; Tollefson, MM; Otley, CC; Weaver, AL; Roenigk, RK			Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NONMELANOMA SKIN-CANCER; INCIDENCE RATES; UNITED-STATES; TRENDS; ADULTS; MINNESOTA; AUSTRALIA; ROCHESTER; AGE; ASSOCIATION	Context The incidence of nonmelanoma skin cancer is increasing rapidly among elderly persons, but little is known about its incidence in the population younger than 40 years. Objectives To estimate the sex- and age-specific incidences of basal cell carcinoma and squamous cell carcinoma in persons younger than 40 years in Olmsted County, Minnesota, and to evaluate change in incidence over time; to describe the clinical presentation, rate of recurrence and metastasis, and histologic characteristics of these tumors in this population-based sample. Design Population-based retrospective incidence case review. Setting Residents of Olmsted County, Minnesota, a population with comprehensive medical records captured through the Rochester Epidemiology Project. Participants Patients younger than 40 years with basal cell carcinoma or squamous cell carcinoma diagnosed between 1976 and 2003. Main Outcome Measures Incident basal cell carcinomas and squamous cell carcinomas and change in incidence of these tumors over time. Results During the study period, 451 incident basal cell carcinomas were diagnosed in 417 patients and 70 incident squamous cell carcinomas were diagnosed in 68 patients. Of these tumors, 328 were histologically confirmed basal cell carcinomas and 51 were histologically confirmed squamous coil carcinomas. Overall, the age-adjusted incidence of basal cell carcinoma per 100000 persons was 25.9 (95% confidence interval [CI], 22.6-29.2) for women and 20.9 (95% Cl, 17.8-23.9) for men. The incidence of basal cell carcinoma increased significantly during the study period among women (P<.001) but not men (P=.19). Nodular basal cell carcinoma was the most common histologic subtype; 43.0% of tumors were solely nodular basal cell carcinoma and 11.0% had a mixed composition, including the nodular subtype. The incidence of squamous cell carcinoma was similar in men and women, with an average age- and sex-adjusted incidence per 100000 persons of 3.9 (95% Cl, 3.0-4.8); the incidence of squamous cell carcinoma increased significantly over the study period among both women (P=.01) and men (P=.04). Conclusions This population-based study demonstrated an increase in the incidence of nonmelanoma skin cancer among young women and men residing in Olmsted County, Minnesota. There was a disproportionate increase in basal cell carcinoma in young women. This increase may lead to an exponential increase in the overall occurrence of nonmelanoma skin cancers over time as this population ages, which emphasizes the need to focus on skin cancer prevention in young adults.	Mayo Clin & Mayo Fdn, Dept Dermatol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Div Epidemiol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Div Biostat, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Christenson, LJ (corresponding author), Mayo Clin & Mayo Fdn, Dept Dermatol, 200 1st St SW, Rochester, MN 55905 USA.							*AM CANC SOC, CANC FACTS FIG 2001; AUBRY F, 1985, CANCER-AM CANCER SOC, V55, P907, DOI 10.1002/1097-0142(19850215)55:4<907::AID-CNCR2820550433>3.0.CO;2-5; Bastiaens MT, 1998, J INVEST DERMATOL, V110, P880, DOI 10.1046/j.1523-1747.1998.00217.x; BETTI R, 1995, INT J DERMATOL, V34, P174, DOI 10.1111/j.1365-4362.1995.tb01561.x; Boyd AS, 2002, J AM ACAD DERMATOL, V46, P706, DOI 10.1067/mjd.2002.120467; Buettner PG, 1998, INT J CANCER, V78, P587, DOI 10.1002/(SICI)1097-0215(19981123)78:5<587::AID-IJC10>3.0.CO;2-E; Chen JG, 2001, DERMATOL SURG, V27, P1035, DOI 10.1046/j.1524-4725.2001.01004.x; CHUANG TY, 1990, J AM ACAD DERMATOL, V22, P413, DOI 10.1016/0190-9622(90)70056-N; CHUANG TY, 1990, ARCH DERMATOL, V126, P185, DOI 10.1001/archderm.126.2.185; COEBERGH JWW, 1991, BRIT J DERMATOL, V125, P353, DOI 10.1111/j.1365-2133.1991.tb14171.x; COX NH, 1992, BRIT J DERMATOL, V127, P26, DOI 10.1111/j.1365-2133.1992.tb14820.x; EMMETT AJJ, 1990, AUST NZ J SURG, V60, P855, DOI 10.1111/j.1445-2197.1990.tb07489.x; GALLAGHER RP, 1990, J AM ACAD DERMATOL, V23, P413, DOI 10.1016/0190-9622(90)70234-9; Gray DT, 1997, ARCH DERMATOL, V133, P735, DOI 10.1001/archderm.133.6.735; GREEN A, 1988, J AM ACAD DERMATOL, V19, P1045, DOI 10.1016/S0190-9622(88)70270-4; Green A, 1996, AM J EPIDEMIOL, V144, P1034, DOI 10.1093/oxfordjournals.aje.a008875; GRODSTEIN F, 1995, J NATL CANCER I, V87, P1061, DOI 10.1093/jnci/87.14.1061; Hannuksela-Svahn A, 1999, ARCH DERMATOL, V135, P781, DOI 10.1001/archderm.135.7.781; Harris RB, 2001, J AM ACAD DERMATOL, V45, P528, DOI 10.1067/mjd.2001.114742; Holme SA, 2000, BRIT J DERMATOL, V143, P1224, DOI 10.1046/j.1365-2133.2000.03892.x; Karagas MR, 1999, INT J CANCER, V81, P555, DOI 10.1002/(SICI)1097-0215(19990517)81:4<555::AID-IJC9>3.0.CO;2-R; Kikuchi A, 1996, ARCH DERMATOL, V132, P320, DOI 10.1001/archderm.132.3.320; KOPF A W, 1979, Journal of Dermatology (Tokyo), V6, P267; LEFFELL DJ, 1991, ARCH DERMATOL, V127, P1663, DOI 10.1001/archderm.127.11.1663; MARKS R, 1993, INT J CANCER, V53, P585, DOI 10.1002/ijc.2910530410; Matta JL, 2003, J AM ACAD DERMATOL, V49, P433, DOI 10.1067/S0190-9622(03)00918-6; McCullagh P, 1983, GENERALIZED LINEAR M, P127; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; MILLER DL, 1994, J AM ACAD DERMATOL, V30, P774, DOI 10.1016/S0190-9622(08)81509-5; OLIPHANT JA, 1994, AM J PUBLIC HEALTH, V84, P476, DOI 10.2105/AJPH.84.3.476; Pearce MS, 2003, MELANOMA RES, V13, P421, DOI 10.1097/00008390-200308000-00013; Robinson JK, 1997, J AM ACAD DERMATOL, V37, P179, DOI 10.1016/S0190-9622(97)80122-3; Roudier-Pujol C, 1999, DERMATOLOGY, V199, P119, DOI 10.1159/000018217; Scotto J., 1983, NIH PUBLICATION, V83-2433; Scrivener Y, 2002, BRIT J DERMATOL, V147, P41, DOI 10.1046/j.1365-2133.2002.04804.x; SEXTON M, 1990, J AM ACAD DERMATOL, V23, P1118, DOI 10.1016/0190-9622(90)70344-H; Staples M, 1998, INT J CANCER, V78, P144, DOI 10.1002/(SICI)1097-0215(19981005)78:2<144::AID-IJC3>3.0.CO;2-Z; Weedon D., 2002, SKIN PATHOLOGY, P765	38	389	410	0	16	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 10	2005	294	6					681	690		10.1001/jama.294.6.681	http://dx.doi.org/10.1001/jama.294.6.681			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	953IA	16091570	Bronze			2022-12-01	WOS:000231068600021
J	Long, SB; Campbell, EB; MacKinnon, R				Long, SB; Campbell, EB; MacKinnon, R			Crystal structure of a mammalian voltage-dependent Shaker family K+ channel	SCIENCE			English	Article							GATED POTASSIUM CHANNEL; BETA-SUBUNITS; ION CHANNELS; ACTIVATION GATE; MOLECULAR-BASIS; ALPHA-SUBUNITS; BOVINE BRAIN; INACTIVATION; DROSOPHILA; DOMAIN	Voltage-de pendent potassium ion (K+) channels (Kv channels) conduct K+ ions across the cell membrane in response to changes in the membrane voltage, thereby regulating neuronal excitability by modulating the shape and frequency of action potentials. Here we report the crystal structure, at a resolution of 2.9 angstroms, of a mammalian Kv channel, Kv1.2, which is a member of the Shaker K+ channel family. This structure is in complex with an oxido-reductase beta subunit of the kind that can regulate mammalian Kv channels in their native cell environment. The activation gate of the pore is open. Large side portals communicate between the pore and the cytoplasm. Electrostatic properties of the side portals and positions of the T1 domain and beta subunit are consistent with etectrophysiologicat studies of inactivation gating and with the possibility of K+ channel regulation by the beta subunit.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10021 USA.	mackinn@rockefeller.edu			NCRR NIH HHS [RR00862] Funding Source: Medline; NIGMS NIH HHS [GM43949] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043949] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; CHOUINARD SW, 1995, P NATL ACAD SCI USA, V92, P6763, DOI 10.1073/pnas.92.15.6763; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P1; del Camino D, 2001, NEURON, V32, P649, DOI 10.1016/S0896-6273(01)00487-1; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; Hackos DH, 2002, J GEN PHYSIOL, V119, P521, DOI 10.1085/jgp.20028569; Heinemann SH, 1996, J PHYSIOL-LONDON, V493, P625, DOI 10.1113/jphysiol.1996.sp021409; Hille B., 2001, ION CHANNELS EXCITAB, V3; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAMB A, 1987, CELL, V50, P405, DOI 10.1016/0092-8674(87)90494-6; Kobertz WR, 2000, BIOCHEMISTRY-US, V39, P10347, DOI 10.1021/bi001292j; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kreusch A, 1998, NATURE, V392, P945, DOI 10.1038/31978; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; MacKinnon R, 2004, ANGEW CHEM INT EDIT, V43, P4265, DOI 10.1002/anie.200400662; MCCORMACK K, 1995, FEBS LETT, V370, P32, DOI 10.1016/0014-5793(95)00785-8; MCCORMACK T, 1994, CELL, V79, P1133, DOI 10.1016/0092-8674(94)90004-3; Miyazawa A, 1999, J MOL BIOL, V288, P765, DOI 10.1006/jmbi.1999.2721; MURRELLLAGNADO RD, 1993, J GEN PHYSIOL, V102, P977, DOI 10.1085/jgp.102.6.977; MURRELLLAGNADO RD, 1993, J GEN PHYSIOL, V102, P949, DOI 10.1085/jgp.102.6.949; Nagaya N, 1997, J BIOL CHEM, V272, P3022, DOI 10.1074/jbc.272.5.3022; Nakahira K, 1996, J BIOL CHEM, V271, P7084, DOI 10.1074/jbc.271.12.7084; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Parcej DN, 2003, J MOL BIOL, V333, P103, DOI 10.1016/j.jmb.2003.07.009; PARCEJ DN, 1992, BIOCHEMISTRY-US, V31, P11084, DOI 10.1021/bi00160a018; PONGS O, 1988, EMBO J, V7, P1087, DOI 10.1002/j.1460-2075.1988.tb02917.x; REHM H, 1988, P NATL ACAD SCI USA, V85, P4919, DOI 10.1073/pnas.85.13.4919; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Ruta V, 2003, NATURE, V422, P180, DOI 10.1038/nature01473; SCOTT VES, 1994, P NATL ACAD SCI USA, V91, P1637, DOI 10.1073/pnas.91.5.1637; Sesti F, 2003, NAT NEUROSCI, V6, P353, DOI 10.1038/nn1028; Sewing S, 1996, NEURON, V16, P455, DOI 10.1016/S0896-6273(00)80063-X; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; Sokolova O, 2001, STRUCTURE, V9, P215, DOI 10.1016/S0969-2126(01)00578-0; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; Webster SM, 2004, NATURE, V428, P864, DOI 10.1038/nature02468; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; Yu WF, 1996, NEURON, V16, P441, DOI 10.1016/S0896-6273(00)80062-8; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	54	1729	1789	6	244	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2005	309	5736					897	903		10.1126/science.1116269	http://dx.doi.org/10.1126/science.1116269			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953SS	16002581				2022-12-01	WOS:000231101400036
J	St Clair, D; Xu, MQ; Wang, P; Yu, YQ; Fang, YR; Zhang, F; Zheng, XY; Gu, NF; Feng, GY; Sham, P; He, L				St Clair, D; Xu, MQ; Wang, P; Yu, YQ; Fang, YR; Zhang, F; Zheng, XY; Gu, NF; Feng, GY; Sham, P; He, L			Rates of adult schizophrenia following prenatal exposure to the Chinese famine of 1959-1961	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OBSTETRIC COMPLICATIONS; EARLY-ONSET; INFLUENZA; RISK; HYPOTHESIS; DISORDERS; STRESS	Context Schizophrenia is a common major mental disorder. Intrauterine nutritional deficiency may increase the risk of schizophrenia. The main evidence comes from studies of the 1944-1945 Dutch Hunger Winter when a sharp and time-limited decline in food intake occurred. The most exposed cohort conceived during the famine showed a 2-fold increased risk of schizophrenia. Objective To determine whether those who endured a massive 1959-1961 famine in China experienced similar results. Design, Setting, and Participants The risk of schizophrenia was examined in the Wuhu region of Anhui, one of the most affected provinces. Rates were compared among those born before, during, and after the famine years. Wuhu and its surrounding 6 counties are served by a single psychiatric hospital. All psychiatric case records for the years 1971 through 2001 were examined, and clinical and sociodemographic information on patients with schizophrenia was extracted by researchers who were blinded to the nature of exposure. Data on number of births and deaths in the famine years were available, and cumulative mortality was estimated from later demographic surveys. Main Outcome Measures Evidence of famine was verified, and unadjusted and, mortality-adjusted relative risks of schizophrenia were calculated. Results The birth rates (per 1000) in Anhui decreased approximately 80% during the famine years from 28.28 in 1958 and 20.97 in 1959 to 8.61 in 1960 and 11.06 in 1961. Among births that occurred during the famine years, the adjusted risk of developing schizophrenia in later life increased significantly, from 0.84% in 1959 to 2.15% in 1960 and 1.81% in 1961. The mortality-adjusted relative risk was 2.30 (95% confidence interval, 1.99-2.65) for those born in 1960 and 1.93 (95% confidence interval, 1.68-2.23) for those born in 1961. Conclusion Our findings replicate the Dutch data for a separate racial group and show that prenatal exposure to famine increases risk of schizophrenia in later life.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai 200031, Peoples R China; Shanghai Jiao Tong Univ, Shanghai 200030, Peoples R China; Fourth Peoples Hosp, Wuhu, Anhui, Peoples R China; Second Peoples Hosp, Huang Shan, Anhui, Peoples R China; Peking Univ, Inst Populat Res, Beijing 100871, Peoples R China; Shanghai Inst Mental Hlth, Shanghai, Peoples R China; Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; Shanghai Jiao Tong Univ, NHGG, Shanghai 200030, Peoples R China; Univ Aberdeen, Dept Mental Hlth, Aberdeen AB9 1FX, Scotland; Inst Psychiat, Div Psychol Med, London, England	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Peking University; University of Hong Kong; Shanghai Jiao Tong University; University of Aberdeen; University of London; King's College London	St Clair, D (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, 294 Taiyuan Rd, Shanghai 200031, Peoples R China.	d.stclair@abdn.ac.uk; helin@nhgg.org	St Clair, David/AAN-2412-2021					American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; *ANH PROV BUR STAT, 1991, ANH STAT YB 1991; Brown AS, 2004, ARCH GEN PSYCHIAT, V61, P774, DOI 10.1001/archpsyc.61.8.774; Cannon M, 2002, AM J PSYCHIAT, V159, P1080, DOI 10.1176/appi.ajp.159.7.1080; Cannon M, 2003, EPIDEMIOLOGY SCHIZOP, P74; Chang Jung., 1991, WILD SWANS 3 DAUGHTE; Chen C. H., 1998, CHINESE J PSYCHIAT, V31, P72; Cotter D, 2002, BRIT J PSYCHIAT, V181, P363, DOI 10.1192/bjp.181.5.363; Goldner EM, 2002, CAN J PSYCHIAT, V47, P833, DOI 10.1177/070674370204700904; Gottesman I., 1991, SCHIZOPHRENIA GENESI; Hultman CM, 1999, BRIT MED J, V318, P421, DOI 10.1136/bmj.318.7181.421; Jablensky A, 2000, EUR ARCH PSY CLIN N, V250, P274, DOI 10.1007/s004060070002; LIXIN W, 1993, AGR REFORMS ANHUI TR; McGrath JJ, 2003, ANN MED, V35, P86, DOI 10.1080/07853890310010005; MCGUFFIN P, 2002, PSYCHIAT GENETICS GE; MEDNICK SA, 1988, ARCH GEN PSYCHIAT, V45, P189, DOI 10.1001/archpsyc.1988.01800260109013; Mortensen PB, 1999, NEW ENGL J MED, V340, P603, DOI 10.1056/NEJM199902253400803; MURRAY RM, 1987, BRIT MED J, V295, P681, DOI 10.1136/bmj.295.6600.681; Neugebauer R, 1999, JAMA-J AM MED ASSOC, V282, P455, DOI 10.1001/jama.282.5.455; OCALLAGHAN E, 1992, BRIT MED J, V305, P1256, DOI 10.1136/bmj.305.6864.1256; Rosenberg SM, 2004, NATURE, V430, P625, DOI 10.1038/430625a; Rutherford SL, 2003, NAT REV GENET, V4, P263, DOI 10.1038/nrg1041; Schwahn B, 2001, Am J Pharmacogenomics, V1, P189, DOI 10.2165/00129785-200101030-00004; SHAM PC, 1992, BRIT J PSYCHIAT, V160, P461, DOI 10.1192/bjp.160.4.461; Smil V, 1999, BMJ-BRIT MED J, V319, P1619, DOI 10.1136/bmj.319.7225.1619; *STAT STAT BUR, 1988, COMP MAT POP CENS ST; Susser E, 1998, AM J EPIDEMIOL, V147, P213; Susser E, 1996, ARCH GEN PSYCHIAT, V53, P25; SUSSER ES, 1992, ARCH GEN PSYCHIAT, V49, P983; van Os J, 1998, BRIT J PSYCHIAT, V172, P324, DOI 10.1192/bjp.172.4.324; Verdoux H, 1997, AM J PSYCHIAT, V154, P1220; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; World Health Organization, 1992, INT CLASS DIS; ZHENG Y, 1987, CHINESE POPULATION A	34	479	492	2	49	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 3	2005	294	5					557	562		10.1001/jama.294.5.557	http://dx.doi.org/10.1001/jama.294.5.557			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951NN	16077049	Bronze			2022-12-01	WOS:000230937500015
J	Ou, GS; Blacque, OE; Snow, JJ; Leroux, MR; Scholey, JM				Ou, GS; Blacque, OE; Snow, JJ; Leroux, MR; Scholey, JM			Functional coordination of intraflagellar transport motors	NATURE			English	Article							CAENORHABDITIS-ELEGANS; CHEMOSENSORY NEURONS; C-ELEGANS; SENSORY CILIA; KINESIN-II; FLAGELLAR; PROTEIN; GENE; EXPRESSION; PARTICLES	Cilia have diverse roles in motility and sensory reception, and defects in cilia function contribute to ciliary diseases such as Bardet-Biedl syndrome (BBS). Intraflagellar transport (IFT) motors assemble and maintain cilia by transporting ciliary precursors, bound to protein complexes called IFT particles, from the base of the cilium to their site of incorporation at the distal tip(1-3). In Caenorhabditis elegans, this is accomplished by two IFT motors, kinesin-II and osmotic avoidance defective (OSM)-3 kinesin, which cooperate to form two sequential anterograde IFT pathways that build distinct parts of cilia(4-7). By observing the movement of fluorescent IFT motors and IFT particles along the cilia of numerous ciliary mutants, we identified three genes whose protein products mediate the functional coordination of these motors. The BBS proteins BBS-7 and BBS-8 are required to stabilize complexes of IFT particles containing both of the IFT motors, because IFT particles in bbs-7 and bbs-8 mutants break down into two subcomplexes, IFT-A and IFT-B, which are moved separately by kinesin-II and OSM-3 kinesin, respectively. A conserved ciliary protein, DYF-1, is specifically required for OSM-3 kinesin to dock onto and move IFT particles, because OSM-3 kinesin is inactive and intact IFT particles are moved by kinesin-II alone in dyf-1 mutants. These findings implicate BBS ciliary disease proteins and an OSM-3 kinesin activator in the formation of two IFT pathways that build functional cilia.	Univ Calif Davis, Ctr Genet & Dev, Sect Mol & Cellular Biol, Davis, CA 95616 USA; Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	University of California System; University of California Davis; Simon Fraser University	Scholey, JM (corresponding author), Univ Calif Davis, Ctr Genet & Dev, Sect Mol & Cellular Biol, Davis, CA 95616 USA.	jmscholey@ucdavis.edu	Blacque, Oliver/AAL-8860-2021	Blacque, Oliver/0000-0003-1598-2695				Awan A, 2004, CELL MOTIL CYTOSKEL, V58, P1, DOI 10.1002/cm.10170; Blacque OE, 2004, GENE DEV, V18, P1630, DOI 10.1101/gad.1194004; Cole DG, 2003, TRAFFIC, V4, P435, DOI 10.1034/j.1600-0854.2003.t01-1-00103.x; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; COLE DG, 1993, NATURE, V366, P268, DOI 10.1038/366268a0; Deacon SW, 2003, J CELL BIOL, V160, P297, DOI 10.1083/jcb.200210066; DERISO L, 1994, GENETICA, V94, P195, DOI 10.1007/BF01443433; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Lawrence CJ, 2004, J CELL BIOL, V167, P19, DOI 10.1083/jcb.200408113; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Mallik R, 2004, CURR BIOL, V14, pR971, DOI 10.1016/j.cub.2004.10.046; MESLAND DAM, 1980, J CELL BIOL, V84, P599, DOI 10.1083/jcb.84.3.599; Miki H, 2001, P NATL ACAD SCI USA, V98, P7004, DOI 10.1073/pnas.111145398; Mueller J, 2005, MOL BIOL CELL, V16, P1341, DOI 10.1091/mbc.e04-10-0931; Orozco JT, 1999, NATURE, V398, P674, DOI 10.1038/19448; Pan JM, 2005, LAB INVEST, V85, P452, DOI 10.1038/labinvest.3700253; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Scholey JM, 2004, BIOCHEM SOC T, V32, P682, DOI 10.1042/BST0320682; Scholey JM, 2003, ANNU REV CELL DEV BI, V19, P423, DOI 10.1146/annurev.cellbio.19.111401.091318; Signor D, 1999, J CELL BIOL, V147, P519, DOI 10.1083/jcb.147.3.519; Signor D, 1999, MOL BIOL CELL, V10, P345, DOI 10.1091/mbc.10.2.345; Snow JJ, 2004, NAT CELL BIOL, V6, P1109, DOI 10.1038/ncb1186; STARICH TA, 1995, GENETICS, V139, P171; Swoboda P, 2000, MOL CELL, V5, P411, DOI 10.1016/S1097-2765(00)80436-0; TABISH M, 1995, J MOL BIOL, V247, P377, DOI 10.1006/jmbi.1994.0146; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9	28	288	307	3	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2005	436	7050					583	587		10.1038/nature03818	http://dx.doi.org/10.1038/nature03818			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049494				2022-12-01	WOS:000230788800067
J	Wang, D; Kennedy, S; Conte, D; Kim, JK; Gabel, HW; Kamath, RS; Mello, CC; Ruvkun, G				Wang, D; Kennedy, S; Conte, D; Kim, JK; Gabel, HW; Kamath, RS; Mello, CC; Ruvkun, G			Somatic misexpression of germline P granules and enhanced RNA interference in retinoblastoma pathway mutants	NATURE			English	Article							C-ELEGANS; CAENORHABDITIS-ELEGANS; VULVAL DEVELOPMENT; LIN-35 RB; COMPLEX; PROTEIN; GENE; DROSOPHILA; HOMOLOG; LINE	Caenorhabditis elegans homologues of the retinoblastoma (Rb) tumour suppressor complex specify cell lineage during development(1,2). Here we show that mutations in Rb pathway components enhance RNA interference (RNAi) and cause somatic cells to express genes and elaborate perinuclear structures normally limited to germline-specific P granules. Furthermore, particular gene inactivations that disrupt RNAi reverse the cell lineage transformations of Rb pathway mutants. These findings suggest that mutations in Rb pathway components cause cells to revert to patterns of gene expression normally restricted to germ cells. Rb may act by a similar mechanism to transform mammalian cells.	Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Ruvkun, G (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	ruvkun@molbio.mgh.harvard.edu		Kennedy, Scott/0000-0002-7974-8155				Black EP, 2003, CANCER RES, V63, P3716; Braas D, 2004, NUCLEIC ACIDS RES, V32, P4750, DOI 10.1093/nar/gkh808; Ceol CJ, 2001, MOL CELL, V7, P461, DOI 10.1016/S1097-2765(01)00194-0; Couteau F, 2002, EMBO REP, V3, P235, DOI 10.1093/embo-reports/kvf051; Debernardi S, 2002, BLOOD, V99, P275, DOI 10.1182/blood.V99.1.275; Fischer U, 1996, HUM GENET, V98, P625, DOI 10.1007/s004390050271; Fong YY, 2002, SCIENCE, V296, P2235, DOI 10.1126/science.1070790; Godbout R, 1998, J BIOL CHEM, V273, P21161, DOI 10.1074/jbc.273.33.21161; Hsieh J, 1999, GENE DEV, V13, P2958, DOI 10.1101/gad.13.22.2958; HUANG LS, 1994, MOL BIOL CELL, V5, P395, DOI 10.1091/mbc.5.4.395; Kawasaki I, 1998, CELL, V94, P635, DOI 10.1016/S0092-8674(00)81605-0; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Kim JK, 2005, SCIENCE, V308, P1164, DOI 10.1126/science.1109267; Klymenko T, 2004, EMBO REP, V5, P373, DOI 10.1038/sj.embor.7400111; Lai A, 2001, MOL CELL BIOL, V21, P2918, DOI 10.1128/MCB.21.8.2918-2932.2001; Lewis PW, 2004, GENE DEV, V18, P2929, DOI 10.1101/gad.1255204; Linder B, 2001, EMBO REP, V2, P211, DOI 10.1093/embo-reports/kve039; Lu XW, 1998, CELL, V95, P981, DOI 10.1016/S0092-8674(00)81722-5; Myers TR, 2005, DEV CELL, V8, P117, DOI 10.1016/j.devcel.2004.11.015; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Pitt JN, 2000, DEV BIOL, V219, P315, DOI 10.1006/dbio.2000.9607; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Robert VJP, 2005, GENE DEV, V19, P782, DOI 10.1101/gad.332305; Sijen T, 2003, NATURE, V426, P310, DOI 10.1038/nature02107; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Streubel B, 2000, GENE CHROMOSOME CANC, V27, P380, DOI 10.1002/(SICI)1098-2264(200004)27:4<380::AID-GCC7>3.3.CO;2-R; Unhavaithaya Y, 2002, CELL, V111, P991, DOI 10.1016/S0092-8674(02)01202-3; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686	30	197	237	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2005	436	7050					593	597		10.1038/nature04010	http://dx.doi.org/10.1038/nature04010			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049496				2022-12-01	WOS:000230788800069
J	Aizenberg, J; Weaver, JC; Thanawala, MS; Sundar, VC; Morse, DE; Fratzl, P				Aizenberg, J; Weaver, JC; Thanawala, MS; Sundar, VC; Morse, DE; Fratzl, P			Skeleton of Euplectella sp.: Structural hierarchy from the nanoscale to the macroscale	SCIENCE			English	Article							SPONGE; BONE; COMPOSITE; TOUGHNESS; BIOSILICA; FEATURES; DESIGN; FIBERS; MODEL	Structural materials in nature exhibit remarkable designs with building blocks, often hierarchically arranged from the nanometer to the macroscopic length scales. We report on the structural properties of biosilica observed in the hexactinellid sponge Euplectella sp. Consolidated, nanometer-scaled silica spheres are arranged in well-defined microscopic concentric rings glued together by organic matrix to form laminated spicules. The assembly of these spicules into bundles, effected by the laminated silica-based cement, results in the formation of a macroscopic cylindrical square-lattice cagelike structure reinforced by diagonal ridges. The ensuing design overcomes the brittleness of its constituent material, glass, and shows outstanding mechanical rigidity and stability. The mechanical benefits of each of seven identified hierarchical levels and their comparison with common mechanical engineering strategies are discussed.	Bell Labs, Lucent Technol, Murray Hill, NJ 07974 USA; Univ Calif Santa Barbara, Inst Collaborat Biotechnol, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Mat Res Lab, Santa Barbara, CA 93106 USA; Max Planck Inst Colloids & Interfaces, D-14424 Potsdam, Germany	Alcatel-Lucent; Lucent Technologies; AT&T; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Max Planck Society	Aizenberg, J (corresponding author), Bell Labs, Lucent Technol, 600 Mt Ave, Murray Hill, NJ 07974 USA.	jaizenberg@lucent.com	Fratzl, Peter/H-9095-2012; Weaver, James C./AAE-7870-2019	Fratzl, Peter/0000-0003-4437-7830; 				Aizenberg J, 2004, P NATL ACAD SCI USA, V101, P3358, DOI 10.1073/pnas.0307843101; Cha JN, 1999, P NATL ACAD SCI USA, V96, P361, DOI 10.1073/pnas.96.2.361; Chai H, 2002, ACTA MATER, V50, P2613, DOI 10.1016/S1359-6454(02)00091-5; CLEGG WJ, 1990, NATURE, V347, P455, DOI 10.1038/347455a0; Currey JD, 1999, J EXP BIOL, V202, P3285; Deshpande VS, 2001, ACTA MATER, V49, P1035, DOI 10.1016/S1359-6454(00)00379-7; Evans AG, 2001, J MATER RES, V16, P2475, DOI 10.1557/JMR.2001.0339; Faber KT, 1997, ANNU REV MATER SCI, V27, P499, DOI 10.1146/annurev.matsci.27.1.499; Fratzl P, 2004, J MATER CHEM, V14, P2115, DOI 10.1039/b402005g; Gao HJ, 2003, P NATL ACAD SCI USA, V100, P5597, DOI 10.1073/pnas.0631609100; Gibson L. J., 1999, CELLULAR SOLIDS STRU, DOI 10.1017/cbo9781139878326.006; Hamm CE, 2003, NATURE, V421, P841, DOI 10.1038/nature01416; Hassenkam T, 2004, BONE, V35, P4, DOI 10.1016/j.bone.2004.02.024; Kamat S, 2000, NATURE, V405, P1036, DOI 10.1038/35016535; Keckes J, 2003, NAT MATER, V2, P810, DOI 10.1038/nmat1019; Kroger N, 2002, SCIENCE, V298, P584, DOI 10.1126/science.1076221; LEVI C, 1989, J MATER SCI LETT, V8, P337, DOI 10.1007/BF00725516; Lichtenegger H, 1999, J STRUCT BIOL, V128, P257, DOI 10.1006/jsbi.1999.4194; Lowenstam H.A., 1989, BIOMINERALISATION; Mayer G, 2002, EXP MECH, V42, P395, DOI 10.1007/BF02412144; MAYER G, 2004, CERAM B, V83, P9305; Perry CC, 2000, J BIOL INORG CHEM, V5, P537, DOI 10.1007/s007750000130; Porter AE, 2002, BIOMATERIALS, V23, P725, DOI 10.1016/S0142-9612(01)00177-6; Saito T, 2002, J ZOOL, V258, P521, DOI 10.1017/S0952836902001681; Sarikaya M, 2001, J MATER RES, V16, P1420, DOI 10.1557/JMR.2001.0198; SCHULZE FE, 1887, REPORT HEXACTINELLID, V21; Seshadri M, 2002, ACTA MATER, V50, P4477, DOI 10.1016/S1359-6454(02)00255-0; Smith BL, 1999, NATURE, V399, P761, DOI 10.1038/21607; Sundar VC, 2003, NATURE, V424, P899, DOI 10.1038/424899a; Wainwright SA., 1976, MECH DESIGN ORGANISM; Weaver JC, 2003, J STRUCT BIOL, V144, P271, DOI 10.1016/j.jsb.2003.09.031; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271	32	811	843	24	531	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 8	2005	309	5732					275	278		10.1126/science.1112255	http://dx.doi.org/10.1126/science.1112255			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944SP	16002612				2022-12-01	WOS:000230449800037
J	Carazo-Salas, RE; Antony, C; Nurse, P				Carazo-Salas, RE; Antony, C; Nurse, P			The kinesin Klp2 mediates polarization of interphase microtubules in fission yeast	SCIENCE			English	Article							POLE BODY; DYNAMICS; SPINDLE; END; NUCLEATION; CONTRIBUTE; MOVEMENT; MOTORS	Fission yeast (Schizosaccharomyces pombe) cells grow longitudinally in a manner dependent on a polarized distribution of their interphase microtubules. We found that this distribution required sliding of microtubules toward the cell center along preexisting microtubules. This sliding was mediated by the minus end-directed kinesin motor Klp2, which helped microtubules to become properly organized with plus ends predominantly oriented toward the cell ends and minus ends toward the cell center. Thus, interphase microtubules in the fission yeast require motor activities for their proper organization.	Canc Res UK, London Res Inst, Cell Cycle Lab, London WC2A 1PX, England; European Mol Biol Lab, D-69117 Heidelberg, Germany; Rockefeller Univ, New York, NY 10021 USA	Cancer Research UK; European Molecular Biology Laboratory (EMBL); Rockefeller University	Carazo-Salas, RE (corresponding author), Canc Res UK, London Res Inst, Cell Cycle Lab, 44 Lincolns Inn Fields, London WC2A 1PX, England.	carazo01@cancer.org.uk	antony, claude/K-5342-2013	Carazo-Salas, Rafael E/0000-0002-5943-3981				Behrens R, 2002, J CELL BIOL, V157, P783, DOI 10.1083/jcb.200112027; Brazer SCW, 2000, YEAST, V16, P149, DOI 10.1002/(SICI)1097-0061(20000130)16:2<149::AID-YEA514>3.0.CO;2-C; Browning H, 2003, NAT CELL BIOL, V5, P812, DOI 10.1038/ncb1034; Brunner D, 2000, CELL, V102, P695, DOI 10.1016/S0092-8674(00)00091-X; Busch KE, 2004, CURR BIOL, V14, P548, DOI 10.1016/j.cub.2004.03.029; Dammermann A, 2003, CURR BIOL, V13, pR614, DOI 10.1016/S0960-9822(03)00530-X; Ding R, 1997, MOL BIOL CELL, V8, P1461, DOI 10.1091/mbc.8.8.1461; Drummond DR, 2000, CURR BIOL, V10, P766, DOI 10.1016/S0960-9822(00)00570-4; Endow SA, 2000, NATURE, V406, P913, DOI 10.1038/35022617; Endow SA, 1999, EUR J BIOCHEM, V262, P12, DOI 10.1046/j.1432-1327.1999.00339.x; Hayles J, 2001, NAT REV MOL CELL BIO, V2, P647, DOI 10.1038/35089520; HEIDEMANN SR, 1991, METHOD ENZYMOL, V196, P469; Hyman A, 1998, J CELL SCI, V111, P2077; Keating TJ, 1999, BIOL CELL, V91, P321, DOI 10.1016/S0248-4900(99)80093-8; Mata J, 1997, CELL, V89, P939, DOI 10.1016/S0092-8674(00)80279-2; Paluh JL, 2000, MOL BIOL CELL, V11, P1225, DOI 10.1091/mbc.11.4.1225; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; Rodionov VI, 1997, SCIENCE, V275, P215, DOI 10.1126/science.275.5297.215; Rusan NM, 2002, J CELL BIOL, V158, P997, DOI 10.1083/jcb.200204109; Sagolla MJ, 2003, J CELL SCI, V116, P4891, DOI 10.1242/jcs.00796; Sawin KE, 2004, CURR BIOL, V14, P763, DOI 10.1016/j.cub.2004.03.042; Sharp DJ, 1999, NAT CELL BIOL, V1, P51, DOI 10.1038/9025; Tran PT, 2001, J CELL BIOL, V153, P397, DOI 10.1083/jcb.153.2.397; Troxell CL, 2001, MOL BIOL CELL, V12, P3476, DOI 10.1091/mbc.12.11.3476; Tulu US, 2003, CURR BIOL, V13, P1894, DOI 10.1016/j.cub.2003.10.002; West RR, 2001, MOL BIOL CELL, V12, P3919, DOI 10.1091/mbc.12.12.3919; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669; Yamamoto A, 1999, J CELL BIOL, V145, P1233, DOI 10.1083/jcb.145.6.1233	28	41	43	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2005	309	5732					297	300		10.1126/science.1113465	http://dx.doi.org/10.1126/science.1113465			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944SP	16002618				2022-12-01	WOS:000230449800044
J	Balagadde, FK; You, LC; Hansen, CL; Arnold, FH; Quake, SR				Balagadde, FK; You, LC; Hansen, CL; Arnold, FH; Quake, SR			Long-term monitoring of bacteria undergoing programmed population control in a microchemostat	SCIENCE			English	Article							MICROBIOREACTOR; GROWTH	Using an active approach to preventing biofilm formation, we implemented a microfluidic bioreactor that enables long-term culture and monitoring of extremely small populations of bacteria with single-cell resolution. We used this device to observe the dynamics of Escherichia coli carrying a synthetic "population control" circuit that regulates cell density through a feedback mechanism based on quorum sensing. The microfluidic bioreactor enabled long-term monitoring of unnatural behavior programmed by the synthetic circuit, which included sustained oscillations in cell density and associated morphological changes, over hundreds of hours.	CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Quake, SR (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	quake@stanford.edu		Arnold, Frances H./0000-0002-4027-364X				Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; DYKHUIZEN DE, 1990, ANNU REV ECOL SYST, V21, P373, DOI 10.1146/annurev.ecolsys.21.1.373; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; FOX MS, 1955, J GEN PHYSIOL, V39, P267, DOI 10.1085/jgp.39.2.267; Kim JW, 1998, J KOREAN PHYS SOC, V33, pS462; Kostov Y, 2001, BIOTECHNOL BIOENG, V72, P346, DOI 10.1002/1097-0290(20010205)72:3<346::AID-BIT12>3.0.CO;2-X; LARSEN DH, 1964, J BACTERIOL, V88, P1380, DOI 10.1128/JB.88.5.1380-1387.1964; Maharbiz MM, 2004, BIOTECHNOL BIOENG, V85, P376, DOI 10.1002/bit.10835; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; MONOD J, 1950, ANN I PASTEUR PARIS, V79, P390; NOVICK A, 1955, ANNU REV MICROBIOL, V9, P97, DOI 10.1146/annurev.mi.09.100155.000525; NOVICK A, 1950, SCIENCE, V112, P715, DOI 10.1126/science.112.2920.715; Smith H L, 1995, THEORY CHEMOSTAT DYN; TOPIWALA HH, 1971, BIOTECHNOL BIOENG, V13, P919, DOI 10.1002/bit.260130614; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491; Zanzotto A, 2004, BIOTECHNOL BIOENG, V87, P243, DOI 10.1002/bit.20140	17	439	462	5	232	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2005	309	5731					137	140		10.1126/science.1109173	http://dx.doi.org/10.1126/science.1109173			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	941KD	15994559				2022-12-01	WOS:000230212800077
J	Petrides, M; Cadoret, GV; Mackey, S				Petrides, M; Cadoret, GV; Mackey, S			Orofacial somatomotor responses in the macaque monkey homologue of Broca's area	NATURE			English	Article							VENTROLATERAL PREFRONTAL CORTEX; FRONTAL EYE FIELDS; PREMOTOR CORTEX; MNEMONIC RETRIEVAL; GREAT APES; LANGUAGE; REGION; VARIABILITY; ACTIVATION; MOVEMENTS	In the ventrolateral frontal lobe of the human brain there is a distinct entity, cytoarchitectonic area 44 ( Broca's area), which is crucial in speech production(1-4). There has been controversy(5,6) over whether monkeys possess an area comparable to human area 44. We have addressed this question in the macaque monkey by combining quantitative architectonic analysis of the cortical areas within the ventrolateral frontal region with electrophysiological recording of neuron activity and electrical intracortical microstimulation. Here we show that, immediately in front of the ventral part of the agranular premotor cortical area 6, there is a distinct cortical area that is architectonically comparable to human area 44 and that this monkey area 44 is involved with the orofacial musculature. We suggest that area 44 might have evolved originally as an area exercising high-level control over orofacial actions, including those related to communicative acts, and that, in the human brain, area 44 eventually also came to control certain aspects of the speech act.	McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	McGill University	Petrides, M (corresponding author), McGill Univ, Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	petrides@ego.psych.mcgill.ca	Galantucci, Bruno/E-5770-2010					Amunts K, 1999, J COMP NEUROL, V412, P319, DOI 10.1002/(SICI)1096-9861(19990920)412:2<319::AID-CNE10>3.0.CO;2-7; Amunts K, 2004, NEUROIMAGE, V22, P42, DOI 10.1016/j.neuroimage.2003.12.031; Brodmann K., 1909, VERGLEICHENDE LOKALI; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; Cadoret G, 2001, EUR J NEUROSCI, V14, P1164, DOI 10.1046/j.0953-816x.2001.01737.x; CADORET G, 2004, SOC NEUROSCI PROG, V324, P3; Cantalupo C, 2001, NATURE, V414, P505, DOI 10.1038/35107134; Duffau H, 2003, NEUROIMAGE, V20, P1903, DOI 10.1016/S1053-8119(03)00203-9; Ferrari PF, 2003, EUR J NEUROSCI, V17, P1703, DOI 10.1046/j.1460-9568.2003.02601.x; HOOVER JE, 1993, SCIENCE, V259, P819, DOI 10.1126/science.7679223; HUERTA MF, 1987, J COMP NEUROL, V271, P473; Hurford JR, 2004, VIENNA S THEOR BIOL, P297; LYNCH JC, 1994, EXP BRAIN RES, V100, P181; MATELLI M, 1986, J COMP NEUROL, V251, P281, DOI 10.1002/cne.902510302; Matelli M., 2004, HUMAN NERVOUS SYSTEM, P973, DOI [10.1016/B978-012547626-3/50027-2, DOI 10.1016/B978-012547626-3/50027-2]; MOHR JP, 1976, STUDIES NEUROLINGUIS, P201; OJEMANN G, 1989, J NEUROSURG, V71, P316, DOI 10.3171/jns.1989.71.3.0316; Penfield W., 1959, SPEECH BRAIN MECH, DOI 10.1515/9781400854677; Petrides M, 2002, NEUROBIOL LEARN MEM, V78, P528, DOI 10.1006/nlme.2002.4107; PETRIDES M, 1995, P NATL ACAD SCI USA, V92, P5803, DOI 10.1073/pnas.92.13.5803; Poeppel D, 2004, COGNITION, V92, P1, DOI 10.1016/j.cognition.2003.11.001; Rasmussen T., 1975, CEREBRAL LOCALIZATIO, P238, DOI DOI 10.1007/978-3-642-66204-1.J9; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Schleicher A, 2000, J CHEM NEUROANAT, V20, P31, DOI 10.1016/S0891-0618(00)00076-4; Sherwood CC, 2003, ANAT REC PART A, V271A, P276, DOI 10.1002/ar.a.10046; STANTON GB, 1989, J COMP NEUROL, V282, P415, DOI 10.1002/cne.902820308; TIAN JR, 1995, J NEUROPHYSIOL, V74, P2204, DOI 10.1152/jn.1995.74.5.2204; Tian JR, 1996, J NEUROPHYSIOL, V76, P2740, DOI 10.1152/jn.1996.76.4.2740; Tokuno H, 1997, J COMP NEUROL, V389, P34, DOI 10.1002/(SICI)1096-9861(19971208)389:1<34::AID-CNE3>3.0.CO;2-F	30	253	260	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 30	2005	435	7046					1235	1238		10.1038/nature03628	http://dx.doi.org/10.1038/nature03628			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940JJ	15988526				2022-12-01	WOS:000230140500044
J	Bell, T; Ager, D; Song, JI; Newman, JA; Thompson, IP; Lilley, AK; van der Gast, CJ				Bell, T; Ager, D; Song, JI; Newman, JA; Thompson, IP; Lilley, AK; van der Gast, CJ			Larger islands house more bacterial taxa	SCIENCE			English	Article							DISPERSAL		NERC, Ctr Ecol & Hydrol, Environm Biotechnol Sect, Oxford OX1 3SR, England; NERC, Ctr Ecol & Hydrol, Mol Microbial Ecol Sect, Oxford OX1 3SR, England; Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Univ Oxford, Dept Engn Sci, Oxford OX1 3PJ, England	UK Centre for Ecology & Hydrology (UKCEH); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); UK Centre for Ecology & Hydrology (UKCEH); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of Oxford; University of Oxford	van der Gast, CJ (corresponding author), NERC, Ctr Ecol & Hydrol, Environm Biotechnol Sect, Mansfield Rd, Oxford OX1 3SR, England.	cjvdg@ceh.ac.uk	Newman, Jonathan/A-5932-2008; van der Gast, Christopher/G-1153-2011	Newman, Jonathan/0000-0003-3155-4084; van der Gast, Christopher/0000-0003-1101-4048; Bell, Thomas/0000-0002-2615-3932; Song, Ji-Inn/0000-0002-0180-6423				Azovsky AI, 2002, ECOGRAPHY, V25, P273, DOI 10.1034/j.1600-0587.2002.250303.x; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Finlay BJ, 1999, NATURE, V400, P828, DOI 10.1038/23616; Green JL, 2004, NATURE, V432, P747, DOI 10.1038/nature03034; Horner-Devine MC, 2004, NATURE, V432, P750, DOI 10.1038/nature03073; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002	6	184	208	5	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2005	308	5730					1884	1884		10.1126/science.1111318	http://dx.doi.org/10.1126/science.1111318			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940BZ	15976296				2022-12-01	WOS:000230120000031
J	Templeton, CN; Greene, E; Davis, K				Templeton, CN; Greene, E; Davis, K			Allometry of alarm calls: Black-capped chickadees encode information about predator size	SCIENCE			English	Article							MOBBING CALLS; EVOLUTION; URGENCY	Many animals produce alarm signals when they detect a potential predator, but we still know little about the information contained in these signals. Using presentations of 15 species of live predators, we show that acoustic features of the mobbing calls of black-capped chickadees (Poecile atricapilla) vary with the size of the predator. Companion playback experiments revealed that chickadees detect this information and that the intensity of mobbing behavior is related to the size and threat of the potential predator. This study demonstrates ani unsuspected level of complexity and sophistication in avian alarm calls.	Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; Univ Montana, Div Biol Sci, Florence, MT 59833 USA; Raptors Rockies, Florence, MT 59833 USA	University of Montana System; University of Montana; University of Montana System; University of Montana	Templeton, CN (corresponding author), Univ Montana, Div Biol Sci, Missoula, MT 59812 USA.	ctemple2@u.washington.edu	Templeton, Christopher/AAY-4832-2021	Templeton, Christopher/0000-0001-8701-3186				Baker MC, 2002, WILSON BULL, V114, P510, DOI 10.1676/0043-5643(2002)114[0510:MCOBCC]2.0.CO;2; Blumstein Daniel T., 2002, Evolution of Communication, V3, P135, DOI 10.1075/eoc.3.2.03blu; Blumstein DT, 1999, BEHAVIOUR, V136, P731, DOI 10.1163/156853999501540; Bradbury Jack W., 1998, pi; Cheney D.L., 1990, MONKEYS SEE WORLD IN; Dial KP, 2003, AUK, V120, P941, DOI 10.1642/0004-8038(2003)120[0941:EOALCO]2.0.CO;2; EVANS CS, 1993, ANIM BEHAV, V46, P23, DOI 10.1006/anbe.1993.1158; Evans CS, 1997, PERSP ETHOL, V12, P99; FICKEN MS, 1977, AUK, V94, P156; FICKEN MS, 1978, AUK, V95, P34, DOI 10.2307/4085493; Foresman K.R., 2001, WILD MAMMALS MONTANA; Greene E, 1998, ANIM BEHAV, V55, P511, DOI 10.1006/anbe.1997.0620; Hauser MD., 1996, EVOLUTION COMMUNICAT; HOWLAND HC, 1974, J THEOR BIOL, V47, P333, DOI 10.1016/0022-5193(74)90202-1; Hurd CR, 1996, BEHAV ECOL SOCIOBIOL, V38, P287, DOI 10.1007/s002650050244; Johnsgard P. A., 1990, HAWKS EAGLES FALCONS; Johnsgard P. A., 2002, N AM OWLS BIOL NATUR; Le Roux A, 2001, BEHAVIOUR, V138, P757, DOI 10.1163/156853901752233398; MACEDONIA JM, 1993, ETHOLOGY, V93, P177, DOI 10.1111/j.1439-0310.1993.tb00988.x; Manser MB, 2002, TRENDS COGN SCI, V6, P55, DOI 10.1016/S1364-6613(00)01840-4; MARLER P, 1955, NATURE, V176, P6, DOI 10.1038/176006a0; Mennill DJ, 2002, SCIENCE, V296, P873, DOI 10.1126/science.296.5569.873; NOWICKI S, 1983, BEHAV ECOL SOCIOBIOL, V12, P317, DOI 10.1007/BF00302899; Seyfarth RM, 2003, ANNU REV PSYCHOL, V54, P145, DOI 10.1146/annurev.psych.54.101601.145121; SEYFARTH RM, 1980, ANIM BEHAV, V28, P1070, DOI 10.1016/S0003-3472(80)80097-2; SHERMAN PW, 1977, SCIENCE, V197, P1246, DOI 10.1126/science.197.4310.1246; Sibley D.A., 2000, SIBLEY GUIDE BIRDS; Smith S.M., 1991, BLACK CAPPED CHICKAD	28	433	440	7	220	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2005	308	5730					1934	1937		10.1126/science.1108841	http://dx.doi.org/10.1126/science.1108841			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940BZ	15976305				2022-12-01	WOS:000230120000047
J	Westbrook, TF; Martin, ES; Schlabach, MR; Leng, YM; Liang, AC; Feng, B; Zhao, JJ; Roberts, TM; Mandel, G; Hannon, GJ; DePinho, RA; Chin, L; Elledge, SJ				Westbrook, TF; Martin, ES; Schlabach, MR; Leng, YM; Liang, AC; Feng, B; Zhao, JJ; Roberts, TM; Mandel, G; Hannon, GJ; DePinho, RA; Chin, L; Elledge, SJ			A genetic screen for candidate tumor suppressors identifies REST	CELL			English	Article							MAMMARY EPITHELIAL-CELLS; TGF-BETA; HUMAN CANCER; TRANSFORMATION; RAS; EXPRESSION; PATHWAY; ADENOCARCINOMA; PROLIFERATION; REQUIREMENTS	Tumorigenesis is a multistep process characterized by a myriad of genetic and epigenetic alterations. Identifying the causal perturbations that confer malignant transformation is a central goal in cancer biology. Here we report an RNAi-based genetic screen for genes that suppress transformation of human mammary epithelial cells. We identified genes previously implicated in proliferative control and epithelial cell function including two established tumor suppressors, TGFBR2 and PTEN. In addition, we uncovered a previously unrecognized tumor suppressor role for REST/ NRSF, a transcriptional repressor of neuronal gene expression. Array-CGH analysis identified REST as a frequent target of deletion in colorectal cancer. Furthermore, we detect a frameshift mutation of the REST gene in colorectal cancer cells that encodes a dominantly acting truncation capable of transforming epithelial cells. Cells lacking REST exhibit increased PI(3)K signaling and are dependent upon this pathway for their transformed phenotype. These results implicate REST as a human tumor suppressor and provide a novel approach to identifying candidate genes that suppress the development of human cancer.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet,Partners Ctr Genet & Genom, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; SUNY Stony Brook, Howard Hughes Med Inst, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA; Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Partners Healthcare System; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; Cold Spring Harbor Laboratory	Elledge, SJ (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet,Partners Ctr Genet & Genom, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu	Hannon, Gregory/AAB-3568-2019	DePinho, Ronald/0000-0002-5625-577X	NATIONAL CANCER INSTITUTE [U01CA084313, R01CA093947, T32CA009361, P50CA090381, R01CA099041, P01CA089021] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA99041, R01CA93947, 5 P01 CA89021-04, 5 P50 CA090381-03, U01 CA084313, 5T32CA09361] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aguirre AJ, 2004, P NATL ACAD SCI USA, V101, P9067, DOI 10.1073/pnas.0402932101; Albert ML, 2004, NAT REV CANCER, V4, P36, DOI 10.1038/nrc1255; Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Avdulov S, 2004, CANCER CELL, V5, P553, DOI 10.1016/j.ccr.2004.05.024; Bachoo RM, 2004, P NATL ACAD SCI USA, V101, P8384, DOI 10.1073/pnas.0402140101; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Balmain A, 2003, NAT GENET, V33, P238, DOI 10.1038/ng1107; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Conery AR, 2004, NAT CELL BIOL, V6, P366, DOI 10.1038/ncb1117; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hamad NM, 2002, GENE DEV, V16, P2045, DOI 10.1101/gad.993902; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Lockyer PJ, 2001, CURR BIOL, V11, P981, DOI 10.1016/S0960-9822(01)00261-5; Neumann SB, 2004, MOL BRAIN RES, V120, P173, DOI 10.1016/j.molbrainres.2003.10.021; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Remy I, 2004, NAT CELL BIOL, V6, P358, DOI 10.1038/ncb1113; Reynolds AB, 2004, ONCOGENE, V23, P7947, DOI 10.1038/sj.onc.1208161; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang J, 2000, NATURE, V405, P755, DOI 10.1038/35015674; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Zhao JJ, 2003, CANCER CELL, V3, P483, DOI 10.1016/S1535-6108(03)00088-6; Zhao JJ, 2004, TRENDS MOL MED, V10, P344, DOI 10.1016/j.molmed.2004.05.005	45	396	416	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 17	2005	121	6					837	848		10.1016/j.cell.2005.03.033	http://dx.doi.org/10.1016/j.cell.2005.03.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	938NX	15960972	Bronze			2022-12-01	WOS:000230011200007
J	Hatfield, SD; Shcherbata, HR; Fischer, KA; Nakahara, K; Carthew, RW; Ruohola-Baker, H				Hatfield, SD; Shcherbata, HR; Fischer, KA; Nakahara, K; Carthew, RW; Ruohola-Baker, H			Stem cell division is regulated by the microRNA pathway	NATURE			English	Article							DEPENDENT KINASE INHIBITOR; DROSOPHILA OVARY; CYCLE; PROLIFERATION; EMBRYOGENESIS; RENEWAL; DACAPO; ROLES; NICHE	One of the key characteristics of stem cells is their capacity to divide for long periods of time in an environment where most of the cells are quiescent. Therefore, a critical question in stem cell biology is how stem cells escape cell division stop signals. Here, we report the necessity of the microRNA (miRNA) pathway(1-4) for proper control of germline stem cell (GSC) division in Drosophila melanogaster. Analysis of GSCs mutant for dicer-1 (dcr-1), the double-stranded RNaseIII essential for miRNA biogenesis, revealed a marked reduction in the rate of germline cyst production. These dcr-1 mutant GSCs exhibit normal identity but are defective in cell cycle control. On the basis of cell cycle markers and genetic interactions, we conclude that dcr-1 mutant GSCs are delayed in the G1 to S transition, which is dependent on the cyclin-dependent kinase inhibitor Dacapo, suggesting that miRNAs are required for stem cells to bypass the normal G1/S checkpoint. Hence, the miRNA pathway might be part of a mechanism that makes stem cells insensitive to environmental signals that normally stop the cell cycle at the G1/S transition.	Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	University of Washington; University of Washington Seattle; Northwestern University	Ruohola-Baker, H (corresponding author), Univ Washington, Dept Biochem, J591,HSB, Seattle, WA 98195 USA.	r-carthew@northwestern.edu; hannele@u.washington.edu	Shcherbata, Halyna/J-5712-2017; Nakahara, Kenji/F-5780-2012	Shcherbata, Halyna/0000-0002-3855-0345; Nakahara, Kenji/0000-0002-9541-3208	NIGMS NIH HHS [R01 GM077581] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077581] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Bartel B, 2003, PLANT PHYSIOL, V132, P709, DOI 10.1104/pp.103.023630; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Calvi BR, 2004, METH MOL B, V247, P203; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; deNooij JC, 1996, CELL, V87, P1237, DOI 10.1016/S0092-8674(00)81819-X; Enright AJ, 2004, GENOME BIOL, V5; Gilboa L, 2004, DEVELOPMENT, V131, P4895, DOI 10.1242/dev.01373; Gonczy P, 1996, DEVELOPMENT, V122, P2437; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Johnson J, 2004, NATURE, V428, P145, DOI 10.1038/nature02316; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Lane ME, 1996, CELL, V87, P1225, DOI 10.1016/S0092-8674(00)81818-8; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; MARGOLIS J, 1995, DEVELOPMENT, V121, P3797; Meyer CA, 2002, DEVELOPMENT, V129, P319; Nakahara K, 2004, CURR OPIN CELL BIOL, V16, P127, DOI 10.1016/j.ceb.2004.02.006; Newfeld SJ, 1997, DEVELOPMENT, V124, P3167; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Schauer SE, 2002, TRENDS PLANT SCI, V7, P487, DOI 10.1016/S1360-1385(02)02355-5; Shcherbata HR, 2004, DEVELOPMENT, V131, P3169, DOI 10.1242/dev.01172; Song XQ, 2004, DEVELOPMENT, V131, P1353, DOI 10.1242/dev.01026; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019	30	546	607	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2005	435	7044					974	978		10.1038/nature03816	http://dx.doi.org/10.1038/nature03816			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935RN	15944714	Green Published			2022-12-01	WOS:000229799700053
J	Wang, HW; Nogales, E				Wang, HW; Nogales, E			Nucleotide-dependent bending flexibility of tubulin regulates microtubule assembly	NATURE			English	Article							SLOWLY HYDROLYZABLE ANALOG; ALPHA-BETA-TUBULIN; CRYOELECTRON MICROSCOPY; STRUCTURAL-CHANGES; GTP HYDROLYSIS; DYNAMICS; ENDS; INFORMATION; COLCHICINE; RESOLUTION	The atomic structure of tubulin in a polymerized, straight protofilament is clearly distinct from that in a curved conformation bound to a cellular depolymerizer. The nucleotide contents are identical, and in both cases the conformation of the GTP-containing, intra-dimer interface is indistinguishable from the GDP-containing, inter-dimer contact. Here we present two structures corresponding to the start and end points in the microtubule polymerization and hydrolysis cycles that illustrate the consequences of nucleotide state on longitudinal and lateral assembly. In the absence of depolymerizers, GDP-bound tubulin shows distinctive intra-dimer and inter-dimer interactions and thus distinguishes the GTP and GDP interfaces. A cold-stable tubulin polymer with the non-hydrolysable GTP analogue GMPCPP, containing semi-conserved lateral interactions, supports a model in which the straightening of longitudinal interfaces happens sequentially, starting with a conformational change after GTP binding that straightens the dimer enough for the formation of lateral contacts into a non-tubular intermediate. Closure into a microtubule does not require GTP hydrolysis.	Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Nogales, E (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.	enogales@lbl.gov			NIGMS NIH HHS [P01 GM051487] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM051487] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDREU JM, 1991, BIOCHEMISTRY-US, V30, P3777, DOI 10.1021/bi00229a027; CAPLOW M, 1994, J CELL BIOL, V127, P779, DOI 10.1083/jcb.127.3.779; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Heald R, 2002, J CELL SCI, V115, P3; HOWARD WD, 1986, BIOCHEMISTRY-US, V25, P8292, DOI 10.1021/bi00373a025; Hyman AA, 1996, CELL, V84, P401, DOI 10.1016/S0092-8674(00)81285-4; HYMAN AA, 1995, J CELL BIOL, V128, P117, DOI 10.1083/jcb.128.1.117; Janosi IM, 1998, EUR BIOPHYS J BIOPHY, V27, P501, DOI 10.1007/s002490050160; Jordan M. A., 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P1, DOI 10.2174/1568011023354290; Li HL, 2002, STRUCTURE, V10, P1317, DOI 10.1016/S0969-2126(02)00827-4; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977; MICKEY B, 1995, J CELL BIOL, V130, P909, DOI 10.1083/jcb.130.4.909; Muller-Reichert T, 1998, P NATL ACAD SCI USA, V95, P3661, DOI 10.1073/pnas.95.7.3661; Nicholson WV, 1999, CELL BIOCHEM BIOPHYS, V31, P175, DOI 10.1007/BF02738171; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Tran PT, 1997, J STRUCT BIOL, V118, P107, DOI 10.1006/jsbi.1997.3844; Wang HW, 2005, J STRUCT BIOL, V149, P65, DOI 10.1016/j.jsb.2004.08.006	20	232	238	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2005	435	7044					911	915		10.1038/nature03606	http://dx.doi.org/10.1038/nature03606			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935RN	15959508	Green Accepted			2022-12-01	WOS:000229799700038
J	Hsu, CC; Kao, WHL; Coresh, J; Pankow, JS; Marsh-Manzi, J; Boerwinkle, E; Bray, MS				Hsu, CC; Kao, WHL; Coresh, J; Pankow, JS; Marsh-Manzi, J; Boerwinkle, E; Bray, MS			Apolipoprotein E and progression of chronic kidney disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DIABETIC-NEPHROPATHY; ATHEROSCLEROSIS RISK; RENAL-FUNCTION; E POLYMORPHISM; ALZHEIMERS-DISEASE; APOE POLYMORPHISM; SERUM CREATININE; ALLELE; TYPE-1; LIPOPROTEINS	Context Apolipoprotein E (APOE) genetic variation has been implicated in diabetic nephropathy with the epsilon 2 allele increasing and the epsilon 4 allele decreasing risk. APOE allelic associations with chronic kidney disease beyond diabetic nephropathy are unknown, with no studies reported in high-risk African American populations. Objective To quantify the risk of chronic kidney disease progression associated with APOE in a population-based study including white, African American, diabetic, and nondiabetic individuals. Design, Setting, and Participants Prospective follow-up (through January 1, 2003) of Atherosclerosis Risk in Communities (ARIC) study participants, including 3859 African American and 10 661 white adults aged 45 to 64 years without severe renal dysfunction at baseline in 1987-1989, sampled from 4 US communities. Main Outcome Measures Incident chronic kidney disease progression, defined as hospitalization or death with kidney disease or increase in serum creatinine level of 0.4 mg/dL (35 mu mol/L) or more above baseline, examined by APOE genotypes and alleles. Results During median follow-up of 14 years, chronic kidney disease progression developed in 1060 individuals (incidence per 1000 person-years: 5.5 overall; 8.8 in African Americans and 4.4 in whites). Adjusting for major chronic kidney disease risk factors, F-2 moderately increased and epsilon 4 decreased risk of disease progression (likelihood ratio test, P=.03). Further adjustment for low- and high-density lipoprotein cholesterol and triglycerides did not attenuate relative risks (RRs) (epsilon 2: 1.08 [95% CI, 0.93-1.25] and epsilon 4: 0.85 [95% CI, 0.75-0.95] compared with epsilon 3; likelihood ratio test, P = .008). epsilon 4 decreased risk of end-stage renal disease (RR, 0.60 [95% CI, 0.43-0.84]). epsilon 2 was associated with a decline in renal function (RR, 1.25 [95% CI, 1.02-1.53]), though not with events, such as hospitalizations or end-stage renal disease. Risks were similar stratified by race, sex, diabetes, and hypertension (all P values for interaction >.05). Excess risk of chronic kidney disease in African Americans was not explained by APOE alleles. Conclusions APOE variation predicts chronic kidney disease progression, independent of diabetes, race, lipid, and nonlipid risk factors. Our study suggests that nonlipid-mediated pathways, such as cellular mechanisms of kidney remodeling, may be involved in the association of APOE alleles and progression of chronic kidney disease.	Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Dept Epidemiol, Baltimore, MD 21205 USA; Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; Univ Texas, Houston Hlth Sci Ctr, Ctr Human Genet, Houston, TX 77004 USA	Johns Hopkins University; Johns Hopkins Medicine; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Health Science Center Houston	Coresh, J (corresponding author), Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Dept Epidemiol, 2024 E Monument St,Suite 2-600, Baltimore, MD 21205 USA.	coresh@jhu.edu		Pankow, James/0000-0001-7076-483X	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055016, N01HC055020, N01HC055022, N01HC055018, N01HC055021, N01HC055019, N01HC055015] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073366, T32HL007024] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-55015, N01-HC-55022, N01-HC-55021, N01-HC-55020, 5T32HL007024, N01-HC-55019, N01-HC-55018, N01-HC-55016, HL73366] Funding Source: Medline; ODCDC CDC HHS [UR6/CCU617218] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ODCDC CDC HHS		Araki S, 2000, DIABETES, V49, P2190, DOI 10.2337/diabetes.49.12.2190; Araki SI, 2003, DIABETES CARE, V26, P2416, DOI 10.2337/diacare.26.8.2416; Boize R, 1998, NEPHROL DIAL TRANSPL, V13, P72, DOI 10.1093/ndt/13.1.72; Chen GP, 2001, J BIOL CHEM, V276, P49142, DOI 10.1074/jbc.M104879200; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DIAMOND JR, 1991, KIDNEY INT, V39, pS29; ECKFELDT JH, 1994, ARCH PATHOL LAB MED, V118, P496; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Eto M, 1995, CLIN GENET, V48, P288; Eto M, 2002, AM J KIDNEY DIS, V40, P243, DOI 10.1053/ajkd.2002.34502; Evans DA, 2003, ARCH NEUROL-CHICAGO, V60, P185, DOI 10.1001/archneur.60.2.185; Freedman BI, 2000, CURR OPIN NEPHROL HY, V9, P273, DOI 10.1097/00041552-200005000-00011; Fried LF, 2001, KIDNEY INT, V59, P260, DOI 10.1046/j.1523-1755.2001.00487.x; Ha SK, 1999, NEPHROL DIAL TRANSPL, V14, P2144, DOI 10.1093/ndt/14.9.2144; Hadjadj S, 2000, NEPHROL DIAL TRANSPL, V15, P1971, DOI 10.1093/ndt/15.12.1971; Hsieh MC, 2002, J NEPHROL, V15, P368; Ioannidis JPA, 2003, LANCET, V361, P567, DOI 10.1016/S0140-6736(03)12516-0; Ji ZS, 1998, J BIOL CHEM, V273, P13452, DOI 10.1074/jbc.273.22.13452; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kimura H, 1998, AM J KIDNEY DIS, V31, P666, DOI 10.1053/ajkd.1998.v31.pm9531184; Krop JS, 1999, ARCH INTERN MED, V159, P1777, DOI 10.1001/archinte.159.15.1777; Liberopoulos E, 2004, AM J KIDNEY DIS, V43, P223, DOI 10.1053/j.ajkd.2003.10.013; Liberopoulos EN, 2004, AM J KIDNEY DIS, V44, P300, DOI 10.1053/j.ajkd.2004.04.035; Liberopoulos EN, 2004, NEPHROL DIAL TRANSPL, V19, P2006, DOI 10.1093/ndt/gfh349; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Morrison AC, 2002, GENET EPIDEMIOL, V22, P233, DOI 10.1002/gepi.0191; Muntner P, 2000, KIDNEY INT, V58, P293, DOI 10.1046/j.1523-1755.2000.00165.x; *NAT HEART LUNG BL, 1987, ARIC MAN OP; Nishida Y, 1997, AM J KIDNEY DIS, V29, P919, DOI 10.1016/S0272-6386(97)90467-4; Oda H, 1999, KIDNEY INT, V56, pS25, DOI 10.1046/j.1523-1755.1999.07107.x; Onuma T, 1996, J AM SOC NEPHROL, V7, P1075; PERRONE RD, 1992, CLIN CHEM, V38, P1933; SANAN DA, 1994, J CLIN INVEST, V94, P860, DOI 10.1172/JCI117407; Schmidt Silke, 2002, Ophthalmic Genet, V23, P209, DOI 10.1076/opge.23.4.209.13883; Shcherbak N S, 2001, BMC Med Genet, V2, P8, DOI 10.1186/1471-2350-2-8; Tang MX, 1998, JAMA-J AM MED ASSOC, V279, P751, DOI 10.1001/jama.279.10.751; Tarnow L, 2000, NEPHROL DIAL TRANSPL, V15, P625, DOI 10.1093/ndt/15.5.625; Werle E, 1998, DIABETES CARE, V21, P994, DOI 10.2337/diacare.21.6.994; WILSON PWF, 1994, JAMA-J AM MED ASSOC, V272, P1666, DOI 10.1001/jama.272.21.1666; Yorioka N, 1999, NEPHRON, V83, P246, DOI 10.1159/000045517; Zeleny M, 2002, BIOCHEMISTRY-US, V41, P11820, DOI 10.1021/bi026202k	41	77	80	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 15	2005	293	23					2892	2899		10.1001/jama.293.23.2892	http://dx.doi.org/10.1001/jama.293.23.2892			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	935MD	15956634	Bronze			2022-12-01	WOS:000229785500024
J	Schwab, JM; Failli, V; Chedotal, A				Schwab, JM; Failli, V; Chedotal, A			Injury-related dynamic myelin/oligodendrocyte axon-outgrowth inhibition in the central nervous system	LANCET			English	Review							GROWTH CONE; FUNCTIONAL RECOVERY; PROTEIN-SYNTHESIS; MYELIN; NOGO; REGENERATION; RAT; INVOLVEMENT; EXPRESSION; RECEPTOR	Context By contrast with the glial scar, myelin was considered a constitutive static inhibitory barrier unreactive to lesions in the central nervous system (CNS). However, recent results suggest considerable add-on inhibition of myelin as a result of CNS injury. Furthermore, catastrophic events cause morphological and biochemical changes in the axon itself This results in the accumulation of cytoskeleton components and intraaxonal transported proteins paralleled by extensive membrane remodelling at the axonal tip (a process called axotomy) which might modify the axonal response to its inhibitory environment. Starting point Ji-Eun Kim and colleagues recently reported an axonal subpopulation with a different capacity to respond to myelin inhibitors (Neuron 2004; 44: 439-51). Axonal specificity but also evidence for injury reactivity summarised here challenges our understanding of axon-growth inhibition in the injured CNS. This might be due to (i) qualitative and quantitative enrichment of the periaxonal environment by myelin/oligodendrocytes, (ii) increased axonal sensitivity to its inhibitory environment, and (iii) axons and lesion-induced, altered axonal signalling. Where next? Postlesional reactive inhibition of myelin or the oligodendrocyte necessitates the development of novel screening approaches and therapeutic agents to promote axonal regeneration. Moreover, we need to improve our understanding of the pathophysiology of the lesion to find more efficient experimental strategies to restore neurological function.	Univ Paris 06, CNRS, UMR 7102, Equipe Dev Neuronal, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Schwab, JM (corresponding author), Harvard Univ, Sch Med, Ctr Expt Therapeut, Brigham & Womens Hosp, Boston, MA 02115 USA.	jschwab@zeus.bwh.harvard.edu	Chedotal, Alain/F-2750-2017	Chedotal, Alain/0000-0001-7577-3794; Schwab, Jan/0000-0001-6784-4919				Asher RA, 2002, J NEUROSCI, V22, P2225, DOI 10.1523/JNEUROSCI.22-06-02225.2002; Bandtlow CE, 1997, EUR J NEUROSCI, V9, P2743, DOI 10.1111/j.1460-9568.1997.tb01703.x; Bartholdi D, 1998, GLIA, V23, P278, DOI 10.1002/(SICI)1098-1136(199807)23:3<278::AID-GLIA10>3.0.CO;2-Q; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; de la Houssaye BA, 1999, J NEUROSCI, V19, P10843, DOI 10.1523/JNEUROSCI.19-24-10843.1999; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Grimpe B, 2002, PROG BRAIN RES, V137, P333; Huber AB, 2002, J NEUROSCI, V22, P3553; Josephson A, 2003, CELL TISSUE RES, V311, P333, DOI 10.1007/s00441-002-0695-8; Kim JE, 2004, NEURON, V44, P439, DOI 10.1016/j.neuron.2004.10.015; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Mandolesi G, 2004, FASEB J, V18, P1934, DOI 10.1096/fj.04-1805fje; Mikule K, 2003, J BIOL CHEM, V278, P21168, DOI 10.1074/jbc.M211828200; Mingorance A, 2004, MOL CELL NEUROSCI, V26, P34, DOI 10.1016/j.mcn.2004.01.001; Moreau-Fauvarque C, 2003, J NEUROSCI, V23, P9229; Pasterkamp RJ, 2001, BRAIN RES REV, V35, P36, DOI 10.1016/S0165-0173(00)00050-3; Schwab ME, 2002, PROG BRAIN RES, V137, P351; Sivasankaran R, 2004, NAT NEUROSCI, V7, P261, DOI 10.1038/nn1193; SOTELO C, 1971, LAB INVEST, V25, P653; Tang S, 2001, MOL CELL NEUROSCI, V18, P259, DOI 10.1006/mcne.2001.1020; Tom VJ, 2004, J NEUROSCI, V24, P6531, DOI 10.1523/JNEUROSCI.0994-04.2004; Zhou CM, 2003, BIOCHEM BIOPH RES CO, V309, P368, DOI 10.1016/j.bbrc.2003.08.006	24	16	19	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 11	2005	365	9476					2055	2057		10.1016/S0140-6736(05)66699-8	http://dx.doi.org/10.1016/S0140-6736(05)66699-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	934IB	15950719				2022-12-01	WOS:000229701400027
J	Khamsi, R				Khamsi, R			Deadly combinations	NATURE			English	News Item																			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 26	2005	435	7041					406	406						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	929IF	15952256				2022-12-01	WOS:000229337800016
J	Chisari, FV				Chisari, FV			Unscrambling hepatitis C virus-host interactions	NATURE			English	Editorial Material							INFECTION; REPLICATION; CHIMPANZEES; ESCAPE; RESPONSES; EFFICACY; PROTEASE; IMMUNITY; CULTURE; GENOME	The human suffering exacted by the hepatitis C virus is enormous. Hundreds of thousands of people die each year from liver failure and cancer caused by this infection. There is no vaccine, and the available antiviral drugs are toxic, expensive and only partly effective. Progress has been hindered by the absence of cell culture and small-animal models of the infection. Nonetheless, recent advances have yielded several promising new antiviral drugs and enhanced the prospects of developing a vaccine. The recent development of a robust in vitro hepatitis C virus infection system will aid this search.	Scripps Res Inst, La Jolla, CA 92037 USA	Scripps Research Institute	Chisari, FV (corresponding author), Scripps Res Inst, La Jolla, CA 92037 USA.	fchisari@scripps.edu	Chisari, Francis V/A-3086-2008	Chisari, Francis/0000-0002-4832-1044				Alter HJ, 2000, SEMIN LIVER DIS, V20, P17, DOI 10.1055/s-2000-9505; Alter MJ, 1999, J HEPATOL, V31, P88, DOI 10.1016/S0168-8278(99)80381-X; Alter MJ, 2002, HEPATOLOGY, V36, pS93, DOI 10.1053/jhep.2002.36389; Alter MJ, 1996, EUR J GASTROEN HEPAT, V8, P319, DOI 10.1097/00042737-199604000-00005; ALTER MJ, 1997, HEPATOLOGY S1, V26, P62; Bartenschlager R, 2002, NAT REV DRUG DISCOV, V1, P911, DOI 10.1038/nrd942; Bassett SE, 2001, HEPATOLOGY, V33, P1479, DOI 10.1053/jhep.2001.24371; Bigger CB, 2004, J VIROL, V78, P13779, DOI 10.1128/JVI.78.24.13779-13792.2004; Bowen DG, 2005, J EXP MED, V201, P1709, DOI 10.1084/jem.20050808; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; Foy E, 2003, SCIENCE, V300, P1145, DOI 10.1126/science.1082604; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; Kato T, 2003, GASTROENTEROLOGY, V125, P1808, DOI 10.1053/j.gastro.2003.09.023; Kato T, 2001, J MED VIROL, V64, P334, DOI 10.1002/jmv.1055; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; Lanford RE, 2002, VIROLOGY, V293, P1, DOI 10.1006/viro.2001.1316; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lohmann V, 1996, J HEPATOL, V24, P11; McHutchison John G, 2003, Clin Liver Dis, V7, P149, DOI 10.1016/S1089-3261(02)00077-6; Meyer-Olson D, 2004, J EXP MED, V200, P307, DOI 10.1084/jem.20040638; Mondelli MU, 2001, ANTIVIR RES, V52, P153, DOI 10.1016/S0166-3542(01)00180-2; Moradpour D, 2004, J VIROL, V78, P13278, DOI 10.1128/JVI.78.23.13278-13284.2004; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Nevens F, 2003, HEPATOLOGY, V38, P1289, DOI 10.1053/jhep.2003.50474; Pawlotsky JM, 2003, ANTIVIR RES, V59, P1, DOI 10.1016/S0166-3542(03)00088-3; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sarnow P, 2003, J VIROL, V77, P2801, DOI 10.1128/JVI.77.5.2801-2806.2003; SHIMIZU YK, 1994, J VIROL, V68, P1494, DOI 10.1128/JVI.68.3.1494-1500.1994; Shoukry NH, 2004, ANNU REV MICROBIOL, V58, P391, DOI 10.1146/annurev.micro.58.030603.123836; Spaulding A, 1999, PREV MED, V28, P92, DOI 10.1006/pmed.1998.0418; Strader DB, 2004, HEPATOLOGY, V39, P1147, DOI 10.1002/hep.20119; Sulkowski MS, 2000, CLIN INFECT DIS, V30, pS77, DOI 10.1086/313842; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wieland SF, 2005, J VIROL, V79, P9369, DOI 10.1128/JVI.79.15.9369-9380.2005; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	39	179	209	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 18	2005	436	7053					930	932		10.1038/nature04076	http://dx.doi.org/10.1038/nature04076			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955XQ	16107831	Bronze			2022-12-01	WOS:000231263900033
J	Verma, S; Marsden, PA				Verma, S; Marsden, PA			Nitric oxide-eluting polyurethanes - Vascular grafts of the future?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									St Michaels Hosp, Div Cardiac Surg, Toronto, ON M5B 1W8, Canada; St Michaels Hosp, Div Nephrol, Toronto, ON M5B 1W8, Canada; Univ Toronto, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Verma, S (corresponding author), St Michaels Hosp, Div Cardiac Surg, 30 Bond St, Toronto, ON M5B 1W8, Canada.		Marsden, Philip A/B-1441-2012					Jun HW, 2005, BIOMACROMOLECULES, V6, P838, DOI 10.1021/bm049419y; Loscalzo J, 2001, CIRC RES, V88, P756, DOI 10.1161/hh0801.089861; Sata M, 2002, NAT MED, V8, P403, DOI 10.1038/nm0402-403; Verma S, 2003, CIRCULATION, V108, P2054, DOI 10.1161/01.CIR.0000089191.72957.ED; Wilcox JN, 1997, ARTERIOSCL THROM VAS, V17, P2479, DOI 10.1161/01.ATV.17.11.2479	5	23	28	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 18	2005	353	7					730	731		10.1056/NEJMcibr052030	http://dx.doi.org/10.1056/NEJMcibr052030			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	955UW	16107627				2022-12-01	WOS:000231254100014
J	Lenart, P; Bacher, CP; Daigle, N; Hand, AR; Eils, R; Terasaki, M; Ellenberg, J				Lenart, P; Bacher, CP; Daigle, N; Hand, AR; Eils, R; Terasaki, M; Ellenberg, J			A contractile nuclear actin network drives chromosome congression in oocytes	NATURE			English	Article							GERMINAL VESICLE BREAKDOWN; CYCLE-DEPENDENT CHANGES; XENOPUS EGG EXTRACTS; MICROTUBULE DYNAMICS; STARFISH OOCYTES; MITOTIC-SPINDLE; ENVELOPE BREAKDOWN; CYTOCHALASIN-B; MOUSE OOCYTES; F-ACTIN	Chromosome capture by microtubules is widely accepted as the universal mechanism of spindle assembly in dividing cells. However, the observed length of spindle microtubules and computer simulations of spindle assembly predict that chromosome capture is efficient in small cells, but may fail in cells with large nuclear volumes such as animal oocytes. Here we investigate chromosome congression during the first meiotic division in starfish oocytes. We show that microtubules are not sufficient for capturing chromosomes. Instead, chromosome congression requires actin polymerization. After nuclear envelope breakdown, we observe the formation of a filamentous actin mesh in the nuclear region, and find that contraction of this network delivers chromosomes to the microtubule spindle. We show that this mechanism is essential for preventing chromosome loss and aneuploidy of the egg - a leading cause of pregnancy loss and birth defects in humans.	European Mol Biol Lab, Gene Express & Cell Biol Programme, D-69117 Heidelberg, Germany; European Mol Biol Lab, Biophys Programme, D-69117 Heidelberg, Germany; German Canc Res Ctr, D-69120 Heidelberg, Germany; Univ Connecticut, Ctr Hlth, Dept Orthodont, Farmington, CT 06030 USA; Univ Connecticut, Ctr Hlth, Dept Oral & Maxillofacial Surg, Farmington, CT 06030 USA; Univ Connecticut, Ctr Hlth, Dept Pediat Dent, Farmington, CT 06030 USA; Univ Connecticut, Ctr Hlth, Dept Adv Gen Dent, Farmington, CT 06030 USA; Univ Connecticut, Ctr Hlth, Dept Physiol, Farmington, CT 06030 USA; Marine Biol Lab, Woods Hole, MA 02543 USA	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Helmholtz Association; German Cancer Research Center (DKFZ); University of Connecticut; University of Connecticut; University of Connecticut; University of Connecticut; University of Connecticut; Marine Biological Laboratory - Woods Hole	Ellenberg, J (corresponding author), European Mol Biol Lab, Gene Express & Cell Biol Programme, Meyerhofstr 1, D-69117 Heidelberg, Germany.	jan.ellenberg@embl.de	Eils, Roland/B-6121-2009; Ellenberg, Jan/I-4688-2014	Eils, Roland/0000-0002-0034-4036; Ellenberg, Jan/0000-0001-5909-701X; Lenart, Peter/0000-0002-3927-248X				Bacher CP, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-45; BELMONT LD, 1990, CELL, V62, P579, DOI 10.1016/0092-8674(90)90022-7; Carazo-Salas RE, 2003, CURR BIOL, V13, P1728, DOI 10.1016/j.cub.2003.09.006; Faire K, 1999, J CELL SCI, V112, P4243; Gadde S, 2004, CURR BIOL, V14, pR797, DOI 10.1016/j.cub.2004.09.021; GARD DL, 1992, DEV BIOL, V151, P516, DOI 10.1016/0012-1606(92)90190-R; GARD DL, 1995, ZYGOTE, V3, P17, DOI 10.1017/S0967199400002331; Gerlich D, 2003, CELL, V112, P751, DOI 10.1016/S0092-8674(03)00189-2; Hand Arthur R., 1995, P205, DOI 10.1016/B978-012286230-4/50006-7; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; HeilChapdelaine RA, 1996, DEV BIOL, V177, P204, DOI 10.1006/dbio.1996.0156; Hinkle B, 2002, J CELL SCI, V115, P4685, DOI 10.1242/jcs.00136; HOLY TE, 1994, P NATL ACAD SCI USA, V91, P5682, DOI 10.1073/pnas.91.12.5682; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Kline-Smith SL, 2004, MOL CELL, V15, P317, DOI 10.1016/j.molcel.2004.07.012; Leader B, 2002, NAT CELL BIOL, V4, P921, DOI 10.1038/ncb880; Lenart P, 2003, J CELL BIOL, V160, P1055, DOI 10.1083/jcb.200211076; LONGO FJ, 1985, DEV BIOL, V107, P382, DOI 10.1016/0012-1606(85)90320-3; Maro B, 2002, NAT CELL BIOL, V4, pE281, DOI 10.1038/ncb1202-e281; Miyazaki A, 2000, DEV BIOL, V218, P161, DOI 10.1006/dbio.1999.9577; Pang KM, 1998, CURR BIOL, V8, P405, DOI 10.1016/S0960-9822(98)70159-9; Peter M, 2001, NAT CELL BIOL, V3, P83, DOI 10.1038/35050607; Piehl M, 2003, MOL BIOL CELL, V14, P916, DOI 10.1091/mbc.E02-09-0607; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; Rusan NM, 2001, MOL BIOL CELL, V12, P971, DOI 10.1091/mbc.12.4.971; RYABOVA LV, 1986, CELL DIFFER DEV, V19, P89, DOI 10.1016/0045-6039(86)90065-5; SPICER SS, 1952, J BIOL CHEM, V199, P289; STRICKER SA, 1991, DEV GROWTH DIFFER, V33, P163; Strickland L, 2004, METHOD CELL BIOL, V74, P371; Szent-Gy_orgyi A., 1951, CHEM MUSCULAR CONTRA, V2nd; TERASAKI M, 1994, J CELL SCI, V107, P1797; Tulu US, 2003, CURR BIOL, V13, P1894, DOI 10.1016/j.cub.2003.10.002; Visegrady B, 2004, FEBS LETT, V565, P163, DOI 10.1016/j.febslet.2004.03.096; Wassmann K, 2003, CURR BIOL, V13, P1596, DOI 10.1016/j.cub.2003.08.052; Waterman-Storer C, 2000, J CELL BIOL, V150, P361, DOI 10.1083/jcb.150.2.361; Weber KL, 2004, NATURE, V431, P325, DOI 10.1038/nature02834; Wollman R, 2005, CURR BIOL, V15, P828, DOI 10.1016/j.cub.2005.03.019; Zhai Y, 1996, J CELL BIOL, V135, P201, DOI 10.1083/jcb.135.1.201; Zhang QY, 2004, DEV BIOL, V266, P190, DOI 10.1016/j.ydbio.2003.10.027	40	178	181	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2005	436	7052					812	818		10.1038/nature03810	http://dx.doi.org/10.1038/nature03810			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953XG	16015286				2022-12-01	WOS:000231116500037
J	Bringmann, H; Hyman, AA				Bringmann, H; Hyman, AA			A cytokinesis furrow is positioned by two consecutive signals	NATURE			English	Article							SAND DOLLAR EGGS; CAENORHABDITIS-ELEGANS EMBRYO; C-ELEGANS; MITOTIC APPARATUS; SPINDLE MIDZONE; CELL-DIVISION; PROTEIN; RNAI; EMBRYOGENESIS; ORGANIZATION	The position of the cytokinesis furrow in a cell determines the relative sizes of its two daughter cells as well as the distribution of their contents. In animal cells, the position of the cytokinesis furrow is specified by the position of the mitotic spindle(1). The cytokinesis furrow bisects the spindle midway between the microtubule asters, at the site of the microtubule-based midzone, producing two daughter cells. Experiments in some cell types have suggested that the midzone positions the furrow(2,3), but experiments in other cells have suggested that the asters position the furrow(4,5). One possibility is that different organisms and cell types use different mechanisms to position the cytokinesis furrow. An alternative possibility is that both asters and the midzone contribute to furrow positioning(6,7). Recent work in C. elegans has suggested that centrosome separation and the midzone are implicated in cytokinesis(8). Here we examine the relative contributions of different parts of the mitotic spindle to positioning of the cytokinesis furrow in the C. elegans zygote. By spatially separating the spindle midzone from one of the asters using an ultraviolet laser, we show that the cytokinesis furrow is first positioned by a signal determined by microtubule asters, and then by a second signal that is derived from the spindle midzone. Thus, the position of the cytokinesis furrow is specified by two consecutive furrowing activities.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Bringmann, H (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauer Str 108, D-01307 Dresden, Germany.	bringman@mpi-cbg.de	Hyman, Tony/F-1923-2011; Hyman, Anthony A/B-3917-2017	Hyman, Anthony A/0000-0003-3664-154X				Bonaccorsi S, 1998, J CELL BIOL, V142, P751, DOI 10.1083/jcb.142.3.751; Canman JC, 2003, NATURE, V424, P1074, DOI 10.1038/nature01860; Canman Julie C, 2004, J Cell Biol, V166, P943, DOI 10.1083/jcb.200409019; Cao LG, 1996, MOL BIOL CELL, V7, P225, DOI 10.1091/mbc.7.2.225; Dechant R, 2003, DEV CELL, V4, P333, DOI 10.1016/S1534-5807(03)00057-1; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560; HIRAMOTO Y, 1956, EXP CELL RES, V11, P630, DOI 10.1016/0014-4827(56)90171-9; Jantsch-Plunger V, 2000, J CELL BIOL, V149, P1391, DOI 10.1083/jcb.149.7.1391; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Mishima M, 2004, NATURE, V430, P908, DOI 10.1038/nature02767; Piekny AJ, 2002, J CELL SCI, V115, P2271; Raich WB, 1998, MOL BIOL CELL, V9, P2037, DOI 10.1091/mbc.9.8.2037; RAPPAPORT R, 1961, J EXP ZOOL, V148, P81, DOI 10.1002/jez.1401480107; RAPPAPORT R, 1985, J EXP ZOOL, V235, P217, DOI 10.1002/jez.1402350208; RAPPAPORT R, 1985, J EXP ZOOL, V234, P167, DOI 10.1002/jez.1402340120; RAPPAPORT R, 1996, CYTOKINESIS ANIMAL; Schumacher JM, 1998, J CELL BIOL, V143, P1635, DOI 10.1083/jcb.143.6.1635; Severson AF, 2002, CURR BIOL, V12, P2066, DOI 10.1016/S0960-9822(02)01355-6; Shelton CA, 1999, J CELL BIOL, V146, P439, DOI 10.1083/jcb.146.2.439; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Verbrugghe KJC, 2004, CURR BIOL, V14, P1755, DOI 10.1016/j.cub.2004.09.055; Wang YL, 2001, CELL STRUCT FUNCT, V26, P633, DOI 10.1247/csf.26.633	25	166	182	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 4	2005	436	7051					731	734		10.1038/nature03823	http://dx.doi.org/10.1038/nature03823			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951XA	16079852	Green Published			2022-12-01	WOS:000230964500050
J	Sterne, JAC; Hernan, MA; Ledergerber, B; Tilling, K; Weber, R; Sendi, P; Rickenbach, M; Robins, JM; Egger, M				Sterne, JAC; Hernan, MA; Ledergerber, B; Tilling, K; Weber, R; Sendi, P; Rickenbach, M; Robins, JM; Egger, M		Swiss HIV Cohort Study	Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study	LANCET			English	Article							MARGINAL STRUCTURAL MODELS; IMMUNODEFICIENCY-VIRUS-INFECTION; SWISS HIV COHORT; COMBINATION THERAPIES; CLINICAL PROGRESSION; CONTROLLED-TRIAL; CELL COUNT; MORTALITY; SURVIVAL; METAANALYSIS	Background Evidence on the effectiveness of highly active antiretroviral therapy (HAART) for HIV-infected individuals is limited. Most clinical trials examined surrogate endpoints over short periods of follow-up and there has been no placebo-controlled randomised trial of HAART. Estimation of treatment effects in observational studies is problematic, because of confounding by indication. We aimed to use novel methodology to overcome this problem in the Swiss HIV Cohort Study. Methods Patients were included if they had been examined after January 1996, when HAART became available in Switzerland, were not on HAART, and were free of AIDS at baseline. Cox regression models were weighted to create a statistical population in which the probability of being treated at each time point was unrelated to prognostic factors. Results Low CD4 counts and increasing HIV-1 viral load were associated with increased probability of starting HAART. Overall hazard ratios were 0.14 (95% CI 0.07-0.29) for HAART compared with no treatment, and 0.49 (0.31-0.79) compared with dual therapy. Compared with no treatment, HAART became more beneficial with increasing time since initiation but was less beneficial for patients whose presumed mode of transmission was via intravenous drug use (hazard ratio 0.27, 0.12-0.61) than for other patients (0.08, 0.03-0.19). Interpretation Our results, which are appropriately controlled for confounding by indication, are consistent with reported declines in rates of AIDS and death in developed countries, and provide a context in which to consider adverse effects of HAART.	Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Univ Zurich, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland; Univ Basel Hosp, Inst Clin Epidemiol, CH-4031 Basel, Switzerland; Univ Basel Hosp, Div Infect Dis, CH-4031 Basel, Switzerland; Swiss HIV Cohort Study, Ctr Data, Lausanne, Switzerland; Univ Bern, Dept Social & Prevent Med, Bern, Switzerland	University of Bristol; Harvard University; Harvard T.H. Chan School of Public Health; University of Zurich; University of Basel; University of Basel; University of Bern	Sterne, JAC (corresponding author), Univ Bristol, Dept Social Med, Canynge Hall,Whiteladies Rd, Bristol BS8 2PR, Avon, England.	jonathan.sterne@bristol.ac.uk	Sendi, Pedram/AAC-2067-2019; Weber, Rainer/D-5175-2012; Tilling, Kate/AAY-1578-2021; Sterne, Jonathan/Z-3106-2019; Ledergerber, Bruno/B-5656-2009; VALLET, Yannick/F-9979-2011; Sendi, Parham/R-3286-2018	Sterne, Jonathan/0000-0001-8496-6053; Ledergerber, Bruno/0000-0002-6881-4401; Egger, Matthias/0000-0001-7462-5132; Tilling, Kate/0000-0002-1010-8926; Sendi, Parham/0000-0002-7347-6312	Medical Research Council [G0100221] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032475, R37AI032475, K08AI049392] Funding Source: NIH RePORTER; MRC [G0100221] Funding Source: UKRI; NIAID NIH HHS [K08-AI-49392, R37 AI032475, AI32475] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Centers for Disease Control (CDC), 1992, MMWR Morb Mortal Wkly Rep, V41, P1; Babiker A, 2000, AIDS RES HUM RETROV, V16, P1123; Barkan SE, 1998, EPIDEMIOLOGY, V9, P117, DOI 10.1097/00001648-199803000-00004; Cameron DW, 1998, LANCET, V351, P543, DOI 10.1016/S0140-6736(97)04161-5; Choi HK, 2002, LANCET, V359, P1173, DOI 10.1016/S0140-6736(02)08213-2; Cole SR, 2003, AM J EPIDEMIOL, V158, P687, DOI 10.1093/aje/kwg206; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Egger M, 1997, BMJ-BRIT MED J, V315, P1194, DOI 10.1136/bmj.315.7117.1194; Fewell Z, 2004, STATA J, V4, P402, DOI 10.1177/1536867X0400400403; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Gebhardt M, 1998, AIDS, V12, P1195, DOI 10.1097/00002030-199810000-00012; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Hernan MA, 2001, J AM STAT ASSOC, V96, P440, DOI 10.1198/016214501753168154; Hirsch MS, 2002, NEW ENGL J MED, V347, P438, DOI 10.1056/NEJMe020072; Hogg RS, 1999, CAN MED ASSOC J, V160, P659; Hughes MD, 1998, AIDS, V12, P1823, DOI 10.1097/00002030-199814000-00014; Jordan R, 2002, BMJ-BRIT MED J, V324, P757, DOI 10.1136/bmj.324.7340.757; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; LEDERGERBER B, 1994, SOZ PRAVENTIV MED, V39, P387, DOI 10.1007/BF01299670; Ledergerber B, 1999, LANCET, V353, P863, DOI 10.1016/S0140-6736(99)01122-8; Levin BR, 2001, EMERG INFECT DIS, V7, P505, DOI 10.3201/eid0707.017704; Lucas A, 1999, BRIT MED J, V319, P245, DOI 10.1136/bmj.319.7204.245; Marseille E, 2002, LANCET, V359, P1851, DOI 10.1016/S0140-6736(02)08705-6; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pezzotti P, 1999, AIDS, V13, P249, DOI 10.1097/00002030-199902040-00013; Phillips AN, 1999, AIDS, V13, P2075, DOI 10.1097/00002030-199910220-00010; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; SELWYN PA, 1989, AM J PUBLIC HEALTH, V79, P1358, DOI 10.2105/AJPH.79.10.1358; Vittinghoff E, 1999, J INFECT DIS, V179, P717, DOI 10.1086/314623; Walker AM, 1996, EPIDEMIOLOGY, V7, P335; Wood E, 2003, ANN INTERN MED, V139, P810, DOI 10.7326/0003-4819-139-10-200311180-00008	37	421	437	0	32	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 30	2005	366	9483					378	384		10.1016/S0140-6736(05)67022-5	http://dx.doi.org/10.1016/S0140-6736(05)67022-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	950IB	16054937				2022-12-01	WOS:000230849700024
J	Collins, CA; Olsen, I; Zammit, PS; Heslop, L; Petrie, A; Partridge, TA; Morgan, JE				Collins, CA; Olsen, I; Zammit, PS; Heslop, L; Petrie, A; Partridge, TA; Morgan, JE			Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche	CELL			English	Article							MYOGENIC SPECIFICATION; MOUSE MUSCLE; BONE-MARROW; REGENERATION; TRANSPLANTATION; EXPRESSION; PLASTICITY; FIBER; FATES	Satellite cells are situated beneath the basal lamina that surrounds each myofiber and function as myogenic precursors for muscle growth and repair. The source of satellite cell renewal is controversial and has been suggested to be a separate circulating or interstitial stem cell population. Here, we transplant single intact myofibers into radiation-ablated muscles and demonstrate that satellite cells are self-sufficient as a source of regeneration. As few as seven satellite cells associated with one transplanted myofiber can generate over 100 new myofibers containing thousands of myonuclei. Moreover, the transplanted satellite cells vigorously self-renew, expanding in number and repopulating the host muscle with new satellite cells. Following experimental injury, these cells proliferate extensively and regenerate large compact clusters of myofibers. Thus, within a normally stable tissue, the satellite cell exhibits archetypal stem cell properties and is competent to form the basal origin of adult muscle regeneration.	Hammersmith Hosp, Fac Med, Imperial Coll, MRC Clin Sci Ctr,Muscle Cell Biol Grp, London W12 0NN, England; UCL, Eastman Dent Inst, London WC1X 8LD, England; Hammersmith Hosp, Imperial Coll, Dubowitz Neuromuscular Ctr, Dept Paediat, London W12 0NN, England	Imperial College London; University of London; University College London; Imperial College London; University of London; University College London	Collins, CA (corresponding author), Hammersmith Hosp, Fac Med, Imperial Coll, MRC Clin Sci Ctr,Muscle Cell Biol Grp, Du Cane Rd, London W12 0NN, England.	charlotte.collins2@csc.mrc.ac.uk; terence.partridge@csc.mrc.ac.uk	Zammit, peter/GXV-7746-2022; Morgan, Jennifer/C-6475-2008	zammit, peter/0000-0001-9562-3072; Collins, Charlotte/0000-0002-8715-9035				Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Bin Cheung Y, 2002, STAT MED, V21, P1461, DOI 10.1002/sim.1088; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blaveri K, 1999, DEV DYNAM, V216, P244, DOI 10.1002/(SICI)1097-0177(199911)216:3<244::AID-DVDY3>3.0.CO;2-9; CARLSON BM, 1986, FASEB J, V45, P1456; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Gross JG, 1999, MUSCLE NERVE, V22, P174, DOI 10.1002/(SICI)1097-4598(199902)22:2<174::AID-MUS5>3.0.CO;2-S; Gross JG, 1999, CELL TISSUE RES, V298, P371, DOI 10.1007/s004419900062; Harris JB, 2003, TOXICON, V42, P933, DOI 10.1016/j.toxicon.2003.11.011; Heslop L, 2001, GENE THER, V8, P778, DOI 10.1038/sj.gt.3301463; Heslop L, 2000, J CELL SCI, V113, P2299; KELLY R, 1995, J CELL BIOL, V129, P383, DOI 10.1083/jcb.129.2.383; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; MORGAN JE, 1993, J NEUROL SCI, V115, P191, DOI 10.1016/0022-510X(93)90224-M; MOSS FP, 1971, ANAT REC, V170, P421, DOI 10.1002/ar.1091700405; Partridge TA, 2003, MUSCLE NERVE, V27, P133, DOI 10.1002/mus.10243; PARTRIDGE TA, 1989, NATURE, V337, P176, DOI 10.1038/337176a0; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; Raff M, 2003, ANNU REV CELL DEV BI, V19, P1, DOI 10.1146/annurev.cellbio.19.111301.143037; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Shefer G, 2004, J CELL SCI, V117, P5393, DOI 10.1242/jcs.01419; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; SNOW MH, 1978, CELL TISSUE RES, V186, P535; STUDITSKY AN, 1964, ANN NY ACAD SCI, V120, P789, DOI 10.1111/j.1749-6632.1964.tb34771.x; Tajbakhsh S, 1996, NATURE, V384, P266, DOI 10.1038/384266a0; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Yang JW, 1997, ANAT RECORD, V248, P40; Zammit PS, 2001, DIFFERENTIATION, V68, P193, DOI 10.1046/j.1432-0436.2001.680407.x; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007; Zammit PS, 2002, EXP CELL RES, V281, P39, DOI 10.1006/excr.2002.5653	33	958	1015	1	81	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 29	2005	122	2					289	301		10.1016/j.cell.2005.05.010	http://dx.doi.org/10.1016/j.cell.2005.05.010			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	951CR	16051152	Bronze			2022-12-01	WOS:000230907000015
J	Wu, LC; Estrada, O; Zaborina, O; Bains, M; Shen, L; Kohler, JE; Patel, N; Musch, MW; Chang, EB; Fu, YX; Jacobs, MA; Nishimura, MI; Hancock, REW; Turner, JR; Alverdy, JC				Wu, LC; Estrada, O; Zaborina, O; Bains, M; Shen, L; Kohler, JE; Patel, N; Musch, MW; Chang, EB; Fu, YX; Jacobs, MA; Nishimura, MI; Hancock, REW; Turner, JR; Alverdy, JC			Recognition of host immune activation by Pseudomonas aeruginosa	SCIENCE			English	Article							NECROSIS-FACTOR-ALPHA; ESCHERICHIA-COLI; EPITHELIAL-CELLS; PA-I; QUORUM; GENES; EXPRESSION; BACTERIA; CULTURE; BINDING	It is generally reasoned that lethal infections caused by opportunistic pathogens develop permissively by invading a host that is both physiologically stressed and immunologically compromised. However, an alternative hypothesis might be that opportunistic pathogens actively sense alterations in host immune function and respond by enhancing their virulence phenotype. We demonstrate that interferon-gamma binds to an outer membrane protein in Pseudomonas aeruginosa, OprF, resulting in the expression of a quorum-sensing dependent virulence determinant, the PA-1 lectin. These observations provide details of the mechanisms by which prokaryotic organisms are directly signaled by immune activation in their eukaryotic host.	Univ Chicago, Pritzker Sch Med, Dept Surg, Chicago, IL 60637 USA; Univ Chicago, Pritzker Sch Med, Dept Pathol, Chicago, IL 60637 USA; Univ Chicago, Pritzker Sch Med, Dept Med, Chicago, IL 60637 USA; Univ British Columbia, Dept Immunol & Microbiol, Vancouver, BC V6T 1Z4, Canada; Univ Washington, Dept Genome Sci & Med, Seattle, WA 98195 USA	University of Chicago; University of Chicago; University of Chicago; University of British Columbia; University of Washington; University of Washington Seattle	Alverdy, JC (corresponding author), Univ Chicago, Pritzker Sch Med, Dept Surg, Chicago, IL 60637 USA.	jaiverdy@surgery.bsd.uchicago.edu	Kohler, Jonathan/C-7753-2009; Patel, Nachiket/J-8019-2019; Turner, Jerrold R/A-6895-2009; Hancock, Robert E. W./E-1145-2013; Zaborina, Olga/AAQ-6977-2021; Turner, Jerrold/H-1502-2019; Shen, Le/E-7866-2010	Patel, Nachiket/0000-0002-5841-7568; Turner, Jerrold R/0000-0003-0627-9455; Hancock, Robert E. W./0000-0001-5989-8503; fu, yang-xin/0000-0001-8441-6617	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038510, R01DK061931, R37DK047722, R01DK047722, R01DK068271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062344] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01DK61931, R01DK68271, DK-47722, DK-38510] Funding Source: Medline; NIGMS NIH HHS [2-RO1 GM062344-05] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Azghani AO, 2002, MICROB PATHOGENESIS, V33, P109, DOI 10.1006/mpat.2002.0514; BAJOLETLAUDINAT O, 1994, INFECT IMMUN, V62, P4481, DOI 10.1128/IAI.62.10.4481-4487.1994; Diggle SP, 2003, MOL MICROBIOL, V50, P29, DOI 10.1046/j.1365-2958.2003.03672.x; Diggle SP, 2002, J BACTERIOL, V184, P2576, DOI 10.1128/JB.184.10.2576-2586.2002; Ikuta S, 2004, SHOCK, V21, P452, DOI 10.1097/00024382-200405000-00009; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Lau GW, 2004, INFECT IMMUN, V72, P4275, DOI 10.1128/IAI.72.7.4275-4278.2004; Laughlin RS, 2000, ANN SURG, V232, P133, DOI 10.1097/00000658-200007000-00019; LUO GY, 1993, INFECT IMMUN, V61, P830, DOI 10.1128/IAI.61.3.830-835.1993; MEKALANOS JJ, 1992, J BACTERIOL, V174, P1; Ochman H, 2001, SCIENCE, V292, P1096, DOI 10.1126/science.1058543; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; PORAT R, 1991, SCIENCE, V254, P430, DOI 10.1126/science.1833820; SCHWARTZENTRUBER DJ, 1991, J IMMUNOL, V146, P3674; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Wagner VE, 2003, J BACTERIOL, V185, P2080, DOI 10.1128/JB.185.7.2080-2095.2003; Whiteley M, 1999, P NATL ACAD SCI USA, V96, P13904, DOI 10.1073/pnas.96.24.13904; Winzer K, 2000, J BACTERIOL, V182, P6401, DOI 10.1128/JB.182.22.6401-6411.2000; Wu LC, 2004, GASTROENTEROLOGY, V126, P488, DOI 10.1053/j.gastro.2003.11.011	19	237	248	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2005	309	5735					774	777		10.1126/science.1112422	http://dx.doi.org/10.1126/science.1112422			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951NU	16051797				2022-12-01	WOS:000230938200051
J	Minn, AJ; Gupta, GP; Siegel, PM; Bos, PD; Shu, WP; Giri, DD; Viale, A; Olshen, AB; Gerald, WL; Massague, J				Minn, AJ; Gupta, GP; Siegel, PM; Bos, PD; Shu, WP; Giri, DD; Viale, A; Olshen, AB; Gerald, WL; Massague, J			Genes that mediate breast cancer metastasis to lung	NATURE			English	Article							EXPRESSION PROFILES; TUMOR PROGRESSION; METALLOPROTEINASES; SIGNATURE; MOLECULES; CARCINOMA; PROTEINS; SURVIVAL; NETWORK; GROWTH	By means of in vivo selection, transcriptomic analysis, functional verification and clinical validation, here we identify a set of genes that marks and mediates breast cancer metastasis to the lungs. Some of these genes serve dual functions, providing growth advantages both in the primary tumour and in the lung microenvironment. Others contribute to aggressive growth selectively in the lung. Many encode extracellular proteins and are of previously unknown relevance to cancer metastasis.	Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Genom Core Lab, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	j-massague@ski.mskcc.org	Gupta, Gaorav/AAL-4472-2021	Massague, Joan/0000-0001-9324-8408; Minn, Andy/0000-0003-1418-0906	NCI NIH HHS [P01 CA094060] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA094060] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amatschek S, 2004, CANCER RES, V64, P844, DOI 10.1158/0008-5472.CAN-03-2361; Arun B, 2004, SEMIN ONCOL, V31, P22, DOI 10.1053/j.seminoncol.2004.03.042; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Davidson B, 2004, CLIN CANCER RES, V10, P7335, DOI 10.1158/1078-0432.CCR-04-0183; Desprez PY, 2003, J MAMMARY GLAND BIOL, V8, P225, DOI 10.1023/A:1025957025773; Duffy MJ, 2000, BREAST CANCER RES, V2, P252, DOI 10.1186/bcr65; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Framson PE, 2004, J CELL BIOCHEM, V92, P679, DOI 10.1002/jcb.20091; Heimann R, 2000, J CLIN ONCOL, V18, P591, DOI 10.1200/JCO.2000.18.3.591; Hynes RO, 2003, CELL, V113, P821, DOI 10.1016/S0092-8674(03)00468-9; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; O'Hanlon DM, 2002, EUR J CANCER, V38, P2252, DOI 10.1016/S0959-8049(02)00218-6; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ponomarev V, 2004, EUR J NUCL MED MOL I, V31, P740, DOI 10.1007/s00259-003-1441-5; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Schairer C, 2004, JNCI-J NATL CANCER I, V96, P1311, DOI 10.1093/jnci/djh253; Shelly M, 1998, J BIOL CHEM, V273, P10496, DOI 10.1074/jbc.273.17.10496; Simon R, 2003, BRIT J CANCER, V89, P1599, DOI 10.1038/sj.bjc.6601326; Solomayer EF, 2000, BREAST CANCER RES TR, V59, P271, DOI 10.1023/A:1006308619659; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wood N, 2003, J EXP MED, V197, P703, DOI 10.1084/jem.20020906; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yokota J, 2000, CARCINOGENESIS, V21, P497, DOI 10.1093/carcin/21.3.497	33	2139	2272	6	198	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2005	436	7050					518	524		10.1038/nature03799	http://dx.doi.org/10.1038/nature03799			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049480	Green Accepted			2022-12-01	WOS:000230788800053
J	Heinsohn, R; Legge, S; Endler, JA				Heinsohn, R; Legge, S; Endler, JA			Extreme reversed sexual dichromatism in a bird without sex role reversal	SCIENCE			English	Article							COLOR PATTERNS; ECLECTUS PARROTS; SELECTION; COMPETITION; POPULATION; EVOLUTION; LIGHT; SIZE	Brilliant plumage is typical of mate birds, reflecting differential enhancement of mate traits when females are the limiting sex. Brighter females are thought to evolve exclusively in response to sex role reversal. The striking reversed plumage dichromatism of Eclectus roratus parrots does not fit this pattern. We quantify plumage color in this species and show that very different selection pressures are acting on males and females. Mate plumage reflects a compromise between the conflicting requirements for camouflage from predators while foraging and conspicuousness during display. Females are liberated from the need for camouflage but compete for rare nest hollows.	Australian Natl Univ, Ctr Resource & Environm Studies, Canberra, ACT 0200, Australia; Australian Natl Univ, Sch Bot & Zool, Canberra, ACT 0200, Australia; Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; James Cook Univ N Queensland, Dept Zool & Trop Ecol, Townsville, Qld 4811, Australia	Australian National University; Australian National University; University of California System; University of California Santa Barbara; James Cook University	Heinsohn, R (corresponding author), Australian Natl Univ, Ctr Resource & Environm Studies, Canberra, ACT 0200, Australia.	Robert.Heinsohn@anu.edu.au	Legge, Sarah/GYE-1554-2022; Endler, John A/B-6659-2009; Legge, Sarah/AAB-7229-2019	Endler, John A/0000-0002-7557-7627; Legge, Sarah/0000-0001-6968-2781				ALMADA VC, 1995, ANIM BEHAV, V49, P1125, DOI 10.1006/anbe.1995.0142; AMUNDSEN T, IN PRESS AVIAN COLOR; Andersson Malte, 1994; BAKER RR, 1979, PHILOS T R SOC B, V287, P63, DOI 10.1098/rstb.1979.0053; BENNETT ATD, 1994, VISION RES, V34, P1471, DOI 10.1016/0042-6989(94)90149-X; CLUTTONBROCK TH, 1991, NATURE, V351, P58; Eens M, 2000, BEHAV PROCESS, V51, P135, DOI 10.1016/S0376-6357(00)00124-8; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Endler J.A., 1978, Evolutionary Biology (New York), V11, P319; ENDLER JA, 1993, ECOL MONOGR, V63, P1, DOI 10.2307/2937121; ENDLER JA, 1991, VISION RES, V31, P587, DOI 10.1016/0042-6989(91)90109-I; ENDLER JA, 1980, EVOLUTION, V34, P76, DOI 10.1111/j.1558-5646.1980.tb04790.x; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; Endler JA, 1996, AM NAT, V148, P421, DOI 10.1086/285934; Forshaw J. M., 1989, PARROTS WORLD, P616; GRAFEN A, 2000, GUARDIAN        0309, P27; Heinsohn R, 2003, J ZOOL, V259, P197, DOI 10.1017/S0952836902003138; Heinsohn R, 2003, AUST J ZOOL, V51, P81, DOI 10.1071/ZO02003; JONES IL, 1993, NATURE, V362, P238, DOI 10.1038/362238a0; Juniper T, 1998, PARROTS GUIDE PARROT; Kemp A., 1995, HORNBILLS; Kokko H, 2001, ECOL LETT, V4, P159, DOI 10.1046/j.1461-0248.2001.00212.x; Kvarnemo C, 1996, TRENDS ECOL EVOL, V11, P404, DOI 10.1016/0169-5347(96)10056-2; Langmore NE, 1998, TRENDS ECOL EVOL, V13, P136, DOI 10.1016/S0169-5347(97)01241-X; Legge S, 2004, WILDLIFE RES, V31, P149, DOI 10.1071/WR03020; Szekely T, 2004, P NATL ACAD SCI USA, V101, P12224, DOI 10.1073/pnas.0404503101; Wallace A. R., 1889, DARWINISM	27	142	147	1	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2005	309	5734					617	619		10.1126/science.1112774	http://dx.doi.org/10.1126/science.1112774			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SE	16040708				2022-12-01	WOS:000230735200050
J	Hartmann, LC; Sellers, TA; Frost, MH; Lingle, WL; Degnim, AC; Ghosh, K; Vierkant, RA; Maloney, SD; Pankratz, VS; Hillman, DW; Suman, VJ; Johnson, J; Blake, C; Tlsty, T; Vachon, CM; Melton, LJ; Visscher, DW				Hartmann, LC; Sellers, TA; Frost, MH; Lingle, WL; Degnim, AC; Ghosh, K; Vierkant, RA; Maloney, SD; Pankratz, VS; Hillman, DW; Suman, VJ; Johnson, J; Blake, C; Tlsty, T; Vachon, CM; Melton, LJ; Visscher, DW			Benign breast disease and the risk of breast cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WOMEN; OVEREXPRESSION; AMPLIFICATION; HYPERPLASIA; AGE; P53	Background: Benign breast disease is an important risk factor for breast cancer. We studied a large group of women with benign breast disease to obtain reliable estimates of this risk. Methods: We identified all women who received a diagnosis of benign breast disease at the Mayo Clinic between 1967 and 1991. Breast-cancer events were obtained from medical records and questionnaires. To estimate relative risks, we compared the number of observed breast cancers with the number expected on the basis of the rates of breast cancer in the Iowa Surveillance, Epidemiology, and End Results registry. Results: We followed 9087 women for a median of 15 years. The histologic findings were nonproliferative lesions in 67 percent of women, proliferative lesions without atypia in 30 percent, and atypical hyperplasia in 4 percent. To date, 707 breast cancers have developed. The relative risk of breast cancer for the cohort was 1.56 (95 percent confidence interval, 1.45 to 1.68), and this increased risk persisted for at least 25 years after biopsy. The relative risk associated with atypia was 4.24 (95 percent confidence interval, 3.26 to 5.41), as compared with a relative risk of 1.88 (95 percent confidence interval, 1.66 to 2.12) for proliferative changes without atypia and of 1.27 (95 percent confidence interval, 1.15 to 1.41) for nonproliferative lesions. The strength of the family history of breast cancer, available for 4808 women, was a risk factor that was independent of histologic findings. No increased risk was found among women with no family history and nonproliferative findings. In the first 10 years after the initial biopsy, an excess of cancers occurred in the same breast, especially in women with atypia. Conclusions: Risk factors for breast cancer after the diagnosis of benign breast disease include the histologic classification of a benign breast lesion and a family history of breast cancer.	Mayo Clin, Coll Med, Div Med Oncol, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Div Expt Pathol, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Div Gen Surg, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Div Gen Internal Med, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Div Biostat, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Div Epidemiol, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Div Anat Pathol, Rochester, MN 55905 USA; Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; Wayne State Univ, Detroit, MI USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Wayne State University; University of California System; University of California San Francisco	Hartmann, LC (corresponding author), Mayo Clin, Coll Med, Div Med Oncol, Rochester, MN 55905 USA.		Vierkant, Robert/AAP-4927-2020	Vierkant, Robert/0000-0001-6242-5221	NCI NIH HHS [R01 CA46332] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA046332] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 2009, SEER STAT DAT; BAIN LJ, 1992, INTRO PROBABILITY MA, P369; CARTER CL, 1988, AM J EPIDEMIOL, V128, P467, DOI 10.1093/oxfordjournals.aje.a114995; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; CONNOLLY JL, 1993, CANCER, V71, P1187, DOI 10.1002/1097-0142(19930215)71:4<1187::AID-CNCR2820710402>3.0.CO;2-V; Crawford YG, 2004, CANCER CELL, V5, P263, DOI 10.1016/S1535-6108(04)00023-6; DUPONT WD, 1993, CANCER, V71, P1258, DOI 10.1002/1097-0142(19930215)71:4<1258::AID-CNCR2820710415>3.0.CO;2-I; DUPONT WD, 1985, NEW ENGL J MED, V312, P146, DOI 10.1056/NEJM198501173120303; DUPONT WD, 1994, NEW ENGL J MED, V331, P10, DOI 10.1056/NEJM199407073310103; DUPONT WD, 1987, AM J EPIDEMIOL, V125, P769, DOI 10.1093/oxfordjournals.aje.a114594; Elmore G, 1998, NEW ENGL J MED, V338, P1089, DOI 10.1056/NEJM199804163381601; Fitzgibbons PL, 1998, ARCH PATHOL LAB MED, V122, P1053; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; JENSEN RA, 1989, CANCER, V64, P1977, DOI 10.1002/1097-0142(19891115)64:10<1977::AID-CNCR2820641002>3.0.CO;2-N; Kandel R, 2001, EUR J CANCER PREV, V10, P43, DOI 10.1097/00008469-200102000-00005; Kandel R, 2000, INT J CANCER, V87, P73, DOI 10.1002/1097-0215(20000701)87:1<73::AID-IJC11>3.0.CO;2-U; KRIEGER N, 1992, AM J EPIDEMIOL, V135, P619, DOI 10.1093/oxfordjournals.aje.a116341; Li JJ, 2004, P NATL ACAD SCI USA, V101, P18123, DOI 10.1073/pnas.0408273101; LONDON SJ, 1992, JAMA-J AM MED ASSOC, V267, P1780; Marshall LM, 1997, CANCER EPIDEM BIOMAR, V6, P297; Melton LJ, 1997, NEW ENGL J MED, V337, P1466, DOI 10.1056/NEJM199711133372012; Page DL, 2003, LANCET, V361, P1994; Page DL, 2003, LANCET, V361, P125, DOI 10.1016/S0140-6736(03)12230-1; PAGE DL, 1985, CANCER, V55, P2698, DOI 10.1002/1097-0142(19850601)55:11<2698::AID-CNCR2820551127>3.0.CO;2-A; Rohan TE, 1998, JNCI-J NATL CANCER I, V90, P1262, DOI 10.1093/jnci/90.17.1262; Schnitt SJ, 2001, CLIN CANCER RES, V7, p4419S; Wang JP, 2004, J NATL CANCER I, V96, P616, DOI 10.1093/jnci/djhs105	27	567	611	1	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2005	353	3					229	237		10.1056/NEJMoa044383	http://dx.doi.org/10.1056/NEJMoa044383			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946YH	16034008	Green Published			2022-12-01	WOS:000230608700003
J	Williams, SC; Schmaltz, SP; Morton, DJ; Koss, RG; Loeb, JM				Williams, SC; Schmaltz, SP; Morton, DJ; Koss, RG; Loeb, JM			Quality of care in US hospitals as reflected by standardized measures, 2002-2004	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MYOCARDIAL-INFARCTION; PERFORMANCE REPORTS; IMPROVEMENT; GUIDELINES; ADULTS	Background: In July 2002, the Joint Commission on Accreditation of Healthcare Organizations implemented standardized performance measures that were designed to track the performance of accredited hospitals and encourage improvement in the quality of health care. Methods: We examined hospitals' performance on 18 standardized indicators of the quality of care for acute myocardial infarction, heart failure, and pneumonia. One measure assessed a clinical outcome (death in the hospital after acute myocardial infarction), and the other 17 measures assessed processes of care. Data were collected over a two-year period in more than 3000 accredited hospitals. All participating hospitals received quarterly feedback in the form of comparative reports throughout the study. Results: Descriptive analysis revealed a significant improvement (P<0.01) in the performance of U.S. hospitals on 15 of 18 measures, and no measure showed a significant deterioration. The magnitude of improvement ranged from 3 percent to 33 percent during the eight quarters studied. For 16 of the 17 process-of-care measures, hospitals with a low level of performance at baseline had greater improvements over the subsequent two years than hospitals with a high level of performance at baseline. Conclusions: Over a two-year period, we observed consistent improvement in measures reflecting the process of care for acute myocardial infarction, heart failure, and pneumonia. Both quantitative and qualitative research are needed to explore the reasons for these improvements.	Joint Commiss Accreditat Healthcare Org, Div Res, Oak Brook Terrace, IL 60181 USA		Williams, SC (corresponding author), Joint Commiss Accreditat Healthcare Org, Div Res, 1 Renaissance Blvd, Oak Brook Terrace, IL 60181 USA.	swilliams@jcaho.org						*AG HEALTHC RES QU, 2004 NAT HEALTHC QUA; *AM HOSP ASS, 2005, HEALTHC QUICK DISK 2; Antman Elliott M, 2004, J Am Coll Cardiol, V44, P671, DOI 10.1016/j.jacc.2004.07.002; ANTMAN EM, 2005, J AM COLL CARDIOL, V45, P1376; Bartlett JG, 1998, CLIN INFECT DIS, V26, P811, DOI 10.1086/513953; Bradley EH, 2004, QUAL SAF HEALTH CARE, V13, P26, DOI 10.1136/qhc.13.1.26; Bradley EH, 2001, JAMA-J AM MED ASSOC, V285, P2604, DOI 10.1001/jama.285.20.2604; Braun BI, 1999, EVAL HEALTH PROF, V22, P283, DOI 10.1177/016327879902200301; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; CLAYTON D, 1987, BIOMETRICS, V43, P671, DOI 10.2307/2532003; Gibberd R, 2004, INT J QUAL HEALTH C, V16, pI37, DOI 10.1093/intqhc/mzh019; Hibbard JH, 2003, HEALTH AFFAIR, V22, P84, DOI 10.1377/hlthaff.22.2.84; Hunt SA, 2001, J AM COLL CARDIOL, V38, P2101, DOI 10.1016/S0735-1097(01)01683-7; Institute of Medicine, 2001, CROSSING QUALITY CHA; Jencks SF, 2003, JAMA-J AM MED ASSOC, V289, P305, DOI 10.1001/jama.289.3.305; Jencks SF, 2002, JAMA-J AM MED ASSOC, V289, P2649; Jha AK, 2005, NEW ENGL J MED, V353, P265, DOI 10.1056/NEJMsa051249; Jha AK, 2003, NEW ENGL J MED, V348, P2218, DOI 10.1056/NEJMsa021899; *JOINT COMM ACCR H, COMPR REV DEV TEST N; *JOINT COMM ACCR H, PERF MEAS SYST REQ O; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; Marshall MN, 2000, JAMA-J AM MED ASSOC, V283, P1866, DOI 10.1001/jama.283.14.1866; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Palmer RH, 1998, INT J QUAL HEALTH C, V10, P477; SAS Institute, 2002, SAS STAT US GUID VER; Schade Charles P, 2004, Jt Comm J Qual Saf, V30, P143; Schneider EC, 1996, NEW ENGL J MED, V335, P251, DOI 10.1056/NEJM199607253350406; Schneider EC, 1998, JAMA-J AM MED ASSOC, V279, P1638, DOI 10.1001/jama.279.20.1638; Watt Ann, 2003, J AHIMA, V74, P20; Winer B.J., 1971, STAT PRINCIPLES EXPT	30	333	336	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2005	353	3					255	264		10.1056/NEJMsa043778	http://dx.doi.org/10.1056/NEJMsa043778			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946YH	16034011				2022-12-01	WOS:000230608700006
J	Delanoue, R; Davis, I				Delanoue, R; Davis, I			Dynein anchors its mRNA cargo after apical transport in the Drosophila blastoderm embryo	CELL			English	Article							BICAUDAL-D PROTEIN; CYTOPLASMIC DYNEIN; BICOID RNA; XENOPUS OOCYTES; MOTOR COMPLEX; BUDDING YEAST; ANTERIOR POLE; LIGHT-CHAIN; KINESIN-I; F-ACTIN	Molecular motors actively transport many types of cargo along the cytoskeleton in a wide range of organisms. One class of cargo is localized mRNAs, which are transported by myosin on actin filaments or by kinesin and dynein on microtubules. How the cargo is kept at its final intracellular destination and whether the motors are recycled after completion of transport are poorly understood. Here, we use a new RNA anchoring assay in living Drosophila blastoderm embryos to show that apical anchoring of mRNA after completion of dynein transport does not depend on actin or on continuous active transport by the motor. Instead, apical anchoring of RNA requires microtubules and involves dynein as a static anchor that remains with the cargo at its final destination. We propose a general principle that could also apply to other dynein cargo and to some other molecular motors, whereby cargo transport and anchoring reside in the same molecule.	Univ Edinburgh, Sch Biol Sci, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Edinburgh	Davis, I (corresponding author), Univ Edinburgh, Sch Biol Sci, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland.	ilan.davis@ed.ac.uk	Davis, Ilan/F-4975-2010; Delanoue, Renald/D-3093-2017; renald, delanoue/D-3109-2017	renald, delanoue/0000-0003-2479-4442; Davis, Ilan/0000-0002-5385-3053	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Altman D, 2004, CELL, V116, P737, DOI 10.1016/S0092-8674(04)00211-9; Babu K, 2004, GENE DEV, V18, P138, DOI 10.1101/gad.282604; Beach DL, 1999, CURR BIOL, V9, P569, DOI 10.1016/S0960-9822(99)80260-7; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Brendza RP, 2000, SCIENCE, V289, P2120, DOI 10.1126/science.289.5487.2120; Bullock SL, 2004, DEVELOPMENT, V131, P4251, DOI 10.1242/dev.01289; Bullock SL, 2001, NATURE, V414, P611, DOI 10.1038/414611a; CALLAINI G, 1988, EXP CELL RES, V178, P415, DOI 10.1016/0014-4827(88)90410-7; DAVIS I, 1995, DEV BIOL, V170, P726, DOI 10.1006/dbio.1995.1251; DAVIS I, 1991, CELL, V67, P927, DOI 10.1016/0092-8674(91)90366-7; DAVIS I, 2000, PROTEIN LOCALISATION, P131; De Bor VV, 2004, CURR OPIN CELL BIOL, V16, P300, DOI 10.1016/j.ceb.2004.03.008; de Heredia ML, 2004, CURR OPIN CELL BIOL, V16, P80, DOI 10.1016/j.ceb.2003.11.002; Duncan JE, 2002, CURR BIOL, V12, P1982, DOI 10.1016/S0960-9822(02)01303-9; EDGAR BA, 1987, GENE DEV, V1, P1226, DOI 10.1101/gad.1.10.1226; ERDELYI M, 1995, NATURE, V377, P524, DOI 10.1038/377524a0; FERRANDON D, 1994, CELL, V79, P1221, DOI 10.1016/0092-8674(94)90013-2; Foe VE, 2000, DEVELOPMENT, V127, P1767; Foe Victoria E., 1993, P149; Gee MA, 1997, NATURE, V390, P636, DOI 10.1038/37663; Gepner J, 1996, GENETICS, V142, P865; Glotzer JB, 1997, CURR BIOL, V7, P326, DOI 10.1016/S0960-9822(06)00156-4; GONZALEZREYES A, 1995, NATURE, V375, P654, DOI 10.1038/375654a0; GORDON JA, 1991, METHOD ENZYMOL, V201, P477; Hoogenraad CC, 2001, EMBO J, V20, P4041, DOI 10.1093/emboj/20.15.4041; Jankovics F, 2002, CURR BIOL, V12, P2060, DOI 10.1016/S0960-9822(02)01256-3; Januschke J, 2002, CURR BIOL, V12, P1971, DOI 10.1016/S0960-9822(02)01302-7; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Lambert JD, 2002, NATURE, V420, P682, DOI 10.1038/nature01241; Latham VM, 2001, CURR BIOL, V11, P1010, DOI 10.1016/S0960-9822(01)00291-3; LI MG, 1994, J CELL BIOL, V126, P1475, DOI 10.1083/jcb.126.6.1475; MacDougall N, 2003, DEV CELL, V4, P307, DOI 10.1016/S1534-5807(03)00058-3; Mach JM, 1997, GENE DEV, V11, P423, DOI 10.1101/gad.11.4.423; Maddox PS, 2003, CURR BIOL, V13, P1423, DOI 10.1016/S0960-9822(03)00547-5; Matanis T, 2002, NAT CELL BIOL, V4, P986, DOI 10.1038/ncb891; Megraw TL, 2002, J CELL SCI, V115, P4707, DOI 10.1242/jcs.00134; Miller KG, 2004, CELL, V116, P635, DOI 10.1016/S0092-8674(04)00213-2; Morris NR, 2003, CURR OPIN CELL BIOL, V15, P54, DOI 10.1016/S0955-0674(02)00004-2; Navarro C, 2004, NAT CELL BIOL, V6, P427, DOI 10.1038/ncb1122; NEUMANSILBERBERG FS, 1993, CELL, V75, P165, DOI 10.1016/S0092-8674(05)80093-5; Oh J, 2000, GENETICS, V154, P713; Palacios IM, 2002, DEVELOPMENT, V129, P5473, DOI 10.1242/dev.00119; Palacios IM, 2001, ANNU REV CELL DEV BI, V17, P569, DOI 10.1146/annurev.cellbio.17.1.569; Schnorrer F, 2000, NAT CELL BIOL, V2, P185, DOI 10.1038/35008601; Schnorrer F, 2002, DEV CELL, V3, P685, DOI 10.1016/S1534-5807(02)00301-5; Sharp DJ, 2000, NAT CELL BIOL, V2, P922, DOI 10.1038/35046574; Simmonds AJ, 2001, CELL, V105, P197, DOI 10.1016/S0092-8674(01)00311-7; Steffen W, 1997, MOL BIOL CELL, V8, P2077, DOI 10.1091/mbc.8.10.2077; STEPHENSON EC, 1988, GENE DEV, V2, P1655, DOI 10.1101/gad.2.12a.1655; STJOHNSTON D, 1989, DEVELOPMENT, V107, P13; SUNDELL CL, 1991, SCIENCE, V253, P1275, DOI 10.1126/science.1891715; SUTER B, 1991, CELL, V67, P917, DOI 10.1016/0092-8674(91)90365-6; Takizawa PA, 1997, NATURE, V389, P90, DOI 10.1038/38015; Tekotte H, 2002, TRENDS GENET, V18, P636, DOI 10.1016/S0168-9525(02)02819-6; Tracey WD, 2000, GENETICS, V154, P273; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; VALE RD, 1989, CELL, V59, P915, DOI 10.1016/0092-8674(89)90614-4; Wagner C, 2001, J MOL BIOL, V313, P511, DOI 10.1006/jmbi.2001.5057; Welte MA, 1998, CELL, V92, P547, DOI 10.1016/S0092-8674(00)80947-2; Wilkie GS, 2001, CELL, V105, P209, DOI 10.1016/S0092-8674(01)00312-9; YISRAELI JK, 1990, DEVELOPMENT, V108, P289	61	73	75	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 15	2005	122	1					97	106		10.1016/j.cell.2005.04.033	http://dx.doi.org/10.1016/j.cell.2005.04.033			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	950EC	16009136	Bronze			2022-12-01	WOS:000230839400014
J	El-Sayed, NM; Myler, PJ; Bartholomeu, DC; Nilsson, D; Aggarwal, G; Tran, AN; Ghedin, E; Worthey, EA; Delcher, AL; Blandin, G; Westenberger, SJ; Caler, E; Cerqueira, GC; Branche, C; Haas, B; Anupama, A; Arner, E; Aslund, L; Attipoe, P; Bontempi, E; Bringaud, F; Burton, P; Cadag, E; Campbell, DA; Carrington, M; Crabtree, J; Darban, H; da Silveira, JF; de Jong, P; Edwards, K; Englund, PT; Fazelina, G; Feldblyum, T; Ferella, M; Frasch, AC; Gull, K; Horn, D; Hou, LH; Huang, YT; Kindlund, E; Ktingbeil, M; Kluge, S; Koo, H; Lacerda, D; Levin, MJ; Lorenzi, H; Louie, T; Machado, CR; McCulloch, R; McKenna, A; Mizuno, Y; Mottram, JC; Nelson, S; Ochaya, S; Osoegawa, K; Pai, G; Parsons, M; Pentony, M; Pettersson, U; Pop, M; Ramirez, JL; Rinta, J; Robertson, L; Salzberg, SL; Sanchez, DO; Seyler, A; Sharma, R; Shetty, J; Simpson, AJ; Sisk, E; Tammi, MT; Tarteton, R; Teixeira, S; Van Aken, S; Vogt, C; Ward, PN; Wickstead, B; Wortman, J; White, O; Fraser, CM; Stuart, KD; Andersson, B				El-Sayed, NM; Myler, PJ; Bartholomeu, DC; Nilsson, D; Aggarwal, G; Tran, AN; Ghedin, E; Worthey, EA; Delcher, AL; Blandin, G; Westenberger, SJ; Caler, E; Cerqueira, GC; Branche, C; Haas, B; Anupama, A; Arner, E; Aslund, L; Attipoe, P; Bontempi, E; Bringaud, F; Burton, P; Cadag, E; Campbell, DA; Carrington, M; Crabtree, J; Darban, H; da Silveira, JF; de Jong, P; Edwards, K; Englund, PT; Fazelina, G; Feldblyum, T; Ferella, M; Frasch, AC; Gull, K; Horn, D; Hou, LH; Huang, YT; Kindlund, E; Ktingbeil, M; Kluge, S; Koo, H; Lacerda, D; Levin, MJ; Lorenzi, H; Louie, T; Machado, CR; McCulloch, R; McKenna, A; Mizuno, Y; Mottram, JC; Nelson, S; Ochaya, S; Osoegawa, K; Pai, G; Parsons, M; Pentony, M; Pettersson, U; Pop, M; Ramirez, JL; Rinta, J; Robertson, L; Salzberg, SL; Sanchez, DO; Seyler, A; Sharma, R; Shetty, J; Simpson, AJ; Sisk, E; Tammi, MT; Tarteton, R; Teixeira, S; Van Aken, S; Vogt, C; Ward, PN; Wickstead, B; Wortman, J; White, O; Fraser, CM; Stuart, KD; Andersson, B			The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease	SCIENCE			English	Article							MULTILOCUS ENZYME ELECTROPHORESIS; PARASITE PLASMODIUM-FALCIPARUM; AMPLIFIED POLYMORPHIC DNA; NON-LTR RETROTRANSPOSONS; RNA INTERFERENCE RNAI; CLONE CL BRENER; TRANS-SIALIDASE; PROTEIN-KINASE; AFRICAN TRYPANOSOMES; NUCLEOTIDE-SEQUENCE	Whole-genome sequencing of the protozoan pathogen Trypanosoma cruzi revealed that the diploid genome contains a predicted 22,570 proteins encoded by genes, of which 12,570 represent allelic pairs. Over 50% of the genome consists of repeated sequences, such as retrotransposons and genes for large, families of surface molecules, which include trans-sialidases, mucins, gp63s, and a large novel family (>1300 copies) of mucin-associated surface protein (MASP) genes. Analyses of the T. cruzi, T. brucei, and Leishmania major (Tritryp) genomes imply differences from other eukaryotes in DNA repair and initiation of replication and reflect their unusual mitochondrial DNA. Although the Tritryp lack several classes of signaling molecules, their kinomes contain a large and diverse set of protein kinases and phosphatases; their size and diversity imply previously unknown interactions and regulatory processes, which may be targets for intervention.	Inst Genome Res, Dept Parasite Genom, Rockville, MD 20850 USA; George Washington Univ, Dept Microbiol & Trop Med, Washington, DC 20052 USA; Seattle Biomed Res Inst, Seattle, WA 98109 USA; Univ Washington, Sch Publ Hlth & Community Med, Dept Pathobiol, Seattle, WA 98195 USA; Univ Washington, Dept Med Educ & Biomed Informat, Seattle, WA 98195 USA; Karolinska Inst, Ctr Genom & Bioinformat, S-17177 Stockholm, Sweden; Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; Univ Fed Minas Gerais, Dept Bioquim 7 Imunol, BR-31270901 Belo Horizonte, MG, Brazil; Uppsala Univ, Dept Genet & Pathol, SE-75185 Uppsala, Sweden; Adm Nacl Labs, Inst Nacl Parasitol Dr M Fatala Chaben, RA-1063 Buenos Aires, DF, Argentina; Inst Salud ANUS, RA-1063 Buenos Aires, DF, Argentina; Univ Bordeaux 2, CNRS, UMR 5162, LabGenom Fonct Trypanosomatides, F-33076 Bordeaux, France; Univ Glasgow, Wellcome Ctr Mol Parasitol, Glasgow G11 6NU, Lanark, Scotland; Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; Univ Fed Sao Paulo, Dept Microbiol Immunol & Parasitol, BR-04023062 Sao Paulo, Brazil; Childrens Hosp, Oakland Res Inst, BACPAC Resources, Oakland, CA 94609 USA; Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; Natl Univ San Martin, Inst Invest Biotecnol, Inst Tecnol Chascomus, RA-1650 Buenos Aires, DF, Argentina; CNR, RA-1650 Buenos Aires, DF, Argentina; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA; Fundacao Oswaldo Cruz, Rene Rachou Res Ctr CPqRR, Belo Horizonte, MG, Brazil; Univ Buenos Aires, Ctr Genom Aplicada, Sch Sci,CONICET,CYTED Project,Natl Res Council, Lab Mol Biol Chagas Dis,Inst Invest Ingn Genet &, RA-1428 Buenos Aires, DF, Argentina; Cent Univ Venezuela, Inst Expt Biol, Caracas 1041A, Venezuela; ADEA MCT, Caracas 1041A, Venezuela; Natl Univ Singapore, Dept Biol Sci & Biochem, Singapore 117548, Singapore; Univ Georgia, Dept Cellular Biol, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA	J. Craig Venter Institute; George Washington University; Center for Infectious Disease Research; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Karolinska Institutet; University of California System; University of California Los Angeles; Universidade Federal de Minas Gerais; Uppsala University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; University of Glasgow; University of Cambridge; Universidade Federal de Sao Paulo (UNIFESP); Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; Johns Hopkins University; University of Oxford; University of London; London School of Hygiene & Tropical Medicine; University of Massachusetts System; University of Massachusetts Amherst; Fundacao Oswaldo Cruz; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Central Venezuela; National University of Singapore; University System of Georgia; University of Georgia	El-Sayed, NM (corresponding author), Inst Genome Res, Dept Parasite Genom, Rockville, MD 20850 USA.	neisayed@tigr.org; peter.myler@sbri.org; bjorn.andersson@cgb.ki.se	Blandin, Gaelle/N-9745-2013; TEIXEIRA, SANTUZA MR/I-8137-2013; Carrington, Mark/N-3653-2019; Andersson, Bjorn/G-9832-2013; da Silveira, Jose Franco/F-5390-2012; El-Sayed, Najib M.A./K-7266-2015; Salzberg, Steven L/F-6162-2011; Arner, Erik/A-1895-2010; Pop, Mihai/A-7987-2013; Cerqueira, Gustavo/AAV-7398-2020; Salzberg, Steven/Q-6514-2019; Nilsson, Daniel/B-8365-2009; Simpson, Amelia/HGB-1823-2022; Carrington, Mark/N-4892-2018; Ghedin, Elodie/Y-5654-2019; MACHADO, CARLOS/AAW-1492-2020; Bartholomeu, Daniella C./J-4714-2015; Tammi, Martti T/C-1115-2008; Sharma, Reuben/AAI-6444-2020; Myler, Peter John/AAR-9535-2021; Machado, Carlos Renato/H-1043-2015; Ramirez, Jose Luis/AAE-3117-2021	Blandin, Gaelle/0000-0003-2790-9524; Carrington, Mark/0000-0002-6435-7266; Andersson, Bjorn/0000-0002-4624-0259; El-Sayed, Najib M.A./0000-0001-7970-3312; Salzberg, Steven L/0000-0002-8859-7432; Arner, Erik/0000-0003-1225-4908; Pop, Mihai/0000-0001-9617-5304; Cerqueira, Gustavo/0000-0002-7692-3886; Salzberg, Steven/0000-0002-8859-7432; Nilsson, Daniel/0000-0001-5831-385X; Carrington, Mark/0000-0002-6435-7266; Ghedin, Elodie/0000-0002-1515-725X; Bartholomeu, Daniella C./0000-0003-0974-7357; Machado, Carlos Renato/0000-0002-8724-3165; Ward, Pauline/0000-0001-9455-0983; Klingbeil, Michele/0000-0002-7236-8424; Lorenzi, Hernan/0000-0003-0910-7894; Horn, David/0000-0001-5173-9284; Parsons, Marilyn/0000-0003-3994-8096; Mottram, Jeremy/0000-0001-5574-3766; Frasch, Alberto Carlos/0000-0001-7532-653X; Fraser, Claire/0000-0003-1462-2428; Wortman, Jennifer/0000-0002-8713-1227; Bontempi, Esteban/0000-0001-8182-2089; Tarleton, Rick/0000-0002-9589-5243; Myler, Peter/0000-0002-0056-0513; Wickstead, Bill/0000-0002-4620-9091; sanchez, daniel/0000-0002-5427-7764	NIAID NIH HHS [AI45061, AI045039, AI45038, R01 AI031077, U01 AI045038, R01 AI031077-11, U01 AI045039] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI045039, U01AI045038, U01AI045061, R01AI031077] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agusti R, 1998, MOL BIOCHEM PARASIT, V97, P123, DOI 10.1016/S0166-6851(98)00137-6; AKSOY S, 1987, EMBO J, V6, P3819, DOI 10.1002/j.1460-2075.1987.tb02718.x; Allen CL, 2001, EXP PARASITOL, V97, P173, DOI 10.1006/expr.2001.4600; [Anonymous], 2002, WORLD HLTH REP 2002; Atwood JA, 2005, SCIENCE, V309, P473, DOI 10.1126/science.1110289; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Beverley SM, 2003, NAT REV GENET, V4, P11, DOI 10.1038/nrg980; Bringaud F, 2004, MOL BIOL EVOL, V21, P520, DOI 10.1093/molbev/msh045; Bringaud F, 2002, EUKARYOT CELL, V1, P137, DOI 10.1128/EC.1.1.137-151.2002; Bringaud F, 2002, MOL BIOCHEM PARASIT, V124, P73, DOI 10.1016/S0166-6851(02)00167-6; Briones MRS, 1999, MOL BIOCHEM PARASIT, V104, P219, DOI 10.1016/S0166-6851(99)00155-3; Brisse S, 1998, MOL BIOCHEM PARASIT, V92, P253, DOI 10.1016/S0166-6851(98)00005-X; Brisse S, 2000, INT J PARASITOL, V30, P35, DOI 10.1016/S0020-7519(99)00168-X; Brisse S, 2003, INFECT GENET EVOL, V2, P173, DOI 10.1016/S1567-1348(02)00097-7; Buscaglia CA, 2004, J BIOL CHEM, V279, P15860, DOI 10.1074/jbc.M314051200; Campo V, 2004, MOL BIOCHEM PARASIT, V133, P81, DOI 10.1016/j.molbiopara.2003.09.006; CANO MI, 1995, MOL BIOCHEM PARASIT, V71, P273, DOI 10.1016/0166-6851(95)00066-A; Cano MIN, 1999, P NATL ACAD SCI USA, V96, P3616, DOI 10.1073/pnas.96.7.3616; Chiurillo MA, 1999, MOL BIOCHEM PARASIT, V100, P173, DOI 10.1016/S0166-6851(99)00047-X; CLARK CG, 1994, MOL BIOCHEM PARASIT, V66, P175, DOI 10.1016/0166-6851(94)90045-0; Conway C, 2002, J BIOL CHEM, V277, P21269, DOI 10.1074/jbc.M200550200; Cross M, 2002, MOL MICROBIOL, V46, P37, DOI 10.1046/j.1365-2958.2002.03144.x; DaRocha WD, 2004, MOL BIOCHEM PARASIT, V133, P175, DOI 10.1016/j.molbiopara.2003.10.005; De Souza W, 2002, CURR PHARM DESIGN, V8, P269, DOI 10.2174/1381612023396276; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; Elias MCQB, 2005, MOL BIOCHEM PARASIT, V140, P221, DOI 10.1016/j.molbiopara.2004.12.016; Ferguson MAJ, 1997, PHILOS T ROY SOC B, V352, P1295, DOI 10.1098/rstb.1997.0113; Frasch ACC, 2000, PARASITOL TODAY, V16, P282, DOI 10.1016/S0169-4758(00)01698-7; Fujimura AE, 2001, INFECT IMMUN, V69, P5477, DOI 10.1128/IAI.69.9.5477-5486.2001; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gaunt MW, 2003, NATURE, V421, P936, DOI 10.1038/nature01438; Ghedin E, 2004, MOL BIOCHEM PARASIT, V134, P183, DOI 10.1016/j.molbiopara.2003.11.012; Grams J, 2002, J BIOL CHEM, V277, P16952, DOI 10.1074/jbc.M200662200; Hammarton Tansy C, 2003, Prog Cell Cycle Res, V5, P91; HASAN G, 1984, CELL, V37, P333, DOI 10.1016/0092-8674(84)90329-5; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; JENNI L, 1986, NATURE, V322, P173, DOI 10.1038/322173a0; Kelman LM, 2003, MOL MICROBIOL, V48, P605, DOI 10.1046/j.1365-2958.2003.03369.x; KIMMEL BE, 1987, MOL CELL BIOL, V7, P1465, DOI 10.1128/MCB.7.4.1465; Klingbeil MM, 2002, MOL CELL, V10, P175, DOI 10.1016/S1097-2765(02)00571-3; Liu Y, 2000, MOL CELL BIOL, V20, P8178, DOI 10.1128/MCB.20.21.8178-8184.2000; Machado CA, 2001, P NATL ACAD SCI USA, V98, P7396, DOI 10.1073/pnas.121187198; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Montagna G, 2002, EUR J BIOCHEM, V269, P2941, DOI 10.1046/j.1432-1033.2002.02968.x; Muller IB, 2002, MOL BIOL CELL, V13, P3787, DOI 10.1091/mbc.E02-02-0093; Olivares M, 2000, ELECTROPHORESIS, V21, P2973, DOI 10.1002/1522-2683(20000801)21:14&lt;2973::AID-ELPS2973&gt;3.0.CO;2-4; Pays E, 2004, CURR OPIN MICROBIOL, V7, P369, DOI 10.1016/j.mib.2004.05.001; Pedroso A, 2003, MOL BIOCHEM PARASIT, V129, P79, DOI 10.1016/S0166-6851(03)00096-3; Pena-Diaz J, 2004, J MOL BIOL, V342, P787, DOI 10.1016/j.jmb.2004.07.043; POLLEVICK GD, 1991, MOL BIOCHEM PARASIT, V47, P247, DOI 10.1016/0166-6851(91)90185-9; Robinson KA, 2003, MOL BIOCHEM PARASIT, V128, P217, DOI 10.1016/S0166-6851(03)00079-3; Saxowsky TT, 2003, J BIOL CHEM, V278, P49095, DOI 10.1074/jbc.M308565200; Sinha KM, 2004, P NATL ACAD SCI USA, V101, P4361, DOI 10.1073/pnas.0305705101; Sturm NR, 2003, INT J PARASITOL, V33, P269, DOI 10.1016/S0020-7519(02)00264-3; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Turner CMR, 2004, PARASITOLOGY, V129, P445, DOI 10.1017/S0031182004005906; Vastenhouw NL, 2003, CURR BIOL, V13, P1311, DOI [10.1016/S0960-9822(03)00539-6, 10.1016/s0960-9822(03)00539-6]; VILLANUEVA MS, 1991, MOL CELL BIOL, V11, P6139, DOI 10.1128/MCB.11.12.6139; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; WESTENBERGER SJ, IN PRESS GENETICS; Wiese M, 2003, EUKARYOT CELL, V2, P769, DOI 10.1128/EC.2.4.769-777.2003; WINCKER P, 1992, MOL BIOCHEM PARASIT, V55, P217, DOI 10.1016/0166-6851(92)90142-7; WOODWARD R, 1990, J CELL SCI, V95, P49; Yao CQ, 2003, MOL BIOCHEM PARASIT, V132, P1, DOI 10.1016/S0166-6851(03)00211-1; Zingales B, 1997, ACTA TROP, V68, P159, DOI 10.1016/S0001-706X(97)00088-0; 1999, MEM I O CRUZ, V94, P429	67	1074	1158	2	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2005	309	5733					409	415		10.1126/science.1112631	http://dx.doi.org/10.1126/science.1112631			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946LY	16020725				2022-12-01	WOS:000230574900035
J	Okie, S				Okie, S			Stem-cell research - Signposts and roadblocks	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Hoffman DI, 2003, FERTIL STERIL, V79, P1063, DOI 10.1016/S0015-0282(03)00172-9; Perry ACF, 2005, NEW ENGL J MED, V353, P87, DOI 10.1056/NEJMcibr052068; Practice Committe of the American Society for Reproductive Medicine, 2003, Fertil Steril, V80, P1309; 2005, DAILY PENNSYLVA 0527; 2005, NY TIMES        0526, pA28	5	11	11	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 7	2005	353	1					1	5		10.1056/NEJMp058129	http://dx.doi.org/10.1056/NEJMp058129			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942FC	16000350				2022-12-01	WOS:000230267300001
J	Tsimikas, S; Brilakis, ES; Miller, ER; McConnell, JP; Lennon, RJ; Kornman, KS; Witztum, JL; Berger, PB				Tsimikas, S; Brilakis, ES; Miller, ER; McConnell, JP; Lennon, RJ; Kornman, KS; Witztum, JL; Berger, PB			Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LOW-DENSITY-LIPOPROTEIN; ELEVATED LIPOPROTEIN(A); MYOCARDIAL-INFARCTION; RISK-FACTOR; APOPTOTIC CELLS; HEART-DISEASE; HUMAN PLASMA; LDL; APOLIPOPROTEIN(A); ATHEROSCLEROSIS	Background: Lp(a) lipoprotein binds proinflammatory oxidized phospholipids. We investigated whether levels of oxidized low-density lipoprotein (LDL) measured with use of monoclonal antibody E06 reflect the presence and extent of obstructive coronary artery disease, defined as a stenosis of more than 50 percent of the luminal diameter. Methods: Levels of oxidized LDL and Lp(a) lipoprotein were measured in a total of 504 patients immediately before coronary angiography. Levels of oxidized LDL are reported as the oxidized phospholipid content per particle of apolipoprotein B-100 (oxidized phospholipid:apo B-100 ratio). Results: Measurements of the oxidized phospholipid:apo B-100 ratio and Lp(a) lipoprotein levels were skewed toward lower values, and the values for the oxidized phospholipid:apo B-100 ratio correlated strongly with those for Lp(a) lipoprotein (r=0.83, P<0.001). In the entire cohort, the oxidized phospholipid:apo B-100 ratio and Lp(a) lipoprotein levels showed a strong and graded association with the presence and extent of coronary artery disease (i.e., the number of vessels with a stenosis of more than 50 percent of the luminal diameter) (P<0.001). Among patients 60 years of age or younger, those in the highest quartiles for the oxidized phospholipid:apo B-100 ratio and Lp(a) lipoprotein levels had odds ratios for coronary artery disease of 3.12 (P<0.001) and 3.64 (P<0.001), respectively, as compared with patients in the lowest quartile. The combined effect of hypercholesterolemia and being in the highest quartiles of the oxidized phospholipid:apo B-100 ratio (odds ratio, 16.8; P<0.001) and Lp(a) lipoprotein levels (odds ratio, 14.2; P<0.001) significantly increased the probability of coronary artery disease among patients 60 years of age or younger. In the entire study group, the association of the oxidized phospholipid:apo B-100 ratio with obstructive coronary artery disease was independent of all clinical and lipid measures except one, Lp(a) lipoprotein. However, among patients 60 years of age or younger, the oxidized phospholipid:apo B-100 ratio remained an independent predictor of coronary artery disease. Conclusions: Circulating levels of oxidized LDL are strongly associated with angiographically documented coronary artery disease, particularly in patients 60 years of age or younger. These data suggest that the atherogenicity of Lp(a) lipoprotein may be mediated in part by associated proinflammatory oxidized phospholipids.	Univ Calif San Diego, Vasc Med Program, Div Cardiovasc Dis, La Jolla, CA 92093 USA; Univ Calif San Diego, Div Endocrinol & Metab, La Jolla, CA 92093 USA; Mayo Clin & Mayo Fdn, Dept Lab Med & Pathol, Div Cardiovasc Dis, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Div Biostat, Rochester, MN 55905 USA; Interleukin Genet, Waltham, MA USA; Duke Clin Res Inst, Div Cardiovasc Dis, Durham, NC USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Mayo Clinic; Mayo Clinic; Duke University	Tsimikas, S (corresponding author), Univ Calif San Diego, Vasc Med Program, Div Cardiovasc Dis, 9500 Gilman Dr,Basic Sci Bldg,Rm 1080, La Jolla, CA 92093 USA.	stsimikas@ucsd.edu	Brilakis, Emmanouil/B-5282-2009	Brilakis, Emmanouil/0000-0001-9416-9701	NHLBI NIH HHS [HL57505, HL56989, HL69646] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057505, F32HL069646, P50HL056989] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Assmann G, 1996, AM J CARDIOL, V77, P1179, DOI 10.1016/S0002-9149(96)00159-2; Berg K, 1997, CLIN GENET, V52, P254; Binder CJ, 2002, NAT MED, V8, P1218, DOI 10.1038/nm1102-1218; Binder CJ, 2004, J CLIN INVEST, V114, P427, DOI 10.1172/jci200420479; Binder CJ, 2003, NAT MED, V9, P736, DOI 10.1038/nm876; Blencowe C, 1995, J BIOL CHEM, V270, P31151, DOI 10.1074/jbc.270.52.31151; Chang MK, 2002, P NATL ACAD SCI USA, V99, P13043, DOI 10.1073/pnas.192399699; Chang MK, 2004, J EXP MED, V200, P1359, DOI 10.1084/jem.20031763; CUSHING GL, 1989, ARTERIOSCLEROSIS, V9, P593, DOI 10.1161/01.ATV.9.5.593; DAHLEN GH, 1986, CIRCULATION, V74, P758, DOI 10.1161/01.CIR.74.4.758; Danesh J, 2000, CIRCULATION, V102, P1082, DOI 10.1161/01.CIR.102.10.1082; Dangas G, 1998, J AM COLL CARDIOL, V32, P2035, DOI 10.1016/S0735-1097(98)00469-0; Edelstein C, 2003, J BIOL CHEM, V278, P52841, DOI 10.1074/jbc.M310425200; Ehara S, 2001, CIRCULATION, V103, P1955, DOI 10.1161/01.cir.103.15.1955; Foody JM, 2000, ARTERIOSCL THROM VAS, V20, P493, DOI 10.1161/01.ATV.20.2.493; HEARN JA, 1990, AM J CARDIOL, V66, P1176, DOI 10.1016/0002-9149(90)91094-M; Hobbs HH, 1999, CURR OPIN LIPIDOL, V10, P225, DOI 10.1097/00041433-199906000-00005; Holvoet P, 1998, CIRCULATION, V98, P1487, DOI 10.1161/01.CIR.98.15.1487; Holvoet P, 2001, ARTERIOSCL THROM VAS, V21, P844, DOI 10.1161/01.ATV.21.5.844; Holvoet P, 1999, JAMA-J AM MED ASSOC, V281, P1718, DOI 10.1001/jama.281.18.1718; KARABINA SAP, 1994, BBA-LIPID LIPID MET, V1213, P34, DOI 10.1016/0005-2760(94)90219-4; Klezovitch O, 2001, J BIOL CHEM, V276, P46864, DOI 10.1074/jbc.M107943200; MAEDA S, 1989, ATHEROSCLEROSIS, V78, P145, DOI 10.1016/0021-9150(89)90218-9; McConnell JP, 2002, CLIN CHEM LAB MED, V40, P56, DOI 10.1515/CCLM.2002.011; Nishi K, 2002, ARTERIOSCL THROM VAS, V22, P1649, DOI 10.1161/01.ATV.0000033829.14012.18; Palinski W, 1996, J CLIN INVEST, V98, P800, DOI 10.1172/JCI118853; RHOADS GG, 1986, JAMA-J AM MED ASSOC, V256, P2540, DOI 10.1001/jama.256.18.2540; SANDKAMP M, 1990, CLIN CHEM, V36, P20; Shaw PX, 2000, J CLIN INVEST, V105, P1731, DOI 10.1172/JCI8472; Sunayama S, 1996, CIRCULATION, V94, P1263, DOI 10.1161/01.CIR.94.6.1263; Thillet J, 1998, ATHEROSCLEROSIS, V136, P389, DOI 10.1016/S0021-9150(97)00217-7; Toshima S, 2000, ARTERIOSCL THROM VAS, V20, P2243, DOI 10.1161/01.ATV.20.10.2243; Trieu VN, 1999, BIOCHEM BIOPH RES CO, V257, P714, DOI 10.1006/bbrc.1999.0519; Tsimikas S, 2004, CIRCULATION, V110, P1406, DOI 10.1161/01.CIR.0000141728.23033.B5; Tsimikas S, 2003, J AM COLL CARDIOL, V41, P360, DOI 10.1016/S0735-1097(02)02769-9; Tsimikas S, 2004, CIRCULATION, V109, P3164, DOI 10.1161/01.CIR.0000130844.01174.55; Tsimikas S, 2001, CIRCULATION, V103, P1930; Tsimikas S, 2004, MOL BASIS CARDIOVASC, P385; Wolk R, 2003, CIRCULATION, V108, P2206, DOI 10.1161/01.CIR.0000095270.85646.E8; Yano Y, 1997, J HISTOCHEM CYTOCHEM, V45, P559, DOI 10.1177/002215549704500408	40	533	559	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 7	2005	353	1					46	57		10.1056/NEJMoa043175	http://dx.doi.org/10.1056/NEJMoa043175			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942FC	16000355	Bronze			2022-12-01	WOS:000230267300007
J	Batlle, E; Bacani, J; Begthel, H; Jonkeer, S; Gregorieff, A; van de Born, M; Malats, N; Sancho, E; Boon, E; Pawson, T; Gallinger, S; Pals, S; Clevers, H				Batlle, E; Bacani, J; Begthel, H; Jonkeer, S; Gregorieff, A; van de Born, M; Malats, N; Sancho, E; Boon, E; Pawson, T; Gallinger, S; Pals, S; Clevers, H			EphB receptor activity suppresses colorectal cancer progression	NATURE			English	Article							MULTIPLE INTESTINAL NEOPLASIA; BETA-CATENIN; APC; COLON; ACTIVATION; MICE; EPITHELIUM; EXPRESSION; MUTATIONS; PATHWAY	Most sporadic colorectal cancers are initiated by activating Wnt pathway mutations(1), characterized by the stabilization of beta-catenin and constitutive transcription by the beta-catenin/T cell factor-4 (Tcf-4) complex(2,3). EphB guidance receptors are Tcf4 target genes that control intestinal epithelial architecture through repulsive interactions with Ephrin-B ligands(4,5). Here we show that, although Wnt signalling remains constitutively active, most human colorectal cancers lose expression of EphB at the adenoma-carcinoma transition. Loss of EphB expression strongly correlates with degree of malignancy. Furthermore, reduction of EphB activity accelerates tumorigenesis in the colon and rectum of Apc(Min/+) mice, and results in the formation of aggressive adenocarcinomas. Our data demonstrate that loss of EphB expression represents a critical step in colorectal cancer progression.	Netherlands Inst Dev Biol, Hubrecht Lab, Ctr Biomed Genet, NL-3584 CT Utrecht, Netherlands; Biomed Res Inst, Barcelona 08028, Spain; ICREA, Barcelona 08010, Spain; Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Inst Municipal Invest Med, E-08003 Barcelona, Spain	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; ICREA; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Clevers, H (corresponding author), Netherlands Inst Dev Biol, Hubrecht Lab, Ctr Biomed Genet, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	clevers@niob.knaw.nl	Pawson, Tony J/E-4578-2013; Gallinger, Steven/E-4575-2013; Sancho, Elena/ABH-4867-2020; Batlle, Eduard/K-8080-2014; Malats, Nuria/H-7041-2015	Sancho, Elena/0000-0002-8182-513X; Batlle, Eduard/0000-0003-2422-0326; Malats, Nuria/0000-0003-2538-3784; Pals, Steven/0000-0002-1419-0939	ICREA Funding Source: Custom	ICREA(ICREA)		Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Gregorieff A, 2004, EMBO J, V23, P1825, DOI 10.1038/sj.emboj.7600191; Huusko P, 2004, NAT GENET, V36, P979, DOI 10.1038/ng1408; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Lal G, 2001, CANCER RES, V61, P6131; Mao WG, 2004, CANCER RES, V64, P781, DOI 10.1158/0008-5472.CAN-03-1047; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Munarini N, 2002, J CELL SCI, V115, P25; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Sancho E, 2003, CURR OPIN CELL BIOL, V15, P763, DOI 10.1016/j.ceb.2003.10.012; Shitoh K, 2001, GENE CHROMOSOME CANC, V30, P32, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1065>3.0.CO;2-I; Sparks AB, 1998, CANCER RES, V58, P1130; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Yamada Y, 2002, CANCER RES, V62, P6367	20	329	354	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2005	435	7045					1126	1130		10.1038/nature03626	http://dx.doi.org/10.1038/nature03626			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937ZT	15973414				2022-12-01	WOS:000229970400055
J	van Wijk, I; Kappelle, LJ; van Gijn, J; Koudstaal, PJ; Franke, CL; Vermeulen, M; Gorter, JW; Algra, A				van Wijk, I; Kappelle, LJ; van Gijn, J; Koudstaal, PJ; Franke, CL; Vermeulen, M; Gorter, JW; Algra, A		LiLAC Study Grp	Long-term survival and vascular event risk after transient ischaemic attack or minor ischaemic stroke: a cohort study	LANCET			English	Article							FOLLOW-UP; INTEROBSERVER AGREEMENT; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; SECONDARY PREVENTION; CEREBRAL-ISCHEMIA; RECURRENT STROKE; PROGNOSIS; MORTALITY; HANDICAP	Background Determinants of survival and of risk of vascular events after transient ischaemic attack (TIA) or minor ischaemic stroke are not well defined in the long term. We aimed to restudy these risks in a prospective cohort of patients after TIA or minor ischaemic stroke (Rankin grade <= 3), after 10 years or more. Methods We assessed the survival status and occurrence of vascular events in 2473 participants of the Dutch TIA Trial (recruitment in 1986-89; arterial cause of cerebral ischaemia). We included 24 hospitals in the Netherlands that recruited at least 50 patients. Primary outcomes were all-cause mortality and the composite event of death from all vascular causes, non-fatal stroke, and non-fatal myocardial infarction. We assessed cumulative risks by Kaplan-Meier analysis and prognostic factors with Cox univariate and multivariate analysis. Findings Follow-up was complete in 2447 (99%) patients. After a mean follow-up of 10.1 years, 1489 (60%) patients had died and 1336 (54%) had had at least one vascular event. 10-year risk of death was 42.7% (95% CI 40.8-44.7). Age and sex-adjusted hazard ratios were 3.33 (2.97-3.73) for age over 65 years, 2.10 (1.79-2.48) for diabetes, 1.77 (1.45-2.15) for claudication, 1.94 (1.42-2.65) for previous peripheral vascular surgery, and 1.50 (1.31-1.71) for pathological Q waves on baseline electrocardiogram. 10-year risk of a vascular event was 44.1% (42.0-46.1). After falling in the first 3 years, yearly risk of a vascular event increased over time. Predictive factors for risk of vascular events were similar to those for risk of death. Interpretation Long-term secondary prevention in patients with cerebral ischaemia still has room for further improvement.	Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol, Utrecht, Netherlands; Rehabil Ctr Hoogstr, Utrecht, Netherlands; Erasmus MC, Dept Neurol, Rotterdam, Netherlands; Atrium Med Ctr, Dept Neurol, Heerlen, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands; Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Atrium Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center	Algra, A (corresponding author), Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol, Utrecht, Netherlands.	a.algra@umcutrecht.nl	Gorter, Jan Willem/AAK-8784-2021; van Gijn, Jan/A-9444-2008	Gorter, Jan Willem/0000-0002-3012-2119; 				Algra A, 1996, J NEUROL NEUROSUR PS, V60, P197, DOI 10.1136/jnnp.60.2.197; ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; Anderson CS, 2004, STROKE, V35, P1920, DOI 10.1161/01.STR.0000133130.20322.9f; [Anonymous], 1993, Stroke, V24, P527; BAMFORD JM, 1989, STROKE, V20, P828, DOI 10.1161/01.STR.20.6.828; Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; Bravata DM, 2003, STROKE, V34, P699, DOI 10.1161/01.STR.0000057578.26828.78; Bronnum-Hansen H, 2001, STROKE, V32, P2131, DOI 10.1161/hs0901.094253; BURN J, 1994, STROKE, V25, P333, DOI 10.1161/01.STR.25.2.333; Clark TG, 2003, J NEUROL NEUROSUR PS, V74, P577, DOI 10.1136/jnnp.74.5.577; Coull AJ, 2004, BMJ-BRIT MED J, V328, P326, DOI 10.1136/bmj.37991.635266.44; De Schryver ELLM, 2000, CEREBROVASC DIS, V10, P147, DOI 10.1159/000016044; Eriksson SE, 2001, CEREBROVASC DIS, V12, P171, DOI 10.1159/000047700; Gresham GE, 1998, STROKE, V29, P793, DOI 10.1161/01.STR.29.4.793; HANKEY GJ, 1992, J NEUROL NEUROSUR PS, V55, P640, DOI 10.1136/jnnp.55.8.640; HANKEY GJ, 1991, J NEUROL NEUROSUR PS, V54, P793, DOI 10.1136/jnnp.54.9.793; Hankey GJ, 1998, STROKE, V29, P2491, DOI 10.1161/01.STR.29.12.2491; Hardie K, 2003, STROKE, V34, P1842, DOI 10.1161/01.STR.0000082382.42061.EE; Jorgensen HS, 1997, NEUROLOGY, V48, P891; KERNAN WN, 1991, STROKE, V22, P1108, DOI 10.1161/01.STR.22.9.1108; KERNAN WN, 1991, ANN INTERN MED, V114, P552, DOI 10.7326/0003-4819-114-7-552; Marini C, 1999, STROKE, V30, P2320, DOI 10.1161/01.STR.30.11.2320; Peltonen M, 1998, STROKE, V29, P1358, DOI 10.1161/01.STR.29.7.1358; Prencipe M, 1998, STROKE, V29, P126, DOI 10.1161/01.STR.29.1.126; Reitsma JB, 1999, HEART, V82, P52, DOI 10.1136/hrt.82.1.52; SAEKI S, 1995, STROKE, V26, P399, DOI 10.1161/01.STR.26.3.399; SANDERCOCK P, 1992, BRIT MED J, V305, P1460, DOI 10.1136/bmj.305.6867.1460; Shah PK, 2003, J AM COLL CARDIOL, V41, p15S, DOI 10.1016/S0735-1097(02)02834-6; Staaf G, 2001, STROKE, V32, P2592, DOI 10.1161/hs1101.098355; TUOMILEHTO J, 1995, STROKE, V26, P971, DOI 10.1161/01.STR.26.6.971; VANGIJN J, 1991, NEW ENGL J MED, V325, P1261, DOI 10.1056/NEJM199110313251801; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Vernino S, 2003, STROKE, V34, P1828, DOI 10.1161/01.STR.0000080534.98416.A0; WARLOW C, 1992, LANCET, V339, P724, DOI 10.1016/0140-6736(92)90608-6; Wilkinson PR, 1997, STROKE, V28, P507, DOI 10.1161/01.STR.28.3.507; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	36	213	213	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 18	2005	365	9477					2098	2104		10.1016/S0140-6736(05)66734-7	http://dx.doi.org/10.1016/S0140-6736(05)66734-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	936LZ	15964446				2022-12-01	WOS:000229858800026
J	Kaiser, J				Kaiser, J			Meeting - American Society of Gene Therapy - Retroviral vectors: A double-edged sword	SCIENCE			English	News Item																			0	7	8	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 17	2005	308	5729					1735	1736						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937LY	15961648				2022-12-01	WOS:000229926800015
J	Nateri, AS; Spencer-Dene, B; Behrens, A				Nateri, AS; Spencer-Dene, B; Behrens, A			Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development	NATURE			English	Article							TERMINAL PHOSPHORYLATION; TARGET GENES; APC GENE; PROLIFERATION; AP-1; TRANSCRIPTION; REGENERATION; CARCINOMAS; EXPRESSION; PATHWAY	The proto-oncoprotein c-Jun is a component of the AP-1 transcription factor, the activity of which is augmented in many tumour types(1). An important mechanism in the stimulation of AP-1 function is amino-terminal phosphorylation of c-Jun by the c-Jun N-terminal kinases (JNKs)(2). Phosphorylated c-Jun is biologically more active, partially because it acquires the ability to interact with binding partners. Here we show that phosphorylated c-Jun interacts with the HMG-box transcription factor TCF4 to form a ternary complex containing c-Jun, TCF4 and beta-catenin. Chromatin immunoprecipitation assays revealed JNK-dependent c-Jun - TCF4 interaction on the c-jun promoter, and c-Jun and TCF4 cooperatively activated the c-jun promoter in reporter assays in a beta-catenin-dependent manner. In the Apc(Min) mouse model of intestinal cancer(6), genetic abrogation of c-Jun N-terminal phosphorylation(3) or gut-specific conditional c-jun inactivation(4,5) reduced tumour number and size and prolonged lifespan. Therefore, the phosphorylation-dependent interaction between c-Jun and TCF4 regulates intestinal tumorigenesis by integrating JNK and APC/beta-catenin, two distinct pathways activated by WNT signalling.	CR UK London Res Inst, Lincolns Inn Fields Labs, Mammalian Genet Lab, London WC2A 3PX, England; CR UK London Res Inst, Lincolns Inn Fields Labs, Expt Pathol Lab, London WC2A 3PX, England; Univ London Imperial Coll Sci Technol & Med, Dept Histopathol, London SW7 2AZ, England	Imperial College London	Behrens, A (corresponding author), CR UK London Res Inst, Lincolns Inn Fields Labs, Mammalian Genet Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	axel.behrens@cancer.org.uk		Behrens, Axel/0000-0002-1557-1143; Shams Nateri, Abdolrahman/0000-0002-6422-6813				Alberts AS, 1998, CELL, V92, P475, DOI 10.1016/S0092-8674(00)80941-1; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; Behrens A, 2000, ONCOGENE, V19, P2657, DOI 10.1038/sj.onc.1203603; Behrens A, 2002, EMBO J, V21, P1782, DOI 10.1093/emboj/21.7.1782; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; Bogoyevitch MA, 2004, BBA-PROTEINS PROTEOM, V1697, P89, DOI 10.1016/j.bbapap.2003.11.016; Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Fodde R, 2002, EUR J CANCER, V38, P867, DOI 10.1016/S0959-8049(02)00040-0; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; MOSER AR, 1993, P NATL ACAD SCI USA, V90, P8977, DOI 10.1073/pnas.90.19.8977; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Raivich G, 2004, NEURON, V43, P57, DOI 10.1016/j.neuron.2004.06.005; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Staal FJT, 2004, J IMMUNOL, V172, P1099, DOI 10.4049/jimmunol.172.2.1099; STEIN B, 1992, PHOTOCHEM PHOTOBIOL, V55, P409, DOI 10.1111/j.1751-1097.1992.tb04255.x; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wada T, 2004, NAT CELL BIOL, V6, P215, DOI 10.1038/ncb1098; Wielenga VJM, 1999, AM J PATHOL, V154, P515, DOI 10.1016/S0002-9440(10)65297-2	24	284	299	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2005	437	7056					281	285		10.1038/nature03914	http://dx.doi.org/10.1038/nature03914			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961YE	16007074				2022-12-01	WOS:000231696900061
J	Agaisse, H; Burrack, LS; Philips, JA; Rubin, EJ; Perrimon, N; Higgins, DE				Agaisse, H; Burrack, LS; Philips, JA; Rubin, EJ; Perrimon, N; Higgins, DE			Genome-wide RNAi screen for host factors required for intracellular bacterial infection	SCIENCE			English	Article							DROSOPHILA; PHAGOCYTOSIS; TIP60	Most studies of host-pathogen interactions have focused on pathogen-specific virulence determinants. Here, we report a genome-wide RNA interference screen to identify host factors required for intracellular bacterial pathogenesis. Using Drosophila cells and the cytosolic pathogen Listeria monocytogenes, we identified 305 double-stranded RNAs targeting a wide range of cellular functions that altered L. monocytogenes infection. Comparison to a similar screen with Mycobacterium fortuitum, a vacuolar pathogen, identified host factors that may play a general role in intracellular pathogenesis and factors that specifically affect access to the cytosol by L. monocytogenes.	Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Agaisse, H (corresponding author), Yale Univ, Sch Med, Sect Microbial Pathogenesis, 333 Cedar St, New Haven, CT 06519 USA.	herve.agaisse@yale.edu; dhiggins@hms.harvard.edu		Burrack, Laura/0000-0002-0821-0980; Perrimon, Norbert/0000-0001-7542-472X; Rubin, Eric/0000-0001-5120-962X	NIAID NIH HHS [AI053669, AI048704] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053669, R01AI048704] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Beauregard KE, 1997, J EXP MED, V186, P1159, DOI 10.1084/jem.186.7.1159; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Cheng LW, 2003, CELL MICROBIOL, V5, P875, DOI 10.1046/j.1462-5822.2003.00327.x; Creaven M, 1999, BIOCHEMISTRY-US, V38, P8826, DOI 10.1021/bi9907274; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Hild M, 2004, GENOME BIOL, V5; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Mansfield BE, 2003, CELL MICROBIOL, V5, P901, DOI 10.1046/j.1462-5822.2003.00329.x; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015	14	228	245	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2005	309	5738					1248	1251		10.1126/science.1116008	http://dx.doi.org/10.1126/science.1116008			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	957TE	16020693				2022-12-01	WOS:000231395400048
J	Yasuda, S; Townsend, D; Michele, DE; Favre, EG; Day, SM; Metzger, JM				Yasuda, S; Townsend, D; Michele, DE; Favre, EG; Day, SM; Metzger, JM			Dystrophic heart failure blocked by membrane sealant poloxamer	NATURE			English	Article							MUSCULAR-DYSTROPHIES; SKELETAL-MUSCLE; CARDIOMYOPATHY; EXPRESSION; INJECTION; DISEASE; CELLS; MICE	Dystrophin deficiency causes Duchenne muscular dystrophy (DMD) in humans, an inherited and progressive disease of striated muscle deterioration that frequently involves pronounced cardiomyopathy(1). Heart failure is the second leading cause of fatalities in DMD1,2. Progress towards defining the molecular basis of disease in DMD has mostly come from studies on skeletal muscle, with comparatively little attention directed to cardiac muscle. The pathophysiological mechanisms involved in cardiac myocytes may differ significantly from skeletal myofibres; this is underscored by the presence of significant cardiac disease in patients with truncated or reduced levels of dystrophin but without skeletal muscle disease(3). Here we show that intact, isolated dystrophin-deficient cardiac myocytes have reduced compliance and increased susceptibility to stretch-mediated calcium overload, leading to cell contracture and death, and that application of the membrane sealant poloxamer 188 corrects these defects in vitro. In vivo administration of poloxamer 188 to dystrophic mice instantly improved ventricular geometry and blocked the development of acute cardiac failure during a dobutamine-mediated stress protocol. Once issues relating to optimal dosing and long-term effects of poloxamer 188 in humans have been resolved, chemical-based membrane sealants could represent a new therapeutic approach for preventing or reversing the progression of cardiomyopathy and heart failure in muscular dystrophy.	Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Metzger, JM (corresponding author), Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	metzgerj@umich.edu						AdamsGraves P, 1997, BLOOD, V90, P2041, DOI 10.1182/blood.V90.5.2041; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Burger AJ, 2000, AM J CARDIOL, V86, P825, DOI 10.1016/S0002-9149(00)01100-0; Coutu P, 2004, CIRC RES, V94, P1235, DOI 10.1161/01.RES.0000126923.46786.FD; Danialou G, 2001, FASEB J, V15, P1655, DOI 10.1096/fj.01-0030fje; Davis DB, 2000, HUM MOL GENET, V9, P217, DOI 10.1093/hmg/9.2.217; Finsterer J, 2003, CARDIOLOGY, V99, P1, DOI 10.1159/000068446; Goyenvalle A, 2004, SCIENCE, V306, P1796, DOI 10.1126/science.1104297; Gregorevic P, 2004, NAT MED, V10, P828, DOI 10.1038/nm1085; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Jewell RC, 1997, J PHARM SCI, V86, P808, DOI 10.1021/js960491e; Lee RC, 1999, ANN NY ACAD SCI, V888, P266, DOI 10.1111/j.1749-6632.1999.tb07961.x; LEE RC, 1992, P NATL ACAD SCI USA, V89, P4524, DOI 10.1073/pnas.89.10.4524; Michele DE, 2002, CIRC RES, V91, P255, DOI 10.1161/01.RES.0000027530.58419.82; Muntoni F, 2003, CURR OPIN NEUROL, V16, P577, DOI 10.1097/00019052-200310000-00003; PASTERNAK C, 1995, J CELL BIOL, V128, P355, DOI 10.1083/jcb.128.3.355; RODRIGUEZ EK, 1992, AM J PHYSIOL, V263, pH293, DOI 10.1152/ajpheart.1992.263.1.H293; Squire S, 2002, HUM MOL GENET, V11, P3333, DOI 10.1093/hmg/11.26.3333; Straub V, 1997, CURR OPIN NEUROL, V10, P168, DOI 10.1097/00019052-199704000-00016; Togo T, 1999, J CELL SCI, V112, P719; Torrente Y, 2004, J CLIN INVEST, V114, P182, DOI 10.1172/JCI200420325; TURNER PR, 1991, J CELL BIOL, V115, P1701, DOI 10.1083/jcb.115.6.1701; Wu GH, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.028101; Yasuda SI, 2001, AM J PHYSIOL-HEART C, V281, pH1442, DOI 10.1152/ajpheart.2001.281.3.H1442; [No title captured]	25	233	247	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2005	436	7053					1025	1029		10.1038/nature03844	http://dx.doi.org/10.1038/nature03844			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955XQ	16025101	Green Published			2022-12-01	WOS:000231263900052
J	Eddy, DM; Schlessinger, L; Kahn, R				Eddy, DM; Schlessinger, L; Kahn, R			Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes	ANNALS OF INTERNAL MEDICINE			English	Article							PRIMARY-PREVENTION; LIFE-STYLE; CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; TYPE-2; PRAVASTATIN; ARCHIMEDES; MELLITUS; MEN; NEPHROPATHY	Background: Lifestyle modification can forestall diabetes in high-risk people, but the long-term cost-effectiveness is uncertain. Objective: To estimate the effects of the lifestyle modification program used in the Diabetes Prevention Program (DPP) on health and economic outcomes. Design: Cost-effectiveness analysis using the Archimedes model. Data Sources: Published basic and epidemiologic studies, clinical trials, and Kaiser Permanente administrative data. Target Population: Adults at high risk for diabetes (body mass index > 24 kg/m(2), fasting plasma glucose level of 5.2725 to 6.9375 mmol/L [95 to 125 mg/dL] 2-hour glucose tolerance test result of 7.77 to 11.0445 mmol/L [140 to 199 mg/dL]). Time Horizon: 5 to 30 years. Perspective: Patient, health plan, and societal. Interventions: No prevention, DPP's lifestyle modification program, lifestyle modification begun after a person develops diabetes, and metformin. Measurements: Diagnosis and complications of diabetes. Results of Base-Case Analysis: Compared with no prevention program, the DPP lifestyle program would reduce a high-risk person's 30-year chances of getting diabetes from about 72% to 61%, the chances of a serious complication from about 38% to 30%, and the chances of dying of a complication of diabetes from about 13.5% to 11.2%. Metformin would deliver about one third the long-term health benefits achievable by immediate lifestyle modification. Compared with not implementing any prevention program, the expected 30-year cost/quality-adjusted life-year (QALY) of the DIPP lifestyle intervention from the health plan's perspective would be about $143 000. From a societal perspective, the cost/QALY of the lifestyle intervention compared with doing nothing would be about $62 600. Either using metformin or delaying the lifestyle intervention until after a person develops diabetes would be more cost-effective, costing about $35 400 or $24 500 per QALY gained, respectively, compared with no program. Compared with delaying the lifestyle program until after diabetes is diagnosed, the marginal cost-effectiveness of beginning the DPP lifestyle program immediately would be about $201 800. Results of Sensitivity Analysis: Variability and uncertainty deriving from the structure of the model were tested by comparing the model's results with the results of real clinical trials of diabetes and its complications. The most critical element of uncertainty is the effectiveness of the lifestyle program, as expressed by the 95% CI of the DPP study. The most important potentially controllable factor is the cost of the lifestyle program. Compared with no program, lifestyle modification for high-risk people can be made cost-saving over 30 years if the annual cost of the intervention can be reduced to about $100. Limitations: Results depend on the accuracy of the model. Conclusions: Lifestyle modification is likely to have important effects on the morbidity and mortality of diabetes and should be recommended to all high-risk people. The program used in the DPP study may be too expensive for health plans or a national program to implement. Less expensive methods are needed to achieve the degree of weight loss seen in the DPP.	Kaiser Permanente, Archimedes Project, Oakland, CA USA; Amer Diabet Assoc, Alexandria, VA USA	Kaiser Permanente; American Diabetes Association	Eddy, DM (corresponding author), 1426 Crystal Lake Rd, Aspen, CO 81611 USA.	eddyaspen@yahoo.com						[Anonymous], 1991, JAMA, V265, P3255; Benjamin SM, 2003, DIABETES CARE, V26, P645, DOI 10.2337/diacare.26.3.645; Blumenthal JA, 2000, ARCH INTERN MED, V160, P1947, DOI 10.1001/archinte.160.13.1947; Buchanan TA, 2002, DIABETES, V51, P2796, DOI 10.2337/diabetes.51.9.2796; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Coffey JT, 2002, DIABETES CARE, V25, P2238, DOI 10.2337/diacare.25.12.2238; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; DEFRONZO RA, 1995, NEW ENGL J MED, V333, P541, DOI 10.1056/NEJM199508313330902; Diabet Prevention Program Res Grp, 2003, DIABETES CARE, V26, P2518, DOI 10.2337/diacare.26.9.2518; DPP Res Grp, 2002, DIABETES CARE, V25, P2165; Eddy DM, 2003, DIABETES CARE, V26, P3102, DOI 10.2337/diacare.26.11.3102; Eddy DM, 2003, DIABETES CARE, V26, P3093, DOI 10.2337/diacare.26.11.3093; EDDY DM, 1992, FAST PRO SOFTWARE ME; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gerstein HC, 2000, LANCET, V355, P253; Gold MR., 1996, COST EFFECTIVENESS H; GREENBERG G, 1985, BMJ-BRIT MED J, V291, P97; Herman WH, 2005, ANN INTERN MED, V142, P323, DOI 10.7326/0003-4819-142-5-200503010-00007; Herman WH, 2003, DIABETES CARE, V26, P36; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Lewis SJ, 1998, ANN INTERN MED, V129, P681, DOI 10.7326/0003-4819-129-9-199811010-00002; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; PEDERSEN TR, 1994, LANCET, V344, P1383; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P351; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Schlessinger L, 2002, J BIOMED INFORM, V35, P37, DOI 10.1016/S1532-0464(02)00006-0; SCHLESSINGER L, 2004, TECHNICAL REPORT A B; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Yusuf S, 2000, NEW ENGL J MED, V342, P145	37	232	234	0	24	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2005	143	4					251	264		10.7326/0003-4819-143-4-200508160-00006	http://dx.doi.org/10.7326/0003-4819-143-4-200508160-00006			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	955PA	16103469				2022-12-01	WOS:000231237100002
J	Longini, IM; Nizam, A; Xu, SF; Ungchusak, K; Hanshaoworakul, W; Cummings, DAT; Halloran, ME				Longini, IM; Nizam, A; Xu, SF; Ungchusak, K; Hanshaoworakul, W; Cummings, DAT; Halloran, ME			Containing pandemic influenza at the source	SCIENCE			English	Article							RANDOMIZED CONTROLLED-TRIAL; AVIAN INFLUENZA; ASIAN INFLUENZA; EPIDEMIC; PREVENTION; MODEL; TRANSMISSION; ZANAMIVIR; VIROLOGY; SPREAD	Highly pathogenic avian influenza A (subtype H5N1) is threatening to cause a human pandemic of potentially devastating proportions. We used a stochastic influenza simulation model for rural Southeast Asia to investigate the effectiveness of targeted antiviral prophylaxis, quarantine, and pre-vaccination in containing an emerging influenza strain at the source. If the basic reproductive number (R-o) was below 1.60, our simulations showed that a prepared response with targeted antivirals would have a high probability of containing the disease, In that case, an antiviral agent stockpile on the order of 100,000 to 1 million courses for treatment and prophylaxis would be sufficient. If pre-vaccination occurred, then targeted antiviral prophylaxis. could be effective for containing strains with an R-o as high as 2.1. Combinations of targeted antiviral prophylaxis, pre-vaccination, and quarantine could contain strains with an R-o as high as 2.4.	Emory Univ, Rollins Sch Publ Hlth, Dept Biostat, Atlanta, GA 30322 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; Minist Publ Hlth, Nonthaburi, Thailand	Emory University; Rollins School Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Ministry of Public Health - Thailand	Longini, IM (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Biostat, 1518 Clifton Rd NE, Atlanta, GA 30322 USA.	longini@sph.emory.edu	Chen, Chien Ku/C-6128-2008		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM070749] Funding Source: NIH RePORTER; NIAID NIH HHS [R01-AI32042] Funding Source: Medline; NIGMS NIH HHS [U01-GM070749] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Antia R, 2003, NATURE, V426, P658, DOI 10.1038/nature02104; Cauchemez S, 2004, STAT MED, V23, P3469, DOI 10.1002/sim.1912; CHAMRAATHRITHIR.A, 1995, NATL MIGRATION SURVE; DAVIS LE, 1970, AM J EPIDEMIOL, V92, P240, DOI 10.1093/oxfordjournals.aje.a121203; ELVEBACK LR, 1976, AM J EPIDEMIOL, V103, P152, DOI 10.1093/oxfordjournals.aje.a112213; Enserink M, 2004, SCIENCE, V306, P2016, DOI 10.1126/science.306.5704.2016; Faust K, 1999, SOC NETWORKS, V21, P311; Ferguson NM, 2004, SCIENCE, V304, P968, DOI 10.1126/science.1096898; Fitzner K. A., 1999, Hong Kong Medical Journal, V5, P87; Guest P, 1994, Asian Pac Migr J, V3, P531; Halloran ME, 1999, EPIDEMIOL REV, V21, P73, DOI 10.1093/oxfordjournals.epirev.a017990; Halloran ME, 2002, VACCINE, V20, P3254; Hayden FG, 1999, ANTIMICROBIAL, P1344; Hayden FG, 2000, NEW ENGL J MED, V343, P1282, DOI 10.1056/NEJM200011023431801; Hayden FG, 2001, PHILOS T R SOC B, V356, P1877, DOI 10.1098/rstb.2001.1007; Hill AN, 2003, MATH BIOSCI, V181, P85, DOI 10.1016/S0025-5564(02)00129-3; JORDAN WS, 1961, AM REV RESPIR DIS, V83, P29; KILBOURNE ED, 1975, INFLUENZA VIRUSES IN; Laver G, 2001, SCIENCE, V293, P1776, DOI 10.1126/science.1063817; LONGINI IM, 1978, MATH BIOSCI, V38, P141, DOI 10.1016/0025-5564(78)90023-8; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Monto AS, 2005, NEW ENGL J MED, V352, P323, DOI 10.1056/NEJMp048343; Monto AS, 1999, JAMA-J AM MED ASSOC, V282, P31, DOI 10.1001/jama.282.1.31; National Statistical Office, POP HOUS CENS 2000; RVACHEV LA, 1985, MATH BIOSCI, V75, P3, DOI 10.1016/0025-5564(85)90064-1; SHARRAR RG, 1969, B WORLD HEALTH ORGAN, V41, P361; Stohr K, 2005, NEW ENGL J MED, V352, P405, DOI 10.1056/NEJMe048344; Stohr K, 2004, SCIENCE, V306, P2195, DOI 10.1126/science.1108165; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; Webby RJ, 2003, SCIENCE, V302, P1519, DOI 10.1126/science.1090350; Webster RG, 2001, SCIENCE, V293, P1773; Welliver R, 2001, JAMA-J AM MED ASSOC, V285, P748, DOI 10.1001/jama.285.6.748; YANG Y, 0409 EM U DEP BIOST	34	827	862	3	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 12	2005	309	5737					1083	1087		10.1126/science.1115717	http://dx.doi.org/10.1126/science.1115717			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955MN	16079251				2022-12-01	WOS:000231230100048
J	Ma'ayan, A; Jenkins, SL; Neves, S; Hasseldine, A; Grace, E; Dubin-Thalere, B; Eungdamrong, NJ; Weng, GZ; Ram, PT; Rice, JJ; Kershenbaum, A; Stolovitzky, GA; Blitzer, RD; Iyengar, R				Ma'ayan, A; Jenkins, SL; Neves, S; Hasseldine, A; Grace, E; Dubin-Thalere, B; Eungdamrong, NJ; Weng, GZ; Ram, PT; Rice, JJ; Kershenbaum, A; Stolovitzky, GA; Blitzer, RD; Iyengar, R			Formation of regulatory patterns during signal propagation in a mammalian cellular network	SCIENCE			English	Article							LONG-TERM POTENTIATION; SMALL-WORLD NETWORKS; TRANSCRIPTION; HIPPOCAMPUS; PROTEIN; MEMORY; LOOP; PHOSPHATASE; DYNAMICS; ELEMENT	We developed a model of 545 components (nodes) and 1259 interactions representing signaling pathways and cellular machines in the hippocampal CA1 neuron. Using graph theory methods, we analyzed ligand-induced signal flow through the system. Specification of input and output nodes allowed us to identify functional modules. Networking resulted in the emergence of regulatory motifs, such as positive and negative feedback and feedforward loops, that process information. Key regulators of plasticity were highly connected nodes required for the formation of regulatory motifs, indicating the potential importance of such motifs in determining cellular choices between homeostasis and plasticity.	Mt Sinai Sch Med, Dept Pharmacol, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Biol Chem, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; Columbia Univ, Dept Biol Sci, New York, NY 10029 USA; IBM Corp, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Columbia University; International Business Machines (IBM)	Iyengar, R (corresponding author), Mt Sinai Sch Med, Dept Pharmacol, New York, NY 10029 USA.	Ravi.Iyengar@mssm.edu	Yang, Chen/G-1379-2010; Ma'ayan, Avi/AAG-3131-2019	Ma'ayan, Avi/0000-0002-6904-1017; Jenkins, Sherry/0000-0003-1730-0977; Ram, Prahlad/0000-0003-4739-3166; Rice, John/0000-0001-8280-8529	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM065065, T32GM062754, R01GM054508, R01GM072853, P50GM071558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015863] Funding Source: NIH RePORTER; NIDA NIH HHS [DA15863, R01 DA015863] Funding Source: Medline; NIGMS NIH HHS [GM-072853, P50 GM071558-020007, F31 GM065065, P50 GM071558-030007, P50 GM071558-01A20007, R01 GM072853-01, GM-62754, R01 GM072853, P50 GM071558, GM-54508, GM-65065, R01 GM054508-12, R01 GM054508, T32 GM062754] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Caldarelli G, 2004, EUR PHYS J B, V38, P183, DOI 10.1140/epjb/e2004-00020-6; HVALBY O, 1987, EXPERIENTIA, V43, P599, DOI 10.1007/BF02126343; Iyengar R, 1996, SCIENCE, V271, P461, DOI 10.1126/science.271.5248.461; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kashtan N, 2004, BIOINFORMATICS, V20, P1746, DOI 10.1093/bioinformatics/bth163; Katsuki H, 1997, J NEUROPHYSIOL, V77, P3013, DOI 10.1152/jn.1997.77.6.3013; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mangan S, 2003, J MOL BIOL, V334, P197, DOI 10.1016/j.jmb.2003.09.049; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Pittenger C, 2002, NEURON, V34, P447, DOI 10.1016/S0896-6273(02)00684-0; Siegelbaum S A, 1991, Curr Opin Neurobiol, V1, P113, DOI 10.1016/0959-4388(91)90018-3; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	22	236	240	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2005	309	5737					1078	1083		10.1126/science.1108876	http://dx.doi.org/10.1126/science.1108876			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955MN	16099987	Green Accepted			2022-12-01	WOS:000231230100047
J	Boyd, CM; Darer, J; Boult, C; Fried, LP; Boult, L; Wu, AW				Boyd, CM; Darer, J; Boult, C; Fried, LP; Boult, L; Wu, AW			Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases - Implications for pay for performance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADVERSE DRUG EVENTS; ELDERLY-PATIENTS; ATRIAL-FIBRILLATION; MEDICAL-MANAGEMENT; AMERICAN-COLLEGE; OSTEOARTHRITIS; POLYPHARMACY; PREFERENCES; ADHERENCE; PITFALLS	Context Clinical practice guidelines (CPGs) have been developed to improve the quality of health care for many chronic conditions. Pay-for-performance initiatives assess physician adherence to interventions that may reflect CPG recommendations. Objective To evaluate the applicability of CPGs to the care of older individuals with several comorbid diseases. Data Sources The National Health Interview Survey and a nationally representative sample of Medicare beneficiaries (to identify the most prevalent chronic diseases in this population); the National Guideline Clearinghouse (for locating evidence-based CPGs for each chronic disease). Study Selection Of the 15 most common chronic diseases, we selected hypertension, chronic heart failure, stable angina, atrial fibrillation, hypercholesterolemia, diabetes mellitus, osteoarthritis, chronic obstructive pulmonary disease, and osteoporosis, which are usually managed in primary care, choosing CPGs promulgated by national and international medical organizations for each. Data Extraction Two investigators independently assessed whether each CPG addressed older patients with multiple comorbid diseases, goals of treatment, interactions between recommendations, burden to patients and caregivers, patient preferences, life expectancy, and quality of life. Differences were resolved by consensus. For a hypothetical 79-year-old woman with chronic obstructive pulmonary disease, type 2 diabetes, osteoporosis, hypertension, and osteoarthritis, we aggregated the recommendations from the relevant CPGs. Data Synthesis Most CPGs did not modify or discuss the applicability of their recommendations for older patients with multiple comorbidities. Most also did not comment on burden, short- and long-term goals, and the quality of the underlying scientific evidence, nor give guidance for incorporating patient preferences into treatment plans. if the relevant CPGs were followed, the hypothetical patient would be prescribed 12 medications (costing her $406 per month) and a complicated nonpharmacological regimen. Adverse interactions between drugs and diseases could result. Conclusions This review suggests that adhering to current CPGs in caring for an older person with several comorbiclities may have undesirable effects. Basing standards for quality of care and pay for performance on existing CPGs could lead to inappropriate judgment of the care provided to older individuals with complex comorbiclities and could create perverse incentives that emphasize the wrong aspects of care for this population and diminish the quality of their care. Developing measures of the quality of the care needed by older patients with complex comorbidities is critical to improving their care.	Johns Hopkins Univ, Ctr Aging & Hlth, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Div Geriatr Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Div Gerontol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Div Gen Internal Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Dept Hlth Policy & Management, Baltimore, MD 21205 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; Johns Hopkins Univ, Roger C Lipitz Ctr Integrated Hlth Care, Baltimore, MD 21205 USA; Midatlantic Permanente Med Grp, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Permanente Medical Groups	Boyd, CM (corresponding author), Johns Hopkins Univ, Ctr Aging & Hlth, 2024 E Monument St,Suite 2-700, Baltimore, MD 21205 USA.	cyboyd@jhmi.edu	Wu, Albert/AAJ-4780-2021		NIA NIH HHS [T32-AG00120, P30 AG021334] Funding Source: Medline; BHP HRSA HHS [5-T32-PE10025] Funding Source: Medline; DIVISION OF MEDICINE, BUREAU HEALTH PROFESSIONS, HRSA [T32PE010025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG021334, T32AG000120] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); BHP HRSA HHS; DIVISION OF MEDICINE, BUREAU HEALTH PROFESSIONS, HRSA(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		*3 REP EXP PAN DET, EV TERATM HIGH BLOOD; *7 REP JOINT NAT C, DET EV TREATM HIGH B; Altman RD, 2000, ARTHRITIS RHEUM-US, V43, P1905; *AM COLL PHYS WEB, MARK FORC NOW PUSH P; American Diabetes Association, 2002, Diabetes Care, V25, P202, DOI 10.2337/diacare.25.1.202; American Diabetes Association Clinical Practice Recommendations, 2001, DIABETES CARE S1, V24, pS1; ANDERSON G, 2002, CHRONIC CONDITIIONS; [Anonymous], 2005, DIABETES CARE, V28, pS4; Arauz-Pacheco Carlos, 2004, Diabetes Care, V27 Suppl 1, pS65; Brown AF, 2003, J AM GERIATR SOC, V51, P665, DOI 10.1034/j.1600-0579.2003.00211.x; Cluzeau FA, 1999, INT J QUAL HEALTH C, V11, P21, DOI 10.1093/intqhc/11.1.21; Colwell John A, 2004, Diabetes Care, V27 Suppl 1, pS72; Current estimates from the National Health Interview Survey, 1994, VITAL HLTH STAT, V10, P1; Elwyn G, 2003, BMJ-BRIT MED J, V327, P864, DOI 10.1136/bmj.327.7419.864; Field TS, 2004, J AM GERIATR SOC, V52, P1349, DOI 10.1111/j.1532-5415.2004.52367.x; Findley LJ, 2002, BRIT MED J, V324, P1466, DOI 10.1136/bmj.324.7352.1466; Flaherty JH, 2000, J GERONTOL A-BIOL, V55, pM554, DOI 10.1093/gerona/55.10.M554; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; Franz MJ., 2004, DIABETES CARE S1, V27, pS36; Fried TR, 2002, J GERONTOL B-PSYCHOL, V57, pS348, DOI 10.1093/geronb/57.6.S348; Fuster V, 2001, J AM COLL CARDIOL, V38, P1231, DOI 10.1016/S0735-1097(01)01587-X; Garber AM, 2005, HEALTH AFFAIR, V24, P174, DOI 10.1377/hlthaff.24.1.174; Gavin JR, 2000, DIABETES CARE, V23, pS4; GIBBONS RJ, ACC AHA 2002 GUIDELI; Gijsen R, 2001, J CLIN EPIDEMIOL, V54, P661, DOI 10.1016/S0895-4356(00)00363-2; Glynn RJ, 1999, J CLIN EPIDEMIOL, V52, P781, DOI 10.1016/S0895-4356(99)00055-4; Goldstein DE, 2004, DIABETES CARE, V27, P1761, DOI 10.2337/diacare.27.7.1761; GOULDING M, 2005, TRENDS PRESCRIBED ME; Graham ID, 2000, INT J TECHNOL ASSESS, V16, P1024, DOI 10.1017/S0266462300103095; Gray SL, 2001, ANN PHARMACOTHER, V35, P539, DOI 10.1345/aph.10295; Greer AL, 2002, INT J TECHNOL ASSESS, V18, P747, DOI 10.1017/S0266462302000569; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Gurwitz JH, 2004, ARCH INTERN MED, V164, P1957, DOI 10.1001/archinte.164.18.1957; Gurwitz JH, 2003, JAMA-J AM MED ASSOC, V289, P1107, DOI 10.1001/jama.289.9.1107; Haffner Steven M, 2004, Diabetes Care, V27 Suppl 1, pS68; Haire-Joshu Debra, 2004, Diabetes Care, V27 Suppl 1, pS74; HAYWARD RSA, 1995, JAMA-J AM MED ASSOC, V274, P570, DOI 10.1001/jama.274.7.570; HOCHBERG MC, 1995, ARTHRITIS RHEUM, V38, P1541, DOI 10.1002/art.1780381104; HOCHBERG MC, 1995, ARTHRITIS RHEUM, V38, P1535, DOI 10.1002/art.1780381103; Hofer TP, 2004, J GEN INTERN MED, V19, P646, DOI 10.1007/s11606-004-0058-0; Hofer TP, 1999, JAMA-J AM MED ASSOC, V281, P2098, DOI 10.1001/jama.281.22.2098; Hoffman C, 1996, JAMA-J AM MED ASSOC, V276, P1473, DOI 10.1001/jama.276.18.1473; HUNT SA, ACC AHA GUIDELINES E; Institute of Medicine, 2001, CROSSING QUALITY CHA; Juurlink DN, 2003, JAMA-J AM MED ASSOC, V289, P1652, DOI 10.1001/jama.289.13.1652; KROENKE LTCK, 1990, J AM GERIATR SOC, V38, P31, DOI 10.1111/j.1532-5415.1990.tb01593.x; Masoudi FA, 2003, AM HEART J, V146, P250, DOI 10.1016/S0002-8703(03)00189-3; Mayfield JA, 2004, DIABETES CARE, V27, pB39, DOI 10.2337/diacare.27.suppl_2.B39; Medpac, 2020, REP C MED PAYM POL; Mojtabai R, 2003, HEALTH AFFAIR, V22, P220, DOI 10.1377/hlthaff.22.4.220; MOLITCH ME, 2004, DIABETES CARE S1, V27, pS79, DOI DOI 10.2337/DIACARE.27.5.1240-A; *NAT OST FDN, PHYS GUID PREV TREAT; *NCQA, HLTH PLAN EMPL DAT I; *PARTN SOL, MED COSTS PREV CHRON; Pauwels R A, 2001, Respir Care, V46, P798; Protheroe J, 2000, BRIT MED J, V320, P1380, DOI 10.1136/bmj.320.7246.1380; Safran DG, 1998, MED CARE, V36, P728, DOI 10.1097/00005650-199805000-00012; Schmader KE, 1998, AGE AGEING, V27, P493, DOI 10.1093/ageing/27.4.493; Schnitzer TJ, 2002, J PAIN SYMPTOM MANAG, V23, pS24, DOI 10.1016/S0885-3924(02)00372-X; Shaneyfelt TM, 1999, JAMA-J AM MED ASSOC, V281, P1900, DOI 10.1001/jama.281.20.1900; Shiffman RN, 2003, ANN INTERN MED, V139, P493, DOI 10.7326/0003-4819-139-6-200309160-00013; Sigal RJ, 2006, DIABETES CARE, V29, P1433, DOI 10.2337/dc06-9910; Snow V, 2004, ANN INTERN MED, V141, P562, DOI 10.7326/0003-4819-141-7-200410050-00014; Sperl-Hillen J, 2000, Jt Comm J Qual Improv, V26, P615; Tinetti ME, 2004, NEW ENGL J MED, V351, P2870, DOI 10.1056/NEJMsb042458; Tinetti ME, 2004, AM J MED, V116, P179, DOI 10.1016/j.amjmed.2003.09.031; Townsend A, 2003, BRIT MED J, V327, P837, DOI 10.1136/bmj.327.7419.837; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; Walter LC, 2004, JAMA-J AM MED ASSOC, V291, P2466, DOI 10.1001/jama.291.20.2466; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2750, DOI 10.1001/jama.285.21.2750; Wenger NS, 2003, ANN INTERN MED, V139, P740, DOI 10.7326/0003-4819-139-9-200311040-00008; Yarnall KSH, 2003, AM J PUBLIC HEALTH, V93, P635, DOI 10.2105/AJPH.93.4.635; 2004, 4 ANN DIS MAN OUTC S; 2002, 2 ANN DIS MAN OUTC S	74	1602	1627	7	192	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 10	2005	294	6					716	724		10.1001/jama.294.6.716	http://dx.doi.org/10.1001/jama.294.6.716			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	953IA	16091574				2022-12-01	WOS:000231068600025
J	Horodecki, M; Oppenheim, J; Winter, A				Horodecki, M; Oppenheim, J; Winter, A			Partial quantum information	NATURE			English	Article							CURRENT SITUATION; ENTANGLEMENT; CAPACITY	Information - be it classical(1) or quantum(2) - is measured by the amount of communication needed to convey it. In the classical case, if the receiver has some prior information about the messages being conveyed, less communication is needed(3). Here we explore the concept of prior quantum information: given an unknown quantum state distributed over two systems, we determine how much quantum communication is needed to transfer the full state to one system. This communication measures the partial information one system needs, conditioned on its prior information. We find that it is given by the conditional entropy - a quantity that was known previously, but lacked an operational meaning. In the classical case, partial information must always be positive, but we find that in the quantum world this physical quantity can be negative. If the partial information is positive, its sender needs to communicate this number of quantum bits to the receiver; if it is negative, then sender and receiver instead gain the corresponding potential for future quantum communication. We introduce a protocol that we term 'quantum state merging' which optimally transfers partial information. We show how it enables a systematic understanding of quantum network theory, and discuss several important applications including distributed compression, noiseless coding with side information, multiple access channels and assisted entanglement distillation.	Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge CB3 0WA, England; Univ Gdansk, Inst Theoret Phys & Astrophys, PL-80952 Gdansk, Poland; Univ Bristol, Dept Math, Bristol BS8 1TW, Avon, England	University of Cambridge; Fahrenheit Universities; University of Gdansk; University of Bristol	Oppenheim, J (corresponding author), Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge CB3 0WA, England.	j.oppenheim@damtp.cam.ac.uk	Winter, Andreas/K-4200-2019; Winter, Andreas/C-4185-2016; Oppenheim, Jonathan/E-1518-2017	Winter, Andreas/0000-0001-6344-4870; Winter, Andreas/0000-0001-6344-4870; Oppenheim, Jonathan/0000-0002-8993-412X	Engineering and Physical Sciences Research Council [GR/S82169/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		AHN C, 2004, ORGQUANTPH0403042; BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; Cerf NJ, 1997, PHYS REV LETT, V79, P5194, DOI 10.1103/PhysRevLett.79.5194; Devetak I, 2005, IEEE T INFORM THEORY, V51, P44, DOI 10.1109/TIT.2004.839515; DEVETAK I, 2004, PHYS REV LETT, V93; DiVincenzo DP, 1999, LECT NOTES COMPUT SC, V1509, P247; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; GROISMAN B, 2004, ORGQUANTPH0410091; Horodecki M, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.062307; HORODECKI R, 1994, PHYS LETT A, V194, P147, DOI 10.1016/0375-9601(94)91275-0; Lieb E. H., 1973, Journal of Mathematical Physics, V14, P1938, DOI 10.1063/1.1666274; Lloyd S, 1997, PHYS REV A, V55, P1613, DOI 10.1103/PhysRevA.55.1613; Schrodinger E, 1935, NATURWISSENSCHAFTEN, V23, P807, DOI 10.1007/BF01491891; Schumacher B, 1996, PHYS REV A, V54, P2629, DOI 10.1103/PhysRevA.54.2629; SCHUMACHER B, 1995, PHYS REV A, V51, P2738, DOI 10.1103/PhysRevA.51.2738; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Shor P, 2002, QUANTUM CHANNEL CAPA; Slepian D., 1971, IEEE T INFORM THEORY, V19, P461; SMOLIN JA, 2005, ORGQUANTPH0505038; Terhal BM, 2002, J MATH PHYS, V43, P4286, DOI 10.1063/1.1498001; WEHRL A, 1978, REV MOD PHYS, V50, P221, DOI 10.1103/RevModPhys.50.221; WYNER AD, 1975, IEEE T INFORM THEORY, V21, P294, DOI 10.1109/TIT.1975.1055374; YARD J, 2005, CAPACITY THEOREMS 1	23	269	269	3	40	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 4	2005	436	7051					673	676		10.1038/nature03909	http://dx.doi.org/10.1038/nature03909			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951XA	16079840	Green Submitted			2022-12-01	WOS:000230964500037
J	Choudhuri, K; Wiseman, D; Brown, MH; Gould, K; van der Merwe, PA				Choudhuri, K; Wiseman, D; Brown, MH; Gould, K; van der Merwe, PA			T-cell receptor triggering is critically dependent on the dimensions of its peptide-MHC ligand	NATURE			English	Article							ANTIGEN RECOGNITION; SURFACE MOLECULES; ACTIVATION; ADHESION; COMPLEX; SYNAPSE; CD2	The binding of a T-cell antigen receptor (TCR) to peptide antigen presented by major histocompatibility antigens (pMHC) on antigen-presenting cells (APCs) is a central event in adaptive immune responses(1,2). The mechanism by which TCR-pMHC ligation initiates signalling, a process termed TCR triggering, remains controversial(3-5). It has been proposed(6-8) that TCR triggering is promoted by segregation at the T cell-APC interface of cell-surface molecules with small ectodomains (such as TCR-pMHC and accessory receptors) from molecules with large ectodomains (such as the receptor protein tyrosine phosphatases CD45 and CD148). Here we show that increasing the dimensions of the TCR-pMHC interaction by elongating the pMHC ectodomain greatly reduces TCR triggering without affecting TCR-pMHC ligation. A similar dependence on receptor-ligand complex dimensions was observed with artificial TCR-ligand systems that span the same dimensions as the TCR-pMHC complex. Interfaces between T cells and APCs expressing elongated pMHC showed an increased intermembrane separation distance and less depletion of CD45. These results show the importance of the small size of the TCR-pMHC complex and support a role for size-based segregation of cell-surface molecules in TCR triggering.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; Univ London Imperial Coll Sci Technol & Med, Wright Fleming Inst, Dept Immunol, London W2 1PG, England	University of Oxford; Imperial College London	van der Merwe, PA (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	k.gould@imperial.ac.uk; anton.vandermerwe@path.ox.ac.uk	Wiseman, David/D-7495-2014; van der Merwe, P. Anton/F-8539-2011	Wiseman, David/0000-0002-8823-1422; Gould, Keith/0000-0003-0913-5422; Choudhuri, Kaushik/0000-0002-3911-027X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Barclay A. N, 1997, LEUKOCYTE ANTIGEN FA; CHAN PY, 1992, MOL BIOL CELL, V3, P157, DOI 10.1091/mbc.3.2.157; Coombs D, 2004, BIOPHYS J, V86, P1408, DOI 10.1016/S0006-3495(04)74211-3; Cresswell P, 1999, IMMUNOL REV, V172, P21, DOI 10.1111/j.1600-065X.1999.tb01353.x; Davis DM, 1999, P NATL ACAD SCI USA, V96, P15062, DOI 10.1073/pnas.96.26.15062; Davis MM, 2002, CELL, V110, P285, DOI 10.1016/S0092-8674(02)00865-6; Davis MM, 2003, ANNU REV BIOCHEM, V72, P717, DOI 10.1146/annurev.biochem.72.121801.161625; Davis SJ, 2003, NAT IMMUNOL, V4, P217, DOI 10.1038/ni0303-217; Davis SJ, 1996, IMMUNOL TODAY, V17, P177, DOI 10.1016/0167-5699(96)80617-7; DILLON SR, 1994, J IMMUNOL, V152, P1790; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Irles C, 2003, NAT IMMUNOL, V4, P189, DOI 10.1038/ni877; Kersh EN, 1998, SCIENCE, V281, P572, DOI 10.1126/science.281.5376.572; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lin J, 2003, J CELL BIOL, V162, P673, DOI 10.1083/jcb.200303040; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Shaw AS, 1997, IMMUNITY, V6, P361, DOI 10.1016/S1074-7613(00)80279-4; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Trautmann A, 2003, TRENDS IMMUNOL, V24, P425, DOI 10.1016/S1471-4906(03)00182-0; van der Merwe PA, 2000, SEMIN IMMUNOL, V12, P5, DOI 10.1006/smim.2000.0203; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; van der Merwe PA, 2001, IMMUNITY, V14, P665, DOI 10.1016/S1074-7613(01)00155-8; WEISS A, 2003, FUNDAMENTAL IMMUNOLO, P321; Wild MK, 1999, J EXP MED, V190, P31, DOI 10.1084/jem.190.1.31; Yu YYL, 2002, J IMMUNOL, V168, P3145, DOI 10.4049/jimmunol.168.7.3145	30	243	254	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2005	436	7050					578	582		10.1038/nature03843	http://dx.doi.org/10.1038/nature03843			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049493				2022-12-01	WOS:000230788800066
J	Padma, TV				Padma, TV			Strength in numbers	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 28	2005	436	7050					492	493						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16089007				2022-12-01	WOS:000230788800047
J	DeBell, D; Carter, R				DeBell, D; Carter, R			Impact of transition on public health in Ukraine: case study of the HIV/AIDS epidemic	BRITISH MEDICAL JOURNAL			English	Article									Anglia Polytech Univ, Inst Hlth & Social Care, Ctr Res Hlth & Social Care, Chelmsford CM1 1SQ, Essex, England; Every Child UK, London EC2A 3DR, England	Anglia Ruskin University	DeBell, D (corresponding author), Anglia Polytech Univ, Inst Hlth & Social Care, Ctr Res Hlth & Social Care, Chelmsford CM1 1SQ, Essex, England.	ddebell@compuserve.com						ADEYI O, 2003, FUNDING REQUIRED RES; Barnett T, 2000, SOC SCI MED, V51, P1387, DOI 10.1016/S0277-9536(00)00104-0; BARNETT T, 2004, REVERSING EPIDEMIC F; BASS E, 2003, IAVI REPORT, V7; *TRANSP INT, 2004, TRANSP INT CORR PERC; *UKR UNAIDS WHO, 2004, UNAIDS WHO EP FACT S; *UNAIDS, 4 UNAIDS; United Nations Development Programme, 2004, HUM DEV REP 2004 CUL; World Bank, 2004, WORLD DEV IND DAT	9	12	12	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 23	2005	331	7510					216	219		10.1136/bmj.331.7510.216	http://dx.doi.org/10.1136/bmj.331.7510.216			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951EA	16037461	Bronze, Green Published			2022-12-01	WOS:000230910700030
J	Kraus, SD; Brown, MW; Caswell, H; Clark, CW; Fujiwara, M; Hamilton, PK; Kenney, RD; Knowlton, AR; Landry, S; Mayo, CA; McLellan, WA; Moore, MJ; Nowacek, DP; Pabst, DA; Read, AJ; Rolland, RM				Kraus, SD; Brown, MW; Caswell, H; Clark, CW; Fujiwara, M; Hamilton, PK; Kenney, RD; Knowlton, AR; Landry, S; Mayo, CA; McLellan, WA; Moore, MJ; Nowacek, DP; Pabst, DA; Read, AJ; Rolland, RM			North Atlantic right whales in crisis	SCIENCE			English	Editorial Material									New England Aquarium, Edgerton Res Lab, Boston, MA 02110 USA; Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; Cornell Univ, Cornell Lab Ornithol, Ithaca, NY 14850 USA; Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA; Provincetown Ctr Coastal Studies, Provincetown, MA 02657 USA; Univ N Carolina, Wilmington, NC 28403 USA; Florida State Univ, Dept Oceanog, Tallahassee, FL 32306 USA; Duke Univ, Marine Lab, Beaufort, NC 28516 USA	Woods Hole Oceanographic Institution; Cornell University; University of California System; University of California Santa Barbara; University of Rhode Island; University of North Carolina; University of North Carolina Wilmington; State University System of Florida; Florida State University; Duke University	Kraus, SD (corresponding author), New England Aquarium, Edgerton Res Lab, Boston, MA 02110 USA.	skraus@neaq.org	Fujiwara, Masami/C-3115-2012; Read, Andrew/AAE-8386-2019; Moore, Michael/E-1707-2015	Fujiwara, Masami/0000-0002-9255-6043; Moore, Michael/0000-0003-3074-6631; Kraus, Scott/0000-0003-4367-6548; Caswell, Hal/0000-0003-4394-6894				Best Peter B., 2001, Journal of Cetacean Research and Management Special Issue, V2, P161; Caswell H, 1999, P NATL ACAD SCI USA, V96, P3308, DOI 10.1073/pnas.96.6.3308; Fujiwara M, 2001, NATURE, V414, P537, DOI 10.1038/35107054; FUJIWARA M, 2002, THESIS MIT; James MC, 2005, ECOL LETT, V8, P195, DOI 10.1111/j.1461-0248.2004.00710.x; Knowlton Amy R., 2001, Journal of Cetacean Research and Management Special Issue, V2, P193; Kraus Scott D., 2001, Journal of Cetacean Research and Management Special Issue, V2, P231; Moore Michael J., 2004, Journal of Cetacean Research and Management, V6, P199; Reeves Randall R., 2001, Journal of Cetacean Research and Management Special Issue, V2, P187; 2004, FED REG         0601, V69, P30857	10	229	239	0	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2005	309	5734					561	562		10.1126/science.1111200	http://dx.doi.org/10.1126/science.1111200			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SE	16040692				2022-12-01	WOS:000230735200030
J	Yuan, GC; Liu, YJ; Dion, MF; Slack, MD; Wu, LF; Altschuler, SJ; Rando, OJ				Yuan, GC; Liu, YJ; Dion, MF; Slack, MD; Wu, LF; Altschuler, SJ; Rando, OJ			Genome-scale identification of nucleosome positions in S-cerevisiae	SCIENCE			English	Article							RNA-POLYMERASE-II; DNA TARGET SITES; IN-VIVO; EQUILIBRIUM ACCESSIBILITY; CHROMATIN-STRUCTURE; PROMOTER ELEMENTS; CHROMOSOME-III; YEAST; TRANSCRIPTION; GENE	The positioning of nucleosomes along chromatin has been implicated in the regulation of gene expression in eukaryotic cells, because packaging DNA into nucleosomes affects sequence accessibility. We developed a tiled microarray approach to identify at high resolution the translational positions of 2278 nucleosomes over 482 kilobases of Saccharomyces cerevisiae DNA, including almost all of chromosome III and 223 additional regulatory regions. The majority of the nucleosomes identified were well-positioned. We found a stereotyped chromatin organization at Pol II promoters consisting of a nucleosome-free region similar to 200 base pairs upstream of the start codon flanked on both sides by positioned nucleosomes. The nucleosome-free sequences were evolutionarily conserved and were enriched in poly-deoxyadenosine or poly-deoxythymidine sequences. Most occupied transcription factor binding motifs were devoid of nucleosomes, strongly suggesting that nucleosome positioning is a global determinant of transcription factor access.	Harvard Univ, Bauer Ctr Genom Res, Cambridge, MA 02138 USA	Harvard University	Rando, OJ (corresponding author), Harvard Univ, Bauer Ctr Genom Res, 7 Divin Ave, Cambridge, MA 02138 USA.	orando@cgr.harvard.edu		Dion, Michael/0000-0002-0434-4236				Anderson JD, 2000, J MOL BIOL, V296, P979, DOI 10.1006/jmbi.2000.3531; Anderson JD, 2001, MOL CELL BIOL, V21, P3830, DOI 10.1128/MCB.21.11.3830-3839.2001; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Ercan S, 2004, MOL CELL BIOL, V24, P10026, DOI 10.1128/MCB.24.22.10026-10035.2004; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; HORZ W, 1981, NUCLEIC ACIDS RES, V9, P2643, DOI 10.1093/nar/9.12.2643; KARLIN S, 1993, NUCLEIC ACIDS RES, V21, P703, DOI 10.1093/nar/21.3.703; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; KORNBERG RD, 1988, NUCLEIC ACIDS RES, V16, P6677, DOI 10.1093/nar/16.14.6677; Kristjuhan A, 2004, EMBO J, V23, P4243, DOI 10.1038/sj.emboj.7600433; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Lowary PT, 1997, P NATL ACAD SCI USA, V94, P1183, DOI 10.1073/pnas.94.4.1183; Moreira JMA, 1998, EMBO J, V17, P6028, DOI 10.1093/emboj/17.20.6028; NELSON HCM, 1987, NATURE, V330, P221, DOI 10.1038/330221a0; Osherovich LZ, 2002, DEV CELL, V2, P143, DOI 10.1016/S1534-5807(02)00118-1; Richard Durbin., 1998, BIOL SEQUENCE ANAL P; SAUNDERS MJ, 1990, MOL CELL BIOL, V10, P5721, DOI 10.1128/MCB.10.11.5721; Schwabish MA, 2004, MOL CELL BIOL, V24, P10111, DOI 10.1128/MCB.24.23.10111-10117.2004; STRUHL K, 1985, P NATL ACAD SCI USA, V82, P8419, DOI 10.1073/pnas.82.24.8419; Stunkel W, 1997, MOL CELL BIOL, V17, P4397; Teng Y, 2001, Nucleic Acids Res, V29, pE64, DOI 10.1093/nar/29.13.e64; van Holde KE., 1989, SPRINGER SERIES MOL; VENTER U, 1994, EMBO J, V13, P4848, DOI 10.1002/j.1460-2075.1994.tb06811.x; WALTZ RD, 1994, AQUAT INSECT, V16, P165, DOI 10.1080/01650429409361551	28	891	918	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2005	309	5734					626	630		10.1126/science.1112178	http://dx.doi.org/10.1126/science.1112178			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SE	15961632				2022-12-01	WOS:000230735200053
J	Manoli, DS; Foss, M; Villella, A; Taylor, BJ; Hall, JC; Baker, BS				Manoli, DS; Foss, M; Villella, A; Taylor, BJ; Hall, JC; Baker, BS			Male-specific fruitless specifies the neural substrates of Drosophila courtship behaviour	NATURE			English	Article							CENTRAL-NERVOUS-SYSTEM; EXPRESSION PATTERNS; GENETIC DISSECTION; SEXUAL-DIMORPHISM; MELANOGASTER; NEURONS; IDENTIFICATION; ABLATION; MUTANTS; COMPLEX	Robust innate behaviours are attractive systems for genetically dissecting how environmental cues are perceived and integrated to generate complex behaviours. During courtship, Drosophila males engage in a series of innate, stereotyped behaviours that are coordinated by specific sensory cues. However, little is known about the specific neural substrates mediating this complex behavioural programme(1). Genetic, developmental and behavioural studies have shown that the fruitless (fru) gene encodes a set of male-specific transcription factors (Fru(M)) that act to establish the potential for courtship in Drosophila(2). Fru(M) proteins are expressed in similar to 2% of central nervous system neurons, at least one subset of which coordinates the component behaviours of courtship(3,4). Here we have inserted the yeast GAL4 gene into the fru locus by homologous recombination and show that ( 1) Fru(M) is expressed in subsets of all peripheral sensory systems previously implicated in courtship, ( 2) inhibition of Fru(M) function in olfactory system components reduces olfactory-dependent changes in courtship behaviour, ( 3) transient inactivation of all Fru(M)-expressing neurons abolishes courtship behaviour, with no other gross changes in general behaviour, and ( 4) 'masculinization' of Fru(M)-expressing neurons in females is largely sufficient to confer male courtship behaviour. Together, these data demonstrate that Fru(M) proteins specify the neural substrates of male courtship.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; Brandeis Univ, Dept Biol, Waltham, MA 02254 USA	Stanford University; Stanford University; Oregon State University; Brandeis University	Baker, BS (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	bbaker@pmgm2.stanford.edu		Manoli, Devanand/0000-0002-7238-2330				Acebes A, 2004, CURR BIOL, V14, P704, DOI 10.1016/j.cub.2004.04.003; Acebes A, 2003, J EXP BIOL, V206, P3095, DOI 10.1242/jeb.00522; Anand A, 2001, GENETICS, V158, P1569; Baker BS, 2001, CELL, V105, P13, DOI 10.1016/S0092-8674(01)00293-8; Billeter JC, 2004, J COMP NEUROL, V475, P270, DOI 10.1002/cne.20177; Boekhoff-Falk G, 2005, DEV DYNAM, V232, P550, DOI 10.1002/dvdy.20207; Eberl DF, 1997, P NATL ACAD SCI USA, V94, P14837, DOI 10.1073/pnas.94.26.14837; EWING AW, 1979, J COMP PHYSIOL, V130, P87, DOI 10.1007/BF02582977; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Goodwin SF, 2000, GENETICS, V154, P725; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; KEIL TA, 1989, TISSUE CELL, V21, P139, DOI 10.1016/0040-8166(89)90028-1; Kitamoto T, 2002, P NATL ACAD SCI USA, V99, P13232, DOI 10.1073/pnas.202489099; Kondoh Y, 2003, P ROY SOC B-BIOL SCI, V270, P1005, DOI 10.1098/rspb.2003.2331; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lee G, 2001, J NEUROSCI, V21, P513, DOI 10.1523/JNEUROSCI.21-02-00513.2001; Lee G, 2000, J NEUROBIOL, V43, P404, DOI 10.1002/1097-4695(20000615)43:4<404::AID-NEU8>3.0.CO;2-D; LIU KS, 1995, NEURON, V14, P79, DOI 10.1016/0896-6273(95)90242-2; Manoli DS, 2004, NATURE, V430, P564, DOI 10.1038/nature02713; McBride SMJ, 1999, NEURON, V24, P967, DOI 10.1016/S0896-6273(00)81043-0; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Scott KC, 1999, GENETICS, V153, P787; Shah NM, 2004, NEURON, V43, P313, DOI 10.1016/j.neuron.2004.07.008; Shyamala BV, 1999, J GENET, V78, P87, DOI 10.1007/BF02924560; Smith SA, 1996, J COMP NEUROL, V364, P311; Song HJ, 2002, GENETICS, V162, P1703; SPIETH HT, 1974, ANNU REV ENTOMOL, V19, P385, DOI 10.1146/annurev.en.19.010174.002125; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; VAIAS LJ, 1993, BEHAV GENET, V23, P91, DOI 10.1007/BF01067558; Wolfner MF, 2002, HEREDITY, V88, P85, DOI 10.1038/sj.hdy.6800017	30	289	297	8	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2005	436	7049					395	400		10.1038/nature03859	http://dx.doi.org/10.1038/nature03859			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	15959468				2022-12-01	WOS:000230623400043
J	Yang, Q; Graham, TE; Mody, N; Preitner, F; Peroni, OD; Zabolotny, JM; Kotani, K; Quadro, L; Kahn, BB				Yang, Q; Graham, TE; Mody, N; Preitner, F; Peroni, OD; Zabolotny, JM; Kotani, K; Quadro, L; Kahn, BB			Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes	NATURE			English	Article							RETINOL-BINDING-PROTEIN; PROLIFERATOR-ACTIVATED RECEPTORS; GLUT4 GLUCOSE-TRANSPORTER; KNOCKOUT MICE; VITAMIN-A; PLASMA RETINOL; ADIPOSE-TISSUE; TRANSTHYRETIN; MUSCLE; ADIPOCYTES	In obesity and type 2 diabetes, expression of the GLUT4 glucose transporter is decreased selectively in adipocytes. Adipose-specific Glut4 ( also known as Slc2a4) knockout (adipose-Glut4(-/-)) mice show insulin resistance secondarily in muscle and liver. Here we show, using DNA arrays, that expression of retinol binding protein-4 (RBP4) is elevated in adipose tissue of adipose-Glut4(-/-) mice. We show that serum RBP4 levels are elevated in insulin-resistant mice and humans with obesity and type 2 diabetes. RBP4 levels are normalized by rosiglitazone, an insulin-sensitizing drug. Transgenic overexpression of human RBP4 or injection of recombinant RBP4 in normal mice causes insulin resistance. Conversely, genetic deletion of Rbp4 enhances insulin sensitivity. Fenretinide, a synthetic retinoid that increases urinary excretion of RBP4, normalizes serum RBP4 levels and improves insulin resistance and glucose intolerance in mice with obesity induced by a high-fat diet. Increasing serum RBP4 induces hepatic expression of the gluconeogenic enzyme phosphoenolpyruvate carboxykinase ( PEPCK) and impairs insulin signalling in muscle. Thus, RBP4 is an adipocyte-derived 'signal' that may contribute to the pathogenesis of type 2 diabetes. Lowering RBP4 could be a new strategy for treating type 2 diabetes.	Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Columbia Univ Coll Phys & Surg, Inst Canc Res, Dept Med, New York, NY 10032 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Columbia University	Kahn, BB (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA.	bkahn@bidmc.harvard.edu	Mody, Nimesh/J-9602-2019	Mody, Nimesh/0000-0002-2215-7952	NIDDK NIH HHS [R01 DK043051] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abahusain MA, 1999, EUR J CLIN NUTR, V53, P630, DOI 10.1038/sj.ejcn.1600825; Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Anai M, 1999, DIABETES, V48, P158, DOI 10.2337/diabetes.48.1.158; Basualdo CG, 1997, J AM COLL NUTR, V16, P39, DOI 10.1080/07315724.1997.10718647; BERNI R, 1993, FASEB J, V7, P1179, DOI 10.1096/fasebj.7.12.8375617; BLANER WS, 1989, ENDOCR REV, V10, P308, DOI 10.1210/edrv-10-3-308; CARVALHO E, 2005, AM J PHYSL ENDOCRINO; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Christensen EI, 1999, J AM SOC NEPHROL, V10, P685; DeFronzo R. A., 1997, DIABETES REV, V5, P171; Despres JP, 1996, NEW ENGL J MED, V334, P952, DOI 10.1056/NEJM199604113341504; Duggirala R, 1999, AM J HUM GENET, V64, P1127, DOI 10.1086/302316; KAHN CR, 1989, MOL ENDOCRINOL, V3, P840, DOI 10.1210/mend-3-5-840; KATO M, 1985, P NATL ACAD SCI USA, V82, P2488, DOI 10.1073/pnas.82.8.2488; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kitamura T, 2003, ANNU REV PHYSIOL, V65, P313, DOI 10.1146/annurev.physiol.65.092101.142540; Kliewer SA, 2001, RECENT PROG HORM RES, V56, P239, DOI 10.1210/rp.56.1.239; Koistinen HA, 2001, DIABETES-METAB RES, V17, P391, DOI 10.1002/dmrr.222; Kotani K, 2004, J CLIN INVEST, V114, P1666, DOI 10.1172/JCI200421341; Kotani K, 2001, DIABETES, V50, pA274; Lee CH, 2003, ENDOCRINOLOGY, V144, P2201, DOI 10.1210/en.2003-0288; Malpeli G, 1996, BBA-PROTEIN STRUCT M, V1294, P48, DOI 10.1016/0167-4838(95)00264-2; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; MATARESE V, 1993, J BIOL CHEM, V268, P18859; Meigs JB, 2002, DIABETES, V51, P833, DOI 10.2337/diabetes.51.3.833; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Minokoshi Y, 2003, J BIOL CHEM, V278, P33609, DOI 10.1074/jbc.R300019200; Monaco HL, 2000, BBA-PROTEIN STRUCT M, V1482, P65, DOI 10.1016/S0167-4838(00)00140-0; Mothe I, 1996, J BIOL CHEM, V271, P11222, DOI 10.1074/jbc.271.19.11222; National Research Council, 1995, NUTR REQ LAB AN, P92; Naylor HM, 1999, BIOCHEMISTRY-US, V38, P2647, DOI 10.1021/bi982291i; Nikoulina SE, 2000, DIABETES, V49, P263, DOI 10.2337/diabetes.49.2.263; Pagliassotti MJ, 2002, AM J PHYSIOL-ENDOC M, V282, pE170, DOI 10.1152/ajpendo.2002.282.1.E170; PEDERSEN O, 1992, J CLIN INVEST, V89, P1964, DOI 10.1172/JCI115804; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; Quadro L, 2002, J BIOL CHEM, V277, P30191, DOI 10.1074/jbc.M205046200; Rodondi N, 2002, ANN INTERN MED, V136, P582, DOI 10.7326/0003-4819-136-8-200204160-00007; SHEIKH MS, 1995, CARCINOGENESIS, V16, P2477, DOI 10.1093/carcin/16.10.2477; Shen Q, 2004, J BIOL CHEM, V279, P19721, DOI 10.1074/jbc.M311729200; SHEPHERD PR, 1993, J BIOL CHEM, V268, P22243; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Shin DJ, 2002, MOL CELL ENDOCRINOL, V195, P39, DOI 10.1016/S0303-7207(02)00215-0; SIVAPRASADARAO A, 1988, BIOCHEM J, V255, P561; Tozzo E, 1997, ENDOCRINOLOGY, V138, P1604, DOI 10.1210/en.138.4.1604; TSUTSUMI C, 1992, J BIOL CHEM, V267, P1805; Um SJ, 2001, CANCER LETT, V174, P127, DOI 10.1016/S0304-3835(01)00697-8; Wang JC, 2000, J BIOL CHEM, V275, P14717, DOI 10.1074/jbc.275.19.14717; WANG TTY, 1993, GENE, V133, P291, DOI 10.1016/0378-1119(93)90654-L; Xie YS, 1998, PROTEIN EXPRES PURIF, V14, P31, DOI 10.1006/prep.1998.0944; ZOVICH DC, 1992, J BIOL CHEM, V267, P13884	50	1555	1712	4	151	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2005	436	7049					356	362		10.1038/nature03711	http://dx.doi.org/10.1038/nature03711			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	16034410				2022-12-01	WOS:000230623400034
J	Spalding, KL; Bhardwaj, RD; Buchholz, BA; Druid, H; Frisen, J				Spalding, KL; Bhardwaj, RD; Buchholz, BA; Druid, H; Frisen, J			Retrospective birth dating of cells in humans	CELL			English	Article							HIPPOCAMPAL NEUROGENESIS; MUTATION-RATE; ADULT MICE; STEM-CELL; DNA; NEOCORTEX; C-14; RADIOCARBON; LYMPHOCYTES; PRECURSORS	The generation of cells in the human body has been difficult to study, and our understanding of cell turnover is limited. Testing of nuclear weapons resulted in a dramatic global increase in the levels of the isotope C-14 in the atmosphere, followed by an exponential decrease after 1963. We show that the level of C-14 in genomic DNA closely parallels atmospheric levels and can be used to establish the time point when the DNA was synthesized and cells were born. We use this strategy to determine the age of cells in the cortex of the adult human brain and show that whereas nonneuronal cells are exchanged, occipital neurons are as old as the individual, supporting the view that postnatal neurogenesis does not take place in this region. Retrospective birth dating is a generally applicable strategy that can be used to measure cell turnover in man under physiological and pathological conditions.	Karolinska Inst, Dept Cell & Mol Biol, Med Nobel Inst, SE-17177 Stockholm, Sweden; Karolinska Inst, Dept Forens Med, SE-17177 Stockholm, Sweden; Lawrence Livermore Natl Lab, Ctr Accelerator Mass Spectrometry, Livermore, CA 94551 USA	Karolinska Institutet; Karolinska Institutet; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Frisen, J (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Med Nobel Inst, SE-17177 Stockholm, Sweden.	jonas.frisen@cmb.ki.se	Spalding, Kirsty/CAF-4248-2022; Buchholz, Bruce A/G-1356-2011; Slagboom, P. Eline/R-4790-2016; Castellani, Gastone c/L-3333-2017; pirazzini, chiara/K-2258-2018; spalding, kirsty/I-6046-2017	Spalding, Kirsty/0000-0002-5189-7028; Buchholz, Bruce A/0000-0002-9531-551X; Slagboom, P. Eline/0000-0002-2875-4723; Castellani, Gastone c/0000-0003-4892-925X; Druid, Henrik/0000-0002-9198-023X	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013461] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR013461, RR13461] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bridges BA, 1997, BIOESSAYS, V19, P347, DOI 10.1002/bies.950190412; Brown TA, 1997, NUCL INSTRUM METH B, V123, P208, DOI 10.1016/S0168-583X(96)00676-3; Chen JH, 2004, P NATL ACAD SCI USA, V101, P16357, DOI 10.1073/pnas.0406795101; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Dayer AG, 2005, J CELL BIOL, V168, P415, DOI 10.1083/jcb.200407053; DEVRIES H, 1958, SCIENCE, V128, P1550, DOI 10.1126/science.128.3338.1550; Ding S, 2004, NAT BIOTECHNOL, V22, P833, DOI 10.1038/nbt987; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Duman RS, 2004, BIOL PSYCHIAT, V56, P140, DOI 10.1016/j.biopsych.2004.02.033; EHRLICH M, 1982, NUCLEIC ACIDS RES, V10, P2709, DOI 10.1093/nar/10.8.2709; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Gould E, 2001, P NATL ACAD SCI USA, V98, P10910, DOI 10.1073/pnas.181354698; Gould E, 1998, P NATL ACAD SCI USA, V95, P3168, DOI 10.1073/pnas.95.6.3168; GREEN MHL, 1995, MUTAT RES-ENVIR MUTA, V334, P323, DOI 10.1016/0165-1161(95)90070-5; HARKNESS DD, 1972, NATURE, V240, P302, DOI 10.1038/240302a0; KAPLAN MS, 1981, J COMP NEUROL, V195, P323, DOI 10.1002/cne.901950211; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; Kornack DR, 2001, SCIENCE, V294, P2127, DOI 10.1126/science.1065467; Levin I, 2004, RADIOCARBON, V46, P1261, DOI 10.1017/S0033822200033130; LIBBY WF, 1964, SCIENCE, V146, P1171; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; Love AH, 2003, ENVIRON SCI TECHNOL, V37, P4330, DOI 10.1021/es034278d; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; Morley AA, 1996, MUTAT RES-FUND MOL M, V357, P167, DOI 10.1016/0027-5107(96)00096-6; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nouspikel T, 2002, DNA REPAIR, V1, P59, DOI 10.1016/S1568-7864(01)00005-2; Nowakowski R S, 2000, Science, V288, P771; NYDAL R, 1965, NATURE, V206, P1029, DOI 10.1038/2061029a0; Pawelczyk S, 2004, RADIOCARBON, V46, P701, DOI 10.1017/S003382220003575X; Rakic P, 2002, NAT REV NEUROSCI, V3, P65, DOI 10.1038/nrn700; Rakic P, 2002, J NEUROSCI, V22, P614, DOI 10.1523/JNEUROSCI.22-03-00614.2002; Reimer PJ, 2004, RADIOCARBON, V46, P1299; Richard Shambavi, 2002, Curr Hematol Rep, V1, P103; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Stuiver M, 1998, RADIOCARBON, V40, P1041, DOI 10.1017/S0033822200019123; Sussman MA, 2004, ANNU REV PHYSIOL, V66, P29, DOI 10.1146/annurev.physiol.66.032102.140723; VOGEL JS, 1987, NUCL INSTRUM METH B, V29, P50, DOI 10.1016/0168-583X(87)90202-3; WANG L, 1994, NUCLEIC ACIDS RES, V22, P1774, DOI 10.1093/nar/22.9.1774; Wersto RP, 2001, CYTOMETRY, V46, P296, DOI 10.1002/cyto.1171	46	395	408	0	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 15	2005	122	1					133	143		10.1016/j.cell.2005.04.028	http://dx.doi.org/10.1016/j.cell.2005.04.028			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	950EC	16009139	Bronze			2022-12-01	WOS:000230839400017
J	Garrison, JL; Kunkel, EJ; Hegde, RS; Taunton, J				Garrison, JL; Kunkel, EJ; Hegde, RS; Taunton, J			A substrate-specific inhibitor of protein translocation into the endoplasmic reticulum	NATURE			English	Article							SIGNAL SEQUENCE RECOGNITION; ER MEMBRANE; NASCENT PREPROLACTIN; SEC PROTEINS; POLYPEPTIDE; TRANSPORT; COMPLEX; COMPONENTS; HUN-7293; PARTICLE	The segregation of secretory and membrane proteins to the mammalian endoplasmic reticulum is mediated by remarkably diverse signal sequences that have little or no homology with each other(1,2). Despite such sequence diversity, these signals are all recognized and interpreted by a highly conserved protein-conducting channel composed of the Sec61 complex(3,4). Signal recognition by Sec61 is essential for productive insertion of the nascent polypeptide into the translocation site(5), channel gating(6) and initiation of transport. Although subtle differences in these steps can be detected between different substrates(7,8), it is not known whether they can be exploited to modulate protein translocation selectively. Here we describe cotransin, a small molecule that inhibits protein translocation into the endoplasmic reticulum. Cotransin acts in a signal-sequence-discriminatory manner to prevent the stable insertion of select nascent chains into the Sec61 translocation channel. Thus, the range of substrates accommodated by the channel can be specifically and reversibly modulated by a cell-permeable small molecule that alters the interaction between signal sequences and the Sec61 complex.	NICHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA; Univ Calif San Francisco, Chem & Chem Biol Grad Program, San Francisco, CA 94107 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94107 USA; Bioseek Inc, Burlingame, CA 94010 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of California System; University of California San Francisco; University of California System; University of California San Francisco	Hegde, RS (corresponding author), NICHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA.	hegder@mail.nih.gov; taunton@cmp.ucsf.edu		Hegde, Ramanujan/0000-0001-8338-852X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [ZIAHD008752, Z01HD008752] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Boger DL, 1999, J AM CHEM SOC, V121, P6197, DOI 10.1021/ja990918u; Chen Y, 2002, J AM CHEM SOC, V124, P5431, DOI 10.1021/ja020166v; CROWLEY KS, 1994, CELL, V78, P461, DOI 10.1016/0092-8674(94)90424-3; DESHAIES RJ, 1991, NATURE, V349, P806, DOI 10.1038/349806a0; Fons RD, 2003, J CELL BIOL, V160, P529, DOI 10.1083/jcb.200210095; FOSTER CA, 1994, JOURNAL OF DERMATOLOGY, VOL 21, NO 11, NOVEMBER 1994, P847, DOI 10.1111/j.1346-8138.1994.tb03300.x; GORLICH D, 1992, NATURE, V357, P47, DOI 10.1038/357047a0; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; Hamman BD, 1998, CELL, V92, P747, DOI 10.1016/S0092-8674(00)81403-8; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; Kim SJ, 2002, DEV CELL, V2, P207, DOI 10.1016/S1534-5807(01)00120-4; KRIEG UC, 1986, P NATL ACAD SCI USA, V83, P8604, DOI 10.1073/pnas.83.22.8604; Kunkel EJ, 2004, ASSAY DRUG DEV TECHN, V2, P431, DOI 10.1089/adt.2004.2.431; KURZCHALIA TV, 1986, NATURE, V320, P634, DOI 10.1038/320634a0; LINDLEY IJD, 2004, Patent No. 20040086904; Lyman SK, 1997, CELL, V88, P85, DOI 10.1016/S0092-8674(00)81861-9; Mothes W, 1998, J CELL BIOL, V142, P355, DOI 10.1083/jcb.142.2.355; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; RANDALL LL, 1989, SCIENCE, V243, P1156, DOI 10.1126/science.2646712; Rapoport TA, 1996, ANNU REV BIOCHEM, V65, P271; Rutkowski DT, 2001, P NATL ACAD SCI USA, V98, P7823, DOI 10.1073/pnas.141125098; Tyedmers J, 2003, EMBO REP, V4, P505, DOI 10.1038/sj.embor.embor826; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Voigt S, 1996, J CELL BIOL, V134, P25, DOI 10.1083/jcb.134.1.25; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WOLIN SL, 1993, J CELL BIOL, V121, P1211, DOI 10.1083/jcb.121.6.1211	28	119	123	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2005	436	7048					285	289		10.1038/nature03821	http://dx.doi.org/10.1038/nature03821			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944VR	16015336				2022-12-01	WOS:000230459500047
J	Imaizumi, T; Schultz, TF; Harmon, FG; Ho, LA; Kay, SA				Imaizumi, T; Schultz, TF; Harmon, FG; Ho, LA; Kay, SA			FKF1F-BOX protein mediates cyclic degradation of a repressor of CONSTANS in Arabidopsis	SCIENCE			English	Article							MOLECULAR-BASIS; COMPLEX; EXPRESSION; CLOCK; GENES; TIME; FKF1	The temporal control of CONSTANS (CO) expression and activity is a key mechanism in photoperiodic flowering in Arabidopsis. FLAVIN-BINDING, KELCH REPEAT, F-BOX 1 (FKF1) protein regulates CO transcription, although the molecular mechanism is unknown. We demonstrate here that FKF1 controls the stability of a Dof transcription factor, CYCLING DOF FACTOR 1 (CDF1). FKF1 physically interacts with CDF1, and CDF1 protein is more stable in fkf1 mutants. Plants with elevated levels of CDF1 flower late and have reduced expression of CO. CDF1 and CO are expressed in the same tissues, and CDF1 binds to the CO promoter. Thus, FKF1 controls daily CO expression in part by degrading CDF1, a repressor of CO transcription.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Kay, SA (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	stevek@scripps.edu	Kay, Steve A/F-6025-2011	Kay, Steve A/0000-0002-0402-2878; Schultz, Thomas/0000-0001-9694-9920				An HL, 2004, DEVELOPMENT, V131, P3615, DOI 10.1242/dev.01231; Beerli RR, 1998, P NATL ACAD SCI USA, V95, P14628, DOI 10.1073/pnas.95.25.14628; Gagne JM, 2002, P NATL ACAD SCI USA, V99, P11519, DOI 10.1073/pnas.162339999; Garner WW., 1920, J AGR RES, VXVII, P553; Han LQ, 2004, PLANT J, V40, P291, DOI 10.1111/j.1365-313X.2004.02207.x; Hayama R, 2004, PLANT PHYSIOL, V135, P677, DOI 10.1104/pp.104.042614; Imaizumi T, 2003, NATURE, V426, P302, DOI 10.1038/nature02090; IMAIZUMI T, UNPUB; Nelson DC, 2000, CELL, V101, P331, DOI 10.1016/S0092-8674(00)80842-9; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Takada S, 2003, PLANT CELL, V15, P2856, DOI 10.1105/tpc.016345; Takahashi N, 2004, PLANT CELL PHYSIOL, V45, P83, DOI 10.1093/pcp/pch009; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Vierstra RD, 2003, TRENDS PLANT SCI, V8, P135, DOI 10.1016/S1360-1385(03)00014-1; Yanagisawa S, 2002, TRENDS PLANT SCI, V7, P555, DOI 10.1016/S1360-1385(02)02362-2; Yanovsky MJ, 2003, NAT REV MOL CELL BIO, V4, P265, DOI 10.1038/nrm1077; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996	17	523	622	12	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2005	309	5732					293	297		10.1126/science.1110586	http://dx.doi.org/10.1126/science.1110586			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944SP	16002617				2022-12-01	WOS:000230449800043
J	Mesecke, N; Terziyska, N; Kozany, C; Baumann, F; Neupert, W; Hell, K; Herrmann, JM				Mesecke, N; Terziyska, N; Kozany, C; Baumann, F; Neupert, W; Hell, K; Herrmann, JM			A disulfide relay system in the intermembrane space of mitochondria that mediates protein import	CELL			English	Article							SMALL TIM PROTEINS; SUPEROXIDE-DISMUTASE; SULFHYDRYL OXIDASE; BOND FORMATION; YEAST; GENE; COMPLEX; TRANSLOCATION; MEMBRANE; MIA40	We describe here a pathway for the import of proteins into the intermembrane space (IMS) of mitochondria. Substrates of this pathway are proteins with conserved cysteine motifs, which are critical for import. After passage through the TOM channel, these proteins are covalently trapped by Mia40 via disulfide bridges. Mia40 contains cysteine residues, which are oxidized by the sulfhydryl oxidase Erv1. Depletion of Erv1 or conditions reducing Mia40 prevent protein import. We propose that Erv1 and Mia40 function as a disulfide relay system that catalyzes the import of proteins into the IMS by an oxidative folding mechanism. The existence of a disulfide exchange system in the IMS is unexpected in view of the free exchange of metabolites between IMS and cytosol via porin channels. We suggest that this process reflects the evolutionary origin of the IMS from the periplasmic space of the prokaryotic ancestors of mitochondria.	Univ Munich, Inst Physiol Chem, D-81377 Munich, Germany	University of Munich	Herrmann, JM (corresponding author), Univ Munich, Inst Physiol Chem, Butenandtstr 5, D-81377 Munich, Germany.	hannes.herrmann@bio.med.uni-muenchen.de	Baumann, Frank/F-7737-2016; Wagener, Nikola/L-3202-2017					Banci L, 2004, J BIOL CHEM, V279, P34833, DOI 10.1074/jbc.M403655200; Becher D, 1999, YEAST, V15, P1171, DOI 10.1002/(SICI)1097-0061(19990915)15:12<1171::AID-YEA443>3.0.CO;2-T; Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389; Collet JF, 2002, MOL MICROBIOL, V44, P1, DOI 10.1046/j.1365-2958.2002.02851.x; Curran SP, 2004, J BIOL CHEM, V279, P43744, DOI 10.1074/jbc.M404878200; Curran SP, 2002, EMBO J, V21, P942, DOI 10.1093/emboj/21.5.942; Endo T, 2002, BBA-MOL CELL RES, V1592, P3, DOI 10.1016/S0167-4889(02)00259-8; Field LS, 2003, J BIOL CHEM, V278, P28052, DOI 10.1074/jbc.M304296200; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; Gerber J, 2001, J BIOL CHEM, V276, P23486, DOI 10.1074/jbc.M100134200; Glerum DM, 1996, J BIOL CHEM, V271, P14504, DOI 10.1074/jbc.271.24.14504; GLICK BS, 1992, CELL, V69, P809, DOI 10.1016/0092-8674(92)90292-K; Grossman SD, 2002, NEUROMOL MED, V2, P61, DOI 10.1385/NMM:2:1:61; HARTL FU, 1987, CELL, V51, P1027, DOI 10.1016/0092-8674(87)90589-7; Heaton D, 2000, J BIOL CHEM, V275, P37582, DOI 10.1074/jbc.M006639200; Herrmann J. M., 1994, CELL BIOL LAB HDB, VI, P538; Herrmann JM, 2005, TRENDS BIOCHEM SCI, V30, P205, DOI 10.1016/j.tibs.2005.02.005; Herrmann JM, 2001, METHOD CELL BIOL, V65, P217, DOI 10.1016/S0091-679X(01)65013-1; Hiniker A, 2004, TRENDS BIOCHEM SCI, V29, P516, DOI 10.1016/j.tibs.2004.08.002; Iwata S, 1996, STRUCTURE, V4, P567, DOI 10.1016/S0969-2126(96)00062-7; Jensen RE, 2002, BBA-MOL CELL RES, V1592, P25, DOI 10.1016/S0167-4889(02)00261-6; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; KOCHLER CM, 2004, ANNU REV CELL DEV BI, V20, P309; Koehler CM, 2004, TRENDS BIOCHEM SCI, V29, P1, DOI 10.1016/j.tibs.2003.11.003; Koehler CM, 1998, SCIENCE, V279, P369, DOI 10.1126/science.279.5349.369; Lamb AL, 2001, NAT STRUCT BIOL, V8, P751, DOI 10.1038/nsb0901-751; Lange H, 2001, EMBO REP, V2, P715, DOI 10.1093/embo-reports/kve161; Lee JE, 2000, FEBS LETT, V477, P62, DOI 10.1016/S0014-5793(00)01767-1; Levitan A, 2004, J BIOL CHEM, V279, P20002, DOI 10.1074/jbc.M312877200; LISOWSKY T, 1992, MOL GEN GENET, V232, P58, DOI 10.1007/BF00299137; Lu H, 2004, J BIOL CHEM, V279, P18952, DOI 10.1074/jbc.M313045200; Lutz T, 2003, EMBO J, V22, P4400, DOI 10.1093/emboj/cdg421; Naoe M, 2004, J BIOL CHEM, V279, P47815, DOI 10.1074/jbc.M410272200; Ostergaard H, 2004, J CELL BIOL, V166, P337, DOI 10.1083/jcb.200402120; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Sevier CS, 2001, NAT CELL BIOL, V3, P874, DOI 10.1038/ncb1001-874; Sirrenberg C, 1998, NATURE, V391, P912, DOI 10.1038/36136; Terziyska N, 2005, FEBS LETT, V579, P179, DOI 10.1016/j.febslet.2004.11.072; Williams JC, 2005, J BIOL CHEM, V280, P15202, DOI 10.1074/jbc.M410705200	40	432	445	2	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 1	2005	121	7					1059	1069		10.1016/j.cell.2005.04.011	http://dx.doi.org/10.1016/j.cell.2005.04.011			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	944RZ	15989955	Bronze			2022-12-01	WOS:000230448000012
J	Akram, R				Akram, R			I am a better doctor now	LANCET			English	Editorial Material									Univ Hosp Aintree, Aintree Cardiac Ctr, Liverpool L9 7AL, Merseyside, England		Akram, R (corresponding author), Univ Hosp Aintree, Aintree Cardiac Ctr, Liverpool L9 7AL, Merseyside, England.	razasida@hotmail.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 18	2005	365	9477					2149	2149		10.1016/S0140-6736(05)66740-2	http://dx.doi.org/10.1016/S0140-6736(05)66740-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	936LZ	15964455				2022-12-01	WOS:000229858800034
J	Muotri, AR; Chu, VT; Marchetto, MCN; Deng, W; Moran, JV; Gage, FH				Muotri, AR; Chu, VT; Marchetto, MCN; Deng, W; Moran, JV; Gage, FH			Somatic mosaicism in neuronal precursor cells mediated by L1 retrotransposition	NATURE			English	Article							CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; LINE-1; GENE; TRANSCRIPTION; NEUROGENESIS; EXPRESSION; SEQUENCE; DIFFERENTIATION; DISRUPTION	Revealing the mechanisms for neuronal somatic diversification remains a central challenge for understanding individual differences in brain organization and function. Here we show that an engineered human LINE-1 (for long interspersed nuclear element-1; also known as L1) element can retrotranspose in neuronal precursors derived from rat hippocampus neural stem cells. The resulting retrotransposition events can alter the expression of neuronal genes, which, in turn, can influence neuronal cell fate in vitro. We further show that retrotransposition of a human L1 in transgenic mice results in neuronal somatic mosaicism. The molecular mechanism of action is probably mediated through Sox2, because a decrease in Sox2 expression during the early stages of neuronal differentiation is correlated with increases in both L1 transcription and retrotransposition. Our data therefore indicate that neuronal genomes might not be static, but some might be mosaic because of de novo L1 retrotransposition events.	Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; Univ Michigan, Sch Med, Dept Human Genet & Internal Med, Ann Arbor, MI 48109 USA	Salk Institute; University of Michigan System; University of Michigan	Gage, FH (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gage@salk.edu						Athanikar JN, 2004, NUCLEIC ACIDS RES, V32, P3846, DOI 10.1093/nar/gkh698; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Brouha B, 2002, AM J HUM GENET, V71, P327, DOI 10.1086/341722; D'Amour KA, 2003, P NATL ACAD SCI USA, V100, P11866, DOI 10.1073/pnas.1834200100; DeBerardinis RJ, 1998, NAT GENET, V20, P288, DOI 10.1038/3104; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GAGE FH, 1995, ANNU REV NEUROSCI, V18, P159, DOI 10.1146/annurev.ne.18.030195.001111; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; Goodier JL, 2001, GENOME RES, V11, P1677, DOI 10.1101/gr.198301; GRIMALDI G, 1984, EMBO J, V3, P1753, DOI 10.1002/j.1460-2075.1984.tb02042.x; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; HOGAN J, 1994, MANIPULATING MOUSE E; Hsieh J, 2004, CURR OPIN GENET DEV, V14, P461, DOI 10.1016/j.gde.2004.07.006; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Lietz M, 2003, EUR J BIOCHEM, V270, P2, DOI 10.1046/j.1432-1033.2003.03360.x; MIKI Y, 1992, CANCER RES, V52, P643; Moran J.V., 2002, MOBILE DNA, P836; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Morrish TA, 2002, NAT GENET, V31, P159, DOI 10.1038/ng898; Naef F, 2002, GENOME BIOL, V3; Ostertag EM, 2000, NUCLEIC ACIDS RES, V28, P1418, DOI 10.1093/nar/28.6.1418; Ostertag EM, 2002, NAT GENET, V32, P655, DOI 10.1038/ng1022; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Perepelitsa-Belancio V, 2003, NAT GENET, V35, P363, DOI 10.1038/ng1269; Prak ETL, 2003, P NATL ACAD SCI USA, V100, P1832, DOI 10.1073/pnas.0337627100; Schwahn U, 1998, NAT GENET, V19, P327, DOI 10.1038/1214; SWERGOLD GD, 1990, MOL CELL BIOL, V10, P6718, DOI 10.1128/MCB.10.12.6718; Symer DE, 2002, CELL, V110, P327, DOI 10.1016/S0092-8674(02)00839-5; Taupin P, 2002, J NEUROSCI RES, V69, P745, DOI 10.1002/jnr.10378; Tchenio T, 2000, NUCLEIC ACIDS RES, V28, P411, DOI 10.1093/nar/28.2.411; TRELOGAN SA, 1995, P NATL ACAD SCI USA, V92, P1520, DOI 10.1073/pnas.92.5.1520; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; Yang N, 2003, NUCLEIC ACIDS RES, V31, P4929, DOI 10.1093/nar/gkg663; Zapala MA, 2002, GENOME BIOL, V3; Zappone MV, 2000, DEVELOPMENT, V127, P2367	44	654	679	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2005	435	7044					903	910		10.1038/nature03663	http://dx.doi.org/10.1038/nature03663			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935RN	15959507	Green Published			2022-12-01	WOS:000229799700037
J	Haddad, MB; Wilson, TW; Iiaz, K; Marks, SM; Moore, M				Haddad, MB; Wilson, TW; Iiaz, K; Marks, SM; Moore, M			Tuberculosis and homelessness in the United States, 1994-2003	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	132nd Annual Meeting of the American-Public-Health-Association	NOV 06-10, 2004	Washington, DC	Amer Public Hlth Assoc			MYCOBACTERIUM-TUBERCULOSIS; TRANSMISSION; OUTBREAK; SHELTER	Context Tuberculosis (TB) rates among US homeless persons cannot be calculated because they are not included in the US Census. However, homelessness is often associated with TB. Objectives To describe homeless persons with TB and to compare risk factors and disease characteristics between homeless and nonhomeless persons with TB. Design and Setting Cross-sectional analysis of all verified TB cases reported into the National TB Surveillance System from the 50 states and the District of Columbia from 1994 through 2003. Main Outcome Measures Number and proportion of TB cases associated with homelessness, demographic characteristics, risk factors, disease characteristics, treatment, and outcomes. Results Of 185870 cases of TB disease reported between 1994 and 2003, 11369 were among persons classified as homeless during the 12 months before diagnosis. The annual proportion of cases associated with homelessness was stable (6.1%-6.7%). Regional differences occurred with a higher proportion of TB cases associated with homelessness in western and some southern states. Most homeless persons with TB were male (87%) and aged 30 to 59 years. Black individuals represented the highest proportion of TB cases among the homeless and nonhomeless. The proportion of homeless persons with TB who were born outside the United States (18%) was lower than that for nonhomeless persons with TB (44%). At the time of TB diagnosis, 9% of homeless persons were incarcerated, usually in a local jail; 3% of nonhomeless persons with TB were incarcerated. Compared with nonhomeless persons, homeless persons with TB had a higher prevalence of substance use (54% alcohol abuse, 29.5% noninjected drug use, and 14% injected drug use), and 34% of those tested had coinfection with human immunodeficiency virus. Compared with nonhomeless persons, TB disease in homeless persons was more likely to be infectious but not more likely to be drug resistant. Health departments managed 81 % of TB cases in homeless persons. Directly observed therapy, used for 86% of homeless patients, was associated with timely completion of therapy. A similar proportion in both groups (9%) died from any cause during therapy. Conclusions Individual TB risk factors often overlap with risk factors for homelessness, and the social contexts in which TB occurs are often complex and important to consider in planning TB treatment. Nevertheless, given good case management, homeless persons with TB can achieve excellent treatment outcomes.	Ctr Dis Control & Prevent, Surveillance Epidemiol & Outbreak Invest Branch, Div TB Eliminat, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Haddad, MB (corresponding author), Ctr Dis Control & Prevent, Surveillance Epidemiol & Outbreak Invest Branch, Div TB Eliminat, 1600 Clifton Rd,Mailstop E-10, Atlanta, GA 30333 USA.	maryam.haddad@cdc.hhs.gov			Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		[Anonymous], 2000, MMWR Recomm Rep, V49, P1; Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1; [Anonymous], 2003, MMWR RECOMM REP; Asch S, 1998, ANN EMERG MED, V32, P144, DOI 10.1016/S0196-0644(98)70128-3; Baldwin GC, 1997, AM J RESP CRIT CARE, V156, P1606, DOI 10.1164/ajrccm.156.5.9704146; Barnes PF, 1996, JAMA-J AM MED ASSOC, V275, P305, DOI 10.1001/jama.275.4.305; *CDCP, 1995, CONTR TB CORR FAC; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P329; *CDCP, 2004, MMWR-MORBID MORTAL W, V53, P556; Centers for Disease Control, 2004, REP TUB US 2003; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P1184; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P734; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P1209; Curtis AB, 2000, INT J TUBERC LUNG D, V4, P308; *I MED, 2000, END NEGL EL TUB US; Iseman Michael D., 2000, CLIN GUIDE TUBERCULO; KLINE SE, 1995, NEW ENGL J MED, V333, P222, DOI 10.1056/NEJM199507273330404; Knopf SA, 1914, J AMER MED ASSOC, V63, P1720; Lathan M, 2002, EMERG INFECT DIS, V8, P1249; Marks SM, 2000, AM J PUBLIC HEALTH, V90, P435, DOI 10.2105/AJPH.90.3.435; Mayaud C, 2001, Rev Pneumol Clin, V57, P259; NOLAN CM, 1991, AM REV RESPIR DIS, V143, P257, DOI 10.1164/ajrccm/143.2.257; Omidvari K, 1998, ALCOHOL CLIN EXP RES, V22, P567, DOI 10.1111/j.1530-0277.1998.tb04294.x; Perlman DC, 1997, J SUBST ABUSE TREAT, V14, P3, DOI 10.1016/S0740-5472(96)00182-1; Phelan JC, 1999, AM J PUBLIC HEALTH, V89, P1334, DOI 10.2105/AJPH.89.9.1334; Reichard AA, 2003, PUBLIC HEALTH REP, V118, P500, DOI 10.1093/phr/118.6.500; REICHMAN LB, 1979, ARCH INTERN MED, V139, P337, DOI 10.1001/archinte.139.3.337; ROSSI PH, 1987, SCIENCE, V235, P1336, DOI 10.1126/science.2950592; Thompson ML, 1998, OCCUP ENVIRON MED, V55, P272, DOI 10.1136/oem.55.4.272; *URB I, 1999, HOM PROGR PEOPL THEY; US Department of Health and Human Services, 2000, HLTH PEOPL 2010	31	78	81	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	2005	293	22					2762	2766		10.1001/jama.293.22.2762	http://dx.doi.org/10.1001/jama.293.22.2762			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	933OV	15941806	Green Accepted, Bronze			2022-12-01	WOS:000229643700025
J	Scholz, H; Franz, M; Heberlein, U				Scholz, H; Franz, M; Heberlein, U			The hangover gene defines a stress pathway required for ethanol tolerance development	NATURE			English	Article							ALCOHOL TOLERANCE; OXIDATIVE STRESS; DROSOPHILA; EXPRESSION; OCTOPAMINE; RESISTANCE; ADDICTION; OXIDANTS; BRAIN	Repeated alcohol consumption leads to the development of tolerance, simply defined as an acquired resistance to the physiological and behavioural effects of the drug. This tolerance allows increased alcohol consumption, which over time leads to physical dependence and possibly addiction(1-3). Previous studies have shown that Drosophila develop ethanol tolerance, with kinetics of acquisition and dissipation that mimic those seen in mammals. This tolerance requires the catecholamine octopamine, the functional analogue of mammalian noradrenaline(4). Here we describe a new gene, hangover, which is required for normal development of ethanol tolerance. hangover flies are also defective in responses to environmental stressors, such as heat and the free-radical-generating agent paraquat. Using genetic epistasis tests, we show that ethanol tolerance in Drosophila relies on two distinct molecular pathways: a cellular stress pathway defined by hangover, and a parallel pathway requiring octopamine. hangover encodes a large nuclear zinc-finger protein, suggesting a role in nucleic acid binding. There is growing recognition that stress, at both the cellular and systemic levels, contributes to drug- and addiction-related behaviours in mammals. Our studies suggest that this role may be conserved across evolution.	Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94143 USA; Univ Wurzburg, Biozentrum, D-97074 Wurzburg, Germany	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Wurzburg	Scholz, H (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	henrike.scholz@biozentrum.uni-wuerzburg.de; ulrike@itsa.ucsf.edu	Scholz, Henrike/ABE-1063-2020		NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA010035] Funding Source: NIH RePORTER; NIAAA NIH HHS [R01 AA010035] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ARKING R, 1991, DEV GENET, V12, P362, DOI 10.1002/dvg.1020120505; BRAND AH, 1993, DEVELOPMENT, V118, P401; Fadda F, 1998, PROG NEUROBIOL, V56, P385, DOI 10.1016/S0301-0082(98)00032-X; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Le A. D., 1996, PHARM TOXIC, P251; LEGRAIN P, 1990, EMBO J, V9, P2775, DOI 10.1002/j.1460-2075.1990.tb07465.x; Min KT, 1997, CURR BIOL, V7, P885, DOI 10.1016/S0960-9822(06)00378-2; MLODZIK M, 1992, METHODS NEUROSCIENCE, V9, P397; Monastirioti M, 1996, J NEUROSCI, V16, P3900; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; PIPER PW, 1995, FEMS MICROBIOL LETT, V134, P121, DOI 10.1016/0378-1097(95)00431-9; Scholz H, 2000, NEURON, V28, P261, DOI 10.1016/S0896-6273(00)00101-X; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Singh CM, 2000, ALCOHOL CLIN EXP RES, V24, P1127, DOI 10.1097/00000374-200008000-00001; Sun AY, 2001, ALCOHOL CLIN EXP RES, V25, p237S, DOI 10.1097/00000374-200105051-00038; Suzuki YJ, 1997, FREE RADICAL BIO MED, V22, P269, DOI 10.1016/S0891-5849(96)00275-4; TABAKOFF B, 1986, ANN EMERG MED, V15, P1005, DOI 10.1016/S0196-0644(86)80119-6; Torroja L, 1999, CURR BIOL, V9, P489, DOI 10.1016/S0960-9822(99)80215-2; Walter HJ, 1999, NEUROCHEM INT, V35, P95, DOI 10.1016/S0197-0186(99)00050-9; WEBER KE, 1990, GENETICS, V125, P585; WILKE N, 1994, EXS, V71, P49	23	95	98	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2005	436	7052					845	847		10.1038/nature03864	http://dx.doi.org/10.1038/nature03864			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953XG	16094367	Green Accepted			2022-12-01	WOS:000231116500045
J	Hviid, A; Wohlfahrt, J; Stellfeld, M; Melbye, M				Hviid, A; Wohlfahrt, J; Stellfeld, M; Melbye, M			Childhood vaccination and nontargeted infectious disease hospitalization	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMMUNIZATION; SURVIVAL; RISK; GUINEA; HEALTH	Context It has been hypothesized that multiple-antigen vaccines, such as measles-mumps-rubella vaccine, or aggregated vaccine exposure could lead to immune dysfunction, resulting in nontargeted infectious diseases as a result of an "overload" mechanism. Objective To evaluate the relationship between routinely administered childhood vaccines (Haemophilus influenzae type b; diphtheria-tetanus-inactivated poliovirus; diphtheria-tetanus-acellular pertussis-inactivated poliovirus; whole-cell pertussis; measles-mumps-rubella; oral poliovirus) and hospitalization for nontargeted infectious diseases. Design, Setting, and Participants Population-based cohort comprising all children born in Denmark from 1990 through 2001 (N = 805 206). Longitudinal information was collected on type and number of vaccine doses received and hospitalization with infectious diseases, specifically acute upper respiratory tract infection, viral and bacterial pneumonia, septicemia, viral central nervous system infection, bacterial meningitis, and diarrhea. Main Outcome Measures Rate ratios for each type of infectious disease according to vaccination status. Results During 2 900 463 person-years of follow-up, 84 317 cases of infectious disease hospitalization were identified. Out of 42 possible associations (6 vaccines and 7 infectious disease categories), the only adverse association was for Haemophilus influenzae type b vaccine and acute upper respiratory tract infection (rate ratio, 1.05; 95% confidence interval, 1.01-1.08 comparing vaccinated participants with unvaccinated participants). This one adverse association of 42 possible outcomes was within the limits of what would be expected by chance alone and the effect was not temporal or dose-response. When considering aggregated vaccine exposure, we found no adverse associations between an increasing number of vaccinations and infectious diseases. Conclusion These results do not support the hypotheses that multiple-antigen vaccines or aggregated vaccine exposure increase the risk of nontargeted infectious disease hospitalization.	Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; Statens Serum Inst, Dept Med, DK-2300 Copenhagen, Denmark	Statens Serum Institut; Statens Serum Institut	Hviid, A (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Artillerivej 5, DK-2300 Copenhagen, Denmark.	aii@ssi.dk	Hviid, Anders/AAH-4319-2020	Hviid, Anders/0000-0002-7509-9127; melbye, mads/0000-0001-8264-6785				Andersen TF, 1999, DAN MED BULL, V46, P263; [Anonymous], 2002, IMMUNIZATION SAFETY; BLACK SB, 1991, AM J DIS CHILD, V145, P746; Breiman RF, 2004, LANCET, V364, P2204, DOI 10.1016/S0140-6736(04)17593-4; BURSTEIN JL, 1994, PEDIATR EMERG CARE, V10, P138, DOI 10.1097/00006565-199406000-00004; Clayton D., 1993, STAT MODELS EPIDEMIO; DAVIDSON M, 1991, AM J DIS CHILD, V145, P750; GRIFFIN MR, 1992, PEDIATRICS, V89, P640; Hviid A, 2004, NEW ENGL J MED, V350, P1398, DOI 10.1056/NEJMoa032665; Knudsen LB, 1998, DAN MED BULL, V45, P320; Kristensen I, 2000, BRIT MED J, V321, P1435, DOI 10.1136/bmj.321.7274.1435; Lehmann D, 2005, INT J EPIDEMIOL, V34, P138, DOI 10.1093/ije/dyh262; Madsen KM, 2002, NEW ENGL J MED, V347, P1477, DOI 10.1056/NEJMoa021134; MADSEN KM, 2004, THESIS AARHUS U AARH; MALIG C, 1996, 66 IIVRS; Miller E, 2003, ARCH DIS CHILD, V88, P222, DOI 10.1136/adc.88.3.222; Otto S, 2000, J INFECTION, V41, P172, DOI 10.1053/jinf.2000.0718; Vaugelade J, 2004, BRIT MED J, V329, P1309, DOI 10.1136/bmj.38261.496366.82; *WHO, 2004, TASK FORC ROUT INF V	19	16	19	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 10	2005	294	6					699	705		10.1001/jama.294.6.699	http://dx.doi.org/10.1001/jama.294.6.699			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	953IA	16091572	Bronze			2022-12-01	WOS:000231068600023
J	Holt, BF; Belkhadir, Y; Dangl, JL				Holt, BF; Belkhadir, Y; Dangl, JL			Antagonistic control of disease resistance protein stability in the plant immune system	SCIENCE			English	Article							DOWNY MILDEW RESISTANCE; SCF UBIQUITIN-LIGASE; TOBACCO-MOSAIC-VIRUS; MOLECULAR CHAPERONE; MEDIATED RESISTANCE; ESSENTIAL COMPONENT; ARABIDOPSIS; HSP90; GENE; SGT1	Pathogen recognition by the plant immune system is governed by structurally related, polymorphic products of disease resistance (R) genes. RAR1 and/or SGT1b mediate the function of many R proteins. RAR1 controls preactivation R protein accumulation by an unknown mechanism. We demonstrate that Arabidopsis SGT1b has two distinct, genetically separable functions in the plant immune system: SGT1b antagonizes RAR1 to negatively regulate R protein accumulation before infection, and SGT1b has a RAR1-independent function that regulates programmed cell death during infection. The balanced activities of RAR1 and SGT1, in concert with cytosolic HSP90, modulate preactivation R protein accumulation and signaling competence.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Curriculum Genet, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Dangl, JL (corresponding author), Univ N Carolina, Dept Biol, 108 Coker Hall,CB 3280, Chapel Hill, NC 27599 USA.	dangl@email.unc.edu	Belkhadir, Youssef/GXM-6743-2022; Holt, Ben F/D-1513-2011	Belkhadir, Youssef/0000-0001-7149-7139				Austin MJ, 2002, SCIENCE, V295, P2077, DOI 10.1126/science.1067747; Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; Azevedo C, 2002, SCIENCE, V295, P2073, DOI 10.1126/science.1067554; Bansal PK, 2004, MOL CELL BIOL, V24, P8069, DOI 10.1128/MCB.24.18.8069-8079.2004; Belbahri L, 2001, PLANT J, V28, P419, DOI 10.1046/j.1365-313X.2001.01155.x; Belkhadir Y, 2004, CURR OPIN PLANT BIOL, V7, P391, DOI 10.1016/j.pbi.2004.05.009; Belkhadir Y, 2004, PLANT CELL, V16, P2822, DOI 10.1105/tpc.104.024117; Bieri S, 2004, PLANT CELL, V16, P3480, DOI 10.1105/tpc.104.026682; Boyes DC, 1998, P NATL ACAD SCI USA, V95, P15849, DOI 10.1073/pnas.95.26.15849; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Dangl JL, 1996, PLANT CELL, V8, P1793, DOI 10.1105/tpc.8.10.1793; Dubacq C, 2002, EUKARYOT CELL, V1, P568, DOI 10.1128/EC.1.4.568-582.2002; FREIALDENHOVEN A, 1994, PLANT CELL, V6, P983; Hohfeld J, 2001, EMBO REP, V2, P885, DOI 10.1093/embo-reports/kve206; Hubert DA, 2003, EMBO J, V22, P5679, DOI 10.1093/emboj/cdg547; Kitagawa K, 1999, MOL CELL, V4, P21, DOI 10.1016/S1097-2765(00)80184-7; Lingelbach LB, 2004, MOL CELL BIOL, V24, P8938, DOI 10.1128/MCB.24.20.8938-8950.2004; Liu Y, 2002, PLANT CELL, V14, P1483, DOI 10.1105/tpc.002493; Liu YL, 2004, J BIOL CHEM, V279, P2101, DOI 10.1074/jbc.M310029200; Liu YL, 2002, PLANT J, V30, P415, DOI 10.1046/j.1365-313X.2002.01297.x; Lu R, 2003, EMBO J, V22, P5690, DOI 10.1093/emboj/cdg546; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; McDowell JM, 1998, PLANT CELL, V10, P1861, DOI 10.1105/tpc.10.11.1861; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Muskett PR, 2002, PLANT CELL, V14, P979, DOI 10.1105/tpc.001040; Peart JR, 2002, P NATL ACAD SCI USA, V99, P10865, DOI 10.1073/pnas.152330599; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Sangster TA, 2005, CURR OPIN PLANT BIOL, V8, P86, DOI 10.1016/j.pbi.2004.11.012; Shirasu K, 2003, TRENDS PLANT SCI, V8, P252, DOI 10.1016/S1360-1385(03)00104-3; Shirasu K, 1999, CELL, V99, P355, DOI 10.1016/S0092-8674(00)81522-6; SIMONICH MT, 1995, MOL PLANT MICROBE IN, V8, P637, DOI 10.1094/MPMI-8-0637; Steensgaard P, 2004, EMBO REP, V5, P626, DOI 10.1038/sj.embor.7400154; Takahashi A, 2003, P NATL ACAD SCI USA, V100, P11777, DOI 10.1073/pnas.2033934100; Tor M, 2002, PLANT CELL, V14, P993, DOI 10.1105/tpc.001123; Tornero P, 2002, PLANT CELL, V14, P1005, DOI 10.1105/tpc.001032; Warren RF, 1999, GENETICS, V152, P401; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Zhang Y, 2004, PLANT J, V40, P213, DOI 10.1111/j.1365-313X.2004.02201.x	38	199	208	4	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2005	309	5736					929	932		10.1126/science.1109977	http://dx.doi.org/10.1126/science.1109977			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953SS	15976272				2022-12-01	WOS:000231101400045
J	Freedland, SJ; Humphreys, EB; Mangold, LA; Eisenberger, M; Dorey, FJ; Walsh, PC; Partin, AW				Freedland, SJ; Humphreys, EB; Mangold, LA; Eisenberger, M; Dorey, FJ; Walsh, PC; Partin, AW			Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANTIGEN DOUBLING TIME; RADIATION-THERAPY; RETROPUBIC PROSTATECTOMY; HORMONAL-THERAPY; CONSECUTIVE PATIENTS; LOCAL RECURRENCE; FAILURE; PROGRESSION; SURVIVAL; DISEASE	Context The natural history of biochemical recurrence after radical prostatectomy can be long but variable. Better risk assessment models are needed to identify men who are at high risk for prostate cancer death early and who may benefit from aggressive salvage treatment and to identify men who are at low risk for prostate cancer death and can be safely observed. Objectives To define risk factors for prostate cancer death following radical prostatectomy and to develop tables to risk stratify for prostate cancer-specific survival. Design, Setting, and Patients Retrospective cohort study of 379 men who had undergone radical prostatectomy at an urban tertiary care hospital between 1982 and 2000 and who had a biochemical recurrence and after biochemical failure had at least 2 prostate-specific antigen (PSA) values at least 3 months apart in order to calculate PSA doubling time (PSADT). The mean (SD) follow-up after surgery was 10.3 (4.7) years and median follow-up was 10 years (range, 1-20 years). Main Outcome Measure Prostate cancer-specific mortality. Results Median survival had not been reached after 16 years of follow-up after biochemical recurrence. Prostate-specific doubling time (<3.0 vs 3.0-8.9 vs 9.0-14.9 vs >= 15.0 months), pathological Gleason score (<= 7 vs 8-10), and time from surgery to biochemical recurrence (<= 3 vs >3 years) were all significant risk factors for time to prostate-specific mortality. Using these 3 variables, tables were constructed to estimate the risk of prostate cancer-specific survival at year 15 after biochemical recurrence. Conclusion Clinical parameters (PSADT, pathological Gleason score, and time from surgery to biochemical recurrence) can help risk stratify patients for prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. These preliminary findings may serve as useful guides to patients and their physicians to identify patients at high risk for prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy to enroll them in early aggressive treatment trials. In addition, these preliminary findings highlight that survival in low-risk patients can be quite prolonged.	Johns Hopkins Med Inst, James Buchanan Brady Urol Inst, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Urol, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21205 USA; Univ So Calif, Childrens Hosp Los Angeles, Keck Sch Med, Los Angeles, CA USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Children's Hospital Los Angeles; University of Southern California	Freedland, SJ (corresponding author), Johns Hopkins Univ Hosp, Dept Urol, Baltimore, MD 21287 USA.	sfreedl1@jhmi.edu	FENTON, MIRIAM C/B-6430-2011		NATIONAL CANCER INSTITUTE [P50CA058236] Funding Source: NIH RePORTER; NCI NIH HHS [P50CA58236] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Albertsen PC, 2004, J UROLOGY, V171, P2221, DOI 10.1097/01.ju.0000124381.93689.b4; Amling CL, 2000, J UROLOGY, V164, P101, DOI 10.1016/S0022-5347(05)67457-5; Crawford ED, 2003, UROLOGY, V61, P8, DOI 10.1016/S0090-4295(02)02394-4; D'Amico AV, 2002, J CLIN ONCOL, V20, P4567, DOI 10.1200/JCO.2002.03.061; D'Amico AV, 2003, J NATL CANCER I, V95, P1376, DOI 10.1093/jnci/djg043; DAMICO AV, 1993, CANCER-AM CANCER SOC, V72, P2638, DOI 10.1002/1097-0142(19931101)72:9<2638::AID-CNCR2820720919>3.0.CO;2-N; DOREY FJ, 1987, STAT MED, V6, P679, DOI 10.1002/sim.4780060605; Han M, 2001, UROL CLIN N AM, V28, P555, DOI 10.1016/S0094-0143(05)70163-4; HANCOCK SL, 1995, J UROLOGY, V154, P1412, DOI 10.1016/S0022-5347(01)66879-4; Hanlon AL, 2004, INT J RADIAT ONCOL, V58, P43, DOI 10.1016/S0360-3016(03)01432-9; Hanlon AL, 2002, INT J RADIAT ONCOL, V53, P297, DOI 10.1016/S0360-3016(02)02717-7; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Hull GW, 2002, J UROLOGY, V167, P528, DOI 10.1016/S0022-5347(01)69079-7; Iversen P, 2002, EUR UROL, V42, P204, DOI 10.1016/S0302-2838(02)00311-1; Kim-Sing C, 2004, INT J RADIAT ONCOL, V60, P463, DOI 10.1016/j.ijrobp.2004.03.004; Messing EM, 1999, NEW ENGL J MED, V341, P1781, DOI 10.1056/NEJM199912093412401; Moul JW, 2004, J UROLOGY, V171, P1141, DOI 10.1097/01.JU.0000113794.34810.D0; Okotie OT, 2004, J UROLOGY, V171, P2260, DOI 10.1097/01.ju.0000127734.01845.99; PARTIN AW, 1994, UROLOGY, V43, P649, DOI 10.1016/0090-4295(94)90180-5; Patel A, 1997, J UROLOGY, V158, P1441, DOI 10.1016/S0022-5347(01)64238-1; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Pinover WH, 2003, CANCER-AM CANCER SOC, V97, P1127, DOI 10.1002/cncr.11166; POLLACK A, 1994, CANCER, V74, P670, DOI 10.1002/1097-0142(19940715)74:2<670::AID-CNCR2820740220>3.0.CO;2-8; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; Roberts SG, 2001, MAYO CLIN PROC, V76, P576; Roehl KA, 2004, J UROLOGY, V172, P910, DOI 10.1097/01.ju.0000134888.22332.bb; Sartor CI, 1997, INT J RADIAT ONCOL, V38, P941, DOI 10.1016/S0360-3016(97)00082-5; Swindle PW, 2003, UROL CLIN N AM, V30, P377, DOI 10.1016/S0094-0143(02)00176-3; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; TRAPASSO JG, 1994, J UROLOGY, V152, P1821, DOI 10.1016/S0022-5347(17)32394-7; Ward JF, 2003, J UROLOGY, V170, P1872, DOI 10.1097/01.ju.0000091876.13656.2e; Zagars GK, 1997, RADIOTHER ONCOL, V44, P213, DOI 10.1016/S0167-8140(97)00123-0	32	1042	1060	2	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 27	2005	294	4					433	439		10.1001/jama.294.4.433	http://dx.doi.org/10.1001/jama.294.4.433			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	948RM	16046649	Bronze			2022-12-01	WOS:000230733400017
J	Marra, J				Marra, J			When will we tame the oceans?	NATURE			English	Editorial Material							SUSTAINABILITY; AQUACULTURE; FISHERIES; FUTURE		Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Columbia University	Marra, J (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.							Baldwin K, 2000, MAR TECHNOL SOC J, V34, P53; Bromhead D, 2003, REV IMPACT FISH AGGR; Dalton R, 2005, NATURE, V435, P1014, DOI 10.1038/4351014b; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; Goldburg R.J., 2001, MARINE AQUACULTURE U; GOUDEY CA, 1998, P OFFSH TECHN AQ, P193; *ICCAT, 1999, SCRS9921 ICCAT; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Pitcher TJ, 2001, ECOL APPL, V11, P601; Pitcher TJ, 2000, FISH FISH, V1, P99, DOI 10.1046/j.1467-2979.2000.00004.x; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014	14	51	52	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 14	2005	436	7048					175	176		10.1038/436175a	http://dx.doi.org/10.1038/436175a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944VR	16015306				2022-12-01	WOS:000230459500016
J	Adegbola, RA; Secka, O; Lahai, G; Lloyd-Evans, N; Njie, A; Usen, S; Oluwalana, C; Obaro, S; Weber, M; Corrah, T; Mulholland, K; McAdam, K; Greenwood, B; Milligan, PJM				Adegbola, RA; Secka, O; Lahai, G; Lloyd-Evans, N; Njie, A; Usen, S; Oluwalana, C; Obaro, S; Weber, M; Corrah, T; Mulholland, K; McAdam, K; Greenwood, B; Milligan, PJM			Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study	LANCET			English	Article							MENINGITIS; INFECTIONS; EPIDEMIOLOGY; PNEUMONIA; EFFICACY; CHILDREN; TRIAL	Background Routine immunisation of infants in The Gambia with a Haemophilus influenzae type b (Hib) polysaccharide-tetanus toxoid conjugate vaccine began in May, 1997. We investigated the effectiveness of the vaccine when delivered through the expanded programme on immunisation and the effect of national immunisation. on incidence of Hib disease. Methods Surveillance for Hib disease was maintained in the western half of The Gambia using standard methods with an emphasis on meningitis. We estimated vaccine efficacy using the case control method, and vaccine coverage and population denominators for incidence rates using a cluster sample survey. Prevalence of Hib carriage in a sample of 1-2-year old children attending health centres for vaccination was ascertained with oropharyngeal swabs plated onto antiserum agar. Findings Between May, 1997, and April, 2002, a total of 5984 children were examined for possible Hib infections. 49 children had Hib disease, 36 of whom had meningitis. The annual incidence rates of Hib meningitis before any use of the vaccine (1990-93) dropped from over 200 per 100 000 children aged younger than 1 year to none per 100 000 in 2002, and from 60 to no cases per 100 000 in children younger than 5 years. The prevalence of Hib carriage decreased from 12% to 0.25% (p<0.0001). Two doses of vaccine were needed for direct protection from Hib disease (vaccine efficacy 94%, 95% CI 62-99). Since most children received a protective dose after the age of greatest disease risk, indirect effects were important in reducing disease incidence. Interpretation The Gambian Hib immunisation programme reduced the occurrence of Hib disease despite irregular vaccine supply. The effect of the programme in The Gambia has important implications for the introduction of the vaccine into routine immunisation. programmes of other developing countries.	MRC Labs, Banjul, Gambia; Natl Hlth Lab, Banjul, Gambia; Dept State Hlth, Banjul, Gambia; Royal Childrens Hosp, Parkville, Vic 3052, Australia; London Sch Hyg & Trop Med, Dept Infect Dis, London WC1, England	MRC Laboratory Molecular Biology; Royal Children's Hospital Melbourne; University of London; London School of Hygiene & Tropical Medicine	Adegbola, RA (corresponding author), MRC Labs, POB 273, Banjul, Gambia.	radegbola@mrc.gm	Milligan, Paul/D-8985-2017	Milligan, Paul/0000-0003-3430-3395				ADAMS WG, 1993, JAMA-J AM MED ASSOC, V269, P221, DOI 10.1001/jama.269.2.221; Adegbola RA, 1996, ANN TROP PAEDIATR, V16, P103, DOI 10.1080/02724936.1996.11747812; Adegbola RA, 1998, J INFECT DIS, V177, P1758, DOI 10.1086/517440; Adegbola RA, 1999, LANCET, V354, P1091, DOI 10.1016/S0140-6736(99)03010-X; BAER M, 1995, LANCET, V345, P661, DOI 10.1016/S0140-6736(95)90570-7; BIJLMER HA, 1990, J INFECT DIS, V161, P1210, DOI 10.1093/infdis/161.6.1210; BIJLMER HA, 1991, VACCINE S, V9, P5; BULKOW LR, 1993, PEDIATR INFECT DIS J, V12, P484, DOI 10.1097/00006454-199306000-00006; COCHI SL, 1988, PEDIATRICS, V81, P166; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Dagan R, 1999, VACCINE, V17, P134, DOI 10.1016/S0264-410X(98)00165-0; DECKER MD, 1992, J PEDIATR-US, V120, P184, DOI 10.1016/S0022-3476(05)80424-X; Garner D, 2003, LANCET, V361, P395, DOI 10.1016/S0140-6736(03)12385-9; GIESECHE J, 1997, LANCET, V349, P670; Goetghebuer T, 2000, TROP MED INT HEALTH, V5, P207, DOI 10.1046/j.1365-3156.2000.00535.x; GREENWOOD B, 1992, J INFECT DIS, V165, pS26, DOI 10.1093/infdis/165-Supplement_1-S26; Jordens JZ, 1995, EUR J CLIN MICROBIOL, V14, P935, DOI 10.1007/BF01691374; Lagos R, 1998, PEDIATR INFECT DIS J, V17, pS139, DOI 10.1097/00006454-199809001-00010; Milligan P, 2004, INT J EPIDEMIOL, V33, P469, DOI 10.1093/ije/dyh096; Mulholland K, 1997, LANCET, V349, P1191, DOI 10.1016/S0140-6736(96)09267-7; PELTOLA H, 1992, LANCET, V340, P592, DOI 10.1016/0140-6736(92)92117-X; Ramsay ME, 2003, J INFECT DIS, V188, P481, DOI 10.1086/376997; WAGGONERFOUNTAIN LA, 1995, CLIN INFECT DIS, V21, P1322, DOI 10.1093/clinids/21.5.1322; Ward JJ, 1996, CLIN INFECT DIS, V22, P1077, DOI 10.1093/clinids/22.6.1077; Wenger JD, 1999, VACCINE, V18, P736, DOI 10.1016/S0264-410X(99)00269-8	25	219	225	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 9	2005	366	9480					144	150		10.1016/S0140-6736(05)66788-8	http://dx.doi.org/10.1016/S0140-6736(05)66788-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	943JH	16005337				2022-12-01	WOS:000230349200033
J	Worm, B; Sandow, M; Oschlies, A; Lotze, HK; Myers, RA				Worm, B; Sandow, M; Oschlies, A; Lotze, HK; Myers, RA			Global patterns of predator diversity in the open oceans	SCIENCE			English	Article							PACIFIC-OCEAN; CLIMATE; VARIABILITY; POPULATIONS; DYNAMICS; COLLAPSE; IMPACTS; HABITAT; DEPTH	The open oceans comprise most of the biosphere, yet patterns and trends of species diversity there are enigmatic. Here, we derive worldwide patterns of tuna and billfish diversity over the past 50 years, revealing distinct subtropical "hotspots" that appeared to hold generally for other predators and zooplankton. Diversity was positively correlated with thermal fronts and dissolved oxygen and a nonlinear function of temperature (similar to 25 degrees C optimum). Diversity declined between 10 and 50% in all. oceans, a trend that coincided with increased fishing pressure, superimposed on strong El Nino-Southern Oscillation-driven variability across the Pacific. We conclude that predator diversity shows a predictable yet eroding pattern signaling ecosystem-wide changes linked to climate and fishing.	Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada; Leibniz Inst Marine Sci, D-24105 Kiel, Germany; Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England	Dalhousie University; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; NERC National Oceanography Centre	Worm, B (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada.	bworm@dal.ca	Oschlies, Andreas/F-9749-2012	Oschlies, Andreas/0000-0002-8295-4013; Lotze, Heike/0000-0001-6258-1304; Worm, Boris/0000-0002-5742-8716				Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Bertrand A, 2002, CAN J FISH AQUAT SCI, V59, P1002, DOI 10.1139/F02-073; Blank JM, 2002, J EXP BIOL, V205, P1881; Block BA, 2002, OCEANOL ACTA, V25, P255, DOI 10.1016/S0399-1784(02)01212-4; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; Cox SP, 2002, CAN J FISH AQUAT SCI, V59, P1736, DOI 10.1139/F02-138; Dulvy NK, 2004, ECOL LETT, V7, P410, DOI 10.1111/j.1461-0248.2004.00593.x; Etnoyer Peter, 2004, Oceanography, V17, P90; Ferraroli S, 2004, NATURE, V429, P521, DOI 10.1038/429521a; Gotelli NJ, 1996, NULL MODELS ECOLOGY; HANEY JC, 1986, MAR ECOL PROG SER, V28, P279, DOI 10.3354/meps028279; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Hyrenbach KD, 2000, AQUAT CONSERV, V10, P437, DOI 10.1002/1099-0755(200011/12)10:6<437::AID-AQC425>3.3.CO;2-H; *IUCN, 2004, 10 YEAR HIGH SEAS MA; Lehodey P, 2003, FISH OCEANOGR, V12, P483, DOI 10.1046/j.1365-2419.2003.00244.x; Malakoff D, 2004, SCIENCE, V304, P1104, DOI 10.1126/science.304.5674.1104; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Myers RA, 2005, PHILOS T R SOC B, V360, P13, DOI 10.1098/rstb.2004.1573; Newman M, 2003, J CLIMATE, V16, P3853, DOI 10.1175/1520-0442(2003)016<3853:EVOTPD>2.0.CO;2; Oschlies A, 1998, NATURE, V394, P266, DOI 10.1038/28373; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Polovina JJ, 2001, PROG OCEANOGR, V49, P469, DOI 10.1016/S0079-6611(01)00036-2; Rutherford S, 1999, NATURE, V400, P749, DOI 10.1038/23449; Springer AM, 2003, P NATL ACAD SCI USA, V100, P12223, DOI 10.1073/pnas.1635156100; Sund P.N., 1981, Oceanography and Marine Biology an Annual Review, V19, P443; Ward P, 2005, ECOLOGY, V86, P835, DOI 10.1890/03-0746; Ward P, 2005, CAN J FISH AQUAT SCI, V62, P1130, DOI 10.1139/F05-021; Worm B, 2004, NATURE, V429, P15, DOI 10.1038/429015a; Worm B, 2003, P NATL ACAD SCI USA, V100, P9884, DOI 10.1073/pnas.1333941100	29	241	253	2	140	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2005	309	5739					1365	1369		10.1126/science.1113399	http://dx.doi.org/10.1126/science.1113399			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TX	16051749	Green Accepted			2022-12-01	WOS:000231543300042
J	Marston, C; Meltzer, H; Majeed, A				Marston, C; Meltzer, H; Majeed, A			Impact on contraceptive practice of making emergency hormonal contraception available over the counter in Great Britain: repeated cross sectional surveys	BRITISH MEDICAL JOURNAL			English	Article							PLAN-B; SALES; FDA	Objective To examine the impact on contraceptive practice of making emergency hormonal contraception available over the counter. Design Analysis of data on contraceptive practice for women aged 16-49 years in the period 2000-2 from the Omnibus Survey, a multipurpose survey in which around 7600 adults living in private households are interviewed each year. Setting Private households in Great Britain. Main outcome measures Use of different types of contraception and rates of unprotected sex. Results After emergency hormonal contraception was made available over the counter, levels of use of different types of contraception by women aged 16-49 remained similar. No significant change occurred in the proportion of women using emergency hormonal contraception (8.4% in 2000,7.9% in 2001, 7.2% in 2002) or having unprotected sex. A change did, however, occur in where women obtained emergency hormonal contraception; a smaller proportion of women obtained emergency hormonal contraception from physicians and a greater proportion bought it over the counter. No significant change occurred in the proportion of women using more reliable methods of contraception, such as the oral contraceptive pill, or in the proportion of women using emergency hormonal contraception more than once during a year. Conclusions Making emergency hormonal contraception available over the counter does not seem to have led to an increase in its use, to an. increase in unprotected sex, or to a decrease in the use of more reliable methods of contraception.	Imperial Coll Fac Med, Dept Primary Care & Social Med, London W6 8RP, England; Off Natl Stat, London SW1V 2QQ, England	Imperial College London	Marston, C (corresponding author), Imperial Coll Fac Med, Dept Primary Care & Social Med, London W6 8RP, England.	c.marston@imperial.ac.uk	Marston, Cicely A/T-3551-2017; Meltzer, Herbert Y/E-8131-2013; Marston, Cicely/ABB-9376-2020	Marston, Cicely A/0000-0002-5529-4646; Majeed, Azeem/0000-0002-2357-9858				*AM LIF LEAG, ALLPRES J BROWN TEST; *AM LIF LEAG, ALL PRES J BROWN TES; Bissell P, 2003, SOC SCI MED, V57, P2367, DOI 10.1016/S0277-9536(03)00129-1; DAWE F, 2002, CONTRACEPTION SEXUAL; DAWE F, 2003, CONTRACEPTION SEXUAL; Drazen JM, 2004, NEW ENGL J MED, V350, P1561, DOI 10.1056/NEJMe048057; Fenichel RR, 2004, BMJ-BRIT MED J, V329, P182, DOI 10.1136/bmj.329.7459.182; Glasier A, 1998, NEW ENGL J MED, V339, P1, DOI 10.1056/NEJM199807023390101; Gold Melanie A, 2004, J Pediatr Adolesc Gynecol, V17, P87, DOI 10.1016/j.jpag.2003.11.018; Grimes DA, 2002, AM J OBSTET GYNECOL, V187, P1536, DOI 10.1067/mob.2002.128521; Harrison-Woolrych M, 2001, BRIT MED J, V322, P186; Jackson RA, 2003, OBSTET GYNECOL, V102, P8, DOI 10.1016/S0029-7844(03)00478-2; Kerins M, 2004, EMERG MED J, V21, P67, DOI 10.1136/emj.2003.007708; Mayor S, 2002, BRIT MED J, V324, P995; Nelson R, 2004, LANCET, V363, P1707, DOI 10.1016/S0140-6736(04)16290-9; Raine T, 2000, OBSTET GYNECOL, V96, P1, DOI 10.1016/S0029-7844(00)00830-9; Rothschild TJ, 2003, NEW ENGL J MED, V348, P82; Vastag B, 2004, JAMA-J AM MED ASSOC, V291, P2805, DOI 10.1001/jama.291.23.2805; Westhoff C, 2003, NEW ENGL J MED, V349, P1830, DOI 10.1056/NEJMcp031990; Williams C, 1996, BRIT MED J, V312, P463, DOI 10.1136/bmj.312.7029.463a	20	99	99	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 30	2005	331	7511					271	273		10.1136/bmj.38519.440266.8F	http://dx.doi.org/10.1136/bmj.38519.440266.8F			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	953FJ	16009669	Green Submitted, Green Published, Green Accepted			2022-12-01	WOS:000231061700020
J	Sugita, M; Shiba, Y				Sugita, M; Shiba, Y			Genetic tracing shows segregation of taste neuronal circuitries for bitter and sweet	SCIENCE			English	Article							PARABRACHIAL AREA; MAMMALIAN SWEET; PHA-L; RECEPTORS; RAT; PROJECTIONS; PATHWAYS; CORTEX; ORGANIZATION; CONNECTIONS	The recent discovery of mammalian bitter, sweet, and umami taste receptors indicates how the different taste qualities are encoded at the periphery. However, taste representations in the brain remain elusive. We used a genetic approach to visualize the neuronal circuitries of bitter and sweet tastes in mice to gain insight into how taste recognition is accomplished in the brain. By selectively expressing a transsynaptic tracer in either bitter- or sweet and/ or umami-responsive taste receptor cells, and by comparing the locations of the tracer-labeled neurons in the brain, our data revealed the potential neuronal bases that underlie discrimination of bitter versus sweet.	Hiroshima Univ, Grad Sch Biomed Sci, Dept Physiol & Oral Physiol, Minami Ku, Hiroshima 7348553, Japan	Hiroshima University	Sugita, M (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Physiol & Oral Physiol, Minami Ku, Kasumi 1-2-3, Hiroshima 7348553, Japan.	sugisan@hiroshima-u.ac.jp	Sugita, Makoto/E-9340-2018	Sugita, Makoto/0000-0002-3157-300X				Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; ALLEN GV, 1991, J COMP NEUROL, V311, P1, DOI 10.1002/cne.903110102; Berman DE, 2001, SCIENCE, V291, P2417, DOI 10.1126/science.1058165; BERNARD JF, 1993, J COMP NEUROL, V329, P201, DOI 10.1002/cne.903290205; Bester H, 1999, J COMP NEUROL, V405, P421; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; HAMILTON RB, 1984, J COMP NEUROL, V222, P560, DOI 10.1002/cne.902220408; HERBERT H, 1990, J COMP NEUROL, V293, P540, DOI 10.1002/cne.902930404; Lindemann B, 2001, NATURE, V413, P219, DOI 10.1038/35093032; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; NORGREN R, 1976, J COMP NEUROL, V166, P17, DOI 10.1002/cne.901660103; Norgren Ralph, 1995, P751; SUGITA M, UNPUB; Yee CL, 2003, J COMP NEUROL, V459, P15, DOI 10.1002/cne.10589; Yoshihara Y, 1999, NEURON, V22, P33, DOI 10.1016/S0896-6273(00)80676-5; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	21	71	75	2	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2005	309	5735					781	785		10.1126/science.1110787	http://dx.doi.org/10.1126/science.1110787			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951NU	16051799				2022-12-01	WOS:000230938200053
J	Choe, J; Kelker, MS; Wilson, IA				Choe, J; Kelker, MS; Wilson, IA			Crystal structure of human Toll-like receptor 3 (TLR3) ectodomain	SCIENCE			English	Article							DOUBLE-STRANDED-RNA; LEUCINE-RICH REPEAT; GLYCOPROTEIN IB-ALPHA; NF-KAPPA-B; RIBONUCLEASE INHIBITOR; CUTTING EDGE; PROTEIN; RECOGNITION; DOMAIN; ACTIVATION	Toll-like receptors (TLRs) play key roles in activating immune responses during infection. The human TLR3 ectodomain structure at 2.1 angstroms reveals a large horseshoe-shaped solenoid assembled from 23 leucine-rich repeats (LRRs). Asparagines conserved in the 24-residue LRR motif contribute extensive hydrogen-bonding networks for solenoid stabilization. TLR3 is largely masked by carbohydrate, but one face is glycosylation-free, which suggests its potential role in ligand binding and oligomerization. Highly conserved surface residues and a TLR3-specific LRR insertion form a homodimer interface in the crystal, whereas two patches of positively charged residues and a second insertion would provide an appropriate binding site for double-stranded RNA.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Wilson, IA (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wilson@scripps.edu			NATIONAL CANCER INSTITUTE [R01CA058896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042266, R37AI042266] Funding Source: NIH RePORTER; NCI NIH HHS [CA-58896] Funding Source: Medline; NIAID NIH HHS [T32 AI077606, R01 AI042266, AI-42266] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Enkhbayar P, 2004, PROTEINS, V54, P394, DOI 10.1002/prot.10605; Evdokimov AG, 2001, J MOL BIOL, V312, P807, DOI 10.1006/jmbi.2001.4973; Hajjar AM, 2001, J IMMUNOL, V166, P15, DOI 10.4049/jimmunol.166.1.15; He XLL, 2003, NEURON, V38, P177, DOI 10.1016/S0896-6273(03)00232-0; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jiang QQ, 2000, J IMMUNOL, V165, P3541, DOI 10.4049/jimmunol.165.7.3541; Jiang ZF, 2003, J BIOL CHEM, V278, P16713, DOI 10.1074/jbc.M300562200; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Kariko K, 2004, J IMMUNOL, V172, P6545, DOI 10.4049/jimmunol.172.11.6545; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; Kobe B, 1996, J MOL BIOL, V264, P1028, DOI 10.1006/jmbi.1996.0694; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; KOBE B, 1993, NATURE, V366, P751, DOI 10.1038/366751a0; Lee HK, 2004, J BIOL CHEM, V279, P10564, DOI 10.1074/jbc.M311564200; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; O'Neill LAJ, 2003, TRENDS IMMUNOL, V24, P287, DOI 10.1016/S1471-4906(03)00115-7; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Ryter JM, 1998, EMBO J, V17, P7505, DOI 10.1093/emboj/17.24.7505; Sarkar SN, 2003, J BIOL CHEM, V278, P4393, DOI 10.1074/jbc.C200655200; Sarkar SN, 2004, NAT STRUCT MOL BIOL, V11, P1060, DOI 10.1038/nsmb847; Seewald MJ, 2002, NATURE, V415, P662, DOI 10.1038/415662a; Sen GC, 2005, CYTOKINE GROWTH F R, V16, P1, DOI 10.1016/j.cytogfr.2005.01.006; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Tian B, 2004, NAT REV MOL CELL BIO, V5, P1013, DOI 10.1038/nrm1528; Uff S, 2002, J BIOL CHEM, V277, P35657, DOI 10.1074/jbc.M205271200; Ulevitch RJ, 2004, NAT REV IMMUNOL, V4, P512, DOI 10.1038/nri1396; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zuany-Amorim C, 2002, NAT REV DRUG DISCOV, V1, P797, DOI 10.1038/nrd914	43	454	506	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2005	309	5734					581	585		10.1126/science.1115253	http://dx.doi.org/10.1126/science.1115253			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SE	15961631				2022-12-01	WOS:000230735200039
J	Mahon, NG; Murphy, RT; MacRae, CA; Caforio, ALP; Elliott, PM; McKenna, WJ				Mahon, NG; Murphy, RT; MacRae, CA; Caforio, ALP; Elliott, PM; McKenna, WJ			Echocardiographic evaluation in asymptornatic relatives of patients with dilated cardiomyopathy reveals preclinical disease	ANNALS OF INTERNAL MEDICINE			English	Article							CONDUCTION-SYSTEM DISEASE; LAMIN A/C GENE; HEART-FAILURE; MUTATION; ASSOCIATION; GUIDELINES; ADULT; LOCUS; MAPS	Background: idiopathic dilated cardiomyopathy is often familial, and apparently healthy relatives may have latent, early, or undiagnosed established disease. Objective: To determine the prevalence and natural history of asymptomatic cardiac abnormalities among sampled relatives of unselected patients referred for management of dilated cardiomyopathy. Design: Prospective cohort study. Patients: 767 asymptomatic relatives of 189 consecutive unselected patients with dilated cardiomyopathy. Measurements: Clinical evaluation, including history, physical examination, electrocardiography, and echocardiography, was performed. Participants were classified in accordance with published echocardiographic criteria. Sampled relatives who did not have evidence of dilated cardiomyopathy at the initial evaluation were followed for a median of 57 months (range, 1 to 133 months). Results: Of the 767 patients evaluated, 592 (77.2%) were assessed as healthy, 35 (4.6% [95% CI, 3.7% to 7.6%]) had dilated cardiomyopathy, 119 (15.5% [CI, 12.5% to 18.8%]) had left ventricular enlargement without systolic dysfunction, and 21 (2.7% [CI, 1.9% to 4.9%]) had depressed fractional shortening without ventricular dilatation. At follow-up, progression to dilated cardiomyopathy occurred in 13 (10%) relatives with left ventricular enlargement or depressed fractional shortening versus 3 (1.3%) healthy relatives. In a multivariate model, only left ventricular enlargement or depressed fractional shortening independently predicted progression to dilated cardiomyopathy (hazard ratio, 10.0 [CI, 2.8 to 35.5]; P < 0.001). Limitations: Because relatives had to be willing to participate and be available geographically, selection bias may have occurred. Conclusion: Treatable asymptomatic dilated cardiomyopathy was identified in 4.6% of asymptomatic relatives. In addition, left ventricular enlargement and depressed fractional shortening were common in asymptomatic relatives of patients with dilated cardiomyopathy and were associated with a statistically significant medium-term risk for disease progression. Evaluation of relatives of patients with cardiomyopathy is recommended.	St George Hosp, Sch Med, London, England; Massachusetts Gen Hosp, Charlestown, MA USA; Univ Padua, Padua, Italy	St Georges University London; Harvard University; Massachusetts General Hospital; University of Padua	McKenna, WJ (corresponding author), Heart Hosp, Westmoreland St, London W1G 8PH, England.	william.mckenna@uclh.org	Caforio, Alida/AAC-3223-2019; Elliott, Perry/AAR-3430-2020; McKenna, William J/C-3243-2008	Elliott, Perry/0000-0003-3383-3984; McKenna, William J/0000-0001-7994-2460; Caforio, Alida Linda Patrizia/0000-0002-4901-5655	NHLBI NIH HHS [R01 HL075431] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075431] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arbustini E, 2000, J AM COLL CARDIOL, V35, P1760, DOI 10.1016/S0735-1097(00)00650-1; Baig MK, 1998, J AM COLL CARDIOL, V31, P195, DOI 10.1016/S0735-1097(97)00433-6; Bowles KR, 1996, J CLIN INVEST, V98, P1355, DOI 10.1172/JCI118922; Brodsky GL, 2000, CIRCULATION, V101, P473, DOI 10.1161/01.CIR.101.5.473; CAFORIO ALP, 1994, LANCET, V344, P773, DOI 10.1016/S0140-6736(94)92339-6; DURAND JB, 1995, CIRCULATION, V92, P3387, DOI 10.1161/01.CIR.92.12.3387; Fadic R, 1996, NEW ENGL J MED, V334, P362, DOI 10.1056/NEJM199602083340604; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; Henderson R, 1999, J R STAT SOC B, V61, P367, DOI 10.1111/1467-9868.00182; HENRY WL, 1980, CIRCULATION, V62, P1054, DOI 10.1161/01.CIR.62.5.1054; Hunt SA, 2001, CIRCULATION, V104, P2996, DOI 10.1161/hc4901.102568; Kamisago M, 2000, NEW ENGL J MED, V343, P1688, DOI 10.1056/NEJM200012073432304; KASS S, 1994, NAT GENET, V7, P546, DOI 10.1038/ng0894-546; KEELING PJ, 1995, BRIT HEART J, V73, P417; KRAJINOVIC M, 1995, AM J HUM GENET, V57, P846; Li DX, 1999, CIRCULATION, V100, P461, DOI 10.1161/01.CIR.100.5.461; Li DX, 2001, CIRCULATION, V104, P2188, DOI 10.1161/hc4301.098285; McLeod RS, 2001, CAN J GASTROENTEROL, V15, P647, DOI 10.1155/2001/284746; Mestroni L, 1999, EUR HEART J, V20, P93, DOI 10.1053/euhj.1998.1145; Mestroni L, 1999, J AM COLL CARDIOL, V34, P181, DOI 10.1016/S0735-1097(99)00172-2; MICHELS VV, 1992, NEW ENGL J MED, V326, P77, DOI 10.1056/NEJM199201093260201; MUNTONI F, 1993, NEW ENGL J MED, V329, P921, DOI 10.1056/NEJM199309233291304; NICKLAS JM, 1992, NEW ENGL J MED, V327, P685; Olson TM, 1996, J CLIN INVEST, V97, P528, DOI 10.1172/JCI118445; Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750; OrtizLopez R, 1997, CIRCULATION, V95, P2434, DOI 10.1161/01.CIR.95.10.2434; *R FDN STAT COMP, 2003, LANG ENV STAT COMP; Rice JP, 2001, ADV GENET, V42, P69, DOI 10.1016/S0065-2660(01)42015-3; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Shaw T, 2002, LANCET, V360, P654, DOI 10.1016/S0140-6736(02)09879-3; Siu BL, 1999, CIRCULATION, V99, P1022, DOI 10.1161/01.CIR.99.8.1022; SUGRUE DD, 1992, ANN INTERN MED, V117, P117, DOI 10.7326/0003-4819-117-2-117; Tiret L, 2000, J AM COLL CARDIOL, V35, P29, DOI 10.1016/S0735-1097(99)00522-7; Towbin JA, 1998, CURR OPIN CELL BIOL, V10, P131, DOI 10.1016/S0955-0674(98)80096-3	34	104	104	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 19	2005	143	2					108	115		10.7326/0003-4819-143-2-200507190-00009	http://dx.doi.org/10.7326/0003-4819-143-2-200507190-00009			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946YG	16027452				2022-12-01	WOS:000230608600003
J	Bundock, P; Hooykaas, P				Bundock, P; Hooykaas, P			An Arabidopsis hAT-like transposase is essential for plant development	NATURE			English	Article							DNA-BINDING DOMAIN; PROTEINS; ELEMENTS; FINGER; GENE; FHY3	A significant proportion of the genomes of higher plants and vertebrates consists of transposable elements and their derivatives. Autonomous DNA type transposons encode a transposase that enables them to mobilize to a new chromosomal position in the host genome by a cut-and-paste mechanism. As this is potentially mutagenic, the host limits transposition through epigenetic gene silencing and heterochromatin formation. Here we show that a transposase from Arabidopsis thaliana that we named DAYSLEEPER is essential for normal plant growth; it shares several characteristics with the hAT ( hobo, Activator, Tam3) family of transposases(1). DAYSLEEPER was isolated as a factor binding to a motif (Kubox1) present in the upstream region of the Arabidopsis DNA repair gene Ku70 ( refs 2, 3). This motif is also present in the upstream regions of many other plant genes. Plants lacking DAYSLEEPER or strongly overexpressing this gene do not develop in a normal manner. Furthermore, DAYSLEEPER overexpression results in the altered expression of many genes. Our data indicate that transposase-like genes can be essential for plant development and can also regulate global gene expression. Thus, transposases can become domesticated by the host to fulfil important cellular functions.	Leiden Univ, Inst Biol, NL-2333 AL Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Hooykaas, P (corresponding author), Leiden Univ, Inst Biol, Wassenaarseweg 64, NL-2333 AL Leiden, Netherlands.	hooykaas@rulbim.leidenuniv.nl	Hooykaas, Paul JJ/S-4256-2017	Hooykaas, Paul JJ/0000-0002-9736-6927				Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P421, DOI 10.1016/S0968-0004(00)01620-0; Bundock P, 2002, NUCLEIC ACIDS RES, V30, P3395, DOI 10.1093/nar/gkf445; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Hudson ME, 2003, PLANT J, V34, P453, DOI 10.1046/j.1365-313X.2003.01741.x; Kempken F, 2001, CHROMOSOMA, V110, P1, DOI 10.1007/s004120000118; Kidwell MG, 2000, TRENDS ECOL EVOL, V15, P95, DOI 10.1016/S0169-5347(99)01817-0; KUNZE R, 1993, P NATL ACAD SCI USA, V90, P7094, DOI 10.1073/pnas.90.15.7094; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lundquist EA, 1996, DEVELOPMENT, V122, P1601; Mack AM, 2001, PLANT CELL, V13, P2319, DOI 10.1105/tpc.13.10.2319; Meijer AH, 1998, YEAST, V14, P1407, DOI 10.1002/(SICI)1097-0061(199811)14:15<1407::AID-YEA325>3.0.CO;2-M; Pardue ML, 2003, ANNU REV GENET, V37, P485, DOI 10.1146/annurev.genet.38.072902.093115; RHIA K, 2002, EMBO J, V21, P2819; Rubin E, 2001, GENETICS, V158, P949; Wang HY, 2002, EMBO J, V21, P1339, DOI 10.1093/emboj/21.6.1339	16	105	113	0	22	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 14	2005	436	7048					282	284		10.1038/nature03667	http://dx.doi.org/10.1038/nature03667			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944VR	16015335				2022-12-01	WOS:000230459500046
J	Haskin, LA; Wang, A; Jolliff, BL; McSween, HY; Clark, BC; Des Marais, DJ; McLennan, SM; Tosca, NJ; Hurowitz, JA; Farmer, JD; Yen, A; Squyres, SW; Arvidson, RE; Klingelhofer, G; Schroder, C; de Souza, PA; Ming, DW; Gellert, R; Zipfel, J; Bruckner, J; Bell, JF; Herkenhoff, K; Christensen, PR; Ruff, S; Blaney, D; Gorevan, S; Cabrol, NA; Crumpler, L; Grant, J; Soderblom, L				Haskin, LA; Wang, A; Jolliff, BL; McSween, HY; Clark, BC; Des Marais, DJ; McLennan, SM; Tosca, NJ; Hurowitz, JA; Farmer, JD; Yen, A; Squyres, SW; Arvidson, RE; Klingelhofer, G; Schroder, C; de Souza, PA; Ming, DW; Gellert, R; Zipfel, J; Bruckner, J; Bell, JF; Herkenhoff, K; Christensen, PR; Ruff, S; Blaney, D; Gorevan, S; Cabrol, NA; Crumpler, L; Grant, J; Soderblom, L			Water alteration of rocks and soils on Mars at the Spirit rover site in Gusev crater	NATURE			English	Article							MINERALOGY; CHEMISTRY; DEPOSITS	Gusev crater was selected as the landing site for the Spirit rover because of the possibility that it once held a lake. Thus one of the rover's tasks was to search for evidence of lake sediments(1). However, the plains at the landing site were found to be covered by a regolith composed of olivine-rich basaltic rock and windblown 'global' dust(2). The analyses of three rock interiors exposed by the rock abrasion tool showed that they are similar to one another, consistent with having originated from a common lava flow(3-8). Here we report the investigation of soils, rock coatings and rock interiors by the Spirit rover from sol (martian day) 1 to sol 156, from its landing site to the base of the Columbia hills. The physical and chemical characteristics of the materials analysed provide evidence for limited but unequivocal interaction between water and the volcanic rocks of the Gusev plains. This evidence includes the softness of rock interiors that contain anomalously high concentrations of sulphur, chlorine and bromine relative to terrestrial basalts and martian meteorites(9); sulphur, chlorine and ferric iron enrichments in multilayer coatings on the light-toned rock Mazatzal; high bromine concentration in filled vugs and veins within the plains basalts; positive correlations between magnesium, sulphur and other salt components in trench soils; and decoupling of sulphur, chlorine and bromine concentrations in trench soils compared to Gusev surface soils, indicating chemical mobility and separation.	Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; Lockheed Martin Space Syst, Littleton, CO 80125 USA; NASA, Exobiol Branch, Ames Res Ctr, Moffett Field, CA 94035 USA; SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Cornell Univ, Ithaca, NY 14853 USA; Johannes Gutenberg Univ Mainz, Inst Anorgan & Analyt Chem, D-55128 Mainz, Germany; Co Vale Rio Doce, BR-20030900 Rio De Janeiro, Brazil; NASA, Lyndon B Johnson Space Ctr, MC KR, Houston, TX 77058 USA; Max Planck Inst Chem, Abt Kosmochem, D-55128 Mainz, Germany; US Geol Survey, Flagstaff, AZ 86001 USA; Honeybee Robot, New York, NY 10012 USA; NASA, SETI Inst, Ames Res Ctr, Moffett Field, CA 94035 USA; NASA, Div Space Sci, Ames Res Ctr, Moffett Field, CA 94035 USA; New Mexico Museum Nat Hist & Sci, Albuquerque, NM 87104 USA; Smithsonian Inst, Washington, DC 20024 USA	Washington University (WUSTL); University of Tennessee System; University of Tennessee Knoxville; Lockheed Martin; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; Arizona State University; Arizona State University-Tempe; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Cornell University; Johannes Gutenberg University of Mainz; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Max Planck Society; United States Department of the Interior; United States Geological Survey; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Smithsonian Institution	Wang, A (corresponding author), Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA.	alianw@levee.wustl.edu	de Souza, Paulo/P-7294-2019; de Souza, Paulo A/B-8961-2008; Blaney, Diana/M-1756-2019; Hurowitz, Joel A/A-8862-2008; de Souza, Paulo/W-2993-2019; Schröder, Christian/B-3870-2009; Farmer, Jack D/B-9343-2019	de Souza, Paulo A/0000-0002-0091-8925; Blaney, Diana/0000-0002-4267-7939; de Souza, Paulo/0000-0002-0091-8925; Schröder, Christian/0000-0002-7935-6039; Tosca, Nicholas/0000-0003-4415-4231; McLennan, Scott/0000-0003-4259-7178				Arvidson RE, 2004, SCIENCE, V305, P821, DOI 10.1126/science.1099922; BARTLETT PW, 2005, LUNAR PLANET SCI C, V36; Bell JF, 2004, SCIENCE, V305, P800, DOI 10.1126/science.1100175; Christensen PR, 2004, SCIENCE, V305, P837, DOI 10.1126/science.1100564; CLARK BC, 1993, GEOCHIM COSMOCHIM AC, V57, P4575, DOI 10.1016/0016-7037(93)90183-W; CLARK BC, 1982, J GEOPHYS RES, V87, P59, DOI 10.1029/JB087iB12p10059; Gellert R, 2004, SCIENCE, V305, P829, DOI 10.1126/science.1099913; GOODING JL, 1992, ICARUS, V99, P28, DOI 10.1016/0019-1035(92)90168-7; GOODING JL, 1978, GEOPHYS RES LETT, V5, P727, DOI 10.1029/GL005i008p00727; Gorevan SP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002061; Govindaraju K., 1994, GEOSTANDARDS NEWSLET, V18, P1; Grant JA, 2004, SCIENCE, V305, P807, DOI 10.1126/science.1099849; Greeley R, 2004, SCIENCE, V305, P810, DOI 10.1126/science.1100108; Haskin LA, 2003, METEORIT PLANET SCI, V38, P13, DOI 10.1111/j.1945-5100.2003.tb01043.x; Herkenhoff KE, 2004, SCIENCE, V305, P824, DOI 10.1126/science.3050824; HUNTEN DM, 1979, J MOL EVOL, V14, P71, DOI 10.1007/BF01732369; Lide D. R., 2001, HDB CHEM PHYS, P4; McSween H.Y., 1998, PLANETARY MAT, V36; McSween HY, 2004, SCIENCE, V305, P842, DOI 10.1126/science.1099851; Morris RV, 2004, SCIENCE, V305, P833, DOI 10.1126/science.1100020; Morris RV, 2000, J GEOPHYS RES-PLANET, V105, P1757, DOI 10.1029/1999JE001059; MORRIS RV, 2005, LUNAR PLANET SCI C, V36; Richardson MI, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002367; SETTLE M, 1979, J GEOPHYS RES, V84, P8343, DOI 10.1029/JB084iB14p08343; Squyres SW, 2004, SCIENCE, V305, P794, DOI 10.1126/science.3050794; Squyres SW, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002121; Wang AL, 1999, J GEOPHYS RES-PLANET, V104, P27067, DOI 10.1029/1999JE001071	27	194	197	2	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2005	436	7047					66	69		10.1038/nature03640	http://dx.doi.org/10.1038/nature03640			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942QJ	16001063				2022-12-01	WOS:000230296600040
J	Kuehn, BM				Kuehn, BM			Evidence-based guidelines needed for osteoporosis screening and treatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item							POSTMENOPAUSAL WOMEN; FRACTURE OUTCOMES; RISK-ASSESSMENT	Despite the prevalence of osteopenia and osteoporosis in the aging female population in the USA, women are not always routinely advised to have osteoporosisscreening. Ethel S. Siris, MD, president-elect of the National Osteoporosis Foundation (NOF), and leader of the National Osteoporosis Risk Assessment (NORA) project, would like to see osteoporosis screening, including bone mineral density measurements or a risk assessment, become part of the standard care for older women. The WHO, in association with NOF and the International Osteoporosis Foundation, is developing evidence-based treatment and intervention guidelines, including a risk assessment algorithm, to address the problem.										Miller PD, 2004, ARCH INTERN MED, V164, P1113, DOI 10.1001/archinte.164.10.1113; Siris ES, 2004, J BONE MINER RES, V19, P1215, DOI 10.1359/JBMR.040508; Siris ES, 2001, JAMA-J AM MED ASSOC, V286, P2815, DOI 10.1001/jama.286.22.2815	3	1	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 6	2005	294	1					34	34		10.1001/jama.294.1.34	http://dx.doi.org/10.1001/jama.294.1.34			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	941JD	15998880				2022-12-01	WOS:000230210200006
J	Leaman, D; Chen, PY; Fak, J; Yalcin, A; Pearce, M; Unnerstall, U; Marks, DS; Sander, C; Tuschl, T; Gaul, U				Leaman, D; Chen, PY; Fak, J; Yalcin, A; Pearce, M; Unnerstall, U; Marks, DS; Sander, C; Tuschl, T; Gaul, U			Antisense-mediated depletion reveals essential and specific functions of microRNAs in Drosophila development	CELL			English	Article							PROGRAMMED CELL-DEATH; C-ELEGANS; COMPUTATIONAL IDENTIFICATION; CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; ENCODES; MELANOGASTER; ACTIVATION; STRIPES; TARGET	MicroRNAs are small noncoding RNAs that control gene function posttranscriptionally through mRNA degradation or translational inhibition. Much has been learned about the processing and mechanism of action of microRNAs, but little is known about their biological function. Here, we demonstrate that injection of 2'O-methyl antisense oligoribonucleotides into early Drosophila embryos leads to specific and efficient depletion of microRNAs and thus permits systematic loss-of-function analysis in vivo. Twenty-five of the forty-six embryonically expressed microRNAs show readily discernible defects; pleiotropy is moderate and family members display similar yet distinct phenotypes. Processes under microRNA regulation include cellularization and patterning in the blastoderm, morphogenesis, and cell survival. The largest microRNA family in Drosophila (miR-2/6/11/13/308) is required for suppressing embryonic apoptosis; this is achieved by differential posttranscriptional repression of the proapoptotic factors hid, grim, reaper, and sickle. Our findings demonstrate that microRNAs act as specific and essential regulators in a wide range of developmental processes.	Rockefeller Univ, Lab Dev Neurogenet, New York, NY 10021 USA; Rockefeller Univ, Lab RNA Mol Biol, New York, NY 10021 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA	Rockefeller University; Rockefeller University; Harvard University; Harvard Medical School; Memorial Sloan Kettering Cancer Center	Gaul, U (corresponding author), Rockefeller Univ, Lab Dev Neurogenet, 1230 York Ave, New York, NY 10021 USA.	gaul@mail.rockefeller.edu	Yalcin, Abdullah/AAG-4175-2019; Sander, Chris/H-1452-2011	Yalcin, Abdullah/0000-0001-8604-4749; Sander, Chris/0000-0001-6059-6270				Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bergmann A, 2002, DEV CELL, V2, P159, DOI 10.1016/S1534-5807(02)00116-8; Boutla A, 2003, NUCLEIC ACIDS RES, V31, P4973, DOI 10.1093/nar/gkg707; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; CARROLL SB, 1990, CELL, V60, P9, DOI 10.1016/0092-8674(90)90711-M; Chang S, 2004, NATURE, V430, P785, DOI 10.1038/nature02752; Chen P, 1996, GENE DEV, V10, P1773, DOI 10.1101/gad.10.14.1773; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Christich A, 2002, CURR BIOL, V12, P137, DOI 10.1016/S0960-9822(01)00658-3; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Enright AJ, 2004, GENOME BIOL, V5; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Hay BA, 2000, CELL DEATH DIFFER, V7, P1045, DOI 10.1038/sj.cdd.4400765; Hipfner DR, 2002, GENETICS, V161, P1527; Hou XS, 1996, CELL, V84, P411, DOI 10.1016/S0092-8674(00)81286-6; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Jacinto A, 2002, DEV CELL, V3, P9, DOI 10.1016/S1534-5807(02)00208-3; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Ketting RF, 2004, EMBO REP, V5, P762, DOI 10.1038/sj.embor.7400207; Lai EC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-115; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lecuit T, 2002, TRAFFIC, V3, P92, DOI 10.1034/j.1600-0854.2002.030202.x; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lin SY, 2003, DEV CELL, V4, P639, DOI 10.1016/S1534-5807(03)00124-2; Mazumdar A, 2002, BIOESSAYS, V24, P1012, DOI 10.1002/bies.10184; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Nambu PA, 1996, DEVELOPMENT, V122, P3467; Nordstrom W, 1996, DEV BIOL, V180, P213, DOI 10.1006/dbio.1996.0296; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Pick L, 1998, DEV GENET, V23, P1; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rajewsky N, 2004, DEV BIOL, V267, P529, DOI 10.1016/j.ydbio.2003.12.003; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; RiveraPomar R, 1996, TRENDS GENET, V12, P478, DOI 10.1016/0168-9525(96)10044-5; Salvesen GS, 2004, ONCOGENE, V23, P2774, DOI 10.1038/sj.onc.1207522; Schock F, 2002, ANNU REV CELL DEV BI, V18, P463, DOI 10.1146/annurev.cellbio.18.022602.131838; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Tittel JN, 2000, GENOME BIOL, V1, pS3; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; Welte MA, 1998, CELL, V92, P547, DOI 10.1016/S0092-8674(00)80947-2; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Yan RQ, 1996, CELL, V84, P421, DOI 10.1016/S0092-8674(00)81287-8; Zhang S, 2002, CELL, V108, P45, DOI 10.1016/S0092-8674(01)00630-4	52	256	289	1	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 1	2005	121	7					1097	1108		10.1016/j.cell.2005.04.016	http://dx.doi.org/10.1016/j.cell.2005.04.016			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	944RZ	15989958	Bronze, Green Published			2022-12-01	WOS:000230448000015
J	Michor, F; Hughes, TP; Iwasa, Y; Branford, S; Shah, NP; Sawyers, CL; Nowak, MA				Michor, F; Hughes, TP; Iwasa, Y; Branford, S; Shah, NP; Sawyers, CL; Nowak, MA			Dynamics of chronic myeloid leukaemia	NATURE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; COMPLETE CYTOGENETIC REMISSION; TIME QUANTITATIVE PCR; IMATINIB MESYLATE; BLAST CRISIS; ABL GENE; HEMATOPOIETIC PROGENITORS; CLINICAL RESISTANCE; TYROSINE KINASE; CHRONIC PHASE	The clinical success of the ABL tyrosine kinase inhibitor imatinib in chronic myeloid leukaemia (CML) serves as a model for molecularly targeted therapy of cancer(1-4), but at least two critical questions remain. Can imatinib eradicate leukaemic stem cells? What are the dynamics of relapse due to imatinib resistance, which is caused by mutations in the ABL kinase domain? The precise understanding of how imatinib exerts its therapeutic effect in CML and the ability to measure disease burden by quantitative polymerase chain reaction provide an opportunity to develop a mathematical approach. We find that a four-compartment model, based on the known biology of haematopoietic differentiation(5), can explain the kinetics of the molecular response to imatinib in a 169-patient data set. Successful therapy leads to a biphasic exponential decline of leukaemic cells. The first slope of 0.05 per day represents the turnover rate of differentiated leukaemic cells, while the second slope of 0.008 per day represents the turnover rate of leukaemic progenitors. The model suggests that imatinib is a potent inhibitor of the production of differentiated leukaemic cells, but does not deplete leukaemic stem cells. We calculate the probability of developing imatinib resistance mutations and estimate the time until detection of resistance. Our model provides the first quantitative insights into the in vivo kinetics of a human cancer.	Harvard Univ, Dept Math, Dept Organism & Evolutionary Biol, Program Evolutionary Dynam, Cambridge, MA 02138 USA; Inst Med & Vet Sci, Adelaide, SA 5000, Australia; Kyushu Univ, Dept Biol, Fukuoka 8128581, Japan; Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Dept Med & Mol Pharmacol,Dept Urol,Mol Biol Inst, Los Angeles, CA 90095 USA	Harvard University; Institute Medical & Veterinary Science Australia; Kyushu University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Michor, F (corresponding author), Harvard Univ, Dept Math, Dept Organism & Evolutionary Biol, Program Evolutionary Dynam, Cambridge, MA 02138 USA.	michor@fas.harvard.edu	Nowak, Martin A/A-6977-2008; Branford, Susan/X-7733-2019; Iwasa, Yoh/G-5368-2010; Hughes, Tim/AAO-9975-2021; Sawyers, Charles/G-5327-2016	Iwasa, Yoh/0000-0003-0691-1852; Branford, Susan/0000-0002-5095-7981				BEDI A, 1993, BLOOD, V81, P2898; Bhatia R, 2003, BLOOD, V101, P4701, DOI 10.1182/blood-2002-09-2780; Branford S, 2002, BLOOD, V99, P3472, DOI 10.1182/blood.V99.9.3472; Branford S, 2003, BLOOD, V102, P276, DOI 10.1182/blood-2002-09-2896; Branford S, 2004, BLOOD, V104, P2926, DOI 10.1182/blood-2004-03-1134; Branford S, 1999, BRIT J HAEMATOL, V107, P587; Branford S, 2003, BLOOD, V102, p414A; CHAUDHARY PM, 1991, CELL, V66, P85, DOI 10.1016/0092-8674(91)90141-K; Chu S, 2005, BLOOD, V105, P2093, DOI 10.1182/blood-2004-03-1114; Cortes J, 2004, BLOOD, V104, P2204, DOI 10.1182/blood-2004-04-1335; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Higashi T, 2004, AM J HEMATOL, V76, P275, DOI 10.1002/ajh.20096; Hochhaus A, 2002, LEUKEMIA, V16, P2190, DOI 10.1038/sj.leu.2402741; Holtz MS, 2002, BLOOD, V99, P3792, DOI 10.1182/blood.V99.10.3792; Holyoake T, 1999, BLOOD, V94, P2056, DOI 10.1182/blood.V94.6.2056; Holyoake TL, 2002, LEUKEMIA, V16, P549, DOI 10.1038/sj.leu.2402444; Hughes TP, 2003, NEW ENGL J MED, V349, P1423, DOI 10.1056/NEJMoa030513; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Mahon FX, 2003, BLOOD, V101, P2368, DOI 10.1182/blood.V101.6.2368; Roche-Lestienne C, 2002, BLOOD, V100, P1014, DOI 10.1182/blood.V100.3.1014; Roche-Lestienne C, 2003, NEW ENGL J MED, V348, P2265, DOI 10.1056/NEJMc035089; Sawyers CL, 2002, BLOOD, V99, P3530, DOI 10.1182/blood.V99.10.3530; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810	27	608	626	0	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2005	435	7046					1267	1270		10.1038/nature03669	http://dx.doi.org/10.1038/nature03669			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940JJ	15988530				2022-12-01	WOS:000230140500050
J	Diepstra, A; Niens, M; Vellenga, E; van Imhoff, GW; Nolte, IM; Schaapveld, M; van der Steege, G; van den Berg, A; Kibbelaar, RE; te Meerman, GJ; Poppema, S				Diepstra, A; Niens, M; Vellenga, E; van Imhoff, GW; Nolte, IM; Schaapveld, M; van der Steege, G; van den Berg, A; Kibbelaar, RE; te Meerman, GJ; Poppema, S			Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma	LANCET			English	Article							REED-STERNBERG CELLS; MAJOR HISTOCOMPATIBILITY COMPLEX; DISEASE; GENE; SUSCEPTIBILITY; POLYMORPHISM; POPULATION; EXPRESSION; PATTERNS; SUGGESTS	Background Associations of Hodgkin's lymphoma with HLA have been reported for many years. In 20-40% of patients with this disorder, Epstein-Barr virus (EBV) is present in the neoplastic cells. Because presentation of EBV antigenic peptides can elicit vigorous immune responses, we investigated associations of the HLA region with EBV-positive and EBV-negative Hodgkin's lymphoma. Methods In a retrospective, population-based study, patients with Hodgkin's lymphoma were reclassified according to the WHO classification, and EBV status was assessed by in-situ hybridisation of EBV-encoded small RNAs. Germline DNA was isolated from 200 patients diagnosed between 1987 and 2000 and from their first-degree relatives. Genotyping was done with 33 microsatellite markers spanning the entire HLA region and two single-nucleotide polymorphisms in the genes for tumour necrosis factor alpha and beta. Classic association analysis and the haplotype sharing statistic were used to compare patients with controls. Findings Classic association analysis (but not the haplotype sharing statistic) showed an association of consecutive markers D6S265 and D6S510 (p=0.0002 and 0.0003), located in the HLA class I region, with EBV-positive lymphomas. The haplotype sharing statistic (but not classic association analysis) showed a significant difference in mean haplotype sharing between patients and controls surrounding marker D6S273 (p=0.00003), located in HLA class III. Interpretation Areas within the HLA class I and class III regions are associated with susceptibility to Hodgkin's lymphoma, the association with class I being specific for EBV-positive disease. This finding strongly suggests that antigenic presentation of EBV-derived peptides is involved in the pathogenesis of EBV-involved Hodgkin's lymphoma. Relevance to practice Polymorphisms in the HLA region could explain ethnic variation in the incidence of Hodgkin's lymphoma. The association of EBV-positive Hodgkin's lymphoma with HLA class I suggests that this polymorphism might affect the proper presentation of EBV antigens to cytotoxic T lymphocytes.	Univ Med Ctr Groningen, Dept Pathol, Groningen, Netherlands; Univ Med Ctr Groningen, Dept Med Genet, Groningen, Netherlands; Univ Med Ctr Groningen, Dept Haematol, Groningen, Netherlands; Univ Med Ctr Groningen, Dept Med Biol, Groningen, Netherlands; Univ Groningen, Groningen, Netherlands; Comprehens Canc Ctr N Netherlands, Groningen, Netherlands; Lab Publ Hlth Friesland, Dept Pathol, Leeuwarden, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen	Diepstra, A (corresponding author), Univ Med Ctr Groningen, Dept Pathol & Lab Med, Hanzepl 1,POB 30-001, NL-9700 RB Groningen, Netherlands.	a.diepstra@path.umcg.nl	Schaapveld, Michael/ABC-9714-2020; Poppema, Sibrand/D-1204-2012; van den Berg, Anke/H-1718-2011	van den Berg, Anke/0000-0002-8894-2638; Schaapveld, Michael/0000-0003-4390-7182; Diepstra, Arjan/0000-0001-9239-1050				Ahmad T, 2003, HUM MOL GENET, V12, P647, DOI 10.1093/hmg/ddg066; Beck J, 2001, SOURCE-NOTE HIST ART, V21, P1; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Boon M, 2001, NEUROGENETICS, V3, P221; Brinkman B M, 1995, J Inflamm, V46, P32; de Jong MM, 2003, HUM MOL GENET, V12, P2311, DOI 10.1093/hmg/ddg245; Ferraris AM, 1997, ANN HEMATOL, V74, P131, DOI 10.1007/s002770050270; Glaser SL, 2002, LEUKEMIA RES, V26, P261, DOI 10.1016/S0145-2126(01)00126-6; Glaser SL, 1996, BAILLIERE CLIN HAEM, V9, P401, DOI 10.1016/S0950-3536(96)80018-7; Harty LC, 2002, BLOOD, V99, P690, DOI 10.1182/blood.V99.2.690; HORS J, 1983, IMMUNOL REV, V70, P167, DOI 10.1111/j.1600-065X.1983.tb00714.x; KLITZ W, 1994, AM J HUM GENET, V54, P497; Leen A, 2001, J VIROL, V75, P8649, DOI 10.1128/JVI.75.18.8649-8659.2001; Levinson DF, 2001, AM J MED GENET, V105, P65, DOI 10.1002/1096-8628(20010108)105:1<65::AID-AJMG1064>3.3.CO;2-S; LEWONTIN RC, 1964, GENETICS, V49, P49; Libura J, 2002, ANTICANCER RES, V22, P921; MACK TM, 1995, NEW ENGL J MED, V332, P413, DOI 10.1056/NEJM199502163320701; Maggio EM, 2001, INT J CANCER, V94, P60, DOI 10.1002/ijc.1438; Mainou-Fowler T, 2000, LEUKEMIA LYMPHOMA, V38, P547, DOI 10.3109/10428190009059274; Meij P, 2002, INT J CANCER, V99, P93, DOI 10.1002/ijc.10309; MESSER G, 1991, J EXP MED, V173, P209, DOI 10.1084/jem.173.1.209; Oudejans JJ, 1996, BLOOD, V87, P3844, DOI 10.1182/blood.V87.9.3844.bloodjournal8793844; OZA AM, 1994, CANCER RES, V54, P5101; Poppema S, 2000, SEMIN CANCER BIOL, V10, P345, DOI 10.1006/scbi.2000.0327; Schwering I, 2003, BLOOD, V101, P1505, DOI 10.1182/blood-2002-03-0839; Skinnider BF, 2002, BLOOD, V99, P4283, DOI 10.1182/blood-2002-01-0099; STEIN HJ, 2001, PROGNOSTIC FACTORS C, P237; Taylor GM, 1999, BRIT J CANCER, V80, P1405, DOI 10.1038/sj.bjc.6690536; Taylor GM, 1996, LEUKEMIA, V10, P854; Wihlborg C, 1999, BRIT J HAEMATOL, V104, P346, DOI 10.1046/j.1365-2141.1999.01176.x	30	115	118	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 25	2005	365	9478					2216	2224		10.1016/S0140-6736(05)66780-3	http://dx.doi.org/10.1016/S0140-6736(05)66780-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	938WT	15978930				2022-12-01	WOS:000230034800032
J	Gozlan, RE; St-Hilaire, S; Feist, SW; Martin, P; Kent, ML				Gozlan, RE; St-Hilaire, S; Feist, SW; Martin, P; Kent, ML			Biodiversity - Disease threat to European fish	NATURE			English	Editorial Material							SPHAEROTHECUM-DESTRUENS; INVASIONS; VIRUS		Winfrith Technol Ctr, Ctr Ecol & Hydrol, Dorchester DT2 8ZD, Dorset, England; Idaho State Univ, Dept Biol Sci, Pocatello, ID 83209 USA; CEFAS Weymouth Lab, Weymouth DT4 8UB, Dorset, England; Oregon State Univ, Dept Microbiol, Ctr Fish Dis Res, Corvallis, OR 97331 USA	UK Centre for Ecology & Hydrology (UKCEH); Idaho; Idaho State University; Centre for Environment Fisheries & Aquaculture Science; Oregon State University	Gozlan, RE (corresponding author), Winfrith Technol Ctr, Ctr Ecol & Hydrol, Dorchester DT2 8ZD, Dorset, England.	reg@ceh.ac.uk	St-HIlaire, Sophie/GSI-8705-2022; Gozlan, Rodolphe/B-3973-2009					Arkush KD, 2003, J EUKARYOT MICROBIOL, V50, P430, DOI 10.1111/j.1550-7408.2003.tb00269.x; Gilad O, 2002, DIS AQUAT ORGAN, V48, P101, DOI 10.3354/dao048101; GIURCA R, 1971, ROMANIEI B CERC PISC, V30, P99; Gozlan RE, 2002, J FISH BIOL, V61, P298, DOI 10.1006/jfbi.2002.2042; LELEK A, 1987, FRESHWATER FISHES EU; LODGE DM, 1993, TRENDS ECOL EVOL, V8, P133, DOI 10.1016/0169-5347(93)90025-K; Mendonca HL, 2004, DIS AQUAT ORGAN, V61, P187, DOI 10.3354/dao061187; St-Hilaire S, 2001, DIS AQUAT ORGAN, V46, P173, DOI 10.3354/dao046173; Vander Zanden MJ, 1999, NATURE, V401, P464, DOI 10.1038/46762; Wolfram-Wais A, 1999, HYDROBIOLOGIA, V408, P123, DOI 10.1023/A:1017014130103	10	226	254	1	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2005	435	7045					1046	1046		10.1038/4351046a	http://dx.doi.org/10.1038/4351046a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937ZT	15973399				2022-12-01	WOS:000229970400034
J	Eder, M; Scherr, M				Eder, M; Scherr, M			MicroRNA and lung cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Hannover Med Sch, Dept Hematol & Oncol, D-3000 Hannover, Germany	Hannover Medical School	Eder, M (corresponding author), Hannover Med Sch, Dept Hematol & Oncol, D-3000 Hannover, Germany.							Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637	3	88	97	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 9	2005	352	23					2446	2448		10.1056/NEJMcibr051201	http://dx.doi.org/10.1056/NEJMcibr051201			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933NL	15944431				2022-12-01	WOS:000229638900016
J	Ritter, C; Maddelein, ML; Siemer, AB; Luhrs, T; Ernst, M; Meier, BH; Saupe, SJ; Riek, R				Ritter, C; Maddelein, ML; Siemer, AB; Luhrs, T; Ernst, M; Meier, BH; Saupe, SJ; Riek, R			Correlation of structural elements and infectivity of the HET-s prion	NATURE			English	Article							FUNGUS PODOSPORA-ANSERINA; SOLID-STATE NMR; HETEROKARYON INCOMPATIBILITY; SECONDARY STRUCTURE; AMYLOID FIBRILS; BACKBONE ASSIGNMENTS; H/D-EXCHANGE; IN-VIVO; PROTEIN; SCRAPIE	Prions are believed to be infectious, self-propagating polymers of otherwise soluble, host-encoded proteins(1,2). This concept is now strongly supported by the recent findings that amyloid fibrils of recombinant prion proteins from yeast(3-5), Podospora anserina(6) and mammals(7) can induce prion phenotypes in the corresponding hosts. However, the structural basis of prion infectivity remains largely elusive because acquisition of atomic resolution structural properties of amyloid fibrils represents a largely unsolved technical challenge. HET-s, the prion protein of P. anserina, contains a carboxy-terminal prion domain comprising residues 218 - 289. Amyloid fibrils of HET-s( 218 - 289) are necessary and sufficient for the induction and propagation of prion infectivity(6). Here, we have used fluorescence studies, quenched hydrogen exchange NMR and solid-state NMR to determine the sequence-specific positions of amyloid fibril secondary structure elements of HET-s( 218 - 289). This approach revealed four beta-strands constituted by two pseudo-repeat sequences, each forming a beta-strand-turn-beta- strand motif. By using a structure-based mutagenesis approach, we show that this conformation is the functional and infectious entity of the HET-s prion. These results correlate distinct structural elements with prion infectivity.	Salk Inst Biol Studies, La Jolla, CA 92037 USA; Univ Bordeaux 2, CNRS,Unite Mixte Rech 5095, Inst Biochim & Genet Cellulaires, Lab Genet Mol Champignons, F-33077 Bordeaux, France; ETH Honggerberg, ETH Zurich, Phys Chem, CH-8093 Zurich, Switzerland	Salk Institute; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Swiss Federal Institutes of Technology Domain; ETH Zurich	Riek, R (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	riek@salk.edu	Ernst, Matthias/A-6732-2010; MADDELEIN, Marie-Lise/G-5395-2010; Meier, Beat H/K-4066-2016	Ernst, Matthias/0000-0002-9538-6086; Meier, Beat H/0000-0002-9107-4464; saupe, sven/0000-0002-5589-721X; Riek, Roland/0000-0002-6333-066X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045774] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS045774-03] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALPER T, 1967, NATURE, V214, P764, DOI 10.1038/214764a0; Balguerie A, 2004, J CELL SCI, V117, P2599, DOI 10.1242/jcs.01116; Balguerie A, 2003, EMBO J, V22, P2071, DOI 10.1093/emboj/cdg213; Bracken C, 1997, J BIOMOL NMR, V9, P94, DOI 10.1023/A:1018679819693; Coustou V, 1997, P NATL ACAD SCI USA, V94, P9773, DOI 10.1073/pnas.94.18.9773; Coustou-Linares V, 2001, MOL MICROBIOL, V42, P1325, DOI 10.1046/j.1365-2958.2001.02707.x; Dos Reis S, 2002, J BIOL CHEM, V277, P5703, DOI 10.1074/jbc.M110183200; Glass NL, 2003, EUKARYOT CELL, V2, P1, DOI 10.1128/EC.2.1.1-8.2003; GRZESIEK S, 1992, BIOCHEMISTRY-US, V31, P8180, DOI 10.1021/bi00150a009; GUNTERT P, 1992, J BIOMOL NMR, V2, P619, DOI 10.1007/BF02192850; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hoshino M, 2002, NAT STRUCT BIOL, V9, P332, DOI 10.1038/nsb792; Javitch JA, 2002, METHOD ENZYMOL, V343, P137; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Laws DD, 2001, P NATL ACAD SCI USA, V98, P11686, DOI 10.1073/pnas.201404298; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; LUHRS T, UNPUB NATURE; Maddelein ML, 2002, P NATL ACAD SCI USA, V99, P7402, DOI 10.1073/pnas.072199199; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Samoson A, 2002, CHEM PHYS LETT, V365, P292, DOI 10.1016/S0009-2614(02)01486-0; Saupe SJ, 2000, MICROBIOL MOL BIOL R, V64, P489, DOI 10.1128/MMBR.64.3.489-502.2000; Siemer AB, 2005, ANGEW CHEM INT EDIT, V44, P2441, DOI 10.1002/anie.200462952; Sparrer HE, 2000, SCIENCE, V289, P595, DOI 10.1126/science.289.5479.595; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; TURCQ B, 1991, MOL GEN GENET, V228, P265, DOI 10.1007/BF00282475; Tycko R, 2004, CURR OPIN STRUC BIOL, V14, P96, DOI 10.1016/j.sbi.2003.12.002; Verel R, 2001, J MAGN RESON, V150, P81, DOI 10.1006/jmre.2001.2310; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Yamaguchi KI, 2004, J MOL BIOL, V338, P559, DOI 10.1016/j.jmb.2004.02.067	30	374	378	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2005	435	7043					844	848		10.1038/nature03793	http://dx.doi.org/10.1038/nature03793			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933NK	15944710	Green Accepted			2022-12-01	WOS:000229638700056
J	Nielsen, NR; Zhang, ZF; Kristensen, TS; Netterstrom, B; Schnohr, P; Gronbaek, M				Nielsen, NR; Zhang, ZF; Kristensen, TS; Netterstrom, B; Schnohr, P; Gronbaek, M			Self reported stress and risk of breast cancer: prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							LIFE EVENTS; HORMONE; WOMEN; COPENHAGEN; MORTALITY	Objective To assess the relation between self reported intensity and frequency of stress and first time incidence of primary breast cancer. Design Prospective cohort study with 18 years of follow-up. Setting Copenhagen City heart study, Denmark. Participants The 6689 women participating in the Copenhagen City heart study were asked about their perceived level of stress at baseline in 1981-3. These women were followed until 1999 in the Danish nationwide cancer registry, with < 0.1% loss to follow-up. Main outcome measure First time incidence of primary breast cancer. Results During follow-up 251 women were diagnosed with breast cancer. After adjustment for confounders, women with high levels of stress had a hazard ratio of 0.60 (95% confidence interval 0.37 to 0.97) for breast cancer compared with women with low levels of stress. Furthermore, for each increase in stress level on a six point stress scale an 8% lower risk of,primary breast cancer was found (hazard ratio 0.92,0.85 to 0.99). This association seemed to be stable over time and was particularly pronounced in women receiving hormone therapy. Conclusion High endogenous concentrations of oestrogen are a known risk factor for breast cancer, and impairment of oestrogen synthesis induced by chronic stress may explain a lower incidence of breast cancer in women with high stress. Impairment of normal body function should not, however, be considered a healthy response, and the cumulative health consequences of stress may be disadvantageous.	Natl Inst Publ Hlth, DK-1399 Copenhagen, Denmark; Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA; Natl Inst Occupat Hlth, Copenhagen, Denmark; Hillerod Hosp, Clin Occupat Med, Hillerod, Denmark; Bispebjerg Univ Hosp, Epidemiol Res Unit, Copenhagen City Heart Study, Copenhagen, Denmark	University of California System; University of California Los Angeles; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital	Nielsen, NR (corresponding author), Natl Inst Publ Hlth, Oster Farimagsgrade 5A, DK-1399 Copenhagen, Denmark.	nrn@niph.dk	Rod, Naja/B-9411-2015	Rod, Naja/0000-0002-6400-5105; Zhang, Zuo-Feng/0000-0002-4669-3995; Gronbaek, Morten Klocker/0000-0002-8473-6474				Achat H, 2000, INT J EPIDEMIOL, V29, P622, DOI 10.1093/ije/29.4.622; Appleyard M., 1989, SCAND J SOC MED, V41, P1; Birk AM, 2002, AP FIRE SCI, V4, P3; Breen KM, 2004, ENDOCRINOLOGY, V145, P692, DOI 10.1210/en.2003-1114; Duijts SFA, 2003, INT J CANCER, V107, P1023, DOI 10.1002/ijc.11504; Ferin M, 1999, J CLIN ENDOCR METAB, V84, P1768, DOI 10.1210/jc.84.6.1768; HALBREICH U, 1997, NEUROLOGY S7, V48, P16; Helgesson O, 2003, EUR J CANCER PREV, V12, P377, DOI 10.1097/00008469-200310000-00006; Johansen C, 1997, BRIT J CANCER, V75, P144, DOI 10.1038/bjc.1997.24; Kroenke CH, 2004, AM J EPIDEMIOL, V159, P1019, DOI 10.1093/aje/kwh148; Lillberg K, 2003, AM J EPIDEMIOL, V157, P415, DOI 10.1093/aje/kwg002; Lillberg K, 2001, INT J CANCER, V91, P888, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1138>3.0.CO;2-D; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; NEGROVILAR A, 1993, ENVIRON HEALTH PERSP, V101, P59, DOI 10.2307/3431377; Olsen AH, 2005, BMJ-BRIT MED J, V330, P220, DOI 10.1136/bmj.38313.639236.82; Olsen AH, 2003, BRIT J CANCER, V88, P362, DOI 10.1038/sj.bjc.6600712; Parkin DM, 2001, EUR J CANCER, V37, pS4, DOI 10.1016/S0959-8049(01)00267-2; Protheroe D, 1999, BRIT MED J, V319, P1027, DOI 10.1136/bmj.319.7216.1027; Rivier C, 1995, ANN NY ACAD SCI, V771, P187, DOI 10.1111/j.1749-6632.1995.tb44680.x; Rothman K., 1998, MODERN EPIDEMIOLOGY, P253; SAPOLSKY R, 1998, WHY ZEBRAS DONT GET, P101; Truelsen T, 2003, STROKE, V34, P856, DOI 10.1161/01.STR.0000062345.80774.40; [No title captured]	23	71	75	0	15	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 10	2005	331	7516					548	550A		10.1136/bmj.38547.638183.06	http://dx.doi.org/10.1136/bmj.38547.638183.06			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965GX	16103031	Bronze, Green Published			2022-12-01	WOS:000231939700017
J	Jin, MH; Li, SH; Moghrabi, WN; Sun, H; Travis, GH				Jin, MH; Li, SH; Moghrabi, WN; Sun, H; Travis, GH			Rpe65 is the retinoid isomerase in bovine retinal pigment epithelium	CELL			English	Article							VERTEBRATE VISUAL CYCLE; BINDING-PROTEIN; MEMBRANE-RECEPTOR; HEK293S CELLS; LECITHIN; ACYLTRANSFERASE; IDENTIFICATION; ESTERS; ISOMEROHYDROLASE; ESTERIFICATION	The first event in light perception is absorption of a photon by an opsin pigment, which induces isomerization of its 11-cis-retinaldehyde chromophore. Restoration of light sensitivity to the bleached opsin requires chemical regeneration of 11-cis-retinaldehyde through an enzymatic pathway called the visual cycle. The isomerase, which converts an all-trans-retinyl ester to 11-cis-retinol, has never been identified. Here, we performed an unbiased cDNA expression screen to identify this isomerase. We discovered that the isomerase is a previously characterized protein called Rpe65. We confirmed our identification of the isomerase by demonstrating catalytic activity in mammalian and insect cells that express Rpe65. Mutations in the human RPE65 gene cause a blinding disease of infancy called Leber congenital amaurosis. Rpe65 with the Leber-associated C330Y and Y368H substitutions had no isomerase activity. Identification of Rpe65 as the isomerase explains the phenotypes in rpe65(-/-) knockout mice and in humans with Leber congenital amaurosis.	Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Travis, GH (corresponding author), Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA.	travis@jsei.ucla.edu	Travis, Gabriel Harvey/AIF-1062-2022	Travis, Gabriel Harvey/0000-0003-4020-9493	NATIONAL EYE INSTITUTE [R01EY015844] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY015844, R01 EY015844-04] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; BAVIK CO, 1991, J BIOL CHEM, V266, P14978; BAVIK CO, 1992, J BIOL CHEM, V267, P23035; Bok D, 2003, BIOCHEMISTRY-US, V42, P6090, DOI 10.1021/bi0342416; Brueggemann LI, 2002, J GEN PHYSIOL, V119, P593, DOI 10.1085/jgp.20018495; Chen YM, 2003, VISION RES, V43, P3037, DOI 10.1016/j.visres.2003.08.001; Choo DW, 1998, FEBS LETT, V440, P195, DOI 10.1016/S0014-5793(98)01459-8; CRABB JW, 1991, J BIOL CHEM, V266, P16674; Gollapalli DR, 2003, BIOCHEMISTRY-US, V42, P11824, DOI 10.1021/bi035227w; Gollapalli DR, 2003, BIOCHEMISTRY-US, V42, P5809, DOI 10.1021/bi0341004; HAMSDORF K, 1979, HDB SENSORY PHYSL, V7, P45; Hanein S, 2004, HUM MUTAT, V23, P306, DOI 10.1002/humu.20010; HARNEL CP, 1993, J BIOL CHEM, V268, P15751; HUBBARD R, 1958, J GEN PHYSIOL, V41, P501, DOI 10.1085/jgp.41.3.501; INTRES R, 1994, J BIOL CHEM, V269, P25411; Kloer DP, 2005, SCIENCE, V308, P267, DOI 10.1126/science.1108965; Ma JX, 2001, INVEST OPHTH VIS SCI, V42, P1429; Ma JX, 1999, FEBS LETT, V452, P199, DOI 10.1016/S0014-5793(99)00606-7; MACDONALD PN, 1988, J BIOL CHEM, V263, P12478; Mata NL, 2004, J BIOL CHEM, V279, P635, DOI 10.1074/jbc.M310042200; Mata NL, 2002, NEURON, V36, P69, DOI 10.1016/S0896-6273(02)00912-1; Moiseyev G, 2003, BIOCHEMISTRY-US, V42, P2229, DOI 10.1021/bi026911y; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Ruiz A, 1999, J BIOL CHEM, V274, P3834, DOI 10.1074/jbc.274.6.3834; SAARI JC, 1989, J BIOL CHEM, V264, P8636; SAARI JC, 1988, J BIOL CHEM, V263, P8084; SAARI JC, 1987, J BIOL CHEM, V262, P7618; SAARI JC, 1993, BIOCHEM J, V291, P697, DOI 10.1042/bj2910697; Sambrook J., 1989, MOL CLONING LAB MANU, V3; SCHWEMER J, 1985, MOL MECHANISMS PHOTO, P303; SHI YQ, 1993, BIOCHEMISTRY-US, V32, P1257, DOI 10.1021/bi00056a009; Thompson DA, 2000, INVEST OPHTH VIS SCI, V41, P4293; Tsilou E, 1997, ARCH BIOCHEM BIOPHYS, V346, P21, DOI 10.1006/abbi.1997.0276; Van Hooser JP, 2000, P NATL ACAD SCI USA, V97, P8623, DOI 10.1073/pnas.150236297; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; Winston A, 1998, BIOCHEMISTRY-US, V37, P2044, DOI 10.1021/bi971908d; Xue LL, 2004, CELL, V117, P761, DOI 10.1016/j.cell.2004.05.016; Yzer S, 2003, J MED GENET, V40, P709, DOI 10.1136/jmg.40.9.709; Znoiko SL, 2002, INVEST OPHTH VIS SCI, V43, P1604	39	334	344	4	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 12	2005	122	3					449	459		10.1016/j.cell.2005.06.042	http://dx.doi.org/10.1016/j.cell.2005.06.042			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	955UZ	16096063	Bronze, Green Accepted			2022-12-01	WOS:000231254400015
J	Wilson, WH; Schroeder, DC; Allen, MJ; Holden, MTG; Parkhill, J; Barrell, BG; Churcher, C; Harnlin, N; Mungall, K; Norbertczak, H; Quail, MA; Price, C; Rabbinowitsch, E; Walker, D; Craigon, M; Roy, D; Ghazal, P				Wilson, WH; Schroeder, DC; Allen, MJ; Holden, MTG; Parkhill, J; Barrell, BG; Churcher, C; Harnlin, N; Mungall, K; Norbertczak, H; Quail, MA; Price, C; Rabbinowitsch, E; Walker, D; Craigon, M; Roy, D; Ghazal, P			Complete genome sequence and lytic phase transcription profile of a Coccolithovirus	SCIENCE			English	Article							EMILIANIA-HUXLEYI; CELL-DEATH; PHOSPHATE TRANSPORTER; VIRUSES; APOPTOSIS; CERAMIDE; PHYCODNAVIRIDAE; PHYTOPLANKTON; LIMITATION; NITROGEN	The genus Coccolithovirus is a recently discovered group of viruses that infect the globally important marine calcifying microalga Emiliania huxleyi. Among the 472 predicted genes of the 407,339-base pair genome are a variety of unexpected genes, most notably those involved in biosynthesis of ceramide, a sphingolipid known to induce apoptosis. Uniquely for algal viruses, it also contains six RNA polymerase subunits and a novel promoter, suggesting this virus encodes its own transcription machinery. Microarray transcriptomic analysis reveals that 65% of the predicted virus-encoded genes are expressed during lytic infection of E. huxleyi.	Plymouth Marine Lab, Plymouth PL1 3DH, Devon, England; Marine Biol Assoc UK, Plymouth PL1 2PB, Devon, England; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Univ Edinburgh, Coll Med, Scottish Ctr Genom Technol & Informat, Edinburgh EH16 4SB, Midlothian, Scotland	Plymouth Marine Laboratory; Marine Biological Association United Kingdom; Wellcome Trust Sanger Institute; University of Edinburgh	Wilson, WH (corresponding author), Plymouth Marine Lab, Prospect Pl, Plymouth PL1 3DH, Devon, England.	whw@pml.ac.uk	Schroeder, Declan C./O-9131-2019; Parkhill, Julian/G-4703-2011; Allen, Michael J/C-1248-2011; Holden, Matthew TG/K-6449-2014; Quail, michael/ABE-6131-2020	Schroeder, Declan C./0000-0001-5991-2838; Parkhill, Julian/0000-0002-7069-5958; Allen, Michael J/0000-0001-8504-7171; Holden, Matthew TG/0000-0002-4958-2166; Ghazal, Peter/0000-0003-0035-2228				Berges JA, 1998, LIMNOL OCEANOGR, V43, P129, DOI 10.4319/lo.1998.43.1.0129; BERHE A, 1995, EUR J BIOCHEM, V227, P566, DOI 10.1111/j.1432-1033.1995.tb20426.x; Berhe A, 2001, BIOCHEM BIOPH RES CO, V287, P837, DOI 10.1006/bbrc.2001.5664; Bidle KD, 2004, NAT REV MICROBIOL, V2, P643, DOI 10.1038/nrmicro956; Brussaard CPD, 1997, J PHYCOL, V33, P980, DOI 10.1111/j.0022-3646.1997.00980.x; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; Delaroque N, 2001, VIROLOGY, V287, P112, DOI 10.1006/viro.2001.1028; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; GALLI I, 1992, NUCLEIC ACIDS RES, V20, P3333, DOI 10.1093/nar/20.13.3333; HANNUN YA, 1995, TRENDS BIOCHEM SCI, V20, P73, DOI 10.1016/S0968-0004(00)88961-6; Iyer LM, 2001, J VIROL, V75, P11720, DOI 10.1128/JVI.75.23.11720-11734.2001; La Scola B, 2003, SCIENCE, V299, P2033; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485; Sandaa RA, 2001, VIROLOGY, V290, P272, DOI 10.1006/viro.2001.1161; Schroeder DC, 2002, ARCH VIROL, V147, P1685, DOI 10.1007/s00705-002-0841-3; Susin SA, 1997, J EXP MED, V186, P25, DOI 10.1084/jem.186.1.25; Teodoro JG, 1997, J VIROL, V71, P1739, DOI 10.1128/JVI.71.3.1739-1746.1997; Van Etten JL, 2003, ANNU REV GENET, V37, P153, DOI 10.1146/annurev.genet.37.110801.143915; Van Etten JL, 2002, ARCH VIROL, V147, P1479, DOI 10.1007/s00705-002-0822-6; WESTBROEK P, 1993, GLOBAL PLANET CHANGE, V8, P27, DOI 10.1016/0921-8181(93)90061-R; WESTBROEK P, 1989, J PROTOZOOL, V36, P368, DOI 10.1111/j.1550-7408.1989.tb05528.x; WESTBROEK P, 1994, HAPTOPHYTE ALGAE, V51, P321; Wilson WH, 2002, J MAR BIOL ASSOC UK, V82, P369, DOI 10.1017/S002531540200560X; WILSON WH, 2005, VIRUS TAXONOMY, P163; WILSON WR, UNPUB	27	210	224	2	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 12	2005	309	5737					1090	1092		10.1126/science.1113109	http://dx.doi.org/10.1126/science.1113109			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	955MN	16099989				2022-12-01	WOS:000231230100050
J	Braig, M; Lee, S; Loddenkemper, C; Rudolph, C; Peters, AHFM; Schlegelberger, B; Stein, H; Dorken, B; Jenuwein, T; Schmitt, CA				Braig, M; Lee, S; Loddenkemper, C; Rudolph, C; Peters, AHFM; Schlegelberger, B; Stein, H; Dorken, B; Jenuwein, T; Schmitt, CA			Oncogene-induced senescence as an initial barrier in lymphoma development	NATURE			English	Article							HISTONE H3; TUMOR-CELLS; LYSINE 9; P53; METHYLATION; HP1; METHYLTRANSFERASE; HETEROCHROMATIN; PROLIFERATION; INACTIVATION	Acute induction of oncogenic Ras provokes cellular senescence involving the retinoblastoma (Rb) pathway, but the tumour suppressive potential of senescence in vivo remains elusive. Recently, Rb-mediated silencing of growth-promoting genes by heterochromatin formation associated with methylation of histone H3 lysine 9 (H3K9me) was identified as a critical feature of cellular senescence, which may depend on the histone methyltransferase Suv39h1. Here we show that E mu-N-Ras transgenic mice harbouring targeted heterozygous lesions at the Suv39h1, or the p53 locus for comparison, succumb to invasive T-cell lymphomas that lack expression of Suv39h1 or p53, respectively. By contrast, most N-Ras-transgenic wild-type ('control') animals develop a non-lymphoid neoplasia significantly later. Proliferation of primary lymphocytes is directly stalled by a Suv39h1-dependent, H3K9me-related senescent growth arrest in response to oncogenic Ras, thereby cancelling lymphomagenesis at an initial step. Suv39h1-deficient lymphoma cells grow rapidly but, unlike p53-deficient cells, remain highly susceptible to adriamycin-induced apoptosis. In contrast, only control, but not Suv39h1-deficient or p53-deficient, lymphomas senesce after drug therapy when apoptosis is blocked. These results identify H3K9me-mediated senescence as a novel Suv39h1-dependent tumour suppressor mechanism whose inactivation permits the formation of aggressive but apoptosis-competent lymphomas in response to oncogenic Ras.	Charite Univ Med Berlin Haematol Oncol, D-13353 Berlin, Germany; Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; Res Inst Mol Pathol, A-1030 Vienna, Austria; Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; Hannover Med Sch, Inst Cell & Mol Pathol, D-30625 Hannover, Germany; Charite Univ Med Berlin, Dept Pathol, D-12200 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Friedrich Miescher Institute for Biomedical Research; Hannover Medical School; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schmitt, CA (corresponding author), Charite Univ Med Berlin Haematol Oncol, D-13353 Berlin, Germany.	clemens.schmitt@charite.de	Lee, Soyoung/T-6669-2019; Lee, Soyoung/AHC-5032-2022; Schmitt, Clemens A/S-9479-2017	Lee, Soyoung/0000-0002-4614-2931; Schmitt, Clemens A/0000-0002-4731-2226; Peters, Antoine/0000-0002-0311-1887				Ait-Si-Ali S, 2004, EMBO J, V23, P605, DOI 10.1038/sj.emboj.7600074; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)82148-6; Chang BD, 1999, CANCER RES, V59, P3761; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Frank O, 2004, BLOOD, V104, P3543, DOI 10.1182/blood-2004-03-0852; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Hamrouni A, 2003, J EXP MED, V197, P601, DOI 10.1084/jem.20021945; HAUPT Y, 1992, ONCOGENE, V7, P981; KEMP CJ, 1993, CELL, V74, P813, DOI 10.1016/0092-8674(93)90461-X; Kim KC, 2003, CANCER RES, V63, P7619; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Leone G, 2003, CLIN IMMUNOL, V109, P89, DOI 10.1016/S1521-6616(03)00207-9; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nguyen CT, 2002, CANCER RES, V62, P6456; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Rane SG, 2002, MOL CELL BIOL, V22, P644, DOI 10.1128/MCB.22.2.644-656.2002; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Schmitt CA, 2003, NAT REV CANCER, V3, P286, DOI 10.1038/nrc1044; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Steele-Perkins G, 2001, GENE DEV, V15, P2250, DOI 10.1101/gad.870101; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6	31	911	949	1	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2005	436	7051					660	665		10.1038/nature03841	http://dx.doi.org/10.1038/nature03841			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951XA	16079837				2022-12-01	WOS:000230964500034
J	Kim, S; Poursine-Laurent, J; Truscott, SM; Lybarger, L; Song, YJ; Yang, LP; French, AR; Sunwoo, JB; Lemieux, S; Hansen, TH; Yokoyama, WM				Kim, S; Poursine-Laurent, J; Truscott, SM; Lybarger, L; Song, YJ; Yang, LP; French, AR; Sunwoo, JB; Lemieux, S; Hansen, TH; Yokoyama, WM			Licensing of natural killer cells by host major histocompatibility complex class I molecules	NATURE			English	Article							NK CELLS; HEMATOPOIETIC TRANSPLANTS; T-CELLS; MHC; RECEPTORS; MICE; CYTOTOXICITY; EXPRESSION; REJECTION; PEPTIDE	Self versus non-self discrimination is a central theme in biology from plants(1) to vertebrates, and is particularly relevant for lymphocytes that express receptors capable of recognizing self-tissues and foreign invaders. Comprising the third largest lymphocyte population, natural killer (NK) cells recognize and kill cellular targets and produce pro-inflammatory cytokines. These potentially self-destructive effector functions can be controlled by inhibitory receptors for the polymorphic major histocompatibility complex (MHC) class I molecules that are ubiquitously expressed on target cells(2-4). However, inhibitory receptors are not uniformly expressed on NK cells, and are germline-encoded by a set of polymorphic genes that segregate independently from MHC genes(5,6). Therefore, how NK-cell self-tolerance arises in vivo is poorly understood. Here we demonstrate that NK cells acquire functional competence through 'licensing' by self-MHC molecules. Licensing involves a positive role for MHC-specific inhibitory receptors and requires the cytoplasmic inhibitory motif originally identified in effector responses. This process results in two types of self-tolerant NK cells - licensed or unlicensed - and may provide new insights for exploiting NK cells in immunotherapy. This self-tolerance mechanism may be more broadly applicable within the vertebrate immune system because related germline-encoded inhibitory receptors are widely expressed on other immune cells.	Washington Univ, Sch Med, Dept Med, Howard Hughes Med Inst,Div Rheumatol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Otolaryngol, St Louis, MO 63110 USA; Univ Quebec, Inst Armand Frappier, INRS, Laval, PQ H7V 1B7, Canada	Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Quebec; Institut national de la recherche scientifique (INRS)	Yokoyama, WM (corresponding author), Washington Univ, Sch Med, Dept Med, Howard Hughes Med Inst,Div Rheumatol, St Louis, MO 63110 USA.	yokoyama@wustl.edu		Sunwoo, John/0000-0002-8393-4196	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033903, R01AI051345, R37AI034385] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI033903, R01 AI051345, R37 AI034385] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andersson M, 1998, J IMMUNOL, V161, P6475; Bakker ABH, 2000, IMMUNITY, V13, P345, DOI 10.1016/S1074-7613(00)00034-0; Barao I, 2003, BIOL BLOOD MARROW TR, V9, P727, DOI 10.1016/j.bbmt.2003.09.002; Bennett M, 1995, Semin Immunol, V7, P121, DOI 10.1006/smim.1995.0016; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; BIX M, 1991, NATURE, V349, P329, DOI 10.1038/349329a0; Brennan J, 1996, J EXP MED, V184, P2085, DOI 10.1084/jem.184.6.2085; Doucey MA, 2004, NAT IMMUNOL, V5, P328, DOI 10.1038/ni1043; Furukawa H, 1999, HUM IMMUNOL, V60, P32, DOI 10.1016/S0198-8859(98)00097-4; Furukawa H, 2002, J IMMUNOL, V169, P126, DOI 10.4049/jimmunol.169.1.126; Hanke T, 1999, IMMUNITY, V11, P67, DOI 10.1016/S1074-7613(00)80082-5; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; Kim S, 2002, NAT IMMUNOL, V3, P523, DOI 10.1038/ni796; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Lybarger L, 2003, J BIOL CHEM, V278, P27105, DOI 10.1074/jbc.M303716200; Lybarger L, 2003, IMMUNITY, V18, P121, DOI 10.1016/S1074-7613(02)00509-5; Moretta L, 2000, IMMUNOL TODAY, V21, P420, DOI 10.1016/S0167-5699(00)01673-X; Murase K, 2004, SCIENCE, V303, P1516, DOI 10.1126/science.1093586; Nakamura MC, 1999, J EXP MED, V189, P493, DOI 10.1084/jem.189.3.493; Nakamura MC, 1997, J EXP MED, V185, P673, DOI 10.1084/jem.185.4.673; Parham P, 2003, NAT REV IMMUNOL, V3, P108, DOI 10.1038/nri999; Raulet DH, 2001, ANNU REV IMMUNOL, V19, P291, DOI 10.1146/annurev.immunol.19.1.291; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Sentman C L, 1995, Semin Immunol, V7, P109, DOI 10.1006/smim.1995.0015; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Trowsdale J, 2001, IMMUNITY, V15, P363, DOI 10.1016/S1074-7613(01)00197-2; Vance RE, 1998, J EXP MED, V188, P1841, DOI 10.1084/jem.188.10.1841; Yokoyama WM, 2003, NAT REV IMMUNOL, V3, P304, DOI 10.1038/nri1055; Yu YYL, 2002, J IMMUNOL, V168, P3145, DOI 10.4049/jimmunol.168.7.3145	30	975	1008	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2005	436	7051					709	713		10.1038/nature03847	http://dx.doi.org/10.1038/nature03847			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951XA	16079848				2022-12-01	WOS:000230964500046
J	Brewer, RD; Swahn, MH				Brewer, RD; Swahn, MH			Binge drinking and violence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ALCOHOL; RISK; INJURIES; TRENDS		Ctr Dis Control & Prevent, Alcohol Team,Div Adult & Community Hlth, Emerging Invest & Analyt Methods Branch, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA; Ctr Dis Control & Prevent, Etiol & Surveillance Branch, Div Violence Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Brewer, RD (corresponding author), CDC, Alcohol Team, Natl Ctr Chron Dis Prevent & Hlth Promot, MS K-67,4770 Buford Hwy NE, Atlanta, GA 30341 USA.	bbrewer1@cdc.gov						[Anonymous], 2002, WORLD HLTH REP 2002; Babor T., 2003, ALCOHOL NO ORDINARY; Barry R., 2004, Morbidity and Mortality Weekly Report, V53, P452; *CDCP, ALC REL DIS IMP SOFT; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P866; CHALOUPKA F, 2004, REDUCING UNDERAGE DR; FAGAN J, 1990, CRIME JUSTICE, V13, P241, DOI 10.1086/449177; Fleming MF, 1997, JAMA-J AM MED ASSOC, V277, P1039, DOI 10.1001/jama.277.13.1039; FOEGE WH, 1987, NEW ENGL J MED, V316, P1407, DOI 10.1056/NEJM198705283162210; GREENFIELD TK, 2003, 131 ANN M AM PUBL HL; Grunbaum Jo Anne, 2004, Morbidity and Mortality Weekly Report, V53, P1; Iyasu S, 2002, JAMA-J AM MED ASSOC, V288, P2717, DOI 10.1001/jama.288.21.2717; Macdonald S, 2005, ADDICT BEHAV, V30, P103, DOI 10.1016/j.addbeh.2004.04.016; Markowitz S, 2000, J HEALTH ECON, V19, P271, DOI 10.1016/S0167-6296(99)00025-9; Naimi TS, 2003, JAMA-J AM MED ASSOC, V289, P70, DOI 10.1001/jama.289.1.70; *NAT CTR STAT AN, 2003, ALC INV FAT MOT VEH; National Institute on Alcohol Abuse and Alcoholism, 2004, NIAAA NEWSLETTER WIN; Quinlan KP, 2005, AM J PREV MED, V28, P346, DOI 10.1016/j.amepre.2005.01.006; Roizen J, 1997, Recent Dev Alcohol, V13, P7; Serdula MK, 2004, AM J PREV MED, V26, P294, DOI 10.1016/j.amepre.2003.12.017; SLOAN FA, 1995, J LAW ECON, V38, P49, DOI 10.1086/467325; Swahn MH, 2004, ADDICT BEHAV, V29, P959, DOI 10.1016/j.addbeh.2004.02.043; *US DEP JUST, 2000, DRINK AM MYTHS REAL; *US PREV SERV TASK, 2004, SCREEN ALC MIS; Vinson DC, 2003, J STUD ALCOHOL, V64, P358, DOI 10.15288/jsa.2003.64.358; Wechsler H, 2002, J AM COLL HEALTH, V50, P203, DOI 10.1080/07448480209595713	26	95	102	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 3	2005	294	5					616	618		10.1001/jama.294.5.616	http://dx.doi.org/10.1001/jama.294.5.616			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	951NN	16077057				2022-12-01	WOS:000230937500023
J	Mandavilli, A				Mandavilli, A			The coming epidemic	NATURE			English	Article																			0	6	6	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 28	2005	436	7050					496	498		10.1038/436496a	http://dx.doi.org/10.1038/436496a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049477				2022-12-01	WOS:000230788800049
J	Babaev, A; Frederick, PD; Pasta, DJ; Every, N; Sichrovsky, T; Hochman, JS				Babaev, A; Frederick, PD; Pasta, DJ; Every, N; Sichrovsky, T; Hochman, JS		NRMI Investigators	Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COOPERATIVE CARDIOVASCULAR PROJECT; PERCUTANEOUS CORONARY INTERVENTION; EARLY REVASCULARIZATION; NATIONAL REGISTRY; TRIAL REGISTRY; MEDICARE PATIENTS; TEMPORAL TRENDS; GUIDELINES; QUALITY; CARE	Context Early mechanical revascularization in patients with acute myocardial infarction (AMI) complicated by cardiogenic shock is a therapeutic strategy that reduces mortality. It has been a class I recommendation in guidelines from the American College of Cardiology and the American Heart Association since 1999 for patients younger than 75 years. However, little is known about implementation of these guidelines in practice. Objectives To assess trends in early revascularization and mortality for patients with cardiogenic shock complicating AMI and to determine whether the national guidelines affect revascularization rates. Design, Setting, and Patients Prospective, observational study of 293 633 patients with ST-elevation myocardial infarction (25311 [8.6%] had cardiogenic shock; 7356 [29%] had cardiogenic shock at hospital presentation) enrolled in the National Registry of Myocardial Infarction (NRMI) from January 1995 to May 2004 at 775 US hospitals with revascularization capability (defined as the capability to perform cardiac catheterization, percutaneous coronary intervention [PCI], and open-heart surgery). Main Outcome Measures Management patterns and in-hospital mortality rates. Results There was an increase in primary PCI rates from 27.4% to 54.4% (P<.001) in hospitals with revascularization capability that paralleled the change in PC[ for ST-elevation myocardial infarction. There was no significant change in rates of immediate coronary artery bypass graft surgery (from 2.1% to 3.2%). Propensity-adjusted multivariable analyses demonstrated that primary PCI was associated with a decreased odds of death during hospitalization (odds ratio, 0.46; 95% confidence interval, 0.40-0.53). There were no differences in the rates of change in revascularization rates based on the date when the guidelines were released regardless of patient age. Overall in-hospital cardiogenic shock mortality decreased from 60.3% in 1995 to 47.9% in 2004 (P<.001). Conclusions The use of PCI for patients with cardiogenic shock was associated with improved survival in a large group of hospitals with revascularization capability. The American College of Cardiology and American Heart Association guidelines had no detectable temporal impact on revascularization rates. These findings support the need for increased adherence to these guidelines.	NYU, Sch Med, Cardiovasc Clin Res Ctr, New York, NY 10016 USA; Ovat Res Grp, Seattle, WA USA; Ovat Res Grp, San Francisco, CA USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Univ Washington, Sch Med, Dept Cardiol, Seattle, WA USA; St Lukes Roosevelt Hosp, Div Cardiol, New York, NY USA	New York University; University of California System; University of California San Francisco; University of Washington; University of Washington Seattle; Mount Sinai St. Luke's; Mount Sinai West	Hochman, JS (corresponding author), NYU, Sch Med, Cardiovasc Clin Res Ctr, 530 1st Ave,HCC 1173, New York, NY 10016 USA.	judith.hochman@med.nyu.edu		Hochman, Judith/0000-0002-5889-5981; Frederick, Paul/0000-0002-7936-5488; Pasta, David/0000-0003-2637-9293				Adams RJ, 2004, CIRCULATION, V110, P2512, DOI 10.1161/01.CIR.0000134791.68010.FA; Andersen HR, 2003, NEW ENGL J MED, V349, P733, DOI 10.1056/NEJMoa025142; Antman Elliott M, 2004, J Am Coll Cardiol, V44, P671, DOI 10.1016/j.jacc.2004.07.002; Becker RC, 1996, J AM COLL CARDIOL, V27, P1321, DOI 10.1016/0735-1097(96)00008-3; Curry SJ, 2000, CHEST, V118, p40S, DOI 10.1378/chest.118.2_suppl.40S; Dauerman HL, 2001, AM J CARDIOL, V87, P844, DOI 10.1016/S0002-9149(00)01524-1; Dzavik V, 2005, AM HEART J, V149, P1128, DOI 10.1016/j.ahj.2005.03.045; Dzavik V, 2003, EUR HEART J, V24, P828, DOI 10.1016/S0195-668X(02)00844-8; Eagle KA, 2002, LANCET, V359, P373, DOI 10.1016/S0140-6736(02)07595-5; ELLERBECK EF, 1995, JAMA-J AM MED ASSOC, V273, P1509, DOI 10.1001/jama.273.19.1509; Goldberg RJ, 1999, NEW ENGL J MED, V340, P1162, DOI 10.1056/NEJM199904153401504; GUNNAR RM, 1990, J AM COLL CARDIOL, V16, P249, DOI 10.1016/0735-1097(90)90575-A; Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901; Hochman JS, 2001, JAMA-J AM MED ASSOC, V285, P190, DOI 10.1001/jama.285.2.190; Hochman JS, 2000, J AM COLL CARDIOL, V36, P1063, DOI 10.1016/S0735-1097(00)00879-2; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; Mehta RH, 2002, JAMA-J AM MED ASSOC, V287, P1269, DOI 10.1001/jama.287.10.1269; Moscucci M, 2005, J AM COLL CARDIOL, V45, P1759, DOI 10.1016/j.jacc.2005.01.055; ROGERS WJ, 1994, CIRCULATION, V90, P2103, DOI 10.1161/01.CIR.90.4.2103; Rogers WJ, 2000, J AM COLL CARDIOL, V36, P2056, DOI 10.1016/S0735-1097(00)00996-7; Ryan TJ, 1999, J AM COLL CARDIOL, V34, P890, DOI 10.1016/S0735-1097(99)00351-4; Webb JG, 2001, AM HEART J, V141, P964, DOI 10.1067/mhj.2001.115294	23	447	472	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 27	2005	294	4					448	454		10.1001/jama.294.4.448	http://dx.doi.org/10.1001/jama.294.4.448			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	948RM	16046651	Bronze			2022-12-01	WOS:000230733400019
J	Kerr, T; Tyndall, M; Li, K; Montaner, J; Wood, E				Kerr, T; Tyndall, M; Li, K; Montaner, J; Wood, E			Safer injection facility use and syringe sharing in injection drug users	LANCET			English	Article								Safer injection facilities provide medical supervision for illicit drug injections. We aimed to examine factors associated with syringe sharing in a community-recruited cohort of illicit injection drug users in a setting where such a facility had recently opened. Between Dec 1, 2003, and June 1, 2004, of 431 active injection drug users 49 (11.4%, 95% CI 8.5-14.3) reported syringe sharing in the past 6 months. In logistic regression analyses, use of the facility was independently associated with reduced syringe sharing (adjusted odds ratio 0.30, 0.11-0.82, p=0.02) after adjustment for relevant sociodemographic and drug-use characteristics. These findings could help inform discussions about the merits of such facilities.	St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; Univ British Columbia, Dept Med, Vancouver, BC, Canada	B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of Saskatchewan; University of British Columbia	Kerr, T (corresponding author), St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, 608-1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	tkerr@cfenet.ubc.ca	Montaner, Julio/K-7621-2012	Tyndall, Mark/0000-0003-4450-5679				Hedrich D., 2004, EUROPEAN REPORT DRUG; Kerr T, 2004, ANTIVIR THER, V9, P407; *MED SUP INJ CTR E, 2003, FIN REP SYDN MED SUP; Wood E, 2004, CAN MED ASSOC J, V171, P731, DOI 10.1503/cmaj.1040774; Wood E, 2004, LANCET INFECT DIS, V4, P301, DOI 10.1016/S1473-3099(04)01006-0; Wood E, 2002, AIDS, V16, P941, DOI 10.1097/00002030-200204120-00021; Wood E, 2001, CAN MED ASSOC J, V165, P405; Wright NMJ, 2004, BRIT MED J, V328, P100, DOI 10.1136/bmj.328.7431.100	8	209	209	0	11	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 23	2005	366	9482					316	318		10.1016/S0140-6736(05)66475-6	http://dx.doi.org/10.1016/S0140-6736(05)66475-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	948RJ	16039335				2022-12-01	WOS:000230733100031
J	Holden, CA; McLachlan, RI; Pitts, M; Cumming, R; Wittert, G; Agius, PA; Handelsman, DJ; de Kretser, DM				Holden, CA; McLachlan, RI; Pitts, M; Cumming, R; Wittert, G; Agius, PA; Handelsman, DJ; de Kretser, DM			Men in Australia Telephone Survey (MATeS): a national survey of the reproductive health and concerns of middle-aged and older Australian men	LANCET			English	Article							URINARY-TRACT SYMPTOMS; BENIGN PROSTATIC HYPERPLASIA; ERECTILE DYSFUNCTION; WAIST CIRCUMFERENCE; POPULATION; PREVALENCE; COMMUNITY; ASSOCIATION; INDEX; RISK	Background The Men in Australia Telephone Survey (MATeS) describes the prevalence of self-reported reproductive health disorders as well as related concerns and health behaviours among middle-aged and older Australian men. Methods A representative sample population (n=5990) of Australian men (>= 40 years) was obtained by contacting a random selection of households with unbiased sampling, stratified by age and state. A 20-min computer-assisted telephone interview was done to assess reproductive health and related knowledge and beliefs, sociodemographic factors, general health, and lifestyle factors. Findings A response rate of 78% (5990/7636) was achieved. 34% (1627/4737) of men surveyed reported one or more reproductive health disorder, all of which were most common in the oldest age group. Age-standardised prevalence of significant lower urinary tract symptoms was 16%, erectile dysfunction was 21%, and prostate disease was 14%. About 50% of participants reported having had a prostate cancer test whereas only 30% (300/1012) of men with erectile dysfunction sought medical help. Willingness to seek medical help for erectile dysfunction was related to age and ethnic origin. Although men aged 40-69 years expressed a moderate or high level of concern about prostate cancer and loss of erectile function, concern about reproductive health was less in the oldest age group (>= 70 years). Interpretation The high prevalence of reproductive health disorders and associated concerns in middle-aged and older Australian men draws attention to the need to develop appropriate services and education strategies specifically directed to improving reproductive health in these men.	Monash Univ, Androl Australia, Monash Inst Med Res, Monash Med Ctr, Clayton, Vic 3168, Australia; Prince Henrys Inst Med Res, Melbourne, Vic, Australia; La Trobe Univ, Australian Res Ctr Sex Hlth & Soc, Melbourne, Vic, Australia; Univ Sydney, Concord Hosp, Ctr Educ & Res Ageing, Sydney, NSW 2006, Australia; Univ Adelaide, Adelaide, SA, Australia; Univ Sydney, Concord Hosp, Dept Androl, ANZAC Res Inst, Sydney, NSW 2006, Australia	Monash University; Prince Henry's Institute of Medical Research; La Trobe University; Concord Repatriation General Hospital; University of Sydney; University of Adelaide; Concord Repatriation General Hospital; University of Sydney; ANZAC Research Institute	Holden, CA (corresponding author), Monash Univ, Androl Australia, Monash Inst Med Res, Monash Med Ctr, Clayton, Vic 3168, Australia.	carol.holden@med.monash.edu.au	wittert, gary/AAE-2398-2019; Research Institute, ANZAC/CAE-9030-2022; Handelsman, David/AAR-9580-2021; Carol, Holden/A-4971-2009	Handelsman, David/0000-0002-4200-7476; Holden, Carol/0000-0002-4011-6628; Agius, Paul/0000-0002-6075-8548				ARRIGHI HM, 1991, UROLOGY, V38, P4, DOI 10.1016/0090-4295(91)80191-9; Australian Health Technology Advisory Committee, 1996, PROST CANC SCREEN; Baldwin K, 2003, INT J IMPOT RES, V15, P87, DOI 10.1038/sj.ijir.3900948; BARRY MJ, 1992, J UROLOGY, V148, P1549, DOI 10.1016/S0022-5347(17)36966-5; Boyle P, 2003, BJU INT, V92, P719, DOI 10.1046/j.1464-410X.2003.04459.x; Dalton M, 2003, J INTERN MED, V254, P555, DOI 10.1111/j.1365-2796.2003.01229.x; *DEP EC SOC AFF UN, 2003, WORLD POP PROSP 2002; Derby CA, 2000, INT J IMPOT RES, V12, P197, DOI 10.1038/sj.ijir.3900542; FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1; GARRAWAY WM, 1991, LANCET, V338, P469, DOI 10.1016/0140-6736(91)90543-X; Green JSA, 2001, BJU INT, V88, P551, DOI 10.1046/j.1464-4096.2001.01274.x; Handelsman DJ, 2004, MED J AUSTRALIA, V180, P529, DOI 10.5694/j.1326-5377.2004.tb06060.x; LEAN MEJ, 1995, BRIT MED J, V311, P158, DOI 10.1136/bmj.311.6998.158; McCredie M, 2001, J Epidemiol Biostat, V6, P211, DOI 10.1080/135952201753172980; Mozes B, 1997, PROSTATE, V33, P246; *NAT OFF INF EC, 2002, CURR STAT PLAY AUSTR; Pinnock C, 1998, AUST NZ J PUBL HEAL, V22, P368, DOI 10.1111/j.1467-842X.1998.tb01393.x; Pinnock CB, 1999, MED J AUSTRALIA, V171, P353, DOI 10.5694/j.1326-5377.1999.tb123691.x; Pinnock CB, 1997, MED J AUSTRALIA, V167, P72, DOI 10.5694/j.1326-5377.1997.tb138783.x; Rosen RC, 2004, CURR MED RES OPIN, V20, P607, DOI 10.1185/030079904125003467; Sanders KM, 1999, OSTEOPOROSIS INT, V10, P240, DOI 10.1007/s001980050222; Sladden MJ, 2000, AUST NZ J SURG, V70, P322, DOI 10.1046/j.1440-1622.2000.01738.x; Smith AMA, 2003, AUST NZ J PUBL HEAL, V27, P103, DOI 10.1111/j.1467-842X.2003.tb00796.x; Welch G, 2002, UROLOGY, V59, P245, DOI 10.1016/S0090-4295(01)01506-0; Weller D, 1998, AUST NZ J PUBL HEAL, V22, P400, DOI 10.1111/j.1467-842X.1998.tb01400.x; Zakaria Lara, 2001, International Urology and Nephrology, V33, P283, DOI 10.1023/A:1015292603884	26	181	188	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 16	2005	366	9481					218	224		10.1016/S0140-6736(05)66911-5	http://dx.doi.org/10.1016/S0140-6736(05)66911-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	945RG	16023512				2022-12-01	WOS:000230519200030
J	Besemer, J; Harant, H; Wang, S; Oberhauser, B; Marquardt, K; Foster, CA; Schreiner, EP; de Vries, JE; Dascher-Nadel, C; Lindley, IJD				Besemer, J; Harant, H; Wang, S; Oberhauser, B; Marquardt, K; Foster, CA; Schreiner, EP; de Vries, JE; Dascher-Nadel, C; Lindley, IJD			Selective inhibition of cotranslational translocation of vascular cell adhesion molecule 1	NATURE			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; SIGNAL SEQUENCE RECOGNITION; ER MEMBRANE; PROTEIN TRANSLOCATION; EXPRESSION; COMPLEX	Increased expression of vascular cell adhesion molecule 1 (VCAM1) is associated with a variety of chronic inflammatory conditions, making its expression and function a target for therapeutic intervention(1-3). We have recently identified CAM741, a derivative of a fungus-derived cyclopeptolide that acts as a selective inhibitor of VCAM1 synthesis in endothelial cells. Here we show that the compound represses the biosynthesis of VCAM1 in cells by blocking the process of cotranslational translocation, which is dependent on the signal peptide of VCAM1. CAM741 does not inhibit targeting of the VCAM1 nascent chains to the translocon channel but prevents translocation to the luminal side of the endoplasmic reticulum ( ER), through a process that involves the translocon component Sec61 beta. Consequently, the VCAM1 precursor protein is synthesized towards the cytosolic compartment of the cells, where it is degraded. Our results indicate that the inhibition of cotranslational translocation with low-molecular-mass compounds, using specificity conferred by signal peptides, can modulate the biosynthesis of certain secreted and/or membrane proteins. In addition, they highlight cotranslational translocation at the ER membrane as a potential target for drug discovery.	Novartis Inst Biomed Res, A-1235 Vienna, Austria	Novartis	de Vries, JE (corresponding author), Novartis Inst Biomed Res, Brunner Str 59, A-1235 Vienna, Austria.	jan.devries@novartis.com	Hanna, Harant/AAA-7120-2022	Hanna, Harant/0000-0003-3842-0249				BEVILACQUA MP, 1994, ANNU REV MED, V45, P361, DOI 10.1146/annurev.med.45.1.361; Boger DL, 1999, J AM CHEM SOC, V121, P6197, DOI 10.1021/ja990918u; DeMartino GN, 1999, J BIOL CHEM, V274, P22123, DOI 10.1074/jbc.274.32.22123; Fons RD, 2003, J CELL BIOL, V160, P529, DOI 10.1083/jcb.200210095; Hommel U, 1996, FEBS LETT, V379, P69, DOI 10.1016/0014-5793(95)01453-5; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; Kalies KU, 1998, J CELL BIOL, V141, P887, DOI 10.1083/jcb.141.4.887; Kim SJ, 2002, DEV CELL, V2, P207, DOI 10.1016/S1534-5807(01)00120-4; Matlack KES, 1998, CELL, V92, P381, DOI 10.1016/S0092-8674(00)80930-7; MOTHES W, 1994, EMBO J, V13, P3973, DOI 10.1002/j.1460-2075.1994.tb06713.x; Rutkowski DT, 2001, P NATL ACAD SCI USA, V98, P7823, DOI 10.1073/pnas.141125098; Schreiner EP, 2003, EXPERT OPIN THER PAT, V13, P149, DOI 10.1517/13543776.13.2.149; SPRINGER TA, 1995, ANNU REV PHYSIOL, V57, P827, DOI 10.1146/annurev.ph.57.030195.004143; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cellbio.10.1.87	15	98	103	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2005	436	7048					290	293		10.1038/nature03670	http://dx.doi.org/10.1038/nature03670			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944VR	16015337				2022-12-01	WOS:000230459500048
J	Goodman, NW				Goodman, NW			Horizon: Does the MMR jab cause autism? We cannot win	BRITISH MEDICAL JOURNAL			English	Letter							POWER		Southmead Gen Hosp, Bristol BS10 5NB, Avon, England	Southmead Hospital	Goodman, NW (corresponding author), Southmead Gen Hosp, Bristol BS10 5NB, Avon, England.	Nev.W.Goodman@bris.ac.uk						Draper G, 2005, BRIT MED J, V330, P1290, DOI 10.1136/bmj.330.7503.1290; MACAULEY D, 2005, BRIT MED J, V330, P1335; Watts G, 2005, BMJ-BRIT MED J, V330, P1293, DOI 10.1136/bmj.330.7503.1293	3	1	1	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 9	2005	331	7508					111	111		10.1136/bmj.331.7508.111-a	http://dx.doi.org/10.1136/bmj.331.7508.111-a			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	945XR	16002901	Green Published			2022-12-01	WOS:000230536800036
J	Shpak, ED; McAbee, JM; Pillitteri, LJ; Torii, KU				Shpak, ED; McAbee, JM; Pillitteri, LJ; Torii, KU			Stomatal patterning and differentiation by synergistic interactions of receptor kinases	SCIENCE			English	Article							FLOWER DEVELOPMENT; ARABIDOPSIS; MOUTHS; ORGAN; TOO	Coordinated spacing and patterning of stomata allow efficient gas exchange between plants and the atmosphere. Here we report that three ERECTA (ER)family leucine-rich repeat-receptor-like kinases (LRR-RLKs) together control stomatal patterning, with specific family members regulating the specification of stomatal stem cell fate and the differentiation of guard cells. Loss-of-function mutations in all three ER-family genes cause stomatal clustering. Genetic interactions with a known stomata[ patterning mutant too many mouths (tmm) revealed stoichiometric epistasis and combination-specific neomorphism. Our findings suggest that the negative regulation of ER-family RLKs by TMM, which is an LRR receptor-like protein, is critical for proper stomatal differentiation.	Univ Washington, Dept Biol, Seattle, WA 98195 USA; Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Saitama 3320012, Japan	University of Washington; University of Washington Seattle; Japan Science & Technology Agency (JST)	Torii, KU (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	ktorii@u.washington.edu	TORII, KEIKO U./A-6041-2013	TORII, KEIKO U./0000-0002-6168-427X				Berger D, 2000, GENE DEV, V14, P1119; Bergmann DC, 2004, SCIENCE, V304, P1494, DOI 10.1126/science.1096014; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Carles CC, 2003, TRENDS PLANT SCI, V8, P394, DOI 10.1016/S1360-1385(03)00164-X; Geisler M, 1998, PLANTA, V205, P522, DOI 10.1007/s004250050351; Geisler M, 2000, PLANT CELL, V12, P2075, DOI 10.1105/tpc.12.11.2075; Geisler MJ, 2003, PLANTA, V216, P571; Glover BJ, 2000, J EXP BOT, V51, P497, DOI 10.1093/jexbot/51.344.497; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Jeong S, 1999, PLANT CELL, V11, P1925, DOI 10.1105/tpc.11.10.1925; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Nadeau JA, 2002, SCIENCE, V296, P1697, DOI 10.1126/science.1069596; Nadeau JA, 2002, THE ARABIDOPSIS BOOK; REDEI GP, 1962, Z VEREBUNGSL, V93, P164; Sack FD, 2004, SCIENCE, V304, P1461, DOI 10.1126/science.1099445; Serna L, 2000, TRENDS PLANT SCI, V5, P458, DOI 10.1016/S1360-1385(00)01782-9; Serna L, 2004, NATURE, V430, P302, DOI 10.1038/430302a; Shpak ED, 2004, DEVELOPMENT, V131, P1491, DOI 10.1242/dev.01028; Shpak ED, 2003, PLANT CELL, V15, P1095, DOI 10.1105/tpc.010413; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Yang M, 1995, PLANT CELL, V7, P2227, DOI 10.1105/tpc.7.12.2227	21	412	454	0	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 8	2005	309	5732					290	293		10.1126/science.1109710	http://dx.doi.org/10.1126/science.1109710			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	944SP	16002616				2022-12-01	WOS:000230449800042
J	Goetz, W; Bertelsen, P; Binau, CS; Gunnlaugsson, HP; Hviid, SF; Kinch, KM; Madsen, DE; Madsen, MB; Olsen, M; Gellert, R; Klingelhofer, G; Ming, DW; Morris, RV; Rieder, R; Rodionov, DS; de Souza, PA; Schroder, C; Squyres, SW; Wdowiak, T; Yen, A				Goetz, W; Bertelsen, P; Binau, CS; Gunnlaugsson, HP; Hviid, SF; Kinch, KM; Madsen, DE; Madsen, MB; Olsen, M; Gellert, R; Klingelhofer, G; Ming, DW; Morris, RV; Rieder, R; Rodionov, DS; de Souza, PA; Schroder, C; Squyres, SW; Wdowiak, T; Yen, A			Indication of drier periods on Mars from the chemistry and mineralogy of atmospheric dust	NATURE			English	Article							MAGNETIC-PROPERTIES EXPERIMENTS; X-RAY SPECTROMETER; GUSEV CRATER; MOSSBAUER SPECTROMETER; MERIDIANI-PLANUM; SPIRIT; PATHFINDER; ROVERS; SPECTROSCOPY; OPPORTUNITY	The ubiquitous atmospheric dust on Mars is well mixed by periodic global dust storms, and such dust carries information about the environment in which it once formed and hence about the history of water on Mars(1). The Mars Exploration Rovers have permanent magnets to collect atmospheric dust for investigation by instruments on the rovers(2,3). Here we report results from Mossbauer spectroscopy and X-ray fluorescence of dust particles captured from the martian atmosphere by the magnets. The dust on the magnets contains magnetite and olivine; this indicates a basaltic origin of the dust and shows that magnetite, not maghemite, is the mineral mainly responsible for the magnetic properties of the dust. Furthermore, the dust on the magnets contains some ferric oxides, probably including nanocrystalline phases, so some alteration or oxidation of the basaltic dust seems to have occurred. The presence of olivine indicates that liquid water did not play a dominant role in the processes that formed the atmospheric dust.	Max Planck Inst Sonnensyst Forsch, D-37191 Katlenburg Lindau, Germany; Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; Aarhus Univ, Inst Phys & Astron, DK-8000 Aarhus, Denmark; Max Planck Inst Chem, D-55128 Mainz, Germany; Univ Mainz, Inst Anorgan & Analyt Chem, D-55128 Mainz, Germany; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; Space Res Inst IKI, Moscow, Russia; Co Vale Rio Doce, BR-29090900 Vitoria, ES, Brazil; Cornell Univ, Ithaca, NY 14853 USA; Univ Alabama, Birmingham, AL 35203 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	Max Planck Society; University of Copenhagen; Niels Bohr Institute; Aarhus University; Max Planck Society; Johannes Gutenberg University of Mainz; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; Cornell University; University of Alabama System; University of Alabama Birmingham; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Goetz, W (corresponding author), Max Planck Inst Sonnensyst Forsch, D-37191 Katlenburg Lindau, Germany.	goetz@mps.mpg.de	de Souza, Paulo/W-2993-2019; Schröder, Christian/B-3870-2009; Kinch, Kjartan Bergeron/C-5742-2015; de Souza, Paulo A/B-8961-2008; de Souza, Paulo/P-7294-2019; Madsen, Morten Bo/D-2082-2011; Gunnlaugsson, Haraldur/L-6535-2016	de Souza, Paulo/0000-0002-0091-8925; Schröder, Christian/0000-0002-7935-6039; Kinch, Kjartan Bergeron/0000-0002-4629-8880; de Souza, Paulo A/0000-0002-0091-8925; Madsen, Morten Bo/0000-0001-8909-5111; Gunnlaugsson, Haraldur/0000-0002-8958-0245				Bertelsen P, 2004, SCIENCE, V305, P827, DOI 10.1126/science.1100112; Gellert R, 2004, SCIENCE, V305, P829, DOI 10.1126/science.1099913; HARGRAVES RB, 1979, J GEOPHYS RES, V84, P8379, DOI 10.1029/JB084iB14p08379; Hviid SF, 1997, SCIENCE, V278, P1768, DOI 10.1126/science.278.5344.1768; KINCH KM, UNPUB PLANET SPACE S; Klingelhofer G, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002138; Klingelhofer G, 2004, SCIENCE, V306, P1740, DOI 10.1126/science.1104653; KNUDSEN JM, 1991, HYPERFINE INTERACT, V68, P83; Lemmon MT, 2004, SCIENCE, V306, P1753, DOI 10.1126/science.1104474; LEVIN GV, 1976, SCIENCE, V194, P1322, DOI 10.1126/science.194.4271.1322; Madsen MB, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002029; Madsen MB, 1999, J GEOPHYS RES-PLANET, V104, P8761, DOI 10.1029/1998JE900006; Morris RV, 2004, SCIENCE, V305, P833, DOI 10.1126/science.1100020; Morris RV, 2001, J GEOPHYS RES-PLANET, V106, P5057, DOI 10.1029/2000JE001328; POLLACK JB, 1979, J GEOPHYS RES, V84, P2924; Rieder R, 2004, SCIENCE, V306, P1746, DOI 10.1126/science.1104358; Schroder C, 2004, PLANET SPACE SCI, V52, P997, DOI 10.1016/j.pss.2004.07.018; SMITH P, 2004, LUNAR PLANET SCI C, V35, P2050; Squyres SW, 2004, SCIENCE, V305, P794, DOI 10.1126/science.3050794; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; SQUYRES SW, 2003, J GEOPHYS RES, V108; Tomasko MG, 1999, J GEOPHYS RES-PLANET, V104, P8987, DOI 10.1029/1998JE900016; YEN A, 2005, LUNAR PLANET SCI C, V36, P1571	23	99	100	3	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 7	2005	436	7047					62	65		10.1038/nature03807	http://dx.doi.org/10.1038/nature03807			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942QJ	16001062				2022-12-01	WOS:000230296600039
J	Maskos, U; Molles, BE; Pons, S; Besson, M; Guiard, BP; Guilloux, JP; Evrard, A; Cazala, P; Cormier, A; Mameli-Engvall, M; Dufour, N; Cloez-Tayarani, I; Bemelmans, AP; Mallet, J; Gardier, AM; David, V; Faure, P; Granon, S; Changeux, JP				Maskos, U; Molles, BE; Pons, S; Besson, M; Guiard, BP; Guilloux, JP; Evrard, A; Cazala, P; Cormier, A; Mameli-Engvall, M; Dufour, N; Cloez-Tayarani, I; Bemelmans, AP; Mallet, J; Gardier, AM; David, V; Faure, P; Granon, S; Changeux, JP			Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors	NATURE			English	Article							VENTRAL TEGMENTAL AREA; ACETYLCHOLINE-RECEPTORS; PHYSIOLOGICAL DIVERSITY; NUCLEUS-ACCUMBENS; NEURONS; MICE; RAT; BEHAVIOR; IDENTIFICATION; ADDICTION	Worldwide, 100 million people are expected to die this century from the consequences of nicotine addiction(1), but nicotine is also known to enhance cognitive performance(2). Identifying the molecular mechanisms involved in nicotine reinforcement and cognition is a priority and requires the development of new in vivo experimental paradigms. The ventral tegmental area (VTA) of the midbrain is thought to mediate the reinforcement properties of many drugs of abuse. Here we specifically re-expressed the beta 2-subunit of the nicotinic acetylcholine receptor (nAChR) by stereotaxically injecting a lentiviral vector into the VTA of mice carrying beta 2-subunit deletions(3,4). We demonstrate the efficient re-expression of electrophysiologically responsive, ligand-binding nicotinic acetylcholine receptors in dopamine-containing neurons of the VTA, together with the recovery of nicotine-elicited dopamine release and nicotine self-administration. We also quantified exploratory behaviours of the mice, and showed that beta 2-subunit re-expression restored slow exploratory behaviour (a measure of cognitive function) to wild-type levels, but did not affect fast navigation behaviour. We thus demonstrate the sufficient role of the VTA in both nicotine reinforcement and endogenous cholinergic regulation of cognitive functions.	Inst Pasteur, CNRS, URA 2182, Unite Recepteurs & Cognit, F-75724 Paris, France; Univ Paris Sud, Fac Pharm, Lab Neuropharmacol EA3544, F-92296 Chatenay Malabry, France; Univ Bordeaux 1, CNRS, UMR 5106, Cognit Neurosci Lab, F-33405 Talence, France; Hop La Pitie Salpetriere, CNRS, UMR 7091, Lab Genet Mol Neurotransmiss & Proc Neurodegenera, F-75013 Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Changeux, JP (corresponding author), Inst Pasteur, CNRS, URA 2182, Unite Recepteurs & Cognit, 25 Rue Dr Roux, F-75724 Paris, France.	changeux@pasteur.fr	Guiard, Bruno/A-3955-2016; Bemelmans, Alexis-Pierre/H-4476-2019; Guilloux, Jean-Philippe/B-3726-2015; JP, Guilloux/Z-5069-2019	Bemelmans, Alexis-Pierre/0000-0001-7605-5225; Guilloux, Jean-Philippe/0000-0003-0982-3751; JP, Guilloux/0000-0003-0982-3751; David, Vincent/0000-0003-2263-7275; Faure, Philippe/0000-0003-3573-4971; Granon, sylvie/0000-0001-9384-3119				Bardo MT, 1996, BEHAV BRAIN RES, V77, P23, DOI 10.1016/0166-4328(95)00203-0; Carr DB, 2000, SYNAPSE, V38, P114, DOI 10.1002/1098-2396(200011)38:2<114::AID-SYN2>3.0.CO;2-R; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; CUNNINGHAM MG, 1993, J NEUROSCI METH, V47, P105, DOI 10.1016/0165-0270(93)90026-N; David V, 2002, PSYCHOPHARMACOLOGY, V160, P307, DOI 10.1007/s00213-001-0981-2; Dehaene S, 1998, P NATL ACAD SCI USA, V95, P14529, DOI 10.1073/pnas.95.24.14529; Faure P, 2003, FRACTALS, V11, P233, DOI 10.1142/S0218348X03002166; GRACE AA, 1983, NEUROSCIENCE, V10, P301, DOI 10.1016/0306-4522(83)90135-5; Granon S, 2003, P NATL ACAD SCI USA, V100, P9596, DOI 10.1073/pnas.1533498100; GRENHOFF J, 1986, ACTA PHYSIOL SCAND, V128, P351, DOI 10.1111/j.1748-1716.1986.tb07988.x; Klink R, 2001, J NEUROSCI, V21, P1452, DOI 10.1523/JNEUROSCI.21-05-01452.2001; Laviolette SR, 2004, NAT REV NEUROSCI, V5, P55, DOI 10.1038/nrn1298; Levin ED, 2002, CNS NEUROL DISORD-DR, V1, P423, DOI 10.2174/1568007023339102; Mansvelder HD, 2003, EUR J PHARMACOL, V480, P117, DOI 10.1016/j.ejphar.2003.08.099; Maskos U, 2002, P NATL ACAD SCI USA, V99, P10120, DOI 10.1073/pnas.152266799; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; MESULAM MM, 1983, NEUROSCIENCE, V10, P1185, DOI 10.1016/0306-4522(83)90108-2; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Peto R, 1996, BRIT MED BULL, V52, P12, DOI 10.1093/oxfordjournals.bmb.a011519; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; PICCIOTTO MR, 1995, NATURE, V374, P65, DOI 10.1038/374065a0; Pontieri FE, 1996, NATURE, V382, P255, DOI 10.1038/382255a0; Poucet B, 1997, CRIT REV NEUROBIOL, V11, P101, DOI 10.1615/CritRevNeurobiol.v11.i2-3.10; RENNER MJ, 1990, PSYCHOBIOLOGY, V18, P16; Robbins TW, 2000, EXP BRAIN RES, V133, P130, DOI 10.1007/s002210000407; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; Thinus-Blanc C., 1996, ANIMAL SPATIAL COGNI; Zoli M, 1998, J NEUROSCI, V18, P4461; Zoli M, 1999, EMBO J, V18, P1235, DOI 10.1093/emboj/18.5.1235	30	428	443	2	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2005	436	7047					103	107		10.1038/nature03694	http://dx.doi.org/10.1038/nature03694			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	942QJ	16001069				2022-12-01	WOS:000230296600047
J	DiLuzio, WR; Turner, L; Mayer, M; Garstecki, P; Weibel, DB; Berg, HC; Whitesides, GM				DiLuzio, WR; Turner, L; Mayer, M; Garstecki, P; Weibel, DB; Berg, HC; Whitesides, GM			Escherichia coli swim on the right-hand side	NATURE			English	Article							3-DIMENSIONAL TRACKING; FLAGELLAR FILAMENTS; MOTILITY; CHEMOTAXIS; BACTERIA; SURFACE; DIFFERENTIATION; TYPHIMURIUM; MICROSCOPY; MUTANTS	The motion of peritrichously flagellated bacteria close to surfaces is relevant to understanding the early stages of biofilm formation and of pathogenic infection(1-4). This motion differs from the random-walk trajectories(5) of cells in free solution. Individual Escherichia coli cells swim in clockwise, circular trajectories near planar glass surfaces(6,7). On a semi-solid agar substrate, cells differentiate into an elongated, hyperflagellated phenotype and migrate cooperatively over the surface(8), a phenomenon called swarming. We have developed a technique for observing isolated E. coli swarmer cells(9) moving on an agar substrate and confined in shallow, oxidized poly( dimethylsiloxane) ( PDMS) microchannels. Here we show that cells in these microchannels preferentially 'drive on the right', swimming preferentially along the right wall of the microchannel ( viewed from behind the moving cell, with the agar on the bottom). We propose that when cells are confined between two interfaces - one an agar gel and the second PDMS they swim closer to the agar surface than to the PDMS surface ( and for much longer periods of time), leading to the preferential movement on the right of the microchannel. Thus, the choice of materials guides the motion of cells in microchannels.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA; Harvard Univ, Rowland Inst, Cambridge, MA 02142 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University; Harvard University	Whitesides, GM (corresponding author), Harvard Univ, Dept Chem & Biol Chem, 12 Oxford St, Cambridge, MA 02138 USA.	gwhitesides@gmwgroup.harvard.edu	Mayer, Michael/C-1299-2010; Mayer, Michael/AAS-1777-2020; Garstecki, Piotr/ABA-9188-2020	Mayer, Michael/0000-0002-6148-5756; Garstecki, Piotr/0000-0001-9101-7163				ALLISON C, 1992, MOL MICROBIOL, V6, P1583; ARMSTRONG JB, 1967, J BACTERIOL, V93, P390, DOI 10.1128/JB.93.1.390-398.1967; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; BERG HC, 1973, NATURE, V245, P380, DOI 10.1038/245380a0; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; BERG HC, 1990, BIOPHYS J, V58, P919, DOI 10.1016/S0006-3495(90)82436-X; Biondi SA, 1998, AICHE J, V44, P1923, DOI 10.1002/aic.690440822; Brandrup J., 1999, POLYM HDB, V4th; Damiano ER, 2004, J FLUID MECH, V500, P75, DOI 10.1017/S0022112003006566; Darnton N, 2004, BIOPHYS J, V86, P1863, DOI 10.1016/S0006-3495(04)74253-8; FRYMIER PD, 1995, P NATL ACAD SCI USA, V92, P6195, DOI 10.1073/pnas.92.13.6195; Frymier PD, 1997, AICHE J, V43, P1341, DOI 10.1002/aic.690430523; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; HARSHEY RM, 1994, P NATL ACAD SCI USA, V91, P8631, DOI 10.1073/pnas.91.18.8631; HENRICHSEN J, 1972, BACTERIOL REV, V36, P478, DOI 10.1128/MMBR.36.4.478-503.1972; Ottemann KM, 1997, MOL MICROBIOL, V24, P1109, DOI 10.1046/j.1365-2958.1997.4281787.x; PARKINSON JS, 1978, J BACTERIOL, V135, P45, DOI 10.1128/JB.135.1.45-53.1978; Pernodet N, 1997, ELECTROPHORESIS, V18, P55, DOI 10.1002/elps.1150180111; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; RAMIA M, 1993, BIOPHYS J, V65, P755, DOI 10.1016/S0006-3495(93)81129-9; TAYLOR G, 1952, PROC R SOC LON SER-A, V211, P225, DOI 10.1098/rspa.1952.0035; Toguchi A, 2000, J BACTERIOL, V182, P6308, DOI 10.1128/JB.182.22.6308-6321.2000; Turner L, 2000, J BACTERIOL, V182, P2793, DOI 10.1128/JB.182.10.2793-2801.2000; Vigeant MAS, 1997, APPL ENVIRON MICROB, V63, P3474, DOI 10.1128/AEM.63.9.3474-3479.1997; Vigeant MAS, 2002, APPL ENVIRON MICROB, V68, P2794, DOI 10.1128/AEM.68.6.2794-2801.2002; Visick KL, 2000, J BACTERIOL, V182, P1779, DOI 10.1128/JB.182.7.1779-1787.2000; WOLFE AJ, 1987, J BACTERIOL, V169, P1878, DOI 10.1128/jb.169.5.1878-1885.1987; Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G	28	326	331	7	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2005	435	7046					1271	1274		10.1038/nature03660	http://dx.doi.org/10.1038/nature03660			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940JJ	15988531				2022-12-01	WOS:000230140500051
J	Paciorek, T; Zazimalova, E; Ruthardt, N; Petrasek, J; Stierhof, YD; Kleine-Vehn, J; Morris, DA; Emans, N; Jurgens, G; Geldner, N; Friml, J				Paciorek, T; Zazimalova, E; Ruthardt, N; Petrasek, J; Stierhof, YD; Kleine-Vehn, J; Morris, DA; Emans, N; Jurgens, G; Geldner, N; Friml, J			Auxin inhibits endocytosis and promotes its own efflux from cells	NATURE			English	Article							BREFELDIN-A; ARABIDOPSIS; TRANSPORT; LOCALIZATION; GRADIENTS; GENE; ACCUMULATION; MUTATIONS; MECHANISM; HORMONE	One of the mechanisms by which signalling molecules regulate cellular behaviour is modulating subcellular protein translocation. This mode of regulation is often based on specialized vesicle trafficking, termed constitutive cycling, which consists of repeated internalization and recycling of proteins to and from the plasma membrane(1). No such mechanism of hormone action has been shown in plants although several proteins, including the PIN auxin efflux facilitators, exhibit constitutive cycling(2,3). Here we show that a major regulator of plant development, auxin, inhibits endocytosis. This effect is specific to biologically active auxins and requires activity of the Calossin-like protein BIG. By inhibiting the internalization step of PIN constitutive cycling, auxin increases levels of PINs at the plasma membrane. Concomitantly, auxin promotes its own efflux from cells by a vesicle-trafficking-dependent mechanism. Furthermore, asymmetric auxin translocation during gravitropism is correlated with decreased PIN internalization. Our data imply a previously undescribed mode of plant hormone action: by modulating PIN protein trafficking, auxin regulates PIN abundance and activity at the cell surface, providing a mechanism for the feedback regulation of auxin transport.	Univ Tubingen, Zentrum Mol Biol Pflanzen, D-72076 Tubingen, Germany; ASCR, Inst Expt Bot, Prague 16502 6, Czech Republic; Rhein Westfal TH Aachen, Cellome Res Grp, D-52074 Aachen, Germany; Univ Southampton, Sch Biol Sci, Southampton SO16 7PX, Hants, England	Eberhard Karls University of Tubingen; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; RWTH Aachen University; University of Southampton	Friml, J (corresponding author), Univ Tubingen, Zentrum Mol Biol Pflanzen, D-72076 Tubingen, Germany.	jiri.friml@zmbp.uni-tuebingen.de	Friml, Jiri/D-9511-2012; Kleine-Vehn, Jürgen/C-8984-2014; Eva, Zazimalova/G-7432-2014; Geldner, Niko/Y-2481-2019; Petrasek, Jan/C-8240-2009; Petrasek, Jan/AAW-1081-2021	Friml, Jiri/0000-0002-8302-7596; Kleine-Vehn, Jürgen/0000-0002-4354-3756; Eva, Zazimalova/0000-0002-8325-7092; Petrasek, Jan/0000-0002-6719-2735; Petrasek, Jan/0000-0002-6719-2735; Geldner, Niko/0000-0002-2300-9644				Baluska F, 2002, PLANT PHYSIOL, V130, P422, DOI 10.1104/pp.007526; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Berleth T, 2001, CURR OPIN PLANT BIOL, V4, P57, DOI 10.1016/S1369-5266(00)00136-9; BOERJAN W, 1995, PLANT CELL, V7, P1405, DOI 10.1105/tpc.7.9.1405; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Delarue M, 1999, PHYSIOL PLANTARUM, V107, P120, DOI 10.1034/j.1399-3054.1999.100116.x; Delbarre A, 1996, PLANTA, V198, P532, DOI 10.1007/BF00262639; Emans N, 2002, PLANT CELL, V14, P71, DOI 10.1105/tpc.010339; Friml J, 2003, CURR OPIN PLANT BIOL, V6, P7, DOI 10.1016/S1369526602000031; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2003, PLANT J, V34, P115, DOI 10.1046/j.1365-313X.2003.01705.x; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Gadow A. von, 1997, Journal of Agricultural and Food Chemistry, V45, P632, DOI 10.1021/jf960281n; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Gil P, 2001, GENE DEV, V15, P1985, DOI 10.1101/gad.905201; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Kanyuka K, 2003, PLANT J, V35, P57, DOI 10.1046/j.1365-313X.2003.01779.x; KARLINNEUMANN GA, 1991, PLANT CELL, V3, P573, DOI 10.1105/tpc.3.6.573; Morris DA, 2000, PLANT GROWTH REGUL, V32, P161, DOI 10.1023/A:1010701527848; Petrasek J, 2003, PLANT PHYSIOL, V131, P254, DOI 10.1104/pp.012740; Petrasek J, 2002, PLANTA, V216, P302, DOI 10.1007/s00425-002-0845-y; Pimpl P, 2000, PLANT CELL, V12, P2219, DOI 10.1105/tpc.12.11.2219; Richards S, 1996, GENETICS, V142, P1215; Royle SJ, 2003, BIOESSAYS, V25, P39, DOI 10.1002/bies.10200; Ruegger M, 1997, PLANT CELL, V9, P745, DOI 10.1105/tpc.9.5.745; Swarup R, 2001, GENE DEV, V15, P2648, DOI 10.1101/gad.210501; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449; Zhao YD, 2001, SCIENCE, V291, P306, DOI 10.1126/science.291.5502.306	30	574	600	3	148	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 30	2005	435	7046					1251	1256		10.1038/nature03633	http://dx.doi.org/10.1038/nature03633			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940JJ	15988527				2022-12-01	WOS:000230140500047
J	Fairhurst, RM; Baruch, DI; Brittain, NJ; Ostera, GR; Wallach, JS; Hoang, HL; Hayton, K; Guindo, A; Makobongo, MO; Schwartz, OM; Tounkara, A; Doumbo, OK; Diallo, DA; Fujioka, H; Ho, M; Wellems, TE				Fairhurst, RM; Baruch, DI; Brittain, NJ; Ostera, GR; Wallach, JS; Hoang, HL; Hayton, K; Guindo, A; Makobongo, MO; Schwartz, OM; Tounkara, A; Doumbo, OK; Diallo, DA; Fujioka, H; Ho, M; Wellems, TE			Abnormal display of PfEMP-1 on erythrocytes carrying haemoglobin C may protect against malaria	NATURE			English	Article							FALCIPARUM-INFECTED ERYTHROCYTES; PLASMODIUM-FALCIPARUM; RED-CELLS; SURFACE; ANTIGENS; ANTIBODIES; DISEASE; PATHOGENESIS; POPULATION; RESISTANCE	Haemoglobin C, which carries a glutamate-to-lysine mutation in the beta-globin chain, protects West African children against Plasmodium falciparum malaria(1,2). Mechanisms of protection are not established for the heterozygous (haemoglobin AC) or homozygous (haemoglobin CC) states. Here we report a marked effect of haemoglobin C on the cell-surface properties of P. falciparum-infected erythrocytes involved in pathogenesis. Relative to parasite-infected normal erythrocytes (haemoglobin AA), parasitized AC and CC erythrocytes show reduced adhesion to endothelial monolayers expressing CD36 and intercellular adhesion molecule-1 (ICAM-1). They also show impaired rosetting interactions with non-parasitized erythrocytes, and reduced agglutination in the presence of pooled sera from malaria-immune adults. Abnormal cell-surface display of the main variable cytoadherence ligand, PfEMP-1 (P. falciparum erythrocyte membrane protein-1), correlates with these findings. The abnormalities in PfEMP-1 display are associated with markers of erythrocyte senescence, and are greater in CC than in AC erythrocytes. Haemoglobin C might protect against malaria by reducing PfEMP-1-mediated adherence of parasitized erythrocytes, thereby mitigating the effects of their sequestration in the microvasculature.	NIAID, Lab Malaria & Vestor Res, NIH, Bethesda, MD 20892 USA; NIAID, Malaria Vaccine Dev Branch, NIH, Bethesda, MD 20892 USA; NIAID, Biol Imaging Facil, Res Technol Branch, NIH, Bethesda, MD 20892 USA; Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB T2N 4N1, Canada; Univ Bamako, Fac Med Pharm & Odontostomatol, Dept Parasitol, Malaria Res & Training Ctr, Bamako, Mali; Univ Bamako, Fac Med Pharm & Odontostomatol, Dept Hematol, Malaria Res & Training Ctr, Bamako, Mali; Minist Hlth, Ctr Natl Transfus Sanguine, Bamako, Mali; Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Calgary; University of Bamako; University of Bamako; Case Western Reserve University	Wellems, TE (corresponding author), NIAID, Lab Malaria & Vestor Res, NIH, Bethesda, MD 20892 USA.	twellems@niaid.nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000483, ZIAAI000483] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agarwal A, 2000, BLOOD, V96, P2358, DOI 10.1182/blood.V96.7.2358.h8002358_2358_2363; ALLISON AC, 1961, ANN NY ACAD SCI, V91, P710, DOI 10.1111/j.1749-6632.1961.tb31102.x; Arie T, 2005, J STRUCT BIOL, V150, P163, DOI 10.1016/j.jsb.2005.02.008; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; BUNN HF, 1982, P NATL ACAD SCI-BIOL, V79, P7527, DOI 10.1073/pnas.79.23.7527; CHARACHE S, 1967, J CLIN INVEST, V46, P1795, DOI 10.1172/JCI105670; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; Fairhurst RM, 2003, BLOOD, V101, P3309, DOI 10.1182/blood-2002-10-3105; Flint J, 1998, BAILLIERE CLIN HAEM, V11, P1, DOI 10.1016/S0950-3536(98)80069-3; FRIEDMAN MJ, 1979, AM J TROP MED HYG, V28, P777, DOI 10.4269/ajtmh.1979.28.777; Gamain B, 2001, P NATL ACAD SCI USA, V98, P2664, DOI 10.1073/pnas.041602598; Giribaldi G, 2001, BRIT J HAEMATOL, V113, P492, DOI 10.1046/j.1365-2141.2001.02707.x; HUISMAN THJ, 1972, CLIN CHIM ACTA, V40, P159, DOI 10.1016/0009-8981(72)90264-1; KAUL DK, 1991, BLOOD, V78, P812; LOW PS, 1985, SCIENCE, V227, P531, DOI 10.1126/science.2578228; MACDONALD VW, 1982, BIOCHIM BIOPHYS ACTA, V701, P39, DOI 10.1016/0167-4838(82)90309-0; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; MARSH K, 1989, T ROY SOC TROP MED H, V83, P293, DOI 10.1016/0035-9203(89)90478-1; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Modiano D, 2001, NATURE, V414, P305, DOI 10.1038/35104556; MURPHY JR, 1973, J LAB CLIN MED, V82, P334; Oh SS, 2000, MOL BIOCHEM PARASIT, V108, P237, DOI 10.1016/S0166-6851(00)00227-9; Ricke CH, 2000, J IMMUNOL, V165, P3309, DOI 10.4049/jimmunol.165.6.3309; ROWE A, 1995, INFECT IMMUN, V63, P2323, DOI 10.1128/IAI.63.6.2323-2326.1995; Rowe JA, 1997, NATURE, V388, P292, DOI 10.1038/40888; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; WILLIAMS AR, 1980, SCAND J HAEMATOL, V24, P57; Winterbourn CC, 1985, CRC HDB METHODS OXYG, P137; Yipp BG, 2000, BLOOD, V96, P2292, DOI 10.1182/blood.V96.6.2292.h8002292_2292_2298	30	143	147	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2005	435	7045					1117	1121		10.1038/nature03631	http://dx.doi.org/10.1038/nature03631			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937ZT	15973412	Green Published, Bronze			2022-12-01	WOS:000229970400053
J	Litman, RS; Rosenberg, H				Litman, RS; Rosenberg, H			Malignant hyperthermia - Update on susceptibility testing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CENTRAL CORE DISEASE; DEPENDENT CALCIUM-CHANNEL; VITRO CONTRACTURE-TEST; HYPOKALEMIC PERIODIC PARALYSIS; HYPERKALEMIC CARDIAC-ARREST; MUSCLE RYANODINE RECEPTOR; SKELETAL-MUSCLE; RYR1 GENE; SARCOPLASMIC-RETICULUM; CHROMOSOME 19Q12-13.2	Malignant hyperthermia (MH) is a pharmacogenetic clinical syndrome that manifests as a hypermetabolic crisis when a susceptible individual is exposed to an anesthetic triggering agent. Clinical signs include unexplained elevation of end-tidal carbon dioxide, muscle rigidity, acidosis, tachycardia, tachypnea, hyperthermia, and evidence of rhabdomyolysis. This process is a result of an abnormally increased release of calcium from the sarcoplasmic reticulum, which is often caused by an inherited mutation in the gene for the ryanodine receptor (RYR1) that resides in the membrane of the sarcoplasmic reticulum. The gold standard for determination of MH susceptibility is the caffeine-halothane contracture test. However, it is invasive, requiring skeletal muscle biopsy and is not widely available. Researchers have begun to map mutations within the ryanodine receptor gene (chromosome 19q13.1) responsible for conferring MH susceptibility. Ryanodine receptor mutations are found in at least 25% of known MH susceptible individuals in North America. Mutation analysis has recently become available in the United States and is expected to play an integral role in the diagnosis of MH susceptibility in the future.	Univ Penn, Dept Anesthesiol & Crit Care Med, Childrens Hosp Philadelphia, Sch Med, Philadelphia, PA 19104 USA; St Barnabas Hosp, Dept Med Educ, Livingston, NJ USA; Mt Sinai Sch Med, New York, NY USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Icahn School of Medicine at Mount Sinai	Litman, RS (corresponding author), Univ Penn, Dept Anesthesiol & Crit Care Med, Childrens Hosp Philadelphia, Sch Med, 34th St & Civ Ctr Blvd, Philadelphia, PA 19104 USA.	Lit-manr@email.chop.edu	Litman, Ron/AAK-6146-2020					Allen GC, 1998, ANESTHESIOLOGY, V88, P579, DOI 10.1097/00000542-199803000-00006; Anetseder M, 2002, LANCET, V359, P1579, DOI 10.1016/S0140-6736(02)08506-9; Bachand M, 1997, CAN J ANAESTH, V44, P696, DOI 10.1007/BF03013380; Bendahan D, 1998, ANESTHESIOLOGY, V88, P96, DOI 10.1097/00000542-199801000-00017; Bendahan D, 2001, ANESTH ANALG, V93, P683, DOI 10.1097/00000539-200109000-00030; Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; Davis MR, 2003, NEUROMUSCULAR DISORD, V13, P151, DOI 10.1016/S0960-8966(02)00218-3; DENBOROUGH MA, 1962, BRIT J ANAESTH, V34, P395, DOI 10.1093/bja/34.6.395; DEUFEL T, 1995, AM J HUM GENET, V56, P1334; Dirksen RT, 2004, BIOPHYS J, V87, P3193, DOI [10.1529/biophysj.104.048447, 10.1529/biophysj.104.049447]; Fletcher JE, 1999, ANESTHESIOLOGY, V90, P1294, DOI 10.1097/00000542-199905000-00012; FLETCHER JE, 1991, LIFE SCI, V49, P1651, DOI 10.1016/0024-3205(91)90060-O; Fortunato G, 1999, EUR J HUM GENET, V7, P415, DOI 10.1038/sj.ejhg.5200314; GILLARD EF, 1992, GENOMICS, V13, P1247, DOI 10.1016/0888-7543(92)90042-Q; Guis S, 2004, ARCH NEUROL-CHICAGO, V61, P106, DOI 10.1001/archneur.61.1.106; ILES DE, 1994, HUM MOL GENET, V3, P969, DOI 10.1093/hmg/3.6.969; Larach MG, 1997, CLIN PEDIATR, V36, P9; LEVITT RC, 1992, GENOMICS, V14, P562, DOI 10.1016/S0888-7543(05)80152-1; Loke J, 1998, AM J MED, V104, P470, DOI 10.1016/S0002-9343(98)00108-9; LOUIS CF, 1992, ANESTHESIOLOGY, V77, P114, DOI 10.1097/00000542-199207000-00017; MACLENNAN DH, 1990, NATURE, V343, P559, DOI 10.1038/343559a0; *MAL HYP ASS US WE, MH MUSCL BIOPS TEST; Marchant CL, 2004, MUSCLE NERVE, V30, P114, DOI 10.1002/mus.20068; Mathews KD, 2004, ARCH NEUROL-CHICAGO, V61, P27, DOI 10.1001/archneur.61.1.27; McCarthy T V, 2004, Biochem J, V380, pe1, DOI 10.1042/BJ20040512; McCarthy TV, 2000, HUM MUTAT, V15, P410, DOI 10.1002/(SICI)1098-1004(200005)15:5<410::AID-HUMU2>3.0.CO;2-D; MCCARTHY TV, 1990, NATURE, V343, P562, DOI 10.1038/343562a0; Mickelson JR, 1996, PHYSIOL REV, V76, P537, DOI 10.1152/physrev.1996.76.2.537; Monnier N, 1997, AM J HUM GENET, V60, P1316, DOI 10.1086/515454; Nathan A, 2005, ANESTH ANALG, V100, P672, DOI 10.1213/01.ANE.0000146533.21771.2F; O'Sullivan GH, 2001, BIOCHEM PHARMACOL, V61, P1479, DOI 10.1016/S0006-2952(01)00604-9; OLCKERS A, 1992, GENOMICS, V14, P829, DOI 10.1016/S0888-7543(05)80206-X; Ording H, 1997, ACTA ANAESTH SCAND, V41, P955, DOI 10.1111/j.1399-6576.1997.tb04820.x; ORDING H, 1985, ANESTH ANALG, V64, P700; Paul-Pletzer K, 2002, J BIOL CHEM, V277, P34918, DOI 10.1074/jbc.M205487200; Phillips MS, 1996, GENOMICS, V34, P24, DOI 10.1006/geno.1996.0238; POLLOCK N, 1992, ANAESTH INTENS CARE, V20, P520, DOI 10.1177/0310057X9202000427; Rajabally YA, 2002, MUSCLE NERVE, V25, P453, DOI 10.1002/mus.10069; Robinson RL, 2003, EUR J HUM GENET, V11, P342, DOI 10.1038/sj.ejhg.5200964; Robinson RL, 2002, HUM MUTAT, V20, P88, DOI 10.1002/humu.10098; Robinson RL, 1997, HUM MOL GENET, V6, P953, DOI 10.1093/hmg/6.6.953; Rosenberg H, 2002, ANESTHESIOLOGY, V96, P232, DOI 10.1097/00000542-200201000-00036; Sei Y, 2004, ANESTHESIOLOGY, V101, P824, DOI 10.1097/00000542-200410000-00005; Sei Y, 2002, ANESTHESIOLOGY, V97, P1052, DOI 10.1097/00000542-200211000-00005; Serfas KD, 1996, ANESTHESIOLOGY, V84, P322, DOI 10.1097/00000542-199602000-00009; Stewart SL, 2001, CLIN GENET, V59, P178, DOI 10.1034/j.1399-0004.2001.590306.x; Struk A, 1998, BIOPHYS J, V75, P2402, DOI 10.1016/S0006-3495(98)77684-2; SUDBRAK R, 1995, AM J HUM GENET, V56, P684; Tobin JR, 2001, JAMA-J AM MED ASSOC, V286, P168, DOI 10.1001/jama.286.2.168; Wappler F, 2001, ANESTHESIOLOGY, V94, P95, DOI 10.1097/00000542-200101000-00019; Weiss RG, 2004, AM J PHYSIOL-CELL PH, V287, pC1094, DOI 10.1152/ajpcell.00173.2004; Yang TZ, 2003, J BIOL CHEM, V278, P25722, DOI 10.1074/jbc.M302165200	52	106	117	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 15	2005	293	23					2918	2924		10.1001/jama.293.23.2918	http://dx.doi.org/10.1001/jama.293.23.2918			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	935MD	15956637				2022-12-01	WOS:000229785500027
J	Grisendi, S; Bernardi, R; Rossi, M; Cheng, K; Khandker, L; Manova, K; Pandolfi, PP				Grisendi, S; Bernardi, R; Rossi, M; Cheng, K; Khandker, L; Manova, K; Pandolfi, PP			Role of nucleophosmin in embryonic development and tumorigenesis	NATURE			English	Article							TUMOR-SUPPRESSOR PROTEIN; LEUKEMIA; GENE; NPM; CHROMOSOME-5; INHIBITION; FUSION; ARF	Nucleophosmin ( also known as NPM, B23, NO38) is a nucleolar protein directly implicated in cancer pathogenesis, as the NPM1 gene is found mutated and rearranged in a number of haematological disorders(1-5). Furthermore, the region of chromosome 5 to which NPM1 maps is deleted in a proportion of de novo human myelodysplastic syndromes (MDS)(6-9), and loss of chromosome 5 is extremely frequent in therapy-related MDS9,10. NPM is a multifunctional protein(11-15), and its role in oncogenesis is controversial as NPM has been attributed with both oncogenic and tumour suppressive functions(16-19). To study the function of Npm in vivo, we generated a hypomorphic Npm1 mutant series (Npm1(+/-) < Npm1(hy/ hy) < Npm1(-/-)) in mouse. Here we report that Npm is essential for embryonic development and the maintenance of genomic stability. Npm1(-/-) and Npm1(hy/hy) mutants have aberrant organogenesis and die between embryonic day E11.5 and E16.5 owing to severe anaemia resulting from defects in primitive haematopoiesis. We show that Npm1 inactivation leads to unrestricted centrosome duplication and genomic instability. We demonstrate that Npm is haploinsufficient in the control of genetic stability and that Npm1 heterozygosity accelerates oncogenesis both in vitro and in vivo. Notably, Npm1(+/-) mice develop a haematological syndrome with features of human MDS. Our findings uncover an essential developmental role for Npm and implicate its functional loss in tumorigenesis and MDS pathogenesis.	Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol, Canc Biol & Genet Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Med, Lab Cellular Immunobiol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Mol Cytol Core Facil, Dev Biol Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Pandolfi, PP (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	p-pandolfi@ski.mskcc.org	Rossi, Marco/AAF-6413-2020; bernardi, rosa/B-1650-2013	Rossi, Marco/0000-0002-7258-475X; bernardi, rosa/0000-0002-3607-6336; Khandker, Luipa/0000-0001-6274-0520				Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Bertwistle D, 2004, MOL CELL BIOL, V24, P985, DOI 10.1128/MCB.24.3.985-996.2004; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; Chung YJ, 2004, GENOME RES, V14, P188, DOI 10.1101/gr.1878804; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Giagounidis AAN, 2004, LEUKEMIA, V18, P113, DOI 10.1038/sj.leu.2403189; Grisendi S, 2005, NEW ENGL J MED, V352, P291, DOI 10.1056/NEJMe048337; Hingorani K, 2000, J BIOL CHEM, V275, P24451, DOI 10.1074/jbc.M003278200; KHAN SH, 1998, CANCER RES, V58, P369; Kondo T, 1997, ONCOGENE, V15, P1275, DOI 10.1038/sj.onc.1201286; Korgaonkar C, 2005, MOL CELL BIOL, V25, P1258, DOI 10.1128/MCB.25.4.1258-1271.2005; Kurki S, 2004, CANCER CELL, V5, P465, DOI 10.1016/S1535-6108(04)00110-2; Lanni JS, 1998, MOL CELL BIOL, V18, P1055, DOI 10.1128/MCB.18.2.1055; Lerch-Gaggl A, 2002, J BIOL CHEM, V277, P45347, DOI 10.1074/jbc.M208338200; Li J, 2004, J BIOL CHEM, V279, P41275, DOI 10.1074/jbc.C400297200; List Alan F, 2004, Hematology Am Soc Hematol Educ Program, P297; Mendes-da-Silva P, 2000, J CLIN PATHOL-MOL PA, V53, P184, DOI 10.1136/mp.53.4.184; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Olney HJ, 2002, BAS CLIN ON, V27, P89; Redner RL, 1996, BLOOD, V87, P882, DOI 10.1182/blood.V87.3.882.bloodjournal873882; Savkur RS, 1998, NUCLEIC ACIDS RES, V26, P4508, DOI 10.1093/nar/26.19.4508; Spike BT, 2004, EMBO J, V23, P4319, DOI 10.1038/sj.emboj.7600432; Stewart ZA, 1999, MOL CELL BIOL, V19, P205; VandenBerghe H, 1997, CANCER GENET CYTOGEN, V94, P1, DOI 10.1016/S0165-4608(96)00350-0; Westbrook CA, 2000, BRIT J HAEMATOL, V110, P847, DOI 10.1046/j.1365-2141.2000.02285.x; Wu MH, 2002, J BIOL CHEM, V277, P48234, DOI 10.1074/jbc.M206550200; YonedaKato N, 1996, ONCOGENE, V12, P265; Zhang H, 2004, J BIOL CHEM, V279, P35726, DOI 10.1074/jbc.M403264200	30	425	453	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2005	437	7055					147	153		10.1038/nature03915	http://dx.doi.org/10.1038/nature03915			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	960AC	16007073				2022-12-01	WOS:000231560400059
J	Liu, J; Xiao, H; Lei, F; Zhu, Q; Qin, K; Zhang, XW; Zhang, XL; Zhao, D; Wang, G; Feng, Y; Ma, J; Liu, W; Wang, J; Gao, GF				Liu, J; Xiao, H; Lei, F; Zhu, Q; Qin, K; Zhang, XW; Zhang, XL; Zhao, D; Wang, G; Feng, Y; Ma, J; Liu, W; Wang, J; Gao, GF			Highly pathogenic H5N1 influenza virus infection in migratory birds	SCIENCE			English	Article									China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China; Chinese Acad Sci, Inst Microbiol, Beijing 100080, Peoples R China; Chinese Acad Sci, Inst Zool, Beijing 100101, Peoples R China; Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; Acad Mil Med Sci, Inst Microbiol & Epidemiol, Beijing 100071, Peoples R China; Chinese Acad Sci, Beijing Genom Inst, Beijing 101300, Peoples R China	China Agricultural University; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Academy of Military Medical Sciences - China; Beijing Genomics Institute (BGI); Chinese Academy of Sciences	Liu, J (corresponding author), China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China.	jhl@cau.edu.cn; gaof@im.ac.cn	Feng, Youjun/E-5670-2010; Feng, Youjun/E-8386-2010; Gao, George Fu/ABD-5229-2021					Chen H, 2004, P NATL ACAD SCI USA, V101, P10452, DOI 10.1073/pnas.0403212101; Cheng TX, 1979, FAUNA SINICA AVES; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Webby RJ, 2003, SCIENCE, V302, P1519, DOI 10.1126/science.1090350	6	552	683	3	358	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2005	309	5738					1206	1206		10.1126/science.1115273	http://dx.doi.org/10.1126/science.1115273			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	957TE	16000410				2022-12-01	WOS:000231395400035
J	Philips, JA; Rubin, EJ; Perrimon, N				Philips, JA; Rubin, EJ; Perrimon, N			Drosophila RNAi screen reveals CD36 family member required for mycobacterial infection	SCIENCE			English	Article							I SR-BI; RECEPTOR; PHAGOCYTOSIS; TUBERCULOSIS; PHAGOSOME; IDENTIFICATION; MACROPHAGES; VIRULENCE; PROTEINS; MODEL	Certain pathogens, such as Mycobacterium tuberculosis, survive within the hostile intracellular environment of a macrophage. To identify host factors required for mycobacterial entry and survival within macrophages, we performed a genome-wide RNA interference screen in Drosophila macrophage-like cells, using Mycobacterium fortuitum. We identified factors required for general phagocytosis, as well as those needed specifically for mycobacterial infection. One specific factor, Peste (Pes), is a CD36 family member required for uptake of mycobacteria, but not Escherichia coli or Staphylococcus aureus. Moreover, mammalian class B scavenger receptors (SRs) conferred uptake of bacteria into nonphagocytic cells, with SR-BI and SR-BII uniquely mediating uptake of M. fortuitum, which suggests a conserved role for class B SRs in pattern recognition and innate immunity.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard T.H. Chan School of Public Health	Philips, JA (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Louis Pasteur Ave, Boston, MA 02115 USA.	jphilips@partners.org; perrimon@receptor.med.harvard.edu	Eckhardt, Erik/G-1567-2010	Rubin, Eric/0000-0001-5120-962X; Perrimon, Norbert/0000-0001-7542-472X				Agaisse H, 2005, SCIENCE, V309, P1248, DOI 10.1126/science.1116008; Cirillo JD, 1997, INFECT IMMUN, V65, P3759, DOI 10.1128/IAI.65.9.3759-3767.1997; da Silva TRM, 2002, INFECT IMMUN, V70, P5628, DOI 10.1128/IAI.70.10.5628-5634.2002; Dionne MS, 2003, INFECT IMMUN, V71, P3540, DOI 10.1128/IAI.71.6.3540-3550.2003; El-Etr SH, 2001, INFECT IMMUN, V69, P7310, DOI 10.1128/IAI.69.12.7310-7317.2001; Fischer O, 2001, MED VET ENTOMOL, V15, P208, DOI 10.1046/j.1365-2915.2001.00292.x; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; Griffith D E, 1996, Semin Respir Infect, V11, P301; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Husemann J, 2001, J NEUROIMMUNOL, V114, P142, DOI 10.1016/S0165-5728(01)00239-9; Kelley VA, 2003, MOL BIOL CELL, V14, P3366, DOI 10.1091/mbc.E02-12-0780; Mulcahy JV, 2004, BIOCHEM J, V377, P741, DOI 10.1042/bj20030307; Pearson AM, 2003, MICROBES INFECT, V5, P815, DOI 10.1016/S1286-4579(03)00157-6; Ramakrishnan L, 2000, SCIENCE, V288, P1436, DOI 10.1126/science.288.5470.1436; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; Rhainds D, 2004, INT J BIOCHEM CELL B, V36, P39, DOI 10.1016/S1357-2725(03)00173-0; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015; Zimmerli S, 1996, AM J RESP CELL MOL, V15, P760, DOI 10.1165/ajrcmb.15.6.8969271	20	275	289	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2005	309	5738					1251	1253		10.1126/science.1116006	http://dx.doi.org/10.1126/science.1116006			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	957TE	16020694				2022-12-01	WOS:000231395400049
J	Keegan, M; Konig, F; McClelland, R; Bruck, W; Morales, Y; Bitsch, A; Panitch, H; Lassmann, H; Weinshenker, B; Rodriguez, M; Parisi, J; Lucchinetti, CF				Keegan, M; Konig, F; McClelland, R; Bruck, W; Morales, Y; Bitsch, A; Panitch, H; Lassmann, H; Weinshenker, B; Rodriguez, M; Parisi, J; Lucchinetti, CF			Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange	LANCET			English	Article							DEMYELINATING DISEASE; ANTIBODIES	Early, active multiple sclerosis lesions show four immunopathological patterns of demyelination. Although these patterns differ between patients, multiple active lesions from a given patient have an identical pattern, which suggests pathogenic heterogeneity. Therapeutic plasma exchange (TPE) has been successfully used to treat fulminant demyelinating attacks unresponsive to steroids. We postulated that patients with pattern II would be more likely to improve after TPE than those with other patterns since pattern II lesions are distinguished by prominent immunoglobulin deposition and complement activation. We retrospectively studied 19 patients treated with TPE for an attack of fulminant CNS inflammatory demyelinating disease. All patients with pattern II (n=10), but none with pattern I (n=3) or pattern III (n=6), achieved moderate to substantial functional neurological improvement after TPE (p<0.0001). Patients with multiple sclerosis with pattern II pathology are more likely to respond favourably to TPE than are patients with patterns I or III.	Mayo Clin Coll Med, Dept Neurol, Rochester, MN 55905 USA; Mayo Clin Coll Med, Dept Hlth Sci Res, Rochester, MN 55905 USA; Mayo Clin Coll Med, Dept Lab Med & Pathol, Rochester, MN 55905 USA; Mayo Clin Coll Med, Dept Immunol, Rochester, MN 55905 USA; Mayo Clin Coll Med, Mayo Grad Sch, Rochester, MN 55905 USA; Inst Neuropathol, Gottingen, Germany; Ruppiner Kliniken GmbH, Neuruppin, Germany; Univ Vermont, Burlington, VT USA; Univ Vienna, Brain Res Inst, Vienna, Austria	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Ruppiner Kliniken GmbH; University of Vermont; University of Vienna	Lucchinetti, CF (corresponding author), Mayo Clin Coll Med, Dept Neurol, Rochester, MN 55905 USA.	lucchinetti.claudia@mayo.edu	Weinshenker, Brian G/ABH-6146-2020; Lassmann, Hans/Z-2269-2019	Weinshenker, Brian G/0000-0001-5806-6203; Lassmann, Hans/0000-0001-8617-5052; Odia, Yazmin/0000-0003-3602-3899; Rodriguez, Moses/0000-0001-6328-6497				Berger T, 2003, NEW ENGL J MED, V349, P139, DOI 10.1056/NEJMoa022328; Cross AH, 2001, J NEUROIMMUNOL, V112, P1, DOI 10.1016/S0165-5728(00)00409-4; Keegan M, 2002, NEUROLOGY, V58, P143, DOI 10.1212/WNL.58.1.143; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; PITTOCK SJ, IN PRESS J NEUROL NE; WEINSHENKER B, 2001, MULTIPLE SCLEROSIS T, P267; Weinshenker BG, 1999, ANN NEUROL, V46, P878, DOI 10.1002/1531-8249(199912)46:6<878::AID-ANA10>3.0.CO;2-Q	8	304	316	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 13	2005	366	9485					579	582		10.1016/S0140-6736(05)67102-4	http://dx.doi.org/10.1016/S0140-6736(05)67102-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	955LL	16099294				2022-12-01	WOS:000231227300030
J	Ryan, J; Montgomery, H				Ryan, J; Montgomery, H			The London attacks - preparedness - Terrorism and the medical response	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									UCL, London WC1E 6BT, England; Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; UCL Hosp, London, England	University of London; University College London; Uniformed Services University of the Health Sciences - USA; University College London Hospitals NHS Foundation Trust; University of London; University College London	Ryan, J (corresponding author), UCL, London WC1E 6BT, England.		Montgomery, Hugh/L-1229-2019; Montgomery, Hugh/C-2592-2008	Montgomery, Hugh/0000-0001-8797-5019				Chaloner E, 2005, BRIT MED J, V331, P119, DOI 10.1136/bmj.331.7509.119; Gutierrez de Ceballos J Peral, 2005, Crit Care Med, V33, pS107, DOI 10.1097/01.CCM.0000151072.17826.72; Kluger Y, 2004, Scand J Surg, V93, P11	3	37	38	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 11	2005	353	6					543	545		10.1056/NEJMp058177	http://dx.doi.org/10.1056/NEJMp058177			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	953ST	16093460	Bronze			2022-12-01	WOS:000231101500002
J	Chen, ZB; Trotman, LC; Shaffer, D; Lin, HK; Dotan, ZA; Niki, M; Koutcher, JA; Scher, HI; Ludwig, T; Gerald, W; Cordon-Cardo, C; Pandolfi, PP				Chen, ZB; Trotman, LC; Shaffer, D; Lin, HK; Dotan, ZA; Niki, M; Koutcher, JA; Scher, HI; Ludwig, T; Gerald, W; Cordon-Cardo, C; Pandolfi, PP			Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis	NATURE			English	Article							PROSTATE-CANCER; P53; CELLS; PATHWAY; REGION; MDM2	Cellular senescence has been theorized to oppose neoplastic transformation triggered by activation of oncogenic pathways in vitro(1-3), but the relevance of senescence in vivo has not been established. The PTEN and p53 tumour suppressors are among the most commonly inactivated or mutated genes in human cancer including prostate cancer(4,5). Although they are functionally distinct, reciprocal cooperation has been proposed, as PTEN is thought to regulate p53 stability, and p53 to enhance PTEN transcription(6-10). Here we show that conditional inactivation of Trp53 in the mouse prostate fails to produce a tumour phenotype, whereas complete Pten inactivation in the prostate triggers non-lethal invasive prostate cancer after long latency. Strikingly, combined inactivation of Pten and Trp53 elicits invasive prostate cancer as early as 2 weeks after puberty and is invariably lethal by 7 months of age. Importantly, acute Pten inactivation induces growth arrest through the p53-dependent cellular senescence pathway both in vitro and in vivo, which can be fully rescued by combined loss of Trp53. Furthermore, we detected evidence of cellular senescence in specimens from early-stage human prostate cancer. Our results demonstrate the relevance of cellular senescence in restricting tumorigenesis in vivo and support a model for cooperative tumour suppression in which p53 is an essential failsafe protein of Pten-deficient tumours.	Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Med, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Radiol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Med Phys, New York, NY 10021 USA; Columbia Univ, Inst Canc Genet, Dept Anat & Cell Biol, New York, NY 10032 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Columbia University	Pandolfi, PP (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	p-pandolfi@ski.mskcc.org	Ludwig, Thomas/Q-6484-2016	Ludwig, Thomas/0000-0003-3461-2585; Dotan, Zohar/0000-0002-9005-2992	NATIONAL CANCER INSTITUTE [P50CA092629, R01CA137050] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD004038] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA092629, R01 CA137050] Funding Source: Medline; NIMHD NIH HHS [R01 MD004038] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)82148-6; Di Cristofano A, 2001, NAT GENET, V27, P222, DOI 10.1038/84879; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Feilotter HE, 1998, ONCOGENE, V16, P1743, DOI 10.1038/sj.onc.1200205; Freeman DJ, 2003, CANCER CELL, V3, P117, DOI 10.1016/S1535-6108(03)00021-7; Hermans KG, 2004, GENE CHROMOSOME CANC, V39, P171, DOI 10.1002/gcc.10311; Jonkers J, 2002, NAT REV CANCER, V2, P251, DOI 10.1038/nrc777; Levi F, 2004, PROSTATE, V60, P46, DOI 10.1002/pros.20058; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Miyauchi H, 2004, EMBO J, V23, P212, DOI 10.1038/sj.emboj.7600045; Muller M, 2000, Prostate Cancer Prostatic Dis, V3, pS32, DOI 10.1038/sj.pcan.4500457; Navone NM, 1999, J UROLOGY, V161, P304, DOI 10.1016/S0022-5347(01)62136-0; Qian JQ, 2002, MODERN PATHOL, V15, P35, DOI 10.1038/modpathol.3880487; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Serrano M, 2001, CURR OPIN CELL BIOL, V13, P748, DOI 10.1016/S0955-0674(00)00278-7; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Stewart Sherri L., 2004, Morbidity and Mortality Weekly Report, V53, P1; Suzuki H, 1998, CANCER RES, V58, P204; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Trotman LC, 2003, CANCER CELL, V3, P97, DOI 10.1016/S1535-6108(03)00022-9; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Weinberg RA, 1997, CELL, V88, P573, DOI 10.1016/S0092-8674(00)81897-8; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	30	1468	1522	1	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2005	436	7051					725	730		10.1038/nature03918	http://dx.doi.org/10.1038/nature03918			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951XA	16079851	Green Accepted			2022-12-01	WOS:000230964500049
J	Collado, M; Gil, J; Efeyan, A; Guerra, C; Schuhmacher, AJ; Barradas, M; Benguria, A; Zaballos, A; Flores, JM; Barbacid, M; Beach, D; Serrano, M				Collado, M; Gil, J; Efeyan, A; Guerra, C; Schuhmacher, AJ; Barradas, M; Benguria, A; Zaballos, A; Flores, JM; Barbacid, M; Beach, D; Serrano, M			Tumour biology - Senescence in premalignant tumours	NATURE			English	Editorial Material							RAS; P53		CNIO, Spanish Natl Canc Ctr, Madrid 28029, Spain; Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, London W12 0NN, England; CSIC, CNB, Spanish Natl Ctr Biotechnol, E-28049 Madrid, Spain; Univ Complutense, Dept Anim Surg & Med, E-28040 Madrid, Spain; Inst Cell & Mol Sci, Ctr Cutaneous Res, London E1 2AT, England	Centro Nacional de Investigaciones Oncologicas (CNIO); Imperial College London; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Complutense University of Madrid; University of London; Queen Mary University London	Collado, M (corresponding author), CNIO, Spanish Natl Canc Ctr, Madrid 28029, Spain.	mserrano@cnio.es	Benguria, Alberto/M-9911-2014; Serrano, Manuel/H-2634-2015; Guerra, Carmen/K-5852-2014; Efeyan, Alejo/J-8197-2016; Gil, Jesus/C-7739-2012; Schuhmacher, Alberto J./R-6765-2019; Zaballos, Ángel/O-2853-2015; Collado, Manuel/K-8140-2014; J. Schuhmacher, Alberto/F-4028-2016	Benguria, Alberto/0000-0002-5536-566X; Serrano, Manuel/0000-0001-7177-9312; Efeyan, Alejo/0000-0002-3806-6799; Gil, Jesus/0000-0002-4303-6260; Schuhmacher, Alberto J./0000-0002-0136-1049; Collado, Manuel/0000-0002-0330-0880; Zaballos, Angel/0000-0002-7555-5815; Flores, Juana M/0000-0002-7995-4426; Guerra, Carmen/0000-0002-3891-046X				DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6	7	1117	1154	2	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2005	436	7051					642	642		10.1038/436642a	http://dx.doi.org/10.1038/436642a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	951XA	16079833	Bronze			2022-12-01	WOS:000230964500030
J	Bayley, PJ; Frascino, JC; Squire, LR				Bayley, PJ; Frascino, JC; Squire, LR			Robust habit learning in the absence of awareness and independent of the medial temporal lobe	NATURE			English	Article							HIPPOCAMPAL-LESIONS; SEMANTIC KNOWLEDGE; BASAL GANGLIA; MEMORY; MONKEYS; PERFORMANCE; AMNESIA; DAMAGE; SYSTEMS; TASK	Habit memory is thought to involve slowly acquired associations between stimuli and responses and to depend on the basal ganglia(1). Habit memory has been well studied in experimental animals but is poorly understood in humans because of their strong tendency to acquire information as conscious ( declarative) knowledge. Here we show that humans have a robust capacity for gradual trial-and-error learning that operates outside awareness for what is learned and independently of the medial temporal lobe. We tested two patients with large medial temporal lobe lesions and no capacity for declarative memory. Both patients gradually acquired a standard eight-pair object discrimination task over many weeks but at the start of each session could not describe the task, the instructions or the objects. The acquired knowledge was rigidly organized, and performance collapsed when the task format was altered.	Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA; Vet Affairs Med Ctr, San Diego, CA 92161 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Squire, LR (corresponding author), Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA.	Lsquire@ucsd.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH024600] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH024600] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Amaral DG, 1990, HUMAN NERVOUS SYSTEM, P711; Bayley PJ, 2005, NEURON, V46, P799, DOI 10.1016/j.neuron.2005.04.034; Bayley PJ, 2005, HIPPOCAMPUS, V15, P273, DOI 10.1002/hipo.20057; Buffalo EA, 1998, BEHAV NEUROSCI, V112, P3, DOI 10.1037/0735-7044.112.1.3; CORRELL RE, 1965, J COMP PHYSIOL PSYCH, V60, P175, DOI 10.1037/h0022290; Driscoll I, 2004, BEHAV NEUROSCI, V118, P1427, DOI 10.1037/0735-7044.118.6.1427; Eichenbaum H, 2004, CONDITIONING CONSCIO; Fernandez-Ruiz J, 2001, P NATL ACAD SCI USA, V98, P4196, DOI 10.1073/pnas.061022098; Gaffan D, 1996, SEMIN NEUROSCI, V8, P33, DOI 10.1006/smns.1996.0005; Gold JJ, 2005, HIPPOCAMPUS, V15, P79, DOI 10.1002/hipo.20032; HAYES KJ, 1953, J COMP PHYSIOL PSYCH, V46, P105, DOI 10.1037/h0055072; Hood KL, 1999, NEUROPSYCHOLOGIA, V37, P1375, DOI 10.1016/S0028-3932(99)00048-2; Hopkins RO, 2004, NEUROPSYCHOLOGIA, V42, P524, DOI 10.1016/j.neuropsychologia.2003.09.005; Insausti R, 1998, AM J NEURORADIOL, V19, P659; Knowlton B J, 1994, Learn Mem, V1, P106; Levy DA, 2004, P NATL ACAD SCI USA, V101, P6710, DOI 10.1073/pnas.0401679101; MALAMUT BL, 1984, BEHAV NEUROSCI, V98, P759, DOI 10.1037/0735-7044.98.5.759; Myers CE, 2003, J COGNITIVE NEUROSCI, V15, P185, DOI 10.1162/089892903321208123; Nosofsky R, 1999, TRENDS COGN SCI, V3, P125, DOI 10.1016/S1364-6613(99)01291-7; Petri HL, 1984, NEUROPSYCHOLOGY MEMO, P287; SCHACTER DL, 1994, MEMORY SYTEMS 1994; SHANKS DR, 1994, BEHAV BRAIN SCI, V17, P367, DOI 10.1017/S0140525X00035032; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Squire LR, 2004, NEUROBIOL LEARN MEM, V82, P171, DOI 10.1016/j.nlm.2004.06.005; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; SQUIRE LR, 1988, BEHAV NEUROSCI, V102, P210, DOI 10.1037/0735-7044.102.2.210; Stefanacci L, 2000, J NEUROSCI, V20, P7024, DOI 10.1523/JNEUROSCI.20-18-07024.2000; Teng E, 2000, J NEUROSCI, V20, P3853, DOI 10.1523/JNEUROSCI.20-10-03853.2000; Wise SP, 1996, SEMIN NEUROSCI, V8, P39, DOI 10.1006/smns.1996.0006	29	117	120	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2005	436	7050					550	553		10.1038/nature03857	http://dx.doi.org/10.1038/nature03857			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949LE	16049487	Green Accepted			2022-12-01	WOS:000230788800060
J	Lloyd-Jones, DM; Evans, JC; Levy, D				Lloyd-Jones, DM; Evans, JC; Levy, D			Hypertension in adults across the age spectrum - Current outcomes and control in the community	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NUTRITION EXAMINATION SURVEY; BLOOD-PRESSURE CONTROL; UNITED-STATES; SYSTOLIC HYPERTENSION; ANTIHYPERTENSIVE DRUGS; RANDOMIZED-TRIAL; ACTIVE TREATMENT; ELDERLY-PATIENTS; NATIONAL-HEALTH; SWEDISH TRIAL	Context Data are sparse regarding current rates of hypertension treatment and control, and risks associated with hypertension, among persons older than 80 years. Objective To determine the prevalence of blood pressure stages, hypertension treatment and control, and cardiovascular risk among older patients with hypertension. Design, Setting, and Participants A community-based cohort study in which data were collected during all Framingham Heart Study examinations attended in the 1990s. Participants were pooled according to age: younger than 60 years, 60 to 79 years, or 80 years or older. There were 5296 participants who contributed 14458 person-examinations of observation, including 7135 hypertensive person-examinations (4919 treated). Main Outcome Measures Prevalence of hypertension, its treatment, and its control were compared across age groups. Risks for incident cardiovascular disease during follow-up of up to 6 years were estimated as multivariate-adjusted hazard ratios (HRs) and 95% confidence intervals (Cls) using Cox proportional hazards regression. Results Prevalence of hypertension and drug treatment increased with advancing age, whereas control rates were markedly lower in older women (systolic <140 and diastolic <90 mm Hg). For ages younger than 60 years, 60 to 79, and 80 years and older, respectively, control rates were 38%, 36%, and 38% in men (P=.30) and 38%, 28%, and 23% in women (P<.001). Relative risks for cardiovascular disease associated with increasing blood pressure stage did not decline with advancing age, and absolute risks increased markedly. Among participants 80 years of age or older, major cardiovascular events occurred in 9.5% of the normal blood pressure (referent) group, 19.8% of the prehypertension group (HR, 1.9; 95% Cl, 0.9-3.9), 20.3% of the stage 1 hypertension group (HR, 1.8; 95% Cl, 0.8-3.7), and 24.7% of the stage 2 or treated hypertension group (HR, 2.4; 95% Cl, 1.2-4.6). Conclusions Relative to current national guidelines, rates of blood pressure control in the community are low, especially among older Women with hypertension. Short-term risks for cardiovascular disease are substantial, indicating the need for greater efforts at safe, effective risk reduction among the oldest patients with hypertension.	Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; Blood Inst, Framingham Heart Study, Framingham, MA USA	Northwestern University; Feinberg School of Medicine; Framingham Heart Study	Lloyd-Jones, DM (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, 680 N Lake Shore Dr,Suite 1102, Chicago, IL 60611 USA.	dlj@northwestern.edu	Levy, Daniel/ABB-2752-2021; Levy, Daniel/ABF-6873-2021; Lloyd-Jones, Donald M/C-5899-2009	Levy, Daniel/0000-0003-1843-8724; Lloyd-Jones, Donald/0000-0003-0847-6110	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL004253] Funding Source: NIH RePORTER	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abbott RD, 1987, FRAMINGHAM STUDY EPI; *ALLHAT OFF COORD, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; AMERY A, 1986, J HYPERTENS, V4, pS642; [Anonymous], 1991, JAMA, V265, P3255; [Anonymous], 1999, SAS STAT US GUID VER; Bulpitt C, 2001, DRUG AGING, V18, P151, DOI 10.2165/00002512-200118030-00001; Bulpitt CJ, 2003, J HYPERTENS, V21, P2409, DOI 10.1097/00004872-200312000-00030; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; BURT VL, 1995, HYPERTENSION, V26, P60, DOI 10.1161/01.HYP.26.1.60; Chaudhry SI, 2004, JAMA-J AM MED ASSOC, V292, P1074, DOI 10.1001/jama.292.9.1074; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; COOPE J, 1986, BRIT MED J, V293, P1145, DOI 10.1136/bmj.293.6555.1145; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; DAHLOF B, 1991, LANCET, V338, P1281, DOI 10.1016/0140-6736(91)92589-T; DAWBER TR, 1963, ANN NY ACAD SCI, V107, P539, DOI 10.1111/j.1749-6632.1963.tb13299.x; Fields LE, 2004, HYPERTENSION, V44, P398, DOI 10.1161/01.HYP.0000142248.54761.56; Fischer MA, 2004, JAMA-J AM MED ASSOC, V291, P1850, DOI 10.1001/jama.291.15.1850; Franklin SS, 2001, HYPERTENSION, V37, P869, DOI 10.1161/01.HYP.37.3.869; Franklin SS, 1997, CIRCULATION, V96, P308; Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967; Gueyffier F, 1999, LANCET, V353, P793, DOI 10.1016/S0140-6736(98)08127-6; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; Hansson L, 1999, LANCET, V354, P1751, DOI 10.1016/S0140-6736(99)10327-1; HO KKL, 1993, J AM COLL CARDIOL, V22, pA6, DOI 10.1016/0735-1097(93)90455-A; Joint National Committee on Detection Evaluation and Treatment of High Blood Pressure, 1993, ARCH INTERN MED, V153, P154, DOI DOI 10.1001/archinte.1993.00410020010002; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Liu LS, 1998, J HYPERTENS, V16, P1823, DOI 10.1097/00004872-199816120-00016; Lloyd-Jones DM, 2000, HYPERTENSION, V36, P594, DOI 10.1161/01.HYP.36.4.594; MANOLIO TA, 1995, ARCH INTERN MED, V155, P829, DOI 10.1001/archinte.155.8.829; Meyer J., 2001, AGE 2000 CENSUS 2000; PERRY HM, 1989, STROKE, V20, P4, DOI 10.1161/01.STR.20.1.4; Psaty BM, 2002, ARCH INTERN MED, V162, P2325, DOI 10.1001/archinte.162.20.2325; Psaty BN, 2003, JAMA-J AM MED ASSOC, V289, P2534, DOI 10.1001/jama.289.19.2534; Rhoads Caroline S, 2004, Am J Geriatr Cardiol, V13, P161, DOI 10.1111/j.1076-7460.2004.02124.x; Siegel D, 1997, JAMA-J AM MED ASSOC, V278, P1745, DOI 10.1001/jama.278.21.1745; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; STAMLER J, 1993, ARCH INTERN MED, V153, P598, DOI 10.1001/archinte.153.5.598; Vasan RS, 2002, JAMA-J AM MED ASSOC, V287, P1003, DOI 10.1001/jama.287.8.1003; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; Xu KT, 2003, AM J MANAG CARE, V9, P529; 1997, ARCH INTERN MED, V157, P2413	42	416	445	1	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 27	2005	294	4					466	472		10.1001/jama.294.4.466	http://dx.doi.org/10.1001/jama.294.4.466			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	948RM	16046653				2022-12-01	WOS:000230733400021
J	Barnes, PM; Norton, CM; Dunstan, FD; Kemp, AM; Yates, DW; Sibert, JR				Barnes, PM; Norton, CM; Dunstan, FD; Kemp, AM; Yates, DW; Sibert, JR			Abdominal injury due to child abuse	LANCET			English	Article								Diagnosis of abuse in children with internal abdominal injury is difficult because of limited published work. We aimed to ascertain the incidence of abdominal injury due to abuse in children age 0-14 years. 20 children (identified via the British Paediatric Surveillance Unit) had abdominal injuries due to abuse and 164 (identified via the Trauma Audit and Research Network) had injuries to the abdomen due to accident (112 by road-traffic accidents, 52 by falls). 16 abused children were younger than 5 years. Incidence of abdominal injury due to abuse was 2.33 cases per million children per year (95% CI 1.43-3.78) in children younger than 5 years. Six abused children died. 11 abused children had an injury to the gut (ten small bowel) compared with five (all age >5 years) who were injured by a fall (relative risk 5.72 [95% CI 2.27-14.4]; p=0.0002). We have shown that small-bowel injuries can arise accidentally as a result of falls and road-traffic accidents but they are significantly more common in abused children. Therefore, injuries to the small bowel in young children need special consideration, particularly if a minor fall is the explanation.	Cardiff Univ, Acad Ctr, Llandough Hosp, Dept Child Hlth, Penarth, S Glam, Wales; Cardiff Univ, Acad Ctr, Llandough Hosp, Dept Epidemiol Stat & Publ Hlth, Penarth, S Glam, Wales; Hope Hosp, Trauma Audit & Res Network, Salford M6 8HD, Lancs, England	Cardiff University; Cardiff University	Sibert, JR (corresponding author), Cardiff Univ, Acad Ctr, Llandough Hosp, Dept Child Hlth, Penarth, S Glam, Wales.	sibert@cardiff.ac.uk						COANT PN, 1992, PEDIATRICS, V89, P274; COOPER A, 1988, J TRAUMA, V28, P1483, DOI 10.1097/00005373-198810000-00015; Huntimer CM, 2000, PEDIATRICS, V106, P301, DOI 10.1542/peds.106.2.301; LEDBETTER DJ, 1988, ARCH SURG-CHICAGO, V123, P1101; Sibert JR, 2002, CHILD ABUSE NEGLECT, V26, P267, DOI 10.1016/S0145-2134(01)00324-6; Verity C, 2002, ARCH DIS CHILD, V87, P269, DOI 10.1136/adc.87.4.269	6	48	48	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 16	2005	366	9481					234	235		10.1016/S0140-6736(05)66913-9	http://dx.doi.org/10.1016/S0140-6736(05)66913-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	945RG	16023514				2022-12-01	WOS:000230519200032
J	Bassermann, F; von Klitzing, C; Munch, S; Bai, RY; Kawaguchi, H; Morris, SW; Peschel, C; Duyster, J				Bassermann, F; von Klitzing, C; Munch, S; Bai, RY; Kawaguchi, H; Morris, SW; Peschel, C; Duyster, J			NIPA defines an SCF-type mammalian E3 ligase that regulates mitotic entry	CELL			English	Article							ANAPHASE-PROMOTING COMPLEX; F-BOX PROTEINS; UBIQUITIN-LIGASE; CYCLIN B1; S-PHASE; DEGRADATION; CELL; MITOSIS; PHOSPHORYLATION; LOCALIZATION	The regulated oscillation of protein expression is an essential mechanism of cell cycle control. The SCF class of E3 ubiquitin ligases is involved in this process by targeting cell cycle regulatory proteins for degradation by the proteasome, with the F-box subunit of the SCF specifically recruiting a given substrate to the SCF core. Here we identify NIPA (nuclear interaction partner of ALK) as a human F-box-containing protein that defines an SCF-type E3 ligase (SCFNIPA) controlling mitotic entry. Assembly of this SCF complex is regulated by cell-cycle-dependent phosphorylation of NIPA, which restricts substrate ubiquitination activity to interphase. We show nuclear cyclin B1 to be a substrate of SCF NIPA. Inactivation of NIPA by RNAi results in nuclear accumulation of cyclin B1 in interphase, activation of cyclin B1-Cdk1 kinase activity, and premature mitotic entry. Thus, SCFNIPA-based ubiquitination may regulate S-phase completion and mitotic entry in the mammalian cell cycle.	Tech Univ Munich, Dept Internal Med 3, D-81675 Munich, Germany; St Jude Childrens Res Hosp, Dept Pathol & Hematol Oncol, Memphis, TN 38105 USA	Technical University of Munich; University of Munich; St Jude Children's Research Hospital	Duyster, J (corresponding author), Tech Univ Munich, Dept Internal Med 3, D-81675 Munich, Germany.	justus.duyster@lrz.tum.de			NATIONAL CANCER INSTITUTE [R01CA069129] Funding Source: NIH RePORTER; NCI NIH HHS [CA 69129] Funding Source: Medline; PHS HHS [21765] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ayad NG, 2003, CELL, V113, P101, DOI 10.1016/S0092-8674(03)00232-0; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Bai RY, 2002, NAT CELL BIOL, V4, P181, DOI 10.1038/ncb753; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Bassermann F, 2002, J BIOL CHEM, V277, P12437, DOI 10.1074/jbc.M112397200; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; DUYSTER J, 1995, P NATL ACAD SCI USA, V92, P1555, DOI 10.1073/pnas.92.5.1555; Duyster J, 2001, ONCOGENE, V20, P5623, DOI 10.1038/sj.onc.1204594; Galan JM, 1999, P NATL ACAD SCI USA, V96, P9124, DOI 10.1073/pnas.96.16.9124; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; Hagting A, 1999, CURR BIOL, V9, P680, DOI 10.1016/S0960-9822(99)80308-X; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Jackson PK, 2002, MOL CELL, V9, P923, DOI 10.1016/S1097-2765(02)00538-5; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Li J, 1997, P NATL ACAD SCI USA, V94, P502, DOI 10.1073/pnas.94.2.502; Michael WM, 1998, SCIENCE, V282, P1886, DOI 10.1126/science.282.5395.1886; MINSHULL J, 1989, CELL, V56, P947, DOI 10.1016/0092-8674(89)90628-4; Moore JD, 2003, SCIENCE, V300, P987, DOI 10.1126/science.1081418; Nakayama K, 2004, DEV CELL, V6, P661, DOI 10.1016/S1534-5807(04)00131-5; Ng RWM, 1998, FEBS LETT, V438, P183, DOI 10.1016/S0014-5793(98)01299-X; Ouyang T, 2003, J BIOL CHEM, V278, P30028, DOI 10.1074/jbc.M300883200; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Yamano H, 2004, MOL CELL, V13, P137, DOI 10.1016/S1097-2765(03)00480-5; Yamano H, 2000, MOL CELL, V6, P1377, DOI 10.1016/S1097-2765(00)00135-0; Yang J, 1998, GENE DEV, V12, P2131, DOI 10.1101/gad.12.14.2131; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zhou PB, 1998, MOL CELL, V2, P571, DOI 10.1016/S1097-2765(00)80156-2	33	61	66	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 15	2005	122	1					45	57		10.1016/j.cell.2005.04.034	http://dx.doi.org/10.1016/j.cell.2005.04.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	950EC	16009132	Bronze			2022-12-01	WOS:000230839400010
J	Sanada, K; Tsai, LH				Sanada, K; Tsai, LH			G protein beta gamma subunits and AGS3 control spindle orientation and asymmetric cell fate of cerebral cortical progenitors	CELL			English	Article							HETEROTRIMERIC G-PROTEINS; DEPENDENT ACTIVATION; RECEPTOR KINASE; DIVISION; NEUROGENESIS; NEURONS; NUMA; ORGANIZATION; INHERITANCE; EXPRESSION	Neurons in the developing mammalian brain are generated from progenitor cells in the proliferative ventricular zone, and control of progenitor division is essential to produce the correct number of neurons during neurogenesis. Here we establish that G beta gamma subunits of heterotrimeric G proteins are required for proper mitotic-spindle orientation of neural progenitors in the developing neocortex. Interfering with G beta gamma function in progenitors causes a shift in spindle orientation from apical-basal divisions to planar divisions. This results in hyperdifferentiation of progenitors into neurons as a consequence of both daughter cells adopting a neural fate instead of the normal asymmetric cell fates. Silencing AGS3, a nonreceptor activator of G beta gamma, results in defects similar to the impairment of G beta gamma, providing evidence that AGS3-G beta gamma signaling in progenitors regulates apical-basal division and asymmetric cell-fate decisions. Furthermore, our observations indicate that the cell-fate decision of daughter cells is coupled to mitotic-spindle orientation in progenitors.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Tsai, LH (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	li-huei_tsai@hms.harvard.edu	SANADA, YOSHIKADO/G-5014-2014	Sanada, Kamon/0000-0002-0280-8957	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037007] Funding Source: NIH RePORTER; NINDS NIH HHS [NS37007] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Asano T, 2001, J NEUROCHEM, V79, P1129, DOI 10.1046/j.1471-4159.2001.00662.x; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Cai L, 2002, J NEUROSCI RES, V69, P731, DOI 10.1002/jnr.10398; Cayouette M, 2003, DEVELOPMENT, V130, P2329, DOI 10.1242/dev.00446; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Chenn A, 1998, MOL CELL NEUROSCI, V11, P183, DOI 10.1006/mcne.1998.0680; Cismowski MJ, 1999, NAT BIOTECHNOL, V17, P878, DOI 10.1038/12867; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; FEDERMAN AD, 1992, NATURE, V356, P159, DOI 10.1038/356159a0; GAGLIO T, 1995, J CELL BIOL, V131, P693, DOI 10.1083/jcb.131.3.693; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.biochem.56.1.615; Gotta M, 2003, CURR BIOL, V13, P1029, DOI 10.1016/S0960-9822(03)00371-3; Haydar TF, 2003, P NATL ACAD SCI USA, V100, P2890, DOI 10.1073/pnas.0437969100; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; KORNACK DR, 1995, NEURON, V15, P311, DOI 10.1016/0896-6273(95)90036-5; Li HS, 2003, NEURON, V40, P1105, DOI 10.1016/S0896-6273(03)00755-4; Mandato CA, 2003, CURR BIOL, V13, P1096, DOI 10.1016/S0960-9822(03)00420-2; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Mochizuki N, 1996, GENE, V181, P39, DOI 10.1016/S0378-1119(96)00456-8; Natochin M, 2000, J BIOL CHEM, V275, P40981, DOI 10.1074/jbc.M006478200; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Petersen PH, 2004, NAT NEUROSCI, V7, P803, DOI 10.1038/nn1289; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; Rajan P, 1998, J NEUROSCI, V18, P3620; RHYU MS, 1995, CELL, V82, P523, DOI 10.1016/0092-8674(95)90022-5; Roychowdhury S, 1997, J BIOL CHEM, V272, P31576, DOI 10.1074/jbc.272.50.31576; Sanada K, 2004, NEURON, V42, P197, DOI 10.1016/S0896-6273(04)00222-3; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Shen Q, 2002, DEVELOPMENT, V129, P4843; Shinohara H, 2004, J BIOL CHEM, V279, P41141, DOI 10.1074/jbc.M406721200; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Takahashi T, 1996, J NEUROSCI, V16, P6183; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; ZHONG W, 1996, NEURON, V17, P45	39	215	222	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 15	2005	122	1					119	131		10.1016/j.cell.2005.05.009	http://dx.doi.org/10.1016/j.cell.2005.05.009			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	950EC	16009138	Bronze			2022-12-01	WOS:000230839400016
J	Scheuring, S; Sturgis, JN				Scheuring, S; Sturgis, JN			Chromatic adaptation of photosynthetic membranes	SCIENCE			English	Article							LIGHT-HARVESTING COMPLEX; X-RAY-STRUCTURE; RHODOBACTER-SPHAEROIDES; CORE COMPLEX; CRYSTAL-STRUCTURE; RHODOSPIRILLUM-RUBRUM; NATIVE MEMBRANES; ELECTRON-DENSITY; RESOLUTION; LH2	Many biological membranes adapt in response to environmental conditions. We investigated how the composition and architecture of photosynthetic membranes of a bacterium change in response to light, using atomic force microscopy. Despite large modifications in the membrane composition, the local environment of core complexes remained unaltered, whereas specialized paracrystalline light-harvesting antenna domains grew under tow-light conditions. Thus, the protein mixture in the membrane shows eutectic behavior and can be mimicked by a simple model. Such structural adaptation ensures efficient photon capture under low-light conditions and prevents photodamage under high-light conditions.	Inst Curie, CNRS, Unite Mixte Rech 168, F-75231 Paris, France; CNRS, Unite Propre Rech 9027, Lab Indenierie Syst Macromol, Inst Biol Struct & Microbiol, F-13402 Marseille, France	UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS)	Scheuring, S (corresponding author), Inst Curie, CNRS, Unite Mixte Rech 168, 11 Rue Pierre & Marie Curie, F-75231 Paris, France.	simon.scheuring@curie.fr	Sturgis, James/F-6051-2011; Sturgis, James/AAU-8103-2020; Scheuring, Simon/L-9843-2018	Scheuring, Simon/0000-0003-3534-069X; Sturgis, James/0000-0001-5125-7699				ALLEN JP, 1987, P NATL ACAD SCI USA, V84, P6162, DOI 10.1073/pnas.84.17.6162; Bahatyrova S, 2004, NATURE, V430, P1058, DOI 10.1038/nature02823; Berry EA, 2004, PHOTOSYNTH RES, V81, P251, DOI 10.1023/B:PRES.0000036888.18223.0e; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; CROFTS AR, 1983, BIOCHIM BIOPHYS ACTA, V723, P202, DOI 10.1016/0005-2728(83)90120-2; DEISENHOFER J, 1984, J MOL BIOL, V180, P385, DOI 10.1016/S0022-2836(84)80011-X; Engel A, 2000, NAT STRUCT BIOL, V7, P715, DOI 10.1038/78929; Fotiadis D, 2004, J BIOL CHEM, V279, P2063, DOI 10.1074/jbc.M310382200; Hartigan N, 2002, BIOPHYS J, V82, P963, DOI 10.1016/S0006-3495(02)75456-8; Jamieson SJ, 2002, EMBO J, V21, P3927, DOI 10.1093/emboj/cdf410; Joliot P, 2005, BBA-BIOENERGETICS, V1706, P204, DOI 10.1016/j.bbabio.2004.11.002; Jungas C, 1999, EMBO J, V18, P534, DOI 10.1093/emboj/18.3.534; Koepke J, 1996, STRUCTURE, V4, P581, DOI 10.1016/S0969-2126(96)00063-9; MCDERMOTT G, 1995, NATURE, V374, P517, DOI 10.1038/374517a0; Noro MG, 2001, J CHEM PHYS, V114, P2477, DOI 10.1063/1.1338504; PANAGIOTOPOULOS AZ, 1995, GIBBS ENSEMBLE TECHN, V460; Papiz MZ, 2003, J MOL BIOL, V326, P1523, DOI 10.1016/S0022-2836(03)00024-X; Roszak AW, 2003, SCIENCE, V302, P1969, DOI 10.1126/science.1088892; Scheuring S, 2004, EMBO J, V23, P4127, DOI 10.1038/sj.emboj.7600429; Scheuring S, 2004, J BIOL CHEM, V279, P3620, DOI 10.1074/jbc.M310050200; Scheuring S, 2004, P NATL ACAD SCI USA, V101, P11293, DOI 10.1073/pnas.0404350101; Scheuring S, 2005, J BIOL CHEM, V280, P1426, DOI 10.1074/jbc.M411334200; Scheuring S, 2003, P NATL ACAD SCI USA, V100, P1690, DOI 10.1073/pnas.0437992100; Scheuring S, 2003, J MOL BIOL, V325, P569, DOI 10.1016/S0022-2836(02)01241-X; Scheuring S, 2001, EMBO J, V20, P3029, DOI 10.1093/emboj/20.12.3029; Siebert CA, 2004, EMBO J, V23, P690, DOI 10.1038/sj.emboj.7600092; STURGIS JN, 1988, PHOTOCHEM PHOTOBIOL, V48, P243, DOI 10.1111/j.1751-1097.1988.tb02817.x; Sturgis JN, 1996, ARCH MICROBIOL, V165, P235, DOI 10.1007/s002030050321; Walz T, 1998, J MOL BIOL, V282, P833, DOI 10.1006/jmbi.1998.2050	29	216	226	4	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2005	309	5733					484	487		10.1126/science.1110879	http://dx.doi.org/10.1126/science.1110879			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946LY	16020739				2022-12-01	WOS:000230574900052
J	Perry, ACF				Perry, ACF			Progress in human somatic-cell nuclear transfer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							EMBRYONIC STEM-CELLS		RIKEN, Ctr Dev Biol, Lab Mammalian Mol Embryol, Kobe, Hyogo, Japan	RIKEN	Perry, ACF (corresponding author), RIKEN, Ctr Dev Biol, Lab Mammalian Mol Embryol, Kobe, Hyogo, Japan.			Perry, Tony/0000-0003-3136-5355				Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; Hwang WS, 2004, SCIENCE, V303, P1669, DOI 10.1126/science.1094515; HWANG WS, IN PRESS SCIENCE; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Tabar V, 2005, NAT BIOTECHNOL, V23, P601, DOI 10.1038/nbt1088	5	8	8	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 7	2005	353	1					87	88		10.1056/NEJMcibr052068	http://dx.doi.org/10.1056/NEJMcibr052068			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942FC	16000361				2022-12-01	WOS:000230267300015
J	Davis, SR; Davison, SL; Donath, S; Bell, RJ				Davis, SR; Davison, SL; Donath, S; Bell, RJ			Circulating androgen levels and self-reported sexual function in women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SERUM TESTOSTERONE; BREAST-CANCER; HORMONES; DEHYDROEPIANDROSTERONE; ESTROGENS; THERAPY; PROFILE; RISK	Context It has been proposed that low sexual desire and sexual dysfunction are associated with low blood testosterone levels in women. However, evidence to support this is lacking. Objective To determine whether women with low self-reported sexual desire and sexual satisfaction are more likely to have low serum androgen levels than women without self-reported low sexual desire and sexual satisfaction. Design, Setting, and Participants A community-based, cross-sectional study of 1423 women aged 18 to 75 years, who were randomly recruited via the electoral roll in Victoria, Australia, from April 2002 to August 2003. Women were excluded from the analysis if they took psychiatric medication, had abnormal thyroid function, documented polycystic ovarian syndrome, or were younger than 45 years and using oral contraception. Main Outcome Measures Domain scores of the Profile of Female Sexual Function (PFSF) and serum levels of total and free testosterone, androstenedione, and dehydroepiandrosterone sulfate. Results A total of 1021 individuals were included in the final analysis. No clinically significant relationships between having a low score for any PFSF domain and having a low serum total or free testosterone or androstenedione level was demonstrated. A low domain score for sexual responsiveness for women aged 45 years or older was associated with higher odds of having a serum dehydroepiandrosterone sulfate level below the 10th percentile for this age group (odds ratio [OR], 3.90; 95% confidence interval [CI], 1.54-9.81 ; P = .004). For women aged 18 to 44 years, having a low domain score for sexual desire (OR, 3.86; 95% Cl, 1.27-11.67; P=.02), sexual arousal (OR, 6.39; 95% Cl, 2.30-17.73; P<.001), and sexual responsiveness (OR, 6.59; 95% Cl, 2.37-18.34; P<.001) was associated with having a dehydroepiandrosterone sulfate level below the 10th percentile. Conclusions No single androgen level is predictive of low female sexual function, and the majority of women with low dehydroepiandrosterone sulfate levels did not have low sexual function.	Alfred Hosp, Monash Med Sch, Dept Med, Womens Hlth Program, Prahran, Vic, Australia; Jean Hailes Fdn, Clayton, Vic, Australia; Monash Univ, Dept Biochem, Clayton, Vic 3168, Australia; Univ Melbourne, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia	Florey Institute of Neuroscience & Mental Health; Monash University; Monash University; Murdoch Children's Research Institute; University of Melbourne; University of Melbourne	Davis, SR (corresponding author), Monash Univ, Alfred Hosp, Cent & Eastern Clin Sch, Womens Hlth Program, Commercial Rd, Prahran, Vic 3181, Australia.	susan.davis@med.monash.edu.au	Davis, Susan D/GZL-2361-2022; Davis, Susan R/A-3111-2009; Bell, Robin J/H-6750-2014	Davis, Susan R/0000-0002-2955-0415; Bell, Robin J/0000-0003-1935-7627; Donath, Susan/0000-0003-2489-3977				Agarwal VR, 1997, J CLIN ENDOCR METAB, V82, P70, DOI 10.1210/jc.82.1.70; Bachmann G, 2002, FERTIL STERIL, V77, P660, DOI 10.1016/S0015-0282(02)02969-2; BEJIN A, 1994, SEXUAL BEHAV AIDS, P163; Burger HG, 2000, J CLIN ENDOCR METAB, V85, P2832, DOI 10.1210/jc.85.8.2832; Burger HG, 2002, FERTIL STERIL, V77, pS3; Cameron DR, 2004, FERTIL STERIL, V82, P273, DOI 10.1016/j.fertnstert.2003.11.062; Chen C, 2003, CANCER EPIDEM BIOMAR, V12, P1410; DAVIS SR, 1995, MATURITAS, V21, P227, DOI 10.1016/0378-5122(94)00898-H; DAVISON S, IN PRESS J CLIN ENDO; Dennerstein L, 1997, MATURITAS, V26, P83, DOI 10.1016/S0378-5122(96)01093-6; Derogatis L, 2004, J SEX MARITAL THER, V30, P25, DOI 10.1080/00926230490247183; GOEBELSMANN U, 1974, AM J OBSTET GYNECOL, V119, P445, DOI 10.1016/0002-9378(74)90199-9; Goldstat R, 2003, MENOPAUSE, V10, P390, DOI 10.1097/01.GME.0000060256.03945.20; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; KONTULA O, 1995, ENHANCEMENT SEX LIFE; Labrie F, 2003, ENDOCR REV, V24, P152, DOI 10.1210/er.2001-0031; Labrie F, 1998, STEROIDS, V63, P322, DOI 10.1016/S0039-128X(98)00007-5; Labrie F, 1997, J CLIN ENDOCR METAB, V82, P2403, DOI 10.1210/jc.82.8.2403; LABRIE F, 1991, MOL CELL ENDOCRINOL, V78, pC113, DOI 10.1016/0303-7207(91)90116-A; Lamar CA, 2003, CANCER EPIDEM BIOMAR, V12, P380; Laumann EO, 1999, JAMA-J AM MED ASSOC, V281, P537, DOI 10.1001/jama.281.6.537; McHorney CA, 2004, MENOPAUSE, V11, P474, DOI 10.1097/01.GME.0000109316.11228.77; Miller KK, 2004, J CLIN ENDOCR METAB, V89, P525, DOI 10.1210/jc.2003-030680; NATHORSTBOOS J, 1992, GYNECOL OBSTET INVES, V34, P97, DOI 10.1159/000292735; SHERWIN BB, 1987, PSYCHOSOM MED, V49, P397, DOI 10.1097/00006842-198707000-00009; Shifren JL, 2000, NEW ENGL J MED, V343, P682, DOI 10.1056/NEJM200009073431002; Sinha-Hikim I, 1998, J CLIN ENDOCR METAB, V83, P1312, DOI 10.1210/jc.83.4.1312; SODERGARD R, 1982, J STEROID BIOCHEM, V16, P801, DOI 10.1016/0022-4731(82)90038-3; ZUMOFF B, 1995, J CLIN ENDOCR METAB, V80, P1429, DOI 10.1210/jc.80.4.1429	29	345	358	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 6	2005	294	1					91	96		10.1001/jama.294.1.91	http://dx.doi.org/10.1001/jama.294.1.91			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	941JD	15998895				2022-12-01	WOS:000230210200029
J	Hinnerwisch, J; Fenton, WA; Furtak, KJ; Farr, GW; Horwich, AL				Hinnerwisch, J; Fenton, WA; Furtak, KJ; Farr, GW; Horwich, AL			Loops in the central channel of ClpA chaperone mediate protein binding, unfolding, and translocation	CELL			English	Article							SPECIFICITY-ENHANCING FACTOR; MOLECULAR CHAPERONE; SUBSTRATE RECOGNITION; CRYSTAL-STRUCTURE; HSP100 CHAPERONE; DEGRADATION; PROTEASES; ATPASE; PORE	The cylindrical Hsp100 chaperone CipA mediates ATP-dependent unfolding of substrate proteins bearing "tag" sequences, such as the 11-residue ssrA sequence appended to proteins translationally stalled at ribosomes. Unfolding is coupled to translocation through a central channel into the associating protease, ClpP. To explore the topology and mechanism of ClpA action, we carried out chemical crosslinking and functional studies. Whereas a tag from RepA protein crosslinked proximally to the flexible N domains, the ssrA sequence in GFP-ssrA crosslinked distally in the channel to a segment of the distal ATPase domain (D2). Single substitutions placed in this D2 loop, and also in two apparently cooperating proximal (D1) loops, abolished binding of ssrA substrates and unfolded proteins lacking tags and blocked unfolding of GFP-RepA. Additionally, a substitution adjoining the D2 loop allowed binding of ssrA proteins but impaired their translocation. This loop, as in homologous nucleic-acid translocases, may bind substrates proximally and, coupled with ATP hydrolysis, translocate them distally, exerting mechanical force that mediates unfolding.	Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Yale University; Howard Hughes Medical Institute; Yale University; Scripps Research Institute	Horwich, AL (corresponding author), Yale Univ, Sch Med, Dept Genet, 295 Congress Ave, New Haven, CT 06510 USA.	horwich@csb.yale.edu						DeLaBarre B, 2005, J MOL BIOL, V347, P437, DOI 10.1016/j.jmb.2005.01.060; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Flynn JM, 2001, P NATL ACAD SCI USA, V98, P10584, DOI 10.1073/pnas.191375298; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Guo FS, 2002, J BIOL CHEM, V277, P46743, DOI 10.1074/jbc.M207796200; Hoskins JR, 2000, P NATL ACAD SCI USA, V97, P8892, DOI 10.1073/pnas.97.16.8892; Hoskins JR, 2002, P NATL ACAD SCI USA, V99, P11037, DOI 10.1073/pnas.172378899; Hoskins JR, 2002, ADV PROTEIN CHEM, V59, P413; Hoskins JR, 2000, J BIOL CHEM, V275, P35361, DOI 10.1074/jbc.M006288200; HUANG GS, 1995, P NATL ACAD SCI USA, V92, P6878, DOI 10.1073/pnas.92.15.6878; Ishikawa T, 2004, J STRUCT BIOL, V146, P180, DOI 10.1016/j.jsb.2003.11.018; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Kenniston JA, 2003, CELL, V114, P511, DOI 10.1016/S0092-8674(03)00612-3; Kim DY, 2003, J BIOL CHEM, V278, P50664, DOI 10.1074/jbc.M305882200; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Levchenko I, 2000, SCIENCE, V289, P2354, DOI 10.1126/science.289.5488.2354; Levchenko I, 2003, MOL CELL, V12, P365, DOI 10.1016/j.molcel.2003.08.014; Mancini EJ, 2004, CELL, V118, P743, DOI 10.1016/j.cell.2004.09.007; Piszczek G, 2005, J BIOL CHEM, V280, P12221, DOI 10.1074/jbc.M411733200; Reid BG, 2001, P NATL ACAD SCI USA, V98, P3768, DOI 10.1073/pnas.071043698; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Schlieker C, 2004, NAT STRUCT MOL BIOL, V11, P607, DOI 10.1038/nsmb787; Siddiqui SM, 2004, GENE DEV, V18, P369, DOI 10.1101/gad.1170304; SINGH SK, 1994, J BIOL CHEM, V269, P29537; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Song HK, 2003, MOL CELL, V12, P75, DOI 10.1016/S1097-2765(03)00271-5; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a	33	190	190	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 1	2005	121	7					1029	1041		10.1016/j.cell.2005.04.012	http://dx.doi.org/10.1016/j.cell.2005.04.012			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	944RZ	15989953	Bronze			2022-12-01	WOS:000230448000010
J	Hunte, C; Screpanti, E; Venturi, M; Rimon, A; Padan, E; Michel, H				Hunte, C; Screpanti, E; Venturi, M; Rimon, A; Padan, E; Michel, H			Structure of a Na+/H+ antiporter and insights into mechanism of action and regulation by pH	NATURE			English	Article							DEPENDENT CONFORMATIONAL-CHANGE; ESCHERICHIA-COLI; GLYCEROL-3-PHOSPHATE TRANSPORTER; PLASMA-MEMBRANE; NHAA; PROTEIN; PROTON; ARABIDOPSIS; EXCHANGER; ANGSTROM	The control by Na+/ H+ antiporters of sodium/proton concentration and cell volume is crucial for the viability of all cells. Adaptation to high salinity and/or extreme pH in plants and bacteria or in human heart muscles requires the action of Na+/H+ antiporters. Their activity is tightly controlled by pH. Here we present the crystal structure of pH-downregulated NhaA, the main antiporter of Escherichia coli and many enterobacteria. A negatively charged ion funnel opens to the cytoplasm and ends in the middle of the membrane at the putative ion-binding site. There, a unique assembly of two pairs of short helices connected by crossed, extended chains creates a balanced electrostatic environment. We propose that the binding of charged substrates causes an electric imbalance, inducing movements, that permit a rapid alternating-access mechanism. This ion-exchange machinery is regulated by a conformational change elicited by a pH signal perceived at the entry to the cytoplasmic funnel.	Max Planck Inst Biophys, Dept Mol Membrane Biol, D-60438 Frankfurt, Germany; Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, IL-91904 Jerusalem, Israel	Max Planck Society; Hebrew University of Jerusalem	Hunte, C (corresponding author), Max Planck Inst Biophys, Dept Mol Membrane Biol, Max von Laue Str 3, D-60438 Frankfurt, Germany.	carola.hunte@mpibp-frankfurt.mpg.de; etana@vms.huji.ac.il; hartmut.michel@mpibp-frankfurt.mpg.de	Hunte, Carola/E-4071-2015	Hunte, Carola/0000-0002-0826-3986				Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Apse MP, 2003, PLANT J, V36, P229, DOI 10.1046/j.1365-313X.2003.01871.x; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; ARONSON PS, 1985, ANNU REV PHYSIOL, V47, P545, DOI 10.1146/annurev.ph.47.030185.002553; Auer M, 2001, BIOCHEMISTRY-US, V40, P6628, DOI 10.1021/bi010138+; Counillon L, 2000, J BIOL CHEM, V275, P1, DOI 10.1074/jbc.275.1.1; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Engelhardt S, 2002, CIRC RES, V90, P814, DOI 10.1161/01.RES.0000014966.97486.C0; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Galili L, 2004, J BIOL CHEM, V279, P23104, DOI 10.1074/jbc.M400288200; Galili L, 2002, BIOCHEMISTRY-US, V41, P609, DOI 10.1021/bi011655v; Gerchman Y, 1999, J BIOL CHEM, V274, P24617, DOI 10.1074/jbc.274.35.24617; Gerchman Y, 2001, BIOCHEMISTRY-US, V40, P3403, DOI 10.1021/bi002669o; GLUSKER JP, 1991, ADV PROTEIN CHEM, V42, P1; Harding MM, 2004, ACTA CRYSTALLOGR D, V60, P849, DOI 10.1107/S0907444904004081; Hase CC, 1999, P NATL ACAD SCI USA, V96, P3183, DOI 10.1073/pnas.96.6.3183; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; INOUE H, 1995, FEBS LETT, V363, P264, DOI 10.1016/0014-5793(95)00331-3; Jencks W P, 1980, Adv Enzymol Relat Areas Mol Biol, V51, P75; Jin J, 2002, J BACTERIOL, V184, P4722, DOI 10.1128/JB.184.17.4722-4732.2002; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; KLINGENBERG M, 1985, ADP ATP CARRIER MITO; Krulwich TA, 2001, BBA-BIOENERGETICS, V1505, P158, DOI 10.1016/S0005-2728(00)00285-1; Liang J, 1998, PROTEIN SCI, V7, P1884, DOI 10.1002/pro.5560070905; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Myers ML, 2003, SODIUM-HYDROGEN EXCHANGER: FROM MOLECULE TO ITS ROLE IN DISEASE, P279; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Padan E, 2004, BBA-BIOENERGETICS, V1658, P2, DOI 10.1016/j.bbabio.2004.04.018; Padan E, 2001, BBA-BIOENERGETICS, V1505, P144, DOI 10.1016/S0005-2728(00)00284-X; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; Qiu QS, 2003, PLANT PHYSIOL, V132, P1041, DOI 10.1104/pp.102.010421; Rimon A, 2002, BIOCHEMISTRY-US, V41, P14897, DOI 10.1021/bi0261342; Rimon A, 1998, J BIOL CHEM, V273, P26470, DOI 10.1074/jbc.273.41.26470; Rothman A, 1996, J BIOL CHEM, V271, P32288, DOI 10.1074/jbc.271.50.32288; TAGLICHT D, 1991, J BIOL CHEM, V266, P11289; TAGLICHT D, 1993, J BIOL CHEM, V268, P5382; Tzubery T, 2004, J BIOL CHEM, V279, P3265, DOI 10.1074/jbc.M309021200; Venturi M, 2000, J BIOL CHEM, V275, P4734, DOI 10.1074/jbc.275.7.4734; VIITANEN P, 1984, P NATL ACAD SCI-BIOL, V81, P1629, DOI 10.1073/pnas.81.6.1629; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Wakabayashi S, 2003, SODIUM-HYDROGEN EXCHANGER: FROM MOLECULE TO ITS ROLE IN DISEASE, P35; Wakabayashi S, 2003, J BIOL CHEM, V278, P43580, DOI 10.1074/jbc.M306690200; West IC, 1997, BBA-REV BIOMEMBRANES, V1331, P213, DOI 10.1016/S0304-4157(97)00007-5; WEST IC, 1974, BIOCHEM J, V144, P87, DOI 10.1042/bj1440087; Williams KA, 1999, EMBO J, V18, P3558, DOI 10.1093/emboj/18.13.3558; Williams KA, 2000, NATURE, V403, P112, DOI 10.1038/47534; ZILBERSTEIN D, 1982, J BIOL CHEM, V257, P3687	50	520	525	3	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2005	435	7046					1197	1202		10.1038/nature03692	http://dx.doi.org/10.1038/nature03692			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940JJ	15988517				2022-12-01	WOS:000230140500035
J	Lavados, PM; Sacks, C; Prina, L; Escobar, A; Tossi, C; Araya, F; Feuerhake, W; Galvez, M; Salinas, R; Alvarez, G				Lavados, PM; Sacks, C; Prina, L; Escobar, A; Tossi, C; Araya, F; Feuerhake, W; Galvez, M; Salinas, R; Alvarez, G			Incidence, 30-day case-fatality rate, and prognosis of stroke in Iquique, Chile: a 2-year community-based prospective study (PISCIS project)	LANCET			English	Article							ACUTE CEREBROVASCULAR-DISEASE; TRANSIENT ISCHEMIC ATTACKS; RISK-FACTORS; INTRACEREBRAL HEMORRHAGE; CEREBRAL INFARCTION; ETHNIC-DIFFERENCES; SUBTYPES; OXFORDSHIRE; EPIDEMIOLOGY; POPULATION	Background The epidemiology of stroke in Latin-American populations and variation of subtypes between communities are unclear. Our aim was to ascertain prospectively the incidence of first-ever stroke in the predominantly Hispanic-Mestizo population of Iquique, a city in the northern desert region of Chile. Methods We prospectively identified all possible cases of stroke and transient ischaemic attacks between July 1, 2000, and June 30, 2002, from several overlapping sources. Patients were rapidly assessed by two field neurologists. Standard definitions for incident cases, stroke, transient ischaemic attack, pathological type, and infarction subtype were used. All cases identified were adjudicated by at least two stroke neurologists and followed up at 6 months. Incidence rates of first-ever strokes were calculated from the population of Iquique (214 526) according to the national census of 2002. Findings Of 380 cases of stroke identified, 292 were incident. CT scans were done in 267 (91%) patients and the mean time to scan was 2.2 days. The hospital admission rate was 71% (207/292). The overall age-adjusted incidence rate of first-ever stroke was 140.1 per 100 000 (95% CI 124.0-156.2). The incidence rates per 100 000 according to pathological type were: infarcts 87.3, intracerebral haemorrhage 27.6, and subarachnoid haemorrhage 6.2. The 30-day and 6-month case-fatality rates were 23.3% and 33.0%, respectively. Interpretation Our results show incidence rates of stroke similar to those reported in other community studies. Although the proportion of intracerebral haemorrhages was higher than reported in previous studies, the overall incidence was not, which could indicate a slightly lower incidence of ischaemic strokes in this population than in other countries. The prognosis was similar to that found in other population-based studies.	Clin Alemana Santiago, Dept Med, Serv Neurol, Programa Enfermedades Cerebrovasc, Santiago, Chile; Serv Salud Metropolitano Oriente, Inst Neurocirugia, Unidad Neurointens, Santiago, Chile; Univ Chile, Dept Ciencias Neurol, Santiago, Chile; Univ Valparaiso, Dept Med, Unidad Neurol, Valparaiso, Chile; Hosp Reg Iquique, Med Serv, Unidad Neurol, Iquique, Chile; Hosp Salvador, Serv Salud Metropolitano Oriente, Serv Neurol, Santiago, Chile; Serv Salud Metropolitano Oriente, Inst Neurocirugia Invest Cerebr Alfonso Asenjo, Serv Neuroradiol, Santiago, Chile; Inst Salud Publ Chile, Santiago, Chile	Clinica Alemana; Universidad de Chile; Universidad de Valparaiso; Universidad de Chile	Lavados, PM (corresponding author), Clin Alemana Santiago, Dept Med, Serv Neurol, Programa Enfermedades Cerebrovasc, Santiago, Chile.	pablolavados@yahoo.com	Lavados, Pablo M/E-9918-2016	Lavados, Pablo M/0000-0002-9118-9093				AHMAD OB, 2002, AGE STANDARDISATION; AHO K, 1980, B WORLD HEALTH ORGAN, V58, P113; Alvarez G, 1997, REV MED CHILE, V125, P561; BAMFORD J, 1988, J NEUROL NEUROSUR PS, V51, P1373, DOI 10.1136/jnnp.51.11.1373; BAMFORD J, 1990, J NEUROL NEUROSUR PS, V53, P16, DOI 10.1136/jnnp.53.1.16; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Bonita R, 1997, STROKE, V28, P758, DOI 10.1161/01.STR.28.4.758; BONITA R, 1993, LANCET, V342, P1470, DOI 10.1016/0140-6736(93)92938-P; Bruno A, 1996, NEUROLOGY, V47, P405, DOI 10.1212/WNL.47.2.405; Bustos P, 2003, REV MED CHILE, V131, P973; Carolei A, 1997, STROKE, V28, P2500, DOI 10.1161/01.STR.28.12.2500; Coull AJ, 2004, STROKE, V35, P2041, DOI 10.1161/01.STR.0000137605.48864.2f; DELBRUTTO OH, 1993, STROKE, V24, P1833, DOI 10.1161/01.STR.24.12.1833; DENNIS MS, 1993, STROKE, V24, P796, DOI 10.1161/01.STR.24.6.796; DENNIS MS, 1989, STROKE, V20, P333, DOI 10.1161/01.STR.20.3.333; Diaz V, 2003, NEUROEPIDEMIOLOGY, V22, P339, DOI 10.1159/000072923; Ellekjaer H, 1997, STROKE, V28, P2180, DOI 10.1161/01.STR.28.11.2180; Feigin VL, 2004, STROKE, V35, P2045; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; FEIGIN VL, 1995, MAYO CLIN PROC, V70, P847; Frey JL, 1998, STROKE, V29, P29, DOI 10.1161/01.STR.29.1.29; Fustinoni O, 2000, STROKE, V31, P1013, DOI 10.1161/01.STR.31.5.1013; Goldstein LB, 2001, STROKE, V32, P280, DOI 10.1161/01.STR.32.1.280; Hajat C, 2001, STROKE, V32, P37, DOI 10.1161/01.STR.32.1.37; Hankey GJ, 1994, TRANSIENT ISCHAEMIC; HOPPE A, 2004, P 5 WORLD STROK C JU, P199; Hsu RT, 1999, INT J EPIDEMIOL, V28, P853, DOI 10.1093/ije/28.5.853; *INE, 2004, RES CENS 2002; *INE, 2003, CHIL AN EST VIT 2000; Keir SL, 2002, J NEUROL, V249, P1226, DOI 10.1007/s00415-002-0816-z; KEYFITZ N, 1966, HUM BIOL, V38, P309; Kolominsky-Rabas PL, 1998, STROKE, V29, P2501, DOI 10.1161/01.STR.29.12.2501; LAURIA G, 1995, STROKE, V26, P1787, DOI 10.1161/01.STR.26.10.1787; Lavados P, 2000, STROKE, V31, P2789; Lee JW, 2003, LANCET, V362, P2083, DOI 10.1016/S0140-6736(03)15107-0; MEDINA E, 1992, REV MED CHILE, V120, P702; *MIN SAL CHIL, 2003, BAS DAT EGR HOSP DEP; Nogales-Gaete J, 2000, REV MED CHILE, V128, P1227; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; Sacco RL, 1998, AM J EPIDEMIOL, V147, P259, DOI 10.1093/oxfordjournals.aje.a009445; SACKS C, 1999, P 54 ANN M CHIL SOC, P25; SANDERCOCK PAG, 1989, BRIT MED J, V298, P75, DOI 10.1136/bmj.298.6666.75; Saposnik G, 2003, STROKE, V34, P2103, DOI 10.1161/01.STR.0000088063.74250.DB; Saposnik G, 2000, STROKE, V31, P2385, DOI 10.1161/01.STR.31.10.2385; Sarti C, 2000, STROKE, V31, P1588, DOI 10.1161/01.STR.31.7.1588; Schulz UGR, 2003, STROKE, V34, P2050, DOI 10.1161/01.STR.0000079818.08343.8C; Smadja D, 2001, STROKE, V32, P2741, DOI 10.1161/hs1201.099385; Stewart JA, 1999, BRIT MED J, V318, P967, DOI 10.1136/bmj.318.7189.967; Sudlow CLM, 1997, STROKE, V28, P491, DOI 10.1161/01.STR.28.3.491; Sudlow CLM, 1996, STROKE, V27, P550, DOI 10.1161/01.STR.27.3.550; TAPIA J, 1992, REV MED CHILE, V120, P1414; Thrift AG, 2001, STROKE, V32, P1732, DOI 10.1161/01.STR.32.8.1732; URAKAMI K, 1987, STROKE, V18, P396, DOI 10.1161/01.STR.18.2.396; Vemmos KN, 2000, J NEUROL NEUROSUR PS, V69, P595, DOI 10.1136/jnnp.69.5.595; Vemmos KN, 1999, STROKE, V30, P363, DOI 10.1161/01.STR.30.2.363; Wardlaw JM, 2003, J NEUROL NEUROSUR PS, V74, P77, DOI 10.1136/jnnp.74.1.77; Warlow CP, 1998, LANCET, V352, pSIII1; WARLOW CP, 2001, STROKE PRACTICAL GUI, P416; Wein TH, 1999, STROKE, V30, P1501, DOI 10.1161/01.STR.30.8.1501; Wolfe CDA, 2002, J NEUROL NEUROSUR PS, V72, P211, DOI 10.1136/jnnp.72.2.211	60	183	195	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 25	2005	365	9478					2206	2215		10.1016/S0140-6736(05)66779-7	http://dx.doi.org/10.1016/S0140-6736(05)66779-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	938WT	15978929				2022-12-01	WOS:000230034800031
J	Hohmann, AG; Suplita, RL; Bolton, NM; Neely, MH; Fegley, D; Mangieri, R; Krey, JF; Walker, JM; Holmes, PV; Crystal, JD; Duranti, A; Tontini, A; Mor, M; Tarzia, G; Piomelli, D				Hohmann, AG; Suplita, RL; Bolton, NM; Neely, MH; Fegley, D; Mangieri, R; Krey, JF; Walker, JM; Holmes, PV; Crystal, JD; Duranti, A; Tontini, A; Mor, M; Tarzia, G; Piomelli, D			An endocannabinoid mechanism for stress-induced analgesia	NATURE			English	Article							STIMULUS-EVOKED ACTIVITY; DORSAL-HORN; NEURONS; BRAIN; SUPPRESSION; INHIBITORS; RECEPTORS; LIPASE; ESTERS; FORMS	Acute stress suppresses pain by activating brain pathways that engage opioid or non-opioid mechanisms. Here we show that an opioid-independent form of this phenomenon, termed stress-induced analgesia(1), is mediated by the release of endogenous marijuana-like (cannabinoid) compounds in the brain. Blockade of cannabinoid CB1 receptors in the periaqueductal grey matter of the midbrain prevents non-opioid stress-induced analgesia. In this region, stress elicits the rapid formation of two endogenous cannabinoids, the lipids 2-arachidonoylglycerol(2) (2-AG) and anandamide(3). A newly developed inhibitor of the 2-AG-deactivating enzyme, monoacylglycerol lipase(4,5), selectively increases 2-AG concentrations and, when injected into the periaqueductal grey matter, enhances stress-induced analgesia in a CB1-dependent manner. Inhibitors of the anandamide-deactivating enzyme fatty-acid amide hydrolase(6), which selectively elevate anandamide concentrations, exert similar effects. Our results indicate that the coordinated release of 2-AG and anandamide in the periaqueductal grey matter might mediate opioid-independent stress-induced analgesia. These studies also identify monoacylglycerol lipase as a previously unrecognized therapeutic target.	Univ Georgia, Dept Psychol, Neurosci & Behav Program, Athens, GA 30602 USA; Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA; Univ Calif Irvine, Ctr Drug Discovery, Irvine, CA 92697 USA; Brown Univ, Dept Psychol, Schrier Res Lab, Providence, RI 02912 USA; Brown Univ, Dept Neurosci, Schrier Res Lab, Providence, RI 02912 USA; Univ Urbino Carlo Bo, Inst Med Chem, I-61029 Urbino, Italy; Univ Parma, Dept Pharmaceut, I-43100 Parma, Italy	University System of Georgia; University of Georgia; University of California System; University of California Irvine; University of California System; University of California Irvine; Brown University; Brown University; University of Urbino; University of Parma	Hohmann, AG (corresponding author), Univ Georgia, Dept Psychol, Neurosci & Behav Program, Athens, GA 30602 USA.	ahohmann@uga.edu; piomelli@uci.edu	Mangieri, Regina/N-1602-2019; Mor, Marco/D-2394-2009	Mangieri, Regina/0000-0002-4499-6183; Mor, Marco/0000-0003-0199-1849				AKIL H, 1986, ANN NY ACAD SCI, V467, P140, DOI 10.1111/j.1749-6632.1986.tb14625.x; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; CANNON JT, 1982, BRAIN RES, V243, P315, DOI 10.1016/0006-8993(82)90255-4; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; De Petrocellis L, 2000, FEBS LETT, V483, P52, DOI 10.1016/S0014-5793(00)02082-2; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Dinh TP, 2004, MOL PHARMACOL, V66, P1260, DOI 10.1124/mol.104.002071; Giuffrida A, 2000, ANAL BIOCHEM, V280, P87, DOI 10.1006/abio.2000.4509; HERKENHAM M, 1991, J NEUROSCI, V11, P563, DOI 10.1523/jneurosci.11-02-00563.1991; HOHMANN AG, 1995, LIFE SCI, V56, P2111, DOI 10.1016/0024-3205(95)00196-D; Hohmann AG, 1999, J NEUROPHYSIOL, V81, P575, DOI 10.1152/jn.1999.81.2.575; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Kozak KR, 2004, CURR PHARM DESIGN, V10, P659, DOI 10.2174/1381612043453081; LEWIS JW, 1980, SCIENCE, V208, P623, DOI 10.1126/science.7367889; Martin WJ, 1996, J NEUROSCI, V16, P6601; MARTIN WJ, 1995, LIFE SCI, V56, P2103, DOI 10.1016/0024-3205(95)00195-C; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Meng ID, 1998, NATURE, V395, P381, DOI 10.1038/26481; Mor M, 2004, J MED CHEM, V47, P4998, DOI 10.1021/jm031140x; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Tarzia G, 2003, J MED CHEM, V46, P2352, DOI 10.1021/jm021119g; TERMAN GW, 1986, BRAIN RES, V368, P101, DOI 10.1016/0006-8993(86)91046-2; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Valverde O, 2000, EUR J NEUROSCI, V12, P533, DOI 10.1046/j.1460-9568.2000.00929.x; Vaughan CW, 2000, MOL PHARMACOL, V57, P288; Walker JM, 2005, HANDB EXP PHARMACOL, V168, P509; Walker JM, 1999, P NATL ACAD SCI USA, V96, P12198, DOI 10.1073/pnas.96.21.12198; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	30	556	588	2	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2005	435	7045					1108	1112		10.1038/nature03658	http://dx.doi.org/10.1038/nature03658			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	937ZT	15973410	Green Published			2022-12-01	WOS:000229970400051
J	Tleyjeh, IM; Steckelberg, JM; Murad, HS; Anavekar, NS; Ghomrawi, HMK; Mirzoyev, Z; Moustafa, SE; Hoskin, TL; Mandrekar, JN; Wilson, WR; Baddour, LM				Tleyjeh, IM; Steckelberg, JM; Murad, HS; Anavekar, NS; Ghomrawi, HMK; Mirzoyev, Z; Moustafa, SE; Hoskin, TL; Mandrekar, JN; Wilson, WR; Baddour, LM			Temporal trends in infective endocarditis - A population-based study in Olmsted County, Minnesota	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	54th Annual Scientific Session of the American-College-of-Cardiology	MAR 06-09, 2005	Orlando, FL	Amer Coll Cardiol			PATIENT CHARACTERISTICS; EPIDEMIOLOGY; DIAGNOSIS; MORTALITY; SPECTRUM; CRITERIA; DENMARK; ADULTS	Context Limited data exist regarding population-based epidemiologic changes in incidence of infective endocarditis (IE). Objective To evaluate temporal trends in the incidence and clinical characteristics of I E. Design, Setting, and Patients Population-based survey using the resources of the Rochester Epidemiology Project of Olmsted County, Minnesota. One hundred seven IE episodes occurred in 102 Olmsted County residents between 1970 and 2000. The modified Duke criteria were used to validate the diagnosis of definite or possible IE. Main Outcome Measures Incidence of IE, proportion of patients with underlying heart disease, and causative microorganisms and clinical characteristics. Results Age- and sex-adjusted incidence of, IE ranged from 5.0 to 7.0 cases per 100000 person-years during the study period and did not change significantly over time (P=.42 for trend). Infective endocarditis caused by viridans group streptococci was the most common organism-specific subgroup, with an annual adjusted incidence of 1.7 to 3.5 cases per 100000; in comparison, IE due to Staphylococcus aureus had an annual adjusted incidence of 1.0 to 2.2 cases per 100000. No time trend was detected for either pathogen group (P=.63 and P=.66, respectively). An increasing temporal trend was observed in the proportions of prosthetic valve IE cases (P=.09). Among people with underlying heart disease, there was an increasing temporal trend in mitral valve prolapse (P=.04) and a decreasing trend in rheumatic heart disease (P=.08). However, the absolute numbers were small. There was no time trend in rates of valve surgery or 6-month mortality during the study period (P=.97 and P=.59, respectively). Conclusions In this community-based temporal trend study, we found no substantial change in the incidence of IE over the past 3 decades. Viridans group streptococci continue to outnumber S aureus as the most common causative organisms of IE in this population.	Mayo Clin, Mayo Clin Coll Med, Dept Med, Rochester, MN USA; Mayo Clin, Mayo Clin Coll Med, Div Infect Dis, Rochester, MN USA; Mayo Clin, Mayo Clin Coll Med, Dept Physiol & Biomed Engn, Rochester, MN USA; Mayo Clin, Mayo Clin Coll Med, Div Biostat, Rochester, MN USA; Univ Illinois, Michael Reese Hosp, Dept Med, Chicago, IL USA; Univ Minnesota, Div Hlth Serv Res & Policy, Minneapolis, MN USA; Univ Ottawa, Inst Heart, Div Cardiol, Ottawa, ON, Canada	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Michael Reese Hospital & Medical Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Minnesota System; University of Minnesota Twin Cities; University of Ottawa; University of Ottawa Heart Institute	Tleyjeh, IM (corresponding author), 200 1st St SW, Rochester, MN 55905 USA.	tleyjeh.imad@mayo.edu		Ghomrawi, Hassan/0000-0003-1291-5278; Tleyjeh, Imad/0000-0002-5551-0353	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR030582] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL59205] Funding Source: Medline; NIAMS NIH HHS [AR30582] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BAYLISS R, 1986, J ROY COLL PHYS LOND, V20, P15; Benn M, 1997, J INTERN MED, V242, P15, DOI 10.1046/j.1365-2796.1997.00153.x; BERLIN JA, 1995, AM J CARDIOL, V76, P933, DOI 10.1016/S0002-9149(99)80264-1; Cabell CH, 2002, ARCH INTERN MED, V162, P90, DOI 10.1001/archinte.162.1.90; DURACK DT, 1994, AM J MED, V96, P200, DOI 10.1016/0002-9343(94)90143-0; Fonager K, 2003, SCAND J INFECT DIS, V35, P27, DOI 10.1080/0036554021000026993; GRIFFIN MR, 1985, JAMA-J AM MED ASSOC, V254, P1199, DOI 10.1001/jama.254.9.1199; Hoen B, 2002, JAMA-J AM MED ASSOC, V288, P75, DOI 10.1001/jama.288.1.75; HOGEVIK H, 1995, MEDICINE, V74, P324, DOI 10.1097/00005792-199511000-00003; KING JW, 1988, AM J MED SCI, V295, P517, DOI 10.1097/00000441-198806000-00005; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; MCKINSEY DS, 1987, AM J MED, V82, P681, DOI 10.1016/0002-9343(87)90001-5; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X; Mylonakis E, 2001, NEW ENGL J MED, V345, P1318, DOI 10.1056/NEJMra010082; NISSEN H, 1992, EUR HEART J, V13, P872, DOI 10.1093/oxfordjournals.eurheartj.a060285; Roder BL, 1999, ARCH INTERN MED, V159, P462, DOI 10.1001/archinte.159.5.462; STECKELBERG JM, 1990, AM J MED, V88, P582, DOI 10.1016/0002-9343(90)90521-E; Targonski P, 2001, ANN EPIDEMIOL, V11, P264, DOI 10.1016/S1047-2797(00)00220-9; VANDERMEER JTM, 1992, ARCH INTERN MED, V152, P1863, DOI 10.1001/archinte.152.9.1863; VONREYN CF, 1981, ANN INTERN MED, V94, P505, DOI 10.7326/0003-4819-94-4-505; WHITBY M, 1985, INT J CARDIOL, V7, P391, DOI 10.1016/0167-5273(85)90093-2	22	229	241	0	10	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	2005	293	24					3022	3028		10.1001/jama.293.24.3022	http://dx.doi.org/10.1001/jama.293.24.3022			7	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	937SG	15972564	Bronze			2022-12-01	WOS:000229945200017
J	Scolding, N				Scolding, N			Stem-cell therapy: hope and hype	LANCET			English	Editorial Material							PURKINJE NEURONS; REPAIR		Univ Bristol, Frenchay Hosp, Dept Neurol, Inst Clin Neurosci, Bristol BS16 1LE, Avon, England	University of Bristol	Scolding, N (corresponding author), Univ Bristol, Frenchay Hosp, Dept Neurol, Inst Clin Neurosci, Bristol BS16 1LE, Avon, England.	n.j.scolding@bristol.ac.uk						Blau HM, 2002, NATURE, V419, P437, DOI 10.1038/419437a; Cogle CR, 2004, LANCET, V363, P1432, DOI 10.1016/S0140-6736(04)16102-3; Devine SM, 2003, BLOOD, V101, P2999, DOI 10.1182/blood-2002-06-1830; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Gussoni E, 2002, J CLIN INVEST, V110, P807, DOI 10.1172/JCI200216098; Hwang WS, 2004, SCIENCE, V303, P1669, DOI 10.1126/science.1094515; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; KITE M, 2000, TIMES LOND      1216; Klimanskaya I, 2005, LANCET, V365, P1636, DOI 10.1016/S0140-6736(05)66473-2; Korbling M, 2003, NEW ENGL J MED, V349, P570, DOI 10.1056/NEJMra022361; LAPHAM LW, 1968, SCIENCE, V159, P310, DOI 10.1126/science.159.3812.310; Pochampally RR, 2004, P NATL ACAD SCI USA, V101, P9282, DOI 10.1073/pnas.0401558101; Prockop DJ, 2003, P NATL ACAD SCI USA, V100, P11917, DOI 10.1073/pnas.1834138100; Rehen SK, 2005, J NEUROSCI, V25, P2176, DOI 10.1523/JNEUROSCI.4560-04.2005; Rice CM, 2004, LANCET, V364, P193, DOI 10.1016/S0140-6736(04)16633-6; Rice CM, 2003, TRANSFUSION MED, V13, P351, DOI 10.1111/j.1365-3148.2003.00463.x; SAMPLE I, 2004, GUARDIAN        0819; Sigurjonsson OE, 2005, P NATL ACAD SCI USA, V102, P5227, DOI 10.1073/pnas.0501029102; Smith LC, 2004, CLONING STEM CELLS, V6, P126, DOI 10.1089/1536230041372319; Weimann JM, 2003, P NATL ACAD SCI USA, V100, P2088, DOI 10.1073/pnas.0337659100; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9; 2001, LANCET, V358, P163	22	10	11	1	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 18	2005	365	9477					2073	2075		10.1016/S0140-6736(05)66554-3	http://dx.doi.org/10.1016/S0140-6736(05)66554-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	936LZ	15964432				2022-12-01	WOS:000229858800009
J	Scholte, EJ; Ng'habi, K; Kihonda, J; Takken, W; Paaijmans, K; Abdulla, S; Killeen, GF; Knols, BGJ				Scholte, EJ; Ng'habi, K; Kihonda, J; Takken, W; Paaijmans, K; Abdulla, S; Killeen, GF; Knols, BGJ			An entomopathogenic fungus for control of adult African malaria mosquitoes	SCIENCE			English	Article							INSECTICIDE-TREATED NETS; SOUTH-AFRICA	Biological control of malaria mosquitoes in Africa has rarely been used in vector control programs. Recent developments in this field show that certain fungi are virulent to adult Anopheles mosquitoes. Practical delivery of an entomopathogenic fungus that infected and killed adult Anopheles gambiae, Africa's main malaria vector, was achieved in rural African village houses. An entomological inoculation rate model suggests that implementation of this vector control method, even at the observed moderate coverage during a field study in Tanzania, would significantly reduce malaria transmission intensity.	Univ Wageningen & Res Ctr, Entomol Lab, NL-6700 EH Wageningen, Netherlands; Ifakara Hlth Res & Dev Ctr, Ifakara, Tanzania; Swiss Trop Inst, Dept Epidemiol & Publ Hlth, CH-4002 Basel, Switzerland; IAEA, Agcy Labs Seibersdorf, A-2444 Seibersdorf, Austria	Wageningen University & Research; Ifakara Health Institute; University of Basel; Swiss Tropical & Public Health Institute; International Atomic Energy Agency	Knols, BGJ (corresponding author), Univ Wageningen & Res Ctr, Entomol Lab, POB 8031, NL-6700 EH Wageningen, Netherlands.	B.Knols@IAEA.org	Paaijmans, Krijn/ABC-9928-2020					Blanford S, 2005, SCIENCE, V308, P1638, DOI 10.1126/science.1108423; Boucias D.G., 1998, PRINCIPLES INSECT PA, P177; Curtis CF, 2000, B WORLD HEALTH ORGAN, V78, P1389; Fillinger U, 2003, TROP MED INT HEALTH, V8, P37, DOI 10.1046/j.1365-3156.2003.00979.x; Hargreaves K, 2000, MED VET ENTOMOL, V14, P181, DOI 10.1046/j.1365-2915.2000.00234.x; Hargreaves K, 2003, MED VET ENTOMOL, V17, P417, DOI 10.1111/j.1365-2915.2003.00460.x; Killeen GF, 2000, AM J TROP MED HYG, V62, P535, DOI 10.4269/ajtmh.2000.62.535; Kouznetsov R L, 1977, Trop Doct, V7, P81; Lengeler C., 2004, COCHRANE DB SYST REV, V2; Mabaso MLH, 2004, TROP MED INT HEALTH, V9, P846, DOI 10.1111/j.1365-3156.2004.01263.x; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; PAPIEROK B, 2001, P 8 EUR M IOBC WPRS; Schellenberg JRMA, 2001, LANCET, V357, P1241, DOI 10.1016/S0140-6736(00)04404-4; Scholte EJ, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-29; SCHOLTE EJ, IN PRESS J INVERTEBR; *WHO, 1993, WHO TECH REP SER, V839; World Health Organization (WHO), 1975, WHO OFFS PUBL, V13	17	253	267	1	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2005	308	5728					1641	1642		10.1126/science.1108639	http://dx.doi.org/10.1126/science.1108639			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	936BH	15947190				2022-12-01	WOS:000229827000061
J	Wardle, DA; Zackrisson, O				Wardle, DA; Zackrisson, O			Effects of species and functional group loss on island ecosystem properties	NATURE			English	Article							MICROBIAL BIOMASS; CURRENT KNOWLEDGE; PLANT DIVERSITY; MODEL SYSTEMS; PRODUCTIVITY; BIODIVERSITY; COMMUNITIES; RICHNESS; AREA	Considerable recent attention has focused on predicting how the losses of species and functional groups influence ecosystem properties(1,2), but the extent to which these effects vary among ecosystems remains poorly understood(3,4). Island systems have considerable scope for studying how biotic and abiotic factors influence processes in different ecosystems, because they enable the simultaneous study of large numbers of independent replicate systems at ecologically meaningful spatial scales(5-7). We studied a group of 30 islands in northern Sweden, for which island size determined disturbance history, and therefore vegetation successional stage and biotic and abiotic ecosystem properties. On each island we conducted a seven-year study that involved experimental removals of combinations of both plant functional groups and plant species. We show that although losses of functional groups and species often impaired key ecosystem processes, these effects were highly context-dependent and strongly influenced by island size. Our study provides evidence that the consequences of biotic loss for ecosystem functioning vary greatly among ecosystems and depend on the specific abiotic and biotic attributes of the system.	Swedish Univ Agr Sci, Fac Forestry, Dept Forest Vegetat Ecol, S-90183 Umea, Sweden; Landcare Res, Lincoln 8152, New Zealand	Swedish University of Agricultural Sciences; Landcare Research - New Zealand	Wardle, DA (corresponding author), Swedish Univ Agr Sci, Fac Forestry, Dept Forest Vegetat Ecol, S-90183 Umea, Sweden.	david.wardle@svek.slu.se	Wardle, David A./F-6031-2011	Wardle, David A./0000-0002-0476-7335				ANDERSON JPE, 1978, SOIL BIOL BIOCHEM, V10, P215, DOI 10.1016/0038-0717(78)90099-8; Anderson WB, 1999, OECOLOGIA, V118, P324, DOI 10.1007/s004420050733; Coomes DA, 2000, ECOL MONOGR, V70, P171, DOI 10.1890/0012-9615(2000)070[0171:IORCIF]2.0.CO;2; Diaz S, 2003, TRENDS ECOL EVOL, V18, P140, DOI 10.1016/S0169-5347(03)00007-7; Enquist BJ, 2001, NATURE, V410, P655, DOI 10.1038/35070500; Fridley JD, 2002, OECOLOGIA, V132, P271, DOI 10.1007/s00442-002-0965-x; Gonzalez A, 2002, J ANIM ECOL, V71, P594, DOI 10.1046/j.1365-2656.2002.00625.x; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hooper DU, 2004, ECOL LETT, V7, P95, DOI 10.1046/j.1461-0248.2003.00555.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Mulder CPH, 1999, ECOL LETT, V2, P237; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Schmid B, 2002, TRENDS ECOL EVOL, V17, P113, DOI 10.1016/S0169-5347(01)02422-3; Spiller DA, 1997, OIKOS, V78, P15, DOI 10.2307/3545795; *TECHN IND SYST, 1997, IND SIM DET NITR PHO; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Tscharntke T, 2002, ECOL APPL, V12, P354, DOI 10.2307/3060947; Vitousek PM, 2002, J BIOGEOGR, V29, P573, DOI 10.1046/j.1365-2699.2002.00707.x; Wardle DA, 1998, BIOL REV, V73, P305, DOI 10.1017/S0006323198005192; WARDLE DA, 1993, FUNCT ECOL, V7, P346, DOI 10.2307/2390215; Wardle DA, 2003, SCIENCE, V300, P972, DOI 10.1126/science.1082709; Wardle DA, 2002, J BIOGEOGR, V29, P583, DOI 10.1046/j.1365-2699.2002.00708.x; Wardle DA, 1997, SCIENCE, V277, P1296, DOI 10.1126/science.277.5330.1296; WARDLE DA, 2002, COMMUNICATIES ECOSYS	27	198	218	8	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2005	435	7043					806	810		10.1038/nature03611	http://dx.doi.org/10.1038/nature03611			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	933NK	15944702				2022-12-01	WOS:000229638700048
J	Lechler, T; Fuchs, E				Lechler, T; Fuchs, E			Asymmetric cell divisions promote stratification and differentiation of mammalian skin	NATURE			English	Article							C-ELEGANS; EPIDERMAL MORPHOGENESIS; CONDITIONAL ABLATION; DROSOPHILA; NUMA; INTEGRIN; BETA-1-INTEGRIN; HEMIDESMOSOMES; PROLIFERATION; LOCALIZATION	The epidermis is a stratified squamous epithelium forming the barrier that excludes harmful microbes and retains body fluids. To perform these functions, proliferative basal cells in the innermost layer periodically detach from an underlying basement membrane of extracellular matrix, move outward and eventually die. Once suprabasal, cells stop dividing and enter a differentiation programme to form the barrier(1). The mechanism of stratification is poorly understood. Although studies in vitro have led to the view that stratification occurs through the delamination and subsequent movement of epidermal cells(2-4), most culture conditions favour keratinocytes that lack the polarity and cuboidal morphology of basal keratinocytes in tissue. These features could be important in considering an alternative mechanism, that stratification occurs through asymmetric cell divisions in which the mitotic spindle orients perpendicularly to the basement membrane(5-7). Here we show that basal epidermal cells use their polarity to divide asymmetrically, generating a committed suprabasal cell and a proliferative basal cell. We further demonstrate that integrins and cadherins are essential for the apical localization of atypical protein kinase C, the Par3 - LGN - Inscuteable complex and NuMA - dynactin to align the spindle.	Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016		NIAMS NIH HHS [R01 AR027883-28] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR027883] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Brakebusch C, 2000, EMBO J, V19, P3990, DOI 10.1093/emboj/19.15.3990; Cowan CR, 2004, ANNU REV CELL DEV BI, V20, P427, DOI 10.1146/annurev.cellbio.19.111301.113823; Dowling J, 1996, J CELL BIOL, V134, P559, DOI 10.1083/jcb.134.2.559; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; GAGLIO T, 1995, J CELL BIOL, V131, P693, DOI 10.1083/jcb.131.3.693; Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560; Kaushik R, 2003, MOL BIOL CELL, V14, P3144, DOI 10.1091/mbc.E03-04-0212; Kisurina-Evgenieva O, 2004, J CELL SCI, V117, P6391, DOI 10.1242/jcs.01568; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Lu BW, 2001, NATURE, V409, P522, DOI 10.1038/35054077; Mariotti A, 2001, J CELL BIOL, V155, P447, DOI 10.1083/jcb.200105017; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Parmentier ML, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-14-j0003.2000; PRICE CM, 1986, EXP CELL RES, V166, P95; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Roegiers F, 2004, CURR OPIN CELL BIOL, V16, P195, DOI 10.1016/j.ceb.2004.02.010; Schlaepfer DD, 1996, MOL CELL BIOL, V16, P5623; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Srinivasan DG, 2003, GENE DEV, V17, P1225, DOI 10.1101/gad.1081203; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; vanderNeut R, 1996, NAT GENET, V13, P366, DOI 10.1038/ng0796-366; Vasioukhin V, 2001, NAT CELL BIOL, V3, P1076, DOI 10.1038/ncb1201-1076; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; WATT FM, 1984, J CELL BIOL, V98, P16, DOI 10.1083/jcb.98.1.16; WATT FM, 1982, NATURE, V295, P434, DOI 10.1038/295434a0; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5	31	732	752	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2005	437	7056					275	280		10.1038/nature03922	http://dx.doi.org/10.1038/nature03922			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961YE	16094321	Green Accepted			2022-12-01	WOS:000231696900060
J	Li, WK; Kamtekar, S; Xiong, Y; Sarkis, GJ; Grindley, NDF; Steitz, TA				Li, WK; Kamtekar, S; Xiong, Y; Sarkis, GJ; Grindley, NDF; Steitz, TA			Structure of a synaptic gamma delta resolvase tetramer covalently linked to two cleaved DNAs	SCIENCE			English	Article							SITE-SPECIFIC RECOMBINATION; TN3 RESOLVASE; CRYSTAL-STRUCTURE; COMPLEX; ARCHITECTURE; MUTANTS; MODEL; SUBUNITS; IDENTIFY; INVITRO	The structure of a Synaptic intermediate of the site-specific recombinase gamma delta resolvase covalently linked through Ser(10) to two cleaved duplex DNAs has been determined at 3.4 angstrom resolution. This resolvase, activated for recombination by mutations, forms a tetramer whose structure is substantially changed from that of a presynaptic complex between dimeric resolvase and the cleavage site DNA. Because the two cleaved DNA duplexes that are to be recombined lie on opposite sides of the core tetramer, large movements of both protein and DNA are required to achieve strand exchange. The two dimers linked to the DNAs that are to be recombined are held together by a flat interface. This may allow a 180 degrees rotation of one dimer relative to the other in order to reposition the DNA duplexes for strand exchange.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Dept Chem, New Haven, CT 06520 USA; Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute	Steitz, TA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	eatherton@csb.yale.edu	Steitz, Thomas A./C-6559-2009		NIGMS NIH HHS [GM57510, GM28470] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028470, R37GM028470, R01GM057510] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arnold PH, 1999, EMBO J, V18, P1407, DOI 10.1093/emboj/18.5.1407; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen Y, 2003, ANNU REV BIOPH BIOM, V32, P135, DOI 10.1146/annurev.biophys.32.110601.141732; CHOTHIA C, 1975, NATURE, V256, P705, DOI 10.1038/256705a0; CRAIG NL, 2002, MOBILE DNA, V2; Dhar G, 2004, CELL, V119, P33, DOI 10.1016/j.cell.2004.09.010; Grindley NDF, 2002, MOBILE DNA, P272; Guo F, 1997, NATURE, V389, P40, DOI 10.1038/37925; HATFULL GF, 1986, P NATL ACAD SCI USA, V83, P5429, DOI 10.1073/pnas.83.15.5429; HUGHES RE, 1990, CELL, V63, P1331, DOI 10.1016/0092-8674(90)90428-H; Krebs WG, 2000, NUCLEIC ACIDS RES, V28, P1665, DOI 10.1093/nar/28.8.1665; Leschziner AE, 2003, MOL CELL, V12, P775, DOI 10.1016/S1097-2765(03)00351-4; McIlwraith MJ, 1997, J MOL BIOL, V266, P108, DOI 10.1006/jmbi.1996.0765; Murley LL, 1998, CELL, V95, P553, DOI 10.1016/S0092-8674(00)81622-0; Nollmann M, 2004, MOL CELL, V16, P127, DOI 10.1016/j.molcel.2004.09.027; REED RR, 1981, CELL, V25, P721, DOI 10.1016/0092-8674(81)90179-3; RICE PA, 1994, STRUCTURE, V2, P371, DOI 10.1016/S0969-2126(00)00039-3; RICE PA, 1994, EMBO J, V13, P1514, DOI 10.1002/j.1460-2075.1994.tb06413.x; SANDERSON MR, 1990, CELL, V63, P1323, DOI 10.1016/0092-8674(90)90427-G; Sarkis GJ, 2001, MOL CELL, V8, P623, DOI 10.1016/S1097-2765(01)00334-3; STARK WM, 1989, CELL, V58, P779, DOI 10.1016/0092-8674(89)90111-6; STARK WM, 1994, J MOL BIOL, V239, P25, DOI 10.1006/jmbi.1994.1348; WASSERMAN SA, 1985, SCIENCE, V229, P171, DOI 10.1126/science.2990045; YANG W, 1995, CELL, V82, P193, DOI 10.1016/0092-8674(95)90307-0	24	94	98	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 19	2005	309	5738					1210	1215		10.1126/science.1112064	http://dx.doi.org/10.1126/science.1112064			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	957TE	15994378				2022-12-01	WOS:000231395400037
J	Artsimovitch, I; Vassylyeva, MN; Svetlov, D; Svetlov, V; Perederina, A; Igarashi, N; Matsugaki, N; Wakatsuki, S; Tahirov, TH; Vassylyev, DG				Artsimovitch, I; Vassylyeva, MN; Svetlov, D; Svetlov, V; Perederina, A; Igarashi, N; Matsugaki, N; Wakatsuki, S; Tahirov, TH; Vassylyev, DG			Allosteric modulation of the RNA polymerase catalytic reaction is an essential component of transcription control by rifamycins	CELL			English	Article							RIFAMPICIN-RESISTANCE MUTATIONS; ELECTRON-DENSITY MAPS; COLI RPOB GENE; ESCHERICHIA-COLI; MYCOBACTERIUM-TUBERCULOSIS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; BETA-SUBUNIT; INHIBITION; DNA	Rifamycins, the clinically important antibiotics, target bacterial RNA polymerase (RNAP). A proposed mechanism in which rifamycins sterically block the extension of nascent RNA beyond three nucleotides does not alone explain why certain RNAP mutations confer resistance to some but not other rifamycins. Here we show that unlike rifampicin and rifapentin, and contradictory to the steric model, rifabutin inhibits formation of the first and second phosphodiester bonds. We report 2.5 angstrom resolution structures of rifabutin and rifapentin complexed with the Thermus thermophilus RNAP holoenzyme. The structures reveal functionally important distinct interactions of antibiotics with the initiation sigma factor. Strikingly, both complexes lack the catalytic Mg2+ ion observed in the apo-holoenzyme, whereas an increase in Mg2+ concentration confers resistance to rifamycins. We propose that a rifamycin-induced signal is transmitted over 19 angstrom to the RNAP active site to slow down catalysis. Based on structural predictions, we designed enzyme substitutions that apparently interrupt this allosteric signal.	RIKEN, Harima Inst, Struct & Mol Biol Lab, Sayo, Hyogo 6795148, Japan; Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; RIKEN, Harima Inst, High Throughput Factory, Sayo, Hyogo 6795148, Japan; High Energy Accelerator Res Org, KEK, Inst Mat Struct Sci, Photon Factory,Struct Biol Res Ctr, Tsukuba, Ibaraki 3050801, Japan; Univ Alabama, Sch Med, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; Univ Alabama, Sch Dent, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA	RIKEN; University System of Ohio; Ohio State University; RIKEN; High Energy Accelerator Research Organization (KEK); University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Vassylyev, DG (corresponding author), RIKEN, Harima Inst, Struct & Mol Biol Lab, Spring 8,1-1-1 Kouto,Mikazuki Cho, Sayo, Hyogo 6795148, Japan.	dmitry@uab.edu	Vassylyev, Dmitry/A-9005-2008; Artsimovitch, Irina/L-3467-2019	Tahirov, Tahir/0000-0002-1238-0069; Wakatsuki, Soichi/0000-0001-5896-7968; Igarashi, Noriyuki/0000-0003-2617-3690; Matsugaki, Naohiro/0000-0001-9640-1949; Svetlov, Dmitri/0000-0002-2094-3183	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI064819] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074252, R01GM067153] Funding Source: NIH RePORTER; NIAID NIH HHS [AI64819, R21 AI064819-01] Funding Source: Medline; NIGMS NIH HHS [GM74252, GM67153, R01 GM074252-01, R01 GM067153-02] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTMANN CR, 1994, P NATL ACAD SCI USA, V91, P3784, DOI 10.1073/pnas.91.9.3784; Artsimovitch I, 2004, CELL, V117, P299, DOI 10.1016/S0092-8674(04)00401-5; Artsimovitch I, 2003, J BIOL CHEM, V278, P12344, DOI 10.1074/jbc.M211214200; Bacchi A, 1998, J MED CHEM, V41, P2319, DOI 10.1021/jm970791o; BARH W, 1976, RNA POLYMERASE, P369; BOYD DH, 1974, MOL GEN GENET, V130, P315, DOI 10.1007/BF00333870; BRUFANI M, 1982, MOL PHARMACOL, V21, P394; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Campbell EA, 2005, EMBO J, V24, P674, DOI 10.1038/sj.emboj.7600499; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Floss HG, 2005, CHEM REV, V105, P621, DOI 10.1021/cr030112j; GILL S, 1990, J MOL BIOL, V220, P307; JIN DJ, 1988, J MOL BIOL, V202, P45, DOI 10.1016/0022-2836(88)90517-7; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAWAI M, 1976, MOL GEN GENET, V143, P233, DOI 10.1007/BF00269399; KERRICHSANTO RE, 1974, EUR J BIOCHEM, V43, P521, DOI 10.1111/j.1432-1033.1974.tb03439.x; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Maggi N, 1965, Antimicrob Agents Chemother (Bethesda), V5, P765; Marr MT, 1997, SCIENCE, V276, P1258, DOI 10.1126/science.276.5316.1258; MCCLURE WR, 1978, J BIOL CHEM, V253, P8949; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MUSTAEV A, 1994, P NATL ACAD SCI USA, V91, P12036, DOI 10.1073/pnas.91.25.12036; Nickels BE, 2004, CELL, V118, P281, DOI 10.1016/j.cell.2004.07.021; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OVCHINNIKOV YA, 1983, MOL GEN GENET, V190, P344, DOI 10.1007/BF00330662; ROMERO E, 1973, NATURE-NEW BIOL, V246, P225, DOI 10.1038/newbio246225a0; Sarubbi E, 2004, EUR J BIOCHEM, V271, P3146, DOI 10.1111/j.1432-1033.2004.04244.x; SCHULZ W, 1981, NUCLEIC ACIDS RES, V9, P6889, DOI 10.1093/nar/9.24.6889; SEVERINOV K, 1993, J BIOL CHEM, V268, P14820; SEVERINOV K, 1994, MOL GEN GENET, V244, P120, DOI 10.1007/BF00283512; SIPPEL AE, 1970, EUR J BIOCHEM, V16, P152, DOI 10.1111/j.1432-1033.1970.tb01066.x; STENDER W, 1975, EUR J BIOCHEM, V56, P129, DOI 10.1111/j.1432-1033.1975.tb02215.x; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vassylyeva MN, 2002, ACTA CRYSTALLOGR D, V58, P1497, DOI 10.1107/S0907444902011770; Wang ZM, 1997, NAT STRUCT BIOL, V4, P519, DOI 10.1038/nsb0797-519; Wegrzyn A, 1998, FEBS LETT, V440, P172, DOI 10.1016/S0014-5793(98)01449-5; WEHRLI W, 1969, BIOCHIM BIOPHYS ACTA, V182, P24, DOI 10.1016/0005-2787(69)90516-4; Wichelhaus TA, 2001, J ANTIMICROB CHEMOTH, V47, P153, DOI 10.1093/jac/47.2.153; Williams DL, 1998, ANTIMICROB AGENTS CH, V42, P1853, DOI 10.1128/AAC.42.7.1853; YIN H, 1995, SCIENCE, V270, P1653, DOI 10.1126/science.270.5242.1653; Zenkin N, 2004, P NATL ACAD SCI USA, V101, P4396, DOI 10.1073/pnas.0400886101	44	131	138	3	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 12	2005	122	3					351	363		10.1016/j.cell.2005.07.014	http://dx.doi.org/10.1016/j.cell.2005.07.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	955UZ	16096056	Bronze			2022-12-01	WOS:000231254400008
J	Ehrlich, PR; Kennedy, D				Ehrlich, PR; Kennedy, D			Millennium assessment of human behavior	SCIENCE			English	Editorial Material									Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Inst Int Studies, Stanford, CA 94305 USA	Stanford University; Stanford University	Ehrlich, PR (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	pre@stanford.edu						Brady H.E., 2003, BROOKINGS REV, V21, P16; KAHNEMAN D, 1984, AM PSYCHOL, V39, P341, DOI 10.1037/0003-066X.39.4.341; Kirch PV, 1997, AM ANTHROPOL, V99, P30, DOI 10.1525/aa.1997.99.1.30	3	91	96	3	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2005	309	5734					562	563		10.1126/science.1113028	http://dx.doi.org/10.1126/science.1113028			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	948SE	16040693				2022-12-01	WOS:000230735200031
J	Leutgeb, S; Letugeb, JK; Barnes, CA; Moser, EI; McNaughton, BL; Moser, MB				Leutgeb, S; Letugeb, JK; Barnes, CA; Moser, EI; McNaughton, BL; Moser, MB			Independent codes for spatial and episodic memory in hippocampal neuronal ensembles	SCIENCE			English	Article							FREELY-MOVING RAT; PLACE CELLS; PATH-INTEGRATION; FIRING PATTERNS; UNIT-ACTIVITY; ENVIRONMENT; LOCATION; TASK; CA1; REPRESENTATION	Hippocampal neurons were recorded under conditions in which the recording chamber was varied but its location remained unchanged versus conditions in which an identical chamber was encountered in different places. Two forms of neuronal pattern separation occurred. In the variable cue-constant place condition, the firing rates of active cells varied, often over more than an order of magnitude, whereas the location of firing remained constant. In the variable place-constant cue condition, both location and rates changed, so that population vectors for a given location in the chamber were statistically independent. These independent encoding schemes may enable simultaneous representation of spatial and episodic memory information.	Norwegian Univ Sci & Technol, Med Tech Res Ctr, Ctr Biol Memory, N-7489 Trondheim, Norway; Univ Arizona, Arizona Res Labs, Div Neural Syst Memory & Aging, Tucson, AZ 85724 USA	Norwegian University of Science & Technology (NTNU); University of Arizona	McNaughton, BL (corresponding author), Norwegian Univ Sci & Technol, Med Tech Res Ctr, Ctr Biol Memory, N-7489 Trondheim, Norway.			Leutgeb, Jill/0000-0002-2014-842X				Bostock E, 1991, Hippocampus, V1, P193, DOI 10.1002/hipo.450010207; Bower MR, 2005, J NEUROSCI, V25, P1313, DOI 10.1523/JNEUROSCI.2901-04.2005; Cressant A, 2002, EXP BRAIN RES, V143, P470, DOI 10.1007/s00221-002-1013-0; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Ferbinteanu J, 2003, NEURON, V40, P1227, DOI 10.1016/S0896-6273(03)00752-9; Gothard KM, 1996, J NEUROSCI, V16, P8027; Gothard KM, 1996, J NEUROSCI, V16, P823; Hollup SA, 2001, EUR J NEUROSCI, V13, P1197, DOI 10.1046/j.0953-816x.2001.01487.x; Hollup SA, 2001, J NEUROSCI, V21, P1635, DOI 10.1523/JNEUROSCI.21-05-01635.2001; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; KNIERIM JJ, 1995, J NEUROSCI, V15, P1648, DOI 10.1523/JNEUROSCI.15-03-01648.1995; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; Moita MAP, 2004, J NEUROSCI, V24, P7015, DOI 10.1523/JNEUROSCI.5492-03.2004; MULLER RU, 1987, J NEUROSCI, V7, P1935; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1978, EXP BRAIN RES, V31, P573; Samsonovich A, 1997, J NEUROSCI, V17, P5900; Shapiro ML, 1997, HIPPOCAMPUS, V7, P624, DOI 10.1002/(SICI)1098-1063(1997)7:6<624::AID-HIPO5>3.0.CO;2-E; Skaggs WE, 1998, J NEUROSCI, V18, P8455; Tanila H, 1999, HIPPOCAMPUS, V9, P235, DOI 10.1002/(SICI)1098-1063(1999)9:3<235::AID-HIPO4>3.0.CO;2-3; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605	30	522	529	3	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 22	2005	309	5734					619	623		10.1126/science.1114037	http://dx.doi.org/10.1126/science.1114037			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SE	16040709				2022-12-01	WOS:000230735200051
J	Lindenbach, BD; Evans, MJ; Syder, AJ; Wolk, B; Tellinghuisen, TL; Liu, CC; Maruyama, T; Hynes, RO; Burton, DR; McKeating, JA; Rice, CM				Lindenbach, BD; Evans, MJ; Syder, AJ; Wolk, B; Tellinghuisen, TL; Liu, CC; Maruyama, T; Hynes, RO; Burton, DR; McKeating, JA; Rice, CM			Complete replication of hepatitis C virus in cell culture	SCIENCE			English	Article							EFFICIENT REPLICATION; PROTEASE INHIBITOR; RNA REPLICATION; CD81; MUTATIONS; REPLICON; ENTRY	Many aspects of the hepatitis C virus (HCV) life cycle have not been reproduced in cell culture, which has slowed research progress on this important human pathogen. Here, we describe a full-length HCV genome that replicates and produces virus particles that are infectious in cell culture (HCVcc). Replication of HCVcc was robust, producing nearly 10(5) infectious units per milliliter within 48 hours. Virus particles were filterable and neutralized with a monoclonal antibody against the viral glycoprotein E2. Viral entry was dependent on cellular expression of a putative HCV receptor, CD81. HCVcc replication was inhibited by interferon-alpha and by several HCV-specific antiviral compounds, suggesting that this in vitro system will aid in the search for improved antivirals.	Rockefeller Univ, Ctr Study Hepatitis C, New York, NY 10021 USA; MIT, Ctr Canc Res, Howard Hughes Med Inst, Cambridge, MA 02139 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Rockefeller University; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Scripps Research Institute; Scripps Research Institute	Rice, CM (corresponding author), Rockefeller Univ, Ctr Study Hepatitis C, 1230 York Ave, New York, NY 10021 USA.	ricec@rockefeller.edu		Evans, Matthew/0000-0002-4991-3877; McKeating, Jane/0000-0002-7229-5886	NATIONAL CANCER INSTITUTE [R01CA085883, R01CA057973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI051820, R01AI050798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK070497] Funding Source: NIH RePORTER; Medical Research Council [G0400802] Funding Source: Medline; NCI NIH HHS [CA57973, CA85883, CA10702] Funding Source: Medline; NIAID NIH HHS [AI51820, AI50798, AI40034] Funding Source: Medline; NIDDK NIH HHS [DK70497] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Agapov EV, 2004, J VIROL, V78, P2414, DOI 10.1128/JVI.78.5.2414-2425.2004; [Anonymous], 2000, Wkly Epidemiol Rec, V75, P18; Bartenschlager R, 2004, ADV VIRUS RES, V63, P71, DOI 10.1016/S0065-3527(04)63002-8; Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; BRADLEY D, 1991, J MED VIROL, V34, P206, DOI 10.1002/jmv.1890340315; Bukh J, 2002, P NATL ACAD SCI USA, V99, P14416, DOI 10.1073/pnas.212532699; Carroll SS, 2003, J BIOL CHEM, V278, P11979, DOI 10.1074/jbc.M210914200; Cormier EG, 2004, P NATL ACAD SCI USA, V101, P7270, DOI 10.1073/pnas.0402253101; Date T, 2004, J BIOL CHEM, V279, P22371, DOI 10.1074/jbc.M311120200; Fujita N, 2001, J MED VIROL, V63, P108, DOI 10.1002/1096-9071(20000201)63:2<108::AID-JMV1004>3.0.CO;2-6; Heller T, 2005, P NATL ACAD SCI USA, V102, P2579, DOI 10.1073/pnas.0409666102; HIJIKATA M, 1993, J VIROL, V67, P1953, DOI 10.1128/JVI.67.4.1953-1958.1993; Kato T, 2003, GASTROENTEROLOGY, V125, P1808, DOI 10.1053/j.gastro.2003.09.023; Kummerer BM, 2002, J VIROL, V76, P4773, DOI 10.1128/JVI.76.10.4773-4784.2002; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; Lin K, 2004, ANTIMICROB AGENTS CH, V48, P4784, DOI 10.1128/AAC.48.12.4784-4792.2004; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Pietschmann T, 2002, J VIROL, V76, P4008, DOI 10.1128/JVI.76.8.4008-4021.2002; PIETSCHMANN T, 2004, 11 INT S HCV REL VIR; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; SAKSENA AK, 2002, Patent No. 02008244; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; WAKITA T, 2004, 11 INT S HCV REL VIR; Zhang J, 2004, J VIROL, V78, P1448, DOI 10.1128/JVI.78.3.1448-1455.2004; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	27	1835	2011	4	157	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2005	309	5734					623	626		10.1126/science.1114016	http://dx.doi.org/10.1126/science.1114016			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SE	15947137	Green Submitted			2022-12-01	WOS:000230735200052
J	Ridker, PM; Rifai, N; Cook, NR; Bradwin, G; Buring, JE				Ridker, PM; Rifai, N; Cook, NR; Bradwin, G; Buring, JE			Non-HDL cholesterol, apolipoproteins A-I and B-100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; LOW-DOSE ASPIRIN; PRIMARY PREVENTION; MYOCARDIAL-INFARCTION; ATHEROSCLEROSIS RISK; STATIN THERAPY; PREDICTION; HEALTH; MEN	Context Current guidelines for cardiovascular risk detection are controversial with regard to the clinical utility of different lipid measures, non-high-density lipoprotein cholesterol (non-HDL-C), lipid ratios, apolipoproteins, and C-reactive protein (CRP). Objective To directly compare the clinical utility of total cholesterol, low-density lipoprotein cholesterol (LDL-C), HDL-C, non HDL-C, apolipoproteins A-I and B-100, high-sensitivity CRP, and the ratios of total cholesterol to HDL-C, LDL-C to HDL-C, apolipoprotein B-100 to apolipoprotein A-I, and apolipoprotein B-100 to HDL-C as predictors of future cardiovascular events in women. Design, Setting, and Participants Prospective cohort study of 15 632 initially healthy US women aged 45 years or older (interquartile range, 48-59 years) who were enrolled between November 1992 and July 1995. All participants were followed up over a 10-year period for the occurrence of future cardiovascular events. Main Outcome Measure Hazard ratios (HRs) and 95% confidence intervals (Cls) for first-ever major cardiovascular events (N = 464) according to baseline levels of each biomarker. Results After adjustment for age, smoking status, blood pressure, diabetes, and body mass index, the HRs for future cardiovascular events for those in the extreme quintiles were 1.62 (95% Cl, 1.17-2.25) for LDL-C, 1.75 (95% Cl, 1.30-2.38) for apolipoprotein A-I, 2.08 (95% Cl, 1.45-2.97) for total cholesterol, 2.32 (95% Cl, 1.643.33) for HDL-C, 2.50 (95% Cl, 1.68-3.72) for apolipoprotein B-100, 2.51 (95% Cl, 1.69-3.72) for non-HDL-C, and 2.98 (95% Cl, 1.90-4.67) for high-sensitivity CRP (P<.001 for trend across all quintiles). The HRs for the lipid ratios were 3.01 (95% Cl, 2.01-4.50) for apolipoprotein B-100 to apolipoprotein A-I, 3.18 (95% Cl, 2.12-4.75) for LDL-C to HDL-C, 3.56 (95% Cl, 2.31-5.47) for apolipoprotein 13100 to HDL-C, and 3.81 (95% Cl, 2.47-5.86) for the total cholesterol to HDL-C (P<.001 for trend across all quintiles). The correlation coefficients between high-sensitivity CRP and the lipid parameters ranged from -0.33 to 0.15, and the clinical cut points for CRP of less than 1, 1 to 3, and higher than 3 mg/L provided prognostic information on risk across increasing levels of each lipid measure and lipid ratio. Conclusions Non-HDL-C and the ratio of total cholesterol to HDL-C were as good as or better than apolipoprotein fractions in the prediction of future cardiovascular events. After adjustment for age, blood pressure, smoking, diabetes, and obesity, high-sensitivity CRP added prognostic information beyond that conveyed by all lipid measures.	Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Boston, MA 02215 USA; Brigham & Womens Hosp, Donald W Reynolds Ctr Cardiovasc Res, Boston, MA 02215 USA; Brigham & Womens Hosp, Leducq Ctr Mol & Genet Epidemiol, Boston, MA 02215 USA; Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA; Brigham & Womens Hosp, Div Cardiol, Boston, MA 02215 USA; Harvard Univ, Childrens Hosp, Sch Med, Dept Lab Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Ridker, PM (corresponding author), Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, 900 Commonwealth Ave E, Boston, MA 02215 USA.	pridker@partners.org						Ballantyne CM, 2004, CIRCULATION, V109, P837, DOI 10.1161/01.CIR.0000116763.91992.F1; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; Freeman DJ, 2002, DIABETES, V51, P1596, DOI 10.2337/diabetes.51.5.1596; Gotto AM, 2000, CIRCULATION, V101, P477, DOI 10.1161/01.CIR.101.5.477; GROVER SA, 1995, JAMA-J AM MED ASSOC, V274, P801, DOI 10.1001/jama.274.10.801; HAINLINE A, 1982, MANUAL LAB OPERATION; KINOSIAN B, 1994, ANN INTERN MED, V121, P641, DOI 10.7326/0003-4819-121-9-199411010-00002; Koenig W, 2004, CIRCULATION, V109, P1349, DOI 10.1161/01.CIR.0000120707.98922.E3; Lamarche B, 1996, CIRCULATION, V94, P273, DOI 10.1161/01.CIR.94.3.273; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Miremadi S, 2002, CLIN CHEM, V48, P484; Moss AJ, 1999, CIRCULATION, V99, P2517, DOI 10.1161/01.CIR.99.19.2517; Natarajan S, 2003, AM J PREV MED, V25, P50, DOI 10.1016/S0749-3797(03)00092-8; Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000; Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Ridker PM, 2005, J AM COLL CARDIOL, V45, P1644, DOI 10.1016/j.jacc.2005.02.080; Ridker PM, 2001, NEW ENGL J MED, V344, P1959, DOI 10.1056/NEJM200106283442601; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; RIFAI N, 1986, CLIN CHEM, V32, P957; Roberts WL, 2001, CLIN CHEM, V47, P418; Shai I, 2004, CIRCULATION, V110, P2824, DOI 10.1161/01.CIR.0000146339.57154.9B; Sharrett AR, 2001, CIRCULATION, V104, P1108, DOI 10.1161/hc3501.095214; Sniderman AD, 2003, LANCET, V361, P777, DOI 10.1016/S0140-6736(03)12663-3; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P373, DOI 10.1056/NEJM199108083250601; Talmud PJ, 2002, ARTERIOSCL THROM VAS, V22, P1918, DOI 10.1161/01.ATV.0000035521.22199.C7; van Lennep JER, 2000, ARTERIOSCL THROM VAS, V20, P2408, DOI 10.1161/01.ATV.20.11.2408; Walldius G, 2001, LANCET, V358, P2026, DOI 10.1016/S0140-6736(01)07098-2; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	36	544	561	0	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 20	2005	294	3					326	333		10.1001/jama.294.3.326	http://dx.doi.org/10.1001/jama.294.3.326			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946YL	16030277	Bronze			2022-12-01	WOS:000230609100017
J	SantaCruz, K; Lewis, J; Spires, T; Paulson, J; Kotilinek, L; Ingelsson, M; Guimaraes, A; DeTure, M; Ramsden, M; McGowan, E; Forster, C; Yue, M; Orne, J; Janus, C; Mariash, A; Kuskowski, M; Hyman, B; Hutton, M; Ashe, KH				SantaCruz, K; Lewis, J; Spires, T; Paulson, J; Kotilinek, L; Ingelsson, M; Guimaraes, A; DeTure, M; Ramsden, M; McGowan, E; Forster, C; Yue, M; Orne, J; Janus, C; Mariash, A; Kuskowski, M; Hyman, B; Hutton, M; Ashe, KH			Tau suppression in a neurodegenerative mouse model improves memory function	SCIENCE			English	Article							PAIRED HELICAL FILAMENTS; NEUROFIBRILLARY TANGLES; ALZHEIMERS-DISEASE; PROTEIN-TAU; P301L TAU; A-BETA; ASSOCIATION; EXPRESSION; PATHOLOGY; PLAQUES	Neurofibrillary tangles (NFTs) are the most common intraneuronal inclusion in the brains of patients with neurodegenerative diseases and have been implicated in mediating, neuronal death and cognitive deficits. Here, we found that mice expressing a repressible human tau variant developed progressive age-related NFTs, neuronal loss, and behavioral impairments. After the suppression of transgenic tau, memory function recovered, and neuron numbers stabilized, but to our surprise, NFTs continued to accumulate. Thus, NFTs are not sufficient to cause cognitive decline or neuronal death in this model of tauopathy.	Univ Minnesota, Sch Med, Dept Neurol, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Dept Neurosci, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Grad Program Neurosci, Minneapolis, MN 55455 USA; Mayo Clin Jacksonville, Dept Neurosci, Jacksonville, FL 32224 USA; Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA 02129 USA; Minneapolis VA Hosp, Ctr Geriatr Res Educ & Clin, Minneapolis, MN 55417 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic; Harvard University; Massachusetts General Hospital; Geriatric Research Education & Clinical Center	Ashe, KH (corresponding author), Univ Minnesota, Sch Med, Dept Neurol, Minneapolis, MN 55455 USA.	hsiao005@umn.edu	Spires-Jones, Tara/AAR-7697-2020	Spires-Jones, Tara/0000-0003-2530-0598	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033249, R01NS082672, R01NS046355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026252, R01AG026249, R01AG008487, P50AG005134, P01AG015453] Funding Source: NIH RePORTER; NIA NIH HHS [P01-AG15453, R01-AG26249, P01 AG015453, T31-AG00277, R01 AG026252, P50 AG005134, R01-AG08487, R01 AG008487, R01 AG026249] Funding Source: Medline; NINDS NIH HHS [R01 NS033249, R01 NS046355, R01 NS082672, R01-NS46355] Funding Source: Medline; PHS HHS [R01-026252] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; BANCHER C, 1993, NEUROSCI LETT, V162, P179, DOI 10.1016/0304-3940(93)90590-H; Bennett DA, 2004, ARCH NEUROL-CHICAGO, V61, P378, DOI 10.1001/archneur.61.3.378; Chen GQ, 2000, NATURE, V408, P975, DOI 10.1038/35050103; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Gotz J, 2001, J BIOL CHEM, V276, P529, DOI 10.1074/jbc.M006531200; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Guillozet AL, 2003, ARCH NEUROL-CHICAGO, V60, P729, DOI 10.1001/archneur.60.5.729; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Lewis J M, UNPUB; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Oddo S, 2004, NEURON, V43, P321, DOI 10.1016/j.neuron.2004.07.003; Spillantini MG, 1998, TRENDS NEUROSCI, V21, P428, DOI 10.1016/S0166-2236(98)01337-X; Tatebayashi Y, 2002, P NATL ACAD SCI USA, V99, P13896, DOI 10.1073/pnas.202205599; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002	26	1420	1498	2	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2005	309	5733					476	481		10.1126/science.1113694	http://dx.doi.org/10.1126/science.1113694			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946LY	16020737	Green Accepted			2022-12-01	WOS:000230574900050
J	Chen, DL; Kon, N; Li, MY; Zhang, WZ; Qin, J; Gu, W				Chen, DL; Kon, N; Li, MY; Zhang, WZ; Qin, J; Gu, W			ARF-BP1/mule is a critical mediator of the ARF tumor suppressor	CELL			English	Article							UBIQUITIN-PROTEIN LIGASE; RING-FINGER DOMAIN; CELL-CYCLE ARREST; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; NUCLEAR EXPORT; P53 PATHWAY; G(2) ARREST; DNA-DAMAGE; IN-VIVO	Although the importance of the ARF tumor suppressor in p53 regulation is well established, numerous studies indicate that ARF also suppresses cell growth in a p53/Mdm2-independent manner. To understand the mechanism of ARF-mediated tumor suppression we identified a ubiquitin ligase, ARF-BP1, as a key factor associated with ARF in vivo. ARF-BP1 harbors a signature HECT motif, and its ubiquitin ligase activity is inhibited by ARK Notably, inactivation of ARFBP1, but not Mdm2, suppresses the growth of p53 null cells in a manner reminiscent of ARF induction. Surprisingly, in p53 wild-type cells, ARF-BP1 directly binds and ubiquitinates p53, and inactivation of endogenous ARF-BP1 is crucial for ARF-mediated p53 stabilization. Thus, our study modifies the current view of ARF-mediated p53 activation and reveals that ARF-BP1 is a critical mediator of both the p53-independent and p53-dependent tumor suppressor functions of ARE As such, ARF-BP1 may serve as a potential target for therapeutic intervention in tumors regardless of p53 status.	Columbia Univ Coll Phys & Surg, Inst Canc Genet, Dept Pathol, New York, NY 10032 USA; Baylor Coll Med, Dept Biochem & Cell Biol, Houston, TX 77030 USA	Columbia University; Baylor College of Medicine	Gu, W (corresponding author), Columbia Univ Coll Phys & Surg, Inst Canc Genet, Dept Pathol, 1150 St Nicholas Ave, New York, NY 10032 USA.	wg8@columbia.edu						Aravind L, 2001, TRENDS BIOCHEM SCI, V26, P273, DOI 10.1016/S0968-0004(01)01787-X; Bertwistle D, 2004, MOL CELL BIOL, V24, P985, DOI 10.1128/MCB.24.3.985-996.2004; Boyd SD, 2000, NAT CELL BIOL, V2, P563, DOI 10.1038/35023500; Brady SN, 2004, MOL CELL BIOL, V24, P9327, DOI 10.1128/MCB.24.21.9327-9338.2004; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Buchberger A, 2002, TRENDS CELL BIOL, V12, P216, DOI 10.1016/S0962-8924(02)02269-9; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; CUMMINS JM, 2004, NATURE, V428, P486, DOI [DOI 10.1038/NATURE02501, 10.1038/nature02501]; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Eymin B, 2003, ONCOGENE, V22, P1822, DOI 10.1038/sj.onc.1206303; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Freedman DA, 1999, CELL MOL LIFE SCI, V55, P96, DOI 10.1007/s000180050273; Fuchs SY, 1998, ONCOGENE, V17, P2543, DOI 10.1038/sj.onc.1202200; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; GU J, 1994, MOL BRAIN RES, V24, P77, DOI 10.1016/0169-328X(94)90120-1; Gu W, 1999, MOL CELL, V3, P97, DOI 10.1016/S1097-2765(00)80178-1; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hollstein M, 1999, MUTAT RES-FUND MOL M, V431, P199, DOI 10.1016/S0027-5107(99)00162-1; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kelly-Spratt KS, 2004, PLOS BIOL, V2, P1138, DOI 10.1371/journal.pbio.0020242; Korgaonkar C, 2005, MOL CELL BIOL, V25, P1258, DOI 10.1128/MCB.25.4.1258-1271.2005; Korgaonkar C, 2002, MOL CELL BIOL, V22, P196, DOI 10.1128/MCB.22.1.196-206.2002; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kuo ML, 2003, CANCER RES, V63, P1046; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Lin AW, 2001, P NATL ACAD SCI USA, V98, P5025, DOI 10.1073/pnas.091100298; Llanos S, 2001, NAT CELL BIOL, V3, P445, DOI 10.1038/35074506; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; LUNA RMD, 1995, NATURE, V378, P203; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; McKeller RN, 2002, P NATL ACAD SCI USA, V99, P3848, DOI 10.1073/pnas.052484199; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Midgley CA, 2000, ONCOGENE, V19, P2312, DOI 10.1038/sj.onc.1203593; Modestou M, 2001, CANCER RES, V61, P3145; Munger K, 2002, VIRUS RES, V89, P213, DOI 10.1016/S0168-1702(02)00190-9; Nikolaev AY, 2003, CELL, V112, P29, DOI 10.1016/S0092-8674(02)01255-2; Normand G, 2005, J BIOL CHEM, V280, P7118, DOI 10.1074/jbc.M412330200; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Prives C, 1999, J PATHOL, V187, P112; QUELLE DE, 1995, CELL, V83, P993; Rocha S, 2003, MOL CELL, V12, P15, DOI 10.1016/S1097-2765(03)00223-5; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Sharpless NE, 2004, J CLIN INVEST, V113, P160, DOI 10.1172/JCI200420761; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Shirangi TR, 2002, FASEB J, V16, P420, DOI 10.1096/fj.01-0617fje; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Weber JD, 2000, GENE DEV, V14, P2358, DOI 10.1101/gad.827300; Xirodimas D, 2001, ONCOGENE, V20, P4972, DOI 10.1038/sj.onc.1204656; Xirodimas DP, 2001, EXP CELL RES, V270, P66, DOI 10.1006/excr.2001.5314; Yarbrough WG, 2002, CANCER RES, V62, P1171; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4	69	429	455	3	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 1	2005	121	7					1071	1083		10.1016/j.cell.2005.03.037	http://dx.doi.org/10.1016/j.cell.2005.03.037			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	944RZ	15989956	Bronze			2022-12-01	WOS:000230448000013
J	Pufall, MA; Lee, GM; Nelson, ML; Kang, HS; Velyvis, A; Kay, LE; McIntosh, LP; Graves, BJ				Pufall, MA; Lee, GM; Nelson, ML; Kang, HS; Velyvis, A; Kay, LE; McIntosh, LP; Graves, BJ			Variable control of Ets-1 DNA binding by multiple phosphates in an unstructured region	SCIENCE			English	Article							TRANSCRIPTION FACTOR NFAT1; ALLOSTERIC REGULATION; NMR-SPECTROSCOPY; PROTEIN; PHOSPHORYLATION; DOMAIN; AUTOINHIBITION; DYNAMICS; SITES; TRANSACTIVATION	Cell signaling that culminates in posttranslational modifications directs protein activity. Here we report how multiple Ca2+-dependent phosphorylation sites within the transcription activator Ets-1 act additively to produce graded DNA binding affinity. Nuclear magnetic resonance spectroscopic analyses show that phosphorylation shifts Ets-1 from a dynamic conformation poised to bind DNA to a well-folded inhibited state. These phosphates lie in an unstructured flexible region that functions as the allosteric effector of autoinhibition. Variable phosphorylation thus serves as a "rheostat" for cell signaling to fine-tune transcription at the level of DNA binding.	Univ Utah, Dept Oncol Sci, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Michael Smith Lab, Vancouver, BC V6T 1Z3, Canada; Univ Toronto, Dept Med Genet, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Chem, Toronto, ON M5S 1A8, Canada	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of British Columbia; University of British Columbia; University of British Columbia; University of Toronto; University of Toronto; University of Toronto	Graves, BJ (corresponding author), Univ Utah, Dept Oncol Sci, Huntsman Canc Inst, Salt Lake City, UT 84112 USA.	Barbara.Graves@hci.utah.edu		Pufall, Miles/0000-0002-7022-6916; Kang, Hyun-Seo/0000-0003-4029-5096	NATIONAL CANCER INSTITUTE [T32CA093247, P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008537, R01GM038663] Funding Source: NIH RePORTER; NCI NIH HHS [P01-CA24014, T32-CA93247] Funding Source: Medline; NIGMS NIH HHS [R01 GM38663, R01 GM038663, GM08537] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baillat D, 2002, J BIOL CHEM, V277, P29386, DOI 10.1074/jbc.M200088200; Cowley DO, 2000, GENE DEV, V14, P366; Feher VA, 1999, NATURE, V400, P289, DOI 10.1038/22357; Finerty PJ, 2005, BIOCHEMISTRY-US, V44, P694, DOI 10.1021/bi048641k; Garvie CW, 2002, J BIOL CHEM, V277, P45529, DOI 10.1074/jbc.M206327200; Garvie CW, 2001, MOL CELL, V8, P1267, DOI 10.1016/S1097-2765(01)00410-5; Goetz TL, 2000, MOL CELL BIOL, V20, P81, DOI 10.1128/MCB.20.1.81-90.2000; Hudson BP, 2000, J MOL BIOL, V304, P355, DOI 10.1006/jmbi.2000.4207; Jonsen MD, 1996, MOL CELL BIOL, V16, P2065; Kalodimos CG, 2004, SCIENCE, V305, P386, DOI 10.1126/science.1097064; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Lee GM, 2005, J BIOL CHEM, V280, P7088, DOI 10.1074/jbc.M410722200; Liu H, 2002, MOL BIOL CELL, V13, P4497, DOI 10.1091/mbc.E02-03-0149; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; PETERSEN JM, 1995, SCIENCE, V269, P1866, DOI 10.1126/science.7569926; RABAULT B, 1994, J BIOL CHEM, V269, P28143; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Salazar C, 2003, J MOL BIOL, V327, P31, DOI 10.1016/S0022-2836(03)00085-8; Skalicky JJ, 1996, PROTEIN SCI, V5, P296; Slupsky CM, 1998, P NATL ACAD SCI USA, V95, P12129, DOI 10.1073/pnas.95.21.12129; SUN WW, 1995, J VIROL, V69, P4941, DOI 10.1128/JVI.69.8.4941-4949.1995; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; Wang H, 2002, J BIOL CHEM, V277, P2225, DOI 10.1074/jbc.M109430200; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110	30	195	197	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2005	309	5731					142	145		10.1126/science.1111915	http://dx.doi.org/10.1126/science.1111915			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	941KD	15994560				2022-12-01	WOS:000230212800079
J	Dennis, C				Dennis, C			Brown clouds cast a dark shadow	NATURE			English	News Item								In recent years China has seen increasing summer floods in the south and drought in the north. The likely culprit is air pollution, which has escalated withChina's rapid industrial growth. A blanket of aerosol particles over parts ofAsia is thought to be key factor in this change of climate. India is also a major contributor to clouds of black and organic carbon, sulfates and nitrates.											0	0	0	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 30	2005	435	7046					1154	1154						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940JJ	16021695				2022-12-01	WOS:000230140500011
J	Schartl, M; Hornung, U; Hissmann, K; Schauer, J; Fricke, H				Schartl, M; Hornung, U; Hissmann, K; Schauer, J; Fricke, H			Relatedness among east African coelacanths	NATURE			English	Editorial Material							LATIMERIA-CHALUMNAE; HOME		Univ Wurzburg, Biozentrum, D-97074 Wurzburg, Germany; Max Planck Inst Seewiesen, Arbeitsgrp Fricke, D-82327 Tutzing, Germany	University of Wurzburg; Max Planck Society	Schartl, M (corresponding author), Univ Wurzburg, Biozentrum, D-97074 Wurzburg, Germany.	hfricke@jago-sub.de		Schartl, Manfred/0000-0001-9882-5948				Cane MA, 2001, NATURE, V411, P157, DOI 10.1038/35075500; de Ruijter WPM, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013714; DURVILLE C, 2005, COELACANTH FISH CAUG; Fricke H, 2000, MAR BIOL, V136, P379, DOI 10.1007/s002270050697; FRICKE H, 1994, MAR BIOL, V120, P171, DOI 10.1007/BF00349676; Hissmann K, 2000, MAR BIOL, V136, P943, DOI 10.1007/s002270000294; Holder MT, 1999, P NATL ACAD SCI USA, V96, P12616, DOI 10.1073/pnas.96.22.12616; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; SCHLIEWEN U, 1993, NATURE, V363, P405, DOI 10.1038/363405a0	9	13	14	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2005	435	7044					901	901		10.1038/435901a	http://dx.doi.org/10.1038/435901a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935RN	15959506	Bronze			2022-12-01	WOS:000229799700034
